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INTRODUCTION. Acute kidney injury is characterized by sustained rise
in serum creatinine and reduction in urine output. It may also be ac-
companied by retention of nitrogen products and electrolyte distur-
bances. The incidence of AKI varies between 36 and 67% among
critically ill patients with a mortality rate of 50 to 70%.
OBJECTIVES. We determined the incidence and outcome of acute
kidney injury in critical care patients
METHODS. A total of 177 patients, 18 years and older were studied.
Data were collected on admission and daily during hospitalization until
discharge or death. AKI was defined as:1-2 1) absolute increase in
serum creatinine ≥0.3 mg/dL or ≥1.5 times the baseline level, or 2) re-
quirement for renal replacement therapy, or 3) oliguria defined as urine
output <400 ml in 24 hours
RESULTS. AKI was observed in 34.3% of our ICU admission, among of
whom 4.7% developed AKI during their ICU stay. The mean duration
of onset of AKI was 1 (25th to 75th percentile 1-2) days. The overall
ICU 30 days mortality was 42.4%, however the 30 days mortality in
patients with AKI was 85.5%. Renal replacement therapy was only
possible in 36.6% patients. Inotropic support was administered in
59.1% patients with AKI. Factors mitigating against dialysis included
proctated hypotension in 63.6%, lack of fund in 18.1%, delayed
screening for HIV and Hepatitis B in 18.3%.
CONCLUSION. Acute kidney injury is a common problem in the critic-
ally ill patient and is associated with a high mortality rate at our
institution.
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INTRODUCTION. Acute kidney failure (AKF) is identified in 30-40% of
cases in post-operative patients. There is limited literature on the im-
portance and the correlation between peripherical vascular surgeries
and the development of AKF.
OBJECTIVES. Analysis of the connection between factors related to
AKF or acute-on-chronic-kidney failure (AOCKF) in the ICU during the
first 7 days after peripherical vascular surgeries, for example: arterial
bypasses, amputations, angioplasties and embolectomies.
METHODS. The definition of AKF is defined by the AKIN: abrupt in-
crease in serum creatinine ≥ 0.3 mg/dL or 50% from the baseline. This
study is prospective, observational and non-randomized. Patients on
previous dialysis were excluded. Continuous variables were summa-
rized as medians and ranges, and categorical variables as percentages.
RESULTS. A database of 65 patients was evaluated. The data was ac-
quired between April 2018 and March 2019. The median age was 70
(range 22-88 y); 73% were male. 25 patients (38%) had AKF.
The average age in both groups is similar, as well the prevalence of
comorbidities (hypertension and DM), distribution of sexes and mor-
tality. 46% of the patients with chronic-kidney disease developed an
AOCKF (28% of the AKF group). The frequencies of the following
values are bigger in AKF group: Re-surgery, emergency surgery, use
of vancomycin, gentamicin or amikacin.
CPK values were different in the two groups (4332 AKF; 2937 no
AKF), but our sample was inconclusive to demonstrate a real correl-
ation with AKF. When CPK in the first 24h was divided in three cat-
egories (<10.000; 10000-20000 and >20000), it was observed in a
Kaplan Meier analyses a correlation between these categories and
post-operative hemodialysis.
CONCLUSION. Despite our small sample, CPK when analyzed as a
categorical variable, showed a statistical significance in patients sub-
mitted to hemodialysis. Despite differences in both groups, as CPK
average as well as further factors related to a more serious condition;
like patient urgency surgery, re-surgery and the use of antibiotics;
our analysis was inconclusive to stablish those factors as predictiveis distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
changes were made.
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insufficient for stronger evidences, and it is a single center study. We
suggest that a multi-center study can resolve these problems.Fig. 1 (abstract 000742). See text for description
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INTRODUCTION. The withdrawal of respiratory support is key in
the evolution of the patient, the identification of the optimal mo-
ment to advance in the weaning is fundamental, avoiding the
problems associated with both an early and delayed withdrawal
with increased morbidity and mortality.
The decision based solely on the clinic has proved unreliable. Wean-
ing predictors offer support for decision making. Among the classic
predictors is the combination of two of them, MIP / P0.1, which as-
sesses the capacity of the respiratory musculature and the intensity
of the stimulus of the respiratory center.
OBJECTIVES. To assess the predictive capacity of MIP / P0.1 with re-
spect to the classic predictors in patients undergoing prolonged
mechanical ventilation.
METHODS. Prospective study including 17 patients submitted to MV
due to different causes (TBI, CCV, urgent surgery, respiratory failure).
Once criteria for advancing weaning are met, an SBT is made in PSV
5 - 8 cmsH2O over 5 cmsH2O of PEEP, and the following determina-
tions are made: MIP, P0.1, MIP / P0,1, RSBI, FR, Vt. Epidemiologicalvariables are collected, cause of IOT, VM time, weaning failure,
mortality.
RESULTS. The average age was 56.12 years +/- 13.95. 70.9% were
male. Reason for admission: TBI (29.4%), CCV (29.4%), Urgent Surgery
(23.5%). The average duration of MV was 12.76 days +/- 8.82. 64.7%
presented weaning failure.
We observe a significant relationship between MIP / P0.1 and wean-
ing failure (Test Chi2 p 0.011). ANOVA was performed, we found a re-
lationship between the variables (F 8.08, p 0.012). We performed a
COR curve presenting AUC 0.92 (p 0.005, 95% CI 0.78-1). We found
the best cut-off at 0.095 (S 90%, E 83%). If we analyze subgroups
(Group 1: MV <10 days, Group 2: MV> 10 days) we did not observe a
significant relationship between MIP / P0.1 and failure of weaning
CONCLUSION. - In our sample, MIP / P0.1 is a good predictor of
weaning failure in patients undergoing short-term mechanical venti-
lation, if we compare it with the rest of the classic parameters.
- However, in patients undergoing prolonged mechanical ventilation,
their prognostic capacity is limited
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INTRODUCTION. EARLY PREDICTORS OF THE DURATION OF MECHAN-
ICAL VENTILATION IN THE CRITICAL PATIENT:OXYGENATION AND AGE
INDEX
OBJECTIVES. To determine the early predictors of MV duration, with
emphasis on age and the inspired oxygen/inspired fraction of oxygen
(PaO2/FiO2), in critically ill patients.
METHODS. Descriptive, retrospective study. Sample consisting of 143
patients, ventilated for more than 24 hours. Demographic, clinical
and risk factors were studied in relation to time in MV and mortality.
RESULTS. The mean number of days in VM (8,5 +/- 7). (53,4%)remained
for less than 5 days in MV and the duration of ventilatory support was
shorter in young patients (18-50 years). Patients older than 70 years,
with APACHE II>15pts, were associated with higher mortality. There
was a linear relationship between age and oxygenation index. PaO2/
FiO2 between 101-200, was associated with longer duration in MV and
with values of PaO2/FiO2<100, mortality increased. The positive water
balance(BH+) was linked to PaO2/FiO2<100. Shock, FiO2>60%,
Peep>10cmH20,bronchoaspiration, pneumonia, renal failure, BH+ and
use of benzodiazepines were associated with mortality; while the dur-
ation of MV was associated with FiO2>60%, shock,bronchoaspiration
and hypoalbuminemia. Tracheostomies were performed in (6,9%)pa-
tients and general mortality (39,1%)
CONCLUSION. PaO2/FiO2 and age can be considered as determining
factors in the duration of MV and mortality in critically ill patients.
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INTRODUCTION. Trial evidence suggests that early application of
APRV is associated with better oxygenation and shorter length of
stay in ICU (1). Animal studies suggest early APRV may improve oxy-
genation, minimise histological lung damage and even prevent ARDS
development entirely (2, 3). However, the use of APRV is inconsistent
and not widespread (4).
OBJECTIVES. To review the use of APRV within our ICU and describe
the course of ARDS and clinical outcomes in those patients.
METHODS. A protocol for intital settings, weaning and trouble-
shooting APRV is in place in our 16 bed mixed medical and sur-
gical ICU. Data were collected between 09/2018-03/2019 on
patients receiving APRV for management of ARDS (using the
Berlin definition) (5). Nursing charts were reviewed to retrieve
PaO2 & FiO2 values. PaO2:FiO2 ratios (PF) were calculated for ad-
mission, initiation of APRV, and 6 & 24 hours post initiation. Elec-
tronic patient records were reviewed to find mortality rates at 28
and 90 days.
RESULTS. 9 patients were initiated on APRV for management of
ARDS. On admission to ICU, 5 were classified severe, 2 moderate.
Mean time between the point where the patient first met the ARDS
criteria on ICU (T0) and initiation of APRV was 12 hours (range: 0-47
hours). PF deteriorated in 5 patients from T0 to APRV initiation by
12-50%; by which point 7 patients were severe, and 2 moderate
ARDS. 3 of the 4 patients who died were noted to have the most sig-
nificant drop in PF (31%, 38% and 50%). In 2 cases APRV was used
within 2 hours of T0 and PF was not observed to deteriorate. In the
remaining 2 cases, PF improved between T0 and APRV initiation by
13% & 28%. 4 patients were discussed with ECMO, and 2 transferred.
1 was lost to follow up as they were transferred within 4 hours of
APRV initiation. PF improved on APRV by 16-342% at 6 hours (with
one patient’s PF ratio dropping by 41%), 4-364% at 24 hours, and 49-
321% at point of APRV termination. 7 of the remaining 8 patients stillmet the criteria for ARDS on APRV cessation (4 = Moderate, 3 = Mild).
Mortality was 44% at 28 days (unchanged at 90 days).
CONCLUSION. In this small study, most patients were admitted to
ICU with already well-established ARDS, suggesting that it may not
have been possible for them to achieve the benefits of early APRV. In
addition, further delay before initiation of APRV was associated with
deterioration in PF in 5 out of 9 patients. The most significant deteri-
oration in PF was seen in 3 of the 4 patients who died. There was
variation in the apparent indication to start APRV (with no obvious
PF threshold) implying inconsistency with the practice of APRV. In
addition many patients with ARDS will have undergone prone posi-
tioning instead of APRV, as there is little evidence to guide which pa-
tients will respond optimally to each technique. Further work is
needed to clarify optimal timing of APRV use and the role of earlier
ICU admission, in order to reduce ARDS progression, and to guide
where APRV may be more appropriately used than prone
positioning.
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INTRODUCTION. The increasing availability of modern emergency
respirators, allows for differentiated ventilation strategies, such as In-
verse ratio ventilation (IRV) also in the pre-hospital emergency care
setting. While there are detailed guidelines for preclinical airway
management , recommendations for preclinical ventilation are just
based on guidelines for in-hospital intensive care. The present survey
was designed to determine the use of IRV in the prehospital setting
by German emergency physicians (GEP).
METHODS. An anonymous web-based questionnaire encompassing
7 questions was sent to GEP from September to December of 2018.
They were asked to specify their medical specialty; their education
level, their experience in intensive and prehospital emergency care,
their average number of assignments per month, their used ventila-
tor model and ventilation mode.
RESULTS. 60 % of the questionnaires were completed (157/261). 95
% of participants had preclinical access to respirators with the ability
to perform IRV. 9.9% of respondents (male 11, female 4) stated that
they were already performing preclinical IRV (I:E 1.5=1; I:E 2:1 = 1).
The proportion of consultants in the IRV group was higher than in
the non-IRV group. The proportion of experience in intensive care
medicine and the number of assignments per month differed signifi-
cantly between both groups. The corresponding group characteristics
are shown in tables 1 and 2.
CONCLUSION. Approximately 10% of the surveyed GEP employ IRV
in the pre-hospital setting. Compared to their colleagues not using
Page 4 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55IRV, IRV using GEP had a longer experience in intensive care and a
higher rate of monthly missions. These results suggest, that , training
in differentiated ventilation strategies such as IRV should be inte-
grated into the training of GEP.
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11 (73,3 %) 2 (13,3 %) 1 (6,7
%)
0 (0 %) 1 (6,7%) -
Non-
IRV[n(%)]
102 (70,8%) 19 (13,2%) 10 (6,9
%)
6 (4,2 %) 2 (1,4 %) 5 (3,5
%)






Experience in intensive care (y) 3,03 # 1,96
Experience in prehospital emergency medicine
(y)
3,53 3,26
Number of monthly missions (n/mon) 37,6 # 26,5
# p < 0.05 vs. non-IRV001348
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INTRODUCTION. Septic shock is a severe pathology in ICUs, with high cost
for the society. There is a recent interest about vitamins therapy in septic
shock patients in our unity as much as in the critical medical literature.
OBJECTIVES. Describes epidemiological, clinical data and treatments
dispended (vitamins and hemodynamic) of all patients admitted with
septic shock in our ICU of a third level hospital.
METHODS. Retrospectively, all patients diagnosed with septic shock ac-
cording to SOFA criteria between January 2018 and November 2018 were
analyzed. Epidemiological characteristics, gravity scores, admission causes,
treatment dispended (vitamins and steroids), complications (acute renal fail-
ure, acute liver failure, acute myocardial failure, ARDS and multiorgan fail-
ure) and outcome like ICU stay and mortality were collected. We also
analyzed hemodynamic data (type of monitoring, need of noradrenalin,
use of second vasopressor and use of ionotropic support).
RESULTS. A total of 39 patients were analyzed (63.2% ± 2.59% males), the
average age was 63.23±2.59 years, the SAPPS II gravity score at admission
was 47 ± 2.81, SOFA was 9 ± 1.58 and PCR was 34 ± 14.3. Lactate peak of
the first 72 hours was 52.53 ±6.14.
The ICU admission most frequent causes were septic shock (65.8%),
post operatory (15.8%) and low conscience level (5.6%).55.3% of the patients receive surgical treatment, 44.75% emergently.
65.8% had acute renal failure (ARF), 39.5% receive extra renal depura-
tion therapy (ERDT), 15.8% develop an acute liver failure (ALF), 13.2%
an ARDS, 26.7% an acute myocardial failure (AMF) and 36.8 % a mul-
tiorgan failure (MOF). Use of noradrenalin in 94.7% and in 44.7% of
theses case in higher concentration than 0.5 5 μg/kg/min, use of a
second vasopressor in 7.9%, dobubutamin was receive in 39.5% and
second ionotropic agent in 5.3%.
55.3% of the patients receive thiamine (Vitamin B1), the same per-
centage steroids and 21.1% vitamin C. The use of vitamin B1 is statis-
tically related with use of steroids (p=0.001) and vitamin C (p=0.018),
develop ARDS (p=0.003) and need to ERDT (p=0.037). The use of vita-
min C is statistically related with use of steroids (p=0.039) and vita-
min B1 (p=0.032), develop ALF (p=0.012), need a second vasopressor
(p=0.006) and need to ERDT (p=0.039).
Mortality at hospital discharge was 36.1% in which 46.13% was for
multiorgan failure and the same percentage for limitation of effort.
CONCLUSION. Vitamin B1 is use more frequently than vitamin C,
more than half of the patients with septic shock receive it. Both of
them are use in a refractory septic shock with the same indication
that we use steroids. Vitamin C is dispended in a few desperate cases
with data of high severity like acute liver failure or use of second
vasopressor. It is, in our unit a compassionate treatment.
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INTRODUCTION. Blood gas analysis is probably the most common
diagnostic tool used in intensive care. A proper understanding and
use of arterial and pulmonary/central venous blood gas analysis
makes it possible to correctly interpret most of the respiratory, circu-
latory and metabolic derangements which may occur in septic shock
patients1.
OBJECTIVES. To assess the effectiveness of arterial and venous
blood analysis in predicting mortality of patients with septic
shock.
METHODS. Prolective cohort study conducted in two general in-
tensive care units, between June 2018–April 2019. Adults >18yo
with septic shock diagnosis based on SEPSIS-3 criteria were in-
cluded. Time 0 when diagnosis was made. All patients monitored
from admission to hospital discharge. Simultaneously, blood gas
analysis were carried out to obtain: PaO2/FiO2, ScvO2, Qs/Qt, P(v-
a)CO2, C(a-v)O2, P(v-a)CO2/C(a-v)O2, O2ER. Primary outcome was
usefulness of arterial and pulmonary/central venous blood ana-
lysis as mortality predictor. Standard deviation and medians with
interquartile ranges for quantitative variables. Frequencies and
percentages for qualitative variables. Student´s t-distribution or
Mann-Whitney U-test for groups comparison depending on distri-
bution. Binary logistic regression to control for confoundings.
Pearson test for correlation analysis between two quantitative
variables. Multiple linear regression analysis to generate an equa-
tion with the significant variables of the model.
RESULTS. 66 patients with mean age of 66.5 ± 17 years, 35 (53%)
men, 16 (24%) diabetics and 27 (40%) with hypertension. SAPS II
41.5 (12 – 97) and SOFA 8.4 ± 3.2. 13 (19.7%) patients died. Pa-
tients who died had CKD (30 vs 8; p = 0.05), higher BMI (29.14 ±
10.53 vs 24.92 ± 5.6; p = 0.05) and lower PaO2/FiO2 (139.51 ±
48.48 vs 218.48 ± 98.07; p = 0.04). Logistic regression analysis
showed that PaO2/FiO2 in time 0 was associated with mortality
Page 5 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55[OR 0.95 (IC95% 0.90 to 0.99); p = 0.04]. There is correlation of
PaO2FiO2 with SvcO2 (r 0.3; p = 0.013) and Qs/Qt (r 0.6; p <
0.001), by these results we generate the following equation with
a multiple linear regression analysis: PaO2/FiO2 = 84,748 + 3.136
(SvcO2) - 4.411 (Qs/Qt) [r2 0.45;p< 0.001].
CONCLUSION. We found association of PaO2/FiO2 with mortality in
patients with septic shock. There is correlation of PaO2/FiO2 with
SvcO2 and Qs/Qt, so we believe that this should be adjusted to these
variables. To increase statistical power, a larger sample size is
required.REFERENCE
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Renal function deterioration, n(%) 89 (35.9) 84 (33.8) 0.706
- Creatinine >0.3mg/dL increase 41 (16.5) 45 (18.2) 0.722
- 1.5fold increase in creatinine 23 (9.3) 24 (9.7) 1.000
- Urine output < 0.5ml/kg/hr for
>6hr
69 (27.8) 56 (22.6) 0.215
ICU death within 3 days 4 (1.6) 2 (0.8) 0.686
RRT during ICU stay, n(%) 24 (9.7) 20 (8.1) 0.636
ICU length of stay, days(IQR) 3.4 (1.9-6.7) 3.0 (1.9-6.0) 0.236
Hospital length of stay, days(IQR) 26 (16-52) 30 (17-53) 0.434
Chronic HD after discharge, n(%) 6 (2.4) 2 (0.8) 0.285
Serum creatinine at discharge 0.75 (0.59-1.09) 0.74 (0.58-1.02) 0.148
ICU mortality 10 (4.0) 7 (2.8) 0.623
Hospital mortality 34 (13.8) 23 (9.3) 0.159AKI - Critical care nephrology 1
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INTRODUCTION. In recent years, several papers reported that renal
dysfunction caused by contrast media is less frequent than previ-
ously reported in critically ill patients(1). However, it remains unclear
whether the administration of contrast media for critically ill is harm-
ful, as previous studies focused on specific subpopulations in the
ICU(2) or were conducted in a single center(3-5).
OBJECTIVES. To assess the risk of contrast media administration
by examining the renal function and prognosis of patients with
or without receiving contrast media in critically ill patients.
METHODS. This was a post-hoc analysis of the Japan AKI Data-
base study, which was a prospective cohort study on acute kid-
ney injury (AKI) conducted in the 13 mixed ICUs in Japan from
July through December in 2016(6). Adult patients who stayed for
>24 hours in the ICU were consecutively registered. Patients were
divided into Group C, who received contrast media within 48
hours before the ICU admission and Group NC, who did not re-
ceive contrast media. The primary outcome was deterioration of
renal function (DRF) defined as elevation of serum creatinine
level (>0.3mg/dL or 1.5-fold from baseline) or decreased urine
output (<0.5ml/kg/hr for 6 hours). ICU mortality and hospital mor-
tality were also assessed as the secondary outcomes. The effects
of contrast media on the outcomes were analyzed using propen-
sity score matched analysis.
RESULTS. A total of 2246 patients were eligible to the study. Of
which, 606 patients were given contrast media within 48 hours be-
fore the ICU admission. After propensity score matching, the propor-
tions of DRF were similar between group C and group NC (35.9 vs
33.8%, P= 0.706). As for secondary outcomes, ICU and hospital mor-
tality (4.0 vs 2.8%, P =0.623 and 13.8 vs 9.3%, P =0.159, respectively)
were similar between two groups.
CONCLUSION. The effect of contrast media on the deterioration of
renal function was not evident in critically ill patients.
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INTRODUCTION. Renal replacement therapy (RRT), as a cornerstone
of supportive treatment, has long been performed in critically ill pa-
tients with acute kidney injury (AKI). However, the majority of studies
may have neglected the effect of the duration of RRT on the out-
come of AKI patients. To explore the effect of the long duration of
RRT on the outcome of critically ill patients with AKI
METHODS. This retrospective study was conducted by using the Mul-
tiparameter Intelligent Monitoring in Intensive Care II (MIMIC-II) data-
base, which is a publicly available clinical database developed by the
Massachusetts Institute of Technology (MIT), Phillips Healthcare, and
Beth Israel Deaconess Medical Center (BIDMC). This database con-
tains data from more than 32,000 critically ill patients who were
treated in the ICUs at BIDMC from 2001 to 2008.The primary out-
come measure of this study was the survival rate at 28 days, 60 days
and 90 days in the long-duration RRT group and the non-long-
duration RRT group. The secondary outcomes assessed the difference
Page 6 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55in clinical outcome in these two groups. Lastly, the effect of the dur-
ation of RRT on mortality in AKI patients was determined as the third
outcome.
RESULTS. We selected 1,020 patients in total who received RRT treat-
ment according to the MIMIC-IIdatabase. According to the inclusion
and exclusion criteria, we finally selected 506 patients with AKI: 286
AKI patients in the non-long-duration RRT group and 220 in the
long-duration RRT group. After 28 days, there was a significant differ-
ence in all-cause mortality between the long-duration RRT group and
the non-long-duration RRT group (p=0.001). However, the difference
disappeared after 60 days and 90 days (p=0.803 and p=0.925, re-
spectively). The length of ICU stay, length of hospital stay and dur-
ation of mechanical ventilation were significantly longer in the long-
duration RRT group than those in the non-long-duration RRT group.
Considering 28-day mortality, the longer duration of RRT was shown
to be a protective factor (HR=0.995, 95% CI 0.993-0.997, p<
0.0001),while 60-day and 90-day mortality were not correlated with
improved protection.
CONCLUSION. The long duration of RRT can improve the short-term
prognosis of AKI patients, but it does not affect the long-term prog-
nosis of these patients. Prognosis is determined by the severity of
the illness itself. This suggests that RRT can protect AKI patients
through the most critical time, however, the final outcome cannot be
altered.
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INTRODUCTION. It has been demonstrated in various ICU patient
populations that an elevated gamma-glutamyl transpeptidase (GGT)
between the 6th and 14th ICU day is associated with a better out-
come [1-3]. Whether a relatively high GGT also confers a lowered risk
for acute kidney injury (AKI) has not been investigated. In this study
we examined the dynamics of GGT during the first ICU week and its
relation with AKI and outcome.
METHODS. A cohort of patients previously studied for the glucose/
lactate interaction with liver and renal function was analyzed [4].
Daily creatinine levels were used for the assessment of the develop-
ment of AKI during the first ICU week. GGT levels were determined
frequently. We selected patients with initially normal GGT (i.e. <55
IU/L). GGT levels were compared between AKI and no AKI and hos-
pital survivors and hospital non-survivors. We also analyzed the rela-
tion of GGT with AKI in the group of survivors.
RESULTS. The cohort existed of 9074 patients (63% male; median
age 64 years) and a hospital mortality of 11%. The incidence of AKI
in the cohort was 21% (n=1877) and was significantly lower in the
group hospital survivors compared to the group hospital non-
Table 1 (abstract 000292). Adjusted OR and 95% confidence interval
for one-year mortality in all ICU survivors, as well as in the subgroup of
patients with low serum creatinine at discharge (i.e. <1.5 fold baseline)
All patients Screat <1.5 baseline at discharge
sCreat 1.79 [1.17 - 2.73] 1.68 [1.04 - 2.69]
eGFR 2.06 [1.30 - 3.27] 1.94 [1.15 - 3.29]
uNGAL 2.08 [1.35 - 3.21] 1.99 [1.23 - 3.21]
pNGAL 2.61 [1.71 - 3.97] 2.63 [1.61 - 4.27]
pCystC 3.11 [1.88 - 5.16] 2.84 [1.67 - 4.83]
penKid 2.20 [1.44 - 3.38] 2.08 [1.29 - 3.37]
Page 7 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55survivors (17 vs 51%, p<0.001). After selecting patients with a normal
GGT at ICU day 1 (n = 5399), median [IQR] GGT levels were signifi-
cantly higher in the group AKI vs no AKI on the first 2 days of ICU ad-
mission (26 [17-37] vs 22 [15-32] p=0.02 resp 27 [17-37] vs 24 [16-34]
p<0.001). On ICU day 6 GGT was significantly higher in the patients
with no AKI vs AKI (80 [45-154] vs 70 [39-119] p<.01). On the first 2
days of ICU admission GGT was also significantly higher in the group
non-survivors (29 [19-40] vs 22 [15-33] p<0.001 resp 28 [19-38] vs 24
[16-34] p<0.001) and on day 6 GGT was higher in the group survivors
compared to non-survivors (79 [44-148] vs 66 [38-103] p<0.01). Also
when only survivors were analyzed, higher GGT at ICU day day 6 was
associated with lower risk of AKI (p=0.04).
CONCLUSION. In patients with a normal GGT level at day 1 of ICU
admission, higher GGT on the first 2 days of ICU admission were as-
sociated with a higher incidence of AKI and hospital mortality. How-
ever, during ICU admission overall GGT levels progressively increased
and higher GGT levels on day 6 of ICU admission were associated
with a lower incidence of AKI and hospital mortality. This suggests a
protective role of GGT itself or that elevated GGT may be a marker of
regeneration and recovery of the liver or kidneys.
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INTRODUCTION. Serum creatinine (Screat) may overestimate renal
function at discharge from the intensive care unit (ICU). The objective
was to evaluate the association between biomarkers of kidney func-
tion and injury at ICU discharge and one -year survival.
METHODS. Ancillary study of the FROG-ICU cohort, a prospective ob-
servational cohort in 21 ICUs in France and Belgium, including ICU
patients receiving mechanical ventilation and/or hemodynamic sup-
port, with one-year follow-up. Kidney biomarkers were measured at
ICU discharge among ICU survivors (plasma Cystatin C (pCystc);
plasma and urinary Neutrophil gelatinase associated lipocalin (pNGAL
and uNGAL); plasma proenkephalin (penKid®)). A Sub-group analyseswere performed in the sub-group of patients with discharge serum
creatinine < 1.5-fold of baseline.
RESULTS. Among 1207 ICU survivors with complete biomarker as-
sessment and follow-up, 231 died during the year following ICU dis-
charge (19.4%). One-year non-survivors had higher discharge
biomarkers level (79 (56.5 to 113.5) vs. 63 (50 to 86) mmol/L for
Screat, 91.9 (31.6 to 266.9) vs. 47.7 (23.1 to 141.2) ng/mL for uNGAL,
201 (106 to 350.8) vs. 115 (71 to 189.2) ng/mL for pNGAL, 1.6 (1.2 to
2.4) vs. 1.1 (0.9 to 1.6) 1 mg/L for pCystC and 80.7 (53.3 to 132.9) vs.
55 (40.7 to 82.9) ng/mL for penKid, all p<0.0001). Un-adjusted and
adjusted (i.e. on prognostic factors previously identified in the FROG
cohort: Age, Charlson comorbidity score, vascular disease, severe
valvular disease, chronic kidney diseases, cancer, loss of autonomy,
systolic blood pressure, body temperature, total protein and platelet
counts, and white blood cell count at ICU discharge, red blood cell
transfusion and prolonged ICU length) odds ratios showing associ-
ation between kidney biomarkers and one-year mortality are pre-
sented in Table 1.
CONCLUSION. Kidney biomarkers measured at ICU discharge are
associated with one-year outcome, including patients with low
serum creatinine at ICU discharge. These results suggest that pa-
tients with sub-clinical acute kidney injury at discharge are identi-
fied using these biomarkers.000325
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INTRODUCTION. It is unclear as to whether intensivist coverage has
an effect on improving outcomes of patients postoperatively admit-
ted to the surgical ICU.
OBJECTIVES. This study aimed to assess the effect of intensivist
coverage on the incidence rate of postoperative acute kidney injury
(AKI) and postoperative ventilator time among patients postopera-
tively admitted to the ICU
METHODS. Adult patients postoperatively admitted to the ICU be-
tween January 2012 and December 2017 were retrospectively enrolled.
The incidence rate of AKI within 72 hours after surgery and the
Page 8 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55postoperative ventilator time were compared between the intensivist
coverage group and the non-intensivist coverage group.
RESULTS. In total, 5,494 subjects were included in the final ana-
lysis (2,747 subjects in each group). The incidence rate of AKI
was significantly higher in the non-intensivist coverage group
than that in the intensivist coverage group (22.8% vs 20.2%;
P=.017). Moreover, logistic regression analysis showed that the in-
cidence rate of postoperative AKI in the non-intensivist coverage
group has increased by 17% compared to that in the intensivist
coverage group (odds ratio: 1.17, 95% confidence interval: 1.03-
1.33; P=.017). Lastly, the median time of ventilator use in the
non-intensivist coverage group was significantly longer than that
in the intensivist coverage group [7.8 hours [interquartile range,
IQR: 2.7-13.5] vs 5.5 hours [IQR: 2.1-8.5]; P<.001).
CONCLUSION. High-intensity intensivist coverage is associated with
lower risk of postoperative AKI and shorter postoperative ventilator
time, indicating the need for full-time intensivist coverage at the sur-
gical ICU.
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INTRODUCTION. The Kidney Disease Improving Global Outcomes
(KDIGO) guidelines recommend using regional citrate anticoagulation
for continuous renal replacement therapy (RRT) in critically ill patients
with acute kidney injury. We introduced citrate RRT in May 2017 in
our intensive care unit.
OBJECTIVES. To assess the effect of citrate RRT on filter usage, RRT
days, and filter downtime in critically ill patients in a district general
hospital.
METHODS. We performed a retrospective observational study looking
at patients admitted to our 7 bedded Level 3 critical care unit (370 pa-
tients per annum) for one year after the introduction of citrate RRT. We
included patients over 16 years of age who had received RRT in our
unit. Data was collected from WardWatcher, a Scottish Intensive Care
Society Audit Group (SICSAG) database, electronic patient records (EPR)
and PACS (a radiology information system). 53 patients received RRT
on the unit during the year. A total of 8 patients were excluded; five of
these patients had no RRT prescription chart on the EPR and three of
them had received heparin.
RESULTS. There were a total of 53 patients, median age 58 years with
60% males. Of the 45 patients whose data were available, the average
time on citrate RRT was 3.1 days vs 4.6 in 2015 giving a p value of
0.157. Average number of set changes was unchanged with 1.8 set
changes per patient after introduction of citrate vs 1.8 in 2015, giving a
p value of 0.362. We achieved the prescribed blood pump speed 80%
of the time with citrate RRT as opposed to only 50% of the time in
2015. In 40% of the patients who received citrate RRT, the filter ran
100% uninterrupted. Filter clotting was still the commonest reason for
filter set changes. A subgroup analysis based on line site (i.e. right in-
ternal jugular (RIJ), left internal jugular (LIJ), femoral veins (FV), or sub-
clavian veins (SV)) was carried out due to the high proportion of LIJ
lines in our unit. This revealed an average of 1.2 set changes for RIJ
lines, 1.4 for LIJ, 0.67 for FV and 0 for the single SV line inserted. These
included changes due to routine filter set changes at 72 hours.
CONCLUSION. It was predicted that the introduction of citrate RRT
would reduce number of filter set changes per patient and filter
downtime, ultimately reducing cost. The reasons for not being ableto demonstrate reduction in filter set usage may include small num-
bers, line position (LIJ), and not recommencing filter after short
planned interruptions such as CT transfers. It has not been possible
to do a composite cost analysis at this stage to demonstrate cost re-
duction. We hope to feedback results of this study to the multidiscip-
linary team, improve awareness regarding choice of site for dialysis
lines, and re-examine our outcomes in a year's time.
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INTRODUCTION. Acute kidney injury (AKI) occurs in up to 50% of pa-
tients admitted to the intensive care unit (ICU) [1]. Predicting recov-
ery from AKI could be valuable, for patient and family counseling,
prognostication, and post-ICU care planning. Patients with lower pre-
dicted probability of AKI recovery could benefit more from a focused
health care management. However, early prediction of AKI recovery
remains a major challenge.
OBJECTIVES. The purpose of this study was to identify predictors for AKI
recovery. For this purpose, we developed and validated an AKI recovery
prediction model in adult ICU patients, to predict AKI recovery at ICU
discharge.
METHODS. This study was a retrospective preplanned secondary analysis
of the EPaNIC multicenter randomized controlled trial database. AKI recov-
ery was defined as no longer having AKI stage 3 [2], not receiving renal
replacement therapy (RRT), and not being deceased at ICU discharge. The
development cohort (n= 227) consisted of patients with AKI stage 3 and/
or RRT during the ICU stay. Clinical data were retrieved from the EPaNIC
research database and from the clinical patient data management system
database. The model was developed by using a random forest (RF)
machine-learning algorithm. Feature selection was performed with a RF-
based selection approach. Performance was evaluated by discrimination,
calibration, and decision curve, and internally validated (with 95% confi-
dence intervals (CI)) by bootstrapping with 200 replications.
RESULTS. A total of 49 patients (21.59%) recovered from AKI at ICU
discharge. Multivariate predictors for AKI recovery included age,
baseline serum creatinine (SCr), SCr before onset of AKI stage 3
(mean, 25th percentile, mean of difference above mean, median, and
slope), maximum lactate on day1, bilirubin on day1, heart rate before
onset of AKI stage 3 (proportion above 75th percentile, and mean of
difference above 75th percentile), mean arterial blood pressure be-
fore onset of AKI stage 3 (mean of difference below 25th percentile),
C-reactive protein (CRP) level on day1, urea level on day1, and urine
output volume on day1. The AKI recovery prediction model had an
area under the receiver operating characteristic curve (AUROC) of
0.76 (95% C.I. 0.64 – 0.83), calibration slope of 0.98 (95% C.I. 0.43 –
1.73), and calibration in the large of 0.00 (95% C.I. -0.07 – 0.07). At
the classification threshold that maximized sensitivity and specificity,
sensitivity was 0.76 (95% C.I. 0.63 – 0.89), specificity was 0.74 (95%
C.I. 0.61 – 0.86), net benefit with respect to treat-none was 0.09 (95%
Page 9 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55C.I. 0.05 – 0.16), and net benefit with respect to treat-all was 0.16
(95% C.I. -0.00 – 0.48).
CONCLUSION. Although the determinants of AKI recovery are diffi-
cult to define, a prediction model based on routinely collected clin-
ical data was able to fairly predict AKI recovery at ICU discharge.Fig. 1 (abstract 000442). A Shows a statistically significant
association (p<0.0001 with Kruskal-Wallis rank sum test) between
higher levels of creatinine and worse outcomes on discharge from
ICU. B Illustrates a statistically significant difference in highest
creatinine between the ‘Lived’ and ‘Died’ groups (on ultimate
discharge from hospital), with p-value <0.0001 (unpaired Wilcoxon
rank sum test), further supporting the hypothesis that patients with
poor outcomes have worse renal functionREFERENCE(S)
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INTRODUCTION. Many patients admitted to the intensive care unit
(ICU) have some element of kidney injury, whether acute or on a
background of chronic renal failure. Acute kidney injury (AKI) requir-
ing renal replacement therapy (RRT) develops in around 5-10% of pa-
tients admitted to ICU¹. It has previously been found that a low
serum creatinine is associated with a poor outcome². It has also been
shown that AKI is an independent risk factor for mortality¹. There are
many parameters that can be used to identify and monitor AKI, such
as urine output, serum potassium, fluid balance and serum creatin-
ine. Raised serum creatinine is also a marker of chronic kidney dis-
ease. However, there is little research into the relationship between
serum creatinine and critical care outcome. Our primary aim was to
investigate whether there is a correlation between serum creatinine
and ICU outcome, and hospital outcome.
METHODS. We searched our local ICU database, Ward Watcher,
which contains data from 13,927 patients from 1993-April 2019.
Emergency and non-emergency admissions were included. Pa-
tients with incomplete data regarding outcome were excluded.
We assessed whether an association existed between the highest
serum creatinine and critical care/hospital outcome.
RESULTS.
CONCLUSION. Our data suggest a relationship between raised serum
creatinine, and poor critical care and hospital outcome. Creatinine is
a readily available test and is usually measured daily in critical care,
so could be considered to be a useful aid in considering a patient’s
prognosis. While serum creatinine may not be the best marker of
renal function (GFR)³, there does appear to be a relationship between
creatinine and ICU outcome. In our study we did not isolate emer-
gency admissions, nor did we account for baseline creatinine or any
prior chronic kidney disease. Further work is needed to study the ef-
fects of these parameters on unit outcome.
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INTRODUCTION. Volatile anesthetic agents have been reported to
exert a protective effect on the lungs and heart, whereas intravenous
anesthetic agents exert a protective effect on the brain. Acute kidney
injury (AKI) is a serious complication associated with morbidity and
mortality. The effect of anesthetic agents on renal function remains
unclear.
OBJECTIVES. We aimed to investigate the incidence and risk factors
of AKI in relation to the use of different anesthetic agents in patients
undergoing thoracoscopic and laparoscopic esophageal surgery.
METHODS. We reviewed the electronic medical records and labora-
tory results of all patients who underwent thoracoscopic and laparo-
scopic esophageal surgery at Fujita Health University Hospital
between November 2015 and February 2018. We excluded patients
undergoing hemodialysis. We analyzed sex, age, weight, height, body
mass index, anesthesia time, operative time, thoracoscopic and lap-
aroscopic time, volume of fluid infused, urinary output, intake and
output balance, blood urea nitrogen, creatinine(Cr), aspartate trans-
aminase, alanine aminotransferase, white blood cell, C-reactive pro-
teinand hemoglobin.We used Mann-Whitney U-test and chi-squared
test for statistical analysis. We used EZR statistical software. Postoper-
ative AKI was defined by the Kidney Disease Improving Global Out-
comes guidelines. This study was approved by the FHU Ethics
Review Committee(HM17-286).
RESULTS. A total of 83 patients [43 inhalation anesthesia (sevoflurane
or desflurane), 40 propofol] were included in this review. There were
12 AKI cases in the inhalation anesthesia group (12/43: 28%) but
none in the propofol group (0/40: 0%) (p=0.015).Urinary output vol-
ume was significantly increased in the propofol group compared
with that in the inhalation anesthesia group (p=0.000002) and was
significantly decreased in the AKI group compared with that in the
non-AKI group (p=0.000006).There were no significant differences be-
tween the AKI and non-AKI groups except for height (p=0.036).
CONCLUSION. There was a significant decrease in AKI with propofol.
Propofol may have a protective effect on renal function in patients
undergoing laparoscopic esophageal surgery. Our investigation was
a retrospective single center study. Further studies are required.
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Table 1 (abstract 000461). See text for description
Propofol Volatile anesthesia
all(N=40) all(N=43) AKI(N=12)
Age, y 67.5(59-71.5) 68(63-72) 65(62.3-73)
Sex, male 33(82.5%) 36(83.7%) 11(91.7%)
Height, cm 165(159-169) 165(158-168) 168(165-173)
Weight, kg 57(48-64.4) 55(47.6-62.9) 62.2(51.1-71)
BMI, kg/m2 19(18.6-22.8) 21.3(18.6-22) 22.2(18-23.5)
preoperative Cr, mg/dL 0.9(0.72-1.05) 0.8(0.72-0.91) 0.89(0.8-1.07)
operation time, min 775(692-880) 715(645-809) 693(603-758)
Intraoperative urinary output, ml/kg/h 2.0(1.4-2.5) 0.9(0.7-1.4) 0.5(0.4-0.7)
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INTRODUCTION. Cardiopulmonary bypass (CPB) during cardiac sur-
gery impairs microcirculatory perfusion, which is paralleled by micro-
vascular leakage and associated with acute kidney injury. Thrombin
is excessively released during CPB, which leads to endothelial and
platelet activation and increased endothelial permeability. Aprotinin
(Trasyslol), an anti-fibrinolytic, is also suggested to inhibit thrombin/
PAR1-induced endothelial hyperpermeability. Therefore, this study in-
vestigated whether aprotinin reduces renal edema formation and
whether this is paralleled by preserved renal and cremaster perfusion
and reduced renal injury following CPB.
OBJECTIVES. To show that reduction of CPB-induced microvascular
leakage by targeting the thrombin/PAR1 system using aprotinin pre-
serves renal perfusion and reduces renal injury.
METHODS. Male rats were anesthetized and subjected to 75 minutes
of CPB after treatment with aprotinin (n=15) or PBS (n=15) as control.
Microcirculatory perfusion was measured in the cremaster muscle
using intravital microscopy and in the renal cortex using contrast
echography before CPB, and 10 and 60 minutes after weaning from
CPB (post-CPB). Renal perfusion was calculated by multiplying micro-
vascular filling velocity and microvascular blood volume. Wet/dry
weight ratios were determined from harvested kidney tissue. Plasma
creatinine, kidney injury molecule-1 (KIM-1) and neutrophil
gelatinase-associated lipocalin (NGAL) were measured by ELISA as
markers for kidney injury.
RESULTS. Onset of CPB decreased hematocrit levels (39±3 to 22±2
%, P<0.01) and blood pressure (88±15 to 73±9 mmHg, P=0.02). In
addition, CPB resulted in a 2-fold reduction in the number of per-
fused capillaries in the cremaster muscle (P<0.01), which did not re-
store in the first hour post-CPB. One hour post-CPB, renal
microvascular filling velocity (1.3±0.4 to 0.9±0.5 /sec, P<0.01) and
renal perfusion (258±173 to 135±88, P=0.03) were reduced, paral-
leled by increased plasma levels of creatinine (28±3 to 58±13 nmol/
ml, P<0.01) NGAL (123±37 to 2621±577 ng/ml, P=0.003) and KIM-1
(197±39 to 273±81 pg/ml, P<0.01).
Aprotinin preserved cremaster perfusion following CPB (P=0.002), whereas
renal microvascular filling velocity (P=0.5) and perfusion (P>0.9) were not
affected compared to untreated CPB animals. In parallel, no differences
were observed in plasma levels of creatinine (P>0.9), NGAL (P=0.7) or KIM-
1 (P=0.2). Aprotinin treated animals required less additional fluids (3.9±3.3
vs 7.5±3.0 ml, P=0.006) during CPB and reduced kidney wet/dry weightratios (4.6±0.2 vs 4.4±0.2, P=0.046) were found 1 hour post-CPB compared
to untreated CPB animals.
CONCLUSION. Treatment with aprotinin preserved cremaster micro-
circulatory perfusion following CPB, but did not prevent renal perfu-
sion disturbances nor renal injury following CPB despite reducing
renal edema formation. Future studies should focus on identifying
therapeutic strategies to improve renal perfusion and function fol-
lowing CPB.
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INTRODUCTION. Spleen plays an important role in the regulation
of immune response during sepsis and acute kidney injury (AKI)
[1]. α7 nicotinic acetylcholine receptor (α7nAChR) is a key factor
involved in the cholinergic anti-inflammatory pathway. Dexmede-
tomidine (Dex) can exert protective effects against sepsis through
α7nAChR signaling, which is mediated by spleen [2].
OBJECTIVES. To investigate the role of splenectomy in Dex-
activated cholinergic anti-inflammatory pathway in alleviating sep-
tic AKI.
METHODS. C57BL/6 mice were randomly divided into Control
group, LPS group (10mg/kg LPS intraperitoneal injection),
Dex+LPS group (Dex 40μg/kg before LPS injection), Splenectomy
group, Splenectomy+LPS group and Splenectomy+Dex+LPS
group. The mice in splenectomy groups survived for 7days after
splenectomy and re-entered the group. Mice were terminated 16
h after LPS challenge.
RESULTS. The septic AKI model was established successfully
(Figs1-3). The apoptosis in LPS group increased significantly com-
pared to control group. The Dex reduced the apoptosis of kidney
cell, however, the apoptosis increased after splenectomy plus Dex
(Fig4). Cr and Cys-C were significantly increased after LPS, which
were reduced by Dex treatment. However, Cr and Cys-C increased
again after splenectomy combined with Dex (Fig5). The levels of
IL-6, NF-κB p65, p-STAT3, Caspase-3 and Bax were significantly in-
creased and the levels of α7nAChR and Bcl-2 were significantly
decreased in LPS group. Dex treatment resulted in an attenuation
of IL-6, NF-κB p65, p-STAT3, Caspase-3 and Bax, and an increase
of α7nAChR and Bcl-2. Splenectomy down-regulated the expres-
sion of IL-6, NF-κB p65 and p-STAT3 (Fig6).
CONCLUSION. Dex effectively alleviated septic AKI, while splenec-
tomy could inhibit anti-inflammatory, anti-apoptotic and renal pro-
tective effects of Dex. Splenectomy reduced the production of pro-
inflammatory cytokines and had a protective effect on kidney. The
Kidney-spleen axis mediated by α7nAChR signaling pathway was in-
volved in the development of septic AKI.REFERENCE(S)
1. van der Poll T, van de Veerdonk FL, Scicluna BP, et al. The
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Fig. 1 (abstract 000504). HE staining results
Fig. 2 (abstract 000504). Tunel results
Fig. 3 (abstract 000504). HE results of renal pathology in
each group
Fig. 4 (abstract 000504). Tunel apoptosis results in kidney tissues
of each group
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Fig. 1 (abstract 000565). Cx32 deficiency Attenuated AKI and renal
fibrosis after renal IR with Concomitant Reduction of Post-Renal IR
cellular senescence
Fig. 5 (abstract 000504). The contents of Cr and Cys-C in
different groups
Fig. 6 (abstract 000504). IL-6, NF-kB p65, p-STAT3, α7nACHR,
Caspase-3, Bcl-2 and Bax expression in different groups (*P<0.05 vs.
Control; #P<0.05 vs. LPS)
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INTRODUCTION. Renal ischemia/reperfusion (IR) can induce acute kidney
injury (AKI), which often progresses to chronic kidney disease (CKD). Our pre-
vious study demonstrated that Dexmedetomidine (Dex), a highly selective
α2 adrenergic receptor (α2-AR) agonist, improves renal fibrosis to moderate
the AKI-to-CKD transition. However, the precise underlying mechanisms
were largely unknown.
OBJECTIVES. This study focuses on the underlying mechanisms related to
gap junction (GJ) composed of connexin32 (Cx32)-induced senescent by-
stander effect responsible for Dex renal protection.
METHODS. Cx32 knockdown mice (Cx32-/-), kidney specific Cx32-
overexpressing mice (Cx32-rAAV), and wild-type C57BL/6 mice (Cx32+/+)
underwent surgical bilateral renal IR in the absence or presence of treat-
ments with Dex(10μg/kg). Histopathological changes, renal dysfunction, cellsenescence and tubular fibrotic markers, reactive oxygen species, inflamma-
tory factors and the expression of NF-κB were studied.
RESULTS. Cx32 deficiency alleviated, while Cx32 overexpression en-
hanced renal IR-induced AKI, renal senescence and chronic tubuloin-
terstitial fibrosis in later stages (Fig1). Cx32 GJ was found to transfer
ROS and further activate NF-κB and the senescence-associated
secretory phenotype (SASP) (Fig2). Similar to Cx32 knockdown, pre-
treatment with Dex also decreased the number of senescent tubular
cells and tubulointerstitial fibrosis, and weakened the protein expres-
sion of senescence and fibrosis-associated markers including p21,
p16, α-SMA and TGF-β1 (Fig3). Furthermore, the expression of SASP
markers was also decreased in Dex-treated IR mice; and these pro-
tective effects of Dex could be abolished by Cx32 overexpression
(Fig4).
CONCLUSION. Cx32 plays a critical role in Renal IR-induced senes-
cence and chronic tubulointerstitial fibrosis and that inhibition of
Cx32 function may represent a new and major mechanism whereby
Dex alleviated the senescent bystander effect by inhibiting the Cx32
GJ, which further inhibited ROS/NF-κB-mediated senescent bystander
effect.
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Fig. 4 (abstract 000565). Effects of Dexmedetomidine on ROS/ NF-
κB axis-mediated senescent bystander effect
Fig. 2 (abstract 000565). Cx32 GJ regulates ROS/ NF-κB axis-
mediated senescent bystander effect following renal IR
Fig. 3 (abstract 000565). Dexmedetomidine Protected against HR-induced
senescence-associated fibrosis by Inhibiting Cx32 GJ
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INTRODUCTION. Acute kidney injury (AKI) is a critically ill syndrome with a
high incidence and mortality. It was reported that severity of oliguria and
anuria were associated with worse outcomes and a rapid decline in urine
output might be the earliest indication of renal dysfunction ahead of other
indicators. However, the utility of urine output as a specific indicator for
renal dysfunction is somewhat controversial. Therefore, we performed this
study to evaluate the prognostic value of different level of urine output for
critically ill patients with AKI.
METHODS. We conducted a secondary data analysis of the Beijing
Acute Kidney Injury Trial (BAKIT) database, which was a multicenter,
prospective, observational study involving 9,049 adult patients admit-
ted to 30 ICUs in 28 tertiary hospitals in Beijing [1]. Overall, there
were 3,107 patients recruited consecutively into the database. Those
who lacked body weight, daily creatinine and hourly urine volume
were excluded from the study. All recruited patients were evaluated
by the Kidney Disease: Improving Global Outcomes (KDIGO) criteria
and four types of urine output [2]. The urine output criteria were as
following: UO1, a urine volume of less than 0.5 mL/kg/hour for six
hours; UO2, an average urine volume of less than 0.5 mL/kg/hour for
six hours; UO3, a urine volume of less than 0.3 mL/kg/hour for six
hours; and UO4, an average urine volume of less than 0.3 mL/kg/
hour for six hours. Demographic information, underlying disease,
diagnostic information, lab and physiological data and patient
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renal replacement therapy (RRT), ICU mortality, hospital mortality, 28-
day mortality, length of ICU stay, and hospitalization costs. Differ-
ences in mortality and other prognostic indicators among the KDIGO
criteria and the four different urine volume criteria were compared.
Logistic regression analysis was used to assess the association of dif-
ferent criteria with prognostic indicators. P<0.05 was considered to
be significant.
RESULTS. Of the 1,080 patients enrolled in the final analysis, 555 (51.4%)
patients met the KDIGO criteria, and 191 (17.7%), 290 (26.9%), 110 (10.2%)
and 170 (15.7%) met the UO1, UO2, UO3 and UO4 criterion, respectively.
The hospital mortality based on the different criteria was 23.1% (KDIGO),
39.8% (UO1), 33.5% (UO2), 47.3% (UO3) and 43.5%(UO4), and UO3 was sig-
nificantly higher than other groups (P<0.05) (Figure1). The other prognostic
indicators including the RRT rate, ICU mortality, 28-day mortality, length of
ICU stay, and hospitalization costs were incompletely equal, with the high-
est in the UO3 (Table 1).
CONCLUSION. Alterations in urine output might be a sensitive prog-
nostic indicator of AKI. A 6-hour average urine volume of less than 0.3
mL/kg/hour might be associated with worse clinical outcomes, such as
higher mortality, more RRT, longer ICU stay and higher medical costs.
REFERENCE(S)
1. Luo X, Jiang L, Du B, Wen Y, Wang M, Xi X, et al. A comparison of different
diagnostic criteria of acute kidney injury in critically ill patients. Crit Care.
2014;18:R144.
2. KDIGO AKI Work Group. KDIGO clinical practice guideline for acute
kidney injury. Kidney Int Suppl. 2012;17:124–138.Table 1 (abstract 000570). Comparison of clinical outcomes based on
the different criteria
Fig. 1 (abstract 000570). The hospital mortality based on the
different criteria000595
Chronic Kidney Disease Epidemiology Collaboration formula (CKD-
EPI) for the assessment of renal function in the critically ill patient
V. Philibert1, P. Marcos Neira1, Y. Rovira Vallès1, L. Bielsa Berrocal1,
S. Triginer Roig1, A. Campos Gómez1, JM. Manciño Contreras1,
M. Sánchez Satorra1, S. Malumbres Serrano2, TM. Tomasa Irriguible1
1Intensive care department, Hospital Germans Trias i Pujol, Badalona,
Spain; 2Clinical analysis department, Hospital Germans Trias i
Pujol, Badalona, Spain
Correspondence: V. Philibert,
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000595
INTRODUCTION. Equations (as CKD-EPI) for renal function estimation
are usually used in the critical patient despite not having been vali-
dated in this population. Utilization of estimation formulas of renal
function may lead to incorrect drugs dosage.
OBJECTIVES. To analyse the concordance between CKD-EPI and
the gold standard glomerular filtration rate (GFR) to verify its val-
idity for the correct estimation of renal function in the critically
ill patient.
METHODS. Observational study conducted in a polyvalent ICU of
a 3rd level hospital. Between March 2017 and August 2018 blood
samples and 24h urine samples were collected to determine
serum and urine creatinine levels. We graded the sample in
stages of CKD for grading severity, and we added a new stage
for augmented renal clearance (GFR> 130 mL/min). To evaluate
the concordance between CKD-EPI and GFR in the overall sample
and in each stage we applied Passing-Bablok and Bland Altman
statistic tests.
RESULTS. 949 samples of 255 patients (a mean age of 58 years
and 66% of males) were collected. The obtained n was exces-
sive for an adequate power for the normal GFR stage so that
the size of the sample was automatically and randomly reset
and thus the global sample was reduced to 643. In the GFR<30
mL/min stage sample group there is a proportional discordance
between both tests. In the other subcategories and the overall
sample there is a proportional and constant discordance.
CONCLUSION. There is no concordance between CKD-EPI and
GFR. The obtained results question the validity of the CKD-EPI
formula for correct renal function estimation in the critically ill
patient. Physicians should take into account that CKD-EPI is not
accurate for dosing drugs with renal elimination mechanism.REFERENCE(S)
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Table 1 (abstract 000595). See text for description
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INTRODUCTION. The incidence of acute kidney injury (AKI) in the in-
tensive care units ranges from 32% to 50%. Only 5% of these pa-
tients are treated with renal replacement therapy (RRT), but the
mortality is high, often reaching up to 50%. In spite of the modality
of the RRT, the access point to the circulation is a central venous dia-
lysis catheter (CVDC). The CVDC and the central venous catheter
(CVC) are often placed in the same vessel in order to salvage the
veins. As a consequence, the tips of both catheters end up in the su-
perior vena cava (SVC). Therefore, there have been speculations that
this might cause immediate aspiration of the drug infused via CVC
through the CVDC.
OBJECTIVES. Determine the degree of immediate aspiration of the
drug infused via central venous catheter (CVC) through the distally
positioned central venous dialysis catheter (CVDC).
METHODS. A 9.53mm polyvinyl chloride (PVC) tube was used to
mimic the SVC. We used water to simulate blood. A centrifugal pump
was used to keep a constant flow rate of 1.2 liters per minute. 1mg/
mL (0.1%) methylene blue aqueous solution was selected as a tracer
and was infused into the tube using a syringe pump via the CVC as a
constant infusion (200ml/hour) and as a bolus infusion (800ml/hour).
To simulate RRT we performed a manual aspiration through the
CVDC using 20ml syringes at the speeds of 100ml/min and 300ml/
min. The CVC point was moved in reference to a fixed CVDC point.
The most distal point was at +2 cm, and the most proximal point
was at -8 cm distance. Four different sets of samples were generated:
continuous infusion - slow aspiration (situation – A), continuous infu-
sion - fast aspiration (situation – B), bolus infusion - slow aspiration
(situation – C), bolus infusion – fast aspiration (situation – D). The
samples were obtained at every of the 6 different distances betweenthe CVC and CVDC tips. 3 samples were taken per each measure-
ment, mixed to one medium sample, amounting to 24 different sam-
ple syringes. Spectrophotometry and Beer-Lambert-Bouguer law
were used to evaluate the degree of aspiration.
RESULTS. When the CVC tip was placed at +2cm distance the aspir-
ation of the tracer was <0.027% in all situations. The levels of aspir-
ation were also minimal at the 0cm distance (<0.27%). Moving the
CVC catheter up resulted in increased aspiration of the tracer reach-
ing its peak at -4cm: situation A (1.37%), situation B (0.35%), situation
C (5.16%), situation D (2.61%). The levels of the aspirated tracer were
higher in bolus infusion setting, reaching an average of 2.07% in situ-
ation C and 1.77% in situation D compared to 0.46% in situation A
and 0.32% in situation B.
CONCLUSION. Our experimental study showed that the degree of im-
mediate drug aspiration is influenced by the position of the adjacent
catheters and the speed of infusion. There was no aspiration seen in
the +2cm and 0cm positions. These are the safest positions in the set-
ting of adjacent catheters in order to avoid unwanted drug aspiration.
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INTRODUCTION. Acute kidney injury (AKI) is a recurrent finding in
critically ill patients and is linked to some short- and long-term ad-
verse outcomes. In addition, previous studies(1) showed that Strepto-
coccus pneumoniae (SP) infections could be associated with an
increased risk of AKI even if that relationship was not extensively an-
alyzed in critically ill patients.
OBJECTIVES. We compared patients with SP pneumonia and similar
patients affected by other types of pneumonia (OP) hypothesizing that
SP infection could be linked with increased AKI and mortality rates.
METHODS. We performed a retrospective analysis, reviewing all pa-
tients with pneumonia admitted to our Intermediate Care Unit (IMCU)
from December 2015 to December 2018. The inclusion criteria were:
age ≥ 18 years old; radiological evidence of pneumonia; positive micro-
biological samples (urinary antigen for SP or Legionella pneumophila;
endotracheal aspirate or bronchoalveolar lavage; blood culture; pleural
culture). Exclusion criteria were: patients with bronchitis, aspiration
pneumonia and lung tumors. We analyzed two groups of patients (SP
and OP) matched for age, SAPS2 score, SOFA score, PaO2/FiO2 ratio at
IMCU admission, chronic kidney disease (CKD) and circulatory failure
(CF). KDIGO criteria were used to classify AKI. We investigated rates of
AKI, IMCU mortality and mortality at 90 days.
RESULTS. We reviewed 110 patients and 34 respected the inclusion
criteria (17 in SP group and 17 in OP group). The two groups were
well matched (age: 78 ± 9 (SP), 74 ± 12 (OP) p= 0.3; CKD 6/17 (SP),
6/17 (OP) p = 1; PaO2/FiO2 149 ± 79 (SP), 134 ± 37 (OP) p = 0.5;
SAPS2 42 ± 11 (SP), 40 ± 13 (OP) p = 0.7; SOFA 6 ± 1 (SP), 5 ± 1 (OP)
p = 0.3; CF 5/17 (SP), 4/17 (OP) p = 0.7). Furthermore, there was no
significant difference in the two groups concerning the use of iodin-
ated contrast media (p= 0.09), aminoglycosides (p= 1), glycopeptides
(p= 0.4), colistin (p=1), except for ACEi/sartan use (p= 0.03 in OP). No
significant difference was found in AKI rate between the two groups
(AKI 9/17 SP; 7/17 OP p = 0.5; KDIGO stage: 1 (5/9 SP; 5/7 OP p= 0.5),
2 (3/9 SP; 1/7 OP p= 0.4), 3/renal replacement therapy (RRT) (1/9 SP;
1/7 OP p = 0.8). As well, IMCU mortality (OR 4.1, 95% CI 0.69-24.24,
p= 0.1) and 90-day mortality (OR 1.6, 95% CI 0.41-6.96, p= 0.5) were
similar in the two groups.
CONCLUSION. In our cohort of patients, SP pneumonia was not asso-
ciated with increased risk of AKI and mortality when compared with
other types of pneumonia in similar adult patients.
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INTRODUCTION. Among many conditions and interventions diabetes
mellitus and major abdominal surgery have been recognized as risk
factors in acute kidney injury (AKI) (1). However, some research stud-
ies denied association between diabetes mellitus and AKI in patients
after surgery (2, 3, 4).
OBJECTIVES. To determine the association and clinical features of AKI in
patients with unrecognized and/or poorly regulated diabetes mellitus
after major abdominal surgery.
METHODS. This prospective, observational, monocentric study in-
cluded sixty patients who underwent major abdominal surgery and
were admitted to the intensive care unit after the surgery. Patients’
follow-up, anamnestic, medical, measured and laboratory data were ob-
tained on the 0, 1st, 2nd, 3rd, 7th, and 14th postoperative days as well
as data on patients' condition at hospital discharge. Hemoglobin A1c
(HbA1c) was used as a screening tool for previously unrecognized or
unregulated diabetes.
RESULTS. AKI was recorded in 33.3% of patients. Patients with previ-
ously known diabetes mellitus, poorly regulated diabetes mellitus
and unrecognized diabetes mellitus did not have a higher incidence
of AKI (P>0.05). In patients with hypertension (P= 0.025) and patients
who received furosemide (P=0.034, P=0.036, P=0.033), vasopressor
(P=0.036, P=0.036) and blood derivatives (P=0.022) a higher inci-
dence of AKI was observed at one or more days. The appearance of
AKI did not affect the length of stay in the intensive care unit (P=
0.567), readmission in the intensive care unit (P=0.548), total
hospitalization time (P=0.504) and mortality (P=0.595).
CONCLUSION. The results of this study did not confirmed association
between diabetes mellitus and AKI after major abdominal surgery.
Use of HbA1c helped in avoiding inadequate interpretation of results
due to poorly controlled and unrecognized diabetic patients.
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INTRODUCTION. Clinical effectiveness of Neurally Adjusted Ventila-
tory Assist (NAVA) has not been demonstrated and feasibility data
are required. The aim of this survey was to assess NAVA from the
perspective of staff users, and inform a feasibility trial prior to a de-
finitive RCT.
METHODS. Web (SurveyMonkey) and paper-based, anonymous, self-
administered cross-sectional survey, approved as part of a concurrent
randomised feasibility trial (NCT01826890). Organised into four
domains:
 Training and experience
 Advantages and disadvantages
 Barriers and attitudes
 Views on research
RESULTS. Of the 462 distributed surveys, 301 (65.4%) were returned
from 236 nurses (78.4%), 56 doctors (18.6%) and 12 physiotherapists
(4.0%). Responses were well distributed between levels of staff
seniority.
NAVA training had been received by >50% of participants; 227/301
(70.4%) had clinical experience of NAVA and 123 (64.4%) of those
had used Edi monitoring. Despite this, NAVA was perceived as infre-
quently used with staff citing ‘low confidence’ and ‘lack of experi-
ence’ as key barriers to acceptance.
Most participants agreed or strongly agreed that the NAVA mode
was safe (136/177, 76.8%) and clinically effective (99/176, 56.3%), and
that Edi monitoring was clinically effective (101/172, 58.7%), citing
improved synchrony, comfort and reduced time on ventilation as the
main perceived advantages. ‘Technical issues’ was the most cited
clinical disadvantage (129, 68.3%). Mode cross-over was also per-
ceived to occur often, with ‘Edi signal problems’ the most cited cause
(39/168, 23.2%).
In comparison to PSV, respondents perceived NAVA as performing
equally well, and to be ‘easier’ in respect to synchrony, comfort and
weaning (all p<0.0001), with no increase in workload. NAVA was,
however, perceived as generally harder to use (105/174, 60.3%), par-
ticularly in relation to ‘set-up and start’ and ‘reliability’ (p<0.01). PSV
was preferred to NAVA for ventilator weaning (93/171 [54.4%] versus
29/171 [17.0%]; p=<0.0001), although a large proportion (49/171,
27.1%) were ambivalent.
In relation to research, almost all 161/180 (89.4%) were generally
supportive; 110/180 (61.1%) had cared for a patient on the trial; no
participants felt that the protocol was unacceptable, with the major-
ity (60/119, 50.4%) finding it very or completely acceptable.
CONCLUSION. These results highlight key factors that may interact
with parameters in a future trial. The difficulty and lack of confidence
perceived by respondents may be modified via training and NAVA
usage guidelines. Of more concern are the technical difficulties as re-
ported here and elsewhere 1. Further assessment of these factors
may be necessary prior to a definitive RCT.
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INTRODUCTION. Different Lung Injury Prediction Scores (LIPS) had
been derived to identify patients at risk for acute respiratory distress
syndrome (ARDS).
OBJECTIVES. This study was intended to derive a new ARDS predic-
tion score in high risk critically ill patients.
METHODS. We recruited 200 patients [63(43-70)years old, 120(60
%)males] admitted to ICU with APACE-II≥15 and at least one ARDS
risk factor after excluding patients with ARDS on admission, cardiac
patients, and readmission. The presence of risk factors together with
the admission and 48-hours CRP (CRP-0&CRP-48) were tested in uni-
variate then multivariate regression models for identifying significant
predictors whose weights were assigned according to the β-
coefficient of the regression model. Our score was compared with a
previously derived score by Trillo-Alvarez et al on 2011 (LIPS-T). The
primary and secondary outcomes were the development of ARDS
and in-hospital mortality respectively.
RESULTS. ARDS developed in 88 patients(44%). Logistic regression
revealed that only pneumonia, tachypnea, increased heart rate and
increased CRP-48 are significant ARDS predictors. The weight of each
predictor was estimated according to its β-coefficient. The new score
was 35.5(27-44) and 14(9-24.3) in ARDS and non-ARDS patients
respectively(P=0.000). The AUC of the new score was 0.827 com-
pared to 0.74 for the LIPS-T(P=0.014). A score of 20 had a sensitivity
and specificity of 82 % and 71 % in predicting ARDS. Our score was
significantly lower in survivors compared to non-survivors(P=0.000).
Its AUC in predicting in-hospital mortality was 0.761 compared to
0.657 for the LIPS-T(P=0.0045).
CONCLUSION. This study derived new simple LIPS score which could
be better than the previously derived scores in terms of predicting
ARDS and in-hospital mortality in critically ill ICU patients.
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INTRODUCTION. Blood oxygen desaturation is the most common
physiological change in mechanically ventilated patients during
nurse cares periods that are routinely performed in the intensive care
unit (ICU).
OBJECTIVES. To assess the ability of an automated closed-loop venti-
lation mode (Intellivent-ASV®) to reduce blood oxygen desaturation
incidence and depth during daily nurse cares.
METHODS. We performed a prospective randomized crossover study
in a 22 beds French mixed ICU, including mechanically ventilated pa-
tients with FiO2 ≤ 60% and without prone position and/or neuro-
muscular blocking agent. After inclusion, patients had two
consecutive nurse cares periods (each separated by six hours) per-
formed in a randomized order: one using Intellivent-ASV® andanother using conventional mode. Ventilation modes were set by the
attending physician 30 minutes before the procedure. The primary
endpoint was the minimal pulse oxygen saturation level (SpO2min)
during the procedure.
RESULTS. Among the 265 included patients, 93% were admitted for a
medical pathology, and were intubated for pneumonia (50%), coma
(32%), sepsis (32%) and acute respiratory distress syndrom (20%). Pres-
sure support was the most common ventilation mode used in the con-
ventional arm (91%). There was no difference between both modes
regarding use of sedation, nurse cares duration and ventilator parame-
ters except for spontaneous cycling higher and peak pressure lower in
Intellivent-ASV® (p < 0.001 respectively). SpO2min ≤ 85% incidence was
significantly lower and more patients had a SpO2min in the optimal
range (between 90 and 95%) with Intellivent-ASV® (p = 0.02 and 0.002
respectively). Nurses had to manually increase FiO2 to 100% less fre-
quently with Intellivent-ASV® (p = 0.004). Finally, multivariable logistic
regression showed that nurse cares periods performed in Intellivent-
ASV® reduced significantly the SpO2min ≤ 85% incidence (OR 0.5;
95%CI [0.3 – 0.9]; p = 0.01).
CONCLUSION. In this monocentric study, Intellivent-ASV® mode
seems to be an interesting tool for nurses to stay focus on patients
cares by reducing blood oxygen desaturation incidence and depth,
with less manual interventions in comparison with conventional
modes.
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INTRODUCTION. APRV is a relatively new mode of mechanical
ventilation which can be used in treatment of patients with im-
paired oxygenation, but this mode is not widely used by clini-
cians. Physiological dead space (VDphys.) is an important
parameter to assess respiratory function which is equal to the
the volume of airway plus ventilated non- perfused alveoli. We
conducted this study to compare APRV and BiPAP modes regard-
ing VDphys. and other respiratory variables (pressures and blood
gases). Our hypothesis is that the long inspiratory phase in APRV
may increase VDphys. (by impairing perfusion) and may affect
other respiratory variables.
OBJECTIVES. To compare APRV and BiPAP modes regarding VDphys.,
respiratory pressures and blood gases parameters.
METHODS. Mechanically ventilated patients with PO2/FiO2 ratio<
300 were randomized into two groups: Group A (APRV group)
:APRV mode was used with high pressure (Phi) 20 cmH2O , low
pressure (Plo) 5 cmH2O with I:E ratio ( Phi phase: Plo phase ratio
) 4:1 for 3 hours. Group B(BiPAP group) : BiPAP mode was used
with high pressure (Phi) 20 cmH2O, low pressure (Plo) 5 cmH2O
with I: E ratio (Phi phase: Plo phase ratio) 1:1 for 3 hours. Then
all patients were left for ventilation according to the preference
of the physician in charge. VDphys. was measured using the
metabolic module of GE ventilators. Respiratory variables were
also recorded. All measurements were done at 30 minutes and at
Page 18 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55the end of the intervention period (3 hours).
RESULTS. Sixty patients were available for final analysis (30 in each
group). There was no statistically significant difference in age (51.7±15.2
vs 54.3±16.1, p=0.52) and weight (75.80±13.28 vs 76.57±15.93, p=0.840)
between the two groups. VDphys/tidal volume (VT) at 30 minutes was
(0.47 ±0.09 vs 0.46 ± 0.08, P=0.61) and at 3 hours was (0.44 ± 0.10
vs 0.43 ± 0.11 , p=0.67) in the two groups respectively. there was a reduc-
tion in VDphys/VT within each group at 3 hours but it was not statistically
significant (p=0.11 for group A and 0.13 for group B). There was improve-
ment of dynamic compliance within each group (36.17 ± 9.1 vs 39.7±
8.33, p=0.002 for group A) and (37.87 ± 7.84 vs 42.37 ± 7.84, p=0.001 for
group B). PCO2 was increased in group B (39.17 ± 8.72 vs 42.67 ± 7.73,
p=0.013) but it was not clinically significant.
CONCLUSION. APRV mode didn’t increase physiological dead space
compared to BiPAP mode. Both modes improved dynamic compliance.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000049INTRODUCTION. Whilst the dangers of hypoxia are well documented, it
has recently been proposed that too much oxygen, hyperoxia, may also be
harmful to patients. There is a greater risk of mortality associated with
hyperoxia, due in part to increased production of reactive oxidative species
and vasoconstriction. Due to the widespread use of supplemental oxygen
in ICU patients, this group is at a high risk of hyperoxia.
OBJECTIVES.
 To determine the prevalence of hyperoxia in patients receiving
supplemental oxygen in ICU.
 To determine whether action is taken to reduce the amount of
oxygen delivered to patients based on hyperoxic capillary oxygen
saturation (SpO2) and arterial partial pressure of oxygen (PaO2).
METHODS. As part of a medical school project, a prospective audit was
undertaken in a UK general mixed ICU/HDU of SpO2 and PaO2 of 53 con-
secutive patients receiving oxygen therapy, over 255 patient bed days, be-
tween 19/1/2019 and 6/2/2019.
Data was obtained from patient observation charts, and SpO2 >96%
(or >92% in the case of carbon dioxide retention), and PaO2 >14kPa
were considered ‘hyperoxic’. Any action taken to reduce the fraction
of inspired oxygen (FiO2) as a result of hyperoxia was documented.
RESULTS. Over 255 bed days on ICU 4338 SpO2 and 609 PaO2 of 53 con-
secutive patients receiving supplemental oxygen were analysed to identify
the prevalence of hyperoxia and the likelihood of action being taken to re-
duce the FiO2 as a result. 2364 SpO2 (54%) and 135 PaO2 (22%) were found
to be ‘hyperoxic’.
Action was taken to reduce FiO2 in a total 372 instances of recorded
hyperoxia (15%). A PaO2 above target was more likely to prompt ac-
tion (FiO2 reduced in 33% hyperoxic recordings) than an SpO2 above
target (FiO2 reduced in 16%) as illustrated in Figure 1.
CONCLUSION. A significant proportion of recorded SpO2/PaO2 in 53 con-
secutive ICU patients were above target showing that there is a high preva-
lence of hyperoxia in ICU patients receiving supplemental oxygen. The FiO2
delivered to patients was reduced in a small fraction of those found to be
hyperoxic. A PaO2 above target was more likely to prompt action to reduce
FiO2 than an SpO2 above target.
Staff education with regards to the importance of recognition and
management of hyperoxia and conservative oxygenation targets for
patients may reduce the risks associated with hyperoxia.000058
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Page 19 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. Postextubation respiratory failure in the early postopera-
tive period occurs in 5-25% [1,2] of cardiac surgery patients and various
methods of noninvasive respiratory support are available for it's treatment.
OBJECTIVES. Comparative evaluation of the effect on gas exchange
of conventional oxygen therapy (COT), noninvasive positive airway
pressure mask ventilation (NIPPV) and high-flow nasal cannula ther-
apy (HFNC) in the patients with postextubation respiratory failure
after cardiovascular surgery.
METHODS. 52 cardiac surgery patients (age 60±11years) with respira-
tory failure manifested in the postoperative period after tracheal extu-
bation were included into the study. Respiratory failure criteria: PaO2/
FiO2≤300 mmHg or SpO2≤88% on room air. Patients with pleural effu-
sion, pneumothorax and paresis of diaphragm were excluded from the
study. In each patient sequentially performed blood gas analysis when
breathing room air, COT (mask with pre-volume bag), HFNC and NIPPV.
Duration of application of each method before taking of analyses was 1
hour. Respiratory rate (RR) and SpO2 were monitored throughout the
study. Optimal parameters for HFNC were: FiO2 47±9%, flow rate -
36,7±9 l/min, and for NIPPV: PIP - 13,3±4,0 mmH2O, PEEP - 6,65±2,04
mmH2O, FiO2 - 50±8%, TV - 7,2±1,27 ml/kg.
RESULTS. During COT, mean PaO2/FiO2 ratio was 193±73 mmHg.
After change to HFNC it increased to 247±87 mmHg (p=0.0025), and
on NIPPV - to 234±67 mmHg (p=0.0097). The same tendency was ob-
served with SpO2: at HFNC and NIPPV it was significantly higher than
at COT (97.27±2.29% and 96.37±2.1% versus 94.63±3.51%, p=
0.000028 and p=0.0058, respectively). PaCO2 during COT was higher
than on air (42.16±8.33 mmHg and 38.64±6.58 mmHg, respectively,
p=0.04). After change to the noninvasive ventilatory support PaCO2
decreased by 9.82% (38.02±7.26 mmHg, p=0.015) on HFNC and by
5.86% (39.69±7.59 mmHg, p=0.16) on NIPPV. Significant differences
in values were found in RR during COT (21.02±6.59 bpm) compared
to HFNC (17.27±6.5 bpm, p=0.0042) and on NIPPV it was not signifi-
cant (18.89±5.1 bpm, p= 0.072).
CONCLUSION. NIPPV and HFNC in patients with postextubation re-
spiratory failure after cardiac surgery have similar positive effect on
gas exchange to compare to the mask with pre-volume bag. HFNC
has better effect on RR and CO2 elimination than NIPPV.
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INTRODUCTION. Spontaneous breathing trial (SBT) during weaning
from mechanical ventilation aims at testing ability of respiratory sys-
tem to work without breathing assistance. SBT can be delivered
through T-piece trial or low pressure support (PS) level. Low PS is
thought to compensate for endotracheal tube (ETT) resistance (RET),
and, hence no further assistance would be provided by the ventila-
tor. We reasoned that this may not be true with the modern ICU ven-
tilators. The real way to compensate for RET only is the automatic
tube compensation (ATC) option. Our hypothesis was that low PS
was associated with a significant reduction in work of breathing
(WOB) as compared to ATC.METHODS. We underwent a prospective, short-term, physiological,
cross-over study (NCT02939963) where patients with criteria for SBT
after at least 24 hours of mechanical ventilation in our ICU received PS7
cmH2O positive end-expiratory pressure (PEEP) 4cmH2O without ATC
(low PS group) and ATC PEEP4cmH2O without PS (ATC group) as SBT
trial. Patients with chronic respiratory failure under long term home
oxygen therapy and/or noninvasive ventilation before ICU admission,
tracheotomy, nasogastric tube contra-indicated, thoracic tube in place,
no agreement to participate were not included. Low PS and ATC were
randomly applied for 30 minutes each and preceded by a 30-min con-
trol period with the PS level before the study. ATC was set at 100%
compensation of patient's ETT size. Esophageal and airway pressures
and flow were measured at ETT proximal end. At the end of each
period resistive and elastic components of WOB done by the patient
were obtained from the Campbell diagram over a 2-min recording at
the end of each period. Power of breathing (W) and W/liter ventilation
were determined as WOB times respiratory rate and W divided by mi-
nute ventilation, respectively. Primary end-point was total (resistive +
elastic) W. We computed that 16 patients should be required for a 4±4
J/min reduction in W with low PS as compared to ATC be statistically
significant at 5% and 20% risks, respectively. Analysis was done using
linear mixed model testing effect of treatment (low PS vs ATC), period
and interaction between them. Values are median (1st-3rd quartiles).
RESULTS. Twenty patients were included over 12 months. Between
low PS and ATC, W was 6.4 (4.3-9.3) and 9.8 (5.3-22.0) J/min (P=
0.011) with no significant effect of both period and interaction be-
tween treatment and period. Both resistive (3.2 (2.1-4.6) vs. 4.7 (1.5-
9.7)J/min P=0.035) and elastic (3.6 (2.3-4.5) vs. 5.2 (3.6-8.8) J/min P=
0.0096) W were significantly lower with low PS than ATC. W/liter mi-
nute ventilation was significantly lower in low PS (0.74(0.53-0.93))
than in ATC group (0.97 (0.68-1.54)) J/L (P=0.004). Both resistive and
elastic components of W/liter minute-ventilation (0.33 (0.23-0.53) vs.
0.47 (0.22-0.74) (P=0.04) and 0.40 (0.32-0.47) vs. 0.63 (0.45-0.69) J/L)
(P=0.00005) were significantly lower with low PS than with ATC, with
no significant effect of period and no interaction.
CONCLUSION. When SBT is done by using low PS a respiratory sup-
port is provided to the patient above the compensation of RET. Low
PS does more than just compensating for RET.
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INTRODUCTION. Direct (Pulmonary) and indirect (extrapulmonary) acute re-
spiratory distress syndrome (ARDS) differs responses and therapeutic effects
of both groups were heterogenous. However, there were few studies to def-
inite results about it, especially critically ill pediatric ARDS (PARDS) patients.
OBJECTIVES. This study aims to compare two ARDS groups in the
clinical outcomes and the risk factors for mortality.
METHODS. This was a single center, retrospective study. Among the chil-
dren admitted to the pediatric intensive care unit (PICU) of a tertiary care
children’s hospital between October 2010 and October 2018, 144 pediatric
patients classified as either pulmonary (n=119) or extrapulmonary (n=25)
ARDS were included. Patients who had L-R shunt and heart failure were
excluded. We used the unpaired student's t-test and Univariate logistic re-
gression for risk factors of mortality in each sutyptes of ARDS.
RESULTS. There was significant difference in the PICU mortality rate
by PARDS level between two groups. The mortality was significant in-
creased by PARDS level in direct ARDS group but not in indirect
ARDS group (p=0.002 vs p=0.774). The direct ARDS group showed
that PaO2/FiO2 (P:F ratio, p=0.005), Oxygen index (OI, p=0.037), FiO2
(p<0.001), peak expiratory end pressure (p=0.002), driving pressure
(p=0.035), peak inspiratory pressure (p<0.001) and mean airway pres-
sure (p<0.001) were significant risk factor in mortality, while the indir-
ect ARDS group had significant risk factor as lactate (p=0.007) and
percentage of neutrophil (p=0.002) in mortality
Table 1 (abstract 000107). AUROC Analysis





Fibrinogen q0h 0.492 0.094 0.932ns 41.7% 57.1%
Fibrinogen q48h 0.538 0.112 0.729ns 55.6% 65.6%
Change in Fibrinogen
(delta fibrinogen)
0.561 0.121 0.581ns 55.6% 62.5%
Page 20 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55CONCLUSION. Our results, showing that clinical outcomes and risk
factors for mortality rate differ by ARDS types suggest that pulmon-
ary and extrapulmonary ARDS could have different clinical courses
and thus should be managed distinctly
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INTRODUCTION. Severe pneumonia is major risk factor to develop
Acute Respiratory Distress Syndrome (ARDS). Early recognition of
patients at risk to develop ARDS is not only crucial but pivotal.
The Berlin criteria aids in diagnosis of ARDS however, the ab-
sence of a standard diagnostic biomarker may lead to under-
recognition and delayed evidence-based interventions. To date,
most studies on ARDS biomarkers are retrospectively done.
Among these, plasma fibrinogen has shown association with
ARDS progression in patients with severe pneumonia.
OBJECTIVES. At present, the clinical utility of plasma fibrinogen for
ARDS is unknown. With this study, we sought to find association
between plasma fibrinogen levels and progression to ARDS among
patients with severe pneumonia.
METHODS. In this prospective cohort study, patients diagnosed
with severe pneumonia based on IDSA criteria were enrolled
from July 2018 to February 2019. Baseline clinical and laboratory
parameters were recorded and disease severity were scored using
APACHE II. Two determinations of plasma fibrinogen were done,
first within 24 hours of disease recognition and the second after
48 hours. The participants were then followed for 7 days with
development of ARDS as the primary outcome. The diagnosis of
ARDS was made by the intensivist on-duty and/or the attending
pulmonologist.
RESULTS. Forty-seven patients were prospectively monitored
within 7 days of enrolment then divided into two sub-groups be-
tween twelve (25%) patients who developed ARDS and thirty-five
(75%) patients who did not. Fibrinogen levels at baseline had sen-
sitivity and specificity of 41.7% and 57.1% respectively (p=0.932),
levels after 48 hours had sensitivity and specificity of 55.6% and
65.6% respectively (p=0.729), and delta fibrinogen levels had sen-
sitivity of 55.6% and specificity of 62.5% (p=0.581) (Table 1). Low
platelet counts and higher PEEP levels used were found to be sta-
tistically significant parameters for ARDS progression.CONCLUSION. Based on this study, plasma fibrinogen is an unreliable
biomarker for predicting ARDS development in patients with severe
pneumonia. To our knowledge, this is the first attempt to investigate
on a biomarker for ARDS progression in the Philippines. A higher-
powered study with more robust sample size is recommended. How-
ever, further analysis regarding local incidence of ARDS should be
made. Hopefully, this study will serve as benchmark for further re-
search as relevant information and local data are still lacking. Other
biomarkers that can predict ARDS development amongst patients at
risk should be further investigated.
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INTRODUCTION. A spontaneous breathing trial is commonly per-
formed to assess whether a patient can tolerate without ventilator
support. However, the reintubation rate is 10-20% even after success-
ful SBT. Although physiologic parameters during SBT, such as the
work of breathing (WOB) or the pressure time product (PTP), may in-
form the risk of reintubation, measurement of such parameters is not
technically simple. Proportional assist ventilation with load-adjustable
gain factors (PAV+) can easily estimate the WOB and the peak inspir-
eatory muscle pressure (Pmus).
OBJECTIVES. We investigated whether the WOB and the Pmus esti-
mated by PAV+ during SBT can predict post-extubation respiratory
failure and necessity of reintubation.
METHODS. This study was a prospective observational study in a single
center in Japan. All patients over 18 years old who were mechanically
ventilated and passed SBT using a mode of PAV+ with a support rate
20% were included. We recorded the average of WOB, peak inspiratory
pressure (Ppeak), compliance and resistance measured by PAV+ during
SBT. And we calculated the peak Pmus from Ppeak. The primary outcome
of this study was post-extubation respiratory failure within 72 hours.
RESULTS. A total of 50 mechanically ventilated patients were included.
Eighteen patients had post-extubation respiratory failure within 72
hours. The patients with post-extubation respiratory failure showed
Page 21 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55significantly higher peak Pmus than those without post-extubation fail-
ure (14.0 vs 12.3 cmH2O, p=0.025). There were no siginificant differ-
ences in WOB (3.81 vs 3.21 J/min, p=0.115), compliance (63 vs 61 mL/
cmH2O, p=0.846), and resistance (5.3 vs 4.8 cmH2O/L/s, p=0.623) mea-
sured by PAV+ between the two groups.
CONCLUSION. Peak Pmus estimated by PAV+ during SBT is a pos-
sible predictor of post-extubation respiratory failure. Larger sample
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INTRODUCTION. EVLW accumulates in the lungs even before the
changes in blood gases and chest x-ray become apparent. The lungs
which have high compliance tend to expand to a greater extent as com-
pared to the lungs with low compliance.Martelius et al found that a signifi-
cant decrease in the number of B lines is associated with improved static
lung compliance in a prospective observational study of 34 infants. How-
ever, till date, no study has been done in adults to correlate EVLW with
lung compliance. Therefore, we planned to do this study in adult patients.
OBJECTIVES. To assess quantitative correlation of B lines on bedside lung
ultrasound with static lung compliance in adult patients on mechanical
ventilation. and to assess correlation of B lines with oxygenation index.
METHODS. The study commenced after the clearance of the ethics
committee of the institute. Informed consent was taken from the pa-
tient or the patient's legal guardian to enroll them in the study. Follow-
ing approval from institutional ethics committee study was conducted
from October 2017 to June 2018. (Ref.No.NK/3868/MD/299).During the
study a total of 200 lung ultrasound readings were recorded along with
static lung compliance and oxygenation index.
Static compliance was recorded along with lung USG. For static compli-
ance, there should be no patient effort. It was calculated with a tool
given in eVent ventilator 10 mins after giving short-acting muscle relax-
ant like atracurium(0.5mg/kg) and sedatives like midazolam or fentanyl.
Oxygenation Index(OI) = FIO2/PaO2×MAP
FIO2 = Fraction of inspired oxygen, Pao2= Partial pressure of arterial
oxygen, MAP= Mean airway pressure
RESULTS. Sixty-one patients, with 200 USG readings in total, were in-
cluded in our study. Minimum gap between 2 readings was 24hrs.
All patients had a comparable demographic profile. The B line score and
static lung compliance appear to be inversely related which means
higher the B line score, lower is the static lung compliance. Correlation
showed R2 of 0.43 which explains the 43% changes in static lung compli-
ance values could be explained by changes in the B line scores.
A positive linear correlation was found between B line score and oxy-
genation index. This suggests as number B lines in lung increases the
oxygenation index also increases. Correlation showed R2 value of
0.403 explains 40% of change in B line scores correlated positively
with the oxygenation index as shown by R2 value of 0.40.
CONCLUSION. The most important finding in our study was a nega-
tive correlation of B line score with static lung compliance having a
significant R2 value of 0.43. Other findings were a positive correlation
of B line score with oxygenation index and a negative correlation of
lung compliance with oxygenation index. Through our analysis, we
can conclude that increase in number of B lines is associated with
concomitant decrease in lung compliance and increase in oxygen-
ation index in adult patients.REFERENCE(S)
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INTRODUCTION. Automatic tube compensation (ATC) is an option
available in intensive care unit (ICU) ventilators to compensate
for endotracheal tube (ETT) resistance. To achieve this ICU venti-
lator delivers a certain amount of pressure/flow that compensates
for the resistive pressure drop across ETT. It requires notifying
size of ETT and percent of compensation. We reasoned that if
ATC works properly tidal volume (VT) should be the same with-
out ATC and no ETT as with ATC and ETT. We tested the per-
formance of ICU ventilators on a bench, expecting furthermore
differences between them.
METHODS. Seven ICU ventilators (Evita XL and V500 infinity (Drae-
ger), C6 and S1 (Nihon-Khoden), Elisa 800 (Lowenstein), 980
(Medtronic), Carescape 860 (GE)) were set in pressure support 0
cmH2O, PEEP 4 cmH2O, FIO2 21% and equipped with the same
double limb ventilator circuit (Intersurgical) without any humidifi-
cation device. ASL 5000 bench model was set with 3 inspiratory/
expiratory resistance (R) and compliance (C) combinations: R13/
12-C54, R12/14-C39 and R22/18-C59 mimicking normal, ARDS and
COPD conditions, respectively (1). Inspiratory effort generated by
ASL 5000 consisted of 30 consecutive breaths obtained from the
esophageal pressure in a real patient at the time of a spontan-
eous breathing trial. For each ICU ventilator and RC combination,
two steps were performed: in the first, ATC was not activated
and ventilator attached to ASL 5000 without ETT (ATC-ETT-); in
the second, ATC was set on at 100% compensation for an ETT 8
mm ID and such an ETT (Shiley Hi contour, Covidien) joined ICU
ventilator to ASL 5000 (ATC+ETT+). The null hypothesis is that
VTATC+ETT+ minus VTATC-ETT- is 0. Primary end point was the
breath by breath paired difference betwen ATC+ETT+ and ATC-
ETT-. It was tested to zero for each ventilator in each RC
condition.
RESULTS. Median VT was 213 ml. Table 1 displays mean (±SD)
difference in VT (ml) between ATC+ETT+ and ATC-ETT-: a nega-
tive value means that ATC under delivers and a positive value
that ATC over delivers VT for a given patient’s inspiratory effort
and RC. In four ventilators (C6, S1, Elisa 800 and 980) ATC almost
systematically under delivered VT. In several instances under
compensation was greater than 10% median VT. By contrast ATC
performed better with the other three ventilators (Evita XL, V500
and Carescape 860).
Page 22 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55CONCLUSION. ATC tended to under deliver VT. Furthermore, there
were marked differences between ICU ventilators the clinician
should be aware of when using the ATC option.
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Evita Carescape 860 C6 S1 Elisa 800 980 V500
ARDS -5±4** 3±14 -21±4Ϯ -16±13Ϯ -17±3Ϯ -39±8Ϯ 0±11
COPD -3±9 9±10Ϯ -12±4Ϯ -12±2Ϯ -12±2Ϯ -24±6Ϯ -8±30**
Normal -8±5** -9±51* -33±7Ϯ -16±14Ϯ -20±4Ϯ -51±7Ϯ -9±14*
*P<0.05 **P<0.01 Ϯ P<0.001 versus 0
Table 1 (abstract 000164). Model performance characteristics








Low 0.85 0.79 0.80 0.85 0.49
Medium 0.69 0.82 0.75 0.79 0.42
High 0.69 0.97 0.72 0.97 0.09000164
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INTRODUCTION. Exercise is considered an important intervention
to facilitate weaning from mechanical ventilation and limit long-
term functional dependence. However, the exercise intensity of
individual patients during rehabilitation is not measured. This
potentially leads to under training of some and overtraining of
others.
Breath-by-breath gas exchange analysis (BBGEA) is the gold standard
for measuring oxygen consumption (VO2) to calculate workload.
While an invaluable research tool, it is impractical for use in routine
clinical practice. Alternative methods of monitoring exercise intensity
during rehabilitation are required.
During BBGEA data collection for previous studies, we noted (i)
how closely minute ventilation (VE) tracked VO2 and (ii) recovery
of VE to the pre-exercise state was indicative of VO2 returning to
baseline. While VE could potentially be used as an indicator of
recovery between exercise bouts during a rehabilitation session,
the complexity of the relationship between VE and VO2 currently
negates its use as a direct estimate of absolute exercise
intensity.
OBJECTIVES. We aimed to establish whether exercise VO2 could be es-
timated from exercise VE, RR, VT and resting end-tidal CO2 (PETCO2).
METHODS. VE, RR, PETCO2, VT and VO2 were recorded using the
Medgraphics Ultima device during rehabilitation of 37 patients on
106 occasions.
Principle component analysis (PCA) was used to describe the vari-
ation in the data between, VE, RR, VT. The first 2 PCA components
accounting for 98% of the variance, were added to a linear
mixed effects model along with the explanatory variables; resting
PETCO2, age, gender and weight. The fixed effect of the model
was patient.
The measured VO2 values were classed as low 3.5 - 4.5 ml/kg/
min, medium >4.5 - 5.5 ml/kg/min and high > 5.5ml/kg/min. The
performance characteristics of the model were assessed using a
confusion matrix.
RESULTS. In a small sample size we demonstrate good agreement
between actual and predicted VO2 from a model using VE, RR,
PETCO2, VT, age, gender and weight. The MROC area under thecurve for this model was 88%. The performance classifiers are
given in table 1. This model requires future validation in an inde-
pendent sample to confirm its utility.
CONCLUSION. Predicting VO2 from easily obtainable observations in
ICU may be possible during rehabilitation.
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INTRODUCTION. During educational process, trainees apply their
knowledge to treat patient in intensive care before achieving full
clinical competency. Moreover, advances in knowledge regarding
mechanical ventilation in particular lung protective ventilation
and asynchronies have been shown to be associated with mortal-
ity. For these reasons we developed a simulator of controlled
and spontaneous artificial ventilation (Sim-VA) and virtual breath-
ing patients. Mathematical model resolved differential equations
of chest and lung movements according to inspiratory effort or
not, in order to match with a clinical database.
OBJECTIVES. The aim of this study was to compare two teaching mo-
dalities on mechanical ventilation: traditional lectures versus virtual
simulation.
METHODS. This randomized controlled study involved 54 resi-
dents. One group of 22 participants attended the same didactic
lecture on mechanical ventilation (3 hours) whereas the other
22 were in the simulator group (3 hours). Performance was
measured using a pre and post-test evaluation of knowledge on
respiratory settings and pressure flow time curves monitoring in
ARDS and COPD patients. A retention test was done at 3
months (The same questioner was used for pre, post and reten-
tion test). Comparison was individual in each group (*ANOVA,
multiple comparison) and between groups (Mann-Whitney), p<
0,05 was considered significant.
RESULTS. Baseline knowledge was not different between groups;
post-test was significantly improved in both groups (figure) but
was significantly higher in the simulator group. Retention test
was only significantly different from the pre-test in the simulator
group.
Page 23 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55CONCLUSION. A computer-based simulation with a modelisation of
controlled and spontaneous mechanical ventilation has the potential
to improve knowledge and skills in ventilator settings in comparison
to traditional didactic lectures.Fig. 1 (abstract 000170). See text for description000172
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INTRODUCTION. In numerous studies, high-flow oxygen through nasal
cannula (HFNC) has proven beneficial for patients with hypoxic respira-
tory failure (1-3). In these studies, patients with hypercapnia are generally
excluded. Therefore, use of HFNC in hypercapnic patients is controversial.
OBJECTIVES. To compare the need for endotracheal intubation and
mortality risk in patients with acute respiratory failure with hypoxemia
and hypercapnia, admitted to the intensive care unit (ICU) and treated
with either HFNC or non-invasive positive pressure ventilation (NIPPV).
METHODS. Retrospective cohort study of adult, hypoxic and hypercapnic
patients admitted to the ICU, identified by start of treatment with either
HFNC or NIPPV at admission. Patients were included between September
2015 and August 2018 at Zuyderland Medical Center, The Netherlands.
RESULTS. After screening 676 patients with 1109 episodes, 95 patients
fulfilled all inclusion criteria. Out of these patients, 35 received HFNC and
60 NIPPV. In both treatment groups, pH and paCO2 values improved 6
and 24 hours after start therapy. Arterial pH improved in the first 24
hours from 7.27 to 7.40 in the HFNC group and from 7.26 to 7.32 in the
NIPPV group (p=0.001 between groups at t=24 hours). The pCO2 im-
proved from 9.3 to 7.1 kPa in the HFNC group and from 9.2 to 8.3 kPa for
patients treated with NIPPV (p=0.05 between groups at t=24 hours).
Need for intubation did not differ significantly between HFNC and NIPPV(35% and 22% respectively; p=0.4). In contrast, mortality was increased
using HFNC instead of NIPPV (41% versus 12% in HFNC; p=0.039). Sub-
group analysis revealed that in patients with chronic obstructive pulmon-
ary disease (COPD), both the need for intubation and mortality risk were
not different between HFNC and NIPPV (p=0.6 and p=1.0, respectively).
Time analysis showed no significant difference between groups in time
between admission and death (Log Rank p=0.5).
CONCLUSION. This study shows a proof of principle of HFNC in pa-
tients with hypercapnic respiratory failure at the ICU in terms of im-
provement of arterial blood gas (ABG) values. However, when
comparing all hypercapnic patients admitted to the ICU in this study,
treatment with HFNC seems to be associated with an increased mor-
tality risk. In patients admitted for COPD, there is no increased risk
for intubation or mortality when compared to NIPPV. These data sug-
gest that HFNC might be useful for hypercapnic patients with an
acute exacerbation of COPD, but may have an adverse outcome in
other hypercapnic patient groups.
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INTRODUCTION. Respiratory support plays an important role in pa-
tient’s recovery after cardiovascular surgery. Adaptive support venti-
lation (ASV) is an automatic closed-loop ventilation mode where
minute volume is controlled by a combination of tidal volume (Vt)
and respiratory rate settings based on patient's respiratory mechan-
ics. There is an ability to reduce workload for physicians without
compromising patient’s safety with using intellectual modes of
mandatory ventilation.
OBJECTIVES. To compare the effect(s) of ASV and conventional venti-
lation modes.
METHODS. In this randomized controlled trial 40 adult patients were
ventilated with ASV and 38 with conventional ventilation modes after
uncomplicated cardiac surgery. Hamilton G5 ventilators were used
and 8 physicians were involved into the study. All actions of physi-
cian’s, ventilator settings and changes were monitored and recorded
during mechanical ventilation and weaning. Care of both groups was
standardized, except modes of postoperative ventilation.
We compared the physician’s workload, through accounting number
of manual ventilator settings made before tracheal extubation and
time, which they spent near the ventilator in every group.
The secondary endpoints were duration of tracheal intubation in ICU, the
frequency of undesirable events and the length of ICU and hospital stay.
RESULTS. There were no significant differences in the duration of re-
spiratory support in ICU: 267,6±76,6 min (ASV) vs 270,5±80 min
(control).
In ASV group the number of manual ventilator settings and time
spent near the ventilator before tracheal extubation was lower: 2 (1-
4) vs 4 (2-6), (p=0,0000) and 99±35 sec vs 166±70 sec (p=0,0001)
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to spontaneous mode after restoration of patient’s respiratory activity
took 36,5(12-76) min. In ASV group spontaneous breathing began
immediately after recover of patient’s respiratory drive, which meant
less risk of patient-ventilator asynchrony.
ASV provided more protective ventilation: the driving pressure
was significantly lower - ΔP on mechanical ventilation was 7,2±
1,6 cm H2O vs 9,3±2,1 cm H2O (p=0,000001) and on pressure
support - 5,5±1 cm H2O vs 7,9±1,5 cm H2O (p=0,0000). There
were no significant differences between the groups in Vt
values: 7,0 (6-8,5) ml/kg (ASV) vs 7 (6-10) ml/kg (control) during
mechanical ventilation and 7,5 (6,6-9,5) ml/kg in ASV vs 8 (7-
10) ml/kg in control group during pressure support ventilation
as well as in undesirable events and duration of ICU and hos-
pital stay.
CONCLUSION. Application of ASV mode after uncomplicated car-
diac surgery provides more protective mechanical ventilation and
reduces the physician’s workload without compromising the qual-
ity of respiratory support and safety of patients.
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INTRODUCTION. Some recent studies have shown that airway pres-
sure release ventilation(APRV) might have some potential benefits in
the patients with acute respiratory distress syndrome(ARDS). How-
ever, these results are inconsistent.
OBJECTIVES. The aim of our study is to conduct a meta-analysis to
analyze the effect of APRV on respiratory variables and outcomes in
ARDS patients.
METHODS. All eligible articles from MEDLINE, EMBASE, CENTRAL,
and Chinese BioMedical Literature Database (January 2000–Janu-
ary 2019) were incorporated into this study. Studies were
assessed independently by two reviewers. We extracted the
data(Standard Mean Difference (SMD) for continuous variables
and Risk Ratio (RR) for dichotomous variables) from the in-
cluded studies. Heterogeneity was defined as P < 0.10 or I2 >
50%. Fixed-effect model was used to combine effective sizes if
homogeneity was fine (P > 0.10,I2 < 50%),otherwise a random-
effect model was used. Results are provided with a 95% confi-
dence interval (CI) and associated p-value. STATA 13.0 software
was used for the meta-analysis.
RESULTS. A total of 446 patients from eight studies were in-
cluded in this meta-analysis. Compared with the LTV group, the
patients in APRV group had a shorter length of hospital stay
(SMD -0.37[-0.64, -0.10] p=0.006), shorter length of ICU stay
(SMD -0.25[-0.45,-0.05] p=0.013) and higher success rate of extu-
bation (RR =1.40[1.02, 1.96] p=0.048).After 72h ventilation,
higher mean airway pressures (SMD 1.08[0.37,1.80] p=0.003)
,higher PaO2/FiO2(SMD 0.56[0.08,1.04] p=0.022), greater respira-
tory system compliance(SMD 0.68[0.11,1.25] p=0.019), lower
PEEP(SMD -1.44[-1.75,-1.14] p<0.001) and lower total minute
ventilation(SMD -0.74[-1.27,-0.21] p=0.007) were seen in APRV
patients.
CONCLUSION. APRV may be a promising ventilation mode for
ARDS patients, which can reduce the duration of both hospital
and ICU stays, contribute to successful extubation and improve
some respiratory indicators in comparison to LTV. However, more
prospective and randomized trials are needed to further clarify
these issues in the future.REFERENCE(S)
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INTRODUCTION. During the period of September 2018 to April
2019, the number of patients admitted to the intensive care
unit with influenza A H1N1 in the city of Laredo was alarming.
We decided to investigate the characteristics of our population
for future health care interventions.
OBJECTIVES. Describe the clinical characteristics of adult patients
who were hospitalized with the influenza A 2009 H1N1 virus in
the city of Laredo (Texas, USA) from September 2018 to April
2019
METHODS. Using medical charts, we collected data on 38 adult
patients who were hospitalized for at least 24 hours for influ-
enza bronchopulmonary infection and who tested positive for
influenza A 2009 H1N1 virus with the use of a real-time
reverse-transcriptase-polymerase-chain-reaction assay.
RESULTS. Of the 38 adults of patients we studied, 42% were ad-
mitted to the intensive care unit for acute respiratory failure.
Ninety-five percent of the patients belonged to the Hispanic
ethnic group. Twenty-six percent were on intubated on mechan-
ical ventilation and 16% received non-invasive mechanical venti-
lation. Only 2 patients were identified to be vaccinated against
the influenza virus. None of the patients in the ICU had the in-
fluenza virus vaccine. There were 6 cases of ARDS of whom two
required ECMO. The average body mass index was 23 ± 2.7 Kg/
m2 in ARDS population versus 33 ± 9.9 kg/m2 in the non-ARDS
patients. There was a moderately statistical significant correl-
ation between BMI and ARDS patients (n=38,r=-0.44, P=0.005).
Twenty-one percent of patients were on vasopressors of whom
all were on mechanical ventilation. The most common comor-
bidities were diabetes mellitus (26%), COPD (24%), obstructive
sleep apnea (10%), liver cirrhosis (8%) and chronic renal insuffi-
ciency (8%). All the patients received oseltamivir on admission.
The average age of patients was 58 years old with 20 males
and 18 females. The average age of ARDS patients was 51 years
old.
CONCLUSION. During the evaluation period, 2009 H1N1 influ-
enza caused a significant number of admissions to the intensive
care unit. The most remarkable findings were the moderately
significant correlation between a low BMI in the ARDS group vs.
the non-ARDS group. Notable, also, was the minimal amount of
patients who received the vaccine before admission. The city of
Laredo is predominantly of Hispanic ethnicity located at the
border with Mexico. This is the first study, in our knowledge,
that includes the intensive care unit epidemiological data of in-
fluenza A 2009 H1N1 in the city of Laredo, Texas, USA. The im-
pact of higher vaccination rate by patient education and closer
surveillance with lower BMI are strategies to be considered for
future studies.
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INTRODUCTION. More than two thirds of patients who enter in In-
tensive care unit (ICU) require invasive or non-invasive mechanical
ventilation (NIMV), diagnosis of ICU weakness and neuromuscular
dysfunction are detected in 25-50% of the patients who require more
than five days of mechanical ventilation. However there is lack of
data of prevalence of diaphragmatic dysfunction (DD) in patients
under non-invasive mechanical ventilation in ICU.
OBJECTIVES. The primary objective of this study was to stablish the
prevalence of diaphragmatic dysfunction in non-invasive mechanical
ventilation.
The secondary objective is to determine if the patients with dia-
phragmatic dysfunction had a larger duration of NIMV vs patients
without diaphragmatic dysfunction.
METHODS. Cohort Study, Observational, Longitudinal, prospective.
73 patients with NIMV were recruited prospectively at the Depart-
ment of critical care medicine ABC Medical Center. The thickness of
the right diaphragm (RDT) was measured in the area of apposition of
the diaphragm to the chest in both hemithorax, using an ultrasound
transducer of 4 MHz and the right diaphragmatic fraction index
(RDFI) and the change in diaphragm thickness(ΔTdi), was calculate-
d.in patients with NIMV. The presence of DD was defined according
to the presence of ΔTdi bilaterally less than 20% or less than 15 mm
of diaphragm thickness.
RESULTS. The inclusion criteria were met for 73 patients. Overall preva-
lence of diaphragmatic dysfunction was 20% for a cutoff of 15 mm
of thickness of the diaphragm or ΔTdi bilaterally less than 20%. the
mean age was 70.4 SD ± 14, with APACHE II mean score of 20 SD±8.2.
Charlston comorbidity index mean score of 4.3 SD ±1.6. The variables
obtained from USG measurements were as follow. Right diaphragm
thickness (RDT) 15.5 mm ± 5 mm, right diaphragmatic fraction index
(RDFi) 23.1 ± 10.7% and change in diaphragm thickness(ΔTdi) was
27% ± 10. Media of Length of VMNI was 11.6 days in patients without
diaphragmatic dysfunction and 16.6 days in patients in VMNI with dia-
phragmatic dysfunction. The diagnosis of DD was associated with incre-
ment in Length of VMNI with media 5 days OR 5.7 (IC 18.2-7.8).
CONCLUSION. A high prevalence of DD was identified in in patients
with VMNI. The presence of DD was associated with an increment in
days of VMNI.
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INTRODUCTION. In patients with chronic pulmonary disease,
high levels of alkaline phosphatase (ALP) are associated with a
neutrophilic inflammatory pattern within the pulmonary com-
partment. (1) Preclinical studies demonstrate markedly elevated
ALP levels in animals with acute lung injury along with
increased inflammatory markers. (2, 3) The role of ALP in
critically-ill patients with acute pulmonary inflammation remains
unknown.
OBJECTIVES. This study aimed to investigate if pulmonary ALP ac-
tivity is associated with pulmonary inflammation in critically-ill pa-
tients. We hypothesized that patients with acute respiratory
distress syndrome (ARDS) present with higher pulmonary ALP ac-
tivity levels compared to non–ARDS patients.
METHODS. ALP activity levels were measured in bronchoalveolar
fluid (BALF) and plasma samples of 125 critically–ill patients with
≥ 2 SIRS criteria from the prospective cohort trial ‘Molecular Diag-
nosis and Risk Stratification for Sepsis’ (MARS). Correlations be-
tween ALP activity and inflammatory cytokines were assessed by
Spearman’s correlation coefficient. Comparisons between groups
were performed using Mann-Whitney U test according to data
distribution.
RESULTS. There is a strong positive correlation between pulmon-
ary ALP activity and pulmonary inflammatory cytokines. (r = 0.71
for IL–6 (Figure 1A); r = 0.80 for IL–8 (not shown)). In critically-ill
patients, no difference in BALF ALP activity was detected be-
tween ARDS and non-ARDS patients (p = 0.413, Figure 1B), nei-
ther between patients with a direct or indirect cause of ARDS (p
= 0.36, Figure 1C).
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strongly correlates with IL–6 and IL–8 levels within the pulmonary
compartment. Pulmonary ALP activity is not different in patients with
the clinical syndrome ARDS compared to patients without ARDS.
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INTRODUCTION. Acute respiratory distress syndrome (ARDS) is a
common critical syndrome in critical care medicine, and lung protect-
ive mechanical ventilation has been recommended in ARDS patients.
However, the mechanism is still not clear. Piezo1 protein is a recently
discovered, which is a stretch-activated channel (SAC) and closely re-
lated to the mechanical signal transduction of eukaryotic cells1-3.
But, there is still no evidence about its function in the ventilator asso-
ciated lung injury in ARDS.
OBJECTIVES. To observe the expression of Piezo1 in the ventilator as-
sociated lung injury in ARDS in vivo., and study its role in LPS in-
duced type II alveolar epithelial cells (AECII) injury, at last, we
explained it`s protective mechanism on AECII injury.
METHODS. We carried animal experiments based on ARDS model
treated with ventilator, and cell experiment under cyclic mechanical
stretch stress(MSS) in vitro. Different tidal volume was given to ARDS
animal induced by oil acid, and lung tissue,blood sample were col-
lected to testify the diagnostic of ARDS, and then observe the ex-
pression of Piezo1 in ACEII cells. In vitro, we observed Piezo1 in ACEII
injury induced by LPS, then we observed the cell apoptosis changes
and studied the influence mechanism of Piezo1 on cells injury which
induced by different cyclic MSS. At last, we combined with Piezo1-
siRNA to study its role in ACEII injury.
RESULTS. From the artery blood gas and pulmonary tissue detection
results, we had built successful ARDS animal model. After treated
with ventilator, the lung injury can be improved, and compared with
high tidal volume ventilation group (HV), low tidal volume (LV) group
improved better. In cells apoptosis of lung tissue and AECII, we found
the apoptosis rate was significantly increased in ARDS, and mechan-
ical ventilation significantly reduced the apoptosis, most importantly,
LV had lower apoptosis rate compared with HV ventilation. For Piezo
1, we had evidenced that it was enhanced in ARDS animal model
and cyclic stretch stress in ACEII cells by western blot and immuno-
fluorescence. The mechanical ventilation could decrease its expres-
sion, compared with HV, the gray value was less in LV group. There
was same trend of Piezo1`s expression in cyclic stretch stress ACEII,
and the less stretch was associated less expression of Piezo1. Further,
we detected the lever of Calcium ion concentration and found intra-
cellular Ca2+ was increased by flow cytometry, Immunofluorescence
and Laser scanning confocal microscope from lung tissue and ACEII.
The intracellular Ca2+ was influenced by the MSS, and it had lowerlever in low cyclic MSS group compared with high cyclic MSS. At last,
we combined with Piezo1-siRNA to study the piezo1`s role in cell in-
jury, and found Piezo1-siRNA inhibited the Calcium influx, decreased
intracellular Ca2+. In cell apoptosis, we found Piezo1-siRNA signifi-
cantly decreased cell`s apoptosis in ACEII induced by cyclic MSS.
CONCLUSION. Piezo1 was high expression in ARDS animal and cyclic
MSS cells, and its different expression was associated with the de-
gree of MSS, the more, the higher. Piezo1-siRNA could decrease intra-
cellular Ca2+ and cell apoptosis induced by cyclic MSS. Piezo1
maybe a new direction in ventilator associated lung injury in ARDS.
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INTRODUCTION. Chronic Obstructive Pulmonary Disease (COPD) is the
third leading cause of death worldwide and it is responsible of import-
ant morbidity and healthcare costs. White blood cell populations are in-
volved in the pathophisiology of COPD. Neutrophil to lymphocyte ratio
(NLR), a simple, low cost index, has been recently proposed as prognos-
tic marker of several inflammatory and cancer diseases.
OBJECTIVES. Neutrophil to lymphocyte ratio (NLR) and eosinophil to
basophil ratio (EBR) could be considered as potential markers of sys-
temic inflammation. We hypothesize that diagnosis and prognosis of
severe patients admitted to Intensive Care Unit (ICU) due to exacer-
bated COPD, can be predicted with a routine blood test that include
these variables.
METHODS. We made a prospective observational cohort study. We ana-
lyse consecutive patients who need hospitalization in ICU due to COPD
exacerbation that require mechanical ventilation. We exclude patients
with other inmunologic disease or antiinflammatory treatment. We ana-
lyse NLR and EBR at the moment of ICU admission, and we follow-up
them in stable phase in external consultation, during 24 month period.
We compare inflammatory markers in both phases and their relation with
prognostic factors. Statistical analysis: STATA version 13
RESULTS. We include 55 patients. In the comparative study of inflamma-
tory markers in exacerbated patients vs stable COPD patients, we found
significant differences between leucocytes (12,3 x vs 5,6 p<0.001); neutro-
phils (10,5 vs 5,3; p<0.001); lymphocytes (1,02 vs 1,64; p:0.018); and eosin-
ophils (0.039 VS 0.119; p<0.001). The NLR was significantly higher in
exacerbated patients (19.310 vs 4.697; p<0.001). EBR was signifi-
cantly higher in stable patients (1.305 vs 3.322; p:0.009).
The results of our study showed correlation between NLR, EBR and hos-
pital mortality. EBR was significantly lower in exitus than survivors (1.816
vs 1.290; p:0.017); while NLR was significantly higher in exitus than survi-
vors (28,567 vs 18,043; p<0.001) (cut-off point of 5.23 with AUC: 0.90, S:
86,27% E: 84,62%).
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tory markers for diagnosis of severe exacerbation of COPD and for
the prognosis. The results of this study show that higher NLR an
lower EBR correlated with poor prognosis.
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INTRODUCTION. The decision-making to move towards weaning
must be based on objective criteria, not only on the criterion of the
responsible physician. In the literature, a large number of predictors
have been described to facilitate this decision-making with the low-
est possible risk, thus minimizing the complications associated with
weaning failure. One of the best known is the Rapid Shallow Breath-
ing Index (RSBI), but it has a limited prognostic capacity. Recently a
modification has been proposed (D-RSBI) that takes into account the
diaphragm, fundamental in the generation of tidal volume.
OBJECTIVES. The aim of the study is to assess the predictive capacity
of D-RSBI and compare it with its predecessor in patients subjected
to MV> 48 hours
METHODS. Prospective study including 17 patients submitted to MV
due to different causes (TBI, CCV, urgent surgery, respiratory failure).
Once criteria for advancing weaning are met, a SBT is performed in
PSV 5 - 8 cmsH2O over 5 cmsH2O of PEEP, and the following deter-
minations are made: RSBI, FR, Vt, Diaphragmatic excursion, D-RSBI.
Epidemiological variables are collected, reason for admission, VM
time, weaning failure, mortality.
RESULTS. The average age was 56.12 years +/- 13.95. 70.6% were male.
Reason for admission: TBI (29.4%), CCV (29.4%), Urgent surgery (23.5%).
The median duration of MV was 11 days. 64.7% presented weaning failure.
We observed a significant relationship between D-RSBI and weaning
failure (Test Chi2 p 0.016). ANOVA was performed, showing a good
correlation between variables (F 8.6 p 0.01). We performed a COR
curve presenting AUC 0.86 (p 0.016, 95% CI 0.688-1), finding a cut-off
in 1.17 (S 72%, E 83%). RSBI presents AUC 0.79 (p 0.05, 95% CI 0.57-
1). However, in the subgroup analysis (Group 1: MV <10 days, Group
2: MV> 10 days), in group 2 we did not observe a significant relation-
ship in the D-RSBI and weaning failure
CONCLUSION. - In our sample, the D-RSBI improves the predictive
capacity of the RSBI in patients with short-term respiratory support
- In patients with prolonged mechanical ventilation, the predictive
capacity of D-RSBI is limited, similar to the RSBI.
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INTRODUCTION. Approximately 10% of the asthma-related hospitaliza-
tions do include an ICU stay. Around 2–4% require mechanical ventilation.
The use of non-invasive mechanical ventilation (NIMV) for acute respira-
tory failure has increased and the indications for its use have expanded
over the past decade. Although it seems to have many advantages and
its use has been extended in asthma exacerbation, its benefits are not well
established and no recommendations had been made in the guidelines.
OBJECTIVES. To describe the use of NIMV in adults presenting severe
asthma exacerbation with respiratory insufficiency admitted to our ICU.
METHODS. Prospective observational study conducted in a 14-bed
intensive care unit of a second level hospital during 18 months. Pa-
tients were all adults with a severe asthmatic crisis who failed with
first step standard treatment in spite of which they had symptoms of
severe respiratory failure with increased in respiratory work with glo-
bal use of accessory muscles, intercostal retractions and nasal flaring.
Demographic data, clinical variables at admission and intensive care
unit and hospital length of stay were recorded.
Qualitative variables are described as number and percentages and
quantitative variables with normal distribution as mean ± S.D.
RESULTS. The total sample comprises 17 patients, having ruled out the
patients that required invasive mechanical ventilation upon admission due
to encephalopathy or cardiac arrest. 73.7% were women, with an average
age of 48.13 ± 14,04 years and a mean APACHE II score of 11.26 ± 6.2. On
admission, the mean pH was 7.22 ± 0.139 with mean pCO2 in arterial
blood of 60.5 ± 21.05 mmHg. A therapeutic trial with NIMV was carried out
in all of them. In 66.7% the ventilatory mode used was BiPAP, with the use
of CPAP being a 13.3%. All patients were monitored both clinically and
analytically: average heart rate (115.87 ± 19.31 bpm), average respiratory
rate (29.8 ± 6 bpm) and mean FiO2 required (0.5 ± 0.18). Control arterial
blood gas was taken two hours after the start of respiratory support. The
average pH was 7.35 ± 0.614, with a pCO2 of 40.19 ± 8.29 mmHg. The
mean stay in the ICU was 4.93± 4.65 days and in hospital was 15.61 ±
10.33 days. In our group only two patients (11,76%) had NIMV failure.
CONCLUSION. In our experience, the use of respiratory support with
NIMV in patients with severe asthma crisis, performed in a safe envir-
onment in which there is no delay in recognizing the failure of the
same, may limit both ICU and hospital stay and the rate of orotra-
cheal intubation with the complications derived from it.
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Page 28 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. During spontaneous breathing (SB) a post-inspiratory
expiratory contraction of the diaphragm, also defined as eccentric dia-
phragmatic contraction (EDC), has been described [1, 2]. EDC is minim-
izing the expiratory flow, preserving the end-expiratory lung volume
and reducing atelectasis formation. However, EDC has also been de-
scribed as cause a of ventilator-induced diaphragm dysfunction (VIDD).
OBJECTIVES. To describe the effects of an additional expiratory resist-
ance (ExpR) during conditions that promote EDC. We hypothesized that
ExpR could reduce EDC, while preserving the positive effects of expiratory
brake. If it holds true, we expect throughout the expiration a reduction
in: 1. expiratory electrical activity of the diaphragm (EAdi exp), 2. expira-
tory transdiaphragmatic activity (Pdi exp), 3. expiratory flow (Flow exp).
METHODS. Nine anesthetized, tracheostomized, SB pigs underwent lung
lavages to achieve mild ARDS (PaO2/FIO2 of 250 mmHg). The animals
breathed at three continuous airway pressures (CPAP 12, 5 and 0 cmH2O).
For each CPAP, three different conditions were studied, depending on the
application of an additional respiratory resistance to the expiratory ventila-
tory limb: 1) no resistance added (R0), 2) ExpR of 4.8*10-2 cmH2O/mL/sec
measured at a flow of 1 L/s (R1), 3) ExpR of 9.6*10-2 cmH2O/mL/sec mea-
sured at a flow of 1 L/s (R2). For each breath EAdi exp, Pdi exp and Flow
exp were divided in four quartiles. EAdi exp, Pdi exp quartiles were
expressed as percent of the end-inspiratory peak. Flow exp quartiles were
expressed as absolute values [L/s]. Statistical analysis: Student-T test.
RESULTS. During SB, the application of an external expiratory resist-
ance decreased the EDC: both EAdi exp and Pdi exp were significantly
reduced by the application of an ExpR. The higher the expR, the lower
the EDC (Figure, first and second rows) at all the applied CPAP levels.
The use of an ExpR reduced the expiratory flow, at all the applied CPAP
levels (Figure, third row). The increase in CPAP reduced the EDC.
CONCLUSION. Expiratory modulation by application of an external
ExpR preserves the positive effects of the expiratory brake while minim-
izing diaphragmatic eccentric contraction, thus potentially reducing the
VIDD and the consequent lung injury in SB subjects.
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Fig. 1 (abstract 001357). Changes in percentages of OD (red), CL
(black) and ODCL (green) in patients with HRF and healthy control
patients during an incremental and decremental PEEP trial001357
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):001357INTRODUCTION. Electrical impedance tomography (EIT) enables cal-
culation of alveolar collapse (CL) and overdistension (OD) during a
PEEP trial[1]. The best balance between OD and CL (ODCL), where
the percentage of CL is subtracted from OD is one of the parameters
developed to optimize ventilator settings.
OBJECTIVES. The aim of this study is to describe the effect of PEEP
on ODCL, OD and CL in hypoxic respiratory failure (HRF), and patients
with healthy lungs as a reference group (control).
METHODS. Twenty control and 43 HRF patients (PaO2/FiO2-ratio <250)
were analysed from retrospective data and our prospective EIT-trial data.
The ODCL, OD and CL was calculated at each PEEP step by EIT during an
incremental and decremental PEEP trial. The analysis is performed in 4
consecutive incremental followed by 4 decremental PEEP steps of 2
cmH2O. An ODCL of 0 would indicate an optimal balance between OD
and CL. Characteristics between HRF and control patients were compared
using independent t-test. Changes in ODCL, OD and CL between HRF
and control patients were tested using two-way ANOVA.
RESULTS. There was a significant difference between HRF and
control patients in APACHE II, PaO2/FiO2-ratio and set PEEP (12
cmH2O (±3) and 8 cmH2O (±0,5) respectively), p<0.05. Changes
in both OD and CL were directly proportional with changes in
PEEP (Fig. 1). The increase in OD is more pronounced by in-
creasing PEEP in HRF then in controls (p<0.05). A low ODCL did
not exclude OD or CL in HRF nor control patients, mean ODCL
2,5 (±2) with an OD of 7 (±4), CL 7(±3) and ODCL 2,6 (±3) with
an OD 8 (±5), CL 7 (±4) respectively.
CONCLUSION. Using solely ODCL to titrate PEEP does not ex-
clude the presence of OD and CL. Ventilation distribution varies
widely among patients, especially in HRF. No single optimal
PEEP value exist for the entire lung. This reinforces the need for
personalised titration of PEEP and tidal volume because the lat-
ter also contributes to tidal recruitment and OD. Using EIT re-
gional lung mechanics can reliably be assessed at different
PEEP levels and tidal volumes. Therefore, EIT can be very help-
ful for patient tailored lung protective ventilation.
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Page 29 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. Diaphragmatic expiratory brake has been shown to
preserve end-expiratory lung volume and avoid/reduce atelectasis
formation [1]. However, the eccentric diaphragmatic contraction
(EDC), that naturally brakes expiration, is a possible cause of
ventilator-induced diaphragm dysfunction (VIDD) [2] during spontan-
eous breathing (SB).
OBJECTIVES. To investigate if an external resistance (ExpR) inserted
into the expiratory circuit can mimic the natural EDC and improve
lung inflation.
METHODS. Nine anesthetized, tracheostomized SB pigs underwent
lung lavages to achieve mild ARDS (PaO2/FIO2 of 250 mmHg).
The animals were studied with high frequency (20 Hz) dynamic
Computed Tomography (CT) at three Continuous Positive Airway
Pressures (CPAP 12, 6 and 0 cmH2O) and three ExpR: 1) no resist-
ance added (R0), 2) ExpR of 4.8*10-2 cmH2O/mL/sec measured at
a flow of 1 L/s (R1), 3) ExpR of 9.6*10-2 cmH2O/mL/sec measured
at a flow of 1 L/s (R2). Image analysis was performed on CT im-
ages acquired at end-inspiration and at four quartiles of the ex-
piratory phase (1/4 Exp, 2/4 Exp, 3/4 Exp, 4/4 Exp). Inflation was
defined based on voxels radiodensity, according to Gattinoni
et al.[3]. Four lung compartments were so defined (atelectatic,
poorly-, normally- and hyper- inflated) and reported as percent-
age of the total lung parenchyma in the same slice. Intrinsic-
Positive End Expiratory Pressure (PEEPi) was calculated. Statistical
analysis: Student-T test.
RESULTS. The application of an additional ExpR (R1 or R2 vs R0) (Fig-
ure) significantly reduced the amount of atelectasis at CPAP 0 and 6
cmH2O; and significantly increased normally inflated areas at CPAP 0
and 6 cmH2O. PEEPi (mean ± SE) varied between a minimum of
0.12±0.06 cmH2O at CPAP 12 and R0 and a maximum of 1.32±0.58
cmH2O at CPAP 0 and R2.
CONCLUSION. The expiratory brake produced by ExpR improved
lung inflation in conditions promoting lung collapse (low CPAP) and
was not associated with hyperinflation. If confirmed in human pa-
tients, external expiratory brakes might gain clinical relevance in ven-
tilated lungs prone to collapse (e.g. laparoscopic procedures, cardio-
thoracic surgery, pediatric ventilation, prolonged weaning and critical
illness).
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INTRODUCTION. COPD is the third leading cause of mortality around
the world according to the World Health Organization. It is interest-
ing to identify COPD patients at the time of ICU admission who are
likely to have poor short-term outcomes.
OBJECTIVES. To identify the characteristics and predictors of mortal-
ity of ICU patients admitted for AECOPD.
METHODS. A prospective cohort study was performed in a 9-bed Tu-
nisian medical ICU between December 2017 and April 2019. All pa-
tients admitted for AECOPD during the study period were included.
For all included patients, demographic, clinical characteristics, thera-
peutic interventions and outcomes were recorded. Univariate and
multivariate regression analyses were carried out to identify factors
independently associated to poor prognosis.
RESULTS. During the study period, 372 patients were hospitalized in
the ICU. 99(26%) COPD patients were included. Patients' characteristics
were: mean age, 64.0±9.2yrs ; male, 71(91%) ; mMRC≥2, 67(88.2%) ; me-
dian SAPSII, 27[22-32] ; invasive mechanical ventilation (IMV) on admis-
sion, 10(10.1%). The most common comorbidity was hypertension
31(31.3%), followed by diabetes mellitus 19(19.2%), cardiovascular dis-
eases 19(19.2%) and psychiatric disorders 7(7.1%). The triggering factor
of AECOPD was tracheobronchitis 73(73,7%) followed by pneumonia
7(7.1%) and pulmonary edema 3(3%).
During their ICU stay, 46(46.46%) required intubation, 25(25.3%) were put
under vasoactive drugs and 12(12.1%) had hospital-acquired infections.
The median duration of mechanical ventilation and the length of stay were
respectively 11[5.7-15.5]days and 9[6-14.5]days. Mortality rate was 23.3%.
Univariate analysis identified four factors associated with ICU mortal-
ity : SAPS II on admission (34[29.5-44] vs 25[20.25-30] ; p=0.001) ; IMV
use on admission ( 21.7% vs 6.6% ; p=0.035) ; vasopressors use (
60.9% vs 14.5% ; p<0.001) and NIV failure (78.9% vs 27.8% ; p<0.001).
In multivariate analysis, NIV failure was an independent risk factor as-
sociated with mortality in critically ill COPD patients (HR, 9.75 ;
95%CI, [2.9-32.9] ; p<0.001).
CONCLUSION. NIV failure was the sole independent risk factor associ-
ated with ICU mortality in patients admitted with AECOPD.
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INTRODUCTION. 10 % of all patients admitted to the Intensive Care
Unit and 23 % of mechanically ventilated patients has ARDS (1). The
mortality rate is of 46.1 % for patients with severe ARDS (2). The
mainstay of treatment is lung protective ventilation with low tidal
volumes and optimal PEEP, prone positioning is a validated strategy
for patients with moderate and severe ARDS (3). The driving pres-
sure, more than tidal volume, is the best predictor of VALI, as inferred
by increased mortality, DP is one of the components of the mechan-
ical power, which also includes respiratory rate, flow and PEEP. Mech-
anical Power is the energy delivered per unit of time to the
respiratory system by the mechanical ventilator. Finding the
Page 30 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55threshold for mechanical power could simplify assessment and pre-
vention of VALI (4).
OBJECTIVES. To analyze the change in Mechanical Power (ΔMP) after
prone position and outcome in patients with severe ARDS
METHODS. : An analytical, retrospective and cross-sectional study in pa-
tients with severe ARDS and prone position strategy in the Intensive Care
Unit of Hospital Juarez de México (January 01, 2018 to March 31, 2019).
RESULTS. 71 patients with ARDS were admitted, 46 (64.7 %) had se-
vere ARDS and received prone position. Global Mortality was 42.2%,
Mortality in severe ARDS group was of 65.2%. Average MP before
prone position in survivors was 19.5 J/min in contrast with 24.16 J/
min in nonsurvivors (OR 9.6, CI 95 %, 0.97 – 95.67, P: 0.052). Average
MP after prone position in survivors was 18.5 J/min in contrast with
28.59 J/min in nonsurvivors (OR 9.6, CI 95 %, 0.97 – 95.67, P:
0.052). ΔMP was -0.504 in survivors, but it was +4.103 in nonsurviors
(OR: 0.064, (IC 95 %, 0.109 – 3.72, P: 0.61).
CONCLUSION. In patients with severe ARDS MP was higher in non-
survivors before and after prone position in comparison with survi-
vors. ΔMP showed a trend to reduce in survivors and to increase in
nonsurvivors after prone position.Table 1 (abstract 001385). Baseline and outcome data grouped by the
level of respiratory support
No Ventilation NIV only IMV only NIV + IMV
N= 122 383 315 166
Age (mean) 84 84 83 83
SOFA (median+IQR) 5 (5-7) 5 (5-6) 8 (8-9) 8 (8-9)
LOS ICU (days;
median+IQR)
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INTRODUCTION. Severe acute respiratory failure (ARF) is a main
cause of ICU admission, also for elderly patients (1), frequently
warranting respiratory support. The proportion of elderly patients
receiving mechanical ventilation is reported to be comparable to
younger ICU patients (2). Despite representing a rapidly growing
ICU population, outcome data are scarce for ARF with or with-
out respiratory support in elderly ICU patients.
OBJECTIVES. The objective is to describe the modality of respiratory
support and short-term outcomes in an unselected group of very old
intensive care patients (VIP) ≥ 80 years admitted with ARF.METHODS. This is a predefined sub-study of the VIP-1 study; a pro-
spective observational study enrolling 5132 VIP admitted to 311 ICUs
in 21 European countries (3). The patients for the present study are
selected from the VIP-1 study population by ARF reported as the
main admission diagnosis. Patients presenting with both ARF and
acute circulatory failure upon ICU admission are excluded.
RESULTS. A total of 986 patients are included. 864 patients (87.6%)
were given respiratory support. Invasive mechanical ventilation (IMV)
compared to non-invasive ventilation (NIV) was associated with a sig-
nificantly longer ICU stay and a trend towards increased mortality,
but patients receiving IMV also had a significantly higher degree of
organ failure.
CONCLUSION. Acute respiratory failure in very old ICU patients
carries a high mortality, ranging from 25% in patients without
any form for respiratory support to almost 50% in patients with
IMV after a trial of NIV. Patients having received NIV only were
less sick and had a shorter ICU stay; however no significant sur-
vival benefit of NIV compared to IMV could be shown.REFERENCE(S)
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INTRODUCTION. The Integrated Pulmonary Index (IPI) use an algorithm
based on the measurement of exhaled carbon dioxide, respiratory rate,
Page 31 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55heart rate and oxygen saturation to provide an assessment of the pa-
tient’s ventilatory status. IPI has been maintained as part of respiratory
monitoring but not as part of a mechanical ventilation removal protocol.
OBJECTIVES. Determine whether the lung integration rate predicts
success or failure in the removal of mechanical ventilation.
METHODS. In a cohort study, prospective and observational, patients
admitted to UTI with support from VMI were analyzed, using the Intelli-
Vue MX800 monitor software to obtain the IPI algorithm. Demographic,
hemodynamic and respiratory variables were recorded to perform a
multivariable statistical analysis, using regression models to compare
patterns in 2 repeated IPI measurements. The extubation protocol kept
the patient in support pressure mode (PS) with PS 7 and PEEP 0.
RESULTS. IPI was collected in 90 patients, 79 successfully extubated
(88%) and 11 with failure (12%), IPI was taken at the time of weaning
from mechanical ventilation and 5 minutes before extubating the patient.
The value of IPI at the moment of the extubation had an specificity of
97% and sensitivity of 57%, it was observed that an increase of +2 in the
basal number of IPI predicts success to the extubation, but a decrease of
-2 may or may not determine failure at extubation, with a p of 0.001.
CONCLUSION. In this study a variation of the basal IPI at the begin-
ning of the mechanical ventilation removal protocol was observed
and compared with the IPI at the time of extubation, with a delta of
+2 being found, when the patient had an increase in IPI was ob-
served success at extubation, instead when the variation was in de-
cline (-2), extubation could fail or not.
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INTRODUCTION. High flow nasal cannula (HFNC) is increasingly used
in managements of acute respiratory failure (ARF). HFNC can contribute
to improve diaphragm function due to washout of carbon dioxide in
anatomical dead space, increasing lung volume, and decreasing work
of breathing. However, there are few clinical data to assess the changes
of diaphragm function during weaning from HFNC.
OBJECTIVES. To evaluate the changes of diaphragm function before
and after withdrawal of HFNC in patients with ARF.
METHODS. We included adult patients with ARF who were stable and
ready to have HFNC withdrawn. Diaphragm function were assessed by
thickening fraction (TF) and diaphragm excursion (DE) using ultrasonog-
raphy before and after liberation from HFNC. HFNC was set to deliver 30
L/min flow at FIO2 of 0.21 to 0.30. After liberation from HFNC, patients
were treated with low flow oxygen of 1 to 3 L/min through nasal cannula.
TF was measured at the zone of apposition, 0.5 to 2 cm below the costo-
phrenic sinus. DE was measured in the subcostal area. TF and DE were
measured three times, and the mean values were used for evaluation. We
compared the values of TF and DE before and after withdrawn of HFNC.
RESULTS. Twenty subjects (12 male, 8 female; mean age 68 ± 16 years)
were enrolled in this study. APACHE II score was 18 (inter-quartile range:
IQR, 13, 20), and duration of HFNC was 2 days (IQR, 2, 3 days). There were
no significant difference in TF (13.8 vs. 12.5 %, p=.48) and DE (1.4 vs. 1.5 cm,
p=0.37) before and after withdrawn of HFNC. However, four patients pre-
sented with paradoxical motion of the diaphragm after withdrawal of HFNC.
CONCLUSION. In patients with ARF, HFNC at 30 L/min had no signifi-
cant effect on diaphragm function before and after withdrawal of
HFNC. However, in some cases, paradoxical diaphragmatic move-
ment became noticeable after withdrawal of HFNC. Novel weaningprotocol of HFNC to prevent diaphragm dysfunction after liberation
from HFNC is warranted.
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INTRODUCTION. Positive end-expiratory pressure (PEEP) is an es-
sential treatment for patients with acute respiratory distress syn-
drome (ARDS) to reopen collapsed or flooded alveoli and closed
airways. However, PEEP may also overdistend previously open
lung units and/or worsen circulation. The individual response to
PEEP depends on lung recruitability but assessing recruitability at
the bedside is challenging (1). We propose a simple approach to
estimate the recruited volume (ΔVrec) at the bedside, based on
the hysteresis-like behavior, which requires only one prolonged
expiration maneuver (2). We also propose to standardize the
ΔVrec by the real change in pressure for assessing the lung
recruitability, taking into account the possible presence of
complete airway closure (3). This standardized ΔVrec is defined as
the compliance of the recruited lung (Crec) in our study.
OBJECTIVES. To validate an experimental method for measuring
ΔVrec and calculating Crec; and to test whether Crec differenti-
ates patients with different responses to PEEP in other
dimensions.
METHODS. Patients with moderate or severe ARDS were passively
ventilated at two PEEP levels different by 10 cmH2O when pos-
sible (e.g., 15 vs. 5 cmH2O). Respiratory mechanics, absolute lung
volumes, and low-flow inflation pressure-volume curves were
assessed at each PEEP levels. We used the multiple pressure-
volume curves as the reference method (4). A reduction in lung
volume between two PEEP levels at a given elastic pressure was
measured as ΔVrec (4). The airway opening pressure (AOP) was
also measured(3). The “real change in pressure” was not always
10 cmH2O but the difference between high PEEP and AOP in pa-
tients with complete airway closure (3). ΔVrec was thus standard-
ized in mL per cmH2O, termed as Crec. In other words, Crec was
the ratio of recruited volume to the real change in pressure over
which recruitment was assessed. To define lung recruitability, we
arbitrarily divided patients into “high recruiters” and “low re-
cruiters” by using the median of Crec. We then tested whether
the patients have different response to PEEP in terms of gas ex-
change, mechanics, and circulation.
RESULTS. Forty-five patients were enrolled. In four patients with
airway closure, higher PEEP was insufficient to reopen airways
and recruitment could not be assessed. In others, the experi-
mental method (single breath) was strongly correlated with the
reference method (multiple curves) in measuring ΔVrec and Crec
(P< 0.001, R2= 0.798 and 0.817, respectively). Bias in measuring
Crec was -2 mL/cmH2O and limits of agreement were -14 to 10
mL/cmH2O. At PEEP of 15 cmH2O, only high recruiters had better
oxygenation compared to lower PEEP 5 (P = 0.020), whereas only
low recruiters experienced lower mean arterial pressure (P =
0.009).
CONCLUSION. Our simple method can quantify both the recruited
volume and the compliance of the recruited lung at the bedside,
allowing clinicians to personalize PEEP based on lung recruitability.
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INTRODUCTION. Chest ultrasound (CUS) is mandatory to confirm a full
lung expansion after pleural drainage for pneumothorax in the critically
ill. With regards to high rate of chest drain (CD) malposition its subse-
quent controls by chest X-ray (CXR) during ICU radiology rounds are
warranted. Even a small PNO is still important because it may easily en-
large due to positive inspiratory pressure (IPPV). Our pilot paper (1) util-
izing CXR and chest CT showed that greater foreshortening of the
CD and a steep angle of inclination of the CD above the horizontal at
chest entry taken from CXR should raise suspicion of CD migration.
They mandate further investigation by CUS to rule out residual
pneumothorax occult on CXR. The role of CD location by CUS in the
diagnosis of pneumothorax has not been explored yet.
OBJECTIVES. CD foreshortening taken from CXR may associate with an
absence of CD detection between ventral pleural layers on CUS in a su-
pine patient and presence of an occult pneumothorax confirmed on CUS.
METHODS. Patients were prospectively monitored with CUS and CXR
after drainage for pneumothorax performed by intensivists using 16-
20F CDs and blunt forceps technique in the safe triangle. All drains
were connected to a closed suction system providing a pressure of
-20 mbar. The foreshortening was estimated as a decrease of chest
drain index (CDI=length of CD in chest taken from CXR/depth of in-
sertion on CD scale+5 cm). The angle of inclination of the CD was
measured as the angle between the horizontal line and CD at the
pleural space entry on CXR. Pneumothorax was diagnosed on CUS
according to current standards (2).
RESULTS. 85 pneumothoraces were prospectively monitored in 61 pa-
tients on IPPV, age 56.2±19.8, APACHE II 22±4, SOFA 9±2.2. CDs were
located on CUS in 55 patients, the full interpleural course of a CD until
its tip was detected in 43 patients. There were 6 small occult pneu-
mothoraces in this group (13.9%) particularly due to a steep angle of
the CD >50°(n=4), the CDI was 0.96±0.13. In 30 patients the CDs could
not be located by CUS, 6 of those were excluded for subcutaneous em-
physema. There were 13 pneumothoraces in this group (54%), the CDI
was 0.76±0.23 (p<0.001). The risk ratio for pneumothorax in a patient
with low CDI on CXR and associating absence of the interpleural CD lo-
cation on CUS is 3.88, CI 1.70-8.89, p=0.001, NNT 2.49.
CONCLUSION. A low CDI on CXR calls for a CUS verification of a CD pos-
ition and exclusion of an occult pneumothorax not detected by the CXR.
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INTRODUCTION. There is a great concern to carry out surveil-
lance, prevention and control programs of Healthcare-
associated infections (HAIs), with emphasis on hand hygiene
(HH). It is important to know the perceptions of the healthcare
professionals to try to improve the adherence to these
programs.
OBJECTIVES. To identify the perceptions and knowledge of the
healthcare workers of an Adult Intensive Care Unit (AICU) and
a Pediatric Intensive Care Unit (PICU) about HH and correlat-
ing them with the adherence of the compliance program to
HH.
METHODS. Cross-sectional, prospective, descriptive and compara-
tive study, about the knowledge and perceptions of the health
professionals with respect to HH, through the realization of a
survey published and validated by the World Health
Organization. In addition, these perceptions are compared with
the evaluation of the adherence to the HH that had been done
prior to this study by direct observation of the workers during
their daily work.
RESULTS. 187 surveys were obtained (142 from AICU and 43
from PICU); >80% of total the population. >90% had received
formal training on HH in the last 3 years and regularly use of
alcohol-based solution (ABS). Regarding knowledge, there are
no significant differences between the units. 35% of the AUCI
professionals and almost 50% from the PICU consider that
hand washing (HW) is more effective than hand friction (HF)
with alcohol-based solutions (ABS) for the elimination of micro-
organisms. >30% believe that it is advisable to perform the HW
and HF sequentially. Only 55.8% know the minimum adequate
time to eliminate microorganisms by HF. They overestimate the
percentage of occasions in which they perform HH cor-
rectly with respect to adherence rates to HH, through direct
observation, (PICU 89.32% vs 73,8% and AICU 82.93% vs
51,4%)(p = 0.0001).
CONCLUSION. Despite being a sample of professionals with for-
mal training on HH, the results indicate that they have incom-
plete knowledge and overvalue their perception compared
with the adherence rates obtained through observational
studies.
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INTRODUCTION. The World Health Organization (WHO) promotes
that proper hand hygiene (HH) is the main practice, with the
lowest economic cost and the easiest to perform to reduce the
incidence and spread of antimicrobial resistant microorganisms,
which improves patient safety in all health areas. However,
WHO rates the HH compliance index by health professionals is
insufficient (less than <40%).
OBJECTIVES. To know the adherence rates to the HH, between the Health-
care workers (HCWs) in an adults ICU (AICU) and other pediatric (PICU).
METHODS. An observational study was conducted on the com-
pliance of HH for the five WHO moments. HCWs were observed
during their work shift. The observers also measured the tech-
nique of HH through hand washing or HH with alcohol-based
disinfectant. HH opportunities and attempts were designated as
appropriate or inappropriate per WHO criteria.
The percentage of adherence was calculated as the number of oppor-
tunities of HH (with soap and water or alcohol-based solutions (ABS))
multiplied by 100 and dividing by the total of identified opportunities.
RESULTS. 391 opportunities were identified in the AICU and 320
in the PICU, a HH adherence rate in the AICU of 51.40% and
73.80% in the PICU was determined. By professional profile it
was observed that the nursing staff is significantly the most ad-
herent (64% in the AICU and 82% in the PICU). It was found that
in the AICU the adherence is greater after being in contact with
the patient), unlike the PICU where they perform it predomin-
antly before in all professional profiles.CONCLUSION. The adherence to hand hygiene in the AICU is
low. The adherence to HH is greater before contacting the pa-
tient in the PICU, unlike the AICU where it is predominantly car-
ried out afterwards. So it is necessary to implement effective
education programs that improve adherence to hand hygiene
compliance.
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INTRODUCTION. –Emergence of antimicrobial resistance and MDROs
has resulted in a global health burden, increasing cost of health care, length
of hospital/ ICU stay and mortality. Risk of bacterial transmission through
equipment transfer is not given as much importance as hand hygiene.
–Studies have proven contamination of stethoscopes with both non-
pathogenic and pathogenic (including MDR) organisms. Jones et al
showed that out of 150 stethoscopes used by emergency medical
staff, 89% grew staphylococci and 19% S aureus[1]. Marinella et al
showed that coagulase-negative staphylococcus was present on
100% of stethoscopes and Staphylococcus aureus on 38% of 40 ran-
dom stethoscopes examined [2].
–CDC guidelines suggest performing low level disinfection for non-
critical patient care surfaces and equipment that touch intact skin e.g.
bed rails, blood pressure cuffs and stethoscopes
OBJECTIVES. - To determine whether stethoscopes can be potential
sources of cross-infection/cross contamination in our ICU
METHODS. -All 4 adult ICUs (total 73 beds) were surveyed between Nov-
Dec 2018 for the number of bedside stethoscopes at random times for a
total of 2 weeks. Each bedside stethoscope was also labelled with unique
identfier codes, and movement of stethoscopes between bed spaces and
patients was tracked on a daily basis.
-A survey questionnaire was also sent to all the ICU medical staff re-
garding infection control practices with respect to use of bedside
stethoscopes in ICU.
RESULTS. -Average number of stethoscopes found in ICU's 1,2,3 & 4
were 71.4%, 66.6%, 77.7% and 110% respectively and number of
times stethoscopes were found to be misplaced were 24.4%, 31.7%,
34.92% and 8% respectively
-Unit acquired infection rates from April 2018-March 2019 for ICUs 1,2, 3
& 4 were 17.1/1000, 33/1000, 20.3/1000 & 5.8/1000 respectively
-A total of 210 people responded to the survey questionnaire (23% doctors,
74% nurses). 69% said they share stethoscopes between bedspaces, be-
cause of non-availability of 1:1 dedicated bedside stethoscopes (5%), poor
Page 34 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55quality of stethoscopes (17%), or (50%). 100% said they clean stethoscopes
after every use. Asked whether there was a checklist to ensure stethoscopes
are cleaned, 7% answered "yes", 65% said "no" and 28% were not sure.
CONCLUSION. –Our audit revealed that there is evident sharing of
stethoscopes between bed spaces mainly because of poor quality and
lack of adequate number of dedicated bedside stethoscopes in ICU.
-Units with the highest proprotion of stethoscopes and the lowest fre-
quency of misplaced stethoscopes had the lowest unit-acquired infection
rates, suggesting that stethodscopes may play a role in cross infection
–The survey questionnaire showed that there is inadequate educa-
tion around cleaning stethoscopes and documentation, and import-
ance of having dedicated 1:1 bedside stethoscopes
–CDC recommends monitoring for adherence to recommended environ-
mental cleaning practices as an important determinant for success in con-
trolling transmission of MDROs and other pathogens in the environment[5].
–Based on the above factors, having 1:1 dedicated bed side stethoscopes
would be a prudent solution to reduce risk of cross contamination.
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INTRODUCTION. Many studies have researched about the contamin-
ation of differents surface that there are in the different units of hos-
pitals. In the Intensive Care Units (ICU), several studies have found
important microorganism in the personal mobile phones of health
workers. Some studies have detected germs such as P. aeruginosa,
Acinetobacter, S. aureus and Enterococcus. These findings make its
important to consider this surface as an element to monitor in the
transmission of nosocomial diseases.
OBJECTIVES. Identify the presence of microorganisms in the mobile
phones of the profesionals of an Intensive Care Unit (ICU).
METHODS. Experimental controlled trial for 5 months among heath
and non-health profesionals who had mobile devices during their
workday. The collection was performed by a wet swab in Brain Heart
Infusion (BHI). A single researcher was in charge of collecting the sam-
ples after receiving specific training. Follow up was done in the micro-
biological findings of the patients in charge of the professionals of
which samples were taken. The Medicine Preventive unit collaborates
in the microbiological analysis of the samples collected. This study was
approved by the ethical and research committee.RESULTS. In our study, 111 samples of mobile devices were collected. In
these samples, the 49.5 per cent were contaminated by relevant micro-
organism. Of this samples 64 microorganisms were detected, with the fol-
lowing distribution by groups: Gram (+) 71.8% predominated, followed by
Gram (-) 18.7% and fungi 9.3%. It was relevant for the research to find in
the contaminated mobiles, the presence of multi-resistant microorganisms
of the type of methicillin-resistant Staphylococcus aureus (10.9%), Pseudo-
monas aeruginosa (12.5%) and Stenotrophomonas maltophilia. (4.7%)
CONCLUSION. Despite not being able to establish causality between the
isolations of patients and the findings in mobile phones, if pathogenic
microorganisms have been detected, they should alert us that they could
serve as a reservoir of transmission to the critical patient. There were only
two cases: a nurse and a doctor where a germ of the same type that the
patients had, grew in the culture plates. The training in hand hygiene
should be carried on. The high adherence in hand hygiene could have
an important impact to reduce the contamination of the mobiles.
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INTRODUCTION. Ventilator-associated pneumonia(VAP) occurs in 9-
27% among patients on mechanical ventilation. The main risk factor
is the endotracheal tube and microaspirations. The bacteriology of
mouth flora responsible for that, are Gram-negative bacteria and fun-
gal species. Through the past years, different strategies of decontam-
ination of oropharyngeal cavity have been applied with conflicting
evidence on effectiveness and safety.
OBJECTIVES. The aim of our study was to compare the effectiveness
of antibiotic Selective Oropharyngeal Decontamination(SOD) along
with the use of oral antiseptic agent (Chlorhexidine) versus standard
care with topical chlorhexidine alone, concerning the prevention of
IVAC (Infection-related ventilator-associated complications) and VAP.
METHODS. A randomized controlled study of patients in a general ICU.
Inclusion criteria contained all intubated patients of age≥18 years old who
were mechanically ventilated for≥48h. Patients admitted in the ICU with
respiratory infection were excluded from the study. Two groups during a
6month period were studied. The control group was treated with oral ap-
plication of Chlorhexidine 2% three times a day. To the other group, anti-
biotic paste with colistine and fluconazole was applied to the oropharynx
twice a day additionally to Chlorhexidine for a period of ten days. We re-
corded the episodes of Ventilator-associated Complications (VACs)/Infec-
tion-related (IVACs) and Ventilator-associated pneumonia (VAP) using the
Centers for Disease Control and Prevention (CDC) classification, during the
first 10 days of ICU stay.
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with Chlorhexidine and 35 to additional application of antibiotic paste.
The patient's characteristics concerning median age (63 vs 57 years), APA-
CHE II score (17.8 vs 17.7), mean ICU days (16.2 vs 16.4days) and death
rate (22.8% vs 21.6%) among the two groups respectively were compar-
able. Using statistical analysis, we compared the VAC/IVAC occurrence be-
tween the two groups (95% confidence interval [CI], 0.332, 13.082; p=
0.472; OR 1.87) and VAP (X-squared = 1.3455, p-value=0.246).
CONCLUSION. Applying antibiotic decontamination therapy in addition to
standard care with oral Chlorhexidine in our ICU, didn't prove to reduce the
development of VAC/IVAC and VAP in intubated patients, in a statistically sig-
nificant way. Although the comparison between two groups (Figure) showed
higher VAP occurrence in the group treated with chlorhexidine alone
(21.62% vs 11.43%) this was not statistically significant (p=0.246). Our results
are limited by the small size of our sample and more patient recruitment is
needed.
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INTRODUCTION. Multi-drug resistant (MDR) colonization is a major
issue worldwide (WHO, 2019), mostly for perioperative and intensive
care medicine, frequently resulting in life-threatening infections.
OBJECTIVES. Within our ICU admissions, the aim of this study was to
evaluate MDR colonized patients undergoing surgery and their post-
operative course compared to non colonized patients.
METHODS. We retrospectively analyzed all consecutive patients under-
going surgery in our hospital for a period of 12 months (July 2017-July
2018) who required ICU admission on POD 0. According to their surveil-
lance swab, we defined patients as negative, negative for MDR bugs,
MDR positive (Enterobacteriaceae beta-lactamase producer-ESBL, Entero-
bacteriaceae carbapenemase producer-e.g.KPC, non-lactose fermenting-
e.g. Pseudomonas and Acinetobacter spp, MRSA). We then compared
MDR colonized (rectal and/or pharyngeal swab) patients (MDR+) to non
colonized patients (MDR-) for post operative complications, ICU and
hospital LOS and mortality.
RESULTS. 274 patients were included in the study (186 men), median
age 70(61-77) years; they underwent either elective (n=234, 85.4%) or
emergency (n=40, 14.6%) surgery; 119 pts (43.4%) were submitted to
pancreatic surgery, 67 (24.5%) to hepato-biliary surgery, 51 (18.6%) to
intestinal resection and the rest to other abdominal surgery; they were
admitted to ICU on POD 0 for scheduled (n =244, 89.1%) or unsched-
uled intensive PO monitoring. 43 pts were pre operatively MDR+
(15,7%), 13 of whom were either Klebsiella Pneumoniae Carbapenema-
sis Producer or Enterococcus Faecium VRE colonized and 28 were ESBL
colonized. 50 pts resulted colonized early on ICU admission screening.
ICU LOS was significantly higher in MDR+ compared to MDR- (6.2±13
vs 2.1±4 days, p <0.05). Hospital mortality occurred in 17 patients, 9
were MDR+, 6 of them died in the ICU. Complication rate and type
were significantly different between the two groups. Only 19 MDR+ pa-
tients (6.9%) received targeted pre-operative antibiotic therapy com-
pared to standard prophylaxis but, despite a positive trend with
regards to infectious complications, LOS and mortality, our results were
significant in terms of outcome.
CONCLUSION. Pre-operative surveillance swab positivity correlates
with both ICU LOS and post-operative mortality. Might these results
be confirmed, targeted perioperative antibiotic prophylaxis should
be seriously settled so as to be routinely used to improve patients’
outcome. More studies are needed to further investigate the possi-
bile therapeutic options in MDR+ patients undergoing surgery.
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INTRODUCTION. Thanks to the development of the most recent culture-
independent methods, changes in lung microbiota composition has been
Page 36 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55observed in pulmonary diseases. Its role among critically ill patients need
to be largely investigated because many questions are still unanswered
in particular regarding pathogenesis of infective complications. In our
study we tried to understand which are the major changes that occur
during mechanical ventilation and which are critical for the development
of VAP (Ventilation Associated Pneumonia).
METHODS. Tracheal aspirates were sampled from 23 patients without
pulmonary diseases in progress at the moment of the intubation (T0),
after 72 hours (T1) and then every 48 hours later until T7 (day 15) or
until the moment of the extubation or the dismission/death of the sub-
ject. Analysis of microbiota was performed by 16s rRNA amplifications.
Results from QIIME related to taxa classification will be described ac-
cording diversity measures. Bacterial communities diversity will be ana-
lysed applying the Principal Coordinate Analysis (PCoA) based on
phylogenetic distance (UNIFRAC) among all samples.
RESULTS. The preliminary molecular analysis have shown the presence
of 360 different bacterial taxa. In the first part of our study we focused on
the description of the microbial community at the moment of the intub-
ation (T0) and after 72 hours (T1). Three out of 23 patients developed
VAP during follow up respectively at day 5, 13 and 15 after mechanical
intubation. Overall, the comparison of the samples collected at two dif-
ferent times showed that: Bergeyella Veillonella, Leptotrichia, Variibacter,
Stenotrophomonas significantly are less present at T1 than T0 while Pep-
tostreptococcus in T0 than T1. Among three patients with VAP genera
Eubacterium, Lachnospiraceae, Lachnospira, Lactobacillus, Leptotrichia,
Bradyrhizobium and Anaeroplasma were significantly higher in T0 than
T1 while commensal strains characteristic of the upper airway such as
Porphyromonas, Alloprevotella, Prevotella, Howardella, Solobacterium,
Dialister, Veillonella and Fusobacterium increased in T1 than in T0.
CONCLUSION. Preliminary results highlighted the impact of oro-
tracheal intubation procedure on the pulmonary microbiota
changes, in agreement with the previous data emerged in litera-
ture (Kelly, 2016) (Vladimir Lazarevic, 2014). Given the few cases
of VAP, comparisons between VAP and no-VAP patients do not
allow to identify microbiota characteristics associated to develop-
ment of pneumonia. Larger studies are needed to compare
healthy controls and cases that develop VAP and in order to
clear the significance of our findings and to achieve a better un-
derstanding of the phenomenon.
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INTRODUCTION. Immunosuppressive therapy following liver trans-
plantation(LT) makes these patients more susceptible to infections
which can lead to poor outcomes following LT.1 Recurrent hos-
pital admissions predispose these patients to colonization with
drug resistant organisms and gut is the most common site.2. We
therefore decided to study the incidence of Carbapenem Resist-
ant Enterobacteriaceae (CRE) colonization in the gut in our LT re-
cipients, risk factors and the outcome of CRE colonization in
those LT recipients.METHODS. This study was conducted between September 2017
and July 2018 at Gleneagles Global Hospital. All adult living
donor liver transplant (LDLT) recipients except acute liver failure,
re transplantation and combined organ transplants who con-
sented were included. Rectal swab was done in the week preced-
ing the transplant and immediately cultured on Hi chrome KPC
Agar. Any growth was subcultured on Blood agar and MacConkey
agar, followed by Identification and Antimicrobial Susceptibility
Testing in Vitek 2-Compact system. Antibiotics for perioperative
period were started as per institution protocol. Preoperative pa-
rameters like MELD score, hospital admissions, episodes of infec-
tion and antibiotics used, spontaneous bacterial peritonitis (SBP),
UGI bleeding, encephalopathy, acute kidney injury (AKI) large vol-
ume paracentesis(LVP) and hydrothorax requiring drainage (HTD)
were noted. Intra op details like graft versus body weight ratio
(GRWR), surgical duration, blood components used and other
complications were noted. Postoperative parameters recorded in-
clude prolonged ventilator/ vasopressor requirement, AKI requir-
ing continuous renal replacement therapy(CRRT), graft function &
other graft related complications, intraabdominal collections &
pleural effusions requiring drainage, infections, duration of ICU
and hospital stay and mortality. Data collected was analysed
using STATA statistical software. Two-sided independent-sample t
test to compare means across dichotomous variables & the one-
way ANOVA test for comparison of means across multilevel vari-
ables were used. A p value <0.05 was considered statistically
significant.
RESULTS. Please see uploaded table. 40 recipients were included.
15 (37.5 %)recipients had CRE colonization - CREpos & 25 (62.5%)
were CREnegative. No difference in medical comorbidities were
noted except high MELD score in CREpos. Ascitis, LVP,SBP,HTD,
malnutrition, AKI, UGI bleeding, encephalopathy, preop ICU were
more frequent in CREpos. Requirement of PRBC and other blood
components, vasopressors, surgical duration and lactate were
higher in the CREpos group. Postoperatively graft function was
similar but CREpos had more prolonged requirement of vasopres-
sor/ ventilator and CRRT, reintubations, drainage of intraabdom-
inal collection and pleural effusion, more ICU readmissions,
wound infection and bacteremia. The duration of ICU and hos-
pital stay was higher in the CREpos. 2 (13.33%)patients died in
CREpos while 1(4 %) died in the CREneg group. Statistically sig-
nificant difference was noted in the requirement for LVP, preop
AKI, PRBC requirement, duration of ICU stay and CRRT require-
ment. More preop carbapenem exposure was noted in CREpos
though it was not statistically significant.
CONCLUSION. LT recipients who require more interventions and
hospitalizations in the preoperative period seem more suscep-
tible to CRE colonization. These patients are at a higher risk of
complications in the intraoperative and postoperative period
with higher mortality rates. The most probable cause for CRE
colonization is presumed to be gut translocation although the
yield of positive cultures is low. Preemptive selective digestive
decontamination needs to be vigorously tested in these
immunocompromised patients keeping in mind the presumed
risk of emergence of more resistant microorganisms.3,4
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INTRODUCTION. Multidrug resistant infection in Intensive Care is in-
creasingly common and is associated with significant patient mortality
and morbidity. St Georges hospital is a Level 1 trauma and tertiary re-
ferral centre covering the catchment area of South West London and
Surrey. The Adult Critical Care directorate provides 61, level 2 and 3
beds spread across three units; General, Cardiothoracic and Neuro In-
tensive Care. The aim of this retrospective observational study is to as-
sess the frequency and degree of antimicrobial resistance among
common Gram Negative (GN) and Gram Positive (GP) bacteria isolated
from patients in a large London Intensive Care Facility.
METHODS. Clinically indicated specimens collected from the three in-
tensive care units over a four year period (2013-2016) were included
consisting of community and hospital acquired infection, and colonisa-
tion specimens. Resistant categories were defined by Minimum Inhibi-
tory Concentration (MIC) using EUCAST breakpoint recommendations.
Data was collected and analysed using WHONET software
RESULTS. 2911 patient isolates over a 4-year period from January
2013 to December 2016 were included. Of these isolates 59% (1726)
were gram negative organisms and 40% (1185) gram positive.
Among Enterobactericae, all tested isolates were sensitive to merope-
nem. 3rd Generation cephalosporin resistance was most prevalent
among Enterobacter clocae with 22.8% and 24.4% of isolates resistant
to ceftazidime and cefotaxime respectively. 10.6% of Escherichia coli
(E. coli) isolates were resistant to ceftazidime and 13.3% to cefotax-
ime. Ceftazidime and cefotaxime resistance was present in 8.6% and
9.3% of Klebsiella pneumonia (K. pneumonia) isolates. Ciprofloxacin re-
sistance was highest among E. coli (15.5%) followed by K. pneumonia
(8.9%). Meropenem resistance was present in 3.7% of Pseudomonas
aeruginosa (P. aeruginosa) isolates, ciprofloxacin resistance in 7.8%
and piperacillin/tazobactam resistance in 6.1%. Vancomycin resist-
ance was present among 14.3% of Enterococcus faecium isolates.
CONCLUSION. Intensive care is commonly considered to be a reser-
voir for infection due to its vulnerable immunosuppressed popula-
tion, frequency of invasive procedures, and use of medications such
as muscle relaxants and sedation. A significant percentage of E. coli
and K. pneumonia at our ICU were resistant to 3rd line cephalosporin.
This is comparable to national data demonstrating resistance to 3rd
generation cephalosporin’s to be 10.8-12.4% for E. coli and 10.0-
11.5% for K. pneumonia over similar period (2012-2016). Carbapenem
resistance among P. aeruginosa is a growing concern nationally.
London has the highest level of resistance with over 10-14% resist-
ance recorded between 2012-2016. Interestingly the percentage re-
sistant isolates was significantly lower among our critically ill patients
(3.7%).This study provides an interesting insight into the ecology of a
large London ICU and how it compares to national UK nosocomial
data. It reinforces the need for appropriate and diligent infection
control practices and antimicrobial stewardship going forwardREFERENCE(S)
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INTRODUCTION. Early administration of appropriate empirical anti-
biotic therapy has been shown to reduce the morbidity and mortality
in severe infections. Nowadays, in the context of increased antibiotic
resistance, clinicians who treat critically ill patients at risk of multi-
drug resistant bacteria (MDRB) infections initiate broad-spectrum
antibiotic therapy with one or more antibiotics, entailing an add-
itional risk of increased resistance. Many studies have shown that sur-
veillance cultures allow us to assess the dimension of the multi-drug
resistance problem in an ICU.
OBJECTIVES. Our aim was to analyse the impact of surveillance cul-
tures in predicting multi-drug resistant bacterial infections.
METHODS. We conducted a prospective observational study in an 8-
bed medical ICU between January 2016 and November 2018. All pa-
tients included in the ENVIN-HELICS database (ICU-acquired infection
surveillance program promoted by the Spanish Society of Intensive
and Critical Care Medicine and Coronary Units, SEMICYUC) were ana-
lysed. ENVIN-HELICS database collects data from all infections within
the ICU. We routinely performed a nasal and rectal swab test to all
patients upon admission and on a weekly basis for the detection of
MDRB. We describe demographics, severity at admission (APACHE-II),
ICU length of stay (LOS), MDRB colonisation on admission and ICU-
acquired MDRB infections. We analysed previous MDRB colonisation
in patients with ICU-acquired MDRB infections.
RESULTS. 735 patients (57% males) were included during the study
period. Mean age was 68.5 years (SD 16.37), mean APACHE-II at admis-
sion was 21.5 (SD 8.08) and mean ICU LOS was 7.5 days (SD 13.45).
Intra-ICU mortality among our cohort of patients was 16.3%. On admis-
sion, 16.6% of the patients were colonised by a MDRB. Most frequent
microorganisms were: ESBL-producing Escherichia coli (32.3%), carbape-
nemase-producing Klebsiella spp. (19.8%), methicillin-resistant Staphylo-
coccus aureus (MRSA - 17.6%) and ESBL-producing Klebsiella spp. (13.2%).
During ICU stay (after 48 hours of admission) a MDRB was isolated in
7% of the patients. Carbapenemase-producing Klebsiella spp. (49.1%),
ESBL-producing Klebsiella spp. (12.3%), Pseudomonas spp. (7%) and MRSA
(7%) were the most frequent microorganisms. Twenty-one patients
(2.9%) had 23 ICU-acquired MDRB infections. Ventilator-associated tra-
cheobronchitis (VAT - 47,8%), ventilator-associated pneumonia (VAP -
13%), urinary tract infection (13%) e skin and soft tissue infection (13%)
were the most frequent infections. Most frequent microorganisms
were: carbapenemase-producing Klebsiella spp. (47,8%), ESBL-producing
Escherichia coli (13%) and Acinetobacter baumanni (13%). Among pa-
tients with an ICU-acquired MDRB infection, 69.5% were previously
colonised by a MDRB and in 21.7% a MDRB was isolated in a rectal
swab and in clinical samples simultaneously. Only 8.7% of the patients
were not colonised at the time of infection.
CONCLUSION. In the majority of ICU-acquired MDRB infections,
infection is preceded by colonization. VAT is the most frequent
ICU-acquired MDRB and carbapenemase-producing Klebsiella spp.
is the most frequently isolated microorganism.
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INTRODUCTION. Peripheral intravenous catheter (PIVCs) is the
easiest, quickest and least resource demanding way to adminis-
ter intravenous fluids, medication and blood transfusion. PIVCs
are considered harmless devices, however they account for a
mean of 38% of catheter associated bloodstream infections
(CABSI) of Staph.aureus (1), which is a serious complication
often in need of long antibiotic treatment, ICU stay and with
high mortality. PIVC related CABSI are preventable complications
if PIVC quality is addressed properly. However, there exist no
quick validated tool to assess and improve PIVC quality and
thereby CABSI reduction (2). Thus, we aimed to develop and
test validity for an efficient screening tool regarding overall
PIVC quality for systematic measurements of quality improve-
ment to reduce PIVC related CABSI.
METHODS. The PIVC-miniQ consists of 16 items (yes/no) regarding
observation of problems related to the insertion site, condition of
dressing and equipment, documentation, and indication for use.
Each problem gives one point and all items can be summed up in a
total score (0-16). Two hospitals tested the PIVC-miniQ for feasibility
and inter-rater agreement. Each PIVC was assessed twice, 2-5 mi-
nutes apart by two independent raters. We calculated the intraclass
correlation coefficient (ICC) for each hospital and overall. For each
of the 16 items, we calculated negative agreement, positive agree-
ment, absolute agreement and Scott’s pi.
RESULTS. Sixty-three raters evaluated 205 PIVCs in 177 patients. ICC
between raters was 0.678 for hospital A, 0.577 for hospital B, and
0.604 for the pooled data. Mean time used for each PIVC assessment
was 3.02 (SD 1.76) minutes, where most of the time was used to an-
swer the documentation item. The most frequent insertion site symp-
tom was “pain and tenderness” (14.4%), followed by “redness”
(12.6%), whereas the most prevalent overall problem was lack of
documentation of the PIVC (26.8%). Up to 50% of PIVCs were placed
near joints or were inserted under suboptimal conditions, i.e. emer-
gency department or ambulance.
CONCLUSION. We found the PIVC-miniQ sum score to be a reliable
and efficient outcome measure for quality control, taking only 3 mi-
nutes on average to complete. The measure of consistency can be
described as moderate to high with an ICC of 0.604 for the sum
score. The observed PIVC quality were far from optimal and the PIVC-
miniQ can thus reliably measure development in PIVC quality in point
prevalence audits and evaluate interventions to reduce CABSI.
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INTRODUCTION. Catheter related bloodstream infections (CR-BSIs)
not only increase hospital length of stay, affecting the cost of hospi-
talisation but may, as an independent factor, affect mortality. Accord-
ing to the CDC there is consensus regarding the strong
recommendation for the prompt removal of intravascular access that
is no longer essential, and the preference of peripheral venous cathe-
ters that seem to be rarely associated with bloodstream infection.
The implementation of ultrasound guided peripheral venous cannuli-
sation (UGPVC) seems to be helpful according to the relevant litera-
ture and clinical practice especially in cases of difficult or failed
peripheral cannulisation especially in ICU patients.
OBJECTIVES. The main aim of this study is the incorporation of
UGPVC and the subsequent examination of the effect of the use of
ultrasound guidance for peripheral vein cannulisation on CR-BSIs.
METHODS. A retrospective cohort study was performed in the ICU of
the Limassol General Hospital, Cyprus from January 2015 until De-
cember 2016. During the study data was collected regarding CR-BSIs
using ICU protocol (ECDC-NHSN, HAI-ICU Protocol, v1.01 standard
edition). Additionally, during 2016 data was collected regarding the
use of UGPVC on patients where methods for vein cannulisation such
as palpation from experienced practitioners were expected to be dif-
ficult or else failed. Patients were included in the study that were ad-
mitted in ICU for more than 48 hours. Data was collected regarding
demographics, CVC utilization, acute physiology and chronic health
evaluation (APACHE II), simplified acute physiology score, days of pa-
tient’s device exposure, length of stay and outcome on discharge
from ICU. During 2016 a UGPVC survey was conducted with add-
itional data being collected regarding attempts of cannulation, num-
ber of succeeded or/and failed cannulations, peripheral cannulation
site, cannula diameter size, and body mass index.
RESULTS. During 2015, surveillance data was collected for 198 (125
males) patients hospitalized in the ICU for a total of 2,269 ICU days. A
total of 43 instances of DA-HAIs were detected in 25 of the 198 patients.
CR-BSIs was the most commonly encountered type of infection account-
ing for 21(48.8%) incidents with a rate of 15.93 (9.9-24.3) per 1000 CVC
days. During the 2016 period of the study, surveillance data was collected
for 184 (113 males) patients hospitalized in the ICU for a total of 2,029
ICU days. A total of 24 instances of DA-HAIs were detected in 16 of the
184 patients. CR-BSIs was the least commonly encountered type of infec-
tion accounting for 4 (16.7%) incidents and a rate of 4.16 (1.1-10.6) per
1000 CVC days. CVC utilization ratios was reduced by 10.7% (p<0.05)
(58% to 47%) and CR-BSI incidence rate was reduced by 11.7 per thou-
sand device–days (15.9 to 4.16/1000 CVC days).
CONCLUSION. The reduction of CR-BSIs found in the current study
(74% reduction) seems to be more than the reduction described
in relevant literature (about 66%). The combination of five
evidence-based procedures recommended by the CDC together
with the utilisation of UGPVC, may effectively decrease the CR-
BSIs, affecting costs, length of stay and even patient outcome.
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INTRODUCTION. Increased hospital exposure and transmission of
Multi-Drug Resistant Organisms (MDROs), increase costs, length
of hospital stay, morbidity and mortality and facilitate the need
for increased surveillance and facility level prevention strategies.
The CDC recommends in cases of positive MDROs cultures, sin-
gle room isolation and specific dedicated staff allocation add-
itional to standard contact precaution measures, and other
prevention strategies. In the absence of single room facilities,
the CDC advises the cohorting of patients with similar culture
results. The compliance nevertheless with the recommendations
of single room isolation and cohorting of patients may be im-
possible due to the ICU configuration.
OBJECTIVES. The development and implementation in the ICU of
a unique MDRO transmission prevention and infection approach
was evaluated. The approach was named the “Z Concept
Approach”.
METHODS. The study was conducted in the ICU of the Limassol
General Hospital in Cyprus. Since isolation rooms and cohort-
ing MDRO-positive patients was not feasible, the open plan
ICU space was divided in theory in two grading zones (red and
green zone) with application of behavioural restrictions, to-
gether with contact precautions based on the above-
mentioned zones. The effectiveness of the approach was stud-
ied in a prospective cohort study. Data regarding active MDRO
screening was collected using a protocol based on the ICU
(ECDC HAI-ICU Protocol, v1. 01 standard edition) for a period
of four months. All patients admitted in the ICU, were
screened for MRSA & MDROs by obtaining nasal and rectal cul-
ture swabs during admission, followed by weekly screening
and on discharge. In the event of MDRO positive patients,
pathogen/s species and resistance pattern were correlated with
the rest of the infection positive ICU patients (colonization
pressure), in order to locate or decline the patient/infection
source.
RESULTS. During the 4-month study period, 78 patients were ad-
mitted to the ICU for a total of 942 patient days. In total 432
swabs for the detection of MRSA and MDROs were collected
during the study period. Patients were monitored for a total of
942 ICU days leading to MDROs incident density of colonisation
on admission of 17 per 1000 days [95% CI, 12. 1 – 31. 4]. Fur-
thermore, the overall colonisation pressure during the study
period, was 19/78 (24. 4%). A total of 17 (21. 8%) patients were
admitted with a pre-existing infection and 2 (2. 5%) patients ac-
quired an infection during their stay. The two microorganisms
involved in the two acquired ICU infections were Acinetobacter
baumanni and Pseudomonas aeruginosa, with one acquisition
respectively. The acquisition rates for each of the MDROs in our
ICU were 1.28 instances of A. baumanni and P. aeruginosa per
1000 patient days, while no acquisitions were documented for
Klebsiella pneumoniae, Enterococcus faecalis and Staphylococ-
cus aureus.
CONCLUSION. The low MDRO acquisition rates documented in
the current study, indicated that the development and implemen-
tation of unique infection control strategies may effectively pre-
vent pathogen transmission in the ICU. This strategy was
successful even in an open plan ICU with high colonization pres-
sure, inadequate space separation, and understaffing by nursing
professionals.000792
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INTRODUCTION. The most important risk factor for the development of
nosocomial Urinary Tract Infection (UTI) is the presence of a urinary cath-
eter (UC). The duration of catheterization is also important for CAUTI devel-
opment in patients with long-term Intensive Care Unit (ICU) requirements.
OBJECTIVES. Between the years of 2014-2018, the aim of this study
was to evaluate the catheter associated urinary tract infection (CA-
UTI) rate, invasive device use rate and causative microorganisms iso-
lated in these infections.
METHODS. This study was conducted in an Anesthesiology and Reani-
mation Intensive Care Unit. Five year’s surveillance data was evaluated
in this study. CA-UTI rate per 1000 UC-days and device utilization ratios
are retrospectively evaluated. Microbiological culture results of invasive
device associated urinary tract infection were also evaluated. Standard
laboratory methods were used to identify and test the susceptibility of
the microorganisms, and standardized US Centers for Disease Control
and Prevention (CDC) definitions was used for CA-UTI diagnosis (CA-UTI
rate = CA-UTI number / Urinary catheter day x 1000).
RESULTS. 2944 patients were included in the study. Urinary catheter
usage ratio was 97.2 % in the ICU for 41.972 catheter days. The mean
rate of CA-UTI was 7.56. The total CA-UTI number was 271and the
mean was 54.2/year. The CA-UTI rate was 10.8 in 2014. This rate was
decreased to 5.3 in 2018, although the urinary catheter use ratio were
similar. Most commonly detected causative agents were Escherichia coli
(20.9 %), Klebsiella spp. (20.4 %), and Enterococcus spp. (14.8 %) for
catheter associated urinary tract infections during the five-year study
period. When we analyze by years, the most commonly isolated micro-
organisms were Candida spp. (20.2 %), Escherichia coli (21.6 %), Klebsi-
ella spp. (18.7 %), Escherichia coli (26.4 %) and Klebsiella spp. (31.1 %),
in 2014, 2015, 2016, 2017 and 2018, respectively.
CONCLUSION. Patients admitted to ICU are the most appropriate can-
didates for CA-UTI due to their more frequent necessity of urinary
catheterization and longer duration of catheter use. CA-UTI rate in stud-
ies involving European countries was 62.2 %. Short-term catheterization
rate was 90.8 %. Risk factors leading to CAUTI in ICU and microorgan-
isms should be considered in order to prevent CAUTIs.
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Page 40 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. Sternal wound infections (SWI) following open-heart sur-
gery are a serious complication that have a significant impact on patient
morbidity, mortality and length of hospitalization. Despite the implementa-
tion of a SWI policy in 2017 in our in center , after one year the incidence
of infection is still significant and it needs a proactive action from our team.
OBJECTIVES. Identify risks factors for SWI and lack of adherence to
our policy. Plan strategies to decrease SWI.
METHODS. Review of our SWI prevention policy based on Lazar at
al.2016 recommendations.Retrospective review of 684 cardiac surgi-
cal procedures performed in 2018. A dedicated Infection Control
Nurse (IC) reviewed charts and conducted audits during the pre-op
admission, assessing for SWI risks factors and surgeons’ performance.
Descriptive statistics and plan for quality improvement are presented
RESULTS. 684 procedures were performed. Age 64±12.4 , 65% were
male. Surgeries: 259 valve replacements, 38%; 116 valvuloplasty, 17%;
116 CABG, 17%; 13 transplants, 2 %; 26 type A aortic dissection 4%; 150
others, 22%.EuroScore 3.39± 4.98,length of stay in ICU 3,56± 6,3,lactate
level 4,06 ±4,45,SOFA score4,9±2,48,CEC 111.1±53,38.
SWI were n=24 (3,4%) compared to 3,6% in 2017with a benchmark
in literature of 0.5%.
SWI age : 64 ± 12.4, 33% were male. Surgeries: 15 Valve replace-
ments 63%; 6 CABG 25%; 1 transplant,4%; 1 type a Aortic dissection
4%,1 other4%
15 Patients(63%) had pre-op outpatient consultation, 9(37%) were
transferred from other hospitals and had no infection prevention
screening. No evidence of Pre- op patient education on nutritional
status or smoking cessation.
N=9 ;60% had a nasal swab performed pre-op, 4 (44%) were positive
to Staph. Aureus, and for them there was no evidence of Mupirocin
therapy and Chlorhexidine 4% shower prescription. Showers with
chlorhexidine 4% were prescribed for 21 patients (88%), but a lack of
accurate documentation makes it impossible to assess this.
Oncall antibiotics were administered to 100% of patients, however,
there was no standardized documentation on timing for the second
dose. Intraoperative glycemic control was rarely performed. On 86%
of the 15 patients, insulin drip was started post-op.
We identified grey areas in which we need to improve.Mupirocin will be
prescribed to all patients undergoing cardiac surgeries, whether they are
positive or negative;our IT team will make some changes on the electronic
medical and nursing notes in order to obtain accurate nursing and med-
ical records, an educational brochure and video on smoking cessation, nu-
trition, diabetes control, and oral care will be provided to patients pre-op.
CONCLUSION. Despite the presence of an up to date policy, the rate of
SWI is still high at our center.The audit was able to highlight grey zone
in clinical practice that were used to revise the current policy in SWI
prevention.The role of an IC nurse dedicated to SWI will be crucial in
identifying SWI champions to further train staff and create a multidis-
ciplinary network for SWI prevention.The involvement of leadership will
be decisive in order to put into place what we have on policy.
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INTRODUCTION. Paromomycin is a aminoglycoside antibiotic. Emer-
gence of bacterial resistance led to many of us to consider the combin-
ation of antimicrobial agents. We tested the effect of paromomycin onisolates of multidrug resistant pathogens (MDR) including: Pseudo-
monas aeruginosa, Klebsiella pneumoniae, Escherichia coli, and
methicillin-resistant Staphylococcus aureus. Paromomycin combined
with ceftriaxone, ciprofloxacin, ampicillin/sulbactam, azithromycin, clin-
damycin or doxycycline showed mostly synergistic effect on these clin-
ically important MDR pathogens. We routinely apply Selective Digestive
Decontamination (SDD) with topic colistin. However, some patients had
rectal colistin and / or carbepenemase (CPN) resistant microorganisms
colonization. The aim of this study was to administrate enteral paromo-
mycin to decontaminate these MDR microorganisms and to prevent
the development of ICU nosocomial infections.
METHODS. All consecutive patients admitted to the ICU from October
2011 to June 2017, expected to require tracheal intubation for longer
than 48 hours were given SDD with a 4-day course of intravenous cefo-
taxime, plus enteral colistin, tobramycin and nystatin in an oropharyngeal
paste and in a digestive solution. Patients with rectal swabs colonized by
colistin and / or carbepenemase resistant microorganisms were treated
with enteral paromomycin 1 gr every 6 hours a day, in order to become
it negative and prevent nosocomial infections. Categorical variables were
summarized as frequencies and percentages and the continuous ones as
medians and interquartile ranges (IQR) or means and standard deviations.
Statistical significance was set at p ≤ 0.05.
RESULTS. We applied paromomycin treatment to 102 colonized
patients with rectal colistin resistant microorganisms. All of them
but six had colonization by Extended Spectrum Beta-lactamases
(ESBLs) producing Klebsiella pneumoniae. Two patients was colo-
nized by ESBL producing
Enterobacter spp , other one by ESBL producing Escherichia coli., 1 by
Acinetobacter baumannii and 2 by Serratia marcescens. Demographic
data and type of admission are shown in Table 1. Seventy-nine out
of 102 (80.5%) negativized the rectal exudate after paromomycin. Of
those negativized, 26 patients received an appropriate antibiotic dur-
ing the application of paromomycin. Five out of the seven patients
with CPN were decolonized. 47 patients died in the ICU and 24 of
them, died without being de-colonized being two of them with CPN
resistant microorganisms. Only 3 patients developed infections after
decolonization.
CONCLUSION. Our data show that enteral paromomycin is effective
in treating rectal colistin and / or carbapenemase resistant micro-
organism colonization to prevent the development of ICU nosoco-
mial infections.
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INTRODUCTION. Selective digestive decontamination (SDD) have been
associated with reduced mortality and lower ICU-acquired rates However,
the effect SDD in areas where multidrug-resistant Gram-negative bacteria
are endemic is less clear. We want to prospectively.evaluate the impact
of SDD application on nosocomial muli-resistant (MR) infections (NI) and
colonization rates, after 7 years in a mixed ICU.
METHODS. This study was conducted in a 30-bed-medical-surgical ICU.
All consecutive patients admitted to the ICU from October 1, 2011 to
September 30, 2018 expected to require tracheal intubation > 48 hours
were given SDD (SDD study group) with a 4-day course of intravenous
cefotaxime, plus enteral colistin, tobramycin, nystatin in an oropharyn-
geal paste and in a digestive solution. Oropharyngeal and rectal swabs
were obtained on admission and once weekly. We used ENVIN NI cri-
teria. We compared all patients admitted to ICU with ICU NI from Octo-
ber 1, 2010 to September 30, 2011 (non-SDD group) to the SDD study
group. A univariate and a multivariate logistic regression analysis was
performed. For each one of the infections the incidences per 1000 days
of exposure in each cohort and the corresponding relative risks were
obtained using the Poisson regression. Statistical significance was p ≤
0.05.We analyzed colistin- and tobramycin-resistant colonization and
also antibiotic consumption as Defined antibiotics Daily Doses (DDD).RESULTS. Results are shown in Tables 1, 2 and 3. There were no
statistical significant differences between both groups in type of
admission or demographic data. Patients with SDD had signifi-
cantly less Extended Spectrum Betalactamase (ESBL), Gram
Negative Bacteria Multirresistant (GNB-MR) and Acinetobacter
spp infections. We had also a significant reduction in ventilator
associated pneumonias ( VAP), urinary infections and other sec-
ondary bacteremias and antibiotic resistant bacteria infection
rates, in SDD group versus non SDD. There was no infection by
Clostridium difficile. The exogenous infections were 499 (74%).
Colistin resistant colonization was 16,5% and tobramycin resist-
ant colonization was 25,7% of samples. There was a decrease
on the DDD/100 ICU stays after SDD.
CONCLUSION. After 7 years applying SDD a significant reduction
of infections by ESBL, GNB-MR and Acinetobacter, was observed.
A significant decrease of VAP, secondary bacteremias, urinary
and ARB infections rates was also shown. An antibiotic con-
sumption reduction was found after SDD. Low rates of colistin
and tobramycin-resistant colonization bacteria were observedCD - Managing haemodynamic
challenges
000017
Should I admit this patient with pulmonary embolism to the ICU?
D. Pérez-Torres, V. Fraile-Gutiérrez, E. Prol-Silva, JA. De Ayala-Fernández,
C. Díaz-Rodríguez, GJ. Posadas-Pita, P. Blanco-Schweizer, JJ. Sanz-Hernán,
PM. Enríquez-Giraudo
Department of intensive care medicine, Hospital Universitario Río
Hortega, Valladolid, Spain
Correspondence: D. Pérez-Torres
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000017
INTRODUCTION. Risk stratification is essential to decide the best lo-
cation and resource use for each patient.
OBJECTIVES. To describe the risk factors and their association with
mortality of the patients with pulmonary embolism (PE) who are ad-
mitted to the Intensive Care Unit (ICU).
METHODS. We conducted a retrospective observational study in the
Intensive Care Unit of a single university hospital. All the patients
who were admitted to the ICU with PE as a primary diagnosis were
Page 42 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55included, over an 8-year period. Demographics, comorbidities and
worst values of vital signs and laboratory tests within the first 24
hours of admission were registered. Risk stratification was performed
with the simplified Pulmonary Embolism Severity Index (sPESI) and
according to the recommendations of the European Society of Cardi-
ology (ESC). Chi-square, Fisher’s exact test and Student’s T test were
applied as appropriate. Bivariate analysis was performed to show the
relationship between variables and mortality.
RESULTS. A total of 82 patients were included, 43% male, aged 64 (44-
77), APACHE-II 12 (8-17), 42% fibrinolytic therapy, 15% hospital mortal-
ity. Mortality risk according to sPESI: high 82%, low 18%. Mortality risk
according to ESC: high 34%, intermediate 56%, low 10%. Common co-
morbidities were: arterial hypertension 34%, dyslipidaemia 22%, hos-
pital admission/surgery/trauma (HA/S/T) within the previous 3 months
22%, smoking 18%, previous episode of deep venous thrombosis (DVT)
12%, use of oral contraceptives 12%, diabetes mellitus 11%, neoplasm
10%, autoimmune disorder 8%, thrombophilia 6%, previous episode of
PE 6%. Reasons for admission were: recovered cardiopulmonary arrest
(CPA) 5%, cardiogenic shock (CS) 11%, acute heart failure 7%, acute re-
spiratory failure (AFR) requiring mechanical ventilation (MV) 17%, ARF
with no need for MV 29%, high-risk stratification with clinical stability
30%. Risk factors for mortality were: male sex (OR 3.3, p=0.07), presence
of ≥1 cardiovascular risk factor (OR 1.7, p=0.39), HA/S/T (OR 3.1, p=
0.07), previous DVT/PE (OR 1.1, p=0.93), presence of ≥2 items in the
sPESI (OR 16.5, p<0.01), severe form of presentation (CPA, CS, ARF with
MV) (OR 37.1, p<0.01). Vital signs and laboratory test results, survivors
vs deceased: MAP 107 vs 81 mmHg, p<0.01; HR 103 vs 122 bpm, p=
0.02; SpO2 91 vs 85%, p=0.05; RR 25 vs 30 bpm, p=0.05; haemoglobin
13.2 vs 11.8 g/dl, p=0.03; platelets 232 vs 168×10³/μl, p=0.03; creatinine
0.95 vs 1.59 mg/dl, p<0.01.
CONCLUSION. The presence of ≥2 items in the simplified PESI score
predicts mortality better than the simply positive result (≥1 item)
within patients with PE who are admitted to the ICU. These pa-
tients might benefit from a closer and more aggressive manage-
ment in the ICU.
Severe forms of presentation (CPA, CS or ARF requiring MV) dramatic-
ally increased the risk of mortality, and should be admitted to the ICU.
However, high-risk stratification with clinical stability was not associated
with mortality, so admission in a regular ward might be safe.
Patients who died because of a PE showed more hypotension, tachy-
cardia and kidney failure within the first 24 hours of presentation, so
admission to the ICU should be considered when these parameters
are abnormal.
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INTRODUCTION. Cardiogenic shock (CS) is a state of critical end-
organ hypoperfusion due to primary cardiac dysfunction. Most epi-
demiological data for CS focus on patients with acute myocardial in-
farction managed in intensive care units (ICUs) of cardiology
departments. Little is known about the most severe forms of CS, with
multi-organ failure, managed in general ICUs.
OBJECTIVES. Identify main predictors of mortality in CS and evaluate
their impact in the outcome. Evaluate usefulness of SOFA, APACHE II
and SAPS II scores in predicting the outcome in CS patients (P) and
identify the most useful one, if applicable
METHODS. Retrospective analysis of patients (P) admitted in our ICU,
with confirmed diagnosis of CS, within a period of 5 years (January2012- December 2016). We analyzed common epidemiological vari-
ables, evolution during ICU stay, established therapeutics and outcome.
RESULTS. 90 P were included. The mean age of the population was
69,59 ± 12,23 years, with a predominance of males (56,7%). Majority
of P coming from the Emergency Room (45,6%) and 26,7% present-
ing cardiopulmonary arrest at admission. Admission SOFA of 10,39 ±
3,19. The main cause of CS was non-ischemic (66,7%). In 27,8% of P
the presence of mixed shock was verified. 68,9% needed mechanical
invasive ventilation. Maximum PEEP of 8,22 ± 2,76 and median wean-
ing of 3 days during ICU stay, respectively. PaO2/FiO2 ratio and lac-
tactes at admission of 178,5 and 2,85, respectively. All the patients
needed aminergic support. 34,4% needed renal replacement ther-
apy. At discharge, the patients presented median ICU stay of 5 days
with SOFA, APACHE II and SAPS II of 7.6±5,06, 24,5 and 56,61 ±
19,71, respectively. Hospital mortality of 45,6%.
We found a statistically significant association between outcome
and:1) etiology (p=0,024), 2) admission SOFA (p=0,006), 3) APACHE II
(p< 0,001), 4) SAPS II (< 0,001) and 5) lactates variation in the first
24h (p=0,027). We also point out that after applying a logistic regres-
sion, to compare the impact of the used scores, only APACHE II (OR:
1,13; IC95%: 1,028-1,253) had relevant prediction power.
CONCLUSION. CS requires rapid diagnosis and appropriate therapy
to have a positive influence on the outcome. In our study, we found
that APACHE II was the best score to use in this kind of patients.
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INTRODUCTION. Cardiac surgery performed with cardiopulmonary
bypass (CPB) is frequently complicated by hemodynamic [1] instabil-
ity due either to an inflammatory response [2] or to cardiac dysfunc-
tion during or immediately after the weaning from CPB [3]. There are
limited studies on the incidence and the risk factors of prolonged
vasopressor dependence following cardiac surgery [4].
OBJECTIVES. The objective of the study was to identify risk factors
related to prolonged dependence on vasopressors after weaning
from bypass.
METHODS. Approval has been obtained by our Research Ethics Com-
mittee. In this single-center retrospective cohort study, we analyzed
data from consecutive adult patients who underwent cardiac surgery
with CPB enrolled in two prospective studies between November
2016 and July 2017 in a specialized cardiac surgery center. The study
excluded all cardiac surgery without CPB, heart transplantation and
ventricular assist devices. Postoperative prolonged vasopressor de-
pendence was defined as the need for at least one vasopressor
agent from the end of CPB for a duration greater than 24 hours.
Vasopressor agents included norepinephrine, vasopressin, epineph-
rine, dopamine and phenylephrine. A follow-up was conducted for
all patients until the end of intensive care unit (ICU) day 1. A multi-
variable logistic regression model using a forward stepwise selection
approach was developed to identify independent predictors of vaso-
pressor dependency.
RESULTS. A total of 247 out of 263 patients underwent cardiac sur-
gery with CPB between November 2015 and July 2017 using our ex-
clusion criteria. The mean age of the study patients was 65 ± 12
years old and 126 (51%) were female (Table 1). The incidence of pro-
longed vasopressor dependence was 40% and was associated with
more prolonged mechanical ventilation (5h (IQR4-9) vs. 4h (IQR3-5);
p<0.001), prolonged ICU stay (3 days (IQR1-2) vs. 1 day (IQR1-2); p<
0.001) as well as hospital stay (7 days (IQR6-10) vs. 5 days (IQR4-7);
Page 43 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55p<0.001). In multivariable analysis, pre-existing reduced left ventricu-
lar ejection fraction (LVEF<30%) (OR: 9.52, 95%CI:1.14-79.24; p=0.03),
preoperative pulmonary hypertension (PH) (moderate PH (sPAP≥30
but <55mmHg) OR:2.5, 95%CI:1.14-5.52, severe PH (sPAP>55mmHg)
OR:8.12, 95%CI:2.53-26.02; p=0.001) and first 24h cumulative fluid
balance (OR:1.78, 95%CI:1.41-2.24; p<0.0001) were independently as-
sociated with the development of prolonged vasopressors depend-
ence: with a good ability to predict vasoplegia after cardiac surgery
based on ROC analysis (AUC=0.80, 95%CI: 0.73-0.86; p<0.0001).
CONCLUSION. Vasopressor dependency remains a frequent complica-
tion after CPB surgery. Its associations with PH and large fluid balance
is unreported and potentially reversible. Prospective studies and clinical
trials should explore the role of these two factors in future studies.
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INTRODUCTION. Levosimendan (Lv) is a calcium sensitizing inotrope
indicated for short-term treatment of acutely decompensated severe
chronic heart failure (1). Venous-arterial extracorporeal membrane
oxygenation (VA-ECMO) provides temporary mechanical circulatory
support in patients with refractory cardiogenic shock (2). Few data is
available on the impact of Lv on VA-ECMO weaning.
OBJECTIVES. Evaluate the safety and efficacy of Lv on VA-ECMO
weaning in patients admitted to intensive care.
METHODS. Retrospective study of 68 patients (57% male; mean age
48.9 years) who received Lv to assist weaning from VA-ECMO.
Successful outcome was described as VA-ECMO decannulation within
48 hours after Lv infusion and patients had also to be alive for, at
least, 48 hours after the procedure.
Safety data (hypotension, arrhythmias and hypokalaemia) was recorded.
RESULTS. More than half of the patients (54.4%) were established on
VA-ECMO after cardiac surgery.
The first Lv infusion was started ± 7 days after admission to intensive
care. 2 patients received loading dose. The infusion ran for ± 23 hours
and the maximum infusion rate (0.2mcg/kg/min) was achieved in 66.2%.
After the first Lv infusion, 4 patients (5.9%) were successfully bridged
to a long term ventricular assist device (VAD) and 26 (40.6%) were
successfully weaned off VA-ECMO. On the remaining group of 38 P,
10 received at least one further dose of Lv, 7 or more days after the
first dose, enabling successful VA-ECMO decannulation in other 4 pa-
tients and bridging to VAD in 1 patient.
Side-effects analysis documented: 53% of clinical significant
hypotension and 25% of new atrial fibrillation. One patient had ven-
tricular fibrillation and 3 patients hypokalaemia.
The average ITU length of stay was 25 days and 44.1% of patients
survived intensive care admission.
CONCLUSION. In this heterogeneous group of patients that required
VA-ECMO for cardiogenic shock, the administration of Lv prior to trial
of decannulation was associated with successful weaning in 51% of
the patients. Nevertheless, the incidence of known side-effects,
namely hypotension and arrhythmias, cannot be neglected,
highlighting the high level of monitoring that this specific population
demands.The identification of surrogate markers of potential successful decan-
nulation is warranted, enabling a more tailored therapy.
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INTRODUCTION. Cardiac index (CI) is one of the hemodynamic vari-
ables to be assessed and monitored in shock patients. FloTrac/Vigileo
is a less-invasive uncalibrated arterial pressure waveform analysis.
However, its validation is limited in hemodynamically unstable septic
shock patients.
OBJECTIVES. The aim of our study was to compare CI measured
by 4th generation of FloTrac/Vigileo device with transpulmonary
thermodilution obtained by PiCCO in septic shock patients.
METHODS. A prospective observational study was performed in the
Medical Intensive Care Unit. We simultaneously measured the CI
using a Vigileo device (CIv) and compared it with the CI derived from
transpulmonary thermodilution (CItp) as well as the pulse contour-
derived CI using PiCCO (CIp). The measurement agreements were
evaluated using the Bland-Altman analysis, percentage error and
concordance analysis.
RESULTS. Thirty-one septic shock patients were included. Their
mean APACHE II score was 26.5±8.1. All of the patients received
norepinephrine with a mean dose of 0.33±0.18 ug/kg/min. In the
comparison of CIv with CItp, there were 156 data pairs. The CIv
and CItp values ranged from 1.5 to 6.8 and 1.5 to 6.9 L/min/m2,
respectively. CIv correlated with CItd as indicated by r = 0.62 (p<
0.001). The Bland-Altman analysis corrected for repeated measure-
ments showed a bias of 0.14, and the limits of agreement were
-1.62 to 1.91 L/min/m2 with a percentage error of 48.4%. When
comparing CIv with CIp (n=352 paired measurements), CIv ranged
from 1 to 6.2 and CIp ranged from 1.4 to 6.9 L/min/m2. Here,
the Bland-Altman analysis revealed a bias of -0.163, and the limits
of agreement were -1.46 to 1.79 L/min/m2 with a percentage
error of 45.7%. The overall correlation coefficient between CIv
and CIp was 0.63 (p<0.001). Moreover, a four-quadrant plot ana-
lysis was performed to evaluate the trending ability of ΔCI
change between the two devices. The concordance rate between
CIv vs. CItd was 95.6%, and that for CIv vs. CIp was 85.4%. There
were 56 and 16 pairs of CI measurement performed before and
after the increase of norepinephrine dose and fluid bolus, re-
spectively. In terms of the absolute changes in CIv and CIp in-
duced by the increased dose of norepinephrine, the bias value
was -0.47, and the limits of agreement were -1.73 to 0.8 L/min/
m2. In addition, the coefficient of correlation and concordance
rate between the percent changes in CIv and in CIp were 0.8 (p<
0.001) and 95.8%, respectively. However, the bias was 0.05 and
the limits of agreement between the absolute changes in CIv
and CIp induced by volume expansion were -0.28 to 0.38 L/min/
m2. Finally, concerning the percent changes in CIv and in CIp in-
duced by fluid expansion, the coefficient of correlation and con-
cordance rate was 0.49 (p=0.05) and 83%, respectively.
CONCLUSION. Our study demonstrated a moderate agreement be-
tween the CI derived from a 4th generation FloTrac/Vigileo device with
that using the transpulmonary thermodilution method. However, the
Table 1 (abstract 000158). Hemodynamic characteristics. Data are
presented as mean (SD)
A-group F-group p value
Heart rate 97 (21) 102 (24) 0.434
Mean arterial pressure (mmHg) 71 (11) 67 (14) 0.217
Page 44 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55uncalibrated CI measured using updated FloTrac software exhibited a
more reliable trending ability to track changes in CI compare to trans-
pulmonary thermodilution CI obtained by PiCCO.
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INTRODUCTION. Pharmacological scores, such as inotrope score (IS) and
vasoactive-inotropic score (VIS) were created to improve the adrenergic
dose evaluation in infants cardiac surgery. Later these scores have started
to use in adult. However, the significance of IS and VIS as an indicator of
hemodynamic profile and predictor of the clinical outcomes in adult car-
diac surgery remains unclear.
OBJECTIVES. To estimate IS and VIS as an approach for monitoring of
the hemodynamic profile and clinical outcomes in adult cardiac surgery.
METHODS. 144 patients over 18 year had undergone cardiac surgery
with CPB were enrolled in prospective observational study. Тhe aver-
age age was 63.6 ± 10.4 years. Hemodynamic was estimated by a
Swan-Ganz catheter, at the same time points we calculated IS and
VIS using standard formulas. For further analysis, we used data that
was obtained 6 h after ICU admission. Differences were assessed by
the Mann-Whitney and Fisher's exact tests. Data are presented as:
median (25th percentile, 75th percentile).
RESULTS. At 6 h after ICU admission, VIS ≥10 was observed in 53/144
patients (36.8%), when only 7/144 (4,9%) patients had IS ≥10.
VIS ≥10 did not show high prognostic significance for adverse outcomes.
Thus, in the ROC-analysis, the area under the curve (AUC) of the duration
of respiratory support (RS) was only 0.58, and AUC of ICU length of stay
(LOS) was 0.59. There was no significant difference between VIS ≥10 and
VIS <10 in the duration of RS (12 (6; 18) vs 9 (5; 16) h, p = 0,07), LOS (24
(20; 58) vs 22 (19; 24) h, p = 0,06) and mortality (3.8% vs 0, p = 0,13).
IS ≥10 was significantly associated with adverse postoperative out-
comes. ROC analysis showed good prognostic models for both the
duration of RS (AUC = 0.86) and the LOS (AUC = 0.91). We found sig-
nificant differences between IS ≥10 and IS <10 in the duration of RS
(83 (15; 120) vs 9 (5; 16) h, p = 0,002), LOS (85 (60; 143) vs 22 (19; 26)
h, p = 0,001) and mortality (28.6% vs 0, p = 0,02).
VIS ≥10 was not associated with low cardiac output syndrome (LCOS).
There were no significant differences between VIS ≥10 and VIS < 10 in
stroke volume index (SVI), SvO2 and lactate. 43.4% patients with VIS
≥10 were treated only with vasopressors without any inotropes.
In contrast, patients with IS ≥10 tended to a lower SVI than ones with
IS > 10 (31(17; 47) vs 35(30; 41) ml/m2, p = 0,36). Moreover, patients
with IS ≥10 had significantly higher lactate level (7,6(6; 10) vs 2,2(1,7;
3) mmol/l, p = 0,001).
CONCLUSION. We suggest that VIS ≥10 is less sensitive than IS
≥10 for adverse postoperative outcomes. The results of our study indi-
cate that VIS ≥10 characterizes patients with postoperative vasoplegia,
while IS ≥10 is associated with LCOS and organ perfusion disorder.Norepinephrine (μg/kg/min) 0.43 (0.42) 0.47 (0.50) 0.746000158
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000158INTRODUCTION. Axillary artery catheterization from the axillary fossa is
an alternative approach for arterial line placement in intensive care.
However, this access is cumbersome and has many drawbacks. Another
technique - an ultrasound-guided approach via an infraclavicular route
has been described, but to date, it is unknown whether this method is
clinically useful in critically ill patients [1].
OBJECTIVES. To examine the efficacy of the infraclavicular, real-
time, ultrasound-guided, in-plane percutaneous catheterization of
the axillary artery in mechanically-ventilated critically ill patients.
METHODS. A prospective randomized controlled study was conducted
in a 11-bed mixed ICU. We included mechanically-ventilated adult pa-
tients who had an arterial catheter inserted to monitor arterial pressure
or to perform hemodynamic monitoring. An arterial catheter for arterial
pressure monitoring was inserted only when radial artery
catheterization was impossible. Patients were randomly assigned into
two groups. In the A-group, an infraclavicular ultrasound-guided, real-
time, in-plane catheterization of the axillary artery was performed using
an arterial catheter 3.8Fr (Arrow/Teleflex, USA) or PiCCO catheter 4Fr
(Pulsion, Germany). In the F-group, an ultrasound-guided, real-time,
out-of-plane catheterization of the common femoral artery was per-
formed using an arterial catheter 3.8Fr (Arrow/Teleflex, USA) or PiCCO
catheter 5Fr (Pulsion, Germany). In both groups Seldinger’s technique
was used. The artery puncture success rate, catheterization success rate,
and early mechanical complications were assessed.
RESULTS. From January 2018 to February 2019, a total of 51 patients were
randomized: 25 to the A-group and 26 to the F-group. There was no differ-
ence in demographic variables. Out of 51 patients, 88.2% were in shock
and treated with norepinephrine. Hemodynamic characteristics were simi-
lar in both groups (Table 1). The puncture success rate of the artery was
100% in both groups. The catheterization success rate of the axillary and
femoral artery was 96% and 92.3%, respectively (difference – 3.7%, 95%CI:
[-9.1%, 16.5%]). Directly after the procedure, a small periarterial hematoma
in six patients in each group (11.7%) was identified using an ultrasound
examination. The rate of inadvertent puncture of the opposite wall of the
artery was 15.4% in the F-group and 4% in the A-group (difference –
11.4%, 95%CI: [-4.5%, 27.2%]). No puncture of the vein in the A-group oc-
curred. There was one inadvertent puncture of the vein in the F-group.
CONCLUSION. Preliminary results indicate that the catheterization
success rate of the ultrasound-guided axillary artery catheterization
via an infraclavicular route is comparable to the femoral approach –
we have not found a sufficient evidence against that claim. In terms
of early mechanical complications, the axillary approach is not infer-
ior to the femoral approach.
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INTRODUCTION. To estimate the effect of early fluid removal on the
early postoperative recovery in children after surgical repair of com-
plex congenital heart disease with enlarged right ventricle via a ran-
domized trial.
Page 45 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55METHODS. One hundred and twenty patients with right-sided com-
plex congenital heart defect who underwent cardiac surgery by car-
diopulmonary bypass during 2017.1-2017.6 were enrolled and were
divided to two groups when the hemodynamics was stable within 3
hours after the surgery. Patients in Group-E were treated with early
fluid removal, but Group-C remained conventional therapy. The Data
of the hemodynamics and outcomes were collected from the post-
operative day to the 2ndday post-operation.
RESULTS. Fluid removal therapy was started in Group-E at 4.39±
0.85hr postoperatively vs. 10.17±2.77hr(P<0.05)in Group-C. Patients in
Group-E showed lower extravascular lung water index (ELWI) , lower
fluid overload and lower NT-proBNP compared with patients in
Group-C on the first day of post-operation(P<0.01). Also, the advan-
tages remained in Group-E on the second day but the ELWI showed
no remarkable difference. The rate of reintubation(P<0.05), the dur-
ation of mechanical ventilation and the length of ICU stay (P<
0.01)were significantly reduced in Group-E.
CONCLUSION. In patients with right ventricle enlarged complex con-
genital heart defect who underwent cardiac surgery by cardiopulmonary
bypass, utilizing early negative fluid balance when the hemodynamics
were stable and the right ventricle is obviously enlarged could achieve
negative fluid balance, get extubated and discharge from ICU earlier, also
present lower extravascular lung water index, lower incidence of
weaning-induced pulmonary edema and reintubation.
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INTRODUCTION. The aims of this survey is to know the current status
and specialty of postoperative hemodynamic monitoring and peri-
operative application vasoactive agents in 17 pediatric heart centers
in China, and to establish some basics for further investigations.
METHODS. A survey was raised with perioperative hemodynamic mon-
itoring, prophylactic using of vasoactive agents during surgery with car-
diopulmonary bypass and postoperative application of vasoactive
agents according some articles and surveys published recently.
RESULTS. Basic hemodynamic monitoring can be 100% imple-
mented, but only 77% and 41% of the centers measured cardiac out-
put and microcirculation. Dopamine was preferred by most centers
for preventing low cardiac output syndrome (LCOS) following heart
surgeries. Patients suffering from LCOS with high systemic vascular
resistance (SVR) , LCOS with low SVR and LCOS with high pulmonary
vascular resistance were more likely be treated with Milrinone, Dopa-
mine or Adrenaline and Milrinone+Catecholamines+Pulmonary vaso-
dilators, which was similar to the results in western countries.
CONCLUSION. Basic hemodynamic monitoring can be implemented
well in Chinese pediatric heart centers, but the application of advanced
hemodynamic monitoring still has a great disparity comparing to some
centers abroad. The using of vasoactive drugs was similar to foreign
centers but differs obviously, lacking symposiums or guidelines. More
randomized control tests and clinical guidelines were prospected to in-
struct intensivists to utilize vasoactive agents in the future.
REFERENCE(S)
1. Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, Bailey
JM, Akbary A, Kocsis JF, Kaczmarek R, Spray TL, Wessel DL. Efficacy and
safety of milrinone in preventing low cardiac output syndrome in infants
and children after corrective surgery for congenital heart disease.
Circulation. 2003; 107: 996–1002.
2. Morales DLS, Almond CSD, Jaquiss RDB, Rosenthal DN, Naftel DC,
Massicotte MP, Humpl T, Turrentine MW, Tweddell JS, Cohen GA,
Kroslowitz R, Devaney EJ, Canter CE, Fynn-Thompson F, Reinhartz O, Ima-
mura M, Ghanayem NS, Buchholz H, Furness S, Mazor R, Gandhi SK, Fraser
CD Jr. Bridging children of all sizes to cardiac transplantation: the initial
multicenter North American experience with the Berlin Heart EXCOR ven-
tricular assist device. J Heart Lung Transplant. 2011; 30: 1–8. doi: 10.1016/
j.healun.2010.08.033.
3. Jones B, Hayden M, Fraser JF, Janes E. Low cardiac output syndrome in children.
Curr Anaesth Crit Care. 2005;16(6): 347-358. doi:10.1016/j.cacc.2006.02.011
4. Algarni KD, Maganti M, Yau TM. Predictors of low cardiac out- put
syndrome after isolated coronary artery bypass surgery: trends over 20
Page 46 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55years. Ann Thorac Surg. 2011;92(5): 1678-1684. doi:10. 1016/
j.athoracsur.2011.06.017.
5. Vogt W, Laer S. Treatment for paediatric low cardiac output syn- drome:
results from the European EuLoCOS-Paed survey. Arch Dis Child.
2011;96(12): 1180-1186. doi:10.1136/archdischild- 2011-300370.
6. Pérez Vela JL, Martín Benitez JC, Carrasco Gonzalez M, de la Cal López
MA, Hinojosa Pérez R, Sagredo Meneses V, del Nogal Saez F, et al.
Summary of the consensus document: "Clinical practice guide for the
management of low cardiac output syndrome in the postoperative





8. Marino BS, Tabbutt S, MacLaren G, Hazinski MF, Adatia I, Atkins DL,
Checchia PA, DeCaen A, Fink EL, Hoffman GM, Jefferies JL, Kleinman M,
Krawczeski CD, Licht DJ, Macrae D, Ravishankar C, Samson RA,
Thiagarajan RR, Toms R, Tweddell J, Laussen PC; American Heart
Association Congenital Cardiac Defects Committee of the Council on
Cardiovascular Disease in the Young; Council on Clinical Cardiology;
Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular
Surgery and Anesthesia; and Emergency Cardiovascular Care Committee.
Cardiopulmonary Resuscitation in Infants and Children with Cardiac
Disease: A Scientific Statement from the American Heart Association.
Circulation. 2018;137(22): e691-e782. doi: 10.1161/CIR.0000000000000524.
9. Brissaud O, Botte A, Cambonie G, Dauger S, de Saint Blanquat L, Durand P,
Gournay V, Guillet E, Laux D, Leclerc F, Mauriat P, Boulain T, Kuteifan K.
Experts' recommendations for the management of cardiogenic shock in
children. Ann Intensive Care. 2016;6(1):14. doi: 10.1186/s13613-016-0111-2.
10. Burkhardt BE, Rücker G, Stiller B. Prophylactic milrinone for the
prevention of low cardiac output syndrome and mortality in children
undergoing surgery for congenital heart disease. Cochrane Database Syst
Rev. 2015;(3):CD009515. doi: 10.1002/14651858.CD009515.pub2
11. Rizza A, Bignami E, Belletti A, Polito A, Ricci Z, Isgrò G, Locatelli A, Cogo
P. Vasoactive Drugs and Hemodynamic Monitoring in Pediatric Cardiac
Intensive Care: An Italian Survey. World J Pediatr Congenit Heart Surg.
2016;7(1):25-31. doi: 10.1177/2150135115606626.
12. Pei XB, Ma PL, Li JG, Du ZH, Zhou Q, Lu ZH, Yun L, Hu B. Extensive
variability in vasoactive agent therapy: a nationwide survey in Chinese
intensive care units. Chin Med J (Engl). 2015;128(8):1014-20. doi: 10.4103/
0366-6999.155064.
13. van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, Kilic A,
Menon V, Ohman EM, Sweitzer NK, Thiele H, Washam JB, Cohen MG;
American Heart Association Council on Clinical Cardiology; Council on
Cardiovascular and Stroke Nursing; Council on Quality of Care and
Outcomes Research; and Mission: Lifeline. Contemporary Management of
Cardiogenic Shock: A Scientific Statement from the American Heart
Association. Circulation. 2017;136(16): e232-e268. doi: 10.1161/
CIR.0000000000000525.
14. Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, Jaeschke
R, Mebazaa A, Pinsky MR, Teboul JL, Vincent JL, Rhodes A. Consensus on
circulatory shock and hemodynamic monitoring. Task force of the
European Society of Intensive Care Medicine. Intensive Care Med. 2014
Dec;40(12):1795-815
15. Daniel De Backer. Detailing the cardiovascular profile in shock patients.
Critical Care 2017, 21(Suppl 3):311. DOI 10.1186/s13054-017-1908-6
16. Yuerek M, Rossano JW, Mascio CE, Shaddy RE. Postoperative
management of heart failure in pediatric patients. Expert Rev Cardiovasc
Ther. 2016;14(2):201-15. doi: 10.1586/14779072.2016.1117388.
17. Saugel B, Vincent JL. Cardiac output monitoring: how to choose the
optimal method for the individual patient. Curr Opin Crit Care.
2018;24(3):165-172. doi: 10.1097/MCC.0000000000000492.
18. Fuda G, Denault A, Deschamps A, Bouchard D, Fortier A, Lambert J,
Couture P. Risk Factors Involved in Central-to-Radial Arterial Pressure Gra-
dient During Cardiac Surgery. Anesth Analg. 2016;122(3):624-32. doi:
10.1213/ANE.0000000000001096.
19. Dubin A, Henriquez E, Hernández G. Monitoring peripheral perfusion and
microcirculation. Curr Opin Crit Care. 2018;24(3):173-180. doi: 10.1097/
MCC.000000000000049520. Fornier W, Jacquet-Lagrèze M, Collenot T, Teixeira P, Portran P, Schweizer
R, Ovize M, Fellahi JL. Microvascular effects of intravenous esmolol in pa-
tients with normal cardiac function undergoing postoperative atrial fibril-
lation: a prospective pilot study in cardiothoracic surgery. Crit Care.
2017;21(1):302. doi: 10.1186/s13054-017-1889-5.
21. Cavigelli-Brunner A, Hug MI, Dave H, Baenziger O, Buerki C, Bettex D,
Cannizzaro V, Balmer C. Prevention of Low Cardiac Output Syndrome
After Pediatric Cardiac Surgery: A Double-Blind Randomized Clinical Pilot
Study Comparing Dobutamine and Milrinone. Pediatr Crit Care Med.
2018;19(7):619-625. doi: 10.1097/PCC.0000000000001533.
22. Vogt W, Läer S. Drug use patterns for the prevention of paediatric low
cardiac output syndrome in Europe. Intensive Care Med. 2011; 37: 1390–
1391. doi: 10.1007/s00134-011-2266-5.
23. Boehne M, Sasse M, Karch A, Dziuba F, Horke A, Kaussen T, Mikolajczyk R,
Beerbaum P, Jack T. Systemic inflammatory response syndrome after
pediatric congenital heart surgery: Incidence, risk factors, and clinical
outcome. J Card Surg. 2017;32(2):116-125. doi: 10.1111/jocs.12879.
24. Davis AL, Carcillo JA, Aneja RK, Deymann AJ, Lin JC, Nguyen TC,
Okhuysen-Cawley RS, Relvas MS, Rozenfeld RA, Skippen PW, Stojadinovic
BJ, Williams EA, Yeh TS, Balamuth F, Brierley J, de Caen AR, Cheifetz IM,
Choong K, Conway E Jr, Cornell T, Doctor A, Dugas MA, Feldman JD, Fitz-
gerald JC, Flori HR, Fortenberry JD, Graciano AL, Greenwald BM, Hall MW,
Han YY, Hernan LJ, Irazuzta JE, Iselin E, van der Jagt EW, Jeffries HE, Kache
S, Katyal C, Kissoon NT, Kon AA, Kutko MC, MacLaren G, Maul T, Mehta R,
Odetola F, Parbuoni K, Paul R, Peters MJ, Ranjit S, Reuter-Rice KE, Schnitz-
ler EJ, Scott HF, Torres A Jr, Weingarten-Abrams J, Weiss SL, Zimmerman
JJ, Zuckerberg AL. American College of Critical Care Medicine Clinical
Practice Parameters for Hemodynamic Support of Pediatric and Neonatal
Septic Shock. Crit Care Med. 2017;45(6):1061-1093. doi: 10.1097/
CCM.0000000000002425.
25. Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, Hanna
BD, Rosenzweig EB, Raj JU, Cornfield D, Stenmark KR, Steinhorn R,
Thébaud B, Fineman JR, Kuehne T, Feinstein JA, Friedberg MK, Earing M,
Barst RJ, Keller RL, Kinsella JP, Mullen M, Deterding R, Kulik T, Mallory G,
Humpl T, Wessel DL; American Heart Association Council on
Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council
on Clinical Cardiology; Council on Cardiovascular Disease in the Young;
Council on Cardiovascular Radiology and Intervention; Council on
Cardiovascular Surgery and Anesthesia; and the American Thoracic
Society. Pediatric Pulmonary Hypertension: Guidelines from the American
Heart Association and American Thoracic Society. Circulation. 2015 Nov
24;132(21):2037-99. doi: 10.1161/CIR.0000000000000329.
000200
Prognostic accuracy of qSOFA in patients with Heart Failure
T. Wagner1, J. Haumann1, S. Blankenberg1, H. Grahn2
1Cardiology, University Heart Center Hamburg GmbH, Hamburg,
Germany; 2University Heart Center Hamburg GmbH, Hamburg, Germany
Correspondence: H. Grahn
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000200
INTRODUCTION. The Sepsis-3 Task Force proposed the quick
Sequential (Sepsis-related) Organ Failure Assessment (qSOFA)
to replace SIRS as a new screening tool for the identification
of patients with sepsis [1]. Diagnostic and prognostic value for
patients outside the ICU is controversial. Further, there are no
data regarding the usability in patients with heart failure.
OBJECTIVES. To assess the prognostic accuracy of qSOFA score
in patients with heart failure admitted to a Heart Failure Unit
(HFU).
METHODS. Data from patients admitted to HFU were retrospectively
analyzed. qSOFA, and sSOFA score as well as SIRS criteria were as-
sessment at admission. In addition, demographic, clinical, laboratory
and echocardiographic value were recorded. A follow-up was per-
formed 30 days after discharge. Primary outcome was death or re-
admission to hospital due do worsening of heart failure symptoms
RESULTS. Of 240 patients (73% male, median age 64 years), 25
patients (10%) had a qSOFA score ≥2 points and 126 patients
Fig 2 (abstract 000205). ROC curves. FPR in (b) is log scaled to
emphasize performance at low FPR settings.
Page 47 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55(53%) fulfilled none of qSOFA criteria (0 points). Within these
patients 28 patients (12%) fulfilled the criteria of cardiogenic
shock.
Patients with a qSOFA score ≥1 point more frequently had a severe
systolic heart failure (EF ≤30%) and had a higher risk to develop
multi organ failure during hospital stay (28% vs. 9%, P=0.005).
Within 30 days, the primary endpoint occurred in 46 patients
(19%). Seventeen patients (7%) died and 34 patients (14%) were
readmitted to hospital due to heart failure. Patients with positive
initial qSOFA score reached this endpoint significantly more fre-
quent (48% vs. 19%, p=0.002). Follow-up showed that with posi-
tive qSOFA score reported a more often a worsening of heart
failure symptoms (p=0.021) representing a higher median NYHA
class (p=0.008).
CONCLUSION. In our study, qSOFA was useful to identify
patients with heart failure with a high risk to have a worse out-
come.Therefore, identification of these patients is of vital im-
portance but the diagnosis of sepsis is often not easy made in
patients with heart failure because of overlapping symptoms
(hypotonia, dyspnoe, tachycardia). qSOFA score is useful to
operationalize disease severity in adult in-patients with heart
failure.Table 1 (abstract 000205). Performance of models with 95% CI in
square brackets
Model TPR at low FPR (FPR=0.0001) AUC
GTC-Top 0.7 [0.556, 0.844] 0.869 [0.758, 0.980]
GTC-DF 0.6 [0.448, 0.752] 0.848 [0.732, 0.964]
Logistic regression 0.3 [0.156, 0.444] 0.638 [0.488, 0.788]
Random forest 0.0 [0.000, 0.048] 0.648 [0.499, 0.797]
Fig. 2 (abstract 000205). An example pattern from the GTC-Top
model which manifests in 7/10 IHS subjects and 0/26 non-IHS
subjects, and its manifestation on one example IHS subject.REFERENCE
1. Singer M, Deutschman CS, Seymour CW, et al. The Third International
Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;
315:801-10.
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INTRODUCTION. Substantial blood loss can induce Irreversible
Hemorrhagic Shock (IHS), which can lead to adverse patient
outcomes and mortality [2]. We hypothesize that a patient’s
response to rapid but short blood loss, such as blood draw,
can be indicative of cardiovascular reserve and thus predictive
of the risk of developing IHS when subject to prolonged
bleeding.
OBJECTIVES. To develop an approach to predict the likelihood of IHS
due to blood loss during surgery by analyzing the physiological pat-
terns of response to pre-operative blood draws.
METHODS. 36 healthy pigs were anesthetized and had a 20 mL of
blood rapidly drawn while stable, then bled at 20 mL/min until mean
arterial pressure (MAP) fell to 30 mmHg. 10 pigs had IHS (defined as
MAP < 20 mmHg) despite cessation of bleeding. Plethysmograph
(PLE) was recorded at 250 Hz. One-minute segments of data cen-
tered at blood draw start were statistically featurized and normalized
using pre-draw stable baseline data. Patterns were extracted from
data using Graphs of Temporal Constraints [1], and a decision forest
(GTC-DF) model was trained to identify patterns most informative of
IHS. To mitigate overfitting and for easy interpretation, only a few
patterns with the highest information gain were used to assess the
subjects (GTC-Top).
RESULTS. In a leave-one-subject-out cross-validation, GTC-Top
and GTC-DF respectively identify 70% (95% CI: [55.6%, 84.4%])
and 60% (95% CI: [44.8%, 75.2%]) of the subjects who are prone
to develop IHS, while giving only 1 false alert in 10,000 predic-
tions on average. They both outperform logistic regression (LR)
and random forest (RF) models [Fig 1, Tab 1].
CONCLUSION. We can identify, pre-operatively, the majority of
patients who are likely to develop IHS due to blood loss during
surgery, by using a tractable number of highly interpretablepatterns found in plethysmograph waveform changes during
pre-operative blood draws.
REFERENCE(S)
[1] Guillame-Bert et al. JMLR, 18(121):1–34, 2017.
[2] Gutierrez et al. Critical care. Crit Care, 8(5):373, 2004.
[3] This work is funded by NIH R01GM117622 and DARPA FA8750-17-2-0130.000220
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Age >75 15(13,9%) 44(15,3%) 0,75
Females 16(14,8%) 28(9,8%) 0,2
Smoking 46(42,6%) 106(36,9%) 0,35
DM 47(43,5%) 109(38%) 0,35
PCI 22(20,4%) 47(16,4%) 0,37
MI 80(74,1%) 197(68%) 0,64
PHT 51(47,2%) 56(19,5%) <0,01
CPB >120 41(38%) 67(23,3%) 0,05
Page 48 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. Primary percutaneous coronary intervention (pPCI) is
the ideal method of reperfusion for acute STEMI. Although, in some
areas it is very difficult to implement pPCI between two hours, and it is
well-known that 'Time is myocardium'.
OBJECTIVES. To evaluate the preservation of left ventricular ejection
fraction (LVEF) in patients undergoing a pharmacoinvasive therapy
protocol in a setting without primary percutaneous coronary inter-
vention , Campo de Gibraltar (CG) area.
METHODS. Multicentre observational prospective study of consecu-
tive patients with STEMI treated with fibrinolysis in the CG area and
transferred to our intensive care unit for coronarography and PCI be-
tween January 1, 2012 and March 31, 2018, included in the ARIAM
ANDALUCIA registry. We considered as early fibrinolysis those given
in the first 3 hours from symptom onset. LVEF was measured by
post-fibrinolysis echocardiography and/or by ventriculography during
coronarography. Preserved LVEF was defined as >55%, moderately-
reduced LVEF 35-50% and severely reduced LVEF <30%.R-comander
statistic pack was used for analyses. All continuous variables are de-
scribed as their mean values ± standard deviation and chi square
tests for discrete variables. CI 95%. P< 0.05.
RESULTS. 437 patients were included, mean age (sd) 59.79 (11.89),
242 were inferior STEMI and 194 anterior STEMI. Culprit arthery :
none 44, ACD 192, ADA 163 and ACX 38. Distribution (n) of Killip
grades I, II, III and IV were 383, 10, 13 and 31 respectively. Mean
GRACE (sd) was 149.59(33.49).
80.3% of fibrinolysis treatments were given early and 79.4% in hos-
pital, with a median symptoms-to-needle time of 95 minutes. TIMI 3
was achieved in 79.17% of the cases. 264 coronarographies were per-
formed in the first 24 hours (76 rescue-PCI) and 188 in 48-72 horus.
PCI were effective in 382 (87.8%) cases. 210 ventriculographies and
230 echocardiographies were performed. 265 had a preserved LVEF
(64.6%). Preserved LVEF was significantly associated to early fibrinoly-
sis (p<0.05). We did not find significant differences between PCI per-
formed in 24 hours or more than 48h.
CONCLUSION. Fibrinolysis in the first 3 horus favours LVEF preservation
in patients undergoing pharmacoinvasive therapy. Early fibrinolysis is
an effective alternative to primary PCI for for CG patients unable to
achieve a symptoms-to-ballon time lesser than 180 minutes.
REFERENCE(S)
1. Armstrong PW, Gershlick A, Goldstein p, et al. for the STREAM
Investigative Team. Fibrinolysis or primary PCI in ST-segment elevation
myocardial infarction. N Engl J Med 2013;368:1379-1387
2. To memory of Javier Lozano Cid MD who performed numerous coronary
interventions with excellence.
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INTRODUCTION. Low cardiac output syndrome (LCOS) after cardiac
surgery,- defined as the need for postoperative intraaortic balloon
pump or inotropic support for longer than 30 minutes to maintain
the systolic blood pressure greater than 90 mm Hg and the cardiac
index greater than 2.2 L/min/m2 -is associated with significant mor-
bidity and mortality
OBJECTIVES. Aim of this study is to identify risk factors for LCOS after
isolated CABG surgery with the use of cardiopulmonary bypass in pa-
tients with low ejection fraction(<40%).
METHODS. Patients who underwent isolated elective CABG from
June 2012 to March 2019, in our Cardiothoracic Department wereretrospectively investigated. The following factors were compared
between patients with postoperative LCOS and the rest of the co-
hort: Age>75years old, gender, smoking habit, Diabetes Mellitus(DM),
history of percutaneous coronary intervention(PCI), history of myocar-
dial infarction(MI), preoperative pulmonary hypertension(PHT) de-
fined as systolic pulmonary pressure >30mmHg (ECHO study)and
CPB time >120 min. Chi square test was used for statistical analysis.
RESULTS. A total of 2024 pts underwent isolated CABG. From 395 pts
who had preop EF<40%, LCOS complicated 108 pts (27,3%) Results
of our study are shown in table 1
CONCLUSION. In our study preoperative pulmonary hypertension
and prolonged CPB time found to have statistical significant correl-
ation with postoperative LCOS in patients with low EF.000254
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INTRODUCTION. Acute myocardial infarction (AMI) with coronary ar-
teries without significant obstructions (MINOCA) is a frequent syn-
drome that accounts for 5% to 25% of all AMI. It is a challenge in
clinical practice since there are gaps in their knowledge and thera-
peutic attitude. It assumes an adjusted 1-year mortality risk signifi-
cantly higher than patients with non STEMI (Non-ST-elevation
myocardial infarction) and associated obstructive coronary disease.
OBJECTIVES. To analyze the differences observed among patients
with AMI with and without angiographically significant coronary le-
sions (MINOCA) in patients admitted to the Intensive Care Unit (ICU)
of Hospital Punta Europe, using the ARIAM database.
METHODS. Retrospective descriptive analysis, on a prospective cohort,
accomplished in an ICU of 12 beds for 6 years (2013-2018). Demo-
graphic variables have been registered, comorbidities, risk factors, pre-
vious illnesses, previous medication, diagnosis initial, initial Killip,
location of AMI, stratification scales (TIMI, GRACE) and risk intrahospital
hemorrhage (CRUSADE), arrhythmias, ICU medication, complications
and attention times and procedures. Statistical analysis: variables cat-
egorical (frequencies and percentages), numerical (mean and standard
deviation or median and interquartile range). Comparisons: chi2 (per-
centages), Student's T test (means). Statistical significance with p <0.05.
RESULTS. 767 patients were included. 564 men (73.53%), 203
women (26.47%). STEMI (ST-segment elevation myocardial infarc-
tion) n=362 (47.2%), non-STEMI (Non-ST-elevation myocardial in-
farction) n=405 (52.8%). Non-MINOCA ACS comparison n=722
(94.1%) vs. MINOCA n=45 (5.86%): female (24.3% vs. 62.2%, p
=<.001), DM (37.4% vs. 22.2%; p=.038), obesity (14.5% vs. 26.7%,
p=.021), previous history of AMI (15.8% vs. 2.2%, p=.045), sinus
bradycardia (2.12% vs. 6.8%, p=.047), shock during ICU stay
(9.2% vs. 0%; p=.033), recurrent angina (4.9% vs. 13.3%, p=.015).
Page 49 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Worst Killip (p=.026): I (45.2% vs. 68.4%), II (27.7% vs. 21.1%), III (18.7%
vs. 10.5%), IV (8.5% vs. 0%). ICU length of stay (LOS) (days): 3.8 ± 4.9 vs.
3.3 ± 2.8, p=.543. Hospital LOS (days): 9.5 ± 8.3 vs. 13.9 ± 16.9, p=.308.
Mortality 7.1% vs. 0%, p=.065. Multiple logistic regression: female (OR
7.47, 95% CI [3.80-14.68], p=<.001), age (OR 0.97, 95% CI [0.94-0.99],
p=.016) and DM (OR 0.44, 95% CI [0.21-0.94], p=.035). AUROC: 0.765
(95% CI 0.685-0.845).
CONCLUSION. In our Unit, the prevalence of MINOCA was 5.86%, simi-
lar to the one described in literature. Female sex, a younger age and
the absence of diabetes mellitus were independently associated with
diagnosis of MINOCA. No differences were observed in mortality
among MINOCA and ACS with significant coronary lesions.REFERENCE
1. No grant acknowledgment.
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INTRODUCTION. Eventhough the incidence of STEMI has been
declining over the past 20 years, to produce an accurate assess-
ment of risk and mortality individual patients have a combin-
ation of clinical features that influence prognosis, and these
factors must be appropriately weighted. Time is really important,
as nearly half of potentially salvageable myocardium is lost within
1 hour of the coronary artery being occluded, and two-thirds is
lost within 3 hours.
OBJECTIVES. To analyze the differences between patients diagnosed
with ST-segment elevation myocardial infarction (STEMI) and those
diagnosed with non ST-segment elevation myocardial infarction
(NSTEMI) admitted to the intensive care unit (ICU) of Punta de Eur-
opa hospital using ARIAM database.
METHODS. Descriptive retrospective analysis on a prospective cohort
performed in a 12-bed ICU for 6 years (2013-2018). Two groups were
compared, STEMI vs. NSTEMI. Demographic variables, comorbidities,
risk factors, initial Killip, extension, TIMI, GRACE, CRUSADE have been
registered. Statistical analysis: categorical (frequencies and percent-
ages) and numerical variables (mean and standard deviation). Com-
parisons: X2 test (percentages), Student’s t (means). Statistical
significance with p<0.05.
RESULTS. 767 patients were included: STEMI 362 (47.19%) vs. NSTEMI
405 (52.80%): male (76.8% vs. 70.6%, p=.053), age (62.14 [±13.16] vs.
67.17 [±12.55], p<.001), arterial hypertension (AH) (39.2% vs. 52.1%,
p=.002), smoker (46.1% vs. 32.6%, p=.001), diabetes mellitus (DM) (27.9%
vs. 44.2%, p<.001), previous myocardial infarction (MI) (8.3% vs. 21%,
p<.001), previous coronary lesions (8.6% vs. 18.8%, p<.001), heart failure
(HF) (1.1% vs. 9.6%, p<.001), stroke (3% vs. 8.1%, p=.006), chronic renal
failure (CRF) (1.4% vs. 11.4%, p<.001), coronariography (83.2% vs. 49.2%,
p<.001), TIMI (3.44 [±2.71] vs. 2.72 [±1.41], p<.001), GRACE (155.86 [±
38.63] vs. 147.86 [±46.03], p=.021), CRUSADE (28.78 [±15.45] vs. 35.97 [±
18.66], p<.001). Responsible artery (p<.001): anterior descending artery
(LAD) (35.7% vs. 45.6%), right coronary artery (RCA) (40.9% vs. 18.3). Diag-
nosis (p<.001): unstable angina (2.5% vs. 44.2%), MI (94.2% vs. 52.3%).
Mortality 6.4% vs 6.8% (p=.756). Time (expressed in minutes): first
contact-EKG (14.6 [±24.8] vs. 20.9 [±22.7], p=.019), first contact-ICU (149.9
[±284.3] vs. 493.5 [±674.0], p<.001), first contact-percutaneous coronary
intervention (PCI) (2316 [±3928.7] vs. 7245.2 [±8647.7], p<.001). Time
(expressed in days): first symptoms-ICU discharge (3.5 [±4.2] vs. 4.8 [5.7],
p<.001), ICU admission-ICU discharge (3.3 [±3.9] vs. 4.2 [±5.5], p=.006),
PCI-ICU discharge (1.7 [±4.7] vs. 0.27 [±6.0], p=.002).
CONCLUSION. Patients diagnosed with STEMI were older and had
higher prevalence of AH, DM, previous MI, HF, stroke, CRF and smok-
ing. RCA was the most commonly affected in STEMI while LAD was
in those diagnosed with NSTEMI. Time indicators were worse for
STEMI than NSTEMI except ICU length of stay after PCI.000284
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INTRODUCTION. Zinc is an essential trace element involved in a pleth-
ora of functions, including wound healing, neurological signaling and
immune function. Zinc deficiency is associated with the development
of atherosclerosis and is prevalent among cardiac surgery patients.
OBJECTIVES. To assess the relationship between zinc status and the
inflammatory response, endothelial activation and clinical outcomes
in cardiac surgery patients.
METHODS. One hundred and seventy-nine patients undergoing on-
pump cardiac surgery were included. Blood samples were obtained at
predefined time points before, during, and after surgery to assess zinc
levels (preoperatively) and markers of inflammation (TNF-α, IL-6, IL-8, IL-
10, IL-1RA, MCP-1, MIP-1α, MIP-1β) and endothelial activation (VCAM,
ICAM) serially. The correlation between zinc concentrations and the area
under the curve (AUC) of circulating cytokines, chemokines, and markers
of endothelial cell activation was determined. The relationship between
zinc status and clinical outcomes was assessed by dividing patients into a
low-zinc (below median) and a high-zinc (above median) group.
RESULTS. The median zinc level of the enrolled patients was (median
[IQR]) 7.0 [5.7-9.2] μmol/L and 84% of the study population displayed
below-normal levels (<10 μmol/L). Cardiac surgery induced a substantial
increase in postoperative plasma levels of all measured inflammatory me-
diators, except TNF-α. Zinc status was not related to plasma cytokine
levels, but weak negative correlations were observed for the chemokines
MIP-1α and MIP-1β (r=-0.16, p=0.04 and r=-0.15, p=0.04, respectively). Fur-
thermore, a weak, but statistically significant, inverse correlation was found
between zinc status and VCAM (r=-0.21; p<0.01), and a trend for ICAM (r=-
0.14; p=0.06). The proportion of patients requiring vasopressors on the
day of surgery and on the following day did not differ between the low
and high-zinc groups (84.1% vs. 76.7%, p=0.22 and 53.4% vs. 53.5%, p=
0.99, respectively), but was significantly higher in the low-zinc group on
the second postoperative day (20.5% vs. 7.1%, p=0.01). Zinc status was
not related to ICU length of stay (21.5 [19-24] vs. 22.0 [19-24] hours in the
low and high zinc groups, respectively, p=0.65), but hospital length of stay
was significantly prolonged in the low-zinc group (220 [192-297] vs. 195
[171-264] hours, p=0.02).
CONCLUSION. A majority of cardiac surgery patients has low zinc
levels and this is weakly associated with increased levels of chemo-
kines and endothelial activation markers. Furthermore, low zinc sta-
tus is related with increased postoperative vasopressor requirement
and prolonged hospital stay. Further research is warranted to eluci-
date the mechanisms behind these findings and to assess a possible
role for preoperative zinc supplementation in deficient patients.
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INTRODUCTION. Patients with acute coronary syndromes (ACS) may
develop serious complications and require prolonged intensive care.
The need for invasive mechanical ventilation (IMV) is a common reason
for prolonged intensive care in patients who are admitted with an ACS.
OBJECTIVES. To identify factors associated with the need of IMV in
patients diagnosed with ACS admitted to the intensive care unit
(ICU) of Hospital Punta de Europa using ARIAM database.
METHODS. Retrospective descriptive analysis using a prospective co-
hort performed in a 12-beds ICU for 6 years (2013-2018). Two groups
were compared: patients who suffered ACS and did not required IMV vs.
Page 50 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55those diagnosed with ACS and required IMV. Demographic variables, as-
sociated comorbidities, risk factors, Killip classification at the beginning,
damage extension, TIMI, GRACE, CRUSADE, complications occurred dur-
ing ICU admission, lesions founds in coronary angiography, diagnosis at
ICU discharge and mortality were collected. Statistical analysis was per-
formed: categorical variables (expressed in percentages and frequencies),
continuous variables (expressed using mean and standard deviation).
Comparison: Chi-squaretest (percentages) and T-student test(mean). Mul-
tiple logistic regression. Statistical significance was set at p-value < 0.05.
RESULTS. 756 patients were included. 35 patients (4.63%) were under
IMV, and 721 patients (95.37%) were not. Those who were under IMV:
male (54.38% vs. 74.3%, p=.009), age (69.7 [±11.7] vs. 64.4 [±13.1],
p=.019), body mass index (29.01 [±5.64] vs. 27.02 [±3.87], p=.031), dia-
betes mellitus (DM) (60.0% vs. 35.1%, p=.003), previous ACS (37.1% vs.
13.9%, p<.001), creatinine values (1.91 [±1.13] vs. 1.23 [±0.95], p=.006),
heart rate (91.9 [±22.65] vs. 78.94 [±19.67], p=.002), systolic blood pres-
sure (102.14 [±20.66] vs. 124.21 [±26.01], p<.001). Complications occurred
during ICU admission: shock (71.4% vs. 5%, p<.001), infectious complica-
tions (20% vs. 0.4%, p<.001), renal complications (14.3% vs. 1.5%, p<.001),
encephalopathy (5.7% vs. 0.6%, p=.001). Myocardial infarction loca-
tion (p=.027): anterior(53.6% vs. 43.2%), inferior (28.6% vs. 45.2%). Coron-
ary angiography findings (p=.009): left anterior descending artery (60.9%
vs. 39.2%), right coronary artery (26.1% vs. 31%), left main coronary artery
(13% vs. 3%), circumflex artery (0% vs. 15.2%). ICU length of stay (LOS)
(days): 10.46 ± 12.13 vs. 3.41 ± 3.80; p=.002. Mortality: (48.6% vs. 4.2%,
p<.001). Multiple logistic regression: female (OR 2.82, CI 95% [1.12-7.13],
p=.028), infectious complication (OR 176,37, CI 95% [30.74-1011.90],
p<.001), shock (OR 62.40, CI 95% [23.36-166.70], p<.001), previous MI (OR
2.30, CI 95% [0.86-6.14]. AUROC: 0.92 (CI 95% [0.85-.98]).
CONCLUSION. Female sex, shock and infectious complications were pre-
dictive factors for the need of IMV in patients diagnosis with ACS. The
need of IMV was associated with higher rates or mortality in ICU stay.HSRO - Improving treatment in the ICU
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INTRODUCTION. Persistent Inflammatory, Immunosuppressed, Cata-
bolic Syndrome (PICS) is a phenotype of critically ill patients that cor-
relates as a potential origin of chronic critical illness (CCI). Wedefined PICS as a combination of clinical and laboratory criteria to
predict the occurrence of CCI.
OBJECTIVES. To evaluate the prognostic capacity of our predefined
criteria of PICS on the 8th day of admission (PICS-8) for the develop-
ment of CCI. We analyzed the association between the presence of
PICS-8, one event of PICS, or the accumulation of PICS events with in-
tensive care unit (ICU) length of stay (LOS), hospital-LOS, mortality,
and functional capacity up to 12 months after hospital discharge.
METHODS. We designed a multicenter prospective study enclosing
all patients on 8th day of ICU admission over 3 consecutive months.
Patients were monitored for PICS-8, every 7 days for PICS status and
evaluated 3 times within one year after discharge for functional cap-
acity. When data follows a normal distribution, categorical variables
are expressed as frequencies and percentages; and continuous vari-
ables as mean and standard deviation (SD), or median and interquar-
tile range as needed. If hospital mortality occurred then ICU-LOS and
Hospital-LOS were censored to the right. The distributions of both
times were estimated in each group, defined by the status of PICS,
by the method of Kaplan-Meier (KM) and compared using the log-
rank test. We performed multivariate logistic regression analysis to
identify the factors that maintain independent association with PICS
(at least once throughout the follow-up period). The variables show-
ing significant association with PICS in univariate analysis were en-
tered into the multivariate analysis. The model was summarized as p-
values and OR with confidence intervals at 95% (CI95%). For multi-
variate Poisson regression model, the days between admission to
ICU or Hospital mortality were censored again; these time intervals
were summarized using KM. The number of PICS events along the
follow-up period was considered as the marker of PICS severity. Stat-
istical significance was set at p<0.05.
RESULTS. In the study period, 3398 patients were admitted to 15
hospitals right across Spain. We identified 478 patients that met the
inclusion criteria. ICU LOS (p=.001), hospital LOS (p=.018), and ICU
mortality (p=.022) showed predictive capacity for PICS-8. The me-
dians of ICU-LOS and Hospital-LOS were increased in PICS-8-patients
(25 and 47 days respectively) compared with Non-PICS patients (18
and 36 days respectively). Mortality in the ICU was greater for pa-
tients with PICS-8 (OR 1.74 CI95% 1.08;2.81). The factors associated
with the number of PICS were: male gender, mechanical ventilation
(MV)>16 days, Total parenteral nutrition/complementary nutrition
(TPN/C), and Simplified Acute Physiology Score (SAPS3). There was a
greater incidence of at least one episode of PICS in those patients
who died (43.2% vs 29.7%; p=.004). However, the multivariate logistic
regression showed that PICS was not an independent factor of
mortality.
CONCLUSION. PICS-8 showed higher ICU LOS, hospital LOS, and hos-
pital mortality. PICS severity was greater in males, patients with high
SAPS3, MV time>16 days, and recipients of TPN/C.
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INTRODUCTION. The proper bed management of an ICU is crucial
for its performance, as well as for the prognosis of patients.
Fig. 1 (abstract 000052). Representation of the ICU dynamics
through the change of bed's state.
Page 51 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Simulation has a long history in medical education (1), valued for its
ability to reproduce some conditions in clinical practice and to allow
students to act in a safe environment. More recently, it has been
used as a technique to support improvement in health care systems
and processes (2,3). Virtual simulation allows analysing decision-
making processes in a secure environment and assessing their im-
pact (4).
OBJECTIVES. A computer application development that simulates
the operation of an ICU and which allows analysing how bed man-
agement decisions are made for optimization.
METHODS. All information was obtained by Big Data analysis of data
collected, and previously anonymized, by MetaVision® system (iMD
Sof, Tel Aviv, Israel) implemented in the ICU of the Hospital Complex
of Navarre, Spain (a tertiary care center). Simulator was based on a
dynamic, discrete and stochastic model that represents the evolution
of an ICU over time. The discrete event simulation model was pro-
grammed in JAVA language with a visual interface that reproduces
the general condition of the ICU, surgical programming for the fol-
lowing days and provides the clinical information of each patient,
through screens that mimic those consulted by physicians in their
usual practice and enough for decision making about discharge (Fig-
ure 1). The simulator will advance in time generating both urgent
and scheduled patient arrivals according to real or simulated pat-
terns and events that evolve the health status of each patient admit-
ted (Figure 2), having enough flexibility to be able to define different
ICUs and specific scenarios. The decision-making process about the
discharge of patients is reproduced, so that, in certain moments (clin-
ical sessions, urgent or programmed arrivals, exitus…) it will interact
with the user waiting for indications about possible discharges or ad-
missions, allowing them to modify the occupation of the ICU. The
program will record all the events that occurred during the simula-
tion, including all decisions made by users related to bed manage-
ment. Finally, validation and verification of the simulator was carried
out.
RESULTS. We have developed an interactive simulation program
that, according to ICU staff, reflects the operation of an ICU in a real
way and allows the analysis of the bed management decision mak-
ing. The simulator facilitates the definition of different types of ICU. It
allows analyzing the consequences of decisions in a virtual environ-
ment and proposing better management strategies. It provides per-
formance measures of the management of the ICU, in relation to the
admission (acceptance or rejection), the shortening of the stays and
the delay in admission. It analyses the level of dissimilarity in deci-
sions among users in a quantitative way, identifies its causes and
quantifies its influence on bed management, detecting situations or
patients in which there is a greater discrepancy.
CONCLUSION. A valid simulator has been built, which gathers the
characteristics to reproduce the real operation of an ICU. The quanti-
tative analysis of decisions concerning bed management is possible
in virtual environments that faithfully reproduce the characteristics
and evolution of an ICU. The proposed methodology allows for the
first time to collect relevant and objective information for the ana-
lysis of medical decisions, being able to present scenarios that cause
variability. In this way, the best management strategies are identified,
quantifying their influence on bed management.
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INTRODUCTION. In the 1999 landmark report, "To Err is Human:
Building a Safe Health System", the Institute of Medicine estimated
that avoidable errors in health care contributed to 44 to 98,000
deaths and more than 1 million injuries annually in the United States.
Prospective clinical surveillance using triggers as a tool to identify
the risk of adverse events, along with prompt implementation of in-
terventions may be the answer to improving patient safety, which re-
mains to be a major public health problem 20 years after the
publication of the reference "To err is human".
OBJECTIVES. To evaluate the impact of prospective trigger tools and
near-real-time interventions on the mortality of critically ill patents,
and to determine the impact of these triggers on time taken to
stabilize and specific clinical outcomes.
METHODS. All adult patients admitted to one of the three intensive
care units of a tertiary hospital between November, 2017 to October,
2018 were observed by a multidisciplinary surveillance team com-
posed of physicians, nurses, physiotherapists and pharmacists. If any
one of the five triggers was activated, a team member approached
the care team responsible for the patient within 24 hours, and the
data was presented in the daily multidisciplinary round. This moment
was used to establish change in the therapeutic plan in order to
achieve the expected goal of each trigger. The triggers used were:
KDIGO: early identification of AKI to prevent RRT. Hypoglycemia: gly-
cemia < 60 mg/dL to prevent recurrence. Drug interation (D or X):
early identification to prevent ADR; Antimicrobial stewardship:new/
modified antimicrobial. Adjustments with MALDI-TOF, MIC or antibio-
gram to optimize antibiotic therapy. Delta SOFA. 3rd >admission
SOFA. Expected result 5th day SOFA < 3rd day SOFA.
RESULTS. The analysis was conducted with 948 patients, out of
which 391 had not identified triggers (group 1) and 557 (group 2) had
identified triggers and were subjected to interventions. In relation to
the patient population baseline characteristics there was no significant
difference between the two groups except for a worse SAPS 3 score
observed in group 2. Patients in group 2 had a longer duration of ICU
stay; median duration was 5 (IQR, 4 – 10) days for group 1 and 7 (IQR, 4
– 14) days for group 2 (p < 0.001). Stabilization within estimated time
was comparable between the two groups and preventable and non-
preventable complications were higher in group 2. There was no differ-
ence in the mortality rate between the two groups (p= 0.436). Interven-
tions prevented adverse events in the triggers KDIGO (p<0.001);
Hypoglycemia (p=0.005); Risk/incompatibility (p<0.001) and antibiotic
Table 1 (abstract 000087). Summary of classification of levels of Care
(DoH 2000).
Level 0 Acute ward
Level 1 Acute ward with support from critical care
Level 2 At least 1 organ in failure
Level 3 2 organs in failure / respiratory failure
Page 52 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55stewardship (p<0.001) but not in the trigger Delta SOFA. (p=0.433).
In the logistic regression analysis of each trigger against time taken to
stabilize which was the dependent variable the only trigger interven-
tion that impacted on time taken to stabilize was hypoglycemia.
CONCLUSION. This methodology of prospective surveillance using
trigger tools and near-real-time interventions was effective in the
prevention of adverse events in critically ill patients. Although pa-
tients that had identified triggers were more severely ill, their mortal-
ity rate was comparable to the patients who did not have identified
triggers.
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INTRODUCTION. Providing a staffing model that meets patients’
needs is essential to the delivery of high-quality care. There is incom-
plete evidence for staffing models in ICU. These are primarily influ-
enced by staff:patient ratios and draw on indices of illness severity
(Table 1), which may not be sensitive to patient need. Uni-
professional staffing guidance may not reflect the multi-professional
nature of ICU. Staff perceptions of safety, of which staffing is a factor,
are important organisationally. Perceived safety deficits may contrib-
ute to stress and “burnout” in ICU staff, a current field of concern
(Seaman 2018).
OBJECTIVES. Aim To explore relationships between staff perceptions
of shift safety, (how safe patient care felt) and patient and staff char-
acteristics, using a bedside professional reported safety score
(BPR). Objective 1 To explore the relationship between BPR scores
and the percentage of patients classified as Level 1, 2 or 3. Objective
2 To explore the relationship between BPR scores and the percent-
age of nursing staff with a specialised critical care course (CCC).
METHODS. UK Health Research Authority approval was obtained
(ID249248). Data were collected for 29
consecutive days at Imperial College Healthcare Trust (comprising 70
general critical care beds on 3 sites). The BPR asked all ICU staff to
rate each shift as “safe, unsafe, or very unsafe”. These scores were ex-
plored with relation to; the percentage of Level 1, 2 and 3 patients
per shift and the percentage of nurses per shift who had completed
a CCC. Relationships between reported perceptions of safety and
these factors were analysed for correlation and regression using
PRISM.
RESULTS. A total of 2836 BPR scores were recorded. Results were re-
ceived from 98% of 174 shifts. We found;a significant, positive rela-
tionship between perceptions of safety and the percentage of Level
3 patients (p=0.0001, r= 0.32); no significant relationship between
perceptions of safety and the percentage of Level 2 patients (p=
0.9729, r= 0.003) and a significant inverse relationship between per-
ceptions of safety and the percentage of Level 1 patients on a shift
(p=<0.0001, r= -0.42). We also found a significant relationship be-
tween perceptions of safety and the percentage of staff with a spe-
cialist CCC (p=0.0001, r= 0.42).
CONCLUSION. Staffing models in ICU categorise patients by acuity
and allocate staff accordingly. In this study, staff reported feeling less“safe”: when there were a larger proportion of less acutely unwell pa-
tients in ICU and conversely reported feeling things were safer with
higher volumes of more acute patients. This may indicate that staffing
models and training are not fully responsive to the needs of inten-
sive care patients, these relationships should be investigated fur-
ther. The study supports the guidance that 50% of nursing
establishment should have a CCC. The mechanism by which this im-
proves perceived safety could be explored.
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INTRODUCTION. Timely recognition and escalation of physiological
indicators of worsening conditions in acute hospital wards remains
challenging. Vital signs monitoring using Early Warning Scoring
(EWS) is time consuming and the prescribed observation frequency
may be suboptimal or undeliverable. Wearable ambulatory monitor-
ing systems (AMS) may provide an alternative in the form of continu-
ous monitoring, whilst maintaining patient mobility and comfort.
AMS can also reduce nursing burden of intermittent vital signs moni-
toring, improve early detection of abnormal physiological values, fa-
cilitate timely escalation and offer an intermediate monitoring option
for patients being stepped down from intensive care unit (ICU).
OBJECTIVES. This project directly follows previous research and in-
volves a series of linked studies. There are 3 main objectives: test cur-
rently available and validated AMS; capture and integrate data into
current hospital systems; and evaluate implementation of AMS in
clinical practice.
METHODS.Phase 1: In-house testing of AMS wearability, to identify
the most wearable available devices to move into the next phases.
Phase 2: Semi-structured interviews with staff and patients, exploring
current monitoring practices within an emergency surgical unit. Phase
H-Hypoxia study: Accuracy test of selected AMS in the detection of
hypoxia and movement artefacts during clinical use in healthy volun-
teers. Phase 3: Locational implementation of the AMS to provide con-
tinuous data recording in a clinical setting. A human factors
approach will direct modifications to both hardware and software
and further wearability and user satisfaction assessments will be con-
ducted on clinical staff. Phase 4: Development of a functional user
F2
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We will introduce the devices to patients, collect wearability data
and finalise the locational testing. Phase 5: Implementation of the
AMS and UI in clinical practice to test the acceptability and usability
of the system with clinical staff. We will also analyse patient specific
outcomes such as mortality, length of stay (LOS) and deterioration
episodes captured by the AMS.
RESULTS. Phase 1 provided wearability data from 15 volunteers and
shortlisted half of the AMS to next phases (1 chest patch and 3 wrist-
worn) collecting HR, RR and SpO2 data. The selected devices are now
being subject to locational (phase 3, n=20) and accuracy testing
(hypoxia study, n=30). Fifteen clinical staff have been interviewed
and identified challenges with current monitoring practices, such as
the impact on nursing workload and patient mobility. Current per-
ceptions of an AMS were also explored. These themes will be consid-
ered during user interface development in phase 4 (n=50), alongside
continuous user input (Figure 1).
CONCLUSION. Technology to monitor patients’ vital signs is advan-
cing and clinical vital signs documentation systems need to be syn-
chronous with these changes. Our proposed work aims to develop
an electronic system to continuously capture and report vital signs.
This will integrate real-time AMS data into current hospital systems
via a user interface. The final system has the potential to offer bene-
fits to patient outcomes, nursing workload and facilitate quicker re-
ferral and smoother step-down from ICU. We will discuss current
outcomes and future plans for this project, the first of its kind out-
side of a critical care department.
REFERENCE(S)
1. This study/project is funded by the NIHR Oxford Biomedical Research
Centre.
2. Prgomet, M., Cardona-Morrell, M., Nicholson, M. et al (2016). Vital signs
monitoring on general wards: clinical staff perceptions of current prac-
tices and the planned introduction of continuous monitoring technol-
ogy. International Journal for Quality in Health Care, 28(4), 515–521.
https://doi.org/10.1093/intqhc/mzw062Fig. 1 (abstract 000103). See text for description000120
Pressure injury prevention programs in adult intensive care
patients: a systematic review
F. Lin1, W. Chaboyer1, F. Coyer,2, Z. Wu,3, B. Song,3
1School of nursing and midwifery, Griffith University, Gold Coast,
Australia; 2School of nursing, QUT Gardens Point Campus, Brisbane City,
Australia; 3School of nursing, China Medical University Shenbei
Campus, Shenyang Shi, China
Correspondence: F. Lin
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000120
INTRODUCTION. Pressure injuries are costly, potentially preventable
but frequently occurring adverse events (Padula et al., 2018).Intensive care patients have major risk factors for pressure injury with
a reported pressure injury prevalence of 12-33% (Chaboyer et al.,
2018). Multi-faceted interventions, also known as programs or care
bundles, are recommended to prevent pressure injuries.
OBJECTIVES. This systematic review aimed to: identify pressure injury
prevention programs and their components; the way these programs
were implemented; and their effectiveness.
METHODS. We followed the recommendations from the Preferred
Reporting Items for Systematic Reviews and Meta-Analysis. We
searched databases including PubMed, EMBASE, MEDLINE, CINAHL,
and Cochrane Library databases for papers published in English and
Chinese from the year of 2000 to May 2018. Data extraction and
quality assessment was conducted by one and checked by a second
author. Content analysis was conducted to summarise the findings.
RESULTS. Twenty-one peer reviewed papers (12 quality improvement
projects, and 9 research papers from 8 studies) were included in this
review. Pressure injury prevention care bundles with 2-11 compo-
nents were commonly implemented. Common components of pro-
grams included clarification of staff roles/introducing new roles,
repositioning, staff and patient education, support surfaces use, pres-
sure injury risk assessment, skin assessment, nutrition needs assess-
ment, documentation, multidisciplinary team involvement, and
mobilisation. Implementation strategies commonly used were educa-
tion, audit and feedback, and standardising documentation. Five of
the research studies reported significant decrease in pressure injury
prevalence, significant increase in family satisfaction and participa-
tion, and increase in compliance to pressure injury prevention proto-
cols and strategies. Two quality improvement study reported cost
savings of $1 million and £2.6 million respectively after the imple-
mentation of the programs.
CONCLUSION. Most of the included papers reported findings from
either qualitive improvement projects or before and after research
studies. However, positive outcomes and strong theoretical rationales
for the components in the programs suggest they are beneficial. In
addition, the success of the programs did not seem to be associated
with the number of components included in or complexity of the
programs. This calls for future high-quality research such as rando-
mised controlled trials to test the effectiveness of multi-component
programs.
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INTRODUCTION. Low platelet count and increased INR are frequent
laboratory findings in patients with systemic inflammatory response
syndrome (SIRS) and have prognostic value. Antithrombin (AT) defi-
ciency is reported to be observed early in SIRS, but this test is not
used routinely.
OBJECTIVES. The aim of the study is to determine if AT deficiency is
a useful prognostic tool in ICU patients.
METHODS. 135 consecutive ICU patients with 3 or 4 criteria of SIRS
were included. During 4 days after SIRS manifestation patients were
assessed for thrombocytopenia <120 cells/mcL or severe platelet de-
cline ≥50% during 24 hours in combination with INR>1,2. Also
Page 54 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55general condition, clinical and laboratory test results and 30-days
mortality were evaluated.
RESULTS. Significant laboratory haemostasis disorders (thrombocytopenia
in combination with increased INR) were observed in 26.6% of patients
with SIRS. In patients with severe AT deficiency<50% odds ratio for labora-
tory haemostasis disorders was 3.5 (95% CI 1.2; 10.4).
ratio for laboratory haemostasis disorders was 3.5 (95% CI 1.2; 10.4).
However AT deficiency did not demonstrate significant prognostic
value (p=0.18), while INR was a significant predictor of outcome (p=
0.024)
CONCLUSION. AT deficiency is a frequent finding in patients with
SIRS the same as low platelet count and increased INR. Yet such
common laboratory test as INR in comparison with AT deficiency has
higher prognostic value in ICU patients with SIRS.Table 1 (abstract 000156). Variables, predicting laboratory










1.58 0.007 4.85 1.54; 15.30
AT deficiency <50% 1.26 0.022 3.52 1.20; 10.40
Fibrinolysis time -0.02 0.049 0.98 0.96; 1.00
Table 2 (abstract 000156). Variables, predicting outcome at the 30th
day
Independent variables Regression coefficient p Odds Ratio 95% CI for OR
INR 1.94 0.020 6.92* 1.36; 35.25
APACHE II 0.12 0.014 1.13* 1.02; 1.24
Age (years) 0.03 0.065 1.03 1.00; 1.07
AT deficiency <50% -0.85 0.180 0.43 0.12; 1.48000157
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INTRODUCTION. Safety huddles and checklists are recognised
methods to improve patient safety, and computer-based tools such
as automatic early warning score systems and electronic patient re-
cords can be used to further augment patient care. In a 13-bed crit-
ical care unit within a 550-bed UK district general hospital, a delay in
identification and treatment of critically ill patients, and identification
of potential patient safety issues was noted. A structured electronic
communication tool was developed with the aim of providing accur-
ate, real-time data on patient safety issues, allowing rapid multi-
disciplinary response.
METHODS. A digital checklist was designed using Microsoft Access,
and a morning multi-disciplinary safety huddle was instituted. Data
on the number and location of patients at risk of deterioration as
well as other safety critical issues were systematically highlighted, re-
corded electronically, and automatically audited by the software.
RESULTS. In two months, 202 patients were identified as requiring
urgent review, of whom 68 were outside the critical care unit. Nurse
staffing matched patient acuity only 61% of the time, withequipment issues present on 40% of days. Airway equipment had
been checked 91% of the time, and high flow nasal oxygen or non-
invasive ventilation machines were available to outreach on 73% of
days. There were infection control issues on 52% of occasions. When
surveyed, staff reported more rapid resolution of patient safety is-
sues, and feeling more engaged with the process of task prioritisa-
tion following the introduction of the safety huddle.
CONCLUSION. Use of an automatically audited digital checklist to fa-
cilitate a daily safety huddle has allowed recognition of potentially
significant patient safety issues, and ensured that these are
highlighted to everyone including the most senior members of staff,
allowing corrective action to be undertaken promptly. The data has
led to the ward round being redesigned to facilitate rapid senior re-
view of the most unwell patients. The digital format obviates the
need for laborious data collection, in addition to allowing remote
monitoring by senior management. Following the success of this, we
have increased the huddle to twice daily.
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INTRODUCTION. With the introduction of Focused Intensive Care
Echocardiography (FICE) training programmes in the UK, it is essen-
tial that each FICE training unit should have a local echo governance
structure.
OBJECTIVES. Our quality improvement project involved auditing the
process for local image storage and review and quality assurance of
echo reporting and referral pathways before and after introduction
of a formal echo reporting form.
METHODS. A prospective observational study was performed to
examine all transthoracic echos performed in our tertiary referral
general intensive care unit over a two week period in November
2018 for: (i) local image storage, (ii) network archiving, (iii) echo
reporting documentation and (iv) referral for formal echo. After a
teaching session and introduction of an echo reporting form on the
electronic health record system (Cerner), the data was reaudited two
months later in January 2019.
RESULTS. 20 scans were performed by FICE trainees on ICU in No-
vember 2018 and 22 scans in January 2019 over the two week pe-
riods. Image storage on the local ultrasound hard drive occurred
100% in both periods and network archiving increased from 45% to
50%. Echo reporting documentation improved from 30% to 68%
after introduction of the echo reporting form. Formal echo referral in-
creased from 20% to 45% with performance of formal echo on ICU
occurring 75% and 80% respectively prior to ward discharge.
CONCLUSION. Introduction of a formal echo reporting form has led
to improved quality assurance of reporting and referral pathways.
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INTRODUCTION. The need for 24-hour intensivist coverage of the in-
tensive care unit (ICU) presents several controversial issues. Surgical
patients are rapidly deteriorated compared with medical patients. In
this study, we evaluated the necessity of after-hours intensivist staff-
ing in a surgical intensive care unit (SICU).
METHODS. This study was performed in a tertiary referral teaching
hospital in Korea from March 2018 until February 2019. A total of
586 cases admitted to SICU. The work-hours was defined as 07:00-
19:00, from Monday to Friday. Among them, 571 SICU admissions
which had complete medical records were enrolled in this retrospect-
ive study. We determined the in-hospital mortality as the primary
outcome according to the time of SICU admission.
RESULTS. 333 SICU admissions and 238 SICU admissions were devel-
oped in work-hours and after-hours respectively. The mean age of
the work-hours group was higher than those of the after-hours
group (work-hours vs. after-hours = 68.55±12.52 vs. 64.06±13.84, p<
0.001). APACHE II score of 30 or more of the after-hours group was
two times more than those of work-hours group (work-hours vs.
after-hours = 6.0% vs. 12.6%, p=0.004). Unplanned admission during
work-hours was about one and half times more during after-hours
(work-hours vs. after-hours = 33.3% vs. 47.1%, p<0.001). When com-
pared to the work-hours group, the proportion of patients with venti-
lator treatment was two times more in the after-hours group (work-
hours vs. after-hours = 17.4% vs. 34.0%, p<0.001). Among 571 SICU
admissions, 27 patients died in hospital. In multivariate analyses for
clarifying whether the time of SICU admission affected in-hospital
mortality, the time of SICU admission was not the independent factor
for in-hospital mortality (OR = 2.385; 95% CI 0.928-6.133, p=0.071).
CONCLUSION. In this study, the time of SICU admission did not
foment greater in-hospital mortality. However, these results revealed
our specific situation, high-intensity ICU model. Therefore, in order to
generalize these results, related studies should be preceded.
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INTRODUCTION. Post-ICU sequellae including physical and mental
problems interfere with successful rehabilitation [1]. However, dataon the incidence of long-term non-recovery after critical illness seem
to be lacking.
OBJECTIVES. To assess the incidence of and to identify risk factors
for non-recovery in long-stay ICU patients.
METHODS. In this retrospective, single-centre study, we identified
long-stay ICU patients who visited a specialized post-ICU clinic at 3
months after ICU-discharge. During this visit a Dutch 36-item Short
Form (SF-36) questionnaire was completed. At 12 months, patients
were requested to repeat the SF-36 questionnaire and return by
mail.
RESULTS. Between 2012 and 2018 591 patients visited the special-
ized post-ICU clinic. 241 Patients with a mean age of 64±13 and an
APACHE III score of 79±32 completed a SF-36 questionnaire at both
time points. At 3 months 52 patients (21.5%) recovered to reference
values of the physical functioning (PF) SF-36 domain. However, after
12 months only 36 remained within this normal range (14.9%). At 3
months 190 patients (78.5%) were below the reference values of the
PF SF-36 domain. At 12 months 152 (62.8%) still remained below this
reference values. In total 168 (69.4%) did not reach reference values
for the PF SF-36 domain at 12 months. Between 3 and 12 months
126 patients (52.1%) improved over time, whereas in 116 patients
(47.1%) the PF SF-36 score decreased or remained equal over time.
In a binary multivariate analysis diabetes (OR 0.028, 95% CI 0.001-
0.788, p=0.036), days on mechanical ventilation (OR 0.901, 95% CI
0.821-0.988, p=0.026), need for renal replacement therapy (OR 9.249,
95% CI 1.286-66.551, p=0.027) and the Morton Mobility Index score
(OR 1.063, 95% CI 1.017-1.111, p=0.007) all remained independent
predictors for recovery between 3 and 12 months.
CONCLUSION. In the majority of long-stay ICU patients the PF SF-36
score did not fully recover at 12 months after ICU-discharge. More-
over, only half of the patients improved between 3 and 12 months.
Determination of risk factors may help to identify patients in danger
of non-recovery, and to design individualized rehab strategies.
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INTRODUCTION. Socioeconomic deprivation is associated with less
access to health care services, including intensive care. Choice and
quality of treatment during intensive care may also be influenced by
socioeconomic factors leading to inferior care and poor outcomes
among deprived patients.
OBJECTIVES. Our purpose was to examine if low education and low
income was associated with worse survival after critical illness.
METHODS. We examined records of adult patients in the Swedish In-
tensive Care Registry with an ICU stay > 48 hrs during 2008-2016.
The Charlson comorbidity index (CCI) before critical illness was
Page 56 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55computed by linking to the Swedish hospital discharge register and
SAPS3 was used to describe critical illness severity. Linking with Sta-
tistics Sweden provided disposable household income for the year
preceding ICU admission, level of education (low, medium, high) and
survival. Patients were grouped in quintiles by their income, from
low to high. Outcomes were odds ratios for survival on discharge
from ICU or hospital and at 90 days after admission. The influence of
education and income, separately and combined, was modelled
using multi-level logistic regression after adjusting for age, gender,
CCI and SAPS3 scores. The study was approved by the regional eth-
ical review board.
RESULTS. We analysed 55,091 patients admitted to 74 ICUs (mean
age 64 yrs, SAPS3 risk 0.25, CCI score 2.2; median ICU and hospital
stay was 4.1 and 12 days, respectively). Low income and low educa-
tion was not associated with decreased survival to discharge from
ICU or hospital but they were associated with decreased 90-day sur-
vival (Table).
CONCLUSION. Low education and low disposable income was not
consistently associated with adjusted lower ICU or hospital survival
indicating that ICU and hospital care was not inferior for deprived
patients. However, adjusted 90-day survival was significantly lower
suggesting that post-discharge care was inferior.Table 1 (abstract 000224). Odds ratios (ORs) for the separate models
and the combined model. All models were adjusted for age, gender,
CCI and SAPS3 scores ** and *** denotes that ORs were significantly
different from 1 (P<.01 and <.001, respectively). NA=not applicable
Education model Income model Combined model
Outcomes ICU Hosp. 90 d. ICU Hosp. 90 d. ICU Hosp. 90 d.
Education,
low
Reference NA NA NA Reference
Education,
medium
.99 1.02 1.09*** NA NA NA 1.01 1.02 1.07**
Education,
high
1.07 1.04 1.22*** NA NA NA 1.12** 1.06 1.15***
Income
1st quint.
NA NA NA Reference Reference
Income
2nd quint
NA NA NA .94 .95 1.04 .94 .95 1.04
Income 3rd
quint.
NA NA NA .98 .99 1.18*** .97 .98 1.16***
Income 4th
quint.
NA NA NA .87** .97 1.18*** .85** .94 1.14***
Income 5th
quint.
NA NA NA .88** .96 1.27*** .85** .94 1.21***000251
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INTRODUCTION. A tailored multicomponent program for discomfort
reduction in critically ill patients decreases self-perceived discomfort
in unselected adult critically ill patients (1), with a probable positiveimpact on the post-traumatic stress disorder assessed at 1 year (2).
Patient-centered outcomes and long-term psychological side effects
of the critical illness have gained a growing interest and must now
be taken into consideration.
OBJECTIVES. Should the dissemination of such a program be actively
promoted also for patients requiring intermediate care? Which
organization of care should be recommended? The aim of our pilot
study was to assess and compare discomforts reported by patients
after a stay in an intensive care unit (ICU) and after a stay in a dedi-
cated, separate, intermediate care unit, both units belonging to a sin-
gle department and managed by the same healthcare team.
METHODS. Our intensive care department was composed of a 12-
bed ICU and a 6-bed dedicated, separate, intermediate care unit. On
the day of discharge, the bedside nurse (or the assistant nurse) ad-
ministered the 18-item version of the French questionnaire on ICU-
related self-perceived discomforts (IPREA) to adult patients who sur-
vived a stay of 3 calendar days or more (3). IPREA contains the fol-
lowing discomfort items: noise, excess of light, discomfort related to
sleeping in a different bed from home, sleep deprivation, thirst, hun-
ger, feeling of cold, feeling of heat, pain, being tied down by perfu-
sion lines, tubes or other connected devices, no respect for privacy,
anxiety, isolation, limited visiting hours, absence of phone, lack of in-
formation, shortness of breath, and feeling depressed. Each item was
scored from 0 to 10 (minima to maximal) leading to an overall dis-
comfort score (from 0 to 100) used as the primary outcome.
RESULTS. Between May 1, 2018 and April 20, 2019, 191 and 174 pa-
tients were interviewed using IPREA, respectively after an ICU stay and
after a stay in the intermediate care unit. Stays in the ICU and in the
intermediate care unit were similar for gender (female gender resp.
42% and 36%), age (resp. 62±17 and 62±17 years), and median length
of stay, resp. 6 (IQR 4-11) and 6 (IQR 4-8) days. Patients hospitalized in
the ICU reported a higher overall discomfort score than patients hospi-
talized in the intermediate care unit: 23±15 vs. 18±12, P=0,0008. The
greatest differences in favor of the intermediate care unit were found
for feeling of cold (0.9±2.0 vs. 2.3±3.2), shortness of breath (2.1±2.7 vs.
3.3±3.5), lack of phone (0.5±1.7 vs. 1.6±3.0), and thirst (2.4±3.0 vs. 3.4±
3.6). In contrast, patients complained more about heat in the intermedi-
ate care unit in comparison with the ICU.
CONCLUSION. Patients hospitalized in a dedicated, separate, inter-
mediate care unit reported a lower overall discomfort score than pa-
tients hospitalized in the ICU. Although patient severity was different
depending on the unit, these preliminary results raise the question
of the optimal organization of care for patients receiving intermedi-
ate care: hospitalization inside the ICU for all the patients or
hospitalization in a dedicated, separate, intermediate care unit, be-
fore, after, or without the ICU stay, according the course of the crit-
ical illness? Further studies are needed to compare perceived
discomforts according these two different organisations of care for
patients requiring intermediate care.
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Page 57 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. Many instruments have been developed to evaluate
hospital mortality, but less attention has been paid to the long-term
functional status and quality of life of traumatic brain injury patients
OBJECTIVES. To analyze the quality of life (QOL) and its different
components one year after ICU admission to traumatic brain injury
(TBI).
METHODS. Prospective cohort study. TBI in Carlos Haya Hospital
(Málaga, Spain) between 2004-2008. Evaluation of QOL with ques-
tionnaire PAECC (Project of Epidemiological Analysis of Critical Pa-
tients), We analyzed physiological activities (oral communication,
urinary and defecation control, food intake), daily life (mobility, work
activity, etc.) and emotional state. (0 normal to 29 major
deterioration).
RESULTS. N=531. Age 40.35±19.75 years, APACHE-II 17.94±6.97, GCS
admission 7.53±3.83 points. TAC admission: Type I (10.4%), type II
(28.1%), type III (24.5%), type IV (8.3%), mass evacuated (22.6%), not
evacuated (6.2%). Hospital mortality: 28.6%. Mortality 1 year: 32.2%
(lost:6.6%). Quality of life at one year (n=324) 9.44±8.73 points (sig-
nificant deterioration).
Almost 80% patients have normalized the basic physiological activ-
ities, except oral communication that only maintain 54.8%, another
16.6% communicate with difficulty although with coherent dialogue.
Low percentage of work reintegration and to make great efforts.
They present normality in a high percentage in tolerance to mini-
mum efforts, movements of precision and social relations. Low per-
centage presents normality in the items on emotional state or
subjective aspects of the patient.
CONCLUSION. Patients who enter the ICU due to TBI at one year
present significant deterioration in quality of life. Although a high
percentage present normality in basic physiological activities, social
relationships and physical activities that require little effort. On the
contrary, a low percentage present normality in the subjective as-
pects, make great efforts and work activity.Table 1 (abstract 000261). See text for description
Normal 1º year (%)
Basic physiological activities Normal daily life activities
Oral communication 54,8 Movements 83,1
Urinary control 79,1 Minor effort 71,2
Defecation control 81,9 Major effort 35,3
Food intakes 81 Walking 63,8
Emotional status Mobility 46,6
Subjective well being 41,1 Dressing 63,8
State of mind 40,2 Working life activities 28,5
Vitality 64,4 Social relationship 70,2
Table 1 (abstract 001304). ICU and in hospital mortality split by main
CS aetiology
Aetiology ICU mortality In hospital mortality
Cardiac Arrest 57.4% 62.8%
Decompensaed heart failure 44.7% 51%
Myocardial infarction 44.4% 52.8%
Pulmonary Embolism 61% 65.3%001304
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INTRODUCTION. Cardiogenic shock (CS) describes a physiological
state of end-organ hypoperfusion characterized by reduced cardiac
output. Almost all the data in literature pertains only to CS related to
myocardial infarction (AMI-CS), reporting a mortality up to 45%(1).OBJECTIVES. We sought to analyse clinical and epidemiological data
on patients admitted to general ICU enrolled in nationwide GiViTi
registry (Gruppo italiano per la Valutazione degli interventi in Terapia
intensiva) with a diagnosis of primary CS
METHODS. Observational prospective study. Out of 485509 admitted
in 301 general ICUs from 2011 to 2017, 19250 patients met the enrol-
ment criteria: > 18 years old, diagnosis of CS due to primary cardio-
circulatory failure. Only patients with all data from the admission to
the outcome in the last discharge hospital have been included in the
analysis. CS secondary to other reasons of circulatory shock have
been excluded (2). Patients demographic, admission, complications,
treatment and mortality data have been analysed
RESULTS. Patients mean age admission was 70.9 (±12.7), 61.9 % were
male and 92.3% presented cardiovascular comorbidities in the past
medical history. 16709 (86.8 %) patients were transferred in ICU from
of the same hospital; 12.7% were referred from another hospital and
0.5% from hospices. 52% were transferred from the emergency de-
partment while 10.5% were centralized from an another ICU. The
main cardiovascular disorder leading to ICU admission were: Cardiac
arrest (36.9%); Acute decompensated heart failure (40.1%); myocar-
dial infarction (17.9%); pulmonary embolism (3.9%). Right ventricular
heart failure was diagnosed in 6.9% of the population. 96.2% re-
quired catecholamine; 90.8% of patients underwent invasive ventila-
tion during the admission, 11.7% renal replacement therapy; 13.8%
intra-aortic balloon pump, 2 % received ECMO and 0.5% implanted a
ventricular assisting device.ICU mortality was 50.4%, In-hospital mor-
tality was 57.3% and the mortality at discharge from the last hospital
further increased to 59.5% (Table 1). The mean ICU admission dur-
ation of survived patients was 9.3 days (±11.9) and for those who did
not survive was 11 day (± 19.1)
CONCLUSION. Primary CS has a unacceptably ICU and intra-hospital
mortality.This preliminary descriptive nationwide analysis underlines
the urgency of a better delineation of the pathophysiology and treat-
ment of CS. The organization of large registry aiming at the CS clin-
ical phenotypization in the view of therapy titration has effectively
reduced the burden of adverse outcome in acute heart failure and
myocardial infarction, and it should be considered also for the CS
syndrome
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INTRODUCTION. Mechanical ventilators in the Emergency Depart-
ment (ED) are becoming more common and more advanced. The
benefits of lung protective ventilation versus conventional ventilation
have been well established in the ICU setting1. The LOV-ED trial2 is
the first trial of its kind that displays the benefits on lung protective
Page 58 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55ventilation in the ED setting, showing a decrease in patients develop-
ing Acute Respiratory Distress Syndrome (ARDS) when ventilated
using lung protective strategies.
We carried out this audit in our ED to discover how many patients
were receiving lung protective ventilation. Secondary outcomes in-
cluded adequate oxygenation and time taken to perform the first ar-
terial blood gas (ABG) while receiving mechanical ventilation.
METHODS. We retrospectively recruited all patients who received
mechanical ventilation in the first nine months of 2018. Patients with
restricted medical files were excluded. Using the ventilator observa-
tion sheet in each patient’s medical record, the initial ventilator set-
tings were identified. Initial ABG times and measurements were
recorded from the ClinicalLabs application and cross referenced with
the CIS database.
Patient weight was based on recorded actual weight or estimated
weight, there was no recordings of height and therefore no access to
predicted body weight.
RESULTS. 49 patients were recruited. 8 patients had to be excluded
due to restricted records. Of the 41 patients audited, 17 patients
(41%) had lung protective tidal volumes (4- 6mls/kg) initiated in the
ED. Mean tidal volume was 6.5ml/kg.
15 patients (37%) of patients had no ABG performed during the dur-
ation of their stay in ED while ventilated. Average length of stay
(LOS) for these patients with no ABG performed in ED was 3.6 hours
– the same as the overall LOS of the whole cohort.
Of the remaining 26 patients, only 12 had an ABG performed in the
first 30 minutes of being intubated. Average time to ABG was 72
minutes.
Of the patients who did have an ABG performed post ventilation in
the ED, 17 (65%) were hyperoxaemic (paO2 >120mmHg). Mean
length of stay in the ED post intubation was 3.6 hours.
CONCLUSION. The lack of predicted body weight had a very negative
effect on this audit. Lung protective ventilation settings are all based
of lean body weight, rather than actual or estimated weight. This re-
sulted in mostly over-estimating the tidal volumes required for lung
protective settings. On initial glance the mean tidal volume (6.5ml/
kg) may seem quite close to the recommended lung protective vol-
ume (4-6ml/kg), however if the overestimated weights were to be
taken into account, the mean tidal volume would be much higher.
A surprising secondary outcome was the time to first ABG. 15 pa-
tients not having an ABG performed at all until in a different depart-
ment is a poor statistic. Furthermore, of the patients who did have a
gas done while in the department, most were much too
delayed. A large proportion of patients received high FiO2 resulting
in hyperoxaemia,
thus making the initial ABG timing even more crucial to allow ad-
equate titration.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000696INTRODUCTION. Stress-induced hyperglycaemia in the critically ill
trauma patient is associated with increased mortality and morbidity
[1]. The benefits and risks of strictly controlling glucose have yet to
be determined in this population.
OBJECTIVES. To investigate the effects of strict glycaemic control, in
polytrauma patients, on adverse outcomes through systematic re-
view and meta-analysis.
METHODS. This review was prospectively registered on the Prospero
database (CRD42018102948). A systematic literature search was car-
ried out in three electronic databases: Medline, EmBase, and Web of
Science from 1980-2018. Both randomised controlled trials (RCTs)
and non-randomised controlled trials (nRCT) were included. Studies
were included if they compared two groups under either a strict or
loose glycaemic regime. Risk of bias was carried out by a single re-
viewer. The primary outcome was risk of mortality and the secondary
outcomes were risk of hypoglycaemia (<3.33mol/L), days in hospital,
days on ventilation, and occurrence of septicaemia. Data was ana-
lysed using the random-effects model in RevMan 5.3. Dichotomous
outcomes are given as risk ratios (RR) and continuous outcomes as
mean difference (MD), both with 95% confidence intervals.
RESULTS. 2 RCTs (n=957) and 7 nRCTs (n=6104) were identified. Risk of
bias was high among the studies. The RCTs revealed: no change in mor-
tality RR 1.07 [0.43, 2.71], increased risk of hypoglycaemia RR 15.66 [3.02,
81.09], and reduced risk of septicaemia RR 0.69 [0.59, 0.80]. The nRCTs re-
vealed: no change in mortality RR 0.83 [0.63, 1.09], increased risk of
hypoglycaemia RR 2.14 [1.65, 2.77], no reduction in days on ventilation
MD -3.19 [-6.64, 0.27], no reduction in risk of septicaemia RR 0.95 [CI 0.66,
1.35], however a reduction in hospital days MD -6.70 [-13.06, -0.34].
CONCLUSION. Strict glycaemic control in the polytrauma patient
may not reduce mortality and days on ventilation. There is a signifi-
cant increase in the risk of hypoglycaemia, however the risk of septi-
caemia is inconclusive. There is weak evidence suggesting a
reduction is hospital days. High risk of bias, especially within the
nRCTS, limits strong conclusions. High quality RCTs are needed to fur-
ther investigate strict glycaemic control in the polytrauma patient.
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INTRODUCTION. Trauma is one of the ten leading causes of dead in the
world. Responsible for about 1.4 million deaths a year. Death secondary
to trauma is classified as early (post-injury) due to blood loss followed by
hypovolemic shock; and late (post-resuscitation), if dead occurs more
than 7 days post-injury, due to development of systemic inflammatory
syndrome, tissue damage and multi-organ failure. In order to improve
clinical outcomes permissive hypotension and minimizing fluid adminis-
tration is considered as an effective strategy to reduce coagulopathy.
Therefore, Hypertonic saline solutions have emerged as a promising for
“low volume” fluid resuscitation in trauma patients. Moreover, some ani-
mal models have shown that using HSS in trauma may have immuno-
modulatory effects and may prevent injury of the glycocalyx. However,
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Therefore, this study will attempt to resolve this gap in the literature.
OBJECTIVES. To determine the impact of 3% hypertonic saline solu-
tions in clinical outcomes in polytrauma patients.
METHODS. This an analysis of a retrospective cohort of patients hospi-
talized due to polytrauma in a reference hospital in Bogotá, Colombia,
between 2010 and 2016. Only patients over the age of 18, admitted to
the intensive care unit (ICU) due to polytrauma were included. Trauma
severity, APACHE, fluid strategy, use of vasopressors, development of
MOF at 72 hours after ICU admission and 7-days mortality rate were re-
corded. Categorical variables were studied by Fisher's test and the con-
tinuous variables by Wilconxon and Anova test. Logistic regression
(independent association) was used in order to study the association
between variables and clinical outcomes.
RESULTS. A total of 217 patients were included in the study. Among
them, 123/217 (57%) patients were resuscitated with HSS during the first
72 hours of ICU admission. Out of patients treated with HSS, 59/123
(48%) were treated with 3% HSS. A total of 101/217 (47%) patients devel-
oped MOF and 42 (19%) died within the 7-days after ICU admission.
Demographic characteristics were similar between patients treated with
3% HSS and those who did not. After adjusting for APACHE, trauma se-
verity and type of HSS used in the multivariate analysis; 3% HSS was as-
sociated with decreased of MOF (OR: 0.37, 95% CI: 0.17-0.78). However,
ICU length of stay, vasopressor requirement and mortality at 7-days
among groups remain unchanged in the multivariate analysis.
CONCLUSION. Hypotensive reanimation with 3% HSS may decrease
multiorgan failure in ICU patients admitted due to polytrauma. Fur-
ther randomized controlled trials are needed to confirm this benefi-
cial effect and to determine underling mechanisms.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000834INTRODUCTION. Enzymatic escharolysis is a non-surgical treatment
method for removing necrotic tissue in severe burn injuries, leaving
intact neighboring healthy tissue. In addition it reduces blood loss
and the need for autologous skin grafting.
OBJECTIVES. To describe our experience in the use of NEXOBRID® in
critical burn patients admitted in the Burn Centre at Vall d’Hebron
University Hospital; between January 2015 and December 2018, and
to assess differences between survivors and non-survivors.
METHODS. Retrospective monocentric cohort study of patients of at
least 18 years with major burn injury; defined as total body surface
area (TBSA) burned over 15% who had NEXOBRID® treatment
method for remove total or partial necrotic tissue. Demographic data,
comorbidities, mechanism of burn, vasopressor support requirement,
length of mechanical ventilation (MV-LOS), length of stay (LOS) and
mortality were collected from hospital medical records.
RESULTS. One hundred and thirty-three patients were admitted with
major burns during the study period, 18 received enzymatic escharo-
lysis (13.5%). When comparing patients treated with either enzymatic
or surgical debridement no differences in gender, age, TBSA, Baux
score and comorbidities were observed. Seventeen (94.4%) patients
in the enzymatic group required mechanical ventilation versus 57
(49.56%) in the surgical group p= < 0.001, without difference in the
MV-LOS median days (15, IQR25-75:7-38 versus 14, IQR25-75:5-33).
No differences were observed in blood transfusion units (7, IQR25-
75:4-19 versus 5.9, IQR25-75: 0-8). A higher proportion of patients in
the surgical group required renal replacement therapy 13 (11.3%)
versus 3 (16.3%) in the enzymatic group p= 0.06. Four patients (22%)
died in the enzymatic debridement group versus 30 in the surgical
group (26%) p= 0.003.
CONCLUSION. Patients treated with NEXOBRID® required more com-
monly mechanical ventilation, however no difference in the length of
mechanical ventilation was noticed. Less mortality was observed in
the enzymatic escharolysis when compared to surgical debridement.
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INTRODUCTION. Angiography with embolization (angioembolization)
is an emerging hemostatic procedure for bleeding from splenic injur-
ies. However, its mortality benefit compared with laparotomy re-
mains unclear in patients with blunt splenic injury.
METHODS. This retrospective matched cohort study used data from
the Japan Trauma Databank (2004 to 2017), a nationwide trauma
registry of injuries with the injury severity score ≥9 at 272 institutions
in Japan. Trauma patients who underwent angioembolization or
laparotomy for isolated blunt splenic injury were studied. Patients
were excluded if they needed cardiopulmonary resuscitation before
hospital or in the emergency department, or had unsurvivable injury
of any region of the body as defined by the Abbreviated Injury Scale.
Missing values were handled by multiple imputation. Logistic regres-
sion analysis was done to estimate propensity scores for
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age, gender, vital signs, resuscitative procedures in the emergency
department, severity of injury, and type of splenic injury. Cluster-
exact propensity score matching was performed to select pairs of pa-
tients from the same center, who undergoing angioembolization or
laparotomy. The primary outcome was hospital mortality, while sec-
ondary outcomes were the 28 hospital-free days and complications
(abdominal complications, organ failure, infection, and central ner-
vous system complications).
RESULTS. Of 294,274 trauma patients registered in the JTDB, 1,796
patients had blunt splenic injury treated by angioembolization (N=
1,333) and/or laparotomy (N=564). 101 patients of whom underwent
both angioembolization and laparotomy. Propensity score matching
selected 240 patients each undergoing angioembolization or laparot-
omy. Hospital mortality was similar in both groups(8.0% versus 8.9%,
odds ratio 0.90, 95%CI [0.46-1.73], P=0.74), but 30 patients receiving
primary angioembolization (12.5%) required subsequent laparotomy.
There were no significant differences of secondary outcomes (the 28
hospital-free days (7 versus 7 difference 0 [-1, 1]), abdominal compli-
cations (5.4% versus 5.9%, odds ratio 0.91, 95%CI [0.41, 2.04]), organ
failure (7.2 versus 7.3 odds ratio 0.99, 95%CI [0.48, 2.03]), infection
(5.4 versus 10.1 odds ratio 0.51, 95%CI [0.25, 1.07]), and central ner-
vous system complications(4.1 versus 2.3, odds ratio 1.82, 95%CI
[0.60, 5.51])).
CONCLUSION. This propensity score-matched observational study
found that angioembolization did not significantly reduce hospital
mortality compared with laparotomy.
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INTRODUCTION. Descriptive study in trauma patients about the cor-
relation betwwen inflammatory parameters and mortality, severity of
illness, multiorganic dysfunction (MODS) and nosocomial infection.
OBJECTIVES. OBJECTIVES: To analyse the levels of procalcitonine, C-
reactive protein and leukocytes in the first 24 hours as well as their
correlation with severity scores and association with mortality, MODS
and nosocomial infection.
METHODS. MATERIAL AND METHODS: Cohort study of trauma pa-
tients admitted at intensive care unit from January 2018 to March
2019. Independent variables: age, sex, type of trauma, levels of pro-
calcitonine, C-reactive protein and leukocytes in the first 24 hours.
Dependent variables: nosocomial infection, MODS and mortality. De-
scriptive statitic with mean and standard deviation or median and
interquartile range for quantitative variables; absolute and relative
frequencies for cualitative variables. Bivariant statitic; Student's t-
distribution for independent samples with normal distribution and
Chi-squared test for cualitative variables.
RESULTS. RESULTS: 157 patients were included during the period
under review. Mostly were males (114, 72.6%) and blunt trauma (149,94.9%) with a mean age of 47.45 ± 19.3. The mean stay at ICU was
5,04 days. ISS score, NISS and APACHE II scores were respectively
23.3 ± 12.4; 31.6 ± 16.8 and 15.2 ± 8.4. The median of leukocytes in
the first 24 hours was 15800. C-reactive protein levels were analyzed
in 118 patients with a median of 29.55 and procalcitonine was ana-
lyzed in 74 patients with a median of 0.74. The level of procalcitonine
has a positive and significative correlation with APACHE II, NISS and ISS
scores. The level of leukocytes has only a weak correlation with APA-
CHE II score. The level of C-reactive protein has no correlation with se-
verity scores. 21 patients developed MODS, 20 of them during the first
three days (12.7%) and the last one later (0.6%). 33 patients (21%) were
diagnosed of nosocomial infection during ICU stay with no significative
differences in leukocytes and procalcitonine levels in comparison with
the non-infected patients. Nevertheless, the levels of C-reactive protein
were higher in those with nosocomial infection (p< 0.01). 13.5% of pa-
tients died during ICU stay and 16.1% of patients after ICU discharge
during hospital stay. There are no statistically significant differences in
the levels of leukocytes, C-reactive protein and procalcitonine during
the first 24 hours between died and alive.
CONCLUSION. CONCLUSIONS: During the first 24 hours the levels of
inflammatory parametres are not specific of infection and there is no
differences in mortality and nosocomial infection incidence. There is
statistically significant association between these parametres and
MODS. Procalcitonine could be valuable to predict the development
of MODS and nosocomial infection
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INTRODUCTION. Patients with spinal cord injury require long-term
hospitalization and rest, so they are more likely to develop venous
thromboembolism (VTE). However, the screening for VTE in spinal
cord injury patients has not yet been established.
OBJECTIVES. To clarify the optimal measurement timing and thresh-
old level of the plasma D-dimer for the screening of VTE in patients
with spinal cord injury who require long-term hospitalization and
rest.
METHODS. Of the patients with spinal cord injury who were trans-
ported to our center between April 2011 and March 2019, those who
required at least 10 days of rest and underwent diagnostic imaging
for VTE, with either ultrasonography or enhanced computed tomog-
raphy of the veins of the lower extremities, were included. We retro-
spectively accessed their medical records to determine whether they
were positive or negative for deep vein thrombosis (DVT), the
changes in their plasma D-dimer levels, etc. The subjects were classi-
fied into two groups, the VTE group and non-VTE group, based on
their VTE status.
RESULTS. Of the 87 patients with spinal cord injury, 26 patients were
analyzed. The median age was 67 years (61–77) and 16 patients
(62%) were male. VTE was detected in 12 patients (46%). Prophylactic
anticoagulant administration was given to eight patients (31%). Al-
though the VTE group and non-VTE group showed almost the same
changes in their median plasma D-dimer levels until hospital day 10,
a sharp upward trend was then observed in the VTE group, which
peaked at hospital day 13. The area under a receiver-operator charac-
teristic curve for positive DVT vs D-dimer level at hospital day 13 was
Table 1 (abstract 001023). See text for description
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μg/dL because at that level, sensitivity (80%) and specificity (86%)
were well balanced.
CONCLUSION. The plasma D-dimer levels may be used to screen for
VTE in spinal cord injury patients who require long-term
hospitalization and rest. The optimal measurement timing is 13 days




Development of an ovine model of haemorrhagic shock:
Characterisation of systemic and local oxygen supply/demand
imbalance
G. Li Bassi1, W. Dyer2, JP. Tung,2, K. Wildi1, S. Livingstone1,
S. Rozencwajg1, G. Simonova2, R. Wellburn2, S. Chiaretti,2, F. Temple2,
C. Ainola1, S. Colombo3, N. Bartnikowski1, M. Passmore1, M. Bouquet1,
T. Shuker1, L. Pugh4, D. Irving2, J. Suen1, J. Fraser1
1Critical care research group, The Prince Charles Hospital, Chermside,
Australia; 2R&d, Australian Red Cross, Sydney NSW, Australia, Australia;
3Critical care medicine, University of Milan, Milan, Italy; 4Internal
medicine, St Andrew's War Memorial Hospital, Spring Hill, Australia
Correspondence: G. Li Bassi
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001023
INTRODUCTION. The global burden of haemorrhagic shock (HS) is
substantial and mostly caused by severe physical trauma. Essen-
tial pathophysiologic features of HS are imbalance between oxy-
gen delivery and demand, hyper or hypocoagulatory states and
compensatory anti-inflammatory response syndrome, ultimately
resulting in multi-organ failure (1). Animal models of HS are es-
sential to study underlying pathobiology and develop new
treatments.
OBJECTIVES. To develop an ovine model of severe HS caused by
blood loss > 30% of the estimated blood volume (EBV) and study dy-
namics of oxygen supply/demand imbalance systemically and at
end-organ tissue level.
METHODS. Six adult female Leicester cross breed sheep (46±5
Kg) were anaesthetised, intubated and on mechanical ventilation.
We cannulated the femoral artery for blood sampling and mean
arterial pressure (MAP) monitoring. Swan-Ganz catheter was
inserted through the right jugular vein. Animals were haemor-
rhaged through consecutive collections of 300 mL of blood over
90 min, up to approximately 30% of the EBV. HS was halted in
case of MAP < 50 mmHg, heart rate (HR) >200 beats/min, or ven-
ous oxygen saturation (SvO2) <50%. At baseline, and every 15-
min thereafter, haemodynamic parameters were recorded, and ar-
terial blood gas analysis performed, oxygen delivery (D02) com-
puted. Microdialysis probes were positioned into various organs
to measure, at baseline and end of bleeding period, interstitial
lactate and lactate/pyruvate ratio.
RESULTS. All sheep survived HS. On average, sheep were hae-
morrhaged 1055±193 mL of blood (33.6±5.2% of EBV). At base-
line, and at the end of HS period, Hb varied from 10.3±2.1 to
7.6±10.8 g/dL (p<0.01), arterial lactate from 2.0±1.5 to 4.3±1.2
mmol/L (p<0.01), HR from 102±14 to 154±30 bpm (p=0.06), MAP
from 95.6±8.8 to 51.3±15.2 mmHg (p<0.01), cardiac output from
4.4±1.4 to 2.1±0.8 L/min (p<0.01), SvO2 from 76.3±9.8 to 54.0±
24.3% (p=0.192) and D02 from 552±218 to 241±114 ml/min (p<
0.01). Table below depicts development of organ-specific oxygen
debt, measured by microdialysis.
CONCLUSION. We described an ovine model of HS, characterized
by significant impairment in cardiac output and oxygen delivery,
resulting in multi-organ oxygen supply/demand imbalance. Themodel will be first used to compare the efficacy of different re-
suscitation fluids.
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INTRODUCTION. While supportive treatment in the management of
Traumatic Brain Injury (TBI) has progressed over the past 20 years,
specific drug treatments are lacking [Maas et al]. New strategies are
needed. Altering how patients are ventilated, could be an easily
modifiable variable in TBI management. Data in in vitro and in vivo
models of ischemic heart [Ristagno et al] and brain injury [Loetscher
et al] show that the gaseous agent Argon is endowed with neuropro-
tective potential. Whether Inhaled Argon (iAr) is protective in experi-
mental TBI is presently unknown.
OBJECTIVES. To test the effects of inhaled Argon administered after
experimental TBI in mice on neurological functions and structural
outcome by longitudinal behavioural assessments and magnetic res-
onance imaging (MRI) including T2W and DWI sequences.
METHODS. Severe TBI was performed in anesthetized mice (C57BL/
6J, 8 weeks old, male) over the left parietotemporal cortex by con-
trolled cortical impact as previously described [Zanier et al]. Immedi-
ately after TBI, mice were randomized to 24h treatment by iAr 70%-
O2 30% (n=10) or air (n=10) from 10 minutes after TBI. Sensorimotor
deficits were evaluated at the end of treatment (24h post TBI) and at
1 week by neuroscore and simple neuroassessment of asymmetric
impairment (SNAP) tests. MRI (7 Tesla, Bruker) was performed at 3
days post TBI to evaluate contusion volume by T2W. The effect of iAr
on acute brain edema, was analysed in a subset of mice (n=3 per
group) by DWI-MRI. Maps of the apparent diffusion coefficient gener-
ated by DWI-MRI were used to evaluate iper/ipo intense regions as a
proxy of vasogenic and cytotoxic edema, respectively. A simple ran-
dom allocation was applied to assign a subject to an experimental
group. Data acquisition and analysis were done blindly. Data were
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tween iAr and air treated TBI mice.
RESULTS. Argon inhalation significantly improved neurological func-
tion at 24 hours and 7 days after TBI (Neuroscore 24h post TBI iAr
6.1±0.5 vs. Air 3.7±0.7, p=0.0102). Contusion volume was reduced by
16% in iAr than air breathing TBI mice. Vasogenic brain edema
showed a reduction in iAr treated TBI mice close to significance (p=
0.056).
CONCLUSION. iAr induces an acute and persistent improvement of
sensorimotor function when administered for 24h starting 10 mi-
nutes after TBI. This outcome is reinforced by preliminary MRI data
showing a trend in toward a decrease in vasogenic edema in iAr
treated mice. Our data support future studies to understand the po-
tential of iAr as an accessible treatment in TBI.
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INTRODUCTION. Drug-drug interactions (DDIs) are considered as
concerning issues for public health especially in those admitted to in-
tensive care units (ICUs). There are many studies that show involve-
ment of intensivists in the ICUs improves outcome and limits costs.
Different types of intensivist-driven care exist. This study evaluated
the effect of academic versus non-academic (therapeutic) intensivist
as well as hours of coverage and attendance of intensivist on DDIs in
six adult trauma ICUs of a level one trauma center
OBJECTIVES. Considering the high incidence of pDDIs in the ICU,
and the importance of ADRs caused by DDIs in critically ill patients,
we aimed to investigate the effect of presence of an academic versus
therapeutic intensivists as well as hour of coverage of intensivist on
DDIs in six adult trauma ICUs of a level one trauma center in Shiraz,
Iran.
METHODS. Two hundred patients were included in this prospective
study in a 6-month period. The DDIs were classified into 5 categories,
including type A, B, C, D, and X. Type D and X were considered as
potential DDIs (pDDIs). Effect of three different types of intensivist
staffing models including type A (once daily therapeutic intensivist
visit followed by 24 hour on-call), B (twice daily academic intensivist
visit, 8 hours attendance in ICU and 16 hours on–call) and C (all cri-
teria just like ICU type B except presence of therapeutic instead of
academic intensivist).
RESULTS. 3735 drug orders and 3869 drugs (193 different types)
were assessed and 1826 potential DDIs were identified including
1107 (60.6%) type C, 648 (35.48%) type D and 12 (0.6%) type X. The
mean of DDI per patient was significantly higher (P value <0.001) in
ICU type A than ICU type C and type B. The frequency of DDIs was
highest in type A. There was a statistically significant relationship be-
tween the number of prescribed drugs and ICU length of stay (P
value <0.001 and P=0.009, respectively).
CONCLUSION. Different types of intensivist models affect DDIs to
varying degrees. In this regard, academic versus therapeutic intensi-
vist, twice versus once daily visit and 8 hours attendance with16
hours on-call versus 24 hours on-call is associated with more reduc-
tion in DDIs in adult trauma ICUs.REFERENCE(S)
1. Papadopoulos J, Smithburger PL. Common drug interactions leading to
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INTRODUCTION. High level cervical spinal cord injuries (SCI) often re-
sult in respiratory failure and the need for tracheostomy mechanical
ventilation. The National Trauma Data Bank reports tracheostomy
rate for high cervical injuries to be over 30% and even 20% of pa-
tients with injury below C4 require a tracheostomy. The benefits of
tracheostomy are documented however they do have risks and in
chronic long term use, there is sub optimal management. Early com-
plications include bleeding(2-5%), stomal infection (2-5%) and dis-
lodgement 1%. Late complications approach 65% including
tracheomalacia and stenosis.
OBJECTIVES. This is a report of tracheostomy use in all traumatic SCI
patients who underwent diaphragm pacing (DP).
METHODS. This is a retrospective review of prospective IRB and or
FDA approved protocols involving SCI and DP. Airway management
of traumatic SCI who underwent DP was analyzed pre and post DP
implant.
RESULTS. Out of over 500 implanted DP patients 99 were traumatic
SCI with complete tracheostomy data on 84 patients. Fifty nine or
63% of patients had a cuffed tracheostomy at the time of DP evalu-
ation. Average age at time of injury was 27. 8 years (1 day to 74
years). The average time spent on mechanical ventilation prior to DP
was 9.7 years (6 days to 25.6 years). Within this group are 13
pediatric patients age 0 to 17 in which 54% presented with a cuffed
tracheostomy tube. Post DP implant, 7 patients were decannulated,
15 patients had tracheostomy converted to cuffless tube and 2 pa-
tients went to a stoma stent. One patient required laryngectomy due
to tracheal damage. Two patients went directly from Endotracheal
tube mechanical ventilation to DP to extubation avoiding tracheos-
tomy altogether. T Median survival was 22.2 years (95% CI 14.0 - not
reached) with only 31 deaths. Subgroup analysis showed that earlier
DP implantation leads to greater 24 hour use( 72% ) of DP and no
need for any MV.
CONCLUSION. There continues to be a widely held belief that posi-
tive pressure ventilation must be delivered via cuffed and generally
inflated cuffed tracheostomy tube. Inflated cuffed tracheostomy
tubes has significant morbidity including speech difficulty, aspiration
increases from difficulty swallowing, tracheal stenosis and tracheo-
malacia. The efficacy and benefits of the cuffless tracheotomy was
first described in 1990. Publications in SCI and chronic mechanical
ventilation describe the use of cuffless tracheotomy but this report
confirms cuffed tube usage is dominant. The choice of tracheostomy
style needs to be better scrutinized. DP implantation allowed for
downsizing and decannulation. It obviated the need for tracheos-
tomy in two patients. Early DP use may significantly alter the morbid-
ity of tracheostomies leading to improved survival.
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INTRODUCTION. Alcohol and drug abuse are potentially modifiable
risk factors for critical illness. Increased knowledge regarding the im-
pact of substance abuse on cause of admission in different ICU popu-
lations is needed.
OBJECTIVES. To describe patients with substance abuse-related ad-
missions in a mixed intensive care (ICU) population, and to compare
these patients with patients with non-substance abuse-related admis-
sions on selected parameters.
METHODS. Cross-sectional prospective study of ICU-patients in Oslo
aged ≥18 years included over a one year period from February 3rd
2014 to February 2nd 2015. Data were collected consecutively from a
questionnaire, medical records and toxicology results. Substance
abuse-related admissions were defined as ICU-admissions due to acute
or chronic complications of alcohol or drug use, and included the fol-
lowing subgroups: (A) cause of admission directly associated with acute
substance abuse (e.g. acute intoxication) (B) indirect influence of acute
substance abuse (e.g. trauma in intoxicated patient) and (C) medical
complications of chronic substance abuse (e.g. alcoholic liver disease).
RESULTS. Of the 861 patients included, 537 (62%) were medical and
324 (38%) surgical, 632 (73%) received mechanical ventilation and
279 (32%) died during the hospital stay. Overall, 168 (20%) patients
had substance abuse-related admissions; 104 (12%) were alcohol-
related and 64 (7%) drug-related. Of the 168 patients with substance
abuse-related admissions, 59 (35%) patients were in group A, 77
(46%) in group B and 32(19%) in group C. In age groups 18-39 and
40-59 males had a much higher proportion of substance abuse-
related admissions than females (47/99, 48% vs 10/40, 25%, p<0.02
and 57/167, 34% vs 11/71, 16%, p<0.01, respectively), while there
were no difference between the genders in patients 60 years and
older. Among the 191 trauma patients, substance abuse was predis-
posing factor in 69 (36%). Patients with admissions associated with
acute substance abuse (subgroups A and B) were significantly youn-
ger (mean age 43 and 46 vs. 63), had lower mean Charlson comor-
bidity index (1.2 and 0.8 vs. 2.5) and shorter median time of
mechanical ventilation (0.5 and 1.0 vs 4 days) than patients with
non-substance abuse-related admissions. There were no such differ-
ences between patients in group C and patients with non-substance
abuse-related admissions. Age-adjusted logistic regression analysis
showed lower hospital mortality for patients in group B (OR 0.5, p<
0.04), but not in the other subgroups.
CONCLUSION. One in five ICU-admissions was associated with alco-
hol or drug abuse. Acute substance abuse caused the majority of the
substance abuse-related admissions, and was particularly prevalent
among young, male patients with otherwise few risk factors for crit-
ical illness. Nearly half of the admissions in males aged 18-39 were
associated with substance abuse, and more than one third of the
trauma patients were influenced by alcohol or drugs at time ofinjury. Routine screening for alcohol and drugs in Norwegian trauma
patients should be considered implemented.
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INTRODUCTION. The use of albumin to resuscitate burn patients has
been a controversial issue for more than 50 years. Currently the most
accepted formulas use crystalloids for this purpose and colloids only
as a rescue fluid in order to avoid “fluid creep”. In contrast, BET for-
mula administers albumin from the beginning of the resuscitation
period using it in a progressively decreasing concentration.
OBJECTIVES. The purpose of our study was to review and analyze re-
suscitation related variables of all burned patients treated in our unit
using BET formula
METHODS. Retrospective, observational study conducted in a 5 bed
critical care unit for major burns in a tertiary hospital in Spain. BET for-
mula estimates fluid resuscitation as a function of total burn surface
area (TBSA) (ml/h = TBSA (m2) x 220) and administers it through a com-
bination of Lactated Ringer and 20% Albumin starting at a 1:1 relation-
ship. The proportion of albumin is decreased every 8 hours during the
first 48 hours (resuscitation period) and the infusion rate is modified ac-
cording to urinary output. Study period was from January 2013 to Janu-
ary 2018. Inclusion criteria: TBSA > 20% or > 10% plus inhalation injury,
admission during the first 12 hours after the injury, who had all docu-
mentation regarding fluid resuscitation available. Data are expressed as
means, medians, and proportions and analyzed using T-Test, Wilcoxon
Rank Sum, Chi-Square and Fishers´ Exact Test as needed. Relationship
between variables is expressed as Pearson´s correlation coefficient
RESULTS. 131 patients were admitted in the unit during the study
period. 40 patients met all inclusion criteria. Patients´ characteristics:
age 58 ± 19, 26 (65%), TBSA% 36 ± 17, mechanism fire 28 (70%), inhal-
ation 8 (20%), ABSI 9 ± 2, time injury-admission 4.5h (2.7-6.1), referring
hospital 24 (60%). Resuscitation volume during the first 24 hours
(VOLBSi24) was 2.58 ml/kg/%BBSA, significantly less than Parkland´s es-
timation (4 ml/kg/%BBSA; P<0.05). Patients were successfully resusci-
tated showing a significant base excess and lactate clearance during
the resuscitation period (base excess 135%; lactate 35%; P<0.05). A
slight but significant correlation was found between time from injury to
admission (admission delay) and indexed volume administered in the
first 24 h (r 0.32, p<0.05). An inverse correlation was found between
indexed volumes and TBSA% during the first 24h (r -0.38, p<0.05). Re-
suscitation related complications: mechanical ventilation 27 (67.5%),
ARDS 12 (30%), renal failure (KDIGO ≥ 1) 21 (53%), continous renal re-
placement therapy 5 (12.5%), wound deepening 8 (20%), abdominal
compartment syndrome 2 (4.5%), limb compartment syndrome 0.
CONCLUSION. BET formula is capable of resuscitating burn patients
successfully, limiting fluid administration, and being able to keep
burn related complications low.
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Table 1 (abstract 001410). Factors associated with admission to
Intensive Care Unit in 682 poisoning patients transported by EMS to



















Male gender 18 (54.5) 371 (57.5) 0.736
Priority dispatch 30 (90.9) 414 (63.8) 0.001
Priority transport 33 (100.0) 277 (42.7) <
0.001




SpO2 lowest <94% 11 (37.9) 169 (32.5) 0.544
NEWS ≥7 11 (33.3) 73 (11.2) 0.001


























Suicidal intention 4 (12.1) 70 (10.8) 0.81
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comes at a cost of increased morbidity and mortality in later phases, in-
cluding the occurrence of multiple organ dysfunction syndrome (MODS). If
patients at risk for MODS could be identified early using different cytokine
production profiles, preventative treatment measures could be taken.
OBJECTIVES. The aim of this study is to investigate whether specific
pro- and/or anti-inflammatory biomarkers are associated with devel-
opment of MODS.
METHODS. Adult (18 years or older) multiple trauma patients with an
injury severity score of 16 or higher presenting to a level 1 trauma
center in the Netherlands between 2008 and 2018 were included.
Blood was drawn at presentation to the hospital and analyzed for 19
markers of systemic and pulmonary inflammation, endothelial activa-
tion and coagulation using a Luminex assay. MODS was defined as a
SOFA score of three or more in two organ systems. Comparisons
were made between patients with and without MODS. Univariate
and multivariate logistic regression analysis was used to determine
association between specific biomarkers and MODS. Data are pre-
sented as median with interquartile range. A p-value of less than
0.05 was considered to be statistically significant.
RESULTS. In total, 147 multiple trauma patients were included, of
which, 32 patients developed MODS. Compared to patients without
MODS, patients with MODS had higher injury severity scores (25 [22
– 30] vs 20 [17 – 27], p=0.010), more often had traumatic brain injury
(75 vs 56 %, p=0.048), were deeper in shock with lower base excess
(-2.7 [-6.1 – -0.6] vs -1.2 [-3.1 – 0.8], p=0.005) and were more coagulo-
pathic as determined by higher prothrombin time (12.7 [11.7 – 14.7]
vs 11.7 [11.3 – 12.4] seconds, p=0.001). Overall, baseline levels of
both pro- as well as anti-inflammatory biomarkers were higher in
MODS patients, indicative of a severe host immune reaction. In the
multivariate analysis, the combination of interleukin-1 receptor an-
tagonist (OR 1.27 [1.07 – 1.51], p=0.002) and clara cell protein 16
(1.06 [1.01 – 1.05], p=0.031) was most strongly associated with the
development MODS. Receiver operating curves showed an AUC of
0.73 (IL-1RA) and 0.70 (CC-16), respectively.
CONCLUSION. In trauma, biomarkers IL-1RA and CC-16 have the po-
tential to identify patients at risk for development of MODS. Further
research is warranted to prospectively validate these results.
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INTRODUCTION. Acute poisoned patients are a common occurrence in
intensive care units (ICU). It is estimated that three to six percent of pa-
tients admitted to ICU are due to acute intoxication.(1) ICU admission rate
of patients admitted to hospital in Nordic countries varies largely: from
7.3 % in Finland up to 49 % in Norway, mostly due to different poisoning
treatment policies. (1–3) Majority of poisonings are presented to hospitals
by ambulance operated by emergency medical services (EMS). (3)
OBJECTIVES. We set out to map out factors associated with
hospitalization and intensive care admission to better recognize pa-
tient population in risk of death or other serious sequelae.
METHODS. A retrospective study was conducted in all EMS missions
of poisoning patients in Oulu University Hospital (OUS) catchment
area for three years, from 2015 to 2017. We combined data from
Oulu-Koillismaa Emergency Medical Services database with OUS hos-
pital discharge registry.
RESULTS. From a total of 1,336 EMS missions labeled as poisoning-related, 682 patients were included in the study after excluding pa-
tients under 16 years, those who were discharged with other diagno-
sis and those who were never transported to hospital. 4.8% of
poisoning patients were admitted into ICU. Data for 682 patients are
presented in Table 1.
CONCLUSION. Significant factors associated with intensive care ad-
mission in poisoning patients were pre-hospital intubation, negative
alcohol finding and intravenous fluid resuscitation of >500 ml. Risk
factors should be taken into account in further poisoning missions,
and results of this study may provide support when a poisoning pa-
tient’s need for intensive care is in question.
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mon reason for admission to intensive care units in Scotland. Com-
puted tomography (CT) scanning is often performed, however its
value in this patient group has been debated. CT requires intra-
hospital transfer of the critically ill patient, which has been associated
with increased risk of respiratory and cardiovascular instability.
OBJECTIVES.We wished to ascertain the diagnostic yield of CT head in pa-
tients admitted to the intensive care unit following overdose. We hoped
to identify any differences in length of stay or mortality between those pa-
tients who received a CT head and those who did not. We wished to iden-
tify clinical features which were associated with positive scan results, and
to determine if a positive CT head had any impact on decision making.
METHODS. We performed a retrospective analysis of patients admit-
ted to a single Scottish intensive care unit over a 13 year period
(2005-2018). Patients presenting with “self-poisoning” were identified
using the ward watcher national audit database. Descriptive statistics
were used to analyse patient demographics, pre-intubation GCS,
length of stay, and predicted and actual mortality. Differences be-
tween groups were analysed using unpaired t tests and p values of <
0.05 were considered statistically significant. Diagnostic yield was cal-
culated using percentages. Where a CT head was reported as abnor-
mal, we determined if this affected the treatment plan by reviewing
all associated electronic patient records.
RESULTS. 179 patients admitted to intensive care following overdose
were identified, with a median age of 39. 55% were male. 38% had a
CT scan performed. 15% of these scans were reported as “abnormal”
but only 6% represented an acute pathology. None required inter-
vention or resulted in a change in management. Pre-intubation GCS
was lower in those patients who had CT scans than those who did
not (p = 0.0013). Patients with a recent history, or clinical evidence
of, head injury, were more likely to receive a CT head. There was no
increase in the rate of positive scan in this group. In the small group
of patients with a positive CT scan, there was no history of head in-
jury, seizures, localising neurology or anticoagulation.
CONCLUSION. The yield of CT head scanning following overdose
was low. Only 6% revealed an acute intracranial pathology and non
required intervention or resulted in a change in management. Mor-
tality rates in this patient population are low compared to the gen-
eral ICU population and having a CT head had no demonstrable
effect on mortality. CT scans were more likely to be performed in
those patients with a lower pre-intubation GCS and those with a
head injury, but we did not find any increase in positive findings. We
could not identify any clinical characteristics associated with in-
creased likelihood of a positive scan. We cannot make any recom-
mendations regarding which patients may benefit from early
scanning. Any decision to proceed to intrahospital transfer to facili-
tate diagnostic imaging must be balanced against the very real risks
of instability during transfer. Larger studies are required to provide
appropriate statistical power to identify patient subgroups who may
benefit from early imaging following overdose.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):001659INTRODUCTION. Delirium is a common clinical syndrome in intensive
care unit, correlated with various adverse clinical outcomes.
OBJECTIVES. This study aims at estimating the incidence of delirium
and investigating the associated risk factors and outcomes in ICU pa-
tients with acute poisoning.
METHODS. The data was collected from the ICU patients admitted
via the emergency center over 18 years old presenting with poison-
ing from 2010 to 2015. Delirium was assessed retrospectively using
Intensive Care Delirium Screening Checklist (ICDSC). Risk factors were
evaluated with univariate and multivariate analysis.
RESULTS. 199 patients participated in this study and a total of 68
(34.2%) of the patients were diagnosed with delirium based on
ICDSC score. The delirium group showed statistically significantly
higher association with prolonged length of stay in the hospital and
ICU in comparison with non-delirium group. The use of physical re-
straints and altered mental status were identified as significant risk
factors for delirium with an odd ratio of 1.92 and 3.90. Pharmaceutics
poisoning group was observed to develop delirium faster than non-
pharmaceutics poisoning group. There was no significant difference
between the two groups with respect to age, sex, past history, GCS
score, vital sign, and application of ventilator care and renal replace-
ment therapy.
CONCLUSION. In ICU patients with acute poisoning, the develop-
ment of delirium was found to be common and associated with the
use of physical restraints and altered mental status.
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INTRODUCTION. Exsanguination is the most common cause of early
trauma death. Rapid blood transfusion is crucial in trauma resuscita-
tion. Well-performed scoring system to predict massive blood trans-
fusion(MBT) aids resource utilization with promptly blood
preparation. Previous scoring systems take long time to obtain after
admission and inaccurate in Thailand with a different trauma system.
OBJECTIVES. To create a scoring system to predict MBT in trauma
patients.
METHODS. All patients who met one of trauma activated criteria
which were 1) Systolic blood pressure < 90mmHg 2) Gun shot
wound(GSW) at the chest, abdomen or back 3) Stab wound at the
chest or abdomen 4) Respiratory rate <12/min or >30/min 5) Pulse
rate > 120/min 6) Glasgow coma scale score ≤ 8 7)Present of free
fluid from focused assessment with sonography for trauma(-
FAST) from January 2012 to December 2018 were included. MBT was
defined as receiving packed red cell(PRC) > 10 units in 24 hours or >
4 units in the first hour. Univariable analysis was conducted on all
possible predictors which included patients characteristic, mechan-
ism of injury, and laboratory results. Factor with p value < 0.2 were
included in the stepwise backward multivariable logistic regression.
The score was assigned by coefficient. Sensitivity, specificity and
positive likelihood ratio was estimated. Cutoff point was selected
based on Receiver Operator Characteristic curve analysis then in-
ternal validation was performed with bootstrap replications.
RESULTS. Among of 878 patients, 102(11.6%) received MBT. Nine fac-
tors were significantly associated with MBT with the score of 2.5 for
age ≥ 60 years, 1.5 for female, 2 for GSW, 3 for pelvic fracture from
physical examination, 2 for femur fracture from physical examination,
1 for PR ≥ 105/min, 2 for base excess ≤ -10mEq/L, 2.5 for lactate >
4mmol/l, and 2 for present of free fluid on FAST. The area under the
curve(AUC) was 0.824 (95% CI 0.778 - 0.871). At the cutoff point ≥ 7,
this score has a positive likelihood ratio of 10.22. Internal validation
demonstrated AUC 0.805 (95%CI 0.754 -0.856).
Page 66 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55CONCLUSION. The new score has an excellence discrimination to
prediction of MBT. The parameters were simple and easy to obtain a
few minutes after arrival thus should be applied in clinical practice.
Further, cost-effectiveness and implemental studies should be done.
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SIS - Sepsis phenotypes
000008
Epidemiology of septic patients admitted to the Intensive Care
Unit. Analysis of incidence and outcomes
AB. López Pérez, HG. Khandji Aslan, JB. López Messa
Intensive care unit, Hospital Río Carrión, Palencia, Spain
Correspondence: A.B. López Pérez
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000008
INTRODUCTION. Sepsis incidence is increasing compared to inci-
dence for other leading causes of mortality such as acute myocardial
or stroke. Estimates of sepsis incidence and trends are also essential
to estimate the resources needed to care for these patients. We
would like to emphasize the importance of using local data to moni-
tor trends in results over time. This information has significant impli-
cations for health-care service planning and may be useful to
estimate future care requirements.
OBJECTIVES. To examine the most recent epidemiological character-
estics of sepsis and the temporal changes in its incidence and
outcome.
METHODS. A retrospective study was carried out during a consecu-
tive six years period in a polyvalent ICU of a secondary hospital from
January 1, 2010 to December 31, 2016. To identify episodes of sepsis
we applied the International Classification of Diseases, Ninth Revision,
Clinical Modification. The statistical analysis was perfomance with
IBM-SPSS-22. The hospitalization rate was defined as the yearly num-
ber of admissions per 100.000 population. Qualitative variables are
expressed as frecuency and percentage, and quantitative variables as
mean and standard deviation. The Student t test was used to com-
pare means of the quantitative variables and when the hypothesis of
normality was no accepted, the nonparametric Mann-Whitney U test
was used. And Chi-square test for categorical variables. We per-
formed a logistic regression analysis to identify factors associated
with in-hospital mortality. Odds ratios (ORs) with 95% confidence in-
tervals were computed.
RESULTS. Seven hundred and twenty four patients were included at
ICU admission. Sepsis was present in 180 patients (24.9%) and septic
shock in 544 (75.1%). The mean age was 69.2 years and 67% were
male. 66.9% of all episodes of sepsis were among people aged 65
years or more. Hypertension (53%), non-metastatic cancer (30.7%)
and diabetes (26.8%) were the most common categories of comorbi-
lity. Gram-negative bacteria were the most frequently involved mi-
croorganisms (42.7%). The observed mortality was 38.7%. Elderly
patients (≥65 yrs) were more likely to have 3 or more organ failures
(73.1% vs 61.7%). Between 2010 and 2016 there was an annualized
increase in the incidence of sepsis from 35.4 per 100.000 population
to 53.3 per 100.000 population. The total in-hospital mortality rate
fell from 52.9% in 2010 to 34.6% in 2016. The risk of death was sig-
nificantly associated with the respiratory failure, a low pH, SAPS 3
and mechanical ventilatory support.
CONCLUSION. Our analysis shows that cases of sepsis occur in older
people and develop a greater number of organ failures. Sepsis inci-
dence has risen in recent years in our region while mortality has
fallen despite increase in age and severity of sepsis.REFERENCE(S)
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INTRODUCTION. Identification of predicted sepsis related mortality is
important for patient stratification.
OBJECTIVES. We evaluated the significance of Presepsin in predicting
sepsis mortality.
METHODS. We enrolled 83 sepsis patients according to the SCCM/
ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference in a
prospective observational study. After excluding 28 patients due to
different exclusion criteria, 55 continued the study. Their age was
58(47-65) years-old with 33 (60%) males.
We measured serum Presepsin, Procalcitonin, and CRP on admission,
24 and 72 hours later. APACHE-II score and Capillary leak index (CLI)
were estimated. The primary outcome was the in-hospital mortality.
RESULTS. The median(Q1-Q3) Presepsin24 and Presepsin72 levels
were 1127.5(835.75-2137.5) and 883(429-1214.5)pg/ml in survivors
compared to 2321(1264-3456) and 3421(1900-5432)pg/ml in non-
survivors (P=0.01 and 0.000 respectively). The serum CRP24 and
CRP72 were 123(76-154) and 94(42.5-127)mg/L in survivors com-
pared to 156(101-201) and 187(139-233)mg/L in non-survivors (P=
0.02 and 0.000). PCT72 was 111.5(66-186.25)pg/ml in survivors com-
pared to 231(187-324)pg/ml in non-survivors (P=0.000). Presepsin0,
CRP0, PCT0 and PCT24 were not significantly different between survi-
vors and non-survivors (P=0.4, 0.7, 0.5, and 0.2 respectively). The
APACHE-II score was 18(15-20.8) in survivors compared to 21 (19-24)
in non-survivors (P = 0.02) while the CLI was 42(27.6-57.7) and
42.4(33.3-62.3) in survivors and non-survivors respectively (P = 0.8).
The AUC was the highest for Presepsin72 (0.918). Presepsin72 of
1262pg/ml was seen to be 92.3% sensitive and 81.3% specific for
mortality prediction.
CONCLUSION. This study showed that the serum Presepsin could be
a valuable biomarker for predicting in-hospital mortality in sepsis.
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INTRODUCTION. Sepsis is defined as the host’s inflammatory re-
sponse to a life-threatening infection potentially leading to a septic
shock and the failure of organs initially not infected [1]. Currently,
the most efficient weapon to fight against bacterial infections is
Fig. 1 (abstract 000063). See text for description
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an intrinsic immunomodulatory effect in addition to their antimicro-
bial effect [2]. Endothelial cells are able to detect danger signals from
pathogens and to initiate the innate immune response, and in some
specific conditions, the adaptive immunity [3].
OBJECTIVES. The aim of this study was to highlight the effects of
two antibiotic classes on endothelial cells' immune properties during
sepsis.
METHODS. Human Microvascular Endothelial Cells (HMEC) were stim-
ulated by Lipopolysaccharide, Interferon γ and Tumor Necrosis Factor
α (Cytomix) during 24 hours before the administration of different
antibiotics. The surface expression of Inter-Cellular Adhesion Mol-
ecule 1 (CD54), Program-Death Ligand 1 (CD274), Human Leucocyte
Antigen (HLA) class 1 and HLA-DR were determined using flow cy-
tometry 24 hours after antibiotics’ administration. The production of
cytokines as Interkeukin (IL)-6 or IL-8 by HMEC was determined by
Enzyme-Linked Immunoabsorbent Assay (ELISA). Quantitative poly-
merase chain reaction (qPCR) was used to analyze GAPDH (control),
IL-6, HLA-A and HLA-DR gene expression. To study the effect of anti-
biotics on lymphocytes, the activated HMEC exposed to antibiotics
were co-cultured with peripheral blood mononuclear cells obtained
(PBMC) from healthy donors.
RESULTS. Compared to Cytomix alone, Clarithromycin (1 μg/mL) as-
sociated to Cytomix significantly decreased the expression of HLA-1
(fold change HLA-1 expression to Cytomix 0,67 to 1 p<0,01) and
HLA-DR (0,65 to 1 p<0,01) on HMEC surface. Rovamycin and Erythro-
mycin also significantly decreased both expressions of HLA-1 and
HLA-DR. In qPCR, Clarithromycin (10 μg/mL) significantly decreased
HLA-DR gene expression (1 versus 0,78 HLA-DR fold expression to
GAPDH p<0,01) and IL-6 gene expression (1 versus 0,67 IL-6 fold ex-
pression to GAPDH p=0,03) compared to Cytomix. Compared to
Cytomix, Amoxicillin (1 μg/mL) significantly decreased the expression
of HLA-1 on HMEC surface (0,55 to 1 p<0,01) but did not affect HLA-
DR expression. IL-6 and IL-8 production were not significantly differ-
ent between Cytomix stimulation alone and Cytomix associated with
antibiotics treatment. Co-cultures of HMEC with Rovamycin and
PBMC did not change lymphocytes polarization nor regulatory or
memory T cells proliferation.
CONCLUSION. Macrolides and Penicillin modulate the expression of
HLA molecules on microvascular endothelial cells’ surface. The use of
a second endothelial cell line, co-cultures of endothelial cells with
sorted CD8+ lymphocytes and in vivo experiments could better en-
lighten the potential pathophysiological implications of those results.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000063INTRODUCTION. Sepsis-related myocardial dysfunction is associated
with impaired outcome. Traditionally, in this setting the main focus
has been on left ventricular performance. As of now, specific know-
ledge on the prognostic importance of right ventricular dysfunction
is scarce. The aim of this study was to determine whether right ven-
tricular ejection fraction (RVEF) is predictive of long-term mortality in
sepsis.
METHODS. Single-centre retrospective cohort study in adult patients
admitted to the ICU with severe sepsis and septic shock, and
equipped with a pulmonary artery catheter within 24 hours following
admission. RVEF was recorded as an average over the first 24 hours
(sample rate of 1 per minute). Patients were a priori separated into
subgroups according to their RVEF: RVEF<20% (A), RVEF 20-30% (B),
and RVEF>30% (C). The primary endpoint was one-year all-cause
mortality; secondary endpoints included haemodynamic variables
and use of norepinephrine in relation to RVEF.
RESULTS. In a 7-year period 101 patients fulfilled all entry criteria
and 98 were included in the study. Demographic data, medical his-
tory, reason for admission, and source of infection did not statistically
differ between groups. However, patients in group A had a signifi-
cantly higher APACHE II score and signs of shock were more pro-
found, as indicated by a lower cardiac index, SvO2, and pH, a higher
lactate, and more use of norepinephrine in comparison to other
groups. One-year all-cause mortality was significantly different be-
tween groups: 57.1% in group A (n=21), 18.2% in group B (n=55),
and 22.7% in group C (n=22); p=0.003. Kaplan-Meier survival analysis
revealed a clear separation between group A and B/C (chi square=
14,00; p=0.001). In a multivariate logistic regression analysis, RVEF,
both as a categorical variable (RVEF<20%) and as a continuous vari-
able, remained independently associated with the primary endpoint
(OR 4.1; 95% CI 1.3-13.4; p=0.018 and OR 0.92; 95% CI 0.85-0.99; p=
0.018, respectively).
CONCLUSION. RVEF is independently associated with one-year all-
cause mortality in a highly selected group of patients with severe
sepsis and septic shock. In addition, a low RVEF was associated with
an increase in signs of circulatory failure, suggesting maladaptation.000123
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Page 68 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. The central venous-arterial carbon dioxide differ-
ences (pCO2 gap) is a marker of the adequacy of cardiac output with
the global metabolic conditions that are less affected by an impair-
ment of oxygen extraction capacities. (PCO2 gap =K. VCO2(CO2 pro-
duction)/COP)(1)
OBJECTIVES. To investigate the relation between the pCO2 gap,
serum lactate and cardiac index (CI) and prognostic value on admis-
sion. We also investigated the pattern of Ultrasound chest (US).
METHODS. We performed a prospective observational study and re-
cruited 28 patients, over 6 months, with severe sepsis and septic
shock in mixed ICU. We determined central venous PO2, PCO2, PCO2
gap, lactate, CI at 0 and 6 hours after critical care unit (CCU) admis-
sion. The cardiac index was measured using echocardiography (non-
invasive) in a blinded fashion. The population was divided into two
groups based on pCO2 gap (cut off value 0.8 kPa).
RESULTS. CI was significantly lower in the high gap group (p =
0.001). The high gap CO2 group, on admission, required more bolus
fluid administration and vasopressors (P= 0.01 and 0.009 respect-
ively) table1. The hospital mortality rate for all patients was 24.5 %
(7/28). The in-hospital mortality rate was 20 % (2/12) for the low gap
group and 30 % (5/16) for the high gap group; the odds ratio was
1.6 (95 % CI 0.5–5.5), p = 0.53. Patients with a persistent or ris-
ing pCO2 gap larger than 0.8 kPa at T = 6 and 12, , had a higher
mortality change (n = 6; in-hospital mortality 21.4 %) compared to
patients with a pCO2 gap less than 0.8 kPa at T = 6 (n = 1; in-
hospital mortality 3%); this odds ratio was 5.3 (95 % CI 0.9–30.7); p =
0.08. PCO2 gap has no relation with chest ultrasound pattern.
CONCLUSION. PCO2 gap is an important hemodynamic variable in
the management of sepsis-induced circulatory failure. PCO2 gap can
be a marker of the adequacy of the cardiac output status in sepsis. A
high-value PCO2 gap (>0.8 kPa) can identify situations where increas-
ing cardiac output can be attempted with fluid resuscitation in se-
vere sepsis. PCO2 gap carries an important prognostic value in
severe sepsis
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Age (year) 71 ± 14 69± 17 73.62 ± 13 0.7
SOFA 10.39± 3.9 8.5±3.4 11.75± 3.8 0.03*
Lab & Therapy
Lactate (mmol/L) 2.7 ± 2.3 1.3 ± 0.9 3.76 ± 2.6 0.003*
CI (L/min/m2) 2.6 ± 0.41 3.2 ± 0.37 2.1 ± 0.46 0.001*
Ultrasound chest A/B profiles 8/4 8/8 0.8
vasopressor 18 5 13 0.009*
Fluid boluses 28 10 18 0.01*
Mean BP 60 ± 10 65 ± 9 55 ± 11 0.01*
SvO2 (%) 71.9 ± 10.7 73.2 ± 9.1 70.3 ± 6.6 0.01*000132
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INTRODUCTION. Early changes in biomarker levels probably occur
sometime before bloodstream infection (BSI) is diagnosed. It has clin-
ical relevance to understand when the host inflammatory response
begins. So far, this issue has not been fully addressed.
OBJECTIVES. We aimed at evaluating the kinetics of C-reactive pro-
tein (CRP) and plasma albumin (PA) in the 30 days before the
community-acquired (CA) BSI.
METHODS. From a population-based BSI database we identified 658
patients with at least one measurement of CRP or PA from day −30 (D
−30) through day −1 (D−1) before the day of CA-BSI (D0) and a meas-
urement of the same biomarker at D0 or D1. Amongst these, 502 had
both CRP and PA measurements which fit the above defined criteria.
RESULTS. CRP and PA concentrations began to change inversely
some days before the diagnosis of CA-BSI, CRP increasing by day
−3.1 and PA decreasing by day −1.3. From D−30 to D−4, CRP kinetics
(expressed as slopes – rate of concentration change per day) was
−1.5 mg/L/day. From D−3 to D1, CRP slope increased to 36.3 mg/L/
day. For albumin, the slope between D−30 to D−2 was 0.1 g/L/day
and changed to −1.8 g/L/day between D−1 and D1.
CONCLUSION. We showed that biomarker levels, used as surrogates
of host inflammatory response, begin to change some days before
the CA-BSI diagnosis, CRP 3.1 days and PA 1.3 days before.
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Fig. 1 (abstract 000149). Alluvial plot showing the change of
membership between C and CM phenotypes (panel A); 28-day
mortality by phenotype (panel B)
Page 69 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. The ideal study cohort should have the same num-
ber of biochemical specimens with equal time intervals between all
specimens (as in well-designed prospective studies). This is a limita-
tion of population-based studies with different numbers of samples
per patient and highly variable time intervals between specimens. To
date no study has assessed trajectories of C-reactive protein (CRP)
and plasma albumin (PA) levels in real-life data around Community-
Acquired Bloodstream Infections (CA-BSI).
OBJECTIVES. To assess trajectory patterns of CRP and PA levels be-
fore and after CA-BSI.
METHODS. Population-based study, with 2418 CA-BSI patients, CRP
and PA specimens from 30 days before through 30 days after CA-BSI
episode (day 0). Subgroups were established based on whether spec-
imens were occurring or not in days -30/-1, 0, 1/7 or 8/30. Mean daily
CRP and PA levels on day -30/30 were computed for each subgroup.
RESULTS. Mean CRP rose on day -5 and reached its peak on day 1.
Mean steady PA on day −30/0 declined abruptly on day 1 and in-
creased slowly thereafter. Trajectories did not differ between sub-
groups, in other words the course of CRP and PA around the BSI
episode was independent of the number of specimens. 30-day mor-
tality odds ratios for age, gender, co-morbidity, bacteria group, sepsis
status, and albumin level did not change materially when amending
0 versus ≥1 specimen in day -30/0 to the multivariate model, though
the subgroup with ≥1 specimen had 50% higher mortality.
CONCLUSION. Trajectories of CRP and PA levels around CA-BSI did
not differ in relation to number of specimens from each patient. This
enables longitudinal analyses of real-life data in population-based
studies.
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INTRODUCTION. There is wide heterogeneity in sepsis. The identifica-
tion of sepsis phenotypes may lead to more precise therapy. The
contribution of pathogen data to sepsis phenotypes is unknown.
OBJECTIVES. We aim to assess the effects of adding microbiological
variables on clinical phenotypes determined using clinical data alone.
METHODS. We conducted a secondary analysis of data from the Re-
combinant Human Activated Protein C Worldwide Evaluation in Se-
vere Sepsis (PROWESS) Study. We used latent class analysis (LCA) to
identify phenotypes using 24 clinical-only variables (C) (including
demographic variables, vital signs, markers of inflammation and
organ dysfunction) versus 24 clinical and 3 microbiological variables
(e.g. sites of infection, type of pathogen, and drug resistance) (CM)
using measurements collected prior to randomization. We assessed
model fit using Bayesian Information Criteria (BIC), entropy, and the
probability of cluster membership. We describe clinical characteristics
and outcomes of phenotypes before and after adding microbiology
variables. We tested for heterogeneity of treatment effect of acti-
vated protein C (APC) by phenotype using logistic regression.
RESULTS. Among 1,690 septic patients enrolled in the PROWESS
study, we identified an optimal 4-class model for both C and CM vari-
ables. In clinical-only phenotypes, the α-type (N=327, 19.4%) was
younger and had more pulmonary dysfunction; the β-type (N=518,
30.7%) was old and had greater comorbidity; the γ-type (N=532,
31.5%) had more pulmonary dysfunction; the δ-type (N=313, 18.5%)
had more liver, renal, and hematologic dysfunction and shock. Micro-
biological variables rearranged 772 of 1690 (45.7%) patients (Figure1A) and increased the median probability of the clustering across 4
groups from 0.952 to 0.971. When microbiology was added to clinical
variables, the β-type had more abdominal infection (from 19.7 to
40.1%), while γ-type had increased lung infection (from 50.4 to
77.8%). The 28-day mortality was significantly different across pheno-
types (both chi2 P<0.001), but was similar between C and CM models
(Figure 1B). No heterogeneity of treatment effect by phenotype was
present with either C (P value for interaction=0.25) or CM models (P=
0.40). However, the treatment effect of APC in γ-type significantly
changed from benefit (P=0.04) to neutral (P=0.73) when microbio-
logical variables were added.
CONCLUSION. Compared to sepsis phenotypes determined using
clinical data alone, the addition of microbiological variables such as
site of infection or type of pathogen revised phenotype membership,
increased the probability of cluster members, and contributed to
clinically meaningful rearrangement of sepsis patients. Microbiology
data are an important domain for the investigation of sepsis
phenotypes.
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Page 70 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. NP is a frequently occurring healthcare-acquired in-
fection often caused by gram-negative pathogens and associated
with high mortality rates. Rapid initiation of appropriate antibacterial
therapy is key to improving survival, especially in patients (pts) with
sepsis. In the recently completed, randomized double-blind, multi-
center, phase 3 ASPECT-NP trial, C/T (at double the currently ap-
proved dose) was noninferior to MEM for ventilated NP in both pri-
mary and key secondary endpoints.
OBJECTIVES. Retrospectively evaluate outcomes in pts from ASPECT-
NP who had greater severity of illness and organ failure, by SOFA
component scores.
METHODS. Mechanically ventilated pts with NP were randomized
1:1, stratified by NP type (ventilator-associated pneumonia [VAP] vs
ventilated hospital-acquired pneumonia [vHAP]) and age (<65 y vs
≥65 y), to receive 3 g C/T or 1 g MEM, by 1-h IV infusions every 8 h
for 8-14 d. The primary endpoint was 28-d all-cause mortality in the
intent-to-treat (ITT) population, and the key secondary endpoint was
clinical response at test-of-cure (TOC; 7-14 d after end-of-therapy in
the ITT population). SOFA scores were collected at baseline. We con-
ducted a post-hoc analysis comparing outcomes by treatment arm in
pts with a SOFA respiratory component score ≥2 (RS2) and in pts
with a cardiovascular component score ≥2 (CVS2), regardless of their
other component scores.
RESULTS. The majority of ITT pts in this trial met one or both SOFA
score criteria, with distributions balanced across arms: in the C/T arm,
312/362 (86.2%) had RS2 and 84/362 (23.2%) had CVS2; in the MEM
arm, 321/364 (88.2%) had RS2 and 99/364 (27.2%) had CVS2. In the
CVS2 subgroup, 69 (82.1%) C/T and 91 (91.9%) MEM pts also had
RS2. Baseline characteristics, including causative pneumonia patho-
gens (mostly Enterobacteriaceae and Pseudomonas aeruginosa), were
generally similar between both subgroups and across treatments.
Clinical outcomes in both the RS2 and CVS2 subgroups were compar-
able between C/T and MEM (Table). In RS2, outcomes were consist-
ent with the previously presented overall ITT results (i.e., 28-d
mortality ~25% and TOC clinical cure ~55% in both arms). As ex-
pected, mortality rates in pts with shock (i.e., CVS2) were slightly
higher than in the overall ITT population.
CONCLUSION. These data confirm that ASPECT-NP enrolled a
critically-ill patient population, reflected in the prevalence of acute
lung injury (RS2) and shock (CVS2). In these retrospective analyses,
28-d mortality and TOC clinical cure rates were generally not affected
by severity of illness. Furthermore, greater severity of illness did not
affect the relative efficacy of C/T vs MEM in these high-risk patients
with gram-negative ventilated NP.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000181INTRODUCTION. In the Sepsis 3.0 definition, sepsis is only divided
into 2 groups: sepsis and septic shock. Septic shock is still one of the
most major causes of intensive care unit (ICU) admission and death
in the world[1,2]. However, in Sepsis 3.0, it didn’t tell us what the ac-
curate mean of adequate fluid resuscitation and provide an objective
and detectable indicator in septic patients.
OBJECTIVES. Our aim in the present study was to evaluate the diag-
nostic effect of SOFA on septic shock in septic patients.
METHODS. Firstly, we conducted a retrospective study of patients
with sepsis diagnosis admitted to the ICU using the MIMIC-III
database. They were divided into septic shock and non-shock
based on ICD-9 and SOFA≥2. The multivariate logistic regression
analysis was used to find out the independent risk factors affect-
ing the incidence of septic shock. ROC curve was used to analyze
those risk factors, SOFA, qSOFA, SAPS and SAPSII. What’s more,
we collected clinical data of sepsis and septic shock patients
from three different hospitals within 24 hours after admission.
SOFA, qSOFA, SAPS II and APACHE II were also compared with
ROC curve analysis.
RESULTS. A total of 5724 patients were enrolled in MIMIC-III, with
2811 in septic shock group and 2913 in non-septic shock. The re-
sult of multivariate logistic regression analysis indicated that lac-
tate and SOFA were the independent risk factors (p<0.05). The
result of ROC analysis showed that the AUC of pH-value, lactate
and BUN were 0.587, 0.553 and 0.539. SOFA had the best predict-
ive effect with the statistical results of AUC (0.643) (95%CI 0.550–
0.723, p=0.001), sensitivity (0.620), specificity (0.600); and also
shown that SOFA ≥7 meant the patients have supposed to be
septic shock. Secondly, SOFA, qSOFA, SAPS II and APACHE II were
also compared with ROC by our multicenter data. A total 216 pa-
tients were enrolled in our data, with 80 septic shock group and
136 in sepsis. It also shown that SOFA have a higher diagnostic
efficiency (AUC=0.687, 95%CI 0.550–0.723, sensitivity=0.727, speci-
ficity=0.601, p=0.002) than qSOFA (AUC=0.666, 95%CI 0.582–
0.750, p<0.001), SAPS II (AUC=0.642, 95%CI 0.559–0.724, p=0.001)
and APACHE II (AUC=0.642, 95%CI 0.558–0.727, p=0.001) within
24 hours after admission. It also indicated that SOFA ≥8 meant
the patients have supposed to be septic shock。
CONCLUSION. SOFA score is the best choice for diagnosing the pos-
sibility of septic shock. Our findings suggest that the SOFA≥8 within
24 hours after admission in ICU provides better diagnostic effect for
septic shock in septic patients.
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Page 71 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. Prompt initiation of appropriate empiric antimicro-
bial therapy decreases mortality and improve clinical outcomes. How-
ever, the excessive use of antibiotics has been associated with
antibiotic resistance that has been linked to increased morbidity and
mortality. This study evaluated the appropriateness of empiric anti-
microbial therapy in patients with severe sepsis and septic shock
OBJECTIVES. The objective of the study is to evaluate the appropri-
ateness of empiric antimicrobial therapy in patients with severe sep-
sis and septic shock admitted to intensive care
METHODS. This retrospective study included adult patients admitted
with severe sepsis and septic shock to a 16-bed intensive care unit
(ICU) at a tertiary care facility in the eastern province, Saudi Arabia.
The ICU database was utilized to identify all patients who had an ad-
mission diagnosis of severe sepsis or septic shock in 2015, which was
defined based on the 2012 Surviving Sepsis Campaign guidelines.
Demographic data, empiric antimicrobials, source of infection, and
results of antimicrobial sensitivity testing were recorded. The primary
goal was the appropriateness of empiric antimicrobial therapy in se-
vere sepsis and septic shock patients initiated within 24 hours of ICU
admission against the isolated organisms
RESULTS. A total of 98 ICU admissions were included, among whom
70 (71%) had septic shock while the remaining had severe sepsis.
Among the patients, 57 were males, 53 (54%) had malignancies and
the mean age was 55 years. The most common sources of infection
were pneumonia (35, 36%), intra-abdominal (24, 24%), bacteremia
(14, 14%), urinary tract (8, 8%), and skin/soft tissue (7, 7%). Cultures
were positive in 47 episodes (48%). Empiric antimicrobial therapy
was appropriate in 48 out of 55 (87%) the total isolates causing infec-
tions. Only 13% of the isolated organisms were resistant to initial em-
piric therapy, of which three isolates were carbapenem-resistant
Pseudomonas aeuroginosa. There was a single isolate of carbape-
nemresistant Klebsiella pneumoniae, carbapenem-resistant Acineot-
bacter baummannii, methicillin-resistant Staphylococcus aureus and
candida glabrata. The most frequently prescribed antibiotics were
vancomycin prescribed in 66 (67%) cases, carbapenems in 59 (60%)
cases followed by piperacillin/tazobactam (n=37, 38%), amikacin (n=
21, 21%), and levofloxacin (n=13, 13%). There was a variation as re-
gard to patients type, inappropriateness of empirical antimicrobial
was relatively highest among oncology patients (p= 0.025)
CONCLUSION. The majority of the patients in this study received em-
piric antimicrobial therapy for which the pathogens identified were
susceptible to. Institutional antibiotic susceptibility profile should be
considered in optimizing empirical antibiotics therapy in settings
with a high rate of resistance.
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INTRODUCTION. Disseminated intravascular coagulation (DIC) is one
of the major causes of organ dysfunction and death in sepsis; how-
ever, there are no standard criteria for DIC. Recently, sepsis-induced
coagulopathy (SIC) was developed as a new criterion for coagulopa-
thy of sepsis. It includes the sequential organ failure assessment
(SOFA), similarly the new definition of sepsis revised in 2016. Previ-
ous studies suggested that SIC score might be a prognostic value for
patients with sepsis and coagulopathy.
OBJECTIVES. To evaluate the generalizability of SIC score as a prog-
nostic value generally for patients with sepsis.
METHODS. Data from a multicenter observational study (Japan Sep-
tic Disseminated Intravascular Coagulation [JSEPTIC-DIC] study),
which investigated patients with sepsis in 42 intensive care units
from 2011 to 2013, were analyzed. This contained information about
patients’ backgrounds, examination results, treatments, and mortality.
Primary outcome measure was in-hospital mortality. SIC score, Japa-
nese Association for Acute Medicine (JAAM) DIC score, and the Inter-
national Society of Thrombosis and Haemostasis (ISTH) DIC score
were calculated. Then, patient characteristics and other variables for
survivor and non-survivor groups were compared, using χ2 test or
Fisher’s test. Finally, receiver operating characteristic (ROC) analysis
was performed by estimating the corresponding areas under the
curve (AUC).
RESULTS. This study included 2283 patients (mean age, 68.7
years; standard deviations [SD] 14.6); 1364 were males (59.7%). All-
cause mortality rate was 32.1%. The mean APACHE II score was 23.4
(SD 8.8) and the mean SOFA score was 9.7 (SD 4.1). A total of 1647
patients (72.1%) were diagnosed with SIC – 1291 patients (56.5%)
were positive JAAM DIC and 727 patients (31.8%) met the ISTH DIC
criteria. The proportion of the JAAM DIC and ISTH DIC were signifi-
cantly higher in non-survivor group (66.5% vs 51.8% p<0.01, 43.7%
vs 26.2% p<0.01, respectively); however, there was no statistically sig-
nificant difference in SIC score between non-survivor and survivor
groups (74.2% vs 71.2%, p=0.07). ROC curve showed that AUC for
SIC, JAAM DIC, ISTH DIC, APACHE II, and SOFA scores were 0.52 (95%
confidential interval [CI], 0.49-0.54), 0.57 (95%CI, 0.55-0.60), 0.59
(95%CI, 0.56-0.61), 0.72 (95%CI, 0.70-0.74), and 0.71 (95%CI, 0.69-
0.74), respectively.
CONCLUSION. Generally, SIC score might not be a good prognostic
value for mortality among sepsis patients.
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INTRODUCTION. Sepsis is reported to affect more than 30 million
people every year and is a priority on the global health agenda.[1,2]
It is estimated that 70% of sepsis is community-onset while 30% is
health care-associated (HA).[2] However, there has been only one
study conducted to estimate the global sepsis burden, and specific-
ally, the global burden of HA sepsis as compared to community-
onset is still not well understood. A systematic review was conducted
to assess the burden of HA sepsis and its epidemiology.
METHODS. The following electronic bibliographic databases were
searched from 1 January 2000 to 31 December 2017: MEDLINE,
EMBASE, Global Index Medicus, and PubMed. Epidemiological studies
that described the incidence or prevalence of HA sepsis were in-
cluded. Languages were restricted to English, French, Spanish, Arabic,
Russian, German, Italian, Japanese, and Portuguese. Title/abstract
screening, full-text screening, and data extraction were conducted by
at least two reviewers. The study was registered to PROSPERO
(CRD42018089554).
RESULTS. Title/abstract screening and full-text screening was per-
formed for 8922 and 1772 studies, respectively. Among these, 4
population-based studies and 12 hospital-based studies with clear
definitions of HA sepsis were identified. Studies came from 13 coun-
tries, including 38.5% from low- and middle-income settings, and 4
geographic regions. Two population-based studies focused on a
pediatric population; incidence of HA sepsis ranged from 1.28-6.88
cases per 100,000 population-years. Two studies focused on an adult
population including 1 study which defined only severe sepsis and
septic shock; incidence of HA sepsis ranged from 12.28-13.92 cases
per 100,000 population-years. The proportion of HA sepsis out of all
sepsis cases ranged from 22.8% to 49.1%.
CONCLUSION. Our systematic review highlighted the important epi-
demiological burden of HA sepsis. HA infections leading to sepsis are
preventable, and infection prevention and control measures remain
important to mitigate the sepsis burden in the healthcare setting.
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INTRODUCTION. Septic shock has growing incidence and mortality
rates above 50%. Impairment of immune defences may be common
among this patients and underpin the development of unfavourable
outcomes1. Immunoglobulins deficit is related to higher mortality
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as adjunctive treatment with immune-adjuvant purposes. Nonethe-
less it was not clarified yet if Ig baseline titers can affect the outcome
in patients treated with IgGAM adjunctive treatment.
METHODS. We performed an observational retrospective study ana-
lysing a registry specifically conceived to collect information on im-
mune system’s functionality in patients undergoing septic shock.
Patients admitted to polyvalent intensive care unit of the University
Hospital of Modena from January 2014 to February 2019 with diag-
nosis of septic shock and who received adjunctive treatment with
polyclonal immunoglobulins enriched in IgM and IgA (IgGAM) were
included in the analysis. Patients <18 years, with an end-of-life deci-
sion or too sick to benefit and patients with no Ig titers measured at
baseline were excluded. The population was splitted in tertiles of
basal IgM titers. Survival ad day 30 from shock occurrence was com-
pared among the three groups.
RESULTS. 84 patients were included. Mean age was 65, median SAPS
II score at admission was 62 (IQR 48-76) and baseline SOFA score
was in median 11 (IQR 8-13), more common comorbidities were neo-
plasm, cirrhosis and diabetes. 12 patients had a previous state of im-
mune impairment due to haematological disease, HIV,
immunosuppressant or chemotherapic drugs. Overall 30-days mortal-
ity was 47.6% (40 patients). Median length of stay in ICU was 9 days
(IQR 6-19) and in hospital 22 days (IQR 11-38). IgM titers at T0 were
in median 49.5 (IQR 28.5-94). Tertiles division according to IgM basal
titers splitted the population using threshold values of IgM of 37 and
71 mg/dL. The three groups did not differ for age, sex, basal SAPS II
and SOFA score, immune impairment state, rate of nosocomial and
MDR infections and comorbidities except for cirrhosis, that was more
common in 3° tertile and hematologic diseases, more frequent in 1°
tertile. 30 days mortality in 1st, 2nd and 3rd tertile was 53%, 37%
and 51.9% respectively (P-value 0.407).
CONCLUSION. Patients with septic shock who received adjunctive
treatment with IgGAM had higher survival rates when IgM at admis-
sion had intermediate concentrations (from 37 to 71 mg/dL) com-
pared to lower or higher IgM titers. Further studies are needed to
clarify whether patients with normal or high levels of IgM at diagno-
sis do take advantage from Ig supplementation therapy.
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INTRODUCTION. Patients admitted in an intensive care unit (ICU) are
at the greatest risk of acquiring nosocomial infections. Infectious dis-
eases are associated with higher rates of morbi-mortality and hos-
pital and ICU length of stay (LOS).
OBJECTIVES. To identify the clinical and epidemiological features of
the infections registered in the ICU of Hospital Punta de Europa
using ENVIN database.
METHODS. Retrospective descriptive analysis was performed using a
prospective cohort of 330 patients obtained from a 12-
bedsICUcollected during the year 2018. Demographic variables, ICU
admission diagnoses and their origin (community, ward or another
ICU), risk factors, prognosis scores, ICU LOS, mortality, microorganism
isolated and antimicrobial therapy used were collected. Statisticalanalysis was performed: continuous variables (mean and standard
deviation), categorical variables (percentages and frequencies).
RESULTS. 330 patients were included: male (63.03%), age: 64 [±
15.22], SAPS II 35.78 [±16.23], APACHE II 15.73 [±7.94]. ICU LOS (days)
6.93 [±6.02]. ICU mortality: 88 patients (26.67%).Community-acquired
infections (64 patients, 19.39%): 18 non ventilator-associated pneu-
monias, 8 surgical infections, 8 soft tissue infections. Microbiological
isolation: E. coli(19.51%), H. influenzae(7.32%) and S. aureus(7.32%).
Antibiotic therapy: ceftriaxone (17.89%), piperacillin/tazobactam (PTZ)
(12.11%). Hospital-acquired infections outside the ICU (30 patients,
9.09%): 13 surgical related infections and 3 non ventilator-associated
pneumonia. Microbiological isolation: E. faecium(16.67%), E.
coli (13.33%) and Candida albicans(13.33%). Antibiotic therapy:
metronidazole(12.12%),ceftriaxone(11.11%).ICU-acquired infections
(20 patients, 6.06%): 11 ventilator-associated tracheobronchitis, 5
ventilator-associated pneumonia (VAP), 5 bacteremia due to intra-
abdominal infections and 3 catheter-related bloodstream infections
(CRBSIs):E. coli(12.90%), P. aeruginosa (12.90%) and S. aureus(12.90%).
Antibiotic therapy: levofloxacin (10.61%), PTZ (10.61%), linezolid
(10.61%). CRBSI: 1.36 per 1000 central venous catheter days. Isola-
ted:E. faecalis(33.33%), K. penumoniae(33.33%) and S. aureus(33.33%).
VAP: 168 patients under invasive mechanical ventilation (50.91%),
5.17 VAP per 1000 ventilator-days. 80% of the cases had not micro-
biological isolation.
CONCLUSION. Most of the infections registered were community-
acquired, being E. colithe most frequently isolated.E. coliand P. aerugi-
nosawere the most frequently detected pathogens in ICU-acquired
infections. About antibiotic therapy, ceftriaxone, PTZ, levofloxacin
and meropenem were more frequently used.
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INTRODUCTION. Aspiration pneumonia (AP) is a frequently sus-
pected complication of drug overdose requiring mechanical ventila-
tion (MV) and admitted to intensive care unit (ICU) (1). In the
absence of reliable biomarkers for distinguishing between aspiration
pneumonia and aspiration pneumonia, antibiotic therapy is fre-
quently prescribed (2). Latest studies suggest that a care protocol
could better select patients requiring antibiotic therapy (3).
OBJECTIVES. To determine the impact of a care protocol on the anti-
biotic prescription among patient admitted to ICU for toxic coma
with MV.
METHODS. We conducted a prospective observational cohort study
in four ICU. We included all patients admitted for toxic coma with
MV. In the University-affiliated ICU, a care protocol was applied. In
the three others ICU, physicians declared that they did not follow for-
malized conduct within the service and did as usual.
RESULTS. We included 43 patients in care protocol group and 42 in
control group. The mean SAPS II was 43.3 (±15.3) with a mean Glas-
gow Coma Scale score at 4.9 (±2.1) before intubation. Within the
total population, 40 patients (47%) had a pulmonary bacteriologic
sample (PBS), mostly because purulent tracheobronchial aspirate and
Page 74 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55new infiltrates on the chest X-ray (respectively 36.4% and 29.4% of
the population with a bacteriological sample). Among the patients
with a bacteriological sample, 34 (85%) were culture positive. The in-
cidence of probabilistic antibiotherapy did not differ between the
care protocol group (n=16) and the control group (n=16). There was
no difference for the incidence of PBS (20 in each group). The others
secondary outcomes did not differ either (Table 1).
CONCLUSION. Our study does not show that a care protocol allows a
reduction of antibiotic prescription among patient admitted to ICU
for toxic coma with MV. Our incidence of antibiotic prescription is
lower than the previous studies (4). The absence of difference can be
explain by two reasons: some of physicians of control group had
been trained in the university-affiliated ICU in the last years and may
follow a management approach similar to that of the control group;
despite our precautions, the existence of the study could have mod-
ify the practices in the control group.
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Incidence of probabilistic antibiotherapy,
n (%)
16 (38.1) 16 (39) 0.93
Incidence of antibiotherapy within 12
hours after intubation, n (%)
3 (7.7) 7 (16.6) 0.16
Incidence of PBS, n (%) 20 (46.5) 20 (47.6) 0.91
MV-free days by day 28 (d), mean ± SD 25.3 (4.5) 25.6 (2.4) 0.73
Antibiotherapy-free days by day 28 (d),
mean ± SD
25.3 (3.8) 25.4 (3.2) 0.87
Length of stay in ICU (d), mean ± SD 4.6 (8.5) 3.8 (3) 0.57
Mortality in ICU, n (%) 0 2 (4.7) 0.49000309
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INTRODUCTION. There remains no specific effective therapy for sep-
sis, thought to be due to heterogeneity within the syndrome. How-
ever, recent transcriptomic work has identified two distinct sepsis-
response-signature (SRS) profiles; with SRS1 being associated withincreased mortality compared to SRS2 [1, 2]. The genes that are
differentially expressed between these two groups are involved in
a range of immune processes, the functional implications of
which are not yet understood, although SRS1 appears to be the
relatively immunosuppressed endotype compared to SRS2. Mono-
cytes are implicated in the pathogenesis of sepsis through direct
involvement in the innate and modulation of the adaptive im-
mune responses.
OBJECTIVES. The same SRS endotypes have been identified using
transcriptomic methodology applied to samples collected from pa-
tients with septic shock from the VANISH trial [3, 4]. This aim of this
study was to condition healthy monocytes in plasma taken from
these patients, to model septic monocytes, and assess their func-
tional status via surface phenotype and phagocytic activity, which
may explain the some of the differences between SRS endotypes.
Cell surface markers of interest included those involved with defining
monocyte subsets (CD14, CD16), antigen presentation (HLA-DR),
apoptosis (MerTK) and costimulation (CD86, PD-1, PDL-1).
METHODS. Healthy monocytes were obtained from fresh whole
blood using a two step process of density-gradient centrifugation to
isolate peripheral blood mononuclear cells, and then magnetic cell
sorting to isolate CD14+ monocytes. These were conditioned over-
night in complete media and either SRS-profiled or healthy volunteer
plasma (previously frozen).
Fluorochrome associated antibodies were used to assess surface
phenotype and fluorescent E. coli bioparticles for phagocytic activity.
Results were acquired by flow cytometry, and analysed with FlowJo
V10. Fluorescent activity was reported as percentage of cells positive
(PP) or geometric mean fluorescence intensity (GMFI). Statistical ana-
lyses were performed using Graphpad Prism 8.0.2.
RESULTS. CD14+ monocytes were conditioned using plasma samples
from 28 SRS1 and 28 SRS2 patients with septic shock recruited to the
VANISH trial, and 7 healthy volunteers. There were no significant dif-
ferences in baseline characteristics between the two groups. The
most marked difference in monocyte function was increased expres-
sion of CD14 in SRS1 (PP 39.3% vs 23.4%, p < 0.01), and increased ex-
pression of PD-1 in SRS2 (PP 18.2% vs 11.7%, p < 0.05). No difference
in phagocytic activity was seen between the two SRS groups. Serum
cytokine levels were compared between the two profiles (from the
same plasma samples), with increased levels of IL-6, IL-10 and MCP-1
in SRS1 (p < 0.01).
CONCLUSION. These results indicate that the transcriptomic differ-
ences that distinguish SRS1 and SRS2 translate to the cellular level,
with the main finding being increased CD14 expression on healthy
monocytes conditioned in SRS1 plasma. In this in vitro model, it
could be assumed that this is an effect of the increased cytokine
levels found in SRS1 plasma. However, in vivo this may instead repre-
sent a greater proportion of ‘classical’ monocytes, producing more
cytokines. This should be validated by performing similar immuno-
phenotyping on monocytes taken directly from patients who have
been SRS-profiled.
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INTRODUCTION. Organ dysfunction during sepsis or septic shock
may alter antibiotic drug concentrations via changes of drug distribu-
tion and elimination. We therefore studied the pharmacokinetics of
meropenem in critically ill patients with acute-on-chronic liver failure
(ACLF) and without concomitant liver failure (NLF) during continuous
venovenous hemodialysis (CVVHD).
METHODS. In this prospective cohort study, all patients received
meropenem 1g tid. Meropenem pre- and postfilter serum and ultra-
dialysate samples were obtained at the following time points: T0, T1,
T2, T4, T8, T24, T25, T48, T49 and analyzed by high pressure liquid
chromatography with diode array detection (HPLC-DAD). Nonlinear
mixed-effects modelling was performed in NONMEM® 7.3.
RESULTS. 19 patients were studied. Of these, 8 patients suffered
from ACLF. A two-compartment model with linear clearance (CL)
from the central compartment adequately described meropenem
pharmacokinetics in both patient populations. CL was 5.2 L/h with a
coefficient of variation of 28%. The population estimate of the per-
ipheral volume of distribution (Vd) was 19.7 L for critically ill patients
without liver failure and 38.6 L for the ACLF-population (p = 0.05). De-
terministic simulations of meropenem concentration over 24 hours
using typical parameter values for NLF and ACLF showed differences
in trough levels that decreased with consecutive doses.
CONCLUSION. Patients with ACLF receiving CVVHD have a higher Vd
and may require a higher initial dose of meropenem to reach micro-
biological defined targets (i.e. time above minimal inhibitory concen-
tration) compared to critically ill patients without ACLF undergoing
CVVHD.
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INTRODUCTION. Early mobilization prevents muscle atrophy and
functional disability in critically ill patients, while its implementation
is challenging due to the severity of illness and limited resources.
Electrical muscle stimulation (EMS) evokes muscle contractionwithout input from the central nervous system, and it can be applied
to critically ill patients. However there has been much debate if EMS
improves functional ability of the patients.
OBJECTIVES. To investigate if early EMS on upper and lower limb
muscles prevents muscle atrophy and improve physical function in
critically ill patients.
METHODS. We included consecutive adult patients admitted to ICU
and expected to be mechanically ventilated longer than 48 hours
and to stay more than 5 days. The patients were randomly assigned
to EMS or control group. EMS was applied with a low-frequency ther-
apy equipment (Solius, Minato Medical Science Co., Ltd, Osaka,
Japan). EMS group of patients received EMS sessions of bilateral
upper and lower extremities daily for 30 min from day 1 to 5 in
addition to the usual rehabilitation. Patients in control group re-
ceived only the usual rehabilitation. The primary outcome was the
change of upper and lower limb muscle thickness and cross-
sectional area, measured by ultrasound from day 1 to 5. The second-
ary outcomes were Medical Research Council score and the inci-
dence of ICU-acquired weakness at day 5, and ICU Mobility scale at
the discharge from the ICU.
RESULTS. Thirty-seven patients were enrolled, and 4 patients were
excluded (death, pain, and insufficient muscle contraction due to
edema or obesity). Fourteen patients in EMS group and 19 in the
control group were evaluated. Mean age was 73±3 vs. 66±3 years,
(p=0.16), and median APACHE II score was 23(18-28) vs. 22(19-30)
(p=0.94) in EMS and in control, respectively. The change of thickness
in upper limb muscle was -1.0±2.5% vs. -11.2±2.1% (p<0.01), and in
the lower limb was 3.2±3.7% vs. -14.7±3.2% (p<0.01), the change of
cross-sectional area in upper limb muscle was -5.0±3.6% vs. -10.0±
2.4% (p=0.18), and in the lower limb was -1.0±3.4% vs. -10.4±2.9%
(p=0.046) in EMS and in control, respectively. There was no signifi-
cant difference in Medical Research Council score (54±4 vs. 46±4, p=
0.18), ICU-acquired weakness (13% vs. 40%, p=0.20), and ICU Mobility
scale (2.2±0.5 vs. 1.5 ±0.5, p=0.31) between EMS group and the con-
trol group.
CONCLUSION. In critically ill patients, EMS on upper and lower limb
muscles preserved muscle mass. Further research should be done to
clarify if EMS improves physical function and long-term outcomes.
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INTRODUCTION.Introduction: Hyperglycemia is a compensatory meta-
bolic response to acute stress. It reflects the development of insulin
resistance to preserve life during life-threatening conditions, but is
associated with worse prognosis during critical illness (1, 2).
OBJECTIVES.Objectives: The aim of the present study is to investigate
the association of glycemic parameters at intensive care unit (ICU)
admission with outcomes in critically ill patients.
METHODS.Methods: From September 2017 to February 2018, adult
critically ill patients admitted to ICU were prospectively included in
the study. Blood samples were collected at study entry for random
blood glucose and glycated hemoglobin (HbA1c) and were used to
calculate glycemic gap and stress hyperglycemia ratio (SHR). All pa-
tients were assessed for presence of hyperglycemia (>140 mg/dL at
admission), hypoglycemia (<70 mg/dL in 24h) and glycemic variabil-
ity (higher - lower capillary glucose in 24h).
RESULTS.Results: A total of 542 patients were enrolled (mean age 59;
30% with previous diabetes) and were followed until hospital dis-
charge or death for 180 days. Hypoglycemia was associated with in-
creased mortality (54.8% vs. 35.8%, p=0.004), need for renal
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ventilation (MV; 72.6% vs. 57.5%, p=0.024) and higher shock inci-
dence (62.9% vs. 35.8%, p<0.001). Hyperglycemia was associated
with higher mortality (44.3% vs.34.9%, p=0.031) and increased need
for MV (66.1% vs. 55.7%, p=0.018). Patients with glycemic gap >80
mg/dL had increased need for RRT (37.7% vs. 23.7%, p=0.025) and
higher shock incidence (54.7% vs. 37.4%, p=0.014), but no difference
in mortality. SHR >1.1 was associated with increased need for MV
(65.8% vs. 2.8%, p=0.001). Glycemic variability was associated with an
increased need for RRT (28.3% vs. 14.4%, p=0.002, for variability >40
mg/dL; 31.6% vs. 16.6%, p<0.001, for variability > 60 mg/dL and 34%
vs. 18%, p<0.001, for variability > 80mg/dL) and higher shock inci-
dence (41.4% vs.31.2%, p=0.039, for variability >40 mg/dL; 42.9% vs.
34%, p=0.034, for variability >60 mg/dL; and 64.2% vs. 55.9%, p=
0.010, for variability >80 mg/dL). The associations of hypoglycemia
and hyperglycemia with mortality remained after adjustments for dis-
ease severity.
CONCLUSION.Conclusions: In this sample of medical-surgical critically
ill subjects, including patients with and without previous diagnosis of
diabetes, hypoglycemia and hyperglycemia were independently as-
sociated with increased mortality, while glycemic variability, glycemic
gap and SHR were associated with worse outcomes, such as shock
incidence, need for RRT and need for MV, but not with mortality.
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INTRODUCTION. Micronutrients included in nutritional support have
a central role in maintaining human physiological functions.
OBJECTIVES. The aim of this study is to identify serum micronutrient
levels in patients who are transferred from intensive care unit (ICU)
towards and their relation with 90-day mortality rate and re-
admission to ICU.
METHODS. This study was conducted prospectively in Erciyes Univer-
sity Medical ICU. Patients who are above 18 years old and stayed in
the ICU more than 48 hours and then transferred to a ward were in-
cluded into the study. Blood samples for micronutrient levels were
taken at the time of transfer.
RESULTS. We enrolled 100 patients. Mean APACHE II score was 15.4±
7.8. Median SOFA score at the time of discharge from ICU was 3
(range 0-7). The route for nutrition was oral in 41%, enteral in 21%,
oral plus parenteral in 18%, parenteral in 17% and oral plus enteral
in 3% of the patients in last day ICU. Low levels rate of thiamine(98%), vitamin B6 (98%), vitamin B12 (11%), copper (21%), zinc (90%),
selenium (36%), chromium (98%), and cobalt (35%) were identified in
the patients. Low levels of vitamin B6 was an independent risk factor
for 90 day mortality and re-admission to the ICU in multivariate ana-
lysis (OR: 0.283, CI 95%:0.099-0.812, p: 0.019 OR: 0.231 CI 95%:0.071-
0.745, p: 0.014 respectively). Median duration of ICU stay was
5.5(range 3-32) days. Re-admission rate to the ICU within 90 days
was 24% and 90 day mortality rate was 29%.
CONCLUSION. Vitamin B1, B6, zinc and chromium levels were very
low rate in these patients. Low levels of vitamin B6 identified as an
independent risk factor for 90 day mortality rate and re-admission to
the ICU.
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INTRODUCTION. Critically ill patients are at risk of significant nutri-
tional deficits leading to delayed recovery. Nutritional support has
been shown to improve outcomes in these patients(1).
Parenteral nutrition (PN), intravenously administered artificial nutri-
tion, is often thought to ensure secure delivery of the prescribed nu-
trition. However, studies have demonstrated a discrepancy between
the amount of PN prescribed and the amount received(2). In critical
illness, immobilisation and increased inflammatory and stress re-
sponses mean that the catabolic response to an energy deficit is
much greater than in a healthy fasting person. If these patients miss
periods of their PN prescription, they will accumulate a caloric deficit
which can rapidly reach levels that contribute to skeletal muscle loss
and impaired healing. This in turn leads to prolonged intensive care
unit (ICU) admission and rehabilitation(3).
OBJECTIVES.
1. To identify whether the amount of PN received by patients in
the Royal Surrey County Hospital (RSCH) ICU matches the
number of hours prescribed
2. To identify the causal factor in instances where 100%
of prescribed PN is not received
3. To identity the type of vascular access by which the PN is
being administered, and whether this affects the amount of
PN received
METHODS. Retrospective data collection from all patients admitted
to RSCH ICU who received PN during the 6 month period between
1st April and 31st September 2018. The number of hours of PN pre-
scribed each day and the number of hours received each day were
recorded. The reason for any deficit was documented where 100%
administration was not achieved. First bag prescription start time
was taken as 19.00 (2 hours after routine delivery from pharmacy).
RESULTS. 637 patients were admitted to RSCH ICU during this
time. 77 (12%) were prescribed PN. 9395 hours of PN were
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were missed. The reasons for the missed hours are displayed in
Figure 1. PN was administered via central venous catheter (CVC)
in 62 patients (81%), peripherally inserted central catheter (PICC)
in 10 patients (13%) and peripheral cannula (PC) in 5 patients
(6%). The mean percentage delivery for each access type is
shown in Table 1.
CONCLUSION. The largest reason for PN deficit was the first PN bag
being started late. This was due to a combination of factors: phar-
macy delivery time, time required for PN to return to room
temperature, and nursing handover time. This has identified an area
for an improvement initiative that we are implementing to enable
the PN bags to be started earlier. Also, our results suggest PN may
be received more consistently via a PICC vs other types of access,
but a larger study with greater statistical power would be required to
investigate this further.
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Type of Vascular Access Number of patients Mean PN delivery
Central Venous Catheter (CVC) 62 95%
Peripherally Inserted Central Catheter
(PICC)
10 99%
Peripheral Cannula (PC) 5 92%
Total (all access types) 77 97%000274
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INTRODUCTION. Feeding intolerance is common in acute respiratory
distress syndrome (ARDS) patients with the prone position. Prone
position has been proved to improve mortality in ARDS patients but
only a few small sample sized studies talked about the feeding ad-
equacy in these patients. In literatures, there was no outcome differ-
ence regarding feeding amount of ARDS patients. However, the
optimal amount of caloric intake for ARDS patients with the prone
position is still unknown. We hypothesize adequate caloric delivery
influence clinical outcomes in ARDS patients received prone position
therapy.
OBJECTIVES. We retrospectively collected patients’ data from Sep
2015 to Nov 2018 in medical intensive care units at a tertiary medical
center. The inclusion criteria were age older than 20 years old, ARDS
defined by Berlin criteria, ICU stay more than 48 hours, received
mechanical ventilation and prone position therapy. Exclusion criteria
were any non per os order by physicians.
METHODS. Data collection including demographic data, BMI, calories
of parenteral nutrition(PN), enteral nutrition(EN) and hospital mortal-
ity, etc. Nutritional risk was evaluated by modified NUTRIC score. In
addition to descriptive analysis and univarate analysis, we used cox
regression modeling to control multiple variables and to calculate
95% confidence intervals.
RESULTS. There were 110 patients enrolled in the study. The hospital
mortality rate was 58% (64/110). The average age was 61±17 years
old and APACHE II score was 31±7. The first 7 days average EN calo-
ries intake were higher and PN calories intake were lower in survival
group. (EN: 672 kcal/day vs 547 kcal/day, p=0.03; PN: 103 kcal/day vs
179 kcal/day, p=0.001). The cutoff value of average EN calories intake
higher than 564 kcal/day and PN calories intake less than 79 kcal/day
have the lowest mortality by receiver operating characteristic(ROC)
curve analysis. (p<0.05) In cox regression model, EN calories supple-
ment more than 564 kcal/day (HR:1.85, 95% CI:1.10-3.13, p<0.021)
and PN calories supplement less than 79 kcal/day (HR:0.52, 95%
CI:0.29-0.94, p<0.03) decreased hospital mortality after adjust poten-
tial confounders.
CONCLUSION. In order to decrease hospital mortality in ARDS pa-
tients with the prone position, enhance caloric intake from enteral
nutrition rather than parenteral nutrition should be considered.
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INTRODUCTION. Our aim was to analyze plasma levels of vitamins A,
B6, C, E and zinc in septic patients, and to determine their impact on
patient’s outcome.
METHODS. Observational and prospective study. Inclusion criteria:
patients admitted to the ICU due to sepsis (January-July 2018). We
analysed vitamins A, B6, C, E and zinc serum levels at ICU admission.
Statistical analysis: quantitative variables in means (SD) and medians
(min-max) according to their normality and qualitative variables in
proportions and 95% CI. Bivariate analysis: Kruskal-Wallis and khi-
square.
RESULTS. 37 patients (67.6% male). Median age was 62 years old
(45-69). SOFA at admission was 7 (3.5) and the APACHE II was 27
(9.9). They remained in the ICU for 8 days (1-53) and 22 days (1-132)
in the hospital. 5.4% of patients were re-admitted to the ICU. ICU
mortality was 10.8% (95% CI 3.9-26.5) and in-hospital mortality was
21.6% (95% CI 10.8-38.5).
CONCLUSION. 1) We found a remarkable deficit of all micronutrients
analysed, except for Vit E.
2) Septic patients with zinc deficiency had longer stays and higher
mortality in the ICU.
3) Vitamin deficiency was not associated with an increased mortality,
AKI or stay, in this small sample of septic patients.Table 1 (abstract 000304). See text for description
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Occurrence Low 20 (66.7%) 23 (74.2%) 26
(70.3%)
1 (3%) 27 (84.4%)





ICU Stay Low 7.5 (1-53) 5 (1-36) 11 (3-53) 12 8 (3-53)*
Normal 10 (3-21) 28 (3-53) 5 (1-45) 7 (1-53) 9 (4-13)
Hosp. Stay Low 25 (1-132) 21 (1-69) 27 (3-132) 16 29 (3-132)
Normal 33 (14-69) 33.5 (5-
132)




ICU Mort. LOW 4 (20%) 2 (8.7%) 2 (7.7%) 0 3
(11.1%)**





Low 6 (30%) 5 (21.7%) 5 (19%) 0 6 (22%)
Normal 1 (10%) 2 (25%) 3 (27%) 6
(20.7%)
0
AKI Low 12 (60%) 14 (61%) 18 (69%) 1 (100%) 17 (63%)
Normal 5 (50%) 3 (37.5%) 4 (36%) 16 (55%) 1 (25%)
* p 0.04 ** p 0.02000326
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INTRODUCTION. Augmented Renal Clearance (ARC) is currently de-
fined as a Glomerular Flitration Rate (GFR) greater than 130 mL/min/
1.73 m2. ARC is a phenomenon that can lead to therapeutic failure in
critically ill patients. Inadequate antibiotic dose may worsen sepsis
outcome and may increase resistance generation.
OBJECTIVES. To analyze clinical characteristics of patients with ARC in
comparison to patients with normal GFR (nonARC, 90-130 mL/min/
1.73 m2) admitted to the Intensive Care Unit (ICU), and to compare
the prescribed dose of antibiotics (AB), antiepileptic (AE) and diuretic
(DI) drugs between both groups.
METHODS. We set up 3 points of prevalence according to different
seasonal times, November'17, February'18 and May'18, with a follow-
up period of 2 months, measuring the GFR (mGFR) in 4-hour urine
collection twice a week. Inclusion criteria: Adult patients admitted to
the ICU with a bladder catheterization. Exclusion criteria: renal re-
placement therapy, bladder washings and absence of bladder
catheterization. Variables: patients' features and type and dose of
prescribed drugs were recorded. Statistical analysis: Pearson Chi-
square Test.
RESULTS. 18 hospitals were enrolled and 561 patients were included
(61% male) with a median age of 65.5 years old. At ICU admission
10.7% had already ARC. Overall, we found 31% ARC and 22% non-
ARC patients. Prescribed drugs: 67% AB, 17.5% AE and 41% DI. Mech-
anical ventilation was required in 64% and vasopressors agents in
51%. Median SOFA was 6. ICU mortality was 14% and in-hospital
mortality was 18%. Median ICU and hospital length of stay (LOS)
were 15 and 29 days, respectively. Median mGFR was 176 in ARC
and 106 mL/min/1.73 m2 in nonARC. ARC remained with GFR>130
for several days during their LOS. Bivariate analysis: ARC patients
were younger, 56.5 vs. 66 years (P<0.001). ICU mortality was 7% in
ARC vs. 14.5% in nonARC group (P=0.003) and in-hospital mortality
was 10% vs. 16% (P=0.001), respectively. ICU-LOS was 13 vs. 19 days
(P=0.028) and hospital-LOS was 27 vs. 33 days (P=0.022), respectively.
Regarding the use of drugs, neither the number nor the delivered
dose were different between ARC and nonARC groups.
CONCLUSION. 1) Up to 30% of ICU patients had ARC during ICU-LOS
and 10% had already ARC when admitted.
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ARC patients.
3) ARC patients were youger, had shorter LOS and lower mortality
than nonARC patients.
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INTRODUCTION. Sufficient nutrition is necessary to counteract catab-
olism in critical illness. Protein anabolism requires amino acid avail-
ability, one source of which is uptake from enteral nutrition.
Continuous enteral feeding is a common but unphysiological ap-
proach, and little is known about its effects on amino acid uptake.
OBJECTIVES. To characterize the time course of dietary amino acid
uptake into arterial plasma during continuous enteral feeding in ICU
patients and healthy subjects, using a stable-isotope-labeled phenyl-
alanine tracer as a specific indicator for dietary amino acids.
METHODS. 10 healthy subjects and 10 ICU patients were studied. Pa-
tients had invasive ventilatory support and ongoing enteral feeding
at >80% of energy expenditure. All subjects were given enteral nutri-
tion by constant continuous infusion via nasogastric tube or jejunost-
omy at ≥80% (patients) or 100% (healthy subjects) of energy
expenditure.
After a 12-hr equilibration period, a primed constant infusion of 13C-
phenylalanine (13C-Phe) was added to the enteral infusion. Arterial
blood samples were then drawn every 30 minutes for 12 hrs. For iso-
topic analysis, plasma samples were analyzed by gas
chromatography-mass spectrometry. Plasma aminograms were deter-
mined by HPLC.
RESULTS. Data are expressed as median (range). Patients' age was 64
(44-74) yrs, SAPS 3 score was 60.5 (57-85), primary diagnoses were
n=3 surgical, n=3 neurological and n=4 medical, and studies were
performed on ICU day 20 (5-41).
Plasma essential amino acid (EAA) concentration and 13C-Phe enrich-
ment were largely stable in aggregate, but highly variable individu-
ally. Variability over time of 13C-Phe, expressed as coefficient of
variation, was 25.8% (17.5-30.3) in healthy subjects and 20.9% (12.3-
46.3) in ICU patients. Variability of EAA was 10.5% (8.5-18.3) and
10.2% (7.8-13.2), respectively. Significant co-variation between
timepoint-to-timepoint changes of 13C-Phe enrichment and EAA was
found in 9/10 healthy subjects and 3/10 ICU patients.
CONCLUSION. Plasma EAA concentrations and 13C-Phe enrichment
reached a tentative steady state on average, but there was large
intra-individual variability during 12 hours of feeding. The magnitude
of variation was similar to that seen in the only previous study
reporting comparable data (de Betue et al., 2017). Variation in ami-
noacidemia may be physiologically relevant for anabolic stimulation
(Bouillanne et al., 2013), but its significance in critical illness remains
unclear.The physiological mechanism underlying the variability in aminoaci-
demia during continuous enteral feeding is unknown. Co-variation of
changes in EAA concentrations and 13C-Phe enrichment (here a spe-
cific indicator of dietary uptake) suggests a common underlying
process such as gastric emptying, but this appears less obvious in
the ICU patients.
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INTRODUCTION. Acute liver failure (ALF) accounts for up to 6% of
liver related deaths and is characterized by the acute onset of jaun-
dice, coagulopathy and hepatic encephalopathy in patients without
pre-existing hepatic disease. Due to multiple immunological dysfunc-
tions, systemic inflammation and bacterial translocation, patients
with ALF are at higher risk of developing sepsis. Bacterial infections
have been documented in 60-80% of these patients, most commonly
pneumonia (50%), urinary tract infections (22%) and spontaneous
bacteraemia (15%) and are a significant cause of mortality.
METHODS. We assessed a retrospective cohort of 39 patients with
ALF admitted to an Intensive Care Unit (ICU) of a Liver Transplant
Center from January 2015 until December 2018. Baseline characteris-
tics, admission respiratory, kidney and hemodynamic support and
culture samples were recorded.
RESULTS. The median age (IQR) was 40 (28-52) years; 17 were male
(43,6%). Paracetamol etiology was found in 7 patients (17,9%). On
ICU admission, median SAPS II score was 49 (30,8-59,5) with an asso-
ciated risk of mortality of 43,85% (12-71). Paracetamol overdose or
others drugs-related toxicity and unknown causes represented more
than 50% of the ALF aetiologies. Invasive mechanical ventilation,
vasopressor support and renal replacement therapy on admission
were required in 10 (27%), 11 (28%) and 8 (21%), respectively. Admis-
sion hepatic encephalopathy higher than grade 3 was present in 10
patients (27%) with a median arterial ammonia of 248 (161-316) mg/
dL. Median INR, total bilirubin and lactate levels were 2,7 (2,3-3,4),
9,90 (2,52-19,57) mg/dL and 2,6 (1,6-6,0) mmol/L, respectively. King’s
College (KCC) and Clichy’s Criterias were fulfilled by 14 (36%) and 5
(13%) patients. Eleven patients (28%) received liver transplant. Infec-
tion was present in 17 patients (43,6%), predominantly gram-
negative organisms. Median day of infection diagnostic was 3 (2-5).
Time-to-event analysis (Cox regression) with Kaplan-Meyer curves
adapted for the presence of infection revealed a worst 30 day sur-
vival for those patients who developed infection (67% versus50%, p =
0,08). Hospital mortality rate was 36%.
CONCLUSION. In a Portuguese cohort, bacterial infection was present
in almost half of the patients admitted with ALF. As the diagnosis is
difficult, a high level of clinical suspicion, particularly in patients who
have signs of SIRS, refractory hypotension or unexplained progres-
sion to higher grades of hepatic encephalopathy may indicate the
presence of infection. So, careful assessment for ongoing infections
should be performed and treated in order to optimize patient’s
outcome.
Table 1 (abstract 000453). See text for description
Quartile1(n29) Quartile2(n30) Quartile3(n29) Quartile4(n29) p
DM(n%) 25% 21% 39% 15 <0.05*
APACHEII(mean) 18±8 17±7 21±8 23.3±7 <0.05*
PN(n) 9% 10% 17% 38% <0.05*
EN(n) 96.5% 90% 88% 88% NS
Vasoactivedrugs(n) 59% 60% 72% 90% NS
PCT7thDay 1.08±2 1.18±2 3.7±8 4.08±8 NS
MV (days) 9.2±8 10±13 12±7 14±16 NS
ICU LOS 12.5±100 13±14 16±10 17±15 NS
Hospital LOS 33±31 34±27 23±19 40±34 NS
Infectiouscomplications(n) 30% 43% 31% 31% NS
Mortality(coef.ß) -0.18 0.18 1.18 1.2 NS
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INTRODUCTION. Previous research has demonstrated that high Gly-
cemic Variability (GV) is associated with increased mortality among
critically ill patients, but its relationship with other factors such as
nosocomial infections has not yet been determined.
METHODS. Observational prospective study of critically ill patients re-
ceiving artificial nutrition (first 48h). Our exclusive criteria were dia-
betic ketoacidosis or those not receiving artificial nutrition. The study
was carried out at a Medical ICU, from November 2015 until Decem-
ber 2018.
Admission data: demographic data, clinical characteristics,APACHEII,-
SOFA, nutritional parameters during the 1st&7th day, GV during first
7 days, infectious complications, days of mechanical ventilation (MV),
ICU length of stay (LOS) and mortality.
We calculated GV as VC= SD/Mx100. We performed univariate statis-
tical analysis considering the significance p<0.05, T-test [LP1] for
quantitative independent group variables and χ2 for qualitative vari-
ables. We also employed linear regression for continuous dependent
variables and binary logistic regression for dichotomous dependent
variables.
RESULTS. The sample consists of 118 patients, 67% men with a mean
age of 62±14 years, BMI 29±16, diabetics (DM) 24%, dyslipidemics
38%, Arterial hypertension 54% and 38% were smokers. From the
sample 86% presented stress hyperglycemia, 70% needed vasoactive
drugs, 90.5% enteral nutrition (EN) and 20.5% parenteral nutrition
(PN). Mechanical ventilation median 8 days (min 0 – max60), ICU
length of stay (LOS) 10 days (min 2 - max 69), hospital LOS 23 days
(min 3 – max 123) and 32% of mortality.
APACHE II 19.9±8 and SOFA on admission 8±3.
35% suffered nosocomial infections: ventilated-associated pneumonia
(VAP) 26%, tracheobronchitis48%, bacteraemia 1% and catheter re-
lated bacteraemia 4.7%, urinary tract infection7%, ventriculitis 2.3%
and others 4.7%). We divided our sample into quartiles depending
on the level of GV: (1) 8.7–15.49; (2) 15.5–20.37; (3) 20.38–26.48; (4)
26.49–43.9. Mean GV 21.8±8. Table 1 with Results:
CONCLUSION.
 Patients with higher illness severity scores (APACHE II) show
higher GV.
 We observe higher GV among patients receiving PN.
 It is observed that patients with DM present higher rates of GV.
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INTRODUCTION. Recent guidelines suggest using the Nutritional Risk
in Critically ill (NUTRIC) score to detect those patients who would
benefit the most of nutritional therapy by giving them a category of
high (≥5 points) or low (<5 points) nutritional risk.(1) To obtain this
score the clinician most calculate the Acute Physiology and Chronic
Health Evaluation score II (APACHE II) and the Sepsis Related Organ
Failure Assessment score (SOFA) to assign them specific points, fi-
nally adding the obtained points from the age, number of comorbidi-
ties and days of hospitalization before admission to the intensive
care unit (ICU).(2,3)To our consideration some collinearity is given by
using two severity scores in the same calculation, implying a high
probability of obtaining similar results if either one of the severity
scores is omitted from the original model.(4)
OBJECTIVES. To assess the practical validity of using the NUTRIC
score omitting the calculation of either the APACHE II or SOFA scores
given their collinearity.
METHODS. Retrospective observational study including every adult
patient with nutritional assessment (NUTRIC score included) admitted
to the ICU excluding obstetric patients, in a period of 9 months. The
population was divided in two groups: 1) generation sample (first
50% of the population) 2) validation sample (second 50% of the
population). In the generation group two receiver operating charac-
teristics (ROC) curves were generated: 1) NUTRIC score without APA-
CHE II points (model 1) 2) NUTRIC score without SOFA score points
(model 2) and a cutoff point for every curve was assigned to detect
high nutritional risk according to the original NUTRIC score. In the
validation group, 2x2 tables were generated and sensitivity (Se), spe-
cificity (Sp), positive predictive value (PPV) and negative predicted
value (NPV) were calculated for the detection of high nutritional risk
according to the original NUTRIC score using the new cutoff points
previously generated (model 1 and model 2). Comparisons between
groups were also made.
RESULTS. 174 and 173 patients were included in the generation and
validation groups respectively. The generation model had higher
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bidities: 3 (2-6) vs 2 (1-4) points (p<0.05) and 70.7% vs 52.6% (p<
0.05). In the generation phase the model 1 obtained an area under
the curve (ABC) of 0.929 (p<0.05, confidence interval at 95%
(CI95%) 0.892-0.966) selecting a cutoff value of ≥3 points (Se 93.7%
and Sp 78.4%), the model 2 obtained an ABC of 0.973 (p<0.05,
CI9%% 0.953-0.993) selecting a cutoff value of ≥4 points (Se 98.4%
and Sp 77.5%). In the validation phase, the model 1 obtained a Se
98.18%, Sp 81.36%, PPV 71.05% and NPV 98.97% and the model 2
obtained a Se 100%, Sp 70.34%, PPV 61.11% and NPV 100%.
CONCLUSION. Using the NUTRIC score omitting the calculation of ei-
ther SOFA or APACHE II scores could be a practical way to detect pa-
tients with low nutritional risk; this does not imply that both
obtained scores detect high nutritional risk according to the original
NUTRIC in a reliable manner. This could translate to a faster assess-
ment that excludes only low risk patients leaving more time for
complete calculation for patients with a high score.
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INTRODUCTION. Glycosylated hemoglobin (HbA1c), is currently the
best existing parameter of metabolic control in patients with dia-
betes mellitus. Cardiovascular disease is the main cause of morbidity
and mortality in this group of patients
OBJECTIVES. To determinate the association between Hb1Ac and
multivessel coronary disease in patient with ST elevated myocardial
infarction (STEMI)
METHODS. We included 246 patients with STEMI admitted in our
center. Patients were classified according to their Hb1Ac levels at ad-
mission (elevated ≥6.5%; normal < 6.5%).Multivessel coronary disease
was assessed by invasive coronary angiography. The association be-
tween Hb1Ac and multivessel coronary disease was evaluated using
logistic regression.
RESULTS. 36% of patients had elevated Hb1Ac. 91,6% of patients
with known diabetes had Hb1Ac ≥6.5%. Those with Hb1Ac ≥ 6.5%had increased odds of having multivessel disease as compared with
those with hb1Ac < 6.5% (OR: 2.15, 95% CI: 1.01, 4.55, p 0.02)
CONCLUSION. Hb1Ac was positively associated with multivessel cor-
onary disease in patients with STEMI000574
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INTRODUCTION. According to several studies one third (31-38%) of
ICU patients have a low plasma glutamine concentration (<420
μmol/L) at admission. Moreover, this hypoglutaminemia has been
shown to be associated with an increased morbidity and mortality. It
has been hypothesized that an increased utilization of glutamine
cannot be met by the production in spite of an increased net efflux
from skeletal muscle to plasma resulting in the low concentrations.
However, glutamine kinetics in ICU patients has only been studied
scarcely and data to relate endogenous production to glutamine
levels has not been available. It remains important to understand the
mechanisms behind the low glutamine concentrations in order to
determine when, how and if glutamine should be supplemented in
the ICU setting.
OBJECTIVES. To elucidate the relationship between plasma glutam-
ine levels and the endogenous glutamine production in ICU patients.
METHODS. Glutamine kinetics was studied in ICU patients. A tracer
bolus injection method employing 13C-glutamine was used. It has
been validated to give minimum effect on plasma glutamine and in-
sulin concentrations. After bolus injection 18 plasma samples during
90 minutes were taken and the area under the curve for C13-
glutamine calculated.
RESULTS. There was a weak statistical correlation between de
novo endogenous production of glutamine (not emanating dir-
ectly from protein breakdown) and plasma glutamine concentra-
tion in stabilized ICU patients (n=11), with R2 = 0,308. Two sided
P=0,0764 with a power of 41%, which was not statistically
significant.
CONCLUSION. Plasma concentration of glutamine did not directly re-
flect the de novo production of glutamine, although a statistical cor-
relation was at hand. A larger cohort of ICU patients representing a
wider concentration interval will be needed to fully explore the
relationship.
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INTRODUCTION. Pressure Injuries (PI) are characterized by damage
to the skin and either soft tissues resulting from compression of the
bony prominence against a hard surface or related to the use of
some medical device. The time until PI development can be related
to several factors present in critically ill patients, such as their clinical
condition and nutritional status.
Nutritional support is essential for wound healing and it is important
for patients at risk of developing PI. Inadequate nutrition and nega-
tive energy balance combined with catabolic stress and inflammation
caused by severe disease increase the risk of complications, including
PI and bad wound healing.
OBJECTIVES. To compare the time until PI development between
groups of critical care patients with enteral nutrition which achieved
or not the nutritional goals and verify the risks associated with the PI
development over time.
METHODS. Observational, prospective study conducted at the Inten-
sive Care Center of a University Hospital in São Paulo (Brazil) during
2016. Patients admitted to ICU without PI and which received exclu-
sive Enteral Nutrition were selected for the sample. The PI develop-
ment and time to PI were considered dependent variables. The
statistical analysis was performed by applying the survival curve with
the Kaplan-Meier method and the Cox regression model was used to
verify the risks associated with the PI development over time, observ-
ing a significance level of < 5% and confidence interval of 95%.
RESULTS. The sample included 181 patients, 56.4% was male, the
mean age was 55.1 years, the mainly location before ICU admission
was operating room (84.0%) and the main reason for hospitalization
was the neurological causes (44.8%). The mean of ICU stay was 17.5
days and mortality was 30.4%. The mean of the SAPS3 was 59.9 and
the SOFA was 6.7. The incidence of PI was 31.5%. The survival curves
did not show difference in time until PI development, considering
the patients who achieved caloric goal (p = 0.532) or protein goal (p
= 0.694) or caloric + protein goals (p = 0.648). The nutritional goals
were not observed among the risks associated with the time of PI
development. The identified risks were location before ICU admission
(emergency department - HR = 2.05 and ward - HR = 2.40), length of
ICU stay (HR = 1.01), Braden scores (HR = 0.63) and EVARUCI scores
(HR = 1.33).
CONCLUSION. The time of PI development in critically ill patients
with enteral nutrition was not influenced by the achievement of nu-
tritional goals. Moreover, the nutritional goals were not included
among the risks associated with the development of PI over time.
Considering that the occurrence of PI is multifactorial, the early iden-
tification of patients at risk is essential for preventive measures to be
adopted immediately.REFERENCE(S)
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INTRODUCTION. The correlation between elevated plasma lactate
concentration and increased mortality has been firmly established in
ICU patients. Although plasma lactate is heavily relied upon for clin-
ical decision making, the kinetics of lactate in critically ill patients is
still sparsely studied.
OBJECTIVES. To establish and validate a feasible method to study
whole body lactate kinetics in critically ill patients.
METHODS. Healthy volunteers (n=6) received a bolus dose of 13C-
labeled lactate (20μmol/kg body weight) and 43 blood samples were
drawn over two hours to determine the decay in labeled lactate.
Data was analyzed using non-compartmental modeling, calculating
rates of appearance (Ra) as an estimate of lactate production, and
clearance of lactate. The area under the curve (AUC) was calculated
using a linear-up log-down trapezoidal approach with extrapolation
beyond 120 minutes using the terminal slope to obtain the whole
AUC. After evaluation, the same protocol was used in an unselected
group of critically ill patients (n=10).
RESULTS. Ra for healthy volunteers and ICU patients were 12.8 ± 3.9
vs 22.7 ± 11.2 μmol/kg/min (p=0.026) and clearance 1.57 ± 0.39 vs
1.10 ± 0.43 L/min (p=0.047), respectively. ICU patients (n=6) with nor-
mal lactate concentrations showed kinetics very similar to healthy
volunteers (Ra 14.5 (range 12.3 – 18.3) μmol/kg/min, lactate clearance
1.3 (range 0.77 – 1.77) L/min). For ICU patients, there were statisti-
cally significant correlations between plasma concentration and Ra of
lactate, r2=0.85 (p<0.0002) and lactate clearance, r2= 0.50 (p=0.023).
Simulations showed that reducing the number of samples from 43 to
14 gave the same results. Our protocol yielded results on lactate kin-
etics very similar to previously published data.
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labeled bolus dose of lactate was accurate and feasible for studying
lactate kinetics in critically ill ICU patients.
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INTRODUCTION. Subglottic secretion drainage (SSD) is one of the
recommended strategies to prevent ventilator-associated pneumonia
(VAP) with a high level of evidence, especially regarding early-onset
pneumonia. Despite published recommendations, SSD has not been
widely implemented in ICUs and remains underused. Several factors
could account for this: the uncertainty regarding the safety of SSD,
the lack of evidence of benefits in other clinical outcomes than pre-
vention of VAP and the extra cost of the specific endotracheal tubes
(ETs) allowing SSD compared with usual endotracheal tube. To assess
the medico-economic impact of SSD implementation, we performed
a multicenter, pragmatic trial: the DEMETER study (ClinicalTrials.gov,
identifier NCT02515617).
OBJECTIVES. To assess the cost utility of the implementation of SSD
in a VAP prevention bundle with a time horizon of one year.
METHODS. It is a multicenter cluster-randomized and cross-over
study. 26 ICUs were involved (25 located in France and 1 in Belgium).
Two periods of 10 months (period A and B) were planned to include
patients. During the period A, the ICU’s team used endotracheal
tubes not allowing SSD and during the period B, specific endo-
tracheal tubes allowing SSD were used. A 2-month interval between
the two periods was planned to allow the switch of ET type. Both in-
clusion periods correspond to the same seasonal period. Moreover,
during period B, specific endotracheal tubes allowing SSD were also
available in the emergency rooms and the prehospital emergency
units of hospitals located around the ICUs involved in the study. Re-
gardless of the period (A or B), mechanically ventilated patients
benefited from the regular VAP prevention policy which included:measures to reduce the duration on mechanical ventilation (MV) as
well as the exposure to the medical device (sedation algorithm,
standardization procedure for weaning of the MV) and specific mea-
sures to prevent VAP (maintaining a cuff pressure between 25 and
30 cm H20, semi-recumbent positioning of the patient, oropharyn-
geal care). During period B, in addition, SSD was performed intermit-
tently every 2 hours by using a 10ml syringe.
The economic evaluation was performed in accordance with the
CHEERS statement. The prospective analysis was conducted from the
health care perspective to determine the cost per quality-adjusted
life year (QALY) gained with the SSD implementation over a 1-year
period. Hospital resources were considered as well as the cost of the
medical device and the cost of the nursing time required to perform
the SSD procedure during the mechanical ventilation period. Health-
related quality of life was assessed using the EuroQol 5 Dimensions
at baseline, 3-month, 6-month, and 1-year. The utility values are
based on French tariffs for the corresponding EQ5D scores.
RESULTS. During the periods of inclusion (nov 2015-aug 2016 and
nov 2016-aug 2017), 2600 patients were included. Patient’s follow-up
ended in August 2018. The analyses are currently ongoing. The re-
sults will be available and presented in exclusivity at LIVES 2019.
CONCLUSION. The DEMETER study is the first prospective and large
study assessing the medico-economic impact on the SSD use and
could afford new insights on this VAP prevention strategy.
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INTRODUCTION. Morbidity and mortality of Staphylococcus aureus
(SA) pneumonia remain high in mechanically ventilated, intensive
care unit (MV ICU) patients despite best clinical care. Suvratoxumab
(MEDI4893) is an extended half-life, SA alpha toxin-neutralizing
Page 84 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55human monoclonal antibody that may reduce incidence of SA pneu-
monia in MV ICU patients.
OBJECTIVES. To assess efficacy, safety, pharmacokinetics (PK), popu-
lation PK modeling, anti-drug antibody (ADA) responses, and health-
care resource utilization (HRU) benefits of suvratoxumab in MV ICU
patients at risk for SA pneumonia.
METHODS. MV ICU subjects with PCR-confirmed SA colonization of
the lower respiratory tract were randomized to either a single intra-
venous infusion of 5000 mg suvratoxumab (n=96) or placebo (n=
100) and followed for 190 days post dose. Efficacy endpoints in-
cluded relative risk reduction (RRR) vs. placebo within 30 days post
dose in: incidence of SA pneumonia (primary endpoint; tested at 2-
sided α=0.1), all-cause pneumonia, and all-cause pneumonia or death
(all events determined by the Endpoint Adjudication Committee).
HRUs, PK and ADA were measured through 90 days post dose and
TEAEs and serious TEAEs through 190 days.
RESULTS. Baseline characteristics were similar between groups. Suv-
ratoxumab provided 31.9% RRR in incidence of SA pneumonia vs.
placebo (17.7% vs 26%; P=0.166), 30% RRR (P=0.146) in incidence of
all-cause pneumonia, and 23% RRR (P=0.164) in incidence of all-
cause pneumonia or death. Suvratoxumab provided 38% RRR in inci-
dence of SA pneumonia vs. placebo, when adjusted for duration of
initial MV. Suvratoxumab provided greater prevention of SA pneumo-
nia in subjects aged ≤65 years (RRR=47.4%), low SA colonization sta-
tus (RRR=66.7%), and 5 VAP bundles (RRR=46.3%) vs. placebo.
Suvratoxumab was associated with 3.0 fewer hospital days and 2.4
fewer ICU days for every 90 days patient follow-up and greater HRU
reductions in subjects aged ≤65 years (10.1 fewer hospital days, 3.7
fewer ICU days). Over 190 days, proportions of subjects with TEAEs
and serious TEAEs were similar between suvratoxumab and placebo
groups: ≥1 TEAE (90.6% vs 90.0%); ≥1 serious and/or ≥grade 3 sever-
ity TEAE (55.2% vs 52.0%). Mean serum suvratoxumab concentrations
were above the target serum level of 211 μg/mL through day 31
(mean±SD concentration 296±131 μg/mL). Population PK model esti-
mated mean±SD terminal half-life of 72±33 days. No ADA responses
were detected post-dose through 90 days.
CONCLUSION. A single intravenous dose of suvratoxumab produced
a trend toward reduced incidence of SA pneumonia and reduced
HRU in high-risk ICU patients compared with placebo. Greater clinical
benefits were observed in certain subgroups. Suvratoxumab demon-
strated acceptable safety, PK and ADA profiles. These results support
continued development of suvratoxumab in MV ICU patients.
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INTRODUCTION. To test the interest to monitor the expression of hu-
man monocytic Human Leukocyte Antigen-D Related (mHLA-DR) topredict mortality and the occurrence of secondary infections in
a large single-center Intensive Care Unit (ICU) population.
METHODS. We conducted a single-center, prospective, observational
study in a tertiary hospital in France. All patients admitted from 2013
to 2015 in our ICU were included from our data base if mHLA-DR
measurement was performed within the first days (< 4 days) post ad-
mission. Collected parameters were severity score on admission
(SAPS II and SOFA), sex, age, mortality and secondary infections. The
association between mHLA-DR expression and outcomes was tested
by the adjusted Fine and Gray sub-distribution competing risk
models.
RESULTS. 1053 patients having an early mHLA-DR measurement
were included and analyzed: 151 patients (14.3%) died in the ICU;
based on the logarithm cutoff value for median (mHLA-DR < 9.2 log),
a low mHLA-DR was independently associated with mortality (HR =
0.71 [0.57; 0.95], p < 0.01). The performance of mHLA-DR to predict
ICU death was inferior to the gravity scores (mHLA-DR: AUC = 0.65
[0.6-0.69], SAPS II: 0.8 [0.77-0.84], p<0.01) and the performance of the
combination of mHLA-DR and SAPS II was similar to SAPS II alone (p
= 0.81). Two successive mHLA-DR measurements within the first
week were performed in 543 patients allowing to test the 2nd value
or the slope between the 2 values (positive, negative or stable).
Among these patients, 223 patients
(37.7%) had a secondary infection with a sustained lower mHLA-DR
than other patients (mHLA-DR = 9.0 log vs. 9.3 log, p < 0.01). The
second mHLA-DR value was independently associated with the de-
velopment of subsequent secondary infection, regardless of initial se-
verity (HR = 0.66 [0.51 ; 0.84], p = 0.001). A negative slope between
mHLA-DR 1 and 2 was strongly associated with later occurrence of a
secondary infection (HR = 0.62 [0.43; 0.89], p = 0.009).
CONCLUSION. mHLA-DR expression is early decreased in ICU pa-
tients and is associated with ICU
mortality (the higher mortality, the lower mHLA-DR), but with no su-
periority to severity scores even in combination. For a given severity,
persisting low mHLA-DR expression or decreasing mHLA-DR, are in-
dependent and reliable predictors of secondary infection occurrence.
This large survey may then be used to design clinical trials testing
immune-stimulating drugs based on mHLA-DR monitoring to prevent
or cure secondary infections.
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INTRODUCTION. Patients suspected of ventilator-associated lower re-
spiratory tract infections (VA-LRTI) receive antimicrobial therapy, even
though subsequent bronchoalveolar lavage (BAL) microbiological cul-
ture results deem this inappropriate in almost half of these patients
[1]. Breath contains volatile organic compounds (VOCs) produced by
host response or pathogen metabolism, which may be used to diag-
nose pneumonia [2].
OBJECTIVES. We hypothesize that exhaled breath analysis can dis-
criminate between patients suspected of VA-LRTI with positive re-
spiratory tract cultures (confirmed) and those who are negative
(nonconfirmed).
METHODS. This was an international European multicentre observa-
tional cohort study in intubated and ventilated ICU patients who re-
ceived antibiotics for suspected VA-LRTI [3]. Gas-chromatography
mass-spectrometry was used to detect and identify VOCs. A (mini-
)BAL semi-quantitative culture ≥10^4 CFU was considered positive
for VA-LRTI. Comparison of all measured VOCs was performed using
the “limma” function in R statistics, resulting in p-values adjusted for
multiple testing and fold changes.
RESULTS. 108 patients were included consecutively: 52 (48%) had
positive cultures, most commonly Pseudomonas aeruginosa (N=9,
17%) and Staphylococcus aureus (N=15, 29%). The clinical pulmonary
infection score (CPIS) was higher in confirmed VA-LRTI patients (p<
0.001). 5 out of 184
VOCs were significantly higher in culture positive patients (p<
0.05). The AUROCC for the 5 VOCs combined was 0.82 and increased
to 0.85 when added to the CPIS.
CONCLUSION. Exhaled breath analysis can be used to discriminate
between patients with suspected VA-LRTI who had confirmed posi-
tive or negative respiratory cultures, with the potential to reduce de-
lays in diagnosis. Further analysis will result in the identification of
the molecules and further validation of the diagnostic algorithm.
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INTRODUCTION. The effectiveness of decontamination strategies for
eradication of antibiotic resistant GNB in ICU patients remains contro-
versial and has not been studied extensively in ICUs with higher
levels of antibiotic resistance than Dutch ICUs (1). We, therefore,
aimed to determine the efficacy SDD, SOD and CHX 1-2% mouth-
wash on eradication of 3GCR-E and CR-GNB from the rectum and re-
spiratory tract and on acquisition of these bacteria during ICU stay.
OBJECTIVES. To quantify the effects of selective digestive tract de-
contamination (SDD), selective oropharyngeal decontamination
(SOD) and 1-2% chlorhexidine (CHX) mouthwash on eradication and
acquisition of carriage of third generation cephalosporin resistant En-
terobacteriaceae (3GCR-E) and carbapenem resistant Gram-negative
bacteria (CR-GNB) in ICU patients.
METHODS. Nested cohorts study within a European cluster-
randomized cross-over trial (2) with 8,665 patients. Eradication and
acquisition of 3GCR-E and CR-GNB were investigated separately in
the rectum and respiratory tract for the three interventions and com-
pared to standard care (SC) using Cox-regression competing events
analyses.
RESULTS. Adjusted cause specific hazard ratios (CSHR) for eradication
of rectal carriage for SDD were 1.76 (95%CI 1.31-2.36) for 3GCR-E and
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for eradication of 3GCR-E from the respiratory tract were, compared
to SC, 1.47 (95% CI 0.98-2.20) for SDD and 1.38 (95%CI 0.92-2.06) for
SOD. Adjusted CSHRs for acquisition of rectal carriage during SDD
(compared to SC) were 0.51 (95%CI 0.40-0.64) for 3GCR-E and of 0.56
(95%CI 0.40-0.78) for CR-GNB. Adjusted CSHRs for acquiring respira-
tory tract carriage with 3GCR-E, compared to SC, were 0.55 (95%CI
0.42-0.71) for SOD and 0.38 (95%CI 0.28-0.50) for SDD, and 0.60
(95%CI 0.44-0.81) and 0.46 (95%CI 0.33 - 0.64) for CR-GNB during
SOD and SDD, respectively.
CONCLUSION. SDD was associated with faster eradication of 3GCR-E
and CR-GNB from the rectum than SC, and SDD and SOD were asso-
ciated with less acquisition of both 3GCR-E and CR-GNB, compared
to SC, in the respiratory tract.
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INTRODUCTION. The timing of initiation of Norepinephrine (NEP) in
septic shock is still controversial. The most recent guidelines recom-
mend its use after failed trial of fluid resuscitation.
OBJECTIVES. We intended in this study to evaluate the impact of
early starting NEP simultaneously with fluids resuscitation immedi-
ately after diagnosis of septic shock.
METHODS. We recruited 101 patients admitted to the emergency de-
partment (ED) with septic shock who were randomized in 1:1 ratio to
early initiation of NEP simultaneously with IV fluids (early NEP group)
and starting NEP after failed fluid resuscitation trial (late NEP group).
Our primary outcome was the in-hospital survival while the second-
ary outcomes were the time of restoring a mean arterial pressure
(MAP) of 65 mmHg, lactate clearance and volume of fluids used in
resuscitation.
RESULTS. There was no statistically significant difference between
the two groups regarding the baseline hemodynamics, laboratory
findings and the source of infection. NEP infusion started after 25
(20-30) minutes from ED admission in the early group compared to
120 (120-180) minutes in the late group [P=0.000,95% CI:-100(-140,-
100)]. Target MAP of 65mmHg was achieved faster in the early group
[2 (1-3.5)hours Vs 3(2-4.75)hours in the late group][P=0.003,95% CI:-
1(-1,0)]. The post resuscitation serum lactate was decreased by
37.8(24-49)% and 22.2(3.3-38)% in the early and late groups respect-
ively [P=0.005,95% CI:13.96(4,24.2)]. Serum lactate less than 2mmol/L
after resuscitation was achieved in 29 patients (50.9%) in the early
group compared to 12 (27.3%) in the late group (P=0.017). Patients
with early NEP were resuscitated by significantly lower volume of
fluids [25(18.8-28.7)mL/Kg Vs 32.5(24.4-34.6)mL/Kg in the early&lategroups] [P=0.000,95% CI:-5.5(-8.2,-2.8)]. The early group had survival
rate of 71.9 % (41 patients) compared to 45.5 % (20 patients) in the
late group (P = 0.007). The survivors had NEP started after 30(20-120)
minutes Vs 120(30-165) minutes in the non-survivors [P=
0.013,95%CI:-15(-60,0)].
CONCLUSION. We concluded that the early use of Norepinephrine at
the onset of diagnosis of septic shock might cause earlier restoration
of blood pressure, better lactate clearance and consequently better
in-hospital survival
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INTRODUCTION. Mortality of old intensive Patients (80 years and
older; VIP) admitted to an intensive care unit (ICU) for various admis-
sion diagnoses is high, and morbidity causes significant health costs
and leads to human suffering in survivors. Risk stratification is crucial
in VIPs to optimize outcomes. Established clinical scores including Se-
quential Organ Failure Assessment score (SOFA) score are available
to stratify risk. However, these scores were not developed for VIPs.
Assessing frailty through clinical assessment might help, and the
Clinical Frailty Scale (CFS) has been successfully used to risk-stratify
elderly patients. However, patients after elective intervention versus
after acute intervention might differ significantly with regards to
characteristics, outcomes, and predictors of outcomes.
OBJECTIVES. We evaluated differences between patients admitted to
intensive care unit (ICU) after elective versus acute intervention in a
multinational cohort of very old patients (≥80 years; VIP;
NCT03134807). Differences in baseline characteristics, outcomes, and
predictors of mortality, with particular emphasis on frailty, were
assessed.
METHODS. In total, 5063 VIPs were included in this analysis, 922
were admitted after elective surgery or intervention, 4141 acutely,
with 402 after acute surgery. Differences were assessed using Mann-
Whitney-U test and Wilcoxon test in continuous variables. Associa-
tions with mortality were determined by univariate and multivariable
logistic regression. We further matched 296 patients admitted after
acute intervention for age, sex, frailty and SOFA score to 296 patients
admitted after elective intervention.
RESULTS. Compared to patients admitted after acute intervention,
patients admitted after elective intervention suffered less often from
frailty as defined as CFS (28% vs. 46%; p<0.001), evidenced lower
SOFA scores (4±5 vs. 7±7; p<0.001). Presence of frailty (CFS >4) was
associated with significantly increased mortality both in elective sur-
gery patients (7% vs 12%; p=0.01), in acute surgery (7% vs 12%; p=
0.02).
In the matched cohorts both ICU mortality (mean difference 5.07%;
9.37-0.76%; p=0.03) and 30-day mortality (mean difference 10.12%;
3.58-16.65%; p<0.01) was lower in patients admitted after elective
internvention.
CONCLUSION. In VIPs, patients admitted after acute intervention
were compared to patients admitted after elective intervention clinic-
ally less sick, younger and less frail as assessed by CFS. Admission
after acute intervention was an independent predictor of mortality
even after correction for relevant confounders and in a matched-pair
analysis. Frailty assessed by CFS was useful for risk prediction and
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ted after elective and acute intervention.
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INTRODUCTION. In patients resuscitated from cardiac arrest (CA)
with acute myocardial infarction (AMI), the optimal level of inotropic
and vasopressor support is unknown. While overuse may increase
myocardial oxygen consumption and induce arrhythmias, diastolic
hypotension may reduce coronary perfusion and increase infarct size.
OBJECTIVES. We aimed to determine the optimal mean arterial pres-
sure (MAP) in AMI patients after CA.
METHODS. We performed a pooled analysis of post-CA AMI patients
randomised in the Neuroprotect (NCT02541591) [1] and COMACARE
(NCT02698917) [2] trials to either MAP 65 mmHg or MAP 80/85-100
mmHg targets for the first 36 hours after ICU admission. AMI was de-
fined as either ST-elevations in the electrocardiogram at hospital ad-
mission or identification of a clear culprit lesion (a coronary lesion
with at least 70% stenosis and the presence of characteristics of
plaque disruption) in coronary angiography performed within 2
hours after admission.
RESULTS. Out of 235 patients originally included in both trials, 120
patients qualified for our definition of AMI. Of these, 58 patients were
randomised to the MAP 80/85-100 mmHg group and 62 patients to
the MAP 65 mmHg group. Patients assigned to the higher MAP tar-
get received significantly higher doses of norepinephrine (p=0.004)
and dobutamine (p=0.01) and had significantly higher MAP (p<0.001)
and diastolic blood pressure (p<0.001) levels. Myocardial infarct size,
as quantified by the area under the 72-hour high-sensitivity troponin
T (HS-TnT) curve, was significantly lower in patients assigned to the
higher MAP target (median [IQR] 73 μg [24-136 μg] vs 109 μg [46-
317 μg], p=0.01). Additional inotropic and vasopressor support did
not increase the risk of a new CA (8/58 [14%] in the higher MAP
group vs. 9/61 [15%] in the lower MAP group, OR 0.92 [95% CI 0.33-
2.58], p=0.88) or new onset atrial fibrillation (4/58 [7%] in the higher
MAP group vs. 4/61 [7%] in the lower MAP group, OR 1.05 [95% CI
0.25-4.43], p=0.94).
CONCLUSION. Myocardial infarct size, as measured with HS-TnT,
remained significantly smaller in the group targeting MAP between
80/85-100mmHg. The risk for re-arrest or arrhythmia was not
increased.
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INTRODUCTION. Hyperbaric oxygen (HBO2) therapy is thought
to be essential for preventing delayed neurological sequelae
(DNS) in patients with carbon monoxide (CO) poisoning, based
on the results of a randomized controlled trial (RCT) reported by
Weaver et al. [1]. However, the beneficial effect of HBO2 therapy
remains debated because subsequent reports have been contra-
dictory [2].
OBJECTIVES. To identify the appropriate clinical treatment for acute
CO poisoning in Japan and to clarify the effects of HBO2 therapy in
the acute phase of CO poisoning.
METHODS. We conducted a multicenter, prospective, observational
study of acute CO poisoning in Japan, the “COP-J Study”. Patients
with acute CO poisoning were enrolled in the study. The treatments,
including HBO2 therapy, were performed according with each institu-
tion’s policy, and about 30% of institutions did not administer HBO2
therapy [3]. The primary endpoint was the onset of DNS within 2
months of CO exposure. DNS was defined as cognitive dysfunction
after an improvement in disturbed consciousness.
RESULTS. A total of 311 patients were registered form 57 institutions
and 255 were analyzed in this study. Of these patients, 171 re-
ceived HBO2 therapy (HBO2 group) and 84 did not (NBO2 group).
The mean ages were 49 ± 19 and 54 ± 22 years in the HBO2
and NBO2 groups, respectively (P = 0.063). There were no signifi-
cant differences between the HBO2 and NBO2 groups in the esti-
mated exposure time (202 ± 256 and 181 ± 376 min,
respectively; P = 0.605) or the time between exposure and arrival
at hospital (279 ± 350 and 240 ± 382 min, respectively, P =
0.420). The carboxyl hemoglobin concentration upon arrival did
not differ between the HBO2 and NBO2 groups (18.6 ± 11.3%
and 18.9 ± 10.1%, respectively; P = 0.831). HBO2 therapy was
performed once, twice, or three times within the first 24 h in
11.1%, 30.4%, and 56.1% of patients in the HBO2 group, respect-
ively. The treatment pressure in the first HBO2 session was 2.8
F3
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(2.6%). The number of patients with DNS was 13 (7.6%) in the
HBO2 group and three (3.6%) in the NBO2 group (P = 0.212).
CONCLUSION. In this study, the total incidence of DNS was 6.3%
in patients with acute CO poisoning, which is lower than in previ-
ous reports [1,2]. The superiority of HBO2 therapy over NBO2
therapy in terms of the prevention of DNS was not demon-
strated. Furthernore, the clinical practice of HBO2 therapy varied
in this study. Further investigations are required to clarify the ef-
fect of HBO2 therapy on the prevention of DNS after CO
poisoning.Fig. 1 (abstract 001246). See text for descriptionREFERENCE(S)
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INTRODUCTION. Simplified Acute Physiology Score 3 (SAPS 3) is the
most accurate prognostic model for Brazil [1]. However, recent evalu-
ation of its performance in solid cancer patients has not been per-
formed in our country.
OBJECTIVES. To compare the performance of SAPS 3 in patients
with and without solid cancer admitted to the intensive care unit
(ICU) of a comprehensive oncological hospital in Brazil.
METHODS. Retrospective cohort analysis of Epimed® administra-
tive database of adult patients (>18 years) first admission to the
intensive care unit (ICU) of Hospital Sírio Libanês (São Paulo,
Brazil) from 2012 to 2016. Patients were categorized according to
the presence of solid cancer at ICU admission. Hematological pa-
tients were excluded. We evaluated discrimination using the area
under the receiver operating characteristic curve (AUROC) and
the agreement between observed and expected mortality rates
(calibration) using the calibration belt.
RESULTS. We studied 7,390 patients (age 66.1±18.4 years, 54.1%
male, SAPS 3 score 41.6± 13.3, 41.6% had cancer, 12.1% died
during hospitalization). Cancer patients were younger compared
to non-cancer patients (62.6±16.5 years vs 68.7±19.3 years re-
spectively, p<0.001), had lower SAPS 3 (40.9±14 vs 42.1±12.8 re-
spectively, p<0.001), were admitted more frequently after elective
surgery (60.6% vs 24.9%, p<0.001), but had higher hospital mor-
tality (14.1% vs 10.6%, p<0.001). SAPS 3 discrimination was better
for cancer patients (AUROC = 0.85) than for non-cancer patients
(AUROC = 0.79) (p < 0.001). After we applied the calibration belt,
we observed that in cancer patients the SAPS 3 match the aver-
age observed rates for the confidence level of 95%. In non-
cancer patients the SAPS 3 overestimated mortality in those with
low-middle risk (figure).
CONCLUSION. SAPS 3 has different performances in cancer and non-
cancer patients in our single-center cohort.REFERENCE
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INTRODUCTION. Organophosphates (OP) have been used commonly
worldwide as insecticides. OP intoxication is almost a public health
problem in some countries leading to significant morbidity and mor-
tality. Diagnosis and treatment have many difficulties.
OBJECTIVES. The aim of the study was to determine the effect of
standard therapy plus plasmapheresis or only standard therapy on
serum pseudo-cholinesterase (PChE) and plasma erythrocyte cholin-
esterase (AChE) levels in critically ill patients with OP poisoning.
METHODS. This study was performed prospectively Medical Intensive
Care Unit (ICU). OP poisoning patients above 18 years of age were in-
cluded into the study. Patients were randomized into two groups;
Study (intervention) group received standard therapy plus plasmapher-
esis and control (standard) group received only standard therapy.
RESULTS.We enrolled 40 patients (Intervention group: 21, standard group:
19 patients). The mean age was 37±16 years. The mean APACHE II score
was 9±5. The most common cause OP intoxication compound was di-
chlorvos. Serum PChE values of all patients included in the study were
482.5 (177-3883) u / L at baseline, 3723 (227-7078) u / L after plasmapher-
esis, 1529 (174-7078) u / L on 2nd day, 1956 (181-10918) u / L on 3rd day,
2206 (161-9993) u / L on 4th day, 1258 (178-8464) u / L on 5th day, and
2590 (121-10597.00) u / L at the time of ICU discharge.Serum PChE values
of the intervention group and standard group patients were compared in
the first 5 days and the last day of intensive care hospitalization. No statisti-
cally significant difference was found between the two groups (p> 0.05).
Plasma erythrocyte AChE values of all patients included in the study were
1.9050 (0.12- 4.85) u / mL on admission, 2.5300 (0.06-4.47) u / mL after
plasmapheresis, 2.18 (0.01-4.27) u / mL on day 2, 2.13 (0.07-4.30) u / mL on
day 3, 2.015 (0.07-4.24) u / mL on day 4, 2.18 (0.12-4.19) u / mL on day 5
and 1.90 (0.09-4.37) u / mL at the time of ICU discharge. Plasma erythrocyte
AChE values of the intervention group and standard group patients were
compared on the daily from the admission to intensive care of patients,
the first 5 days and the last day of the intensive care unit stay. No statisti-
cally significant difference was found between the two groups (p > 0.05).
CONCLUSION. As a result of this study, in addition to standard treatment,
plasmapheresis therapy did not show any additional effect on serum
PChE and erythrocyte AChE levels compared to standard treatment.
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INTRODUCTION. Prognostication after cardiac arrest (CA) remains
challenging (Rossetti 2016). Traditionally, most emphasis was put on
prediction of poor outcome, but with the introduction of advanced
supportive therapies, such as extra corporeal membrane oxygen-
ation, it becomes increasingly important to identify patients with a
chance of good neurological recovery. For prediction of good out-
come after CA, presence of EEG reactivity (EEG-R) has been proposed
as a valuable marker, but the relation to EEG background pattern has
not been described. The EEG background pattern itself between 12
and 24h post CA is already a reliable predictor of good outcome
(Hofmeijer 2015).
OBJECTIVES. In this study, the primary aim was to define the add-
itional prognostic value of EEG-R per EEG background pattern. Sec-
ondary aims were to explore whether time after CA and sedative
medication influence the prognostic value of EEG-R and to determine
optimal methods of EEG-R testing
METHODS. A post-hoc analysis of a prospective cohort study. EEG-R
was tested twice a day, using a strict protocol of different stimuli.
Good outcome was defined as a Cerebral Performance Category of
1-2 within 6 months. The additional value of EEG-R per EEG back-
ground pattern was evaluated using the diagnostic odds ratio (DOR).
Furthermore, prognostic value (sensitivity and specificity) of EEG-R
was investigated in relation to the timing after CA, sedative medica-
tion, different stimuli, and repeated testing.
RESULTS. Patients with a discontinuous (< 50% suppression) normal
voltage (> 20 uV) background pattern and reactivity were eight times
more likely to have a good outcome (DOR 8.0, 95%-CI 1-64, p-value
< 0.05). In continuous normal voltage background patterns, DOR of
EEG-R was 3.4 (95%-CI 1-12, p-value 0.06). (108 patients, with and
without sedation, 12-24h after CA). EEG-R was not observed in other
background patterns. In 119 patients with (dis)continuous normal
voltage background, prognostic value was highest in sedated pa-
tients (sensitivity 81.3% (95%-CI 70.7-89.4), specificity 59.5% (95%-CI
42.1-75.2)), irrespective of time after CA. EEG-R induced by handclap-
ping and sternal rubbing, especially when combined, had highest
prognostic value for good outcome. Repeated EEG-R testing in-
creased sensitivity from 65% to 89% with a decrease in specificity
from 71% to 46%.
CONCLUSION. These results suggest that EEG-R testing is of add-
itional value for prediction of good outcome in patients with a (dis)-
continuous normal voltage background pattern. The best stimuli
were clapping and sternal rubbing.
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INTRODUCTION. Normal saline is routinely used in post-cardiac arrest
patients based on the belief that management in sepsis setting will
be similarly beneficial in cardiac arrest setting. (1) However, there is
no established evidence supporting such management in cardiac ar-
rest patients. It is known that brain edema is a key prognostic factor
in post-cardiac arrest syndrome (PCAS). (2-5, 7, 8) A clinical study
have shown that hypertonic saline use during cardiopulmonary re-
suscitation might be beneficial to patients with PCAS. (6) But hyper-
tonic fluid could be harmful to those patients after vasogenic edema
occurs. (2, 3)
OBJECTIVES. Therefore, the aim of this study is to evaluate the cor-
relation between electrolyte or osmolality alteration and neurologic
outcome of PCAS patients, thereby providing evidence to the opti-
mal fluid management in post-cardiac arrest care.
METHODS. This is a retrospective observational study based on a
multicenter prospective cohort registry of out-of-hospital cardiac ar-
rest patients from December 2013 to February 2018. 653 patients
were finally included in this study, excluding those with poor base-
line cerebral performance category (CPC 3, 4, or 5) and those with in-
complete data. Outcome variables were defined as 28-day CPC, 6-
month CPC, and 1-year CPC after discharge. We conducted univariate
and multivariate logistic regression analyses to find the relationship
between serum electrolyte at 0, 24 hours after return of spontaneous
circulation (ROSC), calculated osmolality, and main outcomes. The
final multivariate logistic regression model included osmolality at 24
hours after ROSC, total low-flow time, total no-flow time, witnessed
arrest, bystander CPR, ROSC achieved by prehospital emergency
medical service, sequential organ failure assessment (SOFA) score, ini-
tial ECG rhythm after ROSC and initial light reflex after ROSC.
RESULTS. 139 [35%] patients had good CPC (1 or 2) at 28-day after
discharge otherwise, 514 [65%] patients had poor CPC (3, 4 or 5).
Multivariate logistic regression analysis showed that high serum
osmolality at 24 hours after ROSC had significant correlation with
poor neurologic outcome at 28-day after discharge (adjusted odds
ratio [OR], 1.04; 95% confidence intervals [CI], 1.00-1.07; p value,
0.03). Similar results were obtained in the multivariate model using
neurologic outcome at 6 months and 1 year.
CONCLUSION. High serum osmolality at 24 hours after ROSC was in-
dependently associated with short-term and long-term poor neuro-
logic outcome in patients with post-cardiac arrest syndrome.
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INTRODUCTION. Neurological prognostication after cardiac arrest
(CA) is a complex challenge for physicians and requires a multimodal
approach. Neurological Pupil Index (NPI) derived from automated
pupillometry and assessed at 24 hours after the event has been re-
cently shown a high sensitivity to predict unfavorable neurological
outcome after CA. Nevertheless, it is unclear how NPI correlates with
other predictors of brain injury in this setting.
OBJECTIVES. To assess the correlation of NPI with electroencephalog-
raphy (EEG) background, serum neuron-specific enolase (NSE) and
cortical response to somatosensory evoked potentials (SSEPs).
METHODS. Post hoc analysis of an international multicenter (n=10;
n=456 patients) prognostic study on automated pupillometry in co-
matose post-CA patients. The primary study endpoint was the accur-
acy of NPI in predicting 3-month unfavorable neurological outcome,
defined as Cerebral Performance Category (CPC) of 3-5 (severe dis-
ability, unresponsive wakefulness or death). The worst finding over
the first 3 days after CA among EEG background (dichotomized as
“continuous” vs. “’discontinuous”), cortical response to SSEPs (dichot-
omized as bilaterally absent (N20ABS) vs. “other”), and the highest
NSE value were evaluated.
RESULTS. On a total of 456 included patients, 398 (87%) had at least
one other prognostic tool assessed along with NPI. NPI were in-
versely correlated with NSE levels (n=228; r2=0.20; p<0.001). Further-
more, NSE values were significantly higher in patients with NPI ≤ 2
vs. those with NPI ≥ 4.0 (152 [113-415] vs. 31 [18-46] mg/L, respect-
ively; p<0.001). NPI values were significantly lower in patients with a
discontinuous EEG (n=137) (n=234 - 3.5 [1.4-4.0] vs. 3.8 [3.3-4.2]; p<
0.001) and in patients with N20ABS (n=63) than others (n=123 - 3.3
[1.0-3.7] vs. 3.6 [3.3-4.1]; p<0.001).CONCLUSION. Our data corroborate previous findings indicating that
impaired NPI is strongly associated with severe hypoxic-ischemic
brain injury and unfavorable neurological outcome after CA.
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INTRODUCTION. Following severe hemorrhage, proper response to
circulatory dysfunction is essential to immediate survival and
long‑term outcome. Standard approach is replacement fluids and va-
sopressors to treat hypotension. No firm consensus as to type and
volume of fluids exists, and hemodilution, clotting disruption, and in-
creased bleeding may result. Vasopressor use also varies clinically
with some reports documenting increased risk of mortality with use.
The CirQPOD (Zoll Medical) is an active intrathoracic pressure regula-
tion (a‑IPR) device placed between the endotracheal tube and a ven-
tilation source that generates negative intrathoracic pressure. It has
previously been shown to improve systemic and cerebral
hemodynamics.
OBJECTIVES. This study tested the hypothesis that post‑hemorrhage
a‑IPR use would enhance hemodynamics while reducing vasopressor
demand.
METHODS. 14 female farm pigs (38.8±1.3 kg) were bled 40% of circu-
lating blood volume from a central arterial line over 15 minutes,
followed by a 15‑minute stabilization period. Animals were random-
ized to one of two treatment groups, one with continuous a‑IPR ther-
apy, the other without a‑IPR therapy. In the a‑IPR group, the
CirQPOD was started at ‑5cmH2O and stepwise increased to a main-
tenance level of ‑10cmH2O over a 30-minute ramp-up period. At this
point, a target mean arterial pressure (MAP) of 65 mmHg was
achieved in both groups through controlled infusion of norepineph-
rine (NE), delivered to effect as needed, to the end of the 3‑hour
study. After 2 hours of device use, the device was ramped down for
30 minutes. Vasopressor demand and hemodynamic data were re-
corded throughout the study. All animals were anesthetized with
1.0% isofluorane throughout the study and ventilated with an FiO2
of 0.4 and a tidal volume of 8 ml/kg. Student’s t‑tests were used for
statistical comparisons. Data are expressed as mean±SD.
RESULTS. MAP during the study was matched between groups
(64.8±6.3 for NE only vs 67.8±4.5 mmHg for a‑IPR) through careful
dosing of vasopressor. Mean NE demand during the post‑bleed
period was significantly lower in the a‑IPR group compared to NE
only group (0.17±0.1 vs 0.04±0.04 ug/kg/min, p<0.05). Pulse pressure
variation (PPV) was matched between groups at the end of the post-
bleed stabilization period (27.6±6.0 vs 27.7±6.8%) but was lower in
the a-IPR group throughout the study, significantly during a-IPR
ramp‑up from 0-30 minutes (30.1±8.2 vs 17.5±4.9%, p<0.001) and
from 60-120 minutes (25.7±2.7 vs 17.7±2.7%, p<0.001). Cerebral per-
fusion pressure was also consistently higher in the a‑IPR group
throughout the study (49.4±6.8 vs 54.3±6.3mmHg), significantly dur-
ing ramp-up from 0-30 minutes (41.2±4.9 vs 50.3±7.2mmHg, p<0.01).
CONCLUSION. Addition of a‑IPR therapy post‑hemorrhage reduced
vasopressor demand, decreased PPV, and improved cerebral
hemodynamics. Use of a‑IPR has the potential to treat the
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hemorrhagic shock without risk of hemodilution associated with fluid
therapy and the complications associated with high dose norepin-
ephrine use.
CD - Haemodynamic monitoring
000118
Multi-centre clinical validation of a novel point of care
microcirculation assessment tool - the POEM score
J. Watchorn1, U. Goebel2, J. Wollborn2, M. Mccurdy3, H. Fargaly3,
M. Gilani3, J. Assadi3, AR. Deitchman3, DN. Naumann4, SD. Hutchings1
1Critical care, King's College Hospital, Denmark Hill, London, UK, London,
UK, United Kingdom; 2Critical care, Uniklinik Freiburg, Freiberg, Germany;
3Critical care, University of Maryland Medical Center, Baltimore, United
States of America; 4Surgery, Royal Centre For Defence
Medicine, Birmingham, United Kingdom
Correspondence: J. Watchorn
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000118
INTRODUCTION. Microcirculatory impairment has an impact on out-
come in a variety of disease states (1,2)and has been proposed as a
therapeutic target, however interventional studies are hindered by
time consuming off-line analysis. We recently described a 5-point or-
dinal scoring system, the Point Of carEassessment of the Microcircula-
tion (POEM) score (3).
OBJECTIVES. To determine the reliability of the Point of Care Micro-
circulation tool when used at the bedside in critically ill patients.
METHODS. All adult intubated patients in critical care were eligible
for inclusion using an emergency waiver of consent. A minimum of
four standardized video clips were taken by an investigator using an
incident dark field (IDF) video-microscope (Cytocam, Braedius Med-
ical, NL) who subsequently calculated a POEM score and recorded
the time taken. On completion a second investigator blinded to the
results of the first repeated this process. At a later stage (>1 month)
investigators re-scored their own and their co-investigators images.
Scores were analysed using Cohens weighted Kappa score to provide
intra-user, inter-user and test-retest reliability. A kappa statistic was
also calculated for test-retest reliability for POEM score 1-3 against
POEM score 4-5 which is the threshold for fluid administration used
in an ongoing interventional study (Clinical Trials.gov ID).
RESULTS. 80 patients were recruited at 3 sites in 3 countries. Poor
quality video assessments (cumulative Massey score >10) were ex-
cluded resulting in a loss of 15 (18%) of patients. Weighted kappa
analysis showed good agreement ( (0.4-0.6 moderate, 0.61-0.8 sub-
stantial, 0.8-1 excellent(4)) in all circumstances: Intra-User 0.801 (95%
CI 0.722-0.879), Inter-User 0.792(95% CI 0.719-0.861) and Test-Retest
reliability 0.701(95% CI 0.589-0.812). Mean time to record videos and
assess POEM scores was 7 min. (std deviation 03:38) Reliability of
the POEM score used to potentially dichotomise a decision on fluid
administration (POEM 1-3 vs 4,5) was also good, 0.726 (95% CI 0.637-
0.815)
CONCLUSION. Point-of-care assessment of the microcirculation using
IDF video microscopy and POEM scoring appears to be both quick
and have good agreement within and between investigators in a real
life clinical setting. This opens the possibility of using the score as a
resuscitation end-point.
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INTRODUCTION. Atrial fibrillation (AF) is the most common arrythmia
in intensive care unit (ICU). Previous studies reported that develop-
ment of new-onset AF was associated with poor outcomes. However,
information of the clinical course after the AF onset is scarce. More-
over, it is unknown whether sustained new-onset AF contributes to
poor outcomes.
OBJECTIVES. The primary goal is to describe the clinical course after
the AF onset. The secondary goal is to determine whether the dur-
ation of sustained AF contributes to poor outcome.
METHODS. In a prospective cohort study in 32 ICUs in Japan, we en-
rolled patients who were admitted to the participating ICUs from
2017 to 2018 and developed new-onset AF during their ICU stay. Fol-
lowing information was collected for the study patients: demograph-
ics, medical history, physiological variables before and after the AF
onset, AF duration, treatment for AF, mortality and the incidence of
ischemic stroke.
RESULTS. Of the 14,348 adult ICU patients excluding post-cardiac
surgery, 423 patients (2.9%) with new onset AF were enrolled. Medi-
cation for rhythm control, rate control and anticoagulation were ad-
ministered to 30%, 61% and 41% of all the new-onset AF patients,
respectively, during the initial episode of AF. Eighty-six patients
(20%) died within 30 days after the AF onset and 19 patients (4.5%)
experienced in-hospital ischemic stroke. Patients with initial sus-
tained AF longer than 48 hours (long AF) had increased 30-day mor-
tality compared with those with initial sustained AF shorter than 48
hours (15% vs. 28%, p=0.009). Long AF was independently associated
with 30-day mortality (adjusted OR 2.13; 95% CI, 1.17–3.85; p =
0.013) in multivariable regression analysis. Repeating multivariable re-
gression analysis for different duration of the new on-set AF (6,12,
18, 24, 30, 36, 42, 48, 72, 96, 120, 144, 168 hours), the longer initial
AF duration had greater odds ratios for 30-day mortality. Restricted
cubic spline function analysis also showed a dose-response relation-
ship between the initial AF duration and 30-day mortality.
CONCLUSION. The duration of initial sustained AF was associated
with 30-day mortality by various statistical analyses. Our findings pro-
vide strong rationale for further research assessing treatment for
new-onset AF in critically ill patients.
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INTRODUCTION. Early detection of occult hemorrhage is important
for timely treatment. Yet, availability of sensing modalities may be
minimal and knowledge of physiologic baseline often unknown.
Page 92 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55OBJECTIVES. To characterize the differences in bleeding detection
performance of predictive models trained with vital sign waveform
data derived from different monitoring modalities, referenced with a
personalized baseline or not.
METHODS. Waveform data (250Hz) from non-invasive monitoring
(NIM), arterial (ART), central venous (CVC) and pulmonary artery
(PAC) catheters were collected from 38 Yorkshire pigs during a stable
30-min period followed by bleeding at 20 mL/min until a mean arter-
ial pressure of 30 mmHg. Waveform data as well as beat-to-beat
(B2B) parameters were used to compute various secondary measures
(features) in a rolling window including basic statistics, entropy,
power spectral density, and others. Time series data were either ref-
erenced to a personalized stable baseline or not (universal baseline).
Classification models were trained to discriminate between stable
and bleeding states, and the Activity Monitoring Operating Charac-
teristic (AMOC) curve was used to characterize the tradeoff between
time to detection (TTD) of bleeding and false positive rate (FPR).
Nested models were trained to evaluate an increasingly rich sensor
data, starting from NIM, then adding ART, CVC, PAC, ART+CVC and
ART+PAC. The models were optimized and validated in a leave-one-
out cross validation framework.
RESULTS. Increasing availability of sensing modalities and referen-
cing to personalized baseline decreased TTD of bleeding at lower
FPR (Fig. 1). Without personalized baseline all but NIM and CVC
based models detected bleed <10min at a 1 in 100 FPR. With a per-
sonalized baseline, all models detect bleed <10min. PAC and ART+-
PAC detect bleed at 3min.
CONCLUSION. The ability of hemodynamic monitoring to detect
bleed onset improves with the availability of a personalized baseline
and more intense monitoring. Excellent bleed detection can be
achieved by all invasive monitors if referenced to personalized base-
lines whereas NIM performs less well.
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INTRODUCTION. Atrial fibrillation is the most common arrhythmia fol-
lowing cardiac surgery, with a percentage up to 50%. It is associated
with increased morbidity and mortality. Dexmedetomidine is a highly
selective a2 adrenergic agonist. Considering its sympathoinhibitoryaction, dexmedetomidine could be associated with postoperative atrial
fibrillation reduction.
OBJECTIVES. The present study aims to evaluate the effect of post-
operative dexmedetomidine on the incidence of atrial fibrillation
after cardiac surgery.
METHODS. This prospective, randomized, controlled, clinical trial was
carried out at the cardiac surgery unit of a tertiary care university
hospital. 164 patients, undergoing on pump cardiac surgery, were
evaluated. 21 were excluded due to preoperative atrial fibrillation or
flutter. 143 patients were enrolled. After arrival to the cardiac inten-
sive care unit, patients were randomized in two groups, dexmedeto-
midine and control group. Patients in dexmedetomidine group
received an infusion of dexmedetomidine (0.7 mg/kg/h) during the
early postoperative period. Primary endpoint was the incidence of
postoperative atrial fibrillation within the first three postoperative
days.
RESULTS. There were no differences in atrial fibrillation risk factors
between the two groups. There were also no differences in postoper-
ative parameters except for catecholamine (44.4% vs 55.6%, p=0.675)
and beta-blocker use (45.2% vs 54.8%, p=0.967) in dexmedetomidine
and non-dexmedetomidine group respectively. Our results revealed
that the dexmedetomidine group was associated with an increased
incidence of atrial fibrillation compared to the control. Prevalence of
atrial fibrillation in dexmedetomidine group (n=70) was 26 patients
(37.1%) and non-dexmedetomidine group (n=73) 16 patients (21.9%).
Subgroup analysis indicated that postoperative augmented diuresis
and low potassium levels (p<0.001) have an increased influence on
occurrence of atrial fibrillation in patients after cardiac surgery.
CONCLUSION. In our study, dexmedetomidine use after cardiac sur-
gery was associated with a higher incidence of postoperative atrial
fibrillation. More studies are required to determine the dexmedeto-
midine effect on atrial fibrillation after cardiac surgery.
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INTRODUCTION. Invasive blood pressure monitoring is recom-
mended in patients admitted to the ICU with shock (1). Non-invasive
blood pressure measurements are still often used but may be in-
accurate and may lead to erroneous interpretations in patients re-
ceiving vasoactive medication in the ICU (2).
OBJECTIVES. We aimed to compare mean arterial pressure (MAP)
measurements of blood pressure using non-invasive (MAPNi) and in-
vasive (MAPi) methods in a prospective cohort of critically ill patients,
both with and without vasoactive medication.
METHODS. This was a post-hoc analysis of the SICS-I study, in which
all patients acutely admitted to the ICU were included (3). The inva-
sive blood pressure, preferably via an indwelling radial artery cath-
eter, and non-invasive blood pressure, via oscillometric brachial cuff,
was measured within 24 hours of ICU admission. Linear correlation
was assessed by Pearson coefficient and precision and agreement by
Bland-Altman analysis. A difference of more than 10 mmHg was con-
sidered clinically inaccurate.
RESULTS. Of 1075 patients, 734 patients (68%) had both invasive
and non-invasive blood pressure measurements. Overall, MAPi and
MAPNi had strong positive linear correlation (r2=0.62, p < 0.001) (fig
1) which decreased if patients were on vasoactive medication (n =
361, r2= 0.44, p < 0.001) compared to patients not on vasoactive
medication (n = 373, r2=0.64, p <0.001). Bias was 1.0 (95% CI 0.2–1.7)
and limits of agreement of all measurements ranged from -19.5 (95%
CI -20.8– -18.2) to 21.4 (95%CI 20.1–22.7) (fig 2). The difference in
MAP was acceptable in 69.1% of all measurements, in 71.7% of























































Page 93 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55measurements in patients on vasopressors, and in 66.5% of measure-
ments in patients not on vasopressors (table 1).
CONCLUSION. Non-invasive blood pressure measurements are not a
reliable alternative for invasive intra-arterial measurements in critic-
ally ill patients, regardless of receiving vasoactive medication.
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INTRODUCTION. The amino acid citrulline (CIT) is of interest in vari-
ous conditions characterized by reduced enterocyte mass or func-
tion. Decreased CIT levels have been shown in critical illness, sepsis
and shock [1,2]. Less is known about daily dynamics of CIT values in
a general ICU patient population.
OBJECTIVES. To describe CIT in ICU patients during their first week of stay.
METHODS. Consecutive adult patients in 5 ICUs were studied. Plasma
was collected immediately after ICU admission and thereafter daily.
Following storage at -80 °C, samples were deproteinized and ana-
lyzed for CIT, using liquid chromatography-mass spectrometry. Citrul-
line values between groups were compared using the SPSS Median
Test for each day separately.
RESULTS. CIT was measured in 224 patients (median age 66.5, range
29-94 years; median APACHE II 18, IQR 11-23; 28 d mortality 10.3%).
Median CIT value of all measurements was 19.5 (IQR 14.0-25.8) μmol/
L, being higher in 28 d survivors [19.9 (IQR 14.7-26.2)] vs nonsurvivors
[14.4 (IQR 11.8-22.9) μmol/L] independent of renal dysfunction. Me-
dian of the lowest individual CIT value was 16.3 (12.6-22.4) μmol/L
and occurred on day 2 in 54% of patients. CIT values were lower in
patients with sepsis (significant on days 1-4), emergency surgical pa-
tients (days 1 and 2) and those admitted after gastrointestinal sur-
gery (days 1-4). CIT dynamics in all patients, in comparison of 28 d
survivors vs nonsurvivors and related to early enteral/oral nutrition
(within 48 h) and its success are shown in Figures 1-4.
CONCLUSION. A majority of patients had normal CIT values on admission
to ICU, rapidly decreasing to marginally low normal levels that persisted
over the first week. Lowest individual CIT value was reached most often
on day 2. CIT increased with early and successful enteral or oral nutrition.
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INTRODUCTION. Fish oil-containing lipid emulsions (LE), a type of LE
that is high in omega-3 (ω-3) polyunsaturated fatty acids, have been
used over the last years as a long-chain triglycerides source. Evidence
on their effectiveness is accumulating, but an updated pooled esti-
mate is currently unavailable.
OBJECTIVES. We conducted a meta-analysis (MA), asking if ω-3 fatty-
acid enriched PN improves clinical and laboratory outcomes in patients
treated in the ICU, and in a subgroup of critically ill patients, with trial
sequential analysis (TSA) to evaluate the robustness of the estimates.
TSA assesses the conclusiveness of pooled estimates by controlling for
type I errors given heterogeneity of the single estimates.
METHODS. We searched public databases using keywords “PN”, “fish
oil”, “lipids”, “emulsion” and “randomised controlled trial (RCT)”. Publica-
tions eligible for inclusion were RCTs in hospitalised adults given PN (at
least 70% of total caloric delivery) in ICU settings. Intervention and con-
trol groups received ω-3 fatty acids-containing and ω-3 fatty acids-free
LEs, respectively, both as part of PN. A critically ill (defined by the condi-
tion or by ICU stay >48h) subgroup analysis was pre-specified.
RESULTS. 24 publications were included. Pooled treatment effect es-
timates for clinical outcomes are shown in Table 1.
TSA results indicate statistically significant robustness of the esti-
mates on the effect of ω-3-enriched PN regimen compared to stand-
ard PN regimen in reducing infection rate, hospital stay and ICU stay,
which can be considered conclusive.
CONCLUSION. This is the largest MA conducted on this topic. Both in
the ICU and in the critically ill subgroup, risk of infection and lengths
of stay in hospital and ICU were impressively reduced with ω-3 fatty-
acid enriched PN; all effects were confirmed to be conclusive by TSA.
REFERENCE
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Table 1 (abstract 000600). Results for clinical outcomes
Outcome Population, N/n RR/MD (95% CI; p-value)
Infection rate Critically ill, 5/659
Total, 8/795
RR 0.65 (0.46, 0.94; p=0.02)
RR 0.62 (0.45, 0.86; p<0.01)fe
Sepsis rate* Total, 3/336 RR 0.56 (0.26, 1.19; p=0.13)fe
30-day mortality Critically ill, 10/769
Total, 12/925
RR 0.90 (0.69, 1.16; p=0.41)
RR 0.90 (0.69, 1.16; p=0.41)fe
Hospital stay, days Critically ill, 8/742
Total, 11/872
MD –3.89 (–6.90, –1.06; p<0.01)
MD –3.05 (–5.03, –1.07;p<0.01)re
ICU stay, days Critically ill, 9/826
Total, 11/890
MD –2.14 (–3.89, –0.40; p=0.02)
MD –1.89 (–3.33, –0.45; p=0.01)re
Mech-ventilation, days* Total, 6/528 MD –0.02 (–0.10, 0.05; p=0.60)fe
CI confidence interval, ICU intensive care unit, MD mean difference, N number
of studies, n number of patients, RR relative risk, fe fixed effects, re
random effects
Fig. 1 (abstract 000663). See text for description
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INTRODUCTION. The importance of early recognition, prevention
and treatment of refeeding syndrome (RFS) has been emphasized re-
cently[1]. Based on the criteria for high risk of developing RFS pro-
posed by National Institute for Health and Clinical Excellence
(NICE)[2], the new risk classification criteria of developing RFS were
recently published in 2018[3]. However, the frequency of each ap-
plied risk category and the association between the risks and pa-
tients’ prognosis have not yet been investigated.
OBJECTIVES. To describe the frequency of new classification groups
of RFS risk in the ICU and to investigate the association between the
risks and 30-day mortality.
METHODS. This cohort study was conducted at the tertiary-care uni-
versity hospital located in the metropolitan area in Japan from De-
cember 2016 to December 2018. We included critically ill patients
who were aged 18 or older, who were admitted to the ICU via the
emergency department, and who stayed in the ICU for 24 hours or
longer. The registered nurses and dieticians well-trained for this
study prospectively evaluated the NICE RFS risk factors at ICU admis-
sion for all critically ill patients. NICE RFS risk factors consisted of
weight loss, the period of little or no nutritional intake prior to the
ICU admission, and so on. The main exposure was risk classification
of RFS: no risk, low risk, high risk or very high risk, according to the
recently published criteria. The primary outcome was in-hospital mor-
tality censored at 30 day after ICU admission. We performed multi-
variable analysis using Cox proportional hazard regression. As the
primary analysis, the hazard ratio was adjusted for age, sex and pres-
ence of chronic illness.
RESULTS. We analyzed 541 patients who met the eligibility criteria.
The prevalence of four risk classification groups of RFS was 24.4% in
no risk, 24.6% in low risk, 48.8% in high risk, and 2.2% in very high
risk. The 30-day mortality was 5.3%, 6.8%, 14.8%, and 25.0%,
* No subgroup analysis performed due to insufficient number of trialsrespectively (log-rank trend test: p<0.001) (Figure). In multivariable
Cox regression, adjusted hazard ratios as compared to no risk
group were 1.19 (95% CI 0.44–3.23) with low risk group, 2.94 (95% CI
1.31–6.60) with high risk group, 5.33 (95% CI 1.35–21.1) with very
high-risk group.
CONCLUSION. More than half the critically ill patients had high or
very high risk of developing RFS according to the recently published
risk classification criteria. Patients with high or very high risk had
higher 30-day mortality. Early recognition, prevention and treatment
might be required for these patients.
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INTRODUCTION. A polymeric solution is recommended in first
intention for enteral nutrition in critically ill patients. The efficacy to
provide optimal amount of calories is often limited by digestive toler-
ance. Gastroparesis is frequent in neurocritically ill patients, explain-
ing the difficulties to achieve optimal enteral nutrition in the early
days after acute brain injury. A semi-elemental solution with hydro-
lyzed nutrients could facilitate digestive absorption and tolerance. Ef-
ficacy has never been evaluated in this specific condition.
Page 96 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55OBJECTIVES. To evaluate efficacy and tolerance of a semi-elemental
versus a polymeric solution for enteral nutrition in neurocritically ill
patients.
METHODS. Randomized open-label trial (NCT01833624) including
adult (age > 18), comatose (Glasgow Coma Scale (GCS) ≤ 8) patients,
admitted in our ICU after severe acute brain injury. Next-of-kin's con-
sent was obtained, or inclusion was done accordingly to an emer-
gency procedure, as allowed by local ethic committee. Patients in
the SE group received a semi-elemental solution (Peptamen AF®,
Nestlé®, 1.5 kcal/ml, 9.4 g of proteins per 100 ml), patients in the PM
group received a polymeric solution (Sondalis HP®, Nestlé, 1.5 kcal/
ml, 7.5 g of proteins per 100 ml). Protocol considered twice daily re-
sidual gastric volume (RGV) to increase enteral nutrition delivering
until objective was achieved, before 36th hour in case of good toler-
ance[1]. Primary judgement criterion was the daily amount of deliv-
ered calories. Intervention period lasted 10 days maximum.
Secondary judgement criteria were incidence of gastroparesis (de-
fined as RGV > 500 ml/12h) and diarrhea, the need for prokinetic
drugs use, daily amount of delivered proteins, 10th day plasma levels
of albumin and prealbumin, and 28-day mortality. Results are
expressed as mean ± standard deviation, or as number(percent).
RESULTS. 205 patients (128 men, age 53 ± 17, admitted for traumatic
brain injury (34%), subarachnoid hemorrhage (24%) or polytrauma
(15%) – GCS 5 ± 2, IGS2 49 ± 12), respectively 107 and 98 in the SE
and PM groups. Mean daily amount of delivered calories did not dif-
fer between groups (1501 ± 496 vs. 1539 ± 463 kcal/d, p=0.60). Sec-
ondary criteria are presented in table. Mean daily amount of
delivered proteins was significantly higher in the SE group (1.24 ±
0.04 vs. 1.05 ± 0.04 g/kg/d, p=0.0006).
CONCLUSION. The use of a semi-elemental solution did not increase
the daily amount of delivered calories in the first 10 days in neurocri-
tically ill patients, compared to a polymeric solution. The daily
amount of delivered proteins was increased, its interest could be
evaluated in further studies.
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SE group PM group p
Gastroparesis 22 (21%) 16 (16%) 0.43
Diarrhea 16 (15%) 9 (9%) 0.20
Prokinetic drugs 20 (19%) 18 (18%) 0.95
Albumin D10 (g/L) 23 ± 4 23 ± 4 0.73
Prealbumin D10 (g/L) 0.21 ± 0.08 0.18±0.06 0.06
Mortality D28 23 (22%) 21 (21%) 0.99000947
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INTRODUCTION. The intensive care (ICU) patient population has increas-
ing number of very long ICU stays. Long-stayers are usually defined as re-
quiring more than 1 weeks of mechanical ventilation and of ICU therapy.
Little is known about their nutritional and metabolic characteristics. In an
attempt to better coordinate their treatment and reduce their length ofstay (LICU), the service instituted a dedicated program enrolling patients
requiring more than 2 weeks of ICU treatment.
OBJECTIVES. The study aimed at investigating the demographic, nu-
tritional and metabolic aspects of their stay, including in the factors
associated with Hypoglycemia (<4.1mmol/l) or Hyperglycemia
(>10mmol/l) during the different phases of their ICU stay
METHODS. Retrospective analysis of 150 consecutive patients admit-
ted to the ICU long-stayer program. Data extracted from the PDMS:
age, SAPSII, weight, NRS-2002 score, daily energy, protein, and glu-
cose intakes, blood glucose (Glu) and lactate, 24hr insulin needs to
achieve Glu 6-8 mmol/l, 24hr-insulin, length of stay (LICU), and out-
come. Data median [IQR 25-75], univariate analysis.
RESULTS. Cohort characteristics were: age 62 years [52-71], NRS 5 [3-7],
SAPSII score 51[39-66]. LICU was 28 days [22-42] with mortality 18.7%:
NRS was significantly higher in those dying (p=0.007). The nutrition in-
takes were extremely variable during the first week with multiple inter-
ruptions, stabilizing thereafter at values below the protocol
recommendation. Median protein intakes and energy balances from D1-
D7 were 0.92g/kg [0.79-1.15] and -380kcal/d [-1170/19] respectively, and
from D8-D30 were 0.97g/kg [0.82-1.11], and -7 kcal [-259/78] respectively.
During D1-D5, blood glucose was correlated 24hr-insulin (r2 =0.41, p<
0.001), but only weakly with glucose intake, and not with C-Reactive-
Protein, without difference in septic and non-septic patients. Early Hyper-
Glu was associated with higher severity (p=0.040) and lactate (p<0.001),
but not with Glu intake, and resulted in higher Insulin (p<0.001) needs;
late HyperGlu was observed in younger (p=0.013), heavier patients(p<
0.001), and resulted in higher insulin(p<0.001)needs. Early HypoGlu was
observed in younger(p=0.013) and leaner patients(p<0.001), and late
HypoGlu, in younger patients (p=0.003) with low Glu intake (p<0.001).
CONCLUSION. Long-stayer patients were characterized by a higher
NRS-score, highest in those dying. Variability of nutritional intakes com-
pared to the protocol was a striking characteristic. Energy and protein
intakes were especially variable during the first week, and below the
ICU recommendation. Factors associated with Hypo- and HyperGlu dif-
fered over time. Early HyperGlu was associated with higher severity.
Late HypoGlu was associated with low Glu intake. Leaner younger pa-
tients were at highest risk of HypoGlu, while modestly overweight elder
patients were most exposed to HyperGlu. Blood glucose had no clear
association with glucose intake nor with inflammatory status.
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INTRODUCTION. When flow does not go up after increasing expiratory
driving pressure during tidal breathing expiratory flow limitation (EFL) oc-
curs heralding airway closure (AC). We were wondering whether chest
wall can contribute to small airways closure and hence to either EFL or
AC occurrence in acute respiratory distress syndrome (ARDS) patients.
OBJECTIVES. To investigate the role of chest wall elastance (EcW)
relative to lung elastance (EL) as a mechanism by which airways
would close in ARDS patients. Our hypothesis was that the lower the
EcW/EL ratio the higher the likelihood of EFL and AC.
METHODS. Moderate to severe ARDS patients intubated, sedated
and paralyzed were prospectively included in two centers. Mechan-
ical ventilation was delivered in volume-controlled mode (Evita XL or
V500 ICU ventilators, Draeger) with tidal volume 6 ml/kg predicted
body weight at positive end expiratory pressure 5 cmH2O in semi-
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and flow were continuously recorded during 2 minutes by a data
logger (Biopac 150). Then, end-expiratory and end-inspiratory occlu-
sions were performed for 5 seconds each, then respiratory system
was slowly inflated at constant flow from the ventilator. Finally, pa-
tient was allowed to breathe out freely to atmosphere by using a
three-way stop lock by-passing expiratory valve. AC and airway open-
ing pressure (AOP) were determined according to Chen et al. (1)
from the pressure-volume curve. EFL was assessed by the atmos-
pheric method (2). Dynamic elastances of chest wall (Edyn,cW) and
lung (Edyn,L) were obtained from least square linear regression
method over 10 consecutive breaths. Static elastances (Est,cW and
Est,L) were determined by classic formulas and also by taking into ac-
count AOP (Est,cW_aop and Est,L_aop, respectively). The perform-
ance of EcW/EL ratio to predict EFL and AC was assessed by area
under receiver operating characteristic (AUCROC) curve.
RESULTS. Among 21 included ARDS patients EFL was observed in 7
(33%) and AC in 15 (71%). Median AOP was 7.8 (95%CI 7.6-11.7)
cmH2O. The AUCROCs for EcW/EL ratios to detect EFL and AC are
shown in table 1. Edyn,cw/Edyn,L ratio has the best performance to
detect EFL(Edyn,cw/Edyn,L≤0.16 100% sensitivity and 85% specifi-
city). Correction for AOP worsened the performance of Est,cW/Est,L
ratio. AC was poorly predicted but prediction was improved with
AOP correction. AOP values had an AUCROC of 1 (0.84-1) (P<0.0001)
to predict EFL at the threshold of 8.3 cmH2O.
Table 1. Area under ROC curve (95% confidence intervals) for EcW/EL
ratio for EFL and AC prediction
CONCLUSION. Low Edyn,cW/Edyn,L ratio and AOP predicted EFL oc-
currence. However, EFL and AC are two distinct phenomena in ARDS
patients and should be assessed together to identify specific ARDS
subphenotypes in terms of small airway contribution in ARDS.
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EFL P value AC P value
Edyn,cW/Edyn,L 0.90 (0.84-0.94) <0.0001 0.53 (0.45-0.61) 0.51
Est,cW/Est,L 0.79 (0.56-0.93) 0.0099 0.56 (0.33-0.77) 0.69
Est,cW/Est,L_aop 0.57 (0.34-0.78) 0.71 0.79 (0.56-0.94) 0.004








≥ 8.0 kPa to < 12.0 kPa* 2.1 (256/11,930) 1.0
< 8.0 kPa 16.2 (9/55) 6.24 (3.17–12.25)
≥ 12.0 kPa to ≤ 16.0 kPa 2.0 (164/8,010) 1.00 (0.82–1.23)
> 16.0 kPa 3.4 (54/1,571) 1.66 (1.20–2.29)
Among 3,021 patients alive and on ICU 24 hours after primary ICU admission.
*Reference **Adjusted for gender, age, admission type, Simplified Acute
Physiology Score II, being currently ventilated, renal replacement therapy
within the first 24 hours of ICU admission, and inotropes or000247
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000247INTRODUCTION. Oxygen therapy is part of the invasive mechanical
ventilation strategy in the intensive care unit (ICU). Hyperoxaemia
may however increase mortality.
OBJECTIVES. To assess degrees of hyperoxaemia, adjustments of
fraction of inspired oxygen (FiO2) in response to hyperoxaemia, and
associations between hyperoxaemia and mortality in invasively
mechanically ventilated ICU patients.
METHODS. We conducted a retrospective study of all invasively
mechanically ventilated patients in 5 ICUs admitted from January 2011
to June 2016, retrieving all oxygen tension (PaO2) and FiO2 data. Time
between arterial blood gas (ABG) samplings, proportions of hyperoxae-
mia (PaO2 > 16 kPa), FiO2 adjustments upon hyperoxaemia, and associ-
ations between mechanically ventilated exposure-time-divided area-
under-the-curve (AUC) PaO2 and ICU mortality was assessed. Primary
ICU admissions were included in the mortality analyses, which used a
multi-state illness-death model with transition intensities estimated by
Cox proportional hazards models. The exposure-time-divided AUC
measure represents the average PaO2 level during invasive mechanical
ventilation. Permission to use data without patient consent was ob-
tained from the Danish Patient Safety Authority.
RESULTS. The study included 4,998 patients and 177,769 ABGs. Median
time between ABGs was 3 hours (inter-quartile range: 2-4 hours), PaO2
was 11.3 kPa (9.8-13.6 kPa), and FiO2 was 0.40 (0.35-0.50). Hyperoxaemia
was present in 11.9% of the ABGs. In 15.4% of the hyperoxaemic ABGs
with FiO2 ≥ 0.50, the subsequent ABG remained hyperoxaemic with un-
corrected FiO2, whereas this was the case in 64.6% of hyperoxaemic
ABGs with FiO2 < 0.40. Exposure-time-divided AUC PaO2 > 16.0 kPa was
associated with increased ICU mortality (Table 1). This association was ac-
centuated when censoring at the first PaO2 < 8 kPa to diminish the im-
pact of hypoxaemia (adjusted HR: 1.90 (95% CI: 1.27-2.86)).
CONCLUSION. ABG samplings were frequent and hyperoxaemia was
common in invasively mechanically ventilated ICU patients. While FiO2 in
general was adjusted upon hyperoxaemia, several patients remained
hyperoxaemic, especially at FiO2 < 0.40. This may not be optimal as
hyperoxaemia was associated with increased ICU mortality in the cohort.
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vasopressors within the first 24 hours of ICU admission
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pressure (PEEP) limits alveolar collapse, thereby improving oxygen-
ation. However, PEEP-induced increase of end-expiratory lung vol-
ume may flatten the diaphragm dome. Experimentally, we showed
that PEEP induced caudal diaphragm displacement, leading to an
acute reduction in diaphragm fiber length [1]. As the muscle is
forced to act at this shorter length, PEEP might impair diaphragm
function.
OBJECTIVES. To test the hypothesis that PEEP acutely induces a cau-
dal displacement and reduction in contractile efficiency of the hu-
man diaphragm.
METHODS. 18 healthy subjects participated. Non-invasive ventilation
(NIV) was used to apply PEEP at 2, 5, 10 and 15 cmH2O, for 15 min.
per level. For the first part, two nasogastric catheters were inserted
to measure diaphragmatic pressure (Pdi) and diaphragm electro-
myography (EMGdi). Neuromechanical efficiency (NME) was defined
as Pdi/EMGdi during tidal breathing with PEEP. Second, a MRI scan
was made to measure diaphragm position at each PEEP level.
RESULTS.Preliminary results: Fig.1 shows a MRI scan of the diaphragm
at end-expiration. A gradual PEEP-induced caudal displacement of
the diaphragm dome was found for all subjects (mean±SD 20.2±9.5
mm after increasing PEEP from 2 to 15 cmH2O, p<0.001). In 9 of the
subjects, NME could be obtained at all PEEP levels and decreased
gradually with higher PEEP. Median NME reduction was 20% (p=
0.31), 27% (p<0.05) and 41% (p<0.05) after increasing PEEP from 2 to
5, 10 and 15 cmH2O, respectively.
CONCLUSION. In healthy subjects, acute application of PEEP results
in caudal diaphragm displacement and reduction in diaphragm con-
tractile efficiency. If similar effects occur in the critically ill, acute re-
duction in PEEP (i.e. during a spontaneous breathing trial) may result
in an overstretched diaphragm and consequently impair diaphragm
performance.
REFERENCE
[1] Lindqvist J. et al. AJRCCM Vol 198, Iss 4, pp 472–485, 2018.Fig. 1 (abstract 000875). Left: Static MRI image of the diaphragm
(sagittal right view) at end-expiration. An increase in PEEP from 2 to
15 cmH2O resulted in 2.7 cm displacement of the diaphragm dome
(green line). Right: PEEP-induced caudal displacement of the
diaphragm dome (p<0.001, for all PEEP levels).
Fig. 1 (abstract 001591). behaviour in all groups.
Fig. 2 (abstract 001591). Hyperinflated vs Hypoinflated;001591
EtCO2 doesn’t always predict paCO2 during mechanical ventilation
and negative paCO2-EtCO2 gradient can result because of the
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INTRODUCTION. End-tidal carbon dioxide pressure is used routinely
as an indicator of arterial partial pressure of carbon dioxide, giving
an estimation of adequate ventilation. Normally paCO2-etCO2gradient is positive, representing normal ventilation-perfusion mis-
match. This can vary during mechanical ventilation.
METHODS. 42 healthy piglets, 24,2±2 Kg, were mechanically venti-
lated for 48 hours in prone position with a similar mechanical power,
delivered by primarily increasing tidal volume (TV), respiratory rate
(RR) or PEEP. The ventilation was set as follow:
1) High TV group (14 pigs): TV 803±122 ml/min, RR 11±4,5, PEEP 5,3±
0,8 cmH2O, mechanical power 20,8±7,9 J/min
2) High RR group (14 pigs): TV 299±61 ml/min, RR 40±1, PEEP 8,3±1,5
cmH2O, mechanical power 22,2±8,5 J/min
3) High PEEP group (14 pigs): TV 319±21 ml/min, RR 16,3±5,5, PEEP
24±1,1 cmH2O, mechanical power 21,3±8,5 J/min.
RESULTS. We observed after the set of our ventilatory strategy an in-
version of the paCO2 and etCO2 values with a negative gradient for
the entire experiment and in all groups of animals (EtCO2 30±18
paCO2 29±17 p=0,29)(fig1). The degree of hyperinflation was com-
puted as PEEP volume plus FRC and the median value (511,5 ml) was
taken as cut off above which the hyperinflation group was defined.
Hyperinflation significantly affected the inversion of EtCO2 and
paCO2: in fact the hyperinflation group (EtCO2 38±19,9 paCO2 37±
18 pCO2mixed 43±19) compared to the hypoinflation group (EtCO2
22±9, paCO2 21±10,6 and pCO2mixed 26,38±11,12) was significantly
different (p < 0,0001)(fig 2).
CONCLUSION. A possible reason for the inverse relationship between
etCO2 and paCO2 is indeed the development of hyperinflation and
for this reason of areas of the lungs open but without ventilation.
These areas will have longer time constants, behaving like a new
compartment or reservoir of CO2 for the expired air. This will make
the etCO2 more similar to the mixed venous pCO2, having more
time to reach equilibrium, while paCO2 will increase less the etCO2.
The overall phenomenon is the result of an impaired ventilation/per-
fusion mismatch.
F4
Fig. 1 (abstract 001604). Bacterial load (A) and white blood cell
count (B) in BAL. Differences among the groups were tested using
an ordinary one-way ANOVA. Post-hoc comparisons were performed
using the Newman-Keuls test. *p<0.05 vs PBS; # p<0.05 vs UC-MSCs.
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INTRODUCTION. Models of gram negative bacteria induced acute
respiratory distress syndrome (ARDS) have been well established
in rats. The therapeutic role of mesenchymal stromal/stem cells
(MSCs) looks promising in such a model (1). Contrarily, no infor-
mation is available on the role of MSCs in the treatment of pul-
monary ARDS induced by gram positive bacteria. Staphylococcus
Aureus is a clinically relevant gram positive bacteria, which is as-
sociated with >40% health care pneumonia cases and with mor-
tality rates of >50% (2).
OBJECTIVES. Objectives of our investigation were: 1. to establish a
model of gram positive bacterial pneumonia using a clinically rele-
vant strain of S. Aureus from a human isolate (Newman) (3); 2. To
evaluate the potential therapeutic role of naïve and preactivated um-
bilical cord (UC) MSCs freshly harvested from culture in the treatment
of acute lung injury in a new model of Rodent S. Aureus–induced
ARDS.
METHODS. Adult male Sprague Dawley rats underwent intratra-
cheal instillation of S. Aureus Newman to induce pulmonary ARDS.
Animals were randomized, within 2 hours post infection, to intra-
venous administration of: (1) vehicle (phosphate buffered saline
(PBS)); (2) 1x10^7/kg fresh UC-MSCs; and (3) 1x10^7/kg fresh UC-
MSCs preactivated for 24 hours with cytomix (TNF-α; IL-1β; and
IFN- γ [50 ng/mL each]). Comparisons among the groups were
tested for differences in bacterial load and white blood cell count
in the bronchoalveolar lavage (BAL), and arterial oxygenation
after 48 hours.
RESULTS. Endotracheal instillation of S. Aureus Newman induced
a model of moderate ARDS in rats. Fresh naïve UC-MSCs did not
treat the lung injury at 48 hour post infection. In contrast, the
preactivation of fresh UC-MSCs with cytomix for 24 hours allowed
to significantly increase the pulmonary bacterial clearance – as
shown by the lower bacterial load in the BAL (Figure 1A), to re-
duce the lung cell infiltrates – as shown by the lower white
blood cell count in the BAL (Figure 1B), and to improve oxygen-
ation with an average PaO2/FiO2 ratio above 300 at an FiO2 of
1.0 (data not shown).
Data are expressed as mean (SEM). n=6-8 per group. p-UC-MSCs=pre-
activated UC-MSCs.
CONCLUSION. Fresh preactivated UC-MSCs therapy decreased the
severity of S. Aureus induced ARDS by the reduction of bacterial load
and white blood cell infiltrates into the lungs, and by the increase of
arterial oxygenation. The use of preactivated UC-MSCs could repre-
sent a potential clinically relevant treatment of acute lung injury in
patients with gram positive induced ARDS.
REFERENCE(S)
1. Devaney J, Horie S, Masterson C, Elliman S, Barry F, O'Brien T, Curley GF,
O'Toole D, Laffey JG. Human mesenchymal stromal cells decrease the
severity of acute lung injury induced by E. coli in the rat. Thorax. 2015
Jul;70(7):625-35.
2. Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr.
Staphylococcus aureus infections: epidemiology, pathophysiology, clinical
manifestations, and management. Clin Microbiol Rev. 2015 Jul;28(3):603-
61.
3. Bubeck Wardenburg J, Patel RJ, Schneewind O. Surface proteins and
exotoxins are required for the pathogenesis of Staphylococcus aureus
pneumonia. Infect Immun. 2007 Feb;75(2):1040-4.SIS - Septic shock and respiratory
infection
000258
Genetic Association of Body Mass Index With Risk of Dying from a
Bloodstream Infection: A Study of 56,000 Subjects from the HUNT
Study With 23 Years Follow-Up
T. Rogne1, E. Solligård,1, S. Burgess,2, BM. Brumpton3, J. Paulsen4,
HC. Prescott5, RM. Mohus1, LT. Gustad1, A. Mehl6, BO. ÅSvold7,
AT. Dewan8, JK. Damås1
1Department of circulation and medical imaging, Norwegian University
of Science and Technology, NTNU, Trondheim, Norway; 2Mrc biostatistics
unit, University of Cambridge, Cambridge, United Kingdom; 3K.g. jebsen
center for genetic epidemiology, Norwegian University of Science and
Technology, NTNU, Trondheim, Norway; 4Department of medical
genetics, Norwegian University of Science and Technology,
NTNU, Trondheim, Norway; 5Department of medicine, University of
Michigan, Ann Arbor, United States of America; 6Department of
medicine, Levanger Hospital, Levanger, Norway; 7Department of
endocrinology, St Olavs Hospital, Trondheim, Norway; 8Department of
chronic disease epidemiology, Yale University School of Public
Health, New Haven, United States of America
Correspondence: T. Rogne
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000258
INTRODUCTION. In observational studies, higher body mass index
(BMI) has been associated with increased incidence and mortality of
bloodstream infection (BSI) and sepsis in the general population
(1,2), but with reduced mortality among patients with BSI or sepsis
(3). However, traditional observational studies are subject to bias and
confounding (4). Mendelian randomization studies utilizes the fact
that genotypes are randomly assigned at conception, which make
these studies less susceptible to reverse causation and confounding
(5).
OBJECTIVES. To evaluate the causal association of BMI with risk and
mortality of BSI in the general population, and with mortality among
patients with BSI.
METHODS. Non-linear Mendelian randomization study with a 23-year
prospective follow-up between 1995 and 2017 using a population-
based cohort in Norway (The HUNT Study). Of 93,865 invited sub-
jects, 65,236 (70%) participated, and 55,908 (60%) had complete data
on genotype and anthropometric measures. Genetically-predicted
BMI was calculated based on 939 single nucleotide polymorphisms
identified in an independent genome-wide association study. To ac-
count for selection bias, inverse-probability weighting was used in
the sub-analysis restricted to patients with BSI.
RESULTS. The mean age at enrollment was 48.3 years, 26,324 (47.1%)
were men, and mean BMI was 26.3 kg/m2. During median 21 years
Table 1 (abstract 000305). Basal demographic and hemodynamic
characteristics at inclusion
Fig. 1 (abstract 000305). Relationship between Lactate/Pyruvate
and PcvaCO2/CavO2. Dotted lines: normal limits (L/P<10, PcvaCO2/
CavO2<1.8), grey shaded area: normal range. No statistical
correlation was found (r=0,11; p=0,34)
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died from BSI. Compared with a genetically-predicted BMI of 25 kg/
m2, a genetically-predicted BMI of 30 kg/m2was associated with a
hazard ratio (95% confidence interval) for BSI incidence of 1.78 (1.40
– 2.27) and for BSI mortality of 2.56 (1.31 – 4.99) in the general popu-
lation, and for mortality of 2.34 (1.11 – 4.94) in the sub-analysis of pa-
tients with BSI.
CONCLUSION. Supportive of a causal relationship, we found that
genetically-predicted BMI was associated with BSI incidence and
mortality, even within the normal BMI range. Our findings contradict
the “obesity paradox” where previous traditional epidemiological
studies have found increasing BMI to be protective in terms of mor-
tality for patients with BSI or sepsis.
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INTRODUCTION. Targeting normal macro hemodynamics in septic
shock (SS) does not ensure adequate tissue perfusion. Thus, assessing
biological markers of tissue hypoxia may help to titrate therapeutics.
The lactate/pyruvate ratio (L/P) and the venoarterial CO2 gap / ar-
teriovenous O2 content difference (PcvaCO2/CavO2) have been pro-
posed as markers of anaerobic metabolism and as a surrogate of the
respiratory quotient, respectively.
OBJECTIVES. We attempted to determine if L/P ratio and PcvaCO2/
CavO2 correlates adequately as tissue hypoxia markers and if they
may predict lactate outcome in SS patients.
METHODS. Data from an ongoing prospective clinical randomized
control trial performed in 2 ICUs were analyzed. Patients were di-
vided into 2 groups: Lactate improvers (LI), defined as a decrease
≥10% at 6 hours or normalization (<2.0 mmol/L), and no-LI (decrease<10%). L/P ratio and PcvaCO2/CavO2 samples were collected and
compared at time 0 (basal), 2 and 6 h.
RESULTS. Twenty-seven septic shock patients have been studied until
now. Basal demographic and hemodynamic characteristics are described
in Table 1. No clinical differences were observed. No correlation was
found between L/P and PcvaCO2/CavO2 (r=0,11 p=0,34) (figure 1). L/P ra-
tio did not discriminate between LI and no LI, whereas PcvaCO2/CavO2
did as a whole (1.63±0.31 vs 2.26±0.5; p=0,024) and by 2 and 6h (1.26 vs.
2.07; p=0.006 and 1.79 vs 2.84; p=0.006, respectively). No other perfusion
parameter showed a significant difference. These and other perfusion pa-
rameters are shown in Fig 2.
CONCLUSION. PcvaCO2/CavO2 was accurate to identify lactate im-
provers and thus might be a reliable surrogate of tissue hypoxia,
whereas L/P did not. L/P and PcvaCO2/CavO2 values did not correl-
ate in septic shock patients and might represent different biological
mechanisms.
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INTRODUCTION. CAP is the most important cause of infectious death
worldwide. A major hallmark of CAP physiopathology is the high sys-
temic proinflammatory state that generates in part, when pathogens
induce mechanisms of host necrotic cell death, exacerbating inflam-
mation. It is well known that CAP patients experiencing uncontrolled sys-
temic inflammation, have worse clinical outcomes. However, the
underlying mechanisms of these proinflammatory reactions are not well
understood. NETosis, a recently described pro-inflammatory pathway of
neutrophil death and the driver of NET formation, has been shown to be
important in patients with pulmonary diseases such as bronchiectasis or
COPD, and directly associated with lung inflammation and damage. How-
ever, the role of serum NETs has not been investigated as the cause of
the proinflammatory state and mortality observed in patients with CAP.
Therefore, this study attempted to bridge this knowledge gap.
OBJECTIVES. To determine the role of circulating neutrophil extracellular
traps (NETs) in the systemic proinflammatory state and mortality ob-
served in patients admitted with community-acquired pneumonia (CAP).
METHODS. Here, we report a multicenter cohort study designed to better
understand the role of baseline circulating NETs in the systemic inflamma-
tion and mortality of CAP patients. Thirty-seven CAP patients and twenty-
five controls (patients with stroke and healthy individuals) were prospect-
ively enrolled in 2 university hospitals in Spain. Baseline serum cfDNA was
quantified using the Quant-iT PicoGreen® dsDNA Kit. To detect NETs in hu-
man serum samples we used a modification of the MPPO-DNA ELISA
method. Interleukins were tested by ELISA. Descriptive statistics and logis-
tical regressions were used to assess the results.
RESULTS. We show that patients with CAP developed a systemic proin-
flammatory profile characterized by increased serum concentrations of IL-6
and IL-10 (1,025pcg/mL, 172.5pcg/mL respectively). Patients diagnosed with
CAP had higher levels of free-DNA in serum (Median [IQR]; 0.273 [0.216,
0.391] Vs 0.480 [0.357, 0.720], p=<0.001) and NETs (Median [IQR]; 32 [25, 36]
Vs 76 [47, 125], p=<0.001). A linear regression among free-DNA and NETs
was confirmed with a r2=0.5788. The relation among IL-6 (r2=0.11), IL-10
(r2=0.09) and NETs was not significant. Regarding ICU mortality, 7 (19%)
CAP patients died and had lower levels of circulating NETs compared with
patients who survive (Median [IQR]; 34.00 [24.00, 70.00] Vs 50.75 [32.25,
94.50], p=0.12).
CONCLUSION. Our results provide a mechanistic link to the proin-
flammatory state of patients with CAP. Serum concentration of NETs
associated to up-regulation of NETosis and IL-6/IL-10. However,
serum NETs are not associated with mortality due to CAP. Finally,
there is no relation among interleukin levels and NETs concentration.
Other pro-inflammatory cell death pathways should be investigated
to better understand inflammation and mortality in CAP patients.
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INTRODUCTION. Hypocholesterolaemia and catecholamine hypore-
sponsiveness are hallmarks of sepsis, with a greater degree of abnor-
mality associated with worse prognosis [1,2]. Cholesterol is a crucial
component of the cell plasma membrane, regulating membrane per-
meability and responsiveness to hormones though expression and
activity of G-protein coupled receptors such as the β-adrenergic re-
ceptors. We have previously shown in our rat model of sepsis that
membrane cholesterol levels fall in heart and liver, with the extent
correlating with mortality.
OBJECTIVES. To determine whether restoration of membrane choles-
terol concentration levels in a rat model of sepsis would rescue ad-
renergic signalling and improve catecholamine responsiveness.
METHODS. Awake, instrumented male Wistar rats (300±50g) received
an i.p. injection of faecal slurry with i.v. fluid resuscitation com-
menced from 2h. Sham operated rats were treated identically but
did not receive slurry. At 6 h post-induction of sepsis, the interven-
tion group received an i.v. infusion of cholesterol containing lipo-
somes (10 mg cholesterol/300g bw) over 15 hours. Catecholamine
responsiveness was then tested by consecutively administering do-
butamine (10 μg/kg/min for 10 min, and norepinephrine (0.5 μg/kg/
min for 10 min) with a 30 min washout period in between. BP (inva-
sive), HR and SV (by echocardiography) were measured before and
after each drug was administered. Results are presented as mean ±
SE, analysed using Student’s t test and considered statistically signifi-
cant when p <0.05.
RESULTS. Animals treated with cholesterol-containing liposomes
demonstrated a more pronounced cardiac response after dobuta-
mine (DB) administration, with a significant increase in stroke volume
over untreated septic animals (Table 1). No improvement was seen in
the blood pressure response to norepinephrine (NE).
CONCLUSION. Administration of cholesterol-containing liposomes
improved myocardial responsiveness to dobutamine, but not the
pressor response to norepinephrineREFERENCE(S)
1. Journal of Critical Care 2010 25, 361.e7 2. Journal of International Medical
Research 2018 v46 (4), 1303
2. Therapeutic Acceleration Support (TAS) Fund UCL
Table 1 (abstract 001187). See text for description
% change of Sham Septic Liposome treated
Stroke volume
Dobutamine 21 ± 3 5 ± 5 32 ± 9
Norepinephrine 15 ± 18 5 ± 5 22 ± 13
Heart rate
Dobutamine 11 ± 11 13 ± 6 7 ± 3
Norepinephrine 7 ± 9 5 ± 4 2 ± 3
Cardiac index
Dobutamine 34 ± 16 18 ± 11 41 ± 12(b)
Norepinephrine 23 ± 14 10 ± 9(a) 24 ± 14(b)
Blood pressure
Dobutamine 2 ± 8 -9 ± 2(a) -6 ± 3
Norepinephrine 20 ± 12 10 ± 4 4 ± 4
a p< 0.05 vs sham, b p< 0.05 vs septic (untreated)
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INTRODUCTION. Ventilator associated pneumonia (VAP) is common in
critically ill patients and associated with high morbidity and mortality, es-
pecially when caused by antibiotic resistant bacteria. Recently, phage
therapy has emerged as a promising non-antibiotic based treatment of
antibiotic resistant bacterial infections. However, proof-of-concept experi-
mental and clinical studies are missing before its wider use in clinical
medicine. In our previous study, we have shown, that intravenous phage
therapy was as effective as antibiotics (teicoplanin) in improving outcome
of rats with VAP caused by methicillin-resistant S. aureus (MRSA).
OBJECTIVES. The goal of our current study was to evaluate the effi-
cacy of inhalative administration of phage cocktails (aerophage) for
the treatment of lethal MRSA VAP in a rat model.
METHODS. Four hours after intubation and protective ventilation, rats
were inoculated via the endotracheal tube with 1 x 1010 CFU (LD100) of
the MRSA clinical isolate AW7. Two hours after bacterial challenge, rats
were randomised and received either inhalative (n=10), intravenous (n=10)
or combination of both (n=11) administration of a cocktail of four phages
(1 x 1010 plaque forming units/ml of 2003, 2002, 3A and K). Therapy was
repeated after 12 and 24 hours and then once daily for four days in a
blinded manner. The primary outcome was survival at day four. Secondary
outcomes were bacterial and phage densities in the lungs and spleen.
RESULTS. Application of the multiphage cocktail using a combination of
inhalative (aerophage) and intravenous (IV) route significantly improved
survival compared to IV or aerophage monotherapies in this lethal pneu-
monia model (91 % vs. 50 % and 50%, respectively, p< 0.04, log-rank test).
Mortality correlated with high bacterial load within the lungs and spleens.
Animals that succumbed to infection had over 19,000-times more MRSA
in the lung when compared to those that survived until 96 hours (8.8 x
108 CFU/g vs. 4.6 x 104 CFU/g, respectively, p < 0.0001, t test). Similarly,
spleen in dying animals had over 150-times more MRSA when compared
to those that survived until 96 hours (4.1 x 104 CFU/g vs. 2.6 x 102 CFU/g,
respectively, p < 0.0001, t test). Despite improved survival for rats treated
with the combination of aerophage and IV, the treatment groups did not
differ in the bacterial burden in the lung or the spleen (p=0.20, two-wayANOVA). High phage loads were detected in the lungs of all treatment
groups. In contrast to IV administered phages, inhalative phages did not
readily accumulate in the spleen.
CONCLUSION. The combination of aerosol and intravenous phage
therapy significantly improved outcome compared to inhalative or
intravenous phage therapy alone.
REFERENCE
1. This work was supported by ESICM Basic Science Award 2018 to JP
HSRO - What should we do better to
improve (long term) outcome?
000212
A Phase 2 Randomised Clinical Trial to Investigate the Effect of
Intermittent versus Continuous Enteral Nutrition on Muscle
Wasting in Critical Illness: Adverse Events, Gastric Intolerance,
Glucose Variation
A. McNelly1, DE. Bear2, B. Connolly3, G. Arbane3, L. Allum3, A. Tarbhai,4,
J. Cooper5, P. Hopkins6, M. Wise7, D. Brealey8, K. Rooney9, J. Cupitt10,
B. Carr11, N. Hart3, H. Montgomery4, ZA. Puthucheary1
1William harvey research institute, Barts and The London School of Medicine
and Dentistry, London, United Kingdom; 2Critical care unit, Guys & St Thomas
Nhs Foundation Trust, London, United Kingdom; 3Lane fox unit, Guys & St
Thomas Nhs Foundation Trust, London, United Kingdom; 4Centre for human
health & performance, University College London, London, United Kingdom;
5Cardiovascular genetics, University College London, London, United
Kingdom; 6Critical care, King's College Hospital, London, United Kingdom;
7Critical care, University Hospital of Wales, Cardiff, United Kingdom; 8Critical
care, UCL Hospitals NHS Foundation Trust , London, United Kingdom;
9Critical care, Bristol Royal Infirmary, Bristol, United Kingdom; 10Critical
care, Blackpool Victoria Hospital, Blackpool, United Kingdom; 11Critical
care, University Hospitals of North Midlands, Stoke-on-Trent, United Kingdom
Correspondence: A. McNelly
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000212
INTRODUCTION. Early rapid loss of skeletal muscle is common in crit-
ical illness and is associated with negative outcomes[1-4]. Continuous
feeding, routine in most intensive care units (ICUs), suppresses myofi-
brillar protein synthesis[5], whereas intermittent feeding may augment
it[6]. We report safety data from a study comparing muscle mass after
intermittent versus continuous enteral feeding during early ICU care.
METHODS. Adults (mechanically ventilated ≥48hours, on ICU ≥7days, with
multi-organ failure) recruited within 24 hours of admission to one of 8 UK
ICUs were randomised to receive four-hourly intermittent feed (interven-
tion) or continuous (control) enteral feed for 10 days (NCT02358512). We
recorded events associated with significant morbidity or death (Adverse
Events, AEs; Serious Adverse Events, SAEs), including pulmonary aspiration;
gastric intolerance (vomiting, diarrhoea [Bristol Stool Score ≥5], need for
prokinetics use, gastric residual volume (GRV)>300mls); adverse blood glu-
cose levels (>10.1mmol/l hyperglycaemia, <3.9mmol/l hypoglycaemia); Co-
efficient of Glucose Variation [CGV]). Daily insulin use was also documented.
Data are reported descriptively and analysed by two sample t-tests or
Mann-Whitney U-tests as appropriate.
RESULTS. Participants (mean [95% Confidence Intervals] age: 57.7 [54.7-
60.6] years; 67% male) received intermittent (n=62) or continuous (n=59)
enteral feed. No cases of pulmonary aspiration were reported. Groups
did not differ in proportion of days in which prokinetics were used, GRVs
were >300ml, or in which diarrhoea, vomiting, hypoglycaemia or hyper-
glycaemia occurred. Daily insulin use was also similar. Glucose variation
was greater in those intermittently fed (p<0.001, Table 1).
Ten SAEs and AEs were reported (3, Continuous vs. 7, Intermittent): two of
latter AEs were probably/possibly considered to be intervention-related
(both due to abnormal glucose levels). One patient transferred from inter-
mittent to continuous feed (consultant decision).
CONCLUSION. Intermittent enteral feeding in early critical illness is safe
and associated with similar levels of gastric intolerance, but greater glucose
variation than continuous feeding; however, daily insulin use was similar
between patient groups.
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INTRODUCTION. Rapid response teams (RRT) provide critical care services
for deteriorating patients outside of intensive care units to stabilize them, and
if necessary, facilitate transfer to a higher level of care within the hospital [1].
There is a paucity of literature looking into characteristics of RRT activations in
the post-operative period. There is no data looking into the correlation of RRT
activations and outcomes and the types of anesthesia used for adult patients.
OBJECTIVES. Our objective was to explore if specific anesthesia types
had any impact in the disposition of patients who required RRT acti-
vation during the first 24 hours postoperative period.
METHODS. Patients with RRT activations that occurred within 24 hours
after receiving anesthesia at Mayo Clinic in Rochester from July 1, 2012
to November 1, 2017 were included. Only the first RRT activation was
included in those patients who had multiple RRT activations. Anesthesia
types were extracted from established Operation Room DataMart and
divided into 6 groups: general anesthesia (GA), regional block (RB), local
anesthesia (LA), sedation (SE), monitored anesthesia care (MAC) and
combined anesthesia with general anesthesia and regional block (CO).RESULTS. A total of 2,046 (54% men) unique patients aged >=18
years (median 65 years) with RRT activations within 24 hours after
procedures were identified and their anesthesia types were: 825 (40
%) GAs, 91 (4 %) RBs, 165 (8 %) LAs, 445 (22%) SEs, 329 (16 %) MACs
and 191 (9 %) COs. 62% of those patients were ASA 3 or higher. The
median time to the RRT calls after anesthesia was 8 hours (interquar-
tile range: 4, 16). The most common reason for RRT activations in
each group was due to cardiovascular issue, accounting 61% for
2046 RRT activations and including bradycardia (5%), tachycardia
(24%), hypotension (30%), hypertension (6%), chest pain (6%) and
other symptoms (1%). 897 patients (44%) were transferred to a
higher level of care unit immediately after RRT activations. Multivari-
able logistic regression analysis revealed the following factors to be
associated with increased transfers to higher levels of care:
anesthesia type (p=0.004), the procedure type (p<0.001), preopera-
tive history of hypertension (p<0.001), intraoperative use of vaso-
active drugs (p=0.02). Compared with the GA group, patients who
underwent LA (OR=2.39; p<0.05) and SE (OR=1.83; p<0.01) had sig-
nificant more transfers to a higher level of care.
CONCLUSION. Patients who had RRT activations during the first 24
hours after local anesthesia or sedation required transferring to the
higher level of care more often, when compared to general
anesthesia. We hypothesize that this occurs because the above pa-
tients who underwent local anesthesia or sedation had a higher ASA
status and more serious disease so that they might not be able to
undergo the complicated procedures, and the anesthesia type might
not be a direct factor. Maintaining vigilance in non-GA patients is
critical to ensuring postoperative safety in these patients.
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INTRODUCTION. Correlation between mortality and the length of
hospital stay (LOS) prior to ICU admission is relatively understudied.
Some studies have previously shown that admission to ICU from the
ward vs from ED, and LOS prior to ICU admissions, is associated with
higher mortality[1-4]. This study aimed to determine if LOS prior to
admission to the ICU significantly affects mortality rate in emergency
admissions in an undifferentiated patient population at a district
general hospital. We looked for correlation between LOS and likeli-
hood of requiring invasive ventilation and renal replacement therapy
(RRT).
METHODS. This study is a retrospective analysis of 13,270 patients from
the WardWatcher Database at the ICU at East Surrey Hospital. Analysis
included all unplanned ICU admissions (n=8,623). Patient data on LOS
prior to ICU admission was compared against hospital and unit mortal-
ity, and requirement for invasive ventilation and RRT. The mean APA-
CHE II score and the absolute number of patients admitted with
respect to LOS prior to ICU admission was also recorded. We used re-
gression analysis and bootstrapping to assess for significant correla-
tions, producing an R-square value for mortality, the need for invasive
ventilation and RRT.
RESULTS.
Both the hospital mortality and the ICU mortality increased as LOS
on the ward prior to ITU admission increased (fi.g1). Using bootstrap-
ping (1000 samples), we estimated the R-squared value and 95%
confidence interval for mortality in the groups with 14 and 28 day
Fig. 4 (abstract 000128). Percentage of patients requiring
invasiveventilation and RRT with respect to lenght of hospital stay
prior toICU admission
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ively. There was also a weak positive correlation between the mean
APACHE II score (days 0-14) and LOS prior to ICU admission (R=
0.4634). However, there was almost no correlation between LOS prior
to admission and the need for ventilation/RRT (fig.4).
CONCLUSION. In conclusion, this study found no correlation be-
tween duration of stay in hospital prior to ICU admission, and re-
quirement for invasive ventilation and RRT. Interestingly, however,
there was a strong positive correlation between length of ward stay
and hospital and unit mortality up to 14 days. A similar correlation,
albeit not as strong, was seen with APACHE II scores and LOS prior
to ICU admission. Patients admitted to ICU from the ward have been
previously shown to have higher illness severity scores compared to
those admitted from ED[4]. More work looking into ward patients’
antecedent events prior to ICU referral is needed to establish
whether there are predictors of a requirement for critical care that
could prompt earlier referral, and whether earlier critical care input
actually improves outcomes in this cohort.
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INTRODUCTION. Several specific predictive models were developed
to predict outcomes in victims of trauma. Among the most widely
used are those based on anatomical injury patterns, derived from the
Abbreviated Injury Scale (AIS): the Injury Severity Score (ISS) and its
later modification New Injury Severity Score (New ISS). However, it’s
not known whether these scores perform better than general critical
care scores for trauma patients admitted to the intensive care unit
(ICU).
OBJECTIVES. To compare the predictive ability for hospital mortality
of a general critical care score (SAPS 3), an organ dysfunction score
(SOFA) and anatomical injury based scores (ISS and New ISS).
METHODS. Retrospective cohort study of patients admitted to a spe-
cialized ICU from a tertiary university hospital in São Paulo, Brazil be-
tween March, 2012 and January, 2016. Admission data were
prospectively collected in the ICU clinical database. We retrieved
SAPS 3 and SOFA within 24 hours of ICU admission from the data-
base. Both ISS and New ISS were retrospectively calculated based on
the analysis of whole-body CT results and medical records by three
independent and trained evaluators. We compared the different
models overall accuracy with area under the receiving operator char-
acteristic (AUROC) curves using the DeLong method.
RESULTS.
The study cohort included 1110 victims of trauma admitted to the
ICU. Males were 84.1% of the patients and mean age was 40 (±18)
years. Main injury mechanism was blunt trauma (89.1%). Traumatic
brain injury was present in 733 patients (66%). Whole-body CT scan
Page 105 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55was performed in 689 patients (62%). At the time of ICU admission,
861 patients (77.6%) were on mechanical ventilation and 549 (49.5%)
on vasoactive drugs. Hospital mortality was 26.7% (296 patients), ICU
length of stay (LOS) was 7 [4,15] days and hospital LOS was 15 [7,33]
days. Mean SAPS 3 was 48.6 (±16.5) and mean SOFA was 6.4 ± 4.2.
Mean ISS was 30 (±12) and New ISS 41 (±15). In a complete case ana-
lysis, 918 patients were included. AUROCs (95% CI) were as follows:
SAPS 3 = 0.79 (0.76; 0.82); SOFA = 0.78 (0.75; 0.81); ISS = 0.60 (0.56;
0.64); 0.67 (0.63; 0.71). In pairwise comparisons, SAPS 3 and SOFA did
not differ (p = 0.53), while both outperformed the anatomical scores
(p <0.001); New ISS was a better predictor than ISS (p <0.001).
CONCLUSION. Critical care predictive scores outperform anatomical
based injury scores in predicting hospital mortality in trauma patients
admitted to the intensive care unit.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000606INTRODUCTION. At present, there are so many ICUS implement restrictive
visiting system at home and abroad, which could reduce ICU acquired in-
fection by limiting visiting time, number of visitors and other ways. The
concentrated visiting method enables family members and patients to
have certain communication and contact, and that maybe alleviates the
anxiety of family members and patients [1-2]. One study found that the
restricting relative visits is the main cause of patients' pain [3], and another
study also found that ICU patients who lack visitation have a more than
threefold increased risk of delirium[4], but unrestricted relative visitation
may increase infection, affect medical treatment work, and increase job
burnout of ICU medical staff, etc. [2,5]. However, at present, there is no rele-
vant guidance or consensus on the visiting of relatives of ICU patients at
home and abroad [1,2], which visiting mode is more beneficial to ICU pa-
tients, and there is no clear concept on the visiting time and number of the
two visiting modes.
OBJECTIVES. To compare the effects of un-restrictive visiting policy(UVP)
and restrictive visiting policy(RVP) on ICU patients' delirium and ICU ac-
quired infection, to explore the best visiting policy in ICU.
METHODS. Randomized controlled trails (RCTs) and quasi-
experiment about UVP and RVP in ICU were retrieved in CBM, CNKI, Wan-
fang Data, PubMed, Cochrane Library and Web of Science from their foun-
dation to Decmber 31 2018, and other sources as supplement was also
retrieved. Data were extracted after strict evaluation of literature quality by
two researchers, and Meta-analysis was conducted on literatures that met
the inclusion criteria.
RESULTS. A total of 18 studies and 4647 patients were included in this
study. There are 8 RCT studies and 10 quasi-experimental studies. The in-
cluded studies were divided into subgroups according to study design and
length of visitation. The results of the forest plot showed that UVP can not
only effectively decrease the incidence of ICU patients delirium [RR = 0.19,
95% CI (0.10, 0.18), P < 0.00001), reduce the ICU patients anxiety score [RR
= 1.60, 95% CI (1.67, 1.54), P = < 0.00001] and depression score [RR = 1.63,
95% CI (2.76, 0.49), P = 0.005), as well as effectively improve the family
members' satisfaction [RR=3.56, 95%CI(2.32,5.48),P=<0.00001]. Meanwhile,
the UVP did not increase the incidence of ICU acquired infection [RR=0.82,
95%CI(0.53,1.36),P= 0.31], ICU mortality [RR=0.61, 95%CI (0.21,1.79), P=0.37],
and length of ICU stay [RR=-0.40, 95%CI(-1.29, 0.50),P=0.39]. In addition,
without considering the study design, we found that the UVP may reduce
the incidence of ICU acquired infection [OR=0.65, 95%CI (0.51,0.816), P=
0.002], and the longer the visit, the lower the incidence of ICU acquired in-
fection [OR=0.75, 95%CI (0.61,0.91), P=0.004].
CONCLUSION. The UVP does not increase the incidence of ICU acquired
infection , the length of ICU stay and the ICU mortality. On the other hand,
the UVP can effectively decrease the incidence of ICU patients' delirium, re-
duce the ICU patients' anxiety score and depression score and improve the
ICU patients family' satisfaction.
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INTRODUCTION. The epidemiology of traumatic brain injury
(TBI) is rapidly changing, with an increasing number of old and
fragile patients. The aim of this study is to describe the char-
acteristics of elderly TBI and the effect of age on patients’
outcome.
METHODS. The CENTER-TBI (clinicaltrials.gov registration
NCT02210221) is a prospective observational longitudinal cohort
study including patients with TBI from centers across Europe. Data
were extracted from the CENTER-TBI database v1.1 with Neurobot
v2.6. Inclusion criteria were:
– diagnosis of TBI, with indication for Computed Tomography
(CT),
– presentation to study center within 24 hours of injury.
– ICU stay >72h.We excluded patients discharged alive from the ICU in < 72 hrs. Pa-
tients aged ≥65 were classified as elderly.
RESULTS. A total of 4509 patients were included in the CENTER-
TBI study, 2138 were admitted in the ICU and we focused on the
1488 fulfilling the inclusion criteria. Overall, mean age was 48.3
years (sd = 20.37) and 395 patients (26.5%) were considered eld-
erly. Elderly patients presented significant differences (p<0.001)
with respect to not elderly both in the admission characteristics
and in the discharge status:
– higher incidental fall rate (59% vs 32.9%), mainly at home
(43.3% vs 17.3%)
– higher morbidities, as cardiovascular history (70% vs 13.4%), or
pulmonary disease (13.8% vs 8.6%)
– higher use of anticoagulants (20.6% vs 1.3%) and antiplatelet
(27.6 % vs 3.9%)
– higher Glasgow Coma Score at admission (GCS higher than 13:
24.8% vs 15.5%)
– higher non-evacuated mass lesion (Marshal score 6 in 54.3% vs 31.1%)
– more frequent subdural hemorrhage (73.3% vs 51.8%)
– less Intracranial pressure monitoring (ICP 46.7% vs 63.9%)
– less days in ICU (8 days vs 12 days, in median)
– higher mortality in ICU (32.7% vs 13.2%) and at 6 months
(52.7% vs 18.6%)
– more unfavorable status (GOSE ≤4: 79.2 % vs 46.2%) but similar
severe disability (lower or upper) at 6 months (26.5% vs 27.6%
p= 0.728)No statistically significant differences according to age were shown in
pre-hospital hypotension (14.7% vs 17.3%, p=0.285), hypoxia (13.2% vs
17.7%, p=0.052) and also in the discharge location (in both cases, gen-
eral ward was the most common 50.7% vs 48.8%, p=0.599).
CONCLUSION. Elderly patients have more comorbidities, different
mechanism of injury, more severe CT scan findings, and have a
higher mortality when compared to the younger population.
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INTRODUCTION. Acute kidney injury (AKI) is frequent in polytrauma
patients and it is associated with increased mortality, hospital stay,
and morbidity. However, the real prevalence and impact on the out-
come of AKI in isolated traumatic brain injury (TBI) are unclear. Our
aims were
1. to assess the incidence and timing of AKI in a large cohort of
prospectively enrolled TBI,
2. to assess in-hospital factors related to AKI development;
3. to assess the association between AKI at different stages and
patients’ outcome.METHODS. The CENTER-TBI is a prospective observational longitudinal
cohort study including patients with TBI from centers across Europe. Data
were extracted from the CENTER-TBI database v1.1 with Neurobot v2.6.
Inclusion criteria for our study were ICU length of stay >72 h and >
two creatinine values or at least one urine output (UO) available
measures during the ICU stay.
AKI was defined by applying the RIFLE criteria.
RESULTS. 4509 patients were included in the CENTER-TBI study, of
which 2138 were admitted to the ICU. 1317 fulfilled the inclusion cri-
teria. Patients were grouped in three categories: normal renal func-
tion (N), risk or injury (R/I) and failure (F). The median age in the 3
groups was similar (around 50 y/o). The majority of AKI occurred
within the first 10 days from admission, with a median of 2 days
(IQR: 1-4 days) for the R/I category, and a median of 4 days (IQR: 1-6
days) for the F group. Patients with history of cardiovascular (CV) dis-
ease had a higher occurrence of both R/I and F (F= 45%, R/I = 31%
vs N= 25.5%, p = 0.003). During the ICU stay, patients in both the R/I
and in the F group suffered more from: episodes of neuroworsening
(F= 45%, R/I= 43% vs N= 30%, p < 0.001), raised ICP (F= 34%, R/I=
39% vs N= 27%, p=0.003), respiratory failure (F= 40%, R/I= 44% vs
N= 29%, p < 0.001)and pulmonary edema (F= 2%, R/I= 6% vs N= 1%,
p < 0.001). Unsurprisingly, patients in the F group underwent more
renal replacement therapy (F= 27% vs R/I= 3.5%, N= 2%, p < 0.001).
Fig. 1 (abstract 000838). See text for description
Page 107 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Median length of stay in ICU for R/I (14 days, IQR 7.5–28.5) and F (15 days,
IQR 8 –26) is longer than that of N patients (11 days, IQR 6–19.5). Patients
in the R/I and in the F groups showed higher ICU mortality (F 25.5%, R/I
27% vs N 9%, p < 0.001) as well as higher 6-month mortality (F 40%, R/I
28% vs N 17.5%, p < 0.001) and higher incidence of 6-month unfavorable
outcome (GOSE≤4 in F 62%, R/I 66% vs N 47.5%, p < 0.001).
CONCLUSION. The development of AKI seems to be an early
phenomenon, associated with the presence of previous CV history. It
is associated with increase LOS, ICU mortality and 6-month unfavor-
able outcome.
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INTRODUCTION. In patients with Traumatic Brain Injury (TBI), im-
paired cerebrovascular autoregulation (CAR), decreases the abil-
ity of the brain to tolerate the burden of elevated ICP [1]. This
burden is defined as the combination of the intensity and dur-
ation of events of elevated ICP. The association with the 6-
month Glasgow Outcome Score (GOS) can be visualized with
the color-coded plots proposed by Güiza [1]. In these plots, im-
paired CAR shifted the transition curve, which divides good ad
poor neurological outcome, towards lower ICP values. This
methodology can be applied to other neuro-monitored patients.
The proposed study aimed to investigate whether CAR status
plays a role in determining the ability of the brain to sustain el-
evated dose of ICP after subarachnoid hemorrhage (SAH).
METHODS. Retrospective analysis of ICP and mean arterial blood
pressure (MABP) time series of 98 patients with severe-grade
SAH, prospectively collected in two large European centres, (Inns-
bruck University Hospital (Austria); San Gerardo University Hos-
pital, Monza (Italy)). The methodology proposed by Güiza [1] was
used to visualize the association of the dose of ICP with out-
come, for active and passive CAR.
RESULTS. The transition curves resulting from the evaluation of
ICP dose events during passive and active CAR presented a negli-
gible difference with the “all-events” curve, Fig 1. This may be
due to the low prevalence of prolonged elevated ICP, the median
[IQR] percentage of ICP monitoring time above 20mmHg was
equal to 6.2 % [0.4 - 6.5], where CAR status may have a stronger
impact on outcomes.
CONCLUSION. No difference in the association between the ICP
dose burden and outcome could be demonstrated for active and
passive CAR. In absence of prolonged intracranial hypertension
other factors, apart from CAR status, may have a more important
role in determining the outcomes.REFERENCE
[1] F. Güiza et al., “Visualizing the pressure and time burden of intracranial
hypertension in adult and paediatric traumatic brain injury,” Intensive
Care Med., vol. 41, no. 6, pp. 1067–1076, 2015.000934
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INTRODUCTION. Estimation of patients’ neurological prognosis after car-
diac arrest is challenging and reliable prediction of the outcome can usually
be made only after few days. Lack of slow waves in electroencephalogram
(EEG) has been associated with hypoxic ischemic encephalopathy [1]. Quan-
tification of slow wave activity offers a potential tool for early prediction of
neurological outcome in comatose cardiac arrest survivors.
OBJECTIVES. To investigate the association between continuously
measured frontal slow wave activity and neurological outcome
at six months after cardiac arrest.
METHODS. In this study (NCT03485781), data from 66 comatose cardiac
arrest survivors treated in the intensive care units (ICUs) of Helsinki Univer-
sity Central Hospital and Oulu University Hospital was used. EEG was re-
corded from the ICU admission until 48 h from return of spontaneous
circulation (ROSC) using self-adhesive disposable forehead electrode and
wireless measurement device. The slow wave activity was determined by
calculating the low-frequency (< 1 Hz) power of EEG. The low-frequency
activity at different time points after ROSC was statistically compared be-
tween patients with good and poor neurological outcome using Wilcoxon
rank sum test. The outcome was defined by evaluating the patients’
neurological recovery at six months using Cerebral Performance Category
(1-2 = good outcome; 3-5 = poor outcome).
Page 108 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55RESULTS. The patients with poor outcome (N = 26) had less
frontal slow wave activity in the early phase of ICU admission
compared to the patients with good outcome (N = 40). The me-
dian low-frequency power at 6-15 h after ROSC in patients with
poor outcome was 48.4 ± 9.7 % (mean ± std) compared to the
median low-frequency power in patients with good outcome. The
difference between groups was statistically significant until ap-
proximately 15 h from ROSC.
CONCLUSION. Frontal EEG slow wave activity may be a suitable
objective measure for the early prediction of neurological out-
come in comatose cardiac arrest survivors.
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INTRODUCTION. To prevent of secondary ischemic brain damage in
critically ill patients with acute cerebral aneurysm rupture, a level of
PaCO2 should be adjusted to achieve the best cerebral oxygenation
with stable intracranial pressure (ICP). Presently the maximum safety
level of hypocapnia has not been determined.
OBJECTIVES. To determine intracranial pressure and cerebral oxygen-
ation in different levels of PaCO2 in patients with acute cerebral
aneurysm rupture and high risk of cerebral vasospasm.
METHODS. We analyzed the acid-base and gas composition of ar-
terial blood, intracranial pressure, mean arterial blood pressure
(ABPmean) and cerebral perfusion pressure (CPP), jugular bulb
oxygenation (SvjO2) at different levels of PaCO2 in 30 critically ill
patients with acute cerebral aneurysm rupture and high risk of
cerebral vasospasm (Fisher III-IV, Hunt-Hess III-IV). In this patients
were recorded - 84 cases a decrease PaCO2 ≤ 30 mm Hg. and
less (group 1), in 50 cases - PaCO2 30.1-33 mm Hg (group 2), in
36 cases - PaCO2 33.1-36 mm Hg (group 3), in 57 cases - PaCO2
≥ 36.1 mm Hg (group 4).RESULTS. Different levels of PaCO2 were due to different minute
ventilations (MV) (Table 1). The medians of SvjO2 at different
PaCO2 levels were within normal limits, but the severe hypocap-
nia (≤ 30.1 mmHg) was accompanied by episodes of a decrease
SvjO2 ˂ 60%. The back side of the PaCO2 selection for prevention
of cerebral blood flow disturbance is the increase of ICP during
the elimination of hypocapnia. We identified highest ICP levels
with an increase PaCO2 ≥ 33.1 mm Hg and no negative changes
in cerebral oxygenation, despite a decrease in CPP. The minimum
levels of cerebral perfusion pressure were noted in group 3
(Table 1).
CONCLUSION. Moderate hyperventilation with a decrease PaCO2
to 33.1 mm Hg. can be a safe method for the ICP correction in
critically ill patients with acute cerebral aneurysm rupture and
high risk of cerebral vasospasm. PaCO2 ˂ 30.1 mm Hg increased
risk of cerebral desaturation and cerebral metabolism disorders.TEM - Emergency medicine: Trauma,
burns and cardiac arrest
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INTRODUCTION. Objectives: To analyze the relationship between
serum inflammatory cytokines in adult patients in the first hours
of severe trauma, and hospital mortality.
METHODS. Prospective cohort study. Consecutive adult patients
with trauma admitted to a teaching hospital - reference in
trauma (traffic accidents or violence) care. In all patients the
serum cytokines were collected within the first 6 hours of
trauma. Descriptive statistics and univariate analysis were
performed.
RESULTS. It were studied 40 patients (mean age 33.8y, 77.5%
male, APACHE 21.0); 77.5% traffic accidents, 15% violence, 7.5%
Page 109 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55falls/ work accidents, 32.5% had AKI (7% needed dyalisis), 15%
ARDS. Mean ICU and hospital LOT of 11.8 and 25.2 days, respect-
ively. Hospital mortality of 15%. Higher serum cytokines IL-1, IL-6
and TNF where inversely related to hospital mortality (table 1
and figure 1).
Figure 1
CONCLUSION. In adult patients with severe trauma (most of them
with brain trauma), the serum level of inflammatory cytokines
(mainly IL-1, IL-6 and TNF-α) in the first 6 hours of trauma is inversely
related to hospital mortality.Fig. 1 (abstract 000528). See text for description001724
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INTRODUCTION. Bacteremia is a major nosocomial infection problem
in view of its high mortality.
The aim of this study was to identify risk factors and to describe epi-
demiological patterns for early onset (EOB) and late onset (LOB)
bacteremia after trauma
METHODS. All trauma patients admitted to our surgical intensive
care unit (SICU) and general ward (GW) from January 2011 to Decem-
ber 2015 were retrospectively enrolled. The following information
was collected for each patient and recorded in a computer database:
demography, severity of trauma according to the Injury Severity
Score (ISS) and each abbreviated injury score (AIS), severity of coma
according to the Glasgow Coma Scale (GCS), presence of shock and
transfusion. Early onset bacteremia was defined as EOB when onset
occurred within 7 days after trauma, and late onset bacteremia was
defined as LOB when appearing after 7 days from trauma.
RESULTS. Thirty-seven patients developed bacteremia during their hos-
pital stay: 9 (24.3%) EOB, 28 (75.6%) LOB, and 4 (10.8%) patients devel-
oped both of them. Sixty-eight events of bacteremia happened to
these patients: 10 (14.7%) EOB and 58 (85.3%) LOB. Gram-positive cocci
were isolated more frequently than Gram-negative bacilli in both
groups. Gram-positive cocci were more frequently isolated in EOB than
in LOB: otherwise, there was no statistical significance (80% versus
67.2%, P = 0.702). Central line associated blood stream infection
(CLABSI) and surgical site infection (SSI) were the most common identi-
fied source for LOB. The risk of EOB was significantly increased by the
presence of pelvic and liver injury on arrival in emergency department
(ED), transfusion within the first 24 hours after trauma. Presence of liverand pancreas injury, gastrointestinal tract perforation and shock repre-
sented risk factors for LOB. LOB had a different pattern and their risk
was significantly increased by ISS (P = 0.002) and abdominal injury
score (P = 0.003).
CONCLUSION. Presence of pelvic and liver injury on arrival in ED and
transfusion within the first 24 hours after trauma appear a significant
risk factor for EOB. Scoring with the ISS and intra-abdominal injury at
admission to ED appears a useful tool for identifying trauma patients
at increased risk of LOB.
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INTRODUCTION. The burned patient is one of the most complex
cases and Intensivist can face, with a high mortality rate and multi-
ples connotations on the hemodynamics of the patient. Those with
Inhalation Injury have a worst prognosis, typically associated with re-
spiratory complications. However, the possible effects of inhalation in
the cardiac conduction and therefore in the development of critical
arrhythmias have been less studied.
OBJECTIVES. To Study the possible association of toxic gas inhalation
with the development of critical arrhythmias in burned patients with
Inhalation Injury.
METHODS. Retrospective observational study performed in the Critical
Burn Unit (January 2017 to February 2019) including 16 patients over
18 years old with a high suspicion or confirmed Inhalation Injury. Mean
and standard deviation were used for normal quantitative variables
and median and interquartile range in the opposite case. Qualitative
variables were presented by absolute and relative frequencies.
RESULTS. We studied 152 patients admitted in our Critical Burn Unit
of the La Paz Hospital in Madrid Spain from January 2017 until Feb-
ruary 2019. 16 patients (10.5%) with high suspicion or compatible cri-
teria with Inhalation Injury, with initial carboxyhemoglobin over 4%
at admission. Mean age was 59 (± 17.1), Median burned TBSA was
17% (RI 6-36%), Median APACHE II was 13 (RI 10-19), Median ABSI
score was 7 (RI 5-9). The initial Carboxyhemoglobin at the burn site
was not registered in the majority of the patients, so we couldn’t
study it’s correlation with the evolution of the patients. 65% of the
patients received treatment with 5grs of hydroxocobalamin before
Table 1 (abstract 000161). Max grade of doctor review in the 24 hours







Table 2 (abstract 000161). Cardiac Arrest Data (initial rhythm unknown
in 23%), No. (%)




Advanced Airway 27 (73)
ROSC 24(65)
Discharged from Hospital 11(30)
Page 110 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Hospital Admission. The median initial levels of Carboxyhemoglobin
at admission in the ICU was 13 (RI 5-22), mean Lactate at admission
was 4.2. 31% of patients had corrected QT interval prolongation.
Troponin I was measured only in 8 patients, 75% had elevated levels
in the first 24hours. Mortality was 25% (4 patients), 2 patients devel-
oped Ventricular tachycardia followed by cardiac arrest.
CONCLUSION. There might be correlation between toxic gas me-
diated Inhalation Injury and electrocardiographic disorders as sug-
gested by the prolongation of the Corrected QT interval, which
represents a good indicator of myocardial repolarization, elevation
of Troponin I levels and the development of cardiac arrhythmias.
Further studies must be performed.
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INTRODUCTION. There continues to be a significant mortality bur-
den associated with cardiac arrests. The percentage discharged
home remains low. (5 to 27%) [1,2] A failure to recognise clinical
antecedents and involve intensivists has been found in previous
studies. [2, 3]
OBJECTIVES. 1. Identify the frequency and outcomes of in-hospital
cardiac arrests.
2. Asses were the cardiac arrests preceded by clinical antecedents in
the 24 hours before arrest and were they recognised and acted upon
METHODS. An audit was performed of all in-hospital cardiorespira-
tory arrests in 2017. Cardiac arrests in ED, endoscopy, theatre and
ITU were excluded. In the 24 hours before arrest, all clinical anteced-
ents to suggest deterioration were noted.
RESULTS. 37 of the 23,398 inpatients had cardiorespiratory ar-
rests. The median age-adjusted Charlson’s comorbidity index
(CCI) was 6. The median age was 72. (IQR 81-63) In the 24
hours before arrest, the 4 most common symptoms and signs
were dyspnoea, tachypnoea, agitation and arrhythmias. 42% of
patients had an EWS of 7 or higher. 45% had RR >/= 22. 42%
had HR >/=100. 32% had SBP </= 90mmHg. 33% had 02 satura-
tions </= 92%. In the previous 24 hours, 32% of patients did
not have a registrar or consultant review. (Table 1.) Only 11%
had an ICU review. Only 22% had ABGs performed. 67% of ar-
rests occurred after hours. (Table 2.) 65% had ROSC and 30%
were discharged home.
CONCLUSION. Patients who proceed to cardiorespiratory arrest dur-
ing their admission have a high pre-existing morbidity burden and
one third are expected to die within the year. The rates discharged
home after cardiorespiratory arrest remain low. Similar to previous
studies, failure to recognise clinical antecedents and involve senior
doctors and intensivists still occurs. A critical care outreach team is
being introduced to help address this concern.REFERENCE(S)
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INTRODUCTION. Hypoxic-ischaemic brain injury (HIBI) is a common
complication following out of hospital cardiac arrest (OOHCA), and is the
cause of death in 68% of patients surviving to ICU admission(1). Predic-
tion of neurological outcome is a multimodal approach, with no singular
method giving 0% false positive rate(FPR)(2). Neurone specific enolase
(NSE) is a biomarker that positively correlates with poor neurological out-
come, with European Resuscitation Council (ERC) guidelines having an
NSE cut off of 33μg/L for poor neurological outcome(2). Controver-
sially, recent studies have shown higher thresholds. With new techniques
such as targeted temperature management (TTM), previous work gives
little indication of the utility of NSE in clinical practice. This study looked
retrospectively at the use of NSE in a single centre and describes the pre-
dictive value for NSE in prognostication for HIBI post OOHCA.
OBJECTIVES. The Primary outcome was to find an NSE threshold
value with 0% FPR for poor neurological outcome at ICU discharge
(GCS <7/15, or death due to neurological causes).
METHODS. A retrospective study was carried out on all adults with
OOHCA admitted to the Royal County Sussex Hospital ICU between
Page 111 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55April 2017-November 2018. NSE levels, TTM, brain imaging, comorbidi-
ties, survival and GCS at ICU discharge were recorded. NSE was mea-
sured using Chemiluminescent-immunoassay. NSE data was not used
for clinical decision making by the ICU team.
RESULTS. 89 patients were admitted with an OOHCA, 59 patients had an
NSE measured. NSE was sampled 48-72 hours post arrest. 61% had poor
neurological outcome, median NSE was significantly higher in this group
than those with good neurological outcome (103μg/L vs 20μg/L, p=
0.001). ROC analysis showed AUC of 0.901, sensitivity 77.8%, specificity
100%, and Yougen’s Statistic showed an NSE cut off value of 64.5μg/L. A
significant negative correlation was found between NSE and discharge
GCS.
CONCLUSION. Our results show that NSE can reliably and safely be
used to prognosticate for HIBI in clinical practice after an OOHCA, an
NSE over 64.5μg/L indicates poor neurological outcome with 0% FPR.
Furthermore we suggest that ERC guidelines need updating.
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INTRODUCTION. EWS allows detection of patients at clinical risk
of deterioration in order to establish an early and adequate
response.
OBJECTIVES. To implement a system for early detection of pa-
tients at clinical risk in conventional ward based on the NEWS-2
score, using the SBAR tool as a communication system.METHODS. A unicentric and descriptive pilot study. Period: Week-
ends ( Friday 4 pm to Monday 8 am) and bank holidays from 13th
December 2018 to 14th January 2019. Inclusion criteria: Patients allo-
cated in a medical ward (pilot ward) that deteriorate their condition
during the period of study. Exclusion criteria: Palliative patients with
indication of no reanimation orders. The score used NEWS-2 (Figure
2). Response protocol to alerts is shown in figure 1.
RESULTS. 20 patients included: 4 with NEWS-2 ≥ 7; 2 patients with
NEWS-2 = 5-6 and 14 paties with NEWS-2 ≤ 4. 3 patients recorded a de-
termination of 3 points in at least one parameter. NEWS-2 score was cor-
rectly performed in 100% of cases.9 patients met the alert criteria. 78% of
the cases being high risk (NEWS ≥ 7 and/or value 3 in any individual
parameter).Medical team activation was adequate in 67% of cases; in the
other 33%, despite register a score of 3 points in only one parameter, the
alert protocol was not activated.The time until medical evaluation was
adequate in 67% of the casesA single determination of 3 points in one
variable was more common in respiratory system variables: 67% of the
cases of arterial oxygen saturation and in 45% of the cases the respiratory
rate.No patient required admission to ICU, and clinical deterioration was
solved with measures implemented in the ward. We indicated no reani-
mation orders In 2 patients (both with NEWS2 ≥7) after evaluation. These
2 patients died despite treatment implemented.
CONCLUSION. Our EWS system could be a very useful tool to detect pa-
tients at risk of deterioration in a high percentage.Protocol deviations were
related to no medical team activation and delayed response times.Mea-
sures to improve training in the ward teams could improve these results.
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INTRODUCTION. ECG is simply method accesible in prehospital care
and is commonly used in management of OHCA. Previous studies
was focused mainly on ST elevation. Value of ECG after OHCA could
be influenced by haemodynamic instability, acido-basis changes and
hyposaturation after resuscitation.
METHODS. Observation retrospective study from prospective OHCA
registry of Cardiac Arrest Center (CAC). It was described different patholo-
gies and its frequency immediately after ROSC and after Hospital Admis-
sion and their relation to coronarography findings and finaly diagnosis.
RESULTS. It was included 146 patients after OHCA with Restitution of
Spontaneous Circulation (ROSC). Their ECG was provided after OHCA
and than after Admission to Hospital. ST elevation was presented by
52% of patients after ROSC and STEMI diagnosis was confirmed by
65,8% of patients ( senzitivity 66%, specificity 96% for STEMI). ACS
was confirmed by 68,4% of this patients and signifficant Coronary Ar-
tery Disease (CAD) by 91,7% and percutaneous coronary intervention
(PCI) by 73,3% ( patients underwent coronarography).
ST elevation were presented by 36% of patients after Admission, diagnosis
of STEMI confirmed by 75,5% (senzitivity 75%, specificity 89% for STEMI),
ACS was confirmed by 75,5%, significant CAD by by 93,2% and PCI was
provided by 77,3% of patients. Between ROSC and Admision ECG is sig-
nificant difference in STE elevation incidence (p=0,009) and QRS latitude
(p=0,003). We observe no significant diferences between both groups in
incidence of ACS, of significant CAD, PCI and systolic blood pressure. Time
between both curves was median 60 min,( IQR 25-75 ) 45-90 min.
Left bundle branch block (LBBB) was presetend by 9,6% of patients
after ROSC and 11,6% after Admission and has low sensitivity and
specificity for STEMI and ACS. Incidence of STEMI is 7,14% after ROSC
and 11,8% after Admisssion. ACS is present by 21,4% after ROSC and
17,6% after Admission, significant CAD by 62,5% and 75%.
ST depression are by 24,8% of patients after ROSC and 27,8% after
Admisssion, sensitivity and specificity for ACS is low (ACS by 36,1% after
ROSC and 45,7% after Admission, significant CAD by 79,2% after ROSC
and 80,6% after Admission and PCI was provided by 52,4% and 51,6%).
Normal ECG has low incidency after ROSC ( 5,5% after ROSC and
6,85% after Admisssion). ACS was confirmed by 50% of patients after
ROSC and 0% after Admission. (sensitivity for ACS exclusion 100%,
secificity 56% after Admisssion). Significant CAD was by 100% after
ROSC (if coronarography was provided) and 12,5% after Admission.
PCI was provided by 100% and 20%.
CONCLUSION. ST elevation has for STEMI diagnosis no significant
higher sensitivity, if they remain after Admisssion and both ST ele-
vation groups have high incidency of significant CAD and PCI. ST
elevation after ROSC has high specificity for STEMI. Normal ECG
after ROSC has are not well for ACS exclusion and normal ECG after
Admission is very high sensitive for ACS exclusion. LBBB and ST
depression has low sensitivity and specificity for ACS and CAD.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000739INTRODUCTION. CPR related injuries were not properly observed since
were established new guidlines for resuscitation (CPR) 2015 with stron-
ger recomandation for bystader and topless CPR. Data were not objec-
tivised by any scale in effort to establish seriousness of injury.
OBJECTIVES. To describe incidency and seriousness of injuries re-
lated to CPR and compare it by gender, bystander CPR, out vs. in-
hospital CPR and try identify factors for seriousness of injury.
METHODS. Multicentric study, retrospective analysis of autopsy re-
ports of patients after CPR, cardiac arrests caused by trauma were ex-
cluded. We describe damage of particular organs and we
objectivised the most serious injury with Abbreviated injury scale
(AIS)and summary of all injuries with New injury severity score (NISS).
RESULTS. We have enroled 701 autopsy reports , traumatic cardiac arrests
were excluded. We have analyzed 628 autopsies: 80,4% men, age median
67 years, out of hospital cardiac arrests 89,2%, bystander CPR 56,8% and
cardiac ethiology 78,2%. Ribs injury were founded by 94,6%, injury of lung
by 9,9%, sternal injury by 62,4%, liver by 2,5% and spleen by 1,8%. Mech-
anical CPR was provided by 11,5%. Median of the most serious injury was
3 (serious by Abbreviated injury scale) and median of summry of injuries
was 13 by NISS-low risk of fatal injury. By out of hospital cardiac arrest was
hifgher incidency of pleural injury and thorax vessles injuries without influ-
ence on total seriousness of injury compared to hospital cardiac arrests.
Bystanders provided CPR had similar incidency and seriousness of injury
like CPR provided only by professional emergency stuff, also by mechan-
ical chest deviced CPR we have observed no differences comapred to
manually. Women are significant older (p=0,0001), frequency of their injur-
ies are similar to men, but seriousness of their injuries by NISS is significant
higher (p= 0,01). Patients with life threatening injury (AIS 4 and more) has
similar baseline profil to their without injury (AIS 0), exept of significant
higher cardiac etiology of cardiac arrest by AIS 4+.
CONCLUSION. Incidency of CPR related injuries from autopsy reports
is very high, but life threatening injuries create only 3%. The highest
incidency have injuries of thoreax sceleton, especially ribs. There is
no difereneces if patients were resuscitated by bystander or by
mechanical chest devices compared to those by professional stuff or
manually. Women has similar frequency of injuries like men, but sig-
nificant more serious by NISS
MEN - Organ consequences of
endocrine and metabolic pathologies
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INTRODUCTION. Pheochromocytoma represents a rare tumour that
originates in chromaffin tissue, producing distant effects by secretion
of catecholamines. Usual clinical manifestations include headaches,
palpitations, hyperhidrosis and hypertension. Cardiac manifestations
of the disease are rare and throughout the literature sporadic cases
of phaechromocytoma mimicking acute coronary or Takotsubo syn-
drome have been reported. Acute cardiac manifestations in these pa-
tients, may be dramatic and even life threatening.
OBJECTIVES. A review of the literature regarding cardiac manifesta-
tions in patients with pheochromocytoma mimicking acute coronary
syndrome, cardiogenic shock or Takotsubo syndrome. In the review
of the literature we included a case reported in our ICU.
METHODS. A review of the literature was conducted using the key
words ‘pheochromocytoma’ and ‘cardiac manifestations’, ‘acute coronary
syndrome’, ‘Takotsubo syndrome’, ‘pulmonary oedema’ in PubMed, Sco-
pus, and Google Scholar databases. Published case reports and series
written in English were included. Abstracts were not included in the re-
view. Data was extracted regarding the presentation of symptoms such
as pulmonary oedema, Takotsubo syndrome, ECG changes consistent
with acute coronary syndrome, elevated cardiac enzymes and cardio-
genic shock in patients with pheochromocytoma. The second part of the
study includes a case reported in the ICU of our hospital of a 45-year-old
patient, with cardiogenic shock due to pheochromocytoma.
Table 1 (abstract 001574). See text for description
Groups and Mortality
Mortality (%) (number)
Calorie + Balance - 39.2 (249/636)
Calorie - Balance + 34.1 (307/901)
Calorie - Balance - 36.2 (199/550)
Calorie + Balance + 38.5 (276/717)
Table 2 (abstract 001574). See text for description
Demographic data
Mean Standart Deviation
Gender (Male %) 57.7
Age 61.4 20.1
Predicted Body weight 62.0 9.5
Ventilation Hour 223.3 276.7
Weight (admission day) 76.4 19.1
Weight (last day) 77.3 18.9
Height (cm) 167 8.7
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ture, 2 case series and 89 case reports, with a total of 128 patients. The
mean age of the patients was 46 years of age with ages ranging between
17 and 89 years of age with 1 case report not reporting the age. Seventy
nine of the 128 patients were female (62%). Forty nine of the 128 patients
(38%) presented symptoms of pulmonary oedema, 38 of the 128 patients
(30%) Takotsubo syndrome, 38 of the 128 patients (30%) cardiogenic shock,
101 of the 128 patients (80%) ECG changes consistent with ACS, and 45 of
the 128 patients (35%) presented cardiac enzyme elevations. Only 5 of the
128 (4%) patients presented all the above symptoms. A 45-year-old patient
admitted in our ICU with chest pain, emesis, and nausea, and a history of
smoking, presented all the above symptoms of pulmonary oedema, cardio-
genic shock, Takotsubo syndrome, ECG changes consistent with acute cor-
onary syndrome and cardiac enzyme elevation. After percutaneous
coronary angioplasty and exclusion of acute coronary syndrome, abdominal
CT revealed pheochromocytoma.
CONCLUSION. It is rare for pheochromocytoma to present all cardiac
manifestations of pulmonary oedema, cardiogenic shock, Takotsubo
syndrome, ECG changes consistent with ACS, and elevated cardiac
markers. Although reviews of the literature exist regarding the presen-
tation of Takotsubo Syndrome in pheochromocytoma, no other review
has presented all possible cardiac manifestations of pheochromocy-
toma. Every clinician should be aware of the possible presence of
pheochromocytoma especially in middle aged, female patients, with
negative angiography results, however rare the occurrence.
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INTRODUCTION. .
OBJECTIVES. To analyse the epidemiology and prognosis of acute
liver failure in patients admitted to the intensive care unit (ICU).
METHODS. Third level ICU covering the provinces of Malaga and Almeria
(2,350,000 inhabitants) for liver transplantation. This retrospective cohort
study comprised all patients admitted to our unit with acute liver failure
between 2010-2016, excluding acute-over-chronic failure and subacute
decompensated failure after a first admission. All patients or their rela-
tives signed the consent form for use of their data. The results are de-
scribed as mean (standard deviation), median (quartiles) or %. Given the
low number of patients we applied non-parametric tests and no multi-
variate analysis could be performed.
RESULTS. There were 27 cases, 66.7% women, with an average age of
34.1±13.1 years. The failure was hyperacute in 33% of cases, acute in
37% and subacute in 29.6%. The cause was related to use of medicines
in 22.2%, toxic in 14.8%, virus in 7.4%, pregnancy in 7.4%, Wilson in 3.7%,
other in 29.6% and cryptogenic in 14.4%. Biopsy was performed before
the OLT in 29.6% and in the extracted organ in 51.9%. The results con-
firmed the suspected diagnosis in 15.4%, did not agree with the initial
diagnosis in 22.2%, and suggested the diagnosis although not definitively
in 57.7%. Hepatic clearance was used in 96.3% of the cases and 66.7% re-
ceived a transplant during their admission to the ICU.
The ICU stay was 10 (4-16) days and the hospital stay was 25 (18-35).
ICU mortality was 18.5% (5 cases) and hospital mortality 22.2%. None
of the variables analysed was related to mortality but the low num-
ber of cases detracts from this analysis. However, mortality for trans-
planted patients was 11.1% vs. 33.3% in non-transplanted patients
(ns).
CONCLUSION. : Severe liver failure is a condition with a low inci-
dence but nevertheless a very high mortality, especially among pa-
tients who do not receive a transplant, which can reach one third of
cases. These results emphasize the convenience of treating these pa-
tients in reference centres with the possibility of carrying out an
emergency transplant. The aetiology of the liver failure is still difficult
to determine in many cases and biopsy does not prove conclusive in
a high percentage of cases.001574
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INTRODUCTION. The effects of reaching nutritional caloric goals and
negative fluid balance on outcomes have not been clearly demonstrated
in critically ill patients. Electronic recording systems (ERS) are widely used
and may help to answer this question.
OBJECTIVES. Our hypothesis was that achieving the nutritional caloric goals
along with a negative fluid balance would have a positive effect on survival.
METHODS. In our two centered retrospective study, data were
reviewed from the ERS (Metavision) between 2015 and 2018.
2814 critically ill patients ≥ 18 years of age and who had been
hospitalized ≥ 72 hours were included. Predicted body weight on
admission day and data on fluid balance, duration of mechanical
ventilation, length of ICU and hospital stay and mortality were re-
corded. Patients target calorie were calculated from the average
of Harris-Benedict and Schofield formula. Last day NUTRIC scores
were also noted. Caloric balance on third day was recorded as
positive if the target value was achieved and as negative if not.
Fluid balance was recorded as positive if balance was ≥ 500 and
negative if < 500 according to the total balance on third day;
hence, balance-negative, balance-positive, calorie-negative, and
calorie-positive groups were formed.
RESULTS. There were no differences in demographic data between the
groups.
Calorie-positive and negative-groups did not differ significantly in
terms of mortality.
CONCLUSION. Caloric intake and fluid balance on the first three days
does not appear to have an impact on mortality.









Drowning water type Freshwater 0 (0) 2 (100) 2
Saltwater 8 (72.7) 3 (27.3) 11 0.128
CT Findings Normal 5 (100) 0 (0) 5
Minimal Odema 2 (100) 0 (0) 2
Diffuse Odema 1 (16.7) 5 (83.3) 6 0.003
Inotrope / Vazopressor No 6 (100) 0 (0) 6
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INTRODUCTION. It is a common known fact, that cirrhotic patients have
worse prognosis, with high mortality associated with their decompensa-
tions. Admitting these cases in the intensive care unit (ICU) has been
longed discussed, weighting the cost-effectiveness, and the adequacy of re-
sources. Until the canonic study, medical community didn’t understand
which patients would progress worse, and for what reasons. The definition
of the Acute on Chronic Liver Failure (AoCLF) as an individual syndrome, its
diagnostic CLIF SOFA and the prognostic CLIF-C ACLF scores where an im-
portant improvement. Still, to this day, there is no predicting wich AoCLF
will die irrespective of medical intervention, and witch will benefit from
monitoring, early identification and early organ support. Studies also sug-
gest that AoCLF development and evolution is independent of the identifi-
cation of a precipitating event. In our study, we decided to evaluate every
cirrhotic patient admitted to the ICU, evaluating if the decompensating
event was identified, and the mortality rate (comparing it with the prognos-
tic mortality rate calculated).
OBJECTIVES. To prospectively assess and characterize all cirrhotic pa-
tients admitted in the Intensive Care Unit of a secondary hospital
and evaluate decompensation factors and mortality rates.
METHODS. All cirrhotic patients over 18 years, were prospectively en-
rolled between 01/01/2017 to 31/03/2019. For each patient, grade of
ACLF and specific ICU prognostic scores were collected at the time
of ICU admission. All cirrhotic patients over 18 years, were prospect-
ively enrolled between 01/01/2017 to 31/03/2019. For each patient,
grade of ACLF and specific ICU prognostic scores were collected at
the time of ICU admission.
RESULTS. A total of 32 cirrhotic patients were admitted in inten-
sive care unit, of which 71.9%(n=23) were male and the median
age was 55.38 (±8.85) years. The majority (53.1%; n=17) of these
patients died during ICU hospitalization. One-year mortality rate
was 33% (n=5). Mean APACHE score was 26.8 and SAPSII score
was 59.8. The CHILD score at admission was elevated, and
68.8%(n=22) had a C stage. Mean CLIF-SOFA was 11.4. A total of
81.3% had criteria of AoCLF, with 7.7% grade 1, 30.8% grade 2
and 61.5% grade 3 criteria. Mean CLIF-C-SOFA was 54.1. In only 2
patients (6.3%) there was no trigger identified. The trigger factor
mostly identified was infection (56.3%; n=18), particularly spon-
taneous bacterial peritonitis and nosocomial pneumonia.
CONCLUSION. This is a population of adult patients, with high sever-
ity scores, that were predicted to have high risk of short-term mortal-
ity. Their survival is dependent of diagnosis, intensive monitoring
and early organ support, with the difficult decision of admitting and
treating them. The mortality rate observed proves that this syn-
drome, even in CHILD C score patients, doesn’t necessarily mean
short term fatality, since the mortality observed was not as high as it
would be expected. 46.9% of patients survived the ICU stay, even
though the majority of patients (61.5%) where grade 3 AoCLF (with
correspondent 31.3% ICU survival).
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INTRODUCTION. Drowning is a common cause of accidental deaths.
Complication rate and mortality of patients requiring intensive care
support are high. The aim of our study was to reveal the clinical
course and treatment efficiencies of a limited number of patients in
the intensive care unit due to the drowning.
METHODS. Patients who were admitted to the intensive care unit for
>24 hours and who met the inclusioncriterias between January 2010
and August 2018 were examined retrospectively.
RESULTS. Thirteen of the 103 patients needed intensive care who
admitted emergency service. Five (38.4%) of the patients died.
Steroids were used in 6 patients (46.2%) but no statistically sig-
nificant difference was found in terms of mortality (p=0.592). The
presence of diffuse cerebral edema 5(38.5%) was associated with
a statistically higher mortality rate compared to 6 (46.2%) pa-
tients with normal findings (p=0.003). Mechanical ventilator sup-
ports were provided with SIMV mode in 9(69.2%) patients and
APRV mode was used in 4 (31.8%) patients. According to our
clinical observations, the radiological improvement was observed
in patients with APRV mode (Table 1).
CONCLUSION. The effect of steroid and prophylactic antibiotherapy
on mortality was not determined. APRV can provide the recruitment
of consolidated lung areas and prevent the decruitment of alveoli.
These effects should be kept as a mode of choice in cases of severe
alveolar and interstitial edema in drowning cases. Mechanical ventila-
tion strategies, the degree of metabolic acidosis at admission and
the neurological status of the patient may be considered as variable
clinical parameters that may affect patient outcome.
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Table 1a (abstract 001123). Characteristics of the patients according
survival/death
Data are means SD (standard deviation), frequencies (%) and medians (IQR:
Interquatile range). SDD selective digestive decontamination
Table 1b (abstract 001123). Characteristics of the patients according
survival/death
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INTRODUCTION. Aneurysmal subarachnoid hemorrhage (SAH ) is a
worldwide health burden with fatality as permanent disability.To
know risk mortality factors is important,with particular regard to the
identification of potentially avoidable factors, in order to reduce SAH
mortality.
OBJECTIVES. To assess the mortality risk factors in patients with
subarachnoid hemorrhage (SAH), admitted in a neurotraumatic
ICU
METHODS. Prospectively collected data of patients admitted
from October, 2013 to December 2017 to a 10-bed Neurotrau-
matic ICU. We analyzed: main diagnosis at admission; demo-
graphic data including sex and race; neurological data (clinical
examination, pupils reactivity and size, and Glasgow Coma Score:
GCS; localization and aneurysm size; presence of intracranial
hematoma (ICH); presence and volume of intraventricular bleed-
ing; days to develop vasoespam; development of DCI; Fisher
scale, Modified Fisher scale, Hunt and Hess scale, Word Feder-
ation of Neurosurgeons (WFNS) scale; presence of vasoespasm in
doppler or arteriography; delayed of admission in ICU; treatment
of the aneurysm; complications, including infections; Glasgow
Outcome Scale (GOS) at ICU discharge and 6 months after ICU
discharge and several other risk factors. In order to identify fac-
tors that maintain independent association with mortality, a
multivariate logistic regression analysis were performed. It was
considered significant if p ≤.05.
RESULTS. Among 83 SHA admitted patients, 18 (36.44%) out of
64 patients died. In a univariate analysis, age, APACHE II, SOFA
and GCS at ICU admission, GCS at site and at emergency room,
to be oriented and alert, isochoric pupils, posterior cerebral
artery aneurysm, decompressive craniectomy, dead after treat-
ment, hidrocephalus, mechanical ventilation > 7 days, ICH,
frontal ICH, internal carotid artery aneurysm ICH, rebleeding
within 72 hours, McCabe, GOS at ICU discharge and 6 months
after ICU discharge, Fisher scale, Hunt and Hess scale and WFNS
scale were statistically significant. Among the patients who died
versus survivals, ICU stay was not significantly different (Table
1a y 1b). The independent risk factors associated with mortality
were: isochoric pupils OR (95% CI): 0.118 (0.022 ; 0.644), frontal
ICH OR (95% CI): 7.121 (1.577 ; 32.159), GCS at ICU admission
OR (95% CI): 0.824 (0.719 ; 0.944) (Table 2).
From the logistic model also summarized inTable 2, a prediction
score was obtained (require further validation) (Figure 1):SHA mortal-
ity Score=-2.143 X Isochoric pupils + 1.963 X Frontal ICH-0.194 X GCS at
ICU admission
CONCLUSION. In SHA admitted to a neurotraumatic ICU, risk fac-
tors that were independently associated with mortality were: iso-
choric pupils , frontal ICH and GCS at ICU admission. A mortality
prediction score was estimated.Data are means SD (standard deviation), frequencies (%) and medians (IQR:
Interquatile range). SDD selective digestive decontamination
Fig. 1 (abstract 001123). See text for description
Table 2 (abstract 001123). Multivariate logistic regression for death
ICH intracerebral hematoma
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INTRODUCTION. External ventricular drainage (EVD) is frequently
used in different groups of patients in neurocritical care. EVD related
infection (ERI) is a common complication in these patients, and it can
worsen their condition.
OBJECTIVES. Our aim in this study is to analyze which factors are as-
sociated with the development of ERI and its effects in the prognosis
of these patients.
METHODS. A retrospective, observational study including fifty one
patients with EVD was performed during 2017 and 2018. Data col-
lected were analyzed using SPSS Statistics v.24.
RESULTS. Fifty one patients (51% men) with a mean age of fifty eight (
58 ± 13 years) and a APACHE II mean score of thirteen (13 ± 6). Seven-
teen patients were diagnosed of ERI (34%) The mean length of stay was
50 +- 25 days in those with infection and 25 +- 14 p< 0,05 (IC 95% 8-41)
in those without it. Total days with EVD were 15 +- 10 in patients without
ERI and 28 +- 14 days in patients without ERI (IC 95% 4-20), with signifi-
cant association (p=0,03). 23.5% were tunnel EVD and were placed in the
operating room (OR) (ERI in 50%) and the rest (78.5%) were intraventricu-
lar catheters placed bedside in the ICU (ERI in 28,2%), without significant
association. Regarding the relationship between infection and the num-
ber of handlings (opening for treat Intracranial hypertension (IH) or to
provide antibiotics). In 29.4% of patients we used antibiotic through the
EVD and in this group we diagnosed ERI in 100% of patients. Mortality
was 35,5% in the group diagnosed with ERI and 29.4% in the other
group, with no significant association between the two groups.
CONCLUSION. ERI is a common complication in patients with EVD. In our
study this was associated with more days needing a EVD and increased
length of hospital stay. However mortality was not different betweengroups. Despite no significant differences, it seems that tunnel EVD and
handling of these drainage system are associated with a higher infection
rate. Further studies with larger sample size are necessary to identify risk
factors that have impact in the prevalence and development of EVD re-
lated infections.
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INTRODUCTION. External ventricular drainage (EVD) is frequently
used in different groups of patients in neurocritical care. EVD related
infection (ERI) is a common complication in these patients.
OBJECTIVES. In this study, we try to determine the prevalence of ex-
ternal ventricular drainage related infections in our ICU, just as the
demographic characteristics of the patients.
METHODS. A retrospective and observstional study in which we
included 51 patients during 2017 and 2018 with a EVD insertion
as a part of the neurological monitoring and treatment in differ-
ent neurocritical conditions. Data collected was analyze using
SPSS Statistics v.24.
RESULTS. 51 patients were included in the study, 49% were women
and 51% were men. The mean age was fifty eight ( 58 ± 13 years)
and the APACHE II mean score was thirteen (13 ± 6). Patients were
admitted in the ICU with different conditions. 28 patients (54.9%)
had a subarachnoid hemorrhage (SAH), 14 had an hemorrhagic
stroke (27,5%), 1 had ischemic stroke (2%), 7 patients (13,7%) had
traumatic brain injury (TBI) and 1 had acute hydrocephalus (2%).
23.5% were tunnel EVD and were placed in the operating room (OR)
(ERI in 50%) and the rest (78.5%) were intraventricular catheters
placed bedside in the ICU (ERI in 28,2%). ERI confirmed with micro-
biological studies was diagnosed in 24% of patients en in 10% ERI
was highly suspected regarding clinical and laboratory data, but
without microbiological confirmation. We identified gram positive
cocci (GPC) in 70.6% patients with ERI (Staphilococcus epidermidis in
10 patients and Enterococcus faecalis in 2) followed by gram nega-
tive bacteria (GNB) in 11.8% (acnetobacter Pitt and pantoea aglomer-
ans). Empiric antibiotic was used in most of cases (94.4% of patients
diagnosed with ERI). Mortality was 35,5% in the group diagnosed
with ERI and 29.4% in the other group, with no significant association
between the two groups
CONCLUSION. External ventricular drainage (EVD) is frequently used
in different groups of patients in neurocritical care and its been
proved as an useful monitoring tool. However ERI is a common com-
plication in these patients, and can worsen their condition. In this
study we had analyze the characteristics of our patients during two
years. We believe that ERI rate is high in our ICU comparing with the
existing publications. Further studies are necessary to identify the
cause or the risk factors of this high rate of these infections.
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INTRODUCTION. Increasing bloodstream after angioreconstructive
surgery is usually called as cerebral reperperfusion syndrome. It can
Page 117 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55manifested by headache, seizures, neurologic symptoms and in se-
vere cases with cortical edema.
OBJECTIVES. Hyrperfusion injury after carotid artery stenting (CAS)
may engage disruption of the blood-brain barrier (BBB) by sharp rise
of cerebral blood fluid. Recent studies have shown that extravasation
of gadolinium visible on magnetic-resonance imaging (MRI) in the
subarachnoid space are a marker for early BBB damage.
METHODS. We collected all clinical data of 3 patients with severe and
uncommon complications associated with cerebral hyperperfusion syn-
drome (CPS) after stenting of the left internal carotid artery. Each pa-
tient was performed MRI head near after CAS and repeat MRI with
gadolinium on a next day, lumbal puncture was made also.
RESULTS. All patients have had aphasia, meningeal syndrome and
temperature rising. They were initially with mild aphasia after the CAS and
then developed severe aphasia and meningeal syndrome, with a normal
blood pressure. MRI head did not show any acute changes. Ultrasound
ICA showed non-occluded stent. Their body temperature increased to
39.2°C. Repeat MRI head performed 20 hours post-CAS showed cortical
edema of left hemisphere in all patients and leptomeningeal gadolinium-
enhanced MRI has been in 2 patients. Cerebrospinal fluid (CSF) revealed a
white blood cell count of 96x10^6/L in 2 patients and 1856x10^6/L in 1
patient, that was 90% neutrophils, increase proteins of 1.5g/L and normal
glucose. Bacterial culture was negative. These cases with clearly inflamma-
tory CSF and the development of meningeal syndrome in the absence of
infection were regarded as aseptic meningitis. MRI with intravenous gado-
linium was repeated 48 hours after operating and it shown no increase
MR-signal from the subarachnoid space. We repeated the lumbar punc-
ture on the 3st day after surgery to the patient in whose CSF there were
185610^6/L cells and the number of cells in the CFS decreased from 1856
to 4310^6/L. 2 days after CAS their neurologic symptoms were mild and
in 3 days it was resolved, patients were discharged home.
CONCLUSION. Thus, our presented clinical observations are very
rare complications of the hyperfusion syndrome after CAS. Despite
a lot of publications on the reperfusion syndrome, observatios of
aseptic meningitis after carotid artery stenting are few; in the
worldwide literature we have met one clinical case. These clinical
manifestations require further research and develop conception
of pathogenesis.Fig. 1 (abstract 001524). See text for description001567
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INTRODUCTION. Patients with cardiovascular diseases requiring
surgical treatment, especially those that compromise the ascend-
ing aorta and crust, often require extracorporeal circulation (ECC),
aortic clamping and hypothermia. Such procedures are related to
poor perfusion. One of the main concerns of the intensive care
team is to avoid secondary neurological damage after a longtime of blood hypoflow, which can lead to cerebral edema and
seizures. The most common parameters for neurological monitor-
ing would be intracranial pressure and electroencephalogram and
cerebral oximetry, however, for non-neurological patients, this in-
formation is uncommon and impedes optimal management.
OBJECTIVES. Our objective was to evaluate the cerebral compli-
ance and the neurological condition of ICU patients in the imme-
diate postoperative period of cardiovascular surgery using a new
noninvasive intracranial pressure device (NIICP).
METHODS. This new method of noninvasive ICP monitoring consists
of a strain gauge attached to a mechanical device that touches the
surface of the scalp in the frontoparietal region laterally to the sagit-
tal suture. The device can detect small changes in skull size resulting
from changes in ICP, without the need for surgical procedures.
RESULTS. Twenty-two patients were included in this study; 20 re-
quired CPB. The mean ECC time was 123 minutes. Of those who re-
quired ECC, 8 presented alterations in the ICP curves with low
cerebral compliance (P2 / P1 ratio> 1.0) evaluated by the morpho-
logical analysis of the curve and 9 were submitted to cerebral hypo-
flow, 4 of which presented cerebral complacency . Volume
optimization and neuroprotection measures, such as MAP between
90 and 100 mmHg, temperature control, target pCO2 between 35
and 40 mmHg, sodium between 140 and 150 meq / dL, glycemic
control between 140 and 180 mg / dL, and analgesic with RASS tar-
get -3 to -5 were initiated based on this NIICP information for the
management of these cases. Among those patients with altered
PICNI curves, 7 were discharged from ICU with good clinical condi-
tion and Glasgow Coma Scale of 15.
CONCLUSION. The cerebral monitoring of cardiovascular postopera-
tive patients is important to prevent complications and may be a
useful tool for acute neuroprotective treatment in the ICU.001572
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INTRODUCTION. Cervical spine injury often occurs after major
trauma, impairing motor and sensory impairment and causing
complete or incomplete paraplegia or quadriplegia.
Characterization of the patient according to their comorbidities
and the presence of complications during hospitalization in rela-
tion to the prognosis. Follow-up after hospital discharge with
retrospective evaluation of the patient, their evolution as well as
their current health status.
METHODS. Statistical analysis were performed with SPSS (version 24).
Descriptive statistics were presented as means (M) and standard de-
viations (SD) for symmetrical continuous variables and medians
(Mdn) and percentiles P25 and P75 for skewed continuous variables.
Chi-square tests or Fisher exact tests were used to associate prognos-
tic with independent variables. The association of hospital length of
stay (days) and the prognosis, as favorable or unfavorable, with the
independent variables, was performed with Mann-Whitney test. Stat-
istical significance was considered for p<.05 and marginal signifi-
cance for p<.10.
Telephone interviews were carried out in 20 of the 24 patients and a
questionnaire was applied.
RESULTS. A total of 24 patients, mostly males (23; 87.5%), aged from
19 to 89 years old (M=48.88; SD=19.08) with spinal-cord injury (SCI)
were enrolled during 2017 and 2019. Cervical was the most frequent
lesion (13; 54.2%). Surgical fixation was performed in 19 (79.2%) pa-
tients; 4 (16.7%) patients had non invasive ventilation and 11 (45.8%)
tracheostomy. TCE was present in 14 (58.3%) patients, infection in 14
(58.3%) and other complications in 19 (79.2%).
Table 1 (abstract 000515). See text for description




Total recorded incidences 19 (30%) 6 (8%)
Lack of insertion form/data N/A 4 (5%)
Equipment missing/incorrect 8 (12.5%) 1 (1%)
Bedside emergency airway plan/details 11 (17%) 1 (1%)
Page 118 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Infection was associated with unfavorable prognostic (p=.005); 73.3%
of the unfavorable prognostics had infection against 33.3% of the fa-
vorable prognostics. Noninvasive ventilation was associated with hos-
pital length of stay (p=.068) (Mdn=20.5; P25=19.0, P75=25.5).
Tracheostomized patients were hospitalized during longer periods
(Mdn=21.0; P25=15.0, P75=27.0) (p=.006). The follow-up performed
in 20 of the 24 patients involved in the study, 37.5% did not present
any memory of hospitalization. Post-discharge clinical progression is
positive in about 90% of patients.
CONCLUSION. The presence of traumatic brain injury is associated
with a worse prognosis. Surgical fixation did not show statistically
significant values (p=. 367).
There is association between infection and unfavorable prognosis (p=
.006), with significant statistical value. Complications during hospitalization
presented slight variations in prognosis, as well as duration of
hospitalization.
Tracheostomy showed a statistically significant relationship (p = .006)
with duration of hospitalization, but no relation to prognosis (p = .341).
These results may have been affected by the size of the sample, by
polytrauma or hospitalization complications in ICU.ARF - Acute respiratory failure 3
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INTRODUCTION. Tracheostomy insertion is known to be associated
with significant morbidity and mortality (Cipriano et al., 2015). An Al-
tered Airway Ward Round (AAWR) was introduced to the Brompton
Hospital in 2015 as per the NCEPOD (2014) report ‘On the Right
Trach’ in tracheostomy care recommendations. An initial audit in
2015 highlighted that the presence of the ward round had a positive
impact on patient safety 3 months post introduction.
OBJECTIVES. The aim of this study was to assess for ongoing improve-
ment in safety, and to measure the number and types of adverse inci-
dents in altered airway patients since the initial audit of the AAWR.
METHODS. A retrospective review was carried out of all adult in-
patients with altered airways (tracheostomy, laryngectomy, airway
stent) for the period of January 2017-September 2018 inclusive
using electronically recorded AAWRs, tracheostomy insertion data
and all reported incidents. These incidents were collected and an-
alyzed in terms of categories. A 3 month segment of this data
(from January-March 2018) was also directly compared to the ini-
tial audit performed January-March 2015.
RESULTS. A total of 319 patients were seen during the AAWRs from
January 2017-September 2018. 45 incidents were identified (45/319;
13%); Lack of insertion form (n=17; 48%), missing or incorrect equipment
(n=4; 9%), emergency airway plan related (n=22; 38%), other (n=2; 4%).
A direct comparison of a 3 month snapshot is reported below in the table:
CONCLUSION. Three years on from the commencement of an AAWR,
we have seen a considerable reduction in reported clinical incidents
(down from 30% to 13%), reflecting the ongoing efficacy of a dedi-
cated ward round.
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INTRODUCTION. The prognostic value of oxygenation indexes for
mortality prediction in ARDS is limited. Increased dead space fraction
(VD/VT) determined during its first week is a predictor of survival in-
dependent from oxygenation.
Estimated methods for impaired ventilation such as the estimated
dead space fraction calculation and the ventilatory ratio (VR) are feas-
ible to do at the bedside and correlate well with direct dead space
fraction measurements.
OBJECTIVES. The primary objective was the predictive accuracy of
the estimated dead space fraction and ventilatory ratio on mortality
at 30 days after ARDS diagnosis measured by area under the receiver
operating characteristics curve (AUROCC), net reclassification im-
provement and integrated discrimination index on top of a model
with other predictors of outcome and calibration
METHODS. Secondary analysis of 940 patients with ARDS from
the “Molecular Diagnosis and Risk Stratification of Sepsis”
(MARS) project in mixed ICUs of two teaching hospitals. Differ-
ent formulas were used to calculate dead space fraction: 1) Un-
adjusted Harris-Benedict (VD/VTHB); 2) Penn State (VD/VTPS);
and 3) Direct estimate (VD/VTdirect). VR was calculated as per
the following formula: VEmeasured X PaCO2measured/VEpre-
dicted x PaCO2predicted. where VEpredicted is 100 ml/kg/min
on the basis of predicted body weight and PaCO2predicted is
37.5 mm Hg.
RESULTS. VD/VT estimations and VR were significantly higher
among non-survivors for all estimating equations at both days 1
and 2. VD/VTdirect and VR were statistically independent predic-
tors of death at 30 days on day 2. The addition of each one of
the predictors improved the predictive accuracy of the baseline
model on day 2.
CONCLUSION. Estimated methods for impaired ventilation were
associated with mortality in the early course of ARDS patients
and added predictive value to indexes of oxygenation and re-
spiratory system mechanics. These indexes offer clinicians infor-
mation about ventilatory efficiency at the bedside and may
provide useful prognostic information. Measurement of the dead-
space fraction could help clinical investigators to identify the pa-
tients who may benefit most from a particular therapeutic
intervention.
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INTRODUCTION. Early extubation for the critically ill patients on
mechanical ventilation (MV) due to acute respiratory failure (ARF) is
the primary treatment aim in intensive care unit (ICU). Overt sedation
of ICU patients is associated with extended MV, increased ICU length
of stay (LOS) and long-term cognitive impairment.
OBJECTIVES. By using the different ways of quality control, team re-
source management (TRM) and also a bundle-care approach with
evidence-based medicine, we hope to improve the quality of care in crit-
ically ill patients with MV due to ARF.
METHODS. Since 2014, we had established a multi-disciplinary team
(physical therapist, nurse, the medical staff and the patient’s family)
for MV quality improvement in a 19-bed medical ICU at Chi-Mei med-
ical center. We performed early mobilization program (within 72
hours after MV use) with a four-phase rehabilitation protocol, which
range from passive movement to active mobilization, and they were
named as different Chinese kungfus to help the teams to remember.
Although the implementation of this rehabilitation program had
shortened the duration of MV from 2014 to 2015, the outbreak of in-
fluenza in 2016 with the increased sedation use for patient-ventilator
synchrony made the prolonged use of MV. Thus, the performance of
early mobilization might not be easily achieved. In order to improve
the outcome of patients with MV, we represented the use of an
evidence-based, interdisciplinary team approach, patient-centered
and integrated protocol, known as ABCDE care bundle (Awake trial,
Breathing Trial, Coordination of drugs, Delirium management and
Early Mobilization).
RESULTS. Before the quality improvement of care (Jan 1 to March 30,
2014) , the average duration of MV was 6.6 days. After the interven-
tion of early mobilization program, the duration of MV was down to
4.4 days (July 1 to September 30, 2014), 4.1 days (November 1to De-
cember 31, 2014) and an average of 4.5 days in the majority of 2015.
Unfortunately, MV duration raised up to 8.8 days (Dec 1, 2015 to
March 31, 2016). After the performance of ABCDE bundle, the aver-
age duration of MV was gradual reduced to 4.8 days (September 1to
December 31, 2016) and 4.5 days (April 1 to August 31, 2017). Also
the percentage of delirium assessment increased from 0% to 100%
after ABCDE bundle. The ICU LOS (from 2014 to 2017) decreased
gradually each year, as 10.0, 7.5, 7.3 and 6.8 days separately.The hos-
pital cost and delirium rate were also decreased respectively.
CONCLUSION. To improve the outcomes of ARF patients with MV,
we have performed different way of quality control, TRM and
ABCDE Bundle Care. They could effectively decrease the duration
of MV, ICU LOS and hospital cost. Moreover, we hope to share,
expand and promote this effective strategy, ABCDE bundle care
to all hospitals in Taiwan in order to achieve a favorable quality
of care in MV patients.
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INTRODUCTION. Difficult weaning causes a prolongation of the pa-
tient’s hospitalization and of his dependence from mechanical venti-
lation (MV).
OBJECTIVES. The main objective of this study was to identify
whether indices of diaphragmatic function obtained by diaphrag-
matic pressure measurement or ultrasound imaging could predict
successful weaning from MV.
METHODS. The study took place in the Intensive Care Unit of a ter-
tiary Greek hospital. Patients who fulfilled criteria for weaning from
MV were included in the study and underwent a spontaneous
breathing trial (SBT). Successful weaning was defined when a patient
remained 48 hours without mechanical ventilation following a suc-
cessful SBT. Esophageal and gastric pressures were measured with
esophageal balloon-tipped-catheters. Diaphragmatic movement was
assessed by ultrasound using a Linear 3-11 MHz head. The ultra-
sound probe was placed in the mid axillary line perpendicular to the
zone of apposition between the 8th-10th intercostal spaces.
RESULTS. Twenty-five patients were evaluated. Peak esophageal in-
spiratory pressure, peak transdiaphragmatic inspiratory pressure, Peak
Inspiratory (Tdpi) and End Expiratory (Tdee) diaphragmatic thickness,
Diaphragmatic Thickening Fraction (Tfdi), Diaphragmatic Thickness
(Tdth) and Excursion (Tdex) during SBT were significantly different
(p<0.05) between those who succeeded and those who failed wean-
ing. The receiver operating characteristics curves to identify those
who succeeded weaning were: for Esophageal inspiratory pressure
0.872 (p<0,01)(C.I.95% 0.733-1), for Transdiaphragmatic inspiratory
pressure 0.792 (p<0.05) (C.I. 95% 0.616-0.907), for Tdpi 0.868 (p<0.01)
(C.I. 95% 0.682-1) for Tdee 0.819 (p<0.01) (C.I. 95% 0.644 – 0.995), for
Tfdi 0.764 (p<0,05) (C.I. 95% 0.571 – 0.957), for Tdth 0.837 (p<0.01)
(C.I.95% 0.653-1) and finally for the Tdex 0.893 (p<0.01) (C.I. 95%
0.722-1) having a sensitivity of 93.8% and specificity of 85.7%.
CONCLUSION. Ultrasound imaging may be useful in identifying pa-
tients who are ready for weaning from MV and might be useful in re-
ducing MV duration.REFERENCE(S)
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Page 120 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. Maximal Inspiratory Pressure trial (MIP) is used as a pre-
dictive index for weaning from mechanical ventilation (MV). Resistive
Breathing (RB) follows the same physiological rationale as MIP without
fully obstructing the airway.
OBJECTIVES. The main objective of this study was to identify whether
indices of diaphragmatic function obtained by diaphragmatic imaging
or relevant pressures during MIP or RB may be useful in predicting suc-
cessful weaning from MV.
METHODS. The study took place in the Intensive Care Unit of a tertiary
Greek hospital. Patients who fulfilled criteria for weaning from MV were
included in the study and underwent a spontaneous breathing trial (SBT),
with an airway of reduced diameter (RB) and a MIP trial. Successful wean-
ing was defined when a patient remained 48 hours without mechanical
ventilation following a successful SBT. Esophageal and gastric pressures
were measured with esophageal balloon-tipped-catheters. Diaphragmatic
movement was assessed by US using a Linear 3-11 MHz head. The US
probe was placed in the mid axillary line perpendicular to the zone of ap-
position between the 8th-10th intercostal spaces.
RESULTS. 16 out of 25 (64%) patients succeeded and 9 (36%) failed
weaning. Esophageal inspiratory pressure, Diaphragmatic Thicknening
(Tdth) and Excursion (Tdex) during RB and Peak Inspiratory (Tdpi) and End
Expiratory diaphragmatic thickness (Tdee) during MIP were significantly
different (p<0.05) between those who succeeded and those who failed.
The receiver operating characteristics curves to identify successful weaning
were: for Esophageal pressure during RB 0.748 (p<0.05) (C.I. 95% 0.550-
0.946), for Tdth-RB 0.759 (p<0.05) (C.I. 95% 0.540-0.979), for Tdex–RB 0.875
(p<0.01) (C.I. 95% 0.716-1) with a sensitivity (sn) of 93% and specificity (sp)
of 75%, for Tdpi-MIP 0.850 (p<0.05) (C.I. 0.575-1) and Tdee-MIP 0.857 (p<
0.05) (C.I. 95% 0.638-1) both having a sn of 100% and sp of 80%.
CONCLUSION. Ultrasound imaging during RB and MIP might be use-
ful in predicting patients who are ready for weaning from MV.
REFERENCE(S)
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INTRODUCTION. Cardiovascular collapse (CVC) is a serious complica-
tion of endotracheal intubation (ETI). From a physiological point of
view, it could be attributed to the changes that occur in venous return,
intrathoracic pressure, PaCO2 and catecholamine level. Many studies
have evaluated risk factors for postintubation hypotension. However,
there is no universally agreed definition of postintubation cardiovascu-
lar collapse. In this study, we considered severe (CVC) as systolic blood
pressure ≤65 mmHg recorded at least once and/or ≤90 mmHg for ≥30
minutes or the requirement of vasopressors and/or inotropes.
OBJECTIVES. The aim of this study is to assess the incidence and
potential risk factor for severe CVC after ETI and its impact on ICU
length of stay and mortality.
METHODS. This is a prospective cohort study that was conducted on
300 patients. Subjects were classified into two categories: those who
were haemodynamically stable after intubation and those who col-
lapsed. Different variables were documented in both groups and
they were compared with the incidence of postintubation CVC. ICU
length of stay and 28-day mortality were assessed in both groups.
RESULTS. 26.3% of subjects have developed CVC after ETI. Factors that
were associated with increased incidence of CVC include: old age, heart
failure, CKD, COPD, higher heart rate before and during intubation and
propofol usage for intubation. The mean value for ICU length of stay for
collapsed patients was 15.08 ± 8.51 days whereas it was 10.97 ± 9.60
days for non-collapsed patients (P < 0.001). 67.2% of collapsed patients
have died within 28 days of intubation while only 27.1% of non-
collapsed patients have died within the same period (P < 0.001).CONCLUSION. Postintubation CVC is associated with poorer out-
comes as regards ICU length of stay and ICU mortality. There are po-
tential risk factors that need further evaluation to predict and/or
decrease the incidence of CVC after ETI.
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INTRODUCTION. With advanced respiratory care, the number of
critically ill patients receiving home mechanical ventilation (HMV)
therapy has increased. Readmission due to disease progression
and medical emergencies in these fragile patients is also
increasing.
OBJECTIVES. The purpose of this study was to investigate the factors af-
fecting early readmission of patients who received HMV for the first time.
METHODS. This is a retrospective study of adult patients who were
admitted to Asan Medical Center from March 2014 to February 2018.
The inclusion criterion was readmission of patients within a year of
initiating HMV. We compared the clinical characteristics of the pa-
tients at the time of discharge between those who had readmis-
sion within 30 days (early readmission group) and those who had
readmission within a year from the 31st day (late readmission
group). Additionally, we investigated the clinical outcomes at the
time of readmission.
RESULTS. In total, 78 patients had unplanned readmission within a year
from discharge, and 27 (34.6%) had early readmission. Among the
causes of readmission, aspiration event was significantly higher in the
early readmission group than in the late readmission group (29.6% vs
7.8%; p = 0.011). Among the underlying diseases, neoplasm (55.6% vs
21.6%; p = 0.002) and sequelae of acute respiratory failure (63.0% vs
33.3%; p = 0.012) were significantly higher in the early readmission
group. In contrast, chronic respiratory failure was higher in the late re-
admission group (44.4% vs 74.5%, p = 0.008). Among the types of HMV,
use of the tracheostomy tube was more common with early readmis-
sion than non-invasive mask ventilation (66.7% vs 19.6%; p <0.001),
and all-day support was also more common with early readmission
(44.4% vs 17.6%; p = 0.011). In a multivariate logistic regression analysis,
neoplasm and tube-feeding methods, such as nasogastric and gastros-
tomy tubes, had a correlation with early readmission.
CONCLUSION. Underlying diseases and feeding methods were sig-
nificantly associated with unplanned early readmission. The medical
staff should educate the patients, such as on aspiration prevention,
for home mechanical ventilation.
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INTRODUCTION. High flow nasal cannula oxygen (HFNC 02) was
introduced in December 2017. Changi General hospital is a 1000
bedded hospital which caters to the population in the east of Singa-
pore.We have an 18 bedded Medical Intennsive Care Unit and we
recieve around 1000 admissions over a year
OBJECTIVES. To identify indications for the use of HFNC 02 in our
hospital and to look at the impact on need for Invasive Mechanical
ventilation (IMV) and ICU mortality in these patients.
METHODS. All patients who required HFNC 02 from February to No-
vember 2018 were included and data was collected with regards to
their diagnosis, indication for HFNC O2, PF ratio, length of time on
HFNC 02, final outcome on discharge from critical care.
RESULTS. 60 patients received HFNC 02 during the stated time
period. The mean age was 63.5 years, and there were 43 males. The
main diagnoses were Community acquired and hospital acquired
pneumonia. 47 patients received therapy for Type 1 Respiratory fail-
ure, 9 patients were post extubation, 2 for Type 2 respiratory failure
and 2 received therapy as palliation.
The mean Pf ratio was 130.5 .The average length of time spent on
HFNC 02 was 42 hours. At the end of HFNC 02 therapy, 35 patients
were weaned off to face mask oxygen (58.3 %), 2 palliative patients
died and 23 patients (38.3%) needed intubation. The most common
reason for intubation was rapidly progressive respiratory failure. Of the
23 patients 8 patients died in critical care. Overall mortality at discharge
from critical care was 16% including the 2 palliated patients.
CONCLUSION. Despite having a cohort of patients with moderate to
severe hypoxia, a majority of patients (58.3%) avoided IMV and the
average length of therapy was under 2 days. The ability to identify
the right patients, who will benefit from HFNC 02 and avoid IMV,
continues to pose the biggest challenge. Rapidly progressive respira-
tory failure was the main reason for the need for IMV.
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INTRODUCTION. Airway pressure release ventilation (APRV) has been
recently gaining more popularity in many adult critical care units inthe south east of England. Although it is now widely used in the re-
gion as part of the management of severe respiratory failure, it failed
to find its way into the national guidelines for the management of
ARDS (1). I guess the paucity of clinical trials plus some conflicting re-
sults from already published studies could be the reason (2, 3). Since
the publication of Guidelines for the Provision of Intensive Care
Services (GPICS) by the Faculty of Intensive Care Medicine and the
Intensive Care Society in April 2015(4), all critical care units were
encouraged to develop a pathway for refractory hypoxaemia. At the
William Harvey Hospital in south east of England, we introduced our
local pathway for severe respiratory failure that includes APRV as one
option.
OBJECTIVES. One year following the introduction of the APRV into
the local practice, we decided to retrospectively review all the pa-
tient who had received APRV from two points of view; clinical effect-
iveness and safety profile. Effectiveness was measured by the
improvement in oxygenation whilst safety was judged by the inci-
dence of serious adverse events like barotrauma.
METHODS. We retrospectively reviewed all patients admitted to
our critical care unit over a period of a year and had received
APRV for at least six hours or more. Data collection was anonym-
ous and only non-identifiable information was used. There were
no patients with head injury in our audit. Data collected for each
patient included: age, sex, ventilation days and total Intensive
care days. Physiological data collected for each patient were the
worst daily value for PO2, PCO2, peak airway pressure and the P/
F ratio. We also recorded the incidence of barotrauma and pa-
tients’ final outcome.
RESULTS. Seventy six patients received APRV over the period of
the review. The average patients’ age was 55 (16 – 85) years with
male to female ratio of 1.5. The average length for mechanical
ventilation was 6 (2 – 38) days and the length of total ITU stay
before final destination was 8 (2- 28) days. The average P/F ratio
significantly improved over the first three days following the ap-
plication of APRV. This coincided well with a reduction in the
peak airway pressure and no significant hypercapnoea. Pneumo-
thorax occurred in only three patients (incidence of 4%); all those
patients had a chest drain sited promptly and two of them were
eventually transferred to a tertiary centre. One patient developed
Pneumo-mediastinum and was managed conservatively.Regarding
the final outcome, 59 (77%) patients were weaned successfully
from mechanical ventilation, 14 (18%) patients died and 4 (5%)
patients retrieved by a tertiary centre (three of which received
ECMO).
CONCLUSION. The results showed that application of APRV was asso-
ciated with dramatic improvement in oxygenation over a very short
period of time. There was no significant hypercapnoea associated
with the application of APRV and the incidence of barotrauma was
4% which is less than described in the literature for such cohort of
patients(5). Although our patients sample is small, this review
showed that APRV is very effective tool in the management of severe
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INTRODUCTION. Acid-base balance is a complex continuous process
regulated by several organs, including the lung, the kidney and the
liver. The ADVOS therapy is based on albumin dialysis and can sup-
port all three organs by, among others, removing CO2, counterbalan-
cing electrolyte disturbances and correcting acidosis. This is achieved
with a recirculating dialysate formed by mixing an acidic and an alka-
line concentrate at a modifiable ratio to reach a desired pH.
OBJECTIVES. In this work we explain the mechanism of ADVOS to
achieve CO2 removal and acidosis correction in an ex vivo blood model
with a carbonate-free dialysate using the classical (i.e. Henderson-
Hasselbalch) and modern (i.e. Stewart) approach for acid-base balance.
METHODS. Briefly, 5 liters of swine blood were dialyzed with the
ADVOS system using a high pH carbonate-free dialysate. For experi-
mental purposes a pH of 10.0 was set. Combinations of blood flows
(QB = 100, 200 or 400 ml/min) and concentrate flows (QC = 160 or 320
ml/min) were tested for 1 hour each. A pH-probe controlled blood pH
continuously. CO2 was supplied to reach a constant blood pH of 7.35-
7.45. Blood gas analysis were performed every 15 minutes in the inlet
and the outlet of the dialyzer.
RESULTS. With a Qc of 160 ml/min a maximum continuous CO2 sup-
ply of 114 ml/min was achieved with QB of 400 ml/min. Blood pH
was maintained between 7.35-7.45, while pCO2 and HCO3- were ele-
vated. With a QC of 320 ml/min, HCO3- levels were lower. Moreover,
every blood gas value remains physiological with a 70 ml/min CO2
supply and a QB of 400 ml/min.
The acid-base balance can be explained through the physiological
Henderson-Hasselbalch or the quantitative Stewart approach, which
use the relationship between pCO2 and HCO3-, or variations in
pCO2, strong ion difference (SID) and total weak acids, respectively.
Anyhow for ADVOS, the recirculation of the dialysate, to adjust pH to
a desired level, is determinant.
According to dialyzer inlet and outlet values in Table 1, first, the high
pH carbonate-free dialysate induces a concentration gradient between
blood and dialysate for H+ and HCO3-, which triggers CO2 removal
and pH increase. Second, a reduction in pCO2 and SID occurs, which
can predict the increased pH level [1].
CONCLUSION. ADVOS therapy can remove CO2 and correct acid-base bal-
ance using a high pH dialysate. The mechanism of action can be explained
through a H+ and HCO3- gradient and by pCO2 and SID variations.
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INTRODUCTION. The PaO2/fraction of inspired oxygen (FIO2) (P/
F) ratio is correlated with the ratio of the pulse oximetry satur-
ation (SpO2)/FIO2 (S/F) in intubated hypoxic patients. Whether
this correlation exists in acute hypoxic respiratory failure (AHRF)
patients treated by nasal high flow (NHF) remains to be
determined.
OBJECTIVES. To describe the correlation between P/F and S/F values
in patients with AHRF supported by NHF.
METHODS. Measurements of P/F and S/F of the patients enrolled
in the ROX index studies (1, 2) were compared to assess the rela-
tionship between them (derivation cohort). SpO2 values ≥98%
were excluded from the analysis. Scatterplot of S/F and P/F ratios
were used to determine the linear correlation. Generalized esti-
mating equations were used to estimate the best regression line.
S/F threshold values correlating with P/F ratios of 200 and 100
were determined. The area under receiver operator characteristic
(AUROC) curves was calculated to assess the diagnostic ability to
discriminate between patients with P/F ratio ≤200 and ≤100. Pa-
tients from the FLORALI trial (3) and 3 other physiologic studies
(4-6) were used as validation cohort.
RESULTS. Using the 638 measurements of the derivation cohort,
the relationship between S/F and P/F was described by the equa-
tion S/F= 45 + P/F * 0.78, R2=0.68; p<0.0001) (Figure 1). A S/F of
201 corresponds to a P/F of 200, and a S/F of 123 to a P/F of
100. S/F ratios demonstrated high diagnostic accuracy to discrim-
inate between patients with P/F ≤100 and ≤200 (AUROC 0.91
[0.88-0.95] and 0.86 [0.77-0.94], respectively). Sensbility, specificity
and positive and negative predictive values are presented in
Table 1. Similar results were observed in the validation cohort
(280 measurements).
CONCLUSION. S/F ratio correlates with P/F ratio in AHRF treated
with NHF. S/F values of 201 and 123 correlate with P/F of 200
and 100, respectively. S/F thresholds could be a non-invasive but
accurate measure to stratify severity of hypoxic patients treated
with NHF.
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Fig. 1 (abstract 000583). Scatterplot of S/F and P/F ratios in the
derivation and validation chort.
Table 1 (abstract 000583). See text for description
Cohort Se Sp PPV NPV LR+ LR-
S/F≤201 Derivation 89.8% 71.4% 95.8% 49.1% 3.14 0.14
Validation 92.8% 66.7% 95.1% 57.1% 2.78 0.11
S/F≤123 Derivation 89.4% 82.8% 74.0% 93.4% 5.19 0.13
Validation 77.7% 87.3% 81.7% 84.3% 6.14 0.26
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INTRODUCTION. High dose Steroids for ARDS have not shown survival
value, and possible harm beyond 14d (1,2). However, dosing, timing and
variation in study design influence published outcomes (3). Extended
lower doses (1-2mg/kg/d) may improve hospital outcomes (4). High dose
immunosuppression (IS) benefits some patients(pts) with severe ILD on
mechanical ventilation (MV)(5). Furthermore, steroids in severe pneumo-
nia can improve survival (6). Thus, high dose steroids continue to be
given in ARDS when, clinicopathoradiographic features suggest a poten-
tially steroid responsive behavior pattern, or as a last resort, if faced with
an inability to wean off MV. The outcomes from this strategy are unclear.
OBJECTIVES. We reviewed outcomes of pts with ARDS treated with
immunosuppression.
METHODS. A retrospective case matched study from a single tertiary re-
spiratory critical care unit(2009-17), identified sequential pts who received
intravenous Methylprednisolone (MePred), +/- Rituximab, +/- cyclophos-
phamide, for ARDS. ARDS pts, (AECC/Berlin criteria - 10% of all ARDS pa-
tients), 81 given IS, were case matched with 81 pts without IS (by P/F
ratio, gender, age, SOFA-all in 34 cases). Outcomes of survival (30d, 6mo,
12mo), Covariates such as SOFA score, MV days, length of stay (LOS), pres-
ence of infection, antibiotic usage were analysed. Cox multiple compari-
sons regression identified prognosticators.
RESULTS. 162 pts (81 ARDS-IS and 81 ARDS). Mean age 51y±4.9 and
44y±12.9. Male 48(59%) and 45(56%). For ARDS-IS 70(86%) had MePred
and 6(7%) received MePred+cyclophosphamide. Percentage of pts given
IS at <7d 34(42%), 7-14d 24(30%), >14d 23(28%). Veno-venous ECMO in
49(60%) ARDS-IS and 62(77%) ARDS pts. Mean SOFA scores 10.8±3.71 and
13.5±3.47. Neuromuscular blockade in 65(80%) and 68(84%). Mean mech-
anical ventilator days were 34 and 16 days(p<0.05). Mean length of stay
40 and 19 days(p<0.05). Mean total antibiotic (AB) days 97(±101) and 61(±
20); AB/day 2.42 and 3.25 (p>0.05). AB days pre and post ARDS-IS were
34(±34) and 63(±88.5). In ARDS-IS, respiratory was the highest positive
microbiology site. There was a 1.5x increase in positive respiratory and 2xurine/line infection post IS, but not causing worse outcome. Fungal infec-
tions were the most frequently encountered organism followed by gram-
ve. Overall, survival was 29% v 71.4% for ARDS-IS v ARDS (p<0.0001). Sur-
vival at 30d, 6mo and 1 yr was 75, 48 and 46% for ARDS-IS, and 79, 75
and 74% for ARDS. Overall mortality by timing of IS was 70% 24/34(<7d),
58% 14/24(7-14d), 65% 15/23 (>14d). Immunosuppression, diabetes, age,
length of stay were univariately associated with a worse outcome. Hazards
ratio (HR) for death in ARDS given IS was 2.73 (p<0.0001). Only age (HR
1.03, p=0.002), length of stay (HR 0.47, p=0.0001) and diabetes (HR 2.34,
p=0.021) were independently associated with mortality.
CONCLUSION. After high dose IS, post discharge survival for ARDS-IS
was significantly worse than case matched ARDS pts. Age, length of
stay and diabetes were independent factor for increasing risk of
death. No survival difference based on early or late timing of IS. High
dose IS is associated with significantly worse post discharge survival.
Investigation of causes of post 30d deaths and predictors of steroid
responsiveness in ARDS is necessary.
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INTRODUCTION. The importance of gases administered during inva-
sive mechanical ventilation (IMV) reaching the patient in adequate
conditions of heat and humidity through the respirator’s circuits is in-
disputable. Controversy remains about which is the most appropriate
humidification system and its influence on the incidence of mechan-
ical ventilation-related respiratory infection.
OBJECTIVES. To evaluate differences in the rate of incidence of
pneumonia and tracheobronchitis associated with mechanical venti-
lation (VAP and AVT respectively) with a hygroscopic heat-moisture
exchanger with antibacterial filter versus active humidification with
heating of inspiratory and expiratory tubulars.
METHODS. Retrospective descriptive study in a polyvalent ICU. In-
cluded were all patients undergoing IMV for more than 48 hours
during 2014, when passive humidification was used (EdithFlex of
the brand AirlifeTM®), and 2016, when active humidifiers (Fisher
& Paykel MR850®) were used. In both groups, identical measures
were established to prevent VAP (Pneumonia Zero project). Euro-
pean Centre for Disease Prevention and Control (ECDC) diagnostic
criteria were used to define VAP. Centers for Disease Control
(CDC) diagnostic criteria were used to define TAV. Any NAV de-
veloping in ≤7 days from the beginning of the IMV was consid-
ered early NAV. Incidence rates of VAP and TAV were estimated
for 1000 days of IMV in both groups. Late and early VAP were
determined as well. Statistically significant differences between
both groups were assessed between by Poisson regression. Clin-
ical Research Ethics Committee authorization was obtained.
RESULTS. 287 patients were included (116 ventilated with passive hu-
midification and 171 ventilated with active humidification). The mean
age of the sample was 62.3 ± 16.2 years, 61.2% males, average APACHE
II of 23.5 ± 9.5 points and ICU mortality of 31.1%. Demographic charac-
teristics were not significantly different between both groups. The inci-
dence density of VAP for 1000 days of IMV was 5.68 for the passive
humidification group and 5.80 for the active humidification group (p=
NS). The incidence density of TAV was 3.41 and 3.26 cases per 1000
Fig. 2 (abstract 000601). See text for description
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The duration of IMV was identified as a risk factor for NAV. The inci-
dence density of early VAP per 1000 days of IMV was 3.03 with passive
humidification and 2.53 with active humidification (p=NS).
CONCLUSION. In our study, active humidification in patients with
IMV for more than 48 hours was not associated with an increase of
infectious complications.
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INTRODUCTION. It is well documented that lung-protective venti-
lation strategies are associated with favourable outcomes in pa-
tients with ARDS.[1-3] In 2015, Amato et al. showed that
increased driving pressure (ΔP) was associated with increased 60-
day mortality in patients with ARDS, especially during the first 24
hours of ventilation.[4]
OBJECTIVES. To ascertain if there was any association with a median
ΔP greater than or equal to 14 cmH2O during the initial 24 hours of
ventilation and 28-day crude mortality rate.
METHODS. Data were collected at regular intervals during a
one-month period. ΔP (cm H2O) was calculated as the differ-
ence between the peak pressure and positive end-expiratory
pressure. Data were further divided into a survivor and de-
ceased group according to the 28-day crude mortality rate. Pa-
tients ventilated via APRV or NIV were excluded from the study,
as were patients with incomplete data. Statistical analysis was
carried out using R version 3.5.3 (R Foundation).
RESULTS. 32 patients met inclusion criteria. Overall, 22 patients
survived and 10 patients were deceased at 28 days. The mean
ages (SD) for the survivor and deceased groups were 60.8( 18.3)
years and 68.5 (16.1) years respectively (Fig A, p=0.20). During
the first 24 hours of intubation, 90% (9 patients) of the deceased
group and 68% (15 patients) of the survivor group had a median
ΔP ≥ 14cmH20 (Fig B, p=0.30).
CONCLUSION. On Day 1 of intubation 71.8% of our patients had
a median ΔP ≥ 14cmH2O, yet, when data from the initial 24
hours were split into two groups (ΔP < 14cmH2O or ≥
14cmH2O), a Fisher’s exact test showed no significant associ-
ation with outcome at 28 days (p=0.20; Fig. B). Amato et al. evi-
denced that 60-day mortality risk was significantly increased by
both age and median ΔP when compared to multiple vari-
ables.[4] Our data demonstrated neither variable proved signifi-
cant on crude mortality at 28 days. Nonetheless, our data set is
small and looked at all-cause intubation, not just patients with
ARDS, as in the Amato study. In fact, patients ventilated using
APRV (often used for those with severe ARDS) were excluded
from this study, which may have removed a key patient popula-
tion from the mortality analysis. However, Schmidt et al. found
no association with day 1 ΔP and mortality (ICU and at 6-
months) in patients without ARDS, suggesting it is the severity
of respiratory compromise which has the greatest impact on
mortality, not ΔP, which may, therefore, reflect the degree of
morbidity rather than mortality.[5] Further investigation is there-
fore required in a larger patient cohort throughout the full ven-
tilation period to compare ΔP in patients with and without
ARDS if an association between mortality and ΔP is to be
proven.
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INTRODUCTION. Lung transplant (LT) has improved survival (al-
though average is only 5.8 years) [1], whereas the number of LTs
has been progressively increasing. Consequently, the interest for
intensive care specialists, even those not directly involved in LT,
has gone beyond the post-operative period, due to the increase
of ICU readmissions (ICUr) of LT subjects [2, 3], also occurring in
centres without a LT programme. Acute respiratory failure (ARF)
and sepsis have been described as the most frequent conditions
determining ICUr in LT recipients [4–9]. However, factors influen-
cing the ICUr of this unique subgroup of immunocompromised
patients after the post-operative period have been reported by
few, mainly retrospective and single-centre studies. Thus, it is of
paramount importance to have an updated snapshot of this
emerging condition.
OBJECTIVES. We aimed to assess the main causes of ICUr in lung
transplant adults and identify potential predictors of ICU-
mortality.
METHODS. This 5-centre prospective cohort study enrolled all LT
adults readmitted to ICU after post-transplantation ICU dis-
charge (2012-2016). Patients were followed until hospital dis-
charge or death. Primary end-point was to identify independent
predictors of ICU-mortality (by multivariate logistic regression
analysis).
RESULTS. We followed 153 patients (with 174 ICUr), readmitted
a median of 6 months [6-25] (33, 21.6% within 1 month) post-
Page 125 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55LT. Thirty-five (22.9%) had chronic allograft dysfunction (CLAD).
ARF (110, 71.9%) was the main condition requiring ICUr. Pneu-
monia (56, 36.6%) was the main cause (50 admitted due to ARF
and 6 for shock), with P. aeruginosa (50% MDR) being the pre-
dominant pathogen. Graft rejection (6, 5% acute) caused 12
(11%) admissions. The ICU and hospital mortality were 55
(35.9%) and 69 (45.1%) subjects, respectively. CLAD (adjusted-
OR: 3 and 3.5) and pneumonia at ICUr (aOR: 3 and 2.4) were
identified as independent predictors of ICU and hospital mortal-
ity (p<0.05).
CONCLUSION. Acute respiratory failure was the main condition re-
quiring ICU readmission in lung trasnplant recipients and it was
associated with high mortality. Pneumonia was the main cause
and an independent predictor of death.
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INTRODUCTION. Respiratory muscle weakness leads to prolonged
mechanical ventilation, difficulty in machine withdrawal, tracheal in-
tubation again and tracheotomy caused by respiratory weakness,
increased mortality and reduced the quality of life of survivors[1-
3]. There are some studies found that withdrawal time accounts
for about 40% of patients' mechanical ventilation time [4]. If
withdrawal is delayed, significant weakness of respiratory muscles
means that 5%-15% patients cannot successfully withdraw[5]. In-
spiratory Muscle Training (IMT) has been shown to improve the
respiratory muscle strength in patients with chronic obstructive
pulmonary disease (COPD) [6], chronic heart failure[7]and asthma
[8]. The IMT also could improve patients' mobility and the quality
of life [9-10]. However, there is a major controversy whether the
threshold inspiratory muscle training(TIMT) could promoteweaning mechanical ventilation, and benefical to the respiratory
muscle recovery and clinical outcomes.
OBJECTIVES. To study whether the Threshold Inspiratory Muscle Trai-
ning(TIMT) can improve respiratory muscle strength and clinical re-
sults for machinery ventilates patients.
METHODS. To retrieve the related randomized controlled studies
by following databases: the Cochrane Library, PubMed, Embase,
Web Of Science, The Chinese Biomedical Literature Database,
Wan Fang Database, China National Knowledge Infrastructure
(CNKI) and VIP Database, retrieval ends on July 1, 2018. Two re-
searchers strictly evaluated literature quality and extracted infor-
mation, and then meta-analysis the including literatures which
met the inclusion criteria.
RESULTS. There are 1 Chinese and 14 English literatures includ-
ing the study. The total sample size was 657.TIMP can effect-
ively improve the maximal inspiratory pressure(MIP) [RR=6.64,
95%CI(5.10, 8.17), P] and respiratory muscle strength [RR=7.64,
95%CI (2.99,12.29)], reduce weaning time [RR=-2.24,95%CI
(-4.33,-0.15), shorten mechanical ventilation time[RR=-1.04,
95%CI (-1.66,-0.42), P=0.001], P=0.04],the ICU length of stay
[RR=-2.95, 95%CI (-5.38,-0.52), P=0.02], and reduce the rate of
weaning failure [RR=0.57, 95%CI(0.36,0.89),P], in mechanical
ventilation patients compared with conventional treatment.
However, TIMP compared with traditional treatment, there was
no statistically significant difference in improving the maximum
expiratory pressure(MEP) [RR=1.22, 95%CI (-6.55,9.00), P=0.76],
reducing the rate of reintubation/tracheotomy [RR=0.99, 95%CI
(0.56,1.73), P=0.96] and mortality [RR=1.05, 95%CI (0.53,2.06) in
mechanical ventilation patients.
CONCLUSION. The TIMP can significantly improve the mechanical
ventilation patients’ MIP and respiratory muscle strength, shorten
the weaning time, the mechanical ventilation time and the ICU
length of stay, reduce the incidence of weaning failure.
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INTRODUCTION. The clinical practice and the weaning of patients from
the ventilator is a highly time dynamic process. The ventilation parame-
ters must be permanently adjusted individually, as the patient can un-
expectedly become exhausted at any time. However, a target-oriented
weaning therapy can only be realized as soon as all technical dead
space (DS) increasing influences are identified. On the ICU, commonly
used devices influencing the dead space volume are either an HME
(35ml) or anesthetic conserving devices (ACD, AnaConDa, Sedana Med-
ical, Danderyd, Sweden) - ACD (50 ml and 100 ml).
OBJECTIVES. The objective was to determine the influence of devices
that are widely used in intensive care medicine on ventilation pa-
rameters during Controlled Mechanical Ventilation. The elimin-
ation of CO2 and the increase in the tidal volume needed to
compensate for those devices were our main endpoints. In
addition to that, we wanted to quantify the impact of CO2 reflec-
tion in anesthetic gas reflection devices.
METHODS. After written informed consent, a total of 34 patients
undergoing orthopedic surgery under general anesthesia have been
included in our trial. Patients were randomly assigned into two
groups (16 to 18 each). Anesthesia was induced as a TIVA and main-
tained as such for the first phase of measurements. In the second
phase, anesthesia has been maintained using sevoflurane as the
anesthetic agent. Patients were ventilated with the ICU respirator S1,
Hamilton Medical (Bonaduz, Switzerland), which is equipped with a
flow-through capnometry. After a baseline measurement without any
additional dead space (no-DS), the devices have been installed se-
quentially and we waited for a steady state in etCO2 for at least 5 mi-
nutes until proceeding to the next device. Our study has been
designed as a case-control study, randomizing the order in which
the two different AnaConDa-devices have been measured.
RESULTS. As both groups were comparable in age, weight, ASA, sex
and ventilation parameters the groups have been analyzed together.
While maintaining a steady breathing rate and inspiratory pressure, in
TIVA phase the etCO2 (mmHg) changed as following: no-DS-1 30.0±0.0,
HME 33.9±2.5, ACD50 40.2±5.3 and ACD100 44.2±5.8 (ANOVA: p<
0.001). Compensating the devices by an increase of inspiratory pressure
and maintaining the etCO2 measured in the baseline measurement,
the tidal volume (ml) acted as follows: no-DS-1 454.1±94.7, HME 534.1±
100.4, ACD50 603.9±101.8 and ACD100 740.2±113.8 (ANOVA: p<
0.001). After a second baseline measurement with an etCO2 of 30.0±
0.0mmHg, in sevoflurane phase, etCO2 for the ACD50 increased
to 35.5±2.4mmHg and 37.4±2.6mmHg for the ACD100 (ANOVA: p<
0.001). For the ACD50 a tidal volume (ml) of 571.3±92.3 was needed
and for the ACD100 one of 636.7±119.8 in comparison to a no-DS-2
tidal volume of 446.8±99.9 (ANOVA: p<0.001).
CONCLUSION. This study showed, that the usage of devices influen-
cing the dead space volume can drastically change the elimination
of CO2. The ventilation parameters have to be altered significantly to
level out the increased dead space ventilation. Using an anesthetic
gas reflector, the addition of the anesthetic gas sevoflurane reduces
CO2 reflection.
TEM - Clinical studies in trauma and
acute poisoning
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000604INTRODUCTION. Patient selection and optimal timing for coronary
angiography (CA) and percutaneous coronary intervention (PCI) fol-
lowing out-of-hospital cardiac arrest (OHCA) have been contentious.
PCI is resource-intensive, and whilst large observational studies have
concluded that early PCI improves survival in patients with non-ST
elevation myocardial infarction, a recent Dutch randomised con-
trolled trial - COACT - demonstrated no survival benefit of immediate
over delayed PCI in patients without evidence of STEMI. Our 700-
bedded UK DGH has a 24-7 Cardiac Cath Lab service that has rou-
tinely investigated OHCA patients with indications pre-ICU admission.
OBJECTIVES. To identify factors affecting hospital mortality in OHCA
patients admitted to our ICU; in particular, disease severity, CA pre
and post ICU admission, and adoption of 36°C targeted temperature
management (TTM) target on 01/01/15.
METHODS. We analysed prospectively collected data from all coma-
tose OHCA patients admitted to our ICU between 01/01/12 and 31/
12/17 using Trust electronic databases. Data were statistically ana-
lysed using a key driver analysis to identify factors that correlate
most with survival.
RESULTS. Of 283 patients identified, summary values [presented as
median (range) or percentages] were: age 66 (16-93); APACHE II
score 19 (4-44); ICNARC score 28 (9-83); male 70%; presented
with VF 61.8%, PEA 24.7%, asystole 8.8%, VT 2.1%, unknown pri-
mary arrest rhythm 2.5%; CA pre-ICU 62%; PCI pre-ICU 35%, CA
post-ICU 6%; completed 24 hours of TTM 75%; survived to hos-
pital discharge 42%. Of survivors: ICU length-of-stay (LOS) 4.4
(0.5-34) days, hospital LOS 12 (0.5-101). Of non-survivors: ICU LOS
2.5 (0.1-16) days, hospital LOS 3 (0.1-70) days. On univariate ana-
lysis, survival was increased by male sex, VF as primary rhythm,
completing 24 hours of TTM, CA and PCI before ICU, CA after
ICU. On multivariate analysis, drivers for survival were APACHE II
score (p=0.000), VF as primary rhythm (p=0.001), having com-
pleted 24 hours TTM (p=0.004); undergoing CA after ICU admis-
sion (0.01) and ICNARC score (p=0.03).
CONCLUSION. Changing TTM target to 36°C did not affect ICU or
hospital survival. Neither pre-ICU CA or PCI were found to be
significant drivers on multivariate analysis. Strongest independ-
ent predictors of survival in our study were APACHE II mortality
score and VF rhythm, followed by completing TTM, undergoing
CA after ICU admission and ICNARC score, which were all linked
by selection criteria. Our results, in keeping with the recent CO-
ACT study, demonstrate that performing CA before ICU admis-
sion does not improve mortality and we conclude that this
should be considered in comatose OHCA patients only on a
case-by-case basis.
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INTRODUCTION. Cardiac arrest is one of the leading causes of
mortality in Europe, and early prognostication remains challen-
ging. There is a paucity of valid parameters for the prediction of
survival after both in hospital (IHCA) and out of hospital cardiac
arrest (OHCA). Arterial blood gas (ABG) monitoring evaluates par-
tial pressures of gas and acid-base content.
OBJECTIVES. This study aims to investigate if arterial blood gas
parameters correlate with mortality of patients after in and out-
of-hospital cardiac arrest following admission to intensive care
unit (ICU).
Page 127 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55METHODS. This is a single centre retrospective observational re-
view of the database WardWatcher. Cardiac arrest patients who
were admitted between January 2007 to July 2018 to a tertiary
ICU were included. The patient's survival 30 days after resuscita-
tion defined the study end-point. For the statistical analysis, the
mean, standard deviation, Mann Whitney-U test, Chi-square test,
and logistic regression analyses were used (level of significance p
< 0.05).
RESULTS. ABG samples were taken from 1034 patients during the
study period. When compared with OHCA cases, patients admit-
ted with IHCA were older 68 vs 62 years, (p<0.0001), had higher
GCS score 5.4 vs 4.5, (p<0.0001), higher APACHE II scores 18.9 vs
17.1 (p<0.0001). 30-day mortality was higher in the OHCA cohort
but not statistically significant.
In both cohorts (together and independently), lactate ≥ 4.0
mmol/L showed strong and independent correlations with mor-
tality within the first 30 days after admission to ICU [All: OR
2.37 (95% CI 1.77-3.19), IHCA: OR 1.81 (95% CI: 1.19 – 2.76),
OHCA: OR 3.26 (95%CI: 2.12-5.07)], whereas a GCS score > 8
showed strong and independent correlations with survival
within the first 30 days after admission to ICU [All: OR 0.17
(95% CI:0.11-0.26), IHCA: OR 0.31 (95% CI:0.19-0.52), OHCA: OR
0.06 (95% CI: 0.02-0.13)].
CONCLUSION. Our study results indicate that blood gas parame-
ters correlate with mortality of patients after cardiopulmonary
resuscitation. In both IHCA and OOHCA, the most relevant param-
eter is a lactate ≥ 4.0 mmol/L which was observed to be a strong
and independent predictor associated with mortality within the
first 30 days after resuscitation. In contrast, having a GCS>8 on
admission to ICU is associated with good outcome at 30 days.
Despite these findings, it is likely that early prognostication relies
on multiple factors beyond individual covariates. Nevertheless,
these parameters can form a part of a multimodal approach to
assessing the patients’ prognosis.
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INTRODUCTION. Recent studies have shown temporal variations in
the incidence of out of hospital cardiac arrest (OHCA), however, there
is a dearth of studies investigating similar variations in in-hospital
cardiac arrest (IHCA) especially in the Welsh population.
OBJECTIVES. This study aims at investigating the epidemiology, circa-
dian, weekly and seasonal variations of patients with IHCA and OHCA
admitted to a tertiary intensive care unit (ICU) in South Wales.
METHODS. This is a single centre retrospective observational review
of Wardwatcher database. All post cardiac arrest patients admitted to
a tertiary referral ICU from January 2007 until December 2017 were
included. A variety of data including demographics and comorbidi-
eties were collected.
RESULTS. Of the 475 IHCA, 53% were females with mean age of
group 68 ± 14.0 years. Conversely, the majority of the 490 OHCA
cases were males with 53% with mean age of group 62 ± 16.5 years.
From 2007 until 2017, admissions of patients with cardiac arrest in-
creased steadily with an exponential increase within the IHCA group.
During that 11-year period, May and June were the months with the
lowest number of admissions for both IHCA and OHCA.
The incidence of OHCA admitted to ICU in the studied population was
44.5 patients per year. Admission of patient with OHCA to ICU stayed
stable low levels between 22:00 and 4:59 and started to increase at
5:00, with a modal peak: 13:00–14:59. The lowest number of OHCAadmitted to ITU occurred from 07:00 to 8:59, the highest from 13:00 to
14:59 (1.2% vs. 8.2%, p < 0.001). The day with the lowest cases of OHCA
admitted to ITU was Sunday, the highest Monday (12.7% vs. 16.3%, p =
0.01). Summer was the season of the lowest cases of OHCA admitted
to ITU, while winter — the highest (22.4% vs. 29%, p = 0.001).
The incidence of IHCA admitted to ICU in the studied population was
43.2 patients per year. IHCA admitted to ICU increased with age
reaching a peak of 95 years. Patients with IHCA admitted to ICU
stayed high levels between 07:00 and 1:59 and started to decrease
at 02:00, with bi-modal peaks: 00:00–01:59 and 18:00-18:59. The day
with the lowest admission of IHCA to ICU was Sunday, the highest
Thursday (8.8%% vs. 17.1%, p <0.001). Spring was the season of the
lowest number of patients with IHCA admitted to ICU, while winter
— the highest (21.7% vs. 27.3%, p = 0.001)
CONCLUSION. This is the first study of a large Welsh subpopulation
over an 11-year period, which confirmed that times of admission,
weekly variability and seasonal differences exists in both IHCA and
OHCA patient who are admitted to ICU.
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INTRODUCTION. Some studies both support and refute the use of
veno-arterial extracorporeal membrane oxygenation (VA-ECMO)
for out-of-hospital cardiac arrest (OHCA) patients, and there is no
sufficient evidence on the characteristics of patients who should
receive VA-ECMO.
OBJECTIVES. We evaluated the relationship between the use of VA-
ECMO, the outcome and some physiological parameters in OHCA
patients.
METHODS. We extracted 239 OHCA patients from computer-based
medical records from February 2000 to December 2017. The 239 pa-
tients were all hospitalized after a return of spontaneous circulation
(ROSC) from cardiac arrest of cardiac origin at 16 years of age or
older. We divided the patients into two groups: patients who under-
went VA-ECMO (n=84) and those did not (n=155) and established
propensity score (PS) matched groups with patients matched accord-
ing to pre-hospital factors (gender, age, time from the detection of
cardiac arrest to ROSC, and the initial rhythm at cardiac arrest). We
compared the following factors in two groups of 24 PS-matched pa-
tients: platelet count, coagulation and fibrinolysis marker and lactate
levels, International Society on Thrombosis and Haemostasis (ISTH)
DIC score, sequential organ failure assessment (SOFA) score, and
acute physiology and chronic health evaluation (APACHE) II score.
The outcome was measured by all-cause hospital mortality after 28
days of hospitalization.
Furthermore, a sub-group analysis was performed after dividing pa-
tients who received VA-ECMO into two groups according to the
outcome.
RESULTS. The VA-ECMO group had more severe coagulo-fibrinolytic
changes and organ dysfunction than the non-VA-ECMO group. In
addition, the VA-ECMO group showed poorer outcomes. A sub-
group analysis showed that the patients in the VA-ECMO group
with a poor outcome had significantly higher ISTH DIC scores
and lower PT% on day 2, while these parameters were not sig-
nificantly different on day 1.
CONCLUSION. This study showed no beneficial effect of VA-ECMO
on the OHCA patients. Furthermore, among the patients who re-
ceived VA-ECMO, poor outcomes were observed in patients whose
ISTH DIC scores and PT% showed deterioration.
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INTRODUCTION. Mechanisms by which neutrophils contribute to
post-resuscitative brain damage are unknown. In recent years, neu-
trophil extracellular traps (NETs) have emerged as a central player in
inflammation, thrombogenesis and cardiovascular disease. NETs are
chromatin fibers consisting of histones, cell free DNA (cfDNA) and
granular proteins and are released within minutes (1) to hours (2) fol-
lowing activation by various stimuli including ischemia and reperfu-
sion (3). While NETs have primarily been recognized as mediators of
antimicrobial host defense, they may exert detrimental inflammatory
and procoagulant effects causing endothelial damage, platelet activa-
tion, microvessel occlusions and ultimately tissue malperfusion (4). In
particular neutrophil histones and DNA are considered cytotoxic and
procoagulant components of NETs (5) and have been implicated in
organ damage in various medical conditions (6). Despite this, the role
of NETs in cardiac arrest has not yet been investigated. Pro-
inflammatory and pro-thrombotic properties, however, render them
possible mediators of neutrophil-borne brain injury after successful
resuscitation.
OBJECTIVES. We hypothesized that the formation of NETs in the
early phase after successful resuscitation may be associated with
neurologic impairment in cardiac arrest survivors.
METHODS. This prospective cohort study included adult patients
with out-of-hospital cardiac arrest of cardiac etiology who received
targeted temperature management. Plasma levels of specific (citrulli-
nated histone H3, H3Cit) and putative (cell free DNA and nucleo-
somes) biomarkers of NET formation were assessed at 0 and 12
hours after admission and categorized into quintiles prior to analysis.
The primary outcome variable of interest was the effect of H3Cit
levels at 12 hours on 30-day neurologic function, assessed by logistic
regression. Results are given as odds ratio (95% confidence interval).
RESULTS. Between January 2014 and January 2017 62 patients (79%
male, median age: 57 years) were enrolled at the Emergency Depart-
ment at the Medical University of Vienna. In total, 52% of patients
(n=32) had a poor 30-day neurologic function. The odds of neuro-
logic impairment linearly increased with 12-hour levels of H3Cit (1.6,
1.1-2.3; p=0.029) and were highest in patients in the fifth quintile of
the histone level distribution (9, 1.3-63; p=0.027). The effect remained
unchanged after bivariate adjustment for covariables.
CONCLUSION. Increased plasma levels of H3Cit 12 hours after suc-
cessful resuscitation are associated with poor 30-day neurologic re-
covery in adult out-of-hospital cardiac arrest survivors with cardiac
etiology.
REFERENCE(S)
1. Yipp BG, Petri B, Salina D, et al. Infection-induced NETosis is a dynamic
process involving neutrophil multitasking in vivo. Nature medicine
2012;18:1386-93.
2. Fuchs TA, Abed U, Goosmann C, et al. Novel cell death program leads to
neutrophil extracellular traps. The Journal of cell biology 2007;176:231-41.
3. Ge L, Zhou X, Ji WJ, et al. Neutrophil extracellular traps in ischemia-
reperfusion injury-induced myocardial no-reflow: therapeutic potential of
DNase-based reperfusion strategy. American journal of physiology Heart
and circulatory physiology 2015;308:H500-9.
4. Gould TJ, Lysov Z, Liaw PC. Extracellular DNA and histones: double-
edged swords in immunothrombosis. Journal of thrombosis and haemo-
stasis : JTH 2015;13 Suppl 1:S82-91.
5. Noubouossie DF, Whelihan MF, Yu YB, et al. In vitro activation of
coagulation by human neutrophil DNA and histone proteins but not
neutrophil extracellular traps. Blood 2017;129:1021-9.6. Jorch SK, Kubes P. An emerging role for neutrophil extracellular traps in
noninfectious disease. Nature medicine 2017;23:279-87.
7. This study was kindly supported by the Austrian Science Fund FWF grant
SFB 54/APF05404FW (Special Research Program-Cellular Mediators Link-
ing Inflammation and Thrombosis, Medical University of Vienna).
000738
Comparing of CPR related trauma: mechanical chest devices vs.
manual CPR
J. Karasek1, B. Blankova2, T. Pitasova3, A. Doubkova3, J. Seiner1,
M. Strycek1, R. Polasek1, T. Adamek2, J. Hladik4, P. Ostadal5
1Cardiology, Hospital Liberec, Liberec, Czech Republic; 2Forensic
medicine, Hospital Liberec, Liberec, Czech Republic; 33. medical
faculty, Charles University, Prague, Czech Republic; 4Forensic
medicine, Faculty Hospital Kralovske Vinohrady, Prague, Czech Republic;
5Cardiology, Na Homolce Hospital, Prague, Czech Republic
Correspondence: J. Karasek
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000738
INTRODUCTION. Resuscitation (CPR) with mechanical chest devices
are not recomanded for routine CPR according to randomised trials.
One of possible explanation could be CPR related trauma caused
with mechanical chest devices. Current data are based on subanalysis
from randomised trial, but autopsies are limitated by law and aut-
opsy results are not objectivised.
OBJECTIVES. To compare injuries after CPR in autopsy results by
manually resuscitated and mechanical (LUCAS 2, AutoPulse, COR-
pulse) resucitated patients and establish possible proportion of CPR
related injuries on death without respect to cause of cardiac arrest.
METHODS. Retrospective multicentric study based on autopsy re-
ports by patients died after CPR, patients with traumatic cause of car-
diac arrest were excluded. Patients were devided in two groups:
mechanical and manually CPR. For objective evaluation of injury ser-
iousness we used Abbreviated injury scale scoring for the most ser-
ious injury and New Injury Scale Score for summary of all injuries.
RESULTS. We have enroled 704 patients, after trauma exclusion we have
analyzed 630 autopsies. Manually CPR were provided by 559 patients
and mechanical by 64 (11,4%) patients. Both groups are no diferent in
age, gender, bystander CPR and cardiac etiology of Arrest. Mechanical
CRP was significantly longer (p=0,0005). Both groups have no diferences
in incidency of injuries of thoracic vessels, lungs, heart, pericard, pleura,
stomach, liver and spleen. We have observed injuries by 80% of manual
and 87,5% of mechanical CPR (p=0,18). The most frequent was thorax
sceleton injury 85,5% vs. 87,5%. Median of the most seriuos injury was 3 (
serious by Abbreviated injury scale scoring) without statistical difference,
median of summary of injuries (New Injury Severity Score) was 13 in both
groups ( low probability of fatal injury). If we analysed CPR by LUCAS 2
compared to manual, results are similar, only pericard injuries are higher
with LUCAS 2.
CONCLUSION. Incidency a seriousness of CPR related injuries accord-
ing to autopsy reports are no diferent in comapring of manually and
mechanical CPR. Mechanical CPR is significant longer a LUCAS 2
leads to significant more pericard injuries without influence to total
seriousness of injury
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INTRODUCTION. The pathophysiology of the ‘post cardiac arrest syn-
drome’ is complex and often requires multiorgan support, which is
best managed on the intensive care unit. Good quality post-
resuscitation care can greatly influence overall outcome, particularly
neurological recovery. The Resuscitation Council (UK) published
guidelines for post-resuscitation care in 2015, in line with those set
Page 129 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55by the European Resuscitation Council. There are key interventions
that should be followed to optimise outcomes and to facilitate accur-
ate prognostication of patients after cardiac arrest.
OBJECTIVES. To determine whether intensive care units in England
and Wales are following the Resuscitation Council UK Guidelines for
post-resuscitation care.
METHODS. An online survey (generated using SurveyMonkey) was dissem-
inated via e-mail to all Critical Care Network Leads in England and Wales. A
reminder was sent two weeks later. The survey was also advertised in the
Faculty of Intensive Care Medicine website and Twitter account.
RESULTS. We received 49 responses from across England and Wales.
95% of respondents were aware of the post-resuscitation care guide-
lines, but only 56% had an established protocol on their ICU. Most
physiological targets used correlated with guidelines; however, 49%
of respondents used a different target temperature to that recom-
mended in the guideline. With regards to prognostication, the major-
ity (72%) waited 72 hours post-ROSC. Many ICUs have access to EEG
(89%) and CT/MRI (78%); however, only 21% of institutions can meas-
ure neuronal specific enolase (NSE) levels.
CONCLUSION. Despite clear guidance from the Resuscitation Council,
there is heterogeneity in the management of the post-cardiac arrest pa-
tient. In particular, access to prognostication facilities varies greatly; EEG is
not universally available and NSE level measurement is not possible in
most centres. The guideline may therefore not be fit for purpose at all in-
stitutions and may require revision. At present, we recommend that each
institution establishes their own post-resuscitation protocol, tailored to
the facilities available locally. This will ultimately improve the quality of
care provided to survivors of cardiac arrest.
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INTRODUCTION. The International Liaison Committee on Resuscita-
tion guidelines recommend target temperature management be-
tween 32° C and 36° C for patients after out-of-hospital cardiac
arrest, but did not indicate patient-specific temperatures. The associ-
ation of serum lactate concentration and neurological outcome in
out-of-hospital cardiac arrest patient has been reported.
OBJECTIVES. The study aim was to investigate the benefit of mild
therapeutic hypothermia (32ºC–34ºC) in patients with various de-
grees of hyperlactatemia compared to normothermia (35ºC or 36ºC) .
METHODS. This study was a post hoc analysis of the Japanese Asso-
ciation for Acute Medicine out-of-hospital cardiac arrest registry be-
tween June 2014 and December 2015. Patients with complete
targeted temperature management and lactate data were eligible.
Patients were stratified to mild (< 7 mmol/l), moderate (< 12 mmol/
l), or severe (≥ 12 mmol/l) hyperlactatemia group based on lactate
concentration after return of spontaneous circulation. They were sub-
divided into mild therapeutic hypothermia or normothermia groups.
The primary endpoint was an adjusted predicted probability of 30-
day favorable neurological outcome, defined as a cerebral perform-
ance category score of 1 or 2.
RESULTS. Of 435 patients, 139 had mild, 182 had moderate, and 114
had severe hyperlactatemia. One hundred-eight (78%) with mild, 128
with moderate (70%), and 83 with severe hyperlactatemia (73%)received mild therapeutic hypothermia. The adjusted predicted prob-
ability of a 30-day favorable neurological outcome following severe
hyperlactatemia was significantly greater with mild therapeutic
hypothermia (27.8%, 95% confidence interval: 22.6%–33.1%) than
normothermia (15.3%, 95% CI: 6.7%–23.9%; p = 0.015). The differ-
ences in outcomes in those with mild and moderate hyperlactatemia
were not significant.
CONCLUSION. Mild therapeutic hypothermia independently pre-
dicted a greater probability of a favorable 30-day neurological out-
come in patients with severe hyperlactatemia compared with
normothermia.
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INTRODUCTION. Optic nerve sheath diameter (ONSD) is considered
as one of the prognostic factors in cardiac arrest (CA) survivors be-
cause of a parameter reflecting intracranial pressure (ICP) indirectly.
We aimed to investigate the correlation between ONSD measured by
magnetic resonance imaging (MRI) and ICP in CA survivors who
underwent target temperature management (TTM).
METHODS. In this retrospective cohort study conducted in 2018,
ONSD and cerebrospinal fluid (CSF) pressure were measured before
(Day 0 group) and after (Day 3 group) TTM. ICP and ONSD were re-
spectively measured with CSF pressure and an axis perpendicular to
the optic nerve 3 mm behind the eyeball in MRI. Increased ICP was
defined as an opening pressure over 20 mmHg. The primary out-
come was the correlation between ONSD and ICP.
RESULTS. A total of 37 patients who underwent ONSD measurement,
with simultaneous lumbar drainage catheter placement, were en-
rolled in this study. The median and interquartile range [IQR] of ICP
was significantly higher in the Day 3 group than in the Day 0 group
(14.9 mmHg [12.4-19.1] versus 10.5 mmHg [8.4-11.9], P < 0.001).
However, ONSD showed no difference between both groups (5.21
mm [4.80-5.58] versus 5.20 mm [4.79-5.70], P = 0.939). Ten cases
(26.3%) were found to have an increased ICP. Day 3 showed higher
incidence of increased ICP than in the Day 0 group (8% versus 19%,
p=0.178). The median and interquartile range of ONSD in the group
with increased ICP (6.17 mm [5.11-6.45]) was significantly higher than
those without increased ICP (5.19 mm [4.80-5.59]) (P = 0.015). The
group with increased ICP showed a statistically significant strong lin-
ear correlation with ONSD (r = 0.89, P < 0.001) compared to the
other (r = 0.14, P = 0.347). ONSD > 5.99 mm indicated a sensitivity of
60.0% and a specificity of 98.0% for identifying increased ICP.
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creased ICP. Therefore, ONSD measurement at an early stage, with-
out increased ICP from return of spontaneous circulation, may not be
useful for predicting neurological outcomes in CA survivors, due to
poor correlation with ICP. Prospective studies should be conducted
to confirm these results.
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INTRODUCTION. Several clinical scores have been developed to fa-
cilitate a well-timed transfer to the intensive care unit (ICU) that
could potentially prevent a cardiac arrest (CA). The Modified Early
Warning Score (MEWS) is the most studied of these scores and is uti-
lized in many countries to activate rapid response teams. The newer
Cardiac Arrest Risk Triage (CART) score was shown to have greater
accuracy than the MEWS. However, validation studies are lacking.
Several clinical scores have been developed to facilitate a well-timedtransfer to the intensive care unit (ICU) that could potentially prevent
a cardiac arrest (CA). The Modified Early Warning Score (MEWS) is the
most studied of these scores and is utilized in many countries to acti-
vate rapid response teams. The newer Cardiac Arrest Risk Triage
(CART) score was shown to have greater accuracy than the MEWS.
However, validation studies are lacking.
OBJECTIVES. The aim of this study was to validate the CART score
and MEWS for predicting cardiac arrest and ICU transfers among pa-
tients admitted at the Philippine Heart Center. To our knowledge, no
study has validated similar CA predictor scores in our country.
METHODS. This is a case-control study including 82 adult patients
(36 cases, 46 controls) admitted at the Philippine Heart Center. Cases
included patients who had CA at the wards (18 cases) and those
who were transferred to the ICU for any reason (18 cases). Personal
profiles and demographic data were collected. Differences in factors
were determined between cases and controls. Vital signs and “alert-
verbal-pain-unresponsive” (AVPU) scales from 48 hours prior and up
to the time of recruitment (CA or ICU transfer for cases) were noted.
The MEWS and CART scores for each time point were computed and
compared using measures of validity.
RESULTS. There was no significant difference between the case and
control groups in terms of age, sex, height, weight, diagnosis, disease
classification, and prior ICU admissions. A CART score of 12 was
found to have a higher accuracy than a MEWS of 4 across all time
points prior to CA or ICU transfer. The highest accuracy of the CART
score (cut off ≥ 12) was 74.39%, noted 8 hours prior to an event. This
had a corresponding specificity of 80.43% and sensitivity of 66.67%.
At this hour, the MEWS (cut off ≥ 4) had a lower accuracy of 68.29%
with a higher specificity of 97.83% but a lower sensitivity of 30.56%.
However, area under the curve analysis revealed that the differences
in scores between the CART and MEWS were not statistically signifi-
cant. Among CA patients detected by both tools, the CART was able
to detect CA earlier at a median of 30 hours prior versus 24 hours
prior for the MEWS.
CONCLUSION. The accuracy of the CART score is comparable to the
MEWS which is currently the internationally recognized tool for de-
tecting CA at the wards. In our opinion, the CART is simpler than the
MEWS as: 1) it has fewer variables, and 2) it does not contain a factor
requiring a higher level of proficiency (such as the AVPU scale of the
MEWS). Thus, we recommend the use of the CART score.
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INTRODUCTION. Brain injury remains the leading cause of death in
comatose patients resuscitated from out of hospital cardiac arrest
(OHCA). Markers measuring global cerebral ischemia, and reflecting
the metabolic variations after resuscitation are needed for a more in-
dividualized care. The lactate-pyruvate (LP) ratio is an important indi-
cator of compromised cerebral oxidative metabolism. The study aims
to investigate whether the LP ratio obtained by microdialysis (MD) of
the cerebral venous outflow reflects brain injury after OHCA.
METHODS. A feasibility study designed to determine the yield of
bedside monitoring of cerebral energy metabolism after OHCA utiliz-
ing intravenous MD. 15 unconscious patients were admitted to the
intensive care unit following OHCA with presumed cardiac cause. MD
catheters were inserted into the jugular bulb and radial artery (refer-
ence). The primary end-point was a difference in time-weighted
Page 131 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55mean MD parameters and LP ratio measured in venous and arterial
blood.
RESULTS. The median time from OHCA to MD analysis was 369 min
(IQR 255-444) and patients underwent a median of 76 h (IQR 65-82)
of monitoring. The LP ratio of cerebral venous blood increased (LP
ratio > 25) after OHCA indicating compromised cerebral oxidative
metabolism during the first 20 hours. The difference between time-
weighted mean of lactate, pyruvate and glycerol (in intervals of 12
hours) of the jugular venous and the arterial blood was significant
during post-resuscitation care (p < 0.02) when using mixed effects
models. In patients with unfavorable outcome (87 %), cerebral ven-
ous lactate remained high with mean and peak venous lactate level
> 2.2 and 5.5, respectively.
CONCLUSION. Isolated neurochemical changes indicating brain in-
jury were found after OHCA and consecutive resuscitation. Jugular
bulb MD may provide a reliable global estimate of cerebral metabolic
state and can be implemented as a new diagnostic tool for ICU pa-
tients after OHCA, with implications for early prognosis and
treatment.
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INTRODUCTION. Despite recent improvements, some patients after
out-of-hospital cardiac arrest (OHCA) suffer total loss of brain func-
tion, i.e. brain death. Coagulofibrinolyticmarkers and disseminated
intravascular coagulation (DIC) score were known to be associated
with neurological outcome in patients after OHCA, but the associa-
tions between these variables and brain death were not examined.
OBJECTIVES. To evaluate the associations of coagulofibrinolyticmar-
kers and DIC score with brain death after OHCA.
METHODS. We performed a retrospective analysis using data from
the regional UtsteinRegistry and medical records between 2006 and
2012. We enrolled patients who experienced OHCA with successful
return of spontaneous circulation and were admitted to Hokkaido
University Hospital. Outcome measure was brain death during
hospitalization. Logistic regression model was used to evaluate the
associations of coagulofibrinolyticmarkers including platelet count,
prothrombin time, plasma levels of fibrinogen, fibrin/fibrinogen deg-
radation products, and calculated DIC score on admission with brain
death. Classification and Regression Tree (CART) analysis was used to
identify specific thresholds of significant variables.
RESULTS. The overall rate of DIC (defined by DIC score >= 5)
and brain death were 13.0% (n = 41/315) and 9.5% (n = 30/315),
respectively. Compared with non-brain death group, brain death
group gained significant lower level of fibrinogen on admission
(1.97 vs. 2.45 g/L, p=0.005), but there were no differences about
other variables. CART analysis identified fibrinogen level of 2.26
g/L as an optimal threshold. In multivariable logistic regression
analysis, fibrinogen level =< 2.26 g/L was associated with in-
creased risk of brain death (adjusted odds ratio 2.87, 95%CI 1.16-
7.08, p=0.02).
CONCLUSION. Decreased fibrinogen level at admission was an inde-
pendent prognostic factor for brain death after OHCA.
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INTRODUCTION. Hypoxic-ischemic brain injury (HIBI) is the main
cause of death or disability in patients resuscitated from cardiac ar-
rest (CA). Extracorporeal membrane oxygenation (ECMO) is used to
treat refractory CA or post-CA shock. However, the potential benefit
of this resource-intensive treatment should be balanced against the
risk of futility. Automated pupillometry (AP) recently shown to accur-
ately predict HIBI outcome within 24h from CA and may therefore be
useful in this setting.
OBJECTIVES. To assess the accuracy of early AP for outcome predic-
tion in CA patients undergoing ECMO.
METHODS.Post hoc analysis of an international multicenter prognos-
tication study. The primary study endpoint was the accuracy of a
neurological pupil index (NPI) ≤ 2 to predict 3-month poor neuro-
logical outcome defined as severe disability, unresponsive wakeful-
ness or death (Cerebral Performance Category [CPC] 3-5).
RESULTS. On a total of 456 included patients, 66 (14%) were treated
with ECMO during resuscitation or immediately after the return of
spontaneous circulation. Unfavorable outcome was observed in 43
(65%) patients. On admission, 15 (23%) patients had NPI of ≤ 2; 13/
15 had CPC 3-5. The two patients with favorable outcome had a con-
tinuous EEG background and recovered a normal NPI (> 3.5) within
24 hours. Sensitivity, specificity, and positive predictive value of NPI
≤ 2 on admission for unfavorable outcome was 91%, 30%, and 87%,
respectively. On day 1 and 3, NPI ≤ 2 was observed in 11/66 (17%)
and 4/42 (10%), respectively; all of them had unfavorable outcome.
CONCLUSION. NPI measured with AP in CA patients undergoing
ECMO immediately after hospital admission was a sensitive but not
specific predictor of poor neurological outcome. Altered pupillary re-
sponse should not be used as a tool for deciding on ECMO treatment
in this phase.
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INTRODUCTION. Hyperlactatemia(1) and hyperglycemia(2) are fre-
quently observed as part of the stress reaction during critical illness.
Shorter times to normalization or higher rates of decrease of lactate
and glucose have been associated with better outcomes.(3,4) After
return to spontaneous circulation (ROSC) after out-of-hospital cardiac
arrest (OHCA), blood gas analyses usually demonstrate a marked
hyperlactatemia and hyperglycemia. We hypothesize that after ROSC
recovery from hyperlactatemia and hyperglycemia can be faster than
described for several other critical conditions.
OBJECTIVES. To determine the early kinetics of lactate and glucose
in the first 3 hours after ROSC after OHCA in patients presenting with
marked hyperlactatemia.
Page 132 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55METHODS. We retrospectively analyzed patients that presented be-
tween 2006 and 2016 after OHCA in whom initial ROSC was achieved
at departure of the ED. Arterial lactate and blood glucose levels were
determined by point-of-care blood gas analyzers. We only in-
cluded patients with an initial lactate immediately after ROSC of ≥8
mmol/L and with ≥2 measurements in the first 3 hours after ROSC.
With linear regression we estimated the absolute rate of decrease
(mmol/L/h) and relative rate of decrease (% of initial/h) per individual
patient. We compared the early kinetics between hospital survivors
and hospital non-survivors.
RESULTS. We studied 602 blood samples taken from 152 patients,
82.2% male, with a mean age of 59 years. The mean (±SD) initial lac-
tate and glucose levels were 12.1±3.7 and 18.6±5.2 mmol/L, respect-
ively. The mean relative lactate and glucose decreases were 30% and
14% of initial/h over the first 3 hours. The mean absolute lactate and
glucose decrease was 3.6 mmol/L/h and 2.7 mmol/L/h, respectively.
Lactate relative kinetics differed between survivors and non-survivors
(33%/h vs 27%/h p=0.007). Glucose relative kinetics did not differ sig-
nificantly between survivors and non-survivors (16 %/h vs 13 %/h p=
0.27).
CONCLUSION. Lactate is rapidly consumed through oxidation and
gluconeogenesis early after ROSC. Hospital survivors have relatively
higher initial decreases of lactate compared to hospital non-
survivors, while there was no difference in the decrease of glucose
between the two groups in the first 3 hours after ROSC.
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INTRODUCTION. This study aimed to compare the efficacy of endo-
vascular cooling device (ECD) like Thermogard® compared to surface
cooling device (SCD) such as Arctic Sun® in outcomes of adult post-
cardiac arrest patients treated undergoing targeted temperature
management (TTM).
METHODS. We systematically searched MEDLINE, EMBASE, and the
Cochrane Library (search date: 14 February 2019) to identify studies
on TTM for post cardiac arrest patients. Randomized controlled stud-
ies (RCT) and observational studies (OS) comparing in-hospital moral-
ity and neurological outcomes between ECD and SCD were selected.We additionally performed subgroup analyses based on confounding
factors that could affect patient outcomes. To assess the methodo-
logical quality of the included studies, Cochrane Risk of Bias Tool for
randomized trials and Risk of Bias Assessment Tool for Non-
randomized Studies was used independently by two authors.
RESULTS. A total of 4311 patients from nine studies were finally in-
cluded. Two RCT and seven OS were included in the meta-analysis.
Overall pooled analysis showed no significant difference on in-
hospital mortality between ECD and SCD (nine studies; RR, 0.93; 95%
CI 0.86–1.00; I2 = 0%). Likewise, there was no statistical difference in
RCT (RR, 0.80; 95% CI 0.56–1.14; I2 = 0%) and OS (RR, 0.94; 95% CI
0.86–1.01; I2 = 2%)
In the pooled analysis for neurologic outcome, overall pooled data
analysis revealed that neurologic outcome in ECD recipients was bet-
ter than in SCD recipients (RR, 0.91; 95% CI 0.86–0.96; I2 = 0%), How-
ever, ECD showed significantly better neurological outcome
compared to SCD only in OS (RR, 0.90; 95% CI 0.85–0.95; I2 = 0%).
There was no statistical difference in RCT (RR, 0.95; 95% CI 0.75–1.21;
I2 = 0%).
CONCLUSION. This study suggested that ECD could be associated
with better neurologic outcomes compared with SCD. However, fur-
ther studies would be needed to confirm the obvious benefit of ECD
in TTM recipients because that most included studies were observa-
tional studies.
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INTRODUCTION. According to the World Health Organization, trauma
is one of the leading causes of death worldwide. Trauma-related in-
juries are responsible up to 30% of admissions in the Intensive Care
Unit (ICU), mainly in young people and it has been recognized as a
serious social and economic issue. As expected, traumatic brain injury
(TBI) is the main cause of the majority of trauma-related deaths,
followed by haemorrhage-induced hypovolemic shock and multiple
organ failure syndrome (MODS).
OBJECTIVES. To describe the epidemiology of major trauma and ana-
lyse the prognostic factors of ICU-mortality.
METHODS. Prospective, observational and single centre study. All ad-
mitted trauma patients and registered in RETRAUCI (National data-
base of trauma in ICU) during 18 months, were consecutively
included. Demographic data, severity scores, pre- and intra-hospital
care variables and outcomes were recorded. Mann-Whitney U test
(continuous variables) and Chi-squared test (categorical variables)
were used; Mortality risk factors were evaluated by a multivariable
analysis with logistic regression (95% CI) and survival analysis with
Cox hazard regression analysis.
RESULTS. Total population comprises 140 patients admitted on ICU
due to major trauma. 73.6% (n = 103) were male. The median age
was 55 years old (IQR 39-70), and 32.1% were older than 65 years
old. The median ISS (Injury Severity Score) was 21 (IQR 13-26); 72.8%
(n = 102) had ISS ≥ 16. Blunt trauma was predominant (95%). The
most common causes of trauma were traffic accidents (47.1%)
followed by falls (37.4%). Alcohol and drug consumption was fre-
quent (40.7% and 63%, respectively of available data). 62.9% required
mechanical ventilation (MV), 27.1% developed shock and intracranial
hypertension occurred in 25.7%. Only four patients required massive
transfusion, and the mean of blood transfusion in the first 24 hours
was 3.45 (± 2.5) packed red blood cells. Neurotrauma was frequent
(n = 80, 57.1%); among them, 40 patients had severe TBI. 72.5% of
these had intracranial pressure catheter (ICPc) monitoring and 30%
needed neurosurgery (17.5% of them required decompressive
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length of stay was 13.2 days, and the mean of MV duration was 7
days. The most frequent cause of early mortality (<48 hours) was
intracranial hypertension (n=7). The factors independently associated
with ICU-mortality were ISS (OR 1.06, CI 1.00-1.12, p=0.034), severe
TBI (OR 4.48, CI 1.37-16.61, p=0.014) and shock (4.02, CI 1.21-13.3, p=
0.023). The adjusted survival analysis showed higher ICU-mortality
over time in severe TBI patients (HR 2.9, CI 1.18-7.17, p=0.02).
CONCLUSION. The factors associated with ICU-mortality were ISS, se-
vere TBI and shock. It emphasizes the importance of neurotrauma for
its frequency as well as its implication as a prognosis in mortality.
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INTRODUCTION. Pesticide self-poisoning accounts as a high percent-
age in suicidal attempts, especially in agricultural countries. Although
many of the systemic effects of organophosphate exposure have
been extensively studied, endocrine consequences are still unclear.
METHODS. In order to assess the effects of acute organophosphate
poisoning we performed a prospective, observational and cross-
sectional study on 13 patients admitted in the Intensive Care Depart-
ment after self-ingestion of pesticides. Patients with documented
pre-existing endocrine dysfunction or in treatment with acetyl-
cholinesterase inhibitors were excluded. The final study group in-
cluded seven patients in whom we determined levels of acetyl-
cholinesterase, cortisol, free triiodothyronine (fT3), free thyroxin (fT4),
thyroid-stimulating hormone (TSH) and prolactin on admission and
after 24 hours. Results were statistically analyzed using t-test and cor-
relations, setting a standardized significant P value of 0.05.
RESULTS. All patients in the study group survived after adequate
treatment was administered. Acetyl-cholinesterase level was signifi-
cantly lower on admission indicating an acute organophosphate in-
toxication status (mean difference between determinations 1312 U/L,
p = 0.0034). Cortisol level was significantly lower on the second
measurement with a mean difference of 25 ng/ml (p = 0.011). Levels
of fT3, fT4 and TSH were also significantly lower at 24 hours post-
exposure (p=0.001). Increase of fT3 correlated with increase of fT4 on
admission with a p = 0.053. Moreover, increase of fT4 on admission
was proportional with the increase of cortisol levels (p= 0.04). Prolac-
tin levels registered no statistically significant changes.
CONCLUSION. The present study demonstrates that acute organo-
phosphate poisoning can induce an endocrine dysfunction. High
levels of cortisol can be induced by the accumulation of acetylcho-
line as well as by the direct effects of organophosphate compound.
Therefore, normalizing acetyl-cholinesterase levels can solve the ad-
renal dysfunction. This study identified changes in thyroid hormone
levels, suggesting the possibility of a non-thyroidal illness in these
patients.
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INTRODUCTION. Antibiotics are overused in elderly patients with
acute respiratory tract infection because virus infection is under-
evaluated. We aimed to evaluate the effectiveness of combining
point-of-care multiplex PCR test (FilmArray Respiratory Panel, BioFire
Inc.) and serum procalcitonin (PCT) level for antibiotic stewardship in
the emergency department (ED).
OBJECTIVES. To test whether combining procalcitonin test and rapid
molecular test for respiratory virus would change physician's anti-
biotic prescription and patients' outcome
METHODS. We conducted a prospective bi-center cohort study that
enrolled elderly (aged ≥ 65 years) patients who presented to the ED
with severe acute respiratory illness (SARI) between January 2017
and March 2018. Eligible patients received a rapid molecular test
with 17 respiratory viruses and a PCT test. Physicians were recom-
mended to stop or de-escalate antibiotics if a patient had a PCT level
< 0.25 ng/mL and a positive test for respiratory viruses. To evaluate
the clinical impact, we compared the outcomes of SARI patients be-
tween the experimental cohort and a propensity score matched his-
torical cohort. The primary outcome was the proportion of antibiotics
discontinuation or de-escalation in the ED. The secondary outcomes
included duration of intravenous antibiotics, length of hospital stay,
and mortality.
RESULTS. Between January 1, 2017, and March 30, 2018, we enrolled
169 eligible patients, of which 36 (27.9%) were tested positive for
virus. Influenza A or B (7.7%) and respiratory syncytial virus (5.3%)
were the major two viruses identified. By propensity score matching,
we selected 507 SARI patients with similar demographic and comor-
bidity characteristics in 2016 as the control group. Compared with
controls, the experimental group had significantly higher proportion
of antibiotics discontinuation or de-escalation in the ED (26.0%
vs.16.1%, p = 0.007), neuraminidase inhibitor use in the ED (8.9% vs.
0.6%, p < 0.001), shorter duration of intravenous antibiotics (12.5 ±
12.0 vs. 16.8 ± 13.6, p < 0.001), shorter length of stay (17.0 ± 14.5 vs.
19.7 ± 17. 2, p = 0.042). The 30-day mortality rates were not different
in the two groups.
CONCLUSION. Viral infection is under-evaluated in elderly patients
with SARI. Combining FilmArray RP and PCT testing may be a useful
strategy for antibiotic stewardship in this group of patients.
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INTRODUCTION. The randomized, double-blind, multi-center, phase
3, noninferiority ASPECT-NP trial evaluated C/T (at double the cur-
rently approved dose) vs MEM for treating ventilated nosocomialpneumonia (NP). As part of randomization, pts were stratified by NP
type, i.e., ventilator-associated pneumonia (VAP) vs vHAP, the latter
of which is associated with worse prognosis. The expected higher
28-day mortality rate in the vHAP subgroup was only seen in the
MEM arm (37.0% in vHAP vs 20.3% in VAP) but not the C/T arm
(24.2% in vHAP vs 24.0% in VAP).
OBJECTIVES. To retrospectively explore potential reasons behind the
between-treatment mortality difference observed in the vHAP sub-
group of ASPECT-NP.
METHODS. Mechanically ventilated pts with NP were randomized 1:1,
stratified by NP type (VAP vs vHAP) and age (<65 y vs ≥65 y), to receive
3 g C/T or 1 g MEM, by 1-h IV infusions every 8 h for 8-14 d. Lower re-
spiratory tract (LRT) cultures were obtained from all pts at baseline.
Pathogen identification and susceptibility were confirmed at a central
laboratory. The primary endpoint was 28-d all-cause mortality in the
intent-to-treat (ITT) population, with a 10% noninferiority margin. Path-
ogens and antibacterial susceptibility are presented for the microbio-
logic ITT (mITT) population (i.e., pts with ≥1 dose of study drug and
with baseline LRT pathogens susceptible to C/T and/or MEM).
RESULTS. 362/362 C/T (27.3%) and 108/364 (29.7%) MEM pts had
vHAP. Baseline characteristics and causative pathogens (mostly Kleb-
siella pneumoniae, Pseudomonas aeruginosa, and Escherichia coli) in
pts with vHAP were generally similar between treatment arms
(Table). In the MEM arm of the mITT population (MEM MIC50/90 for
gram-negative pathogens: <0.064/8 μg/mL), there were 8 MEM non-
susceptible baseline isolates in the 71 mITT pts with vHAP; all Entero-
bacteriaceae were MEM susceptible (MIC ≤1 μg/mL). In the C/T arm
of the mITT population (n=55), the C/T MIC50/90 for gram-negative
pathogens was 0.5/128 μg/mL. In the ITT population, 28-day mortal-
ity was 24.2% (24/99) with C/T and 37.0% (40/108) with MEM (differ-
ence: 12.8%; 95% confidence interval: 0.18, 24.75). As assessed by the
investigator, the proportion of vHAP patients who died by Day 28
due to fatal AEs was 9/99 (9.1%) in the C/T arm vs 17/108 (15.7%) in
the MEM arm; the proportion of pts who died due to underlying con-
ditions was 10/99 (10.1%) vs 16/108 (14.8%), respectively; and the
proportion of pts who died due to NP was 5/99 (5.1%) vs 5/108
(4.6%), respectively.
CONCLUSION. These exploratory analyses in the vHAP subgroup of
the ASPECT-NP trial are limited by their retrospective nature and the
smaller sample size. Fewer vHAP patients in the C/T arm died due to
fatal AEs/underlying conditions compared with MEM. The difference
in 28-day mortality observed in the MEM- vs C/T-treated vHAP pts
does not appear to be due to clinically meaningful differences in
baseline clinical characteristics, causative pathogens, or antibacterial
susceptibility.
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INTRODUCTION. Methicillin-resistant Staphylococcus aureus (MRSA)
and multidrug-resistant Acinetobacter baumannii (MRAB) are rising
microorganisms in ICUs
OBJECTIVES. We evaluate the utility of the novel loop-mediated iso-
thermal amplification (LAMP) to rapidly detect MRAB and MRSA in
bronchoalveolar lavage (BAL) fluids for surveillance of colonization
and etiologic diagnosis
METHODS. Two conditions of LAMP reactions that have different
limit of detection have been developed using reference strain that
target mecA/femB gene (Genbank No. AB505630.1/CP010300.1) of
MRSA and blaOXA-23/blaOXA51-like gene (Genbank No. KF305669.1/
DQ385606.1) of MRAB by adjusting composition of primers and reac-
tion time. these two conditions of LAMP reaction were applied to
123 of BAL samples from clinically suspected VAP patients and com-
pared it with quantitative BAL fluid culture method
RESULTS. Compared to quantitative BAL fluid culture method, the
sensitivity, and specificity of the M-/C- condition of LAMP reaction
was 81.8%/65.9% and 84.8%/91.1% in MRSA and 90.2%/97.5% and
71.9%/56.1% in MRAB. And The diagnostic accuracy of the M-/C- con-
dition of LAMP reaction in was 83.73%/82.11% in MRSA and 65.91%/
78.04% in MRAB
CONCLUSION. The LAMP assay is promising method to surveillance
and etiologic diagnosis of MDR pathogen in VAP patients
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INTRODUCTION. The global incidence and mortality of Tubercu-
losis (TB) progressively decreased along the past years around
the world. However, some patients coursing advanced stages of
the disease may require vital support in Intensive Care Units
(ICU). Comorbidities, HIV infection, and other community or noso-
comial infections are frequently associated and may contribute to
decreasing survival. The clinical course could evolve with respira-
tory failure, circulatory shock, and sepsis with variable organ dys-
function. Patients who need mechanical ventilation show
mortality rates higher than 50%. Since ICU admission occurs in a
low percentage of the patients, few communications are describ-
ing the clinical phenotype and outcome in the critical care
setting.
OBJECTIVES. To describe the phenotype and genotype characteris-
tics of critically ill TB patients, and to investigate possible molecular
biomarkers of virulence.
METHODS. One hundred and four TB patients were admitted in a
general ICU. Mycobacterium tuberculosis was suspected based on
compatible clinical, radiologic, and epidemiological factors. The
microbiologic diagnosis was confirmed by a) Positive cultures; b)
Acid-Alcohol Resistant Bacilli in sputum or bronchoalveolar lav-
age; c) Positive GeneXpert for Mycobacterium tuberculosis; d)
Histopathological findings in tissue autopsy/biopsy when
corresponding.
Molecular genotyping of Mycobacterium tuberculosis strains were
made by MIRU-VNTR and Spoligotyping techniques. miRNA profiles
in serum were studied as potential biomarkers of severity. Clinical,
radiologic, laboratory and physiological variables were correlated
with ICU mortality.
RESULTS. During the study period, 104 among 6.353 critically ill pa-
tients (1.6%) were admitted to the ICU with active TB disease. The
patient population was relatively young with male predominance
and low HIV-positive incidence (20%). Genotype investigation identi-
fied Ghana, Haarlem, Lam10, Lam9, and Lam3 lineages. Haarlem
(49.2%) followed by Lam3 (28%) strains predominated in these ICU
patients.
The miRNA profiles from 16 patients were compared with normal
serum from a public database. Bioinformatic analysis showed that
some specific miRNAs significantly enriched in plasma from TB indi-
viduals making them as possible biomarkers for diagnosis, prognosis,
and virulence.
The global ICU mortality was 50%, but it was higher in patients
under mechanical ventilation (64.5%). After multivariate analysis,
APACHE II score and cardiovascular dysfunction (p<0.05) were inde-
pendently associated with death.
CONCLUSION. A better phenotype and genotype characterization
and the identification of possible miRNA biomarkers of severity could
contribute to an earlier and more effective therapeutic intervention
in these patients.REFERENCE(S)
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INTRODUCTION. The incidence of parapneumonic effusion and
empyema in the intensive care unit is not well studied. Pleural
effusions in ICU are common with some studies suggesting an in-
cidence of 40-60% of which parapneumonic effusions may ac-
count for approximately 40% of these effusions. Pleural infections
result in a longer ICU stay compared with those without pleural
infections. We aimed to review the assessment of pleural effu-
sions associated with pneumonia and diagnosis of parapneumo-
nic effusions in a mixed level 2/3 ICU in a large teaching hospital
(Glasgow Royal Infirmary).
METHODS. The Electronic Patient Record (EPR) was interrogated to
identify any patient admitted between 01/01/2017 and 01/07/2017
that had a diagnosis of “pneumonia” in the problem list. The radi-
ology reports for these patients were reviewed (Chest X-Ray and CT
Thorax) and those that commented on pleural effusion were in-
cluded for assessment. The radiology was reviewed by two senior re-
spiratory registrars who made a recommendation regarding pleural
ultrasound to further assess or facilitate diagnostic aspiration of the
effusion. Those patients identified by the electronic search also
underwent a case review by a senior intensive care medicine regis-
trar to confirm the diagnosis of pneumonia.
RESULTS. Six hundred patients were admitted during the audit
period. Sixty patients (10%) were identified using the electronic
search parameters. Of these, 16 (27%) met the inclusion criteria – a
diagnosis of pneumonia and radiologically confirmed pleural effu-
sion. Nine patients had a diagnosis of Community Acquired Pneumo-
nia, 5 Hospital Acquired Pneumonia, 1 Aspiration Pneumonia and 1
ongoing pleural infection following a community acquired pneumo-
nia. Two patients were excluded as the imaging reviewed was out-
side the audit period.
Assessment of effusions: Of the 16 patients; 6 (37.5%) had the
presence of the effusion recorded in the notes and 2 (12.5%) ef-
fusions were assessed by ultrasound. Pleural fluid samples were
sent in 2 (12.5%) patients: one who was assessed by ultrasound
and underwent pleural aspiration. One of which had fluid sent
from a pre-existing drain. Of the patients with potential para-
pneumonic effusions in ICU, 10 (62.5%), did not have any assess-
ment or investigation performed.
Complications: Of the 16 patients with an effusion associated with
pneumonia, 3 (18.75%), developed a complication from pleuralinfection. This included systemic sepsis, a multi-loculated effusion re-
quiring a prolonged course of antibiotics and a hospital readmission
with recurrence of pleural infection.
Review of imaging by Respiratory Registrars: Twenty-four chest x-
ray and 12 CT studies were assessed. Ultrasound assessment was
suggested by both respiratory clinicians for 12 patients (75%). Only 2
(12.5%) of these patients underwent ultrasound examination.
CONCLUSION. Pleural effusions occur commonly in ICU patients with
potential parapneumonic effusions seen in 27% of the study group.
Complications were significant and developed in over one sixth of
patients (18.7%, n=3). We believe that most of these patients should
have had an ultrasound evaluation and an aspiration with analysis of
pleural fluid considered. This occurred in less than 19% of patients in
our study. Education on assessment of potential parapneumonic ef-
fusions and thoracic ultrasound is ongoing.
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INTRODUCTION. Recent studies propose plasma midregional pro-
adrenomedullin (MR-proADM) as early marker of organ dysfunction
in critically ill patients with infections and sepsis.
OBJECTIVES. As severe microcirculatory derangement has been
demonstrated in patients with sepsis-related organ failure admit-
ted to critical care unit (ICU), the primary objective of this study
is to assess if a correlation existsbetween plasma MR-proADM
and Microcirculatory Flow Index (MFI) in 20 adult patients admit-
ted to ICU with suspected infection. It is also purpose of the
study to evaluate the relationship between MR-proADM and Total
Vessel Density (TVD), Perfused Vessel Density (PVD), Proportion of
Perfused Vessels (PPV) and with organ failure in this group of
patients.
METHODS. Prospective observational study articulated in five days of
monitoring (T1-T5). Plasmatic MRproADM was dosed for all time-
points. At T1, T2 and T5 the sublingual microcirculation was assessed
using Incident Dark Field technology. Laboratory and clinical data
were collected to calculate the Simplified Acute Physiology Score
(SAPS) II and Acute Physiology and Chronic Health Disease
Fig. 2 (abstract 001592). Correlation between MR-proADM in
Page 137 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Classification System II (APACHE) scores at admission in ICU and
daily Sequential Organ Failure Assessment (SOFA) score. Exclusion
Criteria: Age<18 years old, ICU stay>24 hours before inclusion, refusal
to consent, conditions that do not allow clear monitoring of sublin-
gual microcirculation.
RESULTS. This is a half-sample preliminary analysis. MRproADM>
1.5 nmol/l showed good discrimination capacity toward SAPS II
and APACHE II scores at admission in ICU, Area Under the Curve
(AUC) respectively 0.90[CI 0,69-1] p=0.04 and 0.96[CI 0.84-1] p=
0.06 [Fig. 1]. Persistence of MRproADM>1.5 nmol/l at T5 was able
to discriminate worsening microcirculation in term of MFI of ei-
ther small, AUC 0.92[CI 0.73-1] p=0.03 and total vessels, AUC
0.92[CI 0.73-1]p=0.03 and of PPV, AUC 0.83 [CI 0.57-1] p=0.09
[Fig. 2]
CONCLUSION. The preliminary results of the study confirm the asso-
ciation between MR-proADM and severity scores at admission in ICU
and they show that a correlation exists between moderate-to-high
levels of this marker and microcirculatory dysfunction in critically ill
patients with infection.
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INTRODUCTION. Serum procalcitonin level is a valuble biomarker for
diagnosing infection and sepsis in critically ill patients (1). Recent
studies suggest that procalcitonin levels can be increased in non crit-
ically ill patients with chronic kidney disease (CKD) without any infec-
tion (2). The aim of this study was to investigate the effect of renal
failure on serum procalcitonin levels and the value of serum procalci-
tonin for diagnosis of infection in patients with renal failure
METHODS. Patients who were admitted to our intensive care unit
between January 2012 and November 2015 and whom procalcitonin
levels were obtained during their hospitalization were examined
retrospectively. The diagnosis of renal failure were made according
to RIFLE score.
Page 138 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55RESULTS. Out of 907 patients included in to the study, 304 patients
had normal renal function, 379 patients had acute renal failure (ARF),
133 patients had CKD and 91 patients had ARF on CKD. Serum pro-
calcitonin levels were higher in patients with CKD and in patients
with ARF than in ones with normal renal function (p <0.05) (Table
1). According to ROC analysis procalcitonin level was a good pre-
dictor for diagnosing infection and sepsis in both patients with and
without normal renal function. However higher treshold values were
obtained for diagnosing infection and sepsis in patients with renal
failure (Table 1).
CONCLUSION. Serum procalcitonin level is a good predictor marker
for diagnosing infection and sepsis in patients with and without renal
failure. However, higher threshold values should be used in patients
with renal failure compared to patients without any failure.
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AUCinfeksiyon 0.813 (p=0.00) 0.871 (p=0.00) 0.853 (p=0.00)
AUCsepsis 0.760 (p=
0.000)



























*When comparing with patients with normal renal function, p<0.001
**When comparing with patients with normal renal function, p=0.006001076
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):001076INTRODUCTION. Elder patients are becoming a noteworthy popula-
tion in-ICU. Tools aimed to predict their performance in-ICU could
have a main role to help the clinicians manage ICU resources.
OBJECTIVES. To design predictive models to estimate the risk to ac-
quire different nosocomial infections in-ICU for patients older than
64 years old.
METHODS. Data was obtained from the 2013-2016 ENVIN-HELICS
registry, prospective multicentric study of in-ICU acquired infections.
Data regarding demographics, comorbidities, used techniques and
outcome was gathered. The studied infections were: ventilator asso-
ciated pneumonia (VAP), catheter related urinary infection (CUI) and
primary and secondary bloodstream infections (BSI). The population
was geographically divided in two groups, for the model to be devel-
oped in the first one and validated in the second one. The factors re-
lated to the development of in-ICU infections were determined by
multivariate analysis, each of them related to its logical population;
its predictive value was evaluated by the AUC and goodness of fit by
the Hosmer Lemeshow test (HS).
RESULTS. A total of 37172 patients older than 64 years old were reg-
istered in the study period, most of them for medical causes (65.5%).
Mean age was 75,1 years (SD 6,5 years). 41.8% needed mechanical
ventilation and 76.0% urinary catheter. 165 VAP, 409 CUI, 472 pri-
mary BSI and 404 secondary BSI were diagnosed. Overall in-ICU mor-
tality was 11.5%, higher in patients with any in-ICU acquired
infection but mostly remarkable in those who suffered VAP (41.9%)
or secondary VSI (40.1%). Regarding factors associated to VAP, gen-
der (male vs. female OR 1.7; CI 95%1.4-2.0), malnutrition (OR 1.70; CI
95% 1.3-2.2), devices such as renal replacement therapies (OR 3.0;
CI95% 2.8-3.7), tracheostomy (OR 7.4; CI95% 6.2-8.8) or central ven-
ous catheter (OR 3,7; CI95% 2,1-6,6), and the acquirement of a MRSA
were related to its diagnosis. In the CUI predicting model similar vari-
ables were used, and in those regarding both kinds of BSI most of
the variables included in the model regarded used devices. The AUC
in all of them was higher than 0,78, showing excellent fit according
to the HS test (p value over 0.1 in all of them).
CONCLUSION. In-ICU acquired infections are associated to several
factors regarding demographics, comorbidities and used devices. The
predictive models developed for VAP, CUI and primary and second-
ary BSI out of the sum of prognosis factors had a good discriminatory
power and excellent fit.000015
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INTRODUCTION. Patients admitted to the intensive care unit (ICU)
are frequently treated with antimicrobial agents. Optimizing anti-
microbial use is imperative to reduce infection-related morbimortality
and to limit the emergence of multidrug-resistant microorganisms
(MDRMs).
OBJECTIVES. To describe the process of implementation of an anti-
microbial stewardship program (ASP) in a 22-bed mixed ICU of a
third-level university hospital in Spain (608 beds) and the results of a
6-month pilot experience.
METHODS. A multidisciplinary ASP group was created (intensivist, in-
ternist, microbiologist, pharmacist, preventivist, nurse and intensive
Page 139 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55care resident). Theorical need for antimicrobial agents use was dis-
cussed in daily meetings of the group, whenever a result of a micro-
biological test was positive, taking into account the clinical setting,
infectious syndrome, isolated microorganism and antimicrobial
pharmacology. Non-mandatory recommendations concerning better
use of antimicrobials were proposed to the intensive care physician
after each meeting, including de-escalation (switch to narrower
spectrum or discontinuation of treatment), adequacy (change to
same spectrum or start a new treatment), optimization (duration,
dose or route of administration) and escalation (switch to broader
spectrum). We report antimicrobial utilization and expense,
expressed as daily defined dose (DDD) per 100 bed-days (BD) and
euros (€), respectively, in the ASP period and in the same period of
the previous year (baseline period), as an exploratory endpoint.
RESULTS. A total of 120 meetings were held, where 92 recommenda-
tions were proposed over 54 patients (54.3% male, age 61±15 years
old), with a 90.2% of adherence (77.8% of the rejected interventions
were due to severity of the condition). The most common microbio-
logical samples to trigger an intervention were blood cultures
(52.2%) and respiratory samples (26.1%), and the most common mi-
croorganisms were Gram-negative bacteria (46.7%), Gram-positive
bacteria (37.8%) and fungi (17.4%). Most infections were community-
acquired (55.4%), with 9.8% of MDRMs, and the most common sites
of infection were the lungs (40.2%), abdominal organs (14.1%) and
urinary tract (13%). Antimicrobial stewardship was essentially pro-
posed as de-escalation (70.7%), but also as adequacy (18.5%), escal-
ation (7.6%) and optimization (3.2%). Most interventions were
advised over carbapenems (imipenem and meropenem) (20.5%),
other antibacterials (linezolid and daptomycin) (20.5%) and penicillins
(ampicillin, amoxicillin/clavulanic, cloxacillin and piperacillin/tazobac-
tam) (14.5%). Antibiotic and antifungal use increased from 135.8 to
162.4 and from 40.7 to 72.4 DDD/100 BD, respectively, during the
ASP period, with a decrease in expense (33,642 to 32,777 € and
152,590 to 99,547 €). A higher incidence of Aspergillus during the in-
fluenza season and a change of price of echinocandins during the
ASP period may limit the interpretation of antifungal utilization re-
sults. Differences in terms of severity and reason for admission may
limit the comparison of baseline and ASP periods.
CONCLUSION. Implementation of an antimicrobial stewardship pro-
gram in intensive care is feasible, cost-effective and safe. The most
common intervention was de-escalation, with a high adherence rate
to the proposed recommendations.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000038INTRODUCTION. despite macrolides are widely used in chronic re-
spiratory diseases such as cystic fibrosis and chronic obstructive pul-
monary disease because of its anti-inflammatory and
immunomodulator effects, its use in acute pulmonary infection re-
mains controversial.
OBJECTIVES. the main objective of our study was to evaluate the im-
pact in prognosis of macrolide treatment in critical care patients with
severe viral pneumonia.
METHODS. prospective, cohorts and multicenter study in critically ill
patients with confirmed viral pneumonia. Study period went from
June 2009 to April 2018, and 181 Intensive Care Units participated.
Patients admitted to an ICU due to confirmed influenza pneumonia
were included. Demographic, clinic and analytic variables, comorbidi-
ties, level of severity according to Acute Physiology and Chronic
Health Evaluation II (APACHE II) score and antibiotic treatment re-
ceived were registered, among other variables. We only considered
patients who received combined empiric antibiotic therapy and com-
pared those who received combined therapy with macrolides and
those who received other combinations. Differences between groups
were assessed using Chi-square and T-Student test as appropriate.
We performed a multivariate analysis by binary logistic regression to
determine which variables were independently associated with mor-
tality. Significant p<0,05.
RESULTS. Of the 4175 patients who presented confirmed viral pneu-
monia, 2962 (70,9%) received combined empiric antibiotic treat-
ment. Mean age was 54 years with a mean APACHE II score of 17.
Global mortality was 22,5%, and it was significantly lower in the
group of patients who received macrolides (17,5%) comparing to the
ones that received other combinations (25,1%; p<0.05). Receiving
macrolides was independently associated with a lower risk of mortal-
ity after adjusting the regression logistic model according to age,
APACHE II score, need of mechanical ventilation, presence of shock,
comorbidities and corticosteroid treatment (OR= OR 0,75, IC 95%
0,60-0,93; p=0,008). Bacterial coinfection was present in 702 patients.
Mortality in this group was 29,3% and having received macrolides
was not associated with lower risk of mortality (OR 0,92, IC 95% 0,61-
1,38, p=0,68). On the other hand, the group of 2260 patients who
presented primary viral infection showed lower risk of mortality
when receiving combined antibiotic treatment with macrolides (OR=
0,69, IC 95% 0,54-0,89; p=0,005).
CONCLUSION. our results suggest there is a beneficial effect in
macrolides treatment in patients with influenza virus infection. This
effect does not seem to be related with its antibacterial activity. Its
possible immunomodulatory effect in this specific population should
be addressed in future studies.
001409
Right Dose, Right Now - Developing a clinical dosing algorithm for
AutoKinetics, a clinical decision support system for personalised
antibiotic dosing
L. Roggeveen1, T. Guo,1, L. Fleuren1, PJ. Thoral1, A. Girbes, PHJ. Van Der
Voort2, RJ. Bosman2, PWG. Elbers1
1Intensive care medicine, Amsterdam UMC, locatie VUmc, Amsterdam,
Netherlands; 2Intensive care medicine, OLVG location East, Amsterdam,
Netherlands
Correspondence: L. Roggeveen
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001409
INTRODUCTION. Antibiotic dosing in critically ill patients is difficult
because of altered pharmacokinetics (PK) [1,2]. Population PK model
based dose adaptation plays an important role in optimizing anti-
biotic dosing due to its ability to include covariate effects and PK
variability. Population PK models are able to describe the time course
of drug concentration after administration of a dose. Further, PK
models can predict concentrations following the dosage regimens
under consideration. These techniques are increasingly applied in
clinical care though typically require specialized expertise and soft-
ware [3]. Moreover, the use of software based dose adaptation has
to date not been widely investigated and trials are eagerly antici-
pated [4]. We developed a clinical decision support system for real-
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going randomised controlled trial. For this, we required an auto-
mated clinical dosing algorithm to determine the recommend
dosage regimen.
OBJECTIVES. To develop a clinical dosing algorithm based on PK
models to generate real-time antibiotic dosing advices that can be
implemented in a software package for personalised antibiotic dos-
ing in critically ill patients.
METHODS. Dose recommendations are based on pharmacokinetic
principles. The goal is to inversely find a dose which is able to main-
tain a needed PK exposure of the target given a dosing time sched-
ule. An important presumption that is made in dose calculation is
the linearity of PK. Accordingly, PK exposure is proportional to the
dose. Thus, if one measures the area under the concentration-time
curve (AUC) for a 500 mg dose, one can estimate the AUC for a 750
mg dose in the same patient as being 50% greater. The Target main-
tenance dose (MD) can be calculated using the following equation:
MDtarget ¼ AUCtargetAUCtest MDtest ð1Þ
Particularly, when the clearance (CL) of a patient is expected consist-
ent over the time period of interest, the target maintenance dose
can also be calculated through the following equation:
MDtarget ¼ AUCtarget  CL ð2Þ
For adaptive dosing advice it is also required to calculate a loading
dose. The design of loading dose (LD) calculation is to derive a dose
that enables the concentration right after the administration to
achieve the target maximum concentration (Cmax) of MD-
maintained steady state. Lastly, a dosing interval needs to be chosen.
RESULTS. Based on these pharmacokinetic principles we devised an
iterative method for deriving a clinical dosage regimen. The final ad-
vice consists of a start time, if needed a loading dose, a maintenance
dose and a dose interval. They are incorporated in a closed looped
algorithm while taking safety precautions into account.
CONCLUSION. We successfully developed a clinical dosing algorithm.
It is incorporated in AutoKinetics, a clinical decision support system
for personalised antibiotic dosing. It alllows for automated adaptive
antibiotic dosing regimes. if proven effective in improving clinical
outcomes, it could pave the road forward towards true personalised
antibiotic dosing.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):001763INTRODUCTION. Ventilator-associated pneumonia due to methicillin-
resistant Staphylococcus aureus (MRSA) is associated with excess
mortality and costs. Molecular biology test allows rapid identification
of MRSA. Our hospital reaches an incidence of 28% of infection by
MRSA and is responsible for a high cost in the intensive care unit.
Clinical suspicion of VAP is the most frequent cause to use Linezolid
as a first antibiotics treatment, in spite of Guidelines recommend
considering methicillin-resistant Staphylococcus aureus (MRSA) just
in case of hight suspicion of infections, according to the bacterial
ecology of the unit. Initially designed to identify MRSA in nasal secre-
tions, its use has been then validated in bronchial aspirations. We hy-
pothesized that use of a rapid diag- nostic test was associated with a
decreased use of anti-MRSA antibiotics prescribed for patients with
suspected VAP. Using this diagnostic test, we checked how we saved
on the cost of antibiotics. This is important not only in what implies
a lower cost, since linezolid resistant microorganisms appear every
time, posing a challenge for the clinical doctor and serious infections
in ICU.
METHODS. We carry out this observational, descriptive and retro-
spective study. For this, we chose a total of 50 patients admitted to
the ICU for any pathology during January 2016 and December 2017
in our intensive care unit. (Reina Sofía University Hospital, Córdoba,
Spain) that had developed NAVM and which had been requested
PCR in respiratory samples for etiological diagnosis. Age, mortality in
the ICU, the date on which the CRP was requested, the APACHE II
scale, SOFA, the days of ICU stay, the days of MV and the antibiotic
therapy before and after the PCR outcome of the study were col-
lected as variables.
RESULTS. 50 patients admitted during 2016 and 2017 in our ICU, the
median age was 56 years and 34 were men (68%) and 16 women
(32%). The median length of stay in the ICU was 16 (2-117). Mortality
during admission was 48%. We use the APACHE II and SOFA scales
as prognostic scales, being 20 and 5 the mean, respectively. The
average of the days of mechanical ventilation were 19. With respect
to the result of the diagnostic tests by PCR, in 46 of them no bacter-
ial growth was obtained, a sample of MRSA and 3 of MSSA were iso-
lated. The initial antibiotic regimen that included Linezolid was
administered in 13 patients prior to the PCR result, of which, it was
substituted after the result of the test in 7 patients.
CONCLUSION. The use of PCR as a rapid diagnosis of VAP caused by
MRSA resulted in a total cessation of the administration of broad-
spectrum antibiotic therapy in a patient whose result was negative.
The rapidity with which the microbiological diagnosis is obtained
with this type of technique, led us to diagnose in a short period of
time that the cause of the pneumonia associated with the ventilator
was not MRSA, and therefore, de-escalate antibiotic therapy, with the
consequent cost savings and improving the usual clinical practice be-
fore the remarkable increase of new resistance against these antibi-
otics at present.
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Fig. 2 (abstract 001406). The changes in the share of ESKAPE-
bacteremia and candidaemia in the ICU.
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tion of antibiotic stewardship programs (ASP), including intensive care
units (ICUs), provide conflicting data on their effect on antimicrobial re-
sistance, antibiotic consumption and secondary outcomes [1-3].
OBJECTIVES. To assess the effect of ASP on antibiotic consumption,
antimicrobial resistance and clinical outcomes in patients with infec-
tion in the ICU.
METHODS. A prospective interventional single-center study was con-
ducted in the period from January 2011 to December 2017. The
intervention: ASP, including multidisciplinary team building, anti-
microbial therapy and prophylaxis protocols, infection control mea-
sures, personnel training and internal audit. The data from 2012 (pre-
intervention) and 2017 (intervention) reports were compared. We
assessed consumption of antibiotics in the ICU, antibiotic therapy
duration, drug resistance index (DRI) of gram-negative ESKAPE patho-
gens in the ICU, the share of ESKAPE-bacteremia and candidemia in
the ICU, length of hospital stay (LOS) and mortality of the patients
with infection, complicated by bacteremia in the ICU.
RESULTS. Total consumption of antibiotics has not significantly chan-
ged: 227.3 from 238.6 DDD/100 days. Meanwhile, the structure of
consumption significantly changed with the decrease in antibiotics for
the treatment of the following infections (DDD/100 days): carbapenems
from 46.4 to 34.4, aminoglycosides from 10.0 to 2.2, fluoroquinolones
from 29.8 to 21.3. The consumption of 1st generation cephalosporins
for perioperative antibiotic prophylaxis increased from 4.2 to 98.1. The
average duration of therapy in patients with infection in the ICU de-
creased from 15.7 to 10.4 days, p<0.01, with bacteremia from 22.7 to
12.8, p<0.001. The dynamics of changes in the DRI of gram-negative
ESKAPE pathogens in the ICU and the share of ESKAPE-bacteremia and
candidaemia in the ICU are shown in Figures 1 and 2. LOS for patients
with an infection complicated by bacteremia decreased from 48.8 days
to 35.4 days, p = 0.039, Hospital mortality of ICU patients decreased
from 38,8% to 31,5%, p<0.536.
CONCLUSION. The introduction of ASP into the ICU leads to a signifi-
cant change in the structure of antibiotic consumption shortening
the average duration of antibiotic therapy for infections including
those complicated by bacteremia. This leads to the reduction of
prevalence and antibiotic resistance of nosocomial pathogens, but
does not lead to a significant improvement in secondary outcomes.
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INTRODUCTION. Health care associated infections (HAI) suspicious
require immediately empiric antibiotic treatment, most of times with
broad spectrum antibiotics. The implementation of Antimicrobial
Stewardship Program (ASP) seems to be a useful way to improve
antibiotic management, also in HAI.
OBJECTIVES. To compare the evolution of antibiotics used for HAI in
Paediatric Intensive Care Units (PICU) from the Spanish registry
Paediatric-ENVIN-HELICS, after a progressive ASP implementation.
METHODS. Multicentre, prospective and observational study. HAI di-
agnosed in 24 Spanish PICU, from April to June of 2013–2017, were
included. The ENVIN diagnostic criteria adapted to paediatrics were
used, based on CDC recommendations. ASP was consensuated and
recommended, with progressive implementation along 2014-2017.
SPSS®21 programme was used.
RESULTS. The total number of patients included in 5 years was 8717.
Eight PICU (32%) had an Antimicrobial Stewardship Program (ASP) in
2017 compared with none in 2013 (p=0.000). The rate of antibiotics
use progressively decreased (4%, p=0.0179).
In 2017 the number of antibiotics indicated per patient was 1.34 and
per patient with antibiotics was 1.81. Whereas in 2013 that number
was greater: 1.6 and 2.06, respectively.
Regarding the antibiotic indicated for HAI previous PICU admission,
there was an increase on meropenem use of 1.64% (not statistically
significant), while the use of piperacillin-tazobactam significantly de-
creased (4.97%, p=0.0123). However, meropenem indication for HAI
in PICU patients dropped down (4.62%, p=0.05).
During 2017, the practice of antibiotic stewardship was 13.93%
higher (p=0.0048). There was also an increasing tendency for early
suspension antibiotic rate (6.78%, not statistically significant). The re-
sults also showed a decrease of antibiotic modification due to ad-
verse event (1.19%, p=0,0021), compared with 2013.
CONCLUSION.
1. The rate of antibiotics use was high, with almost 2 antibiotics
indicated per patient, but results showed a decreasing trend
during 2017.
2. The implementation of ASP in PICU probably has led to a
better use of carbapenems, and to an increase of antibiotic
de-escalation and early suspension rate.
3. Modifications of the antibiotic regime due to adverse event
have decreased.
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INTRODUCTION. Although antifungal de-escalation therapy has been
previously studied in critically ill patients, few data has been pro-
vided about its consequences on antifungal use in this setting
OBJECTIVES. The aim of this study was to analyze the impact of an
Antimicrobial Stewardship Program (ASP) on antifungal consume
from ICU to ICU.
METHODS. Retrospective study during 24 months from April 2016
to June 2018 with a pre-post intervention design in two ICU in
an unique universitary hospital. Medical (16 beds) and Surgical (6
beds) ICUs were included. Preintervention period (Pre ASP imple-
mentation) lasted from April 2016 to March 2017 and post im-
plantation period from July 2017 to June 2018. All patients
treated with Liposomal amphotericine B, anidulafungin, caspofun-
gin, micafungin, voriconazole and posaconazole were analyzed.in
both periods. Clinical and microbiological variables were re-
corded. Daily doses DDD/100 stays and economic impact
(expressed in euros) of the intervention were also studied. Wil-
coxon Rank-sum test was performed to compare the pre and
post consume of prescribed antifungal drugs.
RESULTS. In Medical ICU there were a clearly decrease of DDD/ 100
stays of all the antifungals studied : posaconazole (100%; 0,16 vs.
0,00), liposomal amphotericine B (93,6%; 14,81 vs. 0,95), micafungine
(73%; 0,10 vs. 0,03), anidulafungin (54%; 0,98 vs. 0,45), voriconazole
(28%; 1,64 vs. 1,18) and caspofungin (11%; 3,63 vs. 3,25). In Surgical
ICU, a clearly reduction of DDD/100 stays was also observed in lipo-
somal amphootericine B (100%; 2,18 vs. 0,00), micafungine (61%;
5,87 vs. 2,31), caspofungin (55%; 12,73 vs. 5,77) and anidulafungine
(41%; 11,07 vs. 6,51), whereas voriconazole experimented an in-
creased use (18%; 0,89 vs. 1,94). Posaconazole was not used in SICU
in the study period
In economical terms , median of cost was reduced with statistical sig-
nificance 70% in Medical ICU (10.859,4 (5.083,30-19.785,35) vs.
3.154,15 (1.745,45-6.380,28); p=0,042) and 58% in Surgical ICU
(16.041,85 (14.601,75-19.762,75) vs. 6.789,45 (5.382,35-9.630,00); p=
0,0005). As a consequence a cost saving of 67,4% in the antifugal
consume in Medical ICU (associated saving cost of 94.500 euros)
and 58% (associated saving cost of 115.803 euros) in surgical ICU. A
global reduction of cost of 210.303 euros in a year was obtained in
critically ill patients setting.
CONCLUSION. ASP from ICU to ICU had an exceptional impact on
antifungal use and was associated with a real, significant and import-
ant cost saving.
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INTRODUCTION. Cancer affects up to 20% of critically ill patients,
and sepsis is one of the leading reasons for ICU admission in this set-
ting [1, 2]. No recent formal estimation of outcome changes has
however been performed. Studies to appraise outcomes in critically
ill cancer patients with sepsis are warranted.
OBJECTIVES. To assess trends in survival rates in cancer patients ad-
mitted to the intensive care unit (ICU) for sepsis or septic shock over
the last two decades.
METHODS. Data from onco-haematological patients admitted to the
ICU for sepsis or septic shock were extracted from the GRRR-OH
database (1994-2015). A hierarchical model taking into account the
year of inclusion and the source dataset as random variables were
used to identify risk factors for day 30 (D-30) mortality. A sensitivity
analysis within patients with bacterial pneumonia at ICU admission
was performed.
RESULTS. Overall, 2062 patients were included in the study. 1225
(42%) patients were male and the median age was 59 [48-67]
years. Underlying malignancies included solid tumors (n= 638;
31%), acute leukemia (n=591; 29%), non-Hodgkin lymphoma (n=
461; 22%) and myeloma (n=244; 12%). Two hundred and fifty pa-
tients (12%) underwent allogenic stem cell transplantation and
640 (31%) were neutropenic at ICU admission. Death at day 30
occurred in 812 (39%) patients. After adjustment on SOFA score
at ICU admission, the year of ICU admission was significantly as-
sociated with mortality, decreasing over time (OR 0.96; 95%CI
0.94-0.98) (Figure 1). Mechanical ventilation (OR 3.43; 95%CI 2.73-
4.32), vasopressor use (OR 1.51; 95%CI 1.20-1.90) and renal re-
placement therapy (OR 1.40; 95%CI 1.10-1.78) were independently
associated with D-30 mortality, whereas the type of underlying
malignancy, allogenic stem cell transplantation and neutropenia
were not. Sensitivity analysis in the subgroup of patients with
bacterial pneumonia (n=858) found similar results.
CONCLUSION. Survival in critically ill oncology and hematology pa-
tients with sepsis improves significantly over time. Studies are
needed to identify targets to further improve survival in this growing
subgroup of ICU patients.
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INTRODUCTION. Alveolar hemorrhage (AH) is characterized by the
acute onset of alveolar bleeding and hypoxemia and can be fatal.
Thrombin has been widely used to achieve coagulation and
hemostasis. However, the efficacy of thrombin in patients with AH is
unclear. Thus, this study aimed to evaluate the efficacy of thrombin
administration in patients with hematological malignancy and AH.
METHODS. This retrospective study included 15 hematological malig-
nancy patients (eight men and seven women; mean age 47.7 ± 17.3
years) with AH who were administered intrapulmonary thrombin be-
tween March 2013 and July 2018. All patients received bovine-origin
thrombin (1,000 IU/ml, Reyon Pharmaceutical Co., Ltd., Seoul, Korea)
via a fiberoptic bronchoscope. A maximum of 15 ml of thrombin was
injected via the working channel to control bleeding. The ability of
thrombin to control bleeding was assessed. Additionally, the change
in the PaO2/FiO2 (PF) ratio after intrapulmonary thrombin adminis-
tration was evaluated.
RESULTS. Intrapulmonary thrombin was administered a minimum of
3 days after starting mechanical ventilation in all patients, and it im-
mediately controlled the active bleeding in 13 of 15 patients (86.7%).
However, AH relapse was noted in 3 of the 13 patients (23.1%). The
PF ratio improved in 10 of 15 patients (66.6%), and the mean PF ratio
was significantly higher after thrombin administration than before
administration (p = .03). No adverse thromboembolic complications
or systemic adverse events were observed.
CONCLUSION. Thrombin administration was effective in controlling
bleeding in hematological malignancy patients with AH. Intrapul-
monary thrombin administration might be a good therapeutic option
for treating AH.
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INTRODUCTION. Surgical reoperation as a complication after cardiac
surgery. ARIAM-Andalusia Registry.
OBJECTIVES. To analyze the clinical profile and evolution of reoper-
ated patients after cardiac surgery, as wellas the main causes for
reoperation.
METHODS. Retrospective study of patients undergoing cardiac sur-
gery in our hospital during5 years (January-2014 to December-2018),
and included in the ARIAM-Andalusia registry. We excludedpatients
undergoing TAVI. The demographic and surgical characteristics,
causes of reoperation and themoment of it, complications and mor-
tality are collected. The quantitative variables are expressed as x +sd
and the qualitative ones as number and percentage. T student was
made for comparing v.quantitativeand X2 for v.qualitative, and a
multivariate analysis of risk factors for reoperation.
RESULTS. 2152 patients were included during the period of the
study. 116 of them (5.4%) were reoperatedat the same hospital ad-
mission. The re-operated patients had longer surgical times (ECC: 136
+ 60 minvs 115 + 50 min, p <0.05) and higher severity scores (Euro-
score I: 13.8 + 13.7 vs 9.7 + 11.3, p <0.05)than the non-reoperated
ones. When initial emergent surgery happened, reoperation was
more frequent(11.2%). Valve or aortic surgery was a risk factor for re-
operation (OR 2.7, 95% CI 1.6-4.6). Mortality wassignificantly higher in
reoperated patients (28.4% vs 9.9%, p <0.001), and similarly there
were higherrates of renal failure (75.2% vs 48.9%, p <0.05) and pro-
longed times for mechanical ventilation (62.1 vs15.2). %, p <0.005).
Early reoperation (<48 hours) was performed in 62 patients (53.4%),
beingtamponade (64.5%) and mediastinal bleeding (30.6%) the most
frequent causes. In patients whounderwent a delayed reintervention
(> 48 hours), tamponade (46.3%), sternal dehiscence (24.1%) andvalv-
ular problems (14.8%) were the most important causes. There were
no differences in age, sex, timeor mortality between the two groups;
but early reoperation was more frequent after an emergent sur-
gery(18.3% vs 5.6%, p = 0.05).
CONCLUSION. Reoperation after cardiac surgery associates high mor-
tality and more complications, beingtamponade and mediastinal
bleeding the most frequent causes.
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INTRODUCTION. The Fontan surgery, the 3rd procedure in single-
ventricle palliation, redirects systemic venous blood into the pulmonary
Fig. 1 (abstract 000355) See text for description
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can lead to major complications and grave outcome. Even though data
shows that these patients benefit from negative pressure ventilation [2,
3], a delicate balance between sedation & analgesia, pharmacological
cardiac support and early extubation may be difficult to achieve. To
date there are neither validated protocols nor auxiliary tests to predict
tolerability of early extubation and guide clinicians with early postoper-
ative management. Alveolar dead-space fraction (AVDSf) represents the
portion of inhaled air that does not participate in gas exchange and
quantifies ventilation-perfusion abnormalities in the lung[4]. Increased
AVDSf has been associated with prolonged mechanical ventilation and
worse outcome after congenital heart surgery [5, 6]. The association of
AVDSf with clinical outcomes in patients undergoing Fontan operation
has not been reported.
OBJECTIVES. Our goal was to find AVDSf and arterial saturation cut-
off values which predicts bad post-operative outcome
METHODS. A retrospective charts review of all pediatric Fontan pa-
tients from 6/2010-11/2018 in a tertiary-care pediatric hospital was
performed. Associations between AVDSf and SaO2 to a composite
outcome (need for surgical\catheter-based intervention, ECMO use,
prolonged ventilation, prolonged hospital LOS or death) were ex-
plored. Secondary endpoints were parameters of severity of illness,
chest drainage duration, and LOS
RESULTS. Of 128 patients undergoing Fontan operation, 34 patients
met criteria for composite outcome. AVDSf was significantly higher in
the composite groups (0.33±0.14) versus control group (0.25±0.26;
p=0.016). AVDSf ≥0.29 indicated a 37% increase in the risk to meet
composite criteria. Admission SaO2 was significantly lower in com-
posite versus the control group (93.4% Vs 97.1%, p=0.005). AVDSf
was significantly associated with increased durations of mechanical
ventilation, ICU LOS, duration of thoracic drainage, and parameters
of severity of illness
CONCLUSION. We found that high AVDSf and low SaO2 are associated
with more complicated postoperative course in children undergoing the
Fontan operation. AVDSf value≥0.29 or arterial saturation≤86% should
raise concern that the patient may have complex postoperative course
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INTRODUCTION. ECMO is an emerging rescue therapy for severe car-
diopulmonary failure. ECMO treatment is technically demanding and
assessment of native cardiac output is difficult.
OBJECTIVES. We performed an in vitro simulation on an ECMO
Model to assess whether it is possible to calculate pulmonary bloodflow (QLung) from ECMO Blood flow (QECMO) and carbon dioxide
elimination (VCO2) by a modified Fick-principle.
METHODS. The in-vitro simulator consisted of two perfusate pumps,
simulating QECMO and QLung. Two oxygenators (OxyECMO and Oxy-
LUNG) were used to eliminate CO2 and oxygenate the blood. QLung
could be diverted into a shunt, bypassing OxyLUNG. CO2 production and
O2 consumption were simulated by two oxygenators in series, rinsed
with a mixture of CO2 and N2. The system was filled with discarded hu-
man blood and heated to 36.5 °C. The experimental protocol consisted
of weaning steps with differing shunt values. Exhaust CO2 was measured
with a capnometer. VCO2 was calculated as the exhausted fraction of
CO2 times gas flow. The modification of the Fick principle Q_total* Δ_(v-
ao) CO2 = Q_LUNG* Δ_(v-LA) CO2+ Q_ECMO* Δ_(v-pm) CO2 can be
transferred to 〖ΔQ〗_LUNG=〖ΔQ〗_ECMO*(-Δ〖VCO2〗_LUNG)/〖ΔVCO2〗
_ECMO. (Δ_(v-ao): veno-aortal, Δ_(v-LA): veno-left atrium, Δ_(v-pm): veno-
post membrane). In cases of V/Q ≠1, a normalization factor f was applied
to correct VCO2 towards a V/Q of 1: f(V,Q)= (Q*(V/Q+c))/(V*(1+c)). Con-
stant c was calculated from a blood gas sample as a function of
temperature T, pH, CO2 solubility and the gas constant R.q
RESULTS.
We normalized both VCO2Lung and VCO2ECMO and calculated
QLung. Our QLung calculations showed a small bias with wide limits
of agreement and good correlation (Figure 1A, r2=0.6372, p=0.0003).
Shunt leads to an underestimation of blood flow and decreases cor-
relation (Figure 1B). Normalizing only QECMO increases bias and re-
duces correlation (Figure 1C, r2=-0.1576, p=0.4230).
CONCLUSION. Our simulation shows that simulated pulmonary blood
flow calculations are possible from VCO2 measurements within clinic-
ally acceptable limits. V/Q mismatch and shunt will decrease the pre-
cision of the method. Measurements are readily available and non-
invasive. We will perform animal and human trials to further investi-
gate this method.000366
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INTRODUCTION. Early identification and treatment of vasoplegia fol-
lowing CF-LVAD implantation is imperative to prepare patients for
post-surgery recovery. In the absence of a consensus definition of
vasoplegia following CF-LVAD, interventions and outcomes can’t be
reliably assessed.[1-4]
OBJECTIVES. This study aimed to construct criteria that would be re-
producible, standardized, and associated with clinical outcomes. This
Page 145 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55study reports incidences and associations with non-favorable dis-
charge disposition (death, hospice, long term acute care, and rehab)
for 8 permutations of vasoplegia criteria.
METHODS. This retrospective, cohort study included patients who
underwent initial CF-LVAD implantation on cardiopulmonary bypass
(CPB) at an academic medical center from 08/2016 through 08/2018. In-
vestigators identified 6 considerations for constructing vasoplegia cri-
teria: (1) Period of observation: Observation started at CPB termination
and lasted for 72 hours; (2) Unit of time for measurement: Analysis
was conducted at each 15-minute interval; (3) Clinical constructs: Three
clinical constructs were chosen: low blood pressure using mean arterial
pressure (MAP; mmHg) or systemic vascular resistance (SVR;
dynesseccm-5), normal cardiac index (CI; L/min/m2), and vasopressor
support using norepinephrine equivalents (NEE; mcg/kg/min);
(4) Threshold logic strategies: Multiple hemodynamic measurements
documented within an interval were categorized as having “ever” or
“always” crossed the threshold for detection; (5) Duration: The number
of consecutive intervals where criteria were sustained were analyzed;
(6) Missing data: The last documented MAP and SVR were carried for-
ward for 3 intervals, and CI for 288 intervals. We evaluated 8 permuta-
tions of criteria: two versions, two threshold logic strategies, and two
duration cut points. Version 1 used MAP <60 or SVR <800 combined
with CI >2.2 and NEE ≥0.1. Version 2 used MAP <60 or SVR <700 com-
bined with CI >2.5 and NEE ≥0.2.
RESULTS. This study included 98 CF-LVAD recipients, accounting for
28,224 intervals. Version 1 had a larger incidence and risk for non-
favorable discharge compared to version 2. Meeting criteria for ≥2
consecutive intervals decreased incidence but increased risk for non-
favorable discharge.
CONCLUSION. Version 1 “always” for ≥1 interval and version 1 “ever”
for ≥2 consecutive intervals occurred frequently (32% to 40%) and in-
creased risk for non-favorable discharge by 19% to 27%.
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Absolute risk difference for non-
favorable discharge, % (95% CI)
Criteria met for ≥1 interval
1 Ever 60 (61%) 16% (-4% to 36%)
1 Always 31 (32%) 27% (9% to 44%)
2 Ever 27 (28%) 1% (-21% to 22%)
2 Always 14 (14%) 23% (1% to 45%)
Criteria met for ≥2 consecutive intervals
1 Ever 39 (40%) 19% (0% to 37%)
1 Always 20 (20%) 32% (14% to 49%)
2 Ever 15 (15%) 8% (-18% to 33%)
2 Always 8 (8%) 25% (0% to 50%)000403
Predictive value for survival in pre-ECMO lactate level of VA ECMO
in adult cardiogenic shock
DW. Kim, IS. Jeong,
Thoracic and cardiovascular surgery, Chonnam National University
Medical School, Gwangju, Republic of Korea
Correspondence: D.W. Kim
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000403
INTRODUCTION. The effectiveness of extracorporeal membrane oxygen-
ation for patients with cardiogenic shock is well-established, and lactate is
well known as the biochemical biomarker of end organ perfusion. How-
ever there were no sufficient data of correlation between pre-ECMO lac-
tate level and survival. We evaluate the efficacy of pre-ECMO lactate level
for prediction of survival in patients with cardiogenic shock.
METHODS. We respectively reviewed the medical records of patients
who underwent ECMO for cardiogenic shock between January 2015
and December 2017. Of these, 79 adult patients underwent the
venoarterial ECMO for cardiogenic shock. These patients were di-
vided into survivor and nonsurvivor groups, based on survival to hos-
pital discharge. The patient characteristics in pre-ECMO condition
were compared between 2 groups.
RESULTS. Mean age was 60.9±14.8 years and the overall survival rate
to hospital discharge was 46.8%(n=37). In multivariate analysis, inde-
pendent predictors of mortality were the pre-ECMO lactate level
(OR,1.1703; 95% CI,1.0521-1.3017;P=0.0038). The optimal cut-off value
for pre-ECMO lactate was 9.2(AUC 0.696, p=0.0015). Kaplan-Meier sur-
vival curves showed that the cumulative survival rate at hospital dis-
charge was significantly higher among patients with pre-ECMO
lactate of 9.2 or less compared with patients greater than 9.2 (65.1%
versus 28.1%;p=0.0007).
CONCLUSION. We conclude that pre-ECMO lactate of 9.2 or less may
be an indicator of favorable outcomes with the use of ECMO in adult
cardiogenic shock. However it is still difficult to predict survival with
only pre-ECMO lactate levels and to determine whether to apply the
ECMO for adult cardiogenic shock. Further research on how to pre-
dict reversibility more accurately is essential.
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INTRODUCTION. The goals of resuscitation in critically ill patients are
to ensure adequate tissue perfusion and cellular metabolism [1]. The
gut has been hypothesized as the “motor” of critical illness [2,3]. A
mucosal injury surveillance system with a special orogastric tube with
four electrodes in the distal tip, Florence (Critical Perfusion Inc., Cali-
fornia) [4], has been proposed for surveying the integrity of the mu-
cosal tissue of the stomach, in critically ill patients through the
reactance biomarker (XL).
Page 146 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55OBJECTIVES. Evaluate the safety and effectiveness of the XL trend
measured by Florence in the prediction of morbimortality (cardio-
genic shock, excessive bleeding, vasoplegic syndrome, and death)
and with hemodynamic variables (CI, MAP, MPAP, CVP, PCWP), lac-
tate, SVO2, and the risk predictors (EUROSCORE II, STS, APACHE II,
and SOFA) of patients post-operated of elective cardiovascular
surgery.
METHODS. The study was approved by the local ethics committee
and regulatory entity (193300912X0085/2019)[5]. Patients with an
elective surgery for a coronary artery bypass (CABG) and/or valvular
replacement, and complies with the following STS ³6% or EuroScore
II ³ 6% or LVEF< 45% or TAPSE < 17mm or TSVI < 0.1 m/s, pulmonary
artery catheter (PAC) and an orogastric tube were eligible for the
study. Subjects with recent gastrointestinal bleeding, paraplegic or
hemiplegic, congenital background, maxillofacial malformation,
woman in breastfeeding period, were excluded from the study. Fol-
lowing general induction anesthesia and endotracheal intubation,
the orogastric tube was positioned in the stomach to measure XL;
positioning was confirmed during surgery by aspiration of gastric
content and chest radiography after ICU admission. All patients were
under cardiopulmonary bypass (CPB), aortic cross-clamp, mechanic-
ally ventilated and were monitored during surgery and the first
seventy-two postoperative hours or until removal of the orogastric
probe during this period. For statistical analysis, we used T-Student
and Kruskal-Wallis tests as appropriate considering the significance
p< 0.05.
RESULTS. 10 patients were included, with mean age 49.30 ± 13.38
years, 6(60 %) male,4 (40%) female, had 7(70%) undergone valvular
surgery, 1(10%) CABG surgery and 2(20%) valvular surgery and CABG,
ICU length of stay (LOS): 3.97± 3.82 days, Hospital LOS: 8.86 ±6.8 days,
ICU mortality: 8.4%. Seven 7(70%) patients developed complica-
tions: 4(57%) required vasopressor (more than 48h), 5(71%) had pro-
longed mechanical ventilation (more than 24h), 2(29%) underwent
re-operation due to excessive bleeding (at the first 72h), 3(43%) car-
diogenic shock, 4(57%) excessive bleeding, 1(14%) vasoplegic syn-
drome, and overall mortality was 71%. No significant differences
between complications and without complications in age, sex, ICU
LOS, CPB time, LVEF @ICU, EuroScore II, STS, APACHE and SOFA was
founded. Significant differences between XL, lactate was founded in
Post-CPB and in the first 24h at ICU. Lactate and XL trend shows the
same behavior in both groups
CONCLUSION. The results suggest that XL trend is a relevant bio-
marker during surgery and the first 24h at ICU and has a similar be-
havior as lactate. The sample size must be completed to obtain the
final results.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000410INTRODUCTION. The shock index (SI) is calculated dividing the heart
rate by the systolic blood pressure, it is a bedside assessment tool
that has been used to predict outcomes in different states of circula-
tory failure as trauma, sepsis, and hypovolemia[1]. Different studies
regarding acute coronary syndromes, have proposed distinct cutoffs
for SI to predict the development of cardiac shock or mortality (0.7,
0.9, 0.93)[2,3].
OBJECTIVES. To determine whether SI is a reliable tool to identify
pre-shock state in the postoperative period, to anticipate the devel-
opment of cardiogenic shock.
METHODS. A retrospective, observational study was conducted, in
which medical information of patients who underwent aortic valve
replacement surgery, from January 2017 to December 2018, was col-
lected. The exclusion criteria encompass those patients who had an-
other surgical procedure besides aortic valve replacement in the
same surgical time. Additionally, patients in whom an intra-aortic bal-
loon pump (IABP) was placed prior or during surgery, patients with
vasopressors in the intensive care unit (ICU), and those who had sys-
tolic blood pressure <90 mmHg when the surgery finished were ex-
cluded. The data regarding patients with SI ≥0.7 and SI ≥0.9 was
analyzed using STATA 12.1, a p value of <0.05 was considered
significant.
RESULTS. Total 136 patients were included. Male patients 64.7% and
female 35.3%, the mean age was 55 years SD 14.4, mean left ven-
tricular ejection fraction (LVEF) 58.2% SD 8.7. SI: 0.72 SD 0.16, SI ≥0.7
52.9%, SI ≥0.9 13.2%. Pearson correlation between SI and LVEF, mor-
tality, cardiogenic shock, cardiac tamponade, and length of stay after
surgery did not show correlation but it correlates with low cardiac
output syndrome (LCOS) (R=0.23, p=0.006), bleeding during surgery
(R=0.17, p=0.044), and the need for a second surgery during the stay
at the ICU (R=0.20, p=0.016). The ≥0.7 cutoff did not demonstrate
correlation with any variable, albeit the ≥0.9 cutoff showed correl-
ation with LCOS (R=0.22, p=0.009), the need for second surgery (R=
0.22, p=0.008), bleeding during surgery (R=0.20, p=0.019), and length
of stay after surgery (R=0.21, p=0.011). In the multivariate analysis,
the SI ≥0.9 only demonstrated significance for the need for a second
surgery (OR=3.88, p=0.047, CI=1.02-14.87).
CONCLUSION. Pre-shock state defined by SI ≥0.7 is present in more
than a half of our population but this cutoff showed no correlation
with mortality or any other factors related to shock state, neverthe-
less SI ≥0.9 showed correlation with the performing of a second sur-
gery due to major bleeding or cardiac tamponade, and LCOS. This
suggests that SI ≥0.9 could be an assessment tool in the ICU to
recognize patients at possible risk of development of circulatory fail-
ure before arterial pressure reaches shock values. The SI warrants fu-
ture investigation in cardiac surgery.
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Page 147 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. The cardiorenal syndrome comprises a spectrum of
disorders affecting both the heart and the kidneys, in which acute or
chronic organ dysfunction can induce dysfunction in the other, and
central venous pressure (CVP) is of paramount importance in its
pathophysiology.
OBJECTIVES. To analyze the relation of PVC with acute renal failure
in the first 48 hours (ARF-48) and at 15 days (ARF-15) in the postop-
erative period of cardiac surgery.
METHODS. Patients in the immediate postoperative period of cardiac
surgery. Variables analyzed: history of diabetes mellitus (DM), arterial
hypertension (HT), stroke (ST) and previous arrhythmias (ARR). CVP in
the first hours (h) postoperatively (1, 3, 6, 12, 24 y 36). Presence of
ARF-48 and ARF-15 according to AKIN criteria. The results are shown
as means and 95% confidence interval in the case of quantitative
variables and as a percentage in qualitative variables.
RESULTS. 1016 patients. 65% men and 35% women. Age of 65.3
(64.7-66). Mortality of 6.5%. IRA-48: 31%. AKIN-48 (1: 67,1%; 2: 27,2%
y 3: 5,7%). IRA-15: 3.6%. There was a significant relationship of IRA-48
with HT (40,2% vs 22,4%, p= 0.00), DM (45,1% vs 28,5%, p= 0.00),
ARR (46,4% vs 29,5%, p= 0.000) and stroke (48,2% vs 33,2%, p= 0.02).
CVP was significantly higher in valvular and aortic surgery (p= 0.000).
The CVP was higher in the patients who developed IRA-48 (p= 0.00),
and with a proportional relation to the AKIN grade, so the greater
dysfunction the higher CVP (Table 1). The CVP of the first hours were
associated with ARF-15, so that a CVP-12h > 10 mmHg has a risk of
up to 10 times higher for ARF-15 (OR: 10.78, 5.08-22,88).
CONCLUSION. The elevation of CVP in the first hours of postoperative
cardiac surgery are associated with IRA-48. The CVP at 12 hours postop-
eratively could predict the persistence of renal failure at 15 days.Table 1 (abstract 000424). See text for description
AKIN-48 CVP
Stage 1 h 3 h 6h 12 h 24 h 36 h
0 6,16 5,80 5,11 5,09 6,68 7,71
1 7,33 6,89 6,42 6,34 7,88 8,37
2 8,11 7,31 6,90 6,72 8,24 8,83
3 8,75 7,82 8,53 7,06 8,11 9,67
Value of p 0,012 0,000 0,000 0,000 0,000 0,104
Table 1 (abstract 000467). See text for description
Non shock n=1209 Shock n= 97
Age(mean±SD) years 61,77 ±14 66,39 ± 11
Female gender(%)* 24,25 36,36
Diabetes mellitus (%)* 22,23 36,84
Killilp class at presentation > 1(%)* 17 76
Anterior IM(%)* 39 51
Nonanterior IM(%)* 51 34
HR (mean ±SD) bpm* 132 ±23 102 ±27
SBP (mean ±SD) mmHg* 71 ± 18 88 ±25
Lysis reperfusión (%) 17,5 12,3
Primary PCI (%) 72,6 76,7
No reperfusión (%) 9,9 11
Time pain-reperfusion < 120 min (%) 21,26 13,11
Time pain-reperfusion < 180 min (%)* 51,28 37,7
Successful reperfusión (%)* 81,2 59,5
Unsuccessful reperfusión (%)* 8,9 29,5
In-hospital mortality (%)* 3,33 61,11
*p<0,005000467
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INTRODUCTION. Cardiogenic shock is defined as an acute haemo-
dynamic disorder due to a critical reduction of heart’s pumping cap-
acity, caused by a systolic or diastolic dysfunction leading to a
reduced ejection fraction or impaired ventricular filling. A signifi-
cant proportion of patients suffering a ST-segment elevated myocar-
dial infarction may develop cardiogenic shock, and the early
recognition of these would be very important in order to improve
their outcome.
OBJECTIVES. The aim of the current study was to identify the clinical
predictors that may lead to this complication, and describe the out-
come of these patients with ST-segment elevated myocardial infarc-
tion (STEMI) who have developed cardiogenic shock (CS).
METHODS. Data for this study is collected from a prospective cohort
of patients admitted to a terciary level ICU after an STEMI from the
1st January 2009 to 31th December 2018. There patients are all in-
cluded in the ARIAM-ANDALUCIA registry. Statistical analysis wasperformed using the Statistical Package for the Social Sciences
(SPSS), version 20.0 (IBM Corp., Armonk, NY).
RESULTS. From January 1, 2009 to December 31, 2018, a total of
1306 patients with STEMI were admitted to the ICU. Upon admission
or lately during their stay, 97 of these presented CS.
CONCLUSION. The present study shows that a relevant proportion of
patients with STEMI develop CS after presentation (7,43%). This com-
plication occurred more frequently in patients with advanced Killip
class, anterior IM, low systolic blood pressure (BP) and higher heart
rate (HR) at presentation, history of diabetes or female gender. Un-
successful and delay reperfusión (PCI/Lysis) also increased the risk of
developing CS.
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INTRODUCTION. Despite prophylactic measures, the reported inci-
dence of deep vein thrombosis (DVT) during ICU stay remains signifi-
cant and varies between 2 and 15 %[1].
Table 1 (abstract 000473). See text for description
ΔPCO2≤6mmHg ΔPCO2>6mmHg p
Dobutamine (hours) 2,9±13,1 2,7±10,1 N.S.
Norepinephrine (hours) 35,2±74,2 51,5±82,1 N.S.
ICU admission days 4,9±8,9 6,9±11,9 N.S.
Hospitalization days 13,4±7,8 21±23,1 <0,05
IMV days 2,9±8,5 3,1±3,3 N.S.
Euroscore II (%) 1,1±0,1 2,6±0,1 N.S.
SOFA score t0 4,2±2,1 5,2±2,6 N.S.
Deaths 5% 7,14% N.S.
Page 148 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55OBJECTIVES. To evaluate the incidence of DVT in the mixed ICU, to
assess compliance with the local DVT prophylaxis protocol and to
measure the course of anti-Xa activity levels in patients receiving
enoxaparin in a prophylactic regimen.
METHODS. We conducted a prospective observational cohort study in
mixed ICU from March to December 2017. Patients with expected ICU
stay longer than 72 hours were included and screened for the presence
of proximal DVT by compression ultrasound test (CUS). Baseline CUS
was performed within the first 24 hours of admission to the ICU, pa-
tients with positive finding were excluded. Patients with negative base-
line CUS were included. CUS was performed twice a week until ICU
discharge or until new DVT or pulmonary embolism occurred. Prophy-
laxis with enoxaparin was initiated on admission (40 mg of enoxaparin
QD in body mass index ≤35, 60 mg QD in body mass index >35, half
dose in the presence of renal failure requiring hemodialysis) unless a
risk of severe bleeding was present. Mechanical prophylaxis with grad-
uated compression stockings were used until enoxaparin could be ad-
ministered. Compliance with the protocol was assessed by comparing
expected and delivered prophylactic regimen on each day of CUS
evaluation. Peak anti-Xa activity levels were measured twice a week 4
hours after enoxaparin administration.
RESULTS. A total of 225 patients were enrolled. Two of them were
excluded after positive baseline CUS for the presence of DVT (both
clinically suspected) and four were not included in the analysis due
to failure to obtain baseline CUS. In 219 analyzed patients, mean±SD
Simplified Acute Physiology Score II was 60±20. The largest propor-
tion of the patients was medical (38%), 29% were trauma patients,
28% surgical and 8% post-cardiac arrest patients. Median length of
ICU stay was 5 days (IQR 3-11). During ICU stay, 6 patients developed
deep vein thrombosis, for an incidence of 2,7%. None of the diag-
nosed DVT was clinically suspected. No new pulmonary embolism
developed. The median peak level of anti-Xa activity in patients
treated with enoxaparin was 0.2 IU/mL (IQR 0.1-0.3). Up to 29% of
the patients were receiving enoxaparin during the first 24h of ICU
stay, 68% between the day 2-4 and 85% after day 4. The agreement
between the expected and delivered DVT prophylaxis was 94% for
pharmacological and 95% for mechanical prophylaxis.
CONCLUSION. We observed a low incidence of deep vein thrombosis
in our cohort of mixed ICU patients despite very low levels of anti-Xa
activity. Compliance with the DVT prophylaxis protocol was excellent.
Therefore, enoxaparin dose adjustment based on regular monitoring
of anti-Xa activity is unlikely to result in more effective DVT prophy-
laxis in a mixed ICU population.
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INTRODUCTION. Venous to arterial CO2 difference is a valid marker to
evaluate tissue hypoperfusion after cardiac surgery. A pathological gap
(>6) correlates with a reduced cardiac index (CI) and tissue
hypoperfusion.
OBJECTIVES. This observational, prospective study aimed whether
the CO2 gap was a faster parameter than serum lactate and central
venous saturation (ScvO2) in diagnosing tissue hypoperfusion and re-
duced cardiac index (CI).
METHODS. 62 patients who had undergone cardiac surgery in our
centre during 2018 and were admitted to our general Intensive Care
Unit (ICU) during the immediate postoperative period and were moni-
tored with VIGILEO or LiDCO. Patients with arrhythmias, extubation <6
hours or death <24 hours were excluded. Demographic variables, type
of surgery (valve surgery, CABG), time of extracorporeal circulation
(ECC), aortic cross-clamping, SOFA and EuroScore II were collected.The cohort was divided in two groups: initial ΔPCO2≤6 (n=20) and
ΔPCO2>6 (n=42). From each we analysed: serum lactate, ScvO2 and
CI at the moment of admission (T0) and in six hours (T6); differences
in days of admission in the ICU, hospitalization, need of vasopressors,
days of invasive mechanical ventilation (IMV) and morbimortality.
RESULTS. From our 62 patients, the CI was remarkedly lower in the
ΔPCO2>6 group at T0 and T6 and we observed a tendency of the
serum lactate and ScvO2 to worsen during the first 6 hours versus
the ΔPCO2≤6 group, although none of it was significantly associated.
Days of hospital admission were significantly longer in the ΔPCO2>6
group.
CONCLUSION. Given the results, we concluded that venous to arter-
ial CO2 difference might be faster than serum lactate and ScvO2 in
diagnosing tissue hypoperfusion and reduced cardiac index; that pa-
tients with ΔPCO2>6mmHg at the moment of admission have a ten-
dency of needing more vasopressors, IVM days, higher SOFA and
EuroSCore II punctuation, and longer ICU stay although the p value is
not significant. And finally, hospitalization days were significantly lon-
ger in the ΔPCO2>6 group.000480
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INTRODUCTION. Left ventricular (LV) dysfunction is potentially harm-
ful in the critically ill patient as it might compromise circulatory sta-
tus. LV dysfunction can be triggered by many conditions in the
critically ill e.g. myocardial infarction, toxic cardiomyopathy, hypoxia
or severe stress (Takotsubo syndrome). Previous studies of LV dys-
function have focused on specific patient categories but the impact
of LV dysfunction in the mixed ICU population has not been suffi-
ciently studied. ClinicalTrials identifier: NCT03787810.
OBJECTIVES. To evaluate the incidence, pattern, risk-factors and im-
pact on mortality of LV dysfunction in a mixed ICU population.
METHODS. This is a single center, prospective observational study
performed at the Sahlgrenska University Hospital, Gothenburg,
Sweden. The study was performed during an eight month period,
mainly on weekdays. On study days, all patients admitted to the gen-
eral or neuro ICU within 24 hours were eligible for inclusion. Included
patients were examined using a standard echocardiography protocol
[1]. Left ventricular dysfunction was defined as having a global hypo-
kinesia with an ejection fraction <50% or detected regional wall mo-
tion abnormalities (RWMA). Patients with LV dysfunction were
evaluated for myocardial ischemia, or not, based on findings on cor-
onary angiography, troponin levels, ECG-recordings and distribution
of RWMA.
Page 149 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55RESULTS. A total of 426 patients were included and fulfilled the
study protocol. Mean age was 61 ± 17 years, mean SAPS 3 score was
59 ± 16 and 60% were male. A total of 113 patients (26%) had LV
dysfunction of whom 86 (20%) patients had RWMA and 27 (6%) had
global hypokinesia. Of the 86 patients with RMWA, 17 (20%) had
myocardial infarction and 68 (80%) were regarded as non-infarction
hypokinesia. Twelve of these patients (3%) demonstrated a circum-
ferential pattern of hypokinesia in concordance with the Takotsubo
syndrome. In a multivariable model, independent SAPS 3 risk factors
of LV dysfunction were cardiac arrest, circulatory chock of any cause
or respiratory failure as cause of admission (pseudo R-square 0.117).
Neither total SAPS 3 score, any of the physiological SAPS 3 variables
or surgical status were independently associated with LV dysfunction.
Ninety-day mortality was higher in patients with LV dysfunction
(41%) vs patients with normal LV function (21%, p<0.001), also when
adjusting for SAPS 3 score (p=0.005). Mortality was higher in patients
with regional hypokinesia (44%) vs patients with global hypokinesia
(33%), but this was not statistically significant (p=0.379). There were
no differences in mortality if having RWMA due to myocardial infarc-
tion or not (p=0.790).
CONCLUSION. This preliminary analysis suggest that left ventricular
dysfunction is common in the critically ill but not easily predicted by
the patient SAPS 3 admission status. Regional hypokinesia is more
common than global hypokinesia and RWMA is not obviously caused
by myocardial ischemia. LV dysfunction is independently associated
with an increased risk of death. Future studies need to address the
potential causality between LV dysfunction and an increased risk of
death to adapt treatment and improve prognosis.
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INTRODUCTION. Critical illness is associated with multiple organ fail-
ure and increased mortality, potentially due to impairment of the
endothelial barrier, resulting in microvascular leakage, edema and
disturbances in microcirculatory perfusion. Angiopoietin-2 is a known
predictor for organ failure and mortality in critically ill patients. Dur-
ing stress and inflammation, angiopoietin-2 impairs endothelial bar-
rier function via inactivation of the endothelial Tie2 receptor. We
previously showed that activation of Tie2 reduced microvascular
leakage and restored microcirculatory perfusion in a rat model of
critical illness, proposing the angiopoietin/Tie2 system as a promising
target in critically ill patients.
OBJECTIVES. To further explore the angiopoietin-2/Tie2 system, we
studied the direct effect of angiopoietin-2 administration to WT or
heterozygous Tie2+/- mice, expressing 50% of normal Tie2 gene and
protein levels, on microvascular leakage and edema formation in
mice.
METHODS. Male mice with a 50% reduction of Tie2 expression (het-
erozygous exon 9 deletion, Tie2+/-) and wild type controls (WT) re-
ceived either angiopoietin-2 (WT+Ang-2 n=8, Tie2+/-+Ang-2 n=8) or
PBS as control (WT+PBS n=7, Tie2+/-+PBS n=7) and were monitored
for one hour. Microvascular leakage and edema formation were de-
termined by extravasation of Evans Blue dye (EBD) or wet/dry ratio,
respectively, in kidney and lung tissue.
RESULTS. In healthy WT mice, angiopoietin-2 administration did not
affect pulmonary or renal EBD extravasation (lung 0.08±0.03 vs 0.06±0.02 μg/g, p=0.15; kidney 0.07±0.02 vs 0.07±0.02 μg/g, p=0.66), but
induced pulmonary edema formation (lung 7.0±1.5 vs 4.5±1.4, p<
0.05; kidney 4.8±0.4 vs 4.5±0.5, p=0.20).
Genetically reduced expression of Tie2 did not affect pulmonary and
renal EBD extravasation (lung 0.08±0.02 vs 0.06±0.02 μg/g, p=0.10;
kidney 0.07±0.02 vs 0.07±0.02 μg/g, p=0.70) compared to WT con-
trols, but increased pulmonary edema formation (lung 8.0±1.8 vs
4.5±1.4, p<0.01; kidney 4.8±0.1 vs 4.5±0.5, p=0.18).
Administration of angiopoietin-2 in mice with genetically reduced
Tie2 expression tended to increase pulmonary (0.12±0.05 vs 0.08±
0.02 μg/g, p=0.07) and renal EBD extravasation (0.10±0.03 vs 0.07±
0.02 μg/g, p=0.07) compared to control mice with genetically re-
duced Tie2 expression, but edema formation remained unaltered
(lung 6.9±1.9 vs 8.0±1.8, p=0.30; kidney 4.8±0.2 vs 4.8±0.1, p=0.88).
CONCLUSION. Angiopoietin-2 mediated Tie2 inactivation, as ob-
served during critical illness, leads to microvascular leakage and
edema formation in mice. Future studies should reveal whether
therapeutically targeting the angiopoietin/Tie2 system reduces
microvascular leakage and improves organ function in critically ill
patients.
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INTRODUCTION. Cardiovascular diseases are the main cause of mor-
bidity and mortality in the developing world, currently occurring at
younger ages. Acute coronary syndrome (ACS) has a high prevalence
in mortality in long-term in young adults
OBJECTIVES. The purpose of this study was to determine the factors
that are associated with poor prognosis in long-term in this
population
METHODS. We performed a retrospective analysis with consecutive
inclusion of 253 patients admitted with a diagnosis of ACS between
January 2011 and January 2013, aged equal or less than 60 years old.
We classsified these patients into 2 groups: those who have died (n:
32 (12,7%), 77,8% male), and those who have survived (n: 221
(87,3%); 66,4% male) during the follow- up of 5 years. First, we tested
for factors that were associated with mortality during the follow-up.
Then, we used a multivariable logistic regression to identify the pre-
dictors of mortality in a long-term period.
RESULTS. During the folow-up of 5 years, age-independent predic-
tors factors of mortality were: chronic kidney diseas (OR 30,199; p =
0,02); myocardial reinfarction (OR 14,022; p = 0,041); cardiac arrhyt-
mias (OR 13,922; p = 0,035); heart failure following myocardial infarc-
tion (OR: 7,994; p = 0,001); hemorrhagie complications (OR 5,273; p =
0,17); Cardiac shock (OR 4,62; p = 0,001); and diabetes (OR 2,856; p =
0,035). Regarding continous variables isolated were serum creatin-
ine (OR 2,311; p = 0,011); and heart rate (OR 1,027; p = 0,03).
The patients registered higher mortality rate were the ones that were
less frequently submitted to angioplasty (OR 0,309; p = 0,003), that
were not as promptly selected and treated in the emergency depart-
ment (OR 0,298; p0 =0,14) and that suspended dual anti-platelet
therapy before 1 year (OR 0,276; p = 0,007). Continous variables iso-
lated were hemoglobin (OR 0,717; p = 0,003); and hematocrit values
(OR 0,906; p = 0,012).
Then, we analyzed those variables using Logistic regression analysis,
and we observed that Killip class at admission ≥ 2, diabetes mellitus,
Table 2 (abstract 000533). In-hospital complications and mortality
Complication Group 1 Group 2 p-value
Heart failure 33,8% 14,7% 0,006
Need for non-invasive ventilation 7,6% 1,8% 0,007
Need for invasive ventilation 6,1% 1% 0,006
Need for blood transfusión 43,9% 1,5% p < 0,001
CS, stroke or mechanical complications - - ns
Page 150 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55heart rate; myocardial reinfarction, , serum creatinine were the stron-
gest predictors mortality and standard dual anti-platelet therapy a
predictor of survival.
CONCLUSION. Acute cardiac ischemia in < 60 years old, the stron-
gest predictors of mortality during the follow-up of 5 years were ad-
mission Killip ≥ 2, diabetes mellitus, myocardial reinfarction, heart
rate a serum creatinine. The standard dual antiplatelet therapy during
the follow-up of 1 year was an independent survival predictor.
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INTRODUCTION. Major bleeding (MB) is a feared complication in pa-
tients with Non-ST elevation acute myocardial infarction (NSTEMI)
and may have impact in the therapeutic strategy and prognosis of
these patients.The aim was to characterize the population of these
patients (defined MB by Gusto criteria) and to assess their impact on
therapeutic approach and in-hospital complications and mortality
METHODS. We studied 3216 patients with NSTEMI included in ARIA-
M(Analysis of delay in myocardial acute infarction )We considered 2
groups:Group 1–Patients with MB(n=67p,2,1%)Group 2–Patients with-
out MB(n=3149p,97,9%)We collected: age,gender,Cardiovascular and
non-cardiovascular co-morbidities,laboratory parameters,coronary
angiography performed,coronary anatomy and type of implanted
stent,in-hospital therapy,ejection fraction(EF)In-hospital complications
considered:Heart Failure(HF)and cardiogenic shock(CS);cardiac mech-
anical complications;stroke;need for mechanical ventilation and need
of blood transfusion
RESULTS. Regarding clinical profile of patients: With MB and with-
out MB respectively : Age: 70 +/- 9 vs 65+/-12(p < 0,001); Hyper-
tension 84,2% vs 75,3% (p=0,03); Previous HF 19,2% vs 9,2% (p <
0,001); Chronic Renal Failure 15,2% vs 7,9% (p= 0,03); Peripheral
artery disease 14,6% vs 6,8% (p=0,02); Previous bleeding 11,5% vs
2% (p < 0,001).Table 2. In-Hospital therapy and coronary
angiography
CONCLUSION. The presence of MB is present in 2,1% of patients
with NSTEMI and is associated with an increased in-hospital mor-
tality and heart failure.Table 1 (abstract 000533). See text for description
With MB Without MB p
Aspirin 93,9% 98,2% 0,036
UF Heparin 27,7% 15% 0,004
Other antiplatelets or anticoagulants - - ns
Loop diuretics 55,4% 29,9% p < 0,001
Aldosterone Antagonists 18,5% 9,8% 0,02
Inotropes 6,3% 1,9% 0,03
Coronary angiographt 78,8% 84% 0,249
Radial acess 68,1% 75,7% 0,228
Multi-vessel disease 76,1% 55,7% 0,006000535
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INTRODUCTION. Major bleeding (MB) is a feared complication and
a daily reality in patients with Non-ST elevation acute myocardial
infarction (NSTEMI) as a result of pharmaological management.
This may have impact in the therapeutic strategy and prognosis of
these patients
OBJECTIVES. To characterize the population of patients with NSTEMI
and MB ( defined by Gusto criteria) and to evaluate possible predic-
tors of the onset of MB
METHODS. We studied 3216 patients with NSTEMI included in ARIAM
(Analysis of delay in myocardial acute infarction)We considered 2
groups:Group 1:Patients with MB(n=67p,2,1%).Group 2:Patients with-
out MB(n=3149p,97,9%)We collected :age,gender,Cardiovascular and
non-cardiovascular co-morbidities,laboratory parameters,coronary
angiography performed, coronary anatomy and type of implanted
stent,in-hospital therapy,ejection fraction(EF)We compared the in-
hospital mortality and multivariate analysis was performed to identify
the predictors of MB
RESULTS.
By multivariate analysis, were identified as predictors of MB : age ,
previous history of bleeding and unfractionated heparin
CONCLUSION. The presence of major bleeding is present in 2,1%
of patients with NSTEMI .
There were identified as major bleeding predictors : age, previous
history of bleeding and therapy with unfractioned heparin.Table 1 (abstract 000535). Clinical profile
With MB Without MB p
Age 70 +/- 9 65+/-12 p < 0,001
Hypertension 84,2% 75,3% 0,03
Previous HF 19,2% 9,2% p < 0,001
Chronic Renal Failure 15,2% 7,9% 0,03
Peripheral artery disease 14,6% 6,8% 0,02
Previous bleeding 11,5% 2% p < 0,001
Table 2 (abstract 000535). In-hospital complications and mortality
Complication Group 1 Group 2 p-value
Heart failure 33,8% 14,7% 0,006
Need for non-invasive ventilation 7,6% 1,8% 0,007
Need for invasive ventilation 6,1% 1% 0,006
Need for blood transfusión 43,9% 1,5% p < 0,001
CS, stroke or mechanical complications - - ns
Table 1 (abstract 000262). See text for description
Normal 1º and 3-4 year (%)
Basic physiological activities Normal daily life activities
Oral communication 54,8 64,3 Movements 83,1 89,9
Urinary control 79,1 84 Minor effort 71,2 82,4
Defecation control 81,9 88,2 Major effort 35,3 47,9
Food intakes 81 88,7 Walking 63,8 75,6
Emotional status Mobility 46,6 68,1
Subjective well being 41,1 49,2 Dressing 63,8 78,2
State of mind 40,2 50 Working life activities 28,5 41,2
Vitality 64,4 73,1 Social relationship 70,2 80,6
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INTRODUCTION. Low cardiac-output syndrome (LCOS) is a common
complication during the first days after heart surgery, increasing the
need of circulatory support, length of stay and mortality in the inten-
sive care unit (ICU).(1) This syndrome lacks one precise definition (2),
and the role of cardiac ultrasound in its diagnosis and management
is also unclear. The purpose of this study is to investigate if any echo-
graphic patterns arise in patients with low cardiac-output syndrome
after cardiac surgery, and if these findings could have any prognostic
implications.
OBJECTIVES. The aim of this study is to evaluate echocardiographic
findings in patients who develop LCOS after heart surgery, defined
as the sustained need of inotropic support during the first 48 hours
of admission. A secondary objective is to study the implications of
these findings until discharge from the ICU.
METHODS. This is a unicentric, descriptive, retrospective study, set in
an adult surgical intensive care unit specialized in heart surgery, at
the Hospital Doce de Octubre in Madrid, Spain. Patients were in-
cluded if they showed a sustained cardiac index less than 2.2 L/mn/
m2 or were in need of sustained inotropic support for at least 48
hours after surgery in the intensive care unit. To be included these
patients had to receive a cardiac ultrasound evaluation during the
first 3 days of admission, performed by a trained practitioner.
RESULTS. Seventy patients with LCOS were included, 58% were
women. Patients were admitted after heart valve surgery (41%), heart
transplant surgery (17%), combined procedure of valve repair and
coronary artery bypass grafting (CABG) (13%) and isolated CABG
(11%). Median length of stay was 10 days (IQR 5-19), and 8 patients
died (11%). Median cardiopulmonary bypass time was of 137 mi-
nutes (105-168), median aortic cross-clamp time was of 124 minutes
(82-147). Median time of inotropic use was 72 hours (48-118). Before
surgery, 54% patients had a normal left ventricular ejection fraction,
or LVEF ≥50%. After surgery, 25% of this subgroup presented low
LVEF <50%, but 74% still had a normal LVEF. Among the latter, im-
paired right ventricle ejection fraction (RVEF) was found in 68%, and
diastolic dysfunction (DD) in 50%. Among patients with low LVEF be-
fore surgery, excluding transplants, most of them still had an altered
LVEF after surgery. Having a LVEF <30% after surgery was associated
with higher mortality.
CONCLUSION. LCOS remains a fearful complication during the first
days after heart surgery. Cardiac ultrasound is an important tool in its
diagnosis and management. In our findings, reduced RVEF and DD
were more common in patients with LCOS who had a normal LVEF
after surgery. A higher mortality was associated with a LVEF<30%.
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INTRODUCTION. Many instruments have been developed to evalu-
ate hospital mortality, but less attention has been paid to the
long-term functional status and quality of life of traumatic brain
injury patients
OBJECTIVES. To analyze the evolution of quality of life (QOL) and
its different components between the 1st year and 3-4 years of
admission to the ICU due to traumatic brain injury (TBI).
METHODS. Prospective cohort study. TBI in Carlos Haya Hospital
(Málaga) between 2004-2008. Evaluation of QOL with question-
naire PAECC (Project of Epidemiological Analysis of Critical Pa-
tients), We analyzed physiological activities (oral communication,
urinary and defecation control, food intake), daily life (mobility,
work activity, etc.) and emotional state. (0 normal to 29 major
deterioration).
RESULTS. N = 531. Age 40.35 ± 19.75 years, APACHE-II 17.94 ± 6.97,
GCS admission 7.53 ± 3.83 points. Hospital mortality: 28.6%. Mortality
1 year: 32.2% (lost: 6.6%). 3-4 years 33% (lost 16.2%) QOL 1st year:
9.44 ± 8.73 points (significant deterioration) and at 3-4 years 6.77 ±
7.70 points, (p <0.001).
At 3-4 years, almost 90% have normalized physiological activities,
except oral communication (64.3%), and another 17.2% with diffi-
culty but with coherent dialogue. First year low percentage in
work reintegration and capacity for great efforts , improve to 3-4
years without reaching 50% normality. High percentage in toler-
ance to minimum efforts, precision movements and social rela-
tions at year and 3-4 years. Emotional state presents high
percentage of abnormality.
CONCLUSION. TCE, a year show significant deterioration of QOL im-
proving to 3-4 years. At one year they present high normality of
basic physiological activities, physical ones of small effort, social rela-
tion and movements of precision and that even improves something
at 3-4 years. First year, normality in ability to make great efforts, work
activity and subjective aspects a low percentage that improves to 3-4
years, although it does not reach 50%.
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INTRODUCTION. Identification of microcirculatory alterations in critic-
ally ill patients using hand-held vital microscopes (HVMs) is com-
monly applied sublingually. The sublingual area however, contains
different types of vessel morphology related to capillaries, salivary
gland structures and large veins. Although several studies have
shown the importance of sublingual microcirculatory assessment dur-
ing health and disease, no attention has been paid to the heterogen-
eity of the microcirculatory morphology in the sublingual cave. This
study introduces the anatomy guided area in the sublingual cave,
which is called the sublingual triangle. The sublingual triangle is most
suited to perform sublingual measurements due to its rich vascula-
ture with content conform the international consensus ESICM guide-
lines on microcirculatory monitoring. (1).
OBJECTIVES. The objective of this study is to identify the optimal sublin-
gual location for measurement of the microcirculation and to validate
that with suitable training this optimal location can be readily identified.
METHODS. A trained observer performed sublingual microcirculation
assessments with HVM using incident dark field (IDF) imaging. Mea-
surements were done before and after suitable training aimed at
identifying its location(2) , with an interval of 3 months. The instruc-
tions consisted of introducing a specific region of interest, guided by
the anatomical structure which can be seen adjacent on either side
of the frenulum of the sublingual area. Small vessel density (SVD)
(vessels <20μm in diameter), Large vessel density (LVD) (vessels be-
tween 20 – 100 μm in diameter) and Total vessel density (TVD), of
non-instructed (NIM) and instructed (IM) measurements were ana-
lyzed and compared. Also the vessel structures were morphologically
analyzed, and the appearance of salivary gland structures related
microcirculation identified.
RESULTS. A total of 9 healthy volunteers were included. During each
time point (T0:NIM and T1:IM) 4 video clips of the sublingual micro-
circulation were captured. Poor quality videos were excluded accord-
ing to the microcirculation quality assessment (1) before offline
analysis. A total of 53 videos were analyzed with MicroTools(3). TVD,
but not LVD and SVD, was higher in IM compared to NIM, indicating
a bigger contribution to TVD from capillaries, which are associated
with oxygen transport to tissue. (TVD NIM vs IM: 24.76 ± 1.74 vs
27.29 ± 3.1 mm/mm2 p=0.044 , LVD NIM vs IM: 6.6 ± 1 vs 7.6 ± 1.3
p=0.092 , SVD NIM vs IM: 18.19 ± 1.65 vs 19.88 ± 3.07 p=0.103). In
the NIM 6 video clips were identified containing salivary gland struc-
ture related microcirculation, whereas in the IM videos only small
and large vessels were detected.
CONCLUSION. The sublingual triangle identified in this study showed
a higher vessel density and avoided salivary gland structure related
microcirculation. These findings indicate that the sublingual triangle
is the optimal location for measurement since it can be identified by
its morphology and contains the optimal vessel content conform the
international guidelines. We propose the sublingual triangle to be-
come the target of microcirculatory assessment using HVM to reduce
heterogeneity and increase reproducibility of the studies.REFERENCE(S)
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INTRODUCTION. Reduced antithrombin-III (AT-III) is an important
component in the latest diagnostic criteria for disseminated intravas-
cular coagulation (DIC) established by the Japanese Society of
Thrombosis and Hemostasis. However, some severe cases show re-
duced AT-III, but do not meet the diagnostic criteria for DIC. In our
experience, patients with low AT-III levels show very poor outcomes,
regardless of their disease or DIC status. However, few reports have
examined the prognostic ability of AT-III in all patients admitted to
the ICU.
OBJECTIVES. To investigate the relationship between the AT-III level
and the outcomes of patients admitted to the ICU and evaluate the
prognostic value of the AT-III level.
METHODS. We conducted a retrospective observational study of 672
patients who were admitted to our hospital ICU from January to De-
cember in 2018. Cases involving patients of <18 years of age, APA-
CHE II scores of <10 points, cases without AT-III measurement, and
cases involving patients who died within 1 day of admission to the
ICU were excluded. We divided the included cases into 4 groups
based on the AT-III values measured at the early stage of
hospitalization: AT-III ≥71% (H group), 70-51% (M group), 50-31% (L
group), and ≤30% or less (VL group). We also checked the rates of
death within 7 days, 28 days, and at hospital discharge. The accuracy
of the predicted prognosis was then compared with the APACHE II
score using an ROC curve analysis. The JMP software program was
used to perform the multivariate and ROC curve analyses.
RESULTS. The 56 subjects in this study were classified into the fol-
lowing groups: H group, n=13; M group, n=25; L group, n=12; and VL
group, n=6. In most target cases, the basic disorders were post-
operative patients, sepsis patients, or acute myocardial infarction pa-
tients. The APACHE II scores were 20, 24.5, 21 and 30 (groups H, M, L,
and VL, respectively). The rates of death within 7 days were 0%, 4%,
8.3% and 50%; the rates of death within 28 days were 0%, 28%, 25%
and 67%, and the rates of death at hospital discharge were 25%,
32%, 50% and 100%, respectively. The multivariate analysis revealed
that the AT-III value and APACHE II scores were independent predic-
tors of death at hospital discharge. In comparison to the APACHE II
Page 153 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55score, the AT-III value appeared an equally or more powerful prog-
nostic predictor for any outcome (Fig. 1). The cut-off values of the for
AT-III level and APACHEII score for predicting 7-day mortality were
47% and 26; those for 28-day mortality were 57% and 26, death and
those for death at discharge were 56% and 26, respectively.
CONCLUSION. Early morbidly low AT-III values may be a prognostic
predictor of hospital mortality in patients admitted to the ICU.
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INTRODUCTION.
 Our medium sized 544 bed acute hospital lacked a dedicated
HDU for many years. Accordingly patients were admitted to
ITU with higher APACHE scores, and the hospital had an
outlying mortality rate. This data led to the construction of a
new 8 bedded HDU facility, opened at 50% capacity in May
2018.
 Six months after opening, and encouraged by a fall in
admission APACHE to ITU, we audited the degree of unmet
need throughout acute and elective care. We present this audit
so others can use our methodology to assist in their cases for
expansion of Critical Care (CC) capacity within their institutions.
OBJECTIVES.
 To identify: Adult patients who would benefit from admission
to Critical Care (HDU and ITU) but are not actually admitted,
where CC beds are occupied by patients who have recovered
but cannot leave due to a shortage of hospital beds
 To determine if additional HDU capacity would help mitigate
this problemMETHODS.
 14 day 24 hour data collection of CC bed state, record of all
referrals / escalations to CC, record of all theatre / recovery
patients potentially requiring CC
RESULTS.
 CC services were in high demand, ITU being at 100% capacity
for 43% time
 HDU capacity was the biggest cause of delayed discharge from
ITU
 25% of all HDU bed hours were filled with patients fit for step
down to the ward
 Elective surgery was cancelled more often than usual due to
CC capacity constraints
 Surgical patients were less likely to get a bed on CC than
medical patients, with patients being nursed in areas lacking
CC resources and training
CONCLUSION.
 Surgical patients are being cancelled or nursed in
innapropriate areas. Seperately, national data shows below
average admission of high risk emergency laparotomies to CC.
Thus both elective and emergency patients are experiencing
suboptimal care.
 Capacity pressures on wards block HDU discharges, in turn
blocking ITU
 This audit informed the business case for additional HDU
capacity, and our materials made it repeatable for the audit
cycle. We hope this model may be of use to others.
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INTRODUCTION. There are numerous studies describing the adverse
long-term physical, mental and cognitive outcomes among ICU survi-
vors. However, their pre-ICU health status is often not taken into
account.
OBJECTIVES. To assess patients’ physical, mental and cognitive
health status before and one year after ICU admission.
METHODS. Adult patients admitted for ≥12 hours to a university hos-
pital ICU between July 2016 and December 2017 were included
(MONITOR-IC study, clinicaltrials.gov NCT03246334). Moribund pa-
tients were excluded. Patients (or proxies) rated their health status
before and one year after ICU admission, by completing the Short
Form-36 Physical and Mental Component Summary (PCS and MCS)
(range 0-100; higher scores indicate better physical or mental func-
tion), Hospital Anxiety and Depression Scale (HADS) (range 0-21;
higher scores indicate more symptoms of anxiety and depression)
and abbreviated Cognitive Failure Questionnaire (CFQ-14) (range 0-
100; higher scores indicating more cognitive failure). Moreover, new
physical symptoms within the first year were noted.
RESULTS. A total of 1300 patients was included: mean age 61.5 (±
14.8 years), 65% male. Median ICU and hospital stay were 1 [IQR 1-2]
Page 154 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55and 9 days [IQR 6-15] respectively, with mainly elective surgery ad-
missions (65%).
One year after ICU admission, mean SF-36 PCS score was significantly
higher compared to baseline; 42.6(±11.4) to 45.2(±10.8); p <.001, with
a mean difference score of 2.60 (95%CI, 1.79 to 3.41), while 41% of
the patients experienced a physical decline. Reported new physical
symptoms within the first year were impaired physical function
(70%), joint stiffness, dizziness, muscle weakness and/or shortness of
breath (40%). Sexual problems were experienced by 25% of the ICU
survivors.
Mean SF-36 MCS score increased significantly from 48.5 (±11.3) to
50.0 (±10.3); p<.001, mean difference score 1.55 (95% CI, 0.75 to
2.35), while 46% of the patients experienced a mental decline. De-
pression scores decreased from median 4 [IQR 1-7] to median 3 [IQR
1-7]; p=.057, and anxiety scores decreased significantly from median
4 [IQR 2-7] to 3 [IQR 1-7]; p<.001.
Contrary to the improvements in physical and mental health, the
cognitive status decreased significantly from median 21 [IQR 11.3-
29.5]) to median 23.7 [IQR 13.6-33.2]); p<.001, and 60% of the pa-
tients reported a cognitive decline.
CONCLUSION. Although statistically significant, improvement in
physical and mental outcomes and decline in cognitive outcomes
were small after one year. Nevertheless, the vast majority of patients
experienced new physical problems, such as impaired physical func-
tion, muscle weakness and/or shortness of breath. Identifying pa-
tients who are at risk of these adverse long-term outcomes may lead
to better and tailored care for ICU patients and survivors.
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INTRODUCTION. Ageing of the world's population is influencing in
an increase in the number of elderly patients admitted to intensive
care units (ICU). However, invasive treatments tend to be avoided in
elderly patients. The identification of predictive mortality factors for
older old patients (older than 80 years) admitted to the ICU could as-
sist the medical team, patients and families in planning advanced
care and decision-making.
OBJECTIVES. Our main objective is to identify predictive factors for
hospital mortality in patients older than 80 admitted at an ICU in a
community hospital
METHODS. Retrospective Study in a cohort of consecutive patients
over 80 years admitted to the ICU during the year 2018. We collected
the demographic data, comorbidity, Barthel Index prior hospitalisa-
tion, reason for ICU admission, severity (SOFA, APACHE II, SAPS III),
therapy received in ICU, in-hospital mortality, and in the group of
survivors we also collected data on destiny at ICU discharge
RESULTS. A total of 71 patients older than 80 years were admitted
at the ICU, representing 15.56% of all ICU admissions. The average
age was 83.5 years (SD 2.3), 52.1% were women. In hospital mortality
was 24 patients (33.65%), being mortality at ICU of 16 patients(22.5
%), the 75% of them due to limitation of therapeutic effort.Patients
with in-hospital mortality had non-significant higher frequencies
of diabetes , chronic obstructive pulmonary disease, chronic renal
disease , cognitive impairment, previous oncological history, as well
as higher body mass index than survivors.Up to 70% of survivors
came from the emergency department as compared to 50% of non-
survivors. The most common reason of ICU admission in the non-surviving group was septic shock (50% vs10, 6%, P = 0,000), followed
by cardiogenic shock (20.8% vs 8.5%, P = 0.015). The Severity Indexes
at ICU admission (SAPS III, SOFA and APACHE II) were significantly
higher in the non-surviving group compared to survivors (P = 0.000).
The use of vasoactive drugs was significantly more frequent in non
survivors (95.8%vs 61.7%,P= 0.000), with a trend to higher need for
invasive/non-invasive mechanical ventilation and for renal replace-
ment purification therapy. For survivors, the Barthel index at dis-
charge remained above 85 (mild disability).
CONCLUSION. Older old patients represent up to 15.56% of ICU ad-
missions. The main predictive factor for in-hospital mortality is sever-
ity at ICU admission by SAPS III, APACHE II or SOFA,as well as the
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INTRODUCTION. Starting work as a junior doctor in critical care can
be intimidating and overwhelming1. Junior doctors starting a clinical
placement in intensive care medicine (ICM), can come from a variety
of specialties2, with differing levels of knowledge and practical skills.
We were unable to find any institution that offers specific training to
address these issues.
METHODS. We developed a standardised one-day course for novices,
timed before their first clinical shift, free of cost to them, and inte-
grated into their normal working hours. We constructed a
programme of lectures and practical workshops, covering core know-
ledge and themes in; mechanical ventilation, non-invasive ventila-
tion, cardiac output monitoring, inotropes and vasopressors, sedation
and delirium, renal replacement therapy and airway management -
“Intensive Care Essentials (I.C.E)”. Allowing comprehensive, protected
teaching, to new starters in intensive care, we aimed to improve key
knowledge and skills, and, allay anxiety amongst doctors new to ICM.
Candidates were asked to rank how strongly they agreed or dis-
agreed with pre-defined questions and statements along a numerical
scale (0 (strongly disagree) - 5 (strongly agree)), before the course
(n=26), and then after course completion(n=24). Data were com-
pared using independent t-tests.
RESULTS. Candidates indicated that they felt significantly more pre-
pared for their first shift in ICU after attending the course (mean pre-
course score 2.4 (SD=0.76) vs mean post-course score 3.74 (SD=
0.45), p=<0.0001). In addition, they felt their knowledge was more
sufficient to start on the critical care unit (mean pre-course 2.28 (SD=
0.68) vs mean-post course 3.7 (SD=0.56), p=<0.0001), and were more
confident in tackling problems encountered in each of the clinical
scenarios.
CONCLUSION. It is both feasible and beneficial, to deliver a targeted
teaching programme covering basic knowledge and practical skills,
required for safe practice in the critical care environment. Further-
more, we have demonstrated that this can be delivered within the
framework of the UK Junior Doctors Contract, as protected,
mandatory education, built into rostered working hours.
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Non-inavsive Ventilation 2.5 (0.95) 3.83 (0.89)
Mechanical Ventilation 1.92 (0.98) 3.57 (0.95)
Cardiac output monitoring 2.12 (0.77) 3.35 (0.78)
Inotropes 2.00 (0.96) 3.35 (0.78)
Sedation 2.27 (0.96) 3.78 (0.80)
Renal replacement therapy 1.69 (0.88) 2.95 (0.84)
Airway management 2.73 (0.92) 3.78 (0.67)
All p=<0.0001000438
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INTRODUCTION. Registration of quality indicators is crucial for ac-
countability and quality improvement. However, nurses and physi-
cians suffer from the amount of administrative tasks. Clerical burden
is a cause of physician burnout.
OBJECTIVES. To analyse the nature and consequences of registration
burden experienced by nurses and physicians working in the ICU.
METHODS. A mix-methods observational study in an academic hos-
pital in 2017, including a questionnaire survey (N=158), individual
semi-structured interviews (N=5), and participative observations (3
days).
RESULTS. On average, physicians and nurses spend 54.9 (SD±43.1)
minutes per day on quality registrations; nurses more than physi-
cians, median 45 (min-max 0-241) and median 29 (min-max 0-119)
respectively. They register 102 quality indicators and 1438 underlying
variables for several stakeholders, including government bodies
(Healthcare Inspectorate and National Health Care Institute), accredit-
ation institutes, professional societies and registries, and internal de-
mands from the board of directors. In total, 20% is registered for
accountability purposes, 25% for institutional governance, and 54%
for quality improvement. Almost half (48%) of the quality indicators
were requested by multiple stakeholders, but the timing and content
(operationalisation of definitions) of the demands were not aligned.
Of all 102 quality indicators, 34% was perceived as useful for quality
improvement in daily practice.
In the interviews, eight types of registration burden were identified,
such as excessive amount of quality registrations, low efficiency of
quality registrations to achieve quality improvements, feelings of dis-
trust by mandatory registrations, registrations are not relevant for cli-
nicians and nurses, and ICT-problems. The interviewees mentioned
that the amount of registrations and other types of registration bur-
den diverts time and focus from patient care and improving quality,
with, paradoxically, lower quality as a consequence.CONCLUSION. In sum, registration burden perceived by physicians and
nurses can be classified into four main categories: 1) time spend on
quality registrations; 2) amount of quality indicators; 3) usefulness for
quality improvement, and 4) inefficiencies in the registration process.
Registering less quality indicators, but more what matters (usefulness)
is paramount to increase the efficiency of quality registrations, and to
mitigate the registration burden and its consequences on nurses, physi-
cians and their patients.000440
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INTRODUCTION. UK Intensive care units (ICUs) have a high turnover
of junior staff across the multidisciplinary team (MDT)1. Our general
ICU has a regular intake of new staff who are inexperienced in critical
care and in this hospital’s specialties. They enter a high intensity,
high risk environment and need rapid access to supporting informa-
tion and resources2. Current information systems within our hospital
are not streamlined enough for effective point of care use.
OBJECTIVES. Our purpose was to improve access to educational re-
sources and support for junior staff across the MDT. The use of mo-
bile devices to support learning is recognised as a strong emerging
educational technology3. Quick Response (QR) codes offer a shortcut
to provision of information and we aimed to site them appropriately
on the ICU, seeking improvements in assessed confidence and know-
ledge among medical and nursing staff.
METHODS. We took a two-part approach, siting QR codes on posters
and on equipment. The posters took a question/answer format, each
QR code linking to the appropriate educational source (protocol, guide-
line etc). We assessed new groups of junior medical staff in their know-
ledge and confidence about each poster topic at the beginning of their
rotations and again after the introduction of the posters. Multiple
choice and multiple answer questions were used in the quiz and a
seven point Likert-type scale was used to assess confidence.
A QR code was sited on the ABG machine: this linked to an inde-
pendent website which tests understanding of blood gas results in a
quiz format. We assessed nursing staff confidence in blood gas inter-
pretation before and after introducing the code.
RESULTS. Both quiz performance and confidence improved among
junior doctors after the introduction of the educational posters.
Across eight quiz questions, the average number of respondents an-
swering correctly improved from 48% to 75%. Confidence among
the same respondents also improved across all topics assessed: there
was an average improvement of 1.6 points on the seven point Likert-
type scale.
The initial survey of nursing staff showed a wide range of confidence
in blood gas interpretation. The QR code on the ABG machine re-
ceived more than 60 hits in the study month and the post-
intervention survey showed an increase in confidence among nurs-
ing staff of an average 2.6 points on the Likert-type scale.
CONCLUSION. The ICU is challenging for new staff, who are faced
with a steep learning curve in a specialised and complex environ-
ment. Many aspects of ICU care are highly protocolised, and there-
fore well suited to independent learning if the appropriate resources
can be easily accessed. QR codes facilitate this learning using readily
available mobile technology. Introducing QR codes to make re-
sources immediately available at the point of care has shown im-
provements in both knowledge and confidence, for all tested topics,
among staff across the MDT.
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INTRODUCTION. Critical care is associated with significant consump-
tion of health resources, both in the intensive care unit (ICU) and
after ICU discharge. The number of critically ill patients is anticipated
to rise over the coming years, and healthcare systems will need to
adjust to meet increasing demands.
OBJECTIVES. The aim of this study was to assess the impact of crit-
ical illness on patients and the healthcare system during the three
years following ICU discharge, including determination of long-term
mortality, analysis of patients’ healthcare utilization, and assessments
of HR-QOL (Health-Related Quality of Life) at six months and three
years after ICU discharge.
METHODS. The study was a mixed retrospective/prospective ob-
servational study conducted at the Centro Hospitalar Universitário
do Algarve, a tertiary-level university hospital and regional trauma
and neurosurgical centre in Faro, Portugal. All patients admitted
during the year of 2015 were eligible (n = 415). Patients were
subdivided by prior health status (healthy, chronic non-disabling
disease, chronic disabling disease). HR-QOL was assessed using
the Euro Quality of Life – Five Dimensions (EQ-5D) questionnaire.
Six month EQ-5D results were extracted retrospectively from 2015
follow-up records while three-year EQ-5D telephone assessments
were performed prospectively by the same investigators. Patients’
trajectories during ICU stay and after ICU discharge were evalu-
ated through hospital and national records and summarized in
schematic form.
RESULTS. Our results reveal that out of 271 patients who sur-
vived to hospital discharge, nearly 20% were discharged to
post-acute facilities and 10,7% remained institutionalized at
three years (Figure 1). Patients admitted to the ICU with septic
shock, emergent neurosurgery and neurologic emergencies
were more likely to remain institutionalized. Hospital readmis-
sions during the three years following the critical event were
frequent (46,5% of patients) as were emergency department
visits (73,4% of patients). At 3 years, cumulative survival was
60% for patients with a “healthy” premorbid status and <20%
for patients with pre-ICU chronic disabling illness. Results of the
EQ-5D questionnaire applied three-years after hospital discharge
revealed a deterioration in HR-QOL relative to the evaluation
completed at six months.
CONCLUSION. Survivors of critical illness show persistently high
healthcare resource utilization during the 3 years after hospital
discharge along with a deterioration in HR-QOL at 3 years rela-
tive to 6 months post-discharge. Further research in this field is
required to better support healthcare systems, improve care for
ICU survivors, and contribute to gains in HR-QOL.REFERENCE(S)
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INTRODUCTION. Over a third of critical illness survivors manifest sig-
nificant psychological impairments following discharge from the in-
tensive care unit (ICU). Memories of frightening delusional
experiences and in-ICU psychological distress are the strongest po-
tentially modifiable risk factors. Our prior surveys and interviews of
physicians, nurses, patients and their families revealed that inad-
equate communication was universally viewed as the key aspect con-
tributing to patient distress and fear. The Get to Know Me Board is
one of the tools adapted from palliative medicine that can be used
to overcome anonymity of the critically ill patient.
OBJECTIVES. Given known challenges in communication with critic-
ally ill patients and their families, we explored providers' knowledge
of the ‘Get to Know Me board’ as a tool to help facilitate such
communication.
METHODS. We administered a web-based survey consisting of mul-
tiple choice and open ended questions to critical care physicians and
nurses in medical and surgical ICUs at the Mayo Clinic.
RESULTS. 170 clinicians responded to the survey (23% response rate);
of those 118 were nurses (69%) and 52 physicians (30%). All used
the Get to Know Me board, although a third were not aware of
where the blank forms were located. 152 (89%) found the board
helpful in communication, such as in seeing the human side of the
patient, being able to apply things patient may like in their interac-
tions, and creating bridges with families. Most common information
clinicians found helpful was the knowledge of patient’s favorite
movie, sport or food, hobbies, and achievements as well as their
stressors and de- stressors. Ninety four (55.4%) respondents
expressed no difficulty in incorporating the board as a part of routine
clinical care, whereas the rest reported some level of difficulty. When
asked about barriers to incorporating the board in clinical practice,
the most common response was getting too busy with clinical duties
(85 or 50.6%) followed by ‘whether it gets filled out depends on who
is on staff’ (73 or 43%); 40 (23.8%) encountered no barriers. Most
Page 157 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55participants 102 (61%) expressed that the best time to fill out the
board was anytime during the stay, particularly when the family ar-
rives or upon admission. About 7% of providers cautioned that pa-
tients should be stabilized first. See Figure 1 for an example of the
filled out Get to Know Me board.
CONCLUSION. The Get to Know Me board is not a consistently uti-
lized instrument in our critical care unit environment. However, when
applied, it can be helpful to providers to get to know their patient as
a person and not a disease, develop therapeutic relationship with
them and their families, thereby improving communication and po-
tentially outcomes. Further studies will be needed to measure effects
on patient specific outcomes and ICU experiences of patients as well
as providers.
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INTRODUCTION. An increasing number of patients are surviving the
acute critical illness, however prolonged critical care treatment may
be necessary. A prolonged ICU-stay from weeks to months is associ-
ated with increased mortality of up to 50%. Data on outcome and
functional status of patients with an ICU-stay ≥90 days are scarce.
The aim of this study was to investigate mortality and functional out-
come of patients with a very prolonged ICU stay.
METHODS. Single-center retrospective study at the University Med-
ical Center Hamburg-Eppendorf, Germany including all critically ill
adult patients with an ICU stay ≥90 days treated at our institution be-
tween January 1st 2008 and December 31st 2016.
RESULTS. 65,249 patients were treated during the study period, of
these we identified 96 (0.1%) patients with a very prolonged ICU
stay. Median age was 61 (49.8 – 67) years, 30 (31%) patients werefemale. Reason of ICU admission were abdominal/gastroenterological
(28%, n=27), followed by sepsis (23%, n=22) and transplantation
(15%, n=14). All patients needed mechanical ventilation (MV), with a
median duration of 74.1 (55 – 95.1) days. 63 (66%) patients survived
the ICU-stay, of these 95% (n=60) had unfavourable overall outcome
(Overall performance category III/IV) at ICU discharge. One-year sur-
vival rate was 28% (n=27), 44% (n=12) had overall performance cat-
egory III/IV. Severity of illness (SOFA, SAPS II) on admission were
comparable in ICU-survivors and non-survivors. Length of MV, use of
renal replacement therapy (both p < 0.01) and maximum lactate (5.3
vs 11.5 mmol/l; p < 0.001) were significantly higher in ICU non-
survivors. ICU-stay was significantly longer in ICU non-survivors (137
vs 107 days; p < 0.05)
CONCLUSION. Only a small proportion of critically ill patients re-
quires ICU-therapy ≥90 days. Although two-third of these patients
survive the ICU stay, almost all of these patients have an unfavour-
able overall outcome.
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INTRODUCTION. Patient safety events (PSEs) are commonly reported
in the ICU setting, despite the advent of information technology with
the proliferation of corresponding online processes to be connected
to the real-world patient care tasks. Increasing work burden, complex
care environment, and high variety of the patients' condition might
render the probability of discordance between the corresponding
online and real-world processes, threatening safety.
METHODS. We retrieve the case records of PSEs from the institu-
tional incident reporting system of the intranet at an academic med-
ical center in Taiwan. Cases related to the care of ICU patients were
selected, and the investigators reviewed the reporting contents in-
cluding the descriptions on the occurrence of PSE, provisional causes
for the occurrences, and recommendations and suggestions on
the improvement of the processes and further prevention of event
occurrence. Online processes related to discordance with the real-
world patient are were identified and classified by investigators, who
also provided the possible causes related to discordance.
RESULTS. From 2011 to 2018, a total of 20,032 PSEs were reported to
the institutional incident reporting system. Of these reports, 2,300 were
related to the patient care of the ICU setting, resulting in patient harm
of varying severity in 723 (31.4%) cases. We identified 832 cases to have
corresponding online processes; 559 (67.2%) of them had at least one
online process harboring discordance with the real-world patient care
tasks, including 412 (74%) errors of the real-world tasks, 80 (14%)
wrong timing in performing tasks, including delays and too early
provision of care, and 67 (12%) omissions of tasks. The most common
related patients care process for the discordance included medication
administration (n=312, 56%), transfusion (n=92, 16%), laboratory tests
(n=53, 9%), care of tubes (n=33, 6%), and transportation (n=21, 4%).
For cases with discordance, errors were found in 90% of events of
medication administration, 48% of transfusion events, and 70% of the
laboratory test events. Analysis showed that for all 2,300 reports ICU
cases, those with a corresponding online process had fewer patient
harm than those without a corresponding online process (14.5% vs.
41.0%, p<0.001). However, for the 832 reported ICU cases with corre-
sponding online processes, the cases with discordance with real-world
tasks had significantly more patient harm than those without discord-
ance (21.1% vs. 2.6%, p<0.001).
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cesses for real-world patient care tasks might generally enhance effi-
ciency and safety in the healthcare setting, the discordance of the
online process and real-world patient care is an important source of
patient harm due to the occurrence of patient safety events at the
ICUs. Timely cross-validation between the online and offline process
during patient care should be strongly considered in future design-
ing and modification of the implementation of information technol-
ogy in the intensive care setting.
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INTRODUCTION. The idea of shared decision making(SDM) was first
proposed in 1972, with gradually increasing its importance as the
upsurging interest in patient centredness and autonomy in health
care interactions since the 1970s. Tracheostomy creation has long
been poorly accepted, though with superiorly odds to pros, owing to
cultural mis-understanding.
OBJECTIVES. Retrospective cohort study from single tertiary medical
center adult ICU revealed introducing shared decision making on
early Tracehostomy in prolonged intubated critical patient might im-
prove total Tracheostomy rate, reduce ventilator days and length of
hospital stay, and shorten the Tracheostomy decision time delay.
METHODS. Medical record of tertiary medical center adult ICU admit-
ted respiratory failure patient from Jan. 1st, 2016 to Dec. 31th, 2017
was retrospectively reviewed, and further subdivided into pre-SDM and
post-SDM(after Jan. 1st , 2017) intervention period for analysis. Pro-
longed intubation was defined as using mechanical ventilation support
more than 14 days and sub-acute respiratory care center transferral
needed. Early and late Tracheostomy were defined as created within 14
days and beyond the 14th day since being intubated and ventilated in-
dividually. Patient who was successful weaning, chronic ventilator
dependent before admission, post Tracheostomy creation surgery, or
expired was excluded. Data including total Tracheostomy rate, early
and late Tracheostomy rate, ventilator weaning rate and ventilator days,
in-hospital mortality, and length of hospital stay were collected. SPSS
was applied for statistically analysis, and a p value less than 0.05 was
considered significant difference.
RESULTS. Medical records from total 1253 patient from Jan. 1st ,
2016 to Dec. 31th , 2017 were reviewed, and total 7137 patient venti-
lator days were recorded. Among the total 1253 patients, the pre-
SDM(2016) total Tracheostomy rate was found 8.8%, in compared to
post-SDM(2017) total Tracheostomy rate 9.6%, and 9.1% improve-
ment impressed. By inclusion and exclusion, 128 patients from year
2016 and 112 patients from year 2017 were considered prolonged
intubated left for further analysis. Pre-SDM early and late Tracheos-
tomy rate were 42% and 58% individually, with ventilator weaning
rate(43(79.6%) v.s 46(62.2%), p: 0.034), ventilator days(35.3+/-18.1 v.s
47.2+/-16.1, p< 0.001), in-hospital mortality(1(1.9%) v.s 6(8.1%), p:
0.237), and length of hospital stay(59.7+/-35.1 v.s 69.2+/-24.6, p:
0.091) of prolonged intubated patient. Post-SDM early and late Trace-
hostomy rate were 39% and 73% individually, with ventilator wean-
ing rate(27(69.2%) v.s 56(76.7%), p: 0.389), ventilator days(34.6+/-17.6
v.s 47.5+/- 28.4, p: 0.004), in-hospital mortality(4(10.3%) v.s 6(8.2%), p:
0.737), and length of hospital stay(57.2+/-21.8 v.s 68.4+/-26.8, p:
0.028) of prolonged intubated patient. After SDM was introduced,
ventilator days and length of hospital stay of prolonged intubated
patient was found reduced 13 days and 11 days individually in com-
pared in between early and late groups. The Tracheostomy decision
making time delay was found 5 days less after SDM introduced.
CONCLUSION. Our retrospective cohort study from a single tertiary
medical center adult ICU revealed introducing shared decision makingon early Tracheostomy in prolonged intubated critical patient might
improve total Tracheostomy rate, reduce ventilator days and length of
hospital stay, and shorten the Tracheostomy decision time delay.
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INTRODUCTION. The improvement in the treatment of critical patholo-
gies has increased the survival of patients admitted to intensive care
units. Secondarily, some of these patients present psychic and emo-
tional physical alterations encompassed in Post Uci syndrome (PICS)
OBJECTIVES. To know the quality of life of patients who survive an ICU
admission nine months after discharge through the SF-36 survey to es-
tablish the incidence of the post-ICU syndrome in our intensive care
unit.Relate these values with the pre-existing clinical situation to obtain
risk factors associated with this syndrome.To assess if there are intra-ICU
interventions that favour the appearance of the Post-ICU Syndrome.
METHODS. Prospective and longitudinal observational study of a co-
hort of patients during the months of March and April 2018 in a
polyvalent ICU.We recorded demographic data (sex, age, weight), co-
morbidity (Barthel, Charlson), psychopathology (psychiatric history,
psychotropic, treatment and toxic habits), as well as the reason for
admission to our unit and associated severity (APACHE II and SAPS
II).The days of admission to the ICU, death in ICU or hospital, the
need for mechanical ventilation and complications (pneumonia asso-
ciated with mechanical ventilation, cognitive impairment and pain at
discharge) were documented.We recorded interventions performed
intra-ICU such as treatment with benzodiazepines and its maximum
dose, corticosteroids, muscle relaxants or anxiolytics by nasogastric
tube.In a second phase, 9 months after discharge, patients who
could be contacted by telephone were evaluated,discarding the de-
ceased patients and those residing abroad, and SF-36 survey was
conducted for the evaluation of the quality of life (by pone)
RESULTS. Out of a total of 50 patients, the survey could be per-
formed on 29, of which 24 answered it. The overall results of the SF-
36 survey showed that 95% of our patients obtained values between
56.10 and 75.40, so our patients nine months after discharge had a
positive state of health. No intra-ICU intervention was associated with
a worse SF-36 score. The only item prior to admission that is related
in a statistically significant way to a worse score of SF 36 is previous
psychiatric treatment.
CONCLUSION. The post-ICU syndrome is a low-frequency entity in
our unit.
Although the sample from our study is small, we cannot demonstrate
that any intra-ICU factor influences the presence of a post-ICU syndrome.
The only factor that is related in a statistically significant way to the pres-
ence of the post-ICU syndrome, is previous psychiatric treatment000018
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Page 159 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. Pulmonary embolism (PE) may lead to the release
of brain natriuretic peptide (BNP) due to right ventricular (RV) pres-
sure overload, or troponin (Tn) due to transmural RV infarction with
patent coronary arteries. Although cardiac biomarkers (CB) have been
associated with worse prognosis, correlation with imaging tech-
niques might not be strong.
OBJECTIVES. To describe the relationship between angio-CT, trans-
thoracic echocardiography (TTE) and CB in the assessment of RV
function and acute pulmonary hypertension (aPH) in patients with PE
admitted to the Intensive Care Unit (ICU).
METHODS. We conducted a retrospective observational study in the
ICU of a single university hospital. All the patients who were admit-
ted to the ICU with PE as a primary diagnosis were included, over an
8-year period. Angio-CT, TTE and admission CB were recorded. Mann-
Whitney U test was applied, as CB were not normally distributed.
RESULTS. A total of 82 patients were included, 43% male, aged 64
(44-77), APACHE-II 12 (8-17), 42% fibrinolytic therapy, 15% hospital
mortality. Angio-CT, TTE and CB were performed in 92%, 84% and
100% of the patients, respectively. Thrombus was located in main
pulmonary arteries (74%) or lobar/distal arteries (26%). TTE detected
52% RV systolic dysfunction and 59% tricuspid regurgitation, with an
estimated pulmonary artery systolic pressure (PASP) of 53±15 mmHg.
48.4% of patients with thrombus in main or lobar arteries developed
aPH, whereas no patient developed aPH with more distal thrombus
(OR 14, 95%CI 0.8-257.1, p=0.07). TTE findings and their relationship
with CB, expressed as P50 (P25-P75), are summarized in the Tables.
A cut-off point of troponin I ≥1 ng/mL showed 89% specificity, 18%
sensitivity (53% NPV and 37% PPV) for the diagnosis of right ven-
tricular disfunction.
CONCLUSION. Patients with PE in main or lobar arteries on angio-CT
were more likely to develop aPH. In our series, CB did not correlate
with RV function or aPH, although patients with highly abnormal
levels of troponin were more likely to develop RV dysfunction. Per-
formance of a TTE may be necessary to diagnose RV dysfunction or
aPH in the setting of acute PE.
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assessed by TTE and cardiac biomarkers
TAPSE ≥17 mm TAPSE <17 mm p
Tn I (ng/mL), n=55 0.51 (0.09-0.77) 0.56 (0.15-1.6) 0.27
High-sensitivity Tn I (ng/L), n=9 12 (5-20) 86 (20-150) 0.24
BNP (pg/mL), n=30 198 (124-810) 112 (45-636) 0.37
Table 2 (abstract 000018). Relationship between PASP assessed by TTE
and cardiac biomarkers
PASP <30 mmHg PASP ≥30 mmHg p
Tn I (ng/mL), n=55 0.15 (0.02-0.3) 0.16 (0.04-0.71) 0.42
High-sensitivity Tn I (ng/L), n=9 86 (20-150) 12 (3-20) 0.14
BNP (pg/mL), n=30 150 (70-703) 320 (90-504) 0.93HSRO - Preventing adverse events
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INTRODUCTION. The readmission rate in the intensive care unit (ICU)
is associated with an increased mortality risk and is identified as a
quality indicator. Several predictors of readmission are described in
the literature, such as age, gender, severity of disease, type of admis-
sion, comorbidities and length of stay in ICU. However, these factors
are not modifiable. Therefore, an appropriate analysis of potentially
modifiable factors that may influence the readmission of these pa-
tients is lacking.
OBJECTIVES. This study aims to determine the rate of readmission,
analyze the population of patients readmitted, and evaluate the de-
terminants of the readmission rate.
METHODS. Retrospective and observational study conducted at Cen-
tro Hospitalar e Universitário do Porto, from January, 2016 to Decem-
ber, 2018.
All patients discharged alive from their first ICU admission were in-
cluded. The exclusion criteria were age bellow 18 years, not at risk of
readmission in the same hospital, due to transference to another
center and patients with limitation of care after ICU discharge. Re-
admission to the ICU was defined as any return of a patient to the
ICU after ICU discharge during the same hospitalization. A multivari-
ate logistic regression analysis for determinants of readmission at
any time during the same hospital episode was performed.
RESULTS. A total of 750 patients were included, of which 54 were re-
admitted during the same hospital episode (7.2%).
When conducting the univariate analysis, the factors independently
associated with readmission were admission from emergency service
and operating room; admission due to urgent surgery or medical
problem without infection; confirmed infection at admission; lower
Glasgow Coma Scale (GCS) at admission; acute kidney injury (AKI)
during ICU stay; fever, lower GCS and delirium at ICU discharge; and
higher Stability and Workload Index for Transfer (SWIFT) Score. In a
multivariate model the retained variables were SWIFT score, AKI dur-
ing ICU stay, lowest GCS at admission, confirmed infection at admis-
sion and operating room source of admission. The overall model
with readmission at any time during the same hospital episode had
a moderate performance with the Area Under an ROC Curve (AUC)
of 0.75, 95% CI, 0.686–0.824; p < 0.001.
CONCLUSION. Several factors can be related to readmission in ICU. In
our study, the variables associated with readmission were SWIFT
score, AKI during ICU stay, lowest GCS at admission, confirmed infec-
tion at admission and operating room source of admission. These
variables are patient related and non-modifiable, showing that in our
population this indicator is not very useful in quality of care and is
not probably potentially modifiable.
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INTRODUCTION. The Intensive Care Unit (ICU) occupies 7% of the
hospital beds, representing 20-30% of the hospital cost, equivalent
to 62 billion dollars per year in the United States (REF). Studies have
demonstrated a relationship between discharge criteria, length of
stay and patient outcome (refs), so it is in the interest of physicians
and managers to study the topic to avoid excessive patient time in
the ICU and the scheduling of expenditures for rehospitalization,
both related to increased mortality.
OBJECTIVES. To evaluate the early rehospitalization rate and the
main associated characteristics in Neurological ICU in the period of 4
years, from 2014 to 2018.
METHODS. A review of all early rehospitalizations (<48 hours) was
carried out in the period from 2014 to 2018 through a database of
the hospital management system and evaluated compliance with the
discharge criteria according to the ICU discharge protocol and its cor-
relation with readmission.
RESULTS. In the analyzed period, 9,319 patients were admitted to
the unit with 25 readmissions (0.32%), 7 in 2014, 7 in 2015, 4 in 2016
and 2 in 2017 and 5 in 2018. Of the 25 patients, only 1 (4%) did not
present criteria according to ICU discharge protocol. Patients who
were readmitted had increased length of stay when compared to the
unit profile (8.4 days x 5.6 days), and there was no correlation with
increased mortality in the analyzed sample. Average age: 64.78 years
Occupancy Rate: 88.14% SAPS 3: 43.41 SOFA: 2.28. Surgical: 39.57%
CONCLUSION. Despite the high complexity, there is a low rate of
early rehospitalization in the unit, which evidences a safe process of
high and quality care.
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INTRODUCTION. Several studies have evaluated the impact of so-
dium disturbances on outcomes in critically ill so far but although
chloride (Cl−) abnormalities are also very common, the number of
studies reporting the relevance of dyschloremia and its association
with intensive care (ICU) outcomes, are still limited. We aimed to in-
vestigate the prevalence of dyschloremia at the time of ICU admis-
sion and its relation with severity of illness and outcome implications
of dyschloremia in critical care settings.OBJECTIVES. The primary objective of our study was to evaluate the
incidence of dyschloremia in critically ill and its relationship with ICU
mortality and length of ICU stay, while the association between dys-
chloremia and severity of illness and organ failure were the second-
ary objectives.
METHODS. Non-surgical, adult patients who required ICU for more
than 48 hours were included in our retrospective study, con-
ducted in three ICUs, between 2015-2018. Demographic data,
Acute Physiology and Chronic Health Evaluation (APACHE)II and
Sequential Organ Failure Assessment (SOFA) scores, admission Cl
− levels and blood gas analyses were abstracted from clinical in-
formation systems (MetaVision, iMDsoft and Consult, Orion
Health) within first 24 hours of ICU admission. Patients were clas-
sified into three groups (Clnormo=97-108 mmol/L, Clhypo<97
mmol/L and Clhyper>108 mmol/L) accordingly their worst Cl−
values measured within 24 hours. One-way ANOVA, Chi-square,
Kruskal Wallis tests were used to analyze data while the associ-
ation between ICU mortality and chloride levels was examined
using multivariate logistic regression. (p<0.005 was considered to
be statistically significant)
RESULTS. Of 3985 patients, 909(22.8%) were hyperchloremic and
475(11.9%) were hypochloremic. Clhyper had higher ICU mortal-
ity (p<0.001; p=0.008, respectively) and longer length of ICU
stay (p=0.001; p<0.001, respectively) when compared to
Clnormo and Clhypo. APACHE II scores were higher in Clhypo
when compared to Clnormo and Clhyper. (p<0.001; p<0.001, re-
spectively), on the other hand SOFA scores were higher in Clhy-
per when compared to Clnormo and Clhypo (p<0.001; p<0.001,
respectively). (Table 1) We also evaluated baseline sodium levels
in these patients and found an statistically significant associ-
ation between dysnatremia and higher ICU mortality rates; while
length of ICU stay was not associated with sodium disturbances.
(Table 2) Multivariate analysis showed that dyschloremia and
dysnatremia was independently associated with increased ICU
mortality and longer length of ICU stay (OR 0.99, 95% CI 0.98-1;
p=0.02, OR 1.01, 95% Cl 1-1.02; p=0.03, respectively) as well as
APACHE II (OR 0.97, 95% Cl 0.96-0.98; p<0.001) and SOFA scores
(OR 0.88, 95% Cl 0.86-0.9; p<0.001).
CONCLUSION. Chloride disturbances are associated with severity of
illness, organ failure and poor patient outcomes in critically ill. This
study suggests that the both sides of the moon is the real picture to
be seen by underlining the clinical importance of chloride.
Table 2 (abstract 001501). characteristics and outcomes of
dysnatremic patients
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INTRODUCTION. Mechanical ventilation can induce lung injury,
phenomenon known as VILI. An important mechanism of the VILI is
the excessive global strain. Even more, regional strain is spatially cor-
related with regional inflammation. Information on regional strain
could help to develop protective ventilatory strategies. The standard
for this evaluation is computed tomography (CT), which does not
allow continuous assessmentand exposes to radiation. Electrical im-
pedance tomography (EIT) is able to monitor changes in regional
lung ventilation and it could become a surrogate for CT-measured
strain
OBJECTIVES. To compare the global and regional strain measured by
CT with the change in electrical impedance (ΔZ) adjusted by an-
thropometric measurements in pigs and ARDS patients
METHODS. The study was approved by Ethics Committee. Three pigs,
mechanically ventilated using VT of 250 and 500 mL, underwent
whole-lung CT at end-inspiration and end-expiration with PEEP 10
and 20 cmH2O, before and after lung injury induction. Eleven ARDS
patients also underwent whole-lung CT during at end-expiration and
end-inspiration with PEEP 5 and best PEEP according EIT. A biomech-
anical analysis was employed to construct 3D maps of the volumetric
strain. CT and EIT examinations were performed simultaneously.
Strain maps were divided into 4 regions of interest “ROI” (Upper and
Lower, Right and Left), coinciding spatially with the regions upon
which inflation was calculated for EIT. Due to repeated measures in
pigs an humans, linear mixed effect models were performed to pre-
dict lung strain and aeration measured by CT from ΔZ obtained by
EIT, adjusting for known confounders. For all models, individual pigs
or humans were considered as random effects, and PEEP as repeated
measures. Diagnostic performance of EIT-based predictions of lung
strain was evaluated by the Lin’s concordance coefficient (LCC) and
Bland-Altman GraphRESULTS. In pigs, linear association for global strain was acurate (R =
0.974, p-valor<0,001), and large positive relations were found at dif-
ferent regions of interest. In humans, linear association at global, as
well as in many lung ROI were high and positive with R > 0.932.
Agreement of lung strain measured by CT and predicted by EIT-
based models were excellent in overall terms in humans (LCC >0.95).
CONCLUSION. The change in electrical impedance provides a nonin-
vasive assessment of global and regional strain, without radiation at
bedside.
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INTRODUCTION. Unnecessary laboratory test ordering in the Inten-
sive Care Unit can be a prominent source of patient discomfort, mor-
bidity, increased workload and wasteful spending.
Providing blood tests order data to physicians has been considered a
promising strategy to reduce unnecessary procedures in the inten-
sive care unit but its impact on patterns of care remains unclear.
OBJECTIVES. The purpose of this study is to determine whether pro-
viding complete and personalized laboratory tests data could change
clinicians practice behaviors.
METHODS. We conducted a preliminary study in a 16-bed polyvalent
intensive care unit from April 2017 to April 2019 with a pre-
intervention and post-intervention design.
1. Pre-intervention: during a baseline period (April 2017 through
January 2018) a randomized non-consecutive 8 day follow up
of the blood tests prescribed was carried out.
2. Intervention (January 2019): the intervention consisted of
sending by e-mail to all the Intensive Care physicians relevant
information about the prescription of blood tests performed
in the last year which included:
– Number and type of tests ordered by each physician
– List of laboratory test costs per physician, from highest to
lowest.
3. Post-intervention: after the intervention (February through
April 2019) a randomized non-consecutive 9 day follow up of
the blood tests prescribed was carried out.
Descriptive statistics include frequencies and percentages for cat-
egorical variables. Chi- squared test were used to compare variables
during pre-intervention and post-intervention periods.
RESULTS. Six attending physicians provided input for a total of 229
patient-days. Results are shown in this table:
CONCLUSION. There is a global decrease in ordering and prescribing
behavior after laboratory information was provided to the Intensive
Care physicians.
This intervention may reduce the number of unnecessary blood tests
specially in the most critical patients.
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Total number of patients-day 114 117
Critical patients (%) 41 (36%) 35 (30%)
Semi-critical patients (%) 73 (64%) 82 (70%)
Total number of unnecessary
blood test (%)
17 (15%) 10 (8,5%) P = 0,13
Critical patients (%) 10 (59%) 2 (20%) P = 0,02*
Semi-critical patients (%) 7 (41%) 8 (80%) P = 0,9001543
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INTRODUCTION. Intra-hospital transport is related to a high inci-
dence of adverse events and negative outcomes. The objective of
this work is to describe the incidence of clinical and non-clinical
events during in-hospital transport of critical patients and to analyze
the associated risk factors
OBJECTIVES. To describe the incidence of clinical and non-clinical
events during in-hospital transport of critical patients and analyze
the associated the risk factors.
METHODS. A cohort study with retrospective collection, from Octo-
ber 2016 to October 2017, which analyzed all intrahospital transports
for diagnostic and therapeutic purposes in a large hospital, and eval-
uated the adverse events and related risk factors.
RESULTS. : In the period, 1559 intrahospital transports were per-
formed in 1348 patients, with a mean age of 66 ± 17 years, with
mean transport time of 43 ± 34 minutes. 19.8% of patients were
on vasoactive drugs; 13.7% in sedatives and 10.6% in mechanical
ventilation. Clinical events occurred in 117 transports (7.5%) and
non-clinical in 125 transports (8.0%). Communication failures were
prevalent, however, by applying multivariate analysis, the use of
sedatives, noradrenaline, nitroprusside and time of transport were
associated with clinical adverse events. Use of dobutamine and
transport time have been associated with non-clinical events. At
the end of transport, 98.1% of the patients presented clinical
conditions unchanged in relation to their baseline state
CONCLUSION. Intrahospital transport is related to a high incidence
of adverse events, and the time of transport and use of sedatives
and vasoactive drugs have been related to these events.001563
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INTRODUCTION. Ultrasound (US) is increasingly recognized as an essential
tool in the ICU setting. The safety and utility of bedside ultrasonography by
an appropriately trained ICU physician has now been well demonstrated.¹
Despite the worldwide routine use of ultrasound in ICUs, a large number of
ICU physicians remain unacquainted with US techniques. Following the
2011 international expert statement, the training of every ICU physician
should incorporate basic level of critical care ultrasonography (CCUS).² We
decided to investigate how the evolving CCUS paradigm of ICU physician
skills and competencies is applied in our country.
OBJECTIVES. To summarize knowledge on the current use of CCUS and at-
titudes towards its utilization in the ICUs of a university teaching hospital.
METHODS. Our study focused on the ICU physicians (n=55) of the
university teaching hospital. Data collection was performed with the
help of an electronic survey.
RESULTS. The response rate of the survey was high (90%). 66% of the re-
spondents were young specialists. The majority (61.7%) had no previous ex-
perience in CCUS and only 36.2% were aware of the locally organized
training programs. The most useful CCUS modalities reported were pleural/
lung US, vascular US for access, FAST, nerve block and vascular US-DVT. All
of the respondents recognized the existence of barriers to CCUS training,
citing lack of training, curriculum and financial costs as the most significant
ones. Although CCUS remains the prerogative of the on-call radiologists, it
was not perceived as a training barrier.
CONCLUSION. While Ukraine is lacking a formal CCUS training program,
there is an unmet demand for it in the ICU. Our survey has demonstrated a
prevailing lack of US skills among the young ICU physicians. At the same
time there was a general consensus on the list of core US modalities that
should be incorporated in such training as well as on the barriers that pre-
vent ICU physicians from mastering them. The young demographics of the
study has also highlighted the potential for international training programs
and initiatives. Due to the limited number of respondents in our survey, fur-
ther study across hospitals is required to fill in the knowledge gap on the
country-specific state of CCUS training. In future perspective, we hope to
impact awareness of the ICU physicians and stimulate the activity of the lo-
cally organized training programs. In a broader sense, we expect this study
to start a cross-country conversation on the challenges of CCUS standards
implementation and the possible ways forward.
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Fig. 2 (abstract 001569). Simulator sickness
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in treating several psychiatric disorders like combat-related posttrau-
matic stress disorder (PTSD). In recent years, follow-up studies
demonstrated that ICU survivors suffer frequently from loss of quality
of life due to long term psychiatric morbidity, especially symptoms
of PTSD. An effective strategy is currently lacking to prevent and
treat psychiatricsequelae in intensive care (ICU) survivors despite it is
known that post-ICU patients are motivated to undergo VRET in the
aftermath of critical illness (1). To date, the safety and feasibility of
ICU specific-VRET is unknown.
OBJECTIVES. To evaluate the feasibility, safety, and suitability of a
newly developed ICU-specific VRET module compared to 2D expos-
ure in healthy adults.
METHODS. Forty-fivehealthy adults were randomly assigned into
three groups to receive a newly designed ICU-specific exposure ther-
apy module on different platforms; a 2D flatscreen (n=15; 2D group),
VR-goggles (n=15; VR group) and a crossover group that first
watched the video on a 2D flatscreen followed by the VR-goggles
(n=15; crossover group). Safety was assessed using the cyber sick-
ness questionnaire (SSQ) and by monitoring vital signs (mean arterial
pressure, heart rate, respiratory rate and saturation). Feasibility and
suitability were assessed through the feeling of presence (immersion)
with the Igroup Presence Questionnaire (IPQ).
RESULTS. Mean age was 57.7 years (SD 7.1) and 30 out of 45
adults were woman (66.7%). Adults experienced a higher sense
of presence using VR (IPQ; VR to 2D group, mean difference
[SE], 0.967 [0.345], p=0.01; crossover group, mean difference
[SE], 2,787 [0.183], p < 0.001 ) (figure 1).There was no difference
in total cyber sickness, nausea or oculomotor score in adults in
the crossover group. Comparing the VR group with the 2D
group, adults in the VR group showed higher total cyber sick-
ness (mean difference [SE], 2.067 [0.599], p<0.01) and nausea
score (mean difference [SE], 0.667 [0.319], p<0.05) (figure 2). All
participants scored their cyber sickness as clinically irrelevant
and no session was stopped early because of side effects. No
differences were found in vital signs during the intervention
and between groups.
CONCLUSION. We demonstrated that ICU-specific VR exposure is
more immersive compared to 2D. This increased feeling of presence
(immersion), suggests that VR may be a suitable medium to treat the
psychological sequelae of an ICU stay, such as PTSD. Although VR
demonstrated to befeasible, safe and well tolerable, one must be
aware of the well-known side-effect: cybersickness.REFERENCE
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INTRODUCTION. Integrated health services are embedded in a
process that provides a continuum of care and have been advocated
by the World Health Organisation (WHO) as the vehicle to improve
health outcomes worldwide (Regional Office for Europe of the WHO,
2016). The health loss to injuries, conditions and risk factors are
quantified using an index called the global burden of disease (GBD).
The three leading causes of GBD in the 1990-2016 period have been
ischaemic heart disease, cerebrovascular disease, and lower respira-
tory infections (GBD 2016 DALYs and HALE Collaborators, 2017), all
conditions that often need intensive care. The GBD and sequelae in
Intensive Care Unit (ICU) survivors depends on the number of critic-
ally ill patients, the resources available to treat them and the morbid-
ity protracted after discharge (Stevens et al., 2014). It is hypothesised
that low resources limit the possibility of admitting patients to inten-
sive care units and the services offered after ICU discharge.
OBJECTIVES.
 To identify how critically ill patients are triaged in Low-Middle-
Income Country (LMIC) compared to High-Income Country
(HIC) to determine whether triage practice is linked to resource
settings;
 To evaluate which post discharge services are available to
critically ill patients in LMIC compared to HIC to detect if there
is a difference in service provision;
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and identify potential opportunities for quality improvement
initiatives driven by cross-country learning.
METHODS. 14 intensive care doctors from Europe, Africa, America
and Asia participated in a online survey and five of them in in-depth
interviews. The survey included three sections in order to collect data
on the services’ context, the triage and the post ICU practice. The in-
terviews were conducted to explore barriers and facilitators of ICU
triage and post ICU care in different settings. Descriptive statistics
and thematic analysis have been used to analyse data. Triangulation
has been applied to identify convergence, complementarity or dis-
crepancy between data collected via the two research methods.
RESULTS. Nine of the 14 participants who completed the question-
naire described practice in a LMIC, while five respondents provided
examples of HIC practice. Globally, there are several models of care:
public, governmental funding (6 LMIC and 4 HIC study units); private
funding (1 LMIC unit); fee-for-service model where family/relatives
contributes (2 LMIC units); access to health insurance (1 HIC unit). Ac-
cording to study results, when family needs to contribute financially
there may be no other choice than limit treatment during and after
intensive care. Also, lack of standardised end of life procedures in
LMIC make triage a challenging process. Post discharge services are
limited by resources according to the majority of participants with a
tendency to holistic care in the LMIC units. Staffing, bed availability,
and infrastructures (equipment, logistics) have been named as poten-
tial barriers to triage and discharges from ICU in all resource set-
tings. Outreach services have been advocated for appropriate triage
and after discharge monitoring
CONCLUSION. Barriers and facilitators of triage are similar between
LMIC and HIC study units despite resources available. Capacity of triage
and post discharge services are limited in settings where relatives need
to contribute to cost of care. Indeed, triage may be easier in the context
of low resources because there may be no other choice than refusing
admission. Therefore deciding which patient to admit or not should be
planned as soon as possible. Outreach and post discharge services
could facilitate the prevention of deterioration and therefore help to
decrease the global burden of critical illness.
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INTRODUCTION. The need for critical care service is on the increase;
however, ICU services are not readily available and accessible. Lagos,
Nigeria with a steaming population of approximately 21 million, who
have access to only four government owned ICU centers with 13
beds. This has led to private initiatives in critical care services.OBJECTIVES. We determined the indication and outcome of ICU ad-
mission in a private critical care center in Lagos, Nigeria.
METHODS. This is a prospective observational study of critically ill
patient admitted between January, 2016 and March, 2019. The case
note and ICU charts for all patients referred to our center were
reviewed.
RESULTS. A total of 162 patients were admitted, of whom females
were 92 (56.8%), the most common specialist of admission was sur-
gery 50% followed by medicine with 29.2%. The median apache
score was 19.8 (25th -75th percentile, 14.5-26.7).
There was delay in referral in 82.2% of patients, with a median period
of 34 hours (2-72hours). The most common reason for delay was un-
availability of ICU bed space in 63.7% followed by no ICU facility at
referral center 26%. The ICU survival at our center is 106 (65.4%).
CONCLUSION. There is an urgency need for provision of critical care
services to meet the teeming population in Lagos, Nigeria. The most
common reason for delay in ICU services is lack of bed space.
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INTRODUCTION. Critical Care patients often experience pronounced
psychological distress during intensive care treatment due to its ex-
tremely disempowering nature (e.g. Wade et al., 2013). As such they
are highly at risk of developing low self-efficacy regarding influencing
negative psychological states. This passive attitude can slow their rate
of recovery, and is also strongly predictive of future psychological prob-
lems (Wade et al. 2012, Davydow et al. 2009)
METHODS. A sample of 64 critical care patients from the Intensive Care
and Neurological Intensive Care Units of Addenbrooke’s hospital was of-
fered cognitive, behavioural or mindfulness therapeutic input. At the begin-
ning of treatment a focus was agreed with each patient on a main
problem area: depression, anxiety or stress (early post-traumatic response,
pain response, or agitation). Patients rated their level of confidence that
they could improve their psychological symptoms on a 5-point scale at the
end of each treatment session. This scale consisted of the options: ‘1 = low’,
‘2 = quite low’, ‘3 = moderate’, ‘4 = quite high’, and ‘5 = high’. The resulting
data was analysed using match-pair T-tests in order to investigate if patients
self-rated levels of confidence changed from the beginning to the end of
treatment for: (a) all patients in the sample, (b) for patients within each area
of psychological distress, and (c) for patients within each modality of treat-
ment (cognitive, behavioural, or mindfulness). Variance amongst means for
(b) and (c) was also examined using one-way ANOVA.
RESULTS. T-test (a) was significant at p<0.0001; the T-tests for (b) and (c)
were all significant at p<0.05 apart from when applied to those offered be-
havioural input p>0.05; the ANOVA conducted for (b) and (c) were all non-
significant apart from when this test was applied to the problem experi-
enced at the end of treatment p<0.05.
CONCLUSION. The finding that (other than patients offered mainly
behavioural treatment) all treatment conditions measured showed a
significant increase in self-rated levels of self-efficacy suggests that
cognitive and mindfulness techniques are effective for this purpose.
These results also indicate that this treatment is very effective in this
area for patients overall, and at a lower level of significance, for
Page 165 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55psychological problems considered individually. However, although
the use of behavioural techniques showed a signal for improvement
in self-rated patient self-efficacy, this did not reach significance
within this cohort, a finding which if substantiated, could indicate
that cognitive and mindfulness techniques possess self-efficacy
boosting properties for this patient population which behavioural
techniques do not stimulate.
The ANOVA results indicate that, both in terms of psychological
problem experienced and modality of treatment offered, the patients
in this sample do not display statistically significant differences in
levels of self-efficacy at the beginning of treatment. This finding
maintains to the end of treatment for treatment modality, but does
not for problem experienced. This suggests that one or more of the
psychological problems responds differently to treatment than the
others, which may indicate that patient self-efficacy in this area can
be altered more for certain psychological problems than others.
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INTRODUCTION. Prolonged length of stay (LOS) in the intensive care
unit (ICU) is associated with severe morbimortality (1) and high cost
of care. Nevertheless, there is no consensus regarding the exact def-
inition of prolonged ICU stay (2), with studies ranging from 3 days to
14 days. There is a lack of evidence regarding even longer periods of
stay (30 days), and which factors and critical care outcomes are asso-
ciated with such duration.
OBJECTIVES. 1. Analyse predictors for prolonged ICU stay.
2. Understand the impact of prolonged ICU stay on critical care
outcomes.
METHODS. Case-control study of the 1509 patients admitted to a
polyvalent ICU between 2016-2018. Cases were defined by a LOS in
the ICU superior to 30 days.
Forty-two cases were identified and 84 controls were chosen ran-
domly on a 2:1 ratio.
RESULTS. During the study period, 2.7% of patients had a prolonged
LOS. Median length of stay was 10 days [IQR 7-15] for the control
group and 35 [IQR 33-45] for the case group. Average age was 57
years (20-83). There were no statistically significant differences re-
garding age, gender, time to ICU admission, APACHE II and SAPS II
between study groups.
Cases had significantly lower Charlson Comorbidity Index values (p=
0.047), needed more antibiotic regimens (p= 0.047) and longer dur-
ation of antibiotic therapy (p<0.01).
They also had significantly longer duration of ventilation (p<0.01).
and required more frequently tracheostomy for invasive ventilation
weaning (p<0.01; OR 16.0).Similarly, cases needed more frequently vasopressor support (p=0.07;
OR 10.403) and for a longer duration (p<0.01).
The readmission rate was significantly higher in the case group (p=0.01).
Cases also had and days of vasopressor support (p<0.01)
On multivariate analysis, admission because of urgent surgery was a
predictor of prolonged ICU stay (p= 0.039; OR 2.47) and an ICU LOS
superior to 30 days was a significantly associated with ICU mortality
(p=0.045; HR 13.594) in the survival analysis.
Regarding post-discharge outcomes, cases were more prone to be
discharged to an institution for continued care and rehabilitation (p=
0.002; OR 4.167). There were no differences in 6-month mortality be-
tween study groups (p=0.768). On univariable analysis, the only vari-
able associated with 6-month mortality post-ICU discharge was the
need for tracheostomy (p= 0.016; HR 3.871).
CONCLUSION. Prolonged ICU stay is associated with a higher rate of
tracheostomy and reduced survival in the ICU setting, but similar
mortality rate at 6-month post-discharge. Prolonged ICU stay is asso-
ciated with higher institutionalization rates and, as such, these pa-
tients probably require a more intensive rehabilitation care program
to ensure adequate quality of life post-ICU stay.
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INTRODUCTION. Background: The aerosol therapy during mechanical
ventilation is simplified through technological advances however the
scientific knowledge about optimal implementation is infrequently
applied.
OBJECTIVES. To determine the practice and knowledge of inhalation
therapy during mechanical ventilation.
METHODS. A questionnaire was sent to nurses taking care of mechan-
ically ventilated patients who attended 5 regional respiratory care
conferences.
RESULTS. Totally, 401 nurses responded to the questionnaire and
84.8% of them were the general nurses working in general medical
and surgical wards. Majority of them worked in secondary and ter-
tiary public hospitals with the median experience-year of taking care
of ventilated patients of 4[2, 11] and the median numbers of venti-
lated patients of 15 [4, 30] per month. Of the total responders,
241(60.1%) used metered dose inhaler (MDI) and 295 (73.5%) used
nebulizers in mechanical ventilation. Of the 241 nurses who used
MDI, only 54% placed the MDIs on the correct position (15 cm. from
endotracheal tube). Most of them (93%) did not know how often
MDIs needed to be primed. Approximately, 87.5% of them shook
MDI before providing to the patients however only 10.6% knew MDI
needed to be shaken for 8 actuations. Additionally, 14.5% of them
administered MDI at the wrong point of time (at the end of expir-
ation or mid inspiration). Noticeably, 9.2% of them turned off heat
humidifier, 28.3% of them did not remove heat moisture exchange
and 7.2% of them ignored to check and remove fluid in ventilator
circuits before MDI administration. Moreover, 35.4 % did not know
an appropriate actuation interval for MDI therapy.
Table 1 (abstract 001641). Teaching instruments adopted for different
ultrasound techniques (VA: vascular access; LUS: lung ultrasound; TTE:
transthoracic echocardiography; FAST: focused-assessment sonography














VA 89.9% 5.6% 38.3% 17.4% 7.0% 3.9% 3.5%
LUS 77.7% 10.5% 51.9% 14.3% 20.6% 10.8% 2.9%
TTE 63.8% 7.0% 40.8% 7.7% 9.4% 16.7% 9.4%
FAST 43.9% 5.2% 22.3% 7.0% 2.4% 24.0% 20.9%
TCD 46.7% 6.6% 29.6% 3.8% 7.0% 26.8% 14.3%
RA 78.8% 6.6% 49.8% 13.2% 7.7% 10.1% 4.9%
DUS 53.3% 7.7% 35.2% 10.1% 21.6% 18.5% 14.6%
Page 166 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Of the 295 nurses who used jet nebulizers, 70.5% placed the genera-
tors on the appropriate position (45 cm. from endotracheal tube),
but only 49.5% diluted medication to 4 ml. to maximize aerosol de-
livery. Additionally, 22.4% of them did not remove heat moisture ex-
change before nebulization and 24.2% of them used inappropriate
flow rates during nebulization.
CONCLUSION. The knowledge of inhalation therapy needed to be
improved, suggesting the future educational programs focusing on
aerosol therapy during mechanical ventilation.
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INTRODUCTION. Point-of-care ultrasound (PoCUS) became increasingly
used to assess critically ill patients[1,2]. Appropriate training is required and
should integrate anesthesiology and intensive care residency programs.
The purpose of this study is to assess the current state of PoCUS training in
Anesthesiology and Critical Care residency programs[3].
OBJECTIVES. To assess methods, adequacy and limitations of PoCUS
teaching during anesthesia and critical care residency in Italy.
METHODS. On-line anonymous survey sent to all residents, as ap-
proved by the CPAR (Collegio Professori Anestesia Rianimazione),
concerning the actual teaching practice for: vascular access (VA), lung
ultrasound (LUS), transthoracic echocardiography (TTE); focused-
assessment sonography trauma (FAST); transcranial Doppler (TCD);
regional anesthesia (RA) and diaphragm ultrasound (DUS).
RESULTS. 340 residents from 21/41 universities filled the survey (first
year 17.4%, second 20.3%, third 23.8%, fourth 23.5%, fifth 15.0%).
Bedside teaching is the most frequent tool for all techniques (Tab.1);
frontal lecture is the second one. LUS and DUS teaching more fre-
quently includes research activities. Overall, the most neglected ultra-
sound technique is FAST. 47.1% of residents never attended an
extra-curricular ultrasound course; residents are mentored by attend-
ing physicians (73.5%) and/or older residents (46.2%). Acquisition of
ultrasound competences is mainly evaluated during bedside activity
(64.1%); in only 12.1% a theoretical-practical certification is per-
formed. Ultrasound knowledge is considered extremely important by
residents for VA (67.0%), RA (60.9%), FAST (51.8%), TTE (51.2%), LUS
(50.3%), DUS (27.9%), TCD (27.6%); the impact of ultrasound tech-
nique is mainly perceived to guide procedures (VA and RA) and to
improve patient’s understanding (LUS, TTE, TCD, DUS, FAST). The
training is mainly considered as adequate or more than adequate for
VA (62.7%) and RA (42.7%), and nearly sufficient or inadequate for
LUS (40.3%), DUS (37.1%) TTE (50.0%), FAST (52.9%) and TCD (44.4%).
The main perceived limiting factor is the absence of a standardized
didactic process.
CONCLUSION. PoCUS teaching is present although not optimal for
all the techniques in Italian critical care residency schools. Standardiz-
ing resident’s ultrasound curriculum is suggested to improve ultra-
sound teaching.
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INTRODUCTION. The presence of immature granulocytes was origin-
ally assigned to the diagnosis of sepsis. Thereafter their rate was cor-
related with the severity of sepsis. The aim of our study was to
assess its prognostic value in patients admitted to emergency
department.
OBJECTIVES. The aim of our study was to assess its prognostic value
in patients admitted to emergency department.
METHODS. We conducted a case-control study over a period of two
months from march 1st to april 30, 2014. In the group (GI+), we in-
cluded patients which had immature granulocytes on their blood
count. Then, by frequency matching, we included patients of the
group (GI-) which had not immature granulocytes. Our primary end-
points were in-hospital mortality and the length of stay in emergency
department. Our secondary endpoints were the presence of organ
dysfunction and elevation of CRP level over 100 mg/l.
RESULTS. We included 122 patients. 61 in the GI+ group and 61 in
the GI- group. There were 58 women and 64 men. The sex ratio was
1.1 without difference between the two groups (p=0.46). Sepsis was
diagnosed in 84 patients (68.8 %). The two groups had similar past
medical history and consultation patterns. Patients in GI+ had Ambu-
latory Simplified Acute Physiologic Score (ASAPS) significantly higher
on admission (5.1 vs 4.1 in GI-, p=0.035) and at least one vital distress
at the first examination (p=0.029). Blood glucose level greater than
1.40 g/l was found in 22.1 % of patients. 66.7 % of them belonged to
GI+ (p=0.01). In GI+. 45.9% of patients had a creatinine level higher
than 17 mg/l (p=0.008, OR =2, [CI=1.17 - 3.41]). Acidemia was found
in 90.7 % of patients in GI+ (p=0.008). For an anion gap value greater
than 22 mmol/l. the difference was significant in GI+ (p=0.005, OR =
3.1, [CI=1.3 – 6.97]). The average value of ASAT was 50.6 mmol/l in
GI+ vs 28.1 mmol/l in GI- (p=0.03). 55.7% of patients in GI+ had a
CRP rate greater than 100 mg/l vs 36.1% of patients in GI- (p=0.029).
The average length of stay was 78.2 ± 65.7 hours in GI+ vs 54.4 ±
31.9 hours in GI- (p=0.01). Mortality was 16.3% in GI+ vs 8.2% in GI-
(p=0.16).
CONCLUSION. The presence of immature granulocytes on blood
count of patients admitted to emergency department, regardless of
diagnosis, is associated with a significantly longer length of stay and
a higher number of organ dysfunction. Mortality is twice as high in
Fig. 1 (abstract 001656). See text for description
Fig. 2 (abstract 001656). See text for description
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nostic biomarker in emergency department.
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INTRODUCTION. ESICM NEXT fellowships are an intense 5 days learn-
ing program held at center of excellence. Fellowships are promoted
by NEXT, the ESICM Committee representing young members in-
training or within 3 years of training, which is responsible for the fel-
lowship application and selection process. As recently published, in-
equity leads to major loss of potentially important contribution and
should be avoided (1). To improve equity in the fellowship applica-
tion evaluation and to standardize the process, a new scoring system
based on 6 criteria was developed through a Delphi-Consensus
process (2) on June 2018, and compared with the previous evalu-
ation system.
OBJECTIVES. To compare the performance of the new fellowship ap-
plication scoring system with the previous one.
METHODS. Applications of candidates for an ESICM NEXT fellowship
were evaluated by two independent raters using the previous scor-
ing criteria, and by two raters per item using new scoring criteria.
Data are described as percentage, or median and IQR. Skewness was
assessed by skewness and kurtosis test. Interrater agreement was
assessed using weighted Cohen’s Kappa. Data were specifically
assessed in terms of gender and geographical distribution of success-
ful applications. Study obtained IRB approval.
RESULTS. A total of 100 applications were included, with 54% male
and a median age of 34 (IQR 32-38). Old scoring displayed a right
skewed distribution, while the new scoring system was normally dis-
tributed (skewness and kurtosis test 0.01 vs 0.6, respectively. Fig. 1).
Inter-rater agreement between old and new scoring was 67% (p=
0.001 to refuse agreement by chance), using weighted-Cohen’s
kappa. New criteria allowed selection of about 30% different appli-
cants compared to old criteria (Fig 2) . Involvement in teaching was
the most discriminative variable, followed by quality of published re-
search and quality of recommendation letter. There was no differ-
ence in gender (45.6% successful female application over all female
application in both scores). There was variation in geographical distri-
bution, with the highest reduction in successful application from Italy
and UK.
CONCLUSION. The gaussian distribution of new evaluation system,
based on more objective criteria selected through a consensus
process, reflects a higher discriminative power, compared to the
former right skewed distribution. This is mainly related with assess-
ment of personal teaching activity and personal research. The new
scoring selected about 30% different candidates compared to the
previous system, with no difference in gender selection and no clear
pattern in geographical distribution.
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INTRODUCTION. To measure quality is a delicate task and there are
a lot of quality indicators (QI) from different countries. A previous re-
port (1) showed that among 111 QI there was only nine that had a
consensual agreement of 90%. The Swedish Intensive Care Registry
(SIR) have formed national QI since 2005 and a thorough revision
was performed 2014-2016.
T7
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ber one, “National guidelines in Intensive Care”.
METHODS. The revision of all QI focused on the improving character-
istics and (QI 1) is describing nationwide resources and how well the
different ICU:s fulfills the goals of the national guidelines in intensive
care. Results concerning academic profile, EDIC I+II for the head of
the ICU and the level of nurse’s education altogether with number of
beds, isolation rooms and staffing ratio was reported 2016 for the
first time.
RESULTS. The results from 2018 showed and described here, are
from all ICU:s that report data to SIR (83/84) in Sweden. In the Uni-
versity ICU:s the head of the ICU had EDIC I+II in 55% and 18/29
(62%) had an academic grade of at least PhD. The guideline stipu-
lates 100%.
In 35 of 83 ICU:s there was a discrepancy between what has been re-
ported by the head of the ICU concerning data delivered to SIR for
the eight QI and what was actually found in the database (Table 1).
CONCLUSION. To be able to report ICU resources available nation-
wide including academic profile, education level and how many ICU:s
that reach the goals of the guidelines open for public can be a
powerful tool for improvement both for the individual ICU and for
the intensive care in Sweden.
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Category
In % of all
ICU:s
Reported result that all data for all QI is delivered to




I 20% 77% 47%
II 45% 78% 35%
III 35% 62% 17%
Fig. 1 (abstract 000627). See text for descriptionPOIC - Perioperative circulation and
biomarkers
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INTRODUCTION. Hyperlactatemia (HL) during cardiac surgery is com-
mon, occurring in 10-20% of patients (1). The most studied mechan-
ism is tissue hypoperfusion usually a marker of impaired outcome.There are however, other less well-known causes of perioperatrive
HL (2).
Surgical stress response involves metabolic changes aimed at mobil-
izing different energetic substrates. Lactate is a well-known and im-
portant source of energy in different tissues. Most previous studies
on HL have focused on the role of intra- or early post-operative hy-
poperfusion associated HL on morbity and mortality. There are how-
ever few studies analyzing the prevalence and clinical significance of
delayed HL occurring several hours after surgery in the absence of
clinical evidence of shock or tissue hypoperfusion.
OBJECTIVES. Analyze the incidence and clinical implications of late
onset hyperlactatemia (LOH) after cardiac surgery.
METHODS. Observational retrospective study in a tertiary university
hospital. We analyzed patients scheduled for cardiac surgery be-
tween January 2016 and December 2018. LOH was defined as an in-
creased in lactate ≥3mmol/l after the first 4hours of ICU admission.
We excluded patients with intra- or early postoperative HL, those
with cardiac arrest, severe arrhythmia or needing reintervention or
cardiac assistance in the first 4 hours of ICU admission. We analyzed
mortality, prolonged mechanical ventilation, ICU and hospital length
of stay (LOS) and occurrence of post-operative adverse events by
comparing LOH cases with a matched control population. We also
analyzed the presence of hyperglycemia and inflammation as poten-
tial mechanisms of LOH.
RESULTS. Of the 744 patients analyzed, we detected 55 (7%) cases of
LOH that were compared to 52 matched controls. We did not find
any differences in mortality (P=0.618 CI95%) and in ICU and hospital
LOS (P=0.116 and P=0.063 CI95 respectively). In addition, there were
no differences in renal failure, continuous renal replacement, arrhyth-
mias or prolonged ventilation (P=0,77 P=0,16 P=0,14 P=0,44).
We found a significant increase in glucose (p<0,0001) being 52% of
those non-diabetics. There was a positive correlation between glu-
cose and lactate levels (r 0.45 Pearson P=0.001 r2 0.21,). Also, we
found an increase in leucocytes levels at 4 hours in the LOH group
but it was not significative (P=0,29 CI95%).
CONCLUSION. LOH is neither associated with a worse prognosis
(mortality, ICU and hospital LOS) nor with post-operative adverse
events. It seems to represent a secondary postoperative metabolic-
inflammatory response that does not require any specific therapeutic
intervention other than metabolic control.
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INTRODUCTION. Kidneys are important organs in regulation of vas-
cular tone via several circulating systemic mediators Chronic Renal
Disease (CRD) has systemic effects, including accelerated atheroscler-
osis, affecting also the microcirculation (1). We made sublingual IDF
imaging video sequences analyzed by new automated analysis soft-
ware to investigate the microcirculation called MicroTools deveoped
by us (2) in healthy volunteers, dialysis patients, and kidney trans-
plant recipients.
METHODS. This study was registered at the ClinicalTrials.gov Protocol
registration system (ID: NCT02412839 and NCT02940275). A total of 270 pa-
tients were recruited in the study with different groups, yielding a total of
1983 videoclips. Analysis of the image sequences was performed by our
newly developed automatic software called Microtools. To validate the use
of this software on the present data set, two researchers compared image
from randomly selected 17 patients independently from each other using
the gold standard AVA analysis and showed agreement between their
values. Then these results were run through MicroTools for analysis. Bland
Altman analysis between AVA data and MicroTools data showed agree-
ment within levels of agreement. After this validation step, 1373 videoclips
out of 1983 were excluded due to poor quality based on the existing cri-
teria. The remaining eligible 610 videoclips were run through the Micro-
Tools software providing the following parameters: Total Vessel Density
(TVD), Functional Capillary Density (FCD), Capillary Blood Volume (CBV).
Quantitative RBC velocity was calculated from Space Time Diagrams of
each capillary in a videoclip provided by MicroTools, conform the inter-
national consensus.
RESULTS. TVD and FCD of Dialysis patients was significantly lower com-
pared to healthy volunteers, and renal transplantation reverted this vascu-
lar reaction. Systemic vasoconstriction was shown in reduced capillary
blood volume in dialysis patients, which was again improved by renal
transplantation. Mean Red Blood Cell Velocity was increased both dialysis
and renal transplantation patients, suggesting permanent structural
change in extended disease progress.
CONCLUSION. CRD affects systemic microcirculation and these ef-
fects are relieved to some extent by renal transplantation.
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INTRODUCTION. The vasoplegic syndrome is a condition charac-
terized by low systemic vascular resistance, low blood pressure,
as well as normal or elevated cardiac output. It has been found
in many contexts, including postoperative state. The pathophysi-
ology coincides with the activation of different intrinsic vasodila-
tion pathways, as well as the poor response to intravenous fluids
and vasopressors. [1] The importance of Vasoplegia in Cardiac
surgery with extracorporeal circulation lies in its high frequency,
its high morbi-mortality, as well as its association with multiple
organ failure. [2] Despite being a relatively common syndrome in
critical patients, the absence of a definition makes its study, and
management more difficult. Historically the cornerstone for the
management of vasoplegia has been based on hemodynamic
support with vasopressors, giving the best profile to the vaso-
pressin. [3] However, with advances in the study of the patho-
physiology, the methylen blue has been proposed as an
alternative management. The action of methylene blue is based
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the blockade of nitric oxide. There is evidence that suggest that
the use of methylene blue as management of vasoplegia after
cardiac surgery reduces morbidity and mortality, as well as the
time of vasoplegia. [4].
OBJECTIVES. To assess the effect of methylene blue in terms of mor-
bidity and mortality in patients who have undergone cardiac surgery
complicated with vasoplegic syndrome.
METHODS. A retrospective, observational study was conducted.
The data of the patients diagnosed with vasoplegic shock , was
collected between 2014 and 2018. Those patients were divided in
two groups, those who were treated with methylene blue (MB)
2mg/kg, and those who did not received it (they receive the
standard treatment ov vasoplegic shock). The criteria used to de-
termine vasoplegic syndrome was hypotension <65mmHg, vascu-
lar systemic resistance <1600 dynes, cardiac index >2.2, high
doses of vasopressor needed. The exclusión criteria includes pa-
tients who did not fulfill the criteria for vasoplegic syndrome,
and those with incomplete clinical record. The information was
analyzed using STATA 12.1, a p value of <0.05 was used as
significant.
RESULTS. A total of 50 patients were collected. In the MB group
the mean age was 59.6 years SD 14.37, the 59.26% were male,
40.74% had hypertension, 14.81% had diabetes mellitus type II
(DM), 22.2% had atrial fibrillation, and 51.85% underwent non
elective surgery. In the non MB group the mean age was of
58.4 years SD 13.6, 73.91% were male, 43.48% had hyperten-
sion, 34.78% had DM, 4.35% had atrial fibrillation, and 73.91%
were of non elective surgery. Non of this data had significant
difference. A Pearson correlation did not show any significant
difference between the 2 groups regarding mortality, duration
of the vasoplegia, neumonia, mediastinitis, reexploration, and
lenght of stay.
CONCLUSION. Our results suggest that the use of methylene blue as
a management of vasoplegic syndrome in post-operative patients of
cardiac surgery, did not reduce mortality, duration of vasoplegia,
length of stay in intensive care, days of in-hospital stay, or postopera-
tive complications.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000705INTRODUCTION. Clonidine is an α2-agonist that is registered for the
treatment of hypertension. It is also used as an off-label drug for sed-
ation in the intensive care unit (ICU). However, no standardized dos-
ing regimens are available for this indication [1]. Based on previous
studies [2], we defined a target plasma concentration for sedation
between 1.5 to 4.0 μg/L.
In order to achieve clonidine levels in the target range, we did a
population pharmacokinetic study in ventilated and sedated patients,
using various doses of clonidine.
OBJECTIVES. To develop a population pharmacokinetic (PK) model
to optimize dosing regimens for clonidine as a sedative.
METHODS. Mechanically ventilated patients receiving intravenous
sedation were included after informed proxy consent. Clonidine was
added to standard sedation. Three cohorts of eight patients received
continuous infusions of intravenous clonidine in doses of 600, 1200,
and 1800 μg/24 h for seven days or less. The second half of each co-
hort received a loading dose of 300, 600 and 900 μg of clonidine, re-
spectively, infused over 4 h. Biometric and biochemical data were
recorded and plasma was sampled at fixed times.
A population nonlinear mixed effects model was constructed using
NONMEM 7.3. One, two and three compartment models were tested.
The following covariates were tested on the PK parameters: body
weight, body surface area, body mass index, age, gender, creatinine
clearance, albumin, bilirubin and time after start infusion. After uni-
variate selection, covariates were liberally introduced into the multi-
variate model using linear and power functions, and then stepwise
eliminated using more rigid criteria. The stability of the model was
tested by goodness-of-fit plots, bootstrapping and a visual predictive
check. After modelling, Monte Carlo simulations were performed to
find optimal dosing regimens.
RESULTS. We collected 287 plasma samples from 24 patients. Ages
ranged from 25 to 83 years (median 67); body weights ranged from
53 to 113 kg (median 84).
A two-compartment model fitted the concentration-time data best.
Time had a significant influence on the clearance (CL), which in-
creased with 0.21% per hour. Body weight was a significant covariate
on the central volume of distribution (V1), using allometric scaling.
Population PK parameters (relative standard errors) were: CL 17.1 L/h
(10%), V1 123 L/70kg (33%), Q (inter-compartmental CL) 84.4 L/h
(31%), and V2 (peripheral volume of distribution) 179 L (18%).
Simulations with the final model showed that a continuous infusion
of 1200 μg/day resulted in 90% of the population reaching target
concentrations during steady state, irrespective of body weight or
kidney function.
Without a loading dose, 50% of the population reached the target
concentration in 14 hours. After a 450 μg loading dose infused over
4 hours, 50% of patients reached the target concentration within 4
hours. Loading doses below 300 μg had little effect on the time to
reach target concentration. After 4 days of continuous infusion,
serum half-life was 12 hours.
CONCLUSION. The developed population PK model allowed the
optimization of dosing regimens for clonidine as a sedative agent in
ICU patients.
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INTRODUCTION. The recommended strategy for the prevention and
treatment of delirium are non-pharmacological approaches com-
bined and focused on reducing modifiable risk factors in order to
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and vision. The use of multiple combined strategies is a plausible rec-
ommendation, since the etiology of delirium is multifactorial.
OBJECTIVES. To verify the impact of non-pharmacological interven-
tions in the development of delirium in the ICU, according to the hy-
pothesis that natural light, mobilization, presence of family member
and absence of physical restriction reduce the risk of delirium.
METHODS. Prospective and longitudinal study. Inclusion criteria: pa-
tients over 18 years old, hospitalized in the ICU for a period longer
than 24 hours. Exclusion criteria: patients with delirium at the time of
admission to the ICU, those with a stay in the unit less than 24 hours,
transferred to another institution, as well as those that could not be
reliably assessed for delirium, such as sustained coma , inability to
understand the predominantly spoken language in the ICU, aphasia,
or severe auditory or visual disturbances. On a daily basis, the pa-
tients were evaluated using CAM-ICU, applied in two moments. To
verify the predictive factors of delirium, a logistic regression model
was constructed, with odds ratio calculation and respective 95% con-
fidence intervals. We included in the multivariate model all variables
that had p <0.10 in the univariate analysis
RESULTS. The study sample consisted of 356 patients, 55.9% were
males and the median age was 69 years, with a predominantly inde-
pendent functional capacity (89.0%), admitted to the ICU more fre-
quently from the surgical center (49, 4%) and emergency room
(27.8%), with median SAPS3 of 39 points, median SOFA of 2 points
and ICC of 2 points. Of the total number of patients, delirium was ob-
served in 64 patients (18.0%) during ICU stay. Natural light, present
in 18.8% of the sample, was not associated with the occurrence of
delirium (p = 0.297). Physical restraint was observed in 12.4% of the
sample. There was an association between physical restraint and oc-
currence of delirium (p <0.001). After adjustment of covariates (age,
gender and mechanical ventilation), the multivariate analysis re-
vealed that age, type of patient, SOFA, family presence (OR=0,15;
95% CI = 0,06-0,41; p<0,001) and mobilization (OR=0,07; 95% CI =
0,03-0,16; p<0,001) were independent variables associated with the
development of delirium.
CONCLUSION. Mobilization and presence of family members are pro-
tective factors for the development of delirium.
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INTRODUCTION. To reduce patient discomfort and pain in ICU, intraven-
ous opiates, e.g. morphine bolus, are used routinely (1). These analgesics
have side effects, one of the most potent is respiratory inhibition (2).
OBJECTIVES. To measure acute changes in respiratory drive in re-
sponse to a morphine bolus.
METHODS. Preliminary results for 12 ICU patients on weaning mech-
anical ventilation modes in prospective observational study. Informed
consent and ethical approval were obtained in all cases. Arterial
blood gases, ventilation and respiratory drive were measured prior to
and 15 minutes following an intravenous 5 mg morphine bolus. Re-
spiratory drive parameters of central chemoreflex threshold inhydrogen ion concentration (TC) and cerebrospinal fluid strong ion
difference (SIDcsf) were estimated using a model-based method (3)
implemented in a decision support system (Beacon Caresystem, Mer-
maid Care, Nørresundby, Denmark). This system estimated pulmon-
ary gas exchange parameters (shunt and ventilation/perfusion
mismatch) prior to morphine bolus for use in respiratory drive meas-
urement (3). Pre- and post-morphine measurements were compared
using paired t-test or Wilcoxon signed rank test, according to normal-
ity as assessed by Shapiro-Wilk test.
RESULTS. Pre-morphine levels and (average ± SD) or (median (inter-
quartile range)) change from pre- to post-morphine bolus were for
SIDcsf 31.9 (0.3 ± 1.0) mmol/L, TC 41.1 (-0.2 ± 2.3) nmol/L, respiratory
rate (RR) 27.8 (-3.3 ± 4.8) min-1, alveolar ventilation (VA) 7.6 (-0.4 ±
1.2) L/min, minute ventilation 13.7 (-1.1 ± 2.3) L/min, tidal volume
515 (30 (-14 – 134)) mL, effective respiratory system compliance 39.8
(-0.2 ± 4.5) ml/cm H2O, end-tidal CO2 3.7 (0.1 (-0.1 – 0.4)) %, CO2
production 291 (-8 ± 31) mL/min, O2 consumption 333 (3 ± 41) mL/
min, arterial PCO2 5.03 (0.19 ± 0.34) kPa, pH 7.45 (-0.01 ± 0.02) and
PO2 12.8 (-0.8 ± 3.0) kPa. Significant RR reduction followed morphine
bolus (p = 0.036). Although no systematic changes were observed in
other variables (p > 0.05), most patients showed a VA reduction, in-
creasing arterial PCO2 and decreasing pH. Largest changes in VA
were associated with opposite changes in TC.
CONCLUSION. Predominant acute response to morphine bolus was a re-
duction in RR. Larger studies are necessary to understand the different ob-
served individual responses.
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INTRODUCTION. More elderly patients are receiving emergency treat-
ment and undergoing unplanned surgical procedures with increasing co-
morbidities and infirmity. Risk stratification tools are utilized to predict
outcomes. P-Possum is used by the National Emergency Laparotomy
Audit (NELA) database in the UK. However, these measures have been
criticized for not adequately quantifying frailty and morbidity burden of
an elderly population. It remains unclear if surgical and ICU management
are beneficial in consideration of long-term outcomes in this population.
OBJECTIVES. This evaluation of service aims to view 6 and 12 month
mortality for our elderly patients and assess predictive scores cur-
rently used. Secondary objectives include the age stratification of
post-operative recovery in terms of length of stay on the ICU, dur-
ation of ventilation and necessity for organ support.
METHODS. All patients older than 70 admitted to ICU after an emer-
gency laparotomy at a British district general Hospital between August
2015 and November 2017 were included. Data was collected from the
NELA Database, ICU charts and electronic patient records. Survivorship
was measured at 6 and 12 months. T-Test analysis was performed be-
tween surviving and non-surviving groups, then stratified into decades
(patients 70, 80, and 90) and ANOVA analysis was performed.
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due to incomplete documentation. Of the 80 remaining 63 (79%) sur-
vived to both 6 and 12 months. The average age of the surviving
group was older than the non-surviving group and lacked signifi-
cance (81.8.4±6.2 yrs vs. 80.5±5.5 yrs; p=0.43). All patients, (n=8)
older than 90 were alive at 12 months.
NELA’s measure of Operative Severity did not yield a significance in
mortality (p=0.16). Other measures employed by NELA were found to
be more predictive. Physiology Severity Score (P<0.005) and P-
Possum Mortality (18.0±20.6% vs. 34.0±27.4%; p<0.01, 95% CI 3.9 to
28.1%) were good markers of outcome irrespective of age. Length of
time mechanically ventilated was associated with poor outcome
(1.4±2.3 days vs. 5.1±8.0 days; p<0.01, 95% CI 1.4 to 5.9 days) but
not duration of ICU stay (P=0.13). ANOVA stratification between de-
cades saw a reduced length of stay on ICU (F=4.77; P<0.05) and
number of days ventilated (F=3.60; P<0.05) as age increased.
CONCLUSION. Our results reveal that for patients over the age of 70
admitted to the ICU, age itself is not predictive of outcome. This
group demonstrated a 12 month survival of almost 80%. Therefore,
in our institution very elderly patients who have been selected for
emergency operations can expect to do well after surgery and ICU
admission. Future work should be carried out to describe the fea-
tures of patients declined for surgery.
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INTRODUCTION. The last decade several randomized controlled trials
(RCTs) studied different transfusion strategies in critically ill patients.
In several studies the safety of restrictive transfusion strategies was
proven. Due to the lack of international transfusion guidelines spe-
cific for the intensive care unit (ICU), we hypothesized that a large
heterogeneity in transfusion practice in this patient population exists.
OBJECTIVES. To quantify the variety of current transfusion practices
and identify knowledge gaps in critically ill non-bleeding patients.
METHODS. An online, anonymous, worldwide survey among physi-
cians working in the intensive care (intensivists and non-intensivists)
was performed, in which red blood cell (RBC), platelet and plasma
transfusion practices were questioned, including questions regarding
transfusion thresholds, transfusion triggers and blood conservations
measures. Furthermore, the presence of a hospital or ICU specific
transfusion guideline was asked. Only completed surveys were
analysed.
RESULTS. In total 947 respondents participated of which 725 could
be analysed. Hospital transfusion protocol available in their ICU was
reported by 53% of the respondents. Only 29% of the respondents
used an ICU specific transfusion guideline. The applied haemoglobin
(Hb) threshold for the general non-bleeding ICU population was 7 g/
dL IQR (7-7 g/dL). For subpopulations including patients on ECMO
and patients with traumatic brain injury the highest variance was ob-
served (8 g/dL IQR (7.0-9.0 g/dL)). For patients with acute coronary
syndrome (ACS) highest Hb threshold was applied (9.0 g/dL IQR (8-
9.7 g/dL)). Thrombocytopenia was treated at a median level of
20x109 cells/L IQR (10-25 x109 cells/L). However, prior invasive proce-
dures significantly higher platelet count thresholds were applied (p<
0.001). In non-bleeding critically ill patients with a vitamin K induced
international normalized ratio (INR) >1.5, 43% and 57% of the re-
spondents would consider plasma transfusion without any upcoming
procedures or prior a planned invasive procedure respectively. Fi-
nally, doctors with base specialty anaesthesiology transfused critically
ill patients more liberally compared to internal medicine physicians.CONCLUSION. Current RBC transfusion practice in the general non-
bleeding ICU population is restrictive while for different subpopula-
tions higher Hb thresholds are being used. There is a high need for
well powered randomised trials investigating the optimal Hb thresh-
old for subpopulations in the critically ill. Furthermore, current prac-
tice in plasma and platelet transfusion is liberal and local transfusion
guidelines are lacking in the majority of the ICUs.
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INTRODUCTION. Cardiac surgery is at high risk of bleeding, inducing
additional morbidities and costs. Post-operative fibrinogen plasma
levels have been described as associated with enhanced bleeding
but very few data are available for pre-operative leves, whereas its
correction could may prevent the occurence of bleeding.
METHODS. Retrospective cohort study at Rouen University Hospital
from January 2016 to July 2018 including patients scheduled for a
cardiac surgery with cardiac bypass. EB was defined as a blood loss >
1.5 mL/kg/hour during the first 6 postoperative hours or a need for
reoperation [1]. Preoperative, perioperative and postoperative data
were collected. Results are presented as medians with first and third
quartiles. Comparisons between EB group and no-EB group were re-
alized using a Mann and Whitney test or a χ². A multivariable analysis
was then realized using a logistic regression model (backward
process). P < 0.05 was considered as significant.
RESULTS. 1822 patients were included, 107 showed significant bleed-
ing (EB group).
Preoperative data: No difference was observed between no-EB and EB
groups concerning age, gender, preoperative cardiac and renal functions,
antiplatelet therapies. A significant difference was observed for Body Mass
Index (BMI) (27.8 [24.7-31.2] vs 25.3 [22.1-28.4] kg/m², p<0.0001), past history
of cardiac surgery (4.8 vs 13.1%, p=0.01), anti-vitamin K therapy (10.7 vs
18.7%, p=0.02), prothrombin time (PTT) ratio (91 [80-100] vs 85 [70-100]%,
p=0.001), platelets count (221 [185-263] vs 200 [160-243] G/L, p=0.001) and
fibrinogen plasma level (3.5 [3.1 vs 4.0] vs 3.3 [2.6-4.1], p=0.04).
Peroperative data: excessive duration of cardiac bypass (80 [60-112]
vs 118 [79-155] min, p<0.0001] in EB group.
Postoperative data: rised PTT (59 [54-65] vs 55 [48-62]%, p<0.0001),
diminushed platelets count (145 [119-177] vs 133 [104-170] G/L, p<
0.0001) and fibrinogen plasma level (2.5 [2.1-3.0] vs 2,3 [1.9-2.7] g/L,
p<0.0001) in EB group. EB group presented more frequent complica-
tions: higher plasma troponin (969 [610-1835] ng/dL vs 607 [385-
1032], p<0.0001) and lactate (2.3 [1.7-3.5] vs 1.7 [1.2-2.4], p<0.0001),
kidney failure (KDIGO score ≥ 1 : 17 vs 8%, p=0.003). ICU Length of
stay and mortality were higher (5 [3-8] vs 3 [2-5] days, p=0.002 and 5
vs 1%, p=0.02).
Elements independently associated with a lower risk of EB were BMI
≥ 30 kg/m² (OR 0.46 IC95% [0.45-0.78] p=0.006) and preoperative fi-
brinogen (OR 0.98 IC95% [0.95-1.00] for each 0.1 g/L, p=0.04). Cardio-
pulmonary bypass was independently associated with a greater risk
of EB (OR 1.11 IC95% [1.07-1.15] for each 10 min, p<0.0001). A pre-
operative fibrinogen level greater than 3.035 g/L (Se 45%, Sp 71%)
appear to be protective factor against EB (Area Under the Curve
0.557 [0.492-0.623]).
CONCLUSION. Low levels of fibrinogen before cardiac surgery is as-
sociated with an excessive postoperative bleeding. Further random-
ized study may explore the effect of pre-emptive administration
of exogenous fibrinogen to prevent excessive bleeding during car-
diac surgery.
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INTRODUCTION. Intraoperative hypotension (IOH) is a frequently oc-
curring event associated with an increased morbidity and mortal-
ity.[1,2] Current treatment of IOH is mostly reactive. A machine-
learning algorithm was developed to predict IOH minutes before the
blood pressure actually decreases. This algorithm, the hypotension
prediction index (HPI), was internally and externally validated with
good sensitivity and specificity.[3] However, no randomised studies
testing the effectivity of HPI to prevent IOH have been performed.
We hypothesise, that use of IOH will reduce the time weighted aver-
age (TWA) spent in hypotension during surgery.
OBJECTIVES. Our primary objective was to determine whether the
use of a machine-learning based algorithm can reduce IOH, mea-
sured as the TWA during surgery. TWA combines both the time and
depth of IOH.[4] Our secondary objectives were to assess whether
the use of this algorithm increases the TWA of hypertension and
whether it increases the cumulative dose of vasopressors and fluids
given during anaesthesia. We also assessed the compliance with the
algorithm by the number of protocol violations.
METHODS. This was a single center trial in a tertiary academic center
consisting of two phases, an observational phase and a randomised
clinical trial phase. Adult patients (aged 18 years and older) sched-
uled to undergo an elective non-cardiac surgical procedure under
general anaesthesia and requiring an arterial line were eligible for in-
clusion. IOH was defined as a MAP < 65 mmHg for more than 1 mi-
nute. A HPI alarm was defined as a HPI value above 85%.
RESULTS. A total of 100 patients were included between November
2017 and January 2019. The TWA of IOH in the intervention group
was 0.13 compared to 0.46 in the control group, p=0.001. Patients
suffered from IOH 3.3% versus 10.5 %, p<0.001 of their duration of
surgery. The TWA of hypertension was 0.09 versus 0.06, p=0.548. Pa-
tients experienced hypertension 1.67% versus 0.98%, p=0.379 of their
duration of surgery. Neither the cumulative dose of vasoactive medi-
cation given nor fluid balance was significantly different between
groups. 80% of all HPI alarms were treated according to protocol.
CONCLUSION. This is the first randomised clinical trial employing a
machine-learning based tool in the field of anaesthesia. Use of the al-
gorithm resulted in less hypotension without an increase in hyper-
tension or the cumulative of vasoactive medication and fluids given
during anaesthesia. Future studies should assess clinical endpoints.
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INTRODUCTION. Objetives: Presenting clinical and epidemiological
data of patients with cytoreductive surgery and hyperthermic intra-
peritoneal chemotherapy who are admitted in ICU.
METHODS. Retrospective, descriptive study of patients admitted in
ICU from January 2018 to December 2018. Clinical, epidemiological
and result-related variables were analyzed. Quantitative variables are
expressed as mean and standard deviation, while qualitative vari-
ables are expressed as ratios and absolute value.
RESULTS. A total number of 14 patients took part in this study; mean
age was 57.71± 8.90 years, 78.6% were females. APACHE II at the ad-
mission was 17.21 ± 6. SOFA 3 6.85±2.95
78.6% of the patients presented comorbidities; the most frequent
was high blood pressure (28.6%), followed by dyslipidemia (21.4%)
and smokers (14.3%). 57% had chronic disease: Pulmonary
14.3%(OCPD and asthma), Cardiac 7.1%, and others 42.9%.
Gynecological tumors were the most usual, 57.2% (6 ovarian cancer,
2 uterine cancer); follow by gastrointestinal tumor, 42.8% (3 colon
adenoacarcinoma, 3 gastric tumor) Metastasis were presented in
28.6%, been hepatic location the most frequent (75%).
Cytorreduction were successful in all of the patients. Peritonectomy
was done in 78.6% of the cases, Omentectomy in 35.7%. 71.4% of
the patients need intestinal resection, 21.4% gastrectomy, 14.3%
cholecystectomy, and 7.1% appendicectomy. In one case spleen re-
moval was needed, and another patient needed nephrectomy. Oo-
phorectomy was done in 28.6% of the women and same frequency
was observed in hysterectomys. Cytoreduction at other levels, such
as lymph nodes, pancreas or muscles, was done in 57.1% of the pa-
tients. The most used chemotherapic drug was Paclitaxel(50%), next
was Cisplatin combined with Doxorrubicin(14.3%). Mitomycin, Fluoro-
uracil and Oxaliplatin were used only once. The treatment was kept
and average of 53.57± 12.77 minutes, with a mean temperature of
41.92 ± 1.07 ºC.
At the ICU admission, in the firsts few hour 64.3% of the patients
needed Norepinephrine and intensive fluid resuscitation. Amoxicilin-
Clavulanic was the most frequent antibiotic used as prophylaxis
(92.9%). Early complications were found in 50% of the cases, the
main one was hemodynamic shock (50%). In 14.3% of the cases ARF
was observed, as well as pleural effusion and infections. Two patients
had wound dehiscence. And other two needed re-intubation and
mechanical ventilation support; CVVHDF was needed in 14.3%.
Length of stay in UCI was 7.78±7.07 days. Three patients were re-
entry due to wound dehiscence, two of them with sepsis associated,
none of them present renal failure neither respiratory failure; with an
average UCI stay of 7.33± 3.51 days. The average hospital stay was
18.88±10.66 days.
CONCLUSION. The profile of the patient admitted to the ICU, after
Cytoreductive surgery and HIPEC, was a 58 year old female, with co-
morbidities and gynecological or gastrointestinal cancer; who need
Norepinephrine and intensive fluid resuscitation due to initial shock,
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INTRODUCTION. Resolution of acute inflammation requires a newly
discovered group of lipid Specialized Pro-resolving mediators (SPMs)
derived from omega-3 fatty acids to control the inflammatory re-
sponse and avoid transition to chronic inflammation. Little is known
about the kinetics of SPMs in response to an acute inflammatory in-
sult in humans. Few surgeries are associated with more inflammation
than left ventricular assist device (LVAD) implantations.
OBJECTIVES. The aim of this study was to determine if and when the
SPMs Resolvin D1 and D2 are detectable after a major inflammatory
insult.
METHODS. After IRB approval/consent, the plasma of 10 patients
undergoing LVAD implantations was analyzed for resolvin D1 and D2
using liquid chromatography and mass spectrometry (LC-MS) pre-
operatively and then daily until postoperative day 10. Arterial lactate
concentrations were determined as an indicator of inflammation.
RESULTS. Ten patients were studied from August to October 2018.
Resolvin D1 was 827 +/- 187 pg/mL at baseline, decreased initially to
then 327 /- 185 pg/mL and then increased again with a peak on
postoperative day 4 of 960 +/- 308 pg/mL. Mean Resolvin D2 levels
were 169 +/- 44 pg/mL at baseline and fluctuated around 180 to 340
pg/mL postoperatively with no discernable trend. The lactate con-
centrations were elevated preoperatively and decreased to normal
levels within 4 days.
CONCLUSION. We were able to detect SPMs after acute inflammation:
Resolvin D1 peaked at day 4 at a time when inflammation decreased
as indicated by normalizing lactate concentrations. However, Resolvin
D2 remained unchanged throughout the postoperative period.
Patients undergoing LVAD implantation are in end-stage heart failure
with other end-organ failures and, therefore, already have high levels
of inflammation prior to surgery. Thus, it may be more difficult to
identify a pattern of resolution.
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INTRODUCTION. Patients admitted to the intensive care unit (ICU) are
subject to sleep disturbance[Devlin et al, 2018]. Inadequate quality
sleep or restlessness at night requiring sedation is a marker of circadian
dysfunction in critical illness[Drouot et al, 2008; Pandharipande PP,
et al., 2013]. Circadian rhythm disruption is increasingly implicated as a
key factor leading to ICU delirium[Madrid-Navarro CJ,et al., 2015]. ICU-
related delirium has been associated with ongoing sleep disturbance
and cognitive morbidity after critical illness[Orwelius L., 2008].OBJECTIVES. The aim of this study was to evaluate the risk factors as-
sociated with long term cognitive dysfunction in patients after ICU
admission.
METHODS. We conducted a retrospective review of patients admitted
to our ICU from January to December 2018. Inclusion criteria were age
>18 years, Length of stay>48 hours, mechanical ventilation and use of
sedatives. Demographics, comorbidities and known risk factors for ICU-
delirium were collected. Patients’ overnight state, sleep quality and
symptoms of delirium, as documented by nurses each day were also re-
corded. Patients or Next of Kin were then contacted by telephone for
interview, when consent was obtained. Health-related Quality of Life
(HRQoL) and Post-traumatic Stress Disorder (PTSD) screening Question-
naires were administered over the phone.
RESULTS. Of the 87 patients who met the inclusion criteria, 24 did
not survive ICU, 6 were transferred elsewhere and 12 deceased since
discharge. Therefore 45 were available for phone interview, with a
62% response rate and one declining consent. Of the 27 patients in-
cluded, 11 had Mental Component HRQoL scores at 6 months below
the population average (42±7 vs 58±3). Patients with lower Mental
Component HRQOL scores at 6 months had a higher rate of blood
transfusions (6/11 vs 3/16, p=0.056), and circadian rhythm disruption
(5/11 vs 14/16, p=0.018) in ICU. They also presented a higher rate of
PTSD screen score at 12 months (5 [3,7] vs 1 [0,1.25], p=0.011).
CONCLUSION. Long-term cognitive dysfunction is common after ICU
admission. These patients had circadian rhythm disturbance in ICU
and were transfused more frequently. They were also more prone
to develop long-term PTSD. This small retrospective study encour-
ages further investigation of this interesting relationship.
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INTRODUCTION. New or worsening cognitive impairment occurs in
up to 58% of survivors of critical illnesses and is long-lasting, with
significant disability and socioeconomic cost[1]. There are currently
no known interventions that reduce the incidence of cognitive im-
pairment after critical illnesses. Immersive Virtual Reality (IVR) is the
use of technology to create a perception of presence in a three-
dimensional, computer-generated interactive simulated environ-
ment[2]. A prior clinical study has demonstrated potential efficacy in
cognitive rehabilitation of severe traumatic brain injury [3,4]. Clinical
data on the use of virtual reality in the critical care unit is limited to
case report[5], paediatric population[6] or non-immersive virtual
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mechanically ventilated adult patients.
OBJECTIVES. The primary aim of this study is to evaluate the safety
and tolerability of immersive virtual reality for potential early neuro-
cognitive stimulation in critically-ill, mechanically ventilated patient-
s.The secondary aim of the study is to evaluate the potential of 4-
channel electroencephalogram (EEG) headbands in detecting differ-
ences in attention during the use of immersive virtual reality.
METHODS. Patients aged above 21, admitted to the intensive care
unit for acute respiratory failure or septic shock, were evaluated for
recruitment from 1st July 2018 to 1st April 2019. Recuited patients
were randomised into the control or intervention groups. Patients in
the intervention group would have two 15-minute sessions of IVR
daily for up to a maximum of 3 days. The IVR videos were specially
curated for this study and comprised of a combination of nature
scenary coupled with soothing classical music. In both intervention
and control groups, a 4-channel EEG headband would be applied
over the subject’s forehead. Assessment of safety involved monitor-
ing for physiological derangements in heart rate, respiratory rate,
pulse oximetry and blood pressure during the IVR session, compared
with the control group. Assessment of tolerability involved monitor-
ing for increased agitation.
RESULTS. 6 patients were randomised into the intervention group
and 5 patients were in the control group. There were no significant
differences between both groups in the baseline variables such as
age, gender, race, Charlson Co-morbidity Index, APACHE II scores.
The patients in the control group required more days of mechanical
ventilation compared to the intervention group (5.4 ± 3.6 days vs.
2.8 ± 1.2 days). Use of vasopressors, renal replacement therapy and
sedatives were similar in both groups. 2 of 6 patients in the interven-
tion group had delirium during and after the ICU stay compared with
1 of 5 patients in the control group. The intervention group com-
pleted an average of 1.3 ± 0.8 IVR sessions compared to the control
group, which completed 3.0 ± 1.9 session. In the intervention group,
83.3% (5 of 6) patients did not have significant physiological de-
rangements compared to 100% (5 of 5) patients in the control group.
However, 50% (3 of 6) patients in the intervention group demon-
strated increased agitation compared to 20% (1 of 5) patients in the
control group.
CONCLUSION. The use of IVR in mechanically ventilated patients is
safe, however, it may not be tolerated in some patients, resulting in
increased agitation. It is uncertain if it can provide neurocognitive
stimulation, further correlation with EEG data is required.
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INTRODUCTION. Acute pancreatitis (AP) can lead to an increase in
the intra-abominal pressure (IAP) that, if it is not recognized, can de-
velop an abdominal compartment sindrome (ACS), causing multiple
organ failure and a high mortality rate.
OBJECTIVES. To evaluate if intra-abdominal pressure (IAP) can deter-
mine the therapeutic attitude and contribute to increase the survival
rate in patients diagnosed with critical acute pancreatitis admitted to
a medical ICU in a second-level Hospital in an eight-year period
(January 2011- December 2018)
METHODS. Descriptive and retrospective study of patients with
acute pancreatitis admitted to a medical ICU in eight years (
2011-2018). Acute pancreatitis was classifed accordig to the
determinant-based classification of acute pancreatitis severity pub-
lished in Annals of Surgery1 : mild-moderate (AP-MM), severe (AP-
S), critical (AP-C). In critical acute pancreatitis the following pa-
rameters were analyzed: gender, age, etiology, APACHE II score
(within 24 hours of admission), Balthazar CT severity index, type
of early nutrition (within 48 hours), multiple organ failure (MOF):
respiratory ( Rp: PaO2/FiO2 ratio<300), cardiovascular ( Cv: ino-
tropic support required), renal ( R: creatinine >2 mg/dL), need for
mechanical ventilation ( MV > 5 days), renal support (continu-
ous renal replacement therapy (CRRT)), IAP value2 ( maximum
value maintained for at least 12 hours), laparotomy performed (
Lap-P) : if IAP>30 mmHg and MOF (> 1), laparotomy not-
perfomed ( Lap-noP): IAP<30 mmHg and MOF ( >1), and mortal-
ity rate. Statistical analysis: quantitative variables are expressed as
mean and standard deviation (SD) and qualitative variables as
percentages (%). The difference between qualitative variables are
expressed using chi-square test and quantitative using an ANOVA
analysis.
RESULTS. 88 patients diagnosed with AP were admitted: type AP-
MM 26, type AP-S 30 and type AP-C 32. Of critical AP: 21 male (11 fe-
male), age: 59,5±15,3 years old, etiology: gallstone-related 15, alcohol
abuse 10, idiopathic 4 and other 3. APACHE II score: 14,7±6,3, Baltha-
zar: 6,1±2,5, nutrition: parenteral 15, enteral 10, mixed 4, none 3.
Need for mechanical ventilation: 20 ( 62,5%) and CRRT required: 12
(37,5%). In group Lap-P (20 patients): 8 with Rp+CV, 8 with Cv+R and
4 with Rp+Cv+R. In the Lap-noP group (12 patients): 6 with Rp+Cv, 3
with Cv+R and 3 with Rp+Cv+R. Mortality in Lap group: 6 patients ( 1
Rp+Cv, 3 Cv+ R, 3 Re+Cv+R), and in group Lap-noP: 4 patients ( 1
Rp+Cv, 2 Cv+R, 1 Rp+Cv+R).
CONCLUSION. According to our series, in group Lap-P, 80% of the
patients with critical AP had failure of at least two organs, whilst the
Lap-noP had 75%. In terms of mortality rate, it was 30% in the Lap-
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INTRODUCTION. Delirium in general intensive care unit (ICU) patients
has been associated with prolonged ICU and hospital length of stay
(LOS), more ventilator days, increased short- and long-term mortality
and long-term cognitive impairment [1-3]. However, knowledge on
delirium in oncological ICU patients is scarce.
OBJECTIVES. To assess the frequency of delirium and its impact on
resource utilizations and outcomes in ICU patients with malignancy.
METHODS. This retrospective, single-center longitudinal cohort study
included all patients with malignancy admitted to ICUs of a Univer-
sity Hospital during one year. Delirium was diagnosed by an Inten-
sive Care Delirium Screening Checklist (ICDSC) score ≥ 4. Group
comparisons were made with Fisher’s exact and Mann-Whitney U
tests. Multivariate analysis was performed with binary logistic regres-
sion, Cox regression with hazard ratios < 1 indicating longer LOS,
and multiple linear regression. Results are given as number (percent-
age) and median (interquartile range).
RESULTS. Of the 488 ICU patients with malignancy, 176/488 (36%)
developed delirium during their ICU stay. Delirium showed high fre-
quencies in patients with hepatic (13/21 [62%]) and lung malignan-
cies (29/65 [45%]) as well as lymphomas (7/15 [47%]). In addition, it
was particularly frequent in patients from thoracic (27/47 [57%]) and
abdominal surgery (54/136 [40%]) and internal / general medicine
(16/29 [55%]). Delirious patients had higher age (66 [55-72] vs 61
[51-69] years, p = 0.001), Charlson Comorbidity Index (4 [2-8] vs. 4 [2-
8]), p = 0.034) and SAPS II (41 [27-68] vs 24 [17-32], p < 0.001), and
more often a sepsis (26/176 [15%] vs 6/312 [1.9%], p < 0.001) and a
shock (30/176 [6.1%] vs 6/312 [1.9%], p < 0.001). Univariate and
multivariate analysis show that delirium was independently associ-
ated with longer LOS in ICU (HR [95% CI] 0.295 [0.234-0.371], p <
0.001) and hospital (HR [95% CI] 0.619 [0.500-0.765], p < 0.001), as
well as higher ICU nursing workload (B [95% CI] 1.917 [1.665-
2.206], p < 0.001) and ICU (B [95% CI] 2.077 [1.811-2.382], p < 0.001)
and total costs per case (B [95% CI] 1.442 [1.301-1.597], p <
0.001). However, while being a strong marker of in-hospital mortality
in univariate analysis (OR [95% CI] 5.909 [2.872-12.160], p < 0.001),
delirium did not independently increase in-hospital mortality in
multivariate analysis (OR [95% CI] 2.263 [0.925-5.537], p = 0.074).
CONCLUSION. In ICU patients with malignancy, delirium was a fre-
quent complication independently associated with high resource uti-
lizations, but it was not an independent risk factor of in-hospital
mortality.
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INTRODUCTION. Red blood cell (RBC) transfusion is a frequently ap-
plied intervention at the intensive care unit. However, transfusion is
associated with adverse outcome including organ failure and
thrombo-embolic events, the mechanism of which is not known, but
may be related to the underlying disease severity.
OBJECTIVES. The aim of this study was to investigate the effect of
RBC transfusion on endothelial cell activation and coagulation
markers in critically ill patients.
METHODS. In 74 non-bleeding patients admitted to the ICU of a ter-
tiary academic hospital receiving one RBC unit, biomarkers of endo-
thelial cell activation, inflammation and coagulation (von Willebrand
Factor (vWF) antigen, soluble ICAM-1, soluble thrombomodulin (sTM),
soluble syndecan-1, TNFa, IL-6, d-dimer, fibrinogen, APTT and PT)
were measured before transfusion, at one hour after transfusion and
24 hours after transfusion. The impact of disease severity was
assessed by comparing septic and non-septic patients and by correl-
ation of biomarkers with organ injury score (SOFA).
RESULTS. Included patients were predominantly male (55%) with a
median age of 63 years. 55% of the patients was septic according to
Sepsis-3 criteria. Levels of vWF antigen, soluble ICAM-1, sTM, fibrino-
gen and d-dimer were already high at baseline. VWF antigen levels
increased significantly 24 hours after RBC transfusion (478% vs 526%,
p = 0.02). The other biomarkers did not change. Post transfusion
change of the measured biomarkers was not different between sep-
tic and non-septic patients and was not correlated with SOFA score.
CONCLUSION. RBC transfusion in critically ill patients was associated
with an increase in circulating vWF antigen levels, suggesting a fur-
ther increase in activation status of the endothelium, a finding that
was independent of sepsis status or organ injury level.
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Page 177 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. In recent, intravenous immunoglobulin(IVIG) has
been used as one of the adjunctive therapy for septic patients. Al-
though IVIG is not recommended in the Survival Sepsis guideline, it
has still debate to be estimated as an effective treatment for sepsis.
OBJECTIVES. The authors tried to evaluate the effect of IVIG in the
critically ill patient who got abdominal surgery due to pan-peritonitis.
METHODS. It is a retrospective study analyzing 646 patients’ elec-
trical medical record from March 2013 to June 2018. The patients
who had been diagnosed as secondary pan-peritonitis and managed
in the ICU after getting emergency operation were indicated in this
study. In this population, the comparison was made between pa-
tients who were injected with IVIG and those who did not administer
IVIG. As outcome variables, mortality curve, 30-day mortality, hospital
mortality and ICU duration were evaluated in each group. Of the 576
patients who were operated for pan-peritonitis during the study
period, 169 were analyzed, excluding 307 patients who had left ICU
within three days due to minor severity and 100 patients with con-
traindications. 44 patients were injected with IVIG and 125 patients
were treated with conventional management without IVIG. After pro-
pensity scoring matching adjusted by APACHE II score and SOFA
score, IVIG group (34 patients) and non-IVIG group ( 34 patients)
were compared to each other.
RESULTS. There was no significant different outcome between the
IVIG group and non-IVIG group however the hazard ratio of the non-
IVIG group was higher than the IVIG group significantly in mortality
and hospital mortality. (Overall mortality, Crude HR 1.68 (0.68~4.12),
Adjusted HR 1.75 (0.69~4.44); Hospital mortality, Crude HR 1.83
(0.61~5.47), Adjusted HR 2.12 (0.68~6.67)) In the survival curve, there
was a trend to separate completely between the IVIG group and
non-IVIG group as the time went on. (Overall mortality, P=0.105; Hos-
pital mortality, p=0.093)
CONCLUSION. In septic patients with pan-peritonitis, the use of IVIG
after proper surgery and the use of antibiotics could affects the risk
of overall mortality and hospital mortality.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000557INTRODUCTION. Blood cultures are part of the septic shock protocol
for patients admitted to the Intensive Care Unit (ICU) at Glasgow
Royal Infirmary (GRI) Hospital. This aims to identify causative organ-
isms quickly and guide or refine antibiotic therapy. However, patients
with sepsis should rarely be admitted to ICU without blood cultures
and antibiotic therapy initiated. As per surviving sepsis guidelines,
these cultures should have been carried out prior to treatment with
antibiotics. Recent antibiotic therapy reduces positive culture rates,
therefore it's possible that repeating cultures does not contribute to
patient care.
OBJECTIVES. To evaluate the clinical value in carrying out blood cul-
tures routinely in all septic shock patients and to determine the fre-
quency at which new causative organisms idetntified.
METHODS. This was a retrospective analysis of 241 patients with
vasopressin dependent septic shock admitted between Jan 17-Nov
18 to our ICU. Mean age of the cohort was 60.8 yrs (range 19-
92) and 56% were male. We recorded blood cultures performed up
to 24hrs pre and 24hrs post ICU admission.
RESULTS. Of 241 patients, 144 (59.7%) had cultures prior to ICU ad-
mission. 45 (31.25%) were positive. Post ICU admission, 115 (47.7%)
patients had blood cultures, 13 (11.4%) of these were positive for an
organism.
A total of 65 (56.5%) out of 115 patients who were cultured post-ICU
admission had not had cultures previously. 8 (6.9%) of these cultures
grew micro-organisms. Three (2.6%) patients had cultures which re-
ported no growth prior and became positive following admission cul-
tures. Two (1.7%) patients had blood cultures which were positive
before and after admission, however the second set of cultures did
not provide any new information only confirming the initial result. 30
(12.45%) of 241 patients had no cultures taken.
CONCLUSION. While new information was gained from repeat cul-
tures the yield was low. There remains a significant number of pa-
tients who don't have cultures taken prior to ICU admission. Given
that septic patients’ outcomes are time sensitive and early cultures
are more likely to be positive, efforts to improve yield should be con-
centrated here. This project supports the notion that there is value in
post-ICU admission blood cultures, though the number of new posi-
tive results is relatively low.
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INTRODUCTION. Carbapenem resistance among Gram-negative ba-
cilli (CR-GNB) has been increasing over the past several decades, par-
ticularly in Enterobacteriales species. Infections due to CR-GNR are
increasing in frequency and result in high morbidity and mortality.
Overuse/misuse of carbapenems as initial antibiotic therapy is a risk
factor to develop carbapenem resistance in hospitalized patients.
OBJECTIVES. To find out the correlation between early carbapenem
exposure and other risk factors in the development of carbapenam
resistance amongst Gram negative bacilli.
METHODS. We have conducted a retrospective study of all patients
with positive cultures from any source over a 2-year period at a ter-
tiary care hospital from 2016 to 2018 to develop a comprehensive
model for risk of infection or colonization with CR-GNB, with separate
analyses for Ertapenem resistant (ER-GNB) and antipseudomonal car-
bapenem resistant (ACR-GNB) isolates. Routine susceptibility testing
was performed by the either the CLSI reference broth microdilution
method (BMD) or using a Vitek 2. All antimicrobial susceptibility data
were interpreted using current CLSI breakpoints for carbapenems.
RESULTS. A total of 2450 GNB isolates from 1320 patients were ana-
lyzed, of which 412 were CR (ER 130 and ACR 282). The majority of
ER-GNB were Klebsiella species, whereas the most common ES-GNB
were Escherichia coli; the most common ACR-GNB were Acenetobacter
species. Risk factors for CR-GNB were, receipt of any carbapenem in
the prior 30 days, any surgical intervention in recent past, admission
from another health care facility, ventilation at any point before cul-
ture during the index hospitalization, any invasive device including
foley’s catheterization and receipt of any anti-MRSA agent in the
prior 30 days.
CONCLUSION. Initial choice of antibiotic remains a challenging
and high-stakes decision. Early exposure with carbapenem is a risk
factor for development of CR-GNB infection in later days of
hospitalization. Delayed antimicrobial therapy in carbapenem resist-
ant infections has higher mortality, highlighting the need for rapid
identification of patients at high risk for CR-GNB. Rational antibiotic
therapy and antimicrobial stewardship is the need of the hour.
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INTRODUCTION. We previously showed that an intervention devel-
oped by ‘Iceman’ Wim Hof enables voluntary activation of the sym-
pathetic nervous system, reflected by profoundly increased plasma
adrenaline levels, which subsequently caused profound attenuation
of the inflammatory response during experimental humanendotoxemia. The intervention consisted of a training program
encompassing several elements that may have contributed to the
observed effects, namely two different breathing techniques per-
formed during the endotoxemia experiments, and exposure to cold
in the days before endotoxemia.
OBJECTIVES. For possible future clinical application, we aimed to deter-
mine the contribution of the different elements of the training program
to the effects observed in our previous study. Furthermore, we assessed
if the duration of the training is of relevance, and whether it can be
provided by an independent trainer instead of Mr. Hof.
METHODS. To determine the optimal breathing technique to induce
adrenaline release, 40 healthy male volunteers were randomized to
training in both techniques (cycles of hyperventilation followed by
either muscle tightening for 10 seconds or breath retention for sev-
eral minutes) for either 4 days or 1 hour, by either Mr. Hof or an in-
dependent trainer. In a subsequent endotoxemia study, 48 healthy
male volunteers were randomized to four groups: 4-day cold expos-
ure training (CLD group), training in the optimal breathing technique
(BRT group), a combination of both interventions (CBR group), or no
intervention (CON group). The CLD and CBR groups were subjected
to cold exposure in snow and water of 1 oC. All 48 subjects were
subsequently challenged with 2 ng/kg LPS to induce endotoxemia.
RESULTS. In the first part of the study, arterial blood saturation
levels and pO2 were significantly lower when subjects performed
the breathing technique with breath retention (both p<0.001),
but plasma adrenaline levels increased to a similar extent imme-
diately after initiation of both breathing techniques (0.48 nmol/L
[-0.01-1.2] vs. 0.50 nmol/L [0.25-0.91] upon the breath retention
and muscle tightening techniques, respectively). No effects of
training duration or trainer were observed on adrenaline levels or
any other parameters. In the second part of the study, we there-
fore employed a short training in the breathing technique with-
out breath retention, and all training procedures were provided
by an independent trainer. Peak endotoxin-induced flu-like symp-
tom scores were significantly lower in the CLD group (4.1±0.6 vs.
7.9±1.4 in the CON group, p=0.02), and resolved more rapidly. In
the CBR group, plasma levels of pro-inflammatory cytokines were
attenuated (TNF-α: -33%, p=0.03, IL-6: -58%, p=0.03), whereas
concentrations of the anti-inflammatory cytokine IL-10 were in-
creased by 73% (p=0.02) compared with the CON group. In the
BRT group, similar, but less pronounced effects on plasma cyto-
kines were observed, whereas no differences in cytokine levels
were observed between the CLD and CON groups.
CONCLUSION. The combination of cold exposure and the breathing
technique without breath retention attenuates the in vivo inflamma-
tory response most potently. These results demonstrate that the im-
munomodulatory effects of the intervention developed by Wim Hof
can be reproduced making use of short standardized protocols and
an independent trainer.000589
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the Emergency Department (ED) is crucial. Therefore, identification of
patients at high risk of organ failure or shock is key to prevent deteri-
oration and reduce mortality. Currently, no prognostic tool seems ef-
ficient to identify these patients. The infection site could represent a
major factor of heterogeneity in the prognostic performance of bio-
markers in septic patients.
OBJECTIVES. To evaluate the prognostic performances of biomarkers
to predict the clinical deterioration of patients with sepsis in ED ac-
cording to their site of infection.
METHODS. TRIAGE was an international multi-centre (France and Belgium)
prospective observational study (ClinicalTrials.gov: NCT02739152) designed
to evaluate a panel of prognostic biomarkers in adult septic patients admit-
ted in ED (SIRS criteria). Blood samples were collected at 0, 6 and 24 hours
after ED inclusion. Main outcome was subsequent deterioration (death, ICU
admission, 1-point increase of SOFA score) within 72 hours. The diagnosis
of sepsis and the evolution criteria were centrally validated by an independ-
ent adjudication committee of sepsis experts. The prognostic performances
of endothelial biomarkers (sVEGFR2, sUPAR) were assessed according to
the site of infection using logistic regression models. AUC were calculated
using the DeLong method.
RESULTS. Overall 462 patients were analysed, 124 patients were con-
firmed as deterioration and 338 patients without deterioration. Sites
of infection were mainly lungs (29%), urinary tract (27%) and abdo-
men / pelvis (25%). Patients with pulmonary infection were signifi-
cantly more severe (qSOFA, and Charlson score) (p<0.001) than the
other patients. These patients were also the ones who deteriorated
the most within 72 hours and had a higher D28 mortality (p=0.0047).
Expression of biomarkers was significantly associated with the risk of
deterioration regardless of the site of infection (Lung: OR = 1.9 [1,24-
2.86], Urinary: OR = 2.6 [1.3-5.82], Abdomen-pelvis: OR = 2.4 [1.26-
4.97], Others: OR = 1.67 [1.05-2.74], p <0.05). Nevertheless, the pre-
dictive performance of short-term deterioration by the biomarkers
was higher in patients with urinary and abdominopelvic infections
(AUC = 0.70, sp=51, NPV=95 and AUC = 0.81, sp=51, NPV=93, re-
spectively) compared to lung infections and other sites of infection
(AUC = 0.66, sp=19, NPV=79).
CONCLUSION. Although biomarkers were associated with a risk of
deterioration of septic patients, the predictive performance of
sVEGFR2 and sUPAR was significantly lower in patients with pulmon-
ary infection when compared to those with urinary tract or abdomi-
nopelvic infection.
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INTRODUCTION. Accurate prognostic assessment of septic patients is
challenging in the emergency department (ED). Identification of pa-
tients at high risk of organ failure or shock could help to prevent de-
terioration and reduce mortality. Clinician’s assessment is based on
initial severity, scoring, social context, hospital bed capacity, and on
personal experience. The performance of emergency physicians in
predicting septic patient’s outcome has been scarcely described, andthe additional value of a prognostic biomarker has not often been
evaluated in the ED.
OBJECTIVES. To calculate the prognostic performance of emergency
physicians to predict clinical deterioration of septic patients during
their initial management in the ED and to evaluate if adding bio-
markers information could improve this clinical prediction.
METHODS. This is an ancillary study of the TRIAGE study (Clinical-
Trials.gov: NCT02739152) designed to evaluate a panel of prognostic
endothelial biomarkers (sVEGFR2 and sUPAR) in a cohort of adult
septic patients admitted to the ED. The analysis was performed on
non-severe patients (SOFA<2) of two teaching hospitals. The risk of
clinical deterioration was assessed by an adjudication committee
composed of three independent emergency physicians (blinded from
deterioration outcome) according to the emergency medical records
and the first conventional biological and imaging results. This first
judgement allowed to calculate the clinical emergency physician’s
performance. Then, adjudicators were unblinded from the results of
biomarkers (which helped classifying patients into two groups: “high
risk” or “low risk”) and were asked to keep or revise their first judge-
ment. This second judgement allowed assessing the additional value
of biomarkers. Finally, the performance of biomarkers alone was
calculated.
RESULTS. Analyses were performed on 145 patients (age = 50±20 yr;
Charlson score: 1.7 [0-3]; SOFA score: 0.5 [0-1]; lactates: 2.03 [1.17-
2.41]; site of infection: pulmonary 12.4%, urinary 32.4%, abdomino-
pelvic 34.5% and 30 patients deteriorated (21%). The clinical per-
formance of emergency physicians to predict deterioration was:
Sensitivity=80; Specificity=21; Negative Predictive Value=80; Positive
Predictive Value=21. Adding the biomarkers improved the clinical
prognostic performance of emergency physicians (Sensitivity=90;
Specificity=19; Negative Predictive Value =88; Positive Predictive
Value =23). Biomarker alone was the best predictor of deterioration
(Sensitivity =93; Specificity =50; Negative Predictive Value =97; Posi-
tive Predictive Value =33).
CONCLUSION. This study confirms that predicting the clinical deteri-
oration of septic patients in the ED remains challenging. Adding
prognostic biomarkers (sVEGFR2 and sUPAR) to clinical evaluation
could be helpful in early assessing the risk of deterioration of septic
patients, and safely ruling out patients after ED admission due to its
high negative predictive value.
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INTRODUCTION. Calcium can be considered an adjunctive rescue ther-
apy for refractory septic shock, but research on calcium use is limited.
In this study we aimed to investigate short-term hemodynamic re-
sponse after calcium supplementation in patients with refractory septic
shock.
METHODS. This was a single-center, retrospective study of patients
who presented to the emergency from October 2014 through February
2018. Patients with refractory septic shock requiring norepinephrine-
equivalent (NE) dose ≥ 0.5 μg/kg/min and receiving calcium supple-
mentation were included. Patients were categorized into a response
group and no-response group based on the changes in NE doses and
MAP after calcium administration. A multivariable logistic regression
model was used to evaluate the association between hemodynamic re-
sponse and 28-day survival.
RESULTS. A total of 66 patients were included. Among them, the re-
sponse group included 34 (52%) patients and the no-response group
31 (48%) included 17 patients who deteriorated and 15 patients who
had no significant changes in clinical status. The 28-day mortality
Page 180 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55was 44% in the response group and 63% in the no-response group
(P = 0.14). Multivariable analysis revealed that the response group
had a significant association with lower 28-day mortality (the ad-
justed OR, 0.23; 95% CI, 0.06–0.89; P = 0.03).
CONCLUSION. Short-term hemodynamic changes after calcium ad-
ministration were variable in patients with refractory septic shock.
Hemodynamic improvement after calcium supplementation was as-
sociated with better survival. Further studies are needed to deter-
mine when calcium should be considered and how it impacts
patient-centered outcomes in refractory septic shock.
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INTRODUCTION. Community-acquired pneumonia (CAP) is the pri-
mary cause of infectious death in developing countries. During CAP,
infected patients initiate immune responses that promote local and
systemic inflammation. While several proinflammatory molecules
have been described and linked to a greater risk of complications,
longer hospital stays and mortality; novel biomarkers are still
required for superior identification of disease severity. TNF-like weak
inducer of apoptosis (TWEAK) is a member of the TNF-alpha super-
family, involved in immune response, cell growth, angiogenesis, NF-
kB activation and apoptosis induction in tumor cells. It is known that
serum-TWEAK promotes inflammation in diseases such as multiple
sclerosis, atherosclerosis and pancreatitis. Importantly, its role in dis-
ease severity of CAP patients is still unknown. Therefore, this study
aims to determine whether there is a relationship between serum
concentration of TWEAK and prognosis in CAP patients.
OBJECTIVES. To determine the relationship of serum concentration
of tumor necrosis factor (TNF)-like weak inducer of apoptosis
(TWEAK) and mortality in community-acquired pneumonia (CAP)
patients.
METHODS. This is a multicenter 2-year cohort study in Spain, de-
signed to better understand the role of sTWEAK concentrations in
CAP patients. A total of forty-three patients were enrolled in two Uni-
versity hospitals (10 healthy users, 10 uninfected controls and 23
CAP patients). sTWEAK was measured within the first 24 hours of ICU
admission. Samples were collected and stored for laboratory ana-
lyses. To detect sTWEAK in human samples, we used a commercially
available ELISA kit following manufacture’s instructions. Demographic
patients’ characteristics and ICU mortality were prospectively col-
lected. Descriptive statistics and logistical regressions were used to
assess the proposed aims.
RESULTS. In comparison to healthy volunteers, patients admitted to
the hospital (both, infected and non-infected) had lower level of
sTWEAK. During hospital admission, 7 (17%) patients died. Patients
whom died during ICU stay had significantly lower levels of sTWEAK
when comparing with patients whom survived (Median [IQR]; 509.35
[357.49, 953.92] Vs 1103.03 [716.93, 1663.16]; p=0.015). In contrast,
patients that developed shock did not have different concentrations
of sTWEAK (Median [IQR]; 1008.04 [531.87, 1390.80] Vs 1062.29
[575.24, 1598.83], p=0.84).
CONCLUSION. To our knowledge, this is the first study to show a role
for sTWEAK in the morbidity and mortality of CAP patients. Here weshow that CAP patients with lower systemic sTWEAK had increased
mortality rate, suggesting a beneficial role for sTWEAK in the host re-
sponse against infection. This biomarker may identify patients at risk
of developing severe CAP and subsequently died in the ICU. How-
ever, further studies are needed to confirm these findings.
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INTRODUCTION. Although the role of automatic alerts for early de-
tection of sepsis remains unclear, it is true that majority of electronic
alerts for early detection of sepsis are based on sepsis 2 definitions.
No data about alerts based on sepsis 3 definition has been provided.
OBJECTIVES. The aims of this study were to describe SEPSIS SAVER, a
new electronic alert based on sepsis 3 definition; to compare it with
an electronic alert based on sepsis 2 and to know its sensiblity, speci-
ficity, negative predictive value (NPV) and positive predictive value
(PPV).
METHODS. SEPSIS SAVER is a new electronic tool designed by a
multidisciplinary group composed by members of three sepsis units
of three teaching hospitals based on sepsis 3 definition.
During a month period (March 2018) it has been implemented as a
pilot in one of the hospitals and has been prospectively evaluated.
This unique center has been working with a previous electronic sep-
sis alert based in sepsis 2.0 six years ago.
Clinical and microbiological variables were recorded. Any patient ad-
mitted at Emergency room was potentially eligible using the two sis-
tems simultaneously. Sensibility, specificity, NPV and PPV were
calculated for both alerts using sepsis team criteria as Gold standard.
RESULTS. Among 1378 electronic activations, 58 (4,2%) were con-
firmed as a sepsis severe/ septic shock (sepsis 2) or sepsis (sepsis 3)
by the members of sepsis team. It means a rate of 22,8 episodes/
100.000 inhabitants a month . The most frequent sources of infec-
tions were the respiratory focus (39%) following by urinary (26.6%)
and abdominal (18.5%). Only 18.9% of patients were admitted to
ICU. Global mortality was 18.9%. The majority of episodes were com-
munity adquired (85%). Forty episodes were detected by the two
alerts. SEPSIS SAVER detected 46 true episodes with 12 false negative
results compared with the tool based on sepsis 2 definitions which
detected at the same time 52 episodes with 6 false negative results.
Sensibility, Specificity, NPV and PPV of SEPSIS SAVER were 79,3%;
50,6%; 3,3% and 99,1% respectively. Sensibility, Specificity, NPV and
Fig. 1 (abstract 000710). See text for description
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respectively
CONCLUSION. SEPSIS SAVER showed an adequate capability to de-
tect sepsis as well as did alert based on sepsis 2 definition. Both tools
need to be modified in order to improve their specificity with new
definitions
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INTRODUCTION. Sepsis is a major health issue in Brazil and, is in-
creasing death rate in recent years[1]. A comparison between our
country and England showed that crude hospital mortality in sepsis
has no difference[2]. The incidence of septic shock (SS) in a French
study was 13.7% and the 28 day mortality rate was 42%[3], charac-
terizing a high-risk death population.
OBJECTIVES. To identify the epidemiological profile, resource
utilization and mortality in SS patients admitted to a single center
ICU, in Southern Brazil.
METHODS. All patients that presented SS criteria (need of vasopres-
sor therapy despite adequate fluid resuscitation to maintain MAP ≥
65 mmHg) during ICU stay were enrolled in the study. Data collected
prospectively were: age, gender, comorbidities [diabetes mellitus
(DM), hypertension, cancer and chronic renal disease (CRD)], site of
infection, SAPS 3 and SOFA at admission. Resource utilization was
considered mechanical ventilation (MV), invasive hemodynamic mon-
itoring (IHM) and renal replacement therapy (RRT). ICU and hospital
mortality were reported. Continuous variables were presented as
mean±SD, using Student t test for comparison and categorical vari-
ables presented as percent. Mortality prediction was done using the
receving characteristic curve (ROC).
RESULTS. Between February 2012 and December 2018, 2707 patients
were ICU admitted in ICU and 315 (11.6%) presented SS. Mean age
was 63,2±15,6 yrs and 56,8% were male. DM, hypertension, cancer
and CRD were present in 21.3%, 42.5%, 15.2% and 6.3%, respectively.
Average SAPS 3 and SOFA were 66.3±13.7 and 8.4±3.0. The use of
MV, IHM and RRT was 93.7%, 7.6% and 15.9%, respectively. Mortality
in ICU was 43.5% and in hospital 55.6%. Factors associated with ICU
mortality were cancer (OR 1.429; CI 95% 1.081-1.889), CRD (OR 1.546;
CI 95% 1.091-2.191), MV (OR 4.576; CI 95% 1.222-17.142) and RRT (OR
1.55; CI 95% 1.192-2.015).
CONCLUSION. In Southern Brazil, SS incidence and mortality is simi-
lar to the recent published data. The presence of comorbidities and
severity of organ dysfunction increase the mortality risk in a similar
rate of observational studies. These patients demand an important
resource use, mainly MV and RRT.
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INTRODUCTION. Emergence of multidrug-resistant bacteria (MDR)
are facilitated by the abusive use of antibiotics. Multiple clinical trials
have evaluated the usefulness of procalcitonin (PCT) to guide the ini-
tiation and completion of antibiotic therapy. However, they included
mainly patients with sepsis of the community, with few MDR isolates.
OBJECTIVES. Investigate the kinetic of PCT and the time necessary to
decrease it in MDR infections.
METHODS. Retrospective observational study, PCT curves of all
bacterial rescues of ventilation associated pneumonia (VAP) and
catheter-related bloodstream infections (CRBSI) were analyzed
during the period from November of 2016 to May of 2018 in the
intensive care unit of the Hospital Italiano de Buenos Aires,
Argentina. Patients with an infectious intercurrence during the
antibiotic course were excluded from the study together with
those dead before the expected decrease in PCT or with chronic
infections.
RESULTS. During the period analyzed, 73 bacterial rescues were re-
covered. 47 patients were excluded from the analysis due to the ex-
clusion criteria. 12 patients with sensitive bacteria (SB) and 14
patients with MDR were selected for the final analysis, without sig-
nificant differences between population. Patients with CRBSI gener-
ated by MDR showed significantly higher maximum values of PCT:
MDR mean 39 ug/l (SD+/-30) vs. SB mean 10.7 ug/l (SD+/-11), (p=
0.02). The time elapsed from the detection of the bacteria to the de-
crease of 80% or values lower than 0.5 ug/l, with effective antibiotic
treatment, was in MDR 7.2 (SD+/-2.9) days vs. 5 (SD+/-1.8) days in SB
with a significant difference (p=0.03). The PCT decrease was expo-
nential in both groups, with quicker decrease in SB than in MDR (Fig-
ure 1).
CONCLUSION. The inflammatory response measured by PCT in MDR
was greater and longer, even with an effective antibiotic treatment,
which could be due to greater virulence. However, the decline occurs
before conventional antibiotic schemes are completed. In this sense
it is necessary to study the potential application of antibiotic proto-
cols guided by PCT to this population.
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INTRODUCTION. Sepsis is characterized by a simultaneous imbalance
of hyperinflammation and immunosuppression. The decreased ex-
pression of HLA-DR molecules on circulating monocytes (mHLA-DR)
has been associated with anti-inflammatory immune response, re-
ferred to as “immunoparalysis” status. On the other hand, in a proin-
flammatory scenario, neutrophils can increase the expression of
CD64 molecules (nCD64), emerging as a potential biomarker in the
diagnosis of sepsis. Sepsis Index (SI), which is defined as the ratio be-
tween nCD64 and mHLA-DR, is considered a novel parameter in
prognostication of sepsis.
OBJECTIVES. This study aims to evaluate the behavior of the nCD64,
mHLA-DR and SI biomarkers in critically ill patients and their associ-
ation with the development of infection and sepsis.
METHODS. A total of 77 critically ill neurological patients were re-
cruited for two years (2015-2016) from the Intensive Care Unit (ICU)
of Germans Trias i Pujol Hospital, Spain. Infection was ruled out in all
patients enrolled in the study at the time of admission. Patients
under 18 years of age or with an ICU stay of less than 24 hours were
excluded of the present study. The nCD64, mHLA-DR and SI bio-
markers were analyzed in a standardized flow cytometry protocol at
different times after admission. The study was previously approved
by the Hospital Ethics Committee.
RESULTS. A total of 55 patients developed infection (infected group);
the other 22 patients did not develop infection (non-infected group).
No significant differences were detected in mortality between groups
(p=ns). Nevertheless, SOFA score, days of mechanical ventilation and
stay in ICU were higher in infected patients (p<0’05). In the first 24
hours after admission, no differences were observed in the percent-
age of mHLA-DR and nCD64 between groups. On the third day after
admission, however, infected patients showed lower percentage of
mHLA-DR, higher expression of nCD64 and an increased Sepsis Index
(p<0’05).
CONCLUSION. Patients who become infected are in a state of im-
munosuppression, since they express lower levels of mHLA-DR. These
results suggest that nCD64, mHLA-DR and SI could be considered
useful biomarkers to evaluate the susceptibility to develop infection
in critically ill patients.
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INTRODUCTION. The retina is a window where the microvascular
profile can be imaged directly and non-invasively at the bedside.Sepsis is associated with a decrease in microvascular density and its
severity is related to mortality [1]. However, features of retinal vessels
calibers and density during sepsis are not fully characterized.
OBJECTIVES. To compare the retinal vasculature between septic pa-
tients and age matched healthy volunteers.
METHODS. Prospective observational study from January 2018 to
April 2019 in a third-level ICU. We performed a single fundus im-
aging using a hand-held digital fundus camera (Aurora, Optomed Oy,
Finland) in patients with sepsis or septic shock (n=37) during first 24
hours after ICU admission and compared these data with age-
matched healthy controls (n = 20). Image analysis was performed
using ARIA software. The average retinal arteriolar and venular caliber
were calculated and summarized as the central retinal arteriolar
equivalent (CRAE) and central retinal venular equivalent (CRVE). Ar-
teriole–venular ratio (AVR) defined as the ratio of CRAE to CRVE. The
density of manually segmentated retinal vessels was calculated using
ImageJ software: vascular length density = skeletonized vessel area/
total area * 100%. Data are reported as medians with 25th and 75th
percentiles.
RESULTS. Out of 37 patients, 35 (95%) were in septic shock, 37
(100%) required mechanical ventilation. Median APACHE II and SOFA
scores were 16 (12-20) and 9 (7-11), respectively. Mean arterial pres-
sure (MAP) and cardiac index (CI) were 74 (64-81) mmHg and 2.9
(2.1-4.1) L/min/m2, respectively, and the median norepinephrine (NE)
dose was 0.24 (0.10-0.33) mcg/kg/min. Patients with sepsis had a me-
dian CRAE of 161.8(146.6-183.2) μm compared with 146.3(141.9-
157.7) μm in healthy subjects (p = 0.008). Their median CRVE was
257.6(225.0-286.7) μm compared with 243.7(215.1-272.2)μm in
healthy subjects (p = 0.221) and AVR was 0.6(0.6-0.7) compared with
0.6(0.5-0.7) in healthy subjects (p=0.508). We found significant correl-
ation between CRAE and diastolic blood preesure (r=0.35, p=0.047),
between arterial tortuosity and systolic blood pressure (r=-0.36, p=
0.042). Patients with sepsis showed a significant decrease in retinal
vascular lenght density compared with healthy subjects (p=0.001).
CONCLUSION. We found retinal signs of arteriolar vasodilation and
decreased retinal vascular density in septic patients.
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INTRODUCTION. The retina is a unique site where the microcircula-
tion can be imaged directly at the bedside and non-invasively, pro-
viding an opportunity to study changes in the microvasculature
relating to the development of hemodynamic state. Altered microcir-
culation is cornerstone of sepsis and its severity is related to mortal-
ity [1]. However, changes of retinal vessels during course of sepsis
and their relationship to hemodynamics and outcomes are not fully
characterized.
OBJECTIVES. To evaluate changes in retinal microvasculature during
24 hours period of time and compare it with hemodynamic profile
and outcomes in patients with sepsis or septic shock.
METHODS. Prospective observational study from January 2018 to
April 2019 in a third-level ICU. We performed retinal imaging using a
hand-held digital fundus camera (Aurora, Optomed Oy, Finland) and
systemic hemodynamic measurements at three time points: at
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hours later. Retinal image analysis was performed using ARIA soft-
ware. The average retinal arteriolar and venular caliber were calcu-
lated and summarized as the central retinal arteriolar equivalent
(CRAE) and central retinal venular equivalent (CRVE). Arteriole–venu-
lar ratio (AVR) defined as the ratio of CRAE to CRVE. The density of
manually segmentated retinal vessels was calculated using ImageJ
software: vascular density = vessel area/total area * 100% and vascu-
lar length density = skeletonized vessel area/total area * 100%. Data
are reported as medians with 25th and 75th percentiles.
RESULTS. Thirty seven patients with median age of 66(54-77) were
included. 35 (95%) were in septic shock, 37 (100%) required mechan-
ical ventilation. Median APACHE II and SOFA scores were 16 (12-20)
and 9 (7-11), respectively. We compared data between survivors (n=
17) and non-survivors (n=20). We found significant difference in AVR
between survivors and non-survivors during first measurement
0.6(0.5-0.6) vs 0.7(0.6-0.8),(p=0.008) as after 6 hours (p=0.041) and 24
hours (p=0.029). We detected significant difference in retinal vessel
density (p=0.015) and vessel length density (p=0.05) during second
measurement (6 hours after first measurement). We didn’t find the
difference in mean arterial pressure between survivors and non-
survivors during all three measurements.
CONCLUSION. We found an association between retinal arteriole-
venular ratio, retinal vascular density and mortality in sepsis and sep-
tic shock.
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INTRODUCTION. The cardiovascular system is affected by sepsis and
is associated with high mortality in seriously ill patients (1). Myocar-
dial dysfunction occurs in half of septic shock patients despite nor-
mal or high cardiac output. Echocardiography and cardiac
biomarkers are useful to evaluate cardiac dysfunction (2, 3).
OBJECTIVES. To identify if cardiac dysfunctions and cardiac markers
are associated with ICU mortality in septic patients.
METHODS. This is the first phase of a larger study to evaluate the
predictive value of bedside echocardiography at ICU setting. We
assessed a cohort of septic and septic shock patients. Systolic and
diastolic dysfunction were defined as ejection fraction function: nor-
mal >55%, mild deterioration 45-54%, moderate 30-44% and severe
<30%. Sepsis and septic shock were defined according to Sepsis 3
criteria (4). SOFA and APACHE-II scores were calculated on the day of
admission with the diagnosis of sepsis.
RESULTS. 59 patients were included. Mean age was 67.3±16.6 years,
27(45.8%) were women. Median time in ICU was 8 (range, 2-49) days.
ICU mortality was 22.0% (n=13). Thirty-three (56%) had septic shock.
Thirty-eight (66.7%) patients showed diastolic dysfunction (DD), 13
(22%) showed moderate systolic dysfunction (SD) and 1(1.7%) patient
had severe SD. SOFA score at admission and maximum SOFA were
significantly higher in non-survivors than in survivors: 8.6±4.0 vs. 5.7±
2.1, P=0.0009, respectively and 12.1±4.6 vs. 7.0±2.6, P=0.000, respect-
ively. Apache was 21.3±7.9 vs. 15.9±14.2 in non-survivors vs. survi-
vors, respectively, P<0.05. Fifty-one (86.4%) patients received
vasopressors and 40(60.8%) were mechanically ventilated. Of 41 pa-
tients who had systolic or diastolic dysfunction, 9(19.5%) patients
died. Comparing markers in those patients with any dysfunction vs.patients with no dysfunction, ProBNP was 111.8±223.1 ng/ml vs.
188.2±336.4 ng/ml (P>0.05), troponin-T was 91.9±121.5 vs. 117.9±
197.4 ng/ml (P>0.05), and procalcitonin was 25.1±41.7 vs. 22.6±34.5
ng/ml (P>0.05).
CONCLUSION. In our preliminary analysis of a small cohort, dysfunc-
tion was not associated with mortality. SOFA score was associated
with mortality. Research of a larger sample and robust analysis is ne-
cessary to assess the predictive value of echocardiographic tools.
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INTRODUCTION. Patients with sepsis have a high risk of developing
new onset arrhythmias, such as atrial fibrillation (AF). Previous reports
have shown that AF is associated with adverse clinical outcomes in
these patients.
OBJECTIVES. To assess echocardiographic and clinical variables of
patients with sepsis and new onset AF, admitted to a surgical med-
ical intensive care unit.
METHODS. We prospectively assessed a cohort of septic and septic
shock patients with bedside echocardiography. Atrial depolarization
speed was measured in all patients by tissue Doppler echocardiog-
raphy (TDE). Sepsis and septic shock were defined according to Sep-
sis 3 criteria. SOFA and APACHE-II scores were calculated on the day
of admission with the diagnosis of sepsis.
RESULTS. A cohort of 27 patients was evaluated. Five (18.5%) pa-
tients presented with AF. SOFA scores at admission were comparable
in patients with AF versus patients with no AF (9.2 ± 4.8 vs. 6.5 ± 1.8,
p=0.0445). Left atrial area was higher in patients with AF compared
to those without AF (21.7 ± 2.0 vs. 18.0 ± 3.5cm2, p=0.029). Left atrial
volume was also higher in AF patients (69.4 ± 3.6 vs. 47.8 ± 14.9cm3,
p=0.026). Right atrial area was 16.2 ± 1.1cm2in AF patients and 16.1
± 3.3cm2in patients without AF (p=0.982). Right atrial volume was
also similar between both groups (45.3 ± 21.7cm3vs. 38.2 ± 15.5cm3,
p=0.44). Atrial depolarization speed was 127 ± 29.1ms in patients
with AF and 141.9±37.9ms in patients without AF (p=0.42). Mortality
during ICU stay was 2/5 (40%) in patients with AF and 2/22(9.1%) in
patients without ICU (p=0.144).
CONCLUSION. Atrial fibrillation is a relatively common complication
in septic patients. Although septic patients with AF showed unique
echocardiographic features, mortality was not significantly higher as
compared to thosewithout AF. Larger studies are needed to assess
the clinical impact of AF in septic patients.
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Table 1 (abstract 001306). Reference range values of ROTEM®-PLT and
PFA®-100
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INTRODUCTION. Recent advances in oncology have led to better
long-term survival and therefore the benefit of admitting patients
with advanced cancer to the intensive care unit (ICU) may be increas-
ing. A leading cause of admission of cancer patients to the ICU is
sepsis, so it is important to understand its outcomes.
OBJECTIVES. To describe the incidence, aetiology and outcomes of
cancer patients admitted to ICUs with sepsis.
METHODS. All adult admissions to all Icelandic intensive care units (ICU)
during six whole calendar years (2006, 2008, 2010, 2012, 2014 and 2016)
were screened for severe sepsis or septic shock using the ACCP/SCCM cri-
teria. Demographics and clinical course of sepsis patients with cancer were
compared with data from 731 sepsis patients without cancer.
RESULTS. During the study period 240 cancer patients were admit-
ted to the ICUs with severe sepsis or septic shock (25% of all sepsis
patients). Their mean age was higher (67 vs. 64 years, p = 0.005) and
they were more likely to be male (62% vs 55%, p = 0.045) compared
with sepsis patients without cancer. Of the patients with cancer, 104
patients had solid tumours, 71 solid tumours with metastases, 34 leu-
kaemia and 31 lymphoma. The most frequent source of infection in
patients with solid tumours with or without metastases was abdom-
inal, but the lungs were the most common infection site in patients
with lymphoma and leukaemia. Infections were more likely to be
hospital-acquired in cancer patients compared with other sepsis pa-
tients (51% vs. 18%, p < 0.001) and the incidence of resistant patho-
gens was higher (11% vs 7%, p = 0.03). Patients with metastases and
leukaemia were less likely to receive invasive ventilation (32% and
35% respectively) than other sepsis patients (51%, p < 0.001) and
their length of stay in the ICU was shorter (median 2 days vs 4 days,
p < 0.001). Treatment limitations were more commonly applied in
cancer patients than other sepsis patients (35% vs 20%, p < 0.001).
Both ICU (24% vs. 13%, p < 0.001), hospital (45% vs. 25%, p < 0.001),
and one-year (66% vs. 32%, p < 0.001) mortality was higher in cancer
patients compared with other sepsis patients.
CONCLUSION. Cancer is a common co-morbidity in patients admit-
ted to ICUs with sepsis. The length of stay in the ICU for cancer pa-
tients is short, limitations of treatment common and both short- and
long-term mortality is high. This suggests that a trial of ICU admis-
sion is commonly applied with a change towards palliation for pa-
tients that do not respond to treatment. The survival rates in this
study are similar as in recent studies.
POIC - Perioperative journey, from
delirium to infections
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):001306INTRODUCTION. Platelet functionality test are being ingreasingly
used in critically ill patients. However local reference values has been
poorly investigated.
OBJECTIVES. To establish local reference range in the use of the
platelet functionality aggregometry test ROTEM®-platelet, and to
compare them with the reference values provided by manufacturer.
METHODS. Prospective study (ABCD study, NCT:026552897) funded
by Carlos III Institute (PI15/00512). Forty consecutive healthy volun-
teers selected from the Blood and Tissue Bank of the hospital, after
obtaining their informed consent, were included. Subjects with
known coagulopathy and/or on antiagregant/anticoagulant therapy
were excluded. Blood samples were taken for standard coagulation
tests, ROTEM® and platelet function tests (ROTEM®-platelet and PFA®-
100 Col-Epi).
The following ROTEM®-platelet tests were performed: ARATEM (acti-
vation with arachidonic acid), ADPTEM (activation of the ADP recep-
tor) and TRAPTEM (activation with thrombin activating peptide). The
parameters determined in each test were the area under the curve
(AUC, ohm*min), maximum amplitude at 6 minutes (A6, ohm) and
the maximum slope (MS, ohm/min). The reference ranges were
expressed by 2.5-97.5% percentiles, according to the recommenda-
tions of the Clinical and Laboratory Standards Institute, NCCLS-
Guidelines.
RESULTS. Forty subjects [men 19 (47.5%), age 58.5 (56.25-60)] were
included. Table depicts the local tests values outside of manufac-
turer´s range.
CONCLUSION. The local values of the impedance aggregometry
ROTEM®-platelet differ significantly from the manufacturer's reference
range, underlining the need to establish local reference values. This
could have important consequences related to platelet transfusion
and antiplatelet drug management.
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INTRODUCTION. As a WHO essential medication, ketamine remains
clinically significant for sedation, anesthesia, and analgesia. Although
ketamine has shown promise in treating psychiatric illness, and for
Fig. 1 (abstract 001347). See text for description
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operative delirium is controversial. It has been shown in one small
RCT in cardiac surgery patients to reduce the incidents of delirium5;
a larger RCT in a heterogeneous group of surgical patients failed to
reproduce this effect6. Spectral features of the electroencephalo-
gram, EEG have recently been associated with delirium7 yet, the ef-
fects of ketamine on these features remain largely unexplored.
OBJECTIVES. We present an initial characterization of the neurophysi-
ologic effects of single-dose ketamine in patients undergoing exten-
sive surgery with general anesthesia for treatment of head/neck
cancer. This is the initial exploration of preliminary EEG results from a
larger study intended to investigate postoperative delirium in these
patients.
METHODS. We prospectively randomized patients into a placebo,
0.5mg/kg (low) and 1mg/kg (high) ketamine group. Patients received
the study drug after induction. 5-channel EEG was recorded using a
SEDLine monitor (Masimo, Irvine, CA) from frontal positions at a sam-
ple rate of 250 Hz. In order to evaluate the influence of single dose
ketamine we only analyzed the EEG from 4h after the start of EEG re-
cording at induction until 15 minutes before the end of the EEG re-
cording at the end of the procedure.
RESULTS. Out of 29 enrolled patients, 8 were excluded due to per-
sistent EEG signal distortion. The analysis included 3 groups: placebo-
10, low-ketamine (LK)- 6 and high-ketamine (HK) 5 patients. We
found a significant effect of the HK on spectral EEG features for up
to 4h. Alpha and beta band total power were significantly higher in
the HK group compared to the placebo group (alpha KW: p=0.014,
Chi-Sq=8.53; beta KW: p=0.031, Chi-Sq=7.01, Fig1A-B) Examination of
relative band power (normalized to total power) showed a significant
difference for the relative alpha power (KW: p=0.0259; Chi-sq: 7.31),
but not for the relative beta-band (KW: p=0.0852; Chi-sq: 4.39)
(Fig1C-D). The power spectral density (PSD) and normalized power
spectral density (nPSD) plots in Fig2A-B show the difference in the
spectral power (PSD, A) and composition (nPSD, B) between the pla-
cebo and the HK group. AUC graph presents the AUC (o) and the
95% confidence interval (x). Black dots indicate a significant effect,
defined by a 95% Ci not containing 0.5. Grey dots indicate a (non-
significant) AUC<0.3, but an AUC <0.3 may indicate a clinically rele-
vant effect8.
CONCLUSION. Our preliminary results of a prospective randomized
study investigating the effects of ketamine on EEG and delirium re-
veal that a single dose of subanesthetic ketamine has lasting effects
on the EEG (240 min). As enrollment progresses the effects of these
spectral features on delirium risk will be determined.
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INTRODUCTION. Delirium is associated with poor outcomes and is
an independent predictor of mortality in intensive care patients. Early
recognition and management of delirium may improve prognosis of
delirious patients.
OBJECTIVES. to describe our experience in the management of deliri-
ous patients.
METHODS. A prospective cohort observational study conducted over
nine months duration from October 2017 to June 2018 including all
patients admitted in a 9-bed medical ICU for more than 24 hours. Pa-
tients who were deaf or unable to speak or understand were ex-
cluded. All included patients were screened by psychiatrist for
delirium using DSM-V (Diagnostic and Statistical Manual of Mental
Disorders, Fifth Edition) criteria.
RESULTS. During the study period, 137 patients were included. Pa-
tients' characteristics were : median age, 60[49-68] years ; female,
29(27.9%) ; median Charlson comorbidity index, 3[2-5] ; median SAP-
SII, 27[22-33.5] ; invasive mechanical ventilation (IMV), 57(41.6%),
remifentanil use, 67(51.1%) ; midazolam use, 24(17.5%) and vasopres-
sors use, 52(38%).
Using DSM-V criteria, 46(33.6%) had delirium. The most common
subtype of delirium seen was hypoactive type, 27(58.6%), followed
by hyperactive subtype, 15(32.6%) and few patients had mixed sub-
type of delirium, 4(8.87%).
Management in all delirious patients included non-pharmacologic
procedures when appropriate to decrease or treat the modifiable risk
factors : Assess patient for common causes of delirium (hypoxia, hy-
percapnia, electrolyte imbalance, nicotine withdrawal, medications or
infection) ; early ambulation ; encourage family to stay with patient
during day as much as possible to improve orientation ; encourage
social interaction and family visits during visiting hours and try to
maintain sleep-wake cycle by limiting unnecessary awakenings. All
these interventions were systematic. When insufficient, pharmaco-
logic and other procedures were performed : antipsychotic medica-
tion (haloperidol), 17 (36.9%) ; antidepressants medication, 7(15.22%)
; sedation, 9(18.8%) and physical restraint, 6(15.22%). For 6 patients,
neither pharmacologic nor physical restraint were performed.
CONCLUSION. The first-line of management of delirium was non-
pharmacological. Haloperidol seems to be overused as a result to
some physicians’beliefs.
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INTRODUCTION. Bleeding often results in coagulopathy through sev-
eral mechanisms, including consumption of clotting factors. Pro-
thrombin complex concentrate (PCC) contains either three or four of
the vitamin K-dependent coagulation factors and is increasingly be-
ing used to correct coagulopathy in bleeding patients. However, a
summary of the efficacy of PCC to treat bleeding is lacking.
OBJECTIVES. The aim of this systematic review and meta-analysis is
to evaluate the efficacy of PCC administration in bleeding patients.
METHODS. PubMed, EMBASE and CINAHL were searched for studies
investigating the efficacy of PCC to treat bleeding in adult patients
and providing data on either mortality, red blood cell (RBC)
utilization, blood loss or thromboembolic (TE) events. Data were
pooled using Mantel-Haenszel random effects meta-analysis or in-
verse variance random effects meta-analysis.
RESULTS. From 3944 identified studies, 14 observational studies were
included (with a total of 2187 patients). Of these, 7 studies included
patients undergoing cardiac surgery, 4 included trauma patients, 2
included patients undergoing liver surgery and 1 study included
bleeding patients due to various causes. In all patient groups taken
together, PCC administration was not associated with reduced mor-
tality (odds ratio = 0.95; CI = 0.71 – 1.28; p = 0.75; I2 = 0%). Patients
receiving PCC required significantly less RBC units (mean difference
= -1.80; CI = -3.22 - -0.38; p = 0.01; I2 = 92%) compared to patients
not receiving PCC. Cardiac surgery patients had significantly lower
volumes of blood loss (mean difference = -384; CI = -640 - -128, p =
0.003, I2 = 81%) when receiving PCC. In all patient groups together,
PCC administration was not associated with TE event rate (odds ratio
= 1.13; CI 0.80 -1.60; p = 0.48, I2 = 0%).
CONCLUSION. PCC was associated with a reduction in blood loss in
cardiac surgery patients and with a decreased RBC transfusion rate
across a wide range of bleeding patients, without effecting mortality.
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INTRODUCTION. Hemorrhage is the most common cause of shock in
trauma patients, and the volume replacement, including the transfu-
sion of blood and blood products, is an important part of treatment
to maintain tissue perfusion and oxygenation. We present a descrip-
tive study that analyzes the use of blood products in these patients.
OBJECTIVES. To describe the use of blood products in trauma pa-
tients as well as their correlation with severity scores, intensive care
unit (ICU) stay and mortality and incidence of multiple organ dys-
function syndrome (MODS).
METHODS. Data include all trauma patients admitted at intensive
care unit from January 2018 to March 2019, who were followed until
hospital discharge or death.
Descriptive statistics, quantitative variables were presented as mean
values including standard deviation, or median values including
interquartile range as was appropriate. Categorical variables were
presented as counts and percentages. Bivariate statistics are analyzedwith Student's t test for independent variables with normal distribu-
tion, U Mann-Whitney if non-normal distribution and Chi-squared
test for qualitative variables association.
RESULTS. 157 trauma patients were included during the period
under review. Within the study population, 11 (7%) and 9 (5.7%) pa-
tients were previously under antiaggregant and anticoagulant treat-
ment respectively. 44% presented hemodynamic instability and
21.7% coagulopathy associated with trauma. 4 (2’5%) patients devel-
oped massive hemorrhage and 5 (3’2%) required arteriography and
endovascular embolization.
48 patients (30.6%) needed transfusion of blood products: 42 pa-
tients required red blood cells concentrate transfusion during the
first day [3.5 (2, 5.3)], 22 patients were administered fresh frozen
plasma [950 (595, 1275)]cc and 23 patients were transfused with
platelets [2 (1, 2)] pool. Twenty-five patients received prothrombin
complex [1300 (700, 1650)]U, 29 patients received fibrinogen [2 (2,
3)]grams, and tranexamic acid was used in 34 patients.
The mean stay at ICU was 5'04 (2.4, 12.05) days. 13.4% of patients
died during ICU stay and 16.2% of patients during hospital stay. 21
patients developed MODS; 20 of them during the first three days
(12.7%). In our sample, there is statistically significant association be-
tween transfused patients and severity according injury indicators
(ISS and NISS) and APACHE II. In addition, the incidence of MODS,
mortality in the ICU and hospital mortality were also higher in trans-
fused patients. On the other hand, no statistically significant differ-
ences were found in gender, age, previous coagulopathy, incidence
of nosocomial infection, ICU stay or hospital stay.
CONCLUSION. According to our experience, there is a statistically sig-
nificant association between the need of transfusions and severity
according to the injury indicators; as well as an increase in mortality
and the development of MODS in the transfused patients.
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INTRODUCTION. There is an interaction between thyroid hormones,
the immune and inflammatory response and illness severity, leading
to lower levels in the setting of critical illness. Cardiac surgery repre-
sents an important surgical injury associated with non-thyroidal Ill-
ness syndrome (NTIS). However, little is know about NTIS in this
scenario.
OBJECTIVES. Evaluate thyroid function in adult patients undergoing
cardiac surgery. We also correlated thyroid function with parameters
related with inflammatory response.
METHODS. Demographical and surgical characteristics, laboratory re-
sults and outcomes were registered. Blood samples were collected
before surgery, during first 24h ICU admission,and at day 3 and 5. A
serum thyroid profile, including thyroid-stimulating hormone(TSH),
free(fT4) and total(tT4) thyroxine, free(fT3) and tota(tT3) triiodothyr-
onine and reverse triiodothyronine (rT3), was analyzed. Drugs poten-
tially having an effect on thyroid function were collected. An
statistical analysis was performed to evaluate thyroid function over
time.
RESULTS. 10 patients aged 66.7±4.5years were included, mean
BMI:29.9±5.6Kg·m-2 and APACHE II:15.8±4 were included. 6 patients
underwent valve procedures(VP) and 4 coronary artery bypass graft(-
CABG), with a mean CBP time 102±23min. 1 patient died during ICU
stay and 3 required vasopressor and inotrope support for over 24h.
Statistically significant changes (P<0.001) were observed during the
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dropped in the first 24h, returning to baseline afterwards, whereas
fT3 and tT3 levels remained low. tT4 levels were normal, resulting on
a tT4/tT3 drop of 39.4±10.0% in the first 24h. On the other hand, rT3
levels increased 46.6±15.5% above baseline levels and remained high
during the observation period. No statistical correlations with inflam-
mation or tissue hypoperfusion markers (leukocytes, lymphocytes,
lactate and C-reactive protein were observed.
CONCLUSION. Our pilot study showed that NTIS may develop soon
after cardiac surgery with a lasting effect over T3 levels. The effect of
this phenophenon and their influence over outcomes should be eval-
uated when increasing our sample of patients.001432
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INTRODUCTION. Cardiac surgery is one of the most frequently per-
formed surgical procedures in the world. Regardless of the procedure
performed, the final results depend to a great extent on an optimal
postoperative care.
OBJECTIVES. Describe the immediate postoperative complications in
cardiac surgery patients during their ICU stay.
METHODS. Prospective and observationaly, all patients undergoing
cardiac surgery in the year 2018 in Fundación Jiménez Díaz and Rey
Juan Carlos Hospitals in Madrid were recruited.
Demographic variables (age, sex), baseline data (heart rate, Euro-
SCORE II, NYHA), surgery data (type of intervention, CPB and ische-
mia times) and immediate postoperative data (heart rithm, time of
mechanical ventilation, time of ICU stay and re-intervention) were
collected.
RESULTS. 293 patients were recruited (61.4% males) with a mean
age of 65.6 ± 11 years and EuroSCORE II mean of 5.07 ± 9.39.
The type of intervention was: valve replacement 47.3%, coronary re-
vascularization surgery (CRC) 31.4%, CRC + valvuloplasty 3.4% and
other 7.8%. 8.2% of the interventions were emergent or urgent,
26.1% preferred and 65.7% scheduled.
The most frequent complications were cardiac conduction disorders
(18.6%): 3º atrio-ventricular block, 2.4% and de novo atrial fibrillation
15.5%; with a need for a permanent pacemaker (MP) in 2% of the
total. Only 1% (3 patients) presented postoperative acute coronary
syndrome.
There was an acute renal failure rate of 8.5% with need for renal re-
placement therapy of 48% (4.1% of the total) and none required
chronic dialysis.
We only found 6.5% of neurological complications: 73.7% diffuse
(42.3% encephalopathy, 15.8% seizures, 15.8% delirium) and 26.3%
focal. In 10.4% of them there was permanent neurological deficit
(0.7% of the total).
6.1% of the total patients required prolonged MV (>96 hours) of
which 38.9% ended in tracheostomy (2.4% of the total).
There were infectious complications in 4.1% of the patients (50%
pneumonia, 16.7% urinary, 16.7% surgical wound, 8.3% mediastinitis
and 8.3% catheter bacteremia).
3.4% of the patients presented pleural effusion requiring drainage,
0.7% pneumothorax, and 0.3% hemopneumothorax.The average stay in the ICU was 86 hours, the overall mortality was
3.6% and the reoperation rate was 3.4%.
CONCLUSION. The results of cardiac surgery postoperatory in our
sample are excellent with a mortality rate below what was expected
(according to EuroSCORE II). The complications are diverse and ex-
pected, but most are resolved in the immediate postoperative period
without sequelae.
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INTRODUCTION. ECMO post-cardiac surgery is a rescue therapy in
the low cardiac output and in the postcardiotomy refractory shock.
Nowadays, it exists controversy about what is the best approach for
nutritional support in these patients.
OBJECTIVES. The objective of our study was to evaluate how we per-
form enteral nutrition (EN) in this group of patients.
METHODS. Prospective observational study from November 2016 to
March 2018. Preoperative, intraoperative variables, prognosis scores,
postoperative complications and in-hospital and long-term mortality
were collected, as well as the NE administered during the first week
of admission to the ICU.
RESULTS. 16 patients were included with a mean age 61.1±10.3
years; 62.5%(10) were male; BMI:27.6 ± 4.1Kg•m-2; APACHE II: 18±8;
SOFA: 9.3±3.4. 56.25%(9) were coronary revascularization and
31.25%(5) were valvular surgeries. Hospital mortality was 37.5% (6)
and 1-year mortality was 43% (7). The ECMO was initiated during the
first 72h after admission to the ICU post-surgery with a duration of
6±3.2 days. The complications were: bleeding 37.5%(6), re-
exploration 31.25%(5) and sepsis 50%(8). None thrombosis was ob-
served. The EN was started in 12 patients, starting early (<24h) in
50%. They received an average of 11.75±5.1 Kcal/Kg/d and 0.62±0.26
g/Kg/d. In 50% of patients EN was interrupted >24h during ICU stay
due to complications from their cardiovascular status. In those pa-
tients were EN was interrupted a lower caloric (15.48±3.6 vs. 8.02±3.2
Kcal/Kg/d; P=0.004) and protein (0.81±0.16 vs. 0.43±0.18 g/Kg/d; P=
0.004) nutritional intake was shown. Lactate on the 3rd day in pa-
tients in whom the EN was interrupted was higher (1.8±0.4 vs. 1.9±
0.9 mmol/L, P=0.012).
CONCLUSION. Patients with post-cardiotomy ECMO receive inad-
equate nutritional support in our study. Strategies to improve nutri-
tional support, such as supplementary parenteral nutrition among
others, may be evaluated in future studies.
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INTRODUCTION. Nutritional status influences outcomes in critically ill
and new guidelines do not recommend surgery in patients with
malnutrition.
OBJECTIVES. To evaluate the influence of nutritional risk on the re-
sults and prognosis of patients undergoing cardiac surgery.
METHODS. Prospective observational study from 2011 to 2015. Post-
operative nutritional risk was evaluated through the Nutrition Risk in
the Critically Ill (NUTRIC) Score. Likewise, preoperative, intraoperative
variables, prognostic scores, postoperative complications and in-
hospital and long-term mortality were collected.
RESULTS. 2809 patients were included: mean age of 64.6±11.5 years,
63.9% (n=1796) were men, BMI: 27.9±4.2Kg∙m-2, APACHE II:12.9±
5.3.The 51.7% were valvular surgeries, 32.3% were coronary, 6.8%
were mixed and 9.2% were another type of cardiac surgery. In-
hospital mortality was 5.8% (163). According to the NUTRIC Score,
72.3% (2032) of the patients had a low nutritional risk, while 27.7%
(777) had a high nutritional risk. The univariate analysis between sub-
groups identified greater postoperative complications and mortality
in the subgroup with greater nutritional risk. The multivariate analysis
showed that a high nutritional risk was associated with an older age
(OR: 1.107; 95% CI:1.080-1.134;P <0.001), to a higher creatinine before
surgery (OR:1.009; 95% CI:1006-1.013; P <0.001), in the presence of
atrial fibrillation pre-surgery (OR: 1.614; 95% CI: 1.085-2.399; P =
0.018) and smoking (OR: 1.777; 95% CI: 1.076-2.934; P=0.025), while
higher preoperative cholesterol (OR: 0.827, 95% CI: 0.692- 0.987; P <
0.001) and lymphocytes (OR: 0.694; 95% CI: 0.522- 0.924; P <0.001)
were both associated with a lower risk. The same analysis revealed
that a higher nutritional risk was associated with a greater need for
transfusions (OR: 1.092, 95% CI: 1006-1.185, P = 0.036), a higher inci-
dence of low postoperative cardiac output (OR: 3,351; 95 % CI: 2.030-
5.531; P<0.001) as well as a longer time in vasoactive drugs (OR:
1002, 95% CI: 1001-1,004, P = 0.008) and worse renal function (OR:
1006, 95% CI : 1.003-1.010; P = 0.008). Long-term mortality was eval-
uated in 2715 patients: those with higher nutritional risk had worse
survival (87.8% vs.70%; P(LogRank) <0.001) and a higher risk in the
Long-term mortality (HR: 4.369; 95% CI: 3.075-6.206; P <0.001).
CONCLUSION. A higher nutritional risk evaluated according to the
NUTRIC Score was associated with greater postoperative complica-
tions after cardiac surgery, as well as a worse long-term survival in
our population.
REFERENCE
1. Stoppe C. et al. Role of nutrition support in adult cardiac surgery: a
consensus statement from an International Multidisciplinary Expert Group
on Nutrition in Cardiac Surgery. Crit Care. 2017;21:131.001463
High risk Pancreaticoduodenectomy patients admitted in Intensive
Care for perioperative management. Retrospective cohort study
from a high-volume center
R. Pereira1, IF. Barros2, TM. Marques3, I. Marta4, AT. Ferreira3, T. Sequeira1,
J. Paulino5, MF. Pinto6, N. Germano1
1UCIP 7, Hospital Curry Cabral, CHULC, Lisboa, Portugal; 2Cirurgia
geral, Hospital Curry Cabral, CHULC, Lisboa, Portugal; 3Unidade funcional
medicina interna 4, Hospital Santa Marta, CHULC, Lisboa, Portugal;
4Unidade funcional medicina interna 1.4, Hospital São José,
CHULC, Lisboa, Portugal; 5Cirurgia hepato-bilio-pancreática e
transplantação, Hospital Curry Cabral, CHULC, Lisboa, Portugal;
6Microbiologia, Hospital D. Estefânia, CHULC, Lisboa, Portugal
Correspondence: R. Pereira
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001463
INTRODUCTION. The development of postoperative infectious com-
plications is a major determinant of outcome in pancreaticoduode-
nectomy (PD) patients.
Patients with preoperative biliary drainage (PBD) are at high risk for
positive intraoperative bile cultures, infectious complications and
antibiotic resistances.
A short postoperative course of antimicrobial therapy in patients at
high risk for biliary contamination has been shown to reduce infec-
tious complications after PD.
PD patients at our institution are admitted in ICU for post-surgical
care and monitoring. PBD stents are systematically retrieved during
surgery for microbiological culture. Those with PBD are considered
high risk patients and undergo a 5-day protocol course of post-
surgery empirical antibiotic therapy with piperacillin-tazobactam.
OBJECTIVES. To compare clinical and microbiological results be-
tween PBD vs non-PBD PD patients and to analyze antibiotic resist-
ance patterns.
METHODS. Retrospective cohort study of consecutive PD patients ad-
mitted at our ICU for post-operative monitoring and care between
January 2015 and April 2018.
Median and interquartile (IQR) values are presented and Mann-
Whitney and Chi-square tests were used to compare group results.
RESULTS. A total of 313 PD patients were analyzed.
Patient characteristics: median age was 68 years (59-74) and 58,8 %
were male. Median Body Mass Index was 24,9 (22,3-27,6), Charlson
Comorbidity score was 5 (4-6) and ICU admission-day SOFA was 2 (1-
5). Histologic results confirmed malignancy in 81% of patients.
Overall outcomes: median Clavien-Dindo score was 0 (0-2) and 30-
day mortality rate was 5,4%.
PBD stent was present in 44,4% (n=139) patients.
When comparing PBD vs. non-PBD groups no differences were found
between age (p=0,23), Body Mass Index (p=0,39), Charlson Comorbi-
diity score (p=0,32), admission-day SOFA score (p=0,20) nor Clavien-
Dindo score (p=0,33) or 30-day mortality (p=0,82).
A total of 134 PBD stent cultures revealed 122 microorganisms iso-
lated from 66 (47,4%) patients and 68 (48,9%) had polimicrobian cul-
tures. E. faecalis (22%), E. coli (16%) E. cloacae (13%) and K
pneumoniae (12%) were the most frequent bacteria and 7% were
ESBL. Antibiotic testing (n=115) reported resistance rates of 21% to
piperacillin-tazobactam and 19% to ampicillin plus cefotaxime
combination.
CONCLUSION. The presence of PBD in PD high risk patients was not
associated with worse outcomes.
E. faecalis was the most frequent bacteria isolated from PBD cultures.
Overall antibiotic resistance rates from PDB stent cultures were simi-
lar between piperacillin-tazobactam and the combination of ampicil-
lin plus cefotaxime.
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INTRODUCTION.
Introduction: Progress in near-infrared spectroscopy (NIRS) technol-
ogy seem to have improved its accuracy for continuous, non-invasive
monitoring of regional tissue oxygenation and may provide clinicians
with an additional information to achieve patient safety.
OBJECTIVES. Veno-arterial (VA) extracorporeal membrane oxygen-
ation (ECMO) may result arterial blood mixing and delivery of hyp-
oxic blood to the brain. Additionally, VA-ECMO by femoral artery
cannulation may compromise perfusion to the lower limbs. Oxygen
saturation measured by near-infrared spectroscopy (NIRS) can be
used to monitor brain and lower limb oxygenation in the patients
treated by VA-ECMO.
METHODS. We retrospectively analyzed prospectively collected data
of the patients, who treated by veno-arterial ECMO, using femoral
vessels approach, between 01.2015 and 12.2018 in large tertiary cen-
ter. All patients were continuously monitored using the (INVOS™
5100C Cerebral/Somatic Oximeter) tissue oximeter. Sensors were
placed on the patients' foreheads and on the lower limbs. NIRS trac-
ings were recorded, analyzed, and correlated with clinical events.
RESULTS. Ninety-five patients (age 22-78) were monitored with NIRS,
and 83 patients (87.4%) has distal lower limb perfusion. Eight pa-
tients (8.4%), 2 with distal limb perfusion and 6 without, had unilat-
eral persistent decreasing lower limb oximetry (StO2) below 40% and
clinical presentation of lower-limb ischemia: cold limb, mottled skin
and pulseless Doppler ultrasound. In 7 patients were performed sur-
gical placement a distal perfusion cannula and in one patients surgi-
cal placement and trombectomy from lower limb. Eleven patients
(11.6%) had a significant, below 40% and longer than 30 minutes
drop in cerebral oximetry (StO2). In 9 patients (9.5%) interventions,
which involved increasing pressure, oxygenation, and/or ECMO flow
corrected the underlying ischemia. Two patients (2.2%) required fur-
ther diagnostic intervention and were found to have a cerebrovascu-
lar accident (CVA).
CONCLUSION. Use of near-infrared spectroscopy (NIRS) in the pa-
tients treated by ECMO is important in detecting, prevention and
treatment ischemic cerebral and peripheral vascular events.001511
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INTRODUCTION. Toxic Epidermal Necrolysis (TEN) is a rare drug-
related life-threatening acute dermatological condition. The
devitalization of epidermis and immunosuppression predispose pa-
tients to secondary infection that are the major cause of morbidity
and mortality. The mortality rate is higher mainly in those requiring
intensive care admission (REF).
OBJECTIVES. Characterization of the rates and types of infection-
microbials in TEN patients, aged >18 years, admitted to a Burn Unit
(BU) of a tertiary hospital, between 2005 and 2017.
METHODS. Retrospective, descriptive and inferential study, evaluat-
ing: age; gender; onset of symptoms to admission on BU; suspected
etiologies of TEN; percentage of epidermal detachment (% of Total
Body Surface Area, TBSA); severity of TEN assessed by the SCORTEN
score, microbial infections identified by culture; nosocomial pneumo-
nia (NP); Systemic therapy (corticosteroids, Plasmapheresis, intraven-
ous immunoglobulin (IVIG)]; invasive procedures - mechanical
ventilation (MV) or hemodialysis (HD) and BU length of stay. The pri-
mary outcome was in-hospital mortality.
RESULTS. A total of 29 patients were included, 58.6% (n=17) female,
with median age of 65.7 years (min: 22.0; max: 91.0). The median
SCORTEN score and TBSA were 3.0 and 57.3%, respectively. Alopuri-
nol was the most frequent agent identified (24.1%, n=7) followed by
Amoxicilin-Clavulanate, Carbamazepine and Hydantoins with 6.9%
(n=2), each one. Etiological agent was not identified in 31.0% of pa-
tients. The mucous membranes were involved in 89.7% (n=26) of pa-
tients, with the oral mucosa being the most frequent (69.0%, n=20).
The incidence of NP was 44.8% (n=13) and the most common agent
identified was Methicillin-sensitive Staphylococcus aureus (MSSA) with
10.3% (n=3). MSSA was also the most commonly isolated agent in
surgical wound infections (17.2%; n=5). Bacteriemia occurred in
58.9% of the patients. 51.7% of patients were under MV (n=15),
65.5% (n=19) of patients were submitted to plasmapheresis, 44.8%
(n=13) to IGIV and 10.3% (n=3) to HD. The median BU length of stay
was 10.0 days (min: 2, max: 42) and in-hospital mortality was 48.3%
(n= 14). There was a statistically significant relationship between age
and in-hospital mortality (p=0.02), with a worst prognosis in older pa-
tients. The study demonstrated a high variability in the number of in-
fections, and there was no association with regard to mortality (p=
0.275). MV was associated to a higher mortality rate (66.6%, n=10) on
this population (p=0.02).
CONCLUSION. Compared with other reported studies of secondary
infection in TEN patients, our study had a lower rate of bacteremia.
This finding suggests a response regarding the infection control mea-
sures applied in the study population. Despite that, the numbers of
multi resistant microorganisms in this series corroborates the need
for an early diagnosis and timely referral of these patients to special-
ized units.
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INTRODUCTION. Based on our current knowledge, intraoperative
hypotension is common and may have detrimental effect to patients
outcome. HPI (Hypotension probability indicator) is new concept of
artificial intelligence application in clinical medicine. It is based on
machine learning technique analysis of invasive arterial pressure
curve. Development of future hypotensive event (within 5 minutes
time) should be predicted with reasonable sensitivity and specificity
according to the manufacturer data. To which extent HPI may im-
prove patient care has not been established yet.
OBJECTIVES. Major objective of this study was to assess the use of
HPI to avoid hypotension in major intracranial surgery.
METHODS. Randomized prospective study performed in a University
hospital approved by its local ethics committee. Patients undergoing
major supratentorial tumour resection with ASA physical status 1-3
were enrolled and randomly (1:1 randomization) assigned to inter-
ventional (group A) or control group (group B). Anaesthesia was
maintained by propofol and remifentanil. Haemodynamic monitor EV
1000 (Edwards Lifesciences Inc., Irvine, CA, USA) was used for goal di-
rected haemodynamic therapy in both groups with predetermined
mean arterial pressure (MAP) target of more than 65mmHg; fluids,
vasopressors and inotropes were used based on predefined protocol.
In the interventional group, HPI value of more than 85% was consid-
ered significant for prediction hypotensive event and used to prompt
the appropriate treatment. The HPI value was covered for the treat-
ing anaesthesiologist in the control group.
The haemodynamic data were collected in 20-seconds intervals;
hypotension and severe hypotension were defined as mean arterial
pressure below 65 mmHg and 55mmHg. The cardiac index below
2,0l/min/m2 was deemed as hypoperfusion. Number of events and
their duration were used as primary indicators. Because the first 30
minutes after induction are extremely turbulent, a separate mainten-
ance phase of anaesthesia was evaluated too.
RESULTS. We enrolled 40 patients in our study, 20 in each group.
Analysis of the whole anaesthesia time showed only slight trend to-
wards lower hypotension and severe hypotension related burden
without any statistical significance (Table 1). During the maintenance
phase the number of patients free of hypotension (10 pts.in Group A
vs. 4 pts.in Group B, p=0,047) was significantly lower.
CONCLUSION. Based on our data it seems that the inclusion of HPI
into a goal directed treatment strategy could lower the incidence of







MAP<65(mmHg) time in (min) 6,6±8,2 9,6±11,6 0,34
Number of no MAP<65(mmHg)
(pts)
4 2 0,38
Hypotensive events (No) 4,5±1,3 5,2±0,9 0,69
CI < 2,0 (l/min/m2) time in (min) 105,3±134,4 77,9±82,4 0,44
Hypoperfusion events (No) 19,5±3,9 22,0±27,6 0,73001532
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INTRODUCTION. Analgesia and sedation are highly discussed com-
ponents of critically ill patient treatment, aimed at minimizing patient
discomfort and modulating the stress response for the least period
of time. ICU admission for post-operative patients can be scheduled
preoperatively or a consequence of intra-operative complications.
Post-operative sedation is maintained until haemodynamic stability,
adequate respiratory exchanges and necessary instrumental
investigations.
OBJECTIVES. The aim of this study was the evaluation of the sedative
effect of inhaled sevoflurane and intravenous hypnotic agents (pro-
pofol and midazolam) in postoperative ICU sedation after major max-
illofacial surgery. We related their use to hemodynamic stability,
times of awakening and ICU discharge, onset of adverse events
METHODS. Retrospective matched-controlled analysis of prospective,
non-randomized data comparing sevoflurane-SEVO group-MIRUS sys-
tem (courtesy of PALL Medical) and intravenous propofol and
midazolam-TIVA group. Inclusion criteria: Postoperative patients of
maxillofacial oncologic surgery with vascularized flap, Age> 18 years,
Sedation required for> 6 hours. Exclusion criteria: Pregnant Patients,
Controindication to the use of halogenates, Neurological and/or psy-
chiatric disorders in chronic pharmacological therapy. Recorded pa-
rameters: BIS value, Hemodynamic data, Respiratory parameters,
Sedative/analgesic infusions, Inotropic/VP infusion, Hourly administra-
tion of fluids, lab and blood gas analysis. We defined: Time of awak-
ening (minutes from the suspension of spontaneous breathing-
extubation or breath by tracheostomy), Time of ICU discharge, Onset
of adverse events.
RESULTS. 40 consecutive patients were evaluated for the study(20
SEVO and 20 TIVA), 4 were excluded from the analysis for postoperative
surgical complications(1 group SEVO and 3 group TIVA). The study
population was homogeneous and comparable. All patients were in a
medium-high age group (67 ± 12 SD and 64 ± 10 SD years) and were
in normal weight. Surgery duration was similar (10h 07 '± 1h 17' DS
SEVO and 11h 10 '± 2h 20' DS TIVA). No substantial differences in intra-
operative management occurred, as all patients were managed accord-
ing to our Institution procedural protocol. Postoperative management
revealed no statistically significant differences for hemodynamic stabil-
ity, duration of sedation (12.9 ± 1.6 SEVO and 14.4 ± 2.2 TIVA) and ad-
ministered post-operative fluids. The times of awakening to the
suspension of sedation were significantly lower in SEVO patients (27 '±
16' SD) compared to TIVA ones (105 '± 56'DS) with a statistically signifi-
cant difference (p <0.05). There was no significant difference in the
time of ICU discharge and in the total time from the suspension of sed-
ation to discharge. There were no significant differences for complica-
tions during sedation and on awakening.
CONCLUSION. Sevofluorane can be effective in guaranteeing the
sedation depth required for post-operative complex maxillofacial sur-
gery patients, allowing faster recovery and extubation times than
intravenous sedation, maintaining adequate hemodynamic stability
without relevant adverse events.
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regimen in major abdominal surgeries to aviod postoperative compli-
cations such as acute kidney injury (AKI) or prolonged length of hos-
pital stay (LOS Hospital) (1). Its known that intraoperative fluid
management impacts outcome in living donor related liver trans-
plant (LDLT) patients (2).
OBJECTIVES. The aim of this study is to evaluate the effects of re-
strictive versus liberal fluid regimens on outcome in LDLT recipients.
METHODS. We retrospectively evaluated the adult patients who
underwent LDLT surgery between january 2015 and january 2017.
Restricted group has consisted of patients who received <8ml/kg/h
fluid, while liberal group has consisted of patients who received
≥8ml/kg/h fluid. Demographic data, surgery time, clamping time, di-
uresis, noradrenalin requirement, total administered fluid, operation
fluid balance, central venous pressure (CVP), blood loss, erithrocyte
suspension (ES) requirement, pre and postoperative lactate levels,
pre and postoperative serum creatinin levels, delta creatinin, length
of intensive care unit stay (LOS ICU), LOS-hospital, renal replacement
therapy (RRT) requirement, readmission to ICU, reoperation, ICU and
first year mortality rates were recorded.
RESULTS. The baseline demographic and clinic characteristics were
similar in both groups. The operation fluid balance, postoperative
CVP, intraoperative diüresis, intraoperative blood loss, ES require-
ment, noradrenalin requirement, postoperative serum lactate level
and LOS-hospital were signifcantly higher in liberal group (P<0.05 for
all). Postoperative 1st day serum creatinin was higher in restricted
group (P<0.05), whereas need for RRT, increase in postoperative 7th
day serum creatinin levels, ICU and first year mortality rates were
similar between two groups.
CONCLUSION. Intraoperative restricted fluid regimen seems to de-
crease the LOS-hospital and ES requirement without negative effect
on outcome compared to liberal fluid regimen in LDLT recipients.
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INTRODUCTION. Patients with systemic autoimmune diseases pose a
particular challenge for clinicians involved in critical care due to in-
volvement of multiple organs and severe side effects of immunosup-
pressive drugs. Diffuse alveolar haemorrhage (DAH) is one of the
most serious and life-threatening manifestations, typically present in
patients with autoimmune diseases. Available data concerning clin-
ical profile of patients with DAH treated in intensive care units re-
mains scarce.
OBJECTIVES. We aimed to describe patients with systemic auto-
immune disease who developed DAH and were treated in the inten-
sive care unit in terms of baseline demographic and clinical features
as well as mortality.
METHODS. In this retrospective cohort study performed in the Intensive
Care Unit of University Hospital in Krakow (Poland) we included 21 pa-
tients treated for the first time in the ICU due to autoimmune diseases
with diagnosis of DAH. For each patient APACHE II, APACHE III, SAPS II
and SOFA scores were calculated on the admission. Mortality was
assessed during ICU stay and during 5-year follow-up based on tele-
phone calls and available data from national health provider registry.RESULTS. Median age of the patients accounted to 53 (18-78) years.
Majority (15/21; 71.4%) of patients were females. The most common
diagnoses were granulomatosis with polyangiitis (38.1%), systemic
lupus erythematosus (23.8%) and microscopic polyangiitis (14.3%).
Most of the patients required mechanical ventilation (85.7%), renal
replacement therapy (57.1%) and blood products transfusions
(71.4%). Mortality in the ICU was 52.4%, while in both 1-year and 5-
year follow-up it accounted to 76.2%.
CONCLUSION. Our study shows that among patients with systemic
autoimmune diseases, DAH is diagnosed most typically in patients
with primary systemic vasculitides such as granulomatosis with poly-
angiitis and microscopic polyangiitis. These patients often require ad-
vanced therapeutic measures and are characterized by high short-
and long-term mortality.
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INTRODUCTION. Myocardial injury after noncardiac surgery (MINS) is
common and significantly affects patients` outcomes. Its etiology is
uncertain, however available studies suggest association between ac-
tivity of hemostatic and fibrinolytic systems and incidence of MINS.
OBJECTIVES. We aimed to compare patients undergoing vascular
surgeries due to peripheral artery disease (PAD) and abdominal aortic
aneurysm (AAA) in terms of preoperative levels of coagulation and fi-
brinolysis markers.
METHODS. Patients at the age of 45 years or older, who received
general or regional anesthesia for vascular surgery and stayed over-
night in the hospital. We gathered demographic and clinical data on
the patients. Coagulation (fibrinogen, factor VIII [FVIII], von Willebrand
Factor:CoR [vWF:CoR], antithrombin III [ATIII]), fibrinolysis (D-dimer,
plasmin-antiplasmin complexes [PAP], tissue plasminogen activator
[tPA]) and inflammation (soluble CD40 ligand [sCD40L]) markers`
levels were measured before surgery.
RESULTS. The study group consisted of 131 patients at the mean
age of 68.3 years. History of smoking and diabetes were more com-
mon in the PAD group. Platelet count (209.5 vs. 250.5, p=0.001) as
well as level of fibrinogen (4.1 vs. 5.4, p<0.001), FVIII (141.9 vs. 176.9,
p<0.001), vWF:CoR (152.3 vs. 188.9, p=0.009) and sCD40L (7936.6 vs.
9016.0, p=0.005) were higher in the PAD group. The d-dimer level
was higher (2590.5 vs. 808.0, p<0.001) in the AAA group. We did not
observe statistically significant differences in ATIII, tPA and PAP levels
CONCLUSION. Our results suggest more pronounced activation of
coagulation in patients undergoing surgeries for PAD compared to
those with AAA. Together with relative hypofibrinolysis, it may put
this group of patients at higher risk for cardiovascular complications.
However, differences in baseline clinical characteristics may partially
explain these differences. Further studies, performed on larger study
groups, utilizing dynamic assessment of coagulation and fibrinolysis,
are warranted.
REFERENCE(S)
1. Polok K, Górka J, Fronczek J, et al. Impact of arterial procedures on
coagulation and fibrinolysis – a pilot study. Brazilian J Cardiovasc Surg.
2019;In press.
Page 192 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 552. Górka J, Polok K, Iwaniec T, et al. Altered preoperative coagulation and
fibrinolysis are associated with myocardial injury after non-cardiac sur-
gery. Br J Anaesth. 2017;118(5):713-719. doi:10.1093/bja/aex081
3. This work was supported by a grant from the Polish Ministry of Science
and Higher Education, Hoża 20 St., Wspólna 1/3 St., 00-529 Warsaw. Tel.
(+48 22) 52 92 718. Grant number NN402083939 and DI2011023141INF - Infection prevention and
diagnosis: New strategies and ways of
improvement
001684
Effect of antimicrobial stewardship program on carbapenems
consumption and Klebsiella resistance in intensive care units of a
large rural hospital in Egypt, Menoufia
A. Samir1, H. Elsawah1, M. Elrazzaz1, K. Taema2, A. Ramadan1, A. Elnaggar1
1Clinical pharmacy, Elaraby Hospital, Ashmun, Egypt; 2Critical care
medicine, Cairo University, Faculty Of Medicine, Kasr Al Ainy, Cairo, Egypt
Correspondence: H. Elsawah
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001684
INTRODUCTION. Because of high rates of prevalence and related
mortality, Klebsiella species and their resistance need to be ad-
dressed in many rural hospitals of Egypt. Antimicrobial stewardship
program (ASP) based on clinical pharmacy services is required to
optimize antibiotics use especially broad spectrum ones.
OBJECTIVES. to measure the impact of ASP on rational antibiotics
use and bacterial resistance
METHODS. Carbapenems consumption in intensive care units
(ICUs) was recorded by defined daily dose (DDD) per 1000 pa-
tients prospectively from April 2017 to January 2019. Klebsiella
species isolates and their antimicrobial susceptibility were re-
corded from October 2017 to November 2018. The ASP started
on the first of March 2018 and the effects of the program on the
following were measured and compared with the data collected
before: (1) carbapenems-resistant Klebsiella prevalence, (2)
carbapenems consumption in ICUs, and (3) probability of Klebsi-
ella to be in a lower or a higher category of resistance based on
classification of Klebsiella resistance into three categories; carba-
penems resistant, carbapenems only sensitive and cephalosporins
sensitive . The effect of the program was measured in ICUs of El-
Araby hospital.
RESULTS. SPSS 25 software was used. Carbapenems consumption
after starting the ASP was significantly lower than that consumed be-
fore (0.98 vs. 1.51 DDD per 1000 patients respectively, P-value=0.02).
The prevalence of carbapenems-resistant Klebsiella was significantly
lower than the prevalence before the program (48.6% vs. 85.25% re-
spectively, P-value=.000) with odds ratio (OR) =0.164 (.075-.357). The
probability of being in a higher category of Klebsiella resistance was
significantly decreased after implementation of the program with OR
= 6.3 (2.88 – 13.73). The probability of being in a higher category of
Klebsiella resistance was also decreased with the decrease in carba-
penems consumption with OR = 3.17 (1.367 – 7.345).
CONCLUSION. The antimicrobial stewardship program aiming to re-
duce unnecessary carbapenems use is extremely important to reduce
prevalence of highly resistant strains of Klebsiella in similar hospitals.REFERENCE(S)
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INTRODUCTION. Central line (central venous catheter) associated
bloodstream infections (CLA-BSI) which are one of the healthcare-
associated infections pose a great threat to patient safety. Patients
followed in intensive care units (ICU) can be colonized with resistant
microorganisms during their ICU stay and as a result, they have an
increased risk of hospital acquired infections including CLA-BSI. In
this reason, ICU needs to be monitored for nosocomial infections.
OBJECTIVES. The aim of this study was to evaluate the CLA-BSI rate,
invasive device use rate and causative microorganisms isolated in
these infections, between 2014 and 2018.
METHODS. This study was conducted in an Anesthesiology and Reanima-
tion Intensive Care Unit. Five year’s surveillance data was evaluated in this
study. CLA-BSI rate per 1000 central venous catheter-days and device
utilization ratios are retrospectively evaluated (CLA-BSI rate = CLA-BSI num-
ber / central venous catheter-days x 1000). Microbiological culture results of
invasive device associated infections were also evaluated. Hospital acquired
infection definitions are made according to the US Centers for Disease Con-
trol and Prevention (CDC) criteria.
RESULTS. A total of 2944 patients were enrolled. Central venous catheter
usage ratio was 74.8% in the ICU for 28.721 catheter days. The mean rate
of central venous catheter associated bloodstream infection was 6.38. Be-
tween 2014 and 2018, the number of central venous catheter-associated
bloodstream infections was 21, 17, 48, 48, and 57, respectively. When com-
pared with 2014, the CLA-BSI rate was slightly increased in 2018 (6.1 and
7.8 respectively). Candida spp. (25.6%) was the most frequently detected
agent between the years of 2014-2016, while it was Klebsiella spp. (21.5%)
in 2017-2018.Generally, Klebsiella spp. (20.1%), Candida spp. (19.6%) and En-
terococcus spp. (16.6%) were mostly detected in the five-year evaluation.
CONCLUSION. Use of central venous catheter, increases the incidence of
invasive device associated infection rate in ICU. The high mortality rates in
patients with invasive device could be related to high infection rates and in-
appropriate antibiotic use. Incidence of infections can be reduced by educa-
tion of health care givers and use of barrier preventive methods.
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ous catheters (PIVCs) is a daily routine for nurses. However, PIVCs can
pose serious threats to patient safety and can cause catheter associ-
ated blood stream infections if not cared for properly (1). Thus, hos-
pitals have guidelines for PIVC care, but do the nurses follow them?
METHODS. We aimed to measure if the nurses followed procedure
for good PIVC care.
RESULTS. At baseline all PIVCs had at least one deviation from pro-
cedure, whilst at first follow-up 8 PIVCs an 6 at second follow-up
were perfect. At baseline the average PIVC had median 4 deviations
from procedure (95%CI 3.7-5.1%) whilst the average PIVC score fell
to 2 deviations (95% CI 1.1-2.2) on first and 1 deviation after second
measurement after intervention, p<0.001. At second measurement 1
PVK had a score of 7, and this patient and the PVK had just arrived
from another hospital.
CONCLUSION. Nurses do not automatically follow PIVC guidelines.
Improvement processes to improve PIVC care are needed. A 30 mi-
nutes training session gave good effect, which points to a high mo-
tivation for good PIVC care among the nurses. Since we developed
the PIVC quality instrument and only one nurse had the measure-
ment responsibility, the instrument needs testing in different set-
tings, and the interrater reliability needs to be established, as LH
Høvik et al recently have done (2).
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INTRODUCTION. Risk factors related to CSF infection in patients with
CSF drains include drain days, drain insertion conditions, openingand manipulation, diabetes mellitus and CSF leak (1). In most of
these studies and with one exception known to us (2) the role of
pre-existing extracranial infection has not been addressed.
OBJECTIVES. To identify risk factors related to the emergence of
cerebrospinal fluid drain (CSFD) infections and to describe the micro-
organisms cultured in the CSF compared to those cultured in other
specimens.
METHODS. We designed a retrospective single center cohort study.
We reviewed the electronic hospital records of all ICU admissions to
identify the eligible neurosurgical cases admitted between January
1st 2011 and December 31st 2018. Eligibility criteria for the study
participants were: presence of a CSF drain during ICU stay, time
lapsed from drain insertion to ICU admission < 24 hours, no previous
diagnosis of CSF or any other infection either hospital or community
acquired, and length of ICU stay > 24 hours. Patients’ demographic
and clinical characteristics were recorded, as was microbiology la-
boratory data. We used non-parametric statistical methods to identify
possible risk factors for CSFD infection.
RESULTS. We identified 799 neurosurgical admissions of which 70
fulfilled the inclusion criteria. The figure shows the relative frequen-
cies of different pathogens in the form of comparative pie charts [A:
CSF (inner disc) vs blood (annulus); B: CSF vs bronchial; C: CSF vs any-
where else, including bronchial, blood, urine, and wound swab sam-
ples]. Acinetobacter baumannii was the most frequent single
pathogen isolated in the CSF. The relative frequencies of pathogens
in the CSF did not differ significantly from those of pathogens in
other specimens (p = 0.3699). The presence of previous bacteraemia
was the only statistically significant risk factor for CSFD infection in
our population OR = 3.274, CI: (1.082-10.71), p = 0.0274
CONCLUSION. Our data suggests that, in an ICU population, the dis-
tribution of pathogens causing CSFD infections is similar to the over-
all distribution of pathogens cultured in other specimens. The most
frequently isolated pathogens were Gram negative Enterobacteria-
ceae. Among them, the most frequent one was A. Baumannii. In our
population, previous bakcteraemia was the only risk factor for CSFD
infection. This finding warrants further investigation.
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INTRODUCTION. The incidence of Pneumocystis pneumonia (PCP) in
non-HIV individuals is increasing. These patients typically present
with severe disease and may require admission to the Ιntensive Care
Unit (ICU). Modern diagnostic techniques are not widely available
and prompt administration of appropriate treatment is essential.
OBJECTIVES. To examine the underlying diseases in non-HIV patients
with PCP and the diagnostic yield of direct immunofluorescence
(DFA).
METHODS. From June 2016 to March 2019 all cases with confirmed
PCP pneumonia admitted to ICU of Saint Savvas Hospital were identi-
fied. Inclusion criteria were: diffuse pneumonia requiring intubation,
absence of HIV antibodies and detection of PCP morphological struc-
tures with DFA. Bronchial samples were obtained via aspiration and
examined with DFA by the same experienced microbiologist. Pa-
tients’ demographic data, their underlying diseases-risk factors for
PCP, their inflammatory markers as well as co-infection with bacterial
strains were recorded. The number of bronchial samples required to
make the diagnosis and their short-term prognosis- ICU discharge or
death were also recorded. All patients received trimethoprim-
sulfamethoxazole (TMP/SMX) and steroids, initiated when PCP pneu-
monia was suspected.
RESULTS. Overall, 9 cases with documented PCP pneumonia were re-
corded aged from 36 to 72, 3 males. Nobody was receiving TMP/
SMX prophylaxis. Due to severe hypoxemia none of the patients
underwent bronchoscopy to obtain bronchoalveolar lavage. Ιn 4 pa-
tients (44,4 %) the first bronchial sample was diagnostic for PCP, in 3
patients (33.3% ) PCP was detected in the second sample and in 2
cases (22.2%) only the third sample confirmed the diagnosis. The sen-
sitivity of the method on bronchial aspirates was only 44.4%. Seven
patients had solid tumors but only one was receiving concurrent
chemotherapy. One had multiple myeloma with recent autologous
bone marrow transplantation and one had scleroderma on 5 mg
prednisolone daily. Five patients had concurrent blood stream or re-
spiratory infection with gram negative bacteria. 7/9 patients sur-
vived, and were discharged from ICU (77.7% survival).
CONCLUSION. As the accuracy of staining methods is highly
dependent on the quality of respiratory specimen, when bronchial
aspirates are examined especially in non-HIV-patients who have
lower burden of PCP, more than one bronchial samples may be re-
quired to increase the diagnostic yield of DFA.
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based methods in bloodstream infections
I. Cruz Valero1, PA. Carranza1, AME. Poyatos1, J. Tejero Aranguren1,
MT. Cruces Moreno1, ME. Yuste Ossorio1, M. Colmenero Ruíz1
1Intensive care unit, Hospital Universitario San Cecilio, Granada, Spain
Correspondence: I. Cruz Valero
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001548INTRODUCTION. In order to improve the selection of antibiotics,
doses and infusion strategies, we wanted to describe the value of
the Accelerate PhenoTest kit, approved by the Food and Drug Ad-
ministration (FDA) as a method that can be useful to speed up mi-
crobial identification and to predict antimicrobial susceptibility in
patients with bacteraemia compared to the reference standard that
continues being the blood culture.
METHODS. observational, descriptive study. We included the patients
admitted to the Intensive Care Unit and Infectious Diseases Unit, with
clinical suspicion of bloodstream infection, from January to June
2018. Antimicrobial susceptibility testing (AST) results were analysed
for essential agreement and for categorical agreement. Results based
on EUCAST 2016 breakpoints.
RESULTS. 31 samples were evaluated, being excluded two of them.
About the identification performance, 15 of them were gram- posi-
tive bacteria, 13 gram-negative bacteria (achieving a sensitivity and
specificity of 100%) and one of the microorganisms was outside the
PhenoTest panel, so the kit coverage was finally 96.6%. We also
found an essential and categorical agreement of 93.5% and 92.9%,
respectively, compared with the routine methods and we found the
AST discrepancies in gram-negative bacteria. The potential on-
average hours saved to AST was 23,4h compared to current
techniques.
CONCLUSION. The coverage panel of the Accelerate PhenoTest kit
was 96.6%. The essential and categorical agreement were above 90%
and the results were obtained with a saved time of 23,4 hours com-
pared to routine methods.
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INTRODUCTION. Ventilator associated pneumonia (VAP) is the lead-
ing cause of death amongst hospital acquired infections (4,). Guide-
lines for the Provision of Intensive Care Services (GPICS) (2015) states
its prevention as an important and cost-effective healthcare goal.
Studies recommend several components should be adhered to help
prevent VAP; including maintaining endotracheal tube cuff pressure
to reduce micro aspiration.As part of the local Intensive care unit’s
ventilator care bundle it prompts Nursing staff to check cuff pressure
4 hourly, as per Department of Health (2011). GPICS (2015) recom-
mend cuff pressure is kept above 20 cmH20, however over inflation
of the cuff can cause ulceration or fistulation (2).
OBJECTIVES. To audit cuff pressure monitoring for endotracheal
tubes in patients who are mechanically ventilated.
METHODS. A retrospective audit was conducted between the 22/6/
18 and 1/8/18. 256 recordings of cuff pressures were analysed in
total. 15 Patients were included with a total of 44.5 ventilated days,
with stays ranging from 0.5-6 days. Each day was split into 2 x 12-
hour shifts. Cuff pressures were recorded into time zones per shift 2-
4 hourly, 4-6 hourly, 6-8 hourly, 8-10 hourly, once per shift and never
on shift, with a total of 89 recordings taken. Cuff pressure was also
Page 195 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55recorded and split into groups of <20cmH20, 20-30cmH20 and
>30cmH20.
RESULTS. 68.5% of the time recommendations were met and cuff
pressures checked 2-4 hourly. 31.5% of the time the standards ex-
pected were not being met related to timely recordings. 10.11% of
the time cuff pressure was never checked on shift. 96.25 % of re-
corded cuff pressures were between the recommended pressures of
20-30 cmH20. However 3.75% of the time pressure was >30 cmH20
and never recorded <20 cmH20.
CONCLUSION. Despite 68.5% of the time standards being met relat-
ing to timing of cuff pressure measurement, the aim should be 100%
to ensure the best quality care is being provided. Improvements to
education of staff surrounding good cuff pressure maintenance and
monitoring has now been introduced. Highlighting of the cuff pres-
sure box every four hours has been introduced on the nursing obser-
vations charts to act as a visual prompt to staff to check the cuff
pressure. These changes are now in place and there is a plan to re-
audit in 6 months to see if improvement has been made.
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INTRODUCTION. Although rapid response teams (RRTs) are widely
used at many hospitals, their effectiveness in reducing hospital mortal-
ity is uncertain. Improving the understanding of RRTs and their
utilization in specific patient populations, such as cancer patients, might
be helpful to improve the outcome and optimize RRT utilization
METHODS. A retrospective cohort study of hospitalized patients re-
quiring RRT activation over 3-year period from January 2016 to De-
cember 2018 in a single academic medical center in Seoul, Republic
of Korea.
RESULTS. Of the 274 patients, 104 were cancer patients. Cancer pa-
tients had a significantly higher Charlson Comorbidity Score (5.0 vs
8.0. p < 0.001). Also, cancer patients had significantly higher APA-
CHEII (14.0 vs. 17.5, p < 0.001) and MEWS (6.0 vs. 7.0, p < 0.001). Pro-
portion of patients requiring ICU transfer was significantly higher in
cancer patients (52.9% vs. 38.2%, p = 0.001). Cancer patients had a
significantly higher in-hospital mortality compared with other pa-
tients (44.2% vs. 11.8%, p < 0.001). The survival rate was 75.9% and
survival was associated with cancer and Charlson Comorbidity Score.
The utilization of RRT resources during the study period was also
much higher for cancer patients with 2.34 activations per 1,000 pa-
tient discharges compared with 0.78 per 1,000 patient discharges for
the other patients.CONCLUSION. Oncology patients requiring rapid response team acti-
vation have a significantly higher in-hospital mortality and ICU mor-
tality rate. Presence of cancer was the most important factor related
to survival. In addition, cancer patients also utilize RRT resources at a
much higher rate.
SIS - Sepsis pathophysiology and
management
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INTRODUCTION. Antibiotic resistance is an increasing problem in in-
tensive care units and inadequate empiric antibiotic therapy is asso-
ciated with increased mortality. Biomarkers of treatment efficacy can
theoretically be used to determine adequacy of antibiotic therapy
prior to culture results being available. The aim of this study was to
investigate the relationship between C-Reactive Protein (CRP) levels
and (a) appropriateness of antibiotic therapy and (b) the presence of
an untreated infectious focus in ICU patients with culture-confirmed
bacteremia.
OBJECTIVES. To investigate the relationship between CRP levels and
(a) appropriateness of antibiotic therapy and (b) the presence of an
untreated infectious focus in ICU patients with culture-confirmed
bacteremia.
METHODS. This retrospective observational study included all critic-
ally ill patients with culture-confirmed bacteremia admitted to the in-
tensive care of the Algarve University Hospital Centre in Faro,
Portugal from January to December 2018. Patients who did not re-
ceive antibiotic therapy were excluded from the study. Appropriate-
ness of empiric antibiotic therapy was determined based on final
culture and sensitivity results. Bacteremia episodes were designated
as “complicated” or “simple” based on the presence or absence of an
untreated or untreatable source (eg intra-abdominal abscess, in-
fected hardware). CRP levels and standard clinical and biological vari-
ables were collected for 12 days, starting from the day prior to blood
culture draw until 10 days afterwards.
RESULTS. A total of 59 culture-confirmed bacteremia episodes were
identified. CRP concentrations on the day of positive culture varied
widely from 9 mg/L to 480 mg/L. Out of the 59 patients in the co-
hort, a total of 38 (64.4%) patients received adequate empiric anti-
biotic therapy (as determined by final culture results) on the day of
positive blood culture. CRP levels showed an overall negative trend
from Day 0 (day of positive culture) to Day 10 irrespective of the ad-
equacy of empiric antibiotic therapy. The presence of a “compli-
cated” infection also had no significant impact on CRP trend.
However, in multivariate regression analysis time to adequate anti-
biotic therapy was an important determinant of patient mortality, re-
inforcing the need for early appropriate antibiotics.
CONCLUSION. Although some studies have suggested that CRP is a
useful marker of antibiotic adequacy, our results do not support this
conclusion. Instead, we find that CRP levels show a similar downward
trend from Day 0 to Day 10 in bacteremic patients, irrespective of
the adequacy of empiric antibiotics. Further studies are needed to
determine whether other biomarkers show greater utility than CRP in
determining the efficacy of antibiotic therapy in this population.
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INTRODUCTION. The gut as a motor of sepsis hypothesis is an ac-
cepted hypothesis for the pathogenesis of systemic inflammation
in critically ill patients. Impaired gastrointestinal motility may be
a surrogate parameter for intestinal failure including gut barrier
failure.
OBJECTIVES. This retrospective analysis in patients with major
trauma tested different clinical variables of gastrointestinal motility
as independent risk factors for sepsis and death on ICU.
METHODS. Retrospective data analysis of clinical variables from a
patient data management system (IntelliSpace Critical Care &
Anesthesia, ICCA™). Identification of 424 patients with major
trauma (ISS>16) treated on the ICU in the timespan of Jan 2010 -
Oct 2014 using the search items polytrauma and PTR. Chrono-
logic analysis of 100 patients with respect to clinical variables of
gastrointestinal motility (time until 50% of nutritional needs were
achieved, gastric residual volume, time until first defecation) were
analysed on days 0, 1, 2, 3, 5, 7, 10, and 14 as well as outcome
parameters (sepsis, death on ICU). Statistics: multivariate analysis
of prior evaluated variable-candidates for dichotomous outcome
measures sepsis and death on ICU. Comparison of variables of
patients with gastrointestinal motility disorders with and without
sepsis. Group comparison with Mann-Whitney U test. Significance
level at p<0.05.
RESULTS. Patients with a long duration to achieve 50% of nutri-
tional needs were at a higher risk of developing sepsis (odds ra-
tio 0.94; CI 0.89/0.99; p=0.03). This also applied for severe sepsis
and septic shock. As risk factors for death on ICU old age (odds
ratio 0.92; CI 0.86/0.98; p=0.01) and presence of brain trauma
(odds ratio 38.47; CI 1.73/854; p=0.02) could be determined. Pa-
tients with sepsis needed more time until first defecation (173 ±
78 vs. 126 ± 77 h (mean ± SD) p=0.009) and until 50% of nutri-
tional needs were achieved (146 ± 87 vs. 98 ± 51 h (mean ±
SD), p=0.012)
CONCLUSION. In this ICU-cohort of patients with major trauma vari-
ables of gastrointestinal motility served as risk factors for sepsis, se-
vere sepsis and septic shock. Gastrointestinal motility disorders were
more pronounced in patients with sepsis compared to patients with-
out sepsis.001564
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INTRODUCTION. Hemodynamic status of critically ill patients typically
declines during sepsis and requires vasopressor support. Machine
learning models have been recently implemented for a variety of ICU
tasks with considerable success. A model capable of forecasting
hemodynamic changes of septic patients could be critical in stratify-
ing clinical intervention. Along this rationale, we hypothesize that the
most predictive features would be those related to heart rate and
blood pressure measurements, i.e. systolic (SP), diastolic (DP), mean
(MP), or pulse pressure (PP).
OBJECTIVES. The purpose of the analysis was to create a prediction
model for worsening of hemodynamic status in septic patients by
using data from the first 6 hours after ICU admission.
METHODS. Data was pooled from the Medical Information Mart for
Intensive Care III (MIMIC-III)(1) database. Patients in the 18-89 age
range fulfilling the international consensus sepsis-3 criteria(2,3) were
included. An increment of vasopressor equivalents (VPE) above 0.2
mcg/kg/min over the following 6 hours was chosen as indication of
worsening of hemodynamic status. Firstly, a “null” logistic regression
model using clinical data relative to the first 6 hours of ICU stay was
trained to formulate predictions. Secondly, SP, DP, MP and PP were
each integrated in the model and assessed for performance. Finally,
a model with all pressure measurements was built and a feature se-
lection process (LASSO) was run to yield only the most indicative.
Performance was evaluated using the area under the receiver oper-
ator characteristic curve (AUC), recall and F1 score.
RESULTS. 5778 ICU stays were evaluated, of which 4370 (76%) do
not receive vasopressors in the first 6 hours. The described increment
in VPE was observed in 402 (6.9%) patients. Despite thelow preva-
lence, the models achieved moderate performance. The addition of
any pressure measurement only slightly improved the AUC of the
null model (0.84 vs 0.82) while it did improve recall, especially when
using MP (0.83 vs 0.75). In all models, Glasgow coma scale and per-
ipheral oxygen saturation were the the highest graded features; SP
was also particularly highly ranked in its model, and MP and PP in an
intermediate fashion. Likewise, the LASSO model selected SP as the
most predictive feature.
CONCLUSION. Increment of vasopressor dose, as a marker of worsen-
ing of hemodynamic status, could be predicted 6 hours in advance
using clinical data with moderate accuracy. SP was revealed as the
most predictive of all pressure measurements, although it did not
markedly improve accuracy of the model itself.
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INTRODUCTION. Sepsis is the most preventable cause of death
worldwide,whichis estimated between six to nine million deaths
every year [1]. Experimental studies are useful for a better under-
standing of this pathology, but require to follow new guidelines of
animal modeling to fit with a clinical relevance.
OBJECTIVES. We aimed to explore (A) what is realized in articles pub-
lished in 2018 using a cecal ligation puncture (CLP) model in rat, (B)
if the instructions about antimicrobial therapy fit with microbiology
in a peritonitis model based on CLP.
METHODS. (A) The review was performed on Pubmed using as key-
words “CLP” and “RAT”for the year 2018, and selected English-written
papers. We checked if animals received antibiotics and if bacterio-
logical documentation was available before treatment. (B) We ex-
plored bacteria involved in the sepsis, using peritoneal fluid and
blood cultures, at least 16 hours between CLP and sacrifice.
RESULTS. (A) Ninety-five studies were found. Among them 9 were
excluded as they had a different meaning for CLP. Only in 11 cases
(12%) antibiotics were used and mainly ceftriaxone at the dosage of
30mg/kg. None of the studies identified the pathogen before treat-
ment.(B) In our series of eleven rats, we found mainly Escherichia coli,
Enterococcus faecalis, Lactobacillus murinus in peritoneal fluid (fig. 1)
and Escherichia coli, Enterobacter cloacae, Enterococcus faecalis in
blood (fig. 2). All the bacteria exhibit a wild type phenotype for anti-
microbial agent susceptibility.
CONCLUSION. These new recommendations provide a better match
between experimental and clinical approaches, and improve transla-
tion of pre-clinical findings. Our findings suggest a better adequacyof antimicrobial treatment to pathogens and to the animal. More
specific investigations are required to explore the bacterial diversity
in peritoneal fluid and blood culture.
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INTRODUCTION. Optimal drug dosing is crucial in the therapeutic
process. It plays a particularly important role in critically ill patients,
especially those with severe sepsis, when proper antibiotics dosing is
essential. The influence of renal replacement therapy on meropenem
concentration in septic patients is largely unknown.
OBJECTIVES. The aim of this study was to determine the effect of
continuous veno-venous hemodialysis (CVVHD) with regional citrate
anticoagulation on meropenem concentrations in patients with acute
kidney injury due to sepsis.
METHODS. 15 patients with acute kidney injury in the course of severe
sepsis with clinical necessity for CVVHD according to KDIGO guidelines
were enrolled in a prospective observational trial. Meropenem was ad-
ministered by a continuous infusion, 2g every 8 hours. Meropenem
concentrations were measured in blood plasma using high perform-
ance liquid chromatography coupled with tandem mass spectrometry.
Blood samples were obtained prior and then 6 times after introducing
CVVHD with regional citrate anticoagulation (RCA-CVVHD).
RESULTS. Median APACHE IV score was 118 points (IQR 97-134) and
the median SOFA score on the day of admission was 19.5 (18-21).
There were no significant differences in plasma meropenem concen-
trations measured directly prior to RCA-CVVHD and in the first 450
minutes of the procedure. Drug concentration reached its peak 2
hours after start of the infusion and then steadily declined.
CONCLUSION. Continuing high dose meropenem (2g every 8 hours)
after introducing RCA-CVVHD ensures similar concentrations of mero-
penem both prior and after introducing RCA-CVVHD.
T7
Table 1 (abstract 001608). See text for description
Year Total Multiresistant Upon Admission to the ICU Acquired in ICU
2008 6 0 (0%) 6 (100%)
2009 4 0 (0%) 4 (100%)
2010 2 1 (50%) 1 (50%)
2011 15 3 (20%) 12 (80%)
2012 5 1 (20%) 4 (80%)
2013 5 2 (40%) 3 (60%)
2014 8 7 (87,5%) 1 (12,5%)
2015 6 3 (50%) 3 (50%)
2016 6 3 (50%) 3 (50%)
2017 10 7 (70%) 3 (30%)
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INTRODUCTION. The course and outcome of infections is a dynamic
interplay between the host and the pathogen. Central to this inter-
play is the struggle for iron, a micronutrient essential to both the
mammalian host and virtually all microbes.(1,2)
OBJECTIVES. The aim of this study is to test whether markers of iron
metabolism predict patient outcome in a cohort of sepsis patients.
METHODS. Patients admitted with sepsis to the ICU were consecu-
tively enrolled from January 2018 to March 2019. Sepsis was defined
as fulfilment of Sepsis-3 criteria, patients were enrolled within 24
hours after admission or diagnosis of sepsis respectively. Patients
with haemato-oncologic disorders and patients with prior transfu-
sions were excluded from analysis. Serum ferritin, transferrin and
iron, as well as interleukin-6, procalcitonin, c-reactive protein and
SOFA scores were obtained at the day of study inclusion. Patient out-
come was defined as ICU mortality or discharge. Predictor variables
were tested for a significant difference between survivors and non-
survivors and imputed into a multiple logistic regression model. Pre-
dictors were tested for correlation with markers of inflammation.
Statistical analyses were performed in R, results are presented as
mean ±standard deviation. A p-value of >0.05 was considered as sta-
tistically significant.
RESULTS. Of 31 included patients, 4 were excluded due to prior
transfusion of blood products. Of the remaining 27 patients, four
were excluded due to presence of an active haematologic disorder
and one due to missing iron parameters. 27% of patients were fe-
male, mean age was 65 ±14 years with a mean SOFA score of 12 ±3.
64% of patients survived. Iron levels of survivors vs. non survivors dif-
fered significantly (4.87 ±2.47 vs. 7 ±5mmol/L; p = 0.01), as did levels
of ferritin (median 700 vs. 302μg/L; p < 0.0001) and transferrin
(121.64 ±46.67 vs. 87.75 ±58.86 mg/dL; p < 0.0001) between surviving
and deceased patients. Multiple logistic regression analysis of these
parameters against ICU mortality did select transferrin as best pre-
dictor with an AUC of 0.66. Correlation analysis of transferrin and
markers of inflammation did not reveal significant associations.
CONCLUSION. Parameters of iron metabolism differ significantly be-
tween survivors and non-survivors of sepsis in our cohort. Transferrin
levels are inversely correlated with ICU mortality, but no statistical
significant correlation could be shown with parameters of
inflammation.2018 14 11 (78,57%) 3 (21,43%)REFERENCE(S)
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):001608INTRODUCTION. The increase of antibiotic resistance is a serious
threat to public health throughout the world that enhances the costs
of health care the rate of treatment failure and mortality. The main
objective of the “Resistencia Zero” (RZ) program is to reduce by 20%
the rate of patients in whom one or more multiresistant bacteria of
nosocomial origin are identified during ICU stay
OBJECTIVES. To describe, according to the origin, the trend in the
pattern of multiresistant germs in a medical ICU based on the results
of the RZ.
METHODS. Descriptive study of the quantity of multiresistant germs
acquired in our ICU with regards to the total of multiresistant germs
acquired during ICU stay and out of ICU from 2008 to 2018, in a
medical ICU of 26 beds. Data collected from the ENVIN-HELICS study
and expressed as a percentage.
RESULTS. During the period under review, a total of 81 multi-
resistant germs were registered. The following results are described:
14 MRSA (8 of them were adquired at ICU); 2 Enterococcus resistant
to Vancomycin (1 was adquired at ICU); 13 Pseudomonas multiresis-
tant (7 were adquired at ICU); 19 Acinetobacter resistant to Imipe-
nem (12 were adquired at ICU); 21 Enterobacteria-ESBL (9 were
adquired at ICU); 12 BGN producers of Carbapenemase (6 were
adquired at ICU).
According to whether the isolation of the germ was prior to admis-
sion to the ICU or during ICU stay, we obtain the following annual
results.
CONCLUSION. We observe a change in the trend of MR isolations
during the last decade. At first, most isolates were originated at ICU
but during the last years the origin of the majority of isolations is out
of ICU. These data are consistent with those of the RZ program na-
tionwide. Antibiotic policies at ICU and the Zero Projects play a key
role in the decrease of MR isolates within the ICUs.001639
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INTRODUCTION. The beta-adrenergic system is a powerful modulator
of the immune and cardiovascular response to sepsis and inflamma-
tory cytokine production. Recent data suggest a potential beneficial
role of prior β-blockers use in patients with sepsis. The benefit from
beta-blockers in sepsis may not be only derived from a class‐specific
effect. We sought to assess impact of premorbid β-blocker use on
mortality within 28 days of ICU admission.
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Page 199 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55METHODS. We conducted a retrospective cohort study of patients
with sepsis and septic shock admitted to the medical ICU from Janu-
ary 1, 2014, to December 31, 2018. Chronic beta-blockers use was de-
fined to have a previous prescription for β-blocking agent for 3 or
more months prior to ICU admission. Demographics, initial vital signs,
the source of infection, 28-day mortality, SOFA and APACHE II were
obtained from the electronic database. Adjustment for age, gender,
and severity of illness was performed.
RESULTS. We identified 784 patients with sepsis and septic shock,
290 (37%) of whom had a previous prescription for β -blockers be-
fore hospital admission. Common medications used by patients were
metoprolol (54 %) and bisoprolol (22 %). The median age was 67
years (IQR 57- 76), 456 (58%) of patients were males. Patients who
were on chronic β-blockers had lower 28-day mortality (20,8%) com-
pared to patients who were not (31,5%), (p=0.05). After adjusting for
age, gender, and severity of illness using SOFA and APACHE II scores,
the mortality was significantly lower in those on β-blockers (p<0.05).
There were no statistically significant association in admission heart
rate in both groups.
CONCLUSION. Long-term β-blocker therapy decreases 28-day mortal-
ity of ICU patients with sepsis and septic shock.
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INTRODUCTION. SEPSIS-3 was recently reported and validated in pa-
tients admitted to the ICU with sepsis. No study to date has evalu-
ated the usefulness of this definition in patients with ICU-acquired
infections.
OBJECTIVES. The aim of this study is to determine the accuracy of
SEPSIS-3 in diagnosing and predicting mortality of ventilator-
associated lower respiratory tract infections (VA-LRTI).
METHODS. Prospective observational study, conducted in a single
mixed ICU during a 2-year period. All consecutive patients with VA-
LRTI were included. SEPSIS-3 criteria were considered as present if an
increase of total SOFA score ³2, between 48h before and the day of
VA-LRTI diagnosis, was observed. VA-LRTI were defined as ventilator-
associated pneumonia (VAP), and ventilator-associated tracheobron-
chitis (VAT). Only first episodes of VAP or VAT with quantitative
microbiological confirmation were analyzed. Sensitivity (Se), specifi-
city (Sp), positive predictive value (PPV), and negative predictive
value (NPV) for accuracy of SEPSIS-3 in diagnosing or predicting mor-
tality of VA-LRTI were calculated.
RESULTS. 206 patients with VA-LRTI (136 VAP, and 70 VAT) were in-
cluded. SEPSIS-3 criteria were present in 53 (39%), and 6 (8.5%) pa-
tients with VAP, and VAT; respectively (p<0.001, OR 6.8 [95%CI 2.8-
16.8]). No significant difference was found in ICU-mortality between
patients who presented the criteria of SEPSIS-3, and those who did
not (24 of 59 (41%) vs 40 of 147 (27%), p=0.059).
CONCLUSION. Accuracy of SEPSIS-3 was moderate in diagnosing
VAP, and low in predicting mortality among patients with VA-LRTI.
The high positive predictive value of SEPSIS-3 in diagnosing VAP
might be helpful in differentiating VAP from VAT.Table 1 (abstract 001652). Accuracy of SEPSIS-3 in diagnosing and
predicting mortality of VA-LRTI
Se Sp NPV PPV
VAP diagnosis, % 39 91 44 89
Mortality of VA-LRTI, % 38 75 41 73001653
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INTRODUCTION. Intravenous vasoactive agents are key component in
management of persistant hypotension in septic shock after adequete fluid
resusitation ,yet they carry risk of many complications related to the drug
complication and acsess etc..(1) The use of oral Midodrine is hypotheised to
decresase the duration of vasoactive infusion and help their weaning.
OBJECTIVES. Evaluation of the role of midodrine in weaning of vaso-
pressor infusions in patients admitted to the ICU with septic shock
and its impact on outcome.
METHODS. This was a prospective randomized control study per-
formed in a medical intensive care unit (ICU). All study subjects had
a diagnosis of septic shock requiring at least 24 hours of IV vasopres-
sors and demonstrated clinical stability with stable or decreasing
doses of IV vasopressors. The two groups compared were those who
received IV vasopressors only(30 patients) and those who received IV
vasopressors with adjunctive midodrine 10 mg every eight hours(30
patients).Research and Ethics comittee approval was taken prior to
performing the study and a written consent from each patient and
or his next of kin before participating in the study.
RESULTS. There was no difference between both groups regarding
demographics ,baseline charechteristics and source of sepsis (age,
gender, APACHE 2 score and SOFA score on admission etc..).
Study findings showed that the IV vasopressor duration (hours) and
IV vasopressor weaning duration (hours) were lower in the midodrine
group when compared to IV vasopressor only group but the differ-
ence is statistically insignificant (139.03±46.95 VS 141.90±79.77 and
62.37±14.94 VS 74.20±36.78 p value 0.4.0.11 respectively).
Regarding the effect of midodrine on MAP, we found that despite
the decrease of vasopressor dose in the midodrine group, the MAP
in this group had significantly improved from 84.50 mmHg at the
time of midodrine initiation to 88.03 mmHg after 24hours of mido-
drine initiation (p=0.04), this was statiscally higher than group A not
using Midodrine.
Concerning the effect of midodrine on the outcome of septic patients, our
study showed that there was no significant difference between both
groups regarding the ICU length of stay and ICU mortality, reinstitution of
an IV vasopressor after successful discontinuation and survival rate.
CONCLUSION.
 Using midodrine in septic shock patients doesn't reduce
duration of IV vasopressor infusion and weaning during the
recovery phase of septic shock.
 Using midodrine as an adjunct to vasoactive agents has no
impact on overall survival, length of ICU stay and ICU mortality.
 Administration of midodrine improved mean arterial blood
pressure MAP.
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immune cell dysfunction (1-3). Antibiotics are known to impair mito-
chondrial function in non-immune cells (4-7). We hypothesise that
antibiotics impair immune cell mitochondrial function, contributing
to immune cell dysfunction in sepsis.
OBJECTIVES. To investigate the impact of antibiotics on mitochon-
drial function in immune cells ex vivo.
METHODS. Healthy volunteer immune cells were incubated in
Hanks buffered saline solution (37oC, 21% O2, 5% CO2) with one
of five antibiotics (amoxicillin, ciprofloxacin, gentamicin, merope-
nem and teicoplanin) at 5mcg/mL for 5 hours. Cells were subse-
quently incubated with fluorochromes (Thermo Fisher Scientific,
UK) for flow cytometric assessment of mitochondrial membrane
potential (Dψm) (using TMRM at 25nM), mitochondrial reactive
oxygen species (Mitosox Red at 2mM), and cell death (far red cell
viability stain at 1mM) using the LSR Fortessa flow cytometer (BD
Biosciences). The two main cell populations, granulocytes and
peripheral blood mononuclear cells (PBMCs) were identified by
gating on characteristic forward and side scatter profiles. All data
were collected from 3–5 individual experiments expressed as
mean ± standard error of mean (SEM) compared to untreated
cells. Flow cytometric data were analysed using FlowJo version
10.0 (Tree Star Inc, USA). Statistical data analysed using a non-
parametric Kruskal Wallis with post-hoc Dunn’s test using Graph-
Pad Prism v5 (San Diego, USA).
RESULTS. At 5mcg/ml, gentamicin and teicoplanin increased granulo-
cyte mitochondrial ROS production by 22% (p=0.026) and 44% (p=
0.012) respectively, compared to untreated cells. At 15mcg/ml, teico-
planin increased granulocyte mitochondrial ROS production by 43%
(p=0.041). In PBMC population, ciprofloxacin, gentamicin and mero-
penem increased mitochondrial ROS production at 5mcg/ml by 13%
(p=0.0014), 21% (p=0.0148) and 9% (p=0.0296) respectively. At
15mcg/ml, ciprofloxacin, gentamicin and meropenem further in-
creased mitochondrial ROS production by 75% (p=0.0014), 31% (p=
0.026) and 61% (p=0.0369) respectively, compared to untreated
cells.Mitochondrial membrane potential (MMP) in granulocytes was
not altered when treated with 5mcg/ml antibiotic concentrations (p=
0.1585). At 15mcg/ml, teicoplanin induced a reduction in MMP (p=
0.006). However, in PBMCs, MMP was unaffected by antibiotics at
both 5 and 15mcg/ml (p=0.1722 and p = 0.1436, respectively.Cell via-
bility was unaffected by antibiotic exposure (p=0.98 for granulocytes,
p=0.87 for PBMCs compared to untreated cells).
CONCLUSION. A number of antibiotics cause direct mitochondrial
dysfunction in immune cells ex-vivo. This may explain, in part, the im-
mune dysfunction seen in septic patients.F8REFERENCE(S)
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INTRODUCTION. The Surviving Sepsis Campaign [1] recommends to
administer 30 ml/kg of fluid within 3 hours following the onset of
hypotension, before introducing vasopressors. However, evidence
supporting this recommendation is lacking.
OBJECTIVES. Determine i) the optimal timing and ii) the optimal fluid
volume before vasopressor introduction in septic shock.
METHODS. We used the data from the MIMIC II dataset. (2) To be in-
cluded, patients had to present an acute hypotensive episode of sep-
tic origin and a lactate level > 2 mmol/l. The primary outcome
measure was hospital mortality. We used a machine learning ap-
proach accounting for time-varying confounders called longitudinal
targeted maximum likelihood estimation. (3)
RESULTS. 933 patients were included: SOFA 7; arterial lactate 3.3
mmol/L, average hospital mortality rate 11.5%. Hospital mortality was
significantly minimized when vasopressors where introduced by hour
3 following the onset of hypotension. When compared to 30 ml/kg,
switching to vasopressors after 5 or 10 ml/kg was associated with re-
duced mortality (Fig. 1).
CONCLUSION. In septic shock, administering 5-10 ml / kg within 3
hours after the onset of hypotension appears to maximize the
chance of survival.
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Fig. 1 (abstract 000685). Relative risk of mortality amongst ICU
patients by Dynamic treatment vs current protocol Fig. 1 (abstract 001692). See text for description
Fig. 3 (abstract 001692). See text for description
Page 201 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55001692
Pentraxin 3: which role in sepsis?
G. Scarpati, I. Russo, E. Della Rocca, L. Ferrara, O. Piazza
Anaesthesia and intensive care, University of Salerno, Baronissi, Italy
Correspondence: G. Scarpati
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001692
INTRODUCTION. Pentraxin-3 (PTX3) is a molecule of the humoral pat-
tern recognition arm of the innate immune system, as complement
components, collectins, and ficolins [1]. PTX-3 has been appreciated
for its diagnostic value for sepsis and septic shock.
OBJECTIVES. This study evaluated the accuracy of PTX3, Endocan, Ni-
tric Oxide (NO) and Presepsin as biomarkers of severity and progno-
sis in patients with sepsis/septic shock.
METHODS. We enrolled 12 sepsis patients admitted to our ICU. Blood
samples for measuring PTX3, NO, Endocan, and Presepsin were taken
within 12 hours from diagnosis and repeted for the next three days.
A group of patients admitted in ER with hip fracture was used as
controls. Mortality at 28-day was considered as outcome.
RESULTS.
Serum levels of NO, Endocan, and Presepsin in septic patients were
higher than control group, but PTX3, which was higher in the hip
fracture group. Endocan and Presepsin day 1 concentrations in non
survivors were higher than the concentrations measured in survivors.
At day 1, NO and PTX3 concentrations were higher in surviving
patients.
CONCLUSION. Sepsis patients had higher concentrations of Nitric
Oxide, Endocan and Presepsin than those with hip fracture. Beyond
its role as the first line of resistance against pathogens, innate im-
munity is involved in initiating the process of tissue repair. PTX3 ap-
pears to be more closely related to endothelial damage, prevalent in
patients with femur fractures. Furthermore, some authors suggest a
protective role of PTX3 and NO [2].
Models based on the combination of several biomarkers provide a
novel and useful strategy to overcome the limited performance of
one parameter for a given outcome. Hopefully, a new mortality pre-
diction model could improve the prediction of sepsis related mortal-
ity by combining PTX3, NO, endocan and presepsin.
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INTRODUCTION. Sepsis is responsible of both an immune hyperactiv-
ity damage from inflammation and immune suppression and paraly-
sis. A few studies support the role of IgM enriched immunoglobulins
G as adjunctive of antimicrobial treatment
OBJECTIVES. To assess the efficacy of IgM enriched IgG as adjuvant
therapy in treating sepsis in the critically ill.
METHODS. A PCRT was set and performed, since 12/2016 to 01/04/
2019; patients experiencing a septic shock - admitted with a first 24h
SAPS II > 25, associated with a SOFA-score > 4 were randomised in two
group: (A) undergoing treatment with IgM-e-IG, given for three days at
the total dosage of 500 mg/kg plus conventional antimicrobial therapy;
(B) undergoing conventional antimicrobial therapy. The therapy re-
sponse was based on clinical, microbiological and rheological data.
RESULTS. During the study period 23 and 22 patients were respect-
ively recruited in the two groups; no differences were found in me-
dian age [61 (55-78) vs. 63 (58-77) p=0.662], ICU length of stay [14
(5-19) vs. 15 (6-18) p=0.462]; duration of mechanical ventilation [7 (5-
8) vs. 8 (5-9) p=0.348] and antimicrobial treatment [9 (8-11) vs. 11
(12-14) p=0.552]. PCT, CRP, WBC, Lactates and SOFA score were daily
measured and computed the differences between day of stopping
and starting IM-enriched IgG (For the patients of group B, such pa-
rameters ware considered over the same 72 hrs period. No differ-
ences were found in the trend of all parameters but SOFA [3.7 (2-5)
vs. 0.8 (0-2) p=0.025], indicating a quicker and more timely recovery
from sepis related organ failure in the group A. The VLAD computed
on the basis of SMR in the two group showed a higher number of
saved lives in the treatment group (4.7 vs. 0.8, p=0.002). No differ-
ences in survival was found by Kaplan Meier analysis although at 28
days all patients of the treatment group were still alive.
CONCLUSION. IgM enriched immunoglobulins G as adjunctive of
antimicrobial treatment may have a role in improving patient out-
come, however PRCT should be prosecuted up to proper determined
sample size.
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INTRODUCTION. Polymyxin B hemoperfusion (PMX-HP) is one of a
new blood purification therapy for sepsis. PMX-HP can remove circu-
lating endotoxin particularly in gram-negative infection which poten-
tiates improving clinical outcomes.
OBJECTIVES. To evaluate the efficacy of polymyxin-B hemoperfusion
therapy over conventional treatment for sepsis.
METHODS. An ambi-directional cohort was conducted. PMX-HP arm
was collected prospectively in septic patients during 2017-2018 from
5 ICUs in Thailand. PMX-HP treatment was performed 2 hours for 2
consecutive days. South East Asia-Acute Kidney Injury (SEA-AKI)
Study dataset was used as a historical control arm (collected during
2013-2015 from 17 ICU-centers in Thailand, n=5,476). Propensity
score match and survival analyses were used to identify 28-day mor-
tality between patient with and without PMXB-HP therapy.
RESULTS. A total of 1,358 septic cases were enrolled (PMX-HP, n=30
and SEA-AKI Study, n=1,328). Comparing patients who treated with
vs without PMX-HP therapy, 28-day mortality was 14/30 (46.7%) vs
318/1,328 (24.0), respectively, HR = 0.971; 95%CI, 0.567-1.663, p =
0.916. However, there were multiple differences in patient baseline
characteristics, including pre-existing diseases (diabetes mellitus,
hypertension, and coronary heart disease); severity of illness (APA-
CHE-II and SOFA score); and usage of organ support (ventilatory sup-
port, vasopressor, and renal replacement therapy). Although all
baseline variables were similar after matching by propensity score,
28-day mortality remained no significant difference ( 11/21 (52.4%)
vs 8/21 (38.1%), HR=0.938; 95%CI, 0.377-2.334, p = 0.891).
CONCLUSION. In septic patients treated with PMX-HP matched to
conventional therapy, no significant differences in 28-day mortality
were found.
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INTRODUCTION. Prone positioning (PP) decreases mortality of mod-
erate to severe acute respiratory distress syndrome (ARDS) [1]. This
benefit may be related to the prevention of ventilation-induced lung
injury (VILI) by PP. More precisely, it remains unclear whether PP
Page 203 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55modulates the deleterious inflammatory response associated with
VILI, namely biotrauma. [11C]-PK11195 is a positron emission tomog-
raphy (PET) radiotracer that allows the non-invasive quantification of
lung macrophage recruitment in the lungs, in combination with lung
computed tomography (CT) evaluation.
OBJECTIVES. To evaluate the effects of PP on VILI surrogates and
macrophage lung recruitment quantified by [11C]-PK11195 lung up-
take in PET/CT, in an experimental model of ARDS.
METHODS. Experimental ARDS was performed in 9 pigs (weight, 27
[interquartile range, 25–29] kg) in supine position (SP), by means of
tracheal instillation of hydrochloric acid. Animals were under general
anesthesia, neuromuscular blockade, and protective ventilation (tidal
volume 6 ml/kg, positive end-expiratory pressure 5 cmH2O) [2]. Re-
spiratory mechanics, including esophageal pressures, were recorded.
Ventilation settings were not modified thereafter. Immediately after
completion of experimental ARDS, animals were randomized to be
prone positioned or to remain in SP, during 4 hours. Coupled PET/CT
acquisitions were performed immediately before (T1), and after 4
hours of experimental ARDS (T2). Non-invasive measurements in PET/
CT were performed on the whole lungs, and by dividing the lungs
into 2 regions-of-interest (ROI) defined equally along the ventrodor-
sal axis. [11C]-PK11195 was quantified using the standardized uptake
value (SUV), corrected for tissue density in the corresponding CT ROI.
Collapsed lung volume corresponded to the non-aerated volume of
gas fraction in a given ROI.
RESULTS. PP was performed in 5 animals, and SP in 4. The PaO2/FiO2 ra-
tio was 143 [90–169] at 30 minutes of ARDS onset. Experimental ARDS in-
creased the elastance-derived transpulmonary pressure (ΔPL) between T1
and T2 (8 [7–10] to 15 [13–18] cmH2O, P<0.01), and CT-derived lung
weight (427 [409–508] to 608 [572–642] g, P<0.01). At T2, PP animals had
lower ΔPL compared to SP animals (13 [12–14] vs. 20 [17–23] cmH2O, P=
0.03). PP decreased collapsed lung volume in the dorsal region at T2, com-
pared to SP (12 [9–22] vs. 262 [204–275] ml, P=0.02), by redistributing it to
ventral regions (144 [140–169] vs. 13 [9–24] ml, P=0.02). At T2, [11C]-
PK11195 SUV of the whole lung of PP animals was 1.3 [1.2–1.3], and 1.4
[1.2–1.7] in SP animals (P=0.73). However, we observed a lower [11C]-
PK11195 SUV at T2 in the ventral region of PP animals, compared to the
ventral region of SP animals (1.3 [1.2–1.4] vs. 1.6 [1.4–1.9], P=0.03). No dif-
ference existed in dorsal regions (1.4 [1.2–1.5] vs. 1.4 [1.2–1.6], P=0.55).
CONCLUSION. PP improved respiratory mechanics, redistributed col-
lapsed lung volume, and decreased [11C]-PK11195 lung uptake (and
presumably macrophage lung recruitment) in the ventral lung re-
gions of animals with experimental ARDS.
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INTRODUCTION. Severe community acquired pneumonia (sCAP) fre-
quently requires admission to the intensive care unit (ICU) admissionand is associated with significant morbidity and mortality1. The use of
non-invasive ventilation (NIV) in this setting is controversial and may be
associated with worse outcomes2. Characterisation of parameters pre-
dictive of NIV failure may be of value in risk stratification to minimise in-
creased risk of subsequent mechanical ventilation, or death3.
OBJECTIVES. Clarify the role and impact of NIV in sCAP cohort and
identify factors that might allow earlier detection of NIV failure.
METHODS. Retrospective, observational study of consecutive admis-
sions to ICU with sCAP from January 2016 to May 2017. sCAP defined
as CAP requiring critical care management. Adequate NIV trial classi-
fied as minimum of two hours. NIV cohort was sub-divided into three
sub-sets for analysis; NIV as ceiling of care, NIV failure requiring inva-
sive mechanical ventilation (IMV) and NIV success so avoiding intub-
ation. Student t-test utilised in statistical analysis.
RESULTS. Total of 201 sCAP patients identified over the study period.
NIV was utilised in 121 (60%) cases with immediate IMV required in 54
(27%) cases and no NIV support required in 26 (13%) cases. Successful
NIV use was associated with reduced length of ICU (4 days)and hospital
(14 days) stay and reduced long-term (6 month) mortality. In the NIV
group, partial pressure of oxygen to fraction of inspired oxygen (Pa02/
Fi02) ratio improvement in 2 hours of ICU admission was associated with
increased hospital and long-term survival. NIV failure cohort had a re-
duced Pa02/Fi02ratio 2-hour improvement (50% versus 69% in NIV suc-
cess cohort). Daily sequential organ failure assessment (SOFA) scores over
initial 72 hours of admission highlighted daily improvement in the whole
cohort. However, worsening SOFA scores at 24-hours were identified in
the NIV failure cohort (7.84.4 versus 3.52.0, p-value <0.0001). Average
time to intubation in this failed NIV cohort was 25 hours (30 hours).
CONCLUSION. Utilisation of NIV in sCAP patients can be successfully
employed with good clinical outcomes in selective patients. Failure of
NIV is associated with poor short- and long-term outcomes. Worsening
Pa02/Fi02ratios within 2 hours of ICU admission and deteriorating SOFA
scores are associated with NIV failure. Further large, prospective studies
are required to validate clinical indicators of NIV failure.
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INTRODUCTION. Tracheotomy is a usual technique in patients with in-
vasive mechanical ventilation in intensive care units (ICU)
OBJECTIVES. To analyze the variables related to 30-day mortality of
patients who underwent tracheotomy during ICU stay, and create a
predictor model of mortality.
METHODS. Observational and retrospective study conducted be-
tween may-2014 and October-2018 that included all patients who
underwent tracheotomy in ICU. Exclusion criteria: tracheotomy be-
fore the admission and re-admitted patients. There were collected
demographic (age, gender) data, clinical (co-morbidity) data and se-
verity scores, related to invasive mechanical ventilation (IMV) and




Fig. 1 (abstract 000912). See text for description
Page 204 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Fragility before the hospital admission was evaluated by the Clinical
Frailty Scale (CFS) (Fragile CFS ≥ 5). We describe categorical variables as
frequency and percentages; and numerical variables as median and inter-
quartile range (IR). We compared percentages using chi-square or Fisher
exact test, and continuous variables with t-Student or U Mann-Whitney
tests. Multivariate analysis conducted by cox regression model.
RESULTS. Of the 2630 patients admitted to ICU, 105 were analyzed. 30-d
mortality was 32.4%. There were no significant differences comparing by
sex or co-morbidities. Age, severity scores, fragility (CFS) and limitations
of life support techniques (LLST) were significantly higher among dead
patients. Reintubation, days with IMV, days in spontaneous ventilation
(SV), % of time with tracheotomy in SV, ICU and hospital stay were signifi-
cantly lower among dead patients. Dead patients underwent tracheot-
omy earlier (table 1). Multivariate analysis showed that age, fragility, day
of tracheotomy, disconnection from IMV and % of time with tracheotomy
in SV, were independent predictive factors of 30-d mortality (table 2), cre-
ating a mortality predictive normogram (Figure 1).
CONCLUSION. Age, severity scores and fragility were mortality associ-
ated factors in patients with tracheotomy, who also died before. Fragility,
day of tracheotomy, disconnection from IMV and % of time without IMV
were 30-d mortality independent predictive factors since de ICU admis-
sion. Our predictive model could be useful to decide the LLST.Table 1 (abstract 000912). See text for description
Table 2 (abstract 000912). See text for description000918
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INTRODUCTION. Extracorporeal membrane oxygenation (ECMO)
has increasingly found its place in the treatment of severe acute
respiratory failure, as well as severe circulatory collapse. Mechan-
ical ventilation and ECMO are both technologies interacting on
gas exchange. Nevertheless, besides a consensus paper [1], no
evidence-based guidelines regarding protective lung ventilation
on ECMO exist to date. Mechanical Ventilation with Intellivent-
ASV, an algorithm driven, closed loop system, provides an oppor-
tunity to standardize ventilation on ECMO.
OBJECTIVES. To propose and validate lung protective ventilation
with a closed loop ventilation mode in patients with ECMO due to
ARDS or cardiogenic shock.
METHODS. We retrospectively analyzed mechanically ventilated
patients on ECMO for cardiogenic shock or ARDS admitted to the
medical ICU of the University Hospital Zurich from March 2016
on until May 2018. All patients were initially ventilated with the
dual positive airway pressure (DuoPAP) mode and were then
switched to Intellivent-ASV+®. Every eight hours ECMO settings,
ventilation parameters and blood gas analyses were collected.
Driving pressure was calculated as the difference between peak
pressure and PEEP.
RESULTS. 62 patients were included into the study, of which 43 had
a cardiogenic shock and 19 had an ARDS, the ICU mortality for both
groups was 27.4%, population characteristics were homogeneous.
Patients of both groups were on average on ECMO for 11.6 days
and ventilated for 9.9 days on Intellivent-ASV+®. After switch to
Intellivent ASV, during the first 72 hours, at constant blood flow on
ECMO, ASV-Intellivent mode decreased mean FiO2 by 25% while
keeping PEEP constant. Regarding ventilation, keeping airflow on
ECMO constant over time, Intellivent-ASV+® led to a significant de-
crease in mean peak (7%) and driving pressure (14%) (p < 0.0001),
while tidal volumes stayed below 6 in both groups and pCO2
remained constant. On steady state after switch to Intellivent-
ASV+® the driving pressure was 13.12±0.67 kPa, despite significant
differences in lung compliance 37.28±3.75 ml/mbar (cardiogenic
shock) versus 28.46±5.26 ml/mbar (ARDS).
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show that the automated mechanical ventilation algorithm
Intellivent-ASV+® can safely ventilate patients with either ARDS or
Cardiogenic Shock on ECMO.Fig. 1 (abstract 000925). Correlation between CT INTEM / R-TEG K
and UFH infusion, aPTT and ACTREFERENCE
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INTRODUCTION. Optimal anticoagulation monitoring in patients
with extracorporeal membrane oxygenation (ECMO) is controver-
sial, but fundamental to avoid haemorrhagic and thromboembolic
complications. In addition to conventional coagulation tests (ACT,
aPTT), there is growing interest in the use of viscoelastic haemo-
static assays (VHA) for management of anticoagulation, in particu-
lar of tromboelastography (TEG) [1,2]. However, evidence on the
use of rotational tromboelastometry (ROTEM) for this purpose is
lacking.
OBJECTIVES. The aim of our study is to evaluate ROTEM com-
pared to TEG and conventional coagulation assays to monitor
anticoagulation with unfractionated heparin (UFH) during
ECMO.
METHODS. We conducted a prospective, observational, mono-
centric study. We included patients admitted to intensive care
unit at ASST Monza in ECMO support for either respiratory (Veno-
Venous) or cardiac failure (Veno-Arterial), anticoagulated with
UFH. Conventional coagulation tests and viscoelastic assays were
performed daily, as per clinical practice. We focused our statistical
analysis on reaction time parameter (R, min) for Kaolin TEG, and
clotting time (CT, sec) INTEM for ROTEM. Test results were corre-
lated with UFH infusion rate (UI/die) and conventional coagula-
tion test results at the time of sampling.
RESULTS. We included twelve patients in ECMO support; 41 data
points were available for the analysis. CT INTEM parameter
showed a moderate correlation with both UFH dosing and stand-
ard coagulation tests (see Figure 1), while correlation coefficients
for R-TEG K with other variables were poor.
CONCLUSION. CT INTEM parameter shows moderate correlation with
UFH infusion rate and other coagulation tests. Further studies are
needed to identify an appropriate anticoagulation target for ROTEM
during ECMO support.
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INTRODUCTION. Muscle paralysis during mechanical ventilation (MV)
treatment decreases the lung injury through better synchrony and im-
proves survival ultimately. However, some patients have a progress toward
development of severe respiratory acidosis and sometimes encounter
hemodynamically instability. Contrary to a well-known knowledge of in-
tensive care unit (ICU)-acquired weakness induced by prolonged use of
neuromuscular blocking agents (NMBA), respiratory acidosis immediately
after infusion of NMBA has not been reported.
OBJECTIVES. We investigated to reveal the risk factors for post-
NMBA respiratory acidosis in patients under mechanical ventilation
who started cisatracurium just before the event.
METHODS. Following a retrospective review of the medical records of
patients admitted to the ICU of our medical center from January to Octo-
ber 2017, we included adults who received cisatracurium during MV.
Data of vital signs, arterial blood gas analysis (ABGA), and parameters of
the ventilator before and after NMBA infusion were recruited. Respiratory
acidosis developed after cisatracurium infusion was defined discretionally
as decreased arterial pH more than 0.2.
RESULTS. The mean age of the patients was 64 years and 67% (n =
172) was male. Of total 256 Patients, 24 patients (9.4%) showed a pro-
gression of acidosis. Among them, seven patients’ blood pressure
dropped immediately after NMBA infusion and vasopressor was
needed. In univariate analysis, a higher pH, lower arterial partial pres-
sure of carbon dioxide (PaCO2), and higher pulse rate (PR) measured
before NMBA infusion were associated with progression of respiratory
acidosis. Emphysema was more common in patients with respiratory
acidosis. On the other hand, disease severity presented by APACHE II
score and pre-NMBA tidal volume based on patients’ efforts are not
related with a progression of respiratory acidosis. In multiple logistic
regression model including variables of age, sex, emphysema, pre-
NMBA pH, pre-NMBA PaCO2, and pre-NMBA PR, emphysema (OR,
4.11; 95% CI 1.21–13.96), higher pH (OR, 3.10 per 0.1; 95% CI 1.67–
F9
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1.03; 95% CI 1.01–1.05) are associated with progression of respiratory
acidosis after NMBA infusion.
CONCLUSION. Emphysema, higher pH, lower PaCO2 and higher PR
are risk factors for post-NMBA respiratory acidosis. It suggested pa-
tients with respiratory failure who showed active cardiopulmonary
compensation especially in those with emphysema might have a risk
for a progression of respiratory acidosis after muscle paralysis.
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INTRODUCTION. Electrical impedance tomography (EIT) can assess al-
veolar overdistension and collapse during a decremental positive end-
expiratory pressure (PEEP) trial in mechanically ventilated patients [1].
Using this approach, it is possible to identify the “best compromise”
PEEP at which overdistension and collapse are minimized as shown in
patients with acute respiratory distress syndrome (ARDS) [2] and in pa-
tients during general surgery [3]. However, even with the “best com-
promise” PEEP, a variable amount of simultaneous overdistension and
collapse remains. We hypothesized that the sum of overdistension and
collapse detected by EIT at the “best compromise” PEEP is higher in pa-
tients with ARDS than in lung-healthy control patients during general
surgery and might be a marker of disease severity.
OBJECTIVES. To investigate whether the sum of residual overdisten-
sion and collapse at the “best compromise” PEEP is higher in patients
with ARDS than in patients without pulmonary pathology.
METHODS. We compared EIT data sets of 12 patients with ARDS (5 fe-
male, age: 67±11 years, height: 174±9 cm, weight: 79±22 kg, PaO2/FiO2
at baseline: 151±38 mmHg) to 8 patients without pulmonary pathology
(all female, age: 38±19 years, height: 169±5 cm, weight: 77±21 kg) under-
going general anesthesia for laparoscopic gynecological surgery. Decre-
mental PEEP trials were carried out in all patients during pressure-
controlled ventilation with constant driving pressure. In control patients,
one PEEP trial was performed after induction of general anesthesia in the
supine position and another one during capnoperitoneum in the Trende-
lenburg position. All PEEP trials were analyzed as described in [1] and
“best compromise” PEEP was defined as the value associated with equally
balanced overdistension and alveolar collapse. Residual overdistension
and collapse was calculated as the sum of overdistension and collapse at
the “best compromise PEEP”. Data sets were compared by one-way ana-
lysis of variance with Bonferroni post test. Written informed consent was
obtained from control patients and from the legal representatives of
ARDS patients. Numerical values are presented as mean±SD.
RESULTS. In ARDS patients, we identified 14.5±7.1% of residual overdis-
tension and collapse at the “best compromise” PEEP of 13.3±2.4 mbar. In
control patients, the sum of residual overdistension and collapse was
6.3±3.8% at the “best compromise” PEEP of 7.3±2.4 mbar in supine pos-
ition and 3.4±3.5% at 18.0±2.1 mbar in the Trendelenburg position with
capnoperitoneum. The difference between ARDS and lung-healthy pa-
tients was statistically significant both for supine (p<0.01) and Trendelen-
burg positions (p<0.001).
CONCLUSION. Our preliminary results imply that the sum of residual al-
veolar overdistension and collapse at the “best compromise” PEEP level is
higher in patients with ARDS than in control patients both during ventila-
tion in the supine and in the Trendelenburg position with capnoperito-
neum. This supports the hypothesis that this measure might serve as a
marker of disease severity in mechanically ventilated patients.REFERENCE(S)
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INTRODUCTION. Acute Respiratory Distress Syndrome (ARDS) still re-
mains a serious pulmonary condition with substantial mortality and
without specific therapeutic options. Retrospective analysis of random-
ized controlled trials have identified the presence of two distinct phe-
notypes, based on clinical and biological variables (1–3), namely a
hypo-inflammatory (P1) and a hyper-inflammatory (P2) endotype. The
development of clinically relevant models to replicate these endotypes,
will likely enable better understanding of these endotypes.
OBJECTIVES. We aimed to develop an ovine model of P1 and P2
ARDS endotypes and to characterize clinical and biological features,
opening the pathway for further prospective evaluation of endotype-
specific treatment options.
METHODS. We studied 20 anesthetized sheep on mechanical ventila-
tion up to 6 hours, and randomized into three distinct groups: 1) the
oleic acid (OA) only group received an intravenous infusion of OA to
achieve a PaO2/FiO2 ratio <100 mmHg (n=8); 2) the OA-IV-LPS group
received an OA infusion and intravenous infusion of lipopolysaccharide
(n=5) and; 3) the OA-IP-LPS group received an OA infusion and intra-
pulmonary infusion of LPS (n=7). Pulmonary, hemodynamic and labora-
tory parameters were assessed hourly. In addition, interleukin (IL) -6, -8
and -10 were quantified in serum and bronchoalveolar lavage (BAL).
RESULTS. Severe impairment in PaO2/FiO2 ratio was found in all study
groups (Figure 1). We found a) more hemodynamic and pulmonary impair-
ment b) decreased albumin and platelets levels and c) upregulation of in-
flammatory (IL-6 and IL-8) and anti-inflammatory cytokines (IL-10) in serum
and BAL only in OA-IV-LPS in comparison with the other two groups.
Therefore, the OA-IV-LPS model may mimic a pattern closest to the
human P2 endotype and the OA only model the P1 endotype.
CONCLUSION. We developed innovative models of ARDS that mimic clin-
ical and inflammatory status of human P1-P2 endotypes, while characterized
by similar severity of pulmonary dysfunction. These animal models could be
applied to explore in detail mechanical and biological differences between
ARDS subphenotypes and identify endotype-specific treatment options.
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INTRODUCTION. Systemic inflammation and metabolic acidosis, which
characterize patients with sepsis and septic shock, can increase the spon-
taneous respiratory drive and effort and the risk of patient self-inflicted
lung injury, with potentially detrimental effects on outcome[1]. A retro-
spective study reported that septic shock patients intubated during their
intensive care unit (ICU) stay had fewer 28-day alive without organ sup-
port, as compared to patients already intubated upon admission[2].
OBJECTIVES. To compare ICU mortality in a large cohort of patients
with sepsis/septic shock classified as: already intubated upon admis-
sion (early intubation) vs. intubated during ICU stay (late intubation)
vs. never intubated (no intubation). To identify early factors associ-
ated with risk for late intubation.
METHODS. We included 1425 patients with sepsis (824) and septic
shock (601), consecutively admitted to three tertiary level general ICUs
in Italy between 2014-2018. Patients data and outcomes were prospect-
ively collected in a centralized clinical registry (PROSAFE Giviti elec-
tronic case report form). Categorical variables are expressed as counts
(%) and compared with Chi-square or Fisher’s exact test. Median (IQR)
was used for continuous variables and differences in distributions were
assessed by ANOVA on ranks with Dunn’s post-hoc test.
RESULTS. Patients with late intubation were 339 (24%), early intubation
878 (61%), no intubation 208 (15%). Patients in the late intubation group
had significantly higher hospital mortality than patients in the other two
groups (47% late vs. 31% early vs. 10% no, p<0.0001). Table 1 shows dif-
ferences between groups at ICU admission: patients with late intubation
presented more organ failures, lower GCS, higher SOFA and SAPS II
scores in comparison to no intubation
In patients with late intubation, upon admission, we also observed signifi-
cantly lower oxygenation, more severe acute kidney injury, higher biliru-
binemia, lower systolic pressure, higher imbalance of acid-base status vs.
no intubation (p<0.01 for all). Interestingly, early clinical and physiologic
derangements were similar between late vs. early intubation groups.
CONCLUSION. Mortality of ICU patients with sepsis and septic shock
is significantly higher when intubation occurs after ICU admission.
Comparable baseline severity with patients already intubated atadmission might suggest a specific role for injurious spontaneous
breathing. Early identification of patients at risk for late intubation
might prompt prophylactic interventions.
REFERENCE(S)
[1] L. Brochard, A. Slutsky, and A. Pesenti, “Mechanical Ventilation to
Minimize Progression of Lung Injury in Acute Respiratory Failure,” Am. J.
Respir. Crit. Care Med., vol. 195, no. 4, pp. 438–442, Feb. 2017
[2] A. Delbove, C. Darreau, J. F. Hamel, P. Asfar, and N. Lerolle, “Impact of
endotracheal intubation on septic shock outcome: A post hoc analysis of
the SEPSISPAM trial,” J. Crit. Care, vol. 30, no. 6, pp. 1174–1178, Dec. 2015.000952
Bronchoscopy bronchoalveolar lavage in mechanically ventilated
patients in the prone position with Acute Respiratory Distress
Syndrome
A. Estella1, M. Gracia Romero,1, M. Perez Ruiz1, L. Fernadez Ruiz1, B. Diez
Del Corral1, S. Moreno Cano1, B. Gimenez Beltrán1, M. Recuerda Nuñez,2
1University hospital of jerez., Intensive care unit, Jerez, Spain; 2Medicina
intensiva, University Hospital of Puerto Real, Puerto Real, Spain
Correspondence: A. Estella
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000952
INTRODUCTION. Mechanical ventilation in prone position has demon-
strated to decrease mortality in patients with severe Acute Respiratory Dis-
tress Syndrome (ARDS). It is scarcely documented in the literature clinical
experience about use of fiberoptic bronchoscopy (FOB) in prone position ,
only 9 patients, (1,2). Bronchoalveolar lavage in these conditions are
exceptional.
OBJECTIVES. The aim of the present study are: to describe the clinical
experience in the realization of FOB in critically ill patients ventilated in
prone position and to analyze the complications related to the
procedure.
METHODS. Retrospective study performed in an medical-surgical
ICU. Time of study was five years. Inclusion criteria were patients
with ARDS and indication of FOB. Informed consent was requested
for the performance of the procedure. The following variables were
collected: Demographic data, heart rate and arterial pressure during
the FOB, ICU lenght of stay, level of positive end-expiratory pressure
(PEEP) and categories of ARDS according Berlin classification criteria,
complications and mortality. The statistical analysis was performed
using SPSS program, the quantitative variables are shown in mean ±
standard deviation.
RESULTS.
11 FOB were performed during the time of study. Most of patients
(81.8%) were indicated for microbiological study performing bron-
choalveolar lavage. In one case it was indicated due to complete
atelectasis and another case due to pulmonary hemorrhage. The pro-
cedure was performed with control pressure ventilator mode with
FiO2 of 100% without modifying the previous PEEP. Table 1 shows
clinical characteristics. Mean PaO2/FiO2 was 185,1 ± 52,05, resulting
between 200 and 300 in 5 patients, between 100 and 200 in 5 cases
and < of 100 in one. In most patients (72.7%) no complications re-
lated to FOB were observed. 18.2% developed self-limiting supraven-
tricular tachycardia without hemodynamic impact nor needing to
increase vasoactives and we observed in 9% transient hypoxemia
that was corrected by removing the FOB.
CONCLUSION. In our experience the realization of FOB in patients
with ARDS ventilated in prone position is a safe procedure and does
not need to decrease or to withdraw the previous PEEP.
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ICU lenght of stay (days) 15±8
PaO2/FiO2 185,1±52
PEEP 9.7 ± 2.6
Mortality 54,5%
Table 1 (abstract 000958). See text for description000958
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INTRODUCTION. Intensive care acquired skeletal muscle atrophy (SkMA)
during acute respiratory distress syndrome (ARDS) is associated with
long-term functional restriction (1). Veno-venous extracorporeal mem-
brane oxygenation (vvECMO) represents the management of extreme
cases of ARDS (2,3) but the degree of SkMA and the relationship be-
tween lung parenchyma recovery in this cohort has not been described.
OBJECTIVES. In patients rapidly deteriorating within 24-hours due
to ARDS, we will: (i) describe the degree of SkMA and (ii) evalu-
ate relationships between lung parenchyma change and SkMA.
METHODS. Patients with ARDS who presented to hospital, re-
ceived mechanical ventilation (MV) and vvECMO and underwent
thoracic and abdominal computed tomography (CT) imaging
within 24-hours were included to ensure an initial measurement
of muscle mass as close to pre-morbid baseline . A second CT (at
variable intervals) whilst receiving vvECMO was also required. 18
patients met the criteria. Images were assessed for proportions of
normal lung, ground-glass opacity (TLGG) and lung consolidation
(TLCo) with the sum of the scores giving a total lung paren-
chyma score (TLS) as previously described (4). Skeletal muscle
cross-sectional area (SkMCSA) was calculated at the level of the
third lumbar vertebrae (5,6) and sarcopenia was determined by
the muscle index (=SkMCSA/height2; <55.4cm2/m2 for males, <
38.9cm2/m2 for females). Raters were blinded to all identifiable
data and high observer reliability was ensured (intra-class correl-
ation coefficients of >0.9).
RESULTS. The interval between images ranged from 3 to 25
days. The mean decline in SkMCSA was 14.7±11.1% (p<0.001) -
equating to a mean daily decline of 2.2±2.4%. All who were sar-
copenic at admission (9/18, 50%) were male. Males also had a
mean decline in MI of 9.2±6.4% (p<0.001). SkMA (10% over 7
days, or 1.4%/day (7)) was more common in men (58% vs. 33%)
but not statistically significant. SkMA was associated with lower
TV (r=-0.711, p=0.007), higher BMI (r=-0.603, p<0.01) and admis-
sion lactate (r=0.535, p=0.02). Patients who were sarcopenic atadmission had a longer ICU length of stay (LoS) and greater
duration of mechanical ventilation and vvECMO (Table 1). The
median change per day in TLCo and TLS was -1.65 points/day
(-0.43 to -3.30) and -0.75 points/day (-1.33 to -2.40) respectively
– favouring resolution. The median change in TLGG was +0.45
points/day (0.00 to 1.73) indicating increased GG. There was no
significant association between SkMCSA decline and parenchy-
mal changes per day, nor between the absolute/daily change of
TLCO, TLGG and TLS and ventilator/vvECMO parameters or ICU
length of stay.
CONCLUSION. Underlying sarcopenia was significant in those
who required vvECMO for severe ARDS within 24-hours of pres-
entation. This led to significant SkMA, with an average decline
of 14% over an interval of 3-25 days. Those with sarcopenia had
considerably longer ICU LoS and MV and vvECMO duration. The
lung parenchyma score needs further validation over longer time
periods to understand its utility and its relationship to muscle
atrophy and functional restriction in the post-critical illness
period.
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INTRODUCTION. Recruited lung volume (Vrec) elicited by positive
end expiratory pressure (PEEP) can be measured by using either CT
scan or pressure-volume (P-V) curve method.
OBJECTIVES. The purpose of this study was to perform a systematic
review and meta-analysis of Vrec measured by the P-V curve in pa-
tients suffered from Acute Respiratory Distress Syndrome (ARDS). Pri-
mary aim was prevalence of recruiters (R). The secondary aims were
to compare physiologic data and ICU outcome in R and non-
recruiters (NR).
METHODS. We conducted a search on PubMed, including all pa-
pers published from inception to 30/11/2018 containing the key
words: lung recruitment, alveolar recruitment, volume pressure
curve, ARDS, PEEP, humans and adult. Two reviewers independ-
ently screened all articles. Articles concerning animals, children,
case reports and reviews were excluded. We also excluded stud-
ies that didn’t measure Vrec by PV curve or in which Vrec was
not elicited by PEEP. Disagreements were resolved by discussion.
Subsequently, same both reviewers extracted data into a pre-
defined case record form. The data of Vrec was obtained directly
from the studies or from reported graphs using the GetData
Gaph Digitizer software to retrieve values or by contacting dir-
ectly the authors. Extracted data also included the baseline value
of anthropometric variable, ARDS cause, physiologic characteristic
of patients, ventilator settings, respiratory mechanics. Patient out-
come at ICU discharge was also recorded. We used the threshold
of Vrec > 150 ml to define R patients. Data are expressed as
mean±SD. The meta-analysis was performed using R (meta pack-
age). For the continuous variables we used the mean difference
and for the binary variable the relative risk (RR) with their confi-
dence intervals (C.I.) between R and NR. A random effects model
was applied for pooling the data.
RESULTS. From a total of 650 studies, 26 were potentially eligible.
After full-text evaluation, 16 articles were kept for the present
study and included 316 patients. Vrec was measured between
PEEP 5 and 15 cmH2O in 6 papers, from 0 to 15 in 4, from 0 to
10 in 3 and from other range in 3. Vrec averaged 373±146 ml in
R and 81±33 ml in NR (P<0.001). The prevalence of R was 71%
(0.57; 0.82). The pooled data analysis showed no significant differ-
ence between R and NR groups for baseline anthropometric vari-
ables, PEEP, tidal volume, PaO2/FIO2, FIO2, Simplified Acute
Physiology score 2, ARDS cause, and for days in ARDS before the
start of the investigation. However, we found a significantly
higher compliance (mean difference 9.40 (C.I. 2.26; 16.53) ml/
cmH2O) and significantly lower plateau pressure (mean difference
2.41 (4.11; 0.72) cmH2O) in R than in NR. Finally, mortality at ICU
discharge was similar in R and NR: 40.7 (40.0; 41.0) vs: 47.8%
(41.0; 55.0) (P=0.40, Fisher exact test), RR 1.11 (0.85-1.45).
CONCLUSION. Most of ARDS patients exhibited lung recruitment
after increase in PEEP. However, this recruitement did not correlate
with any difference in mortality.REFERENCE(S)
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INTRODUCTION. Multiple studies have shown the potential of elec-
trical impedance tomography (EIT) as a tool for monitoring of re-
gional lung function in neonates and infants with respiratory failure.
In this high-risk population, EIT can detect one-sided intubation [1],
pneumothorax [2, 3] and identify recruitable atelectasis and overdis-
tension [4]. As all previous studies have used EIT for analyzing short
and specific episodes, the feasibility and safety of long-term monitor-
ing with EIT has not yet been established.
OBJECTIVES. To assess the feasibility and safety of continuous EIT
monitoring for up to 72 hours in neonates and preterm infants at risk
for respiratory failure.
METHODS. In the ´Continuous Regional Analysis Device for neonate
Lungs´ (CRADL) study (clinicaltrials.gov NCT02962505), we deter-
mined the feasibility and safety of continuous EIT monitoring for up
to 72 hours in critically ill neonates and infants. We included patients
needing supplemental oxygen, non-invasive or invasive respiratory
support who were treated in neonatal or pediatric intensive care
units. After obtaining written informed consent from the parents or
legal representatives, a 32-electrode EIT belt was placed around the
patient’s chest and connected to an EIT image acquisition system
(Sentec BB2, Landquart, Switzerland). At the bedside, investigators
were blinded to the EIT findings but were prompted by the device to
reattach the EIT belt if a loss in electrode contact occurred. The max-
imum duration of EIT examinations was 72 hours, but examinations
could be terminated earlier, e.g. if the patients were discharged or
transferred to another unit.
The study was conducted between November 2016 and March 2019
at four European university hospitals. As a primary outcome param-
eter, we assessed the overall percentage of EIT examination time
with at least 26 out of 32 electrodes exhibiting sufficient skin contact
impedance, the minimum required for reliable EIT image reconstruc-
tion with the Sentec BB2 system. Numerical results are presented as
mean±SD unless otherwise specified.
RESULTS. 200 patients were included in the study. For our prelimin-
ary analysis, we included the first 194 data sets of 117 male and 77
female patients with a gestational age of 31±5 (range: 24-42) weeks
and postnatal age of 5±15 (range: 0-122) weeks. The most frequent
diagnoses explaining the need for respiratory support included
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Mild ARDS (N) 3 (11%) 2 (7%)
Moderate ARDS (N) 9 (32%) 9 (32%)
Severe ARDS (N) 16 (57%) 17 (61%)
ICU Length of stay (Mean ± SD, days) 20.2 ± 18.9 16.4 ± 14.7
28-day mortality (N) 10 (36%) 18 (64%)
p = 0.056
28-day ventilator-free days (VFD) (Mean ± SD) 4.8 ± 6.4 2.2 ± 4.5
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bronchopulmonary dysplasia.
The average duration of EIT measurements was 54±21 hours. The percent-
age of EIT examination time suitable for analyzing as defined in the primary
outcome parameter was 84.7±17.6%. No moderate or severe study-related
adverse events were recorded. Minor study-related adverse events included
reversible redness of skin or imprint of EIT belt on the patient´s skin.
CONCLUSION. In the CRADL observational study, continuous EIT
measurement for up to 72 hours was feasible and safe in a mixed
population of neonatal and pediatric critically ill patients with respira-
tory failure.
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INTRODUCTION. ARDS remains a major cause of morbidity and
mortality and standard of care involves the treatment of the
underlying cause and supportive care [1]. The Phase III clinical
study of a new potential treatment - Interferon beta-1a [2] -
yielded disappointing mortality outcomes, in part thought to be
related to the concomitant corticosteroid use. Steroids are com-
monly used for septic shock (SS) and for several indications asso-
ciated with ARDS. They have been used in ARDS to improve
oxygenation and airway pressures, however the effectiveness on
ARDS mortality is debatable [3].
OBJECTIVES. We aimed to identify the current ICU practice around
steroid use at UCLH in relation to the severity of ARDS as per the inter-
national definition and SS.
METHODS. Demographic data, physiologic scores and outcomes,
from January 2017 to January 2018 of our 45 bed ICUs, were
accessed via the Unit’s electronic record system Philips Intellivue.
ARDS patients were defined as: mechanical ventilation requirement
>48h, ARDS diagnosis stated in medical notes and ARDS severity ac-
cording to the Berlin definition. SS patients were defined as a nor-
adrenaline requirement.
RESULTS. 56 patients were documented as having ARDS, with 44
(79%) receiving steroids (28-day mortality - 64% on steroids and 25%
no steroids). 28 (50%) of all patients had concomitant SS diagnosis
(Table 1).
Of those without SS, only 3 (16%) received steroids for ARDS and 1
(5%) for PCP; 15 (79%) did not have a clear indication but the major-
ity were haematological malignancy patients (HMP). Of those with
SS, 10 (40%) received steroids per SS protocol, 2 (8%) per ARDS
protocol, 1 (4%) for PCP and 13 (52%) did not have a clear indication
but again were commonly HMP.
CONCLUSION. Septic shock-related ARDS patients had a higher
overall disease severity, mortality and ventilatory support require-
ment. 79% of patients with ARDS were treated with steroids,
mainly not for ARDS indications and appeared to have a higher
mortality rate. This high level of steroid use may have implica-
tions for trials in ARDS.REFERENCE(S)
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INTRODUCTION. Left ventricular diastolic dysfunction (LVDD) is quite
common in critically ill patients. Echocardiography plays a vital role
in identifying diastolic dysfunction at the bedside. It has been dem-
onstrated to have a strong association with weaning failure, abrupt
pulmonary edema and sepsis outcome.
OBJECTIVES. Aim of this study is to investigate the prevalence of
LVDD during the early phase of acute respiratory distress syndrome
(ARDS) and its relationship with lung mechanical properties.
METHODS. We enrolled mechanically ventilated patients within 48
hours after ARDS diagnosis. Demographic characteristics and parti-
tioned respiratory mechanics variables were recorded; CT scan quan-
titative analysis was performed at two levels of airways pressure for
the evaluation of recruitability; functional residual capacity (FRC) was
measured by helium technique. Transthoracic echocardiography, in-
cluding Pulse wave doppler and Tissue doppler imaging, was per-
formed to measure during early left ventricular diastolic phase the
velocity of intracardiac blood flow at the tip of mitral valve (E’) and
the longitudinal excursion of the septal mitral annulus (e’). LVDD
diagnosis was made when septal e’ < 8 cm/sec.
RESULTS. 10 of 16 patients presented a normal LV function [ND], 6
patients (37.5%) had a LVDD diagnosed [DD], 4 patients had a grade
II dysfunction. No significantly differences were reported in terms of
demographic, hemodynamics, respiratory variables and CT parame-
ters between groups. DD group presented a significantly higher FRC
(756 [450 – 878] mL vs. 403 [116 – 490] mL, P = 0.038) but a higher
dead space compared to ND. DD patients demonstrated significantly
higher 28 days mortality compared with ND (5/6 = 83% vs. 2/10 =
20%, p = 0.035).
T8
Table 1 (abstract 0001026). Physiological effects of S-NHF
NHF L/kg PBW O.5 1 1,5 p-value
Set flow, L/min 32±3 63±5 95±14 -
PaO2/FiO2 184 [104-248] 179 [140-264] 181 [142-267] 0.192
Comfort, 0-10 VNS 7±0.0 7±1 5±1.5*$ 0.018
RR, bpm 19±7 18±5 18±5 0.280
MVcorr (AU/min) 41872±22237 46136±22586 47813±17078 0.363
DEELI (AU) # 707±763 1012±1074* 0.017
GI, % 61±14 58±13* 56±13* 0.002
$ p<0.05 vs. HFNC 1 mL/minby post-hoc Bonferroni test;* p<0.05 vs. HFNC 0,5
mL/minby post-hoc Bonferroni test; # Reference group
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and the LVDD development. The higher FRC and dead space in DD pa-
tients could be due to the presence of emphysema in lung parenchyma.
The higher 28-day mortality in DD patients should be further investigated.
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INTRODUCTION. In patients with acute respiratory failure, changes
affecting respiratory mechanical property (compliance and resist-
ance) and the applied ventilatory setting can generate an incomplete
deflation of the respiratory system at end-expiration, promoting a dy-
namic hyperinflation and intrinsic PEEP (iPEEP).
OBJECTIVES. Aim of this study was to evaluate in a large population of
ARDS patients mechanically ventilated, the presence and the amount of
iPEEP, the possible associated factors (patients characteristics and ventila-
tor setting) and the effect of two levels of external PEEP on iPEEP.
METHODS. A secondary analysis of patients previously enrolled in 6 pub-
lished studies. Patients were divided according to the presence of iPEEP.
The iPEEP was computed as the difference between total PEEP mea-
sured at the end of an expiratory pause and external PEEP measured
at end-expiration of a regular breath. 5 and 15 cmH2O of PEEP were
applied. Lung CT scan was performed at 5 and 45 cmH2O of PEEP.
RESULTS. 217 sedated and paralyzed patients were enrolled. iPEEP was
detected in 87 patients. Eighty-seven patients (40%) had iPEEP with a
median value of 1.1 [1.0-2.3] cmH2O at 5 cmH2O of PEEP.
Patients with intrinsic PEEP had a significantly higher body mass
index and arterial carbon dioxide partial pressure.
Both at 5 and 15 cmH2O of PEEP the applied tidal volume was
significantly lower (480 [430-540] vs 520 [445-600] mL at 5 cmH2O of
PEEP; 480 [430-540] vs 510 [430-590] at 15 cmH2O of PEEP) in patients
with intrinsic PEEP while respiratory rate was significantly higher (18
[15-20] vs 15 [13-19] bpm at 5 cmH2O of PEEP; 18 [15-20] vs 15 [13-19]
bpm at 15 cmH2O of PEEP).
At both PEEP levels, total airway resistance and compliance of the re-
spiratory system were not different among patients with and with-
out iPEEP.
The total lung gas volume and the lung recruitability were not dif-
ferent among patients with and without iPEEP (961 [701-1535]vs
973 [659-1433] mL; 15 [0-32] % vs 22 [0-36] % respectively).
CONCLUSION. In our population iPEEP was detected in 40% of ARDS
patients. In sedated and paralyzed ARDS patients the amount of in-
trinsic PEEP during lung protective ventilation is of negligible entity
and does not influence gas exchange and respiratory mechanics
properties.
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INTRODUCTION. Nasal high flow (NHF) in hypoxemic patients is
usually delivered at flows of 30-50L/min and recent studies [1]
showed that higher flow rates may improve the benefit of NHF.
However, only one study in healthy volunteers showed that NHF
delivered at flows >60 L/min (super-nasal high flow (S-NHF)) is
associated with physiologic advantages [2].
OBJECTIVES. Aim of this study was to compare differences in
oxygenation, end-expiratory lung volume, minute ventilation and
patient’s comfort by NHF delivered at three different gas flow
rates: 0.5 L/min/Kg PBW, 1 L/min/Kg PBW; and 1.5 L/min/Kg PBW
(S-NHF).
METHODS. we performed a prospective, interventional, random-
ized cross-over trial in patients with hypoxemia (PaO2/FiO2≤300
mmHg) admitted to the Intensive Care Unit of Ospedale Mag-
giore Policlinico in Milan. We delivered stable air/oxygen mix to
obtain saturation of 90%-96% during all phases. Flow was set as
detailed above for 20 minutes. At the end of each phase, data
on lung volumes were recorded by EIT (Dräger Medical GmbH,
Lubeck, Germany), ABG was performed and comfort was collected
by visual numeric scale (0-10). Statistics were performed by one-
way repeated measures ANOVA. Normally distributed variables
are represented by means and SD, while median [IQR] have been
used for non-normal.
RESULTS. We enrolled 7 patients (73±11) years old, 4 females,ba-
seline PaO2/FiO2(166±47). During S-NHF, End Expiratory Lung Im-
pedance (DEELI) significantly increased in comparison to lower
gas flow rates (p=0.017), indicating larger PEEP effect, and Global
Inhomogeneity (GI) of ventilation distribution was reduced. PaO2/
FiO2, respiratory rate and corrected minute ventilation (MVcorr),
instead, remained stable. Finally, S-NHF was associated with sig-
nificantly poorer patient’s comfort.
CONCLUSION. S-NHF might be associated with partial improvement
of the physiologic effects of NHF at the expense of lower patient’s
comfort.
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Fig. 1 (abstract 000567). Microcirculation measurements preop
(blue) and postop (red). Changes in convective blood flow (MFI, PPV,
HI) and diffusive capacity (TVD, PVD)
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INTRODUCTION. Cardiac surgery with cardiopulmonary bypass
(CPB) is associated with significant microcirculatory impairment
that may impact patient outcomes.1 Post-operative resuscitation
routinely targets normalized systemic hemodynamic goals to
achieve adequate tissue perfusion. Functional microcirculatory de-
rangements are well described in sepsis, but poorly understood
after cardiac surgery. Incident dark field videomicroscopy (IDF) al-
lows for high resolution, real-time functional assessment of hu-
man microcirculation.
OBJECTIVES. To evaluate changes in microcirculatory function after
resuscitation from cardiac surgery compared to baseline measure-
ments when targeting normalization of systemic hemodynamic indi-
ces and identify phenotypes of microcirculatory dysfunction when
compared with arterial lactate levels.
METHODS. These are preliminary results from an ongoing pro-
spective, observational, single center study of elective CABG or
valvular surgery patients. Sublingual microcirculation measure-
ments (CytoCam, Braedius Medical BG, the Netherlands) were ob-
tained in the pre-operative ward and in ICU 2-4 hours post-op
once hemodynamic indices were normalized. Measurements were
required to have a quality score < 10. Microcirculation videos
were analyzed manually, measuring criteria based on ESICM 2nd
consensus recommendations.3
RESULTS. We enrolled 20 subjects, median (IQR) age 63 years (55-
71), 85% male, cardiopulmonary bypass time 115 min (82-143). Post-
operative macrocirculatory indices were MAP 75 mmHg (70-83), CI
2.3 L/min/m2 (2.0-2.9), CVP 10 (7-12). Post-operative SvO2 was 72%
(62-77), and arterial lactate 5.0 mmol/dL (2.1-8.6). Compared to pre-
operative measurements, post-operative convective flow was signifi-
cantly impaired. MFI (AU) 2.9 (±0.1) vs. 2.2 (±0.5), p<0.0001, PPV (%)
93.7 (±3.2) vs. 75.1 (±12.8), p<0.0001, with significant heterogeneity,
HI (AU) 0.1 (±0.1) vs. 0.6 (±0.3), p<0.0001. Diffusive capacity was sig-
nificantly impaired, PVD (mm/mm2) 21.5 (±3.3) vs. 15.8 (±3.9), p<
0.0001, and TVD (mm/mm2) 21.2 (± 4.6) vs. 19.1 (± 3.9) p≤0.05.
CONCLUSION. An elevated lactate level after resuscitation from car-
diac surgery is associated with a significant reduction in both micro-
circulatory convective blood flow and diffusive capacity.
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INTRODUCTION. Cardiac surgery in dialysis-dependent patients is as-
sociated with high mortality and morbidity (1). Lactate is a well-
known marker of ischemia and a prognostic indicator, and kidney
and liver play the main role in lactate metabolism (2). Although sev-
eral studies proved the association between hyperlactatemia and
prognosis in cardiac surgery (3), the prognostic relevance of lactate
levels in dialysis-dependent patients is not well characterized.
OBJECTIVES. We aimed to evaluate the prognostic value of hyperlac-
tatemia on the mortality and length of intensive care unit (ICU) stay
in dialysis-dependent patients who had undergone cardiac surgery.
METHODS. This was a multicenter retrospective study and we in-
cluded dialysis-dependent patients who underwent cardiac surgery
with cardiopulmonary bypass between January 2014 and December
2018 at two mid-size private hospitals. Lactate data were collected at
three time-points: at ICU admission (T1); peak level within 24 hours
after the operation (T2); and 24 hours after the operation (T3). Lac-
tate clearance was calculated using the following formula: (T2 lactate
−T3 lactate)/T2 lactate × 100. We also obtained patient characteris-
tics, hospital mortality, length of ICU stay, and days to return to dry
weight after the operation. Prolonged ICU stay was defined as the
70th percentile of subjects. Using ROC curve analysis, we examined
which point of lactate predicted hospital mortality and prolonged
ICU stay. All statistical analyses were performed using software R
(Ver.3.4.2).
RESULTS. We enrolled 122 dialysis-dependent patients. The median
age was 73 (IQR 69-78) years, and hyperlactatemia was observed in
97 (79.5%) patients. Hospital mortality was 11.5%, median ICU stay
was 7 (IQR 5.0-10.8) days, and the median days to return to dry
weight were 8 (IQR 5.0-12.3) days. Prolonged ICU stay was defined
as ≧10 days by the 70th percentile of ICU stay. On ROC-AUC analysis,
T2 lactate showed the strongest association with hospital mortality
(AUC 0.848) and the cutoff level was 10.6 mmol/L; T1 lactate showed
the strongest association with prolonged ICU stay (AUC 0.778), and
the cutoff level was 2.0 mmol/L.
CONCLUSION. Peak lactate level within 24 hours after the operation
was associated with hospital mortality and lactate at the ICU admis-
sion was associated with prolonged ICU stay.
Table 1 (abstract 000665). Socio-demographic profile and select









56 (18-79) 38(28-52) <0.05
Male % 34 26 (68.4%) 8 (66.66%) 0.12
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11 (28.9%) 2 (16.66%) 0.07
HTN 12
(25%)
10 (26.3%) 2 (16.66%) 0.06
IHD 10
(20%)
10 (26.3%) 0 1.20
CVA 4 (8%) 4 (10.52%) 0 1.25





5.2 DAYS 4.0 DAYS 0.06
MORTALITY 12(25%) 10 (26.3%) 2 (5.26%) 0.05000665
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INTRODUCTION. Arrhythmias are common clinical events in the in-
tensive care unit (ICU) and its impact on continuum of critical illness
is unclear.
OBJECTIVES. To study type of arrhythmias in critically ill patients and
its association with diagnoses, duration of ICU stay and clinical
outcome.
METHODS. Retrospective study of 360 patients admitted to medical
ICU over 3 months period. Socio-demographic data, associated co-
morbidities, arrhythmias identified and interpreted, ICU diagnoses
and various clinical outcomes [mortality, ICU-length of stay (ICU-
LOS)] were studied.
Inclusion criteria: age > 18yrs
Exclusion criteria: Arrhythmias and other waveforms present during
ACLS or CPR.
RESULTS. Out of the 360 patients admitted to ICU during study
period 50pts (13.88%) had arrhythmias , with 46 pts having 1
event , 2 pts having 2 events and 2 pts having 3 events. Of these
50 pts, 61% patients had supra-ventricular Arrhythmias, 18% pa-
tients had ventricular Arrhythmias and 21% patients had prema-
ture complexes. The socio-demographic profile and select clinical
variables of patients is shown in Table 1. Most Arrhythmias (76%
events) occurred in first 3 days of ICU stay, Atrial fibrillation being
the most common. Patients with dys-electrolytemia and myocar-
dial infarction upon admission had increased risk of developing
Supra-ventricular arrhythmias. Development of Ventricular ar-
rhythmias was not found to be associated with any particular clin-
ical mediator. Patients with Ventricular arrhythmias had increased
risk of in-hospital mortality (P<0.05). Patients with Supra-
ventricular Arrhythmias were associated with increased duration
of ICU stay (5.2days) as compared to patients with premature
complexes and ventricular arrhythmias, though not clinically sig-
nificant (p= 0.06).
CONCLUSION. Arrythmias occurring in critically ill patients increase
in-hospital mortality and ICU-LOS.
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INTRODUCTION. Primary coronary intervention (PCI) in STEMI has ad-
vantage over fibrinolysis in terms of mortality and complications.
Hospitals implement its availability during 24 hours for all patients
with STEMI.
OBJECTIVES. Evaluate the impact of disponilility of PCI during 24
hours for all STEMI treated in our hospital, Juan Ramón Jiménez
Hospital
METHODS. Analytical descriptive study of prospective cohort of re-
gional database of Andalusia (ARIAM) of patients with STEMI admit-
ted to Intensive Care Unit between January 2017 and January 2019.
From June 2018 the PCI was available 24 hours, being all patients
with STEMI referred to our hospital and indicated by the emergency
doctor in charge of patient. Prior to this, the indication of PCI was
based on classical criteria, indicated by intensivist in case of cardio-
genic shock, contraindication or failed of fibrinolysis in of-time work
and like fist election in-time work. We used SPSS statistical software
with chi-square for frequency analysis and t student for medians. The
significant result was defined as p<0,05.
RESULTS. There are 206 patients, 82,1% males, median age of 62 years.
The most frequent presentation was anterior AMI (43,5%), Killip I (62,8%)
with LVEF 46,5%. The 53,9% was hypertensive, 48,5% smokers, 44,2%
dyslipidemics, 33,5% diabetics and 19,4% chronic ischemic heart disease.
The 44% presented complications, and they are cardiorespiratory arrest
(10,6%), cardiogenic shock (9,7%), hypotension (7,7%), complete node-
atrial block (4,8%), coronary dissection (3,9%), ventricular tachycardia with
pulse (3,9%), stent thrombosis (2,9%) and haemorrhage (0,5%). The 84
patients presented before 24 hours disponilility of PCI and 122 patients
after this period. The group of pre-disponilility period, had significantly dif-
ference (p<0,05), with predominance of inferior (36,9 vs. 22,1%) and un-
determined AMI (3,6 vs 0%) and presented more Killip III (14,3 vs 4,9%).
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tation of PCI 24 hours shown reduction of hypotension (14,3 vs 3,3%, p=
0,003), statistically significant, and, in time from first medical contact to
PCI (175 vs 136 minutes, p=0,07) and from first electrocardiogram to PCI
(156 vs 118 minutes, p=0,06), in overall mortality (6,0 vs 2,4%, p=0,2) with
related to myocardial ischemia (4,8 vs 1,6%, p=0,19) and cardiogenic
shock (13,1 vs 7,4%, p=0,17), but non-statistically significant.
CONCLUSION. The availability of PCI 24 hours has significantly affected
the reduction of several factors that coan influence in unforable evolution
of patients with AMI as hypotension or worse killip. Its implementation has
improved time from first medical contact to PCI and reduction of global
mortality but in a trend non-statistically significant. Its possible needs more
following in time of our population to see more changes in outcomes.
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INTRODUCTION. Admission for symptomatic bradycardia in the ICU
is frequent and the initial therapeutic option, while waiting for per-
manent pacemaker implantation, depends on the severity of symp-
toms, the center's infrastructure, and the personnel who perform the
care. This study tries to describe the clinical outcome of the three
most frequently used therapeutic options before definite pacemaker
implantation: temporary transvenous pacemaker (TTVP), chronotropic
drugs (C+) and observation (OBS).
OBJECTIVES. To analyze the characteristics and clinical outcomes of
three initial therapeutic options (TTVP, C+, and OBS) in patients ad-
mitted to the ICU due to symptomatic bradycardia.
METHODS. A retrospective cohort study of patients admitted to the
ICU due to symptomatic bradycardia [symptomatic atrioventricular
block (sAVB), sinus node dysfunction (SND), hyperkalemia (HK), drug
overdose (OD), etc.] from January 2014 to December 2018.We collected demographic data: age and sex; and clinical variables:
APACHE II, diagnosis at admission, low cardiac output, agitation, time
from ICU admission to permanent pacemaker implantation (TPPM),
length of stay in ICU (LSICU) and in the hospital (LSH); the last three
measured in days.
The demographic variables were compared by χ2 and the quantita-
tive ANOVA or nonparametric test (Kruskal-Wallis).
RESULTS. We analyzed 137 patients divided into 3 groups: TTVP: 86,
C+: 19, OBS: 32. Of these 54% were men; median age 80.5 (IQR: 72.5-
85.5).
The APACHE II median was 14 (IQR: 10-17) with no significant differ-
ences (NSD) between the 3 groups (p = 0.200).
The most frequent diagnosis was sAVB (82.5%), with NSD in the type
of bradycardia between the 3 groups (p = 0.146).
There where NSD in low cardiac output between the 3 groups (p =
0.535).
Agitation was more frequent in the TTVP (22.1%) and C+ (26,3%)
groups compared with OBS (3.1%), although with NSD (p=0,037).
The TPPM (days) was 0.85 (0.61-1.81) in TTVP; 0.88 (0.73-1.02) in C+;
and 0.83 (0.6-1.75) in OBS; with NSD between the 3 groups (p =
0.275).
The LSICU (days) was significantly larger in TTVP: 1.65 (1-2.38) in
TTVP; 1.1 (1.03-2.17) in C+; 1.06 (0.9-1.35) in OBS (p = 0.028).
The LSH (days) was 4.8 (3.91 - 5.69) in TTVP; 4.78 (1.96-7.6) in C+;
3.83 (3.03-4.63) in OBS; with NSD between the 3 groups (p = 0.334).
Four patients in the OBS group (12.5%) and two patients in the C+
group (10.53%) required an urgent placement of TTVP.
CONCLUSION. In our series, there were no significant differences be-
tween the three groups in any of the studied variables, except for
LSICU days, in which case it was significantly larger in TTVP.
There was a higher incidence of agitation in the TTVP and C + group,
although with no significant difference.
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INTRODUCTION. Peripheral arterial catheters are invasive
hemodynamic monitoring devices used in intensive care unit and are
considered the gold standard in blood pressure monitoring. Al-
though even if the risk of complication is low, arterial catheters are
not harmless and can result in ischemia, infection and thrombosis.
OBJECTIVES. We carried out this prospective analysis to evaluate the
hypothesis that non-invasive blood pressure (NIBP) monitoring would
be as accurate as invasive blood pressure (IABP) monitoring in cer-
tain situations. We also evaluated whether the deviation of pressure
transducer would affect the results of IABP.
METHODS. For the NIBP measurements, oscillometric blood pressure
measurements were performed; cuff size was selected on the basis
of the patient’s limb circumference. For the IABP measurements, a
20-G arterial catheter was present in the radial artery. The transducer
system was connected to the arterial catheter. The pressure trans-
ducer was placed at the level of the heart and zero-calibrated to at-
mospheric pressure. For the study it was elevated 10cm upward and
downward from zero. The correlations between invasive and nonin-
vasive values were assessed using Pearson correlation coefficient.
Agreements between invasive and noninvasive blood pressure
methods were assessed using Bland–Altman analysis and t-test. All
summarized values are presented as mean ± SE. P-value of less than
0,05 was considered statistically significant.
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ferent groups: control, arrhythmia, vasopressor. The mean age was
59,1±17,0. The mean BMI was 27,4±4,6 kg/m2. The correlation coeffi-
cients between invasive and noninvasive devices for systolic, diastolic,
and mean arterial pressure were all significantly correlated with P-
values of less than 0,0001. The mean biases for IABP and NIBP with bra-
chial cuff SAP were 0,36±11,5 mmHg, DAP −6,25±5,96mmHg, and MAP
-5,53±5,5mmHg although with thigh cuff SAP were -6,15±10,2 mmHg,
DAP -5,11±6,9mmHg, and MAP -6,4±5,6. The mean biases for mean
IABP and NIBP in control group were -5,4±5,48mmHg (brachial), -5,78±
5,77mmHg (thigh), in group with arrhythmias -4,75±6,14mmHg; -6,35±
5,46mmHg, in group with vasopressor dose 0,1-0,2mcg/kg/min were
-5,69±4,4mmHg; -6,3±4,1mmHg, and with dose >0,2mcg/kg/min were
-8,14±6,17mmHg; -10,29±6,97mmHg. The correlation coefficients be-
tween invasive arterial pressure before and after pressure transducer
ascending 10cm and descending 10cm from zero were all significantly
correlated with P-values of less than 0,001. The mean biases for cali-
brated IABP and 10cm higher IABP transducer was 7,85±2,6mmHg and
for 10cm lower was -7,59±2,56mmHg.
CONCLUSION. NIBP monitoring is not as accurate as IABP monitoring
in patients especially with high vasopressor doses. Although NIBP mon-
itoring is more accurate than erroneously calibrated IABP in most cases.
REFERENCE(S)
1. Araghi A, Bander JJ, Guzman JA. Arterial blood pressure monitoring in
overweight critically ill patients: invasive or noninvasive? Crit Care 2006;
10:R64.
2. Scheer B, Perel A, Pfeiffer UJ. Clinical review: complications and risk
factors of peripheral arterial catheters used for haemodynamic
monitoring in anaesthesia and intensive care medicine. Crit Care 2002;
6:199–204.
3. Mermel LA. Arterial catheters are not risk-free spigots. Crit Care Med
2008;36:620–622.
4. Lakhal K, Ehrmann S, Martin M, et al. Blood pressure monitoring during
arrhythmia: agreement between automated brachial cuff and intra-
arterial measurements. Br J Anaesth. 2015;115(4):540-549.
5. Lakhal K, Macq C, Ehrmann S, et al. Noninvasive monitoring of blood
pressure in the critically ill: reliability according to the cuff site (arm,
thigh, or ankle). Crit Care Med. 2012;40(4):1207-1213.
6. Chatterjee A, DePriest K, Blair R, et al. Results of a survey of blood
pressure monitoring by intensivists in critically ill patients: a preliminary
study. Crit Care Med. 2010;38(12):2335-2338.
000827
Differences in new onset and chronic atrial fibrillation in a cohort
of critically ill patients
R. Carvalho De Menezes1, I. Bonifácio Brige Ferreira2, M. Lisboa Otero1,
G. Andrade Agareno3, A. Araujo Oliveira2, L. Pamplona Neto1, S. Agareno
De Souza Filho1, NM. Filgueiras Filho3
1Critical care, Hospital da Cidade, Salvador, State of Bahia, Brazil, Brazil;
2Medicine, Bahia State University, Salvador, Brazil; 3Medicine, Salvador
University, Campus Teacher Barros, Salvador, Brazil
Correspondence: N.M. Filgueiras Filho
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000827
INTRODUCTION. Atrial fibrillation (AF) is a common arrhythmia in In-
tensive Care Units (ICUs). It is suggested that different mechanisms
related to patients previously diagnosed with AF are related to the
development of this pathology during ICU stay. Thus, the present
study aims to compare the profile of patients and factors associated
with new onset and chronic AF.
OBJECTIVES. To assess the incidence and differences of new onset
and chronic AF in patients admitted to the general ICU.
METHODS. Retrospective cohort of patients with AF, admitted to an
adult general ICU between August/2015 and August/2018. Data was
prospectively extracted from patient records. The D'agostino test was
used to determine the normality of the studied variables and to
evaluate the difference between means and risk, the student`s T-test
and Chi-square test were respectively used.RESULTS. 2401 patients were admitted, of whom 247 (10.29%) pre-
sented AF during their hospitalization. Patients with chronic AF repre-
sented 61.13% (n = 151) of our population, with a mean age of 77.59 ±
11.10 and mean SAPS3 score 51.94 ± 9.65. The majority were women
[n = 131, (86.75%)], and, of these 26.49% (n=40) presented associated
with cardiovascular diseases. New onset AF (NoAF) corresponded to
38.86% (n = 96), with female gender predominating 57.29% (n = 55),
mean age = 76.53 ± 15.02, BMI 26.24 ± 6.01, SAPS 3 = 51.08 ± 12.57
and of those 39.58% (n = 38) presenting with cardiovascular diseases.
There was identified a higher risk for the development of NoAF in pa-
tients with cardiovascular diseases [OR (95% CI) 1.8 (1.053-3.139); p =
0.031]. Mean arterial pressure (MAP) was higher in patients with NoAF
(95.0 ± 21.8 vs 103.1 ± 22.6, p = 0.01), as well as C-reactive protein
(CRP) = 86, 5 ± 68.1 vs 109.1 ± 72.9; p = 0.037. There were no differ-
ences between the groups (chronic / NoAF) regarding outcome vari-
ables, such as length of hospital stay, use of vasoactive drugs or
mechanical ventilation, changes in sodium, potassium and mortality.
CONCLUSION. In this cohort of critically ill patients, the incidence of AF
was similar with literature. Demographic characteristics were similar in
the new onset and chronic AF groups, but patients with cardiovascular
diseases had higher incidence of NoAF. Higher MAP and CRP values
was identified in NoAF patients compared with chronic AF patients.
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INTRODUCTION. Little is known about the level of distress experi-
enced by patients hospitalized with Acute Coronary Syndrome (ACS)
OBJECTIVES. To describe levels of physical, psychological and spirit-
ual distress among patients admitted to a hospital with Acute Coron-
ary Syndrome (ACS)
METHODS. Every Israeli patient admitted to a hospital over a 2
month period with ACS (n=1958) was included in a bi-annual, na-
tional, two month prevalence study, Acute Coronary Syndrome Israel
Study (ACSIS). Clinical medical data were collected for the entire sam-
ple. A convenience sub-sample of these patients (n=990) completed
the Distress Thermometer. Demographic and clinical data were taken
from the patient's medical record.
RESULTS. The mean overall level of distress was 4.6/10 (Median= 5,
S.D. = 3.5). The most common source of physical distress was dis-
comfort (n=527, 54.7%), followed by fatigue (n=598, 62%). Most were
worried (n=506, 53%) with many reporting feelings of depression (n=
139, 15%) or sadness (n=238, 25%). Few reported having spiritual or
religious concerns (n=18, 2%).
CONCLUSION. Patients admitted to a coronary care unit with ACS ex-
perienced moderate levels of distress, from both physical and psy-
chological sources. While previous reports have described distress
after discharge, this study provides evidence that such responses are
already present in the immediate, acute phase of illness.
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(NO), carbon monoxide (CO) and hydrogen sulphide – are anti-
inflammatory, directly inhibit oxidative phosphorylation, and depress
metabolic activity. They have potential therapeutic utility in hypoxia,
ischaemia/reperfusion and circulatory shock [1]. Selenium is an es-
sential micronutrient and an important antioxidant [2]. Its physio-
logical derivative, hydrogen selenide (comprising gaseous H2Se and
the anion, HSe-) was recently proposed as the fourth gasotransmitter
[3]. It offers potential as a metabolic modulator and antioxidant ther-
apy in critical illness.
OBJECTIVES. To characterise the basic salt, sodium hydrogen selen-
ide (NaHSe), and investigate its effects on mitochondrial function.
METHODS. Sodium hydrogen selenide (NaHSe) was synthesized as
described [4]. H2Se gas liberated by the salt was measured using
a commercially available detector. Chemical reduction of oxygen
to water was assessed in closed chambers. Effects of NaHSe on
oxidative metabolism ex vivo was assessed by oxygen consump-
tion (soleus muscle) and cytochrome C oxidase activity (liver). So-
dium hydrogen sulfide (NaHS), K-cyanide (KCN) and the reducing
agent, sodium dithionite, acted as positive controls. In vivo
pharmacology of intravenous NaHSe was assessed in anaesthe-
tised, instrumented rats.
RESULTS. H2Se gas was detectable from vials containing dissolved
NaHSe (Fig 1A). Selenide was a powerful reducing agent (Fig 1B)
and dose-dependently decreased muscle oxygen consumption
(VO2) (Fig 1C), and inhibited cytochrome C oxidase activity (Fig
1D). Hydrogen selenide was less potent than both sulfide and
cyanide (Fig 1C, D), and its activity on mitochondrial function
was transient (Fig 1D). In vivo, hydrogen selenide exhibited a
striking effect on heart rate (Fig 1E).
CONCLUSION. Hydrogen selenide caused significant (and, desirably,
transient) metabolic effects via inhibition of cytochrome C oxidase
(mitochondrial complex IV). In keeping with the known activity of
other gaseous mediators (NO, CO, sulfide) as inhibitors of complex IV,
hydrogen selenide can indeed be considered the fourth gasotrans-
mitter. The metabolic and antioxidant effects of hydrogen selenide
warrant further investigation as a therapeutic agent.
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INTRODUCTION. Peripheral veno-arterial extracorporeal membrane
oxygenation (pVA-ECMO) has become an accepted treatment optionfor advanced cardiogenic shock, allowing myocardial recovery as well
as limiting or even reversing secondary end-organ damage.[1] Re-
spiratory management of patients on pVA-ECMO-ECMO, in particular
extubation and spontaneous breathing without ventilator support,
remains controversial.
OBJECTIVES. We therefore developed a prediction model to study
the effect of spontaneous breathing without ventilator support (ven-
tilator-free time) during pVA-ECMO on hospital discharge outcome.
METHODS. After IRB approval, we retrospectively analyzed data from
265 patients undergoing pVA-ECMO for cardiogenic shock with or
without concomitant acute respiratory failure. We classified hospital
discharge outcome as unfavorable (death/hospice), intermediate
(skilled nursing facility/other acute care hospital), and favorable (re-
habilitation facility/home). We extracted patient demographics, clin-
ical findings, and laboratory results from the electronic medical
records. Statistical analyses included Wilcoxon test, chi-square test,
Fisher's exact test as well as machine learning based analytics for
model development. P <0.05 was considered statistically significant.
Data are given as median (interquartile range).
RESULTS. Hospital discharge outcome of all patient was as follows:
41.6% unfavorable, 22.3% intermediate, and 36.2% favorable. Overall
hospital length of stay was 21.6 days (12.1-37.9); pVA-ECMO duration
was 7.9 days (4.3-16.7). 26.5 % of all patients were ventilator-free during
29.8% (10.9-51.7) of their time on pVA-ECMO. Overall vascular compli-
cation rates were low and statistically not significantly different
between patients who were extubated and those who were not. After
variable selection by means of generalized regression with machine
learning validation, we fitted a proportional odds model to predict hos-
pital discharge outcome with the following independent variables: age,
race, cardiovascular SOFA scores, respiratory SOFA scores, lactate levels,
need for durable mechanical circulatory support after pVA-ECMO, and
ventilator-free time (as % of pVA-ECMO duration). In addition to age,
need for durable mechanical circulatory support after pVA-ECMO, car-
diovascular SOFA score at the end of pVA-ECMO, and respiratory SOFA
score at the beginning of pVA-ECMO, ventilator-free time emerged as a
significant predictor for hospital discharge outcome [odds ratio 1.18
(95% CI 1.04-1.34) per 10% increase, p=0.011].
CONCLUSION. Analysis of our cohort suggests that patients can be
safely extubated during pVA-ECMO without any relevant adverse ef-
fects. Moreover, our data allows us to hypothesize that ventilator-free
time during pVA-ECMO is an independent predictor of hospital dis-
charge outcome.
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INTRODUCTION. In pulmonary arterial hypertension (PAH), abnormal
proliferation of vascular smooth muscle cells, inflammation and pulmon-
ary vascular remodeling are prominent features. Severalstudieshave dem-
onstrated that both hypoxia-induced factors-1 (HIF-1) and p21-activated
kinase-1 (PAK-1) are involved in the regulation of cell growth, leading to
vascular remodeling.Our previous study showed that intraperitoneal
administration ofinduced pluripotent stem cells (iPSCs) improves the
function of hemodynamics in lung of monorcotaline (MCT) or hypoxia-
induced PAH rats. In recent years, therapeutic benefit of iPSCs may be
F9
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mechanisms mediating these protective effects remain obscured.
OBJECTIVES. To determine whether iPSC-derived exosomes (iPSC-Exos)
treatment can improve chronic hypoxia-induced PAH and vascular remod-
eling in rats, as well as to identify the mechanisms underlying these effects.
METHODS. iPSC-Exos were intraperitoneal injected daily to a chronic
hypoxia-induced PAH rat model which under 10% Oxygen concentration
for 8 weeks. The protocol of iPSC-Exos were designated as (i) prevention
by the provision of iPSC-Exos treatments on same time with under hyp-
oxia condition, or (ii) reversal by administration of iPSC-Exos treatments
after hypoxia situation for 4 weeks. The phenomenon of vascular remo-
delingwere assessed by immunohistochemical and Elastic Van Gieson
staining.Hypoxia-induced HIF-1a and PAK1 expression were determined
by Western blotting and qPCR.Furthermore, MTT assay and BrdU staining,
and TUNEL assay were used to analyze hypoxia-induced pulmonary
smooth muscle cells (PASMCs) proliferation and apoptosis, respectively.
RESULTS. The in vivo study demonstratedthat administration of iPSC-Exos
group decreases the hemodynamic values of RVSP and ameliorates the
lumen diameter and wall thickening of pulmonary arterioles in hypoxia-
induced PAH.Histological examination of lung tissue showed that the
levels of HIF-1a and PAK1 was lower in the iPSC-Exos group than the
no-treatment group. Administration ofiPSC-Exossignificantly inhibited
hypoxia-induced HIF-1a and PAK1 expression inlung tissue lysates revealed
by Western blotting and qPCR.Similar to the results observed
in vivo,treatment of PASMCs with iPSC-Exossignificantly inhibitedhypoxia-
induced HIF-1a and PAK1 protein and mRNA expression.By MTT assay and
BrdU staining, the proliferation of PASMCs induced by hypoxia was signifi-
cantly inhibited by pretreatment with iPSC-Exos. By TUNEL assay, iPSC-
Exos promoted PASMCs apoptosis in response to hypoxia stimulation.
CONCLUSION. Our findings showed that iPSC-Exos exerts a protect-
ive effect on pulmonary vascular remodeling in hypoxia-treated PAH
model through down-regulation of HIF-1a and PAK1,leading to ameli-
orate hemodynamic values of RVSP. In PASMCs, iPSC-Exosinhibits
hypoxia-induced HIF-1a and PAK1 signaling pathway and blocks ex-
cessive cell proliferation. iPSC-Exos also prevents the resistance of
PASMCs to apoptosis. These finding may provideuseful information
about iPSC-Exos as a new therapeutic strategy for PAH diseases.
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INTRODUCTION. Acute circulatory failure is a life-threatening condition.
Fluid loading aims to increase cardiac output and restore organ perfu-
sion. Only 50% of patients are fluid responders, while the remainder
are at risk of volume overload (peripheral and pulmonary edema).
Electrical impedance tomography (EIT) shows lung impedance as deter-
mined by small electrical currents. An increase in intrapulmonary gas vol-
ume increases impedance, while an increase in blood or fluid volume,
lowers it. In healthy volunteers, saline administration led to a decrease in
lung impedance.
OBJECTIVES. Aim of the present study was to assess the effect of a
fluid challenge on EIT-derived lung impedance in critically ill patients
with acute circulatory failure.
METHODS. Hemodynamic and respiratory variables, blood samples,
cardiac ultrasound and EIT measurements were recorded before a 5
ml/kg fluid challenge, and repeated at the end of fluid infusion and
20 minutes after. As a surrogate for stroke volume, the pulsed-waveDoppler examination of the left-ventricular outflow tract velocity-
time integral (VTI) was measured; an increase >15% of VTI identified
fluid responders. Factorial analysis of variance for repeated measures
was used to compare the values obtained during each study phase.
RESULTS. We enrolled 13 patients (8 males, age 70±10 years, BMI
26±4 kg/m2). The average volume of the fluid challenge was 280±90
ml. 5 patients were fluid responders (38.5%).
Systolic blood pressure significantly increased with fluid challenge (105±
13 vs. 119±24 vs. 121±26 mmHg, p=0.005), as did the VTI (19.5±4.2 vs.
22.1±5.6 vs. 21.9±5.4 mm, p=0.002). End-expiratory lung impedance sig-
nificantly decreased after fluid administration: 1700±814 vs. 431±436 vs.
207±202 arbitrary units, p<0.001. The decrease in lung impedance was
associated with worsening oxygenation (R=0.560, p=0.047) (Figure 1).
CONCLUSION. Electrical impedance tomography, thanks to its high
temporal resolution, could be a valuable tool to assess the effect of
fluid loading on lung water.
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INTRODUCTION. Accurately predicting fluid responsiveness in the
critically-ill remains a challenge. Point-of-care ultrasound assessment of
corrected carotid flow time (cFT) has been proposed as a feasible, non-
invasive means of determining fluid responsiveness.1Prior research found
a change in cFT of 7ms following a passive leg raise, as measured by ex-
pert sonologists, was able to predict fluid responsiveness in patients with
undifferentiated shock.2
OBJECTIVES. We aimed to prospectively evaluate the ability of point-
of-care ultrasound assessment of cFT performed by novice sonolo-
gists enrolled in a medical critical care fellowship, to predict fluid re-
sponsiveness in critically-ill intensive care unit patients.
METHODS. Three novice sonologists performed point-of-care ultrasound
assessments of cFT in 115 intensive care unit patients with suspected vol-
ume depletion admitted at two urban academic medical centers from
November 2016 to July 2018. The novice sonologists received a 6-hour
training session and were required to demonstrate proficiency in 10 proc-
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0.9% normal saline intravenous bolus. Fluid responsivenesswas defined
as a ≥ 10% increase in cardiac index following the fluid bolus, as mea-
sured using bioreactance (NICOMTM, Cheetah Medical, Tel Aviv, Israel).
The change in cFT was then compared to this fluid responsiveness defin-
ition. Novice sonologists were blinded to the NICOM results.
RESULTS. Characteristics of the study participants: median age of 53
years old, APACHE II score of 15, BMI of 27 kg/m3, and 57 (50%) were
fluid responders. Diagnosis at hospital discharge included; severe
sepsis/septic shock (29%), DKA/HHS (31%), GI hemorrhage (12%) and
alcohol withdrawal (5%). The optimum change in cFT of 6ms per-
formed poorly at predicting fluid responsiveness: AUC-ROC of 0.53
(95% CI: 0.41-0.63), sensitivity of 55% (95% CI: 43%-67%), specificity
of 54% (95% CI: 42%-67%), and positive and negative likelihood ra-
tios 1.21 (95% CI: 1.19-1.22) and 0.82 (95% CI: 0.81-0.84), respectively.
CONCLUSION. Our study does not support the use of point-of-care
ultrasound assessment of cFT to predict fluid responsiveness in in-
tensive care unit patients by novice sonologists. Further research
examining the relationship between point-of-care ultrasound profi-
ciency and cFT is warranted.
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INTRODUCTION. In critical care patients the positive fluid balance is
associated with highly mortality (HR 1.014 ml/kg)1, therefore the fluid
administration, despite being an essential treatment for septic shock
patients, must be assessed and individualized. Furthermore in the
critical care patients with acute respiratory distress syndrome (ARDS),
the extravascular lung water index (EVLWi) has been an independent
prognostic factor2. In ARDS patients the fluid administration based in
EVLWi meditions is safe and lead to a less fluid balance acummula-
tion, mortality, mechanic ventilation days and UCI stay days3.
OBJECTIVES. To determinate the association between fluid balance and
ELVWi
METHODS. Retrospective, cohort, analytical study establishing the as-
sociation between daily fluid balance, changes in EVLWi and mortal-
ity in ICU at 24, 48 and 72 hours.
RESULTS. We collected data from 20 patients with EVLWi and fluid bal-
ance daily monitoring for the first 3 days, we established an EVLWi cutoff
value of >11 ml/kg, and was associated with a higher mortality; on the
first 24 hours with an OR 36 (95% IC 2.7210 a 476.2989, p = 0.0065), at 48
hours OR 20 (95% IC 1.4161-282.4627, p = 0.0266) and at 72 hours OR
19.2857 (95% IC 0.7977-466.2641 p = 0.0686). Fluid balance cutoff value
was established at ≥ 3.5 L, without association with mortality OR 0.0877
(95% IC 0.0041-466.2647 p = 0.0686) at day 1, OR 0.4667 95% CI 0.0369 –
5.9028 p=0.5561)at day 2 and OR 0.5000 95% CI 0.0374-6.6838 p=
0.6003) at day 3. The association between fluid balance and EVLWi results
in a Pearson’s R2= 0.01269.
CONCLUSION. EVLWi was associated with an increased mortality, as
shown in previous studies3, unlike fluid balance ≥3.5 L, that shows noassociation with mortality, we believed this results from the manage-
ment and neutralization of cumulative fluid balance during the UCI
stay. We did not find correlation between fluid balance and EVLWi. We
believed that lower values of fluid balance and EVLWi maybe correlated
with improvement and good response to treatment.
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INTRODUCTION. Aortic stenosis is the most frequent valvular dis-
ease in adults, its main etiology being degenerative. The gold
standard treatment is the surgical valvular replacement. Al-
though there are non-candidates because of the high surgical
risk, using less invasive methods such as transfemoral TAVI.
OBJECTIVES. To analyze survival, degree of functionality and quality
of life after implantation of transfemoral TAVI.
METHODS. Longitudinal, unicentric study, based on the ARIAM
prospective registry of cardiac surgery. Including 77 patients
consecutively submitted to transfemoral TAVI from January 2015
to December 2016. Follow-up time from 1.5 to 3.5 years, made
by telephone. Descriptive analysis of baseline demographic vari-
ables: age, sex, comorbidities, surgical risk (EuroSCORE) and
NYHA grade. Survival by the Kaplan-Meier method, quality of
life with the SF-12 Health Survey questionnaire and post-TAVI
functional assessment according to NYHA. We used non-
parametric Wilcoxon test for NYHA pre and post, Cox regression
for factors associated with survival and multivariate logistic re-
gression model for factors associated with quality of life.
RESULTS. The mean age was 78.51 ± 8.70 years, with 53.2%
women, NYHA of 2.48 ± 0.66, EuroSCORE of 15.23 ± 9.20 and
EuroSCORE 2 of 3.64 ± 2.96. The survival within the first month
was 98.70% (95% CI: 96-100%), 90.90% at 6 months (95% CI:
85-96%), 80.52% (95% CI : 72-88%) after one year, 72.0% (95%
CI: 63-80%) at two years and 60.30% (95% CI: 50-69%) after
three years. Twenty five patients died, being the most frequent
cause heart failure for 16% of them and cerebral hemorrhage
for 16%. Forty seven patients answered to the quality of life
questionnaire. Our SF-12 scores were below those for the Span-
ish population above ≥75 year. There was a small difference in
the physical summary component and a large difference in the
mental summary component. Functional capacity results show
recovery (NYHA I) in only 17% of patients, with no association
in the explored variables associated with survival after TAVI
(age, sex and NYHA).
CONCLUSION. The implantation of transfemoral TAVI in our cen-
ter shows very good results in terms of survival in the short
and medium terms. Our results for gain in quality of life and
functional recovery are comparable to previously reported
results.Fig. 1 (abstract 001063). See text for description001066
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INTRODUCTION. Atrial fibrillation (AF) is one of the most frequent ar-
rhythmias in the ICU. The prevalence in non-cardiac ICUs is given
with up to 10%. While the incidence of new-onset AF and the risk of
neurological sequelae is well investigated, little is known about the
impact of AF „per se“ on the cardio-circulatory performance in critic-
ally ill patients.
METHODS. Therefore, we analysed a prospectively maintained data-
base on advanced haemodynamic monitoring with transpulmonary
thermodilution (TPTD) and pulse contour analysis (PCA) (PiCCO; Pul-
sion; Germany). Primary endpoint: Comparison of haemodynamic pa-
rameters between patients with SR and AF. The final analysis was
restricted to patients with jugular/subclavian CVC, since femoral CVC
indicator injection might result in overestimation of global end-
diastolic volume index GEDVI. Statistics: Wilcoxon-test for unpaired
samples. ROC-analysis and multiple regression analysis regarding
CI≤2.5L/min/m². IBM SPSS 25.
RESULTS. The database included 19,025 TPTDs in 1,067 patients. AF
and sinus rhythm (SR) were documented in 2925 (15.4%) and 15,653
(84%) of the TPTDs, respectively. Among the 11,297 TPTDs in patients
with jugular or subclavian CVC, 1,771 (15.7%) TPTDs were performed
under AF and 9,306 (82.7%) under SR. 61% of the patients were male,
39% female. The underlying diseases were sepsis (30%), liver cirrhosis
(26%), GI-bleeding (7%), ARDS/pneumonia (10%), cardiogenic (7%),
pancreatitis (3%), various (17%). Biometrics: Measurements under AF
were more frequent among women compared to men (44% vs. 38%;
p<0.001). Patients with AF were older (69±9 vs. 61±13 years; p<
0.001), smaller (171±10 vs. 173±8cm; p<0,001) and had higher
weight (91±28 vs. 80±25kg; p<0.001) and BMI (33±13 vs. 26±7kg/m²;
p<0.001). Patients with AF had a higher heart rate (100±21 vs. 91±
18/min; p<0.001) and CVP (17±6 vs. 15±7 mmHg; p<0.001), but
slightly lower MAP (82±14 vs. 83±15mmHg; p=0.039). Global end-
diastolic volume index GEDVI was substantially higher in patients
with AF (914±210 vs. 816±188mL/m²; p<0.001). As expected, stroke
volume variation SVV was markedly higher in patients with AF (21±7
vs. 13±7%; p<0.001). Contractility was moderately impaired under
AF: CI (3.3±1.2 vs. 4.4±1.4/min/m²; p<0.001), stroke volume index SVI
(35±13 vs. 49±16mL/m²; p<0.001) and dPmax (1392±523 vs. 1446±
596mmHg/s; p=0.007) were lower under AF compared to SR. General
cardiac performance as measured by cardiac power index CPI was
lower for patients with AF (0.60±0.23 vs. 0.81±0.30W/m²; p=0.331).
Extravascular lung water was slightly higher under AF (12±5 vs. 11±
5mL/kg; p<0.001). By contrast, pulmonary vascular permeability index
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ments with AF and SR.
AF (ROC-AUC=0.639; p<0.001), low GEDVI (AUC=0.621; p<0.001) and
low heart rate (AUC=0.532; p=0.002), but not CVP (AUC=0.515; p=
0.149) predicted a CI≤2.5L/min/m². In multivariate analysis AF, low HR
and low GEDVI were independently associated with a CI≤2.5L/min/m².
CONCLUSION. AF resulted in a moderate reduction of SVI and CI.
Heart rate and GEDVI were slightly elevated. General cardiac per-
formance with AF measured by CPI was reduced by 26%.
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INTRODUCTION. dPmax is defined as the maximum increase in arter-
ial pressure per time and can be measured invasively by
catheterization or noninvasively by Doppler-technique. Left ventricu-
lar and aortic dPmax have been suggested as an index of cardiac
performance. However, the usefulness of dPmax is controversely dis-
cussed, since it might also depend on preload, afterload, heart rate
and myocardial hypertrophy.
Several haemodynamic monitoring devices provide continuous
dPmax. Surprisingly, there is a lack of systematic data on the associ-
ation with other haemodynamic parameters as well as with biometric
data. Therefore, we analyzed a large prospectively maintained data-
base on transpulmonary thermodilution and pulse contour analysis
(PiCCO; Pulsion; Germany).
METHODS. Analysis of a database including 19,025 triplicate mea-
surements in 1067 patients. Statistics: Spearman correlation, Wil-
coxon test, multivariate regression, ROC-analysis. IBM SPSS 25.
RESULTS. 61% of the patients were male, 39% female. Age 63±13
years, height 172±8cm, weight 80±23kg. The underlying diseases
were sepsis (30%), liver cirrhosis (26%), GI-bleeding (7%), ARDS/pneu-
monia (10%), cardiogenic (7%), pancreatitis (3%), various (17%).
Among biometric parameters, dPmax had a slight, but significant associ-
ation with low weight (r=-0.099; p<0.001), small height (r=-0-095; p<
0.001) and lower age (r=-0.015; p=0.043). Women had significantly higher
dPmax (1473±593 vs. 1381±555 mmHg/s; p<0.001). In multivariate ana-
lysis (R²=0.019), dPmax was independently associated with low weight
(T=-11.3), small height (T=-10.0) and young age (T=-6.1; all p<0.001).
Preload: dPmax correlated with low GEDVI (r=-0.195, p<0.001), low
CVP (r=-0.018; p=0.039) and high SVV (r=0.195; p<0.001). In multivari-
ate analysis (R²=0.047), dPmax was independently associated with
low GEDVI (T=-2.22) and high SVV (T=6.1; all p<0.001).
With regard to parameters of afterload, dPmax was associated with low
SVRI (r=-0.154; p<0.001) but not with MAP (r=0.010; p=0.282).
With regard to contractility, dPmax significantly correlated with CI (r=
0.194; p<0.001) and SVI (r=0.082; p<0.001). The strongest univariate asso-
ciation of dPmax was found with pulse pressure PP (r=0.601; p<0.001).
Finally, dPmax was associated with heart rate (r=0.161; p<0.001) and
sinus rhythm (vs. atrial fibrillation; r=0.020; p=0.006), but not with
extravascular lung water index EVLWI (r=0.001; p=0.891).
In a combined regression analysis (R²=0.673), dPmax was independ-
ently associated with pulse pressure (T=38.5), low SVRI (T=-6.1), low
preload (GEDVI: T=-5.0); SVV: (T=4.3), high heart rate (T=5.1) and high
weight (T=3.1; p=0.002; all other p-values <0.001).
In ROC-analysis, low dPmax (AUC=0.637; p<0.001) provided the lar-
gest AUC to predict CI≤2.5L/min*m² compared with low GEDVI
(AUC=0.618; p<0.001), low PP (AUC=0.602; p<0.001) and low heart
rate (AUC=0.538; p=0.001), whereas CVP was not predictive.CONCLUSION. dPmax is not substantially influenced by biometry,
MAP, rhythm and CI. The main determinants are pulse pressure, low
peload (GEDVI) and low afterload (SVRI).
HSRO - What can we do better?
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INTRODUCTION. Gastric tubes (GT) are common in intensive care
units (ICU) used for enteral feeding, administration of drugs or aspir-
ation of the digestive tract. Current GT have excellent clinical toler-
ance. Although a malposition may appear as rare, it may have
serious consequences that could lead to patient’s death. The only
method recommended confirming correct positioning of the GT is
chest x-ray. However, restrictive strategies for prescribing chest X-
rays are being developed to limit their negative effects (irradiation,
accidental removal of medical devices, microbial spread, cost). We
hypothesized that ultrasonography (US), now widely used in ICU,
would allow the evaluation of the correct positioning of the GT.
OBJECTIVES. The aim of this study was to evaluate the performance
of gastric US for the validation of the good positioning of the GT.
METHODS. We carried out a prospective, bicentric study in Medical
and Cardiosurgical ICU in Rouen University Hospital. All patients with
new placement of GT, except patients in the post-operative period of
visceral surgery, were included. For each inclusion we compared the
results of a gastric US to the interpretation of a chest x-ray, to valid-
ate the good positioning of the GT.
RESULTS. Two hundred and nineteen US were performed from July
2016 to August 2018. In 160 cases, US concluded that the gastric
tube was correctly positioned. In 59 cases, US did not visualize the
tube in gastric area. Among these 59 cases, only 12 cases of malposi-
tion were detected by the chest x-ray. The sensitivity and specificity
of gastric US were 0.77 [0.71; 0.82] and 1 [0.75; 1]. Positive and nega-
tive predictive values were 1 and 0.20, respectively. The median
duration of US was 3 minutes [1; 10]. The median time spent before
US was performed was 60 minutes [0; 1275]. It was 150 minutes [0;
1900] before the x-ray was performed which is a significant differ-
ence (p<0,0001). US was performed 50 minutes [-781; 1630] earlier
than chest x-ray after gastric tube insertion.
CONCLUSION. Our results suggested a good performance of gas-
tric US to check the positioning of the gastric tube. This result
must be interpreted with caution because of a low power of the
study. A multicentre study with greater power would be neces-
sary to validate this practice.
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Table 1 (abstract 000507). Patients characteristics
Characteristics N=219
SAPS II 46 [10; 102]
BMI 25,4 [11,8;
50,8]
Number of chest X-rays only prescribed for checking GT
positioning*
52/102
Complications related to GT positioning 0
SAPS II (Simplified Acute Physiology Score and the BMI (Body Mass Index)
were expressed using a median [min-max°. Complications were expressed in
absolute values. *N = 102, this data having been collected only during the
Fig. 1 (abstract 000513). See text for description000513
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INTRODUCTION. Frailty characterises increased vulnerability to a dra-
matic decline in functional status from a relatively minor stressor.
There is increasing evidence that frailty is associated with lower sur-
vival and poorer non-mortality outcomes following ICU admission(1).
However, the majority of published frailty studies in critical care
focus on a patient’s frailty status at a single point in time - usually
just prior to hospital or ICU admission. Trajectory may also play an
important role(2).
OBJECTIVES. To explore the range of frailty status in patients admit-
ted to ICU
To investigate the association of frailty and worsening trajectory with
survival outcome
METHODS. Single centre observational study over a 13-month period
from 1/10/2017 to 31/10/2018. Worsening functional trajectory was
defined by a single Y/N question as to whether there was any func-
tional deterioration in the 1-year preceding ICU admission. Frailty
was defined by scores of ≥5 on the Rockwood Clinical Frailty Scale
(RCFS).
RESULTS. Of 916 patients that were admitted to ICU during the study
period, median age was 67 (age range 16-93) with 516 patients ≥65
years of age. Frailty and trajectory data was collected for 634 and 629
patients respectively (349 and 346 in≥65 years subgroup). From this
cohort, prevalence of frailty was 25.9% overall which increased to
34.7% for those ≥65 years. The range of frailty scores is shown (figure).
39.4 % patients (48.8% age ≥65 years) showed a worsening func-
tional trajectory in the 1 year lead up to ICU admission.
There was a significant association between frailty and in-hospital
mortality. Chi-squared=18.397, P<0.0001 (Chi-squared=14.284, P=
0.0002 age ≥65 years)
Worsening trajectory was also significantly associated with in-
hospital mortality Chi-squared=24.125, P<0.0001 (Chi-squared=
11.726, P=0.0002 age ≥65)
Functional deterioration within last 12 months showed much stron-
ger correlation with mortality outcome (R=-0.93181, AUCROC =
0.613) compared with frailty (R= -0.85117, AUCROC = 0.588)
second course of the studyCONCLUSION. This study shows a significant proportion of patients
have a functional deterioration in the 1 year preceding ICU admission
which is more strongly correlated with mortality outcome compared
with frailty status. The concept of functional trajectory warrants fur-
ther exploration in future studies.
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INTRODUCTION. Low phase angle (PA) values and persistence of a
positive fluid balance (FB) are associated with an increased risk of
long-term mortality of intensive care unit (ICU) patients.
OBJECTIVES. We sought to assess the prognostic value of PA and FB
for mortality in critically ill patients.
METHODS. Fat-free tissue mass was assessed by measuring the 50-kHz
phase angle on the first, fifth and seventh day. The inclusion criteria
were: length of ICU stay of ≥7 days; SOFA score of ≥ 3. FB was calcu-
lated at 24, 72 hours and at 7 days upon ICU admission. We collected
demographic and clinical characteristics of the patients. The APACHE II
and SOFA scores were employed to evaluate the severity of illness and
the degree of organ dysfunction respectively. We documented the
highest vasopressor dose administered within the first 24 and 72 hours
of ICU stay. Binary logistic regression analysis was performed to identify
independent risk factors associated with ICU mortality.
RESULTS. A total of 90 patients admitted to the ICU were included in
the present study. 33 patients died during ICU stay. Age 56± 15 y., male
71%, APACHE II 19±7 and SOFA 8±3. There was no statistical difference
of gender distribution, APACHE II and SOFA score averages between
the outcome groups. Patients in the non-survivor group were signifi-
cantly older (53,5±14,5 vs. 60±15,1, P=0,045) and had a lower BMI
(30,5±6,7; 27,2±4,7 P=0,018) compared to the survivor group. The PA at
day 1 and 7 was lower in non-survivors (3,4°± 1,3° vs. 4,0°± 1,2°, P =
0.014 vs. 3,0°± 0,9° vs. 4,1°± 1,4 P= < 0.001). Relative to survivors, non-
survivors and patients with lower PA had greater cumulative FB on
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(P=0,001) respectively. Mean vasopressor dose during the first 72
hours upon admission was significantly higher in non-survivors
(0,17 mcg/kg/min±0,19 vs. 0,08 mcg/kg/min ±0,96, P=0,016). The
results of binary logistic regression revealed that greater positive
FB during the first week of ICU stay was independently associated
with increased mortality (OR 2,2 [1.15- 4,22], P=0,017).
CONCLUSION. Fluid accumulation during the first week of ICU stay
impacts the PA value and is an independent predictor of mortality.
PA at admission is lower in non-survivor. PA is a good prognostic
marker of mortality for critically ill patients.
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INTRODUCTION. The NCEPOD and NICE reports state that consultant
physicians should be involved in referral of patients to critical care. It
is also stated that it is inappropriate for referrals to be made at junior
doctor level. Referrals require the doctor to leave ICU in order to as-
sess patients on general wards. Appropriate referrals make the best
use of ICU resources and prevent delays in treatment.
OBJECTIVES. To review the degree of consultant involvement in the
referral and admission process and to ascertain reasons for deeming
a referral inappropriate.
METHODS. Prospective review of ICU referrals from 01/01/18 to 19/
02/18 to a 16 bed adult general ICU. Data was collected by the re-
ceiving doctor including; time, demographics, referrer grade, special-
ist involvement and whether the patient was admitted or not (with
reasoning). Data was transcribed for analysis using Microsoft Excel.
RESULTS. Data came from 64 referrals over a period of 50 days. The
incidence of consultant level referral was 14.1%, with the majority of
referrals, 67.1%, originating from non-consultant grades. Allied health
professionals and cardiac arrests accounted for 18.8% of referrals. A
higher proportion of junior doctor referrals were associated with pa-
tients that were not admitted (36.2%) than those that were (24.8%).
Referring team consultant awareness occurred in 48.4% of referrals,
with an a higher (60.7%) awareness in patients subsequently admit-
ted to ICU than in those then not admitted. Reasons for non-
admission to ICU following referral predominantly fell into three cat-
egories; no requirement for organ support/invasive monitoring
(36.1%), sub-optimisation (27.8%) and inappropriate/irreversible path-
ology (22.2%). A number of patients were discussed with an ICU doc-
tor but not formally referred for bedside review (8.3%).
CONCLUSION. The majority of referrals were from non-consultant
grades and in over half the referrals there was no referring team con-
sultant involvement. Incidence of admission to ICU was higher with
referring team consultant awareness, suggesting that more appropri-
ate referrals were being generated. Senior involvement, such as that
stated in NICE guidance, may result in better optimisation, decision
making and escalation planning. Further correlation to mortality data
and Apache 2 scores is planned. It is more difficult for escalation de-
cisions to be made out of hours by the critical care team, rather than
by the parent team who have been caring for the patient over time.
Despite guidance from NCEPOD and NICE there is a continued trend
of low referring team consultant level involvement in decisionmaking for patients being referred to ICU. This is potentially due
to culture differences in consultant working styles across special-
ity disciplines. Education, from junior doctor to consultant may
be useful in improving senior involvement in decision making for
complex and critically unwell patients. Particularly, focussed edu-
cation at non-consultant level may breed a culture change in the
future consultant body.
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INTRODUCTION. Bedside ultrasonography is a non-invasive, con-
venient method for volume status evaluation. Recently, Duplex
common carotid artery evaluation was reported to predict fluid
responsiveness in critical patients. But there is no consensus
about optimal index evaluation and very few data on spontan-
eously breathing patients.
OBJECTIVES. To check the validity of Duplex Carotid ultrasonography
evaluation in predicting fluid responsiveness and volume status and
to assess their correlation with Cardiac Output (CO) in spontaneously
breathing patients.
METHODS. This review was based on the PRISMA guideline . The
systematic search of the literature published from 1941 through 31
December 2018 explored the PubMed, Cochrane Library, Web of
Knowledge and Scopus databases. Inclusion criteria were studies
who investigated Carotid Ultrasonography correlation with CO, its
reliability and accuracy in predicting fluid responsiveness and
volume status in adult (>18yrs) spontaneously breathing patients .
Two researchers selected studies using inclusion criteria and then
assessed their quality using the QUADAS-2 guidelines. The key
words for literature search were: fluid responsiveness, spontaneously
breathing, ultrasonography, ultrasound echography, volume status,
cardiac output.
RESULTS. We collected 683 studies: 673 didn’t meet inclusion criteria.
10 studies were included in the final analysis. Duplex common ca-
rotid artery measures (Corrected Carotid Flow Time, CCFT; Carotid
blood flow CBF; variation of carotid artery blood flow peak velocity,
Δ V peak) showed an inter-rater agreement range from good to ex-
cellent . The CCFT and CBF showed a good correlation with CO but
there was a wide range of performance with a range of “r” value
from 0,29 to 0,66 . We found only one study which tested the CCFT
‘s validity in predicting fluid responsiveness: a cut-off value 349 msec
has a good accuracy (AUC = 0.84) . Many studies on healthy volun-
teers showed an increase of CCFT after Passive Leg Raise . The qual-
ity of studies were low : many reports had an high risk of Bias in the
Reference Standard and index test according to QUADAS-2 guide-
lines. The main limit of this review is the heterogeneity in design,
population and setting of studies included.
CONCLUSION. There is only one study investigating duplex carotid
ultrasonography’s validity in predicting fluid responsiveness in spon-
taneously breathing critical patients. The quality of the studies in-
cluded in this systematic review was low. CCFT and CBF seem to
correlate with Cardiac Output in healthy volunteers.
F1
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INTRODUCTION. The long-term prognosis of post-intensive care
unit (ICU) patients is worse than that of the general popula-
tion. 1 They suffer a significant healthcare burden with many
survivors requiring ongoing medical care for over two years. 2
Current scoring systems focus primarily on predicting ICU death
and in-hospital deterioration. The Sabadell score has previously
been shown to be predictive of survival to hospital
discharge. 3,4
OBJECTIVES. To investigate the Sabadell score as a predictor of long-
term outcomes following ICU discharge.
METHODS. We performed a single centre, observational study at
University Hospital Aintree. All patients discharged alive from the
ICU between September 2011 and December 2017 were stratified
according to the Sabadell score as descrived previously 3,4 and
scores recorded along with data including demographics, Acute
Physiology and Chronic Health Evaluation II (APACHE II) score
and diagnosis. Hospital electronic records were reviewed in July
2018 to determine long-term outcomes.
RESULTS. A total of 5953 patients were included in the analysis.
Overall in-hospital mortality following ICU discharge was 5.6%.
Median survival was 2.2 years in those with a Sabadell score of 2
and 12 days in those with a score of 3. Sabadell score was
strongly related to survival (p<0.001) (see figure 1), demonstrat-
ing effective discrimination at all time intervals up to five years
(area under the receiver operating characteristic curve >0.7). In-
creasing age and APACHE II score were also associated with mor-
tality (p<0.001).
CONCLUSION. The Sabadell score is an effective predictor of
long term outcome after ICU discharge with significantly re-
duced survival in patients classified as Sabadell score of 2 and
3. The score may be used to identify patients more likely to de-
teriorate following discharge, in order to target early interven-
tion aiming to reduce poor outcomes and, where appropriate,
to facilitate timely, informed discussions regarding advance care
planning.REFERENCE(S)
1. Gayat E, Cariou A, Deye N et al. Determinants of long-term outcome
in ICU survivors: results from the FROG-ICU study. Crit Care
2018;22(1):8
2. Desai S, Law T, Needham D. Long-term complications of critical care. Crit
Care Med 2011;39(2)371-379
3. Fernandez R, Baigorri F, Navarro G, Artigas A. A Modified McCabe score
for stratification of patients after intensive care unit discharge: the
Sabadell score. Crit Care 2006;10(6):R179
4. Fernandez R, Serrano JM, Umaran I et al. Ward Mortality after ICU
discharge: a multicentre validation of the Sabadell score. Intensive Care
Med 2010;36(7):1196- 1201000561
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INTRODUCTION. Pressure injuries (PI) are a global health issue of multi-
factor and complex causes, being a problem for health services with
physical, psychological and economic implications, given that they cause
pain and suffering, and are the gateway for infections. The occurrence of
PI in hospitalized patients results on an increase in the hospitalization
period, being connected to high morbidity and mortality rates and, con-
sequently, increasing direct and indirect spending. In 2001, a group of
Spanish specialists proposed the Escala de Valoración Actual del Riesgo
de desarrollar Úlceras por Presión en Cuidados Intensivos (EVARUCI) con-
sidering the most frequent known risk factors to which critical patients
are exposed and the opinion of health professional about which would
be the most frequent risk factors in ICU patients. EVARUCI was translated
and adapted to Brazilian Portuguese, having satisfactory results concern-
ing the internal coherence and inter-examiner reliability. To continue the
validation process of the Portuguese version, this study was performed,
aiming to widen the analysis of the scale’s performance and to obtain an-
other option for the evaluation of PI risk specifically for critical patients.
OBJECTIVES. To analyze the concurrent converging validation of
EVARUCI and its correlation with illness severity in ICU patients.
METHODS. This methodological study was conducted in three ICU of the
University Hospital of the Universidade Federal de São Paulo, Brazil. The in-
clusion criteria of patients to the sample were age ≥ 18 years old, absence
of PI and length of ICU stay > 24 hours. The Braden Scale was used for
concurrent converging validation, and Simplified Acute Physiology Score
(SAPS 3) for correlation with the illness severity. Both, Braden Scale and
SAPS 3 were considered as gold standart and it was applied simultan-
eously. The analysis was made applying the Spearman’s Correlation Test.
RESULTS. 324 patients were includes in the sample. 49.4% were female
and the average age of patient was 58 years old (18-95; SD 19.2). 53.7%
were surgical patients and 85.8% were discharged from ICU. A strong
significant correlation was observed between Braden and EVARUCI
scores (r = - 0.778 e p<0.001). EVARUCI’s values moderately and signifi-
cantly correlated with those from SAPS 3 score (r = 0.508 e p<0.001).
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indicating its possibility of use to evaluate PI risk in critical care pa-
tients. The correlation between EVARUCI and SAPS 3 indicated that
the greater the illness severity the greater the risk for PU.
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INTRODUCTION. Upper airway oedema following cervical spine sur-
gery can lead to serious complications such as respiratory failure
after extubation. The cuff leak test (CLT) has been performed on pa-
tients undergoing cervical spine surgery for evaluating the success of
extubation because the CLT is used to predict the occurrence of
post-extubation laryngeal oedema and stridor. However, the cut-off
value of the CLT differs between different studies and there is con-
troversy about its usefulness.
OBJECTIVES. This study aimed to evaluate the usefulness of the CLT
in patients undergoing cervical spine surgery, as the index of suc-
cessful extubation.
METHODS. We retrospectively reviewed the medical records of pa-
tients who underwent a CLT after cervical spine surgery from January
2017 to December 2018. Data from 84 patients were analysed, ex-
cept for patients in whom the CLT failed or those with incomplete re-
cords. The CLT was performed by three respiratory care clinical nurse
specialists and values measured using a mechanical ventilator or a
wright respirometer. In this study, the cut-off value of CLT for suc-
cessful extubation was 15% based on the previous studies.
RESULTS. All 84 patients had successful extubation. One patient with
underlying asthma had a post-extubation stridor and this patient had
a cuff leak of 15.7%. Regarding the CLT results, 51 patients (60.7%)
had an initial leak of less than 15% and 33 patients (39.3%) had an
initial leak of more than 15%. The average leak in the group with ini-
tial leak <15% was 6.1% and that in the other group was 30.2%. In
the initial leak<15% group, the proportion of women (56.9% vs
27.3%, p = 0.008) and obesity (19.4 ± 19.7% vs 11.0 ± 15.5%, p =
0.042) were higher than those in the initial leak≥15% group. In the
initial leak<15% group, the intensive care unit (ICU) length of stay
was increased by 1 day (3.3 ± 1.3 days vs 2.3 ± 0.7 days, p < 0.001)
and intubation days by 0.9 day (3.2 ± 1.1 days vs 2.3 ± 0.7 days, p <
0.001). There was no significant difference in the use of steroidsbefore and after the CLT and the method of CLT. Thirty-two patients
(62.7%) in the initial leak<15% group had CLT results more than 2
times. In this group, the leak just before extubation showed a signifi-
cant increase compared to the initial leak (5.2 ± 4.7% vs 16.3 ±
11.1%, p < 0.001). Among patients with an initial leak of less than
15%, the intubation days were increased by 1.6 days (3.8 ± 0.8 days
vs 2.2 ± 0.8 days, p < 0.001) and ICU length of stay increased by 1.6
days (3.9 ± 1.0 days vs 2.3 ± 1.0 days, p < 0.001) in the group with
CLT more than 2 times compared to the group of single CLT.
CONCLUSION. Earlier successful extubation was performed when the
cut-off value of CLT was more than 15% in patients undergoing cer-
vical spine surgery. However, it is necessary to adjust the cut-off
value considering factors such as female sex and obesity.
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INTRODUCTION. The World Health Organisation has established that
medical errors are the 14thcause of mortality and morbidity world-
wide. Due to the specific characteristics of critically ill patients, ICU
setting is prone to errors. The use of a checklist has been advocated
as a useful tool for reducing the occurrence of errors (1).
OBJECTIVES. The objective of our quasi-experimental study is to evalu-
ate whether the use of a daily checklist could improve the clinical out-
comes of critically ill patients admitted to ICU with resident program (2,3).
METHODS. In 2018 a specific checklist was developed and applied dur-
ing the morning ICU round to all adult patients admitted to our ICU
with an expected length of stay > 24h. To evaluate the effects of
check-list use, ICU mortality and length of stay, occurrence of ventilator
associated pneumonia (VAP) and catheter-related bloodstream infec-
tions (CR-BSI), mechanical ventilation (MV) and central venous catheter
(CVC) free days were compared between patients admitted to ICU in
2018 (intervention group) and in the two years before (control group).
RESULTS. 264patients in the first nine months of 2018 and 838 in
the 2 years before were admitted to ICU and evaluated in the study.
No significant differences in age, sex, GCS and SOFA score were ob-
served between the 2 groups. In the intervention group, SAPS II
score (44,6 ± DS 19,4) was higher than in the 2 previous years (42,3
± 19,4). No differences in ICU mortality, ICU length of stay and MV
free-days were observed between groups. Differently, incidence of
VAP and CR-BSI had a trend in favor of intervention group (1,9% and
1,5% vs 2,7% and 2,3 %) and CVC free-days increased (p<0,05) in
2018 (3 days) compared to other 2 years (2,2 days).
CONCLUSION. Our data indicated that the daily use of a check-list in ICU
setting with resident program may improve patients’ management with
reduction of healthcare infections and use of central venous catheter.
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INTRODUCTION. Fever is predictive of higher mortality and poorer
neurological outcome [1-3] in patients with subarachnoid haemor-
rhage (SAH), intracerebral haemorrhage (ICH) and traumatic brain in-
jury (TBI). In accordance with expert panel guidelines [4],
normothermic TTM should be instituted to improve intracranial pres-
sure control and outcomes.
Retrospective data (Jan-Mar 2018) from our NICU showed that 33%
of our target population had persistent fever defined as a core body
temperature of ≥38°C for ≥4 hours. Only 48.4% of all febrile patients
had hourly temperature monitoring despite an existing protocol.
OBJECTIVES. Our project aims to reduce the incidence of persistent
fever in patients with SAH, ICH and TBI.
METHODS.
A multidisciplinary committee comprising doctors, nurses, pharma-
cists and support staff was convened.
Macro- and micro-processes of current temperature manage-
ment were mapped and barriers to existing practices were
identified.
An ishikawa diagram was produced using root cause analysis.
Three main causes were identified using Pareto Chart of team votes:
1) Lack of standardised anti-shivering protocol
A new protocol was developed based on existing international
guidelines [5].
2) Lack of awareness regarding importance of fever management
We promoted knowledge and skills acquisition through in-service
training, roll-call and handovers for nurses. New medical officers were
educated during orientation.
3) Lack of effective cooling devices
An auto-feedback temperature regulated machine was put on trial.
This device allowed reliable temperature control with minimal in-
crease in staff effort.
RESULTS. Since the commencement of an iterative Plan-Do-Study-
Act (PDSA) Cycle, there has been increased compliance in hourly
temperature monitoring.
After 6 months, the median incidence of persistent fever had re-
duced from 31.8% to 19%.
TTM can potentially decrease ICU LOS by 3.2 days [6]. Based on a
census of 400 patients/year and the 10% reduction we have
achieved in patients with persistent fever, the annual cost savings
would be $42k-$133k.
CONCLUSION. TTM requires education and engagement of a
multidisciplinary team. It is a step towards improved patient out-
comes and significant cost savings. If further extended to patients
with ischemic stroke, we can broaden the spectrum of patients
who will benefit from this initiative.
REFERENCE(S)
[1] Oliveira-Filho J et al. Fever in SAH: relationship to vasospasm and out-
come. Neurology 2001;56:1299–304.
[2] Schwarz S et al. Incidence and prognostic significance of fever following
ICH. Neurology 2000;54:354–61.[3] Bao L et al. Fever burden is an independent predictor for prognosis of
TBI. PLoS ONE 2014;9:e90956.
[4] Alain Cariou et al. TTM in the ICU: guidelines from a French expert panel.
Ann. Intensive Care 2017;7:70.
[5] Choi HA et al. Prevention of shivering during therapeutic temperature
modulation: The Columbia anti-shivering protocol. Neurocrit Care. 2011
Jun;14(3):389-94. doi: 10.1007/s12028-010-9474-7.
[6] Diringer MN et al. Elevated body temperature independently contributes
to increased length of stay in neurologic intensive care unit patients. Crit
Care Med. 2004 Jul;32(7):1489-95.
[7] This initiative was supported by TTSH hospital quality improvement
department. The authors declare no conflicts of interest.
T8
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LD Patients Non-LD Patients
Admissions 49 5273
Number of patients 33 4727
Mean Age (Yrs) 29.3 59.8
Children (%) 20.4 4.6
Male: Female (%) 57 : 43 54 : 46
Unit Mortality (%) 4 12.5
Hospital Mortality (%) 2 5
Mean Length of Stay 10.3 4.4
Mean Admission APACHE II Score 11.2 14.9
Mean Admission ICNARC Score 18.3 16.6
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INTRODUCTION. In the French healthcare system, intermediate care
units (ItCU) were implemented in 2002 under specific legal and fi-
nancial regulations. Their goal is to admit patients whose acute se-
verity requires continuous surveillance of vital functions but no
organ supply. Their use varies among hospitals, depending on the
availability of regular ICUs, of emergency department or surgical ac-
tivities. Some of them may be developed only because their funding
is higher than that of regular medical or surgical ward.
OBJECTIVES. The aim of this study was to define criteria for inter-
mediate care units, as the first part of a research project designed to
establish an admission score to help physicians in the triage process.
METHODS. 189 physicians were selected because they had been sug-
gested as experts by French societies of Intensive care, anesthesiology,
emergency medicine or surgery, and were working either in public or pri-
vate hospitals. They were sent a series of 107 criteria, split into 5 categor-
ies: chronic disease (n = 29), acute dysfunction (n = 26), etiology of acute
disease or specific pathway (n = 35), nursing work-load (n = 11) and
hospital organizational aspects (n = 6). Through Delphi analysis, the re-
sponders had to assess each item for validity and feasibility with a 0 to 9
Lickert scale. Criteria with a median validity and feasibility over 7 and a
concordant response in at least 60% of the responders on the first survey
were kept definitively. The other criteria were sent for a second Delphi
round. Criteria had to be considered sufficient for ItCU admission either
alone or in combination, and had to have the same minimal levels of val-
idity, feasibility and concordance than for the first Delphi round.
RESULTS. 81 out of 189 physicians participated in the first round and
62 out of 81 in the second round. They worked mostly in public hospi-
tals (78%) and were aged 54 [47-59] years. 52/107 criteria were kept
from the 1st round. Out of the remaining 55 criteria, 11 were kept after
the 2nd round and the other ones were definitively discarded. The cat-
egories of the kept items after rounds 1 and 2 were: chronic disease
(round 1/2 : 1/5), acute dysfunction (26/2), etiology of acute disease
(29/2), nursing work-load (3/0) and organizational aspects (3/2).
CONCLUSION. In our series or French physicians, criteria for medical eli-
gibility to an ItCU admission are mostly indicators of acute dysfunction
and causal acute disease. These criteria will be used in a multicenter pro-
spective study to build and validate a score for admission eligibility.
REFERENCE(S)
1. French Ministry of Health
000620
Outcomes of patients with Learning Disabilities admitted to the
Critical Care Unit of a UK District General Hospital: 2012-2017
B. Hopkins1, M. Spivey1, R. Mawer2, W. Woodward1
1Critical care unit, Royal Cornwall Hospital, Truro, United Kingdom;
2Department of anaesthetics, Royal Cornwall Hospital, Truro, UK, United
Kingdom
Correspondence: B. Hopkins
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000620
INTRODUCTION. Learning Disability (LD) describes an individual’s “re-
duced intellectual ability and difficulty with everyday activities – which
affects someone for their whole life”. LD patients have a shorter lifeexpectancy and a higher associated comorbidity e.g. obesity, epilepsy
and swallowing problems (1). A UK confidential inquiry in 2013 into
premature deaths of LD patients (CIPOLD) identified problems with de-
layed diagnosis, treatment and advanced health care planning as con-
tributory factors (2). There is a paucity of data examining these
healthcare outcomes with relation to Critical Care and so a retrospect-
ive study was undertaken to assess this relationship.
OBJECTIVES. To identify the number of admissions of patients with
LD to Critical Care and conduct an initial review of health outcomes.
Primary Outcome Measure: Survival to discharge from Critical Care.
Secondary Outcome Measures: Length of Stay, Survival to Hospital
discharge.
METHODS. A retrospective observational study was performed of all
patients with LD admitted to the 15-bed Critical Care Unit, Royal
Cornwall Hospital from 01/01/2012 - 31/12/2017. Patients with a regis-
tered LD are recorded on the hospital’s central database, an auto-
mated search identified those admitted to Critical Care in the time
period. Patient specific data was captured by a manual review of the
electronic patient record (Philiips ICCA).
RESULTS.
CONCLUSION. Patients with LD represent only 1% of the Critical Care
population, yet 1.8% of the general population. Our data suggests LD
patients present at a much younger age; 20% of our LD patient co-
hort were children, compared to only 4.6% of the non-LD patient co-
hort. Despite comparable illness severity scores, the average length
of stay for LD patients was twice that of non-LD patients, reflecting
perhaps their complex health and social care needs. Furthermore
25% of LD patients were admitted more than once, compared to just
8% of the non-LD patient group. In our cohort, contrary to what
might be expected by existing data regarding outcomes for LD pa-
tients, mortality was found to be lower. This might reflect the youn-
ger age of the LD cohort, or perhaps lower mortality is explained by
higher readmission rates; but this unexpected result demonstrates
the importance of further study in this area.
These issues highlight the importance of individualised multidiscip-
linary care, advanced care planning and treatment escalation discus-
sions, with patient support by specialist LD Liason teams for
individuals who may well present on multiple occasions to Critical
Care. This study identifies the need for further research in this area, to
establish areas for improvement in Critical Care for this vulnerable
patient group.
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INTRODUCTION. A growing body of evidence shows that frailty is an
independent risk factor for hospital mortality (1, 2). Frailty has also
been associated with worse ICU outcomes including increased mor-
tality risk (3, 4). This knowledge base highlights the value of the CFS
as a tool included in ICU admission screening. Clinicians have been
shown to be accurate assessors of CFS (5), but is there evidence for a
“critical value” on the CFS that could increase its utility as part of ad-
mission screening by more easily and tangibly predicting increased
mortality risk?
OBJECTIVES. To review CFS scores in relation to mortality rates to as-
sess evidence for a critical CFS value in predicting mortality, in order
to practically aid ICU admission screening.
METHODS. Electronic patient records at 1 district general hospital
were interrogated to identify all patients admitted to the ICU with a
recorded CFS. Data were collected on CFS at ICU admission, ICU out-
come (“Improved”, “No change”, “Worse”, “Death”) and ultimate hos-
pital outcome (“Lived” or “Died”). Statistical analysis was carried out
using R version 3.5.3 (including packages ggplot2).
RESULTS. A total of 457 patients were identified as having CFS scores
on recorded on ICU admission (from 5/10/15-23/1/19), making 3.3%
of the 13,882 patients admitted to the ICU during this time period.
The Kruskal-Wallis test showed a significant difference in CFS scores
between the 4 categories of ICU outcome (p= 0.02572). Pairwise com-
parison using the Wilcoxon rank sum test demonstrated that this sig-
nificance lay between the “improved” and “died” groups only (p=
0.019). Median CFS scores in these groups were 3 (IQR: 2-4) and 4
(IQR: 3-6) respectively. In ultimate hospital outcome, an unpaired Wil-
cox test found a significant difference in CFS between the “lived”
and “died” groups (p= <0.001). Median CFS scores in these two
groups were 3 (IQR: 2-4) and 4 (IQR: 3-6) respectively.
CONCLUSION. This retrospective, observational study further adds to
the evidence base that CFS is associated with ICU and hospital mor-
tality. The small proportion of ICU admissions that recorded CFS
demonstrated a current inconsistency in its use during admission
screening, possibly uncovering lack of clinicians’ confidence in the
role of CFS in mortality risk prediction. We found a significant differ-
ence in the CFS values between patients who survived ICU or hos-
pital admission and those who did not. These CFS scores may
represent critical CFS values at which point ICU or hospital mortality
becomes more likely. In a “real-world” setting this could suggest that
CFS above a certain level may be a poor prognostic factor of mortal-
ity. The findings of this small study may suggest that CFS could be
incorporated into well-established prognostic tools, such as the APA-
CHE system. If studied further, the role of the CFS in admission
screening could be better defined; allowing clinicians to have an-
other pragmatic, tangible tool to aid them in the real-world when
screening patients for mortality risk during ICU admission.
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INTRODUCTION. In critically ill patients, tissue deficit of oxygen can
generate hyperlactatemia, acidosis and a dysfunction in venous oxy-
gen saturation, all of them at different body levels. This “dysoxic” dis-
order is associated with a high mortality rate but a broad assessment
of the full state of hypoperfusion, in different categories of critically
ill patients, has not been made.
OBJECTIVES. To determine the association between several combina-
tions of LA, BE and ScvO2 -at admission to the intensive care unit
(ICU) and 12, 24 and 48 hours afterwards- and the probability of hos-
pital death in critical patients admitted to the ICU.
METHODS. Prospective cohort study of patients older than 16 years
admitted to polyvalent ICUs of two university hospitals in Antioquia,
Colombia, between August 2014 and May 2017. Those with cancer,
liver failure, expected ICU length-of-stay less than 48 hours or death
within 24 hours of admission were excluded. Several logistic regres-
sion models were fitted for the analysis, including the main perfusion
variables (LA, BE and ScvO2) and their temporal kinetics, as well as
acknowledged confounding covariates of clinical importance for the
outcome hospital mortality rate.
RESULTS. The cohort was composed of 1008 patients, the average
age was 55 ± 21 years, 57% (n=575) were men, 85% (n=855) re-
quired mechanical ventilation, 56% (n=561) were admitted due to
medical problems, 21% (n=211) were post-operative and 23. 4% (n=
236) were trauma patients. At ICU admission, the median SOFA score
was 7 (IQR=5;10), the median APACHE-II was 19 (IQR=15;23) and the
median LA, BE and ScvO2 were 2,3 (IQR=1,4;4), -5.9 (IQR=-9,6;2,3) and
72,8 (IQR=66,2;78,7), respectively; with an overall hospital mortality of
19.6% (n=198). The multivariate analysis found that, among several
potential combinations, only the persistence of abnormal LA and BE
at 24 hours after admission to the ICU were associated with a higher
mortality (LA > 2 mmol/L, OR = 3,06; 95% CI = 2,05 – 4,61 and BE <
-2mm/L, OR 1,56; 95% CI = 1,05-2,32).
CONCLUSION. Twenty four hours after admission to the ICU, the per-
sistence of hyperlactatemia and metabolic acidemia (LA> 2 mmol/L
and BE < -2mmol/L) indicate the greater risk of mortality in critically
ill patients. The abnormality in ScvO2, however, loses clinical import-
ance early in this population.
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INTRODUCTION. Mexico is experiencing an epidemiological transi-
tion that is adversely impacting and pushing for restructuralization in
the healthcare industry. Only a few health institutions in Mexico
(public or private) disclose their ICU data. There is a lack of nation-
wide data to assess the impact of cancer patients admitted to the
ICU in our country. Cancer outcomes are important to understand its
influence in the health care system. Therefore, it is necessary to
standardise statistical cancer-related data across countries, institu-
tions and ICUs.
OBJECTIVES. This study aims to scrutinise the outcomes of cancer
patients admitted to the ICU in a private hospital in Mexico through
statistical analysis.
METHODS. Retrospective, observational and descriptive study con-
ducted in the ICU of a private teaching hospital in Guadalajara,
Mexico. From January 2017 through December 2018, a total of 201
admissions related to cancer were registered. We enrolled 162 pa-
tients, fifteen years of age or older who had cancer and were admit-
ted to the ICU. Patients who were bedridden or receiving palliative
care were not excluded.
RESULTS. A total of 162 patients were included [56.2% (n=91) were
men and 43.8% (n=71) were women], representing 28.2% of the total
ICU population. Mean age was 61.27 ± 15.26 years and mean length of
stay was 9.6 ± 31.9 days. The most common malignancies were Lung
Cancer 18.5% (n=30), Colorectal Cancer 16% (n=26) and Pancreatic
Cancer 13.6% (n=22). Most of the patients were admitted for the Oncol-
ogy service because of complications of its underlying malignant dis-
ease 48.1% (n=78). 41.4% (n=67) of the patients were known to have
metastases and 59.9% (n=97) underwent surgery. Nearly half of the pa-
tients admitted to the ICU presented chronic degenerative conditions
47.5% (n=77) [Hypertension 28.4% (n=46) followed by Type 2 Diabetes
Mellitus (T2DM) 19.8% (n=32)]. During their stay in ICU, 14.8% (n=22)
required Mechanical Ventilation (MV) and 8.1% (n=12) died (p<
0.001). ICU mortality rate was 14.2% (n=23).
CONCLUSION. Cancer incidence in ICU is high and it is common that
these patients present with comorbidities such as Hypertension and
T2DM. In our study mean length of stay was four days less on aver-
age compared to data found in prior studies, this could be due to
the improvement in cancer management and critical care in general.
Most common primary tumor was lung cancer, followed by colorec-
tal cancer and pancreatic cancer. These same malignancies were
more likely to cause readmission to the ICU, this could be due to me-
tastases, however, we did not find any association between metasta-
ses, previous ICU admission and mortality.
MV has been associated with higher mortality rates in numerous
studies. In our study only a few patients required MV but it was
still associated with a higher mortality rate than non-intubated
patients.
Further research in specific groups is required to clarify the variables
that contribute to the complexity of the associations between cancer
and co-morbidities, its complications, and its impact in outcomes.
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INTRODUCTION. Increasing numbers of patients who are admitted
to the ICU are older and have co-existing chronic diseases and
frailty. Whilst acute illness is strongly associated with mortality
risk, there is increased recognition that chronic disease and func-
tional status plays an important role in mortality and long-term
ICU outcomes1. This questions the suitability of using physio-
logical scoring systems that largely focus on acute physiology.
Recent evidence suggests antecedent factors play a more import-
ant role in outcome prediction than acute illness factors for those
with prolonged ICU stay2.
OBJECTIVES. To compare the performance of APACHE II and SOFA
scores in patients with shorter versus more prolonged ICU
admission.
METHODS. Retrospective analysis of all patients admitted to the
ICU at our institution between 1/10/2017 and 30/10/2018. SOFA
and APACHE II scores were calculated on admission to the ICU.
The discrimination ability of each scoring system for in-hospital
mortality (defined by AUROC) was compared in those with short
(ICU stay of ≤5 days) versus prolonged (ICU stay of ≥6 days) ICU
admission.
RESULTS. Over the 13-month period, 916 patients were admitted
to the ICU. Median age was 67 years (age range 16-93). From
those admitted, APACHE II and SOFA scores were calculated for
601 patients. From this cohort, 307 and 294 patients had short
and prolonged ICU stays respectively. For those with short ICU
stays, the AUROC for APACHE II and SOFA scores were 0.83 and
0.84 respectively. For those with prolonged ICU stay, the AUROC
for APACHE II and SOFA were 0.57 and 0.60 respectively.
CONCLUSION. This study shows that the performance of APACHE II
and SOFA scores weakens for patients with more prolonged ICU ad-
mission. Because APACHE II and SOFA scoring systems are largely
based on acute physiology, there may be a greater role for non-
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tus) in patients that survive beyond the initial catabolic phase of crit-
ical illness. Future studies should explore the relevance of these
factors in prolonged critical illness.
REFERENCE(S)
1. Krinsley JS et al Pre-admission functional status impacts the performance
of the APACHE IV model of mortality prediction in critically ill patients.
Crit Care. 2017;21(1):1-9. doi:10.1186/s13054-017-1688-z
2. Bagshaw SM et al. Timing of onset of persistent critical illness: a multi-
centre retrospective cohort study. Intensive Care Med. 2018;44(12):2134-
2144. doi:10.1007/s00134-018-5440-1
000646
Errors of Omission and Commission in Cardiac Arrest Care in the
Intensive Care Setting
HS. Gill1, S. Srikanth1, P. Bharati1, E. Lindgren2, AD. Steele2,
G. Chakraborti1, MS. Braga3
1Critical care medicine, Dartmouth Hitchcock Medical Center, Hanover,
United States of America; 2Critical care medicine, Geisel School of
Medicine, Hanover, United States of America; 3Pediatric critical care
medicine, Dartmouth Hitchcock Medical Center, Hanover, United States
of America
Correspondence: H. Singh Gill
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000646
INTRODUCTION. Cardiopulmonary arrest’s (CPA’s) in the intensive
care unit (ICU) are common (1) and guided by advanced cardiovascu-
lar life support (ACLS) algorithms. Protocol violations are anecdotally
common and their incidence or relation to return of spontaneous cir-
culation (ROSC) in the ICU setting are unknown.
OBJECTIVES. To establish the categories and frequency of errors of
omission and commission during CPA in the ICU setting and its rela-
tionship with CPA outcomes.
METHODS. We retrospectively analyzed CPA data entered into the
Get with the Guidelines registry from 2015 to 2017. Inclusion criteria:
Age above 18, non-traumatic cardiac arrest in the ICU setting. Exclu-
sion criteria: cardiac surgical patients or patients missing data
points. Errors of omission were drugs or procedures which were
omitted during a CPA but would have been recommended by ACLS
algorithms. Errors of commission were drugs or procedures that were
committed during a CPA but were not recommended by ACLS algo-
rithms. CPA’s with ventricular tachycardia(VT) or ventricular fibrilla-
tion(VF) were pooled as were CPA’s with asystole and pulseless
electrical activity (PEA) for analysis.
RESULTS. Of 140 CPA’s that met inclusion criteria, 14 were excluded
due to missing data fields. Of the final 126 CPA’s studied, 103 had
asystole/PEA with 65 attaining ROSC and 18 being alive at hospital
discharge. Of 23 CPA’s with VT/VFib, 20 attained ROSC and 10 were
alive at hospital discharge. Mean CPA duration for those achieved
ROSC vs those that didn’t achieve ROSC were 8.46 minutes and
31.28 minutes respectively.Overall, as errors of omission and com-
mission increased, the percent of patients who attained ROSC de-
creased. The number of patients with no protocol violations during
a CPA was 13.Errors of commission had a statistically significant
odds ratio (OR) of 0.52 (95% CI: 0.38 to 0.72) for ROSC during a
CPA. Use of sodium bicarbonate (OR-0.22,95% CI: 0.08 to 0.60), cal-
cium chloride (OR-0.25,95% CI: 0.09 to 0.69) and atropine (OR-
0.50,95% CI: 0.12 to 2.00) were the most common errors of commis-
sion.Errors of omission also had a statistically significant odds ratio
(OR) of 2.25 (95% CI: 1.28 to 3.98) for ROSC during a CPA. Errors of
omission studied were rate and depth of chest compressions and
compression fractions. Mean depth of chest compressions, rate of
chest compressions and compression fractions for patients who
achieved ROSC vs those that didn’t achieve ROSC were 2.52 vs 2.49
inches, 113.55 vs 115.85 per minute and 0.43 vs 0.72 respectively.-
Vasopressor infusions initiated prior to but continued during a CPA
were also analyzed.This intervention was neither an error of com-
mission or omission but had a statistically insignificant OR of 0.75
(95% CI: 0.52 to 1.10) for attaining ROSC during a given CPA.CONCLUSION. Errors during CPA in the ICU setting were common.Er-
rors of commission,namely sodium bicarbonate and calcium chloride
use were statistically significant in decreasing the likelihood of attain-
ing ROSC and likely represent older clinical practices.Errors of omis-
sion did not decrease the likelihood of attaining ROSC but effects
may be statistically misleading owing to effects of dynamic feedback
during CPR.Vasopressor infusions initiated prior to but continued dur-
ing a CPA decreased the likelihood of ROSC and were almost statisti-
cally significant.
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INTRODUCTION. Cerebral reperfusion injury occurs when cerebral
blood flow is restored after cardiac arrest and resuscitation. Increased
intracellular levels of glutamate, an excitatory neurotransmitter re-
leased from presynaptic terminals, activate ion-channel complexes
that cause calcium to shift from the extracellular to the intracellular
fluid, leading to the accumulation of oxygen free radicals and the ac-
tivation of degradative enzymes. In addition, cerebral hemodynamics
may remain abnormal after resuscitation from cardiac arrest. Several
studies mentioned that induced hypothermia improves outcomes in
patients with comatose after resuscitation from out-of-hospital car-
diac arrest(OHCA). The aim of this study is to investigate the impact
of multidisciplinarytargeted temperature management(TTM) strat-
egies on outcome of patients after cardiac arrest.
METHODS. From May 2017 to December 2018, a multidisciplinary
CQI team including emergency physician, intensivists, cardiologists,
nurses, and quality management team was organized in a tertiaryme-
dical center in Taiwan. The key interventions includedemergent de-
partment (ED) activation system, nursing staffs reminding protocol,
TTM share decision making protocol, green channel for rapid com-
puterized tomography examination, TTM ED prescription formula,
TTM ED quick laboratory and treatment package, comprehensive crit-
ical care system and TTM simulation training. The patientswere di-
vided into three groups: pre-interventionalgroup from Jan to Oct
2017, interventional groupOct 2017 to July 2018 and post-
interventional group from Aug to December 2018.
RESULTS. After implementing multidisciplinary TTM strategies since
2017, the rate of patients with cardiac arrest received TTMincrease
from 0% to 33.3% and finally achieved 86.6% (p<0.001). The rate of
TTM recognition also improved from 50% to 90% in physicians and
from 66% to 90% in nursing staffs. Return of spontaneous circula-
tion (ROSC) to targeted temperature time decreased from 540 to
270 minutes.
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and the survival rate of OHCA with ROSC received TTM therapy could
increase up to 48.4%.
CONCLUSION. This study demonstrated multidisciplinary TTM strat-
egies CQI program could improve rate of patients with cardiac arrest
received TTM therapy, rate of TTM recognitionin physicians and nurs-
ing staffs, ROSC to targeted temperature time, and further survival of
cardiac arrest patients.
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INTRODUCTION. Extracorporeal cardiopulmonary resuscitation (ECPR)
has been introduced as a life-saving procedure in refractory cardiac
arrest.
METHODS. Eligible patients for this analysis had to undergo ECPR
after unsuccessful cardiopulmonary resuscitation with a minimum of
three defibrillation attempts. For extracorporeal life support (ECLS)
was used Cardiohelp system (Maquet-Cardiopulmonary-AG, Hirrlin-
gen, Germany) or Levitronix CentriMag blood pump (Levitronix LLC,
Waltham, MA, USA). LUCAS II (Physio-Control, Lund, Sweden) system
was used for chest compressions during cardiac arrest. The relations
of blood lactate and pH levels, measured before ECPR insertion and
after 24 hours as well as comorbities (diabetes, hypertension, BMI) to
the clinical outcomes at 2 years were evaluated.
RESULTS. We analyzed data from 49 patients treated with ECPR for
refractory cardiac arrest. The mean age of our patients was 59 years.
Out-of-hospital cardiac arrest (OHCA) occurred in 25 patients, 24 pa-
tients suffered from in-hospital arrest (IHCA). Baseline value of lactate
was 11.57 ± 4.22 mmol/l, initial pH 6.95 ± 0.31. In comparison with
survivors, patients who died had significantly higher initial lactate
levels (12.05 ± 0.81 vs. 8.01 ± 0.77; P< 0.05). Moreover, survivors had
significantly lower lactate levels after 24 hours (7.39 vs 2.56) and
lower BMI (27.4 vs 31.2; P< 0.05). Diabetes or hypertension in our
group have no influence on the mortality. The difference of mortality
in the group of OHCA or IHCA was also not significant. 32% patients
survived one month with good neurological outcome (CPC 1-2), 30%
six months, 23% one year and 21% two years.
CONCLUSION. ECPR give the last chance to survive refractory cardiac
arrest. The levels of blood lactate are significantly associated with
clinical outcomes of ECPR. Obesity was associated with significantly
higher mortality in our group.
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INTRODUCTION. In recent years, novel AKI biomarkers, such as NGAL,
KIM-1, IL-18, L-FABP, IGFBP7, TIMP2 have been discovered and vali-
dated to improve early detection for progressive renal failure, need
for renal replacement therapy (RRT), or death. Last year, we reported
the usefulness of urinary L-FABP for the predictive marker of RRT re-
quirement in critical ill patients and prognosis in patients with septicshock. We are focusing on urinary L-FABP for the diagnostic bio-
marker of AKI as well as the prognostic marker in critical ill patients.
OBJECTIVES. This study was to evaluate whether urinary L-FABP POC
kit can predict mortality of refractory ventricular fibrillation (VF) patients
treated with extracorporeal cardiopulmonary resuscitation (ECPR).
METHODS. This was a single-center retrospective observational study
of refractory VF patients treated with ECPR admitted in our intensive
care unit (ICU) from December 2017 to January 2019. A total of 16
patients were screened and 14 patients were included, 2 patients
died within 24 hours after admission were excluded. We examined
the relation of urinary L-FABP POC kit data at ICU admission and 28-
day mortality and 90-day mortality.
RESULTS. A total of 14 patients were included. Median age was 60
years (IQR 51-67) and all patients were male. Median SOFA score and
APACHE2 score were 12 (IQR 10-14) and 35 (IQR 26-38), respectively.
Median urinary L-FABP (ng/ml) value was 804.5 (IQR 172.9-3944.3). 12
patients (85.7%) acquired AKI based on KDIGO criteria. All patients
had received mechanical ventilation and 6 patients (42.9%) had re-
ceived RRT. 28-day and 90-day mortality was 42.8% and 64.3%, re-
spectively. The patients were divided into 2 groups according to the
results of urinary L-FABP POC kit (group L: negative or slightly posi-
tive, group H: strongly positive). The patients who received RRT was
33.3% in group H and 60.0% in group L (p=0.58). There was no sig-
nificant difference between the groups about initiation of RRT. 28-
day mortality was 62.5% in group H and 11.7% in group L. 90-day
mortality was 88.9% in group H and 20.0% in group L. Kaplan-Meier
curves showed 28-day and 90-day mortality were higher in group H
than in group L (p=0.167 and 0.021, respectively).
CONCLUSION. Urinary L-FABP POC kit can predict long term progno-
sis of refractory VF patients treated with ECPR.
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INTRODUCTION. Prolonged duration of targeted temperature man-
agement (TTM) after out-of-hospital cardiac arrest does not improve
neurological outcome.
OBJECTIVES. To describe the quality of TTM after out-of-hospital car-
diac arrest according to the duration of cooling.
METHODS. A retrospective analysis of data from the TTH48 study
(NCT01689077), which compared whether TTM at 33°C for 48
hours results in better neurologic outcomes (i.e. good neuro-
logical outcome defined by Cerebral Performance Category of 1-
2) when compared with standard 24-hour duration. Admission
temperature, speed of cooling and rewarming rates were col-
lected in each patient. Precision was assessed by measuring
temperature variability (TV), i.e. the standard deviation (SD) of all
temperature measurements in the cooling phase. Overcooling
and overshoot were defined as one temperature <32°C or >35°C
during the cooling phase, respectively. Post-cooling fever was de-
fined as a body temperature exceeding 38.5°C.
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those, 175 (50%) were treated with TTM for 48 hours. The pro-
portion of patients treated with intravascular catheter was similar
between 48-h and 24-h groups (65% vs. 59%; p=0.22). Time from
arrest to target (≤34°C) was significantly shorter for patients
treated with TTM for 48-h (5.2 [3.9-6.9] vs. 6.0 [4.4-8.4] hours,p=
0.02), with similar body temperature on admission (35.2 [34.3-
35.8] vs. 35.0 [34.4-35.7] °C;p=0.44). Temperature variability was
similar between TTM for 48-h and 24-h (0.66 [0.46-0.91] vs.0.69
[0.49-0.91]°C; p=0.59), as was rewarming rate (0.34 [0.24-0.46]°C/
hour vs. 0.35 [0.22-0.47]°C/hour; p=0.96). The number of patients
with overcooling (11% vs. 14%) or overshoot (29%vs. 23%) was
also similar between groups. However, the proportion of time
outside the target ranges was 13 [5-32]% in the 48-h and 18 [8-
37]% in the 24-h groups (p=0.049). The proportion of patients
with fever was significantly lower in the 48-h groups than the
other (52% vs. 64%; p=0.03).
CONCLUSION. TTM for 48 hours was associated with a lower propor-
tion of time with body temperature outside ranges and a lower oc-
currence of post-cooling fever.
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INTRODUCTION. Resuscitation guidelines suggest that patients
with hypothermic cardiac arrest should receive prolonged CPR
because reduced core temperature is postulated to result in a
neuroprotective effect, in the absence of clinical evidence.
OBJECTIVES. To investigate whether patients with hypothermic
cardiac arrest can tolerate prolonged CPR and gain a better
neurological outcome compared with patients with other etiology
of cardiac arrest.
METHODS. We performed retrospective analysis using data from
Japan’s nationwide out-of-hospital cardiac arrest (OHCA) registry,
which includes all patients with OHCA transported to the hospital
by emergency medical services from January 2013 through De-
cember 2016. Patients with CPR duration > 20 min were stratified
into hypothermic arrest group and non-hypothermic arrest group,
depending on etiology of cardiac arrest. The relationship of CPR
duration with neurologically intact survival (defined as cerebral
performance category 1 or 2) at 1 month after cardiac arrest was
assessed using multivariable logistic regression.
RESULTS. Of the eligible 310161 OHCA patients with CPR duration
> 20 min, 398 were stratified in hypothermic arrest group and
309763 in non-hypothermic arrest group. Intact survival rate de-
creased linearly 8.9% per 10 min of CPR duration in non-
hypothermic arrest group, but there was no relationship between
CPR duration and intact survival in hypothermic arrest group.
Compared with non-hypothermic arrest group, hypothermic arrest
group had higher adjusted probabilities of intact survival through
entire CPR duration; 6.8% vs. 0.84% for 21-30 min of CPR dur-
ation, 3.7% vs. 0.75% for 31-40 min, 7.0% vs. 0.7% for 41-50 min,
7.0% vs. 0.67% for 51-60 min and 7.4% vs. 0.68% for > 61 min.
Adjusted odds of intact survival for hypothermic arrest were 7.0
(95%CI, 3.7-13.3) for 21-30 min, 7.6 (2.2-25.8) for 31-40 min, 36.9
(12.7-107.4) for 41-50 min and 11.5 (2.2-61.9) for 51-60 min, but
no significant odds ratio was found for >61 min.
CONCLUSION. Patients with hypothermic cardiac arrest tolerated
prolonged CPR. The therapeutic time window of CPR duration
might be extended up to 60 min in hypothermic OHCA setting.001413
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INTRODUCTION. The correct identification of patients that are not
going to recover consciousness after cardiac arrest is not only clinic-
ally challenging but is associated with important ethical and legal
implications.
Current guidelines advocate the combination of bedside clinical
neurological examination, imaging (CT and MRI) in addition to com-
plex neurophysiological investigations (e.g. SSEPs) and biomarkers
(1). These last investigations are not normally available in most cen-
tres in the UK. We communicate our appraisal of current practice.
OBJECTIVES. To provide further insight into how patients admitted
post cardiac arrest are being neuroprognosticated in our general in-
tensive care unit.
METHODS. The clinical records of 42 patients admitted to Intensive
Care post cardiac arrest over a period of 12 months were revised (1st
January 2018–1st January 2019).
RESULTS. Out of the 42 patients, thirty-one (74%) were admitted
after in hospital cardiac arrest and twenty five (60%) died within first
72 hours. Seventeen (40%) patients underwent post-cardiac arrest
prognostication after a period of 72 hours. Sixteen (94%) had a head
CT within 24 hours of admission and six (35%) a second CT scan the
third day post cardiac arrest. Eight (47%) underwent EEG assessment
to neuroprognosticate.
Prognostication was based on bedside clinical examination in all pa-
tients (pupillary reactivity and abnormal motor responses). Even
though nurse records were complete in all the 17 cases (hourly docu-
mentation of pupillary and motor response), we found that the med-
ical clinical notes did not have the same consistency. Furthermore, in
the notes of 13 (68%) patients the 24 hours’ pupillary reactivity were
not stated.
CONCLUSION. This assessment of our current practice showed that
prognostication of patients post cardiac arrest relies on clinical as-
sessment. In addition to a not protocolised use of auxiliary tests,
medical notes documentation need improvement. We should adjust
our practice to international recommendations.REFERENCE(S)
(1) European Resuscitation Council and European Society of Intensive Care
Medicine. Resuscitation 2014; 85:1779-1789
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INTRODUCTION. Neuron-specific enolase (NSE) is a well established
additional prognostic marker in cardiac arrest survivors. However, the
prognostic value of NSE in specific populations remains not fully
understood.
OBJECTIVES. The aim of our study was to compare the prognostic
value of NSE in male and female cardiac arrest survivors at specific
time intervals from collapse.
Page 232 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55METHODS. We analyzed data from a single-center prospective registry
of out-of-hospital cardiac arrest survivors admitted between 2010 and
2017 to the tertiary cardiovascular center. All subjects were treated with
endovascular hypothermia (33°C for 24 hours). NSE was measured at 1, 2,
3, and 4 days from collapse. Clinical outcomes were assessed according
to the Cerebral Performance Category (CPC) at 30 days (good neurologic
outcome was defined as CPC 1-2). Prognostic value of NSE for prediction
of 30-days outcomes was determined using ROC analysis.
RESULTS. A total of 271 individuals were included into the study, 77
female (28%) and 194 male (72%). Female (F) and male (M) popula-
tion were comparable regarding age, time to return of spontaneous
circulation, baseline lactate and pH, and survival with good neuro-
logical outcome (57% vs. 61%, P=0.53); however, women had signifi-
cantly more frequently non-shockable rhythm (43% vs. 19%, P<
0.001). Area under the ROC curve (AUC) at day 1 was 0.78 (P<0.001)
in the F group and 0.74 (P<0.001) in the M group. At day 2 the AUC
was only 0.85 (P<0.001) in F group and 0.92 (P<0.001) in M group. At
day 3 the AUC was only 0.86 (P<0.001) in F group, whereas in M
group we observed the highest AUC value (0.94, P<0.001). The high-
est AUC value in F group was found at day 4 (0.93, P<0.001), corre-
sponding with the AUC of 0.91 (P<0.001) in the M group. NSE values
>39.9 mcg/L recorded at any time in the F group were associated
with poor prognosis with 100% specificity and 61% sensitivity. On
the other hand, the threshold for poor prognosis with 100% specifi-
city in the M group was >57.2 mcg/L (with 52% sensitivity).
CONCLUSION. Our results indicate marked sex-differences in the
prognostic value of NSE in cardiac arrest survivors. Whereas in
women were the prognostic values lower at days 2 and 3 lower in
comparison to men and the highest prognostic value was observed
4 days after collapse with lower threshold for poor prognosis, in male
was the highest prognostic values of NSE 3 days form collapse with
higher threshold for poor prognosis.
REFERENCE(S)
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INTRODUCTION. Neuron-specific enolase (NSE) is a well established
additional prognostic marker in cardiac arrest survivors. However, the
prognostic value of NSE in specific populations remains not fully
understood.
OBJECTIVES. The aim of our study was to compare the prognostic
value of NSE in groups with shockable and non-shockable initial
rhythm at specific time intervals from collapse.
METHODS. We analyzed data from a single-center prospective regis-
try of out-of-hospital cardiac arrest survivors admitted between 2010
and 2017 to the tertiary cardiovascular center. All subjects were
treated with endovascular hypothermia (33°C for 24 hours). NSE level
was measured at 1, 2, 3, and 4 days from collapse. Clinical outcome
was assessed according to the Cerebral Performance Category (CPC)
at 30 days (good neurologic outcome was defined as CPC 1-2). Prog-
nostic value of NSE for prediction of 30-days outcomes was deter-
mined using ROC analysis.
RESULTS. A total of 271 individuals were included into the study,
201 patients (74%) had shockable (S) initial rhythm and 70 subjects
(26%) had non-shockable (NS) initial rhythm. Patients in the S group
were younger (mean age 62 vs. 70 years, P<0.001), more frequently
male (78% vs. 53%, P<0.001), had lower baseline lactate (P<0.05),and had better survival with good neurological outcome (67% vs.
41%, P<0.001); time to return of spontaneous circulation was com-
parable (21 min vs. 18 min, P=0.09). Area under the ROC curve (AUC)
at day 1 was 0.70 (P<0.001) in the S group and 0.86 (P<0.001) in the
NS group. At day 2 the AUC was 0.92 (P<0.001) in S group and only
0.84 (P<0.001) in NS group. At day 3 the AUC was 0.95 (P<0.001) in S
group and only 0.84 (P<0.001) in NS group. At day 4 the AUC was
0.93 (P<0.001) in S group and 0.90 (P<0.001) in NS group. NSE values
>50.2 mcg/L recorded at any time in the S group were associated
with poor prognosis with 100% specificity and 55% sensitivity. On
the other hand, the threshold for poor prognosis with 100% specifi-
city in the NS group was >57.2 mcg/L (with 56% sensitivity).
CONCLUSION. Our results indicate that initial rhythm influences the
prognostic value of NSE in cardiac arrest survivors. In patients with
non-shockable initial rhythm the prognostic values of NSE were gen-
erally lower with the highest value 4 days after collapse.
REFERENCE(S)
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(Nemocnice Na Homolce - NNH, 00023884), IG1505
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INTRODUCTION. Successfully resuscitated patients from a cardiac ar-
rest by out or in-hospital emergency teams are admitted to the In-
tensive Care Unit (ICU) for post-resuscitation care. However, the
prognosis of these patients remains dismal, with only a minority sur-
viving to hospital discharge.
OBJECTIVES. To characterize the population admitted to the ICU
after successful reanimation from a cardiac arrest, and to analyse the
factors associated to the clinical outcomes.
METHODS. A retrospective, descriptive and correlational study was per-
formed encompassing patients admitted in the first 24h after a cardiac
arrest in an ICU, from 1st January 2014 to 31st December 2018.
Through consultation of electronical clinical records, we analysed pa-
tient’s demographic factors, characteristics of the cardiac arrest, imme-
diate and in-hospital approach, mortality and neurologic (evaluated by
Cerebral Performance Category (CPC) Scale) outcomes. Correlation be-
tween variables was performed by Chi-square test and Mann-Whitney
test, with a significance level of 95%. Independent predictors of clinical
outcomes were identified through a binary logistic regression analysis,
considering p=0,05. Statistical analysis was conducted using SPSS 23.0.
RESULTS. During the defined period, 187 patients were admitted after a
cardiac arrest, 65% of whom were male. The median age was 67 years
and 39% suffered an out-of-hospital cardiac arrest. 87% had an initial
non-shockable rhythm and the most frequent presumed etiology was
cardiac (31%). Glasgow coma scale after return of spontaneous circulation
was higher in patients that suffered an in-hospital cardiac arrest (p=
0,003) and in patients that survived to discharge (p=0,003). The in-
hospital mortality rate was 63%, with most of the deaths associated with
initial non-shockable rhythms (93%; p=0,001), higher severity indices (p<
0,001), longer invasive mechanical ventilation (IMV) and vasopressor sup-
port (p<0,001). Furthermore, basic life support (BLS) was more frequently
initiated in patients who survived to discharge (p=0,027). SOFA score at
the admission was statistically significantly higher in males (p=0,007).
30% of the survivors had significant neurologic dysfunction at hospital
discharge (CPC 3 and 4). Non-shockable rhythms (p=0,018), non-
immediate initiation of BLS (p=0,01), higher SAPS II score (p<0,001) and
higher relative duration of vasopressor support (p=0,008) were
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cardiac arrest shock (p=0,016) and epileptic seizures (p=0,026) were inde-
pendent predictors of worse neurologic outcome.
CONCLUSION. This study confirms the importance of immediate initi-
ation of BLS and, consequently, the need for training out and in-
hospital population. Patients with early neurologic dysfunction but no
cardiovascular dysfunction may exhibit a worse neurologic outcome.
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INTRODUCTION. Although targeted temperature management (TTM)
is recommended in comatose survivors after cardiac arrest (CA), the
optimal method to deliver TTM remains unknown. We performed a
meta-analysis to evaluate the effects of different TTM methods on
survival and neurological outcome after adult CA.
METHODS. We searched on MEDLINE/PubMed database until 22/02/
2019 for comparative studies that evaluated at least two different TTM
methods in CA patients. Data were extracted independently by two au-
thors. We used QUADAS-2 tool for assessing risk of bias of each study.
The Jadad quality scoring system was used to assess the methodological
quality of randomized clinical trials (RCT). Primary outcome was the oc-
currence of unfavorable neurological outcome (UO); secondary outcomes
included overall mortality.
RESULTS. Our search identified 6886 studies; 22 studies (n=8027 pa-
tients) were included in the final analysis. When compared to surface
cooling, core methods showed a lower probability of UO (OR 0.85 [95%
CIs 0.75-0.96]; p=0.008) but not mortality (OR 0.88 [95% CIs 0.62-1.25];
p=0.21). No significant heterogeneity was observed among studies.
However, these effects were observed in the analyses of non RCTs. A
significant lower probability of both UO and mortality were observed
when invasive were compared to non-invasive TTM methods and when
temperature feed-back devices (TFD) were compared to non-TFD
methods. These results were significant particularly in non RCTs.
CONCLUSION. Although existing literature is mostly based on retrospect-
ive or prospective studies, specific TTM methods (i.e. core, invasive and
with TFD) were associated with a lower probability of poor neurological
outcome when compared to other methods in adult CA survivors
(CRD42019111021).
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000360INTRODUCTION. Steroid administration during post-arrest period has
been reported to improve myocardial dysfunction and hemodynamic
following return of spontaneous circulation (ROSC) in cardiac arrest
survivors. However the mechanism how post-arrest steroid use ameli-
orate myocardial injury in cardiac arrest survivors remains largely
unknown.
OBJECTIVES. To evaluate the effect of post-arrest hydrocortisone ad-
ministration on myocardial mitochondrial injury and dysfunction in a
rat model of ventricular fibrillation (VF) cardiac arrest model.
METHODS. VF cardiac arrest was induced and left untreated for 5 mi-
nutes in adult male wistar rats. Cardiopulmonary resuscitation and
electric shocks were then applied to achieve ROSC. Successfully re-
suscitated animal were randomized into steroid and non-steroid
groups. The steroid group received intravenous hydrocortisone of 8
mg/kg immediately after ROSC and the non-steroid group received
saline as placebo. The histology and ultrastructural changes of myo-
cardium, myocardial mitochondrial function, and survival and neuro-
logical function at 72nd hour following ROSC were compared
between groups.
RESULTS. There were 12 animals in each group. Within 4 hours fol-
lowing ROSC, the steroid group had significantly better systolic func-
tion (dp/dt) and cardiac output than the non-steroid group. At 4th
hour following ROSC, the histology examination and transmission
electron microscopy demonstrated less myocardial damage and
mitochondrial injury in the steroid group. Besides, steroid prevented
the acceleration of Ca2+-induced mitochondrial swelling (mitochon-
drial permeability transition pore opening) as noted in the non-
steroid group. As compared to the non-steroid group, the steroid
group also had a significantly higher 72 hour survival rate (91.7% v.s.
50%, p = .013) and higher percentage of good neurological function
(75% v.s. 25%, p = .02) at 72nd hour.
CONCLUSION. Post-arrest hydrocortisone administration mitigates
myocardial damage, ameliorates cardiac mitochondrial injury and im-
proves 72-hour survival and neurological recovery in a rat model of
VF cardiac arrest.
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INTRODUCTION. Acute hypoxia results in uncontrolled release of glu-
tamate and the consequent stimulation of N-methyl-D-aspartate
(NMDA) receptors, which affects the homeostasis (1). A potential
therapeutic approach to prevent this sequence of events is a block-
ade of NMDA receptors. Meanwhile, in different models of acute hyp-
oxia, activation of opioid receptors demonstrates significant cardio-
and neuroprotective effects with a consequent increase in animal
survival (2).
OBJECTIVES. Thus, we aimed to test the effects of S-ketamine and
alfentanil on lactate, blood glucose, acid-base status and early sur-
vival in rats after asphyxia cardiac arrest (ACA).
METHODS. After instrumentation under anaesthesia with Isoflurane,
Wistar rats (n=26) weighing between 350–400 g were assigned to
three groups where: 1. Alfentanil 2.5 mcg/kg iv (n=12) was given 10
min before ACA; 2. S-ketamine 40 mg/kg iv (n=7) was given 10 min
before ACA; 3. Control (n=7), the same amount of NaCl 0,9% iv was
given 10 min before ACA. The rats were asphyxiated by clamping
the endotracheal tube at the end of expiration for 5 min. Resuscita-
tion was initiated by an injection of epinephrine (0.02 mg/kg, iv),
followed by manual thoracic compressions (180 compressions/min)
and mechanical ventilation (21% O2, 80 breaths/min). Invasive mean
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(Inj), every 1 min during ACA (As) and every 5 min in post-
resuscitation (PR) period. Blood gas samples, blood for lactate and
glucose were taken at the BL and 20 min at the PR period. Early sur-
vival was determined at the 60 min after ACA.
RESULTS. Selected groups of animals did not differ on the pre-
resuscitation parameters. No differences in blood glucose level and
survival between the rats was found at the postresuscitation period.
The rats pre-treated by S-ketamine got significantly higher produc-
tion of lactate (11,4±1,4 mmol/l vs 2,8±1,3 mmol/l, p < 0,002) when
compared to the rats treated by alfentanil. Base deficit was signifi-
cantly lower in group with using of alfentanil (-1.5±1,3 vs -16,5±3,2, p
< 0,001) when compared to the rats treated by S-ketamine.
CONCLUSION.
Pre-treatment with alfentanil attenuated significantly disturbances in
acid-base balance and production of lactate after ACA when com-
pared to the rats pre-treated by S-ketamine.
REFERENCE(S)
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379. 2. Bell JD. In Vogue: Ketamine for Neuroprotection in Acute Neuro-
logic Injury. Anesth Analg. 2017 Apr;124(4):1237-1243.
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INTRODUCTION. Treatment of post cardiac arrest (CA) syndrome rep-
resents a clinical priority. Argon represents an attractive therapeutic
option.
OBJECTIVES. The purpose of this study was to determine efficacy,
safety and the most effective dose of argon in a porcine model of
high-severity CA and cardiopulmonary resuscitation (CPR).
METHODS. Left anterior descending coronary artery was occluded in
36 pigs, and ventricular fibrillation was induced and left untreated
for 12 min. CPR was then performed for 5 min prior to defibrillation.
Following successful resuscitation, animals were subjected to 4 hr
ventilation with (a) 70% argon - 30% O2 (n=10); (b) 50% argon - 50%
O2 (n=10); (c) 70% N2 - 30% O2 (n=10). Hemodynamic parameters
were monitored and serial blood samples were obtained for blood
gas analysis. Animals were observed up to 96 h for assessment of
survival and neurological recovery.
RESULTS. Ten animals of 12 were successfully resuscitated in each
group. After resuscitation, animals treated with Argon 70% showed
higher systolic, mean and diastolic arterial pressure compared to con-
trols and to the Argon 50% treated animals (p<0.05). Ventilation with
argon did not have any detrimental effects on respiratory gas exchange
during the 4 hr ventilation. There was no statistically significant differ-
ence in the number of the resuscitated animals survived up to 96 hrs.
However, 6 (60 %) and 8 (80 %) resuscitated animals in the Argon 50%
and Argon 70% groups respectively achieved a complete neurological
recovery (Overall Performance Categories, OPC=1 or 2), whereas only 3
(30%) animals survived up to 96 hours with a complete neurological re-
covery in the control group (p<0.0001).
CONCLUSION. Argon prevented post CA brain injury in swine model
of severe CA, without detrimental effects on hemodynamics and re-
spiratory gas exchanges. Beneficial effects was higher at a concentra-
tion of 70% than of 50%.REFERENCE(S)
1. Postresuscitation treatment with argon improves early neurological
recovery in a porcine model of cardiac arrest. Ristagno G, et al. Shock.
2014 Jan;41(1):72-8. doi: 10.1097/SHK.0000000000000049
2. This project was supported by the Italian Ministry of Health and
Fondazione Sestini.
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INTRODUCTION. Out-of-hospital cardiac arrest(OHCA) is associated
with poor survival and can be considered a major global health prob-
lem. The early determination of neurologic outcomes is an essential
element of risk stratification to identify aggressive treatment of
OHCA patients. Hemoglobin A1c(HbA1c) serves as a surrogate marker
of glycemic control and is a key risk indicator for diabetes associated
microvascular and macrovascular complications and mortality.
OBJECTIVES. This study aimed to investigate the association of
HbA1c level and out-of-cardiac arrest patients who underwent
hypothermic-targeted temperature management.
METHODS. This retrospective observational study included adult out-
of-hospital cardiac arrest who underwent hypothermic-targeted
temperature management from December 2011 to February 2019.
Serum HbA1c was measured immediately after return of spontan-
eous circulation. The primary outcome was 6-month survival.
RESULTS. In total, 282 patients were analyzed. Among those,
eighty-three patients survived six months. The mean HbA1c in
patients surviving six months was 5.67%±SD, which was signifi-
cantly lower than in patients who did not survive six months
(6.21%±SD, P<0.001). The AUC calculated on ROC analysis predict-
ing six month survival was 0.66 (95% confidence interval, 0.60 to
0.71; P<0.001), with a sensitivity of 72% and specificity of 57% at
a cut-off of 5.4%. In multivariable logistic regression model,
HbA1c level ≥ 5.4% (OR 5.61, 95% CI 2.46-12.81, P<0.01), non-
cardiac cause (OR 3.21, 95% CI 1.29-8.01, P=0.01), non-shockable
rhythm (OR 2.43, 95% CI 1.02-5.78, P=0.04), non-witness (OR 2.75,
95% CI 1.29-5.88, P=0.01), older age (OR 1.05, 95% CI 1.03-1.08,
P<0.01), longer anoxic time (OR 1.08, 95% CI 1.06-1.11, P<0.01) as
independent factors of 6-month survivor. The AUC calculated on
ROC analysis of multivariable logistic regression model was 0.89
(95% CI 0.85-0.93, P<0.01).
CONCLUSION. This study showed that HbA1c of out-of-cardiac arrest(-
OHCA) was associated with survival in patients underwent
hypothermic-targeted temperature management. But its sensitivity and
specificity are unsatisfactory for a single prognostic marker. HbA1c
should be considered as an additional modality for prognostification
and not as a single reliable variable. Further large multicenter studies
are needed to evaluate the utility of HbA1c for early prognostic factor.
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INTRODUCTION. Severe obstructive shock with cardiac arrest leads
to a decline in cardiac output of primarily the right heart chamber.
We hypothesize, that with return of spontaneous circulation (ROSC)
after an obstructive cardiac arrest, the right heart generates cardiac
output several heartbeats before the left heart, thereby proving the
primary role of venous return for the reconstitution of the circulation.
OBJECTIVES. Description of the time course of stroke volume gener-
ation of right and left heart after resolution of an obstructive cardiac ar-
rest to clarify the role of venous return in the achievement of ROSC.
METHODS. This abstract is based on data from a previous study (1).
We induced obstructive circulatory arrest in ten anesthetized pigs
(equipped with an ultrasonic flow probe on the pulmonary artery
and a pressure catheter in the carotid artery) by balloon occlusion of
the right atrium (inflatable high-compliance balloon) over one mi-
nute in five experimental conditions (PEEP5, PEEP10, euvolemia,
bleeding and hypervolemia). Pulmonary artery pressure and flow
tracings confirmed circulatory arrest and ROSC. Single heartbeats
were analysed during balloon inflation to create circulatory standstill
and then deflation of the balloon after one minute to achieve ROSC.
ROSC was defined as the earliest heart beat from which a steady rise
in PA flow over the succeeding beats could be observed. After ROSC,
PA flow increases by 200%, MAP increases by 10% and arterial stroke
volume (calculated from pulse contour) increases by 50% were con-
sidered clinically significant. The number of beats until these values
were achieved were counted. Comparisons were done with Fried-
man’s ANOVA on ranks and post-hoc Tukey’s test and data presented
as median (range).
RESULTS. We achieved ROSC in 43/50 conditions after 46 (21-84) sec
with a flow in the pulmonary artery of 92 (-18-800) ml/min and a
mean arterial pressure of 32 (18-51) mmHg. During arrest, MAPincreased by 8 (1.9-10) mmHg due to increased sympathetic activity
occurring 19-22 sec after arrest (1), while no significant change in PA
flow was observed. After ROSC pulmonary flow doubled after 2 (1 to
20) heartbeats, whereas MAP increased 10% only after 7 (1 to 20)
beats and arterial stroke volume increased 50% only after 15 (1 to
20) beats, p < 0.001 for all comparisons. Arterial stroke volume and
ABP increased by 50% or 10% after 120 (0 to 339) ml or 3.2 (0 to 9)
ml/kg and 41 (0 to 333) ml or 1 (0 to 9) ml/kg flow through the pul-
monary artery, respectively. Central venous pressure consistently and
immediately dropped after ROSC.
CONCLUSION. We interpret the time delay between the increase in
pulmonary artery flow and arterial pressure and stroke volume as proof
of the role of venous return for the recovery from obstructive shock.
This is supported by the immediate drop of central venous pressure
after ROSC. To what extent these findings may be generalized to non-
obstructive forms of cardiac arrest needs further investigation.
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INTRODUCTION. Capnographic CO2 oscillations have been described
during Cardiopulmonary Resuscitation (CPR).
The Airway Opening Index (AOI) has been recently proposed to quan-
tify the CO2 oscillations at capnography during chest compressions
(CCs).(1) It has been proposed that a low oscillating EtCO2 during CCs
is a result of airway collapse, which obstructs the expiratory airflow. The
aim of this study is to assess the change of AOI over time during 18 mi-
nutes of CPR in a porcine model of cardiac arrest (CA). We will assess
the relationship between manual and mechanical CCs, the compliance
of the respiratory system (Cpl,rs) and the duration of CPR with the AOI.
METHODS. Adult male swine were randomized to 18 min of CPR with
mechanical (LUCAS® 3.0) or manual CCs after 2 minutes of CA. Mechan-
ical ventilation was provided with tidal volume 500 ml, 10 bpm, FiO2
1.0, ZEEP). Hemodynamic parameters, EKG, SpO2, EtCO2were continu-
ously recorded. Cpl,rs was assessed after return of spontaneous circula-
tion (ROSC). The AOI was computed as ΔCO2/CO2max and the values
were averaged on the number of CCs (n=6) during each minute of CPR.
RESULTS. The mean AOI was significantly higher in the manual CCs
group compared to the mechanical group(58±5% vs 24±3%, p<
0.0001 Fig 1a). The AOI was higher in the manual CCs group compared
to the mechanical group throughout the time of CPR. No decrease of
AOI has been identified over time within each group (Fig 1b). The
mean value of AOI measured at the end of CPR (minute 18) showed a
good correlation with Cpl,rs (r=0.749, p=0.0006, Fig 1c).
CONCLUSION. In a randomized porcine model of CA, AOI was signifi-
cantly higher in the manual compared to the mechanical CCs group
during the all 18 minutes of CPR. Cpl,rs was strongly associated with
the AOI at the end of CPR.
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INTRODUCTION. Traumatic bleeding is characterized by trauma-
induced coagulopathy and enhanced endothelial permeability. Cur-
rently, transfusion strategies have been adopted using a balanced
component strategy to prevent or treat coagulopathy. Interventions
aimed at reducing endothelial permeability may further improve out-
come. Tyrosine kinase inhibitors such as bosutinib have the potential
to reduce vascular permeability by increasing intercellular endothelial
adhesion molecules.
OBJECTIVES. To examine whether bosutinib in combination with a
balanced component strategy reduces endotheliopathy, thereby lim-
iting transfusion requirements and organ failure, in a rat polytrauma
transfusion model.
METHODS. Blood products were made using syngeneic donor rats
according to national blood bank standards. Spraque Dawley rats (n=
13 per group) were sedated and mechanically ventilated. Trauma
was induced by crush injury to both the small intestine and liver and
by a femur fracture. Following trauma, rats were exsanguinated until
a MAP of below 40 mmHg, lasting 1 hour. Subsequently, rats were
randomized to receive resuscitation with red blood cells, plasma and
platelets in a 1:1:1 ratio with either bosutinib or vehicle or only
Ringer’s Lactate (RL) infusion. Resuscitation was stopped when MAP
was 60 mmHg. After six hours, organs were harvested for wet/dry
(W/D) ratio. Data are median with interquartile range. A p-value of
less than 0.05 was considered to be statistically significant. Bonferroni
corrections were applied to correct for multiple testing.
RESULTS. The model resulted in shock with increased lactate levels
in all animals. Mortality only occurred in RL infused rats (13%). The
amount of transfusion or infusion needed to obtain a MAP of 60
mmHg was significantly lower in the bosutinib treated animals (1.0
[1.0 – 1.2] ml) when compared to vehicle (2.0 [2.0 – 2.6] ml) and RL
controls (4.0 [4.0 - 5.0] ml, p<0.001). Also, at the end of the experi-
ment, lactate levels were lower in the bosutinib group (2.9 [1.7 –
4.8]) compared to vehicle (6.2 [3.1 – 14.1], p=0.058) and RL controls
(11.7 [4.9 – 16.6] mmol/L, p=0.004). Bosutinib resulted in significant
lower lung W/D ratios (5.1 [4.6 – 5.2]) when compared to vehicle (5.7
[5.4 – 6.0], p=0.003) and RL controls (5.5 [5.3 – 5.7], p=0.012). Kidney
W/D ratios were similar.
CONCLUSION. In this model, bosutinib reduces resuscitation volume
and results in a better stabilized shock as well as a reduction in pul-
monary edema. Whether bosutinib improves outcome should be de-
termined in a trial in patients with traumatic bleeding.
SIS - Sepsis management and
prognostication
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000759INTRODUCTION. As most severe complication of infection, sepsis is a
major health threat for vulnerable populations such as infants or chil-
dren with comorbidity. Every year, sepsis affects more than 4 million
children worldwide, of which 9-20% die (Fleischmann-Struzek et al.
2018). For Germany, data on nationwide and population-level age-
specific pediatric sepsis mortality is scarce.
OBJECTIVES. We aimed to assess infection and sepsis mortality in
hospital-treated children in different age groups between 2010-2015
based on representative hospital discharge data in Germany.
METHODS. Patients <18 years with infection and sepsis were identi-
fied in a nation-wide database (DRG statistics) between 2010-2015
based on ICD-10 coded primary and secondary hospital discharge
diagnoses. The DRG statistics includes nearly complete inpatient data
from German hospital except for military or psychiatric hospitals and
contains more than 18 million annual hospitalizations. Sepsis was de-
fined as organ failure due to infection and was identified by ICD-10-
codes R65.1 and R57.2. To identify infection-related hospitalizations,
ICD-9 infection codes were adapted from Angus et al. and translated
into ICD-10 (Angus et al. 2001).
RESULTS. Between 2010 and 2015, 2.54 million children with infec-
tious diseases were treated in German hospitals. Overall in-hospital
mortality was 0.2%, which corresponds to a mortality rate of 7 deaths
per 100 000 children. Highest mortality rates were found in children
<1 years (0.5%); in all other age groups, mortality ranged between
0.1-0.2%. Among hospitalized children with infection, 10,975 children
had sepsis (0.43%) with an overall mortality of 17.2% (2.4 deaths/100
000 children). Mortality peaked in newborns (18.7%) and was lowest
in 2-5year old children (14.5%). Approx. 25% and 8% of all decedents
<17 years in Germany received an infection and sepsis code during
their terminal hospitalization, respectively.
CONCLUSION. Sepsis is an important cause of death in children in
Germany. Mortality from pediatric sepsis is higher in Germany than
in other high-income countries such as the US with an observed sep-
sis mortality of 11.8% in children between 2014 and 2016 (Evans
et al. 2018). This underlines the need for targeted prevention strat-
egies and quality improvement initiatives in Germany as demanded
by the WHO resolution on sepsis (WHA Resolution 2017).
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INTRODUCTION. Hypertonic sodium lactate have recently shown in-
teresting effects for fluid management in endotoxemia models1. We
therefore evaluated its effects on microcirculation, capillary leakage,
cardiac function and different biological parameters in a sepsis rat
model of caecal ligation and puncture (CLP).
METHODS. 30 rats were randomized in 3 groups (n=10 per group):
Sham; CLP-NaCl 0.9%; CLP-Lactate 11.2%. 2.5 mL/kg/h of fluids were
intravenous administrated from the CLP procedure and during 18
hours. We then evaluated mesenteric microcirculation (laser speckle
imager), cardiac function (echocardiography and pressure-volume
(PV) loops) and inflammation (uremia, VEGF-A, IL-1β, IL-10, TNFα).
Page 237 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Capillary leakage was explored using Blue Evans extravasation in the
lung and gut on 5 additional rats. Results are expressed as medians
with interquartiles and comparisons versus CLP-NaCl were realized
using Kruskall-Wallis or ANOVA test.
RESULTS. CLP-lactate presented an improved mesenteric microcircu-
lation (735.5 [407.4-878.8] vs 240.6 [209.3-390.8]UI/pixel, p=0.0006)
with higher cardiac output (0.34 [0.28-0.43] vs 0.14 [0.10-0.18] mL/
min, p<0.0001) and higher left ventricular shortening fraction (55.2
[46.2-73.2] vs 39.1 [32.9-51.8] %, p=0.009). PV loops also showed
raised dP/dt max slope (6.3 [3.3-12.1] vs 2.7 [2.0-3.9] mmHg/ms, p=
0.04), suggesting an improved inotropism, and a lower Left Ventricu-
lar End-Diastolic Pressure-Volume Relation (1.9 [1.1-2.3] vs 3.0 [2.2-
3.7] RVU/mmHg, p=0.005), suggesting an improvement in diastolic
function independently from preload. Mean arterial pressure be-
tween CLP-NaCl and CLP-Lactate was similar at the end of infusion.
Evans Blue diffusion was reduced in the gut and the lung for CLP-
lactate (37.2 [31.0-43.3] vs. 112.7 [63.3-141.6], p=0.03 and 107.5 [82-
174.3] vs. 272.7 [221.8-444.5] ng EB/mg of tissue, p=0.006). Plasma
levels of lactate and 3OH-butyrate were higher in CLP-lactate (6.03
[3.08-10.3] vs. 3.19 [2.42-5.11] mmol/L, p=0.04; 400 [174-626] vs. 189
[130-301] μmol/L, p=0.03). Inflammatory response was reduced in
CLP-lactate (IL-1β: 172.2 [119.0-446.3] vs. 927.7 [244.8-1470] pg/mL,
p=0.004; TNFα: 17.9 [12.5-50.3] vs. 53.9 [30.8-85.6] pg/mL, p=0.005;
IL-10: 351.6 [267.0-918.6] vs. 904.5 [723.1-1243] pg/mL) as well as
VEGA-A plasma levels (198.2 [185.3-250.0] vs. 260.7 [249.8-268.9] pg/
mL, p=0.009).
CONCLUSION. Hypertonic lactate fluids protect against cardiac dys-
function, mesenteric microvascular alteration and capillary leakage
during sepsis, in association with a significant reduction in inflamma-
tory process and kidney failure.
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INTRODUCTION. Intravenous fluid resuscitation was the mainstay
treatment in early goal-directed therapy for sepsis, which measured
static central venous pressure (CVP) in first 6 hours (hrs)1. Although
several studies demonstrated that dynamic indices were more accur-
ate than static indices for prediction of fluid responsiveness2, no
landmark studies compared the efficacy of both types of indices for
clinical outcomes.
OBJECTIVES. The primary objective is to compare the 30-day all-
cause mortality rate of septic patients in whom fluid resuscitation
was guided by dynamic inferior vena cava (IVC) diameter with static
CVP measurement. The secondary objectives are to compare the pro-
portions of patients achieving ≥1 macrovascular target(s), i.e., mean
arterial pressure ≥65 mmHg and urine output ≥0.5 mL/kg/hr; and ≥1
microvascular target(s), i.e., central venous oxygen saturation (ScvO2)
≥70% and lactate clearance ≥10%, which were assessed at 6 hrs after
treatment of sepsis, between those using dymamic and static
parameters.
METHODS. A Single-blinded randomized controlled trial was con-
ducted in Thammasat University Hospital between August 2016 and
March 2019. The patients were stratified by APACHE-II (<25 or ≥25)
and randomized using block of 2 and 4, to either dynamic IVCdiameter measurement by ultrasound (US) or static CVP measure-
ment. We recorded clinical parameters at baseline, during resuscita-
tion and until completion of 6 hrs, including the vital status at 30
days, macrovascular and microvascular targets.
RESULTS. A total of 91 patients was enrolled, but one withdrew. Forty-
three patients were randomized to dynamic IVC diameter measure-
ment, while 47 patients were randomized to static CVP measurement.
The baseline characteristics between two groups were not different.
The 30-day mortality rates between IVC-guided group and CVP-guided
group were not different (39.5% vs. 44.7%, p=0.622). The proportions of
patients who achieved ≥1 macrovascular target(s) at 6 hrs were not dif-
ferent between both groups (65.1% vs. 63.8%, p=0.899). The propor-
tions of patients achieving ≥1 microvascular target(s) at 6 hrs were also
not different between both groups (83.7% vs. 66.0%, p=0.054), but the
proportion of patients in IVC-guided group achieving ScvO2 ≥70% was
higher than that of the other (77.1% vs. 48.6%, p=0.013).
CONCLUSION. Dynamic US-guided fluid resuscitation does not affect
the mortality of patients with sepsis, however, it may help more patients
achieve ScvO2 ≥70%, compared to static CVP-guided resuscitation.
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INTRODUCTION. Thrombosis in critical states is known to be con-
nected with the formation of Extracellular Traps (ETs), which are pro-
duced by blood phagocytes [1]. ETs activate platelets and visa versa:
activated platelets prime phagocytes to undergo ETosis.
Development of common methods of ETosis determination in blood
is actual. We developed the method for the assessment of phagocyte
circulating in blood that are transformed during ETosis, using stan-
dardized blood smears [2]. Method implies preparation of smears
with monolayer of cells with strictly specified parameters, providing
the standard conditions for heterogenic lysis of circulated phago-
cytes, transformed during ETosis.
OBJECTIVES. The aim of the study is to evaluate the connection be-
tween ETs level and hemostasis indicators with sepsis outcome.
METHODS. ETs levels in standardized blood smears [2], platelets
count and antithrombin III (AT III) activity in blood were determined
for 73 patients in intensive care unit with verified sepsis in dynamics,
using hematological analyzer PENTRA 120 (Horiba Medical, France)
and ACL TOP analyzer (Instrumentation Laboratory, USA).
RESULTS. Among septic patients survival rate was 60% (29 cases of
lethal outcome and 44 cases of recovery). We compared maximal ETs
level during all time of observation of each patient; at this moment
hemostasis indicators were assessed. In group with lethal outcome
ETs level was in average – 24.6% (95% CI: 17.7-31.5%), platelet count
– 152×10^9/L (95% CI: 112-192×10^9/L), AT III activity – 67.5% (95%
CI: 58-77%). In recovery group ETs level was in average – 9.2% (95%
CI: 7.6-10.8%), platelet count – 272×10^9/L (95% CI: 223-321×10^9/
L), AT III activity – 77.4% (95% CI: 70-84%). The differences in ETs
levels and platelet counts between the groups were statistically sig-
nificant according to Mann-Whitney U-test (fig. 1). Thrombocytopenia
(<120×10^9/L) was observed in 48.3% cases of lethal outcome and
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as platelet count significantly differ in the groups of recovered and
died septic patients, they both are significant mortality predictors,
while antithrombin III is not. These preliminary data ensure us in the
significance of future studies of the connection between considered
cellular markers in dynamics.
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INTRODUCTION. Sepsis is the primary cause of mortality in intensive
care units. It can be treated effectively, but it is essential treated it
early. However, differentiate sepsis from non-infectious SIRS at the
early stage has become a challenge. In this context, presepsin is a
new biomarker with better sensitivity and specificity in the diagnosis
of sepsis that other biomarkers.
OBJECTIVES. Evaluate the sensibility and specificity of presepsin for
the diagnosis of positive blood cultures and the prognostic value in
patients with suspected sepsis.
METHODS. Prospective study, carry on in the ICU of the Hospital Ita-
liano de Buenos Aires, Argentina, between August 2015 and March
2017. Patients in ICU with more than 48 hours of hospitalization, with
new diagnosis of suspected sepsis, have been included. Patients with
any antibiotic treatment or SIRS of any cause until three days before
the inclusion were excluded and so were burned, immunodepleted,
pregnancy and subjects who have a do not resuscitate status. Pre-
sepsin were obtained at suspect sepsis, 24 and 72 hours after.
RESULTS. 144 patients have been recruited. Mean age was 64 and
mean APACHE II 15. The main infectious sources were respiratory (33%)
and abdominal (14%). 28 blood cultures (BC) were positive (19%), with
19 rescues of gram-negative bacilli and 9 gram-positive cocci. Baseline
presepsin in patients with positive BC was greater (1655 pg/ml, SD+/-
1137) than patients with negative BC (mean 1015 pg/ml, SD+/-893),
(p=<0.001) (Figure 1). In patients with renal failure (RF), values of pre-
sepsin did not have significative differences (positive cultures: mean of
2520 pg/ml, SD+/-3025; negative cultures: mean of 2789 pg/ml, SD+/-
2476), (p=0.49). The cut point of 400 pg/ml had the best relationship
between sensitivity (96.4%) and specificity (19.8%), with an area under
the ROC curve (AUC) of 0.72. In patients with RF, the AUC was 0.59. Glo-
bal mortality in UCI was 21% (31 patients). Values of basal presepsin, at
24 and 72 hs had a significative correlation with the probability of
death in UCI (Figure 2). Progression of presepsin between basal valuesand 72 hs values did not correlate with the probability of death (in 41%
of patients that death in ICU the presepsin values decreased at 72 hs,
against 49% in patients that survive).
CONCLUSION. Presepsin has good sensitivity for the diagnosis of posi-
tive BC in ICU-sepsis, but only in patients without RF. That is a signifi-
cant problem because it is a common comorbidity in ICU patients. Also,
presepsin values had a good correlation with the risk of dying in ICU.000841
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INTRODUCTION. Therapeutic drug monitoring of antibiotics is
very limited at present and no bedside test is available to offer
rapid results. Tissue microdialysis (MD) is a minimally invasive
technique that measures only the free (unbound), active fraction
of antibiotics in the interstitial fluid of target tissues [1,2]. How-
ever, concentration of drug within the microdialysate samples re-
flects only a fraction of the total unbound concentration in that
tissue. This ratio is called relative recover [3]. For accurate deter-
mination of true tissue concentration, the analyte concentration
measured in microdialysate must be corrected to the relative
recovery (%).
F1 F1
Page 239 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55OBJECTIVES. The aims of this study are to describe in-vivo microdialysis
recovery of meropenem in multiple tissues in healthy rats ,and to com-
pare these levels against those found in early and late stages of sepsis.
METHODS. Healthy male Wistar rats (300-350g), were allocated into
three study groups: sham, 6 hour sepsis and 24 hour sepsis. Sepsis was
induced by faecal slurry injected intraperitoneally. MicroEye® probes
(Probe Scientific Ltd, Bedford, UK) were implanted into 6 tissues:
muscle, subcutaneous, liver, peritoneal cavity, trachea and jugular vein.
Probes were perfused with meropenem 10 μg/mL at a rate of 1 μL/
min. Microdialysate from each tissue was sampled every 10 minutes for
120 minutes’ duration. Meropenem concentration was determined
using High Performance Liquid Chromatography (HPLC, Agilent 1260II).
MD recovery was calculated as [(Cin-Cout/Cin)*100) [3]. ANOVA with
post-hoc Dunn’s test were used to seek statistical significance.
RESULTS. MD recovery in most tissues in sham rats ranged from 35-
41%, except for muscle (23%, p<0.0001) and trachea (27%, p<0.05).
At 6 hours’ sepsis, recoveries were increased to 35-50% (p<0.05), ex-
cept endotracheally (9%, p<0.0001). At 24 hours’ sepsis, recoveries
were significantly lower in all tissues (9-34%, p<0.0001) [Figure 1].
CONCLUSION. We conclude that MD drug recovery in tissues are sig-
nificantly different in health and at different timepoints in sepsis. This
highlights the importance of in-vivo determination of drug recovery
prior to conducting a MD study, to avoid inaccuracies in true tissue
drug concentration measurement.
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Fig. 1 (abstract 000850). Doppler spectrums of left ventricular
outflow derived by echocardiography. LVOT-VTI/Vmax was hand-
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INTRODUCTION. Predicting fluid responsiveness for elder patients,
especially with acute respiratory distress syndrome or arrhythmia or
severe cardiac dysfunction, is still a daily challenge in intensive care
unit. Based on heart-lung interaction, cardiac output (CO) will be
changed derived from occlusion of respiratory.OBJECTIVES. The study was aimed to explore the feasibility of occlu-
sion of end-inspiratory or end-expiratory in prediction of fluid re-
sponsiveness for elder septic patients.
METHODS. 30 elder septic hypotension patients with mechanical
ventilation were enrolled. The ratio of positive fluid responsiveness
(PFR) and negative fluid responsiveness (NFR) was 1:1. After analgesia
and sedation, all of them were suffered end-inspiratory/end-expira-
tory occlusion for 15s. Parameters of CO (CI/SVI and LVOT-VTI/Vmax)
were dynamic monitored via noninvasive pulse contour and echocar-
diography. PFR were identified as △CI≥15% after 500ml saline of fluid
challenge. T-test or Mann-Whitney test and receiver operating char-
acteristic curve (ROC) were applied for data analysis, and then calcu-
lated the diagnostic parameters with regarding to the cutoffs.
RESULTS. Occlusion of end-expiratory increased CO significant in PFR
patients than negative patients; and vice versa, occlusion of end-
inspiratory decreased CO significant in PFR than NFR. ROC for pre-
dicting PFR showed that CO parameters had considerable predictive
value (C-statistics, 0.849-0.951). In addition, CI/SVI decreased ≥5.52%/
6.52 or LVOT-VTI/Vmax decreased ≥7.43%/4.24% derived by occlu-
sion of end-inspiratory and CI/SVI increased ≥4.52%/9.52 or LVOT-
VTI/Vmax increased ≥8.59%/3.88% derived by occlusion of end-
expiratory had 100% reliability to predict PFR in our elder septic
patients.
CONCLUSION. Occlusion of end-inspiratory or end-expiratory may be
used as a promising method to predict fluid responsiveness for elder
septic patients.
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Page 240 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. In septic shock patients, fluid therapy has been fos-
tered as one of the pillars of resuscitation. Inadequate fluid resuscita-
tion can lead to tissue hypoperfusion, while indiscriminate fluid
administration can induce pulmonary edema, abdominal hypertension,
acute kidney injury, among other complications. Fluid responsiveness
(FR) tests are dynamic bedside evaluations that allow identifying the
position of the patient in the cardiac function curve(1).
Despite that these tests are widely available, extensively described in the
literature and almost cost-free, recent surveys have shown that the mi-
nority of intensive care practitioners effectively use them to guide fluid
therapy(2).
In the recently published ANDROMEDA-SHOCK trial, a comprehensive re-
suscitation protocol was applied to early septic shock patients with two
different perfusion targets (lactate and capillary refill time). The protocol
included the evaluation of FR as a mandatory aspect of the
hemodynamic profiling of patients(3)
OBJECTIVES. To determine the use of FR testing, its’ impact on fluid
therapy and on perfusion endpoints during initial septic shock resus-
citation of patients included in ANDROMEDA-SHOCK trial.
METHODS. A secondary analysis of ANDROMEDA-SHOCK study was
performed. 424 patients were divided into three groups according to
baseline FR status: Responders (FR+), non-responders (FR-) and not
analyzable. The first two groups were considered the sample size for
this study. Macrohemodynamic, fluid therapy and perfusion variables
were compared in both groups during the first 24-h of the study
protocol. Non-parametric testing was used.
RESULTS. At ICU admission, FR could be determined in 82% of patients,
while 25% of patients enrolled were FR– after pre-ICU fluid loading. The
most frequent methods used to determine FR were pulse pressure variation
(43%), passive leg raising (42%) and inferior vena cava distensibility (10%).
Both groups presented similar baseline demographic, severity and macro-
hemodinamic characteristics. FR+ had higher CRT at baseline. (Table 1)
FR+ received significantly more fluid bolus than FR– during the first 2
hours (1000[500-1500] vs 0[0-0], p<0.001) and 8 hours (1500 [1000-2500]
vs 0[0-500], p<0.001) of protocol. Figure 1 shows the evolution of FR in
both groups.
CONCLUSION. During initial resuscitation of septic shock patients,
withholding fluids in FR– patients doesn’t seem to delay hypoperfu-
sion resolution. Evolution of FR is dynamic and should be assessed at
every clinical evaluation to avoid unnecessary fluid loading and po-
tential adverse effects.
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Fig. 1 (abstract 000891). Impact of palmitate, butyrate and alpha-
linolenic acid on cytokine secretion by human PBMCs exposed to
LPS and bacteria
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INTRODUCTION. Sepsis involves inflammatory and immunity mediation.
Several mediators, alone or in combination, were proposed to characterize
individual response, but none was proven to have good external validity.
OBJECTIVES. The aim of this work was to establish whether some com-
binations allow to predict occurrence of nosocomial infections in pa-
tients with sepsis, using the data collected in the Captain multicenter
cohort which method and first results were previously published (1).
METHODS. The Captain cohort included 279 patients prospectively at
the time of sepsis criteria, 188 (67%) of whom having confirmed infec-
tion. Community acquired pneumonia was causal in 70% of infections.
SAPS2 score = 55 [50-61], age = 65 years [57-78], male sex = 64 %. 203
patients followed for more than 3 days, in whom usual ICU clinical and
biological parameters were collected, as well as 29 plasma biomarkers
and 10 leucocyte associated RNAs. Patients were classified according to
the occurrence of pneumonia and/or bacteremia after day 5. A non-
supervised principal component analysis of the maximal values of bio-
markers assessed on first 2 days of sepsis, and a Varimax rotation was
performed on the selected components using the SAS software.
RESULTS. Out of 203 patients, 33 developed pneumonia and/or
bacteremia after day 5. Five components explain 57 % of the vari-
ance of the biomarkers on the entire cohort. The second component
of the Varimax rotation is significantly linked to pneumonia occur-
rence (p = 0.02) or bacteremia (p = 0.02). Those biomarkers which
are determinants of this component are HLA-DR RNA (correlation co-
efficient 0.79), CD74 RNA (0.76), CRP (-0.62), CX3CR1 RNA (0.63),
CD3D RNA (0.59), Matrix Metallo Proteinase-8 (MMP8) (-0.58), IL-10
RNA (-0.57) and Pancreatic Stone Protein (PSP) (-0.50).
CONCLUSION. In our cohort, using a non supervised analysis, we
could detect a biomarker association which predicts secondary infec-
tion occurrence. Some of these markers are among those which are
regularly considered as describers of the peripheral alteration of the
immune system observed during sepsis.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000891INTRODUCTION. Sepsis represents life-threatening organ dysfunc-
tion caused by a dysregulated host response to infection [1].
Cardiovascular, neural, coagulation, hormonal, bioenergetic, meta-
bolic, inflammatory and immune pathways are variably deranged
[2]. Depending on their hydrocarbon chain lengths, degree of un-
saturation, number, position and orientation of their double
bonds, fatty acids (FAs) have differential effects on immune func-
tions [3].
OBJECTIVES. This study aims to determine the immunomodulatory
effects of palmitate (long-chain, saturated), alpha-linolenic acid
(ALA) (long-chain, unsaturated) and butyrate (short-chain, satu-
rated) in human peripheral blood mononuclear cells (PBMCs) ex-
posed to lipopolysaccharide (LPS) or clinical strains of bacteria.
METHODS. PBMCs from 5 healthy donors were cultured in RPMI
1640 GlutaMAX medium containing 10% FCS and 1% pen-strep at
37°C in 5% CO2. PBMCs were incubated overnight with LPS (100 ng/
ml), heat-killed Staphylococcus aureus or Escherichia coli O18
(PBMC:bacterium ratio 5:1) in the presence of palmitate, butyrate or
ALA (0.4, 1.8 or 0.3 mM, respectively - concentrations based on
physiological and sepsis range ([4,5] (unpublished data)). Superna-
tants were collected to quantify IL-6, IL-10 and TNF concentrations
by ELISA. The MTT assay was used to assess metabolic activity. Non-
parametric one-way ANOVA tests with Dunn’s correction were used
for statistical analyses.
RESULTS. PBMCs stimulated with bacteria or bacterial product
showed a metabolic activity similar to controls (data not shown) but
secreted appreciable levels of cytokines contrary to unstimulated
cells. FAs variably affected cytokine secretion [Figure 1]. Palmitate
strongly reduced IL-10 secretion, butyrate markedly inhibited all cyto-
kines, whereas ALA increased bacteria-induced IL-6 secretion but
inhibited IL-10.
CONCLUSION. Palmitate, butyrate and ALA display proinflamma-
tory, immunosuppressive and mixed effects, respectively. The vari-
able immune effects suggest that FA supplementation should be
tailored according to the patient’s inflammatory phenotype.
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INTRODUCTION. In sepsis and septic shock administration of broad-
spectrum antibiotics is the mainstay of therapy. De-escalation (DE)
of antimicrobials has been proposed as a safe strategy associated
T9
T9
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the positive culture results. However, for many patients with sepsis,
cultures remain negative, making de-escalation to a targetable
pathogen difficult.
METHODS. All patients admitted from January 2012 to December 2018
were included. This is a retrospective analysis of a prospectively col-
lected database (Spanish national registry ENVINHELICS). At ICU admis-
sions, all patients are screened for the nasal MRSA carriage. DE was
defined as anti-MRSA agent discontinuation within 4 days of initi-
ation. We analysed variables concerning demographic characteristics,
comorbidities, clinical presentation, duration of mechanical ventilation,
need of renal replacement therapy, ICU and hospital length of stay and
mortality. Acute Physiology and Chronic Health Evaluation II (APACHE
II) score and Glasgow Coma Scale (GCS), were used to asses baseline se-
verity of illness.
Results are expressed in mean value and standard deviation (SD) for
numerical variables and percentage over total patients for categorical
variables. Analysis was performed using chi-square or exact Fisher
test for qualitative variables and Student t test or Mann-Whitney U
test for quantitative variables when appropriate. P values of less than
0.05 were regarded as statistically significant.
RESULTS.
Of 9342 patients analysed, 3043 fulfilled criteria of sepsis: 1527 had
positive cultures and 1516 all cultures were negative. Of them, 141
were excluded for being positive for nasal MRSA carriage. Finally, 103
patients were analyzed (59 received empirically vancomycin and 44
linezolid), 36 patients who had anti-MRSA agent de-escalated (vanco-
mycin in 22 and linezolid in 14), and 67 patients in whom de-
escalation did not occur. The main infection foci were pneumonia
and soft tissue infection in both groups. The results are shown in ta-
bles 1 and 2.
CONCLUSION. Anti-MRSA agent can be safely accomplished in
culture-negative community or nosocomial extra-ICU sepsis and sep-
tic shock in non-MRSA nasal carriers.
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INTRODUCTION. An early diagnosis of sepsis can significantly
affect outcome.[1] However, up to date there is still a lack of un-
derstanding in time response of sepsis markers after cardiac
surgery.
OBJECTIVES. We investigated in a close-meshed analysis differ-
ences in the perioperative time response of Interleukin-6 (IL-6),
Procalcitonin (PCT) and C-reactive protein (CRP) during and after
elective cardiac surgery in patients developing postoperative sep-
sis or not.[2]
METHODS. A prospective cohort study in 100 patients undergoing
elective cardiac surgery with cardiopulmonary bypass (CPB) at the
Medical University of Vienna was performed. IL-6 and PCT were mea-
sured simultaneously and consecutively at 19 timepoints until the
10th postoperative day (POD). Additionally, CRP was measured from
POD 1 to 10. Patients were divided into two groups, Sepsis and no-
Sepsis, according to Sepsis-3 guidelines.[3]
RESULTS. 96 patients (four patients dropped out for analysis), with a
mean age of 67.4±11.2 years were analysed. CABG, valve and com-
bined procedures were performed in 16.7% (N=16), 28.1% (N=27)
and 55.2% (N=53), respectively. Sepsis was found in 8.3% of patients
(N=8). Mean SOFA score at ICU admission was 8.6±1.8 in septic and
7.7±2.3 in patients without sepsis (P=0.1905). Septic patients had a
prolonged ICU stay (Sepsis: 8.1±4.2 days vs. no-Sepsis: 2.5±2.1
days; P=0.0062). IL-6 increased continuously during the procedure
with reaching a plateau 2 to 6 hours after CPB until POD 1 in both,
patients with and without postoperative sepsis. Four hours after CPB
we found significantly different median IL-6 values between both
groups (393.9 [IQR 179.9; 484.0] pg/ml, 164.70 [IQR 108.80; 251.00]
pg/ml, respectively; P = 0.0374). PCT began to increase four hours
post CPB with reaching a peak on POD 1 in both groups (Sepsis: 1.91
[IQR 1.01; 5.00] ng/ml vs. no-Sepsis: 0.37 [IQR 0.21; 0.76] ng/ml; P=
0.0066). Patients without Sepsis returned to baseline earlier, com-
pared to those with postoperative Sepsis. We found significantly dif-
ferent median PCT values 6 hours post CPB between both groups
(0.57 [IQR 0.2725; 1.16] ng/ml, 0.17 [IQR 0.09; 0.34] ng/ml, respect-
ively, P=0.01648). Median CRP levels reached a peak on POD 3 in
both groups, whereas the difference did not reach statistical signifi-
cance (23.57 [IQR 19.48; 27.6] mg/dl, 17.22 [IQR 12.97; 21.87] pg/ml,
respectively, P=0.05525).
CONCLUSION. Earlier increases in IL-6 were found in patients devel-
oping later postoperative sepsis, compared with more trad-
itional used inflammation parameters. Nevertheless, rapid changes
in IL-6 plasma concentrations make it difficult to detect peak values
in contrast to PCT. Therefore, increased IL-6 concentrations may
earlier indicate the risk of postoperative sepsis, bu t strong inter-
individual differences make it difficult for routine clinical use.
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INTRODUCTION. Clinical features are still the cornerstone in diagnosis
of sepsis, nevertheless, there are various biomarkers which can help
physicians to confirm or question sepsis. Study of Kauppi et al. identi-
fied myristic acid as a metabolite with highest predictive value in the
metabolome of septic patients with bacteremia, with sensitivity 1,00
(95% CI 0,85-1,00) and specificity 0,95 (95% CI 0,74-0,99) [1]. Cambiaghi
et al. observed its significant decrease in non-responders to the treat-
ment of septic shock [2].
OBJECTIVES. Authors present pilot study of correlation of myristic
acid serum levels with diagnosis of sepsis and its comparison with
control group.
METHODS. The levels of myristic acid, were determined by gas chro-
matography/mass spectrometry (GC/MS) method in deep-frozen serum
samples in the first five days following sepsis diagnosis.Kruskal-Wallis test was used for evaluation of statistical differences
between sepsis group in each time interval and control group. Wil-
coxon signed-rank test was used to evaluate the statistical signifi-
cance of differences in values between time intervals.
RESULTS. Values of myristic acid levels are presented as a median
and interquartile range - IQR (1st quartile; 3rd quartile).
In healthy subjects (n = 66) myristic acid concentration was
18.9 μmol/l (16.2; 22.8), in septic patients (n = 25) in time T0
56.4 μmol/l (34.9; 80.9) with decreasing level trend until day 5. Myr-
istic acid levels were in all measurements in septic patients signifi-
cantly higher than levels in healthy controls (p < 0.001). Statistical
significance of difference in myristic acid levels in individual mea-
surements in septic group is shown in Figure 1.
CONCLUSION. Preliminary results show elevated concentration of
myristic acid (vs. control group) at the time of sepsis diagnosis with
gradual decrease towards day 5 from sepsis onset.
We conclude that myristic acid may be a promising biomarker in the
early identification of septic patients. It is currently being systematic-
ally evaluated [3].
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INTRODUCTION. Recent studies have shown excess mortality in
intensive care unit (ICU) patients with hyperoxemia, particularly
after stroke or cardiac arrest [1]. The effect of hyperoxemia in
sepsis is unknown and few studies have been conducted on the
subject [2]. The objective of our study was to evaluate the impact
of hyperoxemia on mortality during septic shock.
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Page 244 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55METHODS. Design of a retrospective study using the Medical Information
Mart for Intensive Care III (MIMIC-III) database provided by the Massachu-
setts Institute of Technology (MIT) with the approval of the MIT Ethics Com-
mittee and the Beth Israel Deaconess Medical Center in Boston. The
inclusion criteria were: age ≥ 18 years admitted in polyvalent surgical or
medical ICU, SEPSIS 3 septic shock criteria, and ICU stay with invasive venti-
lation ≥ 24 hours after admission. O2 exposure was defined by the average
PaO2 over the first 24 hours of ICU stay with distinction between two
groups: normoxemia (PaO2 70-120 mmHg) and hyperoxemia (PaO2 > 120
mmHg). The primary endpoint was ICU mortality. The variables are
reported as mean (standard deviation) or median [interquartile range]. Uni-
variate analysis was performed by Student or Wilcoxon tests for continuous
variables and Pearson Chi2 tests for categorical variables. A multivariate
analysis was performed by logistic regression adjusting for age, gender,
and clinical or demographic parameters with p < 0.1 between groups.
Gross and adjusted Odds Ratios could thus be calculated. The analyses
were carried out bilaterally, taking a significance threshold of p < 0.05.
RESULTS. Between 2001 and 2012, 628 patients were included, 225 in
the normoxemia group and 403 in the hyperoxemia group. The epi-
demiological data are presented in Table 1. The mean PaO2 in the nor-
moxemia group was 99.8 ± 12.8 mmHg compared to 166.2 ± 41.4
mmHg in the hyperoxemia group. Hyperoxemia was associated with
lower ICU mortality in univariate analysis (34.2% versus 42.7%, OR =
0.69 [0.50-0.98]; p = 0.045) but not in multi-variate analysis (OR = 0.94
[0.65-1.35]; p = 0.72). The parameters associated with mortality in multi-
variate analysis were initial severity (SAPS II, OR = 1.02 [1.00-1.04]; p =
0.024 and APACHE III, OR = 1.01 [1.00-1.03]; p = 0.022) and duration of
norepinephrine treatment (1.00 OR = [1.00 - 1.01]; p = 0.003).
CONCLUSION. In this population of patients with septic shock, hyper-
oxemia was not an independent factor of mortality. These data are in
contradiction with those previously published in other ICU patient
populations. Thus, a prospective study in septic patients with a direct
analysis of the impact of hyperoxemia appears necessary.
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INTRODUCTION. Acute alterations of acid-base equilibrium are common
in septic patients.[1] Non-carbonic buffers (albumin and phosphates in
plasma with the addition of hemoglobin in whole blood) contribute pro-
tecting the human body against metabolic acid-base disorders, while they
are the only buffer system during respiratory derangements. The ability of
these molecules to minimize pH variations due to acute pCO2 changes
has been defined as non-carbonic buffer power (β).[2] Septic patients have
significantly lower values of hemoglobin and albumin, i.e., the major non-carbonic buffers of whole blood.[3] Moreover, albumin is a macromolecule
whose structure might change significantly during pathological conditions
such as inflammation.[4] It is currently unknown if and how pathological
changes of protein structure affect its buffering function.
OBJECTIVES. To compare the β of blood and plasma of septic patients
and healthy volunteers and compute the molar β of plasma (βmol PL)
in order to evaluate the buffering capacity of albumin.
METHODS. Whole blood and isolated plasma collected from septic
patients and healthy controls were tonometered at 2, 5, 12 and 20%
of CO2 in air. Blood gases, pH, albumin and hemoglobin were mea-
sured. For blood and plasma of both groups, variations of [HCO3-]
over pH were modeled according to a polynomial multilevel model
with random intercept at subject level and random slope at pH level.
For each model, a function describing β was obtained as β(pH)=–
d[HCO3-]/dpH, and a representative β at pH=7.40 was calculated. The
same analysis was performed after normalizing [HCO3-] variations for
millimolar albumin concentration (βmmol PL). Patients and controls
were compared by t-test or rank-sum test, as appropriate. Data are
reported as mean ± SD or as median and interquartile range.
RESULTS. Eighteen septic patients (61% with septic shock [1]) and 18
controls were studied. Patients had lower albumin and hemoglobin
than controls (3.0 [2.8-3.2] vs. 4.7 [4.6-4.9] g/dL, p<.001 and 10.5±0.8
vs. 14.3±1.0 g/dL, p<.001, respectively). The β of both blood and
plasma of septic patients was significantly lower as compared to
healthy volunteers (Fig.1). Furthermore, the βmmol PL of septic pa-
tients was also significantly lower (Fig.2).
CONCLUSION. Septic patients are less protected against acid-base
derangements, as the β of both blood and plasma are significantly
reduced. Besides lower buffer concentrations, it is conceivable that
the buffering function of albumin is altered during sepsis.
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Page 245 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55000975
Antibiotic Administration in the Emergency Department for
Suspected Sepsis: An Evaluation of Unintended Consequences
J. Lee1, A. Abbasi1, R. Greene2, P. Chen3, C. Mailloux4, A. Shick5,
N. Hudepohl5, G. Baird6, L. Mermel7, M. Levy1
1Division of pulmonary, critical care and sleep medicine, Warren Alpert
School of Medicine at Brown University, Providence, United States of
America; 2Department of pharmacy, Rhode Island Hospital, Providence,
United States of America; 3Department of respiratory diseases, Shenzhen
Third People's Hospital, Shenzhen, China; 4Lifespan corporate
services, Rhode Island Hospital, Providence, United States of America;
5Emergency department, Rhode Island Hospital, Providence, United
States of America; 6Lifespan biostatistics core at rhode island
hospital, Rhode Island Hospital, Providence, United States of America;
7Deptartment of epidemiology & infection control, Brown
University, Providence, United States of America
Correspondence: J. Lee
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000975
INTRODUCTION. Sepsis is the leading cause of death in U.S. hospi-
tals, and the second most common cause of 30-day hospital-
readmission. The “sepsis bundle” was developed by the Surviving
Sepsis Campaign with the goal to reduce mortality and morbidity
from sepsis. Sepsis bundle compliance is associated with lower risk
and reliability-adjusted mortality. A recent update to the Surviving
Sepsis Campaign guidelines, including a ‘hour-1-bundle’ recommends
the administration of broad spectrum antibiotics to patients present-
ing to the emergency department (ED) with possible sepsis. This has
raised concerns over possible unintended consequences of inappro-
priate antibiotic administration in non-septic patients, such as higher
rates of Clostridium difficile infection (CDI).
OBJECTIVES. We aimed to retrospectively assess the incidence of CDI
in non-septic patients who received antibiotics in the ED for sus-
pected sepsis. We hypothesized that early antibiotic administration
combined with antibiotic stewardship would not be associated with
an increased risk of CDI.
METHODS. This was a single center, retrospective cohort study. All
adult patients admitted from the ED from 2017 to 2018 were in-
cluded in the analysis. Patients were identified that (i) presented with
two or more criteria of the systemic inflammatory response syn-
drome (SIRS), (ii) received intravenous antibiotics in the ED, (iii) re-
ceived intravenous antibiotics for less than and more than 48 hours,(iv) discharged from the hospital with and without a diagnosis of
sepsis, and (v) diagnosed with CDI within two months of admission.
RESULTS. 25,863 non-trauma patients were admitted from the ED
during the study period. 7,432 (28.7%) patients received antibiotics
in the ED, of which 4,259 (57.3%) patients presented with two or
more SIRS criteria and 1372 (32.2%) patients presented with two or
more SIRS criteria and were discharged with a diagnosis of sepsis. Of
4,259 patients that presented with two or more SIRS criteria and re-
ceived antibiotics in the ED, 1,387 (29.2%) patients had antibiotics
discontinued within 48 hours. The CDI incidence of non-septic pa-
tients administered antibiotics in the ED after presenting with two or
more SIRS criteria, and had antibiotics discontinued within 48 hours
was 0.67%, compared to 2.29% in those in whom antibiotics were
not discontinued (p = 0.0028). In comparison, the CDI incidence of
septic patients administered antibiotics in the ED after presenting
with two or more SIRS criteria and treated with antibiotics for more
than 48 hours was 5.1% (p < 0.001). The CDI incidence in patients
not administered any antibiotics throughout their emergency depart-
ment or inpatient stay was 0.33% (p = 0.1).
CONCLUSION. With appropriate antibiotic stewardship, the adminis-
tration of antibiotics to non-septic patients in the emergency depart-
ment does not increase the incidence of CDI.
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INTRODUCTION. Indoleamine 2,3 dioxygenase 1 (IDO1) metabolizes
tryptophan (TRP) through the kynurenine (KYN) pathway (KP) and it
is induced when systemic inflammation is present, as in sepsis. The
upregulation of the KP has been identified as a hypotension culprit
in in vivo models of sepsis and septic shock [1] and associated to
increased mortality in critically-ill patients [2].
OBJECTIVES. We investigated the KP in septic patients to determine if
it was involved in sepsis severity. We evaluated the association be-
tween IDO1 activity and the severity of sepsis-induced hypotension
and we analyzed the association between the plasma concentration of
KP metabolites and mortality, both at ICU discharge and at 90 days.
METHODS. We performed analysis on a subgroup of patients (n=100,
50 survived and 50 deceased at ICU discharge), previously enrolled
in the randomized controlled trial Albumin Italian Outcome Sepsis
[3]. TRP, KYN, kynurenic acid (KYNA) and 3-hydroxyantranilic acid (3-
HAA) concentration were determined through liquid chromatography
mass spectrometry on ICU day 1, 2 and 7. We used KYN/TRP ratio as
a surrogate of IDO1 activity. We considered the inotropic score (IS)
(dopamine + adrenaline x 100 + noradrenaline x 100 [μg/kg/min]) as
the expression of pressors need for keeping a mean arterial pressure
above 65 mmHg. We applied univariate and multivariate models ad-
justed for age, sex, sepsis source, SOFA and SAPS II at ICU admission
to determine associations among variables.
RESULTS. TRP concentration was halved at ICU admission, while KYN,
KYNA, and 3-HAA were increased by 2-10 times, compared to the
physiological values. TRP decrease suggested IDO1 activation, as con-
firmed by the sevenfold increase of the KYN/TRP ratio. IDO1 upregu-
lation and TRP catabolism remained unchanged during all the 7
days, as shown by constantly high KYN, KYNA, 3-HAA and KYN/TRP
ratio. IS increased by 1.68 points [95%CI 1.18–2.41, P=0.006] for each
twofold KYN/TRP ratio increment. KYN and its metabolites were in-
creased in the deceased with respect to the survivors, either at ICU
discharge or at 90 days (P<0.05). The univariate model showed KYN
and KYNA associated to ICU discharge mortality (P<0.01), whereas
KYN, KYNA and 3-HAA associated to 90-day mortality (P<0.01). The
multivariate model showed KYNA associated to ICU discharge
Page 246 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55mortality (HR 1.30, [95%CI 1.10–1.54, P=0.002] for each twofold con-
centration increase). Moreover, KYN, KYNA and 3-HAA were inde-
pendent predictors of 90-day mortality and the hazard ratios were
1.50 [95%CI 1.06–2.13, P=0.02], 1.27 [95%CI 1.08–1.49, P=0.004] and
1.23 [95%CI 1.04–1.46, P=0.02] respectively, for each twofold increase
of the metabolites concentration.
CONCLUSION. The KP was upregulated in septic patients. IDO1 acti-
vation was associated to the severity of sepsis-induced hypotension
and KYN, KYNA and 3-HAA high concentrations were independent
risk factors of mortality in septic patients.
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INTRODUCTION. Patients with spinal muscular atrophy (SMA) who
are unresponsive to appropriate medical treatment, are often treated
with Noninvasive PositivePressure Ventilation (NPPV). Clinical predic-
tors of the outcome of this treatment are scarce. Therefore, we evalu-
ated the role of the biomarkers TLR-2 and TLR-4 in predicting 90-day
mortality in patients with SMA who receive treatment with NPPV.
METHODS. The study population were 17 patients treated with NPPV
for SMA. Clinical and background data was registered and blood
samples taken for analysis of inflammatory biomarkers. TLR-2 and
TLR-4 were selected for analysis, and related to risk of 90-day mortal-
ity (primary endpoint) using Cox proportional hazard models ad-
justed for gender, age and various clinical parameters.
RESULTS. Of the 17 patients, there were 2 subgroup in regards to pri-
mary diagnosis: spinal muscular atrophy TYPE 1 (SMATYPE1, n = 17),
spinal muscular atrophy TYPE 2 (SMATYPE2, n = 7). There was signifi-
cant difference in the basic characteristic of the subgroups, but not in
the clinical parameters that were used in treatment decisions. 10 pa-
tients died within 90 days of admission (58,82%). The Hazard Ratio for
90-days mortality per 1-SD increment of TLR-4 was 4.498 (95% CI 2.34-
8.04, p < 0.001). When TLR-4 values were divided into tertiles, the high-
est tertile had a significant association with 90 days mortality, HR
10.012 (95% CI 1.29-78.17, p for trend 0.022), compared with the lowest
tertile. This correlation was maintained when the largest subgroup with
SMATYPE1 was analyzed. TLR-2 was correlated in the same way, but
when put into the same model as TLR-4, the significance disappeared.
CONCLUSION. TLR-4 is a target to explore further as a predictor of
90 days mortality, in patients with SMA treated with NPPV.
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INTRODUCTION. Patients recovering from critical illness involving a
stay in an Intensive Care Unit (ICU) and their family and friends maystruggle when they go home from hospital. There can be significant
physical, psychological and cognitive sequelae for patients (1). A recent
study of 4943 ICU survivors found that 46% fulfilled the criteria for anx-
iety, 40% for depression and 22% for post traumatic stress disorder
(PTSD), whilst 18% met the caseness threshold for all three psycho-
logical conditions (2). Relatives can also suffer from psychological prob-
lems, referred to as post intensive care syndrome (PICS) and post
intensive care syndrome – family (PICS-F) (3). ICUsteps started at one
peer support group in Milton Keynes, UK, and has grown to 23 support
groups around the UK and Ireland. Anecdotally patients and families re-
port finding it helpful to attend a support group meeting but as yet no
research has been undertaken examining experiences of attending.
OBJECTIVES. The aim of the study was to explore the positive and
negative experiences of attending a peer support group meeting.
METHODS. A survey was undertaken to explore reasons for attending a
support group, benefits and negative aspects of attending. ICUsteps
has a system already established for advertising studies for external re-
searchers from across the English speaking world. This involves the
study being advertised by email to a list of research volunteers (both
ex-patients and family) and, where needed, to the organisers of the 23
ICUsteps support groups. This system was used to advertise this study
and questionnaires sent out by email to respondents. The results were
analysed using qualitative thematic methods.
RESULTS. A total of 40, 37 ex-ICU patients and 3 family members,
returned the questionnaire. Thematic analysis resulted in six bene-
fits:- 1. Being able to talk to others who have been through the same
experience 2. Normalisation of physical and psychological problems
3. Getting information about ICU and recovery 4. Making new friend-
ships 5. Getting support from others 6. Giving something back for all
their care. Over half of the respondents, including the 3 relatives, (n=
26) reported no negative aspects of attending support groups meet-
ings. The remaining 14 patients identified some negative aspects. 1.
Feeling overwhelmed revisiting old memories. 2. Feeling left behind
or sidelined. 3. Finding the time or place of the meeting difficult. 4.
Finding it difficult to see others in the group being upset. 5. Finding
it difficult to ensure everyone had time to talk. 6. Feeling really
angry. While all the respondents felt they had benefited from attend-
ing, 42% reported some negative experiences that would need ad-
dressing by group organisers
CONCLUSION. Peer support works for some but not all. This is the
first research to look at the benefits and negative aspects of attend-
ing an peer support group meeting. While some patients, families
and friends thrive in a group situation, others may need one to one
support and others may find the information available on the inter-
net meets their needs. Although the survival rate from critical illness
has significantly improved, there remain unanswered questions
about how peer support can best enhance survivorship.
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Page 247 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. Some of preterm infants with severe bronchopulmon-
ary dysplasia (sBPD) may require long-term mechanical ventilation be-
yond term corrected gestation age (CGA), and therefore continue to care
after referral to paediatric intensive care unit (PICU). At referral unit, decid-
ing final respiratory support of those patient is the focus of strategy to
shift toward less intensive care, rather than routine neonatal care. How-
ever, since the number of this patient population is small at any single
center, there is very little data regarding the overall outcomes and con-
sideration factors for determining final respiratory support
OBJECTIVES. Our aims was to define the character and outcomes of
preterm infants with sBPD who was required for referral to PICU due to
weaning failure beyond 40 weeks CGA, and to determine the clinical
factors associated with decision timing of final respiratory support.
METHODS. This study is a retrospective review of preterm infants
with sBPD, who was transferred to PICU of a tertiary hospital from
nationwide neonatal intensive care unit (NICU) because of weaning
failure between January 1, 2014 and September 30, 2018.
RESULTS. Of 14 eligible patients, the median gestational age at birth
was 26 (25-29) weeks, and birth weight was 875 (642.5-855.0) g. The
median (range) CGA at referral was 47 (43-55) weeks and the median
length of stay in previous NICU was 154 (10.8-202.3) days after birth. All
of patients had endotracheal tube, and 12 patients (85.7 %) required
mechanical ventilation at the time of referral. After referral, based on
multidisciplinary approach to chronic respiratory failure, the following
problems was found that make wean difficult; large airway malacia, 7
(50.0%), peripheral airway obstruction, 6 (42.9 %), significant upper air-
way obstruction, 3 (21.4 %), and pulmonary arterial hypertension were
discovered 8 (57.1 %) respectively. Finally, 8 of 14 patients (57.2%) was
successfully extubated without tracheostomy, and remaining 6 patients
underwent tracheostomy. Final respiratory support of all patients was
determined at median 56 (48-63) weeks CGA. One patient was died
after tracheostomy, and the patients requiring tracheostomy had a sig-
nificantly longer stay in PICU during admission than patients without
tracheostomy (187.63 vs. 297.67 days, p=0.033). Multivariable analysis
showed that length of stay in previous NICU (p<0.05) and tracheostomy
placement (p=0.021) were each associated with the decision time of
final respiratory support. Until 56-57 weeks CGA, the 75th percentile of
the patient not requiring tracheostomy was liberated from mechanical
ventilation. On the other hands, less than 25th percentile of the patient
who eventually failed to weaning process underwent tracheostomy
until that time (Log rank test p=0.008).
CONCLUSION. There was not uncommon to be successful extubation
after 40 weeks CGA among preterm infant with BPDs requiring pro-
longed mechanical ventilation. However, in patients who finally
underwent tracheostomy, decision of respiratory support tended to
be delayed and the overall outcomes was poor.
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INTRODUCTION. Optimal sedation for mechanically ventilated
pediatric patients is integral to the practice of pediatric critical care, be-
cause both under- and oversedation may have negative effects while
achieving a good level of sedation and analgesia will reduce anxiety,
pain, and agitation, enhance synchronization with mechanical ventila-
tion (1-4). Accidental extubation events were reported many times in
our Pediatric Intensive Care Unit (PICU), root cause analysis identified
sedation is an issue. There is protocol to evaluate the pain and sedation
level in our PICU, but there is a lack of standardized practice of sedation
strategy for those patients, which may lead to increase mechanical ven-
tilation days and its associated complications (4-8).
OBJECTIVES. Pediatric Intensive Care Unit in King Abdulaziz Medical
City, Riyadh, KSA is 25-bed capacity, Sedation and analgesia are neces-
sary components in our patients, especially those requiring mechanicalventilation. The aim of this project was to develop and implement
guidelines for sedation management in PICU and evaluate the impact
of these as a part of quality and patients’ safety program.
METHODS. This project used a pre-post design for data collection. All
PICU ventilated patients receiving continuous sedation infusion were
enrolled over three months for baseline data collection.
Guidelines for sedation and analgesia management for critically ill chil-
dren including algorithm and assessment tools have been implemented.
One month post-implementation data has been collected for three
months. In addition to key outcome variables (length of stay, ventilation
time, sedation duration, successful Extubation rate, unplanned Extubation
rate), process measures data (Sedation boluses use average, Percentage
of patients under sedated, Percentage of patients over sedated) were
evaluated. A sample of patients post implementation: control phase has
been collected and analyzed every two months for one year.
RESULTS. 37 patients have been enrolled in the pre-implementation
phase, and 36 patients also included in the post-implementation
phase, while 19 patients had been included in the control phase. The
decrease of sedation boluses requirement average prior to imple-
mentation from 7.7 Bolus/patient/day to 5.7 post-implementation,
with a remarkable decrease in the percentage of high pain score
(above 4) per day from 19.0% to 15.4% (Graph1) approached signifi-
cance. As well, there was observed a decrease in sedation assess-
ment average by bedside nurses from average 18.9 of pain
assessment/patient/day to 14.1 of pain assessment/patient/
day (Graph 2). Decrease sedation days is noted in results, in the con-
trol phase, but this needs further evaluation (Graph 3).
CONCLUSION. The sedation standardization project demonstrated
better pain and sedation control by achieving a target comfort
level with fewer sedation boluses, which has a positive impact on
patient’s outcome in PICU. This standardization reflected also on
bedside nurses’ work as the sedation assessment become less fre-
quent, and more organized overall. The importance of the find-
ings of this project indicates that guidelines can be used to
manage the PICU patient’s comfort and pain without compromis-
ing the quality of care.
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Page 248 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. The objective of this study was to determine prog-
nostic factors related with mortality in pediatric hemato-oncology pa-
tients admitted for pulmonary complications on the ICU.
METHODS. This was a retrospective cohort study of patients below
21 years old with underlying hemato-oncologic diseases admitted for
pulmonary complications at the ICU of a tertiary referral hospital in
Korea between April 2009 and March 2017. Patients admitted for
perioperative management or non-pulmonary complications were
excluded. Demographics, laboratory parameters, and clinical parame-
ters such as Glasgow Coma Scale (GCS), the pediatric version of the
Sequential Organ Failure Assessment (pSOFA) score and the Pediatric
Logistic Organ Dysfunction (PELOD) score, etc., were extensively
reviewed.
RESULTS. A total of 110 pediatric hemato-oncology patients were ad-
mitted at the ICU for pulmonary complications. The median age was
13 (IQR, 8–16) years old, and 62 (56.3%) were boys. The median dur-
ation of ICU hospitalization was 8 (IQR, 4.25–16) days, and 45 pa-
tients (40.9%) were applied mechanical ventilation. The mortality rate
was 59.1% (65/110 patients). Factors with a significant association to
increased mortality in a multivariable logistic regression analysis were
as follows: low GCS scores, low SpO2/FiO2 ratio, low hematocrit
levels, and increasing total bilirubin levels. The pSOFA score and
PELOD score assessed on the third day of admission had significant
discrimination for in-ICU mortality with an area under the curve of
0.87 (95% CI, 0.80-0.95) and 0.83 (95% CI, 0.74-0.92), respectively.
CONCLUSION. The GCS score, SpO2/FiO2 ratio, hematocrit level, and
total bilirubin level, pSOFA scores, and PELOD scores are useful fac-
tors for the prediction of an increased risk for mortality in pediatric
hemato-oncology patients with pulmonary complication.
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INTRODUCTION. Critically ill patients and their closest relatives often
suffer from post traumatic stress, anxiety and depression after the
patient is discharged from the intensive care unit (1). This may be re-
lated to the traumatic situation of being critically ill and fighting for
survival. Intensive care unit diaries have been proposed to help rela-
tives and patients to process the experience and find meaning.
OBJECTIVES. To achieve a more comprehensive understanding of
how relatives' diaries for intensive care unit patients work.
METHODS. A convergent mixed methods analysis (2) of data from a ran-
domized controlled trial exploring the effect of an intensive care unit
diary on posttraumatic stress symptoms in patients and relatives (3) and
two hermeneutic phenomenological studies of patients' and relatives'
perceptions and uses of the diary after discharge from the hospital (4,5).
RESULTS. The mixed methods analysis expanded the results of the
underlying studies by identifying that writing a diary is a preventive
measure against posttraumatic stress symptoms for relatives. The
process of expressing feelings and thoughts in the critical situation
combined with an opening for discussing the difficult time with the
patient after discharge and having this experience acknowledged by
the patient may have resulted in the lower levels of posttraumatic
stress symptoms found in relatives who wrote a diary. For patients,
the diary did not prevent posttraumatic stress symptoms but helped
the patient interpret fragmented and disturbed memories of the in-
tensive care unit into a coherent story within the framework of the
relatives' diary. This strengthened the bonds between patients and
relatives. However, some patients do not welcome the diary and
want only to look forward.CONCLUSION. Writing a diary supports the relative and patients dur-
ing recovery and furthermore prevents posttraumatic stress symp-
toms in relatives. Offering the relative a diary should take relatives
preferences into account and guide relatives on how to or whether
to share the diary with the patient.
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INTRODUCTION. Data that indicate vitamin A status in critically ill
children with sepsis are sparse. The association between serum vita-
min A levels and the clinical outcomes of sepsis has not been well
assessed.
OBJECTIVES. The aim of this study was to assess the prevalence of
vitamin A deficiency in critically ill children with sepsis and to reveal
its association with the clinical outcomes.
METHODS. Critically ill children with sepsis admitted to the studied
pediatric intensive care unit (PICU) were engaged in this prospect-
ive study. Sex- and age-matched approximate-health children form
the Department of Pediatric Surgery were enrolled as the control
group. Blood samples were collected from all patients in the first 24
hours of admission for measurement of serum vitamin A status. We
compared vitamin A status between sepsis group and control
group. Then, we compared the clinical characteristics of two the
subgroups of septic patients with vitamin A deficiency and those
without vitamin A deficiency. Univariate and multivariable methods
were used to evaluate the association between vitamin A deficiency
and septic shock.
RESULTS. One hundred and sixty septic children, and forty-nine
approximate-health children were enrolled in this study. Serum VA
levels in sepsis group were significantly lower than control group
(0.19±0.11 vs 0.34±0.12, p<0.001). Vitamin A deficiency was found in
94 (58.8%) subjects in studied group and 6 (12.2%) subjects in the
control group (P<0.001). In septic patients, 28-day mortality and hos-
pital mortality in patients with vitamin A deficiency were higher than
that in patients without vitamin A deficiency, but the difference was
not significant (P>0.05). Vitamin A deficiency was associated with
septic shock with an unadjusted odds ratio (OR) of 3.297 (95% confi-
dence interval (CI), 1.169 to 9.300; P=0.019). In a logistic model, vita-
min A deficiency (OR, 4.630; 95% CI, 1.027-20.866; P=0.046),
procalcitonin (OR, 1.029; 95% CI, 1.009-1.048; P=0.003), and the
Pediatric Risk of Mortality scores (OR, 1.132; 95% CI, 1.009-1.228; P=
0.003) were independently associated with septic shock.
Page 249 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55CONCLUSION. The prevalence of vitamin A deficiency was high in
children with sepsis. Serum vitamin A levels were independently as-
sociated with septic shock.
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INTRODUCTION. In pediatric health care, moderately high levels of
nursing burnout risk were found (Pradas-Hernàndez et al., 2018), with
potential negative impacts on professional wellbeing and patient
care (Tawfik et al., 2017). The quality of care has been investigated in
several studies, analysing nurses’ perception about the risk of ad-
verse events, highlighting how this perception matched the actual
incidence of the adverse events (Winning et al., 2018).
OBJECTIVES. To investigate the relationship between nursing burn-
out and the perception of the risk of adverse events in Newborn and
Pediatric Intensive Care Units (NICUs and PICUs) in Italy.
METHODS. Data were extracted from RN4CAST@IT-Ped, a larger cross-
sectional observational study involving nurses and pediatric nurses,
through convenience sampling of 13 hospitals affiliated to the Italian
Pediatric Hospitals Association. Burnout was investigated using the
Maslach Burnout Inventory, and the nurses’ perception of the risk of ad-
verse events was assessed through questions regarding the frequency of
six adverse events. Data were analysed through descriptive analysis and
logistic regression with IBM SPSS 22.0 software.
RESULTS. The responses of 451 NICU and PICU nurses were analyzed.
An increase in 'Emotional Exhaustion' increased nurses’ perception of
the risk of medication errors (p=0.002; OR=1.081) and of the onset of
pressure ulcers (p=0.004; OR=1.051). An increase in 'Depersonalisa-
tion' increased nurses’ perception of the risk of pressure ulcers (p=
0.040; OR=1.079) and pneumonia (p=0.018; OR=1.097).
CONCLUSION. Develop improvement interventions to increase staff
wellbeing and patient safety in the health care system based upon
our results, which are consistent with international literature, could
improve the overall quality of nursing care in NICU and PICU.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000217INTRODUCTION. ICU survivors have a 1-year mortality rate of 30%
(1), and a reduced quality of life associated with post-ICU syndrome
(2); a triad of cognitive decline, physical weakness and psychiatric
disorders. Early rehabilitation improves outcomes, leading to greater
independence. The NICE CG83 guidelines instruct the provision of re-
habilitation information to critical care patients on discharge. Cur-
rently, only a third of UK trusts meet these guidelines (3).
OBJECTIVES. Within 20 weeks, we aimed to achieve 100% patient
and therapist satisfaction with the rehabilitation information given to
patients at risk of physical morbidity on discharge from critical care
at Medway Maritime hospital.
METHODS. Critical care patient and therapist satisfaction was
assessed using questionnaires at baseline and after each PDSA cycle.
In PDSA1, a generalised rehabilitation information booklet was intro-
duced. In PDSA2, a personalised rehabilitation plan for pre-discharge
completion by the therapists was added.
RESULTS. A shift was observed in critical care patient satisfaction
scores, indicating a significant change in the median from 20% at
baseline to 70% after PDSA2. This was also reflected in the therapist
satisfaction scores which increased significantly from 60% at baseline
to 80% after PDSA2.
CONCLUSION. The introduction of a generalised information booklet,
supplemented with a personalised recovery plan, is an effective way
of increasing critical care patient and therapist satisfaction with post-
discharge rehabilitation information provision. This should translate
to greater critical care patient engagement with rehabilitation and
improved long-term outcomes. To further increase satisfaction, the
addition of psychiatric input to the booklet is currently underway.
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INTRODUCTION. Pediatric intensive care units (PICU) has been estab-
lished in many developed countries in order to provide specific in-
tensive cares for children. However, inter-hospital transport to PICU
has been still needed because PICU has been scarce even in devel-
oped countries. Deterioration of outcomes associated with inter-
hospital transport has been concerned [1].
OBJECTIVES. The aim of this study was to evaluate whether inter-
hospital transport for severe pediatric patients was associated with
in-hospital mortality.
METHODS. This study was a multicenter retrospective cohort study.
Data were derived from the Japanese Registry of Pediatric Acute Care
(JaRPAC) from 2013 to 2017. Inclusion criteria for this study were pa-
tients who aged 16 years and under and admitted to the PICU. Pa-
tients after elective surgery were excluded. The primary outcome
was in-hospital mortality. The secondary outcome was deterioration
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compared with at admission. Collected data included institution type
of referral hospital, patient’s baseline characteristics, supportive ther-
apies, PCPC, in-hospital mortality, and length of PICU stay. We de-
fined the patients admitted PICUs from their hospitals as “In-House”
group and transferred from others (referring hospitals) as “Transfer”
group. To adjust for inherent characteristics, severity, and diagnosis
at admission, we conducted a propensity score matched analysis.
RESULTS. A total of 4,011 patients were eligible for our study criteria.
Among those, The Transfer group was 1,603 children and the In-
House group was 2,408 children. The Transfer group was higher
PIM2 score than the In-House group. Transfer group needed more
mechanical ventilation, inhaled nitric monoxide, extracorporeal mem-
brane oxygenation, and continuous hemodiafiltration. ICU length of
stay was longer in the Transfer group (median) than that in the In-
House group (median [IQR]5 [3–9] vs. 3 [2–7], P<0.001). Crude in-
hospital mortality was 27/1603 (1.7%) in the Transfer group and 62/
2408 (2.6%) in the In-House group (P=0.06), In the propensity
matched cohort, the Transfer group was not associated with in-
hospital mortality compared with the In-House group (12/913 (1.3%)
vs 22/913 (2.4%), P=0.08) Moreover, the Transfer group was not asso-
ciated with deterioration of PCPC compared with the In-House group
(84/913 (9.2%) vs 69/913 (7.6%), P=0.21)
CONCLUSION. Inter-hospital transport was not associated with un-
favorable outcomes among children who admitted to PICU. Trans-
port of severe pediatric patients to the PICU may be feasible.
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INTRODUCTION. The Pediatric Sequential Organ Failure Assessment
(pSOFA) scoring system is based on the Multiple Organ Dysfunction
Syndrome and it has been shown to be useful in predicting outcome
in critically ill children. Also, nutritional status on admission to the
pediatric intensive care unit (PICU) has been associated with out-
comes in critically ill children.
OBJECTIVES. To assess nutritional status and organ dysfunction by
pSOFA on children on admission to the PICU and its association with
outcomes.
METHODS. Retrospective cohort study of children admitted to the
PICU at Texas Children’s Hospital (01/2016-06/2016) with a length of
stay (LOS) > 3 days; nutritional status assessed by weight for length/
Body mass index (WFL/BMI: acute malnutrition), z-scores by WHO (0-
24 months) and CDC (2-19 yrs), respectively. Malnutrition defined as
mild, and moderate-severe if z-scores were < -1,< -2, respectively.
Hospital and PICU LOS, risk of mortality (ROM) by the Pediatric Index
of Mortality 2 (PIM2), and mortality were obtained. Organ dysfunc-
tion was defined as pSOFA score > 5, and were collected on day 1.
RESULTS. A total of 358 children (202 males/156 females) were in-
cluded; with age 2.6 yr. (0.7-10.3; median (25-75th IQR)). PICU LOS,
7.1 (4.7-11.4) days, Hospital LOS, 19 days (11-42); PIM2 ROM (%), 3.3
(1.0-5.0), PSOFA score on day 1 was 5 (4-7), for a 46% prevalence of
organ dysfunction. WFL/BMI z-scores of 0.08±1.34 (SD); the preva-
lence of acute malnutrition was 25.1%. A total of 294 (82%) patients
required mechanical ventilation on admission to the PICU and mor-
tality was 7.5%. Patients with organ dysfunction on day 1 vs. pts
without organ dysfunction had: PICU and Hospital LOS of 8.1 days
(4.9-13.3) vs 6.8 days (4.4-10.3) (p< 0.05) and 21 days (11-47) vs 17days (11-29) (p=0.1796), respectively; PIM2 ROM (%) of 3.86 (1.37-
8.09) vs 2.91 (0.92-4.43) (p<0.0001); and were associated with older
age (> 2 years) Odds ratios (OR) (95% CI) 1.56 (1.02-2.38) (p<0.05);
need of ventilatory support on admission, 2.80 (1.53-5.10) (p < 0.001)
and mortality 2.50 (1.09-5.74) (p < 0.05). Patients with underweight
and overweight/obesity vs. normal nutritional status were more likely
to have organ dysfunction; (OR) (95% CI); 2.73 (1.37-5.40) and 2.05
(1.29-3.26) (all p<0.005), respectively.
CONCLUSION. Organ dysfunction was prevalent in critically ill chil-
dren and was associated with longer PICU length of stay, higher se-
verity of illness, older age, need of ventilator support and mortality.
One out of every 4 children had malnutrition and malnourished
children were more likely to have organ dysfunction on admission
to PICU.
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INTRODUCTION. The prevalence of overweight and obesity in hospi-
talized US children has been increasing in the last decade and obes-
ity has been associated with poor outcomes.
OBJECTIVES. To assess nutritional status on children on admission to
the pediatric intensive care unit (PICU) and its association with
outcomes.
METHODS. Retrospective cohort study of critically ill children < 5 yr
of age admitted to the PICU at Texas Children’s Hospital (01/2016-
12/2017); nutritional status assessed by weight for length/Body mass
index (WFL/BMI: z-scores by WHO. The BMI was categorized as: nor-
mal (NOR), underweight (UND), (BMI < 2 SD); overweight (OVE), (BMI
> 2 SD), and obese (OBE), (BMI > 3 SD). Hospital and PICU length of
stay (LOS), risk of mortality (ROM) by the Pediatric Risk of Mortality
(PRISM III), ethnicity, and mortality were obtained.
RESULTS. A total of 2101 children (1210 males/891 females) were in-
cluded; with age 1.17 yr (0.41-2.56; median (25-75th IQR)). PICU LOS:
2.10 (0.99-6.16) days, Hospital LOS: 10 days (4-22); PIM2 ROM (%)
1.14 (0.75-3.86). The prevalence and median age for NOR, UND, OVE
and OBE was: 58.6%, 11.1%, 17.4%, and 12.8%, respectively, and 1.1
yr. (0.4-2.5), (median (25-75th IQR)), 0.7 yr. (0.2-2.6), 1.3 yr. (0.7-2.6),
and 1.3 yr. (0.5-2.7), respectively (p<0.0001). The Hispanic group vs.
the Caucasian and African-American, and Asian groups had the high-
est prevalence of UND, OVE, and OBE at: 35.9%, 42.9%, and 48%, re-
spectively (p<0.005). The PICU and Hospital LOS for NOR, UND, OVE,
and OBE groups were: 2 (1-6), 2.5 (1-7), 2 (1-6), and 2.4 (1-8), respect-
ively; (p<0.05); and 10 (4-22), 11(5-23), 10 (5-20), and 11 (5-28), re-
spectively. Children with UND, OVE, and OBE vs. the normal BMI
group were associated with a higher PRISM III ROM (%) and need of
ventilator support on admission; Odds ratios (OR) (95% CI) 1.10 (0.79-
1.53), (p=0.5750), 1.53 (1.18-1.99) (p<0.005), and 1.64 (1.22-2.19) (p<
0.005), respectively; and 1.24 (0.93-1.67) (p=0.1472), 0.94 (0.74-1.19),
and 1.34 (1.01-1.78) (p<0.05), respectively. Hospital Mortality was
4.05% and was not associated with BMI status.
CONCLUSION. More than half of the patients had a normal BMI and al-
most a third were overweight or obese on admission to PICU. Younger
children were underweight and older children were overweight or
obese. The Hispanic group had a higher prevalence of underweight,
overweight and obesity compared to the other ethnic groups.
Page 251 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Overweight and obese children were more likely to have a higher risk
of mortality on admission and the obese group was associated with
need of ventilator support on admission. Underweight children had a
longer PICU LOS. Mortality was not associated with BMI status.
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INTRODUCTION. ICU-acquired weakness (ICU-AW) is a widespread
involvement of diffuse and symmetrical muscular weakness that
can develop among ICU patients without any other cause that can
justify it. The incidence is different according to some studies,
25-50% in ventilated patients, reaching 50-100% in septic pa-
tients, and it is associated with an incomplete and variable func-
tional recovery.
OBJECTIVES. 1- To analyze the incidence of ICU-AW in critically ill pa-
tients receiving invasive mechanical ventilation (IMV) for at least 24 hours.
2- To analyze the functional consequences of ICU-AW at ICU dis-
charge and one month later.
METHODS. Single-center, prospective study (May-December 2017).
Inclusion criteria: adult critically ill patients, who required>24h of
IMV. Exclusion criteria: previous Barthel score <70, any neurological
disease, trauma patients, and prior cognitive disease.
Patients were consecutively recruited at ICU admission. ICU-AW and func-
tional capacity were assessed at ICU discharge, and one month later. Three
groups were pre-defined according to the Medical Research Council scale
(MRC): MRC> 48, Non-ICU-AW; MRC 36-48, mild-moderate ICU-AW; MRC <
36, severe ICU-AW. Muscle strength was also evaluated with dynamometry
(handgrip strength), ambulation ability with the Functional Ambulation
Categories (FAC) scale, and functional independence was assessed using
the Barthel index for activities of daily living.
A descriptive analysis is presented (median, inter-quartile range and/
or percentages). Comparisons among groups were performed
using non-parametric tests.
RESULTS. We included 52 patients, 46% were women, mean age 69
(51 -74) years old. In 77% of patients, the reason for admission
in the ICU were urgent medical conditions. The incidence of ICU-AW
was 63.5%, severe in 11.5% of cases. As compared to Non-ICU-AW,
patients with ICU-AW showed lower strength in handgrip,
lower Barthel Index and lower walking capacity at discharge from
ICU, and one month later. These functional alterations were signifi-
cantly more pronounced in the group of severe ICU-AW. Patients
with MRC <36 showed severe functional limitations with values of
handgrip 10.5% (9.5-30.6) as compared to healthy popula-
tion, Barthel Index values of 10 (8.7-17.5), and none of them
were able to walk autonomously. At one month of ICU discharge, the
Non-ICU-AW group showed normal functional capacity values
while severe limitations persisted in the MRC group <36.
CONCLUSION. Incidence of ICU-AW is high in patients requiring IMV,
and its functional impact is associated to its severity.000328
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INTRODUCTION. With the development of medical technology, clin-
ical alarms from diverse medical devices, are becoming a new issue
in intensive care units (ICU). An excessive number of alarms will re-
duce the efficiency of medical staff, cause alarm fatigue and com-
promise patient safety.
Among the devices of the ICU, the patient monitor is known to gen-
erate the most alarms.
OBJECTIVES. To examine the effects of patient monitor alarm man-
agement education on nurses’ performances of alarm management,
frequency of false alarms, and alarm fatigue.
METHODS. A quasi-experimental study was conducted on 19 nurses
in ICU at a single teaching hospital.
A preliminary survey was conducted on the frequency and type of ICU
alarm and We analyzed the frequency of false alarms and the effect of
alarm fatigue after patient monitor alarm management education.
RESULTS. After the intervention, nurse performance of alarm manage-
ment was increased from 17.95±1.47 to 23.84±5.40 (t = -5.68, p = 0.001),
and the frequency of false positive alarms also decreased significantly
from 4.42±5.01 to 0.83±1.60 (Z = -4.42, p < 0.001). There was no signifi-
cant difference in the frequency of valid alarms. (1.15±2.02 vs. 1.06±2.07;
Z = -0.16, p = 0.870). The nurse 's alarm fatigue level also decreased sig-
nificantly after education (25.84±4.59 vs. 21.10±6.09; t = 2.71, p = 0.014)
CONCLUSION. The patient monitor alarm management education
proved to have beneficial effects on the level of performance of alarm
management and alarm fatigue of the nurses. In addition, the
frequency of false positive alarms is reduced, but there is no difference
in the frequency of false alarms, which is helpful for safe patient
monitoring.
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INTRODUCTION. The visits that patients receive promote feelings of
support, help and reassurance. On the other hand, there is little lit-
erature regarding the wishes of patients on intensive care unit (ICU)
visits. In recent years is the trend to liberalize access for visits to pa-
tients admitted to the ICU. Experience has demonstrated that neither
the patient's clinical situation nor the structural barriers of the ICU
impede restriction-free visits, but it is due mainly to cultural factors.
OBJECTIVES. Explore the topic of visits during ICU hospitalization by
analysing patients’ wishes and the nurses’ points of view.
METHODS. Qualitative research with thematic analysis of the col-
lected data was done in an ICU. The sample involved in the study
was 8 patients and 12 nurses. Informed consent was signed by every-
one. Data were collected through 8 semi-structured interviews for
patients and 2 focus groups (FG) for nurses. The data analysis was
performed with the NVivo 10 software.
RESULTS. From the analysis of the data have been identified 22
nodes from interviews and 28 nodes from FG. The nodes have been
grouped into themes and macro-themes. It emerged:
2 macro-themes from interviews:
T9
T9
Table 1 (abstract 000343). Baseline characteristics
Table 2 (abstract 000343). Clinical outcomes
Page 252 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Patient experiences related to visits: highlights the presence of strong
emotions, often negative, sometimes in conflict with each other.
Patients’ thoughtson visits: ideas and advice for nurses who could
help the patient in managing visits or making changes to approach.
3 macro-themes from FG:
Patient visits seen by nurses: the behaviours, seen and interpreted by
the nurses, that the patients showed with their relatives or staff, the
perceptions during the visits, the patients’ experience or wishes.
Patients’ visit experiences seen by nurses: the team's perspective was
privileged then attitudes, behaviours and perceptions regarding pa-
tient visits were included.
Needs/suggestions offered by nurses: the improvement ideas
emerged from the team compared to those derived from the pa-
tients tofully understand the problem.
CONCLUSION. The ICU is seen by patients and nurses as a place
where the management of emotions and feelings is complicated.
The patients want the visits because they help to face emotions and
to overcome the physical and psychological insult created in ICU.
The visits maintain contact with the world outside.
The nurses emphasize the importance of clear information to regu-
late the access.
It would be desirable during the admissions in ICU prompted pa-
tients their wishes, wherever possible, about the visits and that this
cannot be taken for granted and absolutely necessary.
Ideally, every structure, follow a path of awareness of this issue in
order to adequately support the wishes of patients without neglect-
ing the suggestions and needs of healthcare staff.
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INTRODUCTION. Prevalence of sepsis is high, affecting millions of
people around the world each year. Previous studies demonstrate that
early antibiotics administration directly reduces mortality. However, be-
cause sepsis is sometimes hard to diagnose promptly, the initial treat-
ment is likely to be delayed. For break through the current situation, the
qSOFA was induced as a rapid screening tool before the ICU to facilitate
the identification of patients with suspected infection in the SSCG 2016.
OBJECTIVES. The objective of this study is to evaluate the impact of
a nurse-initiated quality improvement (QI) by the primary screening
using qSOFA on the sepsis management at the ER and improvement
of patient’s outcome.
METHODS. We conducted a before and after study. Patient older than
20 yrs who were suspected infection in ER were enrolled this study.
Phase 1: In the before phase, consecutive eligible patients were enrolled
from February 2017 to July 2017. Subsequently, educational intervention
for sepsis treatment was provided to the all nurses from August 2017 to
October 2017. Phase 2: From November 2017 to April 2018, nurses per-
formed primary screening with qSOFA to make a diagnosis of sepsis for
patients who were suspected infection, and the results were reported to
doctors and positively proposed for blood cultures obtained and adminis-
tration of antibiotics. Phase 3: From May 2018 to October 2018, ER physi-
cians were incorporated to this study. Primary outcome was the
antibiotic administration rate after visiting the ER, and secondary out-
come was the 28th day mortality.RESULTS. A total of 592 patients were included in this study (table1).
The antibiotic administration rate after visiting the ER was improved
significantly as the phases went on. The time to the initial antibiotic
administration after visiting the ER was significant improved as the
phases went on (table2). In multivariable logistic regression analysis,
intervention for nurses was independently associated with antibiotic
administration rate. 28 th day mortality were not significant between
each phase, and there was no association between early antibiotic
administration and 28 th day mortality.
CONCLUSION. A nurse-initiated QI improved the early administration
of antibiotic for the patients with suspected sepsis. However, there
was no association between early antibiotic administration and
mortality.
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INTRODUCTION. The implementation of an early mobility (EM) proto-
col in an ICU is a difficult process that requires change in culture and
the overcoming of many barriers. But do we really know what the
actual implementation of a protocol is to assess its impact? Clinical
information systems (CIS) can help us in this situation to detect the
different problems in adherence to a protocol.
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mobilization (EM) in an ICU through the Clinical Information System (CIS).
METHODS. Descriptive study in a polyvalent ICU of 30 beds during a
period of two years (January 2017-December 2018). Patients who
met the criteria for inclusion in the EM protocol were included. The
analyzed variables: sex, age, APACHE II, reason for admission, length
of ICU stay, proportion of EM days, EM start day, Medical Research
Council (MRC) and EM level. The reasons why EM was not performed
were analyzed. The data was extracted from the CIS by means of ex-
traction, transformation and loading (ETL) processes with the Qlik-
view® software tool. The mining of the data was done with R.
RESULTS. Of the 1961 patients admitted to the ICU in the study period,
819 (41.76%) required mechanical ventilation (MV), of which 510
received MV > 48h and 272 fulfilled the inclusion criteria, representing
a total of 3940 stays. The majority were men (72%), with a median age
of 63 (53-72) years, a median APACHE II of 24 (18-29), a median SOFA
of 7 (5-9) and a median LOS of 10 (6.8-17.3) days. The most frequent
reason for admission was respiratory failure 21.7%, followed by moni-
toring and post-operative monitoring 20.22% and septic shock 19.12%.
The average ratio of EM days to total stay was 25%. The causes why it
was not carried out were: 47.2% for not meeting the criteria of clinical
stability, 38.9% for being weekend, 4.4% for lack of physiotherapist,
3.1% because patient was out of ICU or rejecting physiotherapy and
6.4% the cause is unknown. In 26% of patients with inclusion criteria it
was never started; 58% did not meet criteria for clinical stability, 1% for
lack of physiotherapist, 28% for being weekend and in 16% the cause
is unknown. The median MP start day was 5.8 days and the patients
who were not started had an average stay of 6.13 days. We analyzed
the number of patients who underwent the MRC and the level of MP
they reached, at 96 (35.29%) and 151 (65.51%) patients respectively. Of
the 151, the proportion of patients who arrived at each level at ICU dis-
charge were: 11.26% (17) level I, 21.85% (33) level II, 7.95% (12) level III,
20.53% (31) level IV and 38.41% (58) level V.
CONCLUSION. The evaluation of the process allowed us to analyze
the adherence to the MP protocol observing that its implementation
is 74%. The results allow us to identify the improvement actions, ad-
just the indications and monitor their impact.
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INTRODUCTION. Due to the side effects of the given different
immuno-suppressive treatments for ANCA-associated vasculitis (AAV)
or disease activation, these patients may deteriorate rapidly and in-
tensive care unit (ICU) follow-up can be required (1). There is a need
for a scoring system that can predict the ICU prognosis of patients
with AAV, but the literature has limited data related with it.
OBJECTIVES. For this reason, the prognostic importance of clinical
scoring systems was investigated in patients who had AAV
activation.METHODS. All adult patients who had to be followed up in ICU due
to AAV activation in the last ten years in four reference university
hospitals in Turkey were included in this study. Demographic infor-
mation, immunosuppressive therapies, Birmingham Vasculitis Activity
Score (BVAS) at the time of vasculit diagnosis and BVAS, APACHE II,
SOFA and SAPS II scores at the ICU admission, treatments and clinical
data were recorded in all patients.
RESULTS. Total 34 patients from 4 study centers were included. The
mean age was 60.5 (42.2-70.2) years, 64.7% of patients were male.
The most common causes of ICU admission were infection with 94.1
percent (82.4% pneumonia) and massive hemoptysis (58.8%). Twenty
patients (58.8%) died in ICU follow-up. All non-survivors had septic
shock. The most commonly identified bacteria related with septic
shock were multidrug resistant Acinetobacter baumannii (%35) and
Escheria coli (%30). There was a significant difference between survi-
vors and non-survivors according to APACHE II (p=0.003) and SAPS II
(p=0.045) scores, serum ALT levels (p=0.012) and platelet counts (p=
0.001). But, there was no significant difference according to BVAS (p=
0.545) and SOFA (p=0.099) scores. APACHE II score was found to be
an independent risk factor for ICU mortality in logistic regression
analysis (RR=1.239, CI=1.021-1.503, p=0.030). When the ROC curve
analysis was performed, APACHE II score greater than 20.5 could pre-
dict ICU mortality with 80% specificity and 70% sensitivity in this pa-
tient group (AUC=0.8, p=0.004, like hood ratio=2.6).
CONCLUSION. APACHE II score can be used as a predictor for ICU
mortality in AAV patient group. This result suggests that mortality of
patients with AAV is caused by other problems that may occur dur-
ing follow-up in ICU instead of disease activation.
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INTRODUCTION. Serum albumin is the most abundant protein and is es-
sential in maintaining the oncotic pressure needed for proper distribution
of body fluids between blood vessels and body tissues. Serum albumin
concentration is altered in critically ill patients especially with septic shock
and after major surgery. Elevated hospital morbidity and mortality has
been linked with hypoalbuminemia, which has been recognized to be a
dependable prognostic indicator among critically ill patients.
METHODS. This was a prospective cross sectional study done at the
intensive care unit of the Philippine Heart Center. Patients’ ≥19 years
old that require the use of invasive mechanical ventilation were in-
cluded in the study. Demographic profile and clinical characteristics
were recorded. Blood extraction for albumin determination was col-
lected 24 hours after attachment to mechanical ventilator and prior
to weaning. Patients outcome was categorized into; Group 1-short
weaning, patients who had successful weaning within 24
hours; Group 2-difficult weaning, patients who completed weaning
more than 24 hours but less than 7 days; Group 3, prolonged wean-
ing, patients who completed weaning from ventilator after 7 days
and Group 4, no weaning, patients with no weaning attempt in 4
weeks or separation attempt failed.
RESULTS. 120 patients were included in the study who met the se-
lection criteria. Patients with higher albumin level had a shorter dur-
ation of weaning (group 1) while a lower albumin concentration
T9







Age, median (IQR, range) 77 (70 − 85) 70 (63 − 78) <0.001
History of cognitive impairment
(%)
17 (12) 12 (1) <0.001
History of alcohol abuse 2 (1) 6(0.9) 0.64
Admission category (%)
Surgery 28 (20) 247 (40)
Medical 108 (78) 354 (58)
Trauma 1 (0.7) 2 (03)
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to extubation (p-value 0.000, 0.000, and 0.029 respectively). Serum al-
bumin of 27.9 g/L has shown to predict the weaning outcome in
mechanically ventilated patients (82.47% sensitivity and 86.96% spe-
cificity). Those with lower albumin levels have a higher SOFA score
(r= 0.4256; p-value <0.001) thus indicating a higher relative probabil-
ity of mortality.
CONCLUSION. Serum albumin has been recognized as a clinical
non-respiratory marker which provides a good predictor of wean-
ing in mechanically ventilated critically ill patients. An admitting
albumin level of >27.9 g/L has shown to predict the weaning
success among critically ill patients with a sensitivity of 82.47%
and specificity of 86.96%. While the association between the dec-
rements in albumin concentration and higher SOFA score predicts
a higher relative probability of mortality.Urgent admission (%) 120 (87) 385 (63) <0.001
MAP at the time of ICU
admission
70 (63 − 78) 77 (70 − 85) 0.02
Use of corticosteroids (%) 9 (6) 12 (1) <0.01
Respiratory failure (%) 38 (27) 34 (5) <0.001
BUN at time of ICU admission 8.9 (6 − 15.3) 6.7 (5 − 9.9) <0.001
The E-PRE-DELIRIC model cut off 23 (16 − 38) 14 (8 − 19) <0.001000073
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INTRODUCTION. Delirium, acute consciousness disturbance with
variable course of impaired cognitive function, is common in
ICU. It is very important to prevent early onset of delirium. The
E-PRE-DELIRIC model has recently received great attention as a
scale to predict delirium at the start of ICU stay. The E-PRE-
DELIRIC model consists of nine predictors assessed on ICU ad-
mission. It is studied to verify its usefulness is various western
populations. However, its usefulness has not been established in
East Asians.
OBJECTIVES. We examined the E-PRE-DELIRIC model in a single facil-
ity to clarify usefulness in Japan.
METHODS. The present study was designed as a retrospective
cohort study in a single center. Enrolled patients were all adult
over the age of 18 years. For evaluation of delirium, CAM-ICU
was used. Patients who had delirium at ICU entry and who can-
not be evaluated as delirium were excluded. The E-PRE-DELIRIC
model was calculated and subjected to following analysis. Pa-
tients were divided two groups: delirium and non-delirium
groups. Primary outcome was to determine the cut off values of
the E-PRE-DELIRIC model. Secondary outcomes were to compare
each factor of the E-PRE-DELIRIC model between two groups.
RESULTS. We enrolled 740 subjects, 137 for delirium and 603 for
non-delirium. The incidence of delirium was 18%.
The cut off value of The E-PRE-DELIRIC model score 21 could predict
delirium development with 0.871 and 0.606 as specificity and sensi-
tivity, respectively, and AUC was 0.792 (95%CI 0.749 to 0.835). A com-
parison between the two groups of each factor is shown in the table.
Logistic analysis indicated that cut off value was independently asso-
ciated with 1.10 times ( 95%CI 1.05 to 1.15, p<0.001 )
CONCLUSION. The E-PRE-DELIRIC model could predict delirium de-
velopment in Japanese ICU patients, but its sensitivity remains
modest.000094
Presence and importance of the agitation psychomotor on the
maxillofacial surgery postoperative
R. Padilla1, M. Dalorzo1, F. Moran1, M. Sanchez Casado1, R. Martin2
1Icu, Virgin Health Hospital, Toledo, Spain; 2Maxillofacial surgery, Virgin
Health Hospital, Toledo, Spain
Correspondence: R. Padilla
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000094
INTRODUCTION. Patients undergoing elective and major maxillo-
facial surgery are one of the groups of greater risk of psychomotor
agitation. It is associated with a greater frequency of complications,
longer stay in ICU and hospital stay.
OBJECTIVES. Evaluate the presence of the psychomotor agitation in
the postoperative of maxillofacial surgery and it repercussion in clin-
ical evolutive variables.
METHODS. Retrospective revission in the clinical histories of the pa-
tients entered into ICU in the postoperative of mayor maxillofacial
surgery in the last 6 years.
It was recorded basal variables, personal history, clinics and evolutive.
To determinate the agitation it was used Riker scale and AgitatedBe-
haviorScales (ABS) scale. We define psychomotor agitation as a ABC
value bigger than or equal to 21. The cuantitative data are expressed
like medium (interquartile range) and cathegorics like counting
(percentage).
RESULTS. We got 60 patients, of wich 86,7% were males, with ages
of 60,5 (54-65,5) years. 28 of them, (46,7%), presented agitation in
ICU. The agitation appeared in the 2nd (1,5-3,5) days of evolution, at
the beginning of 1st weaning (1-2 days), and last 3 (2-3) days. They
presented a result in Riker's agitation scales 6 (5-7); ABS 42 (25-51).
The treatment used were benzodiacepines (96,4%), tiaprizal (82,1%),
haloperidol (71,4%), physical restrictions (53,6%), b-blockers (35,7%),
other atypical antipsychotics (25%) and dexmedetomidine (21,4%),
associating some of them in the most of the cases.
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agitation at plant (3,6% vs 32%; p=0,006), so that the 88,9% of the
patients with agitation at plant, have presented it before in ICU.
CONCLUSION. The presence of agitation on maxillofacial surgery
postoperative is very frequent, affecting almost half of the patients,
and with high intensities, presenting a start pattern from the awak-
ening, and that usually needs a combination of some drugs. That
presence predict the repetition of the agitation at plant in the same
patient.
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INTRODUCTION. Cardiac surgery for structural heart disease has poor
outcomes in the presence of cardiogenic shock and/or multisystem
organ failure. The mortality rate remain high, despite progress in
pharmaceutical therapy, invasive cardiology, and surgical techniques.
OBJECTIVES. We applied venoarterial extracorporeal membrane oxy-
genation (ECMO) as a bridge to surgery to restore end-organ func-
tion and resuscitate patients before high-risk cardiac operation.
METHODS. We reviewed all patients with structural heart disease
and cardiogenic shock who have been admitted to our institute dur-
ing one-year period (2018) and have been resuscitated by ECMO pre-
operatively. Nine patients were included in to present study.
RESULTS. Mean age was 52 ± 17 years. Before surgery, patients were
placed on ECMO for 3.7 days (average 2-7 days). Comorbidities includedacute renal failure (n =7), inotropic support (n = 9), intra-aortic balloon
pump (n = 5) and acute liver injury (n=3). With ECMO support, vasopres-
sor requirement decrease, organ perfusion improved with decreased lac-
tate levels from 67 mg/dL mmol/L to 19 mg/dL, (p = 0.01), normalized
arterial pH (7.24 vs. 7.38 (p < 0.04) and mean arterial pressure (64 mmHg
vs. 83 mmHg, p < 0.01).Follow, patients were undergoing different surgi-
cal procedures: AVR for severe aortic stenosis (n=1), MVR for severe mitral
regurgitation (n=4), TVR+PFO closure (n=1) and closure of acute post-
infarct ventricular septal defect (n=3). Average length of follow-up is 4
months, with 2 patient deaths at 12 and 7 days and the rest of the pa-
tients survived. Complications included acute kidney injury - yet no pa-
tients required dialysis at discharge- and one patient was underwent
above knee amputation as a result of lower limb ischemia.
CONCLUSION. ECMO can be used as a bridge to heart valve or septal
defect surgery in severely decompensated patients, suffered from car-
diogenic shock. Through recovery of end-organ function, ECMO may
allow surgical correction of structural heart disease in patients consid-
ered inoperable or convert a salvage situation to an elective operation.
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INTRODUCTION. In the next decades an expansion of surgical services
to address unmet needs is likely to increase total global deaths, of
which 1.9 million would be in low-middle income countries[1]. Current
evidence suggests that intraoperative management of major elective
gastrointestinal surgery should consider cardiac output (CO) monitoring
and goal-directed therapy[2]. However, cost restrains may determine
low adherence to these practices in low resource settings. We hypothe-
sized that central veno-arterial difference of CO2 [P(v-a)CO2] could
serve as a surrogate for CO monitoring during GDT.
OBJECTIVES. We aimed to evaluate the impact of the use of P(v-
a)CO2 as a surrogate of cardiac output in an algorithm of GDT on
major complications and 90-day mortality.
METHODS. The study was a quasi-randomized controlled and ex-
planatory trial performed in a tertiary university hospital in patients
undergoing elective major gastrointestinal surgeries. In the interven-
tional group a treatment algorithm aiming to keep mean arterial
pressure > 65 mmHg, SpO2 > 94%, CO2 gap lower than 6 mmHg and
pulse-pressure variation (PPV) lower than 13% using fluids, dobu-
tamine and noradrenaline was applied in addition to the stand-
ard practice. The control group comprised all the consecutive
patients that received traditional standard of care from the same
team of surgeons and anesthesiologists in the period before the
intervention phase.
RESULTS. A total of 204 patients were included in this study; 102 in each
group. Measurements of P(v-a)CO2 were lower in the GDT group than in
Control group at T0 (30-60 min after induction): 5.9 ± 2.1 vs. 6.7 ± 2.7
mmHg, p=0.031; T1 (2 h ± 30min): 6.4 ± 2.6 vs. 7.0 ± 2.3 mmHg, p =
0.033 and T2 (4 h ± 30min):5.9 ± 2.1 vs. 7.1 ± 3.4 mmHg, p = 0.036. Cen-
tral venous saturation (ScvO2) was significantly higher throughout the in-
traoperative period in the GDT group, and there was a moderate
correlation between P(v-a)CO2 and ScvO2 (P<0.001 at all-time points and
at ICU admission). The number of patients with major complications was
lower in GDT group than in the control group and there was a significant
decrease in 90-day mortality in the GDT group (22.5% vs. 9.8%, p=0.014).
CONCLUSION. Minimization of P(v-a)CO2 and PPV as therapeutic tar-
gets during elective major gastrointestinal surgeries seems to deter-
mine better postoperative outcomes. Testing lower cost alternatives
during GDT is extremely important for low-resource settings and
countries and its value should be evaluated in prospective random-
ized trials.
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INTRODUCTION. Postoperative hypotension is a common occur-
rence following major non-cardiac surgery. There is evidence of
substantial variation in the management of postoperative
hypotension between centres, countries and continents. In prep-
aration for an international prospective observational cohort
study concerning the use of postoperative vasopressor infusions
('Squeeze'), we surveyed clinicians from perioperative and inten-
sive care medicine regarding use of vasopressors after surgery.
METHODS. With the assistance of staff and resources of ESA and
ESICM we shared a link to a SurveyMonkey questionnaire of our
design. Questions in the survey included location of vasopressor
use after surgery, frequency of vasopressor use, and choice of
vasopressors after surgery. Ethical approval was not required.
RESULTS. Between July 2018 and Feb 2019, we received 2052
complete responses with 97.5% of respondents regularly, or occa-
sionally, taking care of postoperative non-cardiac patients. Re-
spondents were from 102 countries, with the greatest number of
replies from Germany, UK, Spain and Italy (each >100 replies).
27.3% worked in hospitals with 250-499 beds, 33.7% with 500-
999 beds and 19.8% >1000 beds.
Respondents answered “Non-cardiac surgery patients receive
vasopressor infusions after surgery:” ‘occasionally’ in 58%, and
‘frequently’ in 22%. Postoperative patients received infusions of
vasopressors in a range of differently described environments
including PACU, ICU, and HDU; only 7.2% responded that vaso-
pressors could be used on a normal postoperative ward. Re-
spondents answered “Non-cardiac surgery patients receive
vasopressor infusions after surgery:” ‘occasionally’ in 58%, and
‘frequently’ in 22%.
The most common choice of vasoactive drug used was noradrenaline
(used always or frequently by 76%) and phenylephrine (used always
or frequently by 18%)”
CONCLUSION. Vasopressor infusions are commonly used in pa-
tients following surgery. There is variation in choice of drug and
location of treatment. Patient-level data are needed to better
understand practice patterns and outcomes associated with vaso-
pressor use.
SQUEEZE WILL LAUNCH EARLY 2020 - PLEASE REGISTER YOUR
INTEREST
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INTRODUCTION. Critical illness can cause severe cognitive impair-
ments. Studies frequently find more than half of critical illness survi-
vors to have substantial cognitive impairments, often lasting for
years or for a lifetime, significantly affecting quality of life (1). No ef-
fective preventive measures have been established. Delirium seem to
be the most important risk factor for long-term cognitive impair-
ment. Less sedation is encouraged and might lead to less delirium
and less cognitive impairments following critical illness.
OBJECTIVES. The objective was to assess the effect of non-sedation
versus sedation with a daily wake-up call during mechanical ventila-
tion on cognitive function in adult survivors of critical illness.
METHODS. Single center sub-study of the multicenter, randomized
NONSEDA trial. Participants were randomized within the first 24
hours from intubation to either non-sedation with sufficient anal-
gesia or to light sedation with a daily wake-up call during mechanical
ventilation. Three months after ICU-discharge survivors were tested
for cognitive function in-person by a neuropsychologist.
RESULTS. A total of 205 critically ill, orally intubated and mechan-
ically ventilated adults were included; 118 patients survived to
follow-up and 89 participated (75%). The participating survivors
in the two groups did not differ regarding baseline data or pre-
morbid cognitive impairments. Sedated patients had received
more sedatives, whereas doses of morphine and antipsychotics
were equal. We found more patients with delirium in the sedated
group (96% versus 69% of patients, p=0.002) and increased dur-
ation of delirium in sedated patients (median 5 days versus 1, p<
0.001). Delirium sub-types were equally distributed between
groups, with hypoactive delirium most frequent (61%), followed
by mixed delirium (39%). Primary outcome: No significant differ-
ence was found in number of patients with mild/moderate cogni-
tive impairments (non-sedated: 6 patients vs sedated: 4) or
severe cognitive impairments (non-sedated: 16 patients vs se-
dated: 17, p=0.71). Two hypothetical worst-case scenarios where
all survivors and all included patients, respectively, who had not
participated in the follow-up assessment were assumed to have
severe cognitive impairments, were analyzed, but still no differ-
ence between groups was found (p=0.98 and 0.87, respectively).
Secondary outcomes were 1) cognitive test scores, and 2) effect
of delirium on cognitive function, where no differences were
found between groups in either. In both groups a wide array of
cognitive domains was found to be affected, and in both groups
visuo-spatial construction was most seriously affected, followed
by executive function and then visual learning/memory. The
distribution of affected domains did not vary between groups
(p=0.64).
CONCLUSION. Non-sedation did not affect cognitive function three
months after ICU-discharge.
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INTRODUCTION. Critical illness can cause impaired physical function and
lead to dependence of help in everyday activities. In recent years, inten-
sive care unit (ICU) acquired weakness and its possible prevention have re-
ceived much attention, although the pathophysiology is still not clear.
Generally, lower levels of sedation, focus on pain relief, patient comfort
and early mobilization (known as the eCASH concept) are encouraged (1).
OBJECTIVES. The objective of this study was to assess the effect of
non-sedation on physical function.
METHODS. This study was a single-center sub-study of the NONSEDA trial,
a multicenter randomized trial, assessing harms and benefits of non-
sedation versus sedation with a daily wake-up call during mechanical venti-
lation in critically ill adults. All patients from one NONSEDA trial-site (the
ICU in Kolding, Denmark) were included. At extubation, ICU discharge and
3 months after ICU discharge survivors were assessed for physical function.
RESULTS. A total of 205 patients were included, 118 survived to follow-
up and 116 participated (98%) to the extent they were able. The two
groups did not differ significantly regarding baseline data. Sedated pa-
tients had received more sedatives, but doses of morphine, corticoste-
roids and neuromuscular blocking agents were equal, as was mean
blood glucose. Primary outcome: Three months after ICU-discharge,
health-related quality of life (SF-36, physical component score) did not
differ significantly between groups (non-sedated 38.3 vs sedated 36.6, p=
0.3), but a tendency to better function in activities of daily living (Barthel
Index) was found in the non-sedated group (19.5 vs 18, p=0.08). Second-
ary outcomes: Non-sedated patients had a significantly better Barthel
Index at ICU-discharge (median 7 vs 4, p=0.01). There were no differences
between groups regarding handgrip strength, walking distance, muscle
size or biomechanical data on lower extremity function 3 months after
ICU discharge. Explorative outcomes: Handgrip strength at extubation
and ICU-discharge was significantly better in non-sedated patients.
CONCLUSION. Non-sedation did not lead to significantly better quality
of life or better function in activities of everyday living 3 months after ICU
discharge, however non-sedated patients generally had a better physical
function, especially in early phases (extubation and ICU discharge).
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000145INTRODUCTION. Success of NIV mainly depends on patient’s cooper-
ation with the technique. Use of analgesic and sedative drugs during
NIV is not a common practice due to the high risk of respiratory depres-
sion. Dexmedetomidine (DEX) has a sedative, analgesic and anxiolytic
effect and preserves oropharyngeal reflexes. Due to those effects it
could became the ideal sedative drug for patients comfort under NIV
OBJECTIVES. to compare effectiveness of DEX regarding SCP in ARF
under NIV. It will be assess tolerance, patient´s degree of satisfaction,
safety profile and acute respiratory failure evolution
METHODS. A phase IV multicentre, randomised, open label, parallel-
group, controlled clinical trial, from 1/12/16 to 31/10/18. Approved
by Ethics Committee. Clinical Trials NCT02958150. Inclusion Criteria:
>18 years, ARF secondary to Pulmonary Oedema, pneumonia or high
risk of post-extubation failure. Exclusion Criteria: ARF needing intub-
ation, HR<50, AVB 2º-3º, neurocritical patients. Drug allergy. Groups:
SCP: no drugs or midazolam (0,03-0,05 mg/kg) and/or propofol (0,25
mg/kg iv), morphine (3-5mg) and/or fentanyl (50-100μg) bolus or
remifentanil 6 μg/kg/h. DEX: 0,4-1,4μg/kg/h para RASS(0 -1) ± SCP iv
bolus. Categorical variables as percentages % and compared using
X2 o Fisher, continuous variables as mean ±SD/median IQR and com-
pared using two samples T-test. P<,05.
RESULTS. DEX vs SCP: N= 22 vs 27. Age (years) 72.7±8.3 vs 69.0±11.5
(p.23). Female %: 33.3 vs 37.0 (p=1). ARF etiology %: COPD/ Heart fail-
ure: 41vs 37; Pneumonia 32 vs 26; Post-extubation/others 27vs 37
(p.76). Oxygen support pre-NIV Fi02>50 % 52.6 vs 61.9 (p.75). SOFA
score: 6.48±4,4 vs 6.19±3.5 (p.80). Non-respiratory dysfunctions 85.7
vs 100. Other sedatives/analgesics administered: DEX/SCP None 59.1
vs 57.7 (p.92). Dexmedetomidine dose: 0.87±0.33 μg/kg/h
NIV Tolerance %: Nausea 4.8 vs 0 (p.48). Aspiration pneumonia 0 vs
0 (p=1). CAM-ICU+: 14.3 vs 32.0(p.16). Agitation (RASS>+2) 28.5 vs
19.2 (p.45). Interface intolerance 19.0 vs 11.5(p.68). VNS ≥4 14.3 vs
19,2 (p.71). Adverse effects %: Respiratory depression 0 vs 0. HR<60
28.5 vs 16.0(p.30). HR<40 solved with reduction of perfusion 9.5 vs 0
(p.20). SBP<80 28.5 vs 16.0(p.30). TAS>160 4.7 vs 4.0 (p=1). FC>140
8.0 vs 0 (p.49) Patient satisfaction %: Rested during ventilation: agree
(A) 87.5 vs 25.0 (p<.00); Comfortable (A) 80.0 vs 36.6 (p.02). Unpleasant
memories of ventilation (A) 21.4 vs 27.0 (p=1). Sedated with the same
drug? (A) 85.7 vs 44.4 (p.06). Dyspnea (2point decrease)%: pre-
1hpostNIV: 95.4 vs 77.7 (p.11). pre-6hpostNIV: 95.4 vs 88.8 (p.61). ARF
course: pC02 pre 50.8±16.2 vs 54.7±12.5 (p.36). 6h post 45 (34.5-49)
vs 46 (38-55) (p.31). Pa02/Fi02 preNIV144,8 vs 148,6 (p.87). P/F
1hpostNIV 197 (155-235.25) vs 213.5 (147.25-269.75) (p.64). P/F 24h
postNIV 226.5 (208.75-304) vs 187 (147-257) (p.01). Hours of NIV: 15
(9.5-25.5) vs 18 (8.1 -39) (p.44). ICU stay (d): 5 (3-9) vs 8 (3-15) (p.25).
Endotracheal intubation %: 23,8 vs 20.0 (p.75). ICU mortality % 15.7
vs 19.0 (p=1)
CONCLUSION. DEX vs SCP provided higher degree of satisfaction
and better oxygenation to patients under NIV with ARF without im-
proving side effects and percentage of intubation or ICU mortality.
Use of DEX vs SCP could reduce ICU stay and NIV duration
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Page 258 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. Many intensive care unit (ICU) patients suffer from
delirium which is associated with deleterious short-term and long-
term effects, including mortality.
OBJECTIVES. We determined the association between delirium and
the different delirium subtypes and 90-day mortality.
METHODS. Retrospective cohort study of ICU patients admitted be-
tween 2015-2017. Delirium, including its subtypes (i.e. hyperactive,
hypoactive, mixed and rapidly reversible delirium), was determined
using the confusion assessment method-ICU (CAM-ICU) and Rich-
mond agitation sedation scale (RASS-)scores. Exclusion criteria were
insufficient assessments and persistent coma. Cox-regression analysis
was used to determine associations of delirium subtypes with 90-day
mortality, including relevant covariates (i.e. APACHE-IV, length of ICU
stay and mechanical ventilation).
RESULTS. 7,362 ICU patients were eligible of whom 6,323 (85.9%)
were included. A total of 1,600 (25%) patients were prevalent ICU de-
lirium cases of which the mixed subtype occurred the most frequent
(36%). The crude hazard ratio (HR) for overall prevalent delirium with
90-day mortality was 2.84 (95%CI:2.32-3.49), and the adjusted HR
1.29 (95%CI:1.01-1.65). The adjusted HR for 90-day mortality was 1.57
(95%CI:1.51-2.14) for the mixed subtype, 1.40 (95%CI:0.71-2.73) for
hyperactive 1.31 (95%CI:0.93-1.84) for hypoactive and 0.95
(95%CI:0.64-1.42) for the rapidly reversible delirium subtype.
CONCLUSION. After adjusting for covariates, including the compet-
ing risk factor length of ICU stay, only the mixed delirium subtype
was significantly associated with 90-day mortality.
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INTRODUCTION. Delirium is a frequently occurring syndrome which
burdens Intensive Care Unit (ICU) patients. The effect of prophylactic
haloperidol use on long-term quality of life is unknown.
OBJECTIVES. To evaluate the effects of prophylactic haloperidol use
on long-term quality of life in critically ill patients at high risk for de-
lirium, and to explore which factors are associated with change in
quality of life.
METHODS. A pre-planned secondary analysis of long-term outcomes
of the REDUCE study was conducted. In this multicenter randomized
clinical trial, non-delirious ICU patients were assigned to the prophy-
lactic haloperidol or placebo group. Long-term outcomes were
assessed using the Short Form-12 questionnaire at ICU admission
(baseline), and after 1 and 6 months. Quality of life was summarized
in the physical component summary (PCS) score and mental compo-
nent summary (MCS) score. Differences between the haloperidol and
placebo group, and factors associated with changes in quality of life
were analyzed.
RESULTS. Of 1789 study patients, 1245 ICU patients were
approached of which 887 (71.2%) responded. Long-term quality of
life did not differ between the haloperidol and placebo group mean
(±SD) PCS score 39.3±11.0 and 38.9±10.6, respectively; P=0.35, and
mean MCS score 50.3±10.1 and 51.1±10.0, respectively; P=0.68). Fac-
tors associated with physical decline after 6 months were age (odds
ratio [OR] 1.02; 95%CI:1.01-1.04), medical admission (OR 2.08;
95%CI:1.39-3.10), trauma admission (OR 5.34; 95%CI:1.65-17.27), base-
line PCS score (OR: 1.06; 95%CI:1.04-1.08) and number of sedation-
induced-coma days (OR 1.15; 95%CI:1.05-1.25). Factors associatedwith mental decline after 6 months were age (OR 1.03; 95%CI:1.01-
1.04), medical admission (OR 2.09; 95%CI:1.43-3.03), baseline MCS
score (OR 1.03; 95%CI:1.01-1.05) and the number of sedation-
induced-coma days (OR 1.09; 95%CI:1.01-1.17).
CONCLUSION. Prophylactic haloperidol use does not affect long-
term quality of life in critically ill patients at high-risk for delirium.
Several factors, including the modifiable factor number of sedation-
induced-coma days, are associated with decline in long-term
outcomes.
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INTRODUCTION. Pleural adhesions, upper lobe resections and low
forced expiratory volume in one second (FEV1) were proposed as
predictors of prolonged air leak after lung resection surgery. In-
creased ventilatory drive may be associated with dynamic hyperinfla-
tion and may therefore also contribute to the development of
prolonged air leak after lung resection surgery.
OBJECTIVES. We hypothesized increased ventilatory drive, character-
ized by the slope of minute ventilation to carbon dioxide output (VE/
VCO2), predicts prolonged air leak after pulmonary lobectomy. Ac-
cordingly, aim of this study was to compare ventilatory and gas ex-
change parameters during exercise in patients with and without air
leak after pulmonary lobectomy.
METHODS. Consecutive lung resection (lobectomy) candidates were
recruited in this prospective bicenter study. All of the recruited pa-
tients underwent pulmonary function tests and cardiopulmonary ex-
ercise testing prior surgery. Prolonged air leak was defined as
presence of air leak from the chest tube on the 5th postoperative
day. Student t-test, Mann-Whitney U test and two-tailed Fisher exact
test were used for comparison. Stepwise logistic regression analysis
was performed for evaluation of parameters association with postop-
erative prolonged air leak. Data are summarized as mean ± SD; p<
0.05 was considered as significant.
RESULTS. A total of 96 patients were included. Prolonged air leak
was observed in 28 (29%) of patients. Between groups, there was
no significant difference in age, sex, ASA class, type of surgery
(thoracotomy/video-assisted thoracoscopic surgery) and side of
surgery (right/left lung; upper/lower lobes). Patients with pro-
longed air leak had significantly longer hospital (14 ± 7 vs. 9 ± 6
days; p<0.01) and intensive care unit length of stay (7 ± 5 vs. 5
± 4 days; p<0.01), lower FEV1 (82 ± 21 vs. 91 ± 18 %; p=0.03),
longer duration of surgery (210 ± 67 vs. 187 ± 72 min; p=0.04),
more frequent pleural adhesions (50% vs. 21%; p=0.01) and
higher VE/VCO2 slope (35 ± 7 vs. 30 ± 5; p<0.01). Stepwise logis-
tic regression showed only presence of pleural adhesions (OR=
3.9; 95% CI 1.4-10.9; p=0.01) and VE/VCO2 (OR 1.1; 95% CI 1.0-
1.2; p<0.01) to be independently associated with the prolonged
air leak. VE/VCO2 values above 45 were highly specific for the
prediction of prolonged air leak (specificity 96%, sensitivity 18%).
Page 259 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55CONCLUSION. Increased ventilatory drive during exercise (VE/
VCO2 slope) may predict prolonged air leak after pulmonary
lobectomy.
000183
Prognostic value of procalcitonin after gynecological surgery: a
preliminary retrospective cohort study
Y. Fujita, M. Okumura, A. Hashimoto, Y. Sato, Y. Fujiwara
Anesthesiology and intensive care medicine, Aichi Medical University
Hospital, Nagakute, Japan
Correspondence: Y. Fujita
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000183
INTRODUCTION. Procalcitonin (PCT) is a well-known prognostic
marker after elective cardiac surgery. Klingele et al. (1) demonstrated
that measurement of PCT seems to be useful for identification of pa-
tients at risk of delayed complications despite an initially uneventful
postoperative course. However, the prognostic value of PCT after
non-cardiac surgery remains unknown.
OBJECTIVES. We chose gynecological surgery as a non-cardiac sur-
gery with which to evaluate whether PCT is useful for predicting a
risk of delayed complications.
METHODS. In total, 1,015 patients who underwent gynecologic sur-
gery in our institution were retrospectively evaluated. The serum PCT
concentration was measured the morning after surgery. All patients
were screened for the occurrence of delayed complications. Delayed
complications were defined as in-hospital death, intensive care unit
readmission, or a prolonged hospital stay (>10 days). Odds ratios
with 95% confidence intervals were calculated by logistic regression
analysis and adjusted confounders. The confounders used to calcu-
late the odds ratios were age, sex, diabetes mellitus, hypertension,
past stroke, coronary artery disease, hepatic disease, renal disease,
past cancer, active cancer, chronic obstructive disease, allergy, esti-
mated glomerular filtration rate, American Society of Anesthesiolo-
gists physical status, and emergency operation.
RESULTS. Among 1,015 patients, 101 developed delayed complica-
tions. The PCT level was significantly higher in these 101 patients
(1.01ng/ml) than in the remaining 914 patients (1.01 vs. 0.31 ng/ml,
respectively; p = 0.0089). We divided the patients into two groups
using the normal cutoff level for PCT (0.5 ng/ml). Patients with a PCT
level of >0.5 mg/ml on the first postoperative day had a highly in-
creased risk of delayed complications (adjusted odds ratio, 5.73; 95%
confidence interval, 3.57–9.20; p < 0.0001).
CONCLUSION. In our preliminary study, a single measurement of PCT
seems to be a useful marker to identify patients at risk of delayed
complications after gynecological surgery.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000185INTRODUCTION. Pain management and sedation are important
aspects in the treatment of hospitalized patients, especially
those mechanically ventilated. In many hospitals, such patients
are treated not only in intensive care units, but also in other
wards. In the nineteen eighties, numerous studies demonstrated
a wide array of misconceptions and inadequate knowledge re-
lated to commonly used sedative, analgesics and muscle relax-
ants which may prevent appropriate treatment. Since these
publications, multiple studies have shown that appropriate sed-
ation and analgesia are associated with improved clinical out-
comes, educational programs were developed and guidelines
published. Whether the personnel’s knowledge kept up with
these changes is unknown.
OBJECTIVES. To determine the current rate of misconceptions and
knowledge gaps regarding commonly used sedative, analgesic and
neuromuscular drugs.
METHODS. We conducted a prospective, observational, cross-
sectional e-questionnaire survey among physicians and nurses who
routinely treat mechanically ventilated patients. The study was per-
formed in Rambam Health Care Campus ,Haifa, Israel, a 1000-bed
academic hospital, serving a population of over two million
residents.
RESULTS. 355 questionnaires were returned. The response rate was
42.49% (181/ 426) for physicians and 30.05% (174/ 579) for
nurses. Only 82.54% knew that midazolam has no analgesic effect.
Only 71-72% were familiar with the sedative effect of opiates. 27%
believed that propofol has analgesic properties. 30.52% thought that
rocuronium has a sedative effect and 10.17% believed that it has an-
algesic proporties. As much as 40% of emergency room personnel
and 17% of ICU staff believed that muscle relaxants have a sedative
effect.
CONCLUSION. Our findings demonstrate that although a lot has
been done during the last decades in order to improve the treat-
ment of critically ill patients, the rate of misconceptions regard-
ing pharmacological characteristics of commonly used drugs is
unacceptably high. These basic misconceptions are in contrary
with the guidelines recommending an analgesia- first sedation
strategy and may lead medical personnel to provide excessively
deep sedation and lack of analgesia on one hand, and to treat
patients receiving opiates with unnecessary midazolam or propo-
fol, on the other hand. Using muscle relaxants without concomi-
tant sedatives or analgesics may cause a situation in which
patients are aware of their surroundings and feel pain without
having the ability to express it. This terrifying scenario is one of
the biggest fears people have when they are about to undergo a
medical procedure.
Our findings call for immediate action to improve patients’ care in
our hospital and other institutes. It seems crucial to promote new
educational programs, protocols, and guidelines in ICU and other
wards. More rigid “safeguards” such as daily clinical pharmacist re-
view of sedatives, analgesics and paralytics administered as well as
incorporation of automated clinical decision support tools into an
electronic health record system of mechanically ventilated patients
should be considered.
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INTRODUCTION. Renal transplant (RT) is considered the treat-
ment of choice in End-Stage Renal disease(ESRD).Besides graft
characteristics, an important factor in determining immediate
graft function is the intravascular volume maintained during
surgery.(1) Infusion of fluid targeting Central venous pressur-
e(CVP) values are routinely used. The controversies of CVP to
accurately predict fluid status initiated the use of dynamic pa-
rameters of fluid responsiveness like Pulse Pressure Variation
(PPV).Our study was to determine the utility of PPV to guide
fluid therapy during RT.
OBJECTIVES. Primary aim-To determine the ability of PPV guided
fluid therapy as an alternative to CVP in RT surgeries by comparing
the total volume of fluid administered during surgery.
Secondary aim-To compare the adequacy of tissue perfusion by
measuring blood lactate levels and to find out the volume of fluid
administered in two groups in the post-operative period.
METHODS. Consenting ESRD patients aged 18-60 years sched-
uled for RT receiving kidney either living donors or from ca-
davers were randomly allocated in one of the two groups
-Group C (CVP assisted fluid therapy) and Group P (fluid therapy
by PPV).General anesthesia was administered.Fluid resuscitation
in group P was to maintain a PPV of <6% at the time of de-
clamping and in group C, fluid infusion was done to target CVP
of 10-12 mm of Hg at the same time point. Post operatively
signs of fluid overload such as conjunctival edema and fluid re-
quirement for the first 24 and 48 hours were noted. Urine out-
put,urea,and serum creatinine values in the first 24 and 48 hours
were also obtained. A sample size of 70 (35 patients in eachgroup) was calculated assuming a 30% effect size and 80%
power at 5% level of significance for the mean outcome of the
volume of crystalloids administered.
RESULTS. Out of 77 randomised patients,70 completed the study-
Group P (n-35) and Group C (n-35) (Figure1).The total volume of crys-
talloids infused intra-operatively was 1345.71±337.24 (mean±SD) ml
in Group P which was 29% lesser than 1901.4 ± 379.34 (mean±SD)
ml in Group C (p = 0.000). Intra operative lactate levels and postoper-
ative fluid, urine output, serum urea, and creatinine levels were com-
parable (Figure2). Conjunctival edema was significantly higher in
group C.
CONCLUSION. Administering fluid guided by PPV decreases the in-
traoperative fluid requirement by 29 % when compared to CVP
guided therapy with no adverse effect on immediate graft function.




2. Othman MM, Ismael AZ, Hammouda GE. The impact of timing of
maximal crystalloid hydration on early graft function during kidney
transplantation..Anesthesia and analgesia. 2010;110(5):1440-6.
Fig. 2 (abstract 000194). Showing the variables observed between
the groups perioperatively
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INTRODUCTION. Delirium is a frequent problem is the intensive
care unit (ICU) and is associated with adverse outcomes, such as
longer hospital length of stay, cognitive impairment and poten-
tially higher mortality. Haloperidol and atypical antipsychotics are
often used to treat delirium in the ICU. Antipsychotics can lead
to severe adverse effects, such as arrhythmia, pneumonia, ortho-
static hypotension and falling. When antipsychotics are adminis-
tered for delirium in the ICU, patients are at risk of having
antipsychotics continued at ICU and hospital discharge, even
though they are no longer indicated. No European data on hos-
pital discharge of patients with newly administered antipsychotics
is available.
OBJECTIVES. This study aims to determine the incidence of ICU and
hospital discharge with newly administered antipsychotics for ICU
delirium, to identify risk factors for discharge with antipsychotics and
to evaluate follow-up of patients with antipsychotics upon ICU and
hospital discharge.
METHODS. This retrospective observational study was performed in
a tertiary care center. Patients older than 18 years who received anti-
psychotics for delirium in the ICU during 2016 were included. Prelim-
inary risk factors were determined by performing chi-square tests forcategorical variables and univariate binary logistic regression tests for
continuous variables. Preliminary risk factors were included in a
multivariate binary logistic regression model to identify independent
risk factors. Results are expressed as odds ratios with 95% confidence
intervals.
RESULTS. A total of 196 patients met the inclusion criteria, of which
104 (53.1%) were discharged from the ICU with continued anti-
psychotics, and 41 (20.9%) patients were discharged from the
hospital with continued antipsychotics. At ICU discharge, continu-
ation of antipsychotics was independently associated with a
lower Charlson comorbidity index (0.84 [0.73 – 0.97]), treatment
with quetiapine (7.14 [3.06 – 16.67]), less days between anti-
psychotic treatment initiation and ICU discharge (0.95 [0.91 –
0.99]), and a higher ICDSC score at ICU discharge (1.21 [1.04 –
1.39]). At hospital discharge, admission to the medical ICU (2.97
[1.37 -6.41]) and treatment with quetiapine (5.81 [1.63 – 20.83])
were independently associated with continuation of antipsy-
chotics. Sixteen (39.0%) patients who were discharged from the
hospital with continued antipsychotics had no mentioning of
these antipsychotics in their hospital discharge letter. All of these
patients were discharged from a surgical ward.
CONCLUSION. One out of five patients were discharged from the
hospital with continued antipsychotics. This result is comparable
to previous, albeit all US, studies. There is a lack of systematic
follow-up of antipsychotics. Hospital policies should implement
systematic strategies for better follow-up of antipsychotics at
transitions of care.NIC - Neurocritical care 2
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INTRODUCTION. Heatstroke is a life-threatening illness which occurs
in hot environment, especially in the summertime. The summer of
2018 was remarkable, because emergency transport to medical facil-
ities of heat-related illness casualties hit the highest record in history
at Tokyo, Japan.
Rapid and effective cooling is essential for victims of heatstroke.
However, there is little clinical evidence about treatment with new
cooling devices.
We compared combined methods with an extra-cooling device (Arc-
tic Sun 5000®, Medivance, USA) to conventional approaches (e.g.
lukewarm water spray, electric fan and cooling fluid infusion) for
treatment with heatstroke.
METHODS. Patients (aged >16 years) with heat-related illness trans-
ported to our emergency department (ED) via emergency medical
service (EMS) from June to September of 2018 were included in this
study.
We used the Japanese Association for Acute Medicine (JAAM) criteria
for definition and classification (grade I to III) of heat-related illness.
Treatment and clinical outcome of exertional heatstroke cases were
examined. Data was derived from prehospital records and electronic
health record (EHR).
RESULTS. The total number of emergency transport was 1764. Fifty-
one (2.9%) patients presented to ED via EMS with symptoms of heat-
related illness.
With the JAAM criteria, the number of grade III (severe) heat-related
illness that corresponds to heatstroke was 9 (18%). Among them, 4
(7.8%) cases were diagnosed with exertional heatstroke.
With severe exertional heatstroke, three (5.9%) presented with hyper-
thermia (deep body temperature over 40 C). One was treated by
combined methods with Arctic Sun 5000®, and the other two were
treated by conventional approaches. All of three case were treated
Page 262 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55under mechanical ventilation and use of sedatives and muscle relax-
ants at intensive care unit (ICU).
The time required for reaching to target body temperature was
shorter with combined methods than with conventional approaches.
Also, no rebound of body temperature was observed with combined
methods with Arctic Sun 5000®.
Arctic Sun 5000® was considered minimally invasive and easy to
introduce at ED. Overall clinical courses were fine without neuro-
logical dysfunction.
CONCLUSION. Treatment with extra-cooling devices combined with
conventional approaches may be beneficial to patients with exer-
tional heatstroke. Further investigations including large clinical trials
are required.
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INTRODUCTION. Increased intracranial pressure (ICP) is one of the
major clinical complications of acute brain injuries (ABIs) and corre-
lates with poor outcome. ICP monitoring (ICPm) is the most common
neuromonitoring modality used in intensive care units (ICUs). The in-
dications for ICPm are mostly based on traumatic brain injury (TBI),
whereas uncertainties remain for ICPm in non-TBI (acute subarach-
noid haemorrhage (SAH) and intracerebral haemorrhage (ICH)). More-
over, practice about indications and use of ICPm in patients with
ABIs is highly variable in high-income countries (HICs), while data on
ICPm in low- (LICs) and middle-income countries (MICs) is scarce or
inconsistent.
OBJECTIVES. SYNAPSE-ICU is an international, prospective, obser-
vational, cohort study (NCT03257904) designed to describe the
current practice of ICPm using a worldwide sample. Aim is to
quantify practice variations in ICPm and management in HICs,
MICs and LICs, and to provide a correlation between ICPm and
neurological clinical outcome (GOSE: Glasgow Outcome Scale
Extended).
METHODS. From March 2018 to April 2019, all patients fulfilling
the following inclusion criteria were recruited: age >18 years; ABI
due to primary haemorrhagic stroke or TBI; Glasgow Coma Score
(GCS) with Motor score (M) ≤ 5 at ICU admission or within the
first 48 hours. Data related to clinical examination and to ICP in-
terventions was recorded at ICU admission, at day 1, 3 and 7.
GOSE was collected at discharge from ICU, from hospital and at
6-month follow-up.
RESULTS. To date, 41 countries around the world enrolled 2302 pa-
tients in 143 active sites (95 in Europe, 28 in America, 15 in Asia, 3 in
Australia and 2 in Africa).
We described the main characteristics of the first 1000 recruited pa-
tients (68.0 % males, 32.0 % females, mean age 55.0 years ± 19.2)enrolled in HICs (87.5%), in upper-MICs (U-MICs) (6.7%) and in lower-
MICs (L-MICs) (5.8%). Primary diagnosis was TBI in 56.0% of patients
and non-TBI in 44.0% of them (19.1% SAH and 24.9% ICH). In the first
week of ICU stay, ICP was measured in 585 patients (90.8% in
HICs, 5.1% in U-MICs, 4.1% in L-MICs), whereas ICPm was never ap-
plied in 415 patients. ICPm patients had a 6-months lower mortality
compared to no ICPm ones (40.0% vs 56.1%).
CONCLUSION. The high number of enrolled patients and the distri-
bution of active ICUs will represent the worldwide variability in ICPm
practice variations. Further analysis will be presented at the end of
the study period.
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INTRODUCTION. Severe traumatic brain injury (TBI) patients may de-
velop acute respiratory failure or acute respiratory distress syndrome
(ARDS) (1-2). Optimal ventilatory strategies in this setting are not well
established.
OBJECTIVES. To survey practices in the respiratory management of
adult TBI patients with and without ARDS.
METHODS. An electronic questionnaire, including 40 items and 3 dif-
ferent clinical scenarios (PaO2/FiO2: >300, 150-300, <150), was avail-
able on the European Society of Intensive Care Medicine (ESICM)
website between November 2018 and March 2019. The survey was
endorsed and promoted by ESICM.
RESULTS. Respondents (RSP) were 687 [472 (69%) from Europe];
mainly intensivists [328 (48%)] and anesthesiologists [206 (30%)].
A standard protocol for mechanical ventilation in TBI patients
was utilized by 277 (40%) RSP and a specific weaning protocol
by 198 (30%). The most frequently reported ventilator settings
and respiratory targets according to acute lung injury severity are
summarized in Table 1. The most frequent rescue strategies uti-
lized in case of refractory hypoxemia despite conventional venti-
lator settings are represented by neuromuscular blocking agents
[406 (88%)], recruitment maneuvers [319 (69%)] and prone pos-
ition [292 (63%)].
CONCLUSION. Different practices on respiratory management of
adult TBI patients with and without ARDS are identified in this sur-
vey. These findings may be helpful to define future investigations in
this topic.
REFERENCE(S)
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Abbreviations: TV tidal volume, PBW predicted body weight, PEEP positive end-
expiratory pressure, IH intracranial hypertension, PaCO2 partial pressure of
arterial carbon dioxide, SpO2 arterial blood oxygen saturation
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INTRODUCTION. Platelet distribution width (PDW) reflects the vari-
ation and heterogeneity of platelet size, and elevation of PDW indica-
tors of platelet activation. Elevated PDW was associated with poor
prognosis in thromboembolic diseases. However, little is known
about the association between platelet activation and clinical out-
come of intracranial hemorrhage.
OBJECTIVES. To study the role of PDW as a prognostic marker of
acute intracranial hemorrhage.
METHODS. This was a retrospective cohort study conducted in emer-
gency department intensive care units between April 2015 and De-
cember 2016. Patients admitted with diagnosis of acute traumatic
and non-traumatic intracranial hemorrhage were included. The
demographic data, hemorrhage type, platelet count, mean platelet
volume (MPV), PDW were compared between survivors and
nonsurvivors.
RESULTS. A total of 120 patients with acute intracranial hemorrhage
were included, 65% (78/120) were traumatic cause. In our cohort,
overall mortality was 15.4% (16/104). There was no difference in age,
gender, antiplatelet, anticoagulant use, platelet count and MPV level
between survivors and non-survivors. In multivariate logistic regres-
sion model, PDW was an independent predictor for in-hospital mor-
tality (Odds ratio = 6.07; 95% confidence interval (CI.)=[1.17-31.41], p
= 0.031) after adjusting APACHE II score, GCS, mechanism and
hemorrhage type. The receiver-operating characteristic area under
the curve (AUC) of PDW was 0.71 (95% CI=[0.55-0.87], p=0.006). The
PDW level is lowest in aneurysmal SAH group and highest in spon-
taneous ICH group.
CONCLUSION. PDW is simple, inexpensive and available in routine
blood sampling. Our study revealed the potential value of PDW as a
predictor for in-hospital mortality in intracranial hemorrhage.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000240INTRODUCTION. Takotsubo cardiomyopathy (TTC) is an acute, usually
reversible heart failure syndrome, precipitated by emotional or phys-
ical stressors. The initial presentation of TTC has similar features to
acute coronary syndrome, however, coronary angiography usually
shows an absence of significant coronary artery disease. TTC has
been previously described as a notable complication of SAH because
of its impact on cerebral blood flow.
OBJECTIVES. The aim of our prospective observational study was to
investigate the incidence, predisposing factors and cardiac bio-
markers of TTC associated with SAH. Our secondary goal was to
evaluate its effect on outcome.
METHODS. This study was conducted in our neurosugical intensive
care unit between March 2015 and June 2018 (Clinical trials reg. Nr:
NCT02659878). We enrolled non-traumatic SAH patients without a
history of cardiac disease, who were admitted within 48 hours from
symptom onset. On admission we noted the severity of the haemor-
rhage (modified Fisher score) and neurological state (Hunt-Hess and
WFNS scores) and transthoracic echocardiogram was performed. Pa-
tients with wall motion abnormality (WMA) were diagnosed as TTC,
TTC patients with ejection fraction lower than 40% were classified as
severe TTC (sTTC), patients without WMA served as control group
(CG). Cardiac necroenzyme detection and transcranial colour duplex
was performed on a daily basis. Each patient went through follow-up
echocardiograms. We evaluated Glasgow Outcome Scale (GOS) and
Barthel Scale (BS) 30 days and 6 months after the onset of SAH.
RESULTS. During the study period 136 patients fulfilled inclusion cri-
teria. Incidence of TTC was 28,7% (n=39), sTTC was found in 8,1%
(n=11) of the cases. TTC was more common among females than
males (female/male: CG 50/47 vs. TTC 30/9, p=0,007). Higher modi-
fied Fisher score was more frequent in the TTC group (modified
Fisher>2: TTC 32/39 vs. CG 54/97; p=0,004). Higher Hunt-Hess (H-
H>3: sTTC 8/11 vs. CG 29/97; p=0,012) and WFNS-score (WFNS>3:
sTTC 9/11 vs. CG 29/97; p=0,002) was characteristic for sTTC. Serious
vasospasm had higher incidence in the sTTC group (sTTC 3/11 vs. CG
5/97; p=0,04). We found significantly elevated cTnT and NT-proBNP
levels in TTC patients. On 1 and 6 month follow-up sTTC was related
to increased mortality (sTTC vs. CG: 7/11 vs. 15/95, p<0,001; 8/11 vs.
24/93, p=0,004) and lower GOS score (GOS<4: sTTC vs. CG 11/11 vs
44/95, p=0,002; 9/11 vs. 32/93, p=0,007). At 30th day lower quality of
life was observed in the sTTC group (BS<50: sTTC 4/4 vs. CG 23/79,
p=0,016).
CONCLUSION. TTC is a common cardiac complication of SAH, espe-
cially in serious SAH with severe neurological symptoms. cTnT and
NT-proBNP properly signs the presence of TTC. The harmful effect of
TTC on cerebral circulation may contribute to increased mortality
and disability.
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INTRODUCTION. Spontaneous subarachnoid haemorrhage (SAH) is
frequently a devastating type of acute cerebral bleeding which,
despite continuous improvements in treatment and care, often
remains a disease with high mortality and poor functional
outcome.
OBJECTIVES. To understand and map all contributing factors regard-
ing epidemiology, treatment with outcome in patients with both
aneurysmal SAH (aSAH) and non-aneurysmal SAH (non-aSAH).
Page 264 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55METHODS. This retrospective cohort study was carried out in a ter-
tiary university hospital. Data regarding demographics, Intensive Care
Unit (ICU) stay and functional outcome were collected for all patients
during a period of eleven years (2007-2017). Univariate logistic re-
gression was carried out in order to assess the influence of each vari-
able on the occurrence of vasospasm/delayed cerebral ischaemia,
the ICU and hospital survival. Univariate multinominal logistic regres-
sion was used for the analysis on the modified Rankin Scale (mRS), a
functional outcome scale taken five to eight months after SAH.
RESULTS. A total of 498 SAH patients were identified, of which 421
were diagnosed with aSAH. Female gender, being an active smoking,
problematic alcohol use and hypertension are all more prevalent in
aSAH patients than in non-aSAH patients. 65.1% of aSAH and 23% of
non-aSAH patients had polyuria, which was significantly associated
with vasospasm. 24.5% of aSAH and 5.3% of non-aSAH patients ex-
perienced vasospasm, which was significantly related to poorer out-
come. Most aSAH patients (88.8%) were treated with coiling, versus
only 5.5% who were clipped. Epileptic insults occurred in 12.3% of
aSAH opposed to 2.3% in non-aSAH patients. Infections occurred in
50.1% of aSAH, and 20% of non-aSAH patients. Location of the
aneurysm at the posterior communicating artery, and hyponatraemia
(Na<135 mmol/L) during ICU stay were associated with a better ICU
and hospital outcome. Hypernatraemia (Na>150mmol/L) and in-
creased lactate levels (at admission, at 48 hours) were associated
with poor outcome. The hospital mortality of 133 patients (26.7%)
presenting with poor grade SAH (Hunt & Hess scale 4-5) was 38.3%.
Overall mortality was 15.5%. Hospital survival decreased substantially
in patients over 80 years. Most aSAH patients (68.3%) had a good
functional outcome (mRS 0-2).
CONCLUSION. Patients with SAH still have a substantial mortality
and often a poor functional outcome. aSAH and non-aSAH patients
demonstrated distinct characteristics in epidemiology and outcome.
Analysis identified multiple variables which were associated with
vasospasm, ICU and hospital survival and functional outcome.
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INTRODUCTION. The serum lactate level is a useful predictor of mor-
tality in critically ill patients. However, little is known about the asso-
ciation between the serum lactate level and mortality in patients
admitted to neuro-intensive care units (NCUs).
OBJECTIVES. The present study aimed to investigate the association
between the initial lactate level and 90-day mortality in NCU
patients.
METHODS. This retrospective observational study was conducted by
reviewing the medical records of adult (age ≥18 years) patients ad-
mitted to the NCU at a single tertiary care academic hospital during
2013–2017. The initial lactate level (mmol L-1) was defined as the
serum lactate level measured within 6 hours following NCU
admission.
RESULTS. The final analysis included 2,737 patients, of whom 280
(10.2%) died within 90 days of NCU admission. In a receiver operat-
ing characteristic (ROC) analysis, the estimated area under the curve
(AUC) for the initial lactate level in predicting overall 90-day mortality
was 0.55 [95% confidence interval (CI): 0.52–0.59]. The corresponding
values for neurologic and non-neurologic disease-related 90-day
mortality were 0.76 (95% CI: 0.71–0.82) and 0.49 (95% CI: 0.45–0.53),
respectively. In a multivariable Cox regression analysis, a 1-mmol L-1
increase in the initial lactate level was associated with 1.17- and 1.22-
fold increases in overall and neurologic disease-related 90-daymortality, respectively, but not with non-neurological disease-related
90-day mortality (P=0.422).
CONCLUSION. Elevated lactate levels were related with an in-
crease in overall 90-day mortality among NCU patients. This asso-
ciation was specifically attributed to neurologic disease-related
90-day mortality.
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INTRODUCTION. The optic nerve sheath diameter (ONSD) is consid-
ered an indirect marker for intracranial pressure (ICP). Many studies
investigated the normal range of ONSD, the cut-off for increased ICP
and what can affect these values including age and sex. However,
questions remain about the differences of ONSD versus age and sex,
among healthy and brain injured population.
OBJECTIVES. The aim of this study is to investigate the values of
ultrasonographic ONSD in healthy volunteers of different sex and
age and to assess whether there are differences in sex and age in a
cohort of brain injured patients.
METHODS. We prospectively recruited 122 healthy volunteers under-
going pre-assessment evaluation and compared age/sex dependence
of ONSD to 95 patients aged >18 years old with severe traumatic
brain injury (TBI) requiring intubation and invasive ICP monitoring.
The two groups were stratified for sex and age. Age was divided into
3 subgroups (18-44 years; 45-64 years; >65 years).
RESULTS. In healthy volunteers, ONSD was significantly different be-
tween males and females (mean ONSD 4.26 vs 4.00 mm, [p = 0.01]).
ONSD showed a statistically significant correlation with age (R=0.50,
p <0.0001). In TBI patients, no differences in ONSD were found for
sex and the correlation between age and ONSD was non-significant
(R=0.13 p = 0.20).
CONCLUSION. ONSD correlates with age and is significantly different
between males and females in healthy volunteers. However, these
findings do not persist in TBI patients.
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Page 265 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. The incidence of delirium in the ICU ranges from
45% to 87%. Several scales are used to assess the presence of delir-
ium among which two are most widely used – Confusion Assessment
Method-ICU (CAM-ICU) and Intensive Care Delirium Screening Check-
list (ICDSC).
OBJECTIVES. To assess the frequency of manifestation and severity
of agitation/sedation in patients with strokes with speech and with-
out speech disorders; estimate the frequency of occurrence of delir-
ium and its types.
METHODS. We conducted an observational study of 80 patients ad-
mitted to the stroke unit. In the first 24-48 hours from the moment
of arrival, the presence of delirium was evaluated on the ICDSC scale.
The degree of depression of consciousness was assessed according
to the CGS and FOUR scales. The degree of agitation/sedation was
assessed according to the RASS scale. The patients were divided into
2 groups - the 1st group (34 cases) of patients who had speech dis-
orders in the form of total aphasia or motor/sensory aphasia and the
2nd group - patients without speech disorders (46 cases).
RESULTS. The degree of depression of consciousness from CGS and
FOUR, the degree of sedation / arousal on the RASS scale are pre-
sented in Table.
In 1 group agitation (RASS +1 and more) was observed in 20 (59%)
patients, in 2 group agitation was observed in 13 (28%) patients. We
noted a statistically significant (φ = 2.768, p≤0.01) increasing in the
frequency of occurrence of agitation in 1group assessed by the RASS
scale and a statistically significant decreasing in the level of con-
sciousness which was evaluated by the CGS scale. A more pro-
nounced degree of depression of consciousness in patients when
evaluated on the CGS scale compared to assessing the level of con-
sciousness in them on the FOUR scale can be explained by the pres-
ence of verbal contact in the CGS scale, which is absent in the FOUR
scale. In 2 group, where it was possible to assess the presence of de-
lirium on the ICDSC scale, subsyndromal delirium was detected in 18
(40%) patients, delirium was diagnosed in 13 (29%) patients. At the
same time, hyperactive delirium was diagnosed in 6 (14%) patients,
in 7 (15%) - mixed delirium. Hypoactive delirium in patients was not
observed by us.
CONCLUSION. The presence of speech disorders is the significant
factor complicating the assessment of presence of delirium in pa-
tients with stroke. A statistically significant increase in the level of
agitation in the assessment on the RASS scale in patients with
speech disorders can be regarded as manifestations of delirium in
patients of this group based on the frequency of delirium in patients
of 2 group with agitation.Table 1 (abstract 000359). Level of consciousness, the presence of
sedation/agitation, Me [25; 75]
GCS FOUR RASS
1 group 14 [11;15] 16 [12;16] 1 [-1;2]
2 group 15 [14;15] 16 [14;16] 0 [-2;0]
p ≤ 0.05 ≥0.05 ≤0.05000368
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INTRODUCTION. Age is not an exclusion criterion for thrombectomy
(TRB) in acute ischemic stroke (AIS).
OBJECTIVES. To compare six-month mortalities and neurological sta-
tuses of AIS patients of different ages treated with TRB.METHODS. Retrospective study (October 2013–July 2017) including
AIS patients treated with TRB admitted to our ICU. Patients were di-
vided in three groups based on age: group A (<65 years); group B
(65-79 years) and group C (≥ 80 years). Complete reperfusion was de-
fined by a IIb/III punctuation in the modified treatment in cerebral in-
farction score (mTICI). A difference ≥ 4 points between initial and
before discharge National Institutes of Health Stroke Scale (NIHSS)
scores was considered as favorable in-hospital neurological evolution.
A modified Rankin Scale (mRS) score between 0–2 at six months was
acknowledged as good neurological status. Univariate analysis: X2 or
Fishers test (categorical) and Kruskall-Wallis (numerical). Multivariate
analysis: logistic regression.
RESULTS. One hundred and sixty-five patients were included: 64 in
group A; 66 in B and 35 in C. We found no differences in the preva-
lence of previous ischemic/hemorrhagic stroke, initial NIHSS, basilar
artery involvement or initial CT findings evaluated by the Alberta
Stroke Program Early CT Score (ASPECTS). Patients ≥ 65 years had
more comorbidities [A: 2 (1-3) vs. B and C: 2 (2-3); p < 0.05) and
higher APACHE II scores [A: 9 (7-12) vs. B and C: 13 (11-17); p <
0.001].
Regarding treatment characteristics and patient’s evolution, the main
reason for TRB across groups was thrombolysis failure and stent re-
triever was the most used technique. The interval symptom onset to
reperfusion (min) was similar between groups [A: 285 (241 – 382) vs.
B: 305 (252 – 355) vs. C: 313 (270 – 360); NS] as was the rate of
complete reperfusion [A: 43 (78.2%) vs. B: 53 (82.2%) vs. C: 21
(63.6%)]. Even though no statistical differences were found, patients
in group C had a longer AIS duration and a lower reperfusion
rate. TRB was not feasible due to anatomical difficulties in seven pa-
tients (20%) in group C as compared to 1 (1.6%) and 2 (3%) patients
in groups A and B. Forty-four patients (75.9%) in group A, 39 (72.2%)
in B and 18 (64.3%) in C achieved a favorable neurological in-
hospital evolution (NIHSS ≥ 4; NS).
When looking at 6-month mortality, after adjusting by confounding
factors (number of comorbidities, APACHE II, initial NIHSS, basilar ar-
tery involvement, initial ASPECTS, interval symptom onset to reperfu-
sion, TRB complications, hemorrhagic transformation, use of
vasoactive drugs and mTICI < IIb), only patients below 65 years had
a higher probability of survival [OR 0.04 (IC95 0.00 – 0.77); p = 0.03].
No differences were found when studying mRS (0-2) at six-months
[group A: OR 0.24 (IC95 0.04 – 1.32); p = 0.10 and group B: OR 0.57
(IC95 0.11 – 2.80); p = 0.49. Reference category: Group C].
CONCLUSION. In our series, patients below 65 years of age with an
AIS treated with TRB had better chances of six-month survival when
compared to elder patients, but no differences in neurological out-
comes at six-months were demonstrated. We believe age should be
taken into account when TRB is being considered as part of the treat-
ment for AIS.
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INTRODUCTION. Intensive Care Unit Acquired Weakness (ICUAW) is a
common complication affecting peripheral nerves and muscles
resulting in severe immobility and prolonged intensive care treat-
ment with increased mortality [1]. Limited data are available for a
possible impairment of the enteric nervous system in this
Page 266 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55generalized neuromuscular dysfunction. Furthermore, the relevance
of ICUAW for gastrointestinal dysmotility and impaired enteral nutri-
tion was not studied before.
OBJECTIVES. We investigated gastrointestinal function and nutri-
tional status in patients with and without ICUAW.
METHODS. In this retrospective analysis, we included critically ill pa-
tients (main inclusion criterion: SOFA-Score ≥ 8 for three consecutive
days after intensive care unit (ICU) admission; main exclusion criteria:
pre-existing neuromuscular disease or gastrointestinal dysfunction,
present abdominal surgery) on two perioperative ICUs. The Medical
Research Council-Sum Score (MRC-ss) was used to diagnose ICUAW
(MRC-ss < 48 points) [2]. Within a 14-day observational period the
following parameters for gastrointestinal function and nutritional sta-
tus were collected: gastric residual volume (GRV), administered doses
of laxatives, defecation frequency and days with enteral tube
feeding.
RESULTS. Thirty patients were enrolled for an analysis. ICUAW was di-
agnosed in 14 patients (mean age 68.17 ± 11.3 years; APACHE-II 26.1
± 3.5), 16 patients were ICUAW negative (mean age 59.75 ± 15.5
years, p=0.19; APACHE-II 22.9 ± 6.2, p=0.09). Patients with ICUAW
were significantly longer sedated and mechanically ventilated. The
mean cumulative GRV was higher in patients with ICUAW (1797.9 ±
1896.9 ml/patient vs. 835.9 ± 1101.2 ml/patient, p=0.058). Patients
with ICUAW needed higher cumulative doses of laxatives (lactulose:
103.4 ± 41.3 g vs. 69.2 ± 57.2 g, p=0.07; sodium picosulfate: 60 ±
16.4 mg vs. 34.7 ± 28.3 mg, p=0.013; suppositories: 29 vs. 9, p=0.009)
and the cumulative time of administration was longer (lactulose: 123
vs. 91 days, p<0.001; sodium picosulfate: 112 vs. 75 days, p<0.001).
Patients with ICUAW were more frequently depended on enteral
tube feeding after extubation (cumulative: 79/103 days [76.7%] vs.
42/172 days [24.4%], p<0.001) and after 14 days (11/14 [78.6%]
ICUAW positive patients vs. 3/16 [18.8%] ICUAW negative patients,
p<0.01). The cumulative defecation frequency was similar between
both groups (87/195 days [44.6%] vs. 86/222 days [38.7%], p=0.26).
CONCLUSION. Gastrointestinal dysmotility was more frequent in crit-
ically ill patients with ICUAW and might result from an impairment of
the enteric nervous system. Prolonged dependency of enteral tube
feeding might point to a higher risk of nutritional impairment in pa-
tients with ICUAW, which should be further investigated.
REFERENCE(S)
[1] Greet Hermans and Greet Van den Berghe 2015. Clinical review: intensive
care unit acquired weakness.Crit Care. 19(1): 274.
[2] Stevens et al 2009. A framewok for diagnosing and classifying intensive
care unit-acquired weakness. Crit Care Med. 37 (10 Suppl):S299-308.
None.
000378
Effect of sedative drugs on outcome in traumatic brain injury
patients with intracranial pressure monitoring: a CENTER-TBI study
M. Carbonara1, B. Gravesteijn2, T. Zoerle1, F. Ortolano1, T. Birg1,
G. Citerio3, R. Helbok4, A. Chieregato5, N. Stocchetti1, HF. Lingsma2
1Neurointensive care unit, Fondazione IRCCS Ca’Granda Ospedale
Maggiore Policlinico, Milano, Italy; 2Center for medical decision sciences,
department of public health, Erasmus University Medical
Center, Rotterdam, Netherlands; 3School of medicine and
surgery, University of Milano-Bicocca, Monza, Italy; 4Department of
neurology, University of Innsbruck, Innsbruck, Austria; 5Neurointensive
care, ASST Great Metropolitan Niguarda, Milano, Italy
Correspondence: M. Carbonara
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000378
INTRODUCTION. Sedation is a first-line therapy used in intensive care
unit (ICU) to control raised intracranial pressure in severe traumatic
brain injury (TBI) patients. However, it remains unclear what the ef-
fect of different sedative drugs is on outcome. This analysis of the
CENTER-TBI study uses comparative effectiveness research to fill this
knowledge gap.
METHODS. The CENTER-TBI study (clinicaltrials.gov registration
NCT02210221) is a prospective observational longitudinal cohortstudy including patients with TBI from 65 centers across Europe. Data
were extracted from the CENTER-TBI database v1.1 with Neurobot
v2.6. We included all patient who were admitted to the ICU with ICP
monitoring and who had more than one day of mechanical ventila-
tion. For every patient, the primary sedative (the sedative that the
patient received most of the days) was selected. We focused on mid-
azolam and propofol, since these were the most frequently used.
RESULTS. 4509 patients were included in the CENTER-TBI study: we
selected 611 patients who received propofol, and 451 patients who
received midazolam. There was a large variation between centers in
choice of sedative drugs and length of sedation. The length of ICU
stay was 0.84 time shorter (95% CI: 0.81 - 0.87) before adjustment,
and 0.83 (95% CI: 0.80 - 0.86) after adjustment for major confounders
compared to midazolam. Total adjusted hospital length of stay was
similarly 0.97 time shorter (95% CI: 0.95 - 1.00) for propofol versus
midazolam patients. The OR of propofol for a better functional out-
come was 1.10 (95% CI: 0.83 - 1.45) before adjustment, and 0.93
(95% CI: 0.69 - 1.26) after adjustment.
CONCLUSION. There is large variation in length of sedation and
choice of sedative drugs among European neurotrauma centers. Pro-
pofol is associated with a shorter ICU and hospital length of stay but
similar functional outcome as midazolam.
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INTRODUCTION. Measurement of optic nerve sheath (ONSD) using
ocular sonography is an accurate, non-invasive technique for the de-
tection of intracranial hypertension (> 20 mmHg) in a heterogeneous
group of patients with acute brain injury when performed by an ex-
perienced operator. ONSD ≥0.48 cm has the greatest accuracy. In the
same way the Axial Tomography proves to be a good technique for
demostrate intracranial hypertension with the increase ONSD. At
present, these techniques are increasingly used in neurocritical
patients.
OBJECTIVES. To determine the values of the diameter of the optic
nerve sheath (ONSD) by computerized tomography (CT) and ocular
ultrasound (OU), in neurocritical patients admitted to a polyvalent
ICU without neurosurgery. ONSD values of intracranial hypertension
are considered by CT> 5mm and by OU> 4.8mm (measured both at
3mm from the posterior wall of the eyeball).
METHODS. Cross-sectional prospective study from January 2017 to
December 2018, in patients admitted consecutively with neurological
pathologies, performing measurements of the ONSD by CT (SIEMENS,
WW 2; WL 98; thickness of the cut 2mm) to 3mm of the posterior
wall of the eyeball, and measurements of ONSD by OU (ESAOTE
ultrasound, linear probe 7.5MHz) to 3mm of the posterior wall of the
eyeball. Epidemiological variables are studied, and ONSD (bilateral)
measurements are compared by both CT and OU. Statistical study
with IBM SPSS statistics 20.0, determination of the T-Student for inde-
pendent samples and Pearson correlation.
RESULTS. A total of 70 patients with a mean age of 65.23 years (35-
86), males 45 (64.28%) were collected. Causes of admission:
hemorrhagic stroke-17 (24,28%) Ischemic stroke-22 (31,42%) posta-
noxic encephalopathy-9 (12,86%) Meningitis-12 (17,14%) and Others-
10 (14,28%). Mean initial GCS: 6,66 (3-13). They required mechanical




Table 1 (abstract 000419). Mean peak cTnl values associated with
good and poor functional ability as measured by mRS after aSAH
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 In our patients there are no statistically significant differences
when measuring ONSD by CT and by OU.
 There is a very good correlation in ONSD measurements by CT
and OU (the correlation is significant at the bilateral 0.01 level)
and they are good methods, to evaluate intracranial
hypertension non-invasively.
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DATABASE RIGHT EYE LEFT EYE
Mean ± SD Min Max Mean ± SD Min Max
ONSD- CT (3mm) 5,47 ±1,04 2,96 8,6 5,51 ±1,14 3,6 8,5
ONSD- OU (3 mm) 5,35 ±0,66 3,78 7,1 5,39±0,70 3,8 7,1000419
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INTRODUCTION. Patients with aneurysmal subarachnoid hemorrhage
(aSAH) frequently display elevated cardiac troponin-I (cTnI), often
with cardiac transient regional wall motion abnormalities, both of
which often resolve in the days after bleed. However, the peak level
of cTnI associated with poor functional outcomes is not explicated.
OBJECTIVES. To evaluate the cut-point value of peak cTnI associated
with poor functional outcomes as measured by the modified Rankin
Score (mRS) at hospital discharge, and at 3 and 12 months after
aSAH.
METHODS. We recruited 175 aSAH patients (inclusion: ages 21-75
years, Fisher grade >1; exclusions: chronic neurological deficit, history
of myocardial infarction). Serum cTnI was measured daily, and the
patients peak value from days 1-3 used in the analysis. mRS was ob-
tained by trained study staff at hospital discharge by chart review,
and at 3 and 12 months by interview, and dichotomized as good
(scores 0-3) and poor (scores 4-6). Descriptive statistics were ob-
tained, and the cTnI cut-point value associated with poor outcomes
at the 3 time points estimated using Receiver Operating Characteris-
tic Curve where the optimal cut-point maximized the sum of sensitiv-
ity and specificity for all possible values of the cut point.
RESULTS. The sample of 175 patients was primarily female (72%),
with a mean age of 53 years (SD 11), and Hunt and Hess grade mean
2.9 (SD 0.7). As shown in Table 1, mean values of cTnI for patients
with poor outcome were generally greater that 1.0 ng/ml (poor out-
come pateints cTnI means of 1.78, 1.19 and 1.27ng/ml at discharge, 3
and 12 months respectively). Standard deviations were large, while
median values for cTnI for patients with poor outcome were 0, 0.17
and 0.31 at discharge, 3 and 12 months. Cuttpoint values of cTnIassociated with poor outcome were quite low, with poor to moder-
ate sensitivity but good specificity (discharge cTnI cutpoint 0.33ng/
ml, sensitivity 0.343, specificity 0.922; 3 month cTnI threshhold
0.28ng/ml, sensitivity 0.455, specificity 0.810; 12 month cTnI thresh-
hold 0.28ng/ml, sensitivity 0.523, specificity 0.802). Of note, sensitivity
of cTnI threshhold values associated with poor outcome improved
slightly as time from injury lengthened.
CONCLUSION. All patients with a cTnI above 0.28ng/ml during days
1-3 after aSAH have a greater propensity towards poorer outcomes,
but sensitivity for prognostic purposes is low.
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INTRODUCTION. Anticoagulation and antiplatelet medications are
beneficial in the treatment/prevention of a range of conditions. An
estimated 1-2% of the UK population is therapeutically anticoagu-
lated. Recent evidence has demonstrated superiority of direct oral
anticoagulant drugs (DOACs) over warfarin and there has been a
sharp increase in the use of these medications. This is not without
risk and European guidelines recommend a bleeding risk assessment
(e.g. HAS-BLED score). It is estimated that DOACs will account for 5%
of the NHS drug budget in 2020. This means that it is highly relevant
to evaluate real-world data focussing on adverse events associated
with these drugs, particularly intracranial haemorrhage. There have
also been recent updates to evidence and guidance regarding as-
pirin, making it relevant to compare events in patients taking anti-
platelet drugs.
OBJECTIVES. To assess prior anticoagulant or antiplatelet medication
use in patients admitted with haemorrhagic stroke in a neurosci-
ences critical care unit.
METHODS. Retrospective search of the local critical care admissions
database covering the period April 2017 to March 2019. Patients admit-
ted with diagnosis codes “Intracerebral haemorrhage" ("supratentorial"
or "posterior fossa") were included. Subarachnoid haemorrhage and
traumatic injury were excluded. Of the 178 records, 69 were excluded
for secondary causes of bleeding or duplicate entries, resulting in 109
patients included in the analysis.
RESULTS. 26/109 (24%) of identified patients were on anticoagulant
or antiplatelet therapy prior to admission. Of these, 14 (13%) were
anticoagulated (7 DOAC, 6 warfarin, 1 heparin) and 14 (13%) were on
an antiplatelet drug (11 aspirin [1 also on ticagrelor], 3 clopidogrel). 2
patients were on combination anticoagulation/antiplatelet therapy.
Page 268 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Indications for anticoagulation included atrial fibrillation (AF), venous
thromboembolism (VTE) and metallic heart valve. Indications for anti-
platelet therapy included coronary artery disease, stroke or transient
ischaemic attack (TIA). 2 patients on aspirin had no clear indication
to be on antiplatelet therapy. Mortality was 46% and not significantly
different between patients on anticoagulant/antiplatelet therapy and
those who were not (p=0.38), or between patients on aspirin versus
DOAC (p=1.0).
CONCLUSION. A quarter of patients admitted to our ICU with haem-
orrhagic stroke were taking anticoagulant or antiplatelet medications.
Mortality was high and not significantly different between patient
groups. Aspirin use was more frequent than DOACs. This is perhaps
surprising given that DOACs confer a higher intracranial bleeding
risk, and recent trends of increasing DOAC use. One explanation is
that patients on aspirin also have comorbidities that put them at par-
ticularly high risk of haemorrhagic stroke, and the likelihood that as-
pirin is still more frequently prescribed (for a variety of indications)
than DOACs. Two patients on aspirin had no clear reason to be tak-
ing it. This highlights the importance of balancing risks and benefits,
particularly with aspirin, which has been shown not to be of benefit
in the primary prevention of cardiovascular disease, or for stroke pre-
vention in AF. As use of DOACs increases, and specific reversal
agents become more readily available, it will be interesting to ob-
serve for potential changes in rates and patterns of haemorrhagic
stroke.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000538INTRODUCTION. Transcranial Doppler (TCD) offers a view of brain
hemodynamics through the measurements of Flow Velocities (FV) on
cerebral arteries and vein system and the assessment of advanced
parameters such as autoregulation, compliance and intracranial pres-
sure. These parameters may vary with age and sex. Nowadays few
studies describe normal ranges of flow velocities between different
gender and ages especially involving the poorly explored venous
compartment and the coupling between venous and arterial
compartment.
OBJECTIVES. The aim of this study is to determine the normal range
and coupling of flow velocities in the Straight Sinus and in the Mid-
dle Cerebral Artery according to sex and age.
METHODS. We prospectively recruited 122 healthy volunteers under-
going pre-assessment evaluation and 95 patients aged >18 years old
with severe traumatic brain injury (TBI) requiring intubation and inva-
sive ICP monitoring. The two groups were stratified for sex and age.
Age was divided into 3 subgroups (18-44 years; 45-64 years; >65
years). Coupling between arterial and venous flow was assessed
within different age groups and sex and between the two cohorts.
RESULTS. We found a significant correlation between arterial and
venous systolic flows (FVs vs FVVs) in the whole population (R=
0.3953745; p-value < 0.0001) as well as in the females and males sub-
groups, suggesting the presence of physiologic coupling between ar-
terial and venous flow in healthy volunteers. This correlation was
significant even considering the effect of age. In TBI patients, no cor-
relation between FVs and FVVs was found.
CONCLUSION. Arterial-venous coupling can be studied using TCD.
This coupling is lost in TBI patients, maybe for the compression of
the sinuses in high ICP and decoupling of flow from metabolism in
the injured brain. Venous TCD could open new scenarios in the com-
prehension of brain physiopatology.
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INTRODUCTION. Primary percutaneous coronary intervention (pPCI)
is the ideal method of reperfusion for acute STEMI. Although, in
some areas it is very difficult to implement pPCI between two hours,
and it is well-known that 'Time is myocardium'.
OBJECTIVES. To analyze the safety and efficacy of the pharmacoinva-
sive therapy protocol in a setting without primary percutaneous cor-
onary intervention (PCI), Campo de Gibraltar (CG) area.
METHODS. Multicentre observational prospective study of consecu-
tive patients with STEMI treated with fibrinolysis in the CG area and
transferred to our intensive care unit for coronarography and PCI be-
tween January 1, 2012 and March 31, 2018, included in the ARIAM
ANDALUCIA registry. We considered as effective fibrinolysis ( EfFx)
those with post-treatment TIMI 3 flow grade and early fibrinolysis
(EarlyFx)those given in the first 3 hours from symptom onset.
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ing Academic Research Consortium classification.
RESULTS. 437 patients were included, mean age (sd) 59.79 (11.89),
242 were inferior STEMI and 194 anterior STEMI. Culprit arthery :
none 44, RCA 192, DCA 163 and CXA 38.Distribution (n) of Killip
grades I, II, III and IV were 383, 10, 13 and 31 respectively. Mean
GRACE (sd) was 149.59(33.49)
80.3% of fibrinolysis treatments were given early and 79.4% in hos-
pital, with a median symptoms-to-needle time of 95 minutes. TIMI 3
was achieved in 79.17% of the cases. 264 coronarographies were per-
formed in the first 24 hours (76 rescue-PCI) and 188 in 48-72 horus.
PCI were effective in 382 (87.8%) cases. In 48 (11 %) was not per-
formed because of MINOCA, and 0.9% failed. . EfFx was associated
with EarlyFx (p<0.001). Complication rates were 1.83% PCI-related
and 2.28% haemorrhagic.
Procedural mortality was 2.3%, and mortality at 30 days was 3.1%.
CONCLUSION. The efficacy of both prehospital and in-hospital fibrin-
olysis in CG health services was related to its early administration.
The Hemodynamics unit in the Puerto Real University Hospital en-
sured the success of the procedure. Pharmocoinvasive therapy with
fibrinolysis and PCI has demonstrated to be a safe and effective alter-
native to primary PCI for CG patients unable to achieve a symptoms-
to-ballon time lesser than 180 minutes.
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INTRODUCTION. Left ventricle (LV) global longitudinal peak systolic
strain (GLS) and peak systolic strain rate (SSR) are validated speckle
tracking echocardiography indices of systolic function. They have
been shown to be affected by loading conditions in cardiac and crit-
ically ill patients. Nevertheless, we made the hypothesis that patients
with and without preload responsiveness behave differently due to
the effects of the Starling law. In patients with preload responsive-
ness, indices of systolic function should increase because the stretch-
ing of the LV fibers with fluid loading enhances their shortening. This
should not occur in preload unresponsive patients.
METHODS. We included septic shock patients undergoing a passive
leg raising (PLR) test for clinical purposes. GLS and SSR were assessed
before and during the PLR test and compared. The LV GLS and SSR
were calculated as the average of the value obtained in the 4-
chamber view and the value obtained in the 2-chamber and/or the
3-chamber view. Preload responsiveness was defined by a PLR-
induced increase in cardiac output ≥10%.
RESULTS. We performed 24 measurements in 15 patients (SAPSII at
admission = 46±13, SOFA at inclusion = 10±3, pneumonia in 67% of
cases). PLR revealed 8 preload responder cases (R) and 16 preload
non-responder cases (NR). In both groups, LV end-diastolic volume
increased significantly during PLR (from 67 [57;85] to 75 [67;92] mLin R and from 62 [56;87] to 73 [67;92] mL in NR). During PLR, cardiac
output increased by 21±9% in R and by 5±3% in NR. In R, GLS im-
proved from -12.1 [-11.3;-16.4] to -13.7 [-12.1;-18.9]% (p=0.02). Simi-
larly, SSR rose from -1.1 [-0.9;-1.2] to -1.2 [-1.1;-1.3] 1/s (p=0.03). In
NR, GLS and SSR did not change significantly (p=0.30 and p=0.50,
respectively).
CONCLUSION. The preliminary data of this ongoing study show that
GLS and SSR depend on LV preload only in R. This suggests that they
increase as a result of the Starling law.
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INTRODUCTION. Poor quality end-of-life(EOL) care is associated with
psychological distress among dying patients and their families,and
this has been contributed by the inadequacies in physician education
and training.We therefore attempted to determine the competency
levels of Anaesthesiology trainees,who manage surgical intensive
care patients.
METHODS. A self-rated questionaire modified from Weissman[1] was
used to evaluate the competency of physicians in managing 1)pa-
tient-family interactions,2)EOL patient care issues and 3)terminal dis-
charge procedures was administered to all Anaesthesiology senior
residents.
RESULTS. 34/51(67%) trainees responded to the survey with their
baseline demographics in table 1.The comfort level of trainees on
patient-family and physician-physican interactions and their profi-
ciencies in EOL care issues are found in Figures 1 and 2.Trainees
were generally comfortable discussing all aspects of treatment with-
drawal with family over areas ranging from ventilation,transfusions,-
feeding,RRT to vasopressor.
In decisions made by the medical team for a terminally-ill DNR(do-
not-resuscitate) patient with no decision-making capacity,the trainees
felt that the withdrawal of feeding/hydration was associated with
violation of ethical and/or personal beliefs.In contrast,trainees had
less issues when these decisions were made by the surrogate deci-
sion maker.
CONCLUSION. While our trainees are comfortable in basic EOL care,-
most discomfort arises from conflicts management with other team
members,families or personal values and beliefs.This could be as our
current training system focuses largely on active management but
does not prepare the trainee on how to transition to palliative car-
e.This survey helps to identify the gaps in our training system and
can help us to improve it.
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INTRODUCTION. Opioid analgesics are commonly added to intra-
thecal bupivacaine to improve patient comfort during and after
elective gynaecological procedures. The National Institute for Clinical
Excellence (NICE) recommends diamorphine 0.3–0.4 mg for analgesia
after elective Caesarean section in preference to morphine. Risk fac-
tors for development of respiratory depression include long-acting
sedatives, known respiratory disease, increasing age and positive-
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Table 1 (abstract 001459). Baseline characteristics and clinical results
Fig. 1 (abstract 001459). See text for description
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vomiting and pruritus is proportional to the dose of diamorphine
used.
OBJECTIVES. We sought to discover if the quantity of opioid added
to the spinal for elective gynaecological surgery influenced post-op
respiratory function and requirement for vasopressors on intensive
care.
METHODS. A retrospective cohort approach was used. The an-
aesthetic documentation of all patients admitted to intensive
care post op gynaecological surgery over six and a half months
was examined. Eighteen patients met the inclusion criteria. The
age ranged from 43 – 91 years old. The average age was 71
years.
RESULTS. There were 94% planned admissions and 6% were un-
planned. Sixty-seven percent of patients had had a Total Ab-
dominal Hysterectomy + Bilateral Salpingo-oophorectomy.
Seventeen percent of surgeries were complex involving the in-
put of other specialties. ASA ranged from 2-4. Sixty-one percent
of patients had both a general anaesthetic (GA) and spinal.
Seventeen percent had GA only whereas 11% had GA and epi-
dural. Of the anaesthetic charts that were available, Diamor-
phine was used in the spinals of 69% of patients. Doses ranged
from 100 mcg – 1mg with an average dose of 780mcg. In 44%
of patients, an additional opioid was used intraoperatively.
The CO2 on admission to intensive care was raised in 39% of pa-
tients. Metaraminol was required in 22% of patients. One patient re-
quired CPR immediately post-op. Average length of stay was 1 day.
CONCLUSION. There was a positive correlation between the dose
of intrathecal diamorphine used and post-op CO2 on admission
to intensive care. There was no correlation between intrathecal
diamorphine dose and need for vasopressors on admission.
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INTRODUCTION. Anemia is often found among patients undergo-
ing cardiac surgery and it is associated with an increased risk of
perioperative complications [1]. The most frequent cause of
anemia is iron deficiency (ID), and it may have a role in transfu-
sions requirements and clinical outcomes in these patients [2].
OBJECTIVES. To analyze the prevalence of preoperative iron defi-
ciency in cardiac surgery patients, its association with preoperative
anemia and packed red blood cells transfusions.
METHODS. Retrospective, observational, cohort study in which all
adult patients undergoing elective or urgent cardiac surgery at Son
Espases University Hospital were included from April to November
2018.
Anemia was defined as a hemoglobin (Hb) <12/13 g/dL (women/
men) and iron deficiency as ferritin <30 μg/L or ferritin <100 μg/L +
Transferrin saturation index (TSI) <20%.Preoperative clinical variables, transfusions performed, hospital
length of stay and global mortality were analyzed. Patients without
preoperative iron profile study were excluded.
Quantitative variables are expressed as mean ± standard deviation
(SD) and the Student's t-test was used to compare them. Those that
do not follow a normal distribution, are expressed as median and
interquartile range (IQR) and were compared using the Mann-
Whitney U test. The qualitative variables were expressed as absolute
value and percentage (%) and analyzed with Fisher's exact test. To
asses the transfusion requirements, patients were stratified according
to the presence or not of preoperative anemia.
RESULTS. From the initial sample of 231 patients, 48 were excluded.
The most relevant baseline characteristics and clinical results are rep-
resented in Table 1. ID was present in 70 patients (30.3%), associated
with anemia in 32 of them (45.7%) and without it, in 38 cases
(54.35%). ID was more common in women and was associated with
lower presurgical hemoglobin levels (p = 0.002). Preoperative ID
anemia diagnosis was stablished only in 22 (9.5%) patients and 19
(8.2%) of them were treated previously with iron supplements. Pa-
tients with ID, stratified by preoperative anemia, received more
packed red blood cells transfusions (p = 0.000) (Figure 1).
CONCLUSION. Preoperative ID is common in cardiac surgery patients,
even in those without preoperative anemia. ID is associated with a greater
amount of transfusions. Treating the ID could be a strategy to reduce pre-
operative anemia and the need of transfusions in this population.
REFERENCE(S)
1. Kulier A, Levin J, Moser R, Rumpold-Seitlinger G, Tudor I, et al. Impact of
preoperative anemia on outcome in patients undergoing coronary artery
bypass graft surgery. Circulation 2007; 31; 116(5):471-9.
2. Abraham J, Sinha R, Robinson K, et al. Aetiology of Preoperative Anaemia in
Patients Undergoing Elective Cardiac Surgery-the Challenge of Pillar One of
Patient Blood Management. Anaesth Intensive Care 2017; 45(1):46-51.
Page 271 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55001588
Usage of psychotropic drug therapy in a polyvalent ICU: a
retrospective study
L. Lopez, D. Díaz Diaz, M. Villanova, A. Martinez De La Gandara, T. Fariña,
E. Palencia
Intensive care unit, Hospital Universitario Infanta Leonor, Madrid, Spain
Correspondence: L. Lopez
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001588
INTRODUCTION. Acute brain dysfunction is very common in crit-
ical care patients, and may manifest as delirium, agitation, anxiety
or coma. Other psychological conditions can develop in ICU pa-
tients: generalized anxiety, sleep disorders, alcohol/drug with-
drawal syndromes, depressant symptoms, or previous psychiatric
conditions among others. Because of it, the use of psychotropic
drugs (PD) is common in ICU setting.
OBJECTIVES. To identify the different PDs used in a community hos-
pital ICU. We analyze the use of different antipsychotics, BZDs, anti-
depressants and also alpha2 agonists. We did not include other
sedative drugs.
METHODS. Retrospective study in a cohort of patients consecu-
tively admitted to the ICU for more than 24 hours during 2018.
We collected demographic data, reason for ICU admission, ICU
LOS, CAM-ICU, mechanical ventilation (MV), use of the different
PDs, duration of treatment (DOT) and the main indication.
RESULTS. Total of 325 patients (pts) were admitted in our ICU
during 2018. PDs were used in 179 (55%). Average age was 65.3
years (SD 14.1), 53.6% were males. Mean (SD) ICU LOS 9.6 days
(13.8). 80 patients (44.7%) had MV. CAM-ICU + in 43 patients
(24%). Main results:
1. Dexmedetomidine: 23 pts (12,8%), alone or with more PD
in 16 pts (72,8%). Mean (SD) DOT 3.7 days (3.3). CAM-
ICU+ in 13 (59%). Mean (SD) dose: 0.40 (0.16) to 1.01 (
0.42) mcg/kg/h. Indication: sedation (86.4%)
2. Clonidine: 11 pts (6.1%). Mean (SD) DOT 8.2 days (7.8). CAM-
ICU+ in 7 (63%). Indication: withdrawal (36.4%), agitation/delir-
ium (54.6%)
3. Haloperidol: 53 pts (29.6%). Mean (SD) daily dose. 5.1 (2.1) to
7.9 (4.4) mg
Mean (SD) DOT 2.6 (2.4) days. CAM-ICU + in 34 (79.1%). Indi-
cation: agitation (82.7%)
4. Quetiapine: 59 pts (33%). Mean (SD) daily dose: 35.5 (35) to 83
(98) mg
Mean (SD) DOT 6.9 days (8.6). CAM-ICU + in 37 pts (62.7%).
Indication: Delirium (93%)
5. Other antipsychotics: 27 pts (15%). Tiapride 18 pts (10%),
Olanzapine 5 pts (3%), Others 4 pts (2.5%). Indication:
withdrawal 15 (58%), agitation/delirium 3 (8%). Mean (SD)
DOT 2.7 (1.3)
6. Benzodiazepines: 116 pts (64.8%). Lorazepam 64 (36%),
Clorazepate 21 (12%), Bromazepam 16 (9%), Diazepam 6
(3.5%), others 9 (4.5%). CAM ICU + in 43 pts (51.2%). Mean
(SD) DOT 2 (1.8) days. Indication: hypnotic 65 (56%), anxiety
28 (24%), withdrawal 8 (7%), others 15 (13%)
7. Antidepressants: 35 pts (19.6%): Mirtazapine 17 (9.5%),
Citalopram 5 (3%), Sertraline 5 (3%), others 8 (4.5%). Mean
(SD) DOT 7.4 days (0.7). Indication: Usual medication 20 (57%),
depression 9 (26%), hypnotic 6 (17%)
CONCLUSION. In our ICU DEX is used mainly for transition sedation.
Delirium was usually treated with quetiapine and agitation with halo-
peridol. BZPs and antidepressants were also widely used, confirming
the existence of a gap between Guidelines and the routine ICUclinical practice. Further investigations are required for the use of
psychotropic drugs in the ICU.
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INTRODUCTION. Management of pain in critical patients is one of
the most important part of the treatment and it is necessary to im-
prove it in order to get better prognosis.
OBJECTIVES. To describe the prevalence of pain, its quantification and the
analgesic regimens in patients admitted to an Intensive Care Unit (ICU)
METHODS. Weekly registration of patients to an ICU over a month,
type of admission, analgesic regimen and assessment of acute pain
episodes through Visual Analog Scale (VAS), Behaviour Indicators of
Pain, and Richmond Agitation Sedation Scale (RASS) as apropiate, as
well as pharmacological and non-pharmacological interventions.
RESULTS. In a total of 92 patients, of which 62% of them were males, with
an average age of 61.9 +-15.1 years, main causes of admission were: re-
spiratory failure (50%), neurological disabilities (35.6%) and shock (10.9%).
Attending to severity, the average APACHE II was 16.13+-6.2 (2.31) and
SOFA 5.6 +- 3.3. 61% of the patients were awaken and able to self-
report pain and 39% of them were under sedation (25% had light sed-
ation (RASS-2); 16,7% moderate (RASS-3); 25% deep (RASS-4) and 33%
very deep (33%)). 70% of patients required Mechanical Ventilation (MV)
(Invasive MV 78.5% and Non Invasive MV 21.5%) and 26.1% were tra-
cheostomized. Attending to analgesic regimen: 98.9% had a established
treatment: 53.3% of them had a fixed regimen plus adjuvant therapy dur-
ing episodes of acute pain; 28.3% fixed regimen without adjuvant ther-
apy; 17.4% were only prescribed in case of pain and 1.1% had no
analgesic regimen. Acetaminophen was the most frequently prescribed
analgesic (91.3%), followed by opiods (61%): (fentanyl 48.2%, morphine
42.9% and remifentanill 7.1%), metamizole (54.3%) and NSAIDs (3,3%).
Attending to pain: All of patients had at least one measurement of pain
daily. There was also a explicit reference of that in 68% of nursery com-
ments and in 76,1% of medical comments. 41% of patients did not show
pain, 41,3% of them showed mild pain, and 19,6% registered relevant
pain, being intense in 6% of them. 95% of these episodes were solved by
adjuvant medication and 5% of them by other non pharmacological in-
terventions. Regarding non pharmacological interventions: calm environ-
ment was detected in 85% of the registrations, adequate light in 96,7%,
proper sound in 74% and pleasant termperature in 85%. Every patient
had postural changes during the day (81,5% of them had more than five
a day). Only 20,5% of patients were under physical therapy. Pain episodes
were more frequent in patients with respiratory failure (30%) or shock
(21%), specially in those without MV. Existence of tracheostomy did not
imply more pain. Awaken and conscious patiens had higher risk of suffer-
ing pain episodes (RR 4). Physical therapy was related to more pain epi-
sodes, but it was not statistically significant. Environmental factors are not
related to more pain episodes. Attending analgesic regimen, the one pre-
scribed just in case of pain was related to more pain episodes (RR 2,4). Pa-
tients with higher risk of episodes of moderate or severe pain includes:
those conscious and able to self-report pain, those with analgesic regi-
men conditioned to pain, those with more than 2 analgesic, those with-
out MV and those not mobilized. This explanatory model shows a high
discriminative power (AuROC 0.91, CI 0.84-0.97).
CONCLUSION. Pain monitoring and analgesic regimens are adequate,
as well as mobilization of patients, with fewer episodes of severe
pain. Physical therapy is not sufficient. Environmental factors are not
Page 272 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55related to severe pain. Patients with higher risk of pain are those
conscious and collaborative, with regimens conditioned to pain,
without MV and not mobilized.
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Added information through meta-
analyses
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INTRODUCTION. Anemia is common in critically ill patients admitted
to the intensive care unit (ICU). [1,2] The etiology is usually multifac-
torial, including a shortened red blood cell lifespan and impaired
erythropoiesis. [3-5] Currently the most common therapy of anemia
in ICU patients is red blood cell (RBC) transfusion which is known to
be associated with adverse events. [6,7] Erythropoietin stimulating
agents (ESA) could potentially reduce the need for RBC transfusion.
OBJECTIVES. The aim of this systematic review with meta-analysis is
to summarize current evidence on the use of ESA in critically ill pa-
tients with anemia. Our primary outcomes are difference in RBC
transfusion frequency and change in hemoglobin (Hb) concentration.
Our secondary outcomes include adverse events, and mortality.
METHODS. A comphrensive literature search was performed
in EMBASE, Cochrane and PubMed databases up to September 2018.
We restricted inclusion to original studies with adult patients (>18
years of age) in which ESA were given as treatment for anemia of
the critically ill. Case reports, case series, conference abstracts and lit-
erature studies were excluded. Articles were independently reviewed
by two authors for inclusion and data extraction. A third author per-
formed quality assessment for each outcome using the GRADE ap-
proach. [8] A random-effects model was used for the meta-analysis.
RESULTS. A total of 842 articles were identified of which 18 articles
met the inclusion criteria for the qualitative synthesis. Eight of these
studies were randomized clinical trials (RCT), with a total of 3387 pa-
tients. These studies were included in the meta-analysis. Comparing
ESA versus control group, there was a small reduction in the propor-
tion of patients who received one or more RBC transfusions (RR 0.88;
CI 0.78-1.00, moderate certainty). The change in Hb concentration
was trivial (mean difference -0.31 g/dL; CI -0.51 to - 0.05, high cer-
tainty). The number of serious adverse events (RR 1.02; 0.90-1.15, low
certainty) and the overall short-term mortality were similar (RR 0.80;
CI 0.61-1.05, low certainty). Subgroup analysis for trauma patients
showed lower mortality rates in the ESA group (RR 0.49; CI 0.32-0.75,
moderate certainty). If real, this advantage is not due to an increase
in Hb since there is no reduction in RBC transfusions in the trauma
population. The price of recombinant erythropoietin is around
$0.0119 per unit. With an average of 40,000 units per dose, the price
of one single dose is circa $450. [9]CONCLUSION. Use of ESA resulted in a small reduction in proportion
of patients transfused and a trivial increase in hemoglobin concentra-
tion. It is debatable whether these changes are clinically relevant.
There was no overall difference in adverse events or mortality. Based
on this meta-analysis and taking into account the cost of ESA there
is insufficient evidence to recommend use of ESA as substitute for
RBC transfusion in current standard treatment of anemia of the critic-
ally ill.
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INTRODUCTION. The role of extravascular lung water (EVLW) mea-
sured by transpulmonary thermodilution (TPTD) in the management
of critically ill patients remains a matter of debate. We performed a
systematic review and meta-analysis of studies assessing the effects
of elevated TPTD-estimated EVLW on mortality in critically ill patients
with/without septic shock with/without acute respiratory distress syn-
drome (ARDS).
METHODS. MEDLINE, EMBASE and Cochrane Database were screened
for original articles. Random effects meta-analyses estimated the
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pooled area under the receiver operating characteristics curve
(AUROC) of elevated EVLW as a predictor of mortality. Missing data
were provided by the authors of the original studies.
RESULTS. Fifteen studies (1086 patients) were included. Elevated
EVLW levels were associated with a pooled relative risk for mortality
of 3.33 [2.21-5.03]. The pooled AUROC, estimated from 13 studies,
was 0.84±0.04. The pooled sensitivity and specificity were 70[65-
74]% and 69[65-73]%, respectively. Both the baseline and the max-
imal EVLW values were significantly different among survivors and
non-survivors, as well as EVLW variation over time. Subgroup ana-
lyses comparing indexation of EVLW to actual vs. predicted body
weight and specific populations of ARDS patients vs. other ones were
consistent with primary analysis. According to the multivariable ana-
lysis performed in seven studies, the odds ratio of elevated EVLW for
mortality ranged from 1.01 to 6.21.
CONCLUSION. The level of EVLW measured by TPTD and its changes
over time are associated with mortality in critically ill patients, which
may emphasize its clinical value.
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INTRODUCTION. Early mobility can improve patients’ ability of activ-
ity and muscle strength, reduce duration of mechanical ventilation
and improve patients’ life quality after discharge,and the adverse
events of early mobility were less than 1%.there is no uniform defin-
ition of early mobilization initiative time up to now which ranging
from duration of mechanical ventilation less than 24 hours to more
than one week of ICU admitted which hinder the widespread imple-
mentation of early mobilization in clinic.Therefore,Determine a initia-
tive time to start early mobility is very important
OBJECTIVES. To evaluate the effects of different early mobilization
initiative time on the intensive care unit(ICU) mechanical ventilated
patients
METHODS. Chinese Biomedical Literature Database(CBM),Chinese
Knowledge Infrastructure(CNKI),Wanfang Data,PubMed,Cochrane
library,Web of Science,EMbase and other sources were carried out up
to October,2018 about Randomized control trials(RCTs) examining
the effects of early mobilization on ICU mechanical ventilated
patients.Two investigators independently screened literature,ex-
tracted data and evaluated the risk of bias.Outcomes were incidence
of ICU acquired weakness(ICU-AW),duration of mechanical ventilation
and ICU length of stay.Network commands of mvmeta package in
Stata 13.0 were used to perform statistical analyses
RESULTS. A total of fifteen RCTs involving 1,726 patients and eight
kinds of initiative time to start early mobilization.The network meta-
analysis showed that,on the incidence of ICU-AW,there were significant
difference between early mobilization began on duration of mechanical
ventilation≤24h,48h<duration of mechanical ventilation≤72h,72h<dur-
ation of mechanical ventilation≤96h compared with usual care,and no
difference between other comparisons;The ranking results were,72h<
duration of mechanical ventilation≤96h,duration of mechanicalventilation≤24h,48h<duration of mechanical ventilation≤72h,24h<dur-
ation of mechanical ventilation≤48h,usual care.On mechanical ventila-
tion time,duration of mechanical ventilation≤24h,24h<duration of
mechanical ventilation≤48h,48h<duration of mechanical ventila-
tion≤72h,duration of mechanical ventilation>96h were all superior to
ICU admitted>5 days and usual care,and no difference between other
comparisons;The ranking results were,48h<duration of mechanical ven-
tilation≤72h,duration of mechanical ventilation≤24h,24h<duration of
mechanical ventilation≤48h,ICU admitted>7 days,duration of mechan-
ical ventilation>96h,usual care,ICU admitted>5 days.And there were no
difference between the 8 kinds of initiative time on decreasing ICU
length of stay.
CONCLUSION. Based on the Network meta-analysis and ranking
results,early mobilization start on duration of mechanical ventilation<
24h and 48h<duration of mechanical ventilation≤72h were superior
to other time on improving the effects of ICU mechanical ventilated
patients.
000784
High Flow Nasal Cannula use compared to conventional oxygen
therapy in the peri-intubation period: A systematic review and
meta-analysis
D. Chaudhuri1, D. Granton2, D. Wang3, S. Maggiore4, S. Einav5,
L. Brochard6, Y. Helviz5, T. Mauri7, J. Mancebo Cortes8, JP. Frat9, S. Jog10,
G. Hernandez11, C. Hodgson12, S. Jaber13, KEA. Burns14, B. Rochwerg1
1Critical care, McMaster University, Hamilton, Canada;
2Medicine, McMaster University, Hamilton, Canada; 3Medicine, Western
University, London, Canada; 4Anesthesiology, D'Annunzio University of
Chieti–Pescara, Chieti, Italy; 5General intensive care unit, Shaare Zedek
Medical Center, Jerusalem, Israel; 6Interdepartmental division of critical
care- university of toronto, Hospital St. Michael and Keenan research
center, Toronto, Canada; 7Department of anesthesiology, Fondazione
IRCCS Ca’Granda Ospedale Maggiore Policlinico - Servizio Beni
Culturali, Milano, Italy; 8Servei de medicina intensiva, Hospital Universitari
Sant Pau, Barcelona, Spain; 9Medecine intensive reanimation, Poitiers
University Hospital, Poitiers, France; 10Adult intensive care, Pune
University, Pune, India; 11Critical care department, Virgen de la Salud
University Hospital, Toledo, Spain; 12Department of epidemiology and
preventive medicine, Monash University, Melbourne, Australia; 13DAR
B, Hôpital Saint Eloi, Montpellier, France; 14Critical care, St. Michael's
Hospital, Toronto, Canada
Correspondence: D. Chaudhuri
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000784
INTRODUCTION. High flow nasal cannula (HFNC) may be beneficial
to patients in the pre-oxygenation and peri-intubation stages of oro-
tracheal intubation by preventing hypoxemia. Despite a number of
small randomized controlled trials (RCTs) examining this question, a
comprehensive synthesis of the available data has not been con-
ducted previously. Our objective was to conduct a systematic review
and meta-analysis examining the role of HFNC in the peri-intubation
period
METHODS. We performed a comprehensive search of relevant data-
bases (MEDLINE, EMBASE and Web of Science) screening for random-
ized control trials that compared HFNC oxygen to any other non-
invasive modality of oxygen delivery in the peri-intubation time
period. Our primary outcome was severe desaturation (defined as
SpO2 reading less than 80% during intubation procedure). Other out-
comes included short-term mortality, peri-intubation complications,
apneic time, and PaO2 before and after intubation. We performed
meta-analyses using a random effects model. A priori we assessed for
predefined subgroup effects based on patient population, risk of
bias, and the comparator used. We assessed risk of bias (ROB) of indi-
vidual RCTs using a modified Cochrane risk of bias tool and assessed
overall certainty of pooled estimates using the Grading of Recom-
mendations, Assessment, Development and Evaluation (GRADE)
framework.
RESULTS. We identified 9 RCTs with a total of 917 patients that met
eligibility criteria; 4 RCTs examined HFNC in pre-operative patients
and 5 RCTs studied HFNC in acutely hypoxemic critically ill patients.
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the remaining trials compared HFNC to facemask with bag mask ven-
tilation. HFNC showed no effect on the incidence of peri-intubation
hypoxemia (relative risk [RR] 0.93, 95% confidence interval [CI]
0.59 to 1.44, 0.9% absolute risk reduction, 95% CI 5.5% reduction
to 5.9% increase; moderate certainty) when compared to NIV or con-
ventional oxygen therapy and no effect on 28-day mortality (RR 0.91,
95% CI 0.72 to 1.12, 3.0% absolute risk reduction, 95% CI 9.3% reduc-
tion to 3.9% increase, moderate certainty). HFNC also showed no ef-
fect on serious peri-intubation complications (RR 0.87, 95% CI 0.70 to
1.08, 1.4% absolute risk reduction, 95% CI 5.0% reduction to 1.0% in-
crease; low certainty,?) and ICU length of stay (mean difference [MD]
1.15 days less, 95% CI 2.45 days less to 0.16 days more; moderate
certainty). Finally, there was no effect of HFNC on PaO2 measured
after induction and pre-oxygenation (MD 2.7 mm Hg higher, 95% CI
4.1 mm Hg lower to 9.6 mm Hg higher, moderate certainty), or mea-
sured after intubation (MD 30.0 mm Hg higher, 95% CI 8.5 mm Hg
lower to 68.6 mm Hg higher, moderate certainty) or in overall apneic
time (MD 12.3 seconds higher with HFNC, 95% CI 11.9 seconds lower
to 36.6 seconds higher, low certainty) as compared to conventional
oxygen therapy or NIV. There were no credible subgroup effects.
CONCLUSION. We did not find evidence of an effect of HFNC on the
incidence of hypoxemia, complications, oxygenation, ICU LOS, or
overall survival when used in the peri-intubation period.CD - Haemodynamics
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INTRODUCTION. Bedside ultrasonography is used as a noninvasive
method for hemodynamic monitoring, Evaluation of inferior vena
cava diameter by sonography provide an alternative tool for evalu-
ation of intravascular volume. Femoral vein is a superficial compliant
vessel, images can be easily obtained.
METHODS. We enrolled 100 adult patients in this study. During
measurement, patient was in supine position. The CVP was uniformly
measured at end of expiration and the pressure transducer having
been zeroed at the level of mid axillary line. IVC image was obtained
using General Electric ultrasound machine and 3.5 MHz convex
probe. The transducer is placed in a vertical plane in the subxiphoid
view. The intrahepatic portion of the IVC was visualized as it entered
the right atrium. Approximately 3–4 cm from the junction of the IVC
and right atrium the IVC diameter was obtained. Using M mode, the
maximum and minimum diameter during inspiration and expiration
diameter were recorded respectively In order to get the FVD, we
scanned the femoral triangle starting at the inguinal crease using a
linear array transducer (5-10 MHZ). FVD was measured just caudal to
the sapheno-femoral junction.
RESULTS. , mean age was 56 y, mean CVP was 6 cm H2O, mean IVC
diameter during inspiration was 15 cm, while during expiration was
13.6 cm and the of femoral vein diameter was 8.2 cm. There were
significant correlations between CVP , IVC diameter ( Insp, Exp)and
FVD. CVP correlation with FVD was 0.59, IVC diameter during inspir-
ation with FVD was 0.41 and IVC diameter during expiration was 0.42
CONCLUSION. FVD can be used as a noninvasive alternative method
to assess intravascular volume status.
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INTRODUCTION. Right ventricular (RV) failure is one of the most ser-
ious complications after heart transplantation (HTx). It is an inde-
pendent risk factor of mortality. Ventricular Assist Devices (VAD)
must be considered if conservative medical management fails.
OBJECTIVES. Describe our series of patients with RV failure after HTx
that required VAD implantation.
METHODS. We performed a retrospective study from January 2011
to March 2019 in a third-level ICU with heart transplantation pro-
gram. All patients that required VAD after RV failure followed by HTx
were included. We examined demographics, previously hospitalized
in ICU, preoperative VAD implantation, postoperative complications,
and survival rate. Absolute number and frequency described qualita-
tive variables and median and interquartile range (IR) described
quantitative variables.
RESULTS. We collected a total of 10 patients. Demographic data is
shown in Table 1. Causes of heart failure were dilated cardiomyop-
athy (4 cases), congenital cardiomyopathy (2 cases), ischemic cardio-
myopathy (2 cases), hypertrophic (1 case) and restrictive
cardiomyopathy (1 case). Six patients were transferred from the the-
atre, 2 from the ward, 1 from the emergency room and 1 from an-
other centre. Five patients were hospitalized in ICU while waiting for
transplantation, of whom 4 needed a pre-transplantation VAD: Cen-
triMag Right VAD in 2 patients, central ECMO in 1 patient and Periph-
eral ECMO in 1 patient. The causes of hospitalization in ICU previous
to HTx were acute decompensated heart failure in 2 cases, ischemic
cardiogenic shock in 1 case and cardiac electric storm in 1 case. The
most frequent VADs implanted after HTx were peripheral ECMO in 6
patients, followed by CentriMag Right Ventricular Assist Device and
central ECMO in 2 patients each. VAD was placed as a bridge to re-
covery in all cases. The most frequent postoperative complications
were acute kidney injury with renal replacement therapy (7 cases),
critical illness polyneuropathy (6 cases) and stroke (2 cases). The
overall mortality was 40%.
CONCLUSION. Admission in ICU before heart transplantation and
VAD implantation is common in our series, being acute decompen-
sated heart failure the most habitual cause of hospitalized, and Cen-
triMag Right VAD the most frequent device placed. The most
frequent VAD placed after RV failure followed by HTx was peripheral
ECMO. More data is needed to gain a deeper understanding of these
results.
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Male - n (%) 8 (80%)
Age - median (IR) 52 (31.75-57)
Smoking habits - n (%) 5 (50%)
Alcoholism - n (%) 4 (40%)
Hypertension - n (%) 4 (40%)
Diabetes mellitus - n (%) 3 (30%)
Chronic kidney disease - n (%) None
Cirrhosis - n (%) None
LVEF - median (IR) 31.7 (24.5-36.25)001305
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INTRODUCTION. Heart transplant in Congenital Heart diseases is
challenging, but it is the last option when the heart failure is
end.stage.
OBJECTIVES. To describe Heart transplant in congenital Heart Dis-
ease patients in a third Level Hospital
METHODS. Retrospective observational study from 1997 to 2019 in a
third-level cardiovascular ICU. We included all patients with Congeni-
tal Heart diseases who had a heart transplant. We included demo-
graphic data, cardiac catheterization data [pulmonary artery median
pressure (PAPm), wedge pressure (PWP), pulmonary vascular resist-
ance (PVR)]. Heart failure stage according to NYHA and FEVI, renal
failure and liver failure before the transplantation. Complications dur-
ing their stay in ITU after transplant were collected: any infection,
renal failure develop, ECMO support needed, and global survive. Ab-
solute number and frequency described qualitative variables and me-
dian and interquartile range (IR) described quantitative variables
RESULTS. We collected 14 patients, median age was 25,5 (20,7-
32,25), 57,1% were males. 100% had a NYHA ³3 before transplant,
Median FEVI was 37 (22,5-55). Cardiac catheterization values were:
median PAPm was 19 (12-22,5); median PWP was 16 (13,5-19,5), me-
dian RVP 1,83 (1-4). During their stay in ITU 54,5%(6) presented an in-
fection being respiratory tract infection the most frequent (50%). The
21,4 %(3) needed RRT and 36,4% (4) presented liver failure. 28,6 %(4)
develop graft failure, which needs ECMO support, with a median of 6
days (1-17,5) and the mortality in that Group was 50%. Our global
survival was 78,6 %(11)
CONCLUSION. The most frequent complication was the infection
Mortality in those who develop graft failure and need ECMO support
is high.Heart transplant in this population is a valid option with good global
results.
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INTRODUCTION. Mortality in cardiogenic shock remains high, despite
advances in treatment, including mechanical circulatory support,
using ECMO or other alternative systems (1).
METHODS. We performed a retrospective study, analysing the activ-
ity in cardio-pulmonary support via Extracorporeal Membrane Oxy-
genation (ECMO), from November 2015 to October 2018, in a mixed
medical and surgical cardiac ICU. Data were collected from electronic
and hard-copy archives.
RESULTS. Twelve patients were treated with ECMO (CardioHelp Sys-
tem, Maquet). All patients had a veno-arterial (VA) ECMO implanted,
using a percutaneous, femoro-femoral technique, with a posterior
tibial reperfusion cannula, for limb ischemia prevention. Left ventricu-
lar (LV) unloading was attempted using an intra-aortic balloon pump
(IABP) on the contra-lateral leg. Implantation was done using either
ultrasonographic or fluoroscopic guidance.
Refractory cardiogenic shock was the indication for ECLS in all cases:
seven patients with post-cardiotomy shock, two patients with fulmin-
ant acute myocarditis, and three with ST-elevation myocardial infarc-
tion (STEMI), of which one had a mechanical complication – septal
ventricular rupture.
Cardiac dysfunction was severe in all cases, either due to LV dysfunc-
tion (ejection fraction <25%), RV dysfunction or both, after attempt-
ing pharmacologic optimization and, in most cases, IABP. Mean
serum lactate at the moment of implantation was 9,4 mmol/L (SD=
4,73).
Monitoring included lactate dynamics, continuous SvO2, daily echo-
cardiography, either transthoracic or transoesophageal, near-infrared
spectroscopy and a protocol of classic coagulation tests and visco-
elastic point-of-care tests. Adequate multi-organ support was ob-
tained in 11/12 patients.
ECMO support was maintained for a median of 12 days, with a mini-
mum of 6 days and a maximum of 30 days. Seven out of twelve pa-
tients were successfully weaned off ECMO (bridge to recovery),
another was bridged to long-term mechanical assistance via a left
ventricular assist device (LVAD), using an echocardiography guided
weaning protocol, and four patients died while on ECMO.
Five patients survived to discharge, three following cardiac surgery
and two after recovering from myocarditis.
Complications related to cannulation or limb ischemia did not occur
in any of the patients. One patient suffered a severe septic complica-
tion - acute gangrenous cholecystitis and underwent abdominal sur-
gery while on ECMO. The same patient required oxygenator
replacement due to fibrin deposition.
CONCLUSION. ECLS is a technique for multi-organ support in shock
in the most severe of cases. In a case series of twelve patients with
cardiogenic shock due to STEMI, myocarditis or after cardiac surgery
treated with ECMO as a rescue therapy we report a 67% weaning
success and 42% survival to discharge Careful monitoring and proto-
colized weaning can lead to positive outcomes in shock, despite se-
vere illness (mean lactate 9,4 mmol/L).
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INTRODUCTION. Acute coronary syndrome (ACS) frequently requires
Intensive Care Unit (ICU) admission. Percutaneous coronary interven-
tion (PCI) has relegated systemic fibrinolysis as a second line inter-
vention. Delay in time to start the treatment may lead to cardiac
complications.
OBJECTIVES. To analyze the differences observed in patients with
ACS with ST-segment elevation (STEMI), depending on reperfusion
treatment used patients in the ICU of Hospital Punta de Europa using
ARIAM database.
METHODS. Retrospective descriptive analysis on a prospective co-
hort, performed in a 12-bed ICU for 6 years (2013-2018). Two groups
were compared: fibrinolysis vs. PCI. Demographic variables, comor-
bidities, risk factors, initial Killip, extension, TIMI, GRACE, CRUSADE
have been registered. Statistical analysis: categorical (frequencies and
percentages) and numerical variables (mean and standard deviation).
Comparisons: test of X2 (percentages), Student's t (means). Statistical
significance with p <0.05.
RESULTS. 293 patients diagnosed with STEMI were included. Those
patients were compared according to the reperfusion strategy used:
fibrinolysis n = 247 (84.3%) vs. PCI n = 46 (15.6%). There were no dif-
ferences in terms of age, sex, cardiovascular risk factors or comorbidi-
ties. Creatinine (1.04 [± 0.27] vs. 1.21 [± 0.56], p <.001), TIMI (3.06 [±
2.45] vs. 3.88 [± 3.22], p=.024), CRUSADE (27.69 [± 14.42] vs 32.62 [±
20.03], p=.036). Use of clopidogrel during ICU stay: 42 (17%) vs. 1
(2.2%) p=.009. Infectious complications 2 (0.8%) vs. 3 (6.5%) p=.006.
Transthoracic echocardiography 56 (23%) vs. 2 (4.3%) p=.004, defibril-
lation 8 (3.3%) vs 5 (10.9%), p=.022, invasive mechanical ventilation
(IMV) 6 (2.5%) vs. 4 (8.7%) p=.033. Destination after ICU discharge (p
<.001): hospital ward 217 (87.9%) vs. 31 (67.4%), another hospital 17
(6.9%) vs. 11 (23.9%), death 12 (4.9%) vs. 3 (6.5%). Initial TIMI: 0 66
(24.1%) vs. 19 (9.5%), I 98 (35.8%) vs. 80 (40.2%), II 70 (25.5%) vs 65
(32.7%), III 40 (14.6%) vs. 35 (17.6%), p=.001. ICU mortality: 4.9% vs
6.5%, p=.713. First contact-ICU income (minutes) 91.1 ± 150.4 vs.
172.2 ± 116.4, p=.005. ICU length of stay (LOS) (days): 3.4 ± 3.5 vs.
2.1 ± 3.2, p=.008.
CONCLUSION. No significant differences were found in terms of risk
factors, comorbidities, non-infectious complications and mortality. Pa-
tients treated with primary PCI experienced significantly shorter ICU
LOS.
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INTRODUCTION. We have previously observed a potential associ-
ation between thrombocytopenia and the presence of a continuous
cardiac output pulmonary artery catheter (CCO-PAC). Once the CCO-
PAC was removed, platelet counts increased [1]. A potential explan-
ation is the extraordinary sensitivity of platelets to intermittent heat
pulses produced by the thermofilament of the CCO-PAC. It is known
that platelets are more easily damaged by temperatures >42∘C than
erythrocytes or leukocytes [2].
OBJECTIVES. The main objective of our initial experiment was to
measure the temperatures produced by the thermofilament of the
CCO-PAC under simulated blood flow.METHODS. We constructed a circular tubing system, with a mechan-
ical one-way valve, which was able to replicate pulsatile flow of water
at 37∘C, in which the CCO-PAC was centrally positioned, along with a
thermistor with a high sensitivity and a high time resolution. A com-
patible monitor (Edwards Lifesciences) was connected to the CCO-
PAC and to an ECG-simulator. The pulsatile blood flow and ECG-
simulator generated frequencies were both set at 60 /min. Once the
CCO-PAC system generated regular heat pulses compatible with ac-
tual continuous cardiac output measurements, we started recording
the temperature generated by the thermofilament. Under this simu-
lated blood flow, temperature was measured both internally in the
distal lumen halfway the thermofilament and external to the CCO-
PAC directly in contact with the thermofilament.
RESULTS. It took the monitor about 10 minutes to calibrate and
measure a cardiac output. During stable CO measurements we ob-
served a constant repetitive pattern in de temperatures generated
by the catheter. At a ‘blood’ temperature of 37∘C we measured rap-
idly varying temperatures inside and directly near the thermofila-
ment. Such pulses were generated approximately 4 times /min. Once
a pulse terminated, the temperature rapidly dropped to the
temperature of the surrounding fluid. The surface temperature was
8∘C above the ‘blood’ temperature for 35% of the cycle, equivalent
to 45∘C at a blood temperature of 37∘C.
CONCLUSION. Under simulated conditions catheter temperatures
>42∘C were observed for a considerable fraction of the CCO-PAC
heat-pulse cycle. We believe the sustained emission of thermal
pulses may be a key contributor to thrombocytopenia in patients
with this catheter in situ. Further studies could confirm and further
analyze this phenomenon.
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INTRODUCTION. Myocardial infarction after coronary artery bypass
grafting is a serious complication and one of the most common
causes of perioperative morbidity and mortality. Multiple mecha-
nisms have been proposed to explain myocardial injury after CABG.
Diagnosis will be established according to creatine kinase (CK) values
more than five times the 99th percentile of the normal reference
range during the first 72 hours following CABG, (or Troponin or
CKMB more than ten time increase) when associated with the ap-
pearance of new pathological Q-waves or new left bundle-branch
block (LBBB), or angiographically documented new graft or native
coronary artery occlusion, or imaging evidence of new loss of viable
myocardium, should be considered as diagnostic of a CABG related
MI.
OBJECTIVES. : to identify the methods of diagnosis of post coronary
artery bypass graft (CABG) acute myocardial infarction.
METHODS. Data sources: MEDLLINE (PubMed), EMBASE, Google
Scholar and the Cochrane Library and all materials available in the
internet till 2017.
Study selection: this search presented 23 eligible studies which stud-
ied the diagnostic methods for acute myocardial infarction after cor-
onary artery bypass graft (CABG) surgery.
Data extraction: if the studies did not fulfill the inclusion criteria,
they were excluded. The methodological quality of included studies
was assessed using an adjusted QUADAS-tool.
Table 1 (abstract 000630). See text for description
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the results tabulated.
RESULTS. Troponin I and T can both be used to indicate myocardial
damage, with the level correlating well with the level of injury. How-
ever until issues such as a ‘gold standard’ for peri-operative MI are
addressed, one single cut-off point cannot be recommended for ei-
ther test.
CONCLUSION. Troponin I and T can both be used to indicate myo-
cardial damage, with the level correlating well with the level of in-
jury. However until issues such as a ‘gold standard’ for peri-operative
MI are addressed, one single cut-off point cannot be recommended
for either test.
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INTRODUCTION. The knowledge and monitoring of cardiac output
give us fundamental information in critically ill patients. Fick’s
method, previously used to calculate it, has been replaced in clinical
practice by minimally (transpulmonary thermodilution) or non-
invasive techniques (echocardiography, bioimpedance) obtaining car-
diac output measurements in a patient-safe, fast and reliable way
(1,2).
OBJECTIVES. To compare the estimation of stroke volume and car-
diac output by non-invasive methods in critical patients. To deter-
mine if there is a correlation between indicators of cardiac preload
and systolic function between both methods.
METHODS. Prospective observational study. An echocardiographic
study and bioimpedance monitoring were performed in adult pa-
tients admitted to ICU. Stroke volume (SV) and cardiac output (CO)
values were collected; systolic function parameters: aortic acceler-
ation index (AI); heather index (HI); aortic velocity index (VI); preload
parameters: end-diastolic volume (EDV); inferior cava vein diameter
(ICV); thoracic fluid content (TFC) were also retrieved. Correlations be-
tween parameters were scanned.
RESULTS. 7 adult males were studied, 57,1% receiving invasive
mechanical ventilation and 28,6% vasoactive support. The demo-
graphic characteristics and the hemodynamic study are shown in the
table.
000840
No correlation was observed between values of stroke volume and
cardiac output nor between parameters of contractility and cardiac
preload. Determination of stroke volume and cardiac output by
bioimpedance tends to overestimate values respect to ultrasonog-
raphy: +9,7 (-2,5 a 21) ml (p= 0,1); +0,6 (-0,6 a 1,3) l/min (p=0,07).
CONCLUSION. In our sample, there is no correlation in serial haemo-
dynamic assessment by echocardiography and bioimpedance.Cardiac bioimpedance may overestimate stroke volume and cardiac
output relative to echocardiography.
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INTRODUCTION. In the UK and other Western countries, the propor-
tion of elderly patients admitted to intensive care units (ICUs) is ris-
ing (1-3). The challenge of determining which treatments will be
beneficial to this older cohort is significant(4) and one specific deci-
sion, undertaking renal replacement therapy (RRT) holds a delicate
balance of risks and benefits. The South Coast of England where this
study was performed has a population significantly older than the
UK average with 14% over 70 years of age(2), therefore well placed
to examine this issue.
OBJECTIVES. To understand contemporaneous, longer-term out-
comes for older people undergoing acute renal replacement therapy
(RRT) in the intensive care unit (ICU) setting.
METHODS. A retrospective observational cohort analysis of data col-
lected (2013-2018) on adult patients commenced on RRT in two non-
specialist UK ICUs (consisting of a 12-bed and a 10-bed unit) using
data collected as part of routine care. Baseline characteristics and
outcomes between patients younger or older than 75 were
compared.
RESULTS. After excluding cases previously on long-term dialysis (n=
65) the cohort included n=698 admissions with a median age 69
(IQR 57-77), 33% (n=231) were ≥75 years old and 17% (n=121)
were ≥80. Mechanical ventilation was required in 62% and cardiovas-
cular support in 56%. Median ICNARC score was 28 (23-35) and APA-
CHE II score 23 (18-28).
Between those aged <75 and ≥75 there was no significant mortality
difference in ICU (42.4% vs 46.3%, OR 1.17 (95% CI 0.85-1.61), P=
0.332), in-hospital (47.8% vs 55.0% OR 1.34 (0.97-1.83), P=0.077) and
at one year (58.9% vs 63.3% OR 1.21 (0.85-1.71), p=0.329), respect-
ively. In logistic regression age was not an independent predictor of
1-year mortality whilst lactate, and requirement for cardiovascular
support were.
CONCLUSION. 1-year mortality in patients who have required RRT is
substantial, however age alone did not predict survivors.
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Fig. 1 (abstract 000795). Kaplan-Meier survival Blue line <75 years
age Red ≥75 Log-rank P=0.023
Table 1 (abstract 000800). Receiver operating characteristic curve
Area 95%CI Palue
mPNI 0.810 0.740-0.879 <0.001
PNI 0.712 0.625-0.799 0.044
MELD 0.793 0.722-0.865 <0.001
INR 0.705 0.630-0.781 <0.001
Serum Bilirubin 0.637 0.560-0.714 0.001000800
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INTRODUCTION. Acute kidney injury (AKI) is one of the common
complications after liver transplantation (LT) which associated with
increased mortality, long-term risk of chronic kidney diseases, and
prolongated length of hospital stay. Nutritional status, especially
prognostic nutritional index (PNI), has been used as a predictive
value for postoperative complications. However, there is a lack of
prognostic value applied for PNI to the prognosis of LT. We sug-
gested a new predictive model modified by PNI and investigated
which model has the highest predictive accuracy for AKI in patients
who underwent LT
METHODS. Data from a total of 423 patients underwent LT were col-
lected retrospectively. Based on Acute Kidney Injury Network (AKIN)
criteria, the patients in the AKI group are confirmed to AKI within 1-
week after LT. PNI was calculated as 10 X serum albumin (g/dL) +
0.005 X total lymphocyte count (per mm3). After the univariate ana-
lysis, multivariate statistical adjustment for post-operative variables of
AKI was performed. As a new predictive model was developed. It
was called the modified PNI model (mPNI). The mPNI was calculated
as 6.9 X serum bilirubin (mg/dL) + 134 X INR – 29 X PNI + 250. The
individual diagnostic accuracy in AKI within 1-week after LT was eval-
uated using the area under receiver operating characteristic curve
(AUC).RESULTS. 54 patients (12.7 %) were diagnosed AKI within 1-week
after LT. The mPNI has the highest predictive accuracy (AUC = 0.810,
Table 1.). The MELD score and PNI were 0.793 and 0.712, respectively.
The INR and serum bilirubin were 0.705 and 0.637, respectively. The
mPNI was the highest predictive value for development of AKI within
1-week after LT.
CONCLUSION. The mPNI is the highest prognostic model for AKI
within 1-week in patients who underwent LT (AUC = 0.810).
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INTRODUCTION. Intensive care unit (ICU) acquired hypernatremia is
a highly prevalent condition in critically ill patients and is associated
with increased mortality and length of stay. (1) The kidneys play an
important role in the volume and osmolality regulation, and are
therefore a possible key player in sodium derangements. Approxi-
mately 30% of ICU admissions is complicated by acute kidney injury
(AKI). (2) Therefore, this study focused on AKI in the development of
hypernatremia.
OBJECTIVES. This study aimed to provide insight in the effect of AKI
on the development of ICU acquired hypernatremia.
METHODS. A retrospective comparative analysis was performed
using prospectively collected data of ICU patients in a tertiary referral
hospital. All adult patients requiring ICU admission more than
48hours were identified and included between April and December
2018. Urine samples were collected and analyzed for electrolytes and
osmolality. Additional serum osmolality analyses were performed.
Further data collection consisted of detailed fluid balances and medi-
cation use.
RESULTS. Of the 199 included patients, 85 (43%) developed
hypernatremia. According to the RIFLE criteria, 1 (1%) patient was
at Risk for acute kidney injury, 21 (25%) patients developed kid-
ney Injury and 20 (24%) patients had acute kidney Failure in the
hypernatremia group. The proportion of patients with AKI was
not significantly different between the two groups. However,
when comparing the median maximum level of serum creatin-
ine (128,0 μmol/L versus 92,6 μmol) and serum urea (14,0 mmol/
L versus 9,7 mmol/L) between hypernatremic patients and nor-
monatremic patients during ICU stay, a significant difference was
observed (P<0,001 and P<0,001). The total median salt intake was
26 gram in the normonatremia group and 40 gram in the hyper-
natremia group (P=0,004). A significant difference was found in
median serum osmolality levels between the two groups resulting
Table 1 (abstract 000963). Equations compared to the true GFR
calculated using plasma clearance of iohexol
Equation R2 Mean bias SD Accuracy
Modification of Diet Renal Disease 0.57 -13.1 17.8 83%
PENK 0.63 -0.9 16.7 91%
PENK, age, gender 0.69 -2.5 15.6 93%
PENK, age, gender, creatinine 0.77 -3.9 13.6 95%
R2 R-squared; Mean bias and SD in mL/min/1.73m2, SD standard deviation
Page 279 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55in 298 mOsm/kg in the normonatremia group and 319 mOsml/kg
in the hypernatremia group (P<0,001). The urine-osmolality of the
normonatremia group was 695 mmol compared to 612 mmol in
the hypernatremia group.
CONCLUSION. Patients with hypernatremia did not develop AKI
more frequently than patients without hypernatremia. However,
the higher levels of serum creatinine and serum urea in the
hypernatremia group suggest impaired renal function. In addition,
decreased urine osmolality was found in the hypernatremia group
despite an (iatrogenic) increased sodium intake. Therefore, a role
for the kidneys in the development of hypernatremia is not to
be ruled out yet.
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INTRODUCTION. Deterioration of kidney function in critically ill pa-
tients is independently associated with impaired outcome. Diagnosis
of acute kidney injury (AKI) is currently hampered by the lack of ac-
curate markers for timely assessment of kidney function. Conven-
tional creatinine-based methods to estimate glomerular filtration rate
(GFR) are notoriously insensitive, late, and inaccurate. The gold stand-
ard methods to measure GFR using exogenously administered sub-
stances, such as inulin or iohexol, are not used in clinical practice
because they are labour-intensive and expensive. A promising novel
candidate to assess kidney function is plasma proenkephalin (PENK),
a stable byproduct of the endogenous opioid enkephalin.
OBJECTIVES. 1) To determine to what extent PENK reflects the GFR
in a cohort of critically ill post cardiac surgery patients that are prone
to develop AKI. 2) To develop an equation to estimate the GFR using
PENK plasma concentration.
METHODS. We prospectively included 180 patients undergoing car-
diac surgery. Post surgery, patients received an intravenous bolus of
iohexol, and plasma iohexol concentrations were determined in four
samples obtained during the subsequent hours. The true GFR was
determined using the slope-intercept method and the Brøchner-Mor-
tensen correction [1]. Plasma PENK concentrations were determined
using the Sphingotec immunoassay [2]. Using linear regression
model, three equations were developed in a block randomized train-
ing sample of the cardiac surgery cohort. 1) PENK only; 2) age, gen-
der and PENK; 3) age, gender, PENK and creatinine. Bias, precision
and accuracy were assessed and results were compared with the cur-
rently used Modification of Diet in Renal Disease (MDRD) equation.
RESULTS. Median of the true GFR was 81 [IQR: 69-90] mL/min/
1.73m². Results of the equations are listed in Table 1. The mean bias
of the MDRD was significantly different compared to the true GFR
(p<0.0001), while the mean bias of the equation of PENK was not
(p=0.47). The equation using only PENK was significantly more accur-
ate compared to the MDRD (p=0.02), when the covariates age, gen-
der and creatinine were added, accuracy improved (p=0.0003).
CONCLUSION. Our study underscores the inaccuracy of conventional
creatinine-based methods to estimate GFR in critically ill patients,causing misclassification of kidney function. Furthermore, we demon-
strate that a single plasma PENK determination correlates with the
true GFR in cardiac surgery patients and the PENK equation to esti-
mate GFR performs better compared to the MDRD. Therefore, PENK
has potential as an accurate and feasible marker to assess kidney
function in critically ill patients. External validation in additional critic-
ally ill patient cohorts is warranted.
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INTRODUCTION. AKI associated with severe sepsis has a significant
increase in mortality [1] and it is not known whether there is continu-
ity of renal injury in the post sepsis recovery period. The fact is that
survivors have 2.5 times more likely to be readmitted to the hospital
for AKI within 90 days than patients without sepsis [2].
OBJECTIVES. Evaluate the kinetics of renal hemodynamics alterations
in animals surviving from severe sepsis.
METHODS. Following DL50 sepsis model induction (2mL E.coli 108
CFU/mL, iv.) in adult Wistar female rats, the surviving animals were
monitored to macro (MAP, HR and abdominal aorta blood flow by
Transonic, TS420 transit-time flowmeter), regional (renal artery and
vein by Transonic, TS420 transit-time flowmeter), and micro
hemodynamics (kidney cortical microcirculation by SDF videomicro-
scopy). Animals were monitored at 6 hours, 1month, and 3 month
post-sepsis periods. Naïve (N) animals were used as control. (n=4-5/
period). All rats were euthanized at the end of experiments.
RESULTS. There was a stability of MAP at normal levels in post-sepsis
periods. Only in the hypodynamic phase of acute sepsis (S-6h) did a
significant reduction occur. Variations of HR (250-400 bpm) were
dependent on aortic flow, being higher when the flow drop was ob-
served in the S-6h, denoting to be a parameter more related to
hemodynamic adjustment and unrelated to the post- sepsis clinical
condition. Moreover, the significantly diminished renal vessels blood
flow (fig.1) suggests the kidney hypoperfusion state with microcircu-
latory dysfunction showed by SDF (fig. 2).
CONCLUSION. In conclusion, renal damage in severe sepsis seems to
improve partially in the post-sepsis period, but the persistence of the
hypoperfusion may predispose to organ dysfunction in severe sepsis
survivors.
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INTRODUCTION. Remote ischemic preconditioning (RIPC) has dem-
onstrated beneficial effects on acute kidney injury (AKI) and/or car-
diac function after coronary angiography (CA). These protective
effects have been partly explained by enhanced of the antioxidant or
anti-inflammatory mechanisms. However, the effects by RIPC might
be attenuated in diabetic patients, a population with enhanced of
pro-inflammatory and pro-oxidant pathways.
OBJECTIVES. To evaluate the effects of RIPC on the myocardial and
renal function, as measured by plasma Troponin I, N-terminalprohormone of brain natriuretic peptide (NT-proBNP), creatinine (Cre)
and cystatin C (Cysc C) levels (an early marker of glomerular func-
tion), as well as plasma levels of the antioxidant enzyme Heme
oxygenase-1 (HO-1), the acute phase reactants increasing during in-
flammation (ferritin) and protein C reactive (PCR), and the ratio of
neutrofile/linfocites (NLR).
METHODS. A prospective, randomized, single-center trial was con-
ducted at the St. Lucía University Hospital (Cartagena, Spain). Dia-
betic patients admitted to medical intensive care unit, with an acute
coronary syndrome requiring standard CA, were enrolled and ran-
domly assigned to an RIPC group (n = 36) or a control group without
RIPC (n = 35). In the RIPC group, four cycles of 5-min of ischemia and
5-min of reperfusion were applied to the right upper limb by a cuff
inflated to 50mmHg over the systolic blood pressure. We recorded
demographical, clinical and analytical data before and after 24, 48
and 72 hours of CA procedure. We analyzed qualitative variables with
percentages by categories, and square Chi; quantitative variable with
median ± standard deviation and T student; or median, interquartile
rank and U- Mann Whitney, depending on statistical distribution
RESULTS. Patients receiving RIPC showed lower levels of NT-proBNP
(pg/ml) at 72 hours (4010±6600) compared to those in the control
group (6373±9600), p<0.05, without any differences in the troponin I
peak. Regarding to the renal function, the increases in Cre (mg/dl)
and Cysc C (mg/L) before and after 72 hours of CA were similar be-
tween groups (Cre RIPC; 1.05±0.4 vs 1.37±1 and control; 1.10±0.5 vs
1.17±0.6 and Cysc C RIPC; 1.16±0.5 vs 1.35±0.8 and control; 1.28±0.6
vs 1.38±0.6). Importantly, changes before and after 48 hours in fer-
ritin (ng/ml) (RIPC; 175±176 vs 218±161 and control; 115±98 vs 145±
92); HO-1 (ng/mL) (RIPC; 0.72±1.5 vs 1.36±1.5 and control; 0.77±1.5
vs 1.56±2.2); PCR (mg/dL) (RIPC; 4.25±4.3 vs 5.27±4.2 and control;
4.90±6.1 vs 3.96±3.7); and NLR (RIPC; 0.70±0.1 vs 0.70±0.1, control;
0.72±0.1 vs 0.70±0.1); were similar in both groups.
CONCLUSION. The RIPC maneuver before CA in diabetic patients
demonstrated favorable effects on cardiac function without improv-
ing the renal parameters. These effects could not be attributed to
increase in the antioxidant or inflammatory mechanisms analyzed.
Alternative pathways underlying these effects merit further
investigation.
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INTRODUCTION. Regional anticoagulation allows to perform extra-
corporeal treatments avoiding the complications of systemic anticoa-
gulation. Citrate-based regional anticoagulation is the most
widespread technique but, due to limited citrate clearance, may be
applied only to low extracorporeal blood flows (i.e. < 200 ml/min).
We developed a novel technique to highly increase extracorporeal
citrate clearance, thus achieving regional anticoagulation of higher
blood flows.
METHODS. Five healthy swine (42±3 Kg) were sedated, mechanically
ventilated and connected to a prototype extracorporeal circuit for
continuous renal replacement therapy featuring a citrate-removal
stage based on absorbent materials and replacement fluids. Blood
flow was 500 ml/min. Sodium citrate was continuously infused at the
circuit inlet (5 mmol/L). Heparin was continuously infused. Citrate
concentration and Heparinase Kaolin thromboelastography (HK-TEG)
were measured on arterial blood, extracorporeal blood downstream
the citrate infusion port and downstream the citrate-removal stage.
F1
F1
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minutes for citrate and every 30 min for HK-TEG. Calcium chloride
was infused to maintain systemic ionized calcium within physio-
logical range. The experiment lasted 2 hours.
RESULTS. Citrate concentrations in blood samples were stable within
the first 30 minutes than started to slowly increase (Figure-left). The
efficacy of the citrate-removal stage in removing citrate was 88% at
30 minutes and decreased down to 48% at the end of the study (Fig-
ure-right) due to loss of efficiency of the absorbent materials. During
the whole experiment, HK-TEG in artery showed normal coagulation:
Reaction time (R) was 8.6 ±1.3 minutes, with Maximum Amplitude
(MA) of 72.2±6.2 mm. In the extracorporeal circuit, HK-TEG showed
no sign of clot formation R>60min, MA=0 mm.
CONCLUSION. The tested prototype effectively removed the infused
citrate required to anticoagulate 500 ml/min of extracorporeal blood
flow.
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INTRODUCTION. Acute kidney injury is common after cardiac surgery
and is associated with postoperative mortality. Cardiac biomarkers
are more accessible and can help to predict this complication.
OBJECTIVES. To investigate relationship between cardiac biomarkers
and postoperatively acute kidney injury (AKI) in adults undergoing
cardiac surgery1.
METHODS. Prospective cohort study in post-operated cardiac surgery
adults. We measured the following cardiac biomarkers in the first 6
hours of the postoperative period: B-type natriuretic peptide (BNP),
ultrasensitive troponin I (usTI), creatine phosphokinase (CPK), creatine
phosphokinase MB (CPK-MB) and myoglobin.
RESULTS. 63 patients evaluated, 31 (49.2%) had AKI. Patients with
AKI had significantly higher levels of BNP, usTI, CPK-MB, and myoglo-
bin. Myoglobin had a good area under the curve (AUC 0.81, 95% CI
0.66-0.95), followed by usTI (AUC 0.71, 95% CI 0.58-0.92) and BNP
(AUC 0.71 IC 95% 0.53-0.88) to detect AKI. Myoglobin levels ≥731 ng/
mL had a positive likelihood ratio (7.73, 95% CI 1.04-57.24). the time
of extracorporeal circulation (Adjusted Odds-ratio 6.11, 95% CI 1.55
to 9.55) and myoglobin elevation (Adjusted Odds-ratio 1.00, 95% CI
1.00 to 1.01) were independent predictors of AKI.CONCLUSION. The postoperatory levels of cardiac biomarkers are
significantly higher in patients with AKI. Extracorporeal circulation
(CCE) time and myoglobin elevation were shown to be predictors of
AKI. These biomarkers may be suitable for identifying patients at
high risk for AKI after cardiac surgery.
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INTRODUCTION. Indirect calorimetry (IC) is the gold standard for esti-
mating energy needs in critically ill children. There is no reported IC
data in children receiving CRRT. The modified-Weir equation using
real-time carbon dioxide production (VCO2 REE) collected via stand-
ard clinical ventilators might more accurately define energy needs
without the expense of IC or the inaccuracy of predictive equations.
OBJECTIVES. This pilot feasibility study investigates whether VCO2
REE could be used in pediatric CRRT patients.
METHODS. We investigated if a detectable change in VCO2 occurs
after CRRT circuit start and compared daily VCO2 REE to calculated
REE. Patients were classified as hypo or hyper metabolic based on
the VCO2 REE/calculated REE ratio (<0.9, >1.1, respectively). Continu-
ous VCO2 data were obtained from the Sickbay database (Medical In-
formatics Corp, Houston TX). Data were sampled prior to initiation of
CRRT (baseline) and then every 24 hours for a total of five days or
until ventilator discontinuation.
RESULTS. There was no difference in VCO2 between baseline and
first hour of CRRT. Median VCO2 REE was 903 cal/d (IQR 554-1600)
and calculated REE was 874 cal/d (IQR 606-1427) (n=9). There
was a moderate correlation between baseline VCO2 REE and
F1
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Fig. 1 (abstract 001209). See text for description












CrCl-6h (ml/min) 37.85 (52.13) 27.93 (34.05) 35.16 (29.13) 0.03
Ck-G (ml/min) 50.18 (43.96) 56.73 (42.26) 31.52 (34.46) 0.187
Difference [(Ck-G) – (CrCl- 5.68 (24.05) 19.03 (26.55) -9.33 (28.37) <
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day 2 of CRRT. Patients displayed dynamic characteristics
throughout the study period transitioning between hypo and hy-
permetabolic. Hypometabolic patients had lower VCO2 REE (300
cal/d, 95% CI 125-475) and hypermetabolic patients higher (619
cal/d, 95% CI 440-799) than normometabolic patients. On any
given day 1/3 of patients were hypermetabolic but individual pa-
tients varied daily. Longitudinal data were analyzed using mixed-
effects multilevel modeling. Controlling for metabolic state (hypo
or hyper) and baseline values, VCO2 REE increased daily by 44.7
cal (95%CI 20.2-69.1). Calculated REE overestimated VCO2 REE at
baseline, and underestimated it after CRRT start (VCO2 REE base-
line 594 cal/d (IQR 523-1299), day 5 927 cal/d (IQR 554-1251)).
There was an interaction between CRRT day and metabolic state.
Approximately 50% of the variation in VCO2 REE across the study
population was due to patient level differences.
CONCLUSION. Pediatric CRRT patients have dynamic metabolic
needs that are poorly approximated with predictive formulas. If
validated in larger studies, VCO2 derived REE could bridge an im-
portant lacuna by addressing dynamic energy demands of
pediatric CRRT patients, therefore, allowing for individualized nu-
trition prescriptions.
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INTRODUCTION. Ischemia/reperfusion (I/R) is one of the main causes
of acute kidney injury (AKI), which is characterized by sterile inflam-
mation and oxidative stress leading to perturbation of the microcir-
culation and tissue oxygenation.
OBJECTIVES. The primary outcome of this study was to improve
microcirculatory perfusion and oxygenation by use of a hemoglobin-
based oxygen carrier (PEG-COHb) or a colloid (HES-RA) to provide an
improved organ perfusion, oxygenation and function in I/R induced
renal microcirculatory injury in the rat.
METHODS. 36 fully instrumented, mechanically ventilated and anes-
thetized male Wistar albinorats were split into 4 groups consisting of
control (C), I/R (45min. aortic occlusion and 1 hour reperfusion with-
out resuscitation), I/R group resuscitated with either PEG-COHb or
HES-RA at a dose of 5 ml.kg-1h-1. Systemic and renal hemodynamic,
renal oxygenation, blood gas, electrolytes and blood chemistry were
measured.
RESULTS. All of the fluids used in this study improved the MAP simi-
larly compared to the C and I/R groups (p<0.05, respectively). CVP
level was significantly increased by the PEG-COHb and in the IR
group (p<0.05 vs. C) (Fig 1). Plasma lactate level was normalized only
by HES-RA resuscitation (p<0.05 vs. C and I/R). RBF, cortical mPO2,
Clcrea and urine output was depleted after the IR insult but was im-
proved by PEG-COHb and HES resuscitation at T3 (p<0.05 vs. IR).
DO2ren and VO2ren were increased by PEG-COHb and HES at T3 (p<
0.05 vs. IR) (Fig 2). PEG-COHband HES-RA provided efficient buffer
capacity to maintain the plasma HCO3- and anion gap to correct the
pH (p<0.05 vs. C and IR). Additionally, plasma proADMA, inflamma-
tion markers and tissue damage score were also comparable in be-
tween the PEG-COHb and HES-RA groups (p<0.05 vs. I/R).
CONCLUSION. To conclude, PEG-COHb and HES-RA showed similar
beneficial effects on the systemic hemodynamic, renal blood flow,
renal oxygenation and oxygen delivery resulting in better renal
function.001212
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INTRODUCTION. Seriously ill pts receive a great spectrum of antibi-
otics, whose dose is usually determined by estimated creatinine
clearance (CrCl). Given the bad performance of the various equations
for GFR estimation, we decided to evaluate calculated CrCl as a
means to more objectively adjust antibiotics in ICU pts.
METHODS. We retrospectively compared 6-hour creatinine clearance
(CrCl-6h), with the Cockroft–Gault equation (Ck-G) concurrently esti-
mated, and recorded clinical characteristics and the changes in anti-
biotic dosage that were attributed to abnormal values of the
parameters. CrCl was calculated as [Cr urine (mg/dl)× urine volume
(ml)× / Crs (mg/dl)× minutes] and the Ck-G was calculated as [(140-
age)× (weight)×(0.85 females) / 72× Crs].
Results are shown as mean±SD or as median and interquartile ratio.
Comparisons between groups were made by Kruskal-Wallis test, ap-
plying SPSS 21.
RESULTS. In 47 randomly selected pts (age 71.57±12.44, male 22,
APACHE II score 23±8.71, SOFA score 9.02±3.08, length of stay
19.89±15.03 days, mortality 40.4%) 89 recordings were evaluated.
The Ck-G was 50.49 (47.36) ml/min and the CrCl-6h was 34.4 (37.37)
ml/min. The therapeutic amendment according to calculated and es-
timated CrCl is shown in table 1.
CONCLUSION. The use of calculated 6-h led to antibiotics’ dose
amendment in almost half of cases, that in the majority had to do
with dose reduction. Six-hour CrCl proved more reliable of the esti-
mated CrCl, is easily measured regularly and can be used in order to
avoid nephrotoxic doses of antibiotics or undertreatment of
infections.6h)] 0.001
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Dissected aorta 7 (53.85%) 4 (30.77%) 19.69 31.00
Cardiac surgery 12
(38.71%)
14 (45.16%) 25.87 33.03
Cardiogenic shock 16
(72.73%)
4 (18.18%) 19.55 16.36
Cardiac arrest 52
(73.23%)
14 (19.72%) 16.01 20.38






28 (36.36%) 14.49 24.09
Acute coronary 36 16 (23.19%) 12.09 16.71
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INTRODUCTION. Mean perfusion pressure (MPP) is the difference
between mean arterial pressure (MAP) and central venous pres-
sure (CVP). The difference in both pressures is also related to the
patient mortality rate in the ICU. Patients with low MPP were also
found to have high rates of renal failure. Patients with renal fail-
ure in the ICU have a high mortality rate as well. We expacted
that by maintaining a normal MPP value, incidence of acute kid-
ney injury decrease and the mortality rate will decrease. We
hoped that calculating MPP can be an effective way to manage
ICU patients and early detection for acute kidney injury (AKI). By
measuring blood pressure and CVP we can easier to detect pa-
tient with acute kidney injury.
OBJECTIVES. The main purpose of this study is to assess for an asso-
ciation between Mean Perfusion Pressure, creatinine serum, and cu-
mulative fluid balance in Intensive Care Unit (ICU).
METHODS. A cohort study was conducted from January to December
2017 in ICU Adam Malik Hospital Medan. Patients with age over
18 years admitted to our ICU were included. The demographic
data, MPP, creatinine serum, and cumulative fluid balance were
compared.
RESULTS. During the study period, 74 patients were admitted. 58.1%
were male with mean age 45.5 ± 17.3 years old. There was asso-
ciation between Mean Perfusion Pressure with increasing creatin-
ine serum in ICU (p=0.012). But there was no association
between Mean Perfusion Pressure with cumulative fluid balance
in ICU (p=0.203).
CONCLUSION. There was a correlation between Mean Perfusion Pres-
sure and increasing of creatinine serum. Mean Perfusion Pressure can
be a simple sign for acute kidney injury (AKI). Further study with a
bigger sample is needed to explore the accuracy of MPP in ICU.
REFERENCE(S)
1. Ostermann M, Hall A, Crichton S. Low mean perfusion pressure is a risk
factor for progression of acute kidney injury in critically ill patients – A
retrospective analysis. BMC Nephrology. 2017; 18:151.
2. Patel R, Solanski A, Patel H, Pandya H, Patel J, Patel S. Does mean
perfusion pressure during cardiopulmonary bypass affect renal function?
J of Evidence Based Med & Hlthcare. 2015; 2(41): 6946-53.
3. Panwar R, Lanyon N, Davies AR, Bailey M, Pilcher D, Bellomo R. Mean
perfusion pressure deficit during the initial management of shock—an
observational cohort study. J Crit Care. 2013.
4. Amelia P, Lubis M, Mutiara E, Trisnawati Y. Acute kidney injury and
mortality in critically ill children. Paediatr Indones. 2014;54:251-5.
5. Damman K, Deursen VM, Navis G, Voors AA, Veldhuisen DJ, Hillege HL.
Increased central venous pressure is associated with impaired renal
function and mortality in a broad spectrum of patients with
cardiovascular disease. Journal of the American College of Cardiology.
2009; 53 (7): 582-8.
6. Boyd JH, Forbes J, Nakada T, Walley KR, Russell JA. Fluid resuscitation in
septic shock: A positive fluid balance and elevated central venous
pressure are associated with increased mortality. Critical Care Medicine.
2011; 39 (2):1-7.
7. Long Y, Su L, Zhang Q, Zhou X, Wang H, Cui N, et all. Elevated mean
airway pressure and central venous pressure in the first day of
mechanical ventilation indicated poor outcome. Critical Care Medicine.
2017; 1-8.
8. This research was supported by TALENTA 2019 from Universitas
Sumatera Utara.001265
Cardiorenal syndrome type 1 needing renal replacement therapy:
a retrospective cohort study
TM. Huang1, V. Wu1, TS. Chu2
1Attending Physician, National Taiwan University Hospital and College of
Medicine, Taipei City, Taiwan; 2Professor, National Taiwan University
Hospital and College of Medicine, Taipei City, Taiwan
Correspondence: T.M. Huang
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001265
INTRODUCTION. Cardiorenal syndrome type 1 (CRS-1) refers to syn-
dromes denoting acute renal dysfunction caused by acute cardiac
dysfunction or related to cardiac procedures. Patients with CRS-1
who need renal replacement therapy may suffer from a variety risk
for adverse outcomes, including mortality and increased length of
stays. It is unknown the impacts of the etiologies of CRS-1 on pa-
tients’ outcomes.
METHODS. This was a nationwide sampling retrospective cohort
study based on a clinical trial consortium in Taiwan. Up to January of
2016, 30 hospitals have joined this consortium. We enrolled all pa-
tients with acute dialysis in these hospitals and followed them up to
90 days after dialysis. The primary outcome was 90 days’ all cause
mortality and the secondary outcome was free from dialysis and
length of stay.
RESULTS. A total of 1075 patients were in the final analysis. The mor-
tality rates of patients with CRS-1 were listed in Table 1. Patients who
were dialyzed for reasons other than CRS-1 had a mortality rate of
59.69%. After adjusting co-morbidities and acute physiology parame-
ters, patients with CRS-1 after cardiogenic shock have a hazard ratio
(HR) of 1.76 (1.06-2.93) to die within 90 days than patients without
CRS-1; patients with acute decompensated heart failure (ADHF) had a
more favorable 90 days’ survival than non-CRS-1 patients, with an HR
of 0.66 (0.46-0.96). Patients with cardiogenic shock were more likely
to be dialysis dependence, with an HR of 1.78 (1.07-2.97). Patients
with CRS-1 after cardiac surgery or ADHF were more likely to be off
dialysis, [HR=0.53 (0.30-0.94) and 0.65 (0.45-0.94)]
CONCLUSION. Among patients with CRS-1 needing dialysis. The out-
comes differed in terms of etiologies of cardiorenal syndrome. The





214 (27.30%) 19.7 26.40
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Table 1 (abstract 001268). Baseline sociodemographic characteristics
of the study patients








2.3±3.4 3.2±4.1 0.8±0.2 <0.001









Cistatina C (mg/L) 2.4±1.5 2.7±1.5 1.9±1.6 0.051
Median (IQR) 2.1 (1.2,3.1) 2.5 (1.8,3.1) 1.2 (0.9,1.7)
Cilinders in urine 0.029
Absent 11 (47.8) 4 (28.6) 7 (77.8)
Present 12 (52.2) 10 (71.4) 2 (22.2)
AKI Accute Kidney Injury, IQR Interquartile range, SD Standard Deviation
Categorical variables are presented in frequency and percentages; Continuous
variables are presented as mean ± SD. P value for the comparison between
LRA present vs absent
Fig. 1 (abstract 001268). Sensitivity and specificity. Area under the
ROC curve for serum N-GAL in relation to the baseline diagnosis of
acute renal injury
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INTRODUCTION. The incidence of sepsis and acute kidney injury in
critical patients is gradually increasing, both indicate a poor progno-
sis with higher morbidity and mortality. Failure on acute diagnosis
may delay the onset of an adequate therapy which may cause an un-
favorable outcome, such as the need for renal replacement therapy,
generating high costs to the health system. The validation of new
methods that identify the presence of acute kidney injury in its early
stages is needed.
OBJECTIVES. To demonstrate which is the earliest marker for the
diagnosis of acute kidney injury in patients with sepsis, including cre-
atinine, cystatin C, urinary sediment and N-GAL.
METHODS. A prospective, longitudinal and descriptive study is pre-
sented, with data obtained from patients over 18 years of age, with
sepsis, who attended to the American British Cowdray Medical Cen-
ter Emergency Department, between July 2017 and July 2018.
RESULTS.
Cylinders in urine and cystatin C had the same capacity to detect
cases of acute kidney injury on admission (sensitivity 71.4% and spe-
cificity 77.8%).
N-GAL showed a high sensitivity (greater than 85%) and a specificity
of 100% at hospital admission and also maintained a high sensitivity
of 87.5%, although its specificity was reduced due to transitions be-
tween patients from sick to healthy.
CONCLUSION. In this study we found that N-GAL is the most reliable
biomarker for the diagnosis and prognosis of acute kidney injury
compared to creatinine, cystatin C and urinary sediment. Its urinary
levels increased much earlier. Without being modified by the
patient's previous condition.
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INTRODUCTION. Fluid restriction and elimination during stabilization
and de-escalation phases of fluid therapy are the keys to reduce
mortality. Using bioelectrical impedance vector analysis (BIVA), the
body-composition measuring equipment for excessive body fluid
evaluation guiding the negative fluid balance, may reduce mortality
in critically ills undergoing renal replacement therapy.
OBJECTIVES. To compare 28-day mortality between using BIVA-
guided management and using standard clinical management. The
secondary outcomes were ventilator-free days, ICU and hospital mor-
tality, ICU and hospital length of stay, ventilator-associated
Page 285 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55pneumonia occurrence, incidence of hemodynamic instability during
RRT (HIRRT) and renal recovery.
METHODS. In this randomized control trial, the medical intensive
care unit (MICU) patients who had stable hemodynamics and re-
quired renal replacement therapy for fluid removal, were assigned to
either the BIVA and the control groups. In both groups, the rate of
fluid removal and vasopressor requirement were adjusted according
to hemodynamics and clinical needs. Physician’s fluid management
decision depended on only standard clinical data for the control
group, and on additional BIVA-derived values for the BIVA group in
order to achieve %BIVA hydration of 72.4-74.3% and phase-angle of
more than 5.5, respectively.
RESULTS. Of 36 enrolled patients, 17 patients (47.2%) were assigned
to the BIVA group. Most of the reasons for MICU admission (77.8%)
were sepsis/septic shock. Baseline characteristics of the patients in
the two groups were similar. Mean APACHE II score at ICU admission
in both groups were not different (30.5±12.5 in BIVA,29.8±8.2 in con-
trol, p = 0.85). Before enrollment, both groups were comparable in
percentage of fluid accumulation (%FA) [11.3% (6.3,21.5) in BIVA
group, 10.7% (5.7,19.2) in control group, p= 0.66)]. Use of add-on
BIVA to standard treatment did not provide beneficial effect in rate
of fluid removal indicating by body weight and %FA. The mortality
from any cause by day 28 was 47% (8/17) in BIVA and 52.6% (10/19)
in control group (p = 0.78). There was no statistically significant dif-
ference between the two groups in ICU and hospital mortality, ICU
and hospital length of stay, and ventilator free day. For safety and
complication, HIRRT and vasopressor requirements were comparable.
CONCLUSION. Using add-on BIVA guide fluid removal to standard
therapy in critically-ill patient who required renal replacement ther-
apy does not associate with 28-day mortality. Further studies are re-
quired due to small sample size in this study.
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INTRODUCTION. Bacterial infections and systemic inflammation(SIRS)
are the major precipitants of organ failure including acute kidney in-
jury (AKI) in critically ill(CIC) and predispose to increased progression
to Chronic Kidney Disease(CKD). Timely identification of AKI is there-
fore an unmet need. Biomarkers can help in differential diagnosis
and prediction of the trajectory of AKI course. We evaluated Cystatin
C(CysC) and urinary neutrophil-gelatinase-associated lipocalin (NGAL)
as biomarkers of glomerular and tubular injury respectively in pre-
dicting a progressive AKI and maladaptive repair in CIC.
METHODS. CIC admitted to the Liver ICU were prospectively
followed up. Baseline serum creatinine, history of prior AKI (past 3
months) and precipitant for AKI was recorded at admission. Progres-
sive AKI was defined at day 7 as an increase of serum creatinine by
0.3 mg/dl from baseline or percentage increase of more than 50% or
an increase in AKI stage or requirement of dialysis.
RESULTS. A total of 519 CIC, mean age 48.4±11.4 years, 86% males
were followed for 26(8-97) days. The median serum NGAL and CysC
was 759(223-1230) ng/ml and 2.1(1.5-2.7)mg/l respectively. SIRS was
seen in 84%, sepsis in 58%, prior AKI in 18%. AKI at admission was
present in 60% (Stage 1:2:3 43%vs 14%vs 43%) of which 48% recov-
ered and 52% had progressive AKI. Sepsis was the commonest (46%)
cause of AKI. At day 7, 317(61%) patients had progressive AKI of
which 51% had new onset AKI. Of these, 56% had HRS, 10% prerenal
AKI and remaining had acute tubular necrosis (ATN). The levels of
NGAL and CysC were higher in patients in sepsis vs non-sepsis AKI (<
0.001), correlated with the severity of AKI stage (p<0.001), response
to terlipressin (p<0.001), and recovery of AKI (p<0.001) but could notdifferentiate HRS from ATN. On multivariate analysis (OR,95% CI), u-
NGAL (2.53,1.6-4), Cyst C (1.9, 1.1-3.4) and prior AKI ( 3.15,1.36-7.3)
significantly predicted progressive AKI which in-turn was associated
with higher mortality (HR 2.32,95%CI 1.8-3.1). Further, of all patients
with progressive AKI, 144(45%) had transition to chronic kidney dis-
ease which signifies maladaptive repair. The levels of NGAL(OR
1.9,1.3-2.9) and Cyst C(OR 1.9,1.3-2.5) could also predict the develop-
ment of end stage renal disease (ESRD) in CIC.
CONCLUSION. Almost two-thirds of CIC have AKI at presentation,
which in majority is a result of sepsis, is progressive and is associated
with worse outcome. u-NGAL and CysC can accurately predict pro-
gression of AKI and maladaptive repair with development of ESRD,
and can help in stratifying patients for early therapeutic intervention.
Prior AKI itself predisposes to AKI progression in CIC and should be
carefully assessed in readmissions.
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INTRODUCTION. Veno-venous extracorporeal membrane oxygen-
ation (VV-ECMO) in adults is an established therapy used to treat se-
vere acute respiratory failure (SARF). Acute Kidney injury (AKI) is a
major predictor of morbidity & mortality in critical illness, indeed a
single episode of AKI confers an increased long-term mortality. Re-
cently the characteristics of AKI induced by differing conditions has
been better elucidated i.e. sepsis associated-AKI. Studies suggest
renal replacement therapy (RRT) is required in 60% of patients on
ECMO (1). However, to date there is a paucity of evidence in this
area. Some data suggests the use of RRT in ECMO patients is not as-
sociated with an increased mortality (2). Whilst other data shows
higher mortality & prolonged mechanical ventilation (3). There is no
doubt AKI influences ECMO patient outcomes, we hope to add sig-
nificantly to this emerging body of evidence.
METHODS. Retrospective analysis of consecutive patients on VV-
ECMO for SARF over a 9 year period 01/2010-02/2019. Factors con-
tributing to AKI, the need for RRT & duration of ECMO were recorded.
Outcomes included; AKI stage by both creatinine and urine output
criteria (as defined by KDIGO), need for RRT during the critical illness,
persistent AKI on discharge and 28, 90 day & hospital mortality.
These outcomes were further stratified by age group.
RESULTS. Data was obtained from 384 patients out of a total of 447
consecutive SARF patients from 01/2010 – 02/2019. Demographics as
per (table 1). Incidence of AKI: As calculated by creatinine criteria;
AKI1 32.8%, AKI2 9.6%, AKI3 52.3%. We also report the incidence of
AKI as calculated by urine output criteria; AKI1 41.4%, AKI2 3.6%,
AKI3 52.3%. Need for RRT: 50% of patients required RRT, with higher
rates in increasing age groups (40.3% in <30s, 46% in 30-50 years
and 58.6% in >50s). Persistent AKI: Overall, of the patients who re-
ceived RRT and survived, 9.3% of them had persistent versus 0% for
AKI 1/2. Hospital mortality: 24.4% for the 384 patients. Mortality: in
patients who needed RRT was 61/192 (31.8%) compared with 15/66
(22.7%) in those with AKI 1,2&3 (without RRT) and 17/126 (13.5%) in
those with no AKI. Mortality rates for ECMO patients with RRT com-
pared to those without RRT are significant (p0.05). Mortality is further
classified by age (table 2).
CONCLUSION. We report on one of the largest European data sets to
date for VV-ECMO patients and for the first time on AKI as defined
by KDIGO urine output criteria. The incidence of SARF-AKI for pa-
tients requiring ECMO is expectedly high. However reassuringly there
is a relatively low occurrence of persistent AKI amongst ECMO survi-
vors suggesting capacity for organ recovery. Additionally, the risk of
mortality for those with AKI stage 1/2 is not different to those
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tality risk, this is compounded in younger age groups which is of
concern given this patient population.
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INTRODUCTION. The effect of extracorporeal membrane oxygenation
(ECMO) on mortality in patients with severe acute respiratory distress
syndrome(ARDS) remains controversial. To evaluate the use of ECMO
for ARDS on prognosis in critically ill patients, we systematically
reviewed the literature.
OBJECTIVES. Due to the heterogeneity of the study population and
ECMO treatment, the existing clinical results of current studies on the
prognosis of ARDS patients are inconsistent. Therefore, we use the
quantitative evaluation method of meta-analysis to increase the total
sample size and improve statistical efficiency.METHODS. Databases from Pubmed, MEDLINE, EMBASE, and
Cochrane were queried for studies on ECMO in patients with ARDS
from 1948 through to November 2018. Databases from Pubmed,
MEDLINE, EMBASE, and Cochrane were queried for studies on ECMO
in patients with ARDS from 1948 through to November 2018.
RESULTS. Ten studies (three RCTs and seven observational studies)
met our inclusion criteria in this meta-analysis, 1562 patients were in-
cluded. Pooled analysis suggested that ECMO does not increase mor-
tality in patients with ARDS in both the RCTs, (RR=0.83; 95%CI, [0.66-
1.03]; P=0.32; I²=12%) and the observational studies (RR=1.21 95%CI,
[0.81-1.80]; P<0.01; I²= 79%). These findings were also consistent
across all subgroup analyses from observational studies. Four studies
included data for the incidence of neurologic complications in the
ECMO group, in which intracranial hemorrhage is the most frequent
neurologic complication.
CONCLUSION. Our meta-analysis indicates that no statistically signifi-
cantly higher mortality was associated with the application of ECMO
in patients with ARDS. However, this finding largely relies on data
from observational studies and is potentially subject to selection bias;
hence, high-quality and adequately powered RCTs are warranted.
Moreover, venovenous ECMO was also associated with a moderate
risk of neurologic complications, and intracranial hemorrhage is ra-
ther common among patients receiving ECMO.
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INTRODUCTION. Protective mechanical ventilation (low tidal volume,
plateau pressure <30 cmH2O, and high positive end expiratory pres-
sure) has been proposed as a strategy to reduce the risk of ventilator
induced lung injury (VILI). Mechanical power (MP) is a relatively new
concept that takes into account variables that can cause VILI and that
are not included in the protective strategy. Elevated MP could have a
deleterious impact on the outcome of patients, so it should be
monitored.
OBJECTIVES. To determine if elevated MP increases mortality in pa-
tients with invasive mechanical ventilation (MV).
METHODS. A prospective study was conducted in patients with MV
for >24 continuous hours during their stay in the Intensive Care Unit
(ICU). The MP was measured four times a day for the duration of the
MV and the mean MP was calculated. Elevated MP was defined as a
mean value >12 J/min. Mortality in the ICU was compared between
patients with normal and elevated MP. The discriminative capacity
for death of the mean MP was measured by analysis of the ROC
curve. We identified independent risk factors for death through bi
and multivariate logistic regression analysis. A p value <0.05 was con-
sidered statistically significant.
RESULTS. Eighty-seven patients were analyzed, 51.7% were males,
mean age of 54.4 years. Twenty-nine (33.3%) patients had ele-
vated MP. Mortality was significantly higher in patients with ele-
vated MP (44.8%) compared to those with normal MP (8.6%),
with p = 0.001. The area under the ROC curve of the MP for
mortality was 0.799 (95%CI 0.674 - 0.923, p = 0.001). In the multi-
variate analysis, elevated MP showed RR of 1.460 (95%CI 1.091 -
1.954, p = 0.011).
CONCLUSION. The frequency of elevated MP is high. Mortality of pa-
tients with elevated MP is higher than that of those with normal MP.
MP has adequate discriminative capacity to predict mortality and is
an independent risk factor for death in patients with MV.
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INTRODUCTION. Respiratory muscle weakness frequently develops in
ventilated critically ill patients and is associated with adverse out-
come, including difficult weaning from mechanical ventilation. Today,
no drug is approved to improve respiratory muscle function in these
patients. Previously, we have shown that the calcium sensitizer levo-
simendan improves calcium sensitivity of human diaphragm muscle
fibers (from healthy and patients with chronic obstructive pulmonary
disease) in vitro [1] and contractile efficiency of the diaphragm in
healthy subjects in vivo [2].
OBJECTIVES. To investigate the effects of levosimendan on dia-
phragm contractile efficiency in mechanically ventilated patients.
METHODS. In a double-blind randomized placebo-controlled trial
mechanically ventilated patients performed two continuous positive
airway pressure (CPAP) trials for 30-minutes each with 5 hour inter-
val. After the first CPAP trial, study medication (either levosimendan
0.2 μg/kg/min continuous infusion or placebo (equal volume)) was
administered. During the CPAP trials electrical activity of the dia-
phragm (EAdi), transdiaphragmatic pressure (Pdi) and tidal volume
(TV) were continuously measured. Neuromechanical efficiency (pri-
mary outcome parameter; computed as ΔPdi/ΔEAdi) and neuroventi-
latory efficiency (computed as TV/ΔEAdi) were calculated.
RESULTS. Thirty-nine patients were included in the study. Neurome-
chanical efficiency was not different during the CPAP trial after levo-
simendan administration compared to the CPAP trial before study
medication (Figure 1). ΔEAdi and tidal volume were higher only after
levosimendan administration, therefore resulting in no difference in
neuroventilatory efficiency between the CPAP trial before and after
study medication (Figure 1). ΔPdi was higher in both groups in theCPAP trial after study medication compared to the CPAP trial before
study medication
CONCLUSION. Levosimendan does not improve diaphragm contract-
ile efficiency in mechanically ventilated patients. The effects of levosi-
mendan on weaning outcome needs to be established.
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INTRODUCTION. Acute respiratory failure is the leading cause for in-
tensive care unit admission for hematological patients. High flow
nasal canula devices (HFNC) can deliver oxygen up to 60 L/min with
active heated humidification. HFNC was proved to be beneficial in
various forms of acute respiratory failure patients.
OBJECTIVES. We hypothesized that HFNC is beneficial for mild re-
spiratory insufficiency in hematological malignancy patients.
METHODS. The primary goal of the study to show if HFNC can de-
crease need for invasive and non-invasive ventilation as well as comfort
VAS and dyspnea VAS. Eligible patients were hematological malignancy
at our hematogy ward regardless of time from diagnosis and bone
marrow transplant patients with signs of respiratory distress or labored
breathing and SaO2 less than 92% for at least one hour on room air or
PaO2/FiO2 less than 300 mmHg. All randomized patients were included
into the final analysis. The patients were randomized to either standard
medical treatment or HFNC treatment groups
RESULTS. Total of one hundred, 34 female and 66 male patients were
included into the study. Mean age was 56±15. Mean APACHE II score
was 17±5. The most common reason for respiratory insufficiency was
pneumonia with 74 patients. HFNC group was consisted of 51 patients
and standard treatment group 49 patients. Endotracheal intubation
was required in 16 (33.3%) patients in standard group and 24 (48.0%)
patients in HFNC group (p=0.15). A total of 20 (40.8%) patients in stand-
ard group and 21 (41.2%) patients in HFNC group received non-
invasive mechanical ventilation (p=0.97). Median VAS comfort score,
VAS dyspnea score and VAS thirsty score at 2nd and 24th hours were
not different between groups. Baseline median P/F ratio was 276 (min-
max: 190 – 295) in standard group and 257 (min-max: 209 – 295) in
HFNC group (p=0.07). P/F ratios were similar between the groups
Table 1 (abstract 000243). Subgroup analysis: Moderate ARDS patients
VARIABLE SURVIVORS NON-SURVIVORS p value
APACHE II 21.08 ± 6.96 25.83 ± 6.11 0.006
MV (days) 26.53 ± 29.88 21.22 ± 14.33 0.577
ARDS (days) 12.09 ± 7.09 15.22 ± 11.88 0.108
ICU stay (days) 31.12 ± 29.87 25.88 ± 17.61 0.124
Table 2 (abstract 000243). Subgroup analysis: Severe ARDS patients
VARIABLE SURVIVORS NON-SURVIVORS p value
APACHE II 20.08 ± 8.88 25.33 ± 5.33 0.671
MV (days) 26.95 ± 18.01 11.22 ± 11.31 0.001
ARDS (days) 16.72 ± 10.11 8.22 ± 8.91 0.031
ICU stay (days) 33.12 ± 19.87 11.88 ± 9.61 0.001
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(min-max: 3 – 130) days in standard group and 28 (min-max: 3 – 126)
days in HFNC group (p=0.54). Twenty-eight day mortality rate was 18
(36.7%) in standard group and 23 (45.0%) in HFNC group (p=0.42).
CONCLUSION. HFNC is not superior to standard medical treatment in
respiratory insufficient of hematological malignancy patients.
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INTRODUCTION. Acute respiratory distress syndrome (ARDS) is a life-
threatening condition of critically ill patients, characterized by poor
oxygenation and associated with capillary endothelial injury and dif-
fuse alveolar damage. The proposed “Berlin Definition of ARDS”,
published in 2012, predicted mortality ever-so-slightly better than
the existing ARDS criteria (created at the 1994 by American-
European Consensus Conference/AECC).
OBJECTIVES. The aim of this study was to find a new approach from
the impact of ARDS using the Berlin Definition and to analyze APA-
CHE II score, days of mechanical ventilation (MV), duration of ARDS
and mortality in critical ill patients in an ICU of a University Hospital.
METHODS. We collected prospectively from January 2015 to Decem-
ber 2018 and regarded all patients undergoing MV for 48 hours or
more and who met the Berlin criteria of ARDS. All patients were ven-
tilated according to the ARDS.Net protocol and we focused the ana-
lysis on the moderate and severe ARDS, excluding the mild patients
(corresponding to the old AECC definition of acute lung injury - ALI)
with PaO2/FIO2 ≤ 300 mmHg. We also conducted a subgroup ana-
lysis between survivors and non-survivors patients.
RESULTS. During this period 2219 patients were admitted in the ICU,
757 were under MV for at least 48 hours and 117 had ARDS criteria.
Patients with moderate ARDS 60%: 55% male, median age 61 years,
APACHE II mean 21.79 (95% CI=20.21-23.27), mean duration MV
21.84 days (95% CI=18.18-27.60), ARDS duration 10.87 days (95% CI=
7.83-13.90), average stay 26.88 days, mortality 51.4%. Patients with
severe ARDS 40%: 66% male, median age 49 years, APACHE II mean
score 23.79 (95% CI=20.62-25.75), mean duration MV 17.25 days
(95% CI=13.01-24.03), ARDS duration 13.33 days (95% CI=8.72-15.58),
average stay 21.65 days, mortality 48.8% with no statistically signifi-
cant difference with moderate ARDS (p=0.72). Leading cause of
death was refractory multiorgan failure (60%).
CONCLUSION. Using the Berlin criteria of our ARDS patients we
found no statistically significant differences in relation to the vari-
ables of interest to analyze in the two groups. In the analysis by sub-
groups, patients with severe ARDS who survive at the ICU admission
have a longer duration of ARDS, which means more days on MV and
therefore increased ICU stay.
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INTRODUCTION. Moving from ICU ventilator to transportation venti-
lator is commonly performed by clamping endotracheal tube (ETT) to
prevent lung derecruitment. Whether or not this clamping is effective
in preventing derecruitment has not previously been investigated.
OBJECTIVES. The primary objective of this bench study is to evaluate
if this procedure is effective to prevent air leakage. A second object-
ive is to evaluate the role of different clamps and ETT .
METHODS. Elysee 350 ventilator was connected via ETT cuffed in-
flated to a lung model set in passive condition with compliance 40
ml/cmH2O and resistance 10 cmH2O/L/s. Ventilator was set in
volume-controlled mode, tidal volume 400 ml, respiratory rate 21
breaths/min and positive end expiratory pressure 15 cmH2O. Airway
pressure (Paw) and flow were measured between ETT distal end and
lung model and sent to Biopac 150 datalogger. Three kinds of ETT
(nasal, oral, reinforced) of same 8mm internal diameter and three
kinds of clamps (plastic, metallic, ECMO) were tested. A single tube
was used once for each clamp. Absence of leak in the whole setup
was checked. Then after 4 breaths, an end-expiratory occlusion was
done during which ETT was clamped. Then, the ventilator was dis-
connected from the ETT whilst Paw and flow were continuously re-
corded for 30 sec. This procedure was repeated three times for every
combination of ETT and clamp. Leak after disconnection was defined
as flow in the expiratory direction and Paw drop. Primary endpoint
was Paw decay during 5 sec after disconnection and secondary end-
point volume lost over this period. Data are shown as median (1st-
T1
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with Holm procedure.
RESULTS. Every ETT-clamp combination was leaky. The magnitude of
leak is shown in table 1. There was a significant effect of both ETT
and clamp and a significant interaction between them. ECMO clamp
performed better than the two others for the nasal ETT only. For the
two other ETT there were no statistical difference between ECMO
and metallic clamp. Plastic clamp had the worst performance in
every case.
CONCLUSION. Any clamping ETT procedure was leaky. ECMO clamp
performed the best.
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after disconnection of ETT once clamped across ETT and clamps
ETT* ** Clamp* ** Paw decay (cmH2O/s) Volume lost (L)
Nasal ECMO 0.00 (-0.06;0.04) -0.027(-0.028; -0.026)
metallic -3.35 (-3.43;-3.16) Ϯ -0.13 (-0.15; -0.12) Ϯ
plastic -14.62(-14.66;-14.40)Ϯ$ -0.65(-0.65; -0.64)Ϯ$
Normal ECMO 0.00 (-0.73;0.08) -0.030 (-0.056; 0.03)
metallic -3.105 (-3.33;-2.23) -0.13 (-0.13;-0.096)
plastic -15.525(-17.77;-14.99)Ϯ$ -0.72 (-0.79;-0.68) Ϯ$
Reinforced ECMO -0.37 (-0.39;-0.37) -0.042(-0.042;-0.040)
metallic -1.39 (-1.63;-1.06) 0.070 (-0.077;-0.060)
plastic -17.49(-17.99;-17.078)Ϯ$ -0.84 (-0.85;-0.79) Ϯ$
*P<0.001 ** P<0.001 for interaction between ETT and clamp. Ϯ P<0.001 vs.
ECMO $P<0.001 vs.metallic
Fig. 1 (abstract 000295). See text for description
Fig. 2 (abstract 000295). See text for description. *nationwide
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INTRODUCTION. A nationwide study performed in Scotland in 2009
reported the practice and complications of tracheal intubation in In-
tensive Care Units (ICU)1. Since then new guidelines 2,3 and trials 4
have been published. Anecdotally we have noticed changes in prac-
tice in our unit related to drug choice and use of videolaryngoscopy.
To determine the extent of change we performed a pilot study in
the Edinburgh Royal Infirmary, Scotland (RIE).
OBJECTIVES. To determine how intubation practice has changed in
our ICU since 2009 and whether such change might warrant repeat-
ing a nationwide study.
METHODS. We conducted a prospective, observational study in
critically ill adult patients requiring tracheal intubation over a
three month period in 2018. We used an anonymised proforma
to collect data including; timing and urgency of intubation, drugs
used, number of attempts and complications. We used RIE spe-
cific data from the 2009 study for comparison and the Chi-square
test for statistical analysis.
RESULTS. Data from 45 intubations were analysed. Forty-three intu-
bations (95%) were performed by doctors with more than 24 months
anaesthetic experience. Intubation was successful at the first attempt
in 42 (89%). There was a significant change in drugs used forinduction (p<0.001) and paralysis (p=0.03); in 2009 propofol (61%)
and suxamethonium (58%) were commonest, and in 2018 ketamine
(36%) and rocuronium (91%) were commonest [Figure1]. Use of
videolaryngoscopy increased significantly from 0.7% in 2009 (nation-
wide data) to 27% in 2018 [Figure2, p<0.0001]. Severe hypoxaemia
(SpO2<80%) occurred in significantly fewer patients in 2018 (9.5% v
22%, p=0.03), and hypotension appeared to occur less frequently but
this was not statistically significant (16% v 21%, p=0.54) [Figure3].
CONCLUSION. Drugs used for intubation and laryngoscopy tech-
nique have changed, and intubation-related morbidity has decreased
significantly in our ICU in the past ten years. Our pilot study suggests
that a nationwide study should be repeated.
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INTRODUCTION. Acute exacerbation of chronic obstructive pulmon-
ary disease (COPD) is one of the most common reasons for hospital
admissions in the UK. Non-invasive ventilation (NIV) has revolutio-
nised the management of acute hypercapnic respiratory failure and
has become one of the major advances in medicine for the last de-
cades given that it is used correctly with effective settings. Recently
released BTS and NCEPOD guidelines showed the delivery of NIV in
the acute setting is frequently sub-optimal [1,2]. This was also the
case in St John’s Hospital.
In St John’s Hospital NIV is managed by medical staff in high de-
pendency area which is part of the medical admission unit. Our aim
was to audit the current practice in comparison with the British Thor-
acic Society (BTS) quality standards [2] focusing on and aiming to im-
prove ventilator’s settings. Also, we aimed to formalise a hospital
protocol for NIV. We have also looked at our escalation plan in treat-
ment failure.
METHODS. For each round, non-identifiable patient data was col-
lected prospectively aiming for at least 20 patients. We obtained ver-
bal consent to look in to patient’s notes. We used quality
improvement methodology and created an audit tool using the BTS
template example. The first round was carried out between Novem-
ber 2017 and February 2018 where we collected the data for 20 pa-
tients and analysed the results. We presented the findings in our
local hospital medical teaching day and introduced the hospital
protocol. We collected the data in the second round between Febru-
ary and July 2018 for 18 patients and analysed the results.
RESULTS. The total number of patient’s data collected in both
rounds 38. In both rounds patient mix was similar. We have been
consistently managing to obtain CXRs and initial blood gases be-
fore starting non-invasive ventilation 38 (100%). In the first round
13 (65%) reached recommended setting of IPAP 16-22 compared
to 14 (78%) in the second round. On the other hand escalation
decisions were better in the first rounds were 18 (90%) of pa-
tients had a resuscitation decisions made and 14 (80%) had clear
escalation plans before starting NIV compared to 15 (83%) in the
second rounds.CONCLUSION. Having a protocol to guide the use and modification
of NIV settings along with ensuring the medical and nursing staffs’
familiarity with the protocol helps in providing effective care. There
is still scope for improvement in escalation decisions. Also, one of
the issues we encountered was effective documentation which
would be a further project to undertake.
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INTRODUCTION. Bronchoscopy is frequently performed in intensive
care units (ICU) for therapeutic and diagnosis purposes. The tech-
nique is relatively easy to perform bedside, poses few complications
and avoids potentially dangerous patient transfer outside the ICU. As
a result, bronchoscopy is presently considered to be an essential tool
in critical care.
OBJECTIVES. Assessment of main indications, clinical outcomes and
complications associated with bronchoscopy in critically ill patients.
METHODS. A retrospective, single-center observational study over a
period of 2 years (2017- 2019) was carried out in 215 patients under-
going bronchoscopy during their stay in the ICU.
RESULTS. A total of 443 bronchoscopies were carried out. Most of
the procedures (86%) were performed in mechanically ventilated pa-
tients. The average patient age was 52.1 years. The most frequent in-
dication was flexible bronchoscopy (FB) to perform the diagnosis
confirmation of initially suspected pneumonia (38.8% [172]), with
positive bronchoalveolar lavage (BAL) findings in 25.3%, followed by
endoscopic control of percutaneous tracheostomy confection (31.6%
[140]), direct evaluation of the airway (17.6% [78]) and bronchial toi-
lette (9.0% [40]). Other indications, such as rigid bronchoscopy in a
patients with acute tumor obstruction of the bronchial tree (1.6% [7])
and pulmonary cryobiopsy (1.4% [6]) were performed. Main compli-
cation associated with the procedure was bleeding (3.6% [16]). In
most of the cases it was considered mild bleeding (2.0% [9]) and did
not require any particular treatment for their control. Minor compli-
cations were transient hypoxemia (0.7% [3]) and hypotension (0.5%
[2]). No serious events such as pneumothorax, arrhythmias or
hemodynamic collapse were recorded.
CONCLUSION. Microbiological diagnosis of pneumonia with BAL
and endoscopic control of percutaneous tracheostomy are the
most frequent indications in critically ill patients. FB performed
by an intensivist in ICU is a safe procedure, with low incidence
of complications.
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INTRODUCTION. Pulmonary transplantation is life changing for pa-
tients with incurable lung disease. In potential donors, several sup-
portive interventions are performed, in order to improve the yield of
lungs available for transplantation. One purpose of these interven-
tions is to reverse pulmonary atelectasis associated with the brain
death process and to improve oxygenation; PaO2/FiO2 (P/F) ratio is a
key parameter in the acceptability of donor's lungs. Protective venti-
lation and recruitment manoeuvres are two interventions that have
already shown some benefit (1,2).
OBJECTIVES. Our objective was to describe the ventilatory and re-
cruitment interventions performed in potential lung donors in our
centre and their association with P/F ratio improvement.
METHODS. We performed a retrospective study between June
2013 and May 2018 at the Sacré-Cœur Hospital organ procure-
ment centre. For this first analysis, we included all neurologically
dead donors who successfully donated their lungs. We used data
from our prospective database and completed data collection
retrospectively from medical records. We recorded data on inter-
ventions potentially influencing P/F ratio: duration of donor sup-
port, initial tidal volume, positive end-expiratory pressure (PEEP)
applied, recruitment manoeuvres, bronchoscopies, intrapulmonary
percussive ventilation, and the use of diuretics. We calculated the
P/F ratio (at 100% FiO2) and static lung compliance changes for
each patient, between the neurological death (ND) and the last
value before lung harvesting.
RESULTS. Of 268 potential donors, 222 were declared neurologic-
ally dead and 184 had organs harvested. We included 89 patients
in whom lungs were retrieved for transplantation. Mean age was
46±18 years and 37% were women. Mean duration of support
was 33±20h and half of them received at least one dose of diur-
etic. Initial protective tidal volume (≤8mL/kg predicted body
weight) was applied to 42% of patients and at least one recruit-
ment manoeuvre (median 2 [0 -10]) was performed in 69% of
them. The median PEEP was 8 (range 5-12). Median number of
bronchoscopies post ND was 1 (range 1-8) and 50 patients (56%)
received intrapulmonary percussive ventilation. Between the ND
and harvesting, the median change in compliance was 4 mL/
cmH2O (range -25 to 48) and the median change in P/F ratio
was 93 (range -176 to 277). Exposure to percussive ventilation,
adjusted for age, PEEP, protective ventilation and the number of
recruitments, was the only intervention independently associated
with P/F ratio improvement (OR: 4.5, 95% CI 1.7-11.6).
CONCLUSION. In our institution, less than half of lung donors were
ventilated with protective tidal volume. Percussive ventilation wasassociated with significant improvement in oxygenation. Further pro-
spective studies are needed to validate these findings.
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INTRODUCTION. Accurate measurement of respiratory mechanics is
important because end-inspiratory plateau pressure (Ppla), positive
end-expiratory pressure (PEEP) and tidal volume (Vt) remained the
core parameters to be monitored in mechanically ventilated ARDS
patients. It is easy to have reliable measurement of respiratory me-
chanics when patients are paralyzed but may be problemic when re-
spiratory efforts are present. A clean Ppla was proposed to be
trustable. This proposal was not validated in mechanically ventilated
ARDS or acute hypoxemic respiratory failure patients under pressure
control ventilation (PCV).
OBJECTIVES. A crossover study for comparison of respiratory me-
chanics measured during paralysis and spontaneous breathing in
mechanically ventilated patients under PCV
METHODS. Twenty-four patients with ARDS or acute hypoxic respira-
tory failure were included in this study over a two-year period.
Esophgeal pressure monitoring was placed in all cases. Tidal volume
(Vt), total PEEP (PEEPt), airway driving pressure (ΔP), transpulmonary
driving pressure (ΔPL), respiratory system compliance (Crs), lung
compliance (CL), chest wall compliance (Ccw) were calculated with
performance of end-inspiratory occlusion. A clean Ppla was defined
as no steadily increasing or decreasing Ppla and Ppla with periodic
oscillations less than 2–3 cmH2O. Data are presented as mean ± SD.
Mann Whitney test and Spearman’s rank correlation test were used
for statistical analysis.
RESULTS. Fourteen patients have reliably measured respiratory mechan-
ics during both paralysis and spontaneous breathing under PCV. Respira-
tory mechanics measured under paralysis and spontaneous breathing
were: Vt: 468 ± 77 vs. 519 ± 90 ml, p = 0.11; PEEPt: 11.4 ± 3.4 vs. 10.2 ±
2.2 cmH2O, p = 0.42; ΔP : 12.4 ± 2.2 vs. 13.0 ± 2.0 cmH2O, p = 0.60; ΔPL:
8.5 ± 2.1 vs. 9.6 ± 2.7 cmH2O, p = 0.28; Crs: 38.9 ± 8.5 vs. 41.1 ± 9.6 ml/
cmH2O, p = 0.70; CL: 58.8 ± 19.2 vs. 58.8 ± 19.9 ml/cmH2O, p = 0.87;
Ccw: 130.3 ± 40.2 vs 213.1 ± 179.0 ml/cmH2O, p = 0.12. Spearman’s rank
correlation test revealed high correlation in measured Crs (r = 0.85, p <
0.0001) and CL (r = 0.94, p < 0.0001) between paralysis and spontaneous
breathing in individual patient, but poor correlation for Ccw (r = 0.433, p
= 0.12).
CONCLUSION. Our findings suggest a clean Ppla during PCV is reli-
able for measurement of Crs and CL, but not for Ccw in spontan-
eously breathing patients.
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INTRODUCTION. It has been reported that patient-ventilator asyn-
chrony is associated with adverse clinical outcomes [1]. However,
asynchrony is poorly defined in brain-injured patients. This study
aimed to investigate the incidence and risk factors of asynchrony in
this population.
METHODS. In this prospective observational study
(NCT03212482), adult patients with brain injury and mechanical
ventilation were included. Exclusion criteria were age < 18 yrs,
without spontaneous breathing, and presenting with agitation.
After enrollment, esophageal pressure (Pes) monitoring was
established using standard method [2]. A dedicated acquisition
system was used to obtain data of flow, airway pressure and
Pes, which were collected for 15 min at 6-h intervals for 72 h.
Four types of asynchrony were confirmed by Pes tracing accord-
ing to previous reported definitions, which included ineffective-
trigger, double-trigger, premature-cycle and delayed-cycle [1].
The asynchrony index was calculated as previous report [3].
Fifteen-min recording datasets with asynchrony index ≥ 10%
were defined as asynchronous datasets, whereas patients with
asynchrony index ≥ 10% for the sum of all datasets were de-
fined as asynchronous subjects. Demographics data and type of
injury were documented. Prior to each recording period, data of
ventilator settings, blood gas, level of consciousness and the
use of sedation and paralysis were collected. Clinical outcomes
were followed up to hospital discharge or death. Comparisons
between the asynchronous and non-asynchronous datasets and
subjects were performed using t test or Mann-Whitney U test,
as appropriate.
RESULTS. We enrolled 30 patients with mean age of 53 ± 17 yrs and
60% male. A total of 311 fifteen-min datasets were collected yielding
87,260 breaths, in which 11,601 (13.3%) asynchronous breaths were
identified. The most common type of asynchrony was ineffective-
trigger (61.8% of total asynchronous breaths), followed by delayed-
cycle (21.9%), premature-cycle (12.8%) and double-trigger (3.5%).
There were 91 (29.3%) datasets with asynchrony index ≥ 10%, and
11 (36.7%) patients had total asynchrony index ≥ 10%. A more severe
consciousness impairment, more frequent use of synchronized
intermittent mandatory ventilation, higher tidal volume and re-
spiratory rate, and more frequent use of sedation and paralysis
were found in the asynchronous datasets (Table 1). More patients
with traumatic brain injury was found in the asynchronous sub-
jects (Table 2). Adverse clinical outcomes were found in asyn-
chronous subjects (Table 2).
CONCLUSION. Patient-ventilator asynchrony was prevalent among
brain-injured patients. Level of consciousness, and the ventilator
mode and settings, as well as injury type were associated with
asynchrony. Clinical outcomes were worsen in asynchronous
patients.
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INTRODUCTION. Pneumonia can progress in acute respiratory dis-
tress syndrome (ARDS) that usually shows poor outcomes in critically
ill patients. If on one hand the management of severe ARDS is exten-
sively debated in the literature, on the other hand the treatment of
F1
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ation modalities (OM) such as continuous Positive Airway Pressure
(C-PAP) and High Flow Oxygenation through Nasal Cannula
(HFO) could be useful in adult patients with moderate ARDS due to
pneumonia, but no study has ever compared helmet c-PAP and HFO
in this field.
METHODS. We performed a retrospective analysis, reviewing all pa-
tients with moderate ARDS due to pneumonia and admitted to our
Intermediate Care Unit (IMCU) from December 2016 to December
2018. The inclusion criteria were age ≥ 18 years old; moderate ARDS
classified by Berlin definition; oxygenation with HFO or helmet C-PAP
(stand-alone system) for 2 consecutive days at least. Exclusion criteria
were history of chronic obstructive pulmonary disorder (COPD) or
other chronic respiratory disorders; lung cancer; acute cardiogenic
edema; severe neutropenia; circulatory failure. We analyzed two
groups (C-PAP and HFO) matched for age, SAPS2 score, SOFA score
and PaO2/FiO2 ratio before OM. We also collected demographic
characteristics, settings of OM and we investigated rates of ETI, IMCU
mortality and mortality at 90 days.
RESULTS. We reviewed 54 patients and 20/54 respected the inclusion
criteria (10 in HFO group; 10 in CPAP group). The two groups were
well matched (PaO2/FiO2 ratio before OM: 108 ± 39 (C-PAP), 119 ±
35 (HFO) p= 0.5; SAPS 2 score: 38 ± 14 (C-PAP), 30 ± 11 (HFO) p= 0.2;
SOFA score: 5 ± 2 (C-PAP), 4 ± 2 (HFO) p= 0.4; age: 67 ± 14 (C-PAP),
60 ± 19 (HFO) p= 0.4). We found no significant difference in ETI rate
[HFO 3/10 (30%), C-PAP 3/10 (30%)], IMCU mortality [HFO 1/10, C-
PAP 2/10, OR= 2.25, 95% CI: 0.17-29.77, p= 0.5] and mortality at 90
days [HFO 2/10, C-PAP 3/10, OR = 1.7, 95% CI: 0.22-13.41, p= 0.6]
(see Figure). Interestingly, C-PAP induced a higher increase of PaO2/
FiO2 ratio than HFO (although not statistically significant, p=0.1)
without effects on ETI and mortality rates.
CONCLUSION. In adult patients with moderate ARDS due to pneu-
monia, treatment with helmet C-PAP or HFO did not result in signifi-
cantly different ETI and mortality rates.Fig. 1 (abstract 000330). See text for description000339
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INTRODUCTION. Prone positioning more than 10 hours improves
oxygenation and mortality in patients with moderate to severe acute
respiratory distress syndrome (ARDS). Homogenization of lung venti-
lation in prone positioning establishing more uniform distribution of
tidal breath is the possible mechanism contributing to betteroutcome by alveolar recruitment and prevention of ventilator-
induced lung injury. However, the time course of homogenization of
ventilation has not been investigated. Electrical impedance tomog-
raphy (EIT), which is the real-time monitoring tool of ventilation, has
been demonstrated to be used for the evaluation of ventilation
homogeneity in different body positions.
OBJECTIVES. The objective of this study was to examine the impact
of prone positioning on ventilation homogeneity evaluated by EIT in
ARDS patients.
METHODS. In this retrospective study, we performed off-line analysis
of EIT data previously recorded before (in supine position, SP) and
after taking prone position (PP) in clinical settings. In each PP session,
ventilation homogeneity was evaluated using EIT measures; the pro-
portion of ventilation distribution (ventral and dorsal lung parts,
expressed in percentage to the tidal volume=100%), spatial disper-
sion and temporal delay in regional distribution of tidal breath (glo-
bal inhomogeneity index: GI index, regional ventilation delay: RVD).
These EIT measures and oxygenation were compared to the data
measured in SP immediately before PP. Off-line analysis was per-
formed by a blinded researcher. For the comparison between before
and after PP, paired t-test or Wilcoxon rank sum test were used for
statistical analysis as appropriate.
RESULTS. The EIT data of seven PP sessions in five patients (three pri-
mary and two secondary ARDS, mean age 66) were analyzed. Mean
time to EIT measurement from the initiation of PP was 7 ± 2 hours
(mean ± SD). The ventilator mode and/or pressures were changed in
three PP sessions. Ventilator mode was changed from assist control
to airway pressure release ventilation in one session and inspiratory
pressures in assist control were increased in two sessions after taking
PP. The mean proportion of ventilation in dorsal lung region in-
creased from 44 ± 9% to 56 ± 9% (P=0.010) in PP, showing a benefi-
cial effect of lung recruitment in dorsal part in 6 PP sessions. GI
index and RVD significantly reduced after taking PP, indicating more
homogeneous ventilation was achieved compared to SP. The oxy-
genation improved in 6 PP sessions. Significant increase in mean
PaO2/FIO2 was demonstrated after taking PP (SP;130 ± 65 mmHg vs
PP; 202 ± 98 mmHg, P=0.020). All patients were successfully weaned
from the ventilator. Four patients have survived and discharge from
the hospital.
CONCLUSION. In our cohort relatively short period application of
prone positioning provided more homogeneous ventilation com-
pared to supine position, which might result in better oxygenation.
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cation of loss of aeration[1]; it has already been applied to PEEP-
induced recruitment, ARDS lung healing, weaning from mechanical
ventilation and VAP recovery[2].
OBJECTIVES. To determine if LUS score early identifies responders to
non-invasive respiratory support.
METHODS. Prospective observational multicenter international study
(Pavia, Novara, Dijon). LUS score (from 0-normal aeration to 3-
complete loss of aeration computed in 6 standard regions per hemi-
thorax–2 anterior, 2 lateral, 2 posterior) was measured before and
after 2 hours of non-invasive support (high-flow nasal cannula-HFNC,
continuous positive airways pressure-CPAP, non-invasive ventilation-
NIV) in hypoxemic patients (PaO2/FiO2<300). Non-responders re-
quired intubation within 48 hours.
RESULTS. 31 non-invasive supports in 29 patients (males 13, age 71.5±
13.4 yo, BMI 27.1±4.5 kg/m2, SAPS2 35.0 [29.0-47.0]), admitted to ICU
from ED (15), OR (9) and medical ward (5) for acute respiratory failure
(15), major surgery (9), neurological diseases (3), HELLP syndrome (1),
cardiac arrest (1). They required non-invasive respiratory support for
weaning failure (7), pneumonia (7), ARDS (6), derecruitment (6), pul-
monary edema (5). The respiratory support was helmet CPAP (26),
HFNC (3), helmet (1) and mask (1) NIV; 7 failed (22.6%).
Failing and non-failing patients didn’t significantly differ before non-
invasive respiratory support in term of PaO2/FiO2, respiratory rate,
pH and PaCO2; LUS score similarly was not significantly different
(Tab.1). After 2 hours of support, failing patients were significantly
more hypoxemic and hypocapnic, despite pH and respiratory rate
were not significantly different from non-failing ones. They also had
significantly higher LUS score. A LUS score ≥17 predicted the failure
of non-invasive respiratory support with 100% sensitivity and 83.3%
specificity, while a global LUS score ≤12 predicted the success of
non-invasive respiratory support with 100% sensitivity and 85.7%
specificity.
CONCLUSION. LUS score early identifies responders to non-invasive
respiratory support.
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before (T0) and after 2 hours (T1) of non-invasive respiratory support
Non failing (24) Failing (7) p value
T0: PaO2 / FiO2 140.7±62.0 139.4±56.3 0.959
T0: PaCO2 43.5±13.3 33.0±7.3 0.057
T0: pH 7.4±0.1 7.4±0.0 0.517
T0: Respiratory rate 24.5±7.2 26.3±5.7 0.560
T0: Lung ultrasound score 15.3±5.2 17.4±6.1 0.373
T1: PaO2 / FiO2 192.2±55.4 134.0±48.7 0.0181
T1: PaCO2 41.9±10.1 32.8±6.0 0.0308
T1: pH 7.4±0.1 7.4±0.1 0.0880
T1: Respiratory rate 21.5±6.2 26.9±5.7 0.0513
T1: Lung ultrasound score 11.7±5.3 17.3±5.7 0.021000357
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INTRODUCTION. In the last decade, high-flow nasal oxygen therapy
(HFNO) has appeared as an intermediate alternative ventilatory sup-
port between conventional oxygen and mechanical ventilation. Its ef-
ficacy has been demonstrated in patients with respiratory failure due
to different etiologies (1-2). Patients treated with HFNO rapidly
showed a reduction in respiratory rate and work of breathing, associ-
ated with an improvement in functional residual capacity and gas
exchange.
OBJECTIVES. To analyze the outcome of clinical and gasometric pa-
rameters during the first 24 hours of high-flow nasal oxygen therapy
administration in patients with acute respiratory insufficiency with
and without associated hypercapnia. Identify bad outcome predictors
such as: need for mechanical ventilation and mortality.
METHODS. Prospective observational study. Adult patients admitted
in the ICU to whom high-flow oxygen therapy is administered at the
decision of their responsible physician. Demographic data, severity
scales, treatment parameters, physiological variables and gasometry
were collected.
Gasometric monitoring is performed at 1, 3, 12 and 24 hours after
the start of therapy.
RESULTS. 45 patients were recruited. Mostly male (73%), the average
age was 65.7 (61.7-69.7) years. APACHE II 20.5 (17.7-23.3). Among the
causes of acute respiratory failure were found: heart failure (31.1%),
pneumonia (22.2%), exacerbated COPD (13.3%), post extubation re-
spiratory failure (11.1%). The therapy was initiated with FiO2 77.8%
(70.6-68.5) and flow of 52.6 l/min (51-54.2). 12 (26.7%) patients re-
quired mechanical ventilation and mortality in the ICU was 18%.
A statistically significant reduction in respiratory rate was observed:
-6 (-7 to -9.5) rpm and cardiac frequency: -13.6 (-7.2 to -20) bpm. An
increase in SpO2 was observed: 4.4 (1.7-7)%. No significant changes
were observed in pCO2. Similar changes were confirmed in the sub-
group of patients with initial pCO2> 45 mmHg. The cardiac fre-
quency was associated with mortality: area under the ROC curve:
0.72 (0.55-0.89), with an HR of 99 bpm being the cut-off point that
best discriminated between patients who died and survived.
CONCLUSION. High-flow oxygen therapy improved physiological pa-
rameters of acute respiratory failure in our sample. Despite no im-
provement on pCO2, its use seems safe in patients with moderate
hypercapnia. Persistent tachycardia could be a predictor of thera-
peutic failure.
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INTRODUCTION. Oxygen therapy is a mainstay treatment in pa-
tients with hypoxemia or after extubation for maintaining ad-
equate oxygenation and reducing work of breathing.
Conventional low flow oxygen therapy via simple nasal cannula
and oxygen rebreathing mask with bag is commonly used. How-
ever, these devices can only provide a maximum flow rate of 15
LPM which may be inadequate for patients with acute respiratory
failure. High-flow nasal cannula (HFNC) is a high flow oxygen de-
livery system that can deliver up to 60 LPM of air-oxygen mixture
gas via a wide-bore nasal cannula. It can also adjust oxygen con-
centration from 21-100% and provide heated and humidified gas.
HFNC has been demonstrated several benefits in patients who
were admitted in Intensive Care Unit (ICU) with acute hypoxemic
respiratory failure and after extubation. Using HFNC outside ICU
without close monitoring is growing especially in general ward
and emergency department; however, the evidence in terms of
efficacy and safety of HFNC in such places is scant.
OBJECTIVES. To evaluate efficacy and safety of HFNC in general
internal medicine wards and factor associated with failure of
HFNC.
METHODS. We performed a prospective cohort study during Oc-
tober 2017 to April 2018 in general internal medicine wards at
Siriraj Hospital, Bangkok, Thailand. Adult patients who were ad-
mitted in general internal medicine wards and received HFNC
(Airvo-2TM, Fisher & Paykel Healthcare, Auckland, New Zealand)
were enrolled. All included patients were continuously moni-
tored by multidisciplinary care team who were trained and
familiar with HFNC device. The primary outcome was the rate of
HFNC failure (defined by intubation or receiving non-invasive
ventilation). The secondary outcomes included in-hospital mor-
tality, 28-day mortality and factors associated with failure of
HFNC.
RESULTS. A total of 88 patients were enrolled and 17 of them
were patients with do-not-resuscitate (DNR) order. Mean age was
71±15 years old, APACHE II score was 18±6 and SOFA score was
6±3. Lower respiratory tract infection was the leading cause of
hospital admission. The main indications of HFNC were acute
hypoxemic respiratory failure (63.6%) and prophylactic after extu-
bation (31.8%). Mean duration of HFNC use was 76.6±62.8 hours.
Rate of HFNC failure was 39.8% and in-hospital and 28-day mor-
tality were 30.7% and 36.4%, respectively. We performed sub-
group analysis by excluding patients with DNR status and
demonstrated that the rate of HFNC failure was 25.4% and in-
hospital and 28-day mortality were 14.0% and 21.1%, respectively.
The main reasons for failure of HFNC were hypoxemia and in-
creased work of breathing. Factors associated with failure of
HFNC were presence of comorbidity and respiratory rate on the
first day of HFNC use (P< 0.05). Overall adverse event of HFNC
was 6.8% and all of them were minor adverse event.
CONCLUSION. HFCN is safe and effective to use in general in-
ternal medicine wards. Presence of comorbidity and higher re-
spiratory rate on the first day are the risk factors of HFNC failure.
Appropriate patient selection and monitoring are the key for the
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INTRODUCTION. CO2 rebreathing is known to be a cause of Non
Invasive Ventilation (NIV) failure [1]. Recently we showed in a
bench study that a new mask design (DiMax Zero, Dimar srl,
Medolla, Italy) with different ports for inflow and outflow gases
significantly reduced CO2 rebreathing in different ventilation set-
tings [2].
OBJECTIVES. To test wheter a new mask design reduces CO2 re-
breathing in healthy volunteers during NIV.
METHODS. Young adults with no pulmonary or cardiac comor-
bidities were eligible. Volunteers underwent NIV through two
different masks: a traditional one with a single port for inflow
and outflow gases (DiMax) and the new mask with separated
ports (Dimax Zero). Six ventilation settings were tested: cPAP
(PEEP 5 cmH2O) and Pressure Support Ventilation (PSV, PS Level
5 cmH2O) performed with mechanical ventilator and two differ-
ent flow-by (8 and 20 l/min); free flow cPAP (PEEP 5 cmH2O)
with two different gas flows (60 and 90 l/min). A nasal cannula
was inserted in one nostril of the volunteer and connected to a
gas analyzer (ADInstruments) to record CO2 concentration along
the respiratory cycle (Lab Chart, ADInstruments). An EIT belt
(Pulmovista, Draeger) was used to record the change in imped-
ance during tidal breathing, to estimate tidal volume (Vt). Re-
spiratory rate (RR) was also calculated. CO2 during inspiration,
RR and and Vt were compared between the two masks in the
same ventilation setting and within the same mask in different
ventilation settings. ANOVA for repeated measured + post tests
was used for statistical analysis. A p<0,05 was considered
significant.
RESULTS. Seven healthy adults were enrolled in the study and gave
their informed consent. CO2 during inspiration was significantly
lower with DiMax Zero than with DiMax mask (Fig. 1, p<0,001 for
DiMax Zero vs DiMax in all settings).
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The different ventilation settings had no influence on inspired CO2
with both masks. The difference in inspired CO2 was associated with
a slight, non significant reduction in Vt during cPAP settings with
DiMax Zero mask, while there were no differences in Vt during PSV
settings nor in respiratory rate in any setting between the two masks
(Fig. 2).
CONCLUSION. The new mask design with different ports for inhaled
and exhaled gases was able to significantly reduce the amount of
CO2 rebreathing in all the ventilation settings tested. The sample size
has to be increased to highlight if this translate into a reduction in
minute ventilation.
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INTRODUCTION. No consensus exists regarding optimal timing for
performing tracheostomy in mechanically ventilated neurocritical
care patients.
OBJECTIVES. To evaluate the correlation between timing of tracheos-
tomy and ICU mortality. Secondary end points were tracheostomy ef-
fects on: duration of sedation, duration of mechanical ventilation(MV), ventilator-associated pneumonia (VAP) incidence prior and
post-tracheostomy and length of ICU stay (LOS) as well.
METHODS. Single-center study on adult neurocritical care patients
(TBI, aSAH, ICH) admitted to our ICU from January to December 2018.
Percutaneous elective tracheostomy was performed in all expected
to need >14 days MV due to current neurological status. We
assigned patients into two groups: early tracheostomy (ET ≤8 days
after endotracheal intubation) and late tracheostomy (LT >8 days).
Exclusion criteria were: poor prognosis, use of barbiturates, extuba-
tion failure and readmissions. Demographics, diagnosis at admission,
severity of illness estimated using the APACHE II and GCS, Charlson
comorbidity index (CCI) score, duration of sedation and MV, inci-
dence of VAP, LOS and in ICU mortality were recorded. Student t-test
or Mann Whitney U test were used for quantitative data and the
Pearson chi-squared test or Fisher’s exact test for qualitative data as
necessary. The level of significance was set at P<0.05.
RESULTS. 41 patients were recorded but finally 38 (31.6%TBI, 26.3%
aSAH, 42.1% ICH) were included (missing data). Each group consisted
from 19 patients. The median time between ICU admission and ET or
LT was 6(2-8) and 11(9-16) days respectively. Baseline characteristics
(sex, age, GCS, APACHE II) were similar in both ET and LT group
(p>0.05) except from CCI score (2.37±1.42 vs1.47±1.31; p =0.043) and
ICU admission diagnosis (TBI:3vs9, aSAH:1vs9, ICH:15vs1 patients).
Total MV and sedation duration were significantly longer in the LT-
group (9vs16.1d; p<0.001 and 5.74vs10.42d; p=0.005 respectively)
but post-tracheostomy there were no differences neither in sedation
(p=0.682) nor in MV duration (p=0.914). Patients with LT had a higher
incidence of VAP before tracheostomy (p=0.034) but no significant
difference was found in post-tracheostomy MV period (p=0.547). All
survivors were completely weaned from MV but none was decannu-
lated at ICU discharge. The ICU LOS and mortality did not differ be-
tween the compared groups (p=0.075 and p=0.29 respectively).
CONCLUSION. ET reduced sedation requirements, time to wean from
MV and VAP incidence in our cohort. No mortality or ICU LOS benefit
was found between the compared groups. Our findings are in agree-
ment with previous studies. It seems that tracheostomy policy in
neurocritical care patients still remains a challenge and needs to be
personalized.
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INTRODUCTION. Spontaneous breathing (SB) efforts in acute respira-
tory distress syndrome patients on mechanical ventilation, has been
associated with strong diaphragmatic activity and the generation of
excessive strain and high regional pleural pressures in the dependent
lung regions [1]. However, these mechanisms may will be present
F1
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forts during early stages of lung injury may promote high regional
strain and further regional lung inflammation and that controlled
mechanical ventilation is able to avoid and or reverse and control
this inflammation.
OBJECTIVES. To determine the effects of spontaneous breathing ef-
forts, during the early stage of lung injury, on regional ventilation dis-
tribution and regional inflammation.
METHODS. Six pigs (30±5kg) were anesthetized and mechanically ven-
tilated (PEEP 5 cmH2O, VT 8 ml/kg). Lung injury was induced by 2 la-
vages with 30 ml/kg of warm saline. After the injury, pigs were
ventilated 4 hours (T4) in pressure support ventilation (PSV for Vt of 6-8
ml/kg, PEEP between 0 and 5, and FIO2 of 1), and then switched to vol-
ume controlled ventilation (VCV) for 4 more hours (T8) using VT of 6
ml/kg, RR of 30 bpm, PEEP of 5 cmH2O, I:E ratio 1:2 and FIO2 of 1. Re-
spiratory and hemodynamic data, as well as regional lung impedance,
assessed by EIT (Pulmovista 500, Dräger), were collected at baseline, T4
and T8. BAL were performed at the anterior and posterior lung at T4
and T8 for analysis of inflammatory parameters (IL-8 and TNF-a)
RESULTS. VT increased from 8 ml/kg at baseline to 8.2 (7.1-8.8)
(p= 0.03) at PSV. During T8, VT decreased to 6 ml/kg (5.4-6.7) (p=
0.001). Mean airway prressure decreases from 9 (6.7-11) to 2 (3.8-
1.8) cmH2O (p= 0.001) but when switched to VCV it increased to
11 (8.8-12.8) (p=0.003). EIT analysis showed an increase in global
inhomogeneity index (GI) from 1.03 (0.99-1.04) to 1.09 (1.06-
1.38)(p=0.04) (Fig. 1A). In addition, when we compared T4 vs T8,
tidal variation of impedance (TVI) decreased from 2227 (1520-
2933) to 1137 (876-1768) (p=0.03) (Fig. 1B) and impedance ratio
(IR) showed an increased from 0.75 (0.3-1.2) to 1.3 (0.5-2.0) (p=
0.03) (Fig. 1C). Regional IL-8 quantification showed greater inflam-
mation in the dependent lung regions during PSV, situation that
was reversed with VCV (3670 ± 2310 vs 1603 ± 2311 pg/uL, p=
0.02) (Fig. 2).
CONCLUSION. SB efforts during MV were associated with higher VT
than controlled ventilation and lung aeration was mainly distributed
in the dependent lung regions and these regions presented higher
concentration of inflammatory markers, situation that was reversed
during CMV.
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INTRODUCTION. The very elderly patients (i.e., those aged ≥ 80
years-old) represent an increasing subgroup of patients admitted to
intensive care units (ICUs). Community-acquired pneumonia (CAP) is
a common reason for ICU admission and how to best provide initial
ventilatory support in these patients is unknown.
OBJECTIVES. To evaluate if the initial ventilatory strategy is associ-
ated with hospital mortality in very elderly patients admitted to the
ICU.
METHODS. We did a retrospective multicenter cohort study of very eld-
erly patients admitted to the ICU with a diagnosis of CAP from
2009 through 2012. Data was retrieved from the ICU quality data-
base (Epimed Monitor) and checked for consistency. We used lo-
gistic regression to evaluate the primary outcome (hospital
mortality), after adjusting sequentially for potential confounders
chosen from a causal directed acyclic graph. We imputed missing
data with multiple imputation by chained equations using the
predictive mean matching algorithm. We evaluated ad-hoc
defined subgroup effects with interaction terms in the logistic
model. Sensitivity analyses were done to assess model
consistency regarding the primary outcome.
RESULTS. 6,318 very elderly patients were admitted to the 11
ICUs during the study period. 1,713 admissions were due to re-
spiratory causes, of which 678 patients were admitted for CAP.
Mean age was 86.3 years (4.7); 288/678 (42.5%) were male. Mean
F1
Fig. 1 (abstract 001504). Relationship between EAdi and Pdi within
one subject. In panel B, breaths above 60% of maximum have
been excluded
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a median Charlson comordity score of 1 [1; 3]. 191/678 (28.2%)
patients were previouslly bedridden and 253/678 (37.3%) needed
some assistance in activities of daily living. 309/678 (45.6%) did
not use any MV strategy (no MV group); 232/678 (34.2%) under-
went NIV first; 137/678 (20.2%) underwent IMV first. IMV patients
were sicker at ICU admission when compared to both NIV and
no MV groups (SAPS 3: 76.5 vs. 62.6 vs. 58.4, p-value < 0.001),
with no statistically significant differences in the antecedent char-
acteristics (burden of comorbidities and performance status). Hos-
pital mortality was 90/309 (29 %) for no MV; 114/232 (49 %) for
NIV; 90/137 (66 %) for IMV. For the comparison IMV vs. NIV,
crude OR (95% CI, p-value) was 1.98 (1.28 – 3.07, p = 0.002).
After adjusting for age, sex and antecedent characteristics, the
aOR was 2.17 (1.38 – 3.42, p = 0.001). After including non-
respiratory SOFA in the model, aOR was 1.23 (0.74 – 2.03, p =
0.419). After including respiratory variables (Pao2/Fio2; pH; Pco2)
in the model, the aOR was 1.1 (0.65 – 1.85, p = 0.720). Inter-
action terms for the following characteristics showed no evidence
of effect modification: heart failure, chronic obstructive pulmonary
disease, bedridden status, non-respiratory SOFA ≥ 4, acute re-
spiratory acidosis and Pao2/Fio2 ≤ 150. Complete case analysis
(sensitivy analysis) yielded the same results.
CONCLUSION. The initial ventilatory strategy was not associated with
hospital mortality in very elderly patients admitted to the ICU due to
CAP, regardless of antecedent characteristics. Acuity variables were re-
sponsible for the major part of positive confounding for mortality in
this population. This suggests a less invasive approach may be suffi-
cient for most patients to provide the benefit of the doubt during an
ICU trial for very elderly patients.
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INTRODUCTION. The electrical activity of the diaphragm (EAdi) might
be a useful parameter to quantify breathing effort in ventilated pa-
tients because it is continuously available after placing a dedicated
nasogastric catheter. EAdi demonstrated a tight correlation with in-
spiratory muscle pressure (Pmus) in an earlier study(1). The slope of
the relationship between EAdi and Pmus could be predicted by div-
iding the peak of EAdi by the drop in airway pressure (Paw) during
an expiratory hold. However, a narrow range of respiratory muscle ef-
fort was evaluated in that study, and the gold-standard parameter
for diaphragm effort (the transdiaphragmatic pressure, Pdi) was not
obtained.
OBJECTIVES. To study the correlation between EAdi and Pdi in
the full range of breathing effort in healthy subjects. Second, to
assess whether the slope of the correlation between EAdi and
Pdi could be predicted by calculating the Paw/EAdi-ratio within
each subject.
METHODS. Paw, Pdi and EAdi were recorded continuously in 23
healthy subjects. Maximal Pdi against an occluded airway was mea-
sured, and subsequently different levels of inspiratory threshold load-
ing were applied ranging from 10% to 80% of maximal Pdi.
RESULTS. All subjects successfully completed the study protocol. Four
subjects were excluded from analysis for technical reasons. In theremaining 19 subjects, a total of 2327 breaths were analyzed. There
was a significant, but poor linear correlation between peak EAdi and
peak Pdi when pooling data from all subjects (R2=0.14, p<0.0001). Cor-
relations between EAdi and Pdi within subjects were much stronger, es-
pecially when diaphragm effort above 60% of maximum was excluded
(R2=0.80± 0.12, p<0.001). See figure 1 for a representative example.
However, the ratio of Paw/EAdi was not significantly correlated to the
slope of EAdi and Pdi within each subject (p = 0.51).
CONCLUSION. A strong linear correlation exists between peak EAdi
and Pdi within healthy subjects, up to 60% of maximal effort.
The relationship was poor at effort above 60% of maximum, pos-
sibly because of accessory muscle recruitment. The ratio of Paw/
EAdi did not relate to the slope of Pdi/EAdi within each subject.
Further analysis is required to determine whether a more com-
plex model based on EAdi and Paw can reliably estimate trans-
diaphragmatic pressure.
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INTRODUCTION. Mechanical ventilation is a life-saving intervention
in critically ill patients, but may at the same time cause lung injury
characterized by hyperinflammation, endothelial barrier failure, and
edema formation. Yet, the exact mechanotransduction mechanisms
underlying the effects of mechanical ventilation on the microvascular
barrier are still unclear. In previous work, we had identified a critical
role of the endothelial Ca2+ channel TRPV4 in endothelial barrier fail-
ure subsequent to mechanical overventilation. Here, we assessed the
role of TRPV1 and its potential association to TRPV4-induced Ca2+
signaling in vivo, ex vivo and in vitro.
METHODS. Wild type, TRPV4- or TRPV1-deficient mice were ventilated
for 2 h with low (7 mL/kg) and high (20 mL/kg) tidal volumes (LVT/HVT)
in vivo. Endothelial [Ca2+]i in isolated-perfused lungs, inflated with 5 or
15 cmH2O, and in human pulmonary microvascular endothelial cells
(HPMVECs) was quantified by real-time imaging with or without
Page 299 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55inhibition of TRPV1 and TRPV4, or after activation of TRPV1 and/or
TRPV4, respectively.
RESULTS. TRPV1 or TRPV4 deficiency or inhibition by either
SB366791 or HC-067047, respectively, attenuated VILI, and re-
duced the endothelial [Ca2+]i response to high pressure inflation
ex vivo, except SB366791, which only diminished the sustained
[Ca2+]i, but not the initial Ca2+ influx. In vitro, [Ca2+]i measure-
ments in HPMVECs showed a characteristic increase in endothelial
[Ca2+]i response to TRPV4 agonism, in which the sustained phase
could be blocked by TRPV1 inhibition. TRPV1 agonism alone in-
duced no [Ca2+]i increase; yet, TRPV1 and TRPV4 agonism in
combination amplified the TRPV4-induced [Ca2+]i response.
CONCLUSION. Here, we demonstrate a critical role for TRPV1 in
amplification and sustenance of TRPV4-mediated [Ca2+]i influx.
We conclude that both TRPV channels act conjointly to regulate
vascular barrier integrity, with TRPV4 causing endothelial leak
by triggering an initial [Ca2+]i increase and TRPV1 facilitating
the sustenance of the [Ca2+]i response which ultimately results
in gap formation and barrier failure. The novel TRPV1/4 signal-
ing axis may present a putative pharmacological target for the
prevention or treatment of ventilator-associated lung disease.
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INTRODUCTION. Acute respiratory distress syndrome (ARDS) is a
form of non-cardiogenic pulmonary edema due to alveolar in-
jury secondary to an inflammatory process, which may be both
pulmonary and systemic in origin. This syndrome presents as
acute hypoxemia with bilateral pulmonary infiltrate, which can
not be correlated exclusively with cardiac dysfunction. In this
study, we evaluated the use of Passive Ortostatism in ARDS.
OBJECTIVES. To analyze the use of the orthostatic board as an auxil-
iary device for the treatment of severe ARDS by assessing its risks
and benefits.
METHODS. We selected 91 patients, 43 females and 48 males,
hospitalized in a Neurological ICU, between June 2014 and July
2018, in a physiotherapeutic follow-up with diagnosis of severe
ARDS. The patients were submitted to orthotics assisted for 40 to
60 minutes and monitored HR, PAM, FR, SatO2 at 30 ° and 60 °
of inclination and the PaO2 / FiO2 ratio after the procedure. The
mean number of sessions per patient was 6.6. All patients were
undergoing anticoagulation in RASS -5, in the treatment of the
cause of ARDS. The mean time of mechanical ventilation was 8.5
days.
RESULTS. Among the patients selected, 36.3% presented tachy-
cardia above 115 bpm, requiring intervention in 12.1% and
interruption of the procedure in 6.6%. PAM arterial hypotension
<65 mmHg was observed in 34.1%, requiring intervention (in-
crease of vasopressor dose and / or change of plank angulation)
in 22% and interruption of the procedure in 14.3%. Hypoxemia
SatO2 <92% was observed in 8.8%, without interruption, but an
improvement in PaO2 / FiO2 was observed in only 95.6% of the
patients
CONCLUSION. Assisted orthostatism as an auxiliary device for the
treatment of severe ARDS was shown to be an alternative, with
improvement of PaO2 / FiO2 in 95.6% of the patients, safe and
without significant hemodynamic repercussions that could lead to
interruption of the procedure001540
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INTRODUCTION. Non-invasive ventilation (NIV) is being increas-
ingly used in adults and children both in acute intensive care as
well as for chronic home ventilation (1). NIV delivers positive
pressure through an interface without endotracheal or tracheos-
tomy tube. The success of NIV in Pediatric ICU (PICU) depends
on patient selection, type of interface and close monitoring (2,3).
Advantages of NIV are reduced Healthcare associated infection
(HCAI), need for sedation and duration of ventilation and PICU
stay. In children, acceptability of NIV remains poor due to claus-
trophobic nature of face masks, high pressure delivered through
the interface and gastric distension. Introduction of patient
friendly nasal masks, has improved the success of NIV and in-
creased its use in PICU. In settings with limited availability of
ventilators, BIPAP machines can serve as a good alternative to
deliver NIV.
OBJECTIVES. To study the feasibility and outcomes of children re-
quiring non-invasive ventilation
METHODS. Retrospective chart review from January 2018 to
March 2019 (15 months) of children aged 1 month to 12 years
requiring NIV and admitted to PICU of a tertiary care referral hos-
pital. Children on indigenous CPAP and HFNC were not included.
Records of children receiving NIV were analysed from patient
electronic database for demographic data, primary diagnosis, indi-
cation for NIV, type of interface and ventilator used, mode, pres-
sure settings and blood gases prior to initiation of NIV, reasons
for NIV failure, sedation use, complications and final outcome
(survival or death) on a pre designed proforma. The duration of
NIV, need for intubation and length of PICU stay were also
analysed.
RESULTS. During the study period, 1081 children were admitted
to PICU, of which 530 (49%) and 32 (2.9%) required invasive
and non-invasive ventilation respectively. Fourteen of the 32
who required NIV, was for post extubation. The median (IQR)
age of the study group was 72 (36,108) months. Nasal interface
was used in 12 and oronasal face mask in 20; 17 were venti-
lated using conventional ventilator and 15 through BIPAP ma-
chine. Pneumonia with ARDS (n=19) was the most common
diagnosis followed by immunocompromised state (n= 6) and
tropical fevers with capillary leak (n=5). The commonest indica-
tion for NIV was respiratory failure (n=26; 81% ), followed by
neuromuscular weakness (n=4;12.5% ) and cardiac failure (n=2;
6.25% ). The mean ± SD PIP/IPAP (Max) was 14.5 ±2.9 and the
mean ± SD PEEP/EPAP (Max) was 6.4 ±1.4 cm H2O. The median
(IQR) duration of NIV and PICU stay were 3 (2,4) and 7.5 (5,23)
days respectively. The failure rate was 11/32 (34%); 6 failed in
nasal mask and 5 in oronasal mask. Four (12.5%) children died.
Overall survival rate was 87.5%; among survivors, 2 needed long
term NIV for neuromuscular weakness and compressive lesion in
thorax, 1 child underwent tracheostomy for upper airway ob-
struction, and 1 child was referred for cardiac transplant. Com-
pared to year 2018, the use of NIV has tremendously increased
in 2019 (17 in 12 months;1.8% vs 15 in 3 months; 8.7%) prob-
ably due to better awareness and availability of age-appropriate
interface.
CONCLUSION. NIV is a good modality of ventilation in respira-
tory failure, cardiac failure and in post-extubation patients.
F1
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Fig. 2 (abstract 001553). See text for description
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INTRODUCTION. Protective ventilation with low Tidal Volume (TV)
improves outcome of acute respiratory distress syndrome (ARDS) pa-
tients [1]. Usually TV is set on ideal body weight (IBW) which reflects
the size of healthy lung. However, in ARDS the amount of functional
parenchyma, the “baby lung”, is reduced proportionally to the sever-
ity of disease [2]. In these patients the strain applied to the lung can
be determined as TV/EELV (End Expiratory Lung Volume) and an in-
crease in strain is associated with a proinflammatory response [3].
Measuring EELV may allow to set protective TV in order to maintain
strain below a safety threshold [4]
OBJECTIVES. To verify the clinical feasibility of setting TV=0,25*EELV
in ARDS patients.
METHODS. ARDS patients defined according to Berlin criteria,
intubated and mechanically ventilated for less than 96 hours
were enrolled. Exclusion criteria were conditions precluding meas-
urement of EELV (i.e. air leaks, extracorporeal membrane oxygen-
ation), haemodynamic instability, history of COPD, emphysema or
pulmonary fibrosis. EELV was measured with the “oxygen wash-in
wash-out” technique using GE Carescape R860 ventilator. Target
TV (TTV) was set as 0.25*(measured EELV–PEEP related strain), up
to 8 ml/kg Ideal Body Weight and respiratory rate (RR) was ad-
justed to keep baseline pCO2 ±5 mmHg. TTV was maintained for
24 hours unless one of the following occurred: need to increase
RR >35 bpm, desaturation requiring a FiO2 change>0,20, develop-
ment of a plateau pressure >30 cmH2O, need of neuromuscular
blocking agents if not already administered. One-way ANOVA for
repeated measures and Pearson’s linear correlation where used
for statistical analysis.
RESULTS. 11 mild to moderate ARDS patients were enrolled
(mean P/F ratio was 206±48mmHg). TTV was maintained for 24h
in 7 out of 11 patients. 3 patients dropped out because of the
shift to assisted ventilation and did not maintain the TTV; one
dropped out because of calculated TV >8ml/kg. The mean TTV
was 336±94 ml, comparable to clinical baseline TV 371±68 ml
(Fig.1 Panel A). Mean Driving Pressure (DP) slightly decreased
from 9±1,6 to 8,2±0,8 cmH2O (Fig. 1 Panel B). RR and pH were
maintained within the safe limits (Fig. 1 Panel C).
Subsequent analysis revealed a strict correlation between lung strain
and DP (Fig. 2, R=0,96).
CONCLUSION. These preliminary results show the feasibility of setting
the TV as 0.25*(EELV-PEEP related strain) in the majority of patients en-
rolled. Moreover, DP is a good indicator of strain in ARDS patients.REFERENCE(S)
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INTRODUCTION. Extubation readiness is normally assessed by spon-
taneous breathing trials (SBT) of 30-120 min (1). Tension time index
(TTI) calculated from esophageal pressure (Pes) measurement is the
reference technique for assessing breathing effort of a SBT, with a
threshold of >0.15-0.18 following a SBT previously shown to accur-
ately describe SBT response (2,3). However, limited data exist to ex-
plain why some patients pass a SBT despite TTI>0.15-0.18 (3).
OBJECTIVES. To investigate if metabolic measurement may explain
SBT success when TTI is elevated.
METHODS. After ethical approval and informed consent, four patients
(3f/1m, 65±12yrs, 85±7kg), have so far been enrolled. All were difficult
to wean patients according to WIND classification (4), on pressure sup-
port (PS) ventilation, and eligible for SBT (1). Inspired oxygen fraction
was set to 0.4 and a maximal inspiratory pressure effort was performed
F1
Page 301 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55by 20s inspiratory occlusion at baseline (5). A SBT was then performed
using PS=0 cmH2O, and PEEP=5 cmH2O. The SBT was ended after 120
min. Pes, VO2 and VCO2 were measured continuously. SBT outcome
was decided according to guidelines (1). Average VO2 and VCO2 were
calculated across six 1 min intervals throughout the SBT duration.
RESULTS. Throughout the SBT, TTI was close to 0.18 in two cases
(high TTI) and ≤0.1 in the remaining two cases (low TTI) (fig 1). Mean
VO2 and VCO2 were 295 and 359 mlO2/min and 225 and 290
mlCO2/min in high TTI patients, respectively (fig 1). Mean VO2 and
VCO2 were 241 and 206 mlO2/min and 210 and 169 mlCO2/min in
low TTI patients, respectively (fig 1). All patients were successfully
extubated within 24 hours of the SBT. Figure 1 show mean TTI and
VO2 for the four patients at six different time points during a SBT.
CONCLUSION. A higher metabolic response was observed in high TTI
patients which likely reflect the greater breathing effort. Regardless
of the underlying physiological mechanism, these preliminary find-
ings indicate that SBT VO2 may follow TTI, and that there may be dif-
ferent metabolic responses between patients with high vs low TTI
during successful SBTs. Further investigation is required to explore
the patient characterization potential of VO2.
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INTRODUCTION. Ventilator-induced diaphragm dysfunction (VIDD) is
highly prevalent in patients under mechanical ventilation (MV). The
study of this pathology is difficult because histological samples are
difficult to obtain in critically ill patients. Recently, ultrasoundmeasurements have been described as a good method to monitor
diaphragm structure but there are no previous studies that correlates
histological findings with ultrasound measurements.
OBJECTIVES. To correlate the cross-sectional area (CSA) of diaphrag-
matic muscle fibers of diaphragm muscle biopsy, with the ultrasound
measurement of diaphragm thickness (Tdi) in mechanically ventilated
donor patients.
METHODS. We prospectively enrolled 13 adult patients requiring mech-
anical ventilation (organ donor) who were admitted to the intensive care
unit during 2017. Demographic data, clinical data, comorbidities, and se-
verity scores were collected. The diaphragm thickness (Tdi) was deter-
mined by bedside ultrasonography previous to organ donation, as
described previously in literature1. Three measurements were taken by 2
observers and average was performed. Diaphragm(DF) biopsies from DF
anterior lateral costal area were obtained from ICU donor patients. Tissue
was preserved immediately in alcohol-formol bath to be thereafter em-
bedded in paraffin. Immunohistochemical and morphometric analyses
were done: CSA, and proportions of type I(MHCI) and type II(MHCII) dia-
phragm fibers were assessed. Statistical analysis was performed using
Pearson correlation coefficient, significance was set to p<0.05. CEIC
PSMAR 2017/7183/I.
RESULTS. Muscle and ultrasound samples were obtained from 13 pa-
tients. Man were predominant (69,2%), with a mean age of 58(14) years
and APACHEII score of 27(5). ICU median stay was 6(3-11) days with a
median mechanical ventilation days of 6(3-14). Immunohistochemical
and morphometric analyses showed a similar proportion of MHCI
(50,5%) and MHCII (49,4%) diaphragm fibers with a CSA of 1480 (660)
μm2 and 1722 (1031) μm2 respectively. Mean ultrasound measurement
of Tdi was 1.68 (0.33)cm, and had a positive and significant correlation
with MHCI and MHCII and Cross-sectional area (MHCI: r2 0.765 / p=
0.004; MHCII: r2 0.854 / p=0.000).
CONCLUSION. The ultrasound measurement of diaphragm thickness
(Tdi) in mechanically ventilated patients has a good correlation with
the cross-sectional area (CSA) of diaphragm fiber I and II (MHCI and
MHCII).
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INTRODUCTION. Endotracheal intubation in the critically unwell pa-
tient is a life saving procedure, which is frequently performed in the
Emergency Department (1). A high level of skill and training is
Page 302 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55needed to facilitate a controlled, safe environment in which this can
be performed. The 4th National Audit Project (NAP4) of the Royal
College of Anaesthetists (RCoA) and Difficult Airway Society (DAS)
was designed, in part, to look at airway management in the Emer-
gency Department and highlight any deficiencies that could lead to
serious harm (2). In direct response to NAP4, the published 2018
guideline on the management of tracheal intubation in critically ill
adults recommends the use of a checklist to facilitate intubations (3).
Checklists have been shown to significantly reduce mortality globally
in surgery and have been adopted in high-pressure environments in-
cluding in pre-hospital medicine (4,5). This study describes the
current practice of endotracheal intubation in a single centre emer-
gency department in a district general hospital in Greater London.
METHODS. The study was a retrospective observational study. Using
the emergency department’s electronic system a search was carried
out over a one-year period. Cases were identified if they had been
coded as: transferred to another hospital; died in the emergency de-
partment; referred to Intensive Care Unit (ICU); admitted to ICU. A
total of 1553 notes were reviewed and 94 intubations were identi-
fied. Factors studied included: age and sex; indication for intubation;
checklist used; if no checklist, were any pre-defined safety measures
documented; drugs used; arrival time and complications. No ethical
approval was sought, as per institutional guidelines.
RESULTS. 94 intubations were identified in the one-year time period,
averaging 1.8 intubations in the department per week. The most
common indication for intubation was for airway protection (n=35)
and 42% of the cases were due to cardiac/respiratory arrest. Only
16% of cases showed evidence of use of a checklist; in the remaining
79 patients, no patients had all the pre-defined safety measures doc-
umented. The most commonly used neuromuscular relaxant was
found to be rocuronium in 45% of cases. The mean response rate
time of a clinician was 10 minutes 16 seconds. There was no signifi-
cant difference between the response rate times of Emergency Doc-
tors and external physicians (p=0.0477). All intubations were
successful, however, 8 complications were reported of which 100%
of these were in patients without a checklist.
CONCLUSION. This study provides an overview of the intubation
practices in a single-centre Emergency Department after the NAP4
recommendations. It has identified poor compliance (16%) to the use
of a checklist in endotracheal intubations, despite current guide-
lines(2). Whilst checklists have been shown to cognitively off load
the medical practitioner, there may be many barriers limiting its im-
plementation(6). It adds to the growing call for better provision of
care to patients with a deteriorating airway and for the continued
auditing of practice. In response to these findings, our institution has
introduced a structured teaching programme for staff and will aim to
re-study and audit after one year.REFERENCE(S)
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INTRODUCTION. Severe community pneumonia is the most frequent
cause of respiratory failure and acute respiratory distress syndrome
(ARDS). The mortality reported in severe forms reaches 40%. Since
2013, a mechanical ventilation protocol (MV) based on the limitation
of tidal volume (VT), recruitment maneuvers and high levels of PEEP,
the sequential application of neuromuscular blockade (NMB) and
prone positioning, and fluid restriction have been applied in our hos-
pital since 2013, leaving extracorporeal oxygenation (ECMO) as a res-
cue therapy for refractory hypoxemia.
OBJECTIVES. To present the results of the application of a protocol
of respiratory failure in the management of patients with moderate
and severe ARDS.
METHODS. Observational clinical study. We analyzed retrospectively
from 2013 to 2015, and prospectively since 2016 to all patients ad-
mitted with moderate to severe ARDS due to community-acquired
pneumonia. Demographic data, infectious agents, PaO2:FiO2 ratio
(PaO2/FiO2) on admission and worst values during MV, ventilatory
mechanics, treatments received (prone, NMB and/or ECMO). Main
outcomes were hospital stay and hospital mortality. Data were ana-
lyzed by descriptive statistics, distribution was evaluated according
to the Shapiro-Wilk test, and were expressed according to mean ±
SD and/or median and p25-75, as appropriate.
RESULTS. 59 patients were included (age 49.5 years, 36 women
(61%), PaO2/FiO2 at 24 hours was 162 [125 – 197] and worst PaO2/
FiO2 96.4 [66.7 – 115.2). Influenza virus was identified In 49% of
cases as etiology. Mean VT and PEEP during the first day were 331
[294 – 389] ml (5.7 [5.1 – 6.7] ml/kg IBW), and 13 [12-16] cmH2O, re-
spectively. Forty five (76%) patients received NMB for 4 (1-7) days, 36
(61%) were in prone position for 3 (1-6) days, and 8 (13.5%) received
ECMO therapy. From 18 patients transferred from other centers for
ECMO, only 4 (22%) were connected to ECMO. The median time in
MV and hospital were 15 [9 - 25] and 26 [19 - 38] days, respectively.
Five (8.5%) patients died.
CONCLUSION. The implementation of a protective ventilation pro-
gram allows achieving good results, using widely available and low
cost therapies. Using prone positioning and NMB allow to rescue a
high proportion of patients from ECMO, highlighting the importance
of these cost effective therapies.
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INTRODUCTION. Acute respiratory failure (ARF) is one of the leading
causes for ICU admission [1]. Recently, high-flow nasal cannula
(HFNC) oxygen therapy has seen increasing use in patients with ARF.
The physiological benefits of HFNC include higher and more stable
FiO2 values, delivery of heated and humidified gas and reduction of
the anatomical dead space and work of breathing. HFNC also gener-
ates low levels of positive pressure in the upper airways [1, 2].
OBJECTIVES. Describe our ICU initial experience with HFNC oxygen
therapy in non-intubated patients with acute respiratory failure and
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non-intubated patients with acute respiratory failure treated with HFNC
admitted to a polyvalent intensive care unit between January 2017 and
March 2019. The HFNC used consisted of an air-oxygen blender with ad-
justable FiO2 (0.21 to 1.0), delivering a modifiable gas flow up to 60 L/mi-
nute (Optiflow; Fisher & Paykel Healthcare, Auckland, New Zealand).
RESULTS. Twenty-four patients were included, 19 men (79%), mean
age 61 ± 11 years. Mean APACHE II score and SAPS II were 19 ± 8
and 36 ± 11, respectively. The main cause of acute respiratory failure
was hospital-acquired pneumonia (n = 8), followed by community-
acquired pneumonia (n = 5), extrapulmonary sepsis (n = 3), pneumo-
nia related to imunosupression (n = 2) and aspiration (n = 1).
The mean duration of HFNC oxygen therapy was 56 ± 46 hours and 3 pa-
tients received alternating periods with noninvasive ventilation. After 1
hour of therapy, PaO2 increased from 59 ± 9.1 mmHg to 88 ± 33.7 mmHg
(p = 0.005) and to 78 ± 33.7 mmHg (p = 0.018) after 6-12h. PaO2/FiO2 ra-
tio increased from 107 ± 52.4 to 129 ± 76.3 after 1 hour (p = 0.159).
Despite de use of HFNC, in 13 (54%) patients intubation was unavoidable.
In this group the mean duration of HFNC was 28 ± 13 hours.
Mean ICU length of stay was 8 ± 4 days and was higher for patients
who required intubation (14 ± 8 days). Eight patients died in the ICU, in
7 of which was decided not to reanimate or intubate due to extensive
comorbidity. The overall mortality at 90 days was 38% (n = 9). No statis-
tical significance was found between oxygen saturation, PaO2,
PaCO2, PaO2/FiO2 ratio or pH prior to HFNC therapy and mortality.
CONCLUSION. Few studies have examined large cohort of patients
with de novo acute respiratory failure and the results suggesting a re-
duction in the intubation rate with HFNC remain controversial [3].
Although hypoxemia was improved in the first hours, a high propor-
tion of patients still required intubation. Further studies are needed
to clarify the clinical circumstances in which HFNC should be used.
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INTRODUCTION. Non-cardiogenic pulmonary edema and increased
lung weight are hallmarks of ARDS, as a consequence lung weight
and wet-to-dry ratio are often used as markers of lung damage in
animal experimental models of ARDS. However, fluid management
may have a profound impact on these indicators of lung damage.
OBJECTIVES. To describe the impact of different fluid administration strat-
egies on lung weight and wet-to-dry ratio in two series of experiments on
ventilator-induced lung injury in the framework of mechanical power
METHODS. In the first series of experiments, 36 healthy piglets (23.3 ±
2.3 kg) were mechanically ventilated for 52 hours with a mechanical
power of 26.6 ± 12.1 J/min. In the second series, 42 healthy piglets
(24.2 ± 2 kg) were mechanically ventilated for 48 hours with a mechan-
ical power of 21.8 ± 8.3 J/min. Due to institutional policy, the sedation
with propofol was increased from 6-9 mg/kg/h in the first series to 10-
12 mg/Kg/h in the second series, while sufentanil (from 2-3 μg /kg/ h
to 1.5-2.5 μg /kg/ h) and midazolam (from 1.5-2.5 mg/kg/h to 0.8-1.5
mg/kg/h) were reduced. Accordingly, we modified the fluid manage-
ment strategy in order to attain a mean arterial pressure of 60 mmHg:
the first animals received 1-2 ml/kg/h of maintenance Stereofundin 1:1and 150 ± 232 ml/h of Gelafundin 4%, the second group received a
maintenance of 3-4 ml/kg/h and 647 ± 411 ml/h of colloids. Norepin-
ephrine was started in case of persistent hypotension, epinephrine
could also be added, but only in the second group.
RESULTS. The total amount of administered fluids was 4119 ± 910
ml in the first series and 9976 ± 2376 ml in the second series (see
figure 1), at the end of the experiment the pigs gained 2.4 ±1.6 kg
and 5.7 ±2.7 kg respectively (p < 0.001 for both). There was no differ-
ence in norepinephrine (0.13 ± 0.21 vs 0.14 ± 0.21 mcg/kg/min),
while epineprhine was 0.03 ± 0.07 mcg/kg/min in the second group.
Lung weight and wet-to-dry ratio were higher in the second group
(616.6 ±142 and 6.95± 1.1) when compared to the first group (371.2
±105 and 6.26 ±0.6) (p < 0.001 for both). See figure 2. Mechanical
power, instead, was higher in the first group (p = 0.049).
CONCLUSION. Propofol increase, despite decrease in other sedative
and analgesic agents, lead to increased need of fluids to maintain
hemodynamic stability in this animal experimental model. Lung
weight and wet-to-dry ratio were increased in the group with liberal
fluid strategy, despite a lower mechanical power. The assessment of
lung damage via surrogates of lung edema should take into account
the amount of administered fluids. Sedation policies should be stan-
dardized to allow a better comparison among different experiments.001605
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INTRODUCTION. In patients with acute respiratory distress syndrome
(ARDS) lung-protective ventilationstrategies using low tidal volume
F1
Fig. 1 (abstract 001606). See text for description
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tohypercapnia. Controversial effects of hypercapnia in ARDS patients
are nowadays being discussed
OBJECTIVES. Evaluate the effect of hypercapnia on inflammatory re-
sponse, mediators of recruitment and apoptosis in human primary al-
veolar cells (hATII) injured with lipopolysaccharide (LPS)
METHODS. hATII from pulmonary biopsies of patients that under-
went lobectomy were isolated and incubated at 37ºC with 5% CO2
(Normocapnia) or 15% CO2 (Hypercapnia; pCO2=80 mmHg) with or
without 15mM THAM buffer to maintain pH at 7.4. All groups were
injured with 100 ng/ml LPS. Pro-inflammatory molecules (IL-1β,
iNOS), mediators of cellular recruitment (IL-8, CCL-2) and apoptosis
(caspase-3) were analyzed
RESULTS. In hATII injured with LPS the expression of mediators of
neutrophils (IL-8) and monocytes (CCL-2) recruitment was decreased
when cells were exposed to hypercapnia. No effects of hypercapnia
were found when analyzing pro-inflammatory markers and apoptosis
CONCLUSION. Hypercapnic conditions in hATII cells injured with LPS
reduced the expression of mediators of recruitment of pro-
inflammatory cells but did not affect pro-inflammatory molecules nor
apoptosis. There is a need to better understand the biological and
physiological effects of hypercapnia
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INTRODUCTION. A recent systematic review of interstitial lung dis-
ease (ILD) cases admitted to ICU found high short-term mortality,
though few studies reported longer-term outcomes. We examined
short- and long-term mortality in an ICU population of patients with
ILD.
METHODS. To examine associations of short and longer term
mortality we conducted a retrospective cohort study at two non-
specialist UK ICUs (consisting of a 12-bed and a 10-bed unit) of
consecutive adults admitted for respiratory failure with ILD (April
2008- January 2019).
RESULTS. 84 patients were included with median age 72 (IQR 62-78),
57% male and unit stay was 5 (2-9) days. Mechanical ventilation (MV)
was performed in 43%. Median ICNARC score was 18 (14-27) and
APACHE II 18 (14-23). Amongst subtypes idiopathic pulmonary fibro-
sis (IPF) and connective-tissue disease associated ILD (CTD-ILD) were
most common (23% and 18% respectively). ICU mortality was 60%
and one-year mortality 70%. MV was associated with a significant in-
crease in ICU mortality (86.1% vs 39.6%, odds ratio (OR) 9.5 (3.1-28.6),
P <0.001). Of the 4/36 MV patients (11%) alive at 1-year, 2 were
classed IPF, 1 NSIP and 1 drug-induced. Of the patients who did not
require MV 44% remained alive at 1-year follow-up. On Kaplan-Meier
survival analysis MV was associated with a shorter duration of sur-
vival (see figure). There was no significant difference in survival be-
tween ILD subtypes.
CONCLUSION. In this dual-centre ICU cohort ILD was associated with
significant short and longer-term mortality as previously described,
however a small number of patients who were ventilated remained
alive on longer-term follow-up.
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INTRODUCTION. Subarachnoid hemorrhage (SAH) is associated with
high morbidity[1,2].Among all complications, infections, in particular
if hospital-acquired, could represent an important cause of death in
SAH patients[3]. However, few data on this issue are available.
OBJECTIVES. The aim of this study was to describe infectious compli-
cations in SAH patients and to evaluate their impact on outcome.
METHODS. Single-center cohort study including all SAH patients ad-
mitted from January 2011 to December 2016, who stayed in the ICU
for at least 24 hours. Infection diagnosis was retrieved from medical
files; CNS infections were not included. Multivariable logistic regres-
sion analysis was performed to identify risk factors for development
of infection, for ICU mortality and unfavorable neurological outcome
(UO) at 3 months, defined as a Glasgow Outcome Scale of 3-5.
RESULTS. Of the 250 SAH patients without vetriculitis treated, 70
(28%) developed at least one infection; the most frequent site of in-
fection was respiratory (57.1%), primary blood stream (16%) and urin-
ary tract infections (15.7%). Twenty nine patients (41.4%) had at least
on episode of septic shock. ICU mortality rate was similar between
infected and non-infected patients (35.7% vs. 27.2%, p=0.42 but in-
fected patients had a higher UO rate were – 60.0% vs. 33.3%, p=
0,001. ICU length of stay [OR 1.14 (CI 95% 1.07-6.58)], WFNS score of
4-5 [OR 5.34 (CI 95% 1.40-20.33)], delayed cerebral ischemia [OR 3.75
(CI 95% 1.47-9.60)], seizures [OR 2.78 (CI 95% 1.17-6.58)] and fever
[OR 8.69 (CI 95% 3.45-21.86)] were independently associated with
the occurrence of infections. Infection was independently associated
with ICU mortality (OR 3.93 CI 95% 1.31-11.80). The development of
sepsis [OR 25.22 (CI 95% 1.75-363.19)] was independently associated
with UO.
CONCLUSION. Infection is a common complication in SAH patients.
Sepsis is independently associated with poor long-term neurological
outcome.
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INTRODUCTION. Veno-arterial extracorporeal membrane oxygenation
(VA ECMO) is a medical device complicated with high rates of mortal-
ity and morbidity, especially infectious complications occurring in
25% of patients (1-3).
OBJECTIVES. To study the bacterial colonization and biofilm present
on VA ECMO’s cannulae and oxygenator membranes and to deter-
mine the potential use of advanced techniques in daily clinical
practice.
METHODS. A preliminary monocentric prospective physiological
study was performed at Henri Mondor Hospital, France. Samples of
both arterial and venous cannulae and oxygenator membranes were
aseptically collected from patients under VA ECMO support, at the
time of ECMO’s weaning or immediately after patient’s death. Each
sample was analyzed by three different methods in order to detect
bacterial colonization: standard culture, scanning electron micros-
copy (SEM) and 16S rRNA gene-based metagenomic analysis (next
generation sequencing).
RESULTS. Overall, ten patients were included in the study. The
median time of ECMO support was 10 [7-20] days. Seven (70%)
patients developed an infection during VA ECMO support, includ-
ing two (20%) patients with a bloodstream infection. In culture,
three on nine (33%) arterial cannulae and 3/9 (33%) venous
cannulae were positive. In SEM, all the oxygenator membranes
had bacterial biofilm on their surface while being all negative
in culture. Seven on nine (78%) arterial cannulae and 7/9 (78%)
venous cannulae had also bacterial biofilm on their surfaces in
SEM. In metagenomic analysis, 7/9 (78%) arterial cannulae, 4/9
(44%) venous cannulae and 8/9 (89%) membranes were positive.
However, four (44%) negative venous cannulae in metage-
nomics analysis were considered positive in SEM. Bacterial spe-
cies richness was significantly different between oxygenator
membranes and arterial/venous cannulae (p<0,01). Indeed,
Faith's phylogenetic diversity was 71 [58-78] on membranes;
112 [100-117] on arterial cannulae (p<0,01) and 98 [80-118] on
venous cannulae (p=0,01). Antibiotics therapy during ECMO sup-
port did not modify Faith's phylogenetic diversity (81 [39-150]
without antibiotics and 95 [77-108] with antibiotics; p=0,79).
There was no significant difference of bacterial abundance be-
tween the different samples' types (membranes 0,63 [0,62-0,71];
arterial cannulae 0,71 [0,67-0,72]; venous cannulae 0,68 [0,62-
0,70]; p=0,53). Bacterial colonization was mostly found on oxy-
genator membranes followed by arterial cannulae and then ven-
ous cannulae. SEM was the most powerful tool to detect
bacterial colonization. ECMO colonization was systematically de-
tected in patients with bloodstream infection but also in five
(50%) patients without infection.
CONCLUSION. Bacterial colonization’s detection by standard culture
is often negative but SEM and 16S rRNA gene-based metagenomic
analysis improve biofilm detection on ECMO's cannulae and oxygen-
ator membranes, while not being used in this indication in dailyclinical practice. More patients would be necessary to better define
the bacterial colonization's role in the occurrence of infectious com-
plications and to precisely describe the microorganisms responsible
for colonization.
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INTRODUCTION. HIV is a pathology that has evolve much in the past
decades with the introduction of new antiretroviral treatments.
OBJECTIVES. Compare today’s Spanish HIV patients ICU admissions
with the 90's ones.
METHODS. Observational and retrospective study where we included
all HIV patients admitted in the ICU of Jiménez Díaz Fundation from
Madrid (Spain) between 2013 and 2018 [actual sample (AS)].
We collected demographics parameters (age, sex), ICU cause of ad-
mission, time of diagnosis of HIV (before/during ICU stay), severity
scores (APACHE II), lenght of ICU stay and ICU mortality.
Then we compared this information with the existing bibliography,
specifically with the data published by Choperena et cols (1) from
the Arantzazu Hospital in San Sebastián (Spain) between 1985 and
1997 [reference sample (RS)].
RESULTS. We collected 122 HIV patients (2% of the total admitted on
ICU). The demographic characterictics are compared on the table bel-
low. Sexual was the most frequent mechanism of infection. 12 pa-
tients were admitted on AIDS state.
The most common causes of admission in the AS were: infections
(31.2%), intoxications (27.9%) and scheduled surgery (17.1%), mostly
cardiac surgery in 7.3%. However, in the RS, the vast majority of the
patients were admitted for an infection.
The HIV primodiagnosis was performed in the ICU in 11.5% of the
cases on the AS and the majority of this group was admitted for
pneumonia due to penumocystis jirovecii (71.4% with p=0.013) with
a longer ICU stay (5,1 vs 14,3 days, p=0.002) but without more mor-
tality associated. On the contrary, in the RS the HIV diagnosis was
made during ICU stay in 20% of the patients. There has been a re-
markable reduction in ICU stay and mortality between the AS and
the RS.
CONCLUSION. HIV is common desease in today's Spanish ICUs pa-
tients and is associated to infections and intoxications in a remark-
able way. We have found that nowadays' HIV patients are admitted
in ICU for causes independent from their basal disease, with a similar
prognostic to the general population, except in patients with a poor
control of HIV.
T1
Page 306 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55REFERENCE(S)
1. G. Choperena. One-year survival of HIV-positive patients admitted to the
intensive care unit before the era of combined antiretroviral therapy
(Pre-HAART). Med Intensiva, 2001 January; 25(7): 263-268.
2. The authors declare no conflict of interest.
3. Vidal-Cortés P, Álvarez-Rocha LA, Fernández-Ugidos P, Pérez-Veloso MA,
Suárez-Paul IM, Virgós-Pedreira A, Pértega-Díaz S, Castro-Iglesias ÁC. Epi-
demiology and outcome of HIV-infected patients admitted to the ICU in
the current highly active antiretroviral therapy era. Medicina Intensiva.
2019 Apr 7.Table 1 (abstract 001476). See text for description
2013-2018 (5 years) 1985-1997 (12 years)
Actual sample Reference sample
N 122 102
Males 88.5% 70%
Average age 46.8 ± 11.6 32
AIDS state 9.8% 65%
APACHE II 16.1 ± 8.4 21.27 ± 7.18
Infection as cause of admission on ICU 31.2% 60%
Primodiagnosis on ICU 11.5% 20%
Average stay on ICU 6.1 ± 8.9 days 8.9 ± 9.1days
Mortality on ICU 16.4% 48%001486
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INTRODUCTION. Seasonal influenza causes high morbidity worldwide
and high mortality in develope countries. While most influenza pa-
tients have a self-limited respiratory illness, 5-10% of hospitalized pa-
tients develop severe disease requiring Intensive Care Unit (ICU)
admission (1,2).
OBJECTIVES. Describe the hospitalization rate and ICU admission
rate, of patients who came to the emergency room and were diag-
nosed with influenza A, during Influenza Epidemic 2019. Describe the
clinical characteristics of both groups.
METHODS. Descriptive analysis of patients admitted for Influenza A
in two hospitals of Granada, Spain, during the Influenza Epidemic in
2019. The data have been obtained from the microbiology registry
as well as from ENVIN-HELICS registry of Spanish Society of Intensive
Care. We evaluated the clinical records of all the patients with positive
rapid diagnostic testing of influenza A in this period, who were hos-
pitalized. We recorded the epidemiological characteristics, comorbidi-
ties and mortality among patients admitted to the ICU and those
admitted to other wards.
RESULTS. Rapid diagnostic testing on Influenza was performed in 1550
patients, 204 patients were positive for Influenza A. Finally, 111 patients
required hospital admission, 51.8% were women (2.7 pregnant women)
and 48.2% men with an average age of 70.24 years (27-99). In 42.7% of
the cases, the patients were smokers or ex-smokers and 12.7% were
obese. 69.1% of the patients suffered multiple pathologies; 10.9% had
no personal medical history of interest. 24.5% of cases had onco-hematologic disease, 29.6% had corticoid therapy and 18.5% chemo-
therapy. In 70% of cases the clinic debut was fever and in 68.2% they
also associated dysnea. 27.3% associated bacterial infection. 43.3% of
the cultures insolated Streptococcus pneumoniae followed by
Staphylococcus (10%) and Pseudomonas (10%). 64 patients received
antibiotic treatment associated with olsentamivir, with the most com-
monly used combinations being ceftriaxone + azithromycin (28.12%),
levofloxacin (28.12%) and ceftriaxone + levofloxacin (17.18%).
Twenty one patients required admission to Intensive Care Unit: In
this group 47.6% requiered High Flow Nasal Canula or noninvasive
ventilation and 43.3% required mecanic ventilation of which 90%
needed muscle relaxation and 50% tracheotomy. The mean SOFA
upon admission was 4.67 (1-14) and APACHE 15.86 (5-25). Of the pa-
tients admitted to ICU, 38.1% had mild Acute Respiratory Distress
Syndrome (ARDS) , 33.3% had moderate ARDS and 23.8% had severe
ARDS. 19 patients (80%) were suffered an infection associated with
mechanic ventilation: 50% tracheobronchitis and 30% pneumonia.
Two patients died during their stay in ICU.
CONCLUSION. Half of the patients who came to the emergency de-
partment for Influenza A needed hospital admission, 18.9% required
admission to ICU. The rest of clinical and therapeutic characteristics
are similar to those of previous years.
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INTRODUCTION. Invasive aspergillosis (IA) is a fungal infection that
mainly affects immunocompromised patients. However, non-
neutropenic patients in the Intensive Care Unit (ICU) population have
shown an increasing risk profile for aspergillosis mainly due to under-
lying comorbidities such as chronic obstructive pulmonary disease
(COPD), malignancy and prolonged corticosteroid use. In the ICU set-
ting, IA remains difficult to diagnose and problematic to treat.
OBJECTIVES. The aim of this study was to determine the incidence,
risk factors and outcome of patients with Aspergillus colonization or
IA in our ICU.
METHODS. A 10-year retrospective study including all patients with a
positive Aspergillus culture during ICU stay was performed. Cases
were classified as Aspergillus colonization, putative IA and proven IA
according to validated criteria. Clinical records were reviewed in
order to obtain demographic, microbiological and diagnostic data as
well as underlying conditions of these patients.
RESULTS. A total of 87 patients were included, 51 (58.6%) of whom
were colonized, 34 (39.0%) had putative IA and 2 (2.3%) had proven
IA. The lung was the most frequent site of infection (98.8%) and As-
pergillus fumigatus the most commonly isolated species (55.2%).
COPD and liver disease were the most frequent comorbidities,
equally seen in both groups. Patients with IA had higher incidences
Page 307 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55of malignancy (both solid tumors and haematological malignancy)
and history of glucocorticoid treatment.
Compared with other patients, they were more frequently diagnosed
with sepsis and acute respiratory distress syndrome (ARDS) on ICU
admission and more frequently received renal replacement therapy
(RRT) during the ICU stay.
IA patients had increased length of stay (25.2 versus 16.1 days, p<
0.05) and higher ICU mortality (31.3% among colonized patients and
44.4% in those with IA, p <0.05) but there was no difference concern-
ing in-hospital mortality (47.1% and 50%, respectively).
CONCLUSION. IA among critically ill patients is associated with high
mortality. Patients diagnosed with proven or putative IA had greater
severity of illness and more frequently needed RRT than those with
Aspergillus spp colonization.
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INTRODUCTION. Influenza infection causes severe morbidity and
mortality around the world. There are limited data about severe influ-
enza infection among healthcare workers compared to the general
population.
OBJECTIVES. Our aim was to determine clinical differences between
health-care workers and general population with severe influenza in-
fection admitted to the intensive care units.
METHODS. Prospective, observational, multicenter study conducted
in 148 Spanish ICUs from 2009 to 2017. Healthcare workers with se-
vere influenza infection were compared with the general population.
All serotypes were confirmed using RT-PCR at ICU admission. Pa-
tients´ demographic, clinical, radiologic features, laboratory values,
ICU and hospital length of stay (LOS) and outcomes were recorded.
Influenza vaccination status is reported. Discrete variables are
expressed as counts (percentage) and continuous variables as me-
dians with 25th to 75th interquartile range (IQR). Differences be-
tween groups were assessed using the x2 test and the Fisher exact
test for categoric variables and Mann-Whitney U test for continuous
variables.
RESULTS. Of 4175 patients with confirmed influenza infection at ICU
admission, 2915 of working-age adults were selected. A total of
47 healthcare workers were compared to 2864 non-healthcare
professionals. There was a less proportion of male among health-
care workers (58.1% vs 36.2%, P =0.003), and less overall comor-
bidities (69,0% vs 53.2%, P =0.020). Healthcare workers had a
higher history of asthma (21.3% vs 9.8, P=0.009) and less COPD(6.4% vs 14.4%, P=0.048), and heart failure (0% vs 7.7%, P=
0.047). There are no statistical differences in other variables re-
lated to clinical influenza infection and outcome between groups.
There are no differences in MODS, mechanical ventilation, RRT,
cobacterial infection or hospital-acquired pneumonia, influenza
serotype (A/H1N1pdm8, 78.2% vs 76.6%, P=0.758) or proportion
of vaccinated patients (4.3% vs 5.9%, P=0.917). Vaccinated rate
among healthcare workers reported by Spanish Ministry of Health
and Social Policy is 30%. No difference in ICU LOS, hospital LOS
or mortality was observed.
CONCLUSION. The clinical characteristics, evolution and outcome of
healthcare workers with severe influenza admitted to ICU is similar to
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INTRODUCTION. There is little descriptive data on Stenotrophomo-
nas maltophilia hospital-acquired pneumonia in critically ill patients.
However, this non-fermenting Gram negative bacteria is one of the
tenth most isolated bacteria in intensive care units. Due to its unique
resistance profile to antimicrobial agents, the optimal modalities of
antimicrobial therapy remain to be determined.
OBJECTIVES. Our objective was to describe the epidemiology and
prognostic factors associated with Stenotrophomonas maltophilia
pneumonia, focusing on antimicrobial therapy.
METHODS. This nationwide retrospective study included all patients
admitted to 25 French intensive care units between 2012 and 2017
with hospital-acquired Stenotrophomonas maltophilia pneumonia.
The primary endpoint was time to in-hospital death. The secondary
endpoints included microbiologic effectiveness and antimicrobial
therapeutic modalities such as, delay to appropriate antimicrobial
Page 308 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55treatment, mono versus combination therapy and duration of anti-
microbial therapy.
RESULTS. Of the 282 patients included, 84% were intubated at Ste-
notrophomonas maltophilia pneumonia diagnosis for a median dur-
ation of 11 [5-18] days. The median Simplified Acute Physiology
Score II was 47 [36–63] and the in-hospital mortality was 49.7%.
Underlying chronic pulmonary comorbidities were present in 14.1%
of cases. Empirical antimicrobial therapy was microbiologically de-
fined as effective on Stenotrophomonas maltophilia according to
susceptibility patterns in only 30% of cases. Delay to appropriate
antimicrobial treatment had, however, no significant impact on the
primary endpoint. Survival analysis did not show any benefit from
combination antimicrobial therapy (HR=1.27, 95%CI [0.88; 1.83]; p=
0.20) or prolonged antimicrobial therapy for more than 7 days (HR=
1.06, 95%CI [0.6; 1.86]; p=0.84).
CONCLUSION. Stenotrophomonas maltophilia hospital-acquired
pneumonia occurred in severe, long-stay intensive care patients who
mainly required prolonged invasive ventilation. Empirical antimicro-
bial therapy was barely effective while antimicrobial treatment mo-
dalities may have no significant impact on hospital survival.
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INTRODUCTION. Ventilator‑associated tracheobronchitis (VAT) is an
infective complication of mechanical ventilation. In the Intensive Care
Units (ICUs), VAT is a relatively common problem but in comparison
to ventilator‑associated pneumonia (VAP), much less data are avail-
able on VAT and its management. The aim of this study was to deter-
mine the frequency, etiology, microbiological sensitivity and
outcomes of nosocomial tracheobronchitis (NTB) in mechanically
ventilated patients admitted in intensive care unit.
OBJECTIVES. To find out the incidence of ventilator associated tra-
cheobronchitis in ventilated patients.
To map the microbiological profile of ventilator associated tracheo-
bronchitis in the region
METHODS. A prospective observational study was conducted in two
medical Intensive Care Unit (ICU), in Kolkata, India from March 2016
to April 2017. All the patients on mechanical ventilator for more than
48 hours in the ICU were evaluated according to the criteria for the
diagnosis of nosocomial tracheobronchitis (NTB). Out-comes of the
patients were measured in terms of development of nosocomial
pneumonia after NTB, length of ICU stay, duration of mechanical ven-
tilation and mortality in the ICU.
RESULTS. Four hundred and sixteen patients were evaluated for this
study. Nosocomial tracheobronchitis was diagnosed in 48 patients.
The frequency of NTB was 11.5%. Nine types of micro-organisms
were identified, 42% cases were poly-microbial, while in the
remaining 58% cases single organism was isolated. The most com-
mon organism was Klebsiella spp (56%), followed by Acenetobacter
spp (20%) and Pseudomonas aeruginosa (8%). The majority patients
who developed VAT had underlying co-morbidities. The mean time
to develop VAT from the time of mechanical ventilation was 6.8 daysand from time of ICU admission was 9 days, respectively. More than
ninety percent of isolated GNB were multidrug resistant.
CONCLUSION. VAT is a common healthcare‑associated infection
caused mostly by MDR Gram‑negative bacteria that significantly af-
fects the development of pneumonia and length of ICU stay for the
patients. Monitoring and active surveillance are required to detect
VAT at the earliest to initiate appropriate isolation measures and
therapy for better outcome.
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INTRODUCTION. Skin and soft tissue infections (SSTIs) are usually
mild infections, but when severe, they can lead to intensive care unit
(ICU) admission. There is limited published data on the epidemiology
of SSTIs necessitating ICU admission.
OBJECTIVES. To describe the incidence, characteristics and outcomes
of critically ill adult patients admitted to the ICU for a SSTI, as well as
independent predictors of outcomes.
METHODS. A registry-based retrospective cohort study using data
submitted to the Australian and New Zealand Intensive Care Society
Adult Patient Database for admissions between 2006 and 2017. Inclu-
sion criteria: primary diagnosis of SSTI and age ≥16 years. Exclusion
criteria: ICU readmissions (during the same hospital admission) and
transfers from ICUs from other hospitals. Primary outcome was in-
hospital mortality, secondary outcomes were ICU mortality and ICU
and hospital length of stay (LOS). Furthermore, independent predic-
tors of these outcomes were determined.
RESULTS. Of 1,470,197 first admissions at ICU between 2006 and
2017, 10,962 patients (0.7%) were admitted because of SSTI. Of these,
5,706 (52.1%) were medical and 5,256 (47.9%) surgical patients. Of all
medical patients, 3,682 (64.5%) had sepsis. Comorbidities were
present in 25.2% of the study sample. In-hospital mortality was 9.1%
(n=991), which accounted for a 0.07% SSTI in-hospital mortality rate
for all first admissions at ICU between 2006-2017. Incidence of ICU
admissions increased between 2006-2017 from 0.4% to 0.9%, but in-
hospital mortality decreased from 16.1% to 6.8%. Median ICU LOS
was 2.1 days (IQR: 3.4), median hospital LOS was 12.1 days (IQR:
20.6). ICU LOS remained stable between 2006-2017 (2.0 to 2.1 days),
whereas hospital LOS decreased from 15.7 to 11.2 days. Predicting
factors for in-hospital mortality were: ANZROD [1] score (OR: 1.07; CI
(1.05, 1.09); p<0.001), any comorbidity except diabetes (OR: 2.00; CI
Page 309 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55(1.05, 3.79); p=0.035) and admission through an emergency response
call (OR: 2.07; CI (1.03, 4.16); p=0.041).
CONCLUSION. SSTIs are uncommon as primary ICU admission
diagnosis. While the incidence of ICU admissions for SSTI has in-
creased, mortality and hospital LOS have decreased over the last
decade.
REFERENCE(S)
1. Paul E, Bailey M, Pilcher D: Risk prediction of hospital mortality for adult
patients admitted to Australian and New Zealand intensive care units:
development and validation of the Australian and New Zealand Risk of
Death model. Journal of critical care 2013, 28(6):935-941.
2. The authors received no financial support for the research, authorship,
and publication of this article.
000861
Pneumocystis pneumonia critical care management and predictors
of mortality
J. Serodio1, L. Melo1, A. Graça2, P. Fortuna2, AV. Santos2, L. Bento2
1Department of internal medicine iv, Hospital Prof. Dr. Fernando
Fonseca, Amadora, Portugal; 2Unidade de urgência médica, Hospital S.
José, Centro Hospitalar Universitário Lisboa Central, Lisboa, Portugal
Correspondence: J. Serodio
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000861
INTRODUCTION. Pneumocystis pneumonia (PCP) often presents with
severe respiratory failure leading to intensive care admission and
organ support. Patterns of disease have been changing as PCP is in-
creasingly recognized among non-HIV Immunosuppressed patients.
Little is known about critical care management of these patients.
OBJECTIVES. Our aim was to evaluate intensive care management of
severe PCP and to identify clinical predictors of mortality.
METHODS. A retrospective cohort study was performed that in-
cluded all patients with severe PCP from 2005 to 2018 (14 years) ad-
mitted to an intensive care unit of an university hospital. Patients
were characterized according to immunosuppression status into HIV-
positive and HIV-negative. Clinical variables at admission and during
intensive care unit stay were assessed to identify clinical predictors
of in-hospital mortality.
RESULTS. Forty-three patients with PCP were included with me-
dian age 53 (41-65) years and male sex predominance
(71%). HIV-negative patients were responsible for 21 (49%) cases
of PCP. Between 2005-2010 HIV was responsible for all cases of
PCP whereas HIV-negative represented 64% of PCP from 2011-
2018 (p=0,001). Most HIV-negative patients had recognizable
causes of immunosuppression: 15 patients with hematologic can-
cer, 3 with solid organ cancer and 3 with autoimmune disease.
HIV-negative patients were significantly older (63 [56-74] vs. 43
[33-53] years, p=0,0001), presented shorter duration of symptoms
(3 [2-6] vs. 15 [7-31], p=0,0002), had higher APACHEII (24 [23-30]
vs. 20 [15-24], p=0,0143) and increased in-hospital mortality (61%
vs. 36%, p=0,094), but equal pO2/FiO2 on admission (113 [84-
133] vs. 101 [71-151] mmHg, p=0,794) and lactate (1,9 [1,3-2,6]
vs. 1,6 [1,2-2,1] mmol/L, p=0,243). Non-invasive ventilation (NIV)
or high-flow nasal oxygen (HFNO) were attempted on 11 (26%)
patients. Failure of NIV or HFNO was high in both groups (HIV-
negative 57% vs HIV-positive 75%, p=0,473). The rate of mechan-
ical ventilation was equal in both groups (81% vs 82%). Failure of
NIV or HFNO was not significantly associated with mortality.
On univariate analysis, predictors of in-hospital mortality were need
for mechanical ventilation (OR 25,2 [95% CI 1,35 – 471,5], p= 0,031),renal replacement therapy (OR 6,96 [95% CI: 1,57-30,86], p=0,011)
and age (OR 1,07 [95% CI 1,02-1,12], p=0,006).
CONCLUSION. Severe PCP predominantly affects HIV-negative im-
munosuppressed patients during last years. HIV-negative patients
are older, have more abrupt disease onset and seem to have in-
creased mortality. Increased mortality might be associated with
increasing age, comorbidities and need for organ support. Need
for mechanical ventilation and renal replacement therapy were
the stronger predictors of mortality. Use of NIV or HFNO was as-
sociated with a high percentage of progression to mechanical
ventilation but without increased mortality keeping the non inva-
sive strategy as an option in this patients.
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INTRODUCTION. Hantaviral infection is a severe disease caused
primarily by inhalation of contaminated particles of infected ro-
dents. Most deaths are caused by a combination of progressive
respiratory and cardiac failure, which is called the cardiopulmo-
nary syndrome. In 2016, our institution introduced the use of
extracorporeal membrane oxygenation (ECMO) as rescue therapy
in patients who developed cardiopulmonary syndrome and refrac-
tory shock or severe hypoxemia.
OBJECTIVES. The purpose of this abstract is to describe patients,
complications and evaluate the outcomes of this therapy.
METHODS. Retrospective data from ECMO supported patients was
analyzed. Continuous variables were expressed as mean ± stand-
ard deviation, and categorical variables were expressed as the ab-
solute number and proportions (%). Comparisons between
survivors and non-survivors were made with the Mann-Whitney U
test. A descriptive analysis was performed.
RESULTS. A total of 19 patients were described. Table 1 resumes
demographic characteristics and severity scores at admission,
remarking SOFA 11±2,2 and APACHE II of 18,4±7. Before connec-
tion, cardiac index was 1,95±0,3, PaO2/FiO2 111±37 and lactate
3,45±2,1. Table 2 highlights other pre ECMO status. SOFA score
was significantly different between survivors and non-survivors
(figure 1). The most common complication was acute kidney fail-
ure. A tendency to statistical difference was seen on age, APACHE
II and initial PaO2/FiO2. Cardiac output, time of ECMO and
F1
Table 2 (abstract 000914). Baseline characteristic before ECMO
Page 310 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55distance to ECMO center did not show any clinical difference. In-
hospital survival was 68,4%.
CONCLUSION. We described the results of a new developed ECMO
program focusing on the outcomes of Hantavirus patients, showing
an important survival in patients whose mortality remained ex-
tremely high before support therapy.
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INTRODUCTION. Previous studies reported conflicting results regard-
ing the impact of COPD on ventilator-associated pneumonia (VAP)
incidence.
OBJECTIVES. To determine the impact of COPD on incidence, charac-
teristics and outcomes of ventilator-associated lower respiratory tract
infections (VA-LRTI).
METHODS. Retrospective analysis of prospective observational multi-
national TAVeM database (1). From September 2013 to July 2014,
data were obtained from 2960 consecutive patients older than 18
years who received invasive mechanical ventilation (MV) for ≥48
hours. COPD patients (n=494) were compared to non COPD patients
(n=2466). The diagnosis of ventilator-associated tracheobronchitis
(VAT) and VAP was based on clinical, microbiological and radiological
criteria.
RESULTS. VAP and VAT incidences were not significantly different
between COPD and non COPD patients (12% versus13%, p=0.931,
and 13% versus10%, p=0.093, respectively). Among patients with
VA-LRTI, Escherichia coliand Stenotrophomonas maltophiliawere sig-
nificantly more frequent in COPD patients as compared with non
COPD patients. The rate of multidrug-resistant bacteria was simi-
lar between the two groups. Appropriate antibiotic treatment was
not significantly associated with progression from VAT to VAP
among COPD patients who developed VAT, unlike non COPD
patients.MV duration, ICU and hospital length of stay were signifi-
cantly longer in patients with VAT or VAP as compared to pa-
tients without VA-LRTI, in both COPD and non COPD patients.
Among patients who developed VAT, COPD patients exhibited
significantly longer MV duration and ICU length of stay, as com-
pared to non COPD patients (17 [9-30]) versus13 days [8-21], p=
0.042 and 24 [17-39] versus20 days [14-31], p=0.042, respect-
ively). No significant difference regarding ICU mortality was
found between COPD and non COPD groups in patients with
VAT, VAP or without VA-LRTI.CONCLUSION. Incidence of VA-LRTI was similar in both COPD and non
COPD population, but VAT was associated with significantly longer dur-
ation of MV and ICU length of stay among COPD patients as compared
to non COPD patients. Appropriate antibiotic treatment did not reduce
the progression from VAT to VAP among COPD patients.
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INTRODUCTION. A quarter of HAI's will be produced in the ICU, are
an important cause of complications, prolonged ICU stay, increased
costs and mortality (1-2)
OBJECTIVES. To describe the incidence and characteristics of infec-
tions associated with health care in the ICU.
METHODS. A retrospective, observational study of all patients admit-
ted to the ICU of the Hospital Juárez de México between January
2013 and December 2018, who had a diagnosis of HAI's acquired in
the ICU, was registered type of infection, pathogen and outcome.
RESULTS. We analyzed 1727 patients admitted to the ICU, of whom
479 met criteria for HAI's and 316 had at least one positive microbio-
logical isolation. The incidence of infections associated with health care,
acquired in the ICU was 44.03, 41.38, 31.50, 21.77, 20.81, 15.01% during
2013, 2014, 2015, 2016, 2017 and 2018 respectively, observing an in-
crease in the number of patients attended in ICU with a constant and
significant reduction of HAI's in ICU; the average time between admis-
sion to the ICU and the presentation of HAI's was 12 days (IQR 8-20
days). The ventilator associates pmneumonia had incidence of 60.12%,
other pneumonias 9.39% and non cathether related bacteriemia 8.97%.
It was found that A. baumannii (n = 128 cases) as a risk factor for mor-
tality in ICU with OR = 1.0215 (95% CI 0.5455 to 1.9127, p = 0.9470) and
of Pseudomonas sp. There were 91 cases OR 1.1250 (95% CI 0.5639 to
2.2445, p = 0.7382) in comparison to other pathogens.
CONCLUSION. VAPs are the most common cause of HAIs in ICU,
pathogens such as A. baumannii and Pseudomonas are common in
our environment, however, they do not seem to increase mortality in
relation to other pathogens (1-3).
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INTRODUCTION. The timing, severity and treatment of healthcare-
associated CDI are not well described in critically ill patients.
OBJECTIVES. The objectives of this nested cohort study are: 1) the in-
cidence of CDI and timing of CDI (pre-ICU, in ICU, post-ICU); 2) sever-
ity of CDI based on the Infectious Diseases Society of American/
Society for Healthcare Epidemiology of American (IDSA/SHEA), Ameri-
can College of Gastroenterology (ACG) and European Society ofClinical Microbiology and Infectious Diseases (ESCMID) scores; 3)
complications and mortality; 4) treatment for CDI in the ICU.
METHODS. This multicenter study was nested within a clinical trial
testing Lactobacillus rhamnosus GG (Culturelle, Locin Industries Ltd)
versus placebo to reduce ventilator associated pneumonia and other
ICU-acquired infections. Research Coordinators completed a case re-
port form for any patient who was suspected to have CDI. All CDI pa-
rameters were adjudicated in duplicate with respect to timing of the
infection, severity, treatment, and complications; any adjudicator dis-
agreement was resolved by a third adjudicator.
RESULTS. 64 of 1,766 patients (3.6%) developed CDI; 7 of whom
(0.4%) had CDI at ICU admission (pre-ICU), while 41/1766 (2.3%) de-
veloped CDI in the ICU (ICU-acquired), and 16/1766 (0.9%) developed
CDI after post-ICU discharge (post-ICU). The incidence rate of ICU-
acquired CDI was 1.4/1000 patient-days. CDI severity in the ICU was
mostly mild/moderate according to these criteria: 45/64 (70.3%) by
IDSA/SHEA; 49/64 (76.6%) by ACG; 53/64 (82.8%) by ESCMID. Fewer
patients developed severe CDI (12/64, 18.8% IDSA/SHEA; 6/64, 9.4%
ACG; 11/64,17.2% ESCMID) and severe, complicated CDI was rare (7/
64, 10.9% IDSA/SHEA; 9/64, 14.1% ACG). Complications attributed to
CDI were frequent: 17/64 (26.6%) patients had septic shock, 12/64
(18.8%) developed new end-organ failure and 1 (1.6%) had toxic
megacolon necessitating colectomy. ICU and hospital mortality was
338/1766 (22.0%) and 501/1765 (28.4%), respectively. ICU and hos-
pital mortality based on IDSA/SHEA severity was: mild/moderate: 7/
45 (15.6%), 14/45 (31.1); severe: 4/12 (33.3%), 4/12 (33.3%); severe
and complicated: 3/7 (42.9%) and 4/7 (57.1%), respectively. Most pa-
tients with ICU-acquired CDI in our cohort received metronidazole
[total 45/64 (70.3%)] either orally [42/64 (65.6%)] or intravenously
[21/64 (32.8%)], and 40/64 (62.5%) received vancomycin orally [39/64
(60.9%)] or rectally [2/64 (3.1%)]. Fidaxomicin wasn't prescribed, but
3/64 (4.7%) patients underwent fecal transplantation.
CONCLUSION. CDI was more likely to be acquired in the ICU than to
be pre-existing or develop following recovery from critical illness. Most
cases were mild-moderate in severity; treatment primarily involved
metronidazole, consistent with prior CDI guidelines for first episodes of
non-severe CDI. CDI remains a concerning clinical problem; further re-
search should focus on optimal risk stratification and treatment.
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INTRODUCTION. Hand hygiene is the most important infection con-
trol intervention that has proved to decrease the risk of hospital-
acquired infections in intensive care units or hospitals. However,
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faces various challenges in many developing countries due to limited
resources and non-availability of hand hygiene infrastructure.
OBJECTIVES. We aimed to assess the effectiveness of environmental
and behavioral changes before and after the implementation of a
hand hygiene promotion program in a rural public hospital in
Cambodia.
METHODS. This project was operated the cooperation by Kaohsiung
Veterans General Hospital (KVGH), Taiwan, and carried out in a re-
gional public hospital, namely, Bati Referral Hospital (BRH), in Bati
District, Takeo Province, Cambodia during May 2017 to December
2018. A baseline survey was conducted before the implementation
andcontinuous quality improvement program were used to analyze
and solve the problems.
RESULTS. A total of 42 health care workers participated in the pro-
ject, among these ten were chosen as auditors. The rate of technical
practice of hand hygiene was 0% at baseline and rose to 95.6% (p<
0.001) in the follow up assessment. The rate of auditors was from 0%
to 100%. Compliance rates of moment one (before touching pa-
tients) and moment four (after touching patient) of hand hygiene im-
proved from 0% to 100%. The prevalence ratesof diarrhea and
pneumonia decreased from 4.15% to 3.78% and 4.8% to 4.4%, re-
spectively. The length of admission decreased from 3 to 2.7 days.
CONCLUSION. This program showed continuous quality improve-
ment program could establish a pilot hand hygiene promotion pro-
gram and system in a rural hospital in where hand hygiene program
was never implemented in a developing country. Availability of hand
hygiene equipment, periodical training and evaluation, and manager-
ial empowerment are the key factors to ensure long-term sustainabil-
ity. In addition, commitment and support by government and
hospital authorities arealso crucial for successfulimplementation.
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INTRODUCTION. The number of patients with cancer who receive in-
tensive care treatment is growing. However, the prognosis of thesepatients remains poor with a mortality after ICU admission of around
50%. So, efforts are needed in order to improve their outcome.
OBJECTIVES. Our aim was to describe the cohort of patients with
solid organ cancer admitted to a tertiary hospital ICU and analyze
factors that are likely to affect their survival.
METHODS. Retrospective study, including adult (+18 years) patients
with solid organ cancer who required admission to ICU between
2010 and 2016. X-Square, Fisher´s test, T test, U Mann-Whitney and
logistic regression were employed as required. Quantitative variables
are reported as median (IQR) and categorical as frequency (%).
RESULTS. One hundred and fifty patients were included, 77 (51%) fe-
male, with a median age of 62 (52-70) years. Lung cancer was the
most frequent one, being present in 34 (25%), followed by colon 20
(13%), breast 13 (9%) and ovary 13; (9%). Metastatic disease affected
to 84 (58%). The functional status was ECOG 0 in 12 (8%), ECOG 1 in
74 (51%), ECOG 2 in 56 (39%) and ECOG 3 in 3 (2%). The main indica-
tions for ICU admission were respiratory failure in 55 (37%), shock in
31 (21%), post urgent surgery in 29 (20%) and central nervous sys-
tem involvement in 10 (7%). SOFA score at admission was 6 (4-9)
Neutropenia was present in 19 (13%). Ninety-two (62%) required
vasoactive drugs (VAD), 55 (37%) high flow nasal cannula (HFNC), 66
(44%) mechanical ventilation (MV), and 13 (9%) renal replacement
therapy (RRT). ICU mortality affected to 38 (26%) and hospital mortal-
ity to 66 (44%). We identified the following factors related to hospital
mortality in the univariate analysis: SOFA score on admission (OR 1.1,
IC95% 1-1.3, p<0.004), no improvement in SOFA score at day 5 (OR
6.8, IC95% 2.1-22.3, p<0.002), need of MV (OR=5.5, IC95%:2.7-11.2, p<
0.0001), VAD (OR=2.2, IC95%:1.1-4.3, p=0.03). We did not find any dif-
ferences in mortality according to the need of RRT, ECOG status, the
presence of metastatic disease or neutropenia. In the multivariate
analysis, MV (OR=6.8, IC95%:1.4-32.2, p=0.016) and no improvement
in SOFA score at day five (OR 6.7 IC95%:1.7-27: p=0.007) maintained
statistical significance.
CONCLUSION. Despite improvement in cancer therapies and critical
care management, mortality is still high in oncologic patients admit-
ted to ICU. Organ failure and need of mechanical ventilation is re-
lated to mortality, so these patients could benefit of an earlier
admission. Patients with no improvement in organ dysfunction at
day 5 have a greater mortality, so this information could be useful in
the decision process during an ICU trial.
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INTRODUCTION. Redirecting T-cell cytotoxic specificity through
chimeric antigen receptor gene transfer (CAR-T cells) has become
a major breakthrough in cancer immunotherapy, especially
against relapsing/refractory CD19 hematologic neoplasms as acute
lymphoid leukemia (ALL) or non-Hodgkin lymphoma (NHL). Sig-
nificant toxicity is associated with this therapy, requiring some-
times ICU admission. The first academic pilot clinical trial
(clinicaltrials.gov NCT03144583) using our fully academic
(A3B1:CD8:4-1BB:CD3Z) CART-19 (ARI-0001 cells) was approved by
the Spanish Agency of Medicines on May/2017
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of patients treated with ARI-0001 cells
METHODS. Patients with NHL and ALL who had failed standard avail-
able therapy have been included in the trial. The primary objective
of the study was safety, and secondary objectives were response rate
and its duration. After conditioning with fludarabine (90 mg/m2) and
cyclophosphamide (900 mg/m2), we infused 0.4-5 x106ARI-0001 cells
/kg, either as a single infusion or in 2-3 fractions. Data are expressed
in median (range) and n (percentage)
RESULTS. As of April/2018, 25 adult patients have been infused (3 of
them twice and 1 three times), 14 as a single infusion and 11 as frac-
tioned aliquots. Seven patients (28%) have been admitted to the ICU (1
patient was admitted twice). The median age was 27 years (19-54), 4/7
were men. Four had refractory ALL and three NHL, with a median of 4
previous lines of treatment (4-6). Five of them also had been treated
with hematopoietic stem cell transplant (3 allogeneic). All 7 needed
bridging chemotherapy between apheresis and CART-19 infusion. Five
patients received the treatment as a single infusion and two as frac-
tioned aliquots (one of them only received 40% of the planned dose).
Reasons for ICU admission were cytokine releasing syndrome (CRS) (4
patients), neurotoxicity (2 patients), infection (2 patients) and non-CRS
related hypotension (1 patient). One patient was admitted previously
to infusion because of respiratory failure due to illness progression. Me-
dian APACHE II and SOFA were 15 (13-22) and 4 (2-8), respect-
ively. Organ support was needed in 4/7 patients (vasopressors 4/7,
mechanical ventilation 3/7, renal support therapy 3/7). Regarding CRS,
severity was measured by Lee scale. One patient died (grade 5) and 2
and 1 patient had grade 3 and 2, respectively, all of them starting the
day of infusion. Tocilizumab was administered in these 4 cases. Regard-
ing neurotoxicity, the maximum grade was 3 (1 patient) and 1 (1 pa-
tient). Three patients died in the ICU, due to refractory CRS (1 patient),
CRS + Clostridium difficile infection (1 patient) and disease progression
(1 patient). The median length of stay in ICU was 4 days (2-34)
CONCLUSION. Rate of ICU admission in patients treated with ARI-0001
cells was 28%, mainly due to CRS. Fractioned infusion dose seemed as-
sociated with a lower ICU admission rate
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INTRODUCTION. Current guidelines recommend to increase mean
arterial pressure (MAP) in previously hypertensive septic shock
patients to higher levels (80-85 mmHg) when tissue hypoperfu-
sion has not been corrected with the initial fluid resuscitation
and restoration of MAP to 65 mmHg. The impact of incremental
NE titration on cardiac function depends on the balance between
the effects on preload, contractibility and afterload. As NE may
both increase venous return and afterload, a particular concern is
a potential decrease in stroke volume (SV) in fluid-unresponsive
patients.
OBJECTIVES. To determine the impact of an increase in MAP from 65
to 85 mmHg by incremental NE titration on SV and several parame-
ters of cardiac performance in previously hypertensive fluid-
unresponsive patients.
METHODS. We evaluated patients in whom the attending doctor
decided to increase MAP from 65 to 85 mmHg because of per-
sistent hypoperfusion. A comprehensive echocardiographic assess-
ment was performed at baseline (B1), after reaching the MAP
target (MAP 85), and after return to baseline MAP (B2). A SV re-
sponder was defined as patients that increased SV by >10% at
MAP 85. Mean Systemic Filling Pressure (Pmsf) and pressure for
venous return (Pvr) were calculated. Preload, contractility and
afterload variables were assessed. Statistical analysis was per-
formed with Wilcoxon signed-rank test, P < 0.05 was considered
as significant.
RESULTS. Seven mechanically ventilated patients (age 71± 8 yr,
APACHE II 22±7, SOFA on admission 10 ± 2) were included in
this preliminary report. Hemodynamic variables are shown in
table 1. No patient decreased SV after reaching MAP 85. Three
patients were SV-responders this was associated with an in-
crease in Pmsf and Pvr accompanied by a direct increase in left
ventricular contractility as assessed by ventricular elastance.
CONCLUSION. In previously hypertensive and currently fluid unre-
sponsive septic shock patients in whom MAP was increased from
65 to 85mmHg stroke volume did not decrease despite the in-
creased afterload due to an increase in left ventricular
contractility.
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INTRODUCTION. Despite hemodynamic stabilization after resuscita-
tion, tissue hypoperfusion may persist in circulatory shock (CS) pa-
tients. Volume expansion (VE) and increasing mean arterial pressure
(MAP) are two of the strategies to correct tissue hypoperfusion.
OBJECTIVES. We hypothesized that a VE or a change in MAP by nor-
epinephrine (NE) titration would affect skin blood flow (SBF) and the-
nar muscle oxygenation (StO2).
METHODS. Hemodynamically stabilized patients with CS undergoing a
VE or an adjustment of MAP were included. CS was defined as the pres-
ence of NE to maintain MAP ≥ 65 mmHg with ≥ 1 signs of tissue hypo-
perfusion (oliguria, alteration of consciousness, mottled skin) or lactate ≥
2 mmol/L. VE (crystalloid solution administration at 500 ml/30 minutes in-
fusion rate) and the adjustment of MAP (ΔNE) (an increase or decrease in
NE infusion rate ≥ 20%) were decided by the attending physician.
SBF was measured (Periflux 5000, Perimed; index finger, Perfusion unit:
PU) before (T0) and after (T1) VE or ΔNE. Thenar StO2 was measured at
T0 and T1 by near-infrared spectroscopy (NIRS; InSpectra TM Model
325). A vaso-occlusive test (VOT) of 3 minutes was also performed at T0
and T1 to calculate the StO2 ascending slope (AscStO2) (%/min) follow-
ing the end of the VOT. Hemodynamic variables and lactate levels were
obtained at the same times as the measurements. The changes in SBF
(ΔSBF) and AscStO2 were calculated as relative percent changes. Data
are reported as medians with 25th and 75th percentiles.
RESULTS. 19 patients with CS (septic (8), cardiogenic (10), hypovol-
emic (1)) were studied. APACHE score at admission was 19 (17-28),
SOFA score at inclusion time was 11 (8-12). At baseline there were
no differences in MAP (p=0.6), cardiac index (CI) (p=0.7), lactate levels
(p=0.7), StO2 (p=0.6) and AscStO2 (p=0.3) between VE patients (n =
9) and ΔNE patients (n = 10). SBF was lower in VE patients than in
ΔNE patients (20 (12-121) vs 102 (64-201) p=0.04, respectively).
Hemodynamic effects of VE and ΔNE are reported in the Table. SBF
and StO2 did not change, AscStO2 increased in VE patients but not
in ΔNE patients (Table). Changes in CI were not correlated to ΔSBF
(r=0.02; p=0.4) or ΔAscSto2 (r=0.29; p=0.5). Also, changes in MAP
were not correlated to ΔSBF (r=0.05; p=0.8) or ΔAscSto2 (r=-0.04; p=
0.8).
CONCLUSION. Changes in hemodynamic parameters during a VE or
a change in MAP target are not correlated to changes in skin blood
flow or thenar muscle tissue oxygenation.001115
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INTRODUCTION. AF is the most common arrhythmia seen in Critical
Care and is associated with poorer long-term outcomes and an in-
creased incidence of permanent AF. The follow-up of patients with
new-onset AF (NOAF) in Critical Care may help to determine the
long-term risk of recurrence of AF.
Amiodarone and beta-blockers are commonly used to treat AF
in critically ill patients. Long-term use of these medications has
been associated with adverse effects. Anticoagulant therapy also
has well established bleeding risks. The long-term use of these
medications is currently not recommended for patients who
solely develop episodes of AF as part of their critical illness.
OBJECTIVES. The primary outcome measure was the number of
patients with NOAF that were started on an anti-arrhythmic
and/or an anti-coagulant and discharged home on these
medications.
Secondary outcome measures included the number of patients that
were reviewed by cardiology as an inpatient, the number that were
still in AF at discharge and the number of patients with follow-up ar-
ranged upon their discharge from hospital.
METHODS. 95 critically ill patients were found to have AF in
2017. 26 patients who were treated for NOAF in critical care and
survived their admission were included in this analysis.
Electronic clinical notes, referrals and discharge summaries were
reviewed to identify pre-hospital and discharge medications, AF sta-
tus and follow-up arrangements at discharge.
RESULTS. No patients were discharged home on amiodarone. How-
ever, 12 patients were discharged home on bisoprolol and only 6 of
these patients had follow-up arranged for AF. None of these patients
were taking bisoprolol before admission to hospital. Similarly, one
patient was discharged home on digoxin without follow-up.
One patient was anti-coagulated for AF and was discharged home
on a Direct-Acting Oral anticoagulant (DOAC) with follow-up
arranged.
8 of the 26 patients were reviewed by cardiology as inpatients, and
only 7 patients were discharged from hospital with follow-up for
their AF. Of the 6 patients still in AF at discharge, 4 had planned
follow-up.
CONCLUSION. In contrast to previous reports, no patients were dis-
charged home on amiodarone, However, a significant number of pa-
tients with NOAF in critical care were discharged on bisoprolol.
Follow-up for AF was arranged only for two third of patients who de-
veloped NOAF during critical illness.
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INTRODUCTION. Implantation of a permanent cardiac pacemaker is
a surgical procedure associated with minimal patient discomfort and low
percentage of complications in expert centers.
OBJECTIVES. To analyze the safety of implantation of a cardiac pace-
maker as a day case procedure.
METHODS. Retrospective study in a University Hospital from February
2017 to February 2019.Inclusion criteria:over 18 years old, requiring elect-
ive pacemaker and no pacemaker dependent. Patients who did not accept
the program were hospitalized in the usual way, as well as those who pre-
sented some social exclusion criteria.The Pacemaker Unit, dependent from
the Critical Care Department and integrated by medical specialists in inten-
sive medicine accredited for the implantation of pacemakers, established
a program for the implantation of definitive pacemakers without hospital
admission. After the implant, the patients remain under observation for 8
hours. Prior to discharge, chest radiography and pacemaker monitoring
was performed. At 24 hours a patient evaluation was carried out by tele-
phone control, at 48 hours by means of an ambulatory face-to-face visit,
which repeats after 2-3 months and continuing every 6-9 months.
RESULTS. 39 patients included, all of them could be discharged follow-
ing the protocol. Average age 77 (48-91) years old, 69% male. Pacing Sys-
tems: DDDR 79%-VVIR 21%. Indications: Third-degree AV block 26%,
Mobitz II 21%, sick sinus syndrome 20%, Atrial fibrillation Blocked 15%.
Symptom: syncope 46%, bradycardia 26%, dizziness 18% and heart fail-
ure 10%.Etiology was unknown in 95% of cases. 36% of patients were
under treatment with oral anticoagulation.The most frequent placement
of right ventricular electrode was the septum in a 92%. Any patient pre-
sented complications during the procedure or at discharge (table 1); only
one complication at 48 hours due to hematoma in the area of the pace-
maker, related to oral anticoagulation and ambulatory solved.The implant
parameters were the most adequates in all cases (table 1), remaining
stable in the subsequent controls. There was only one case with high
capture threshold in the atrial lead but remained stable at follow-up.
CONCLUSION. Ambulatory implantation of pacemakers has proven
to be a safe treatment in our experience.Table 1 (abstract 001116). See text for description001135
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INTRODUCTION. Hemodynamic optimization is a main goal in the
management of critically ill patients. Right ventricular function, renal
failure and fluid balance are part of this process. Our goal is to ana-
lysis those, after the initial resuscitation and the effects of mechanical
ventilation over them.
METHODS. A prospective, observational study was performed with
all the patients admitted to a Medical Service of Intensive Care of a
Tertiary, University Hospital. All patients analyzed required mechan-
ical ventilation as a support for their underling pathology. All con-
secutive patients admitted to the unit under mechanical ventilation
were collected, in the absence of shock, with the expectation of
remaining under mechanical ventilation for at least 24 more hours
after data collection.
The incidence of right ventricular failure according to the defined pa-
rameters, renal failure, and fluid balance were described. We had de-
scribed its association with mechanical ventilation and mortality.
RESULTS. A total of 30 patients were selected. Right ventricular fail-
ure was observed in 16.6% of patients (5/30). There was no statisti-
cally significant association with the need of tracheotomy, renal
failure or mortality. It was not associated with longer average stay,
days of mechanical ventilation or higher severity scores.
40% of the patients presented acute renal failure. Renal failure was
not associated statistically significant with the need of tracheotomy
or failure in scheduled extubation, however, it was associated with
higher mortality. Patients requiring mechanical ventilation with nor-
mal creatinine values after initial resuscitation, had a mortality rate of
28.5% in comparison to patients who had altered values in which
the mortality rate was 77.7%. (p <0.018).
Regarding the post-resuscitation net fluid balance, no statistically sig-
nificant differences were found in the comparison of means between
survivors and non survivors, with renal failure or right ventricular fail-
ure. No even was it associated with higher mortality.
CONCLUSION. Right ventricular failure, despite not being associated
with mortality, days of mechanical ventilation or failure in extubation in
a statistically significant way, presents an incidence of 16.6% in patients
connected to mechanical ventilation admitted to a polyvalent icu.
Acute renal failure is associated in a statistically significant way with
mortality in our sample. We had not found association between fluid
overload and renal failure in our sample.
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INTRODUCTION. Invasive blood pressure (IBP) is the gold standard
for arterial pressure (AP) monitoring in critically ill patients. Neverthe-
less, IBP may be affected by underdamping/resonance artifacts, that
eventually lead to AP overestimation. In these cases, when a pulse
contour method (PCM) is applied, wrong hemodynamic data are also
delivered by the monitor. In order to overtake this issue, MostCareUp
(a PCM powered by Pressure Recording Analytical Method, PRAM),
T1
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automatically corrects the resonant AP waveform with two modal-
ities: standard and advanced (i.e., higher-intensity).
OBJECTIVES. In order to test the EFMC, the electronically corrected
AP, the derived cardiac output (CO) and the maximal slope of the
systolic upstroke (dP/dtMAX) were compared with respective raw
data corrected with the Accudynamic, an adjustable damping device
specifically manufactured for normalizing the pressure waveform (in
our study: the reference method).
METHODS. Systolic AP, CO and dP/dtMAX, were recorded with EFMC
disabled (A), standard EFMC (B), advanced EFMC (C), Accudynamic
with EFMC disabled (D).
RESULTS. Seventy patients with resonant IBP were enrolled (Table 1).
According to the Bland-Altman analysis, systolic AP biases (LoAs)
(mmHg) were 17.21 (-0.43; 34.87); 13.27 (-2.86; 29.4); 6.68
(-5.18;18.55) in D-A, D-B and D-C conditions respectively. CO biases
(LoAs) (L/min) were 4.1 (-1;9.25); 1.19 (-1.1;3.5); 0.3 (-1.1;1.64) in in D-
A, D-B and D-C conditions respectively. DP/dtMAX biases (LoAs)
(mmHg/ms) were 0.88 (0.09;1.68); 0.28 (-0.04;0.6); -0.04 (-0.4;0.33) in
D-A, D-B and D-C conditions respectively.
CONCLUSION. The EFMC, especially in advanced modality, efficiently
corrects resonant waveforms allowing a correct measurement of AP
values and contributing to improve the estimation of exact
hemodynamic data.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):001160INTRODUCTION. Although the potential ability of magnesium adminis-
tration to prevent and treat arrhythmias has been recognized in clinical
setting, limited evidence exists. In this study, we examined whether intra-
venous administration of magnesium sulfate increases successful electrical
cardioversion for new-onset atrial fibrillation (AF) in critically ill patients.
METHODS. Atrial Fibrillation Treatment Evaluation Registry in the ICU
(AFTER-ICU) was a multicenter, prospective cohort study of adult pa-
tient who developed new-onset AF after ICU admission, conducted
from April 1, 2017 to March 31, 2018 in 31 Japanese ICUs. In this pro-
spectively planned sub-analysis of the AFTER-ICU study, we assessed
the value of magnesium sulfate in facilitating electrical cardioversion.
All delivered electrical cardioversions for AF were assigned to the
magnesium group (administered within 12 hours before electrical
cardioversion) or the control group. The primary outcome was suc-
cessful cardioversion defined as conversion to sinus rhythm after 30
seconds of electrical cardioversion.
RESULTS. Of 158 electrical cardioversions in 52 patients, 19 were
assigned to the magnesium group and 139 to the control group. Com-
pared with the control group, the magnesium group was younger
(66yr vs. 70yr) and had a lower proportion of male (10.5% vs. 23.7%),
but severity of critical illness was similar (APACHE II score, 29 vs. 28).
Successful electrical cardioversion was more frequently observed in the
magnesium group (42.1% vs. 27.3%), and there was non-significant as-
sociation between magnesium pre-administration and successful elec-
trical cardioversion (adjusted odds ratio 2.0, 95%CI 0.7-5.5).
CONCLUSION. Intravenous administration of magnesium sulfate may
increase successful electrical cardioversion in patients with new-
onset AF. This study was not powered to detect any associations due
to the small sample size and future research is warranted.
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INTRODUCTION. According to European and American guidelines,
intravenous (iv) thrombolysis is the primary treatment for high-risk
pulmonary embolism (PE) signified by hemodynamic instability. In re-
cent years, catheter-directed interventions (CDI) has emerged as an
alternative in patients with contraindications to thrombolysis. How-
ever, there are numerous variants of CDI techniques and their effect-
iveness is not sufficiently studied.
OBJECTIVES. To evaluate the outcome and effectiveness of CDI, mea-
sured in terms of survival and reduction of right ventricle distension,
as treatment for massive PE compared to iv thrombolysis or anticoa-
gulation only.
METHODS. This is a retrospective study from a tertiary hospital
where CDI is used for patients with high-risk PE fulfilling all three cri-
teria: (1) distention of the right ventricle (RV); (2) systolic blood pres-
sure <90mmHg or syncope at any time from onset of symptoms; (3)
contraindication(s) to or insufficient effect from iv thrombolysis. We
included patients from July 2013, when CDI with the Angiojet system
as the main technique, was introduced, to December 2018. The con-
trol cohort were PE patients from 2006 to 2013, before CDI was intro-
duced, who fulfilled the CDI criteria above but received either
heparin only or iv thrombolysis, administered despite contraindica-
tions on vital indication.
RESULTS. Ninety-day survival was 60% in the CDI (n=25) and 61%
(p=0.951) in the control group (n=23). The PESI score did not differ
between the groups; CDI 183 ± 46 vs control 168 ± 35 (p=0.211). Me-
dian pre-treatment RV/LV ratio was 2.2 [IQR 1.6 – 2.7] in the CDI
group which was higher than 1.3 [IQR 1.1 – 1.6] which was found in
the control group (p<0.001). When adjusting for PESI-scores and RV/LV
ratio, there was no difference between the groups as to survival at 90
F1
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between the groups. (p=0.975, Figure). In a linear mixed model, with ad-
justment for timing of pre- and post-treatment imaging, the decrease of
RV/LV ratio was 0.4 units higher per 24 hours in the CDI group (p=0.007).
CONCLUSION.
In this retrospective observational study of patients with high-risk PE
and contraindications to thrombolysis, treatment by CDI was as effi-
cient as treatment by iv thrombolysis or anticoagulation with regards
to survival. However, CDI resulted in faster resolution of RV dilatation.
The latter is to be interpreted with caution since the patients in the
CDI group had higher pre-treatment RV/LV ratios.Fig. 1 (abstract 001170). See text for description001198
The Clinical Characteristics of Stress-induced Cardiomyopathy in
Critically ill Patients
S. Park1, J. Jeong2, D. Lee2, H. Lee1
1Department of internal medicine, Chonbuk National University
Hospital, Jeonju, Republic of Korea; 2Department of nursing, Chonbuk
National University Hospital, Jeonju, Republic of Korea
Correspondence: S. Park
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001198
INTRODUCTION. Stress or Takotsubo cardiomyopathy(SCMP) is a syn-
drome characterized by transient regional left ventricular dysfunction
in the absence of significant coronary artery disease. The clinical
presentation of SCMP is similar to that of an acute coronary syn-
drome. Wall motion abnormalities in patients with SCMP are typically
detected by echocardiography.
However, diagnosis of SCMP can be challenging in patients who are
being treated for other diseases in the intensive care unit. And the
clinical characteristics and risk factors of SCMP among patients in in-
tensive care unit with a non-cardiac diagnosis and no prior history of
cardiac disease is not known.
OBJECTIVES. The aim of study was to investigate the clinical charac-
teristics of stress-induced cardiomyopathy in critically ill patients.
METHODS. We retrospectively assessed the medical records of pa-
tients who performed echocardiography (ECG) in the Medical inten-
sive care unit at tertiary university hospital, from January 2015 to
December 2018.Diagnosis of SCMP was based on the following echocardiographic
finding: reversible akinesia or dyskinesia of the apical and mid por-
tions of the left ventricle beyond a single major coronary artery vas-
cular distribution.
RESULTS. A total 62 patients were performed formal echocardiog-
raphy. Of the 62 cases, 11 patients were SCMP (17.7%), and 38 pa-
tients had diagnosed a sepsis or septic shock.
There was no significant difference between the SCMP positive
group and the negative group in baseline characteristics such as age,
sex and other clinical features. T-wave inversion on ECG at admission
day (8/11 vs. 17/51, p=0.038) was statistically different between two
groups (SCMP + vs SCMP -, respectively).
And in subjects who diagnosed sepsis or septic shock (n = 38), initial
T-wave inversion on ECG (7/8 vs. 13/30, p=0.045), abnormal troponin
level at admission day (7/8 vs. 13/30, p=0.027), and elevated lactate
even 48 hours later (3/118 vs. 3/30, p=0.026) were related with the
incidence of SCMP.
CONCLUSION. In critically ill patients, T-wave inversion on ECG may
be a positive SCMP suggesting clue. And also, abnormal troponin
level and elevated lactate at 48 hours later could be a good clinical
features for suggesting SCMP in sepsis or septic shock patients.
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INTRODUCTION. Hypovolemia is a common clinical condition in inten-
sive care units (ICUs) and fluid resuscitation is considered the first line
of therapy. Multiple studies have found that only 50% of
hemodynamically unstable patients in the ICU respond to volume
expansion(VE). It is therefore essential to have reliable tools to predict
the efficacy of VE and ultimately distinguish patients who may benefit
from VE from those who are unlikely to respond.Over the last decade,
new approaches have been developed. Among the tests and indices
that have been developed to predict fluid responsiveness, the end-
expiratory occlusion(EEO) test has gained considerable attention, espe-
cially in mechanically ventilated patients.Following the first study dem-
onstrating the accuracy of the EEO test by Monnet et al, conflicting
results concerning the ability of EEO test have been published.
OBJECTIVES. We performed a systematic review and meta-analysis of
studies investigating the EEO-induced changes in cardiac output
(CO) and in arterial pressure as predictors of fluid responsiveness in
adults receiving mechanical ventilation.
METHODS. MEDLINE, EMBASE, Cochrane Database and Chinese data-
base(China National Knowledge Internet, Wanfang Database) were
screened for relevant original and review articles.The meta-analysis
determined the pooled area under the ROC curve, the sensitivity,
specificity and threshold for the EEO test when assessed with CO
and arterial pressure.
RESULTS. Thirteen studies enrolling 479 adult patients and 523 vol-
ume expansion were included. CO was measured by transpulmonary
thermodilution in ten studies, echocardiography in one study,
oesophageal Doppler in one study, and calibrated pulse contour ana-
lysis in one study. For the EEO-induced changes in CO, the pooled
sensitivity was 0.92 (95% CI, 0.85–0.97) and the pooled specificity
was 0.90 (95% CI, 0.84–0.994). The pooled AUROC was 0.96 (95% CI,
0.94–0.97). The best threshold was a EEO-induced increase in CO ≥5±
2%. For the EEO-induced changes in arterial pressure (4 studies, 149
volume expansion), the pooled sensitivity was 0.88 (95% CI, 0.63–
0.97), the pooled specificity was 0.77 (95% CI, 0.58–0.89) and the
pooled AUROC was 0.87 (95% CI, 0.84–0.90). Significant heterogen-
eity existed among the studies, and meta regression indicated that
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When excluding the only one study in which EEO was performed
during the prone position, the pooled sensitivity for the EEO-induced
changes in CO (or surrogate) was 0.92 (0.88–0.95) and the pooled
specificity was 0.89 (0.83–0.93) in semirecumbent or supine patients.
CONCLUSION. EEO-induced changes in CO very reliably predict the
response of CO to volume expansion in adults with acute circulatory
failure during semirecumbent position or supine position but not
during prone position. When EEO effects are assessed by changes in
arterial pressure, the sensitivity of the EEO test remains acceptable
but its specificity is poor.
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INTRODUCTION. Background: Pulse pressure variation (PPV) is a
dimension-less parameter calculated from the changes in the arterial pres-
sure curve induced by controlled mechanical ventilation CMV. PPV is a pre-
dictor of fluid responsiveness FR. Due to a potential impact of arrhythmia
and spontaneous breathing on PPV, its application usually is restricted to
patients with both sinus rhythm (SR) and CMV. Several other confounders
and “contexts” are considered to impede the use of PPV. However, there is
a lack of systematic studies investigating the exact impact of potential co-
founders on PPV.
OBJECTIVES. We hypothesized that PPV might be adjusted to some of
these confounders (“context-sensitive indexation”). Therefore, we analyzed
a large prospectively maintained database on haemodynamic monitoring
(PiCCO; Pulsion; Germany). The CONSORTION I study investigated the gen-
eral impact of biometrics, other haemodynamic data and contexts (e.g. type
of ventilation, heart rhythm) on PPV in all measurements. The CONSORTION
II study investigated the impact of ventilator setting and potential con-
founders on PPV in the subgroup of measurements with both SR and CMV.
METHODS. Analysis of a database including 9001 haemodynamic
measurements in 513 critically ill patients. Spearman correlation. Mul-
tiple regression analysis. IBM SPSS 25.
RESULTS. Biometrics: In the totality of measurements, PPV was slightly as-
sociated with age (r=0.162; p<0.001), weight (r=0.119; p<0.001) and height
(r=0.068; p<0.001). Men had slightly higher PPV compared to women
(11.9±7.7 vs. 10.2±6.6; p<0.001). In multivariate analysis (R²=0.037) regard-
ing biometric data, all biometrics were independently associated with PPV
(T-values of 10.3, 8.8, 8.8 and -2.4 for age, weight, male gender and height).
Among the „contexts“, there was strong impact of the heart rhythm
on PPV: Patients with atrial fibrillation AF had a markedly higher PPV
compared to patients with sinus rhythm SR (19.9±7.1 vs. 10.2±6.6%;
p<0.001). Patients with mechanical ventilation MV (irrespective of
assisted or controlled modality) had a lower PPV compared to spon-
taneously breathing patients (10.5±7.4 vs. 12.4±6.9%; p<0.001). Pa-
tients with controlled MV (CMV) hat a lower PPV compared to
patients with assisted MV (AMV; 8.9±7.5 vs. 11.3±7.2%; p<0.001).
Among haemodynamic contexts, PPV was most strongly associated with
high heart rate (HR; r=0.253; p<0.001), low stroke volume (SV; r=-0.289;
p<0.001) and low cardiac output (CO; r=-0.155; p<0.001). There were
poor associations with dPmax (r=-0.074; p<0.001), global end-diastolic
volume (GEDV; r=0.070; p<0.001) and low CVP (r=-0.027; p=0.023).
In multivariate analysis (R²=0.333), PPV was strongly associated with atrial
fibrillation (T=19.0), heart rate (T=11.9), low SV (T=-13.1), spontaneous vs.
assisted vs. controlled ventilation (T=10.4) and weight (T=9.2). Further-
more, PPV was associated to low dPmax (T=-6.5), female gender (T=4.2)
and age (T=2.9; all p<0.001 except age (p=0.004)).
CONCLUSION. Among potential confounders, PPV is most strongly associ-
ated to atrial fibrillation, while the impact of assisted or even spontaneous
ventilation seems to be lower. A strong association of PPV with low SV and
high HR might be in line with the role of PPV as marker of fluid de-pletion.
Independent association to age, sex and weight carries the potential for
indexation.
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parameter calculated from the changes in the arterial pressure curve
induced by controlled mechanical ventilation CMV. PPV is a predictor
of fluid responsiveness FR. Due to a potential impact of arrhythmia
and spontaneous breathing on PPV, its application usually is re-
stricted to patients with both sinus rhythm (SR) and CMV. Several
other confounders and “contexts” are considered to impede the use
of PPV. However, there is a lack of systematic studies investigating
the exact impact of potential cofounders on PPV.
OBJECTIVES. We hypothesized that PPV might be adjusted to some
of these confounders (“context-sensitive indexation”). Therefore, we
analyzed a large prospectively maintained database on haemo-
dynamic monitoring with the PiCCO-device (Pulsion; Germany). While
the CONSORTION I study (Abstract 1218) investigated the general im-
pact of biometrics, other haemodynamic data and contexts (e.g. type
of ventilation, heart rhythm) on PPV in all measurements, CONSOR-
TION II analyzed the impact of ventilator setting and potential con-
founders on PPV in the target subgroup of measurements with both
SR and CMV.
METHODS. Subgroup-analysis (measurements with both SR and CMV
(15.5% of all PPV-measurements)) of a database including 9001
haemodynamic measurements in 513 critically ill patients. Spearman
correlation. Multiple regression analysis. IBM SPSS 25.
RESULTS. Among ventilator settings, PPV was univariately associated
with low PEEP (r=-0.198; p=0.006), low mean respiratory pressure
P_mean (r=-0.191; p=0.008), high Delta_P (driving pressure; r=0.180;
p=0.013), high respiratory rate RR (r=0.191; p=0.008), but neither with
tidal volume (TV; r=-0.002; p=0.944) nor with TV/predicted body-
weight (r=0.012; p=0.689). In multivariate analysis restricted to venti-
lator parameters (R²=0.058), PPV was independently associated to
high Delta_P (T=2.2; p=0.028) and low P_mean (T=-2.6; p=0.011),
whereas TV/predicted bodyweight slightly failed significance (p=
0.054).
In univariate analysis regarding biometric and haemodynamic data,
PPV was most strongly associated to low stroke volume (SV; r=-0.427;
p<0.001) and heart rate (HR; r=0.355; p<0.001). Furthermore, PPV was
weakly correlated to low global end-diastolic volume (GEDV; r=-
0.153; p<0.001) and low CVP (r=-0.101; p<0.001).
In a final multivariate analysis (R²=0.363) including age, gender,
weight, height, HR, SV, P_peak, P_mean, PEEP, Delta_P, RR, TV/pre-
dicted bodyweight, SV and HR, PPV was independently associated
only with low P_mean (T=-3.2; p=0.001), heart rate (T=5.2; p<0.001),
low SV (T=-3.9; p<0.001), young age (T=-2.9; p=0.004) and high
weight (T=2.1; p=0.038), but not with any other ventilatory parameter
including Delta_P and TV/predicted bodyweight.
CONCLUSION. 1.) Among ventilatory parameters, pressures were
more strongly associated with PPV than TV/predicted bodyweight. 2.)
PPV increased with higher Delta_P and lower P_mean. 3.) Haemo-
dynamic parameters like high heart rate and low stroke volume as
well as biometric data such as age and weight have substantial im-
pact on PPV. Therefore, adjustment to these contexts might improve
the use of PPV.
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INTRODUCTION. Since multi-organ failure MOF is frequent in critically
ill patients, apparative multi-organ support is intriguing. The ADVOS-
device (ADVanced Organ Support) has been developed for liversupport, renal replacement, CO2-elimination and modulation of the
acid-base balance. To provide high efficiency, the device is equipped
with two dialyzers for blood purification and ultrafiltration as well as
with two dialyzers for regeneration of the albumin-containing dialysate.
The standard treatment period for liver support is 8 hours. In case of
treatment for CO2-elimination and/or large volume ultrafiltration, pa-
tients are treated (up to) 24h per session. Previous studies (see ESICM
2018) reported on haemodynamic effects of connection and disconnec-
tion as well as ultrafiltration (ISICEM 2019) during 8h-treatment
sessions.
OBJECTIVES. This study reports on haemodynamic effects of 24h-
treatment periods primarily aimed at CO2-elimination and/or high
volume ultrafiltration.
METHODS. Transpulmonary thermodilution with the PiCCO-device
(Pulsion; Germany) was performed immediately before and after con-
nection (T1, T2) with the ADVOS-device and disconnection (T3; T4).
The tubing was prefilled with 0.9% saline ("acute connection"). Con-
nection, ADVOS-treatment and disconnection were performed with a
blood flow of 100mL/min. Concentrate flow was 160mL/min. The
vasopressor dosages were kept stable.
RESULTS. We analyzed 20 treatment sessions with a treatment-goal
of 24h in 4 patients. Patients (2m; 2f), 49±14 years, APACHE-II-score
24±4, aetiology: 1 alcoholic cirrhosis, 1 non-alcoholic steato-hepatitis,
2 MOF; mechanical ventilation 20/20 (100%) treatments. Mean treat-
ment time was 21±3h. Five of the sessions had to be terminated
early (after 12h-19h) due to clotting or organizational reasons (sched-
uled diagnostic or therapeutic procedures outside the ICU). Net ultra-
filtration was not significantly different from the pre-set ultrafiltration
goal (3325±2444 vs. 3818±2508mL; p=0.182). 12 sessions were per-
formed for high-volume ultrafiltration ≥4000mL. Also for these ses-
sions the net ultrafiltration was not different from the pre-defined
ultrafiltration goal (4621±1550 vs. 5333±778mL; p=0.139), although
three of the treatments were stopped early after 15-18h.
Over up to 24h, ADVOS-therapy did not result in significant changes
in heart rate (94±16 vs. 94±13/min; p=0.766), MAP (82±11 vs. 76±
13mmHg; p=0. ), CVP 29±9 vs. 27±9mmHg; p=0.482), SVRI 1016±297
vs. 1017±368 dyne/cm2/m4; p=0.123), dPmax (1798±727 vs. 1669±
557mmHg/s; p=0.374), global end-diastolic volume index GEDVI
760±128 vs. 736±92mL/m²; p=0.515), stroke volume variation SVV
(8±3 vs. 9±6%; p=0.541), CI (4.2±0.6 vs. 4.1±0.4L/min/m²; p=0.515),
global ejection fraction GEF (29±3 vs. 29±4%; p=0.673), pulmonary
vascular permeability index PVPI (2.3±0.6 vs. 2.0±0.6; p=0.068) and
cardiac power index CPI (0.73±017 vs. 0.70±0.16W/m²; p=0.493) after
disconnection (T4) vs. before connection (T1). Only extravascular lung
water index EVLWI slightly increased (13.7±4.8 vs. 12.1±4.9mL/kg; p=
0.041). The noradrenaline dosage was comparable after (T4) vs. be-
fore connection (T1; 606±357 vs. 600±278μg; p=1.000).
CONCLUSION. 24h-treatment with high-volume ultrafiltration and/or
CO2-elimination with the ADVOS-device were haemodynamically
well tolerated.
001229
Comparison of Laser Doppler Imaging With Laser Speckle Contrast
Imaging For Assessing Microvascular Function in Healthy
Volunteers
G. Guven1, A. Dijkstra2, Y. Ince3, J. Montomoli3, N. Trommel4, MV. Baar4,
C. Van Der Vlies4, C. Ince3
1Intensive care unit, Erasmus Medical Center, Rotterdam, Netherlands;
2Intensive care unit, Maasstad Hospital, Rotterdam, Netherlands;
3Translational physiology, Academic Medical Centre, Amsterdam,
Netherlands; 4Burn unit, Maasstad Hospital, Rotterdam, Netherlands
Correspondence: G. Guven
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001229
INTRODUCTION. Laser Speckle Contrast Imaging (LSCI) and Laser Dop-
pler Imaging (LDI) are non-contact real-time monitoring techniques
used to assess the microvascular blood flow of tissue surfaces [1]. These
two techniques measure the microcirculation of different skin depth.
The LSCI is used to evaluate the skin at a depth of 300 μm whereas LDI
can evaluate the depth at 1-1.5 mm [2]. Measurement of different skin
T1
Table 1 (abstract 001252). *p<0.05, **p<0.001
t0 t1 t2
t-IVT (sec/min) 23.12±0.42 19.85±0.41** 15.87±0.28**
MAPSE (mm) 5.52±0.11 6.85±0.13** 9.18±0.16**
CO (L/min) 1.34±0.11 1.74±0.09* 3.41±0.19**
EF (%) 12.47±0.60 14.65±0.76* 19.82±0.64**
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states as occurs in burn-injured patients. Currently, LDI is the most
widely used and validated noninvasive technique for the assessment of
burn wounds [3]. However, LDI device is rather costly, cumbersome
and has a poor spatial resolution. LSCI measures perfusion in a similar
way, but it provides high-quality images with a much higher spatial
resolution. Moreover, the use of LSCI is much easier than using LDI [4].
OBJECTIVES. In this study, we sought to test the linearity of the LSCI
device and LDI device, and assess if these two techniques can be
used interchangeably.
METHODS. Fifteen healthy, non-smoker volunteers participated in
the study. Iontophoresis technique with sodium nitroprusside was
performed as a provocation test on the skin of the forearm. All vol-
unteers were measured using LSCI (Perimed AB, Jarfalla, Sweden)
and LDI (Moor Instruments, Devon, UK) devices at baseline and then
consecutively after initiating the iontophoresis test by. Microcircula-
tory blood flow was analyzed by the software PIMsoft 1.5 (Perimed
AB, Järfälla, Sweden) and MoorLDI2-BI Software Version 4.0. The units
of each technique were reported as arbitrary units. Spearman correl-
ation and linear regression were used to compare the values.
RESULTS. The baseline microcirculatory blood flow was 61 AU (IQR,
51-70 AU) and 34 AU (IQR, 28-37 AU) using LDI and LSCI devices, re-
spectively. Coefficient of variance (CV) was similar within two devices
(CVLDI:19% and CVLSCI: 19.8%). An excellent correlation was de-
tected between the two LSCI devices (R2:0.88, p<0.001) (Figure-1).
CONCLUSION. Skin blood flux measured with Perimed LSCI and
Moor LDI are highly correlated with each other. The higher resolution
and considerably faster scan time of LSCI technique may provide an
advantage if used instead of the LDI technique.
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INTRODUCTION. Veno-arterial extracorporeal membrane oxygenation
(VA-ECMO) is an advanced treatment for refractory cardiogenic shock
(CS) and cardiac arrest (CA). VA-ECMO is used as bridge to recovery,
cardiac transplantation or ventricular assist device (VAD). Successful
weaning from VA-ECMO is defined as device removal without further
requirement for re-cannulation over the following 30 days. There are
few data available regarding timing and reliable parameters for the
VA-ECMO weaning. Total isovolumic time (t-IVT) is a Pulse Wave Dop-
pler established echocardiographic parameter of systo-diastolic inter-
action and ventricular efficacy (1). Along with MAPSE (mitral annular
systolic plane excursion), it showed to be the most sensitive echocar-
diographic marker of haemodynamic profile in patients with cardio-
genic shock.
OBJECTIVES. To evaluate which echocardiographic parameters are
able to predict successful VA-ECMO weaning.METHODS. Single-center retrospective observational study of pa-
tients with refractory CS and CA who underwent VA-ECMO insertion
from January 2013 to December 2017. Demographic, clinical, echo-
cardiographic and outcome data were collected. Primary endpoint
was to test the predictive power of echocardiographic indices for VA-
ECMO weaning. We measured left ventricular (LV) t-IVT, MAPSE (cal-
culated as mean of septal, lateral, anterior and inferior values), ejec-
tion fraction (EF), Echo-derived stroke volume (SV) and cardiac
output (CO). Data analysed: time of cannulation (t0), during the first
weaning trial after 48 hours (t1) and, in those who survived, at last
trial before decannulation (t2).
RESULTS. Preliminary results of 46 patients (76% male; 52±12.5 y.o.)
underwent VA-ECMO cannulation. 21 (44.6%) patients died within 24
hours; 19 of them had CA. 25 patients undertook weaning trial: 18 were
weaned (72%; 39% overall population) and 14 (56%; 30% overall popu-
lation) were discharged alive from ICU. At time of cannulation, patients
successfully weaned form VA-ECMO had shorter t-IVT (23.12 vs 33.6
sec/min, p<0.001) and greater MAPSE (5.82 vs 4.83 mm, p<0.05), SV
(15.11 vs 10.42 mL, p<0.05), CO (1.36 vs 0.91 L/min, p<0.05) and EF
(11.4 vs 9.04, p<0.05); heart rate between two groups was not signifi-
cantly different (84.7 vs 95.4, p 0.24). In weaned patients, the variations
from t0 to t2 of all these parameters (left ventricular t-IVT, MAPSE, SV,
CO and EF) were significative, as shown in table 1.
CONCLUSION. The mortality of patients undertaking VA-ECMO re-
mains exceptionally high, especially in patients with refractory car-
diac arrest. Amongst all the echocardiographic parameters tested, t-
IVT at the baseline was the strongest predictor of VA-ECMO weaning.
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INTRODUCTION. Global end-diastolic volume (GEDV) derived by
transpulmonary thermodilution is regarded as indicator of cardiac
preload. The thermistor catheter required for measurements is usu-
ally placed in a femoral artery. A bolus of cold saline injected in a
central vein travels through the right heart, arterial and venous ves-
sels of the lung, the left heart, and finally the aorta until detection.
Surprisingly, the latter is not considered in the theoretical framework
of transpulmonary thermodilution (1).
OBJECTIVES. to investigate the impact of the aortic volume on mea-
surements of GEDV.
METHODS. We screened our database of patients with transpulmonary
thermodilution monitoring for subjects having additionally received a
contrast-enhanced thoraco-abdominal computed tomography (CT)
scan. From the CT scan we calculated the volume of the aorta, using




Fig. 1 (abstract 001294). See text for description
Fig. 2 (abstract 001294). See text for description
Fig. 3 (abstract 001294). See text for description
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GEDV measurement closest in temporal proximity.
RESULTS. 88 patients with 103 CT scans were identified. Median aor-
tic volume was 193.78 ml (IQR: 147.15-248.92 ml). Median GEDV was
1305.67 ml (IQR: 1104-1568.77 ml). Average time difference between
CT and GEDV measurement was 2 hours (IQR: 1-5 hours). GEDV in-
creased linearly by 2.9 ml (95% CI: 1.8 to 4 ml, p < 0.001) per ml of
aortic volume. The variance of thermodilution-derived GEDV ex-
plained by aortic volume was 59.3 % (p < 0.001), without significant
further relationships to sex, age, body height or weight.
CONCLUSION. We provide evidence that the aortic volume is the
main source of variance of GEDV in patients measured by single-
indicator transpulmonary thermodilution, thus representing a so
far unrecognized confounder. Our findings challenge the view of
GEDV as preload indicator. In consequence, guiding clinical vol-
ume therapy by reference ranges of raw or indexed GEDV may
be misleading.
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INTRODUCTION. Mean systemic filling pressure (Pmsf) correlates
with intravascular volume. Bedside estimation of Pmsf has been
described in critically ill patients by three methods(1). Pmsf
along with other haemodynamic variables can provide valuable
information to correctly understand the cardiovascular status of
critically ill patients, and their performance before and after
passive leg raising (2), can facilitate the understanding of venus
return (3).
OBJECTIVES. To determine the grade of correlation beween
Pmsf and other haemodinamic variables during passive leg rais-
ing test (PLRt).
METHODS. observational, retrospective, cross-sectional and descrip-
tive study in patients with continuous hemodynamic monitoring dur-
ing a shock state. Pmsf analogue (4)value before and after a Passive
Leg Raising test was analyzed.
RESULTS. 62 simultaneous measurements of CO, CVP and MAP were
performed, Pmsf was calculated before and after a PLRt. Correlation
between Pmsf and CO was Pearson’s R = 0.6064 (p≤0.00001) that in-
dicate a moderate to strong relationship between both variables,
that support that increases in ΔPmsf will produce increases in ΔCO
during PLR (and viceversa). However, Pearson’s R = 0.2486 (p=
0.0513), that indicates a poor relationship between both ΔPsma and
final CO (after PLRt). Correlation between CVP and CO was Pearson's
R = 0.34562 with p = 0.005831, although technically a positive correl-
ation, the relationship between ΔCVP and ΔCO is pretty low.
CONCLUSION. We found a significative positive correlation between
ΔPmsf and ΔCO, but there was not significative correlation between
ΔPVC and ΔCO. ΔPmsf can be useful as a volumen response indicator
in selected patients.
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INTRODUCTION. Cardiac arrest (CA) is a leading cause of mortality
annually in the USA and Europe. The relationship between socioeco-
nomic status and various components of health is well established.
OBJECTIVES. The aim of this study was to investigate the relationship
between socioeconomic factors and outcomes following admission
to intensive care with cardiac arrest, both in hospital cardiac arrest
(IHCA) and out of hospital cardiac arrest (OHCA) using deprivation
measures calculated on the basis of domicile postcodes.
METHODS. All cardiac arrest cases admitted to our regional intensive care
unit in South West Wales, UK between January 2007 and June 2018 were
included in this analysis. Data included age, gender, domiciliary postcode,
comorbidities, length of stay, follow-up time and survival status. The Welsh
Index of Multiple Deprivation, 2014 (WIMD) was used to stratify cases by
level of social deprivation according to domiciliary postcodes. Outcomes
were investigated using multivariate regression modelling.
RESULTS. Of the 1034 (532OHCA and 502 IHCA) patients included in
the study, 679 patients were deemed ‘less deprived’ while 355 patients
‘more deprived’ according to established definitions. Compared to their
‘more deprived’ counterparts, patients who were ‘less deprived’ were
older on admission, 66.2 vs 62.1 (p<0.001) and predominantly male
(473 vs 205, p<0.001). There were no differences at 7 and 30 days in
terms of mortality, p=0.62 and p=0.26 respectively.
In the OHCA cohort, being ‘more deprived’ showed strong and inde-
pendent correlations with mortality within the first year after admission
to ICU [All: OR 1.71 (95% CI 1.14-2.61), IHCA: OR 1.81 (95% CI: 1.19 –
2.76), OHCA: OR 3.26 (95%CI: 2.12-5.07)]. Conversely, in the IHCA cohort
social deprivation was not a risk factor one-year post admission to ICU.
CONCLUSION. This is the first study in which social deprivation has
been investigated as a risk factor for death following admission to
ICU with cardiac arrest in South West of Wales. Residing in a ‘more
deprived’ area in South West Wales following admission an OHCA is
associated with an increased risk of death compared to IHCA follow-
ing one year after admission to ICU.
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INTRODUCTION. There is a dearth of literature reporting cost analysis
of patients admitted to intensive care unit (ICU) post out of hospital
cardiac arrest especially within the UK. This is essential for assess-
ment of cost-effectiveness of interventions necessary to allow just al-
location of resources within the National Health Service.
OBJECTIVES. We aimed at performing a cost analysis of ICU stay as
well as hospital stay in both in hospital (IHCA) and out of hospital
(OOHCA) cardiac arrest patients admitted to ICU.
METHODS. This is a single centre retrospective observational review
of Wardwatcher database. All post cardiac arrest patients admitted to
a tertiary referral ICU from January 2007 until December 2017 is in-
cluded. The cardiac arrest patients were grouped as out of hospital
cardiac arrest (OHCA) and in hospital cardiac arrest (IHCA).RESULTS. Of 965 consecutive patients admitted 475 were in OHCA
group and 490 in IHCA group. The Trust finance department supplied
ICU and hospital costs. Estimated cost of an ICU bed was £1159.00
and estimated cost of a ward bed was £327.00 according to the NHS
reference costs data 2017-18. Of those patients with return of spon-
taneous circulation (ROSC) admitted to ICU, survival to hospital dis-
charge in OHCA was 37% while IHCA was 35% survivors at hospital
discharge. Mean length of days on mechanical ventilation was higher
in the IHCA group compared to the OHCA (5.3 vs 5.1 days, p=0.006).
Similarly mean length of ICU stay was longer in the OHCA as com-
pared to IHCA (6.8 vs 8.4 days, p= 0.004) as well as mean length of
total stay in hospital was longer in the OHCA as compared to IHCA
(16.7 vs 15.0 days, p= 0.03). Total in-hospital costs was significantly
higher in OHCA compared to IHCA (£12,796 vs £10,825, p=0.02).
CONCLUSION. The costs of in-hospital patient care and mean total
length of stay in hospital for ICU admissions following ROSC after OHCA
are significantly higher than those of IHCA. This might be due to the
fact that OHCA patients have a longer stay in ICU compared to IHCA.
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INTRODUCTION. It was demonstrated by several studies that patients
admitted to hospitals on weekends have a higher mortality rate. The
reasons might be multifactorial and may be limited to certain diag-
nostic groups and admission subtypes.
OBJECTIVES. We aimed at investigating whether the outcomes of cardiac
arrest patients, both in-hospital (IHCA) and out-of-hospital (OHCA) differed
between weekday and weekend admissions at our intensive care unit (ICU).
METHODS. This is a single centre retrospective observational study. The
database WardWatcher is widely used in United Kingdom (UK) ICU’s and
the data was collected from this. Cardiac arrest patients who were admitted
between January 2007 to July 2018 to a tertiary ICU were included. Death
in ICU and death in hospital were used as outcome measure. Logistic re-
gression was used to adjust for potential confounding factors.
RESULTS. Of the 1034 patients admitted with cardiac arrest, 629 pa-
tients were admitted on a weekday while 405 patients on a week-
end. Patients admitted on weekday were older, 65.6 vs 63.5 years
old, (P<0.0001), had worse creatinine function, 172.7 vs 167.2 (P<
0.0001). No significant differences in outcome were found between
weekday and weekend admissions in rates of death in ITU and death
in hospital (P= 0.89 and P = 0.61, respectively) even after adjusting
for possible confounding factors.
CONCLUSION. The rate of survival to hospital discharge was similar for
patients admitted with cardiac arrest on a weekday or weekend even
after adjusting for many potentially confounding factors. This study
demonstrates that increased mortality rates during weekend admission
is limited to certain diagnostic groups and admission subtypes.
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outcomes is well established. However, studies examined the associ-
ation between poverty and mortality among critically ill patients and
results were contradictory. Yet, previous studies were conducted with
sample size of few selected hospitals. In this study, we evaluated the
association between poverty and outcomes including in-hospital
mortality, re-admission of intensive care unit (ICU) and emergency
room (ER) visit after discharge using national health insurance data.
METHODS. This is a retrospective cohort study using the national
database from Health Insurance Review and Assessment (HIRA). We
identified 1,657,218 patients who were 18 years of age or older, who
had a first ICU admission between January 1, 2008 and May 31, 2015
and who was not being poor poverty status during inpatient. Poverty
was defined when patients were Medical Aid beneficiaries. We used
logistic regression and cox regression to evaluate risk of in-hospital
death, re-admission, and ER visit among people with poverty com-
pared to people without poverty.
RESULTS. Of total, 11.0% (n=182,091 patients) were patients with
poverty. People with poverty were more likely to be female (50.7%
vs. 42.2%), had more co-morbidities, and were more likely to be ad-
mitted to lower quality hospitals compared to patients without pov-
erty. In -hospital mortality rate among patients with poverty was
higher (16.5 %) than patients without poverty (12.2 %). The adjusted
OR for in-hospital mortality associated with poverty was 1.20 (95% CI
1.18-1.22) and it remained significant even after matching hospital
(OR 1.10; 95% CI 1.09-1.12). Among patients who were discharged
without death (n= 1,411,008), patients with poverty were more likely
to have re-admissions to ICU (fully-adjusted HR 1.26; 95% CI 1.23,
1.29) and ER visits (fully-adjusted HR 1.28; 95% CI 1.25, 1.32) within a
year after discharge compared to patients without poverty.
CONCLUSION. Poverty was associated with an increased risk of in-
hospital mortality, re-admission to ICU, and ER visits after discharge
from ICU. The association was consistent even after controlling qual-
ity of hospital. It would be necessary to find out factors associated
with worse outcomes among patients with poverty at ICU and ways
to intervene them.
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INTRODUCTION. Research in the critically ill and injured population
often requires time-sensitive enrollment when patients and their
families are focused on making important clinical care decisions. Pa-
tients with chronic medical conditions may have the opportunity to
contemplate clinical choices, and as such more readily consider par-
ticipation in research trials.
OBJECTIVES. To examine if the acuity of illness correlates with pa-
tient’s or surrogate decision-maker’s opinions informing research
participation.
METHODS. Study participants were identified by admission >24
hours to an intensive care unit (ICU) at an urban tertiary hospital. De-
cision makers were approached to complete an anonymous elec-
tronic survey between 3-7 days following ICU admission. Only the
person providing informed consent at the time of survey was asked
to participate. Surveys consisted of closed-ended questions and took
5-15 minutes to complete. A full waiver of consent was granted by
the IRB. Standard statistical techniques were used for analysis.
RESULTS. There were a total of 674 subjects, of which 335 were crit-
ically ill or injured, and 339 were surrogate decision makers. Subjects
completed surveys from April 2018 to January 2019. Participantswere stratified as being admitted to the ICU for either an acute (372)
or chronic (302) condition. There was no difference in mean age
(56.8, 59.3), gender (60.8% and 60.6% male), or race of patients
among the groups. Acute (68.7%) and chronic (71.9%) subjects were
equally as open to consider participating in a research study. Acute
(43.7%) and chronic (41.7%) subjects also had similar, but reduced
interest (p<0.001) in co-enrolling in multiple research studies. Fur-
thermore, both groups were equally more interested (p<0.001) in
participating in a research study if it may potentially benefit the pa-
tient directly (79.3%, 78.8%) vs. benefiting others (57.4%, 56.6%).
CONCLUSION. Acuity of illness does not affect decision makers’ opin-
ions of research. Critically ill and injured patients and their surrogate
decision makers are collectively more open to considering one research
study vs. multiple research studies, suggesting that investigators should
prioritize research in a manner that reduces participant burden. Further,
such prioritization may include potential direct benefit to study partici-
pants. Researchers should not approach patients with acute vs. chronic
conditions differently regarding research participation.
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INTRODUCTION. Central venous catheters (CVCs) are frequently used
in intensive care units (ICUs) for variety of indications. CVC-related
thrombosis (CRT) is a potentially serious complication and may con-
tribute to some adverse effects, including pulmonary embolism, CVC
dysfunction, infection or loss of central venous access [1]. Preliminary
observation studies showed that CRT was mostly asymptomatic, and
the incidence was not low. However, there is a lack of medical litera-
ture about the incidence and characteristics of CRT in ICU [2,3].
OBJECTIVES. This is a multi-center, large-sample prospective study to
identify the incidence, occurrence time, risk factors, treatment of CRT
and outcome in ICU patients, so as to provide a basis for further
optimization of CRT screening protocol and prevention.
METHODS. We prospectively included patients with CVCs and col-
lected patient characteristics in 28 Chinese ICUs during 9-month study
period. Compression test and duplex Doppler ultrasound screening of
catheter-veins were systematically performed prior to insertion, 12h
after insertion, and then, daily until removal of CVC or patient dis-
charge. In addition, CVC characteristics, catheterization, CRT characteris-
tics, treatment and complications of CRT were also daily recorded.
RESULTS. There were 1479 CVCs placed during the study period in
1357 subjects. Of these, 740 (50.03%) were inserted into the internal
jugular veins, 413 (27.92%) in the subclavian veins, 297 (20.08%) in fem-
oral vein, and 29 (1.97%) in axillary vein. The incidence of CVC-related
thrombosis was 15.28% (n=226). Univariate and multivariate analysis
demonstrated that CRT is associated with the major diagnosis, ICU
length of stay, place of catheterization, length of catheterization, and
the catheterization location (p≤0.001). Notably, thrombosis can occur at
any time from the first day after insertion to 3 days after removal, with
a median of 4 days (IQR, 2-7). 88.94% of thrombosis occurred within a
week after insertion. 77.43% of CVCs with CRT injected blood or blood
products. In addition, the treatments of CRT were uniformity. Of these,
21.90% of patients with CRT are treated with anticoagulation, but the
type, dose and duration of drugs were highly variable. 19.91% of CVCs
with CRT were removed immediately, and the rest were no interven-
tions for the thrombosis (Table 1).
CONCLUSION. Central venous catheters-related thrombosis is a rela-
tively common complication in ICU. It is most associated with the
major diagnosis, ICU length of stay, place of catheterization, length
of catheterization, and the catheterization location. It may occur at
any time after catheterization. Thus, a protocol of routine ultrasound
screening for CRT after CVC needs to be developed.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000700INTRODUCTION. Up to 2/3 of patients admitted to the intensive care
unit (ICU) will develop acute respiratory failure (ARF) during their
hospitalization, and thus, will require ventilatory support. Invasive mech-
anical ventilation (IMV) is the most frequently used ventilatory support
strategy in the ICU. Once patients achieve clinical stability, clinicians face
an important challenge when attempting ventilatory weaning; because
around 13% of patients will need re-intubation, which increases morbid-
ity and mortality. High Flow Nasal Cannula (HFNC) is a recently intro-
duced ventilatory strategy used in patients with hypoxemic ventilatory
failure. HFNC has been successfully used as initial ventilatory support and
for weaning in several studies. Whereas bridge therapy with HFNC is a
proved strategy, many patients will still require re-intubation within the
first 48 hours of extubation; and risk factors for HFNC failure are contro-
versial. Therefore, the goal of this study is to identify risk factors that
could predict extubation failure in spite of using HFNC.
OBJECTIVES. To determine the risk factors associated with High Flow
Nasal Cannula (HFNC) treatment failure during ventilatory weaning.
METHODS. This is a 2-year retrospective observational cohort study con-
ducted in a hospital in Bogota, Colombia; between January 2016 and
June 2018. All adult patients receiving IMV for more than 12 hours, who
were posteriorly extubated and treated with HFNC as bridge therapy
were included. HFNC failure was defined as the need for non-invasive
mechanical ventilation (NIMV) or re-intubation within 48 hours after extu-
bation. Difficult weaning group was defined as patients who had fail the
extubation process or did not pass weaning tests. Descriptive statistics,
parametric, non-parametric and logistic regressions were used to deter-
mine risk factors for HFNC failure. All statistical analyzes were performed
using IBM SPSS statistics, version 22.0 Armonk, NY: IBM Crop.
RESULTS. A total of 109 patients were included in the study. 23
(21.1%) patients developed HFNC failure after weaning of IMV. As ex-
pected, patients who require vasopressors during ICU admission
(52.2% Vs 10.5%, p=<0.01) and inotropes (34.8% Vs 10.5%, p=0.01)
were more likely to present HFNC failure. Patients who fail HFNC
were most likely to be in the difficult weaning group (60.9% Vs
30.2%, p=<0.01) and had higher respiratory rate before extubation
(Median, Interquartile Range; 22 breaths per minute (BPM) [IQR 18-
25] Vs 18 BPM [IQR 16-21], p=0.04). No differences were found
among groups regarding gasometrical variables prior extubation,
days of mechanical ventilation, ICU length of stay nor ICU mortality.
CONCLUSION. Bridge therapy with HFNC is a safe method for venti-
latory weaning. We have identified 2 novel risk factors (weaning type
and higher respiratory rate) that were independently associated with
HFNC failure. Further studies are needed to confirm these findings.
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INTRODUCTION. Morbidly obese patients attending for bariatric sur-
gery are at increased risk of complications in the peri-operative
period due their associated medical co-morbidities (1) (2). Our NHS
hospital has performed over 4,000 bariatric surgical procedures since
the service started 12 years ago and we sought to analyse the im-
pact that this has had on critical care.
OBJECTIVES. - To identify what proportion of all bariatric cases were
admitted to the intensive care unit, along with details surrounding
the support required and overall outcome.
- To compare these details to the total ICU workload and thereby
demonstrate the overall impact on the service.
METHODS. We have maintained a single site bariatric anaesthe-
sia airway database since 2006, which was checked for com-
pleteness by cross-referencing against Hospital Episode Statistics
surgical codes. This was then matched against an ICU dataset
of all admissions under the names of the four surgeons who
admitted all bariatric surgery performed between 2007 and
2018. Cases admitted following primary bariatric surgery, or pro-
cedures related to any previous bariatric surgery, were included.
Cases were individually reviewed to verify that they were genu-
inely associated with the inclusion criteria. Key parameters of
interest including type of admission, system and level of organ
support, duration of that support and the final outcome were
obtained.
RESULTS. Over a 12 year period, out of a total of 4405 bariatric
procedures, a cohort of 193 (4.4%) patients required admission.
These cases utilised 533 bed days which accounted for 1.51% of
all ICU bed days in the same period. 36 (19%) of this cohort re-
ceived level 3, i.e. advanced ICU support, which utilised 0.78% of
all ICU level 3 bed days in that period. 81% were level 2 only
(HDU) and utilised 2.44% of all level 2 bed days. 53% were
planned admissions, 32% emergency surgery and 15% were ad-
mitted from wards. APACHE II predicted 30 day mortality was
10.2 deaths; the actual was 6, giving a standardised mortality ra-
tio of 0.59. In 2011 a new model of multi-disciplinary pre-
assessment was introduced where all patients were screened by
a team involving anaesthetic input before surgery was offered.
Since that change, our rate of admission of level 3 patients has
seen a six-fold reduction.
CONCLUSION. A mature Bariatric service is responsible for a small
proportion of the overall workload in our intensive care unit, be-
tween 0.5 and 1% annually. Patients who are admitted tend to
be older, predominantly male and lengths of stay are usually very
short. Critical care units in a centre that is to introduce such a
service may find an initial higher workload, but with agreed and
sensible pre-assessment pathways the number of patients requir-
ing advanced ICU support will be very low.
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INTRODUCTION. Little is known about the prevalence of critically ill
patient-surrogate discordance for treatment goals in the moment, or
about the clinical implications of this discordance. In a recent multi-
center RCT testing a web-based personalized decision aid (DA) for
surrogates of prolonged mechanical ventilation patients, the DA dis-
played the goal of treatment most concordant with patient values
based on surrogates’ reports of patient preferences.1 The unique de-
sign of the DA captured intervention surrogates’ adjustment of the
calculated goal of treatment option on their digital device at the mo-
ment of decision making.
OBJECTIVES. To identify characteristics of surrogates who chose dis-
cordant treatment goals and to determine the impact on patient out-
comes of surrogate decisions that appeared discordant from patient
preferences.
METHODS. 276 participants including all 138 primary decision
makers and 138 patients ventilated for ≥10 days from the RCT’s deci-
sion aid intervention group. We used chi square and t-tests to com-
pare baseline and 1-week surrogate (Hospital Anxiety and
Depression Scale, PTSS, clinician-surrogate prognostic concordance
score) as well as patient outcomes (days of ventilation, ICU
care, hospitalization; 6-month mortality) by decisional groups (surro-
gate-patient decisional discordance vs. surrogate-patient decisional
concordance).
RESULTS. Of 129 (93%) surrogates witht complete data, 56 (43%)
chose a goal of care that was discordant overall with patient prefer-
ences. 20 (11%) were markedly different than patient preferences
(i.e., change among the three main choices [comfort, aim for sur-
vival but avoid prolonged care, aggressive care). 55 (98%) discordant
decisions were related to a desire for more aggressive care than pa-
tients preferred.
We found no statistically significant associations between decisional
discordance and either surrogate characteristics (age, race, gender,
education, medical comprehension, employment, relation to patient,
religion, distress level, amount of decisional conflict) or patient
(demographics, APACHE II, diagnosis, comorbidities, medical vs. surgi-
cal ICU) factors (p >0.05).
Compared to concordant dyads, discordance was not associated with
differences at 1 week in change in either prognostic discordance
with physicians or symptoms of distress (depression / anxiety / PTSD
symptoms; all p >0.05). Compared to concordant patients, discord-
ant patients had numerically greater mean days of ventilation (18.0
[31.6] vs. 13.9 [15.5]), ICU care (23.2 [33.2] vs. 18.7 [16.3]), and
hospitalization (45.6 [36.4] vs. 41.3 [27.8])—though identical 6-month
mortality (39.3% vs. 37.0%); all p <0.05.
CONCLUSION. Surrogates commonly make goals of care decisions
that are discordant with patient preferences they themselves report,
yet we identified no characteristics that separated them from con-
cordant surrogates. Patients linked to discordant surrogates had
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improvement in mortality compared to concordant patients. These
exploratory findings suggest that it may be particularly important to
focus future palliative care and decision support interventions on sur-
rogate decision makers who choose goals of care that are not
aligned with patient preferences.
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INTRODUCTION. Though ultrasonography (USG) guided central ven-
ous catheter (CVC) insertion has been advocated by critical care soci-
eties and hospitals, it has still not become the norm in ‘real life’
scenario in the ICUs. Lack of training in use, ability to handle, and
availability of USG machines have been demonstrated to be the rea-
sons for the same.
OBJECTIVES. We conducted a survey to assess the use of USG during
CVC insertion.
METHODS. A survey comprising 10 questions was designed and
mailed electronically to 386 physicians working in various ICU in our
district. The questionnaire comprised queries regarding aspects of
USG training, use and opinion of USG during/after CVC insertion and
frequency of use, need for further training, etc.
RESULTS. Of the 190 questionnaires returned, 60% were consultant phy-
sicians, while 40% were residents. 28% were working in rural locations.
About 56% of doctors reported training in the use of USG, while 46%
used it routinely for CVC insertion (always 30%, almost always 66%).
The main reasons for non-use of USG during CVC insertion were i)
lack of adequate training (50%), ii) no need of USG guidance during
CVC insertion (54%), iii)landmark technique equally good for CVC in-
sertion (61%),iv) other nonspecified reason (8%).
All respondents thought that landmark technique should be taught
to trainee doctors.
Almost all resident doctors (96%) as compared to seniors declared
that they use USG (always, almost always) for CVC insertion.
CONCLUSION. Despite various guidelines and studies demonstrating
superiority of USG guidance during CVC insertion, its use is still not
widespread and enough. Training and use of USG needs major im-
provement amongst the ICU doctors in our district.
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INTRODUCTION. Many patients admitted to ICU require a prolonged
stay in an intensive care unit (ICU) as they recover from their critical
illness. These patients have been reported to have increased mortal-
ity and morbidity.
OBJECTIVES. To study the incidence, characteristics and outcomes
of prolonged stay critically ill patients admitted to our ICU.
METHODS. Retrospective analysis of patients admitted to our adult
ICU (Total- 40 bedded; 20 bed medical plus cardiac ICU, 20 bed surgi-
cal ICU) during last 2 years. All patients with ICU stay > 21 days (due
to mechanical ventilation and/or for hemodynamic monitoring) were
included in the study. Prolonged stay critically ill patients were classi-
fied according to their location in ICU and reason for ICU admission,
as medical or surgical prolonged stay critically ill patients. The main
endpoints of the study were ICU and hospital length of stay (LOS),
and mortality.
RESULTS. Of the total 1097 patients admitted to the ICU during the
period of study, 67 patients were included in the study, for an inci-
dence of 6.1% (Medical patients- 4.6%; Surgical patients- 7.9%). The
most common diseases at ICU admission were stroke and neuromus-
cular disease in medical patients and intestinal diseases (obstruction
or perforation) in surgical patients. Mean APACHE II score on admis-
sion in the medical and surgical patients were 17 (IQR 11-25) and 19
(IQR 14-28) (p=0.88). There was no significant difference in age, gen-
der, tracheostomy, use of mechanical ventilation and vasopressors
between the two groups of patients (p> 0.05 for all). Surgical pro-
longed stay critically ill patients had more episodes of hospital ac-
quired infections as compared to medical prolonged stay critically ill
patients (p<0.05).
Mean LOS in ICU for medical and surgical prolonged stay critic-
ally ill patients were 26.6 and 33.6 days, respectively (p< 0.001).
Mean LOS in hospital for medical and surgical prolonged stay
critically ill patients was 28.5 and 39.2 days, respectively (p<
0.001). The mortality for medical and surgical prolonged stay crit-
ically ill patients was 50% and 44%, respectively (p=0.08).
CONCLUSION. A small component of critically ill patients admitted
to ICU will turn into prolonged stay critically ill patients, requiring
ICU care for a longer period of time. Prolonged stay critically ill
patients due to surgical indications for admission to ICU have
more hospital acquired infections, longer ICU and hospital LOS
but no significant increase in mortality as compared to prolonged
stay critically ill patients due to medical indications for admission
to ICU. More and larger studies are required to further analyse
prolonged stay critically ill patients.
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INTRODUCTION. In veno-arterial extracorporeal membrane oxygen-
ation (VA ECMO) with femoro-femoral cannulation the watershed is
the location where retrograde ECMO-perfusion and antegrade car-
diac perfusion encounter (figure 1). To date, angiography or contrast
enhanced computed tomography is the only available method to de-
termine the watershed location, which has only been described in
several case reports (1-3).
OBJECTIVES. We hypothesized that contrast-enhanced ultrasound is
a suitable method to detect the watershed at the bedside and exam-
ined its feasibility and safety.
METHODS. This prospective study included consecutive adult pa-
tients undergoing emergency femoro-femoral VA ECMO cannulation.
The primary outcome measure was the feasibility of contrast-
enhanced ultrasound for bedside detection of the watershed. The
Secondary outcome was the safety of the procedure.
1ml of contrast media (Sonovue) was administered via the venous
drainage ECMO cannula while transabdominal and transesophageal
ultrasound was performed to concurrently display the abdominal and
the thoracic aorta. Application of contrast media was repeated until the
watershed was detected or the maximum volume of 4ml was reached.
Safety values obtained included hemodynamic values (mean arterial
pressure, mmHg; heart rate, bpm; SpO2, %; paO2, mmHg; left and
right if applicable; paCO2, mmHg), respirator settings (FiO2, %; peak
pressure, mbar; tidal volume, ml), neurologic assessment (examin-
ation of pupils and computed tomography imaging of the brain if
appropriate) and ECMO settings (FiO2, %; sweep gas flow, l/min;
pump speed, rpm; blood flow, l/min). Patients were assessed for
safety parameters as well as ventilatory demand, hemodynamic in-
stability, arrhythmias, anaphylactic reactions or death at baseline,
5min, 15min, 2h and 6h after contrast media administration. Patients
were followed up until hospital discharge or death.
RESULTS. Between October 2018 and February 2019 10 patients
(90% male, mean age 52 years) were enrolled at three intensive care
units at the Medical University of Vienna. The watershed was de-
tected in the abdominal aorta in five patients (figure 2). In the
remaining patients continuous blood flow was visible in all examined
areas, suggesting the watershed located at the level of the aortic
arch. No adverse events in close temporal relationship to contrast
media administration were observed.
CONCLUSION. Contrast-enhanced ultrasound appears to be a tech-
nically feasible and safe method to determine the location of the
watershed at the bedside in adult patients on VA ECMO with
femoro-femoral cannulation.REFERENCE(S)
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INTRODUCTION. Within healthcare many multidisciplinary teams ro-
tate to gain wider clinical experience, develop skills and promote pro-
fessional development, however within nursing in the UK rotation
programmes are not as widely established. The Department of Health
(2001) advocated for the introduction of rotation programmes within
Critical Care, as an initiative to increase recruitment and retention. Prior
studies looking into rotation programmes found that staff expressed
development of their clinical skills and knowledge (Chen et al., 2015;
Lawton, 2006), which in turn lead to career development opportunities
(Järvi and Uusitalo, 2004; Fujino and Nojima, 2005; Richard-
son et al., 2003). However, it was also recognised that individuals can
find rotating daunting when required to work in an environment or
speciality in which they are unfamiliar (Richardson et al., 2003). The pur-
pose of this study was to explore nurses experience of the Critical Care
Rotation Programme based in a London Trust.
OBJECTIVES. To explore nurses experience of the Critical Care Rota-
tion Programme, specifically looking at pre-rotation preparedness,
the rotation experience and post-rotation reflection.
METHODS. A phenomenological design was used to explore atti-
tudes, experiences and opinions (Parahoo, 2006). An evaluative study
was developed in the form a 'service evaluation', whereby ethical ap-
proval was sort from the Trust and the researchers University of
study. A mixed-methods design was adopted to explore both qualita-
tive and quantitative data; comprising of an electronic questionnaire
and semi-structured interviews. Forty-four individuals completed the
Critical Care Rotation Programme within 2018 and were invited to
participate; 21 (47.7%) electronic questionnaire responses were re-
ceived. A further 10 participants were interviewed to gain further
narrative of their experiences. The data was evaluated using themati-
cal analysis (Braun and Clarke, 2006).
RESULTS. The recognised benefits of the rotation programme in-
cluded improving clinical knowledge and specialist skills, enhancing
interdepartmental teamworking and communication, and the devel-
opment of global awareness and leadership skills. Day to day support
from staff and mentors was highly valued and attributed to an over-
all better experience. However, apprehensions prior to the rotation
where common; which included fears surrounding working in a new
environment and team. Disadvantages of the programme largely fo-
cused on logistical issues such as issues with security access to the
rotation site and an inadequate induction period. Operational issues
were reported including patient allocation and limited access to rota-
tion mentors. However, overall all of the participants valued the
experience.
CONCLUSION. The evidence from this study suggests that the Critical
Care Rotation Programme is a valuable strategy for promoting learn-
ing, enhancing interdepartmental relationships which promote cross-
site working, and encouraging professional development and career
Page 329 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55progression. In order to improve the programme for 2019; a new
mentoring strategy has been introduced to provide improved sup-
port. There is limited prior research in this area, and due to the small
sample included in this study, more research would need to be con-
ducted in the field before conclusions can be drawn to influence
general practice.
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INTRODUCTION. Early identification of hospitalized patients at risk to
develop clinical worsening would reduce the number of preventable
deaths and admission at the Intensive Care Unit (ICU).
OBJECTIVES. To implement, in clinical practice, an early alert system
based on clinical and laboratory findings aimed at establishing an ef-
fective communication between ICU physicians and the wards physi-
cians and to evaluate its usefulness to detect and to prevent the
avoidable clinical deterioration in hospitalized patients.
METHODS. Retrospective analysis of the electronic medical charts of
patients older than 18 years hospitalized in any medical or surgery
ward during the study period (January-December 2018). We col-
lected, within the 6 hours prior to the consultation of the system, the
following variables: age, sex, patient location, heart rate (HR) (<40
lpm; >130 lpm), respiratory rate (RR) (< 10 breaths/min;> 30 breaths/
min.), systolic blood pressure (SBP) < 85 mmHg, partial oxygen satur-
ation (SaO2)< 85%, pH < 7,30, PaCO2 > 65 mmHg and Lactate > 4
mmol/L. Patient´s charts showing alteration of one or more variables
prompt a full evaluation of the clinical chart by the ICU physician
and an on-site intervention with treatment reorientation or intensifi-
cation or immediate transfer to ICU or participation in the decision
to life support therapy limitation (LSTL).
RESULTS. 1189 records were evaluated. The mean age of patients
was 71 years (SD 2.4), 52.34% were males. The hospital wards where
more alerts were detected were the emergency room (n=462; 38%),
internal medicine ward (n=396; 32.5%), oncology ward (n=68;5.6%),
pneumology ward (n=50;4.1%), surgery (n=34;2.9%), digestive ward
(n=35;2.6%), traumatology (n=31; 2.5%) and gynaecology-obstetrics(n=26;2.1%). A single altered variable was detected in 94.2% of the
alerts, being the most frequent the SBP< 85mmHg (26.1%),SaO2 <
85%(23%), lactate > 4mmol/L (13%), HR> 130 lpm (12.5%), pCO2 >
65 mmHg (11.4%), RR > 30 breaths/min. (7.6%) and pH < 7.30
(5.12%). Up to 71 patients (5.8%) showed more than two altered vari-
ables being the most frequent combination pCO2/Ph (n=31). In-situ
evaluation and treatment were done in 167 cases (13.74%), and only
15 patients were considered candidates to immediate admission at
ICU (1.25%), being alterations in SBP and in SaO2 the main causes
for ICU admission. In the remainder patients an intensification of
treatment consisting in the start or adjustment of non-invasive posi-
tive pressure ventilation and initiation or intensification of fluids ther-
apy was recommended (67.5%). In up to 5.45% of the patients the
consensus decision was to not transfer to the ICU, in up to 12.75% of
the patients the patient´s physician had already decided to LSTL.
CONCLUSION. This alert system allowed the early detection of pa-
tients at risk of clinical deterioration. Despite it is a consuming-time
task for ICU physicians, it allows to participate, together with the pa-
tient´s physician, in the optimization of the treatment as well as in
the decisions of LSTL ,and reduce the number of admissions at ICU.
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INTRODUCTION. Up to 60% of the patients hospitalized in the ICU
require ventilatory support, being invasive mechanical ventilation
(IMV) the most frequently used therapy. Patients treated with IMV
are at risk of developing adverse events such as barotrauma, infec-
tions, among others. Re-intubation is needed in 13% of cases, with
associated increased morbidity and mortality. Several scores and
strategies have been developed to prevent reintubation. However,
their efficacy and clinical utility is still being debated. HFNC is a rela-
tively new ventilatory support therapy that allows administration of
high-flow (up to 60Lts/min) humidified gas through a nasal cannula
with 100% O2. This technology has shown a lower risk of complica-
tions (sedation is not required) and provides comfort to patient.
HFNC has been successfully used for hypoxemic respiratory failure
and during weaning of mechanical ventilation (bridge therapy).
Nonetheless, there are some patients that fail HFNC therapy and re-
quire re-intubation, but these patients have not been well character-
ized. The respiratory rate–oxygenation (ROX) index, defined as the
ratio of SpO2/FiO2 to respiratory rate, was recently validated to iden-
tify patients at risk of HFNC failure in pneumonia patients. Therefore,
we hypothesize that ROX Index could accurately predict extubation
failure in patients treated with postextubation HFNC.
OBJECTIVES. To investigate the accuracy of ROX Index to identify pa-
tients at risk of failing postextubation High-Flow Nasal Cannula
(HFNC) therapy in intensive care unit (ICU).
METHODS. This is a 2-year retrospective observational study con-
ducted in a reference hospital in Bogotá, Colombia. All patients in
whom postextubation HFNC therapy was used as bridge to extuba-
tion were included in the study. The ROX index was calculated prior
to HFNC treatment to assess the risk of postextubation HFNC failure.
Secondary, we determine whether ROX index could predict ICU mor-
tality. The cohort was stratified among patients who developed HFNC
failure to compare patients characteristics and statistical analyses.
RESULTS. A total of 162 mechanical ventilated patients were in-
cluded in the study, 38 patients developed HFNC failure and 28
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tions and diseases severity, ROX index was statistically lower in pa-
tients whom fail HFNC therapy (median [IQR], 10.00 [6.78] Vs 12.65
[5.47], p=0.006). However, ROX was not different in patients whom
died during ICU stay (11.59 [8.70] Vs 12.37 [5.23], p=0.3).
CONCLUSION. The ROX index is an easy to calculate score that could
identify patients at higher risk of HFNC failure during postextubation
treatment. A prospective study is needed to confirm the utility of this
index in ICU patients treated with HFNC as bridge therapy.
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INTRODUCTION. At many intensive care units there is need in training
for decision-making for medical staff especially for the novice physicians.
OBJECTIVES. The aim of this study was therefore to develop and im-
plement a training curriculum for novice physicians at intensive care.
The training curriculum, which incorporates different medical special-
ities, aims to increase the physician and patient safety and reliability
in decision-making.
METHODS. The present study was carried out in one of the largest
German interdisciplinary intensive care and weaning centres, the Kli-
nik Bavaria Kreischa in Saxony.
In the first step a survey was send out to all physician in intensive care to
analyse job satisfaction and clinical inconveniencies with medical training.
In the second step a first concept of the training curriculum was de-
veloped and then implemented clinically for 6 months, according to
principles of the PDCA-cycle (plan, do, check, act). We developed a
three-level training curriculum (level A-C). Where the level A is aimed
on beginners with a focus on the basics of work in intensive care
and aims to achieve the knowledge level for the on-call duty. Thelevel B is aimed on the advanced staff and wants to gain deeper spe-
cialist knowledge. The level C is specialised to expand the expertise
with the goal of leading the emergency team. Each level includes a
theoretical part, practical part and hands-on with medical
equipment.
More than 15 months after the pilot-implementation, a follow-up survey
was send out. It focused on overall job satisfaction, training in intensive
care and preparation and safety and reliability in decision-making.
RESULTS. In the first round 27 physicians were surveyed with a re-
sponse rate of 86%. Our first survey showed a large range of satisfac-
tion with the training at intensive care. We concluded that there was
a need in basic knowledge and technical skills for beginners (level A)
and for advanced staff (level B and C) in emergency management.
In December 2018, we surveyed 20 physicians with a response rate
of 83%. Although we found only a slightly higher general satisfaction
(from 7.03 to 7.56 points out of 10), we showed a statistically signifi-
cant improvement in the satisfaction of training at intensive care
(from 6.62 to 7.19, p <0.001), better preparation for on-call duty
(from 5.38 to 7.25, p <0.0031) and a small improvement in reliability
and safety during on-call duty (from 6.76 to 7.00).
CONCLUSION. We conclude that our specific training curriculum is
very useful for a standardized and routinely training of physicians at
intensive care.
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INTRODUCTION. In neurocritical ill patients, a narrow control of the
carbonic anhydride partial pressure (pCO2) must be done as a first
level step to control intracraneal pressure elevation. A continuous
monitoring of pCO2 would help to keep the values in optimal ranges
and would reduce the necessity of arterial gasometries.
OBJECTIVES. To analyze the agreement in the values of CO2 partial
pressure measured by a transcutaneal monitor (PtcCO2) with the
values measured in arterial gasometries samples in patients with
mechanical ventilation joined in a neurocritical ICU.
METHODS. We made an observational study in which were included
6 patients with invasive mechanical ventilation joined in our ICU. We
measured PtcCO2 by SenTec® monitor and simutaneous arterial
gasometry in several moments of their evolution. The continuos vari-
ables are described with averages and typical deviation. We calcu-
lated the Pearson correlation coefficient (r) and the coefficient of
intraclass correlation (ICC) with a confidence interval (CI) of 95% be-
tween PaCO2 and PtcCO2 as agreement measure with Landis and
Koch interpretation. We considered statistically significant p < 0.05.
Bland and Altman analysis was applied for the dispersion data.
RESULTS. 36 samples from the 6 patients were included. The values
obtained of PaCO2 were 42.05 ± 3.34 mm Hg and of PtcCO2 were
42.56 ± 3.68 mmHg. Due to correlation and concordance, the results
were for PaCO2 and PtcCO2, r = 0,843 (p< 0.001) and ICC = 0,91 (CI
95% 0.83 , 0.96). In 95% of the cases the discrepancies are included
between -3.48 y 4.48 mmHg. Bland and Altman analysis did not
show significant dispersion data. It was showed that SenTec® monitor
overvalued the values of PaCO2 in 0.5 mmHg.
CONCLUSION. The agreement between the measures of CO2 is al-
most perfect. The unconformities of the monitor in the measure of
PtcCO2 compared with PaCO2 in arterial gasometry do not have clinical
signification. The values obtained with PtcCO2 monitor seems reliables.
F1
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INTRODUCTION. The Patient´s State Index (PSI) is a useful form of
continuous neuromonitoring in the Intensive Care Unit (ICU). Sup-
pression rate (SR) is a measurement of the suppression of brain
electrical activity. Due to its good correlation with the neuro-
logical status of patients in the ICU, we believe they are associ-
ated with mortality and neurological damage in critically ill
patients.
OBJECTIVES. Establish if there is a relationship between the Patient´s
State Index (PSI) and Suppression rate (SR)values with mortality in in-
tensive care patients in a given period.
METHODS. Retrospective study. From January 2016 to November
2017 all patients admitted to intensive therapy under mechanical
ventilation were included, continuous qualitative electroencephal-
ography was performed, PSI values and SR were recorded, alongwith epidemiological variables and SOFA score upon admission.
The sample was divided into survivors and non-survivors. Primary
objective: association of the PSI and SR with mortality at 28 days
RESULTS. A total of 46 patients were included, 74% of survivors.
The diagnosis of septic shock was the most observed. There were
no differences in the time of need for mechanical ventilation or
in the use of analgesics or sedatives between the groups. The
ROC curve in relation to 28-day mortality shows an AUC for PSI
of 0.813 (95% CI: 0.650-0.975, p = 0.001), and for SR of 0.857
(95% CI: 0.734-0.980, p=0.001) for detection of survival. The cut
point of PSI of 30.5 has a sensitivity of 88.2% and specificity of
83.3%, and the cut point of SR of 2 has 92.3% and 67% of sensi-
tivity and specificity respectively.
CONCLUSION. Under a sedation protocol necessary to achieve mini-
mum RASS 0 to -1, PSI values lower than 30 and SR greater than 2
are auxiliary in the analysis of the mortality risk of the patient in crit-
ical condition.
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INTRODUCTION. Traumatic brain injured (TBI) patients are at high
risk for respiratory complications and in particular of ventilator-
associated pneumonia (VAP). Aim of this study is to evaluate the oc-
currence of VAP after TBI and its effect on patients’ outcome as well
as hospital and intensive care unit (ICU) stay.
METHODS. The CENTER-TBI study (clinicaltrials.gov registration
NCT02210221) is a prospective observational longitudinal cohort
study including patients with TBI from 65 centers across Europe.
Data were extracted from the CENTER-TBI database v1.1 with
Neurobot v2.6. We focused on patients with an ICU length of
stay >72 hours who were intubated (or mechanically ventilated)
for at least 48 hours.
RESULTS. 4509 patients were included in the CENTER-TBI study, 2138
were admitted to the ICU and we focused on 917 patients fulfilling
the inclusion criteria. Of these, 188 (20.5%) developed a VAP at a me-
dian time of 4.5 days (IQR: 3-7 days) from intubation.
Patients who developed VAP were younger (median age 39.5 vs
51 y/o, p<0.001), with a higher incidence of alcohol abuse (35%
vs 28%, p=0.098), thoracic trauma (53% vs. 43.5% p=0.021), and
more frequent neuroworsening episodes during ICU stay (44% vs
35%, p=0.039). VAP cohort had a longer duration of mechanical
ventilation (median 15 vs 9 days, p<0.001) and ICU stay (median
20 vs 13 days, p<0.001) and a higher incidence of tracheostomies
(55 vs. 34%). VAP cohort had lower ICU mortality (7.4% vs 16%
p=0.004) as well as a lower six months mortality (16.4% vs 26%,
p=0.012). Neurological outcome was similar in the two groups
(GOSE ≤ 4 in 51.5% vs 58%, p= 0.154).
CONCLUSION. VAP occurs very often in intubated patients after TBI
and has an important effect on ICU stay. However, the development
of VAP does not seem to have a detrimental effect on mortality and
neurological outcome.
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INTRODUCTION. In traumatic brain injured (TBI), tracheostomy can
facilitate the weaning process and can potentially result in fewer
days in the intensive care unit (ICU). However, the optimal timing
for tracheostomy placement remains uncertain. The aims of our
study are to describe the prevalence and timing for tracheostomy in
TBI patients and its effects on patients’ outcome.
METHODS. The CENTER-TBI study (clinicaltrials.gov registration
NCT02210221) is a prospective observational longitudinal cohort
study including patients with TBI from 65 centers across Europe. Data
were extracted from the CENTER-TBI database v1.1 with Neurobot
v2.6. We focused on patients with an ICU stay >72h. Tracheostomy
was defined as early (≤7 days from admission) or late (>7).
RESULTS. 4509 patients were included in the CENTER-TBI study, 2138
were admitted to the ICU and we focused on 1361 patients fulfilling the
inclusion criteria. Of these, 436 (32%) had a tracheostomy after a median
of 12 days (IQR=6-20 days). Patients who underwent tracheostomy had a
more severe TBI (71.5% vs 52.7%, p<0.001) and more frequent episodes
of prehospital hypoxia (19.6 vs 13%, p=0.003) and hypotension (21 vs
12.2%, p<0.001), as well as a higher number of extracranial injuries, in
particular thoracic trauma (47.7% vs 36.6%, p<0.001).
The decision for late (58%) or early (42%) tracheostomy was strongly
influenced by country and treating center (p<0.001). Respiratory fail-
ure (52 vs 41%, p=0.029) and ventilator associated pneumonia (40 vs
26.5%, p=0.006) were more common in patients who underwent late
tracheostomy. Tracheostomy was associated with longer ICU length
of stay (median 24 vs 15 days, p<0.001) and duration of mechanical
ventilation (median 19 vs 12 days, p<0.001). Effect on ICU mortality
(4.3 vs 7.1%, p=0.302) or 6 months neurological outcome (GOSE ≤ 4:
64.2 vs 68.4%, p=0.44) was not significant.
CONCLUSION. Tracheostomy is commonly performed after TBI. Trache-
ostomy policies are center dependent and are more frequent in more
severe TBI and in patients with respiratory complications. The timing
for tracheostomy seems to have effect on ICU length of stay and dur-
ation of mechanical ventilation, but no effect on patients’ outcome.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000622INTRODUCTION. Seizures are common entities in patients with acute
brain damage which cast their prognosis. Continuous EEG has be-
come a tool of increasing use for its detection but it implies an infra-
structure and costs that make necessary more data that allow us
to identify high risk patient who benefit most from this monitoring,
making its use profitable.
OBJECTIVES. To study the prevalence of seizures as well as the mor-
bidity and mortality associated with them in patients with acute
brain damage. To study the relationship between the presence of
seizures and different clinical and electroencephalographic variables
in order to find predictive factors that guide us in our clinical
practice.
METHODS. It is a cross-sectional study in 74 patients (n = 74) admit-
ted to ICU with diagnosis of acute brain damage and subjected to
study by continuous EEG in the period between 2015-2018. It has
been carried out a descriptive analysis of prevalence, main character-
istics and morbimortality of seizures. Likewise, it has been measured
the association of seizures with different clinical (sex, age, etiology,
history of epilepsy, presence of clinical crises, anti-epileptic prophy-
laxis) and electroencephalographic variables(presence of periodic
discharges, irritating activity and rhythmic patterns).For this purpose,-
descriptive statisticians,Chi-square Test,exact Fisher Test and correl-
ation of Spearman and Pearson have been used, with a statistical
significance level p > 0.05.
RESULTS. Seizures were observed in 59% of the analyzed patients,
77% of whom presented as an epileptic status. The average time to
the onset of seizures is 17.9 hours and the average time of crisis
control is 51.8 hours. An average of two drugs per patient was ne-
cessary for the control of seizures, being the most frequently
used the Levetiracetam (73%). Patients who present seizures had
a worse functional prognosis at the time of hospital discharge, with
a score between 4 and 6 in the Rankin scale in 80% of the cases and
a significantly higher both intrahospital (48% vs 17%) and 6-month
mortality (50% vs 20%) (p < 0.05, OR = 4 (1.4-11.7)). With regard to
the presence of possible predictor factors we have found that sei-
zures prevalence is greater in patients with higher age (Average
age: 62 years vs. 53 years) or with a history of clinical seizures (84%
vs 47%)(p = 0,002 OR 5.9) and lower in those who have received anti-
epileptic prophylaxis (43% vs 70%) (P = 0.02 OR 0.32). It is worth
highlighting the increased risk of seizures in patients with periodic
discharges, considering it as the main electroencephalographic
marker. The presence of seizures is greater when the discharges are
widespread (GPLDs) and it increases proportionally to the frequency
with which these periodic discharges appear.
CONCLUSION. Epileptic seizures are a common entity in patients
with acute brain damage associated with an important morbimortal-
ity so that it is important their early detection and treatment. Given
the average time of onset of seizures, we think that continuous EEG
is a very useful tool because of its greater sensitivity but its high
costs make us neccessary to guide by markers that allow to select
high-risk patients. In this sense, the upper ages, the presence of clin-
ical seizures, the absence of prophylaxis or the appearance of elec-
troencephalographic patterns such as periodic discharges seem to
have an important predictive value.
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INTRODUCTION. To evaluate the presence of epileptic seizures and
surgical treatment in patients with supratentorial spontaneous non-
traumatic intracerebral hemorrhage (ICH) and intraventricular
hemorrhage (IVH).
METHODS. During the years 2009 to 2012, ICU admitted patients
from three Spanish hospitals with Neurosurgery Services with
the diagnosis of supratentorial ICH and IVH were studied. The
effect of the surgical intervention over these patients was stud-
ied. Using a propensity index, 26 patients who underwent sur-
gery were paired with the same number of non-operated
patients.
RESULTS. 163 patients with supratentorial and intraventricular ICH
were admitted. These patients presented in the admission a Glas-
gow 8 + 4, APACHE-II 21.42 + 7.55 and an ICH score of 2.75 +
0.9 with a predicted mortality (30 days) of 65% and with a mor-
tality of 59.5%. At admission, 13.5% had bilateral arreactive my-
driasis. 23.3% (n=38) of patients underwent surgery. Mortality of
those who underwent surgery was 34.2% and of the non-
operated patients it was 67.2% (p <0.001). In the multivariate
analysis, OR for surgical intervention was 0.14 (0.05-0.41).Subse-
quently, 26 surgically operated patients were matched with fur-
ther 26 non-surgically treated patients, based on a propensity
index.This index was calculated based on: age, presence of
pupillary anomalies, size and location of the hematoma and Glas-
gow on admission. The surgical and non-surgical patients pre-
sented similar characteristics (age, Glasgow, ICH score, APACHE II,
volume and location of the hematoma) and none presented bilat-
eral mydriasis at admission.The hospital mortality of the 26 oper-
ated was 30.8% and of the 26 not operated was 65.4%, (p =
0.001) and OR 0.23; CI: 95%: 0.07-0.75.Afterwards, these 52 paired
by propensity index patients were tracked for 6-9 years and mor-
tality was 57.7% in those operated, and 73.1% in those not oper-
ated on.Of the 26 patients non-surgically treated, 6 were alive
and none had epileptic seizures, and of the 26 who were surgi-
cally treated 11 were alive and had epilepsy 6 of them (54.5%),
(p = 0.017).
CONCLUSION. Patients admitted to the ICU for non-traumatic cere-
bral hemorrhage open to ventricle who undergo surgery have lower
mortality than those who have not undergone surgery, but have epi-
leptic disorders with a frequency much higher than those who have
not undergone surgery000756
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INTRODUCTION. Brain multimodal monitoring including intracranial
pressure (ICP) and brain tissue oxygen pressure (PbtO2) is more ac-
curate than ICP alone in detecting cerebral hypoperfusion after trau-
matic brain injury (TBI). No data are available for the role of PaO2
changes on PbtO2 in this setting.
OBJECTIVES. To examine the accuracy of ICP, brain tissue PO2 and
the oxygen ratio (OxR) in detecting cerebral hypoperfusion in pa-
tients with acute brain injury.
METHODS. Single-center study including patients with TBI, subarach-
noid hemorrhage (SAH) and intracranial hemorrhage (ICH) undergo-
ing cerebral blood flow (CBF) measurements using perfusion CT scan
(CTP) concomitantly to ICP and PbtO2 monitoring. Before CTP, FiO2
was increased directly from baseline to 1.0 for a period of 20 minutes
under stable conditions to test the PbtO2 catheter as standard of
care. The difference between PbtO2 and PaO2 at the end of test vs
baseline (ΔPbtO2 and ΔPaO2, respectively) were collected and the
OxR calculated as ΔPbtO2/ΔPaO2. Regional CBF (rCBF) was measured
using CTP in the tissue area around intracranial monitoring. The ac-
curacy of different monitoring tools to predict cerebral hypoperfu-
sion (i.e. CBF < 35 mL/100 g.min) was assessed using area under the
receiver-operating characteristic curves (AUC).
RESULTS. 51 CTP were performed in 33 patients (age 52 [41-65]
years – TBI, n=12; SAH, n=19; ICH, n=2). Median ICP, PbtO2, OxR and
rCBF were 13 [9–18] mmHg, 21 [19-23] mmHg, 0.25 [0.16–0.30] and
30.0 [15.8–37.4] mL/100g.min. 38 (69%) patients had cerebral hypo-
perfusion; rCBF correlated with ICP (r²=0.12; p=0.01), PbtO2 (r²=0.22;
p<0.001) and OxR (r²=0.36; p<0.001). Compared with ICP alone (AUC
= 0.73 [95% CI, 0.59–0.86]), monitoring ICP + PbO2 (AUC=0.81 [0.69–
0.92]) or ICP + PbtO2 + OxR (AUC=0.84 [0.72–0.95]) were more accur-
ate in predicting cerebral hypoperfusion.
CONCLUSION. The combination of ICP and PbtO2 monitoring pro-
vides a better detection of cerebral hypoperfusion than ICP alone in
patients with acute brain injury.
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INTRODUCTION. Mortality rates from non-traumatic subarachnoid
haemorrhage (ntSAH) in the UK are declining (9/100,000)(1). How this
trend correlates with age is unclear. This observational study aimed
to quantify, neurocritical care unit (NCCU) mortality, complications
and functional outcome by age groups.
METHODS. A retrospective, electronic case note review of all patients
admitted with ntSAH to NCCU between 2014-17. 241 patients were
analysed. Functional outcome was defined as good, modified Rankin
Scale (mRS 0/1/2/3) and poor (mRS 4/5/6) at 3 months. The present-
ing grade of ntSAH was defined by the World Federation of Neuro-
logical Surgeons scale (WFNS), good was WFNS 1/2/3 and poor
F1
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criteria), ventilation, infection and vasospasm were analysed for each
age group. Data was analysed using GraphPad Prism by the χ2 test
and length of stay (LOS) by the mean average.
RESULTS.
Overall NCCU mortality was 18.3% in keeping with other NCCUs (2).
NCCU mortality across each age group was similar, except for the ob-
served increase in the 80-89 year olds (p= 0.74). Hospital mortality at
6 months, increased with age but was not statistically significant (p=
0.14). The mean LOS in NCCU was 12 days, with no significant vari-
ation with age. The mean LOS in hospital was 34 days. There was a
non-significant (p=0.12), increasing trend towards poor outcomes
with advancing age.
CONCLUSION. Elderly patients’ required more frequent mechanical
ventilation (p=0.03) and had an increased risk of AKI (p=0.05). This is
possibly due to reduced physiological reserve and a higher grade of
ntSAH, WFNS 4/5 (p=0.03). There was no difference in the incidence
of infection (p=0.17) and vasospasm (p=0.11) across age groups.
Surprisingly, advancing age showed no significant correlation with in-
creased mortality or NCCU LOS, although the numbers in the elderly
groups were smaller. Possible explanations include; centralisation of
neurosurgical services with faster diagnostics, less invasive interven-
tions, specialised multidisciplinary critical care teams and holistic crit-
ical care bundles (e.g. for ventilated patients and management of
AKI). However, there was a trend towards poorer functional out-
comes and increased hospital LOS with increasing age.
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INTRODUCTION. Sedation is used in traumatic brain injury (TBI) patients
admitted to intensive care unit (ICU) without intracranial pressure (ICP)
monitoring to allow invasive treatments as mechanical ventilation and
improve comfort. However, it remains unclear what the effect of pro-
longed sedation is and whether different sedative drugs have different
effect on outcome in this population. This analysis of the CENTER-TBI
study uses comparative effectiveness research to fill this knowledge gap.
METHODS. The CENTER-TBI study (clinicaltrials.gov registration
NCT02210221) is a prospective observational longitudinal cohort
study including patients with TBI from 65 centers across Europe. Data
were extracted from the CENTER-TBI database v1.1 with Neurobot
v2.6. We included all patient who were admitted to the ICU, with-
out ICP monitoring and who had more than one day of mechanical
ventilation. For every patient, the primary sedative (the sedative that
the patient received most of the days) was selected. We focused on
midazolam and propofol, since these were the most frequently used.
RESULTS. 4509 patients were included in the CENTER-TBI study: we
selected 265 patients who received propofol and 101 patients who
received midazolam as primary sedative. There was a large variation
between centers in the cumulative days of sedation. Propofol in-
creased the number of sedation days 4.00 times (95% CI: 1.62 - 9.89)
when adjusted for patient characteristics. Nevertheless, unadjusted
total ICU stay was 0.83 (95% CI: 0.77 - 0.90) times shorter when pro-
pofol was used, and the adjusted was 0.79 (95% CI: 0.73 - 0.86) times
shorter. The unadjusted OR for a better functional outcome was 1.29
(95% CI: 0.80 - 2.09), and the adjusted was 1.15 (95% CI: 0.65 - 2.04).
CONCLUSION. There is large variation in the number of days during
which TBI patients are sedated. The number of sedation days is often
larger when propofol is primarily used. However, propofol is associ-
ated with a shorted length of ICU stay. This study did not find evi-
dence that this improves outcome.REFERENCE(S)
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INTRODUCTION. The different hemodynamic phases in cerebral
blood flow (CBF) after traumatic brain injury (TBI) have previously
been characterized. Moreover, a hyperemic pattern by Doppler is as-
sociated with worse clinical outcomes. Some patients with severe
TBI require a craniectomy as part of their treatment. It is not well
understood how a craniectomy can affect CBF in this population.
OBJECTIVES. We sought to determine the cerebral blood flow veloci-
ties with transcranial Doppler during the first 24 hours in patients
with severe TBI looking at how craniectomy affects these parameters.
T1
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Table 1 (abstract 000822). A summary of the characteristics of studied
patients
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Doppler procedures (TCD) performed during the first 24 hours of ad-
mission on patients with a diagnosis of severe TBI from July 2018 to
March 2019. All studies measured middle cerebral artery (MCA) median
blood flow velocity (MBFV) and accordingly, the results were classified
in three patterns: normal, hyperemia and oligohemia. We compared
the incidence of early hyperemia among patients that received primary
craniectomy plus medical treatment or medical treatment alone.
RESULTS. Thirty-one patients were identified, of which 83.8% were
male with a mean age 29 ± 15 years old and a median Marshall score
of 2. The mean MBFV was 55 ± 17.7 cm/sec, ( 57.4 ±19.6 cm/sec in the
left MCA and 52.7 ± 22.6 cm/sec in the right (p=0.2599) ). Eleven pa-
tients (35.5%) underwent primary craniectomy. There was no difference
in MBFV between patients who underwent craniectomy and those who
did not (52.6 vs 56.4 cm/sec, p=0.5572). There was no difference in the
incidence of early hyperemia in patient that required primary craniect-
omy compared to those who did not (p= 0.999)
CONCLUSION. In patients admitted with severe TBI to whom the cra-
niectomy was performed, we found no difference in the presence of
early hyperemia as well as other parameters measured by TCD.
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INTRODUCTION. Sedation is a significant part of medical treatment
in ICU patients. Patients exposed to a too light sedation can develop
agitation, pain, fear, adverse events as devices removal and respira-
tory distress, which can lead to post-traumatic stress disorder.A too
deep sedation is associated with a longer time of mechanical ventila-
tion and therefore of extubation, lung injury, infections, neuromuscu-
lar disease and delirium. A longer duration of ICU hospitalization and
an increase of morbility incidence and mortality are also demon-
strated. Many patients spend a considerable amount of time in a
non-optimal sedation level. A continuous monitoring system of the
sedation level is therefore necessary to improve clinical evaluation.
Different pEEG analyses have been studied to monitoring sedation
depth, Next Generation SedLine (Masimo) has shown a strong correl-
ation with other monitoring systems, resulting more sensitive and
less susceptible to interferences.
OBJECTIVES. The goal of our study was to evaluate the incidence of
non-optimal sedation (under and over sedation) comparing the pa-
rameters expressed from NGSedLine with clinical evaluations.
METHODS. We have studied a cohort of patients admitted to the ICU
of Spedali Civili of Brescia University Hospital requiring continuous
sedation for more than 12 hours. In addition to standard monitoring,
the patients have been studied using Next Generation Sedline
(Masimo), which provides a continuous 4 channel pEEG monitoring.
Derived parameters were: PSI (Patient State Index), SEFL, SEFR, EMG,
ARTF, DSA and Suppression Ratio (SR). Sedation depth was evaluated
through Richmond-Agitation-Sedation Scale (RASS). Non-optimal sed-
ation has been evaluated by confronting RASS and PSI values.
RESULTS. Clinical data of our patients are shown in Table 1, while a
summary of collected data is shown in Table 2.Average artefacts per-
centage was less than 10% in 32 of 34 patients. Accuracy is alsoconfirmed by the analysis of EMG data: 2 patients of 34 spent more
than half of the time of sedation with an EMG value of 30 or less.Col-
lected data showed high incidence of oversedation: SR analysis
showed that all patients but one had at least one episode of burst
suppression and that 20 of our 34 patients spent more than 10% of
total time with a high level of SR and 16 of our patients spent more
than half the time with a level of PSI lower than 30, confirming an
important oversedation. Also SEFL and SEFR were lower than the ex-
pected: graphic 2 shows that the average values were both lower
than 10 in 18 of 34 patients.
CONCLUSION. Non-optimal sedation is an unsolved problem in ICU, af-
fecting many patients, with a major incidence of over-sedation com-
pared to under-sedation. Association of EEG-based monitoring systems
to clinical evaluations can optimize sedation in critically-ill patients.
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INTRODUCTION. Aneurysmal subarachnoid hemorrhage (aSAH) is a
devastating condition with high morbidity and mortality. Physiopath-
ological mechanisms leading to long term outcome are still partially
unexplained. Previous studies showed an association between
plasma levels of Endothelial Progenitor Cells (EPC) and outcome after
acute brain injury (stroke, traumatic brain injury)[1]. The link between
EPC and aSAH, complicated or not of cerebral vasospasm (CVS), has
not been studied yet. We previouly showed a different EPC kinetic
after serious or non serious aSAH[2], and in patients with or without
CVS[3].
OBJECTIVES. To compare plasma level of EPC 3 days after aSAH ac-
cording to 1-year outcome.
METHODS. Prospective monocentric EVAPROPEC cohort
(NCT01773200) including every adult patient admitted for aSAH, after
obtaining patient's or next-of-kin's consent, or after emergency inclu-
sion as allowed by local ethic committee. Plasma levels of CD34+/
CD133+ and CD34+/CD133+/VEGFR2+ EPC (expressed as stained
cells per 100 000 mononuclear cells) were measured by flow cytome-
try after isolation of mononuclear cells by a Ficoll gradient and sur-
face staining on blood samples collected at admission (D0), and D3,
D6, D10, D14, D21. 1-year neurologic outcome was evaluated by
Glasgow Outcome Scale (GOS) assessed by a standardized question-
naire. EPC levels at D3 (principal judgement criterion), the maximal
variation of EPC level between D0 and D21, and the proportion of
patients with a significant mobilization of EPC (defined as an EPC
level increase > 100% compared to D0 level) (secondary judgement
criteria), were compared between a "bad outcome" (GOS 1-3) and a
"good outcome" (GOS 4-5) group using a Mann-Whitney test(significance was defined by a p value < 0.05). Results are expressed
as median [25th-75th percentiles] or n(%).
RESULTS. 90 patients: 34 with a "bad outcome" and 46 with a "good
outcome" (10 lost of view). Demographical data are presented in
table. D3 plasmatic level of CD34+/CD133+ EPC (46 [26-121] vs. 89
[42-143], p=0.22) or CD34+/CD133+/VEGFR2+ EPC (8 [3-31] vs. 18 [1-
46], p=0.47] (figure), maximal variation of CD34+/CD133+ EPC (9 [0-
48] vs. 30 [0-103], p=0.48) or CD34+/CD133+/VEGFR2+ EPC (4 [0-73]
vs. 4 [0-47], p=0.89), the proportion of patients with a significant
mobilization of CD34+/CD133+ EPC (29% vs. 29%, p=1) or CD34+/
CD133+/VEGFR2+ EPC (38% vs. 35%, p=1) were not significantly dif-
ferent between both groups.
CONCLUSION. Endothelial progenitor cells level and kinetic do not
seem associated with 1-year outcome after aneurysmal subarachnoid
hemorrhage.
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INTRODUCTION. Early endovascular treatment of patients with acute
ischemic stroke has changed according to the new recommenda-
tions published in 2018, mainly focused on an earlier approach over
a longer period for patients with or without thrombolytic therapy
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charge and at 90 days of patients admitted to our ICU over two pe-
riods of time (2018 and pre-2018). Secondary outcomes: 1. To
discover whether global time (minutes from the beginning of the
symptoms until the end of the procedure) is shorter. 2. To analyse
whether any differences exist in the use of vasoactive drugs (anti-
hypertensive therapy / amines).
METHODS. Retrospective study. Review of medical records. Patients
with AIS admitted to our ICU for endovascular treatment are divided
into 2 groups: G1 (year 2018); G2 (years 2015-2017). The recorded
variables include (among others): demographic data, cardiovascular
risk factors, previous treatment with antiplatelet agents/oral antico-
agulants, outcome at discharge and after 3 months using modified
Rankin Scale (mRS-d, mRS-3).
Mann-Whitney U-test (for independent samples) and Wilcoxon test
(for related samples) were used to compare medians. The Student
test was used to compare differences in time between the two
groups. Pearson’s chi-square test and Fisher’s exact test were used to
analyse differences in vasoactive drug use.
RESULTS. A total of 103 patients were included: 63 in G1 and 40 in
G2. The demographic data, risk factors and NIHSS on admission did
not differ, despite the difference in sample sizes.
Primary outcome: there were no statistically significant differences in
mRS-d between G1 and G2, and 50% of patients have mRS-3 ≤ 2.
Nonetheless, though the difference is not statistically significant, out-
come at discharge is better in G1, given that 25% of the patients
have mRS-d ≤1.
Outcome after three months was compared with that at discharge in
each group separately (excluding patients with mRS-d=6, as improv-
ing is impossible for them). We found a statistically significant im-
provement in both groups, which was higher in G1. 50% of patients
in G1 have mRS-3 ≤ 1, while 50% of those in G2 achieve mRS-3 ≤ 2.
Furthermore, 25% of patients in G1 have mRS-3 = 0, and this is not
achieved in G2.
Secondary outcomes: 1. Time is shorter, but the difference is not sta-
tistically significant. There may be external factors which bias this
parameter. 2. We have used fewer vasoactive drugs in G1 than in G2,
and the difference is statistically significant.
CONCLUSION. CONCLUSIONS
1.- The introduction of new recommendations for AIS endovascular
treatment has improved the outcome of our patients. 2.- Thanks to
early endovascular therapy, as a first line treatment for AIS, 25% of
patients have no neurological sequelae. 3.- Although the time period
is shorter, we have not found any statistically significant differences,
probably due to several external factors. 4.-The use of vasoactive
drugs has decreased upon the introduction of the new guidelines
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000862INTRODUCTION. Controversial evidences exist concerning the effect
of hyperoxia on outcome after traumatic brain injury in ICU.
OBJECTIVES. We aimed at evaluating the effect of transient and pro-
longed hyperoxia on outcome.
METHODS. The CENTER-TBI study is a prospective observational lon-
gitudinal cohort study including patients with TBI from centers across
Europe. Data were extracted from the CENTER-TBI database v1.0 with
Neurobot v2.6. We focused on patients receiving mechanical ventila-
tion in ICU > 24 hours. We analyzed previously published predictors
of outcome: age, preinjury state, ISS score, Glasgow motor score, pu-
pils’ examination, imaging results and secondary insults such as hyp-
oxia, hypotension, unwanted hypocapnia, seizures, highest blood
glucose level (BGL) at day 1, lowest hemoglobin level at day 1, raised
ICP episode and length of stay.
Transient hyperoxia was defined as a single blood gas analysis (BGA)
PaO2 >100 (THMild) mmHg and >300 mmHg (THsevere) and pro-
longed hyperoxia as the daily lowest BGA PaO2 >100 mmHg
(PHmild) and 300 mmHg (PHsevere). The main outcome was a nega-
tive outcome at 6 months (Glasgow outcome scale extended, GOSe
≤4). Chi square tests and fisher tests were used to compare variables
between good and bad outcome groups.
RESULTS. 4509 patients were included in the CENTER-TBI study, 2138
were admitted in the ICU and we focused on the 1099 receiving MV
for more than 24 hours. 771/1099 (70.2%) patients were exposed at
least once to PHmild whereas 2487 episodes of PHmild occurred dur-
ing the entire stay, 908 (36.5%) of which during the first 48 hours.
Only 26 episodes of PHsevere occurred in 23/1099 (2.1%) patients,
18 of which in the first 48 hours. 112/214 patients that died before
day 4 had an episode of PHmild vs. 289/885 (p<.0001).
1061/1099 patients were exposed to THMild whereas 6373 episodes
of THMild occurred, 1808 (26.3%) of which during the first 48 hours.
213/1099 patients presented 253 episodes of THsevere, 168(66.8%)
of which in the first 48 hours. 200/214(93.4) patients that died before
day 4 had an episode of THMild vs. 847/884(95.8) and 40/214 vs 136/
884 (p=.280) for THsevere.
THMild or THsevere were not associated with GOSE in univariate ana-
lysis (p=0.259, p=.566) nor PHmild or PHsevere (p=.258, p=.056)
CONCLUSION. Hyperoxia is frequent in ICU after TBI but it is not as-
sociated with worse outcome.
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INTRODUCTION. Severe traumatic brain injury management guide-
lines recommend intracranial pressure monitoring. However, the use
of hospital-level intracranial pressure monitoring varies greatly, and
the association between hospital-level intracranial pressure monitor-
ing utilization and clinical outcomes remains unknown.
OBJECTIVES. To examine whether severe traumatic brain injury pa-
tients treated at hospitals with higher intracranial pressure monitor-
ing utilization rates have better functional outcomes, based on data
from the Japan Neurotrauma Data Bank Project 2015.
METHODS. In this post hoc analysis of a nationwide prospective
registry of patients admitted between April 2015 and March 2017,
Page 338 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55the primary exposure was hospital-level intracranial pressure moni-
toring utilization. Patients treated at hospitals where intracranial pres-
sure monitoring was used for monitoring >80% of severe traumatic
brain injury patients were assigned to a “high” group and all other
patients to a “low” group. The secondary exposure was patient-level
intracranial pressure monitoring utilization (intracranial pressure
monitoring group vs non-intracranial pressure monitoring group).
The primary endpoint was a 6-month favorable functional outcome,
defined as a Glasgow Outcome Scale score of 4 or 5.
RESULTS. Intracranial pressure monitoring utilization at each hospital
ranged from 0%to 100%. Overall, 459 patients from 25 hospitals were
included, with 59 (12.9%) of them assigned to the high group. Mul-
tiple logistic regression model showed that patients in the high
group had significantly better functional outcome than those in the
low group (adjusted odds ratio 2.77; 95% confidence interval, 1.30–
5.92; p = 0.009). However, patients in the intracranial pressure moni-
toring group at the patient-level analysis did not exhibit any clear as-
sociation with a specific functional outcome.
CONCLUSION. Treatment at hospitals with higher intracranial pres-
sure monitoring utilization for severe traumatic brain injury can be
associated with better functional outcomes.
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INTRODUCTION. Anemia is considered as one of the factor that
could aggravate brain injuries after traumatic or non-traumatic le-
sions. However, the “safe” hemoglobin threshold is not clearly de-
fined in this particular population [1].
OBJECTIVES. The objective of this study is to evaluate the association
between the intensity of anemia (defined as the proportion of time
spent under different hemoglobin (Hb) thresholds) and functional
outcome at 3 months in brain damaged patients.
METHODS. Prospective observational study based on data from the
ATLANREA cohort (traumatic or non-traumatic brain-injured patients
hospitalised in intensive care), restricted to the centers of Nantes and
Angers, between 2013 and 2018. From the Hb dosages of the first 8
days, an area index has been calculated by dividing the area repre-
senting the time spent with Hb values below a threshold by the totalmonitored time. The area below the various thresholds (10 g/dl, 9 g/
dl, 8 g/dl and 7 g/dl) has been calculated using the trapezoid
method (figure). Functional status at 3 months has been determined
by the dichotomized GOS score (unfavourable prognosis if death,
vegetative state or severe deficiency). We evaluated the judgment
criterion through multivariate logistic regression by adjusting on the
variables significantly associated in univariate with functional out-
come (centre, age, sex, traumatic entity or not, number of pack blood
cells unit transfused, initial GCS, mydriasis on admission, smoking sta-
tus and SOFA score, Hb, urea, fibrinogen on admission). The statis-
tical analyses were performed with software R (version 3.4.0).
RESULTS. Among the 585 patients studied (mean age: 49±21 years,
women: 177 (30%), SOFA: 8±3; initial Hb level: 11±3 g/dl; initial GCS:
7±3), 394 (67%) had a traumatic brain injury. We recovered 4258 Hb
dosages during the first 8 days (mean 0.90 ± 0.48/patient/day). Dur-
ing this period, 340 patients (58%) had at least one Hb value < 10 g/
dl, 252 (43%) < 9 g/dl, 153 (26%) < 8 g/dl and 65 (11%) < 7 g/dl. 222
patients (38%) had an unfavourable outcome at 3 months, with a sig-
nificant association for the four different hemoglobin thresholds (p-
value < 0.01 for each). After adjusting for confounding factors, Hb
area indexes are not associated with functional outcome at 3
months, regardless of the specified threshold (p-value: 0.746 for 10g/
dl; 0.819 for 9g/dl ; 0.435 for 8g/dl ; 0.128 for 7g/dl).
CONCLUSION. There is no apparent association between the inten-
sity of anemia during the first 8 days of resuscitation and functional
development at 3 months in patients who have undergone a brain
injury. A lack of power may explain the absence of any negative im-
pact below the 7g/dl threshold.
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INTRODUCTION. Circulatory shock results in impaired tissue oxygen-
ation and brain ischemia.[1] Whether this can be alleviated with
higher blood oxygen content is unknown. [2]
OBJECTIVES. We studied the interaction between the severity of cir-
culatory shock and blood oxygen content in patients treated in the
intensive care unit (ICU) with neurologic injury.
METHODS. The Finnish Intensive Care Consortium database was
screened for mechanically ventilated neurologically ill adult patients
treated in tertiary hospitals ICUs in years 2003–2013. Admission diag-
noses included traumatic brain injury (TBI), cardiac arrest (CA), sub-
arachnoid haemorrhage (SAH), intracerebral haemorrhage (ICH) and
stroke. The primary endpoint was neurological outcome one year
after intensive care admission. Independence in self-care was defined
as favourable outcome and disability or death as unfavourable out-
come. Patients were defined as disabled if they were granted a per-
manent disability allowance by the public social insurance institution
at the time of data collection (September 2016). Patients already dis-
abled before ICU admission were excluded from the study. The pri-
mary exposure of interest was arterial PaO2 recorded in connection
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ICU admission. A compromised haemodynamic state was determined by
a cardiovascular SOFA subscore of 4 during the first 24 h of ICU admis-
sion. The association between outcome and predictors were analysed by
multiple logistic regression. The association of oxygen exposure and
haemodynamic state with outcome was inspected with interaction term
PaO2*SOFA subscore of 4 as a confounding factor. Additionally, age, gen-
der and modified APACHE II score (excluding points for oxygenation) and
type of admission were included in the model.
RESULTS. The study population included a total of 10,143 cases of
whom 2,788 (28%) were treated for TBI, 3,390 (33%) for CA, and 3965
(39%) for stroke (SAH 1684 [17%], ICH 1587 [15%] and, ischemic 694
[7%]). Of all cases, 4,056 (40%) survived as independent. Poor haemo-
dynamic state (SOFA cardiovascular subscore of 4) was not an inde-
pendent predictor of favourable neurological outcome (odds ratio
[OR] 1.00: 95% confidence interval [CI] 0.75–1.32). We found no asso-
ciation between PaO2 level and favourable neurological outcome,
(OR 1.01: 95% CI 0.99–1.02) and the interaction PaO2*SOFA subscore
4 remained insignificant.
CONCLUSION. In mechanically ventilated patients treated after TBI,
CA or stroke (SAH, ICH or ischemic) in the ICU there was no associ-
ation between arterial oxygen level and circulatory shock with long-
term neurological outcome.
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INTRODUCTION. Sepsis involves a dysregulated host response to in-
fection, leading to a high mortality rate. As part of this dysregula-
tion, CD4+CD25+ regulatory T cells (Tregs)play an essential role in
sepsis-induced immunosuppression. Here, we studied the effects
of interleukin (IL)-36 cytokines, which are newly described members
of the IL-1 cytokine family, on CD4+CD25+ Tregs and their under-
lying mechanism in sepsis.
METHODS. Our study was designed to investigate the impacts of IL-
36 cytokines on murine CD4+CD25+ Tregs in presence of lipopolysac-
charide (LPS) and in a mouse model of sepsis induced by caecal
ligation and puncture (CLP). IL-36-activated autophagy was evaluated
by autophagy markers (LC3-II, Beclin1, p62), autophagosome forma-
tion and autophagic flux.
RESULTS. We provide evidence that IL-36α, IL-36β, and IL-36γ are
expressed in murine CD4+CD25+ Tregs. Stimulation of CD4+CD25+
Tregs with LPS markedly upregulated the expression of these cyto-
kines, particularly IL-36β. IL-36β strongly suppressed
CD4+CD25+Tregs under LPS stimulation and in septic mice chal-
lenged with CLP, resulting in the amplification of Th1 responses and
the proliferation of effector T cells. Mechanistic studies revealed
that IL-36β triggered autophagy of CD4+CD25+ Tregs. These effects
were significantly attenuated in the presence of the autophagyinhibitor 3-methyladenine (3-MA) or Beclin1 knockdown. Additionally,
early IL-36βadministration reduced the mortality rate of CLP mice.
Depletion of CD4+CD25+Tregs before the onset of sepsis obviously
abrogated IL-36β-mediated protection against sepsis.
CONCLUSION. These findings suggest that IL-36β diminishes the im-
munosuppressive activity of CD4+CD25+ Tregs by activating the au-
tophagic process, thereby contributing to improvement of the host
immune response and prognosis in sepsis.
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INTRODUCTION. Naturally occurring CD4+CD25+regulatory T cells
(Tregs)are required to limit immune-induced pathology and to main-
tain homeostasis during the early phase of sepsis. This study aimed
to investigate the role of interleukin (IL)-38, a newly described mem-
ber of the IL-1 cytokine family, in mediated immune response of
CD4+CD25+Tregs in sepsis.
METHODS. Primary CD4+CD25+Tregs isolated from BALB/c mice
were incubated with lipopolysaccharide (LPS), recombinant murine
IL-38 (rmIL-38), and anti-IL-38 antibody. A mouse septic model in-
duced by cecal ligation and puncture (CLP) was treated with rmIL-38
Page 341 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55or anti-IL-38 antibody. The effects of IL-38 on activity of
CD4+CD25+Tregs and survival rate of mice were assessed.
RESULTS. Expressions of IL-38 and its receptor were detected in
murine CD4+CD25+Tregs. Stimulation of CD4+CD25+Tregs
with LPS markedly up-regulated the expression of IL-38. Treat-
ment with rmIL-38 dramatically enhanced the immunosuppressive
activity of CD4+CD25+Tregs after LPS stimulation as well as in
septic mice induced by CLP, resulting in amplification of helper T
cell (Th) 2 response and reduction in the proliferation of effector
T cells. These effects were robustly abrogated when anti-IL-38
antibody was administered.Administrationof rmIL-38 improved the
survival rate of CLP mice. In addition, CD4+CD25+Tregs depletion
before the onset of sepsis obviously abolished IL-38-mediated
protective response.
CONCLUSION. IL-38 enhances the immunosuppressive activity of
CD4+CD25+Tregs, which might contribute to the improvement of
host immune function and prognosis in the setting of sepsis.
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INTRODUCTION. Sepsis should be treated as medical emergencies
and early management for sepsis is reported to be associated with
improving patient outcomes. Patients on the ward can develop to
septic shock at any time during their hospitalization. Therefore, it is
very important to identify septic patient on the ward and to perform
optimal treatment quickly. Rapid response systems (RRS) are provid-
ing optimal care for sepsis on the general ward. Although studies are
often performed for early detection of sepsis on ward, there is a little
published data on management factors of sepsis on ward.
OBJECTIVES. To study between the outcomes and bundle compli-
ance of patient with septic shock managed by rapid response system
for 10 years
METHODS. Retrospective cohort study of 935 patients with septic
shock who were activated by RRS at an academic, tertiary care hos-
pital in Korea from 2008 to 2017
RESULTS. We provided sepsis management by RRS during study
period. Of the 935 enrolled patients, the compliances of each
sepsis bundle were high (87.8%-99.5%) but the overall success
rate of bundle was shown low (73.4%). Compliance rate for
achieving overall sepsis bundle was increased and the 28 day
mortality was continuously decreased for 10 years in figure 1. Of
the 935 enrolled patients, 686 (73%) completed all sepsis bundle
and 248(27%) were incomplete. We analyzed the two groups ac-
cording to whether they completed sepsis bundle overall or not.
Baseline characteristics were no difference between two groups.
Bundle complete group showed lower 28-day mortality than in-
complete bundle group (43.5% vs. 52.6%; p=0.001) and in the
multivariate logistic regression model, 28 day mortality was sig-
nificantly related to complete of all bundle (adjusted odds ratio,
0.50; 95% CI, 0.32-0.78; p=0.003).
CONCLUSION. Rapid response system provides improving sepsis
bundle compliances & survival in patients with septic shock on the
general ward.REFERENCE(S)
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INTRODUCTION. Meropenem is a cornerstone in the antibiotic treat-
ment of critically ill patients with sepsis. However, complex patho-
physiologic mechanism in sepsis lead to a wide variability of plasma
levels of any given drug. Subtherapeutic dosing can lead to treat-
ment failure and antimicrobial resistance while overdosing is associ-
ated with toxic side effects. Individualized treatment guided by
therapeutic drug monitoring (TDM) might be an effective means to
overcome this dilemma.
OBJECTIVES. The primary aim of this study was to assess the effect
of therapeutic drug monitoring on the use of meropenem in critically
ill patients. The secondary aim was to assess the impact of merope-
nem TDM on Intensive Care Unit (ICU) length of stay and survival.
METHODS. A total of 247 septic patients treated with meropenem
for at least 5 days were included. Baseline characteristics, total doses
of meropenem and duration of meropenem treatment were re-
corded. TDM was done by an attending clinical pharmacologist.
Plasma levels of meropenem were measured by use of HPLC. Dosing
recommendations were based on microbiologic data were available.
In all patients ICU length of stay and ICU mortality were recorded.
Statistical analyses were performed by SPSS.
RESULTS. A total of 101 patients received standard doses of merope-
nem, 146 patients had an individualized treatment by means of TDM.
In patients with TDM, meropenem doses were higher (2731.2 ±
1092.1 mg vs 2327.1 ± 652.7 mg, p < 0.001) and treatment duration
Page 343 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55was longer (14.0 ± 9.7 days vs. 10.5 ± 4.7 days, p < 0.001) than in pa-
tients with standard therapy, respectively. An average of 3.2 merope-
nem plasma level measurements was done in the TDM group. Dose
modifications were 1.6 in the TDM group vs. 0.8 in the standard group
(p<0.001). ICU length of stay was similar between the two groups (14.7
± 10.7 vs. 14.6 ± 9.8 days for TDM vs. standard group, respectively).
However, ICU mortality was lower in the TDM group compared to the
standard group (20 patients (14%) vs. 24 patients (24%), p=0.042).
CONCLUSION. Bearing in mind the high variability of meropenem
plasma levels in critically ill patients and patients with sepsis, risk of
underdosing is evident. The same is true for overdosing and un-
necessary antibiotic therapy. TDM is a potent option to maximize
treatment effects and to avoid resistance and toxic side effects.
In our cohort of patients with sepsis, TDM led to higher meropenem doses
and longer treatment duration. Importantly, in an exploratory analysis, a
lower mortality was seen in our cohort of critically ill patients within the
TDM treated group when compared to a standard non-TDM group.
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INTRODUCTION. It is a challenging issue to reduce mortality of sepsisin
intensive care units. After decades of research, and numerous pre-
clinical and clinical trials, sepsis remains without a specific and effective
pharmacotherapy.In the last few years, cell therapies gained potential
as a therapeutic treatment for various diseases. However, there are still
many problems that limit the therapeutic use of stem cells, including
immunological rejection phenomena and unwanted cells differentiatio-
n.In recent years, researchers have found that therapeutic activity of in-
duced pluripotent stem cells may be mediated by a paracrine effect.
OBJECTIVES. In this study, we investigated the potential protective
effects of iPSCs-conditioned media (iPSCs-CM) on E.coli-induced lung
injury in rats and LPS/IFN-g-induced inflammatory responses in mur-
ine macrophage RAW 264.7 cells, and identified the mechanisms
underlying these effects.
METHODS. Rats underwent intraperitoneal inoculation with 109 CFU
of Escherichia coli isolated from patient. Animals were randomized to
receive (i)co-administration of conditioned medium from iPSCsin
combination withceftriaxone (ii) IV administration of conditioned
medium from iPSCs following 4 hr of infectionin combination with
ceftriaxone; (iii) IV administration of ceftriaxone (30mg/kg)following 8
hr of infection; and (iv) IV instillation of PBS vehicle. Raw 264.7 cells
were pretreated with iPSCs-CM for 2 hr prior to LPS/INF-g stimulation
or were treated with iPSCs-CM after 1 hr of LPS/TNF-g treatment.Le-
thality; lung injury scores, including protein leakage and inflamma-
tory cell infiltration; cell count in bronchoalveolar lavage (BAL)
fluid;and chemokines and cytokines concentrations in serum were
determined to evaluate the effects of iPSCs-conditioned media on
sepsis-induced lung injury.
RESULTS. Administration of iPSCs-CM in combination with ceftriax-
one (iPSCs-CM/ceftriaxone) has a higher survival rate than ceftriaxone
treatment alone.iPSCs-CM/ceftriaxone treatment also significantlydecreased the cell counts in BAL fluid in comparison to ceftriaxone
treatment alone. Histological examination of lung tissue showed that
the iPSCs-CM/ceftriaxone group was less than the ceftriaxone group
in macrophage infiltration and MMP-9 expression.Serum levels of
CXCL2, IL-1b, and IL-6 also showed decreased in E.coli-induced lung injury
rat model, as well as in cells treated with LPS/INF-g.Further, expression of
NLRP3, ASC, HMGB1, IL1b, IL-6, and CXCL2 mRNA was significantly de-
creased in iPSCs-CM/ceftriaxone group compared with no treatment. Simi-
lar effects of iPSCs-CM on LPS/INF-g-stimulated raw 264.7 cells.
CONCLUSION. Our results revealed that treatment of iPSCs-CM ame-
liorates lung inflammatory responses through inhibiting NLRP3
inflammasome activation, which attenuates lung injury and improves
the survival rate.These data suggested that iPSCs-CM may be import-
ant in sepsis and shed light on therapeutic strategies.REFERENCE(S)
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INTRODUCTION. Voriconazole is an azole antifungal agent frequently
used in the treatment of severely ill patients with suspected or
proven fungal infection. While voriconazole has excellent in vitro sus-
ceptibility testing, it´s clinical use is limited by high interindividual
variability, particularly in critically ill and septic patients.
OBJECTIVES. The primary aim of the study was to assess voricona-
zole plasma levels in critically ill patients with sepsis. The secondary
aim was to assess whether therapeutic drug monitoring leads to
dose modifications in these patients.
METHODS. A total of 92 patients with sepsis and voriconazole treat-
ment were included. All patients received an initial dose of 400 mg
voriconazole twice daily. Therapeutic drug monitoring was per-
formed and voriconazole plasma levels were assessed at least once
in all patients. Additional determination of plasma levels were or-
dered if deemed clinically necessary by the treating physicians. Mea-
sured patients´ voriconazole plasma levels were classified as within
target range (0.5 to 5.0 mg/l depending on the underlying disease),
below target range (< 0.5 to 1.0 mg/l) and above target range (>2.5
to 5.0 mg/l).
RESULTS. A total of 45 patients (49%) had voriconzole plasma levels
within the predefined therapeutic range. Seven patients (8%) had
voriconzole plasma levels below target range, 40 patients (43%) had
voriconazole plasma levels above the therapeutic range. Thus dose
modifications became necessary in more than half of the patients
treated with voriconazole as a result of therapeutic drug monitoring.
CONCLUSION. Our results show high variability of voriconazole
plasma levels in critically ill patients with suspected or proven fungal
infection. Standard dosing of voriconazole led to plasma levels within
the predefined therapeutic range in only less than half of the pa-
tients. Therapeutic drug monitoring is therefore an appropriate tool
to avoid treatment failure by underdosing and at the same time toxic
overdosing in patients with sepsis.
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Table 1 (abstract 001020). Correlations between LVLSspeckle, MAPSE
and LWFS
LVLSspeckle MAPSE LWFS
LVLSspeckle 1 0.68 0.77
MAPSE 0.68 1 0.94
LWFS 0.77 0.94 1
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INTRODUCTION. Serum lactate has been incorporated in the new
definition of septic shock as a way to identify hypotensive patients at
higher risk of death (1). Hyperlactatemia at the time of admission has
been shown to be a good prognostic marker (2). The usual cut-off
value for hyperlactatemia is 2 mmol/L. Haas et al. (3) found a mortal-
ity approaching 80% for patients with lactate levels >10 mmol/L.
OBJECTIVES. To evaluate the influence of patient and clinical charac-
teristics on the severity of hyperlactatemia in infected patients at ICU
admission and define differences in outcomes.
METHODS. Post-hoc analysis on hyperlactatemia in the INFAUCI
study, a prospective, observational, cohort, multicenter study, con-
ducted in 14 Portuguese Intensive Care Units (ICU) with data col-
lected between 1 May 2009 and 31 December 2010. Infected
patients at admission were divided in three groups, accordingly to
the severity of hyperlactatemia at admission, mild (2-3.9 mmol/L),
moderate (4.0-9-9 mmol/L) and severe (>10 mmol/L).
RESULTS. Of the 3766 patients admitted to the study, 1652 (43.9%)
were deemed to be infected on admission. Lactate was measured in
1640 patients, with 934 (57%) having hyperlactatemia, distributed as
mild, moderate and severe in 57.0%, 34.4% and 8.7% of the cases.
The degree of hyperlactatemia increased significantly with SAPS II,
APACHE II score, Charlson Score, chronic liver disease as a comorbid-
ity, presence of septic shock and secondary bacteremia. On the other
hand, the degree of hyperlactatemia was significantly inversely asso-
ciated with chronic respiratory disease as a comorbidity and appro-
priate antibiotic selection. ICU and hospital length of stay decreased
with increased hyperlactatemia due to higher and earlier mortality.
ICU mortality rate was 26%, 47% and 68% for mild, moderate and se-
vere hyperlactatemia, which increased to 36%, 55% and 79% for in-
hospital mortality, respectively. ICU and in-hospital mortality adjusted
for age, SAPS II, APACHE II and Charlson score was correlated with
moderate and severe hyperlactatemia but not with mild hyperlacta-
temia with an OR 2.0 [95% CI 1.4-2.8; p<0.001] and 5.4 [95% CI 2.9-
9.9; p<0.001] for ICU mortality and 1.8 [95% CI 1.3-2.5; p<0.001] and
3.8 [95% CI 2.0-7-2; p<0.001] in moderate and severe hyperlactate-
mia, respectively.
CONCLUSION. Hyperlactatemia is a strong predictor of mortality in
ICU infected patients. Lactate level correlates independently with ICU
and in-hospital mortality for moderate and severe degrees of
hyperlactatemia.
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INTRODUCTION. Left ventricular longitudinal strain (LVLS) may be a
better method for detecting systolic dysfunction in critically ill pa-
tients. However, LVLS is limited by poor feasibility, dependency on
high image quality and availability of analysis in scanners. Recently
Huang et al. (1) described a method for estimating LVLS using M-
mode derived longitudinal wall fractional shortening (LWFS), where
MAPSE is normalized to the ventricle length. LWFS is less dependent
on image quality, is more feasible in critically ill patients and may be
done at bedside. However, this method requires validation, especially
within the setting of septic shock.
OBJECTIVES. The aim of this study is to 1) test if LVLS measured
using speckle tracking (LVLSspeckle) is predicted by LWFS and
MAPSE and to assess 2) agreement between LVLSspeckle & LWFS
and 3) agreement between LVLS measurements as predicted by
Huang’s equation (LVLSHuang) & our equation (LVLSpredicted).
METHODS. We retrieved 93 TTE studies from 2 echocardiographic
data repositories of patients admitted to ICU with septic shock. LVLS
was measured offline (Tomtec Image-Arena Ver. 4.6.4.44) using
speckle tracking from the A4C view. MAPSE was measured using the
same software and the ventricle length was measured from DICOM-
images, to generate LWFS.
RESULTS. The correlations between LVLSspeckle and LWFS,
LVLSspeckle and MAPSE, and LWFS and MAPSE were good with r-
values of 0.77, 0.68 and 0.94, see table 1.
The prediction equation demonstrated a slope close to 1 and an off-
set of +3.7%, very similar to those reported by Huang et al (1). The
bias ±2 SD for LVLSspeckle vs. LVLSpredicted was 0 ±6.0% (see figure
1), for LVLSspeckle vs. LVLSHuang it was 3.2 ±6.2%.
CONCLUSION. LWFS is strongly correlated with LVLSspeckle mea-
surements. The utility of LWFS for estimating LVLSspeckle is sup-
ported by its excellent accuracy and precision. This strong
relationship persisted even when applying the previous equation de-
scribed by Huang et al. (1) speaking for the validity of the method.
Our study supports the use of the simpler LWFS method for the bed-
side estimation of LVLS in patients with septic shock.
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INTRODUCTION. The carbapenem class of antibiotics are considered as
the last resort. However, there is an increasing chance of clinical isolation
of carbapenem-resistant gram-negative bacilli globally1). Although ad-
ministration of broad-spectrum antibiotics, such as carbapenem, within
one hour is encouraged in the treatment of sepsis, a carbapenem-
sparing strategy to combat antimicrobial resistance is important2).Cur-
rently, the epidemiology of carbapenem-use in the initial antibiotic ther-
apy for sepsis in Japanese intensive care units (ICUs) is unknown.
OBJECTIVES. To describe the epidemiology of carbapenem-use in ini-
tial antibiotic therapy for sepsis in Japanese ICUs.
METHODS. Design: Secondary descriptive study of the FORECAST
study, which was a multi-center, prospective, cohort study conducted
at 59 ICUs in Japan from January 2016 to March 20173).Participants: Pa-
tients ≥16 years of age with severe sepsis based on the sepsis-2 criteria
were included. Patients whose antibiotic-use data was missing were
excluded.Exposure: Patients were classified into two groups based on
the presence or absence of carbapenem-use in initial antibiotic thera-
py.Variables: Patient background and prognostic data were collected
for each group. The rate of use of carbapenem in ICUs, which enrolled
≥4 cases, were calculated. The log-Poisson regression mixed-effect
model was used to assess the association between initial use of carba-
penem and hospital mortality after adjustment for fixed effects of age,
baseline SOFA score, random effects of facility, and site of infection.
RESULTS. Among the 1184 patients, information of antibiotic-use
was available for 1140 patients. The number of patients who were
treated with carbapenem was 627 (55.0%). Patients’ characteristics
and prognosis with or without carbapenem are shown in Table1.
Among the 59 ICUs that participated in the study, 48 ICUs enrolled
≥4 cases. In these 48 ICUs, the median carbapenem-use rate was
43.6% [minimum: 20.0, maximum: 100.0, interquartile range: 43.6-
67.2] (Fig.1). In the unadjusted and adjusted models with the log-
Poisson regression analysis, there was no significant association be-
tween carbapenem-use and hospital mortality (unadjusted risk ratio[RR]: 1.25, 95% confidence interval (CI)[0.98, 1.61], p=0.078 and ad-
justed RR: 1.02, 95% CI [0.77, 1.35], p=0.888).
CONCLUSION. Approximately half of the patients with sepsis re-
ceived a carbapenem-class antibiotic in the initial antibiotic therapy
in Japanese ICUs. The rate of carbapenem-use for sepsis varied
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Page 346 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55001045
The prognostic role of hyponatremia and hypernatremia in sepsis
and respiratory tract infection-related sepsis (RTI-r): a sub-group
analysis of the Need-Speed trial
F. Gavelli, M. Baldrighi, F. Patrucco, GC. Avanzi, LM. Castello
Dipartimento di medicina traslazionale, Università degli Studi del
Piemonte Orientale ‘Amedeo Avogadro’, Novara, Italy
Correspondence: F. Gavelli
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001045
INTRODUCTION. Early risk stratification of septic patients presenting
to the emergency department (ED) is challenging. Many biomarkers
have been studied to help the emergency physician to accomplish
this goal, with encouraging results. However, some biomarkers are
not readily available in the ED setting. On the other hand, biochem-
ical analyses are routinely performed, giving useful information. The
aim of the study was to evaluate the prognostic value of plasma so-
dium concentration (pNa+) derangements at the ED presentation in
a population of septic patients.
METHODS. This study is a subgroup analysis of the Need-Speed data-
base, a multicenter observational study that included consecutive pa-
tients with suspicious of sepsis admitted to the ED of five Italian hospitals
between March 2013 and March 2015 and in which several biomarkers
were evaluated. The aim of this subgroup analysis was to evaluate the
prognostic role of pNa+ derangements in patients with sepsis and par-
ticularly in those in which sepsis was related to respiratory tract infection
(RTI-r sepsis). Mortality was evaluated at 7 and 28 days according to the
presence of pNa+ derangements (hyponatremia and hypernatremia) and
subsequently according to the severity of hyponatremia. Then, the same
analysis was performed only in patients with RTI-r sepsis.
RESULTS. Among the 1132 patients of Need-Speed, 879 septic pa-
tients were included in this analysis. A pNa+ derangement was
present in 48.7% of patients (40.3% hyponatremia, 5.7% hypernatre-
mia). Mortality was significantly higher at 7 days in dysnatremics
compared to eunatremics (11.9% vs 7.5% p=0.038) but not at 30
days (p=0.082). When patients were analyzed in terms of typology of
pNa+ derangements, only hypernatremia resulted significantly asso-
ciated to mortality, at both end-points (p<0.001). The Cox regression
hazard model showed that both hypernatremia and hyponatremia
were independent predictors of 7-day mortality (HR 3.51[1.67-7.38]
and 1.80[1.02-3.18], respectively) but only hypernatremia remained
significant at 30 days (HR 1.94[1.07-3.53]). Survival analysis of non-
hypernatremics showed that moderate-to-severe hyponatremia inde-
pendently predicted mortality both at 7 and 30 days (HR 5.92[2.83-
12.39] and 1.84[1.03-3.28], respectively). In patients with RTI-r sepsis
(n=549) similar results were observed as for the overall population.
CONCLUSION. Both hypernatremia and hyponatremia at ED admis-
sion are early predictors of mortality in septic patients. Thus, detec-
tion of pNa+ derangements should be part of the initial
management and risk stratification of such patients in the ED.
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Sepsis and septic shock (SS) have been shown to be associated with
substantial mortality and can lead to the consumption of a significant
amount of health care resources. Recognition of SS risk factors and
early intervention of proper broad-spectrum antimicrobial administra-
tion may significantly improve the outcome. Selective Digestive Decon-
tamination (SDD) has been associated with reduced ICU mortality and
acquired infection rates and its use could also modify SS risk factors.
OBJECTIVES. To analyze SS risk factors in patients with nosocomial
infection (NI) in an ICU after seven years of SDD.
METHODS. Prospective study. Patients with NI were included from
October 1, 2010 to September 30, 2018 in a polyvalent ICU of 30 beds.
SDD was applied for 7 years, from October 1, 2011 to September 30,
2018. Patients requiring mechanical ventilation for more than 48 hours
, an enteral solution and a paste with colistin, tobramycin and nystatin
every 8 hours until discharge were applied. Also intravenous cefotax-
ime were administered during the first 4 days. Rectal and pharyngeal
exudates were collected on admission and weekly. The categorical vari-
ables were summarized in frequencies and percentages and the nu-
merical variables in means and standard deviations or in medians and
interquartile ranges. The percentages were compared with the X2 test
or the Fisher exact test, the means with the t-test and the medians with
the Wilcoxon test for independent data. A multidimensional logistic
analysis was carried out. It was considered significant if p≤.05.
RESULTS. Of 7240 patients admitted, 286 (56,7%) out of 504 patients
with NIs developed septic shock (SS). In an univariate analysis had
statistically significant SS, Acinetobacter baumannii NIs (p: 0.009) and
multiresistant (MR) Pseudomonas NIs (p< 0.001). ICU stay (p: 0.003)
and mortality (p< 0.001) were significantly higher in patients who de-
veloped SS (Table 1). Independent factors associated with SS were:
urgent surgery, renal replacement therapy, nosocomial pneumonia,
and secondary bacteremia (Table 2).
CONCLUSION.
In an ICU with SDD, factors that were independently associated with SS
were: urgent surgery, renal replacement therapy, nosocomial pneumo-
nia, and secondary bacteremia. MR Pseudomonas and Acinetobacter
baumannii NIs were also associated with higher development of SS.
T1
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INTRODUCTION. De-escalation (DE) is a strategy to replace empirical
broad-spectrum antimicrobial treatment by using a narrower anti-
microbial therapy. Some studies has no impact on mortality in pa-
tients with sepsis and/or septic shock,.We assess the appropriate use
of antibiotics and their DE along 6 years, in an ICU with Selective Di-
gestive Decontamination (SDD).
METHODS. In a 30 bed mixed ICU from October 1, 2011 to Sep-
tember 30, 2017 nosocomial infections were prospectively col-
lected. Etiology, inflammatory response to infection, antibiotic
treatment (ATB T) and treatment modifications according to cul-
ture results, were analyzed. SDD was applied to patients requiring
endotracheal intubation over 48 hours.We performed a univari-
ate and a logistic multidimensional DE analysis. P was significant
if was ≤ .05.
RESULTS. DE was done in 113 out of 338 patients. Demogaphic data
is shown in Table 1. Mortality was lower in patients receiving DE ATB
(24.8% vs. 46.1%, p< 0.001). In the multivariate study
parenteral nutrition (PN), catheter-related bacteremia (CRB), pneumo-
nia (NN), ICU mortality and septic shock were statistically significant
(Table 2).The ATB T was inadequate in 95 infections (16,1%).Targeted
therapy was performed in 254 infections (43,1%). Also 87 patients
with septic shock had DE.The number of antibiotics used was 1025
and in 158 ATB DE were performed. Fifty-three patients with
CRB (46.9%) and 50 with NN (44.2%) had DE. The ATB T was inad-
equate in 95 infections (16,1%).Targeted therapy was performed in
254 infections (43,1%). Also 87 patients with septic shock had DE.
The number of antibiotics used was 1025 and in 158 ATB DE were
performed. The most DE ATB were levofloxacin (22,.37%), merope-
nem (18.3%) and linezolid (15.38%).
CONCLUSION. ICU patients who received, compared to those that
did not received DE, had a significantly lower mortality. Factors
independently associated to DE were in addition to ICU mortality,
PN, septic shock, CRB and NN.Inadequate ATB T was applied to
16,1% of NI. Finally, the most commonly DE ATB were
levofloxacin.001118
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INTRODUCTION. Abnormal platelet count and function are markers
of poor prognosis in sepsis and may be involved in organ failure.
However, underlying mechanisms have not been fully explained.
Mitochondrial dysfunction has been widely recognized both in septic
patients and laboratory models and has been shown in different or-
gans and blood cells.
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Fig. 1 (abstract 001118). See text for description
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man platelet mitochondrial function in vitro, independently from
hemodynamic alterations.
METHODS. Platelets were collected from healthy donors. Isolated
mitochondria were obtained from platelet-rich plasma (PRP) and pro-
tein concentration was measured. 30-mcg samples were incubated
with plasma collected from septic patients or healthy donors for 1
minutes at 37°C (N=5 or 6). Afterwards Complex I (CI) and citrate syn-
thase (CS) activity were measured with Sinergy HT microplate reader
(Bio-Tek Instruments, Winooski, VT) in duplicate. CI was calculated ac-
cording to Spinazzi et al. protocol [1] and normalised to CS activity.
We also analysed platelet aggregation as a marker of platelet func-
tion, with light transmission aggregometry (LTA) after incubation
with either septic or control plasma.
RESULTS. Complex I activity was significantly reduced after incuba-
tion with septic plasma (Figure 1). As previously shown in burned pa-
tients [2], we confirmed the priming effect of septic plasma on
different agonist involved in platelet aggregation in vitro. Inverse cor-
relation between mitochondrial CI activity and in vitro aggregation
was statistically significant (Figure 2).
CONCLUSION. Circulating factors in septic plasma affect platelet
mitochondrial function. Moreover, mitochondrial derangement corre-
lates with increased aggregation. Microthrombi formation has been
suggested as a possible mechanism of organ failure. Protecting
against humoral factor could improve haematologic and possibly
multi-organ failure in sepsis.
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INTRODUCTION. Sepsis induced cardiomyopathy (SICM) is defined as
a new onset myocardial dysfunction during sepsis that is reversible
within days to weeks, this condition was first described in 1984 by
Parker, et al. (1, 2). While the pathophysiology leading to SICM is
now known to involve a complex interplay of cytokines, endotoxin,
nitric oxide and autonomic dysfunction, it remains a poorly under-
stood entity (3,4). In addition, development of SICM is also known to
be a risk factor for increased mortality, yet specific management is
not clear (5, 6). SICM does not include right ventricular dysfunction
(RVD) in its definition and the presence of RV failure has unclear ef-
fects on patient outcomes. We aim to clarify the prevalence of RV
dysfunction in SICM.
METHODS. A retrospective chart review study was designed to re-
view patients admitted to the medical intensive care unit (ICU) with
a diagnosis of sepsis from January 2016 to December 2017. Patients
were included if an echocardiogram showing an ejection fraction
(EF) ≤ 50% within 72 hours of diagnosis of sepsis was available. A
comparison echocardiogram, before or after the sepsis episode, was
used to characterize patients into SICM from those with preexisting
reduced EF. Patients with acute coronary syndrome or significant
valvular dysfunction were excluded. Descriptive statistics and multi-
variate logistic regression was used to analyze the data
RESULTS. We analyzed 580 patient charts, of which 38 met our inclu-
sion criteria, with SICM being diagnosed in 19 patients. Patients with
SICM had a mean age of 64 (SD 17.5) and were predominantly male
(63%). The prevalence of RVD was 73.6%. Troponin leak was higher
in patients with SICM and RVD 1.103 (0.143 – 1.131) vs 0.017 (0.006-
0.024), p=0.006. On average, over a day had elapsed from admission
T1
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Table 1 (abstract 001142). See text for description
SEPSIS.2 SEPSIS.2+qSOFA IIC COMBINED BISEPRO
AUC-ROC 0,89 0,88 0,94 0,94 0,95
Sensitivity 0,97 0,98 0,93 0,93 0,94
Specificity 0,69 0,62 0,83 0,83 0,83Figure 1:
Fig. 1 (abstract 001142). See text for description
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have a significant effect on mortality.
CONCLUSION. Most patients with SICM have biventricular failure
upon diagnosis, despite the high prevalence of RVD in our cohort we
suspect that this is still underestimating the actual cases of biventri-
cular failure due to delays in obtaining initial TTE. While the presence
of RVD did not impact our patient mortality, this might be a result of
our limited sample size and its presence might have important impli-
cations in management. Its inclusion into diagnostic definitions
might increase its recognition and the overall diagnoses made, ap-
proaching the actual prevalence of SICM.
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INTRODUCTION. Recent studies have shown that the use of AI and
ML techniques have improved the detection of sepsis (SE) and septic
shock (SS) compared traditional models.
OBJECTIVES. Development of predictive models for the detection of
sepsis using AI-ML techniques.
METHODS. We used AI-ML techniques from historical data from the
Electronic Health Record (EHR) in a University Hospital with 450 beds.
Retrospective asessed, but the validation of the cases with the diag-
nosis of SE/SS was made prospectively by the clinical experts of the
Multidisciplinary Sepsis Unit within the Code Sepsis Program. We
used a SEPSIS.2 definition. The predictive variables that make up the
models come from different sources of structured data (clinical, ana-
lytical, pharmacological data), as well as from non-structured text
from the Triage and Emergency Department (ED) reports. The Mann-
Whitney-Wilcoxon test was used to identify statistically significant
clinical and analytical variables, with a significance level of 0.01. And
to obtain relevant unstructured data Natural Language Process-
ing techniques. The total sample was divided into 2 groups: the 5/7
proportion of the total of randomly selected records constituted the
training set and the rest of the records (2/7) formed the test set.
RESULTS. From JAN-2014 to OCT-2018, 815,170 records of the EHR
have been analyzed. We included 218,562 adult patients from all
areas of Hospital (78% from ED) divided into 2 groups: 1) 9301 (4.6%)
had SE/SS; and 2) 209,261 (95.4%) who did NOT have sepsis. A total
of 3,927 variables have been extracted from the different datasources. By relevance 244 (6.2%) variables associated with SE/SS have
been selected. We have analyzed 5 predictive models: Sepsis.2, SEP-
SIS.2 plus qSOFA, general ML (IIC), ML + Sepsis.2 (BISEPRO), ML +
Sepsis.2 + qSOFA (COMBINED), Table I and Figure 1. BISEPRO was the
best approximation of the resulting prediction that offers an AUC-
ROC of 0.95 (95% CI 0,94-0,96).
CONCLUSION. The use of predictive models based on AI-ML and has
provided more dynamic and precision models for the detection of
patients with SE/SS.
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INTRODUCTION. Management of severe septic shock is controversial,
particularly regarding the use of corticosteroids, thiamine, high-dose
norepinephrine (NE) or combination with other vasopressors. Regard-
ing the administration of NE, there is no clear recommendation for
maximum dosage, although certain authors refer that doses above 2
μg/kg/min might be ineffective and associated with adverse drug
events.
OBJECTIVES. To study the median dose of NE perfusion in patients
diagnosed with septic shock, to evaluate the need of very high dose
of NE (here defined as dose > 1 μg/kg/min) and assess it in terms of
duration, adverse reactions, clinical complications and mortality.
METHODS. 31-bed level II-III Intensive Care Unit, tertiary university-
affiliated urban hospital. Retrospective analysis and protocol-driven
data collection from all patients admitted with a diagnosis of septic
shock from 16.09.2018 to 24.01.2019: SAPS II and SOFA scores,
hemodynamic variables, adequacy of antimicrobial therapy,
Page 350 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55associated organ failure (respiratory and need for mechanical ventila-
tion, kidney failure and need for renal replacement therapy), use of
adjunctive therapies (hydrocortisone, thiamine), use of albumin and
other vasopressors (epinephrine, terlipressin) or inotropes (dobuta-
mine), lactate clearance, fluid balance and ischemic complications.
Mortality was the primary clinical outcome. We performed a descrip-
tive statistical analysis using non-parametric tests, as well as regres-
sion analysis as appropriate. Significance was defined as a p value <
0.05.
RESULTS. In a preliminary analysis we included 62 patients. Median
age was 68 years (IQ range: 58-77), median SAPS II was 65 (45-81).
Overall mortality was 49.2%. Median maximum dose of NE was 1.4
μg/kg/min (IQ range: 0.7-2.7), administered for a median time of 5
hours (IQ range: 2-7). In the majority of patients, maximum dose of
NE was administered during the first day of disease, and titration
above 0.5 μg/kg/min was used in 80% of patients. Patients who
needed higher doses in order to achieve target perfusion pressure
tended to be more severe (Coef. 0.04; p< 0.001) and younger (-0.03;
p=0.02). Subgroup analysis revealed a mortality of 64% in patients
treated with NE dose higher than 1.0 μg/kg/min and a mortality of
75% in patients treated with a NE dose higher than 2.0 μg/kg/min.
We did not identify higher incidence of splanchnic (OR 1.1; p=0.947)
or digital ischemia (OR 1.3, p=0.47) from high dose of NE.
CONCLUSION. Septic shock remains a condition with ominous prog-
nosis. Although doses higher than 2.0 μg/kg/min mark a very high
risk of death, we still believe that doses in this range could be used
for a short period of time, during the first day of disease and with
young patients, in order to revert refractory septic shock.
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INTRODUCTION. Prompt diagnosis and initiation of appropriate anti-
microbial therapy can improve morbidity and mortality in patients af-
fected by sepsis or septic shock. Rapid diagnostic tests that can
accurately identify the pathogen causing an infection and the effect-
ive antimicrobials would increase the likelihood that patients are
treated appropriately. In addition, rapid diagnostic tests can also be
used to help clinicians discontinue or de-escalate antimicrobial ther-
apy in favor of narrower-spectrum options. The Accelerate Pheno sys-
tem is a new diagnostic device that can provide rapid bacterial
identification and antimicrobial susceptibility test results directly from
a positive blood culture.
OBJECTIVES. To evaluate the role of Accelerate Pheno system in the
management of septic patients in a hospital with an antimicrobial
stewardship program.
METHODS. At San Giovanni Hospital in Rome, positive blood cultures
from septic patients were loaded onto the Accelerate Pheno system.
The results were immediately communicated to the infectivologist
for the consequent therapeutic choices. Results obtained from the
Accelerate Pheno system were also compared to those of the usual
standard of care.
RESULTS. Twenty positive blood cultures taken from septic patients
were analyzed with Accelerate Pheno™ system from June ’18 to
March ’19. Results were obtained from the microbiology laboratory
after an average of 1.1 days versus an average of 2.95 days using
conventional methods. The isolated organisms were: 6 S. aureus (3MRSA), 6 Enterococcus spp, 5 E.coli (2 ESBL +), 2 K. pneumoniae KPC,
1 coagulase negative Staphylococcus spp. No identification errors or
discrepancies in antimicrobial susceptibility test report were ob-
served when compared to conventional methods. The infectivologist
was able to establish a targeted therapy in 65% of cases, de-escalate
the antibiotic therapy in 25%, and confirm empirical therapy in 10%
of cases.
CONCLUSION. In septic patients, the Accelerate Pheno™ system
seems to represent an effective method to obtain not only a rapid
and accurate microbiological diagnosis, but also to optimize anti-
microbial therapy within the context of antimicrobial stewardship
principles.
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INTRODUCTION. Respiratory infection is a major cause of admission
at Pediatric Intensive Care Unit (30-70% of admissions depending on
the season). Differential diagnosis between viral and bacterial pneu-
monia still is a problem in pediatric population: clinical data is unspe-
cific and Torathic X-Ray (TXR) has its limitations. Lung ultrasound
(LUS) would have a better sensibility and specificity for pneumonia
diagnosis, as it has been demonstrated in adult patients.
OBJECTIVES. To compare the usefulness of LUS (sensibility and speci-
ficity) with respect to TXR, for the diagnosis of severe community
and nosocomial pneumonia. To analyze if LUS implementation could
decrease the TXR indication.
METHODS. Prospective, randomized, blinded and interventional clin-
ical trial, developed between June 2017-march 2019. Inclusion cri-
teria: patients (7 days-18 years) with suspected community (CP) or
nosocomial pneumonia (NP) admitted at PICU. Exclusion criteria: pre-
vious severe respiratory disease (bronchopulmonary dysplasia, cystic
fibrosis…), immunodeficiency, non-acceptance of informed consent.
Pneumonia diagnosis was based on clinical signs, radiological find-
ings (group 1-experimental: LUS initial diagnosis; group 2-control:
TXR initial diagnosis) and analytical data. Images were assessed by
both, the paediatric investigator who was blind to the LUS or RXT,
and the radiologist, blinded to clinical data. Statistics: spps 22.0. Trial
design was accepted by the Institutional Research Board and the Eth-
ical Committee.
RESULTS. There were recruited 112 cases; males 64 (57.1%), mean
age: 21.14 months. Patients randomization: group1-LUS= 59 (52.7%),
and group 2-TXR= 53 (47.3%).
Final diagnosis in CP suspicious (n=78) was: bacterial pneumonia in
28 patients, viral pneumonia in 22, and no pneumonia in 20. The
sensitivity and specificity of LUS for CP was 98.7% and 87.2%, and
90.2% and 73.3% for TXR. LUS allowed an early diagnosis than the
Page 351 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55TXR in 28 patients. The number of TXR in group 1-LUS resulted in
1.8/patient, with respect 2.5 in group 2-TXR, p= 0.075.
NP was confirmed in 21 of the 34 with initial suspicious. Sensitivity
and specificity were also higher for group1-LUS than for TXR (96.7%
and 85% vs 89.2 and 74%); with an early diagnosis for LUS in 18 pa-
tients; and lower rate of TXR in group1-LUS (2.1 vs 2.7, p= 0.084).
CONCLUSION. LUS showed better sensitivity and specificity for the
diagnosis of CP and NP than TXR in this preliminary analysis. LUS
seemed to allow an early diagnosis of pneumonia in some cases. LUS
could lead to a lower irradiation of paediatric patients.
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INTRODUCTION. Diaphragmatic dysfunction (DD) has been reported
to occur in 40- 60% of patients in ICU.1 This impairs the ability of re-
spiratory pump to compensate the increased demand during acute
illness resulting in increased the morbidity and mortality. Early recog-
nition may help to optimize treatment strategy and assist in prog-
nostication.2 Optimal timing of weaning is crucial. Clinical
predictions are often incorrect. Ultrasound has emerged as an inex-
pensive, easily available and reproducible, bed-side tool for assess-
ment of DD.1
OBJECTIVES. To assess incidence of DD till first spontaneous breath-
ing trial (SBT), to identify the risk factors and to evaluate its impact
on weaning outcome, mechanical ventilation (MV) days, ICU length
of stay (LOS) and 28 day mortality.
METHODS. A prospective observational, study in an 18 bed multi dis-
ciplinary ICU of a tertiary care, teaching hospital between November
2018 to March 2019. All consecutive adult patients requiring MV dur-
ing the period were included in the study. These patients were
screened for DD on the day of intubation and then on every 3rd day
till first SBT. They were followed up till 28 days or death. Patients
with neuromuscular disorder, thoracic or abdominal surgery and pa-
tients extubated or died before 48 hr of MV were excluded. Data on
patient demographics, ICU LOS, days on MV, 28 day mortality and re-
sult of first SBT were collected. Risk factors analyzed were sepsis on
admission, duration of assist control ventilation, sedation and para-
lytic infusion duration, hyperglycemia requiring insulin infusion, ster-
oid use and use of polymyxins.2,3 DD was assessed by ultrasound
measurement of diaphragmatic thickness index (DTI) by a linear high
frequency ultrasound probe, placed between 8-9th intercostal space
near the zone of apposition of diaphragm.1 All patients were cared
following standard ICU protocols and guidelines.
RESULTS. 233 patients were screened, 47 were excluded either due
to extubation or death before 48 hours. 23 patients left in between
the study period. The incidence of DD was 47.8% (n=78/163) using
the criteria of DTI < 30%. Out of various risk factors analyzed, in-
creased risk of DD was observed with sepsis on admission (Odds ra-
tio 6) and use of paralytic infusion (odds ratio 16). Patients with DD
had higher failure rate on their first SBT (79.4% vs. 34.1%) with rela-
tive risk of 2.32. Patients who had DD had higher ICU LOS (9.9+4.3
vs. 7.71+3.8 p=0.04). There was no significant difference in MV days
in both the groups. Patients with DD had higher 28 days mortality
(26 vs.16 p=0.034)
CONCLUSION. The incidence of DD was 47.8% till first SBT. Sepsis
and use of paralytic infusion were found to be the significant risk fac-
tors. Patients with DD had a significantly higher failure rate on firstSBT, had a significantly higher 28 days mortality and ICU LOS with
no difference in MV days.
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INTRODUCTION. Acute pancreatitis (AP) is an inflammatory condition
of the pancreas with a broad clinical spectrum that can cause local
injury, systemic inflammatory response syndrome and organ failure
(1). The more severe cases often require management in an intensive
care unit and are associated with significant morbidity and mortality
(2). The objective of the present study was to analyse the outcomes
of patients admitted with AP in the last 5 years to the intermediate
and intensive care units (IntCU/ICU) of a single academic medical
center.
METHODS. A retrospective review of the patients admitted from
January 2014 to December 2018 was undertaken. A review of the
medical records for each patient was performed.
The outcomes evaluated were mortality, the presence of organ dys-
function and the need for antibiotics.
The variables collected were provenience, time of stay in the emer-
gency department (ED) before admission and severity scores [Ran-
son, Bedside Index of Severity in AP (BISAP), Acute Physiology, Age
Chronic Health Evaluation II (APACHE II), Sequential Organ Failure As-
sessment (SOFA), CT Severity Index (CTSI) score].
The collected data was analysed using SPSS.
RESULTS. Ninety-four patients (male 61, mean ± SD age = 64.6 ±
18years) with AP were admitted to the IntCU/ICU in the 5-year
period. The global mortality rate was 22,3%.74.5% of patients came
from the ED, 25,5% came from the wards. Patients that came from
the wards had a higher mortality rate when compared to those who
came from de ED [39,1% vs 18,6% (p=0.044)]. The median time in
the emergency room prior to admission was 13 hours (IQR 15). We
found no statistical significant difference in mortality when evaluat-
ing time of stay in the ED (p=0.530).
Severity scores had a statistically significant correlation with mortal-
ity, with the exception of CTSI [APACHE II ≥ 8 (29,4% vs 3,8%; p=
0.008); SOFA ≥ 8 (60% vs 12,2%; p<0.001); Ranson ≥ 5 (36,0% vs
11,1%; p=0.012); BISAP ≥ 3 (35,9% vs 12,7%; p=0.008); CTSI ≥ 4
(33,3% vs 17,9%; p=0.129)] and a correlation with at least one organ
dysfunction [APACHE II ≥ 8 (p<0.001); SOFA ≥ 8 (p<0.001); Ranson ≥
5 (p<0.001); BISAP ≥ 3 (p<0.001); CTSI ≥ 4 (p=0.019)].
After excluding patients that needed antibiotics for other reasons,
there was no statistical significant diference in the need for antibi-
otics for AP complications when analysing CTSI score severity [CTSI ≥
4 (p=0.078)].
CONCLUSION. Severity scores were statistically significantly associ-
ated with mortality and organ dysfunction. We found no statistical
Page 352 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55significant difference in mortality when evaluating time of stay in the
ED and the need for antibiotics for AP complications when correlated
to CTSI score severity. Mortality was twice higher when patients
came from wards when compared to those who came from ED – this
should draw our attention to this group of patients who may need
earlier admission and intervention.
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INTRODUCTION. The 6-min walk test (6MWT) is a validated measure
of physical function since the walked distance can reflect the cap-
acity to undertake daily activities after ICU stay for acute exacerba-
tion of COPD (AECOPD). Determination of association between
functional variables and health-related quality of life (HRQL) may fa-
cilitate interpretation of disease progression and impacts of therapy.
OBJECTIVES. To evaluate the association between the health-related
quality of life after ICU discharge and the 6MWT in AECOPD ICU ad-
mitted patients.
METHODS. A prospective observational cohort study was performed
in a Tunisian 9-beds tertiary medical ICU between February 2017 and
January 2018, including all consecutive survivors of AECOPD. The
6MWT is performed the day of ICU discharge according to the inter-
national guidelines. Web-based version of the St George's Respiratory
Questionnaire score (SGRQ) was used to measure HRQL. The SGRQ
variables (activity, symptoms, impacts) were collected within three
months of ICU discharge via phone calls. Data collected : clinical fea-
tures at admission, severity of illness and ICU course. Walked and
predicted distances were calculated. Spearman rank correlation was
used to measure the degree of association between mean walked/
predicted ratio and the SGRQ score.
RESULTS. Among 90 patients admitted for AECOPD during the study
period, 62(69%) were included. General characteristics were : age,
66.4±9.5 years; sex ratio, 4,5/1; Charlson index,3.9±1.8; COPD GOLD
D, 55(88%); SAPSII score, 29.8±9.9; initial invasive mechanical ventila-
tion, 17 (27.4%); mean length of stay, 13.64±10.09. Mean walked dis-
tance, 223±96m; mean ratio walked/predicted distance, 0.41±0.17.
Three months after discharge, 58(93%)patients could be interviewed
via phone. SGRQ estimation was as follow: median symptoms score,
59.3[43.6-75]; median activity score, 69[53.7-84.4]; median impacts
score, 49[23.8-74.2] and median total score, 56.8[63.6-77]. Compared
to population norms (Symptoms, 16.1; activity, 16.3; impacts, 8.1 and
total score, 12.2). 6MWD was significantly correlated with all compo-
nents of the SGRQ : symptoms, -0.43(-0.64 to -0.27), p= 0.001; activity,
-0.53(-0.62 to -0.19), p<0.0001; impacts, -0.46(-0.69 to-0.32), p< 0.0001
and total -0.49 (-0.62 to -0.24), p< 0.0001.F1CONCLUSION. 6-min walk distance at ICU discharge was associated
with HRQL among survivors of AECOPD patients admitted in a Tunis-
ian medical ICU.
001355
Lowest admission pH and its association with Mortality in all-cause
emergency and Diabetic ketoacidosis patients in a district general
Critical Care Unit
D. Wright1, J. Morris2, T. Samuels1, P. Morgan1, M. Alice3
1Intensive care, East Surrey Hospital, Redhill, United Kingdom; 2Intensive
care, Croydon University Hospital, Croydon, United Kingdom; 3Icu, East
Surrey Hospital, Redhill, United Kingdom
Correspondence: D. Wright
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001355
INTRODUCTION. Decreasing pH and advancing age are associated
with increased mortality in critically ill patients. Acidosis has vari-
ous etiologies and is common amongst critically ill patients. It is
associated with organ dysfunction and is therefore associated
with worse outcomes. Diabetic ketoacidosis (DKA) is a common
complication of diabetes mellitus which infrequently requires
emergency admission to the critical care unit. The outcome in
these patients are better as they are young patients with a
greater physiological reserve.
OBJECTIVES. The primary aim of the study was to look at mortality
related to the lowest initial pH amongst all-cause emergency admis-
sions and DKA emergency admissions to the critical care unit. Sec-
ondary outcomes looked at the age-related mortality amongst the
higher risk group, that is, pH ≤7.23.
METHODS. A retrospective analysis of all-cause emergency admis-
sions to a 16-bed mixed critical care unit between 2013 and 2019
was done using our electronic patient database. Patients aged ≥18
years with an admission pH of ≥6.8 were included in the analysis. A
subset of the emergency admissions admitted with DKA were ana-
lyzed separately. Wilcoxon rank sum test was used to test for signifi-
cance using R version 3.5.3 (R Foundation).
RESULTS. There was a total of 5,416 all-cause emergency admissions,
2966 (54.8%) of which were male and 1630 (30.1%) were non-
survivors. Of the non-survivors, the mean lowest pH was 7.22 SD 0.16
vs 7.32 SD 0.11 in the survivor group (p=<0.0001). Non-survivors
were older (mean age 69.8 vs 61.9 years p=<0.0001) than those in
the surviving group.
Of those emergency admissions, 99 (1.8%) were admitted with DKA,
10(10.1%) of which were non-survivors. There was no significant dif-
ference in pH between the survivors and non-survivors (mean pH
7.15 vs 7.15 p=0.8724). The non-survivors were older than the survi-
vors (63.8 vs 46.4 years p=0.0016).
CONCLUSION. PH and age are inversely proportional to mortality
amongst all-cause emergency admissions to the critical care unit.
In the DKA patients, however, there was no difference in the pH
related mortality. This subset was limited by the small sample
size and also the group sizes were unequal which may have led
to a type II error. In both groups, the mortality was noted to be
higher amongst the older patients. DKA typically presents in
young patients with good physiological reserve and as such, this
raises the question of whether Hyperosmolar Hyperglycaemic
States were misdiagnosed as DKA.
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INTRODUCTION. Fasting Ramadan is a religious obligation for mus-
lims and one of the five pillars of Islam. Even though those unable tofast are exempt, many individuals refuse and chose to fast. This may
lead to life threatening conditions and an increase in ICU demand.
OBJECTIVES. To investigate the impact of lifestyle changes during
Ramadan on ICU admission patterns and outcomes.
METHODS. It was a retrospective cohort study carried out in a 9-bed
medical ICU of Farhat Hached teaching hospital. Patients who were
admitted to the ICU during the month of Ramadan, the preceding
month (Chaaban), and the following month (Shawal) over a period of
10 years (2018–2009) were included. Underlying condition, severity
of illness, diagnosis at admission, management and outcomes were
recorded. Patients were divided into three groups according to the
time of presentation in relation to the month of Ramadan. Demo-
graphic, clinical features and outcomes were compared between
groups.
RESULTS. During the review period, 748 patients were included (G1=
257 ; G2=230 and G3=261). Patients' characteristics were : median
age 57[35-71]years ; male, 438(58.6 %) ; median SAPSII, 30[20-42] ;
median Charlson index, 3[0-5]. The main reason for admission were
respiratory disorders, 408(54.4 %).
Patients with chronic kidney disease (CKD) as underling condition
and hypovolemic Shock as clinical presentation were more fre-
quently admitted during Ramadan and/or Shawal vs Chaaban re-
spectively (8(3.5%), 19(7.3%), 6(2.3%) ; p=0.016) and (14(6.1%),
13(5%), 4(1.6%) ; p=0.031). Furthermore, patients during Ramadan
and/or Shawal were more likely to have inverted urinary sodium
to potassium ratio vs Chaaban respectively (94(48.7%), 77(36.8%),
58(28.3%) ; p=0.000). There was no significant difference in
length of stay nor in mortality.
CONCLUSION. While there were no differences in any studied out-
comes in patients admitted to ICU before, during Ramadan or after,
there was a significant increase in patients presenting with history of
CKD, hypovolemic shock and inverted urinary sodium to potassium
ratio.
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INTRODUCTION. The patients cared for in intensive care and the
available resources differs between regions. Swedish intensive care is
like in the other Scandinavian countries characterized by short length
of stay and the number of intensive care beds is low.
OBJECTIVES. The objectives of the study is to describe the character-
istics of Swedish intensive care patient characteristics and resources
and describe the outcome measured as raw and risk-adjusted
mortality.
METHODS. Data publicly available from the Swedish intensive care
registry (SIR, www.icuregswe.org) for 2018 is presented. SIR covered
81/84 (96 %) of the Swedish general-, pediatric-, burns-, neuro- and
cardiothoracic intensive care units, 100 % of the general intensive
care units. Mortality data is imported to SIR from the Swedish Na-
tional Population Register.
RESULTS. There were 527 ICU-beds in Sweden in 2018 with enough
staff to be used for intensive care. That is 5.2 intensive care beds per
100 000 inhabitants. There were in mean 0.7 nurses and 0.7 assistant
nurses per bed. The mean SAPS3 score was 56.2 while the intensive
care mortality was 8.9 % and the 30-day mortality 19.2 %. The 30-
day mortality rate has previously been shown to be higher than the
in-hospital mortality rate. The standardized mortality rate (SMR) using
SAPS3 general formulae and 30-day mortality as outcome was 0.63.
A Swedish recalibration of the SAPS3 is therefore used for compari-
sons in Sweden.
F1
Fig. 2 (abstract 001386). kaplan Meier survival in elderly ICU
survivors
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number of beds and high SAPS3 scores, but neither raw- or risk-
adjusted mortality rates are high.
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INTRODUCTION. Patients admitted to intensive care unit (ICU) often
have at least one or more organ failures that require special care
with high mortality risk.
OBJECTIVES. The aim of the present study was to determine ICU
mortality rate and associated risk factors in a Tunisian medical ICU.
METHODS. A prospective observational cohort study over an
eighteen-month period from September 15th, 2015 to March 15th,
2017 in a medical intensive care unit of FarhatHachedUniversity Hos-
pital (Sousse-Tunisia). Were included all patients hospitalized for
more than 48 hours. Data collected were patients’ demographics,
clinical characteristics, therapeutics and outcomes. Multivariate ana-
lyses were performed to identify risk factors associated with ICU
mortality.
RESULTS. 258 were included, they were 60.1±17.7yrs mean aged,
predominantly male, 161(62.4%); with at least two comorbidities,
145(56.2%); immunocompromised, 26(10.1%); Charlson Score
Index>3, 45(17.4%). SAPSII>30 on admission, 119(46.1%); 186(72.1%)
needed mechanical ventilation. Median[IQR] mechanical ventilation
duration, 7[4-12.5]days with median[IQR] length of stay, 8[4-17]days.
Mortality rate was 37.2%. In multivariate analysis, risk factors associ-
ated to ICU mortality were the occurrence of healthcare-associated
infections (RR,7.1,95%CI,[2.6-19.6]; p<0.0001), and non-invasive venti-
lation failure (RR,13.0, 95%CI,[4.5-38.0]; p<0.0001).
CONCLUSION. The present study conducted in a medical ICU identi-
fied healthcare-associated infections and non-invasive ventilation fail-
ure as independent risk factors associated with ICU mortality.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):001386INTRODUCTION. Worldwide there is an increase in the life expect-
ancy and thus an increasing of ICU demand for elderly patients.
However, little is known about their long-term outcomes after ICU
discharge.
OBJECTIVES. To evaluate outcomes and risk factors associated with
6-month mortality after ICU discharge in elderly patients.
METHODS. It is a mixed method study conducted in a 9-bed medical
ICU from January 2016 to January 2017 including all old ICU survivors
(≥65years). Information regarding demographic and clinical charac-
teristics were obtained from medical records. At 6 months post-ICU
discharge, follow-up was performed by phone-calling patients or
their families. Univariate and multivariate analyses were carried out
to identify predictors of 6-month mortality after ICU discharge.
RESULTS. Among 178 old patients admitted during the study period,
94 patients were discharged alive. Baseline characteristics of elderly
ICU survivors were: median age, 74[69-77]years ; median Charlson
score, 4[4-5] ; Knauss C or D, 71(75,5%) ; Mac Cabe≥2, 42(44,7%) ;
median SAPSII, 32[27-40] ; invasive mechanical ventilation (IMV) on
admission 27(28,7%) and vasopressors use, 65(36,5%). The median
length of stay was 8[5-15,5]days. Among the elderly ICU survivors, 27
could not be contacted by phone and 21 died within the 6-month
period after discharge. Figure 1 displays the Kaplan-Meier survival
curve in elderly ICU survivors at 6 months. Univariate analysis identi-
fied factors associated to 6-month mortality after ICU discharge re-
spectively: Knauss C or D (95,2% vs 67.4%, p=0.013) ; history of
arrhythmia (38,1% vs 10,9%, p=0,023) and prolonged ICU stay(≥15
days) (42.9% vs 17.4%, p=0.026). Multivariate regression model iden-
tified the following factors as independently associated to 6-month
mortality: Knauss C or D (OR, 9.01 ; 95%CI, [1.03-78.53] ; p=0.026), his-
tory of arrhythmia (OR, 6.12 ; 95%CI, [1.42-26.42] ; p=0.015) and pro-
longed ICU stay (OR, 4.3 ; 95% CI, [1.15-16.21] ; p=0.03).
CONCLUSION. Knauss C or D, history of arrhythmia and prolonged
ICU stay were identified as risk factors associated with 6-month mor-
tality of elderly ICU survivors.001395
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Table 2 (abstract 001395). Transition matrix of the percentages of
changes of occupation with respect to the changes that occur.
Table 2 (abstract 001395). Transition matrix of the percentages of
change of occupation with respect to a given accupation level.
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age, admissions and discharges are triaged, and shortens length of
stay (1-5).
OBJECTIVES. Relational analysis of the bed occupancy level in the
ICU with respect to admissions and discharges and their possible ef-
fect on the length of stay of patients.
METHODS. An observational, prospective study was performed on
patients admitted from October 1, 2015 to April 30, 2018 in the
medical-surgical ICU of the Hospital Complex of Navarra, with 24
beds. Variables such as age, APACHE II on admission and type of ad-
mission (elective surgical patient, urgent surgical patient, emergency
medical patient, polytrauma, hospitalized in medical service, hospital-
ized in surgical service and others) are also included. Markov chains
transition matrices are used to analyze the probabilities of changing
the bed occupancy, globally and according to an occupation level.
On the one hand, the percentage of each change in the occupation
level is calculated with respect to the possible total changes that
take place, that is, considering 17 beds occupied, moving to 19 beds
in the following day represents 0,74% of the total of all possible
changes for all beds and occupations. And on the other hand, the
percentage of each change considering only the movements that
occur in a given occupation level, of all changes that occur with 17
occupied beds, moving to 19 beds in the next day has a probability
of 11,3%. Multivariate analysis of the relationship between the length
of the stay and bed occupation at the time of patients’ discharge
was carried out, adjusting for the rest of variables studied. Statistical
significance p < 0,05.
RESULTS. We analyzed 2217 patients. Average age of 62,9 years (SD
14,8), APACHE II of 14,2 points (SD 8,1), length of stay of 7,7 days (SD
12,7, median 3,0) and occupation at the time of discharge of 19,4
beds (CI 19,3-19,6, median 20), with 17,2% of > 22 beds occupied
and 8,2% of> 23 beds. In the analysis of the probabilities of transi-
tions in bed occupancy, it is observed that, given an initial occupa-
tion, it is most likely to stay the next day at that same level. In
addition, given an occupation level, there is more probability of ad-
mitting a new patient than of discharging up to 21 beds, where the
trend is reversed being statistically significant. The multivariate ana-
lysis in terms of length of stay was significant only for occupations >
23 beds (-2,4 days, CI -4,5- -0,2). APACHE II (0,2 days, CI 0,1-0,3), ur-
gent surgical patient (3,2 days, CI 1,1-5,3), polytrauma (6,4 days, CI
3,9-9,0) and the admitted medical patient (3,6 days, CI 1,5-5,8) were
also significant.
CONCLUSION. Above 85% occupancy, bed management is observed,
which involves triage of admissions and discharges. The influence of
the occupation level on the patient’s length of stay is only significant
at maximum occupation.
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INTRODUCTION. Endotracheal intubation for airway control is per-
formed in emergency situations and should be documented post
procedure. The United Kingdom Intensive Care Society (UKICS) rec-
ommends using an invasive procedure checklist and post intubation
document. Within Royal Wolverhampton NHS Trust exists an emer-
gency intubation checklist, however documentation of events is vari-
able between clinicians. We have created a standardised method of
documentation using a ‘blue sticker’ which follows a similar structure
to the UKICS post intubation document. It provides a clear, concise
and cost effective method of recording important information re-
garding intubation which can be easily identified in the case notes
with a lower risk of misplacement.
OBJECTIVES. Improve use of the emergency intubation checklist and
documentation of rapid sequence inductions in a clear and concise
manner.
METHODS. Retrospective review of 28 case files for emergency intu-
bations from May to July 2018. We assessed nine important categor-
ies; Rapid sequence induction (RSI), use of intubation checklist,
laryngoscopy grade, endotracheal tube (ETT) parameters (size, length
and confirmation), and administered drugs (name, dose and add-
itional). The data was input into a spreadsheet and analysed, produ-
cing graphs for interpretation. The project was re-evaluated in
February 2019 to measure improvements following the introduction
of the sticker. 22 case files were reviewed and anaylsed using the
same methodology.
RESULTS. Comparisons between the two data sets showed similar in-
dications for intubation. The leading cause was following cardiac
Page 356 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55arrest (32%) in both sets of data. Documentation of the subcategor-
ies all improved individually, with the largest improvements in add-
itional drugs used (41%), drug dose (34%), and tube confirmation
(33%). The sticker was used in 23% of the case note after the first
round of implementation. The use of the checklist had also improved
by 24%. Prior to introduction of the sticker, 11% had no documenta-
tion of events, and 0% covered all 9 categories. After implementa-
tion, 23% had all 9 categories documented. The lowest number of
categories documented was 2 (5%).There was also an improvement
in the mean number of categories from 4.35 to 6. The mode and me-
dian improved from 5 and 6, to 6, and 5 to 6 respectively.
CONCLUSION. Before the project, documentation varied between cli-
nicians, but was poor overall. After introduction of the ‘blue sticker’,
there has been a great improvement. When the sticker is used docu-
mentation has been clear and easily identified in the case notes con-
taining all essential information. Improvement in training clinicians to
use the resources available will improve this further.
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INTRODUCTION. Health care associated infections in the intensive
care setting (ICU-HAIs) presenta worldwide medical challenge, in-
creasing the need to implement national and international surveil-
lance strategies.
OBJECTIVES. The objective of the present study was to determine in-
cidence and risk factors of ICU-HAIs in a Tunisian medical ICU.
METHODS. A prospective observational cohort study, going from
September 15th, 2015 to March 15th, 2017, in a medical intensive
care unit of Farhat Hached UniversityHospital (Sousse-Tunisia). Data
collected were patients’ demographics, clinical characteristics, thera-
peutics, HAIs incidence rate. HAI definitions and incidence rates were
carried out using the Centers for Disease Control and Prevention Na-
tional Health-Care Safety Network (CDC/NHSN) recommendations.
Univariate and multivariate statistical analyses were carried out to de-
termine ICU-HAIs risk factors.
RESULTS. During the study period, 258 patients were included. They
were 60.1±17.7yrs mean aged, predominantly male, 161(62.4%); with
at least two comorbidities, 145(56.2%); immunocompromised,
26(10.1%); Charlson Score Index >3, 45(17.4%). Antibiotherapy prior
to admission, 154(59.7%). SAPSII>30 on admission, 119(46.1%);
186(72.1%) needed mechanical ventilation. Median[IQR]ventilation
duration, 7[4-12.5]days; median[IQR] length of stay, 8[4-17]days
equating to 3.357 patient-days. Eighty four patients (32.6%) devel-
oped 112 HAIs, 33.4 infections/1000days of hospitalization. Ventilator
Associated Pneumonia, 24.3VAP/1000ventilator-days; central-venous-
catheter-associated infection, 27.5CVC-AI/1000CVC-days. Risk factors
associated with acquiring ICU-HAI were length of stay≥7days (RR
9.42, 95%CI[2.33-38.08]; p=0.002), prolonged duration of sedation
(RR,1.15, 95%CI,[1.02-1.31]; p=0.021), and non-invasive ventilation fail-
ure (RR,2.70,95%CI,[1.009-7.27]; p=0.048).
CONCLUSION. The present study showed higher ventilator associ-
ated pneumonia and central-venous-catheter-associated infection
rates compared to International Nosocomial Infection Control Con-
sortium report for 2010-2015. Length of stay>7days, prolonged sed-
ation and non invasive ventilation failure were independent risk
factors associated with acquiring ICU-HAIs.001404
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INTRODUCTION. Healthcare-associated infections (HAI) are a major
cause of morbidity and mortality in patients admitted in intensive
care.
OBJECTIVES. The aim of the present study was to determine mortal-
ity rate and associated risk factors in patients with HAIs in the inten-
sive care unit (ICU).
METHODS. A prospective cohort study was conducted in a medical
intensive care unit (ICU) at Farhat Hached University Hospital
(Sousse-Tunisia), from September 15th, 2015 to March 15th, 2017.
Were included all patients hospitalized for more than 48 hours. Sur-
veillance was carried out till discharge or death. Data collected were
patients’ demographics, clinical characteristics, therapeutics. HAI defi-
nitions and incidence rates were carried out using the Centers for
Disease Control and Prevention National Health-care Safety Network
(CDC/NHSN) recommendations. Logistic regression was performed to
identify independent risk factors of mortality in patients with HAIs.
RESULTS. 258 patients were included over the study period. They
were 60.1±17.7yrs mean aged, predominantly male, 161(62.4%); with
at least two comorbidities, 145(56.2%); immunocompromised,
26(10.1%); Charlson Score Index >3, 45(17.4%). Antibiotherapy prior
to admission, 154(59.7%).SAPSII>30 on admission, 119(46.1%);
186(72.1%) needed mechanical ventilation. Median ventilation dur-
ation, 7[4-12.5] days with median length of stay,8[4 –17] days equat-
ing to3.357 patient-days. Eighty four patients (32.6%) developed 112
HAIs, 33.4 infections/1000 days of hospitalization. Ventilator Associ-
ated Pneumonia, 24.3 VAP/1000ventilator-days; central-venous-
catheter-associated infection, 27.5 CVC-AI/1000CVC-days. Mortality
rate in HAIs patients was at 63.1%. Ventilator associated pneumonia
was identified by multivariate analysis as anindependent risk factor
for HAI-associated mortality (RR, 17.1, 95%CI, [5.1-57.2]; p<0.001).
CONCLUSION. The present study showed Ventilator associated Pneu-
monia to be associated with HAIs mortality the in intensive care.
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INTRODUCTION. Due to advancements in medical technology and
management of illnesses in the past decade, an increasing propor-
tion of critically ill patients are elderly. Given the limited healthcare
resources available, admissions to intensive care in very elderly pa-
tients are often restricted. The benefits of an ICU hospitalization for
those patients remain unclear.
OBJECTIVES. To describe trends of mortality of very old patients ad-
mitted in ICU during the last 9 years.
METHODS. A retrospective observational study was performed in a
medical ICU at a tertiary hospital of Farhat Hached from January
F1
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more. Comorbid illness, severity at admission, diagnosis, length of
stay and outcomes were recorded from medical patients ‘charts.
RESULTS. During the study period 2352 patients were admitted to
ICU. 232(9, 98%) were older than 80 years. Patients demographic and
clinical characteristic’s were : median age, 83[81-85] ; male,
143(61.6%) ; median SAPS II, 40[33-51] ; median Charlson comorbidity
score 5[2-6] ; Knauss C or D, 146(62,9%) ; MacCabe≥2, 193(83,2%) ; in-
vasive mechanical ventilation (IMV), 168(72,4%) ; median duration of
IMV, 3[2-8]days ; vasopressors use 154(66,4%) ; median length of ICU
stay was 6[3-10]days. The mean reason for admission was respiratory
disorder for 139(59, 9%). Overall mortality rate was 59.9%. Figure1
shows trends in mortality rates of ICU admissions and of very elderly
ICU patients between 2009 and 2017.
CONCLUSION. The use of ICU by very elderly patients was similar
throughout the 9-year study period. In-hospital mortality was consist-
ently high in those patients.Fig. 1 (abstract 001411). Mortality rates over years of ICU
admission and very elderly ICU patients001419
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INTRODUCTION. Traditionally, health research has been conducted
in “academic” or university-affiliated hospitals, whereas most patients
receive care in “community” hospitals. However, the line between
“academic” and “community” hospitals is blurring in terms of re-
search involvement, as community hospitals increasingly prioritize re-
search engagement in addition to clinical excellence. In this study
nested within an international probiotics trial (PROSPECT: Probiotics:
Prevention of Severe Pneumonia and Endotracheal Colonization
Trial), we describe the contribution of Canadian community hospitals.
METHODS. In PROSPECT, we randomized critically ill patients with ex-
pected mechanical ventilation of ≥72 hours to receive either
1x10e10 colony forming units (CFU) of L. rhamnosus GG or an identi-
cal placebo, twice daily, to evaluate the effect of probiotics on infec-
tious outcomes, diarrhea and other clinical endpoints. Trial
participation was open to all interested centers. In this study, we
compared trial metrics, patient demographics and outcomesbetween academic and community hospitals using t-tests and Chi-
square, based on the first 2/3 of enrolled patients in PROSPECT.
Trial Registration: www.clinicaltrials.gov : NCT02462590
RESULTS. Of the 44 participating centers, 41 (93.2%) were Canadian
and 7 (15.9%) were community ICUs. All academic hospitals were lo-
cated in urban centres, whereas amongst the 7 community hospitals,
only 1 was located in an urban center, 2 were in suburban areas, and
the remaining 4 were located in smaller communities near urban
centers. Of the 1766 trial patients that were analyzed, 189 (10.7%)
were enrolled in community ICUs. Regarding trial metrics, patients in
community ICUs were less likely than in academic ICUs to be coen-
rolled in other randomized trials or observational studies (9.0% vs
23.0%, p<0.001) whereas protocol adherence defined as patients re-
ceiving at least one dose of study product were similar between
community and academic ICUs (88.1% vs 90.9%). Several patient
characteristics were similar between community and academic ICUs,
including proportion of female participants (34.9% vs 41.0%, p=
0.117) and illness severity (APACHE II score 21.1 vs 22.2, p=0.075).
However, some patient characteristics were different between com-
munity and academic ICUs, including mean age (62.6 vs 59.9 years,
p=0.036), and medical admission status (93.7% vs 76.5%, p<0.001).
Regarding patient outcomes, ICU and hospital mortality rates were
higher in community ICUs than in academic ICUs (29.1% vs 21.2%,
p= 0.015) and (37.2% vs 27.3%, p= 0.006), respectively, whereas the
proportions of patients with C. difficile colitis during ICU stay and
post ICU stay were similar between community and academic ICUs
(1.1% vs 1.8%, p=0.764) and (1.1% vs 0.9%, p = 0.686), respectively.
CONCLUSION. Community hospital engagement in ICU research can
enrich study populations with more geographically diverse partici-
pants, thereby improving the generalizability of results, while simul-
taneously hastening trial completion.
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INTRODUCTION. Increasing complexity in the ICU environment rep-
resents a safety challenge. Medical errors are frequent, and their con-
sequences can be fatal. One of the main sources of error is
interprofessional communication within ICU team. Clinical debriefing,
a process of formal reflection about our clinical practice, can improve
processes, professional performance and safety culture. However, it is
difficult to implement due to lack of knowledge and tools. TALK ® is
a multiprofessional structured clinical debriefing tool designed to
guide reflection in clinical teams to improve safety.
OBJECTIVES. To implement TALK® in the ICU setting and analyze its
effect in culture safety.
METHODS. We designed a prospective and longitudinal study. TALK®
tool was implemented in 2 different ICU in the same University Hos-
pital. The implementation comprised 1h training sessions, focused
discussions and distribution of materials (flashcards, posters).
Page 358 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Debriefing was considered a non-mandatory multidisciplinary
phenomenon. Debriefing events were systematically registered fol-
lowing an interview with the team at the end of every shift. We also
explored leadership and participation in debriefing episodes, im-
provement decisions agreed upon during debriefing and barriers en-
countered. Data were collected in 15-day periods for baseline,
immediate (q week) and 3 months follow-up. Additional follow-up
measurements are planned at 6, 12 and 24 months.
RESULTS. Data on 119 baseline and 114 immediate follow-up shifts
have been collected. There have been 36 debriefings in 30 shifts
among the two periods. Debriefing were performed in 13,5% of the
shifts during pre-implementation period(n=16/119), and in 12,3% of
the shifts in the post-implementation period (n=14/114) (not signifi-
cant difference). However, consideration to do debriefing increased
from 36,8% to 94% between the pre- and post-implementation
period. Not having any issues to discuss was the main reason not to
do debriefing in both periods. Debriefing was led mainly by nurses
(72,2%), followed by physicians (13,8%), residents 8% and nurse assis-
tants (5%). Three months follow up data results will also be available
for presentation at the conference.
CONCLUSION. Implementation of TALK® tool was feasible and it was
associated to an increase in the consideration to do debriefing dur-
ing shifts, but not to an increase in performing debriefing in the im-
mediate post-implementation period.
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INTRODUCTION. Bioimpedance vector analysis (BIVA) is a noninva-
sive, and rapid screening tool for estimation of fluid status in differ-
ent populations, but there are scant data in critically ill patients.
OBJECTIVES. To evaluate the relationship of fluid balance assessed
by percentage of fluid accumulation (%FA), a conventional tool, and
by BIVA-derived variables, and to determine which parameter de-
rived by BIVA is the best for predicting 28-day mortality.
METHODS. We conducted a prospective, clinician-blinded, observa-
tional study in patients admitted to medical ICUs with an expected
length of ICU stay of at least 72 hours. We performed BIVA measure-
ments and cumulative fluid balance calculation and recorded physio-
logical variables on day 0, 3, and 7 after ICU admission. BIVA results
included percentage of fat free mass hydration (%FFMH), and phase
angle (PhA). The correlation between BIVA-derived values, %FA, and28-day mortality were analyzed. The parameters that associated with
28-day mortality were identified, and the significant parameters then
were analyzed using the area under the ROC (aROC) curve for search-
ing the cutoff value to predict the mortality.
RESULTS. Sixty-nine patients were enrolled, with a mean age of 61 ±
21 year, and a mean Acute Physiology and Chronic Health Evaluation
II (APACHE II) score of 23 ± 8. The median %FA were 7.04%, 9.9%,
and 11.48% on day 0, 3, and 7 after ICU admission. Based on BIVA-
derived values, the median %FFMH were 79.8 %, 79.6%, and 79.2%,
and the median PhA were 4.9, 4.9, and 5.1, on day 0, 3, and 7 after
ICU admission, respectively. According to 28-d mortality, no differ-
ences of %FA and BIVA-derived variables, which measured on D0,
and D3 after admission between non-survivors and survivors. The
median %FA on D7 was higher in non-survivors than in survivor
[14.8% (10.9%, 24.1%) vs 6.9% (1.1%, 15.2%), p = 0.003]. The median
PhA on D7 of non-survivors was 3.6 (3.2, 4.1), while that of survivors
was 5.5 (4.6, 6.4) (p < 0.001). Whereas, the median %FFMH on D7 of
non-survivors was not statistically different with that of survivors
[79.2% (75.9%, 85%) vs 78.5% (74.4%, 82.3%), p = 0.4]. Phase angle
of less than 4.5 on the 7th day after admission could predict 28-d
mortality with the OR of 2.1, (95% CI 1.2–3.4, P < 0.001).
CONCLUSION. BIVA-derived variables, percentage of fat free mass hy-
dration (%FFMH) and phase angle (PhA) had good correlation with
percentage of fluid accumulation (%FA) on day 3 and day 7. Only
PhA on the seventh day after admission were associated with the 28-
day mortality. PhA of less than 4.5 might be used as cut-off value for
guidance of fluid management in critically ill patients.
SIS - Optimal antibiotic use in sepsis
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INTRODUCTION. The optimal dosing strategy of aminoglycosides
(AG) remains debated in intensive care units (ICUs).
OBJECTIVES. We investigated the international practices of AG re-
garding dosing and therapeutic drug monitoring in ICU patients.
METHODS. A prospective, multicentre, observational, cohort study
was conducted in 59 intensive care units (ICUs) across 5 countries.
All patients admitted to the ICU and receiving AG therapy for septic
shock were included in the present study.
RESULTS. We enrolled 931 patients (mean ± standard deviation (SD),
age 63 ± 15 years, female 364 (39%), median SAPS II 51
T1
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84%) or directed (147, 16%) antimicrobial therapy for sepsis or septic
shock. The AG used was amikacin in 625 (67%), gentamicin in 312
(34%) and tobramycin in 15 (2%) patients. Aminoglycosides were
mainly used for pulmonary (405, 44%), abdominal (233 (25%), urinary
(126 (14%) infections and bacteremia (158, 17.0%). Aminoglycoside
resistance was reported in 58 (18%) of documented infections. The
median duration of therapy was 2 ((IQR 1-3) days, the median num-
ber of AG doses was 2 ((IQR 1-2), the mean dose was 25 ± 6, 6 ± 2, 6
± 1.6 mg/kg of total body weight for amikacin, gentamicin and
tobramycin respectively, and the median dosing interval was 26 (IQR
23.5- 43.5) h. Proportion of changes in median serum creatinine
levels during AG therapy were -7% (IQR-24%; 12%). Therapeutic drug
monitoring (TDM) of peak and trough concentrations was performed
in 445 (48%) and 501 (57%) patients after the first dose. After the
first AG dose, only 250 (56%) patients achieved the PK/PD target of
Cmax/MIC >8 and 336 (67%) had concentrations above Cmin recom-
mended thresholds. The ICU mortality rate was 27.3% with multivari-
able analysis showing AG resistant isolate (OR 8.31, 95% CI: 1.31-
78.30, p=0.0355), SOFA score (OR 1.54, 95% CI: 1.24-2.03, p=0.0004)
and directed antimicrobial therapy (OR 0.08, 95% CI: 0.01-0.70, p=
0.0254) as independent predictors of ICU mortality. We could show
no correlation between AG dosing or PK/PD target attainment and
clinical outcomes (Table 1).
CONCLUSION. Short courses of high AG doses are mainly used in
ICU patients with septic shock although wide variability in AG prac-
tices is reported. Efforts to optimize the first AG dose and to perform
TDM are still needed.
REFERENCE(S)
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Table 1 (abstract 000363). See text for description
Variables OR (95%CI) p-value
Age 1.03 (0.99;1.09) 0.1923
Sex 1.31 (0.32;5.91) 0.7115
BMI 1.04 (0.92;1.19) 0.5703
SOFA score 1.54 (1.24;2.03) 0.0004
AG resistant isolate 8.31 (1.31;78.30) 0.0355
Directed antimicrobial therapy 0.08 (0.01;0.70) 0.0254
AG dose in mg/kg 0.96 (0.89;1.04) 0.3189
Targeted AG Cmax 1.18 (0.76;91.92) 0.1169
Fig. 1 (abstract 000840). Meropenem bolus dosing regimen:
concentration/time profile000840
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INTRODUCTION. Antibiotic dosing in the critically ill patient is pre-
dominantly “one-size-fits-all” despite often grossly deranged pharma-
cokinetics and pharmacodynamics. Other than intermittentmonitoring of aminoglycosides and glycopeptides (mainly for
toxicity), there is miminal routine therapeutic drug monitoring
(TDM), and none is offered in real time. This leads to dual is-
sues of both under-treatment - post-mortem studies reveal per-
sistent septic foci in >70% cases (1) – or toxicity (2,3). Since
only the free (unbound) fraction of an antibiotic is active
against bacteria in infected tissue, a tissue-based technique
such as microdialysis (MD) may provide real-time monitoring of
tissue concentrations (4).
OBJECTIVES. This study aims to determine the feasibility of in vivomi-
crodialysis, monitoring real-time changes of different dosing regi-
mens of meropenem at six different sites simultaneously, with
comparison against direct blood level measurement.
METHODS. Healthy male Wistar rats (300-350g) underwent general
anaesthesia and surgery for vascular access and MicroEye®(Probe Sci-
entific, Bedford, UK) insertion into 6 sites: muscle, subcutaneous, liver,
peritoneal cavity, trachea and jugular vein. The microdialysate flow
rate was set at 1 μL/min. Six rats received a meropenem bolus of 30
mg/kg i.v., administered over 30 min; another 6 rats received a con-
tinuous meropenem infusion of 2.5 mg/kg/h.Tissue microdialysates
and blood were sampled at 10 and 15 minute intervals, respectively
for 90 minutes’ duration. Meropenem concentrations in all samples
were measured using High Performance Liquid Chromatography
(HPLC, Agilent 1260II) ANOVA with post-hoc Dunn’s tests were used
to seek statistical significance.
RESULTS. The meropenem bolus generated a similar pattern of
microdialysate drug concentration changes over time in all tissues,
with no statistically significant difference in area under the curve
(AUC). Peak concentrations (Cmax 5.43-15.72 μg/mL were reached in
all tissues by 50-60 min (this includes a 20 minute lag-time for dead-
space tubing) followed by a gradual decrease to zero at 100 min
[Figure 1]. With continuous infusion, steady state was reached in all
tissues by 50-60 min (0.33-1.16μg/mL), with liver AUC being signifi-
cantly lower than venous (22.54 vs 69.22 μg/mL; p=0.008) [Figure 2].
CONCLUSION. In conclusion, MicroEye® shows promise as a novel
point-of-care tool for monitoring tissue antibiotic concentrations.
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INTRODUCTION. From humans to rodents, cardiac contractility, vas-
cular tones, fluid homeostasis and kidney function are all physio-
logical hallmarks impacted by the engagement of the Apelin-
receptor (APJ). Both Apelin-13 (APLN-13) and Elabela (ELA) endogen-
ous APJ agonists exhibit bioactive properties and positive effects to
support myocardial function both in endotoxemia and peritonitis
models of sepsis in rats [1,2]. Because the apelinergic system stimula-
tion has gained credibility as a potential alternative therapeutic path-
way a first pilot study was undergone to evaluate the hemodynamic
effects of APLN-13 or ELA perfusion in a clinically relevant large ani-
mal model of sepsis.
OBJECTIVES. Assess the acute hemodynamic impacts of APLN-13 or
ELA infusions in healthy or septic sheep.
METHODS. Polymicrobial sepsis was induced by autologous feces in-
jection into the abdominal cavity. Hemodynamics monitoring was
assessed by arterial thermodilution (right: Swan-Ganz, left: PiCCO)
and Left Ventricle (LV) catheterization to record LV End-Systolic Pres-
sure and dP/dtmax. When shock criteria were reached (decrease of
40% of the baseline (bsl) Mean Arterial Pressure (MAP) and Cardiac
Output (CO), SCVO2 <70%, lactatemia> 2 mmol/L) sheep received a
Lactate Ringer bolus (30ml/kg in 1hr) before random assignment to a
continuous infusion of 5 incremental doses of APLN-13 or ELA per-
fused in 20 min (from 0.007 to 3.6 μM/kg/hr) or equivalent volume of
Normal Saline (NS).
RESULTS. APJ expression (qPCR) was confirmed in ovine heart & kid-
ney. APLN-13 infusion was inotropic compared to NS, while ELA de-
creased cardiac function in healthy sheep (% from bsl at 1.8μM/kg/
hr; CO, NS: 6±4%, APLN-13: 26±9% p<0.05 vs NS, ELA: -20±1% p<
0.05 vs NS; dP/dtmax, NS: 7±8%, APLN-13: 52±15% p<0.05 vs NS,
ELA: -34±2% p<0.05 vs NS).
Sustained Gram negative bacteremia was documented and shock cri-
teria were met 240±55min after feces injection, along with acute kid-
ney dysfunction (urine output: bsl 108±18 ml/hr vs shock 9±3 ml/hr,
p<0.05; creatinine, bsl: 2.7±0.1 mmol/L vs shock: 3.6±0.3 mmol/L, p<0.05). Without significant impact on MAP, APLN-13 was the only one
inotrope in septic sheep (% to shock time-point at 0.7μM/kg/hr; CO,
NS: 11±3%, APLN-13: 48±13% p<0.05 vs NS, ELA: -25±11%, ; dP/
dtmax, NS: 5±15%, APLN-13: 78±12% p<0.05, ELA: -2±9 %).
CONCLUSION. A differential hemodynamic signature of APLN-13 and
ELA was observed in healthy and septic sheep opening new physio-
logical questions on the apelinergic system regulatory role in the car-
diovascular function. The APLN-13/APJ axis is emerging as a new
candidate pathway to manage hemodynamics in septic shock and
could be an alternative to catecholamines.
REFERENCE(S)
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INTRODUCTION. Sepsis combined with cardiac dysfunction leads to
a significant increase in mortality. The renin-angiotensin system (RAS
system) plays an important role in the development of sepsis in-
duced myocardial dysfunction (SIMD), while angiotensinogen (AGT)
is the only known substrate of the RAS system, and its effect on
SIMD has not been illuminated.
OBJECTIVES. To investigate whether inhibition of AGT ameliorates
SIMD and explore its potential mechanism.
METHODS. Male C57BL/6 mice were intraperitoneally injected by ei-
ther lipopolysaccharide (LPS) or PBS, and then taken down after 6
hours. Cardiac function was evaluated by echocardiography and the
survival rate was monitored every hour for a 72-hour period. Plasma
AGT level was measured by ELISA while hepatic and cardiac AGT ex-
pression were determined by real-time quantitative PCR (RT-qPCR)
and western blot. Expression of proinflammatory cytokine was
assessed by RT-qPCR. Combination of AGT and its receptor, low dens-
ity lipoprotein receptor related protein1 (LRP1), was confirmed by
surface plasmon resonance (SPR).
RESULTS. LPS injection significantly activated AGT expression both in
liver and heart, and also elevated plasma AGT level after 6 hours. We
further generated hepatocyte-specific AGT-deficient (hepAGT-/-) mice
and cardiomyocyte-specific AGT-deficient (carAGT-/-) mice. Interest-
ingly, we found that hepatic AGT knock-out led to a distinct reduc-
tion of AGT expression in liver but in heart it showed a remarkably
decreased AGT protein level with a compensatory augment of mRNA
level. However in carAGT-/- mice, cardiac AGT expression was re-
strained in mRNA level but did not change in protein level, while
hepatic AGT remained unchanged compared with their wild-type
counterparts. These facts implied that cardiac AGT was mainly de-
rived from circulation rather than local synthesis. We then demon-
strated that hepatic conditional AGT deletion in mice triggered
resistance to septic cardiac dysfunction and lethality accompanied
with less cardiac proinflammatory cytokine production, like tumor
necrosis factor alpha (TNF-α), Interleukin 1 beta (IL-1β), and Interleu-
kin 6 (IL-6). Contrarily, cardiac conditional AGT deletion in mice had a
similar phenotype with wild-types. Furthermore, we identified liver
derived AGT entered cardiac fibroblast via LRP1 mediated endocyto-
sis, which in turn activated NLRP3 inflammasome and improved TNF-
α, IL-1β as well as IL-6 production.
CONCLUSION. Hepatocyte-specific deficiency of AGT ameliorates
SIMD via preventing cardiac fibroblastic LRP1-dependent endocytosis
F1
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ates proinflammatory factors releasing. These findings provide poten-
tial therapeutic targets in liver to treat SIMD.
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Fig. 1 (abstract 001019). Tissue concentration/time profiles
following a meropenem bolus in septic rats at 6h
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INTRODUCTION. Antibiotic handling is significantly altered in sepsis
and other critical illnesses due to changes in metabolism and excre-
tion, protein binding and volumes of distribution [1,2]. This handling
will vary markedly between septic patients yet antibiotics are gener-
ally given as a ‘one-size-fits-all’ dosing regimen with fixed adjust-
ments only made for severe renal dysfunction. Monitoring of tissue
antibiotic concentrations should enable better titration of dose to
avoid under- or over-treatment [3].
OBJECTIVES. To compare tissue and blood concentrations of mero-
penem in sham rats and during the early stage of sepsis (faecal peri-
tonitis) using a type of microdialysis probe, MicroEye®,and compare
these levels with that measured in blood and healthy rats.
METHODS. Male Wistar rats (300-350g) underwent brief general an-
aesthesia to enable instrumentation for vascular access. They were
randomised to a sham control group or a septic group that received
an intraperitoneal injection of faecal slurry to induce peritonitis. Fluid
resuscitation was commenced from 2 hours. At 6 hours, the animals
were re-anaesthetised and MicroEye® (Probe Scientific Ltd, Bedford,
UK) microdialysis catheters were inserted into muscle, subcutaneous
tissue, liver, peritoneal cavity, trachea and jugular vein. Meropenem
30mg/kg was administered over 30 min with tissue and blood micro-
dialysates sampled respectively at 10 and 15 min intervals for a total
of 90 min. Meropenem concentrations were measured using High
Performance Liquid Chromatography (HPLC, Agilent 1260II). Blood
samples were also taken for a direct measurement of meropenem
levels. ANOVA with post-hoc Dunn’s tests were used to seek statis-
tical significance.
RESULTS. Following a single bolus of meropenem, there was a simi-
lar pattern of microdialysate drug concentration changes over time
in all tissues in both sham and septic groups [Figures 1,2]. Peak con-
centrations were reached by 50-60 minutes in both study groups
(this includes a 20 minute lag-time for deadspace tubing. There was
no statistically significant difference in the area under the curves
(AUC) for meropenem concentration in most tissues, except for tra-
chea (p<0.05) and peritoneum (p=0.11) that were higher in the septic
group [Figure 3].
CONCLUSION. In early sepsis, tissue concentrations were generally
similar to sham rats, except within the trachea. Further work is
needed to increase sample size and to perform repeat studies at later
timepoints.REFERENCE(S)
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when treating patients with sepsis and septic shock. Clin Pharmacokinet.
2002; 41:1135-1151
[2] Varghese, JM et al. Antimicrobial pharmacokinetic and pharmacodynamic
issues in the critically ill with severe sepsis and septic shock. Crit Care
Clin. 2011; 27:19-34
[3] Roberts JA. et al. Therapeutic drug monitoring of antimicrobials. Br J Clin
Pharmacol. 2012; 73:27-36
F1
Fig. 3 (abstract 001019). Comparison of tissue concentration AUC
between 6h-septic and sham-operated rats
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INTRODUCTION. Pendelluft, defined as movement of gas within the
lung from regions characterized by a short time-constant to regions
with long time-constant, has been described in animal models of
assisted mechanical ventilation and associated with lung tissue over-
stretching [1]. Due to the different contents of O2 and CO2 as com-
pared to fresh gas, pendelluft might also reduce ventilation
efficiency. We hypothesized that during weaning, increased patient’s
inspiratory effort due to withdrawal of ventilator support might trig-
ger pendelluft phenomenon, exacerbating patient’s fatigue.
METHODS. We enrolled 18 difficult weaning patients undergoing
pressure support ventilation (PSV). Electrical impedance tomography
(EIT) signal was recorded while PSV was progressively reduced from
clinical level (baseline) to 2 cmH2O (or the lowest tolerable level);
four ventral-to-dorsal lung regions of interest were identified for pen-
delluft measurement. A regional gas movement (>5ml) occurring in a
direction opposite to the global EIT signal was considered diagnostic
for pendelluft.
RESULTS. Pendelluft was detected by EIT in 8/18 patients; in those
patients PSV reduction increased pendelluft (p=0.036), in the others
it did not (see Figure). In pendelluft patients, PSV reduction was asso-
ciated with decreased tidal volumes (from 415 [377-502] to 355 [272-
402] mL, p=0.012) and increased respiratory rates (from 23 [15-27] to
29 [20-36] breaths/min, p=0.017), while minute ventilation remained
stable (from 9 [6.4-11.3] to 9 [7-11.9] L/min, p=NS). In the no-
pendelluft group, the change in tidal volumes was not significant, as
were the change in respiratory rate and minute ventilation (all p=
NS). EtCO2 increased in the pendelluft group (from 38 [32-43] to 40
[33-49] mmHg, p=0.027), but not in the no-pendelluft group.
CONCLUSION. Occult pendelluft can be measured by EIT, and is fre-
quently present in difficult to wean patients. When present, pendel-
luft increases with the reduction of ventilator support and isassociated with a significant change of the ventilatory pattern.
Pendelluft-associated ventilatory inefficiency might play a role in
weaning failure.
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INTRODUCTION. Ultra-protective ventilation with tidal volume (VT)
reduction below 6 ml/kg predicted body weight (PBW) in severe
ARDS may reduce alveolar strain, driving pressure and hence
ventilator-induced lung injury, with main drawback of worsening re-
spiratory acidosis. We hypothesized that VT could be reduced down
to 4 ml/kg PBW, with clinically significant decrease in driving pres-
sure, without the need for extracorporeal CO2 removal, while main-
taining pH in the range targeted in recent randomized controlled
trials on ARDS.
METHODS. We conducted a non-experimental before-and-after mul-
ticenter study on 35 ARDS patients with PaO2/FiO2 ≤ 150 mm Hg,
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duced to 4 ml/kg PBW and further adjusted to maintain pH ≥ 7.20,
respiratory rate was increased up to 40/min and PEEP was set using
the PEEP-FiO2 table of the high PEEP arm of the ALVEOLI trial. This
strategy was applied until positivity of a PEEP weaning trial. The pri-
mary judgment criterion was the driving pressure on day 2 of the
study, as compared to study inclusion. Data are presented as median
[1st quartile-3rd quartile].
RESULTS. One patient’s next of kin withdrew consent leaving 34
analyzable patients. Patients’ age was 67 [53-73] year, SAPS II
amounted to 50 [35-58], 29 patients (85%) had pneumonia as ARDS
risk factor, SOFA at inclusion was 13 [11-14], and PaO2/FiO2 at inclu-
sion was 101 [78-132] mm Hg under a PEEP of 10 [8-12] cmH2O.
From inclusion to day 2, driving pressure decreased significantly from
12 [9-15] to 8 [6-11] cmH2O, while VT decreased from 6.0 [5.9-6.1] to
4.1 [4.0-4.7] ml/kg PBW. On day 2 of the study, VT was below 4.2 ml/
kg in 22 patients (65% [IC95% 48%-79%]), and below 5.25 ml.kg-1 in
30 patients (88 % CI95% [73%-95%]). Time with VT below 4.2 ml/kg
and 5.25 ml/kg averaged 2 [0.5-2.0] days and 2 [1-4] days, respect-
ively. Respiratory rate increased significantly from 28 [23-30] /min to
40 [35-40]/min and 37 [30-40]/min on day 2 and 3 of the study, re-
spectively. PEEP was significantly increased from hour 4 to day 3 after
inclusion as compared to baseline, while intrinsic PEEP was not sig-
nificantly modified during the first four days of the study. PaO2/FiO2
and PaCO2 increased significantly from baseline values as early as
hour 4 up to day 3 after inclusion, while pH was significantly lower
than baseline only at hour 4 and hour 10. Sedation drugs were not
significantly modified.
Regarding safety, 2 patients (6%) presented with acute cor pulmo-
nale after inclusion. Right ventricle/left ventricle ratio increased non-
significantly from 0.50 [0.50-0.72] at H0 to 0.66 [0.60-0.76] on day 2.
Eleven patients (32%) presented with severe mixed acidosis with pH
< 7.15. Multivariate analysis identified renal SOFA at inclusion (OR:
1.91 [CI95% : 1.08-3.71] per 1 unit increase) and pH at inclusion (OR:
0.91 [CI95% : 0.80-0.99] per 0.01 unit increase) as variables independ-
ently associated with occurrence of any episode of severe mixed
acidosis during the study. Fourteen patients (41%) died before day
90 with median delay between inclusion and death amounting to 16
[9-22] days.
CONCLUSION. Ultraprotective ventilation may be applied in approxi-
mately 2/3 of moderately severe to severe ARDS patients, with a 4
cmH2O median reduction of driving pressure, at the price of severe
mixed acidosis in approximately 1/3 of the patients.
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INTRODUCTION. Patients with severe ARDS are likely to develop
cerebral hemodynamic impairment due to respiratory failure leading
to hypoxemia and hypercapnia. ECMO therapy, by restoring normal
level of PaO2 and PaCO2, is a life-saving treatment when hypoxemia
is refractory to conventional treatment. However, ECMO support itself
may cause neurological complications, affecting both long- and
short-term outcome.
OBJECTIVES. Aim of the study was to evaluate cerebral autoregula-
tion (CA) impairment in ARDS patients undergoing v-v ECMO and to
assess whether normalization of arterial blood gases induced by the
treatment can restore this dysfunction.METHODS. Adult patients with severe ARDS requiring v-v ECMO
were consecutively enrolled in our university hospital. Prior neuro-
logical disease and any condition hampering cerebral blood flow
measurement were excluded from study. CA was assessed using
Mxa, a Transcranial Doppler-derived index of dynamic CA, expressing
the correlation between mean flow velocity in middle cerebral artery
and mean arterial pressure; a Mxa values >0.20 shows impaired CA.
Transcranial Doppler was performed before ECMO institution (PRE),
at day 0, 1, 2, 4 and 7 of ECMO therapy and after ECMO removal
(POST). Hemodynamic and respiratory parameters were recorded
concurrently. Data are presented as median (IQR).
RESULTS. We enrolled 31 patients: age 48 (41-57) yrs; male 65%;
pneumonia was the cause of ARDS in 94% of patients; ICU length of
stay 27 (16-38) days; v-v ECMO duration 13 (8-17) days; APACHE II 26
(23-34); SAPS II 66 (60-72); 28-days mortality 35%. During ICU stay,
clinical neurologic complications confirmed at neuroimaging were
found in 5 (16%) patients, 3 ischemic and 2 hemorrhagic. Mxa was
0.25 (-0.12-0.50) PRE ECMO, 0.13 (0.04-0.20), -0.05 (-0.08-0.09), -0.03
(-0.19-0.05), 0.04 (-0.04-0.21) and -0.01 (-0.05-0.08) at day 0, 1, 2, 4
and 7 of ECMO therapy, respectively, and 0.04 (0.00-0.18) POST-
ECMO, showing a trend toward restoration of CA from PRE-ECMO to
day 7 (p=0.063). Furthermore, restored CA was maintained also after
ECMO removal. Concomitant values of PaCO2 in mmHg were 54 (44-
79) PRE ECMO, 47 (35-54), 46 (42-56), 44 (39-52), 44 (41-52), 44 (39-
52) at day 0, 1, 2, 4 and 7 of ECMO therapy, respectively, and 44 (41-
49) POST-ECMO; concomitant values of pH were 7.33 (7.16-7.46) PRE-
ECMO, 7.42 (7.34-7.46), 7.42 (7.35-7.46), 7.43 (7.39-7.48), 7.42 (7.37-
7.47), 7.40 (7.36-7.46) at day 0, 1, 2, 4 and 7 of ECMO therapy, re-
spectively, and 7.43 (7.33-7.46) POST-ECMO. Significant correlations
were found between Mxa and values of PaCO2 (p=0.002), pH (p<
0.001) and hemoglobin (p=0.001). A pH value of 7.35 could discrimin-
ate between impaired and preserved CA with a sensitivity of 0.88
and a specificity of 0.59.
CONCLUSION. In ARDS patients with refractory hypoxia, v-v ECMO
therapy through normalization of arterial blood gas levels, may re-
store CA. Mxa values during ECMO support are significantly corre-
lated with PaCO2, pH and hemoglobin.
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INTRODUCTION. Surface electromyography allows to detect non-
invasively and at the bedside the inspiratory activation of diaphrag-
matic and intercostal muscles.Our hypothesis was that the timing of
neural activation of these muscles during a spontaneous breathing
trial could be different in patients successfully extubated and in pa-
tients failing weaning.
OBJECTIVES. To evaluate the timing of diaphragmatic and intercostal
neural activation during weaning from mechanical ventilation in crit-
ically ill patients.
METHODS. In 24 patients, who underwent at least 72 hours of mech-
anical ventilation, surface electromyography, s-EMG (Dräger, Lubeck,
Germany), was applied for 5-8 minutes during a spontaneous breath-
ing trial (SBT).The delta time between the beginning of diaphrag-
matic neural activation and the peak of intercostal muscles neural
activation was calculated on a breath by breath basis (fig.1). Further,
for each patient, we recorded the percentage of breaths in which the
neural activation of the intercostal muscles occurred after the peak
of the diaphragmatic neural activation (i.e. in the diaphragmatic ex-
piratory phase).
RESULTS. Fourteen patients were successfully extubated whereas 10
patients were reintubated within 48 hours.
Page 364 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55In failed vs successful weaning the delta time between the peak of
diaphragmatic and the intercostal muscles neural activation was re-
spectively 0,63 ± 0,20 and 1 ± 0,39 sec (p < 0.05). (FIG. 2)
The % of intercostal muscles activation occurring in the diaphrag-
matic expiratory phase was respectively 63,8% ± 21,34% vs 14,26%±
8,22% (p< 0.05) in failed vs successful weaning. (FIG. 2)
CONCLUSION. In the present study the delta time between the dia-
phragm and the intercostal muscles activation and the neural activa-
tion of the intercostal muscles during the diaphragmatic expiratory
phase were higher in patients failing weaning than in patients suc-
cessfully weaned from mechanical ventilation.
We speculate that s-EMG may be a promising tool to predict wean-
ing failure in a non-invasive way.
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Fig. 1 (abstract 001233). See text for description
Fig. 2 (abstract 001233). See text for description
Table 1 (abstract 001529). Driving pressure and Mortality
Driving pressure<15 Driving pressure ≥ 15 p
Mortality 60.6 64.3 0.001
Table 2 (abstract 001529). Mortality and Power
Power <17 Power ≥ 17 p
Mortality 44.9 63.5 0.01
Table 3 (abstract 001529). Demographic
Power<17 mean SD Power ≥ 17 mean SD p
Apache II 20.8 8.9 23 8.1 0.6
SOFA 8.1 3.9 8.6 3.9 0.8
ICU stay hours 410.6 465 442 444 0.5
Gender (Male %) 59 63 0.3
Predicted body weight 63 9.5 64 8.9 0.07001529
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INTRODUCTION. Recently, the role of ventilation-associated mechan-
ical ventilation power (MVP) has been emphasized in lung injury. It is
argued that MVP correlates with ventilation-induced lung injury (VILI)
and prognosis. However, the relationship between MVP and progno-
sis needs to be further investigated. Electronic recording systems
(ERS) can easily calculate mechanical ventilation power by using
mechanical ventilator parameters.
OBJECTIVES. The aim of this retrospective study was to evaluate the
relationship of the first 24 hours MVP with the survival and length of
ICU stay.
METHODS. ERS data were retrospectively reviewed for patients re-
ceiving invasive mechanical ventilation for ≥ 24 hours and ICU stay
≥48 hours between 2015-2018. Patients ≥ 18 years were included.During the first 24 hours, MVP was calculated every 30 minutes and
averaged.Formula: MVP(J/minutes)= 0.098 x tidal volume x respira-
tory rate x ( Ppeak – ½ ΔP)ΔP is driving pressure. Based on a previous
study, the patients were classified into two groups (Group 1: MP <
17 J/min, Group 2: MP ≥17 J/min) (ref 1).
Oxygenation, gas exchange values, and APACHE II and SOFA scores
in the first 24 hours and survival were recorded. The primary out-
come was ICU mortality.
RESULTS. A total of 1219 patients were included in the study. A sig-
nificantly higher mortality rate was detected in Group 2 (p<0.001
Table 1). Demographic data and relation of MVP and driving pressure
with mortality are shown in Table 2 and 3.
CONCLUSION. Our results suggest that higher baseline MVP values
are related with poorer outcome.
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INTRODUCTION. Proenkephalin A 119-159 (penKid) is a filtration
marker and has been proposed as a sensitive biomarker of glomeru-
lar function. In this ancillary study of the PRONOburn cohort we eval-
uated the association of admission plasma penKid with kidney
events in severely ill burn patients.
METHODS. PRONOburn is a French prospective, observational study
designed to investigate factors associated with outcome of burn
Page 365 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55patients. All consecutive severely burn patients (inclusion criteria:
age>18 years, total body surface area burn >15% and non-
opposition to participate) admitted to 2 participating burn intensive
care units (ICU) in France were included. The primary endpoint of
this ancillary study was to evaluate the predictive value of penKid for
90 day mortality. Secondary endpoints were to evaluate the predict-
ive value of penKid for in-ICU AKI, as well as for a combined end-
point (90 mortality and/or in-ICU AKI). AKI was defined using the
KDIGO definition. Subclinical AKI was defined as patient without AKI
in the first seven days but a penKid concentration>80pmol/L on
admission.
RESULTS. From April 2014 to April 2016, 109 consecutive patients
were enrolled. Mean age was 48 (IQ 33-64) years, mean Sequential
related organ failure assessment was 4 (IQ1-4), 67% (N=73) were
male. Total burn surface area was 35 (IQR 25-53). Overall 90 day mor-
tality was 27.5 % (N=30), 35.7% (N=39) had AKI during ICU stay and
44% (N=48) had the combined endpoint. Penkid was significantly
higher in non-survivors compare to survivors (113.2pmol/L [IQR 57.5-
182.1] vs 54.8pmol/L [IQR 36.0-76.7]; p<0.0001) and in patient with
in-ICU AKI compare to patient without (91.4pmol/L [IQR 56.5-153.4]
vs 53.1pmol/L [IQR 34.4-67.9]; p<0.0001). Penkid provided added
value on top of creatinine and SOFA score to predict 90 day mortal-
ity (combined c index=0.766 vs. 0.716; p=0.004 and 0.812 vs. 0.762;
p<0.001, respectively). PenKid c index to predict in-ICU AKI was
0.755. Penkid added value on top of creatinine and SOFA score to
predict the combined endpoint (c index=0.839 vs. 0.799; p=0.006
and 0.878 vs. 0.806; p<0.001, respectively). Day 3 penKid measure-
ments added value on top of admission measurement to detect both
mortality and the combined end point. Finally, there was a progres-
sive increase risk of mortality from patients without AKI, sub-AKI and
AKI (Survival rate 91% [95% CI 83.8-98.9], 66.7% [95% CI 48.1-92.4]
and 40.4% [95% CI 26.1-62.4]; respectively, p<0.0001).
CONCLUSION. Admission penKid concentration was associated with
risk of mortality in burn patients. It added value on top of creatinine
and SOFA to predict 90 day mortality. Sub-AKI detected with penKid
was associated with risk of death.
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INTRODUCTION. Plasma proenkephalin A 119-159 (penKid) is a filtra-
tion marker and has been proposed as a sensitive biomarker of
glomerular function. As such it was found predictive for septic kidney
events including acute kidney injury (AKI) in sepsis. In this ancillary
study of the FROG-ICU and AdrenOSS-1 cohorts we evaluated the as-
sociation between subclinical acute kidney injury (sub-AKI; defined
by supra-normal penKid) and outcome.
METHODS. FROG-ICU was a European prospective, observational
study of 2087 critically ill patients designed to investigate long-term
mortality in patients with invasive mechanical ventilation and/orvasopressors or inotropes for more than 24 hours. AdrenOSS-1 was a
European prospective, observational study with 583 sepsis and septic
shock patients. sub-AKI was defined by an admission penKid concen-
tration above the normal range (i.e. > 80 pmol/L) in patients without
acute kidney injury (AKI). AKI was defined by the KDIGO (Kidney Dis-
ease: Improving Global Outcomes) criteria.
RESULTS. 2015 from the FROG cohort and all 583 patients from the
AdrenOSS cohort were eligible for data analysis. 28-day mortality was
22% in both cohorts. 8.6% and 9.4% of patients from the FROG and
AdrenOSS cohorts had sub-AKI (11.5% and 17.5% of non-AKI; respect-
ively). Median SOFA score was similar in non-AKI and sub-AKI pa-
tients in the FROG cohort, and slightly higher for sub-AKI in
AdrenOSS-1 (6 vs 5 points, p=0.011). Compared to non-AKI patients,
patients with sub-AKI were more likely to receive hemodynamic sup-
port (p<0.001). We found a significant stepwise increase of 28-day
mortality risk from non-AKI (9.1%) to sub-AKI (20.5%) to AKI patients
(34.9%) in the FROG cohort, and the AdrenOSS cohort (8.7%, 21.1%
and 28.7%, respectively). In all patients, admission penKid concentra-
tion was associated with 28-day mortality: c index = 0.664 (p<0.001)
for penKid and 0.618 (p<0.001) for creatinine in the FROG cohort and
0.661 (p<0.001) for penKid and 0.589 (p=0.006) for creatinine in the
AdrenOSS cohort.
CONCLUSION. Sub-AKI detected using admission penKid was associ-
ated with high cardiovascular failure and short-term mortality in crit-
ically ill patients. PenKid better predicted 28-day mortality risk than
serum creatinine.
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INTRODUCTION. Acute kidney injury (AKI) is independently associ-
ated with prolonged hospital stay and impaired outcome. Creatinine
is most used to assess kidney function. However, following a de-
crease in glomerular filtration rate, plasma creatinine concentration
increase is insensitive and late. This hampers the diagnosis of AKI
and research related to therapies. The novel plasma biomarker
proenkephalin (PENK), a stable byproduct of the endogenous opioid
enkephalin, is currently studied for its reflection of kidney function
and thereby detection of AKI. Kinetics of PENK during a period of AKI
compared to creatinine are unknown.
OBJECTIVES. To determine whether or not the plasma biomarker
PENK is able to diagnose AKI earlier than plasma creatinine.
METHODS. In this prospective study, all patients admitted to our In-
tensive Care Unit (ICU) with an ICU duration >1 day and not already
fulfilling AKI criteria on admission were included. Plasma creatinine
concentrations were determined using daily routine sampling. Re-
sidual material was collected and frozen to determine PENK retro-
spectively using Sphingotec immunoassay [1]. AKI was diagnosed
using the KDIGO criteria [2] with the most sensitive (AKI-stage 1)
measure of a creatinine concentration rise of 0.3 mg/dL (26.5 μmol/L)
within 2 days. One sample t-test was used to assess the difference in
time of the increase before and decrease after the occurrence of AKI.
Receiver operating characteristics (ROC) curves were created to as-
sess the diagnostic performance of PENK.
RESULTS. We included 189 critically ill patients on the ICU, median
[IQR] age was 65 [55-72] years, 119 patients (63%) were male. 56 pa-
tients (24%) developed AKI during ICU admission. PENK concentra-
tions increased (mean±SEM) 0.4±0.08 day earlier than creatinine (p<
0.0001), figure 1-A. When creatinine decreased, PENK concentrations
also decreased 0.7±0.22 day earlier. The area under the ROC curve of
the PENK concentration the day before the diagnosis of AKI was 0.82
(95%CI 0.75-0.89), with an optimal cut-off value of 66 pmol/L result-
ing in sensitivity and specificity of 83% and 75%, respectively, see
F1
Page 366 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55figure 1-B. The positive and negative likelihood ratio was 3.3 and
0.30, respectively.
CONCLUSION. PENK is freely filtrated through the glomerulus with-
out active secretion or resorption and may therefore be capable to
detect AKI more swiftly compared to plasma creatinine. Furthermore,
PENK plasma concentrations the day before diagnosis of AKI as a
diagnostic test is classified as good in an unselected population of
critically ill patients.
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INTRODUCTION. Venous congestion is considered to play a role in
the development of Acute Kidney Injury (AKI). Currently no strict def-
inition for venous congestion exists and all proxies have limitations.
OBJECTIVES. To assess whether signs of venous congestion, defined
as interstitial pulmonary syndrome and as a non-collapsing inferior
vena cava (IVC), both observed by bedside ultrasonography, were as-
sociated with the development of AKI in a population of critically ill
patients in the Intensive Care Unit (ICU).
METHODS. In this sub-study of the Simple Intensive Care Studies-II
(NCT03577405)(1), bedside ultrasonography was performed by
trained researchers within 24 hours of ICU admission. The number of
B-lines (0-5) was assessed according the Bedside Lung Ultrasound in
Emergency protocol(2). Pulmonary interstitial syndrome was defined
as three or more B-lines in two or more bilateral fields. IVC collaps-
ibility was assessed using the IVC-Collapsibility Index and a value of
less than 20% as cut off score for IVC-congestion (accounting for
mechanical ventilation where appropriate)(3). Congestion was
assessed as a categorical variable (0: no signs of congestion, 1: one
of two signs of congestion, and 2: both signs of congestion) and AKI
as a binary variable following KDIGO criteria. Via multivariate logistic
regression analysis, corrected for age, we determined an association
between signs of venous congestion and AKI.
RESULTS. From May 15th 2018 to April 8th 2019 a total of 426 pa-
tients were included. We excluded 152 patients (36%) with pre-
existing renal failure or lack of ultrasonography images. Of theremaining 274 patients, 128 patients (46%) developed AKI within 72
hours of admission. In total 97 patients (35%) had no collapsing IVC,
31 patients (11%) had pulmonary interstitial syndrome and 11 pa-
tients (3%) had both (figure 1). Congestion was associated with AKI
in univariate analysis, and this association remained after correction
for age (OR 1.54, 95%CI 1.01-2.38, p=0.045).
CONCLUSION. Interstitial syndrome and/or a non collapsing IVC as
signs of venous congestion were associated with AKI in a finding co-
hort. Bedside ultrasonography measurements of venous congestion
early during admission could predict the development of AKI in crit-
ically ill patients. Further studies have to elucidate the validity and ef-
ficacy of these findings.
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INTRODUCTION. Acute kidney injury (AKI) is common in critically ill
patients and is strongly associated with high mortality. Renal replace-
ment therapy (RRT) is an important supportive therapy for patients
with AKI. In particular, continuous renal replacement therapy (CRRT)
is used for hemodynamically unstable critically ill patients with loss
of kidney function. Previous studies have shown that the overall mor-
tality of patients with AKI requiring CRRT is high—over
Page 367 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 5550%—indicating that further improvement is necessary for this un-
acceptable poor outcome.
There have been numerous reports on a recent decrease in mortality
among critically ill patients. It is of interest whether the characteris-
tics and outcomes of patients with AKI-RRT have changed over time.
OBJECTIVES. To examine recent trends in patient characteristics and
mortality in patients with AKI receiving RRT, including CRRT and
intermittent RRT (IRRT), in intensive care units (ICUs)
METHODS. From the Diagnosis Procedure Combination database in
Japan during 6 months (July–December) from 2007 to 2016, patients
with AKI who received RRT in ICUs were identified and examined for
trends in patient characteristics and overall mortality by RRT modality
and main diagnosis category subgroup. Logistic regression analysis
was performed to adjust for patient characteristics.
RESULTS. Overall, 51,758 patients starting RRT were identified (3.9%
of all patients admitted to ICUs; CRRT: 39,471 (76.3%) patients; IRRT:
12,287 (23.7%) patients) in 287 hospitals. The crude in-hospital mor-
tality declined from 44.9% to 36.1% (P for trend <0.001). Compared
with 2007, the adjusted odds ratio (aOR) for in-hospital mortality was
0.66 [95% confidence interval (CI): 0.60–0.72] in 2016, and the de-
creasing trend was observed in both patients starting CRRT (aOR
0.68, 95% CI 0.61–0.75) and IRRT (aOR 0.58, 95% CI 0.45–0.74) and in
all subgroups: sepsis aOR, 0.68 (95% CI 0.57–0.81); cardiovascular sur-
gery, 0.58 (0.45–0.76); coronary artery disease, 0.85 (0.60–1.20); non-
coronary heart disease, 0.78 (0.65–0.94); central nervous system disor-
ders, 0.42 (0.28–0.62); trauma, 0.39 (0.22–0.72); and others, 0.64
(0.50–0.83).
CONCLUSION. This nationwide study confirmed a consistent decline
in mortality among patients with AKI on RRT in ICUs, although sev-
eral patient characteristics were changing over time.
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INTRODUCTION. Unplanned admissions to intensive care units (ICU)
are associated with high mortality rates [1]. In the UK, the Royal Col-
lege of Physicians recommend that patients on general wards with a
National Early Warning Score (NEWS) of ≥7 should be reviewed by
the critical care team [2]. However, the NEWS only considers vital
sign measurements. We recently showed that a simple risk score
(LDTEWS:NEWS), which combines NEWS with routine laboratory re-
sults, was better able to identify patients who may require critical
care [3]. Recently, machine learning algorithms have shown potential
to outperform standard statistical approaches when predicting pa-
tient outcomes using data from electronic health records [4].
OBJECTIVES. To develop and externally validate a risk score to pre-
dict unplanned admissions to intensive care using machine learning.
METHODS. This was a retrospective cohort study of emergency med-
ical admissions to two large acute hospitals groups (PortsmouthHospitals, PH and Oxford University Hospitals, OUH). We excluded ad-
missions where the patient was: discharged alive on the day of ad-
mission or had no vital signs observations in the 24 hours prior to
the initial ICU admission or hospital discharge. Seven vital signs,
seven common laboratory tests and the patient’s gender were ex-
tracted from hospital records as described previously [3]. Using these
data, a novel risk score (XgICU) was developed from five years’ of ad-
missions to one hospital (PH) using gradient-boosted decision trees
(xgboost [5]). Optimal hyper-parameters of xgboost were identified
through a random search with five-fold cross-validation on the devel-
opment cohort. XgICU was externally validated on one year of admis-
sions from OUH. The discrimination of XgICU, NEWS and
LDTEWS:NEWS for observations within 24 hours (median 9 ; inter-
quartile range 4-6) of unplanned ICU admission was assessed using
the c-statistic.
RESULTS. The external validation cohort (OUH) comprised 16,309 ad-
missions (median age = 73 years), of which 159 (1.0%) patients had
an unplanned admission to the ICU. The novel risk score (XgICU)
showed substantially better discrimination (0.920, 95% confidence
interval 0.913−0.927) than both LDTEWS:NEWS (0.894, 0.885−0.904)
and NEWS (0.876, 0.865−0.887). At the recommended escalation
threshold of ≥7, NEWS identified 53% of observations in the 24-hour
window preceding an unplanned ICU admission to be above the
threshold. At an equivalent false positive rate (5%), LDTEWS:NEWS
was marginally more sensitive (55%), whilst the sensitivity of XgICU
was 64%.
CONCLUSION. Using the same vital sign and laboratory data as
LDTEWS:NEWS, gradient-boosted decision trees were substan-
tially better at identifying observations above the escalation
threshold in the 24 hours prior to unplanned transfers to the
ICU. If carefully applied, machine learning algorithms could pro-
vide powerful tools to aid clinical decision making for critically
ill patients.
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Page 368 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. Bibliometric analyses in science show gender dis-
parity exits in publications and citations which are crucial for aca-
demic and professional advancement.
OBJECTIVES. To summarize the state of gender equality in original
critical care research.
METHODS. We conducted a bibliometric analysis of original research
publications in critical care medicine from 2008-2018 in 11 journals:
NEJM, JAMA, Lancet, BMJ, ICM, Critical Care, CCM, CHEST, AJRCCM,
Annals of Intensive Care, and Journal of Critical Care. We included
only clinical trials, observational studies, systematic reviews, meta-
analyses and experimental studies. We utilized PubReMiner to pro-
duce full names and country from PubMed. Gender for the first and
last authors was assigned manually and by Gender API a web-based
gender determination platform. Publication citations were deter-
mined via the Web of Science. We defined the novel Female First Au-
thor index (FFA index) for an individual last author. FFA Index =
(#Female first authors in publications by an individual last author/
#Total publications by the individual last author).
RESULTS. 7370 manuscripts that met criteria had first and last author
gender determined: 2237 manuscripts with female first authors were
identified (30.4%), 1140 manuscripts had female last authors (15.5%).
There were 5153 different individual first authors with 34.1% individ-
ual female first authors. 19.6% of the 3890 individual last authors
were female. The mean impact factor for manuscripts with female
first authors was 5.98 and male first authors was 6.27 (ANOVA p=
0.055). This relationship did not change with restriction to higher im-
pact factors (ie >5, 10, or 20). Average citations per year for female
first authors was lower compared to those for male first authors at
3.79 vs. 4.63 respectively, (ANOVA p< 0.001). Female last authorship
was associated with increased odds of female first authorship. After
adjustment for impact factor, journal and year, female last authorship
was associated with a nearly 2-fold increase in female first authorship
[OR=1.87 (95%CI 1.64, 2.13); P<0.001]. Geographically, only Finland,
the Netherlands and Greece approach gender parity in first author-
ship. In our data, the proportion of female first authorship has not in-
creased over the last 10 years. The mean Female First Author index
(FFA index) for all 3890 individual last authors was 30.5%. In male last
authors (N=3125), the mean (SD) FFA index was 27.6 (41.2)%. In fe-
male last authors (N=763), the mean (SD) FFA index was 42.5
(47.6)%. The gender differences in FFA index were significant (χ2 =
46.6; P < 0.001). For male last authors with 5 or more senior author
manuscripts (N=251), the mean (SD) and median FFA index were
28.7% (26.8%) and 20.0%. For female last authors with 5 or more se-
nior author manuscripts (N=20), the mean (SD) and median FFA
index were 47.5% (23.9%) and 46.4%. The gender differences in FFA
index in those with 5 or more senior author manuscripts were signifi-
cant (χ2 = 12.9; P < 0.001).
CONCLUSION. Female representation at prominent authorship posi-
tions in critical care publications is still far from achieving gender
parity. By creating an authorship index score, we have now estab-
lished a frame of reference for the advancement of female first
authorship. Bridging this authorship gap can advance women in aca-
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INTRODUCTION. Accurate prognostication is important for shared
decision making as well as for benchmarking. Deep Learning (DL)
with many predictors can outperform traditional models (e.g.APACHE II). ICU data is a particular challenge as it consists of multiple
investigations, physiological measurements and treatments at differ-
ent sampling times, any of which may also be subject to error. Fur-
thermore, as ICU admissions are dynamic with prognostic accuracy
which changes over time, and current techniques cannot make pre-
dictions at arbitrary times, a temporally-sensitive model would help
guide optimal decision-making for trials of intensive care.
OBJECTIVES. We present a novel DL survival algorithm using the en-
tire multivariable patient time-series, regardless of variable type or
frequency and without the need for variable selection or clean-
ing. Furthermore, we seek to be able to track predicted survival prob-
ability over time for optimal prediction.
METHODS. Using data from the MIMIC-III dataset, we represent all
57,823 possible event types from the first 48 hours of each patient’s
ICU stay using a flexible latent space embedding previously de-
scribed. In this way, an adaptable recurrent DL model with 1,998,828
parameters is also able to learn erroneous data values to be dis-
carded. By collapsing the time-series to arbitrary resolution, we train
the model to predict mortality after each hour of the patient’s stay.
RESULTS. A total of 18,067 patients with 21,110 ICU stays and
208,572,237 events were used for training. The median [IQR] patient
age was 65.8 [52.8; 77.8] and there were 2,764 (13.1%) in-hospital
deaths. Hourly predictions for patient survival to hospital discharge
were made for the first 48 hours of their stay in the ICU. On a 10-fold
cross-validation, our model obtains a mean AUROC of 0.90 (95% CI
0.88-0.92) for prediction at 48 hours, exceeding several recent deep
learning models. Furthermore, the model is able to track predictions
over time and showed that prediction strength improves throughout
the first 48 hours after admission - rapidly for the first 12 (to
AUROC>0.8) before levelling out at 48 hours.
CONCLUSION. Our model is time-sensitive and able to achieve state
of the art survival predictions while overcoming the need for data se-
lection or pre-processing. This is a significant advantage when con-
sidering the high data density of the ICU. Predictive performance
increases over the first 48 hours of the ICU stay, providing a rationale
for time-limited trials in the ICU and suggesting that the timing of
decision making can be optimised/individualised.
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INTRODUCTION. Acute kidney injury (AKI) is a frequently observed
complication encountered in the intensive care and greatly affects
the elimination of commonly prescribed drugs such as antibiotics
and anti-convulsants. As defining AKI in clinical practice is challen-
ging, pharmacokinetic models often rely on creatinine values as their
input. We hypothesize that predicting creatinine values ahead of
F1
T1
Fig. 1 (abstract 001637). See text for description
Table 1 (abstract 001637). See text for description
ED degrees Flow Hierarchy Transfers between ICUs
"Calm" ED 21 (6 in, 15 out) 0.049 0.089% of all transfers
"Busy" ED 29 (9 in 20 out) 0.039 0.129% of all transfers
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critically ill patients. Additionally, we foresee that clinicians could use
these predictions to guide management. Machine learning provides
a novel approach to analyze large quantities of data and improve
predictive accuracy. To this point, no machine learning models have
focused on the prediction of creatinine values.
OBJECTIVES. We set out to predict creatinine as a continuous vari-
able ahead of time to improve pharmacokinetic modeling and guide
clinical therapy.
METHODS. A retrospective cohort study of 26.251 critically ill adult
patients admitted between 2004 and 2017 was conducted in the
Amsterdam UMC, The Netherlands. Patients with a stay shorter than
48 hours and medium care patients were excluded from the ana-
lyses. A total of 45 features were collected and included patient
demographics, device data, laboratory values, and clinical observa-
tions. Non-sequential methods (Lasso, Random Forest) and sequen-
tial methods (LSTM) were tested. The granularity of data was one
hour, more frequent data was condensed by calculating the mean
per hour, missing data was imputed using several imputation ap-
proaches for the deep learning models (LSTM-naïve, LSTM-Mask,
LSTM-Naïve-MFeat, LSTM-Mask-MFeat). Using a train-validation-test
split (60-20-20%), a continuous value of creatinine was predicted
ahead of time for a 24-hour interval, using 24 hour of previous data
as input into the model. The last known creatinine value served as a
baseline.
RESULTS. A total of 8330 patients fulfilled the inclusion and exclusion
criteria (median age 65.9 [IQR 54.1-74.8], 36% female). Of these, 5482
patients developed AKI during their ICU stay, with median creatinine
values ranging from 92.0 to 242.0 for non-AKI and KDIGO AKI stage 3
patients respectively. 51.2% of the stage 3 patients received renal re-
placement therapy. Last creatinine as a baseline resulted in an R2 of
0.80 (SE±0.002). Random forest performed best (R2 0.86, SE±0.001),
followed by the LSTM-Mask (R2 0.84, SE±0.002). In the random forest
model, last creatinine and creatinine trends, renal replacement ther-
apy, and pH came out as most important predictors.
CONCLUSION. In this study we showed machine learning models im-
prove the prediction of continuous creatinine values. Further en-
hancement of the models is likely to improve performance.
Predictions for different time intervals would make the models more
suitable for integration in the daily workflow.
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INTRODUCTION. Hospitals can be described as complex adaptive
systems, where discrete interventions are often unable to remedy
problems. Network science methods provide tools to analyse the
architecture of such complex systems. We apply these tools to emer-
gency surgical admissions to give a better understanding of the
structure behaviour of our service and will allow us to develop pre-
dictive methods for service needs, eg ICU bed capacity.
METHODS. We selected all unplanned surgical admissions over a two
and a half year period and used the electronic care records to extract
the locations of the patients during their admission. From this we
constructed a network representation of the care system and added
a measure of daily emergency department load to investigate the in-
fluence of hospital strain on the system. Here we focused on patients
who had a stay in ICU or HDU areas.
RESULTS. The graph shows the network representation of the emer-
gency surgical ICU patients with the nodes representing a ward or
area. The edges connecting them represent the transfers of patients
between the two wards (width proportional to the frequency of
transfers). The nodes are coloured by their ‘betweenness centrality’, a
measure of the importance of a node to the function of the system.In this graph ICU is densely connected to most areas of the hospital
and is therefore highly sensitive to disruptions or problems
elsewhere.
We constructed networks for the busiest and calmest days in the
emergency department. The analysis shows that flow through the
system is reduced in busy times (lower flow hierarchy) and patients
are sent to a larger range of areas from ED (higher ED degrees). Add-
itionally, we have a higher percentage of transfers between different
ICU areas during busier times, possibly reflecting increased non-
medical transfers.
CONCLUSION. The network representation yields the expected re-
sults of extensive interconnectedness and the effects of system strain
on flow of patients. The increased load in ED may be due to a bottle-
neck into the hospital or due to higher demand. The next steps will
be further analysis of the influence of strain, patient subgroup ana-
lysis and the development of predictive tools.
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INTRODUCTION. In most emergency situations or severe illness, crit-
ical care patients are unable to give consent for enrollment in a clin-
ical trial. In such circumstances, the decision of whether or not to
participate in a clinical trial is made by a legal representative (1).
Page 370 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55OBJECTIVES. To address the willingness of patients admitted to the
intensive care unit (ICU) to be enrolled in a scientific study as a vol-
unteer and to assess the agreement between ICU patient’s and their
legal representative’s opinion concerning enrollment in a scientific
study.
METHODS. This survey was conducted in two hospitals (one private
and one public) in São Paulo, Brazil. Adult patients (≥18 years) with
preserved cognitive function accompanied by a surrogate admitted
to the ICU were eligible for this study. A survey containing 28 ques-
tions for patients and 8 questions for surrogates was conducted by
the investigator preferably within the first 48 hours of ICU admis-
sion. The survey of patients comprised three sections: demographic
characteristics, opinion about participation in clinical research
andknowledge of the importance of research. The survey of legal
representatives contained two sections: demographic characteristics
and assessment of the legal representatives’ opinion on authorizing
patients’ to be enrolled in research.
RESULTS. Between January 2017 and May 2018, 208 pairs of ICU pa-
tients and their respective legal representatives answered the survey.
The median (IQR) age of patients was 60 (43-75) years, 49% were fe-
male and 56.7% had a higher educational level. The median (IQR)
age oflegal representatives was 49 (37-59) years, 66% were female
and 68.8% were next of kin (spouse/son/daughter). Of the 208 ICU
patients who answered the survey, 73.6% (153/208) would like to be
enrolled in study as a volunteer. Of those patients, 65.1% (97/149)
would continue participating in a research even if their legal repre-
sentative did not support their enrollment. The agreement between
patients’ and surrogates’ opinion concerning participation was
poor [Kappa=0.11 (IC95% -0.02 to 0.25)]. If a deferred consent were
obtained, 69.1% (103/149) of patients would continue participating
in the study until its conclusion, and 23.5% (35/149) would allow re-
searchers to use only the already collected data, but would withdraw
the study in this occasion.
CONCLUSION. The surrogate's opinion reflects poorly on critically ill
patient's opinion concerning enrollment in clinical research. To boost
patient’s recruitment in clinical trials, efforts to improve patients and
relative’s knowledge of the importance and value of medical re-
search need be made.
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INTRODUCTION.Do-not-resuscitate (DNR) orders apply to the decision
to withhold cardiopulmonary resuscitation (CPR) and may already
occur on ICU admission or when the patient´s condition worsens,
alone or with other limitation of life-sustaining therapy (LT).
OBJECTIVES. To investigate the change in use of DNR orders in Euro-
pean ICUs over 16 yearsMETHODS. All centres that participated in the Ethicus-1 study were
invited to participate in a follow-up study (Ethicus-2). Consecutively
admitted patients who died or had LT during a 6 month period from
September 1, 2015 to September 30, 2016 were prospectively stud-
ied. End-of-life Practices (EOLP) and region definitions from the
Ethicus-1 study were used and comparisons made [1].
RESULTS. Twenty-two ICUs participated in both studies, enrolling pa-
tients (Ethicus-2; Ethicus-1): total (1785;2807); Northern Europe (NE)
(424; 587); Central Europe (CE) (893; 906); and in Southern Europe
(SE) (468; 1314). The use (% Ethicus-2; % Ethicus-1) of DNR orders for
the different regions was: NE (93; 80), CE (83; 72), SE (78; 55). When a
decision to either WH CPR or WD CPR was made, a DNR order was
written in (% Ethicus-2; % Ethicus-1): NE (84; 82), CE (93; 84), SE (37;
32).
CONCLUSION. The use and the documentation of DNR orders in-
creased in all European regions ICUs that participated in ETHICUS-1
after 16 years. WH CPR were the first and the most common LT. Writ-
ten DNR orders and documentation of decisions to WH CPR in the
medical record are still not frequent in SE.
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INTRODUCTION. A patient’s admission in the Intensive Care Unit
(ICU) can lead to intense stress symptoms in the patient’s family,
resulting in anxiety, depression and emotional distress.
OBJECTIVES. To investigate on the coping mechanisms of the ICU
patient’s family, depending on socio-demographic characteristics and
the relative-patient closeness.
METHODS. Family members (first degree relatives, close relatives and
intimate friends) of patients hospitalized in a University ICU consti-
tuted our research material. A questionnaire for sociodemographic
data and the Family Crisis Oriented Personal Evaluation Scales (F-
COPES) were completed by family members after their beloved one’s
ICU admission. F-COPES consists of 5 subscales: ‘Acquiring social sup-
port’, ‘reframing’, ‘seeking spiritual support’, ‘mobilizing family to ac-
quire and seek help’ and ‘passive appraisal’.
RESULTS. Two hundred and twenty-three family members, 81
(36.3%) men and 142(63.7%) women, mean-aged 41.4±11.9 years,
corresponded to 147 ICU patients were studied. Family members
were children (40.8%), siblings (19.3%), spouses (16.1%), parents
(4.9%), other family members (17%) and friends (1.8%). Regarding
the strategies used to deal with family crisis, it became evident that
the quest for social help (31.27±4.72), the mobilization of the family
to get and receive help (14.26±3.17) and the passive attitude (14.04±
2.81) were those most commonly used. Gender differences were ob-
served almost in every F-COPES subscale; women achieved higher
scores and differences were more prominent in social support sub-
scale (p=.001). First degree relatives exhibited lower scores in 'spirit-
ual support' and 'accept help' subscales (p=.021 and p=.014
respectively). Offspring exhibited lower scores in 'spiritual support'
subscale compared with siblings (p=.015) and friends (p=.006) and
lower scores in 'accept help' subscale compared with 'friends’
(p=.008). Elementary school graduates exhibited higher scores in ‘re-
framing’ subscale compared with university and postgraduate stu-
dents (p=.005 and p=.021 respectively).
CONCLUSION. Male spouse and offspring are most disadvantaged
among ICU patients' family members in terms of effective coping
Page 371 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55strategies, while ‘reframing’ is used less frequently among family
members with higher level education.
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INTRODUCTION. Communication strategies have an important im-
pact on end-of-life decision (EOLD) processes in intensive care units
(ICUs) (1), but current communication and decision-making practices
in German ICUs are unknown.
OBJECTIVES. This study presents data from the subset of German
ICUs which participated in the worldwide Ethicus-2 study on end-of-
life care practices in ICUs.
METHODS. Observational study of consecutive ICU patients who died
or had end-of-life decisions (EOLD) to limit therapies during a 6-
months period.
RESULTS. A total of 1092 patients were included, 13% of patients
were mentally competent at the time of EOLD. Advance directives
were present in 270 (27%) patients. Discussion of EOLD occurred
with 92% of mentally competent patients and shared decision mak-
ing (SDM) was reported in 90%.
In general, physicians asked for or received information about patient
wishes in 816 (78%) cases, most commonly from the family (94%)
and sometimes from the patient (18%). However, the question
whether patient wishes were followed if they were known was an-
swered positively in 98% of 641 patients, constituting only 59% of
the total. Patients with EOLD more often had advance directives
(29% vs. 11%, Chi2=12.69, p= 0.00037) and information about patienttreatment desires were more frequent (83% vs. 34%), Chi²=118.73,
p≤0.0001) than in patients without EOLD.
The question whether physicians discussed EOLD with the family
was not answered in 11% of patients. For the remaining patients,
physicians reported using SDM in 76%; the family was told the deci-
sion in 19% and the family was asked to decide in 5% of patients.
Physicians’ reasons for not discussing EOLD with the family included
unresponsiveness to therapy (38%) or unavailability of family (19%).
Agreement with the final EOLD occurred in 99% between physicians
and nurses in 98% of cases between health care providers and
family.
CONCLUSION. In the majority of patients, physicians seek knowledge
about patients’ treatment wishes, mostly from the family or the pa-
tients themselves if those are mentally competent. Advance direc-
tives are legally binding in Germany, therefore the fact that every
fourth patient with EOL care has an advance directive is noteworthy.
Our data suggest that when advance directives are present, they are
considered in the process of EOL decision-making. When patient
wishes are known, they are usually followed. On the other hand, our
data suggest that patient wishes remain elusive in about half of the
included ICU patients. Physicians commonly discuss EOL decisions
with the family. The most frequent communication model is shared
decision-making with the family.
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INTRODUCTION. Communication about end-of-life decisions (EOLD)
may have changed over time.
OBJECTIVES. This study evaluated differences in EOLD in European
intensive care units (ICUs) 16 years after the Ethicus-1 study (1,2)
METHODS. Consecutively admitted ICU patients who died or had
life-sustaining treatment limitations during a self-selected 6-month
period from September 1, 2015 to September 30, 2016 were pro-
spectively studied. Previous EOLD definitions from the Ethicus-1
study were used (1) and comparisons made between studies.
RESULTS. Twenty-two ICUs participated in both studies. with 1785
patients in Ethicus-2 (424 in North Europe (NE), 893 in Central Europe
(CE), and 468 in South Europe (SE) versus 2806 patients in Ethicus-1
(587 in NE, 906 in CE and 1,314 in SE). Comparing Ethicus-1 with
Ethicus-2, more patients had capacity to make decisions in Ethicus-2
(4% vs. 16%) and more physicians asked for or received information
about patient’s treatment desires (20% vs. 47%). This information
was elicited more often from patients (11% vs 14%) and less often
from the family (93% vs 40%). More physicians had information
about patient wishes in Northern and Central Europe (54% and 53,)
than in Southern Europe (28%). The most frequent reasons for not
discussing EOLD with family were patient’s unresponsiveness to ther-
apy (39% vs 17%) or unavailability of family (36% vs. 9%).
CONCLUSION. Today, ICU physicians in Europe seem to be better in-
formed about patients’ wishes and patients appear to engage more
Page 372 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55with ICU physicians than 16 years ago. Still, the North-South divide
persists. In Northern and Central Europe, every second ICU physician
who was responsible for EOLD had asked for or had received infor-
mation about patients’ wishes in contrast to less than a third of ICU
physicians in Southern Europe. Cultural differences like patriarchalism
or religiosity may play a role.
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INTRODUCTION. Passive leg raising (PLR) has been promoted as an
confirmation of volume responsiveness perioperatively and in pa-
tients in the intensive care when ΔCO or ΔSV >10-15%. A guideline
has been published (1). Still, much needs to be defined: patient char-
acteristics, feasibility of assessment in ICU populations, impact of
concurrent morbidity and medication, the role of the homeostatic
mechanisms of the body and the physiologic frame necessary to
understand and interpret the PLR.
OBJECTIVES. The aim was to describe the changes in spectral energy
of the sympathetic (SNS) and parasympathetic (PNS) divisions of the
autonomic nervous system in healthy subjects performing a passive
leg raising maneuvre.
METHODS. Eleven healthy subjects passed through 5-10 minute
phases of semi-recumbent, passive leg raising and back to semi-
recumbent positions while ECG was recorded at 1000 Hz and
haemodynamic variables (HR, MAP, SV and CO) were collected by
the Finometer. ECGs were characterized in their spectral aspects
by Kubios Pro. PNS, SNS indices, spectral (LF, HF, LF/HF) and Fin-
ometer variables were analysed with respect to relative and abso-
lute changes through transitions from initial to leg-raised
positions and back to initial position, following the suggestions
of Monnet & Teboul (1).
RESULTS. All subjects increased SV>10% (but not CO) and were by
definition volume responsive. Some increased HR and MAP, some de-
creased. Over all, COs were unchanged by topographical change. In
semirecumbent positions (relative hypovolemia) SNS index increased.
In PLR (relative hypervolemia) PNS index increased.
CONCLUSION. In supposedly normovolemic subjects the gravita-
tional dislocation of central blood volume elicited a response from
the divisions of ANS to maintain homeostasis. From a histocentric
point, incorporating the Guyton venous return (2) and the Krogh
two-compartment venous compartment (3) models, their organisms
had no need of increased SV or CO. Homeostatic reflexes worked to
adapt the ratio of stressed/unstressed volumes by mobilising from
(↗SNS/↘PNS in semirecumbent) or demobilising (↘SNS/↗PNS in PLR)
to the splanchnic circulation. This interpretation warrants closer scru-
tiny of the autonomic nervous system in the context of PLR in the in-
tensive care or perioperative setting.
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INTRODUCTION. Tailored fluid therapy has received increasing atten-
tion in the management of patients with acute circulatory failure in
both the intensive care unit (ICU) and operating room (OR). The only
physiological reason to give a fluid challenge (FC) to a patient with
acute circulatory failure is to increase the stroke volume (SV) ultim-
ately leading to an increase in oxygen transport. However, this is only
achieved in approximately 50% of ICU and OR patients. The values of
the ventilator-induced dynamic changes in pulse pressure and stroke
volume [pulse pressure variation (PPV) and stroke volume variation
(SVV), respectively] are often unreliable in a significant number of
ICU and OR patients. To overcome these limitations, bedside func-
tional hemodynamic assessment has gained in popularity. The func-
tional hemodynamic test (FHT) called passive leg raise (PLR), has
been successfully used since 2009 to assess fluid responsiveness in
ICU patients. Since the reliability and the limits of PPV, SVV and PLR
in predicting fluid responsiveness has been already extensively inves-
tigated in different clinical settings, we conducted a systematic re-
view of the literature and performed a metanalysis aimed at
assessing the overall quality, external validation, consistency and risk
of bias of the other FHTs available in both the ICU and OR.
METHODS. We considered a FHT as a clinical maneuver affecting
heart-lung interactions and causing a different hemodynamic re-
sponse in fluid responders and non-responders. MEDLINE, EMBASE
and Cochrane Databases were screened for relevant articles using a
FHT, with the exception of the PLR. The QUADAS-2 scale was used to
assess the risk of bias of the included studies. In-between study het-
erogeneity was assessed through the I2 indicator. Bias assessment
graphs were plotted and Egger’s regression analysis was used to
evaluate the publication bias. The metanalysis determined the
pooled area under the receiving operating characteristic (ROC) curve,
the sensitivity, specificity and threshold for two FHTs: the EEOT (end-
expiratory occlusion test) and the mini-fluid challenge (FC).
RESULTS. The electronic search identified 7,674 titles. After text se-
lection, 21 studies met the inclusion criteria, 7 performed in the OR
and 14 in the ICU between 2005 and 2018. The search included 805
patients and 870 FCs with a median (IQR) of 39 (25-50) patients and
Page 373 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 5536 (29 - 50) FCs per study. The median fluid responsiveness was 54%
(45-59). The pooled area under the ROC curve for the end-expiratory
occlusion test (EEOT) was 0.96 (95% CI 0.92-1.00). The pooled sensi-
tivity and specificity was 0.86 (95%CI 0.74-0.94) and 0.91 (95%CI 0.85-
0.95) respectively, with a best threshold of 5% (4.0–8.0). The pooled
area under the ROC curve for the mini-FC was 0.91 (95% CI 0.85-
0.97). The pooled sensitivity and specificity were 0.82 (95%CI 0.76-
0.88) and 0.83 (95%CI 0.77-0.89), respectively, with a best threshold
of 5.4% (3.0–7.0).
CONCLUSION. The EEOT and the mini-FC reliably predict fluid re-
sponsiveness in the ICU and OR. Other FHTs have been tested insofar
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INTRODUCTION. New-onset atrial fibrillation (NOAF) occurs com-
monly in critical care and can lead to longer hospital stay, an in-
creased risk of thromboembolic stroke and higher in-hospital
mortality.(1) Treatment guidelines for atrial fibrillation (AF) in the
general population are less safe and effective when applied to the
critically ill patient.(2,3) At present, there are no consensus recom-
mendations for the management of NOAF which are specific to crit-
ically ill patients.(4) Previous systematic reviews have identified a
paucity of high-quality evidence to inform clinical practice and pub-
lished studies suggest that current approaches to treatment vary
considerably.(1,4)
OBJECTIVES. To systematically review published studies that report
current practices for management of NOAF in critically ill patients
METHODS. We searched EMBASE, MEDLINE and Web of Knowledge
for observational studies reporting data related to treatments used
for NOAF in critically ill adult patients. The outcome of interest was
the treatment(s) given to patients with NOAF. Treatments could be
drugs to control cardiac rate or rhythm (including magnesium), DC
cardioversion or anticoagulants. Data relating to study design, set-
ting, population, interventions, outcomes and risk of bias were ex-
tracted. Risk of bias assessment was performed using an adapted
Newcastle-Ottawa Scale.
RESULTS. We initially obtained 1,406 search results, of which we in-
cluded 9 studies with a combined total of 8,689 patients. Of drugs
used for rate/rhythm control, amiodarone use was reported most
often (in 8 studies) followed by beta-blockers (7 studies), calcium
channel blockers (5 studies), digoxin (5 studies) and magnesium (4
studies). Rate of DC cardioversion use was reported in 8 studies. Anti-
coagulant use was reported in 4 studies. As a proportion of all pa-
tients across studies, amiodarone was used in 48.9%, beta-blockers in
36.1%, magnesium in 29.8%, calcium channel blockers in 18.8%, di-
goxin in 17.8% and DC cardioversion in 16.2%. Anticoagulants were
used in an average of 44.0% of patients. When comparing practices
between countries, studies from Europe demonstrated higher rates
of amiodarone use when compared to studies from the USA. The
mean proportion of patients treated with amiodarone in Europeanstudies was 69.3%, compared with 47.7% in American studies. In con-
trast, American studies reported use of either a calcium channel
blocker or beta-blocker in 49.7% of patients, compared with 24.2% in
European studies.
CONCLUSION. There is a clear difference in practice patterns be-
tween the USA and Europe in antiarrhythmic use for NOAF manage-
ment. Even within countries it appears that practices vary
significantly. Furthermore the use of anticoagulation varies consider-
ably. Future research should focus on comparing the efficacy of the
most commonly used anti-arrhythmic agents including amiodarone,
beta-blockers, calcium channel blockers and magnesium. Large co-
hort studies should test the rates of ischaemic stroke and bleeding
associated with anticoagulation in a generally critically unwell popu-
lation with NOAF.
REFERENCE(S)
1. Yoshida T, Fujii T, Uchino S, Takinami M. Epidemiology, prevention, and
treatment of new-onset atrial fibrillation in critically ill: A systematic re-
view. J Intensive Care. England; 2015;3(1):19.
2. Walkey AJ, Evans SR, Winter MR, Benjamin EJ. Practice patterns and
outcomes of treatments for atrial fibrillation during sepsis a propensity-
matched cohort study. Chest. United States; 2016;149(1):74–83.
3. Walkey AJ, Quinn EK, Winter MR, McManus DD, Benjamin EJ. Practice
patterns and outcomes associated with use of anticoagulation among
patients with atrial fibrillation during sepsis. JAMA Cardiol. 2016;1(6):682–
90.
4. Kanji S, Stewart R, Fergusson DA, McIntyre L, Turgeon AF, Hébert PC.
Treatment of new-onset atrial fibrillation in noncardiac intensive care unit
patients: A systematic review of randomized controlled trials. Crit Care
Med. 2008;36(5):1620–4.
5. Peter Watkinson is supported by the NIHR Biomedical Research Centre,
Oxford
6. Funding for this project was obtained through the University of
Melbourne Global Scholars Award for high achieving students to
undertake overseas research.
000729
Higher skin blood flow is associated with better hemodynamic
tolerance to fluid removal in patients with acute respiratory
distress syndrome
W. Mongkolpun1, B. Péter1, JL. Vincent2, J. Creteur1
1Department of intensive care, ULB Erasme, Anderlecht, Belgium;
2Department of intensive care, ULB Erasme, Brussels, Belgium
Correspondence: W. Mongkolpun
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000729
INTRODUCTION. A negative fluid balance (NFB) can improve oxygen-
ation in patients with acute respiratory distress syndrome (ARDS) but
an excessive NFB can result in hemodynamic instability and tissue
hypoperfusion. Skin blood flow (SBF) measurements can provide an
indication of tissue perfusion.
OBJECTIVES. We hypothesized that SBF measurements could predict
hemodynamic tolerance (HT) during induction of a NFB in patients
with ARDS.
METHODS. We prospectively included hemodynamically stable
(mean arterial pressure (MAP) ≥ 65 mmHg with no increase in nor-
epinephrine (NE) dose in the last 6 hours) patients with ARDS (Berlin
criteria) in whom a strategy of fluid removal was applied to reach a
NFB of more than 1 L in 24 hours. SBF was measured (Periflux 5000,
Perimed; index finger; Perfusion unit: PU) for 3 min at basal
temperature before the NFB strategy (T0) and 24 hours later (T24).
Hemodynamic variables, the PaO2/FiO2 ratio, central venous oxygen
saturation (ScvO2) and blood lactate concentrations were also re-
corded at H0 and H24. HT after NFB (H24) was defined as MAP ≥ 65
mmHg with no increase in NE dose. In patients with a NFB ≥ 1 L at
H24, a receiver operating characteristic (ROC) curve was constructed
to assess the best predictive values for HT. Data are reported as me-
dians with 25th and 75th percentiles.
RESULTS. We studied 35 mechanically ventilated patients with ARDS
(pneumonia (29), abdominal infection (5), pancreatitis (1)). Clinical
T1
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ous hemofiltration. At T0, there were no differences in SOFA score,
hemodynamic variables, NE dose, PaO2/FiO2, ScvO2, time from diag-
nosis or furosemide dose between patients with and without HT
(Table 1). At T24, the degree of NFB did not differ significantly be-
tween the group with and without HT (1.7 (1.2-2.0) vs 1.3 (1.1-1.9)
L,p=0.1). Patients who tolerated a NFB had lower lactate levels (1.1
(0.7-1.2) vs 1.4 (1.0-1.7) mmol/L, p=0.03) and higher SBF (151 (81-194)
vs 70 (45-135) PU, p=0.01) than those who did not. MAP, cardiac
index (CI) and ScvO2 were similar in patients with and without HT.
SBF decreased in patients with and without HT (p<0.01) but was
higher at H24 in patients who tolerated the NFB than in those who
did not (100 (35-173) vs 35 (22-78) PU, p=0.01). The area under the
ROC curve to predict HT after a NFB was higher for baseline SBF
(0.92[0.83-0.99]) than for lactate level (0.72 [0.58-0.87]) and ScvO2
(0.69 [0.53-0.85]) (both p=0.03), with a cut-off ≥ 125 PU (sensitivity
90, specificity 93%).
CONCLUSION. Baseline SBF can predict good hemodynamic toler-
ance to a NFB in patients with ARDS.Table 1 (abstract 000729). See text for description001254
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INTRODUCTION. During the resuscitation process of septic shock,
use of dynamic parameters over static parameters to assess fluid re-
sponsiveness has been proposed. Surprisingly, scarce evidence is
available showing a beneficial clinical outcome effect of dynamic pa-
rameters over static parameters to guide fluid resuscitation.
OBJECTIVES. To evaluate the impact on mortality of a fluid resuscita-
tion protocol based on the use of dynamic parameters compared to
static parameters to assess fluid responsiveness in the resuscitation
process of severe sepsis and septic shock patients.
METHODS. Prospective, randomized, multicenter study. Adult pa-
tients with severe sepsis or septic shock, with evidence of tissue hy-
poperfusion, and under mechanical ventilation. At ICU admission,
patients were randomized to one of the two fluid resuscitation proto-
cols: Control Group, where fluid resuscitation was guided by Central
Venous Pressure (CVP), according to the recommendations of Surviv-
ing Sepsis Campaign 2012; and Intervention Group, where fluid resusci-
tation was guided by Pulse Pressure Variation (PPV), Systolic Volume
Variation (SVV), or Passive Leg Raising (PLR) maneuver. The fluid re-
suscitation protocol was followed during the first 72h of ICU stay.
Main study outcome was 28-day mortality. Baseline patient charac-
teristics, hemodynamic data, metabolic data, fluid balance, organ fail-
ure evolution, and ICU/hospital stay were also recorded.RESULTS. The study was interrupted after two years because of low
patient inclusion rate. A total of 60 patients were included in 12 cen-
ters. 66.6% of the patients were randomized to control group (n=40),
and 33.3% to intervention group (n=20). There were no differences
in baseline patients characteristics between the two groups. Median
age was 62 ± 15 years, 65% male, 82% in septic shock, with initial
SOFA score 12 ± 4 points. Lactate at inclusion was 4.7 ± 3.6 mmol/L.
Global mortality was 30%, 47% in the control group and 21% in the
intervention group (p = 0.1). There were no differences in lactate
evolution at 6 and 24 hours of admission. Fluid balance during the
study period (72h) was significantly increased in the control group
(5812 ± 4818 mL vs 3035 ± 3031 mL, p 0.02).
CONCLUSION. A fluid resuscitation protocol based on dynamic pa-
rameters to assess fluid responsiveness is associated to a decreased
fluid balance in the first 72h of the resuscitation process of septic
shock. The inclusion of these dynamic variables may help to limit ex-
cessive fluid administration, potentially improving the outcome in
this population of patients.
HSRO - Predicting outcome, what are
we missing?
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INTRODUCTION. Frailty significantly impacts ICU patient’s outcomes,
recovery and healthcare utilization. However, knowledge about
changes in frailty after ICU admission and associated factors is
limited.
OBJECTIVES. To assess frailty before ICU admission and determine
differences between frail and non-frail patients; to study changes in
frailty in the year after ICU admission and its associated variables.
METHODS. Adult patients admitted for ≥12 hours to a university hos-
pital ICU between July 2016 and December 2017 were included
(MONITOR-IC study, clinicaltrials.gov NCT03246334). Moribund pa-
tients were excluded. Frailty was assessed using the Clinical Frailty
Scale (CFS) (range 1 ‘Very fit’ to 9 ‘Terminally ill’) before ICU admis-
sion (T0), at hospital discharge (T1), and three (T2) and 12 months
(T3) after ICU admission. Baseline differences between ‘non frail’
(scale 1-4) and ‘frail’ patients (scale 5-9) were compared. We calcu-
lated CFS mean differences between time points. We used multiple
linear regression to determine factors associated with frailty change
scores over one year (T0-T3).
RESULTS. A total of 1300 patients was included: mean age 61 (±14.9
years), 65% male and 66% planned ICU admissions. Median baseline
CFS score was 3 [IQR:2-4]. Frail patients (12%) were significantly more
often female, lower educated, divorced or widowed, living in a
healthcare facility, had more often a chronic condition and an un-
planned ICU admission.
At T1 the number of frail patients increased from 12 to 43%. At T2
and T3 this decreased to 15% and 9%. After one year, 30% had a
lower CFS score compared to T0 (less frail), 31% a higher score (more
frail) and in 39% the score did not change. Factors significantly asso-
ciated with lower scores after 12 months, were planned admission
(B=-0.306), mechanical ventilation (B=-0.320) and higher baseline CFS
score (B=-0.711). Factors significantly associated with higher scores
were age (B=0.013), living in a healthcare facility before admission
(B=1.199), hospital LOS (B=0.023), and being discharged to a nursing
home (B=0.861). APACHE IV score, chronic diagnosis, admission type
and ICU LOS were not associated with changes in frailty.
CONCLUSION. Frailty levels changed in the first year after ICU admis-
sion. After one year, one third of the patients were more frail and
one third less frail. Several factors, including age, living in healthcare
Page 375 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55facilities, hospital LOS and discharged to a nursing home were asso-
ciated with being more frail after one year.
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INTRODUCTION. Early identification of the deteriorating patient is a
priority for healthcare professionals. Previous studies have examined
the prognostic accuracy of early warning and critical care scoring sys-
tems, however comparative data is rare(1,2).
OBJECTIVES. Compare the prognostic accuracy of the Intensive Care
National Audit & Research Centre (ICNARC) physiology score, the
NHS National Early Warning Score (NEWS) and the Sequential Organ
Failure Assessment (SOFA) score for predicting acute (7-day) mortal-
ity in the deteriorating ward patient.
METHODS. Data for this abstract were taken from the (SPOT)light
study; a multicentre prospective observational cohort study of the
deteriorating ward patient referred for assessment by critical care.
From the physiology measurements at ward assessment, the ICNARC
physiology, NEWS and SOFA scores were calculated with missing
values given zero weights as previously recommended(3–5). Survival
status was obtained from the NHS Information Service with acute
mortality defined as death within 7 days of the first ward assessment
by critical care. Statistical analysis was undertaken using R. Un-
adjusted logistic regression was used to test for the association be-
tween each score as a continuous variable and acute mortality, with
odds ratios calculated. Performance of scoring systems was assessed
by discrimination using receiver operating characteristic (ROC) curve
analysis. ROC curves were plotted and the area under the curve
(AUC) calculated using the PRROC package(6).
RESULTS. 48 hospitals reported 15,158 visits for ward assessment
over 369 study months (mean age 67 years, 51.9% male). 2708 (18%)
patients died during the 7-days following ward assessment, 1539
(57%) of these deaths occurred within the first 48 hours. There was a
clear correlation between physiological severity and acute mortality
using either ward based (NEWS) or critical care scoring systems
(SOFA, ICNARC). For predicting acute mortality, the AUC-ROC values
(95% CI) were similar between the scoring systems with NEWS 0.67
(0.66-0.68), SOFA 0.65 (0.64-0.67) and ICNARC 0.68 (0.67-0.69).
CONCLUSION. The results demonstrate that NEWS, ICNARC and SOFA
have equivalent accuracy for predicting acute mortality in the deteri-
orating ward patient. This result is of important practical value as
using simpler scores such as NEWS or SOFA could facilitate greater
efficiency when assessing patients in the ward setting.
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INTRODUCTION. Improved survival following sepsis has been widely
reported and asserted, even for those with severe sepsis treated in
an intensive care unit (ICU). These favourable mortality trends are
often interpreted as the success of healthcare investment and sepsis
research. Reliable interpretation of long-term trends requires an ap-
propriate metric with comprehensive data to prevent
misinterpretation.
OBJECTIVES. To review temporal trends in sepsis-related incidence
and mortality based on a retrospective analysis of a eighteen-year
jurisdictional dataset.
METHODS. Sepsis-related hospital admissions were electronically
identified using international consensus criteria mapped to ICD-
10AM codes. Risk-adjustment was derived from available demo-
graphic and diagnostic codes. Mixed-effects regression models were
employed to identify significant temporal trends.
RESULTS. Over eighteen years the population in Victoria (6.2 million)
grew by 34.5%. 447,417 sepsis-related records were identified in-
cluding 80,455 (18.0%) treated in ICU. 44,561 (10.0%) in-hospital
deaths were reported. Annual population-derived mortality rate
remained unchanged for both total (60.0±3.4 per 10^5, p=0.72)
and ICU (19.8±1.6 per 10^5; p=0.73) cohorts. Hospital mortality
rates declined significantly (p<0.001) but were static when ad-
justed for population size (p=0.074) and total sepsis burden (p=
0.14). Total population (VIF=37.6), adult population (VIF=51.0), and
hospitla sepsis burden (VIF=24.2) were all collinear with ‘year of
separation’.
CONCLUSION. Sepsis-related incidence is rising but sepsis-related
mortality has not declined over the past eighteen years in the State
of Victoria. Reports of apparent decline in sepsis mortality rates may
be due to rising admissions and incomplete risk-adjustment.
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Fig. 1 (abstract 001660). See text for description
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INTRODUCTION. Mismanagement of deterioration is the most com-
mon area of systemic failure in avoidable patient death across the
NHS.[1] To address this issue, national guidelines recommend routine
analysis of patient safety data to identify areas of service failure and
to highlight opportunities for corrective action.[2] We previously de-
scribed a novel ‘failure to rescue’ (FR) scoring system that can be ap-
plied to unplanned ICU admissions (UPAs) from ward areas, to
identify any aspects of care that may have contributed to patient
deterioration.[3]
Using data collected over a 4-year period, here we validate this score
and explore the association between the FR score, illness severity
and patient outcome.
METHODS. All adult UPAs in a single university foundation trust be-
tween January 2014 and December 2018 were reviewed. As previ-
ously described, the FR score consists of 18 questions that
objectively appraise four categories of care failure in the pre-ICU ad-
mission period.
1. Failure to record: Were frequency of vital signs increased?
Were vital signs complete?
2. Failure to recognise: Was deterioration recognised?
3. Failure to escalate: Was the patient escalated, was there
evidence of an escalation block?
4. Failure to manage: Where appropriate diagnostic tests
performed? Was there timely review?
Scores range 0 to 18.5; higher scores indicate greater failures in care.
Additional data collected included: patient demographics, APACHE II
score, ICU admission, ICU and hospital mortality.
RESULTS. 3112 patients were included; median age 63(IQR 51-73),
59% male, median admission APACHE II scores 19(14-23) with a 66%
survival rate to hospital discharge. Median total UPA score was 2(1-4)
which was higher in patients who did not survive (p<0.001). Patients
who suffered cardiac arrest prior to ICU admission also had higherUPA scores (p<0.001). The majority of patients scored between 0-3;
and the most commonly occurring category of care failure was Fail-
ure to manage in 20% of cases.
In a multivariate logistic regression model controlling for age, sex
and APACHE II score total UPA score retained significance for predic-
tion of hospital mortality (OR 1.040, 95% CI 1.007-1.040, p=0.017,
overall p value <0.001). The area under the receiver operating curve
for this model was 0.735 (0.718-0.753), p<0.001.
CONCLUSION. In this large observational cohort, we have demon-
strated the ability of the FR scoring system to identify categories of
care failure. We have demonstrated an association between higher
scores (greater failures in care) and worse patient outcomes. This sys-
tem provides critical information about patient deterioration, allow-
ing focused quality improvement projects that may be tracked via FR
scores over time.
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INTRODUCTION. Ultrasound guidance of peripheral venous catheter
(PVC) insertion may increase the success rate of the procedure.
OBJECTIVES. We performed randomized pre-hospital clinical study to
compare two different techniques of ultrasound guided PVC in-
sertion and conventional cannulation technique regarding the
success of the first attempt of PVC insertion, the overall success,
the number of attempts required for successful PVC placement,
the time required to introduce PVC and the incidence of pre-
hospital complications.
METHODS. Pre-hospital prospective controlled randomized clinical
trial allocated patients treated by emergency medical service to ei-
ther undergo PVC insertion fully controlled by ultrasound (ultrasound
guidance of the tip of the PVC until it penetrates the lumen; Group
A); or to undergo PVC insertion partially controlled by ultrasound
(target vein identification only; Group B); or to receive PVC by con-
ventional approach without any ultrasound guidance (Group C). The
study outcomes were monitored until takeover of the patient to the
hospital.
RESULTS. A total of 300 adult patients were enrolled. The success of
the first attempt (group A: 88%, group B: 94%, group C: 76%, p<
0.001) and overall success rate (A: 99%, B: 99%, C: 90%, p<0.001)
were significantly higher in the groups A and B than in the group C
without significant differences between the groups A and B. The
number of attempts was significantly lower (A: 1.18±0.54, B: 1.05±
0.22, C: 1.22±0.57, p<0.001) and the time required for the procedure
shorter (A: 75.3±60.6, B: 43.5±26.0, C: 82.3±100.9 s, p<0.001) in the
group B than in the groups A and C.
CONCLUSION. Pre-hospital ultrasound guidance of PVC placement
was associated with higher success rate than conventional method,
irrespective of the technique of ultrasound guidance. However, PVC
insertion partially controlled by ultrasound was superior to full ultra-
sound guidance in terms of the time and number of cannulation at-
tempts required.
Fig. 1 (abstract 000433). Consort diagram showing enrolment of
patients in the groups (n=number of patients)
Fig. 2 (abstract 000433). See text for description
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INTRODUCTION. Fluid therapy is a cornerstone of modern med-
ical practice, particularly in acute settings such as intra-operative
or intensive care. The acidosis attributed to Normal Saline has a
clear dose-dependent effect with larger volumes associated with
this phenomenon. However, the exact quantitative impact of this
solution when used in a restrictive paradigm is not adequately
assessed in the current literature. Thus, this study attempted to
assess the effects of vs. Normal Saline when used in restrictive
quantities as determined by a predefined the hemodynamic
algorithm.
OBJECTIVES. To determine the equivalence or otherwise of Nor-
mal saline in comparison to balanced salt solution for intra- op-
erative fluid replacement in elective, adult open abdominal
surgery on serum chloride level using a restrictive fluid therapy
algorithm.
METHODS. 120 adult patients were randomized to receive either
Normal saline or Plasmalyte as the predominant fluid during surgery
using a computer-generated the random number. Patients received
a bolus of 150ml of study fluid at induction and 2ml/kg/hr + urine
output+ blood loss every hour. Systolic Pressure variation and Pulse
Pressure variation was assessed every time the systolic blood pres-
sure < 90 mm Hg or < 20% from baseline whichever was higher
using the predefined algorithm. Arterial blood gas samples were re-
peated every two hours until the end of surgery. Additional samples
were also obtained pre-induction and 24 hours after the end of sur-
gery for the biochemistry variables. Previous studies had reported a
difference of approximately 6 mEq L-1 in the chloride levels when sa-
line was used in comparison to Plasmalyte at the volumes infused in
the study. Assuming an α of 0.05 and a power of 80%, 120 patients
were required to demonstrate that the limits of a two-sided 95%
confidence interval would exclude a difference in the Chloride con-
centration of <3 mEq L-1 between the two groups at the conclusion
of surgery.
RESULTS. 120 patients were enrolled in the study. Fig 1is the CON-
SORT diagram.
The chloride anion level decreased by a mean of 0.54 ± 3.29 in the
Plasmalyte group and increased by mean of -0.43 ± 4.90 in the nor-
mal saline group, the difference between the two insignificant (p
value=0.22). Subgroup analysis of 50 patients with duration of sur-
gery exceeding 4 hours demonstrated chloride increase until 2 hours
in both groups and thereafter a drop was noted by the 4th hour.
(FIGURE 2)
Higher total urine output was recorded in Plasmalyte group (p=
0.006, significant) with a mean difference of 69.368 ml, 95% CI (19.0
to 119.7). (FIG 3)
CONCLUSION. CONCLUSIONS: Restrictive fluid regimen shows
equivalence in the choice of crystalloid fluid (Plasmalyte versus Nor-
mal saline) used for intraoperative fluid therapy.
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Fig. 1 (abstract 000704). See text for description
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for perioperative medicine. It is a major contributor to morbidity
and mortality worldwide. Sensitivity and specificity of traditional
biomarkers for predicting and diagnosing infection are often re-
duced in this setting. Lack of precision combined with the im-
portance of early diagnosis and treatment emphasize the need
for more sensitive markers of infection. Adrenomedullin (analyzed
indirectly with mid-regional proadrenomedullin, MR-proADM) is a
novel peptide that has predominantly vasoactive and immuno-
logical properties and seems to be an important prognostic
marker for sepsis. However, whether one could use MR-proADM
for the prediction and early diagnosis of postoperative infections
remains unclear.
OBJECTIVES. To investigate the association between elevated levels
of MR-proADM perioperatively and infectious complications in the 30
days following surgery.
METHODS. This was a preplanned substudy of the Myocardial Injury
in Noncardiac Surgery in Sweden (NCT03436238). We enrolled 504
patients undergoing major elective abdominal surgery in a multicen-
ter prospective cohort study. MR-proADM levels were measured pre-
operatively, immediately postoperatively, and on days 1, 2 and 3
after surgery. Postoperative infections were registered at 30 days
after surgery by a blinded assessor. The relationship between MR-
proADM levels and the presence of infection was investigated. ROC-
curves were constructed in order to obtain a cutoff value maximized
for sensitivity.
RESULTS. MR-proADM was significantly higher at all postoperative
data points across all patients compared to preoperatively. There
were significant differences in MR-proADM levels between pa-
tients who developed an infectious complication and those who
did not. This difference were noted immediately after surgery
and at days 2 and 3. A cutoff was obtained from ROC-analysis
which revealed that 1.043 nmol/L could significantly discriminate
blood infection from no infection groups with a sensitivity of 89
% and specificity of 41 %.
CONCLUSION. MR-proADM levels immediately after surgery, at day 2
and day 3 predict infectious complications in the 30 day postopera-
tive time period.
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INTRODUCTION. Perioperative atrial fibrillation (POAF) is associ-
ated with significant short and long-term complications.
OBJECTIVES. To establish the incidenceof POAF after noncardiac sur-
gery and investigate the association between the preoperative NT-
pro-BNP level and POAF.
METHODS. The Vascular events In non-cardiac Surgery patIents cO-
hort evaluatioN (VISION; NCT00512109) Study was an international
prospective cohort study of a representative sample of adults ≥45 years
of age who underwent non-cardiac surgery. One of the predefinedob-
jectives was to determine the 30-day incidenceof clinically important
POAF (defined as POAFresulting in angina, congestive heart failure,
symptomatic hypotension, or requiring treatment). We estimated the
relationship between preoperative NT-pro-BNP levels and clinically sig-
nificantPOAF using multivariable logistic regression models with re-
stricted cubic splines.
RESULTS. In 37,664 patients with no prior history of AF, the inci-
dence of POAF was 1.0% (95% CI, 0.9-1.1; 369 events). It was
3.2% (95% CI, 2.3-4.4) in patients undergoing major thoracic sur-
gery, 1.3% (95% CI, 1.2-1.5) in major nonthoracic surgery, and
0.2% (95% CI, 0.1-0.3) in low-risk surgery. NT-pro-BNP measure-
ment was obtained in 9789 individuals before surgery. An in-
crease in the preoperative NT-pro-BNP level from 39 ng/ml (first
quartile) to 228 ng/ml (third quartile) was associated with an un-
adjusted OR for developing POAF of 3.92 (95% CI, 2.32-6.65), and
anadjusted OR of 2.55 (95% CI, 1.49-4.36).
T1
Table 1 (abstract 001743). Comparison of Coagulation Parameters
within and between Study Groups. Data are presented as median
(interquartile range)
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hundredth patient having noncardiac surgery. Preoperative NT-pro-
BNP levels were strongly associated with an increased risk of POAF.
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INTRODUCTION. Shivering is an unpleasant condition which usually
occur as a complication after both general and regional anaesthesia
in patient underwent either elective or emergency surgery.
The elderly constitute an important risk group due to the physio-
logical alterations that occur in the aging process and contribute to a
diminished thermoregulation capacity.
OBJECTIVES. Present prospective, randomized, and controlled study
was performed to determine the benefits of warmed liquids infusion
compared with infusion of liquids kept at room temperature in main-
taining normal core temperature and prevent shivering after general
anesthesia in elderly.
METHODS. After obtaining institutional approval and written in-
formed consent from all patients, 62 patients with American Society
of Anesthesiologists physical status of I-III, aged 65 years and above,
who were scheduled for elective surgery under general anesthesia,
were included in this prospective, randomized study. Exclusion criteria
included history of head injury, thyroid disease, severe cardiovascular
and respiratory disease, a core temperature of ≥ 37.5°C.
Our patients were randomly allocated to receive crystalloid at room
temperature (31 patients, Group A, without infusion warmer) or
warmed at 37°C (31 patients, Group B, with infusion warmer) .
Shivering was graded using the Bedside Shivering Assessment Scale.
The occurrence of shivering during surgery and in the recovery room
was recorded.
The data obtained were analyzed with SPSS software with a signifi-
cance level of p.
RESULTS. At the end of surgery, core temperature was 36.8 +/- 0.1
degrees C in the group receiving warmed fluids and 35.7 +/- 0.3 de-
grees C in the control group (P < 0.05).
During recovery, four patient shivered in the group receiving
warmed fluids and seventeen in the control group (P < 0.05).
The severity of post-anesthesia shivering was also significantly less in
the infusion warmer group (P < 0.05).
CONCLUSION. The use of infusion warmer may help in reducing the
incidence of hypothermia and shivering after general anesthesia in
elderly patients.
Prevention of hypothermia and shivering should be done with multimodal
approach, either by pharmacological or non-pharmacological strategies.
Warm IV saline solution given before, during, and after surgery, is the
cheapest and easiest way to maintain core temperature, preventing
hypothermia and shivering.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):001743INTRODUCTION. A standard subcutaneous low-molecular weight heparin
(LMWH) thromboprophylaxis yields subtherapeutic level of plasma anti-
FXa activity (anti-FXa) in intensive care unit (ICU) patients. Moreover, the
ability of the anti-FXa to predict clinical adverse events is limited.
OBJECTIVES. To assess coagulation status in mixed ICU patients ran-
domized to receive enoxaparin thromboprophylaxis either as a
standard subcutaneous bolus (SCB) or continuous intravenous infu-
sion (CII) for three consecutive days.
METHODS. A randomized, single-blind study at two tertiary university
hospitals was conducted. Thirty-eight mixed ICU patients were studied
by conventional coagulation parameters. Additionally, 18 patients were
analyzed for thrombin generation by calibrated automated thrombo-
gram (TG-CAT). Blood samples were taken prior the study start (i.e.
baseline), at 51 (i.e. the final peak level of the SCB group) and at 72 (i.e.
the final through level of the SCB group) hours from the study start.
RESULTS. At baseline, no difference in coagulation status was observed.
The inhibition of prothrombin fragments F1+2 (F1+2) was significantly
superior at 51 and 72 hours in the CII group compared to the SCB
group. Correspondingly, a significant increase in antithrombin (AT 3)
level was observed within the CII group whereas the level in the SCB
group remained unchanged (Table 1). At 51 hours lag time (7.5 vs. 4.3
min, p <0.05) and time to peak (14.3 vs. 7.7 min, p <0.05) of the TG-
CAT analysis were significantly prolonged in the SCB group. At 72 hours
peak thrombin was significantly lower in the CII group vs. the SCB
group: 364 nM vs. 271 nM, p <.05. The final through level of plasma
anti-FXa was higher in the CII group: 0.05 IU/ml vs. 0.12 IU/ml, p=0.067.
CONCLUSION. Continuous intravenous infusion of enoxaparin throm-
boprophylaxis resulted in more prominent inhibition of prothrombin
fragments and better preservation of the natural anticoagulant anti-
thrombin level in comparison to standard subcutaneous care.
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INTRODUCTION. Patients who survive intensive care are left with long
term psychological, physical and cognitive impairments which may persist
Page 380 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55for up to 15 years following discharge. Collectively, these impairments are
known as post intensive care syndrome (PICS), which affects up to 70% of
survivors (1). These impairments are not limited to patients alone, with
carers also carrying a high burden of psychological and social co-
morbidity (2).
OBJECTIVES. To assess the effectiveness of a 5 week multidisciplinary
programme (clinic) for intensive care survivors and their carers on
optimising physical and psychological recovery.
METHODS. Survivors of intensive care were invited to clinic with
their carers, within 3 months of hospital discharge. Patients could
also self-refer, or be referred by their family doctor.
On one morning a week, for 5 weeks, a selection of professionals
from the multidisciplinary team (Consultant, Physiotherapist, Nurse,
Psychologist, Dietician, Occupational Therapist, Pharmacist) attended
and delivered a combination of group sessions and 1:1 sessions.
Using hospital data and self-administered questionnaires, information
on patient characteristics, health status, and caregiver strain were col-
lected. Patient outcome data were collected using the EQ-5D Health
Questionnaire and self-efficacy scores at week 1, week 5, 3 months and
12 months. Carer outcomes were collected using a carer strain
index. Professional interventions were recorded, and qualitative out-
comes collected using standardised feedback forms.
RESULTS. A total of 28 patients have attended in 4 cohorts so far,
with 22 family members. 25% self referred or were referred by their
doctor. All patients completed their programme. 5 patients (18%) were
trauma patients, 13 (46%) were medical, and 10 (36%) were surgical.
CONCLUSION. Patients and carers presented to our clinic with evi-
dence of altered health status and carer strain. This multidisciplinary
follow up clinic is an effective intervention in providing support and
therapy for patients and their carers after intensive care, and results
in improvements in self-efficacy and health status. The clinic is re-
ceived positively by all who attend.
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Week 1 Week 5 3 months
EQ5D visual analogue score - mean ±SD 62.0 ±20.8 72.9±19.9 81.67±12.9
Self efficacy score - mean ± SD 27.7±7.5 29.8±7.3 33.5±5.3
Table 1 (abstract 000057). Patient Characteristics
Median age – years (range) 58.5 (18-83)
Number of patients sedated and ventilated (%) 26 (94)
Median ICU length of stay - days (range) 12.5 (2-54)
APACHE Score- mean ±SD 34.29 (±21.7)
Table 3 (abstract 000057). Other outcomes
Carer Strain Index – mean ± SD 0.44 ± 0.3
Pharmacy interventions - number (%) 7 (25)
Total number of specialist referrals (%) 21 (75)
Median satisfaction scores out of 6 (range) 6 (5-6)000215
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000215INTRODUCTION. Providing high-quality care is a priority worldwide
(WHO, 2018). One way of evaluating quality is the investigation of
nursing care models. A topic under investigation in the last decade,
due to its impact on the quality of health care, is the care left un-
done phenomenon (Ball et al., 2014). Understanding how healthcare
quality is related to care left undone could contribute to quality im-
provement (Recio-Saucedo et al., 2018).
OBJECTIVES. Investigate which nursing staff and work environment
variables could influence the prevalence of care left undone in Neo-
natal and Paediatric Intensive Care Units (NICUs and PICUs).
METHODS.We extracted data from the RN4CAST@IT-Ped project, a larger
cross-sectional, observational, multicentre Italian study. The project in-
volved 13 Italian hospitals, associated to Italian Association of Paediatric
Hospitals, and the NICU and PICU nurses and paediatric nurses was en-
rolled using convenience sampling. We asked which activities, from a list
of 13, were necessary but left undone because of lack of time during the
last shift worked. Data were analysed through descriptive and inferential
statistics methods (logistic regression), with IBM SPSS 22.0 software.
RESULTS. We analyzed the answers of 451 nurses. Poor health care,
depersonalization and emotional exhaustion, and intention to leave
the job are some variables that could influence the omission of some
nursing activities, like surveillance, pain management, information
and education, and mobilization (OR min=OR 1,024, p=0,026; OR
max=OR 2,469, p=0,001). A good work environment is a protective
factor related to the omission of nursing activities, like the develop-
ment of nursing care plans (OR=0,512, p=0,001).
CONCLUSION. Our results are consistent with international literature
showing that nurses miss some activities, especially in the presence
of some environmental and personal conditions. Understanding the
relations that underlay the nursing care left undone could be a start-
ing point to develop improvement measures to both better patient-
centred care and quality of health care.
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INTRODUCTION. Sense of coherence (SOC) relates to the ability to
endure stressful life events, and is divided into comprehensibility
(SOC C), manageability (SOC MA) and meaningfulness (SOC ME). Low
SOC reflects low coping ability and is strongly associated with post-
traumatic stress symptoms (PTSS). It is not known whether nurse led
follow-up consultations can improve SOC in discharged intensive
care unit (ICU) patients with moderate to high PTSS.
Page 381 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55OBJECTIVES. An a priori defined post hoc analysis of a randomized
controlled trial (RCT) on nurse led follow-up consultations in dis-
charged ICU patients with moderate to high levels of PTSS was per-
formed, where both the effect on total SOC (as a composite
endpoint), and on each of the three SOC dimensions (SOC C, SOC
MA and SOC ME) was evaluated.
METHODS. ICU patients ≥18 years admitted to one of five ICUs at
Oslo University Hospital (OUH) for ≥24 hours were included. Patients
were screened on PTSS (PTSS-10) immediately after ICU discharge,
and those with PTSS-10 score ≥25 (clinically relevant symptoms)
were randomized to an intervention (IG) or control (CG) group. IG pa-
tients received up to three individually adjusted nurse led follow-up
consultations immediately after ICU discharge, and one and two
months later. Consultations were based on trauma focused cognitive
behavioural therapy combined with narrative method to process
traumatic memories and achieve coherence of what happened dur-
ing the ICU stay. The SOC Scale with 13 items on a 1-7 scale mea-
sured the total score (range 13-91), but also the score for each of the
three dimensions SOC C, SOC MA and SOC ME. This was done imme-
diately after ICU discharge (baseline), and after 3, 6 and 12 months.
Possible differences between IG and CG were analysed using linear
mixed models for repeated measures.
RESULTS. In total, 523 patients were screened and 224 (43%) had
PTSS-10 score ≥25 (53% male, median age 52 years) and were ran-
domized into IG (n=111) and CG (n=112). No statistically significant
differences were found between IG and CG in total SOC (p= 0.47),
SOC C (p=0.58), SOC MA (p=0.17) or SOC ME (p=0.78) over time from
baseline to 12 months. During the same time period total SOC in-
creased in both groups, with a non-significant trend towards a differ-
ent time trajectory in IG and CG (Table).
CONCLUSION. Nurse led follow-up consultations in discharged ICU
patients with moderate to high risk of PTSS, did not reveal any sig-
nificant effect on the composite endpoint SOC or on any of the three
SOC dimensions.
REFERENCE(S)
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OrganisationTable 1 (abstract 000500). Estimated means dependent variable: Total
Sense of coherence (SOC)
Time Intervention Group (IG) Control Group (CG)
Mean 95% CI Mean 95% CI
1 (baseline) 60.6 57.9, 63.2 62.3 59.6, 65.0
2 (3 months) 62.9 59.8, 65.9 61.4 58.3, 64.5
3 (6 months) 62.2 58.8, 65.7 64.7 61.2, 68.2
4 (12 months) 62.2 59.1, 65.3 64.9 61.7, 68.2000586
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INTRODUCTION. Pain has been shown to be a serious and challen-
ging problem for intensive care unit (ICU) patients. Research is,however, scarce on pain related issues in ICU patients immediately
after ICU discharge to the ward, with a significant lower nurse – pa-
tient ratio compared to the ICU.
OBJECTIVES. The aim of this study was to investigate pain intensity
and pain interference in ICU patients immediately after ICU dis-
charge, and the association between pain and sense of coherence
(SOC, reflecting coping), post-traumatic stress symptoms (PTSS),
memories from the ICU stay and demographic and clinical variables.
SOC, PTSS, and memories from the ICU stay were hypothesized to be
associated with pain after ICU discharge.
METHODS. In this a priori defined sub-study of a randomized con-
trolled trial on PTSS in ICU patients, 523 consenting patients aged ≥
18 years admitted for ≥ 24 hours in one of five ICUs at Oslo Univer-
sity Hospital filled out Brief Pain Inventory (BPI) immediately after ICU
discharge. BPI is measuring pain intensity using a numeric rating
scale (NRS) from 0 (no pain) to 10 (pain as bad as you can imagine),
pain interference with daily life (NRS 0-10) and pain location using a
body map. The patients also answered questionnaires measuring
PTSS (PTSS-10-I), SOC (SOC-13) and memories from the ICU stay (ICU
memory tool). Data analyses were performed using descriptive statis-
tics and multiple linear regression analysis.
RESULTS. Among the 523 included patients, 469 (90%) experienced
pain, and 280 (54%) reported moderate to severe (NRS 4-10) worst
pain intensity. Mean pain intensity and mean pain interference were
5.9 (SD 2.7) and 4.5 (SD 2.7), respectively. The majority of patients re-
ported pain in the abdomen (43%), lower back (28%), and shoulder/
forearm (22%). Variables significantly associated with worst pain in-
tensity were; shorter ICU stay (beta -0.06, 95% CI [-0.09, 0.03]), low
SOC (beta -0.03, 95% CI [-0.05, -0.00]), scary ICU memories (beta
0.44, CI [-0.25, 0.66]) and having undergone surgery (beta 1.15, 95%
CI [0.17, 2.14]).Variables significantly associated with higher pain
interference were scary ICU memories (beta 0.17, 95% CI [-0.02, 0.36),
higher PTSS (beta 0.09, 95% CI [0.07, 0.11), prior anxiolytic use before
hospital admittance (beta 0.53, 95% CI [0.01, 1.05]), trauma admission
(beta 1.24, 95% CI [0.55, 1.92]) and regional analgesic use in the ICU
(beta 0.53, 95% CI [ 0.06, 1.00]).
CONCLUSION. In total, 90% of the patients reported pain immedi-
ately after ICU discharge, and more than half of the patients reported
moderate to severe pain. In addition, the association between low
SOC and pain intensity highlights the importance of coping in pa-
tients after an ICU stay. The association between pain interference
and prior anxiolytic use, scary memories and PTSS brings attention to
the significance of psychological issues when relieving pain in ICU
patients after ICU discharge.
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INTRODUCTION. Survivors of critical illness often experience ongoing
physical, psychological and cognitive morbidity, collectively known
as ‘post intensive care syndrome’ [1]. These effects can last for
months to years after hospital discharge [2]. A recent trial of early
and structured rehabilitation within our Intensive Care Unit (ICU)
demonstrated a greater intensity of physical rehabilitation than that
provided as standard care in previous trials [3]. Currently the psycho-
logical status of patients leaving our ‘rehab active’ ICU is unknown.
OBJECTIVES. 1. To identify levels of anxiety, depression, psycho-
logical distress and mobility reported at ICU discharge.
2. To explore the impact of mobility levels upon psychological
outcomes.
T1
Table 1 (abstract 000865). Differences in pacients and relatives’
Page 382 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55METHODS. All patients under the care of a specialist critical care rehabili-
tation team and surviving to ICU discharge between December 2018 and
February 2019 were included in the analysis. Patients were asked to
complete the Hospital Anxiety and Depression Scale (HADS) and the In-
tensive Care Psychological Assessment Tool (IPAT) questionnaires within
48 hours of transfer from ICU to the ward. Manchester Mobility Scores
(MMS) were also recorded by the patients’ physiotherapist.
RESULTS. A total of 33 patients were included in the analysis,
with 73% (n = 24) able to mobilise at the point of ICU discharge (de-
fined as an MMS score of 6 or above). 42% (n = 14) of patients dem-
onstrated symptoms of anxiety (HADS score > 7), 58% (n = 19)
showed symptoms of depression (HADS score > 7) and 70% (n = 23)
showed risk of psychological distress (IPAT score of 7 or above).
A sub analysis of outcomes (see table 1) demonstrated patients with
MMS of ≤ 5 were more likely to be anxious (78% vs 29%, p<0.05)
and had a longer ward length of stay (38.6 vs 17.5 days, p<0.05). No
significant difference was seen for depression or IPAT.
CONCLUSION. A high prevalence of psychological morbidity was ob-
served amongst ICU survivors on discharge to the ward. Increased mobil-
ity levels at the point of ICU discharge were associated with a reduction
in the incidence of anxiety and shorter ward length of stay. However,
symptoms of psychological distress were high within both groups. Our
results identify the need for more structured follow up and psychological
support of intensive care survivors on discharge to the ward.
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4. n/aTable 1 (abstract 000892). Outcomes on ICU discharge with mobility
as an independent variable
MMS ≦ 5 MMS ≧ 6 p
n 9 24 -
Mean ICU length of stay (days) 21.8 22.1 0.839
Mean ward length of stay (days) 38.6 17.5 <0.05
Anxiety (HADS > 7) 78%(n=7) 29%(n=7) <0.05
Depression (HADS > 7) 78%(n=7) 50%(n=12) 0.118
IPAT score ≧ 7 89%(n=8) 63%(n=15) 0.127
satisfaction in the ICU
Dimensions Mean (T.D.) t (p)
Pacients Relatives
Global satisfaction 6.95 (0.21) 6.59 (0.69) 5.252 (0.000)
Satisfaction with quality of ICU 6.95 (0.21) 6.78 (0.38) 4.103 (0.000)
Satisfaction with healthcare personnel 6.97 (0.16) 6.89 (0.31) 2.201 (0.029)
Satisfaction with watchmen 6.95 (0.25) 6.88 (0.35) 1.718 (0.087)
Satisfacción con instalaciones y
equipamiento
6.93 (0.30) 6.58 (0.73) 4.631 (0.000)
Satisfaction with food 5.47 (1.03) 6.63 (0.66) -10.045
(0.000)
Satisfaction with cleaning 6.95 (0.25) 6.85 (0.44) 2.145 (0.033)HSRO - Important outcomes for
patients, family and doctors
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000865INTRODUCTION. In the past, quality and improvement in healthcare
have focused on what proffesionals think should be valued and have
been less interested in what serve userd felt was important. In the In-
tensive Care Unit, the patient's perspective, as well as their relatives’,
is central to quality improvement.
OBJECTIVES. To evaluate patients and relatives’ satisfaction in an In-
tensive Care Unit (ICU).
METHODS. Information was collected from June to September 2018
through a survey adapted to patients and family members. The ques-
tionnaire included a 7-score Likert scale conformed by different items
aimed at assessing the quality of the service provided to patients in
the ICU.
Based on the work of Mora Lourido (2015), we took the dimensions
created to measure the technical and structural human quality in the
ICU, and we conducted an analysis of means using the student’s T,
to check the differences in patients and relatives’ satisfaction.
RESULTS. The measurement scale was consisted of 7 dimensions,
whose average values are shown in the attached table.
CONCLUSION. There are statistically significant differences in patients
and relatives’ satisfaction in all dimensions except those related to
satisfaction with caretakers. In general, patients are more satisfied
tan realtives with the ICU, with the exception of food, which is worse
valued by patients. The quality of the ICU has received the highest
score by both groups, being the dimension that has more weight in
the satisfaction of patients and relatives. On the contrary, satisfaction
with food is the item that has received the worst assessment.
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INTRODUCTION. Intensive care staff wellbeing is important and often
overlooked. Emotional distress may result from involvement in trau-
matic events and witnessing death on the ICU. ICU staff should be
offered opportunities to discuss these sensitive and emotional issues.
The current morbidity and mortality (M&M) presentation model used
in our ICU is only attended by ICU doctors. It is focused on educa-
tional and clinical aspects of patient deaths. The national General
Page 383 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Provision of Intensive Care Services guidelines version 2 (GPICSv2)
2018 now includes guidance for staff support (1).
OBJECTIVES. To assess whether the current M&M model allows staff
wellbeing and emotional welfare to be explored and if this is re-
quired on a regular basis.
METHODS. ICU doctors of all grades were surveyed; on their attend-
ance at M&M presentations; whether staff wellbeing was discussed;
whether they would like this to be reviewed regularly; and whether
they felt it would be beneficial for other ICU staff (nurses and thera-
pists) to attend and contribute.
RESULTS. Sixteen doctors were surveyed (5 consultants, 6 middle
grades and 5 SHOs). 14 of those had attended an ICU M&M presenta-
tion in the last 12 months. Of those that had attended, 5 out of 14
felt that the current M&M model allowed staff wellbeing and emo-
tional issues to be discussed. 13 (81%) doctors surveyed would like
to have a regular opportunity to discuss such issues. 15 (94%) doc-
tors surveyed felt it would be beneficial for nurses and other MDT
members to attend and contribute at the M&M presentation.
CONCLUSION. Staff wellbeing impacts upon quality of care (2). Doc-
tors working on our ICU feel that it would be beneficial to incorpor-
ate a debriefing section at M&M meetings to discuss emotional
welfare and staff wellbeing. Introducing this discussion and inviting
all members of the multi-disciplinary team (MDT) may reduce the im-
pact of the ‘Second Victim Phenomenon’ (3) caused by distressing
events. M&M meetings could be improved to provide this opportun-
ity by incorporating regular discussion about emotional distress
caused by cases. Although it has been recommended in the consult-
ation document of GPICSv2 (1), we cannot find any large studies in
the literature to assess the impact of this. To enable safe facilitation
of debrief sessions it is likely to be beneficial for staff members to
undertake formal training. Further work is needed to assess the
benefit of inviting members of the MDT to M&M. We plan to expand
this survey out to all MDT members on our own ICU as well as con-
ducting a larger survey across other intensive care units to assess
this. We propose a change in the presentation format to include dis-
cussion on staff wellbeing and invite all MDT members to participate
in discussion to provide a supportive environment.
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INTRODUCTION. The evolvement of airway pressures within the MV
may reflect the modification of the viscoelastic properties of the re-
spiratory system and hence predict poor outcome.
OBJECTIVES. To identify a relationship between airway pressures and
mortality in MV patients.
METHODS. A retrospective charts' review of MV patients admitted to
a medical ICU of Farhat Hached hospital from November 2015 to
February 2018. Were collected patients' characteristics at admission
and respective airway pressures (Peak, plateau, driving and intrinsic
PEEP) at admission and at day 4. Trends of airway pressures (Paw)
(Paw at day 4 - Paw at admission). High pressure ratio (HPR) is de-
fined as the number of days spent with high pressures : Peak≥40and/or plateau ≥30; and/or driving pressure ≥15 and/or; intrinsic
PEEP ≥6; divided bylength of stay) and outcomes were recorded
from chosen eligible charts. Univariate and multivariate regression
analyses were performed to identify factors independently associated
with mortality. ROC curves were used to check for the discriminative
properties of the significant factors.
RESULTS. 304 mechanically ventilated patients were collected within
the study period. 199(65%) were non-COPD patients. They were 50±
18 years aged; ARDS, 17(8.5%); pneumonia, 14(7%); Pulmonary
edema, 10(5%); SAPS II, 35.1±15.7; pH, 7.31±0.14; PCO2, 42.4±19.9
mmHg; PaO2/FiO2, 210.6±109.2 mmHg; MV duration, 8.9±9.4 days;
tracheostomy, 18(9%); length of stay, 10±10 days. Mortality,
114(57%). Median [IOR] trends of Paw : delta Peak, delta plateau,
delta driving, delta intrinsic PEEP were respectively; 0[-5,5], 1[-2,3], 0[-
2,3], 0[-2,0]. Median HPR, 0.15[0,1]. Univariate analysis and multivari-
ate logistic regression analysis showed an association between Paw
trends and mortality : 1) For non-COPD patients; delta Peak, (OR,
1.10; 95%CI, [1.03-1.19]; p=0.007), HPR, (OR, 38.3; 95%CI, [6.4-228.3];
p=0.000), 2) For COPD patients; delta plateau, (OR, 1.11; 95%CI, [1.01-
1.22]; p=0.03), HPR (OR, 14.3; 95%CI, [3.6-56.6]; p=0.000). For non-
COPD patients, respective ROC AUCs for delta Peak and HPR (0.73,
0.69) confirmed interesting discriminative properties to predict mor-
tality. For COPD patients, respective ROC AUCs for delta plateau and
HPR (0.70, 0.75) confirmed interesting discriminative properties to
predict mortality.
CONCLUSION. The present study demonstrated that airway pres-
sures' trends in MV patients could predict mortality.
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INTRODUCTION. Poor outcomes in mechanically ventilated (MV) pa-
tients may be related to strenuous viscoelastic properties of the
lungs and difficult respiratory mechanics which could be illustrated
by elevated airway pressures (Paw).
OBJECTIVES. To identify the properties of a validated airway pres-
sures score for the prediction of poor outcomes in mechanically ven-
tilated patient.
METHODS. A retrospective chart reviews (from November 2015 to
February 2018) of MV patients was conducted in the MICU of Farhat
Hached teaching of Sousse, Tunisia. A Mortality prediction score
(Paw-MPS) was developed and validated around three items (plateau
at day 4 ≥18cmH2O, + 1 point; delta peak ≥2, + 1 point; HPR ≥ 0.34,
+ 2 points) where delta peak=trends of Ppeak (Ppeak at day 4 of ICU
stay - Ppeak upon admission and HPR=number of days spent with
high pressures : Peak ≥40 and/or plateau ≥30; and/or driving pres-
sure ≥14; and/or auto-PEEP ≥6cmH2O; divided by length of stay).
Poor outcomes were defined as : a ventilator-free days at day 28
(VFDs) = 0 and a composite outcome : death or length of stay ≥ 14
days. ROC curves were used to assess discriminativ e properties of
Paw-MPS to predict outcomes.
RESULTS. A total of 304 MV patients were included. Their main char-
acteristics were : mean age, 56±18years; male sex ratio, 64.8%(n=
197); mean SAPS II, 34.9±14.3; pH, 7,3±0,1; pCO2, 50±23mmHg; P/F
ratio, 204±101 mmHg; AE/COPD, 105(34.5%); ARDS, 25(8.2%); restrict-
ive lung disease, 20(6.6%); pneumonia, 14(4.6%); pulmonary edema,
11(3.6%); median mechanical ventilation duration, 3[6-14] days;
tracheostomy, 44(14.5%); median length of stay, 13[6-21] days; me-
dian VFDs, 0[0-2] days; mortality, 173(56.9%). Mean plateau at day 4,
20.9±6.6 cmH2O; median delta peak, 0[-5;5] cmH2O; HPR, 0.15[0-0.6];
mean Paw-MPS, 2.2±1.2. For the prediction of composite outcome,
F1
Fig. 3 (abstract 001117). ROC curve of SAPSII, first SOFA and Frailty
Index
Page 384 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55the Paw-MPS demonstrated respectively for the whole population,
COPD patients and non-COPD patients the following ROC-AUCs :
(AUC=0.75; 95%CI, [0.685- 0.809]; p≤10 ); (AUC=0.7; 95%CI, [0.620-
0.859]; p=0.002) and (AUC=0.74; 95%CI, [0.666- 0.819]; p≤10 ). For the
prediction of zero VFDs, the Paw-MPS demonstrated interesting ROC-
AUC only for COPD patients : (AUC=0.71; 95%CI, [0.602- 0.816]; p≤10
).
CONCLUSION. This simple prognostic score based on airway pres-
sures seems to demonstrate interesting discriminative properties to
predict poor outcomes of patients requiring invasive mechanical
ventilation.
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INTRODUCTION. Nowadays the rate of patients with age ≥ 80
years old (VEP) admitted in intensive care unit (ICU) is increasing.
Prognostic scores are necessary to determine the best therapeutic
strategy, and when to withdrawal therapies. Recently, it was sug-
gested to use Frailty index in elderly to better predict hospital
mortality [1].
OBJECTIVES. It was investigated the predicting hospital mortality
comparing ROC curve of SAPSII, first SOFA and Frailty index in VEP
admitted in ICU.
METHODS. There were collected data from all unselected VEP pa-
tients for 3 consecutive months in ICU for different reasons:
scheduled surgery, sepsis, cardiac arrest, haemorrhage or neuro-
logical coma. There were recorded all general data of patients
and also measured SAPS II, first SOFA, Frailty index and hospital
mortality (28 days mortality). Ethical Committee Modena proced-
ure 184/16.
RESULTS. During the study period were admitted 34 patients with
mean age of 84.06±0.52, 54.29% medical admissions, 31.43% un-
scheduled surgery, and 14.29% scheduled surgery. The hospital mor-
tality was the 57.58%, the mean value for the length of stay in ICU
was 12.47 days (CI 7.78-17.16). The mean value of SAPSII was 50.18±
4.07, first SOFA 7.0±0.71, Frailty Index 3.87±0.24. SAPSII showed an
AUC curve of 0.96 (CI 0.88-0.99), first SOFA AUC 0.90 (CI 0.79-0.99),
Frailty index 0.58 (CI 0.39-0.78). SAPSII and first SOFA did not show
any difference, but both predicted better than Frailty index with
p<0.001.
CONCLUSION. Frailty index can assess the resilience of elderly pa-
tients, but it does not predict hospital mortality as SAPSII or first
SOFA because they measure the impact of multiple organ failure
at ICU admission. The sample size of the study is limited, anyway
SAPSII and first SOFA show a good predicting performance in
VEP with ROC curve ≥0.9. Frailty index does not improve SOFA
score predicting performance even if combined with first SOFA
[2]. Physicians need easy and powerful prognostic scores, in ICU
settings: SAPS and first SOFA represent an useful tools also in
elderly.
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INTRODUCTION. Sepsis and septic shock are worldwide health emer-
gencies. Implementation of early, adequate and effective diagnostic
and therapeutic measures within a protocolized strategy could ameli-
orate patients outcomes. We present the experience of a university
hospital where a physiological, evidence-based protocolized sepsis
management has been progressively implemented and taught to
post-graduate physicians and residents over the last 12 years. Con-
stant post-graduate training and a local well spread protocol could
create in the institution the ability to diagnose and start resuscitation
at the emergency room, operating rooms and wards, before patients
arrive at the ICU, improving their outcomes.
OBJECTIVES. To compare the mortality of septic patients before and
after a teaching program, including a physiological, evidence-based
protocol for sepsis management was installed at a university hospital
in Chile.
METHODS. Retrospective cohort study based on patients medical re-
cords. We included patients with severe sepsis or septic shock admit-
ted to ICU in 2 time periods: 2005-2006 (pre-intervention, n= 109)
and 2017-2018 (post-intervention, n= 91). We characterized septic
patients and assessed outcomes in both periods. To evaluate the in-
terventions’ effect on mortality, we used logistic regression models
adjusting by sex, age, organic dysfunctions, and lactate levels.
RESULTS. Patients in both periods were similar in terms of: age (61.3
± 17.1 versus (vs) 61.4 ± 16.4 years old (yo), p-value= 0.95), sex (45%
vs 57% men, p-value= 0.09), and number of dysfunctions (3 [IQR 2-3]
vs 3 [IQR 2-4], p-value= 0.07). The percentage of septic patients ad-
mitted directly from the emergency room increased significantly in
the post-intervention period compared to the pre-intervention
Page 385 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55period (41% vs 16%, p-value<0.001), and admissions from intermedi-
ate care units decreased significantly (67% vs 40%, p-value< 0.01).
Mortality was higher in the pre-intervention than in the post-
intervention period (42.2 vs 23.1%, p-value= 0.005). The effect of the
intervention was independent of sex, age, organic dysfunctions and
lactate levels (OR= 0.36, p-value= 0.007).
CONCLUSION. A teaching strategy and implementation of a physio-
logical and evidence-based protocol for sepsis management reduced
the mortality of septic patients in our hospital.
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INTRODUCTION. Seasonal influenza epidemic constitutes a global
health problem with serious complications leading to high morbidity
and mortality, particularly among elderly patients and patients with
chronic underlying conditions According to WHO, the most effective
way to prevent the disease is annual vaccination.
OBJECTIVES. To evaluate the complications and outcome of patients
with confirmed influenza infection requiring admission to the inten-
sive care unit during 2018-2019 flu season in a tertiary hospital in
Greece. We also investigated factors associated with poor prognosis.
METHODS. This is a retrospective observational study that included
all patients admitted to the ICU of a tertiary hospital for complicated
influenza infection, between October 1st 2018 and April 10th 2019.
Demographic variables, clinical features, comorbidities, complications
and ICU outcome were reviewed.
RESULTS. A total of 15 patients were included with a median age of
68 (range 49-87) years. Nine of them (60%) were male. Eleven pa-
tients (73%) were infected with influenza A and four patients (27%)
with influenza B. 46,6% of the patients (n=7) were vaccinated against
influenza. Median length of ICU stay was 17 days (range 4-37) and
the ICU mortality rate was 33% (n=5). The median APACHE II score
on admission was 25 (range 21-38). The most common underlying
diseases of the patients were chronic obstructive pulmonary disease
(53%), diabetes mellitus (47%) and coronary artery disease (20%).
60% were smokers and 33% were immunosuppressed (Rheumatoid
Arthritis, Chronic Lymphocytic Leukemia, Multiple Sclerosis, Sarcoid-
osis). The majority of patients presented bacterial superinfections-
40% (n=6) ventilator associated tracheobronchitis or pneumonia and
13% (n=2) secondary bacteremia. More frequent complications wereacute kidney injury (AKI) in 8 patients (53%) requiring CRRT in one
third of the cases, acute heart failure (n=5, 33%), and rhabdomyolysis
(n=5, 33%). Less frequent complications were myopathy/neuropathy
(20%), ARDS (13%), encephalitis (7%), pulmonary embolism/DVT (7%),
and invasive aspergillosis (7%). Compared with survivors, non-
survivors were older (median age 71 vs 63,5), had longer ICU stay
(median 26 days vs 13,5d), higher APACHE II score (median 30 vs 26),
suffered more infectious complications (80% vs 30%), more cardiac
complications (80% vs 20%), and presented AKI in 100% of the cases
(vs 30% of survivors). Among survivors 40% (n=4) were vaccinated,
and 60% (n=3) among non-survivors.
CONCLUSION. Findings from our single center study suggest that pa-
tients requiring intensive care management during the recent influ-
enza outbreak, in contrast with previous years, suffered less ARDS
and more extra-pulmonary complications. Although our study popu-
lation is limited, and we cannot extrapolate conclusions, it seems
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INTRODUCTION. The survivors of diseases, with the presence of im-
pairment of cognitive, psychological and functional, but the revers-
ible potential rooms 5 years after intensive therapy (ICU) therapy has
not yet been Characterized and understood. (1) Cognitive dysfunc-
tion in this population is characterized by new deficits (exacerbation
of preexisting mild deficits) in global cognition, memory, attention /
concentration, and executive functions.
OBJECTIVES. To assess cognitive and functional status in patients
followed by occupational therapy in neurocritical patients.
METHODS. A retrospective analysis of the patients hospitalized in a
neurological intensive care unit, followed by occupational therapy
from March to June 2018, was carried out. The cognitive status was
assessed through CAM-ICU (Confusion Assessment Method) and
MEEM (Mini Mental State Examination), and functional status by
means of the muscular strength degree MRC (Medical Research
Council) and MIF (Functional Independence Measure), applied on ad-
mission and discharge from the ICU.
RESULTS. During the period, 50 patients were followed up, of
which 32 were female, with a mean age of 68.4 years and an
ICU stay of 5.05 days. The activation of the occupational therapy
team occurred in the first 2 days of hospitalization in 80% of the
cases. Among the patients evaluated, there was an improvement
in cognitive ability in 94.1% of ICU discharge, in relation to ad-
mission. The motor capacity showed improvement of 80.4% dur-
ing the evaluation period.
Fig. 1 (abstract 000976). A table showing the number of patients
Page 386 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55CONCLUSION. Early occupational therapy may favor occupational
performance and promote quality of life, exploring the interests,
needs, and functional and cognitive abilities of individuals, minimiz-
ing the impact of long-term stay in the hospital environment.of survived to hospital discharge for shockable and non-shockable
rhythms
Fig. 2 (abstract 000976). The percentage of patients who survived
to hospital discharge for a range of downtimes.
Fig. 3 (abstract 000976). The percentage of patients surviving to
hospital discharge per CT head report findingsTEM - New clinical aspects in cardiac
arrest management
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INTRODUCTION. Out-of-hospital cardiac arrest (OHCA) remains a sig-
nificant cause of mortality[1]. In response to the wide-ranging spe-
cialist input required to optimise the care of these patients dedicated
centres have been set up with evidence they may improve sur-
vival[2]. However, survival rates remain low with considerable on-
going morbidity with respect to neurological recovery.
OBJECTIVES. 1. To examine the demographics of arrests presenting
to a ‘Heart Attack Centre’.
2. To corroborate work investigating prognostic factors for survival to
hospital discharge.
3. To examine our neuroprognostication practices.
METHODS. All patients following OHCA between October 2018 and
March 2018 were included as part of an ongoing prospective regis-
try. Patients were excluded if arrest was secondary to trauma or was
iatrogenic. Patient and arrest demographics were collected alongside
clinical and investigation findings including age, downtime, initial
rhythm, pupil reactivity, corneal reflex, M score and CT and EEG
reports.
RESULTS. 39 patients were identified. Two patients were excluded as
they had traumatic or iatrogenic arrests. 18 of the 37 remaining pa-
tients survived to hospital discharge. The table and graphs
below demonstrate increased survival to hospital discharge with
shockable rhythms and shorter downtimes.
CT heads were performed 27 of 37 cases, with EEGs performed in
only 5 of 37 cases. The right sided graph in the figure demonstrates
the limited role for CT in prognosis. Furthermore, clinical examination
findings which are crucial for neuroprognostication including M score
and pupilliary response were only documented 39%-77% of
occasions.
CONCLUSION. Our findings corroborate previous work that shock-
able rhythms and short downtimes are good prognostic factors. The
higher than previously reported survival rate may lend further sup-
port to the role of specialist centres. Despite this, a combination of
inadequate documentation and a reliance on limited array of tools
for neuroprognostication such CT head alone clearly does not pro-
vide reliable accuracy for neuroprognostication. We are therefore
implementing a new standardised approach, which incorporates a
wider use of multi-modal tools such as quantitative pupillometry and
investigations such as neuron specific enolase.
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INTRODUCTION. Cardiac arrest mortality varies from less than 7%
to up to 26% according to a number of variables, including time
from event to resuscitation and underline cause (1). Post cardiac
F1
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outcome.
OBJECTIVES. To evaluate the importance of clinical and biochemical
data at the time of admission in ICU and their variations over time in
patients admitted for out of hospital cardiac arrest (OHCA).
METHODS. Single centre prospective observational study of patients
admitted for OHCA. Enrollment period was from January 2018 to
January 2019. Primary endpoint was to assess the organ dysfunction
in patient with OHCA considering serum lactate (SL), troponin I and
neuron-specific enolase (NSE) analysed at the admission in our inten-
sive care unit (t0), after 24 h (t1), 48 h (t2) and 72 h (t3). T test statis-
tic and ANOVA for repeated measurement were performed.
RESULTS. Preliminary results of 33 patients were enrolled, the aver-
age age was 62 y.o. (± 19.3), male patients where 25 (75.75%). The
presentation rhythm was ventricular fibrillation in 19 patients
(57.5%), pulseless electrical activity in 7 (21.2%) and asystolia in 4
(12.1%), in 3 patients (9.1%) the initial rhythm was unknown.
Ischemic underlying cause was suspected in 22 patients (66.6%) who
underwent coronary angiography. A culprit lesion was found and
treated in 13 patients (39,4%)(11 mono and 2 multivessel disease).
The putative other causes of CA were: primary ventricular tachyar-
rhythmias (24.2%), hypoxia (18.2%), chronic heart failure decompen-
sation (6.06 %), intoxication and haemorrhagic shock (12.1%). Six
patients have been supported with Veno-Arterial ECMO of whom
two were successfully weaned.
15 patients died in the ICU, with a mortality rate of 45.45% among
all patients admitted for OHCA. 9 patients died within the first 72
hours for the severity of the anoxic brain damage.
Patients survived had lower SL values at t0 (3.88 ± 1.8 mmol/L) that
significantly decreased over time (p 0.002), compared to non-survivor
(p 0.65) who had higher values (8.85 ± 5.39 mmol/L) without signifi-
cant variations (p>0.05). NSE values between survivor (26.9 ±
8.7mcg/L) and non-survivor (128.3 ± 57.7 mcg/L) varies significantly
at t0 (p0.001). NSE increased significantly in non-survivors over time
(p 0.01) whereas it did not change in those who survived (p 0.5). TNI
values and mean temperature obtained during the first 24 hours
mild hypothermia (35.2 ° ± 0.4 vs 35° ± 0.41) did not vary signifi-
cantly amongst groups (p < 0.05).
CONCLUSION. Mortality rate in patients experiencing OHCA re-
mains high. SL and NSE values at the admission and SL variation
over the observation time showed the best discriminator power
between survivor and non-survivor compared with the other
studied variables.
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INTRODUCTION. Medical Emergency Teams (MET) are constituted by
healthcare providers, trained in Advanced Cardiovascular Life Sup-
port (ACLS) and Resuscitation. In our institution, these teams are
composed by one ICU nurse and a physician with experience in in-
tensive care and/or medical emergency.
The activation criteria includes cardiac arrest or patients deteriorating
condition, to any person within the hospital area, either inpatients or
others (visitors, staff.). These teams were implemented to respond to
critical situations avoiding cardiorespiratory arrest (CRA) or to im-
prove outcomes after CRA.
OBJECTIVES. We present a retrospective analysis conducted at Hos-
pital São Bernardo – Centro Hospitalar de Setúbal, Portugal, of the
MET’s intervention in ACLS from 2013 to 2018. Immediate mortality
and intra-hospital mortality post-ACLS were evaluated.
The aim of this work was to compare our results with actual best
practice and with our previous analysis to identify our pitffals in ord-
ing to improve.
METHODS. Data was obtained from the ICU department database,
created in 2011 with the purpose of periodic audits. All activations
due to or that evolved to cardiac arrest during the team approach,
from January 2013 to December 2018, were included.
RESULTS. During the study period, there were a total of 262 cardiac
arrests, 11,7% of all activations, with an average of 43,7 cases per
year.
Time response was around 2 minutes and 36 seconds. The majority
of activations were to Level 0 and level 2 wards, summing up to
85,5% of all cases. The most frequent first documented cardiac arrest
rhythm was asystole in 53%, followed by pulseless electric activity
(PEA) in 31% and pulseless ventricular tachycardia or fibrillation in
16%. An average of 7 cycles of ACLS were performed with a success
rate over 40% (between 31 and 50%, through the years). Survival to
hospital discharge of all CRA was 16,5% with a survival rate after re-
turn of spontaneous circulation (ROSC) of 37,4%
CONCLUSION. Our results are in accordance to the best practice in
rate of discharge post CRA (between 16-18%) (1,2). Nonetheless the
incidence of asystole is still higher than expected (30-40%), which
may reflect delayed recognition (3). Despite this, our study, revealed
a tendency of improvement along the years.
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INTRODUCTION. Extracorporal life Support (ECLS) is a rescue strategy
with increasing popularity and experienced a sharp increase in per-
formance over the years. Nevertheless, survival in this clinical sce-
nario is still pretty low.
Fig. 1 (abstract 001693). See text for description
Page 388 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55OBJECTIVES. In a retsrospective analysis we tried to evaluate the
population who might benefit most from ECLS. We speculate that
ECLS in CPR may be able to increase hospital survial.
METHODS. Retrospective analysis of an institutional data set from
2006-2016
RESULTS. 207 patients in cardiogenic shock were scheduled for
venous-arterial-ECMO as a ECLS system. Mean age was 63,6 years,
13,3 SD. Overall mortality was 67,6% (140/207). 94 received ECLS dur-
ing reanimation. Mortality in this group was 69,1%. 113 patients in
severe cariogenic shock were provided with an ECLS system and in
this group 33,6% survived.
CONCLUSION. Mortality in patients with ECLS is still high and in a re-
cently published systemic review 1-year survival was 36,7% (1). These
results are in line with our data. Amazing is the fact that survival after
cardio-pulmonary resuscitation (CPR) was similar as in non-CPR. In
this regard ECLS seems to be beneficial since hospital mortality after
in hospital CPR has been reported as high as 85% (2). Mortality after
ECLS treatment is still high and the subgroup of patients which will
benefit from this invasive procedure mostly are patients during CPR.
However, these results have to be confirmed by examining a greater
cohort.
REFERENCE(S)
1. Ormseth CH et al. (2019) Resuscitation 139:9-16
2. Wilson-Smith et al. (2019) Ann Cardiothorac Surg 8(1):1-8
001693
A case of intracoronary and endovenous levosimendan as a rescue
therapy for refractory cardiac arrest
B. Ferro1, R. Tofani1, L. Gargani2, G. Borelli3, P. Roncucci1
1Anestesia e rianimazione, Spedali Riuniti Livorno ATNO ESTAR, Livorno,
Italy; 2Cardiology, CNR PISA, Pisa, Italy; 3Cardiology, Spedali RIuniti
Livorno ATNO ESTAR, Livorno, Italy
Correspondence: B. Ferro
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001693
INTRODUCTION. Reducing time of cardiac arrest is the goal to obtain
better prognosis in every setting from the street to the cardiac
catheterization laboratory.
Epinephrine is the standard medication for acls but its effect on
both recovery of spontaneous circulation and amelioration of neuro-
logical prognosis remains controversial (1). As a consequence there’s
need to develop pharmacological strategies to reduce time to ROSC
and to cerebral reperfusion especially when ECLS is not available.
METHODS. We report a case of a 60 years old male patient with re-
fractory cardiac arrest secondary to myocardial infarction unrespon-
sive to common therapies in whom intracoronary injection followed
by endovenous infusion of calcium sensitizer levosimendan was
able to gain and mantain ROSC
RESULTS. The patient was admitted to cardiac catheterization labora-
tory with diagnosis of cardiogenic shock secondary to acute anterior
myocardial infarction. Patient was intubated, an aortic counterpulsa-
tion balloon was placed and PTCA of IVA was performed. During pro-
cedure numerous episodes of shockable rhythms (ventricular
fibrillation and ventricular tachycardia) were treated following ACLS
guidelines. After coronary reperfusion an episode of ventricular
tachycardia followed by pulseless electric activity of more ten mi-
nutes was unresponsive to therapy. A bolus of 10 mcg/kg of levosi-
mendan was injected in the left coronary artery followed by a
continuous endovenous infusion (0,2 mcg/kg/min). After 30 seconds
ROSC was obtained,, foretold by increasing etCO2 from 10 to 25
mmhg during chest compressions (figure) . Hemodynamic was man-
tained with low dosage of norepinephrine and continuous infusion
of levosimendan. In intensive care unit first Bispectral index was 38.
Patients was treated with targeted temperature management and
then gradually weaned from vasoactives, aortic counterpulsation and
ventilation, recovering good neurological condition and discharged
with cpc score of 2.
CONCLUSION. To our knowledge, this is the first report of successful
reversal of refractory cardiac arrest with intracoronary followedendovenous infusion of levosimendan. Only preclinical studies have
analyzed the potentiality of levosimendan in cardiac arrest. Nan et al
showed that a combination of levosimendan and epinephrine was
superior to epinephrine alone to reverse bupivacaine-induced cardiac
arrest in a rat model. (2)
There is evidence that intracoronary injection of levosimendan in
cardiac surgery guarantees optimal drug spread, increasing contractil-
ity, global cardiac function, coronary perfusion pressure and reducing
arrhytmic ischemic events (3). In this case intracoronary administra-
tion was possible because arrhytmic events followed coronary reper-
fusion during catheterization procedure. Intracoronary administration
of drug is important to hypothesize the direct effect of levosimendan
on arrhytmic unresponsive events and ROSC.
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INTRODUCTION. Introduction. SVCS results from compression of the
superior vena cava. Lymphoma - one of the most frequent causes of
the malignant SVCS.
The aim of the study was to identify the incidence of SVCS in lymph-
oma pts and features of the central venous access in lymphoma pts
with SVCS.
Page 389 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55METHODS. Materials and methods. 686 lymphoma pts (311 male,
375 female) were included in the prospective study. The pts suffered
from Hodgkin's lymphoma (HL) (69 pts) and non-Hodgkin's lymph-
oma (NHL) (617 pts). In all pts SVCS was diagnosed clinically and was
confirmed by CT scan or MRI. In pts with confirmed SVCS the central
venous access was provided by non-tunneled central venous cathe-
ters (non-tCVCs) (Certofix DUO 7Fr, BBraun) and totally implantable
central venous port system (PowerPort, Bard Access System). The in-
dwelling time, the number of the replaced CVCs and the incidence
of complications were analyzed. Statistic: SPSS ver.23 (IBM, Chicago,
II., USA). Pearson's chi-squared test and Fisher's exact test were used.
RESULTS. . SVCS was revealed in 70 (10.2%) of 686 lymphoma pts (9
pts with HL and 61 pts with NHL). Among lymphoma pts the fre-
quency of SVCS was highest in pts with primary mediastinal large B-
cell lymphoma (PMBCL). SVCS was revealed in 49 (51.6%) of 95
PMBCL pts. In SVCS pts venous access was provided by non-tCVC
inserted in femoral vein (50 pts) and TIVAPS (20 pts) implanted into
v. cava inferior through the femoral vein. TIVAPS reservoirs were im-
planted on the thigh. During lymphoma treatment most pts with
non-tCVCs needed repeated catheterizations: median 3 (1-14) CVCs.
Among pts with TIVAPS only in 3 pts TIVAPS needed repeated cathe-
terizations; their TIVAPS were removed due to complications. The
median indwelling times were 6 (1-129) catheter days for CVCs and
164 (1-280) catheter days for TIVAPS (p<0.05). Incidences of CVC re-
lated bloodstream infections (CRBSI) were 2.1/1000 catheter days for
CVCs and 0.1/1000 catheter days for TIVAPS. Incidence of CVC associ-
ated thrombosis (CAT) were 4.1/1000 catheter days for CVCs and 0.5/
1000 catheter days for TIVAPS. One patient had infection of the sub-
cutaneous pocket (0.3/1000 catheter days). The reasons for non-
tCVCs removal were the treatment completion (82.8%) and complica-
tions: CRBSI (7.1%), CAT (8.5%), malfunction (1.6%). The reasons for
the TIVAPS removal were the treatment completion (85%), CRBSI
(5%), infection of the subcutaneous pocket (5%) and CAT (5%).
CONCLUSION. SVCS was revealed in 10.2% lymphoma pts. Half of
the PMBCL pts had SVCS. In PMBCL pts central venous access CT
should be perform after assessment of vena cava superior patency
by CT or MRI. In SVCS lymphoma pts implantation of TIVAPS into v.
cava inferior is access of choice.
Key words:lymphoma, superior vena cava syndrome, central venous
catheter, vena cava inferior, totally implantable central venous port
system.
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INTRODUCTION. Cancer immunotherapy is a modality of treatment
that can favor survival; some oncological patients undergoing im-
munotherapy require critical care during the period of their disease.
Immunotherapy itself and cancer can carry complications that need
different organic supports that some oncologic patients in advanced
stages are not typically considered for. Due to multiple factors that
can affect the mortality of these patients, we made an analysis of
mortality and its associations with organic support in patients that
received immunotherapy before or during their stay in the intensive
care unit (ICU).
OBJECTIVES. Describe the causes of admission to the ICU, causes of
mortality, associated factors and the impact of different organic sup-
ports on mortality.
METHODS. Analysis of a historic cohort of patients with cancer diag-
nosis in III and IV clinical stages undergoing immunotherapy previous
or during their stay in two critical care units.RESULTS. 32 patients with a total of 38 admissions to the ICU, female
28.1%, male 71.9%, average age: 63.2%, pembrolizumab 50%, nivolu-
mab 34.4%, ipilimumab 15.6%. 32% patients needed vasopressors,
9.3% inotropes, 25% renal replacement therapy, 56.2% noninvasive
ventilation and 43.7% invasive ventilation. Main cause of admission
was initiation of ventilatory support (39.6%); only 21.1% of all admis-
sions were associated with a progression of the oncological disease.
All around mortality was 34.3%, only 15% of the 32 patients were
considered to have side effects of immunotherapy. Mortality was
mainly associated to the need of ventilatory support yet it was not
meaningful in our analysis (p=0.06), the use of renal replacement
therapy, vasopressors, inotropes was not directly associated with a
higher incidence of mortality. The modality of immunotherapy was
not itself associated with more complications or a higher incidence
of mortality.
CONCLUSION. Patients under cancer immunotherapy are a new
group of patients in the intensive care unit. We presented a historic
cohort in terminal stage that needed critical care and analyzed mor-
tality and possible associated factors. None of the modalities of or-
ganic support and types of immunotherapy were significant factors
for mortality.
Although our cohort is small and our study is retrospective, our re-
sults suggests that these patients can undergo with critical care with-
out conferring a major mortality factor. More studies are needed to
determine if critical care alters the quality of life on these patients.
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INTRODUCTION. Cancer immunotherapy has emerged as a promis-
ing treatment for many tumors. The expanding application of this
new treatments to cancer will have profound consequences for the
use of intensive care.
OBJECTIVES. Our aim is to describe the treatment and clinical evolu-
tion of oncohematological patients that required ICU admission after
cancer immunotherapy.
METHODS. Retrospective study, including adult (+18 years) patients
with cancer either hematologic or solid organ cancer, who received
Page 390 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55immunotherapy and required admission to the ICU between 2017
and 2018. Qualitative variables are expressed as N(%).
RESULTS. Ten patients were admitted in this two years period. Four
(40%) were men and the median age was 64 years. Seven (70%) had
solid tumors and 3 (30%) had hematological malignancies. All of
them were at an advanced stage of their cancer disease, and had re-
ceived at least 3 lines of treatment previously.
The main indication for ICU admission was severe cytokine release
syndrome (CRS) in 5 cases (50%): all of them were grade 3, and one
with severe neurologic impairment (Glasgow Coma Score 10/15). Re-
garding the trigger of CRS, in two cases were hematologic patients
after CAR-T cell therapy and the other three cases were after bispeci-
fic antibodies therapy (BiTe). All patients receive anti-IL6 treatment
with Tocilizumab, and two receive corticosteroids also. The CRS was
controlled in all five patients and all were discharge from ICU and
hospital.
Four (40%) patients were admitted because immune-related events
after checkpoint inhibitors: 1 myasthenia-like syndrome, 1 myocardi-
tis, 1 severe pneumonitis and 1 hepatitis. Two required invasive
mechanical ventilation support, one high nasal flow oxygen and the
other one non-invasive mechanical ventilation. The median SOFA
score at admission was 7 points. Management included corticoste-
roids in all of them, combined with other immunosuppressive ther-
apies (tacrolimus, mycophenolate mofetil) in two of them, combined
symptomatic and support treatment. The outcome was poor, three
can be discharge from the ICU but only one survive and was dis-
charge from the hospital.
The last patient was a preventive ICU admission to receive Tumor-
Infiltrating lymphocytes (TIL) and IL-2 therapy. The patient present
capillary leak syndrome with impairment of renal function, pulmon-
ary and neurologic dysfunction (nightmares, hallucinations, somno-
lence...). The impairments resolved without specific treatment and
can complete the treatment and discharge from ICU and hospital.
CONCLUSION. Adverse events associated to cancer immunotherapy
treatments can be severe and require ICU admission. The treatment
of these complications is mainly supportive but in some cases spe-
cific treatment is needed. A multidisciplinary approach with early ICU
admission is recommended.
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INTRODUCTION. Candidemia has increased in the last decades in pa-
tients admitted to intensive care units (ICU). Candida bloodstream in-
fection is life-threatening, recognition and treatment is frequently
delayed, with clinical deterioration and death often preceding the
detection of Candida in blood cultures.
Thus, it is crucial to maintain a high level of suspicion. Is important
to know the epidemiology of candida infection, risk factors and tools
that allow the selection of patients benefiting from empirical / pre-
emptive therapy.
OBJECTIVES. Establish the incidence of candidemia; the prevalence
and sensitivity pattern of different species; Identify possible risk fac-
tors; Evaluate the predictive value of tools such as candida score.
METHODS. Retrospective evaluation of the candidemia cases from
January 2011 to December 2018, through the consultation of clinical
files from the patients hospitalized in our ICU with candida in blood
cultures.
Patients with ICU length of stay <24h and haematological malignan-
cies patients were excluded.
Evaluation of risk factors. Candida score calculation. Characterization
of the isolated candida species, sensitivity pattern, antifungals used,
duration of therapy and outcome.RESULTS. We enrolled 55 non-neutropenic patients with candidemia
(54,5% males, average age 63,4±17 years, SAPS II 52,2±16,5). Candida
albicans was the most prevalent species - 36 cases (65,5%) - followed
by C. parapsilosis in 11 patients (20%). All Candida albicans isolates
were susceptible to azoles. Fluconazole resistance rate among the
non-albicans candida spp. was 7,3%. An echinocandin was used as
empirical antifungal therapy in 61,8% of the cases and fluconazole in
30,9%. ICU mortality was 38,2% and cumulative mortality 30 days
after ICU discharge was 47,3%. Candida score was 3,61±1,0. There
was no difference in ICU mortality between patients with Candida
score >3 or < 3 (p= 0,46). Despite the slight trend to higher mortality
rate in patients with C. non-albicans vs albicans, we found no statis-
tical relevance (p 0,09).
CONCLUSION. Candidemia in our ICU was mainly caused by albican
species. Although echinocandins were the antifungal of choice, re-
sistance rate to azoles was low. Our patients had a high candida
score and a high overall mortality rate.
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INTRODUCTION. Infections due to Cryptococcus species occur glo-
bally and can affect both immunocompromised (IC) and non-IC
hosts. To date, many cases of cryptococcal infection have been re-
ported, but concomitant influenza and cryptococcal infections are
rare.
OBJECTIVES. To improve diagnosis and management of critically ill
patients with influenza and cryptococcal infections.
METHODS. An unusual case of an avian influenza A (H7N9) infection
with systemic super-infection with Cryptococcus neoformans present-
ing as ventilator-associated pneumonia (VAP) and bloodstream infec-
tion in a previously immunocompetent man during hospitalization
was reported and the literatures were reviewed.
RESULTS. A review of the medical literature revealed only 3 reported
cases regarding concomitant hospital-acquired cryptococcal infection
and severe influenza. Adding our case to the review, a total of four
cases are summarized and analyzed. All cases occurred in patients
with severe influenza virus infection (2 cases with H1N1 and 2 cases
with H7N9) from 7 to 25 days after admission. During the four pa-
tients’ courses, there were 3 cases with cryptococcal pneumonia, 2
cases with cryptococcal fungemia, 1 case with cryptococcal pleurisy
and 2 cases with cryptococcal meningitis, and 3 of them presented
with disseminated cryptococcal infection. In the 3 cases with crypto-
coccal pneumonia, 1 case was diagnosed as hospital-acquired pneu-
monia (HAP), and 2 cases were VAP according to the diagnostic
criteria of HAP and VAP. After the anti-fungual treatment, only one
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cases including our patient all died.
CONCLUSION. Cryptococcal infection can occur in patients with se-
vere influenza during hospitalization with a more severe condition,
and the clinician should be aware of this infection.
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INTRODUCTION. Immunocompetent critically ill patients may be at
risk for Citomegalovirus (CMV) reactivation as a result of immunosup-
pression associated with critical illness. Some studies have related
this reactivation with poor outcomes.
OBJECTIVES. To describe the clinical profile of immunocompetent
patients admitted to a tertiary ICU and tested for detection of CMV
viremia, and address the prognostic implications of CMV viremia.
METHODS. Retrospective study, including adult (+18 years) immuno-
competent patients who were tested for the presence of CMV
viremia between 2014 and 2017. The CMV viral load was determined
using the real time polymerase chain reaction RealStar® CMV PCR Kit
1.2. (Altona®). X-Square, Fisher´s test, T test, U Mann-Whitney and lo-
gistic regression were employed as required. Quantitative variables
are reported as median (IQR) and categorical as frequency (%).
RESULTS. Eighty-one immunocompetent patients were tested for the
presence of CMV viremia, with an age of 62 (43-68) years. Sixty (74%)
were men. Sixteen (22%) had cirrhosis, 15 (21%) COPD, 6 (8%)
chronic renal failure and 4 (5%) chronic heart failure. Thirty-five
(43%) had septic shock and 22 (31%) were surgical patients. Twenty-eight (39%) were treated with high flow nasal cannula (HFNC), 64
(88%) required mechanical ventilation (MV), 52 (72%) vasoactive
drugs (VAD) and 22 (31%) renal replacement therapy (RRT). Forty-
nine (68%) were discharged from the ICU and 43 (60%) were dis-
charged home. Nineteen (26%) were positive for CMV viremia and 13
(16%) were treated with ganciclovir. Hemoglobin levels, leukocyte
count, platelet count, lymphocyte count, aspartate aminotransferase
and alanine aminotransferase levels were similar in both groups
(Table 1). Patients on VAD (OR: 8.7, IC95%: 1.1-71.1, p=0.043) or RRT
(OR: 3.6, IC95%: 1.1-71.1, p=0.043) had a higher risk for CMV viremia,
while use of MV (OR: 1.1, IC95%: 0.2-5.9, p=0.925) or HFNC (OR: 0.5,
IC95%: 0.2-1.6, p=0.246) was not related. CMV viremia was not associ-
ated to ICU (OR: 1.4, IC95%: 0.45-5, p=0.594) or hospital mortality
(OR: 1.4, IC95%: 0.5-5, p=0.464), length of mechanical ventilation (OR:
0.9 IC95%: 1-1, p=0.942), length of ICU (OR: 1.0, IC95%: 1-1, p=0.875)
or hospital admission (OR: 1, IC95%: 1-1, p=0.837).
CONCLUSION. Patients without classical factors for immunosuppre-
sion can suffer CMV viremia, with those on VAD or RRT suffering a
higher risk. Despite the well known laboratory abnormalities related
to CMV infection, these abnormalities have a great prevalence in ICU
patients, so are not useful for suspecting CMV infection. In our co-
hort, CMV viremia was not related to mortality, length of mechanical
ventilation or length of admission.001207
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INTRODUCTION. Invasive pulmonary aspergilosis (IPA) is usually seen
in immunocompromised patients, however over the past years num-
bers patients with flu and IPA as superinfection is increasing, while
data on candida superinfection is scarce. While IPA independently in-
creases mortality in patients with flu effect of candida superinfection
on mortality remains unclear.
OBJECTIVES. We measured IPA and candida (C.) respiratory tract
superinfection incidence in 2018/19 flu season in patients with influ-
enza treated in ICU. Factors and patients characteristics that are
linked to fungal superinfection were determined.
METHODS. Charts from consecutive patients diagnosed with flu hos-
pitalized in tertiary medical ICU in academic hospital were analyzed.
Flu was confirmed using molecular diagnostic test (PCR). Fungal
superinfection was confirmed by immunoassays (galactomannan
assay for IPA and beta-D-glucan for Candida), and by fungal growth
on media plates from speciments. In 3 patients Aspergilus (A) growth
was confirmed during bronshocsopy (Figure 1).
RESULTS. During the 2018/19 influenza season, 40 patients with flu
were admitted (23 male, 17 female). In 11 fungal superinfection was
confirmed (A. fumigatus in 3, C. albicans in 8 pts). In one patient
Aspergilus and Mucor coinfection was demonstrated and in 3 pa-
tients more than 1 Candida species was isolated from various sites.
None of microorganisms demonstrated significant in vitro resistance.
3 patients with IPA (100%) and 3 (38%) with Candida superinfection
died. Selected data are presented in Figure 2. (Figure 2).
CONCLUSION. Fungal superfection was demonstrated in 27% of our
patient with A. fumigatus and C. albicans being predominant species.
F1
F1
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mortality in influenza patients. Metlprednisolone use is associated
with increased fungal infection rate. Inhalation corticosteroids use
was not associated with increased fungal superinfection. Further in-
vestigation is needed for better understanding fungal superinfection
in influenza patients.
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INTRODUCTION. Generally, clinical manifestations of pulmonary tu-
berculosis (PTB) are mild and some were asymptomatic. However, a
series of cases of severe PTB characterized by acute respiratory fail-
ure and diffuse lung disease have been found in recent years in our
hospital. Notably, such patients tend to have a short course of dis-
ease and a rapid disease progression with respiratory distress and se-
vere hypoxia, which are similar to severe pneumonia and interstitial
pneumonia and it is prone to misdiagnosis.
OBJECTIVES. To investigate the clinical features of diffuse type of se-
vere PTB and improve diagnosis and management of the disease.
METHODS. A total of 17 cases of severe PTB, which were characterized
by acute respiratory failure and diffuse lung disease and confirmed by
etiological and (or) pathological examinations , were studied.
RESULTS. 11 of 17 cases (64.7%) were males and the patients were aged
from 20 to 70 years with a median age of 36 years. Patients with and with-
out immunocompromised underlying disease were 9 cases (52.9%) and 8
cases (47.1%), respectively. The most common symptoms were hyperpy-
rexia, shortness of breath, cough and sputum coughing. TypeIrespiratory
failure with a median oxygenation index of 138mmHg occurred in all the
cases. The chest CT manifestations were characterized by diffuse
small nodular or miliary nodules, ground-glass opacities (GGOs), consolida-
tions and fibrotic reticular opacities. Among the 17 patients with PTB, the
test of the lower respiratory secretions (sputum, alveolar lavage or broncho-
scopic brushing smear) showed as followed: 8 cases (47.1%) were positive
for acid fast bacillus (AFB) - smear, 11 cases (64.7%) were positive for myco-
bacterium tuberculosis (MTB) by bacterium culture, 14 cases (82.3%) were
positive for MTB DNA by polymerase chain reaction (PCR). Additionally, the
strains identification of MTB and the detection of rifampin (RFP) and isonia-
zid (INH) resistance in MTB were tested by gene chip technology in 6 cases,
of which 5 cases (83.3%) were positive and confirmed as MTB complex
without RFP and INH resistance. The transbronchial lung biopsy was per-
formed in 8 cases and bone marrow biopsy in 2 cases and all the patho-
logical examination revealed tuberculosis. There were 9 cases (52.9%) with
coexisting extrapulmonary tuberculosis and 11 cases (64.7%) with one or
more complications including secondary pulmonary infection (7 cases),
acute respiratory distress syndrome (6 cases), acute left heart dysfunction (4
cases), hemophagocytic syndrome (3 cases), pneumothorax (3 cases), septic
shock (2 cases), etc. 16 of 17 cases (94.1%) were cured with antituberculosis
drugs and other therapy except one death after abandoning treatment.
CONCLUSION. Diffuse PTB was characterized by acute respiratory
failure and could lead to various complications. The chest imaging
showed bilateral diffuse infiltration distributing and the disease was
easy to be misdiagnosed as interstitial pneumonia and severe pneu-
monia. In combination with bacteriology, pathology, PCR, gene chip
technology and tracheoscopy can significantly improve the diagnosis
ability of severe tuberculosis. Majority of patients can be obtained
satisfactory results after timely diagnosis and early antituberculous
treatment.
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INTRODUCTION. Leptospirosis is a common zoonotic infection in
Thailand which widely presents as a mild to severe disease. The clin-
ical characteristics of leptospirosis in our hospital were reviewed and
the predictive factors of ICU admission were determined.
METHODS. A retrospective review of the medical charts was con-
ducted in patients diagnosed as leptospirosis and hospitalized in our
university hospital from 2007 to 2017. Patients with a positive test
for serum immunofluorescence assay for leptospirosis were defined
as definite cases and patients who had a Thai LeptoScore1 ≥4 were
defined as possible cases. Patients were divided into ICU admission
and non-ICU admission groups. All demographic data, clinical charac-
teristics, and laboratory results were compared between the groups.
Logistic regression was introduced to determine the predictive fac-
tors of ICU admission.
RESULTS. Sixty-eight patients were included. Forty-six (67.6%) pa-
tients were definite cases. Thirty-two cases (47.06%) were admitted
to ICU and of these 20 (62.5%) had sepsis and septic shock. ICU pa-
tients had a shorter onset of symptoms (4.09 ± 1.67 vs. 6.44 ± 4.74
days, p = 0.008), higher Thai LeptoScore (7.64 ± 2.70 vs. 5.65 ± 2.37,
p = 0.002), lower hematocrit (32.69 ± 7.50 vs. 36.59 ± 7.90 %, p =
0.04) and platelet count (88.69 ± 92.19 vs. 173.26 ± 150.13 x103/
mm3, p = 0.01) and higher serum creatinine (4.24 ± 2.94 vs. 2.80 ±
2.09 mg/dL, p = 0.02) and total bilirubin levels (6.20 ± 6.33 vs. 2.98 ±
3.60 mg%, p = 0.01). ICU patients also had diffuse infiltration on
chest x-rays (65.62% vs. 25%, p < 0.001), higher mechanicalventilation requirement (84.38% vs. 5.0%, p < 0.001), higher
hemodialysis requirement (37.5% vs. 0%, p < 0.001), and higher ino-
tropic support (90.63% vs. 11.1%, p < 0.001). The predictive factors
for ICU admission were Thai LeptoScore (OR 1.36; 95% CI 1.10, 1.70,
p < 0.001), requirement for mechanical ventilation (OR 63.24; 95% CI
5.79, 691.39, p < 0.001) and inotropes (OR 53.47; 95% CI 5.45, 524.47,
p = 0.006). A Thai LeptoScore ≥7.5 could predict ICU admission
(AUROC 0.72; 95% CI 0.59, 0.84, p < 0.001).
CONCLUSION. Predictive factors of ICU admission in leptospirosis
were a high Thai LeptoScore and the need for mechanical ventilation
and inotropes. A Thai LeptoScore ≥7.5 can predict ICU admission in
patients with leptospirosis.
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INTRODUCTION. ICU acquired hypernatremia (IAH) occurs frequently
and is associated with increased morbidity and mortality (1). How-
ever the treatment of IAH remains controversial (2) and the relation-
ship between sodium and body fluid volume appears to be complex
(3,4).
OBJECTIVES. To determine the effect of enteral free water treatment
on plasma sodium level in patients with IAH.
METHODS. A retrospective single centre study from 2008-2019 was
conducted in adult patients with IAH treated with enteral free water.
Patients with renal replacement therapy, diabetic ketoacidosis or
hyperosmolar hyperglycemic state were excluded. Primary outcome
was the change in plasma sodium (in mmol/L) after 5 days treatment
(delta sodium). Responders were defined as a decrease in sodium
level of ≥5 mmol/l. The volume of enteral free water and total so-
dium administration were also recorded. Descriptive statistics, Fischer
exact and Mann-Whitney U test were used.
RESULTS. 409 consecutive patients (Table 1) were included. The me-
dian volume of enteral water was 4183 ml (IQR 3296 - 5310) after 5
days and mean sodium decrease was 1.4 mmol (SD 5.0). (Fig. 1).
There was no significant correlation between the volume of enteral
water and delta sodium r2=0.01 (Fig. 2). Responders (97) vs non-
responders (312) did not differ significantly with the administration
of furosemide or hydrochlorothiazide concerning sodium change. Re-
sponders had a significantly lower sodium intake compared to non-
responders (842 mmol vs 894 mmol, p= 0.039).
CONCLUSION. The volume of enteral water was unrelated with so-
dium change over 5 days. The lower sodium intake in responders
suggests that restricting salt intake is more effective then enteral free
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Table 1 (abstract 000241). Patient characteristics (median and IQR)
Age (years) 68 (61-76)
Male (N) 281 (64%)
SOFA score 6 (4-8)
APACHE II score 22 (18-27)000276
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INTRODUCTION. Fibrinogen plays an important role in hemostasis in
the early phase of trauma. Numerous studies have shown that low fi-
brinogen levels were associated with hemostatic impairment,
massive bleeding, and poor outcomes in severe trauma patients. Be-
cause fibrinogen levels deteriorate before other routine coagulation
parameters in the early phase of severe trauma, aggressive supple-
mentation of fibrinogen may improve hemostatic function.
METHODS. We conducted asingle-center retrospective cohort study
with propensity score-matched analysis.Patients with severe trauma
(injury severity score ≥ 16) who were admitted to the emergency de-
partment (ED) of Hokkaido University Hospital from January 2010 to
July 2018 were eligible for inclusion in this study. Exclusion criteria
were as follows: age < 18 years, cardiac arrest before arrival to the
ED, cervical spinal cord injury not caused by a high-energy accident,
and severe burn injury. The patients were divided into the FC and
control groups. The FC group included trauma patients who received
FC within 1 hour of arrival to the ED. The control group included pa-
tients who did not receive FC within 1 hour of arrival to the ED.
Trauma and injury severity score, heart rate at admission to the ED,
and age were included in the propensity score model. We compared
the two groups using propensity score-matching to reduce selection
bias and to balance characteristics and clinical variables that could
potentially affect outcomes. The primary outcome was in-hospital
survival rate.
RESULTS. The c-statistic of the propensity score model was 0.734.
The Hosmer-Lemeshow chi-squared value was 7.036 (degrees of free-
dom=8), with a non-significant p value of 0.533, indicating the good-
ness of model fit. Propensity score-matching created 31 1:1-matched
pairs. The characteristics of the two matched groups were appropri-
ately balanced. In-hospital survival rate was higher in the FC group
than in the control group (p=0.013 by log-rank test). The amounts of
red blood cell and fresh frozen plasmaadministered within 24 hours
after admission to the ED in the FC group were significantly higher
than those in the control group.
CONCLUSION. This propensity score-matched analysis indicates that
early administration of FCs improves in-hospital survival rates in se-
vere trauma patients.Fig. 1 (abstract 000276). See text for description
F1
F1
Fig. 2 (abstract 000276). See text for description
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INTRODUCTION. Intensive care unit (ICU) magnesium administration
for the prevention of atrial fibrillation (AF) after cardiac surgery re-
mains controversial. Previously we demonstrated that a strategy of
bolus magnesium delivery followed by a continuous infusion resulted
in a more sustained and stable serum magnesium level in compari-
son to a single bolus. However, the effectiveness of such approach
has not been demonstrated in clinical studies.
OBJECTIVES. We aimed to evaluate the effectiveness of a post-
operative ‘bolus + continuous magnesium’ strategy on the occur-
rence of AF (primary outcome) and other relevant clinical outcomes
(secondary outcomes).METHODS. We performed a before-and-after study in adult cardiac
surgery patients admitted to the ICU of a tertiary metropolitan hos-
pital. We enrolled patients with normal renal function and a serum
magnesium level lower than 1.5 mmol/L on ICU arrival. Intervention
group patients received a bolus of 10 mmol of magnesium-sulphate
over 1 hour followed by a continuous infusion of 1.5 to 3 mmol/h
until ICU discharge, aiming at a serum magnesium level of 1.5 to 2
mmol/L. Propensity score matching was performed to select control
group patients.
RESULTS. We enrolled 99 intervention group patients and 99 control
group patients. Both groups had similar baseline characteristics, ex-
cept for a lower cardiac index at ICU admission in the intervention
group. By 28-days after ICU admission, the occurrence of AF was
reached by 25 patients (25.3%) in the intervention group and by 40
patients (40.4%) in the control group (OR 0.49 [95% CI: 0.27 to 0.92),
P=0.023). The median ICU length of stay was longer in the interven-
tion group than in the before-group (44.8 h [IQR: 22.2 to 68.2] vs.
24.9 h [IQR: 22.0 to 43.7), P=0.0007). There were no significant differ-
ences between the two groups regarding other secondary outcomes.
A multivariable Cox regression model for ‘time to AF’ showed that
the intervention was associated with reduced incidence of AF (HR
0.45 [95% CI: 0.25 to 0.77], P=0.004), and that the variables age, dur-
ation of bypass and requirement of vasopressors > 6 h were associ-
ated with increased risk of AF.
CONCLUSION. An ICU strategy of bolus followed by continuous mag-
nesium administration after cardiac surgery was associated with a re-
duction in the occurrence of AF.
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INTRODUCTION. The Richmond Agitation-Sedation Scale (RASS) is
widely used for assessing sedation level of the ventilated patients in
intensive care unit (ICU), even though it has clinical limitations such
as subjective and also intermittent measurements. The Patient State
Index (PSI) has been a newly introduced processed EEG parameter
and enables an objective and continuous monitoring of sedation
levels by analyzing electroencephalograms. However, few studies
have examined the correlation between PSI and RASS and the useful-
ness of PSI in assessing sedation levels in ICU patients is unknown.
OBJECTIVES. To analyze the correlation between PSI and RASS in crit-
ically ill ICU patients and the usefulness of PSI in assessing the sed-
ation level.
METHODS. In the medical and surgical ICU at Tokyo Women's Med-
ical University Hospital (Tokyo, Japan), PSI values continuously moni-
tored with SedLine (Masimo, Irvine, CA, USA) and RASS were
recorded every 2 hours for 24 hours in adult critically ill patients who
required mechanical ventilation for 12 hours or more. Patients with a
history of neurosurgery, cerebral infarction, or cerebral hemorrhage
were excluded. Propofol, dexmedetomidine, midazolam, and fentanyl
were used as sedatives and analgesics. The doses of sedatives and
analgesics were adjusted to achieve the target RASS score set for
Page 396 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55each patient, and the bedside doctors and nurses were blinded to
the PSI values. The correlation between PSI and RASS was analyzed
by Spearman's rank correlation coefficient. P-value <0.05 was consid-
ered significant.
RESULTS. In total, 382 PSI and RASS sets were recorded from 50 pa-
tients. The patient’s age was 65.7 ± 10.3 years (mean ± standard de-
viation [SD]); the Acute Physiology and Chronic Health Evaluation
(APACHE) II score was 15.3 ± 6.0 (mean ± SD); and 92% patients were
postoperative. The Spearman's rank correlation coefficient between
PSI and RASS was 0.783, and a positive correlation was observed (p <
0.001). Moreover, a RASS score of -3 or less (-3, -4, or -5) was defined
as deep sedation and of -2 or more as light sedation. The PSI cutoff
value for deep sedation was 53 (Area Under the Curve (AUC): 0.917,
sensitivity: 0.824, specificity: 0.901).
CONCLUSION. In our prospective, single-blinded observational study,
PSI showed a positive correlation with RASS, which is the gold stand-
ard for assessing sedation levels, and PSI was highly sensitive and
specific in detecting deep sedation. PSI could be useful in assessing
sedation levels in critically ill ICU patients.
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INTRODUCTION. Cytoreductive surgery (CRS) with Hyperthermic In-
traperitoneal Chemotherapy (HIPEC) is a viable treatment option for
subjects with locally advanced abdominal cancer but has high risk
complications that make postoperative management challenging for
intensivists.
OBJECTIVES. To report our experience in the immediate postopera-
tive care of subjects who underwent CRS-HIPEC. Subjects were man-
aged following a protocol which included goal directed fluid therapy
and minimally invasive hemodynamic monitoring.
METHODS. Retrospective, single-center observational study of patients
who underwent CRS-HIPEC over a three year period (2015-2018).
RESULTS. A total of 55 patients were included. Mean (SD) age was 52.7
(±12.7) years and 69.1% were women. Mean (SD) Charlson comorbidity
index and APACHE II score were 7.4 (±1.2) and 13 (±5.91) respectively.
The most common indication was colon cancer (41,8%), followed by
appendiceal mucinous neoplasm (25,4%) and ovarian cancer (20%).
Mean (SD) PCI was 12.72 (±7.37). Complete cytoreduction (CC-0/1) was
achieved in all patients. Mitomycin C was used as the main chemother-
apy drug (49,09%) in digestive cancer, followed by oxaliplatin (25,4%)
and cisplatin (18,1%) in gynecological cancer. The most frequent compli-
cations were anemia (60%) and thrombocytopenia (40%). 34.5% subjects
presented acute kidney injury, but only 7 patients needed renal replace-
ment therapy. Other severe complications included ARDS (3.6%) , peritonitis
and intraabdominal bleeding (12.7%), subarachnoid hemorrhage (1.8%[n=
1]) and pulmonary thromboembolism(1.8%). Mechanical ventilation for
more than 24 hours was required by 29% of the subjects and only 3 were
tracheostomized. The median (IQR) LOS in the intensive care unit was 6 (5-9) days and the hospital stay of 13(9-22) days. Global ICU mortality was
5.45% [n=3].
CONCLUSION. Nevertheless the high rate of complications after CRS-
HIPEC surgery, global ICU mortality was low and complications with
protocolized fluid management were similar to other series
published.
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INTRODUCTION. Agitation occurs in up to 70% of critically ill patients
and is a significant source of distress for patients, families, and pro-
viders (Fraser GL, et al.2000). Sedatives are administered to 50% of
intensive care unit (ICU) patients to alleviate agitation (1). Choice of
sedative is complex and largely driven by patient context. No seda-
tive has consistently been shown to be superior to the rest, and al-
ternative agents are greatly needed (2).Most ICU patients, especially
those requiring mechanical ventilation, are treated with opioids, pro-
pofol, and/or benzodiazepines (1&3). Use of these agents is limited
by adverse effects (eg, hemodynamic derangement for safe adminis-
tration (4). New therapies for treating agitation are rarely introduced
into practice, with dexmedetomidine being the most recent in 1999.
Consequently, providers have increasingly repurposed older pharma-
cologic agents as ICU sedatives (eg, clonidine, Phenobarbital, and val-
proate (depakene) (5 & 6).
Recently, valproate has been administered to critically ill patients to
treat agitation and delirium, but there are few published reports to
support this practice (7-9). Valproate is an emerging treatment for
ICU agitation because it allows patients to interact with their care-
givers; can be administered outside of the ICU; has both an intraven-
ous (IV) and enteral formulation; has a low drug acquisition cost; and
has not been associated with respiratory depression, hemodynamic
derangements, or delirium. In this study we describe the use of
depakene & haloperidol for agitation in critically ill patients and
examine their safety.
METHODS. prospective study on 100 critically ill patients with agita-
tion in kasralainy hospital over period from may 2016 to June
2017.patients were divided in to two groups, each group included 50
patients, 1st group patients received depakene orally and 2nd group
patients received haloperidol by i.v infusion for 72h.Richmound agita-
tion sedation score and doses of additional sedative drugs were
noted and calculated daily in the first three days.
RESULTS. our study showed that valproate was equal in efficacy in
controlling agitation; decreasing the RAAS significantly after 48h
from initiation (2.52±0.61 Vs 0.28±0.54 with p<0.001) for depakene
and (2.6±0.67 Vs 0.34±0.48 with p<0.001) for haloperidol. There was
also decrease in the doses of additional sedative drugs used to con-
trol agitation (midazolam & propofol) after 48h from drug initiation.-
both drugs therapy was associated with decrease in heart rate (89±
20 vs. 86.6±13.6 with p=0.002 for valproate and 99.8±23.3 vs. 91±
16.7 with p<0.001 for haloperidol) .theyhad no effect on blood
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prolongation.
CONCLUSION. valproate was equal in efficacy as haloperidol infusion
in controlling agitation in ICU and decreasing the doses of additional
sedative drugs used after 48h from initiation.
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INTRODUCTION. Intracerebral hemorrhage (ICH), sometimes unex-
plained, is one of the most feared complication after brain tumor sur-
gery. Blood clot stabilization after surgery depends on factor XIII
levels. Acquired or congenital factor XIII deficiency could be associ-
ated with hemorrhage after neurosurgery.
OBJECTIVES. To analyse the association between perioperative levels
of factor XIII and ICH after neurosurgery.
METHODS. A prospective, longitudinal, 18-month study was con-
ducted at a single third-level hospital in Spain. The study included all
consecutive adults operated on brain tumor during 2013-2014 and
postoperatory stay in intensive care unit. Informed consent was re-
quired. To evaluate factor XIII three blood samples were taken (A-pre-
surgical or baseline, B-postsurgical and C-24 hours after surgery).
Normal range considered was 70-140%. ICH was defined as bleeding
that generates radiological signs of intracranial hypertension either
by volume or by mass effect on the routine CT scan 24 hours after
surgery. Mann-Whitney U Test and T-Test were used to inferential
analysis. Ethics Committee approval was obtained.RESULTS. The study included 109 patients. ICH was confirmed in 39
of them (35,78%). The average of factor XIII in sample A was 77,52%
in patients without ICH vs 71,2% in patients with ICH, in sample B
70,14% vs 51,57% and in sample C 69,68% vs 52,14%, respectively.
Inferential analysis determined significant association between factor
XIII-B and C deficiency with ICH (both p0,000) and absence of associ-
ation in patients without ICH.Their variation, compared to the base-
line sample, was also significative (factor XIII A-B p0,000 and factor
XIII A-C p0,004).
CONCLUSION. Factor XIII deficiency after brain tumor surgery in-
creased ICH.
Further studies are necessary to demonstrate this association, in
which case deficiency treatment could become a therapeutic target
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INTRODUCTION. Abolished circadian rhythm is associated with re-
duced cognitive function, delirium, and in turn increased mortality (1,
3, 6). Sleep disorders and poor sleep quality are frequent complica-
tions in the critically ill patient, especially when mechanically venti-
lated (4,5). The causes are multifactorial, but research suggests that
changes in the biological 24-hour clock located in the nuclus supra-
chiasmaticus of the hypothalamus affect the circadian rhythm (2).
Melatonin is secreted from this site and plays a physiological role in
the regulation of sleep and daytime rhythm (7). No previous studies
have investigated the melatonin level on sedated vs. non-sedated
patients. This study investigates circadian melatonin rhythm on the
largest population of critically ill patients.
OBJECTIVES. To evaluate the melatonin level in critically ill patients
included in the NONSEDA trial and to investigate the correlation with
delirium.
METHODS. This study was conducted as a sub study to the NONSEDA
study where critically ill patients were randomized either to non-
sedation or sedation with a daily wake-up trail. S-Melatonin was ana-
lyzed 3 times a day (14:00, 22:00 and 03:00 o’clock) for 4 days, starting
on day 2 after intubation. Delirium was evaluated by CAM-ICU.
RESULTS. Seventy-nine of 100 patients included in the NONSEDA
study at the Hospital of Southwest Jutland Esbjerg were included.
CONCLUSION. Circadian melatonin rhythm in patients allocated to
non-sedation was closer to normal after 3 days of intensive care
compared to sedated patients. During the study period the risk of
delirium was significantly higher in the sedated group (OR 0,2). No
correlation between abolished circadian melatonin rhythm and de-
velopment of delirium was established in this study.
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INTRODUCTION. According to the latest recommendations of ESPEN,
one of the following criteria define surgical patients at severe nutri-
tional risk: a weight loss>10-15% within 6 months, BMI<18.5Kg/m2,
subjective global assessment Grade C or NRS>5, preoperative serum
albumin<30g/L(1). Sarcopenia measurement is now recommended in
the nutritional assessment of oncological patients (2). In the setting
of pancreatic cancer and surgical resection, patients are at risk to de-
velop endocrine and exocrine pancreatic insufficiency, leading to
malnutrition and a higher risk of developing a refeeding syndrome
after starting nutritional support. To our knowledge, the prevalence
of sarcopenia and refeeding syndrome in this population remains
unknown.
OBJECTIVES. To describe the perioperative nutritional assessment,
the prevalence of sarcopenia and of refeeding syndrome in subjects
undergoing pancreatic oncologic surgery.
METHODS. A single-center observational study was conducted be-
tween July 2018 and March 2019. This study was endorsed by SFAR's
CERAR. All subjects undergoing pancreatic oncologic surgery were in-
cluded. Demographic, clinical, biological and CT data were collected
on medical records. Total skeletal muscle surface area was evaluated
on a single image at the third lumbar vertebra, using dedicated soft-
ware, by a single researcher blinded to clinical data. Sarcopenia was
defined by a lumber skeletal muscle index (total skeletal muscle sur-
face normalized for stature) of less than 52.4 cm2/m2in men and
38.9 cm2/m2in women. The refeeding syndrome was defined by a
hypophosphatemia £0.7 mmol/L occurring between J1 and J7 post-
operatively. Data were presented median (IQR).RESULTS. Thirty-two patients were included in our study. The sex ra-
tio was 1/1, aged 67 yo (58; 74), a body mass index of 27 Kg/m2(22;
31), an albumin serum 34g / L (28; 39) and a skeletal muscle index of
48 cm2/m2(39; 54). 15% (n = 5) had preoperative chemotherapy, 3%
(n = 1) had radiotherapy, 28% (n = 9) had diabetes, and 13% (n = 4)
chronic renal failure. We did not find the global assessment grade or
NRS. According to the ESPEN malnutrition assessment criteria, the
rates of malnourished patients were 30% (n = 6) for weight loss, 3%
(n = 1) for BMI and 33% (n = 1). 7) for serum albumin. According to
the evaluation of muscle mass, 47% (n = 15) were sarcopenic. Nearly
one third of the patients (n = 9) had preoperative nutritional supple-
mentation. The prevalence of post-operative refeeding syndrome
was 59% (n = 19).
CONCLUSION. The use of a single clinical or biological criterion to
define malnutrition underestimates the prevalence of sarcopenia and
the risk of post-operative refeeding syndrome in patients with pan-
creatic oncologic surgery. The calculation of the skeletal muscle
index may help clinicians to optimize perioperative nutritional sup-
port management. Refeeding syndrome is common and affects more
than one in two patients.
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INTRODUCTION. Locoregional analgesia is one of the cornerstones
of chest trauma management (epidural and paravertebral block)1.
The serratus plane block is a regional analgesia method targeting the
thoracic wall2. Several case reports described sustained pain relief in
chest trauma patients. In a series of consecutive trauma patients pre-
senting with rib fractures, admitted in an intensive care unit, we
studied the effectiveness of the serratus plane block on analgesia, its
feasibility and the incidence of complications.
METHODS. After the approval from the local ethics committee and
informed consent we retrospectively studied the medical records of
all consecutive patients presenting with a chest trauma and who
benefitted from a serratus plane block according to the local practice
between January 2018 and February 2019. The serratus plane block
was performed in the supine or lateral position under ultrasound
guidance. First, the local anesthetic (Ropivacaïne 0.2%) was instilled
in the deep serratus plane followed by the insertion of a perineural
catheter. Another instillation was performed in the superficial serra-
tus plane. An elastomeric pump was then connected to the perineu-
ral catheter for continous infusion (Ropivacaïne 0.2% 10 mL/h).
RESULTS. The records of 13 patients were retrospectively analysed.
The median age was 57 years [44;71], all patients were male. The
trauma was the result of a car accident for 7 patients and of a fall for
5 patients. The rib fractures were bilateral for 7 patients, 9 patients
presented a flail chest, 9 a pneumothorax, 5 an hemothorax. A chest
tube was in place for 7 patients. 4 patients benefited from thoracic
surgery. All a patients presented with an associated trauma, 8 ortho-
pedic trauma, 4 neurosurgical trauma and 4 abdominal trauma. 9 pa-
tients required a surgical procedure. 10 patients received systemic
analgesic alone before the serratus plane block, while 3 were under
sedation. The values of Visual Analog Scale and morphine consump-
tion are presented in Figure 1.No complication was observed.
CONCLUSION. Our results suggest that the serratus plane block is an
effective locoregional analgesia method for pain management in
chest trauma patients. A randomized clinical trial comparing the ser-
ratus plane block with the standard locoregional analgesia methods
F1
T1
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management of chest trauma patients.
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Factor Odds 95% CI P value
age 1.35 1.15−1.59 0.00029
amount of bleeding 0.998 0.996−1.000 0.0389
antipsychotics 4.67 0.723−30.20 0.106
fentanyl 1.06 0.907−1.24 0.460
operative duration 1.01 0.999−1.010 0.0911
Respiratory Failure 0.545 0.12−2.47 0.431
sex 1.63 0.410−6.46 0.489
type of volatile anesthetics 2.90 0.817−10.30 0.0996000434
Type of volatile anesthetics in the long time general anesthesia for
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INTRODUCTION. Postoperative delirium (PD) deteriorates morbidity,
ICU length of stay, prolongation of existing hospitalization, and
healthcare costs. Moreover, PD causes delayed functional recovery,
cognitive dysfunction, and higher mortality. Several reports showed
differences in general anesthesia methods affects incident PD. How-
ever, it is unknown whether type of volatile anesthetics affects inci-
dent PD.
OBJECTIVES. We evaluated retrospectively type of volatile anes-
thetics in long time general anesthesia for elderly patients affects in-
cident PD.
METHODS. This study was a retrospective, single-center, observa-
tional study, which was approved by the ethics board of our hospital.
170 patients (110 male, 60 female, average age: 70 years old) aged at
least 60, underwent surgery more than 8 hours by the general
anesthesia method using volatile anesthetics, and admitted to the
ICU at our hospital from April 2017 to September 2018. We excluded
patients who underwent cardiac surgery or received total intraven-
ous anesthesia (TIVA). After admission to the ICU, Intensive Care De-
lirium Screening Checklist (ICDSC) was measured to diagnose PD.
Delirium defined four or more points. The subjects were divided into
Sevoflurane group (S group) and Desflurane group (D group), and
compared. The primary outcome was the difference in the incidence
of PD between the two groups. The secondary outcomes were to
identify explanatory factors, such as patient factors, surgical factors,
and anesthetic factors that influence the onset of PD. The statistical
method used the chi-square test or Fisher’s exact test for comparison
of incident PD between two groups. After univariate analysis, a multi-
variate analysis was applied to test for independent risk factors forPD. WhenP value was <0.05, the test was considered statistically
significant.
RESULTS. Data of 94 patients in S, 76 in D groups were analyzed.
There were no significant differences in the patients’ background be-
tween the two groups. Delirium developed in 16 patients. The inci-
dence rates of PD in S and D group were 6.4% and 13.2%,
respectively, and there was no significant difference between the
two groups (P=0.186). With regard to PD onset, a causal relationship
was recognized between age (P<0.01) and amount of bleeding (P=
0.0389).
CONCLUSION. In long time general anesthesia for the elderly, the
type of volatile anesthetics is not significantly different in the inci-
dent PD. Further study is required to confirm the risk of PD with
more number of patients and multiple center trial.000457
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INTRODUCTION. Goal-directed therapy is considered as an important
option in perioperative care. However, most of the studies analyze
the postoperative outcomes, but intraoperative hemodynamic
changes seem to be a significant factor in development of hypoper-
fusion during operation. Moreover, laparoscopy effects on
hemodynamic parameters are well known and its influence on car-
diovascular physiology can be challenging.
OBJECTIVES. The aim of this study is to compare two different ap-
proaches to hemodynamic and fluid management during elective
laparoscopic colorectal surgery.
METHODS. 102 patients with curable colorectal cancer were divided
in 2 groups: observational (group №1, n = 46) and goal-directed ther-
apy group (group №2, n = 56). All patients have a non-invasive moni-
toring of hemodynamic (EsCCO, Nihon Kohden, Japan). Management
of hemodynamic and fluids in the group №1 were performed accord-
ing to opinion and agreement of 2 experienced anesthesiologists.
Hemodynamic optimization in the group №2 included some steps:
first is Trendelenburg maneuver after induction and bolus of 500 ml
of balanced crystalloid if stroke volume increased more than 15%,
then assessment during pneumoperitoneum and infusion of small
(3ml/kg) volume if intraabdominal perfusion pressure (IPP) less than
65 mm Hg, and, if patient is a non-responder, infusion of norepin-
ephrine. Total infusion volume, mean norepinephrine dose, duration
of vasopressors, lactate, BE, number of episodes of hypotension
(MAP and/or IPP ≤ 65 mm Hg or decrease of SBP more than 20%
from baseline), changes in HR more than 30% from baseline were
measured. Data was analyzed using IBM SPSS Statistics 20.0. Continu-
ous data variables were compared using Mann-Whitney U tests, re-
sults are reported as median (Q1; Q3).
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tics. Fluid volume were significantly less in the group №2: 2590
(2250; 2900) ml vs 3000 (2500; 3312) ml, Mann-Whitney U tests, p =
0.005. Norepinephrine time and dosage were similar between two
groups. Lactate at the end of operation were lower in the group №2:
1,6 (1,2; 2,1) mmol/l vs 1,05 (0,7; 1,47) mmol/l in the group №1 and 2,
respectively, Mann-Whitney U tests, p = 0.002. Hypotension were
more often in the group №1: 2 (1; 5) episodes vs 1 (0; 1) in the group
№2, Mann-Whitney U tests, p < 0.0001. Drop of SBP from baseline
were significantly higher in the group №1: 35,4% from baseline (13%;
38%) and 21,8% (16,7%; 27,4%) in the group №2, Mann-Whitney U
tests, p = 0.006.
CONCLUSION. Goal-directed hemodynamic and fluid therapy may be
beneficial in terms of hemodynamic stability during elective laparo-
scopic operations in patients with colorectal malignances.
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INTRODUCTION. Unfractionated Heparin (UFH) and Low Molecule
Weight Heparins (LMWH) are commonly used within critical care
to provide therapeutic doses of anticoagulation. Limited evidence
is available whether target concentrations are being met in critic-
ally ill patients, who are at particular risk of over- or underdosing
due to reduction in bioavailability due to vasopressors, lack of
weight-adjusted dosing and renal impairment. The Royal Liver-
pool University Hospital’s current protocol demands monitoring
of activated partial thromboplastin time (APTT) ratios after 6-8
hours for UFH infusions, and anti-factor Xa (anti-Xa) levels 4
hours post dose for subcutaneous LMWH when prescribed for pa-
tients with renal impairment or pulmonary embolism (PE). This
audit evaluates whether target concentrations of therapeutic
LMWH and UFH were met in patients admitted to the Intensive
Care Unit (ICU) and how monitoring was performed in critically ill
patients compared to guideline recommendations.
OBJECTIVES. Standards set included 100% post-dose monitoring at
or within time-limits for all patients - receiving UFH; with renal im-
pairment; with PE. 100% reaching satisfactory anticoagulation -
within 24 hours for an UFH infusion; by the end of ICU admission or
last dose of UFH/LMWH.
METHODS. Data was collected retrospectively over a two-month
period. Patients who received therapeutic doses of UFH and LMWH
were included. Data collected included anonymised patient demo-
graphics, renal function, drug used, indications and monitoring.
RESULTS. 144 patients were screened, and 30 patients receiving
therapeutic anticoagulation were included in the audit. 86.7% of pa-
tients exceeded their ideal body weight. 16.7% had anti-Xa levels or
APTT ratios measured within trust-formulary limits. 50% reached
therapeutic levels of anticoagulation. 44.4% of patients with PE did
not have anti-Xa levels/APTT ratios measured at all. 22.2% reached
therapeutic levels of anticoagulation for PE. 77.8% of UFH patients
reached therapeutic levels of anticoagulation within 24 hours. None
of the patients receiving once daily (OD) LMWH had Anti-Xa levels
checked 4 hours post first dose. 14.3% of OD and 12.5% of patients
receiving twice daily LMWH reached therapeutic levels of anticoagu-
lation during their admission. 64.3% of patients with acute kidney in-
jury, 20% with chronic kidney disease and 33.3% with both achieved
satisfactory levels of anticoagulation.
CONCLUSION. Due to inconsistent monitoring, the level of anticoa-
gulation remained uncertain in patients with renal impairment.Patient safety could have been compromised from over- or under-
dosing. Only 22.2% of PE patients reached therapeutic levels which
could exacerbate symptoms. We conclude that tighter adherence of
the recommended frequency and timing of monitoring is required to
avoid over- or underdosing in critically ill patients.
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INTRODUCTION. Delirium is a major cause of morbidity within the
ICU environment1 and is associated with prolonged stay, longer time
on mechanical ventilation2 and all-cause mortality3. In Royal Preston
Hospital (RPH), a tertiary centre for neurosurgery in the Northwest of
England, it has been anecdotally identified that neurosurgical pa-
tients represent a degree of delirium-related morbidity on the ICU
disproportionate to the size of the group.
OBJECTIVES.
1. To quantify the incidence of delirium in the neurosurgical and
non-neurosurgical ICU populations and
2. To audit compliance with existing Trust pathway for
management of delirium.
METHODS. This was a retrospective audit of all admissions to ICU in
RPH between 01/09/2018 and 30/11/2018. Patient notes were ana-
lysed to determine the primary reason for admission (whether neuro-
surgical or not), the number of days spent delirious based off the
CAM-ICU assessment, the Richmond Agitation and Sedation Score
(RASS), the type of delirium (hypoactive, hyperactive or mixed) and
the treatment given (pharmacological or non-pharmacological).
RESULTS. 397 patients were included, comprising 346 non-
neurosurgical and 51 neurosurgical patients. 100 (28.9%) non-
neurosurgical patients and 29 (57%) neurosurgical patients had at
least 1 delirious day on the ICU.
Neurosurgical patients represented 37.2% of all delirium days despite
their small group size.
Further results of audit will be presented in the poster.
CONCLUSION. Neurosurgical patients have a disproportionately
higher rate of delirium in this centre. We should consider neurosurgi-
cal patients to be an at-risk group for developing acute delirium and
have a documented pharmacological and non-pharmacological plan
as an anticipatory measure.
Our current statistics use delirium days as an outcome. This is a
flawed statistic which is heavily skewed by neurosurgical long-stay
patients. A different reporting measure is therefore required for on-
going audit purposes.
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INTRODUCTION. Neuromuscular blocking agent (NMBA) infusions in
critical care are frequently used in acute respiratory distress syn-
drome (ARDS) where they provide a mortality benefit in early severe
ARDS (1). Administration of such infusions requires a careful ap-
proach; monitoring paralysis with peripheral nerve stimulators and a
train of four twitches (TOF); and monitoring depth of anaesthesia
using clinical judgement and monitors such as Bispectral Index Score
(BIS) (2).
OBJECTIVES. Firstly, to study rate of use of TOF and BIS monitoring
amongst patients receiving NMBA infusion. Secondly, to look at titra-
tion of sedation after commencing NMBA infusion and physiological
signs that could suggest awareness under anaesthesia.
METHODS. A retrospective review was performed of all episodes of
cisatracurium infusion in Manchester Royal Infirmary general adult in-
tensive care during a 23 month period. Data was gathered on use of
BIS and TOF, looking at titration of sedation and change in physio-
logical parameters after commencing NMBA infusion.
RESULTS. 104 patients received NMBA infusion, 18 more than once,
with 130 episodes of NMBA infusion included for analysis. BIS moni-
toring was used in 95% of infusions but TOF monitoring in only 10%.
Sedation was reduced after commencing NMBA infusion in 62% of
episodes. A trend was seen towards increased sympathetic stimula-
tion in the sedation reduction group. Comparing the group with re-
duced sedation to the group without reduced sedation, an increase
of ≥20% in heart rate was seen in 44% Vs 18% respectively.
Pupillary dilatation was seen in 40% Vs 22% respectively. Similar ef-
fects of lesser magnitude were seen with reduction in noradrenaline
dose and increase in systolic blood pressure.
CONCLUSION. BIS monitoring was used frequently in the unit but
use of TOF monitoring was suboptimal; this is of some concern given
potential for variations in dose response amongst a heterogeneous
critical care population. Sedation was reduced after commencing
NMBA infusion in the majority of patients. Although these parame-
ters are non-specific in isolation for predicting awareness, there was
a trend towards increased sympathetic stimulation in patients in the
sedation reduction group. Given uncertainty about BIS monitoring as
a sole indicator of depth of anaesthesia amongst patients undergo-
ing NMBA infusion (3), this raises the question of whether patients
are being exposed to the risks of accidental awareness under anaes-
thesia. A protocol is suggested to combine the use of clinical assess-
ment, BIS and TOF monitoring to safely administer cisatracurium
infusions (Fig 1).
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INTRODUCTION. Low tidal volume (LTV) ventilation in mechanically
ventilated patients has been associated with decreased mortality and
a decreased number of days of ventilator use in patients with acute
respiratory distress syndrome (ARDS).[1, 2] The recommendation is
an initial tidal volume of 6ml per kilogram of ideal body weight
(IBW).
OBJECTIVES. To review the use of LTV ventilation in all mechanically
ventilated patients and determine whether there is an association
with maintenance of LTV ventilation in the initial 24 hours of ventila-
tion and patient mortality.
METHODS. Data were collected retrospectively from all patients who
were mechanically ventilated on the intensive care unit at a UK dis-
trict general hospital over a period of one month (January 2019).
Data were collected at regular intervals over the first 24 hours of ven-
tilation. All ventilated patients were included in this study regardless
of whether they had a diagnosis of ARDS or not. Patients with inad-
equate data or being ventilated with airway pressure release ventila-
tion mode (APRV) were excluded. Outcome was measured as 28 day
mortality. Statistical analysis was carried out using R version 3.5.3 (R
Foundation).
RESULTS. Of the 32 patients included in this study 22 patients sur-
vived and 10 were deceased at 28 days. The mean age of patients
who survived was 60.8 years, compared to the mean age of those
who died which was 68.5 years. We found the mean and median
ideal body weight (IBW) adjusted tidal volumes were 8.1 and 8.4 ml/
kg respectively. The graph illustrates that there is no significant dif-
ference between TV (ml/kg) against 28 day mortality (p = 1.0 ). It
highlights the similar medians between each group and a larger
interquartile range in the group of patients that survived.
CONCLUSION. In conclusion, in this cohort of patients, during the
first 24 hours of admission, we are ventilating slightly beyond the
range recommended by ARDSNet of 6-8ml/kg tidal volume. However,
we found no association between mortality and tidal volume. Limita-
tions of this analysis include a small sample size. In addition, we have
not assessed other aspects of lung protective ventilation, such as
F2
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found to have an impact on mortality.[3] The original ARDSNet study
compared LTV ventilation (6ml/kg of IBW) vs high tidal volume venti-
lation (12ml/kg of IBW).[1] The PREVENT trial compared LTV and
intermediate tidal volume (10ml/kg) in patients without ARDS, find-
ing no difference in the number of ventilator free days.[4] Further
studies may be useful to assess the optimal tidal volume in different
cohorts of patients, i.e. ARDS and non-ARDS.
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INTRODUCTION. Reverse triggering (RT) is a diaphragmatic contrac-
tion triggered by an insufflation initiated by the ventilator. This
patient-ventilator dyssynchrony is potentially harmful through in-
creased tidal volume, breath stacking or eccentric diaphragm con-
traction. The diagnosis at bedside is challenging for the clinician and
automatic monitoring seems required.
OBJECTIVES. We aimed at validating the accuracy of an automatic
detection based on the analysis of ventilator waveforms, (pressure
and flow) against a visual assessment using flow, Paw and esopha-
geal pressure signals (Peso).
METHODS. An algorithm was created to detect RT based only on
flow and airway pressure (Paw) signals. This algorithm has beendeveloped in collaboration between data scientists of Better Care®
and researchers of Dr. Brochard’s laboratory in Toronto and Parc Tauli
University Hospital, using recordings from the BEARDS study having
esophageal pressure (NCT03447288).
Two researchers visually reviewed 16 recordings from 16 different
patients with ARDS included in an observational physiologic study
(BEARDS). Reverse triggering was defined by visual assessment as a
patient effort starting less than 1.5 sec after a machine triggered
breath and generating a Peso deflection ≥ 2cmH2O. This threshold
was chosen has having a potential clinical relevance. The automated
algorithm was based on flow and Paw and detected events in the
same tracings without using esophageal pressure: we compared
automatic detection to visual assessment (gold standard). Sensitivity,
specificities, predictive values, accuracy were calculated.
RESULTS. We included recordings from 16 patients (mean±SD age of
61±12, SOFA 10±3, 63% male, 81% with pneumonia). At time of re-
cording, they had been intubated for a median [IQR] of 4 [1-7] days
and 93% were receiving sedation or analgesia (Midazolam: 56%; Pro-
pofol: 19%; opioid: 94%). Their total duration of mechanical ventila-
tion was 9 [7-14] days and 63% were discharged alive from the ICU.
Sixteen recordings were assessed: under pressure control ventilation
(n=6), volume control ventilation (n=6) and pressure support ventila-
tion (n=4); 3735 breaths were evaluated of which 752 breaths
(20.1%) were considered as RT by visual assessment. The automatic
detection had a global accuracy of 95%: sensitivity of 85%, specificity
of 97%, positive predictive value of 90% and a negative predictive
value of 96%. Individual patients’ tracing assessment showed an ac-
curacy of the automatic detection ranging from 77% to 100%.
CONCLUSION. An automatic detection algorithm can reliably detect
breaths with reverse triggering and a potential clinical relevance
using only ventilator waveforms. This is an essential first step to de-
scribe and understand the clinical impact of this frequent patient-
ventilator dyssynchrony.
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INTRODUCTION. Nebulization is widely used in intensive care unit
(ICU), by up to 99% of intensivists in an epidemiological study (1).
However, even if vibrating mesh nebulizers are actually developed,
efficiency of such administration route remain relatively poor, around
20% of nebulized dose under mechanical ventilation (MV) being de-
posited in the respiratory tract (2). Moreover, aerosol deposition is
impacted by numerous factors such as gas humidification, position
of the nebulizer in the circuit etc. Consequently, a preclinical ex vivo
respiratory model was developed to study regional aerosol depos-
ition under MV.
Page 403 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55OBJECTIVES. To study the impact of humidification and vibrating
mesh nebulizer position in the circuit in order to assess and then
optimize lung deposition under MV.
METHODS. A preclinical ex vivo respiratory model was used, under
controlled volumetric ventilation. Aerosols were performed with a vi-
brating mesh nebulizer (Aerogen Solo, Aerogen Ltd, Galway Ireland)
with or without humidification. Experiments were performed at least
in triplicate for each experimental condition. Without humidification,
the nebulizer was placed just after the inspiratory valve. When
heated humidifier was used, the nebulizer was placed either previous
it or between endotracheal tube (ETT) and the Y piece adapter or 15
cm before this latter one. A quantitative 99mTc-DTPA scintigraphic
study was then performed to determine nebulized fraction and de-
posited fractions on each part of the system and the circuit.
RESULTS. Efficiency of the nebulization was achieved with a mean
nebulized dose higher than 95% of nominal dose. The respiratory
tract deposited fraction of the nebulized dose varied considerably:
18±4% without humidification, and from 25±3% to 57±8% depend-
ing of the nebulizer position on the humidified ventilator circuit (i.e.
25±3% prior the humidifier, 43±11% between ETT and Y piece
adapter and 57±8% upstream the Y piece adapter). These results are
strongly correlated to change of aerosol droplet sizes for the differ-
ent experimental conditions studied. Moreover, the aerosol distribu-
tion varied equally in the repartition between tracheal and
pulmonary deposition but was not significantly different for the ETT
deposition.
CONCLUSION. Nowadays, mesh nebulizers allow an increase in nebu-
lized dose under MV, potentially leading to significant improvements
of aerosol therapies. Consequently, determining factors as humidifi-
cation and nebulizer position could have a higher impact on the de-
livered dose to the respiratory tract. This study showed very
important differences in the dose delivered to the respiratory tract
with potential significant impacts for patients in ICU.
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INTRODUCTION. The use of prone positioning for patients with mod-
erate to severe ARDS has been shown to improve oxygenation and
survival (1). Despite evidence demonstrating benefit, many patients
with ARDS do not undergo prone positioning - one large study
found prone position was used in only 16.4% of eligible patients (2).
Prohibitive reasons are likely to be multiple and include human fac-
tors and lack of a protocolised approach.
OBJECTIVES. To review the effect of introducing protocolised prac-
tise in prone positioning over an 8 month period in one DGH ICU.
METHODS. Following the results of a previous study (3) at the same
unit, a protocol was introduced to guide timing and procedure for
prone positioning. During the 8 months following the introduction of
the protocol, data were collected regarding aetiology of ARDS, sever-
ity at initiation of prone position (determined by P/F ratio), arterial
blood gas (ABG) results, outcome (Hospital Discharge/ITU Discharge/
Death), demographics and adherence to protocol.RESULTS. During the study, 11 patients underwent prone positioning
(1.4 episodes per month). In the previous 2 year study (3), there were
14 patients (0.6 episodes per month). 2 patients from this study
underwent a second episode of prone position soon after being
returned to supine - i.e 13 episodes in total. 11 out of 13 cases
(84.6%) were classified as severe ARDS with a P/F ratio of <13.3 kPa.
The remaining 2 (15.4%) were moderate ARDS (13.3kPa-26.6kPa). The
mean age was 55.3 (SD 10.4 years), 8 male and 3 female. The mean
duration of prone position was 15.3 hours (SD 4.1 hours); the proto-
col targeted 16 consecutive hours of proning. Prone position was im-
plemented as per protocol in 92.3% of cases and intra-proning
checks (head turn etc.) were correct for 84.6% of proning episodes.
Improvement in oxygenation after 6 hours of prone position was ob-
served in 92.3% of cases. In terms of outcome, 7 (63.6%) patients sur-
vived to hospital discharge, 3 (27.3%) survived to ITU discharge and
1 (9.1%) died. In-hospital mortality was 36.6%, which compares with
50% observed in the previous study (3).
CONCLUSION. Introduction of a protocol has increased awareness
and utilisation of prone positioning in our unit. Protocolisation has
also yielded high rates of correct pre-prone and intra-proning checks,
meaning there is standardisation of the way prone position is used
within the unit. The improvements observed in oxygenation in this
patient cohort echo what is also seen in the wider literature (1). Al-
though a reduction in mortality was observed after the introduction
of a protocol, given the size of this study this would not be statisti-
cally significant. Guidance in the protocol on when to initiate prone
positioning may be useful, as the majority of patients (84.6%) under-
went prone positioning when ARDS was severe and may have bene-
fitted from earlier proning. A future study involving a larger cohort
aiming to prone at an earlier, less severe stage would be useful and
may demonstrate improvement in patient outcome.
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INTRODUCTION. Tracheostomy (TT) is performed in ITU patients re-
quiring prolonged ventilation as a means to facilitate weaning. How-
ever, the optimal timing of TT has been debated. The TracMan RCT
2013 failed to demonstrate beneficial effects of early TT on 30-day
mortality or ITU length of stay. Orthotopic heart transplant (OHT) pa-
tients are often complex and require prolonged mechanical ventila-
tion, yet there is limited data available for this cohort. We wanted to
see if there was a benefit to early TT in heart transplant patients who
were likely to require prolonged mechanical ventilation.
METHODS. We retrospectively reviewed 153 consecutive patients
who underwent OHT in our centre between 2013 and 2018. 47 pa-
tients required TT. We compared the baseline factors and outcomes
F2
F2
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went late TT (>10days).
RESULTS. Over one third of OHT patients required TT (TT group; n=
47; 31.5%) during their ITU stay. Risk factors for tracheostomy were
previous stroke/TIA (OR 3.52;95% 1,41-8.79), left ventricle assist de-
vice support prior to OHT (OR2.14; 95% 1.06-4.34; p=0.034), cardio-
pulmonary bypass time (OR 1.1;95%; 1-1.01; p=0.022). Other baseline
factors were normal.
20/47(42.6%) patients underwent early TT, whilst 27/47(57.4%) pa-
tients underwent late TT. Mean time from ITU arrival to TT was 6.5±
2.4 days in the early group versus 15.3±6.3 days in the late group(p<
0.001). There were no life-threatening complications related to pro-
cedure. Early-TT was more common in female patients with 90% of
early-TT being done in female patients(p=0.006), but there were no
other differences in baseline factors. Patients who developed primary
graft failure were significantly more likely to have a TT, 14.7% versus
51.1%(p<0.001), and it was more likely to be performed late p<0.001.
However, total duration of mechanical ventilation (25.4±38.4 vs 35.4±
24.7days; p=0.284), and ITU length of stay was also comparable
(early-TT 27.5±27 days vs late-TT 38.1±19.5 days; p=0.122). All-cause
early mortality within 30-days of OHT was comparable between
early-TT 15% vs Late-TT 7.4% (p=0.438). Although there was a trend
to increased 1-year survival in the early-TT group versus the late-TT
group, this wasn’t significant (25% vs 48.2%; p=0.104).
CONCLUSION. The timing of TT in critically unwell patients has been
debated, and previous trials have failed to show major benefits to
favour early TT. In comparing early-TT versus late-TT, we have found
that female patients are more likely to have early-TT, whilst develop-
ing PGF would appear to be a factor favouring a decision for late-TT.
Despite these differences, there was no difference in over duration of
mechanical ventilation, or short-term survival outcomes. Though
early-TT appears to show a trend towards improved 1-year survival,
the sample size may have been too small to demonstrate
significance.
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INTRODUCTION. Ventilator-induced lung injury significantly increases
patient morbidity and mortality. To reduce the underlying patho-
physiological mechanisms different ventilation strategies are applied.
Flow-controlled ventilation (FCV) is a new ventilation mode to estab-
lish a continuous, stable flow throughout the ventilation cycle result-
ing in a slow and steady change of intrapulmonary pressure during
in- and expiration, to minimize applied and also dissipated energy
(both related to lung injury) and to individualize ventilation based on
measurements of dynamic lung mechanics [1].
OBJECTIVES. Aim of this porcine study was to investigate FCV com-
pared to best “standard of care” pressure-controlled ventilation (PCV)
with corresponding lung-protective ventilator settings.
METHODS. Animals were randomly assigned to FCV or PCV. FCV
(with Evone®, Ventinova, Eindhoven, The Netherlands) was estab-
lished at compliance-guided pressure settings (PEEP and peak), fixed
FiO2 of 0.3 and flow adjusted to maintain normocapnia (paCO2 = 35-
45 mmHg) at an I:E ratio of 1:1. PCV ventilation (with Evita XL®,Dräger, Lübeck, Germany) was performed with at least a PEEP of 5
mbar adjusted to transesophageal pressure, peak pressure set to
achieve a tidal volume of 6 - 8 ml/kg, fixed FiO2 of 0.3 and respira-
tory rate adjusted to maintain normocapnia at an I:E ratio of 1:1.5.
After ventilation for 10 hours a CT-scan was carried out in order to
visualize and quantify lung tissue aeration by Hounsfield unit
analysis.
RESULTS. 12 pigs were enrolled in the study (FCV and PCV n=6).
Baseline characteristics were comparable in both groups. Animals in
the FCV group showed a significant reduction of respiratory minute
volume needed to maintain normocapnia (6.0±0.5 vs. 12.7±0.8 l/
min,p<0.0001; fig. 1) thereby achieving significantly better oxygen-
ation (paO2 = 120.0±6.1 vs. 96.6±7.4 mmHg, p=0.0097; fig. 2) com-
pared to the PCV group. CT scans of FCV animals obtained at the
end of the experiment showed a significantly higher portion of nor-
mally ventilated lung tissue (73.7±3.9 vs. 68.1±5.1 %, p=0.0068) com-
pared to PCV animals.
CONCLUSION. In this porcine study FCV significantly improved gas
exchange and maintained better aeration of lung tissue.
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Page 405 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. Assessing the ability to clear secretions and protect
airway with effective cough is an important part of pre-extubation
evaluation in patients who have passed spontaneous breathing trial
(SBT). We hypothesized that passive cephalic excursion of diaphragm,
peak velocity of the diaphragm, or both during cough expiration
measured by ultrasound might predict extubation outcome.
OBJECTIVES. The aims of this study are 1) to identify associations of
the ultrasonographic indices with simultaneously measured cough
peak expiratory flow (CPEF) and 2) to investigate the predictive
values of the ultrasonographic indices for extubation outcome in pa-
tients who have passed SBT.
METHODS. A total of 323 mechanically ventilated patients who
passed SBT were enrolled in the study. Diaphragm excursion and
max velocity were measured during voluntary and involuntary cough
by ultrasound in the supine position. CPEF was also measured using
the ventilator flow waveforms simultaneously with the ultrasono-
graphic measurement.
RESULTS. Diaphragmatic excursion during voluntary cough has a sig-
nificant correlation with CPEF (r=0.491, p<0.001). The areas under the
curves (AUCs) of diaphragmatic excursion and CPEF during voluntary
cough for extubation failure are 0.753 (95% Cl 0.623 - 0.894, cutoff
value 1.6 cm) and 0.715 (95% Cl 0.54 - 0.89, cutoff value 50 L/min) re-
spectively. There was no significant difference in predictive accuracy
between diaphragmatic excursion and CPEF (p=0.61). Diaphragmatic
excursion during involuntary cough or peak velocity of the dia-
phragm during voluntary or involuntary cough did not predict extu-
bation outcome.
CONCLUSION. Passive cephalic excursion of the diaphragm during
voluntary cough measured by ultrasound is as accurate a predictor
of extubation outcome as CPEF in patients who have passed SBT.
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INTRODUCTION. Veno-venous extracorporeal membrane oxygen-
ation (V-V ECMO) can support arterial oxygenation in case of refrac-
tory hypoxemia. With total ECMO blood flow (QB) being delivered
through the ECMO return cannula, the fraction of QB recirculat-
ing into the drainage cannula constitutes the recirculation fraction
(Rf), which does not contribute to systemic oxygenation and has to
be substracted from QB to determine the effective extracorporeal
flow (QEFF; QEFF = QB – Rf x QB) [1]. Routine calculation of Rf is cum-
bersome and requires mixed venous blood samples. A new ultra-
sound technique supports bedside measurements of Rf without the
need for a pulmonary artery catheter [2].
OBJECTIVES. We investigated whether the bedside quantification of
Rf enables the optimization of ECMO blood flow (QB). Theoretically,
QB can be reduced by Rf without compromising systemic oxygen-
ation. Reduction of QB can minimize adverse effects related to very
negative inlet pressures like hemolysis or vessel damage.
METHODS. In a prospective clinical trial (ClinicalTrials.gov Identifier:
NCT03200314), we measured Rf in patients on V-V ECMO suffering
acute respiratory distress syndrome (ARDS) using a saline ultrasound
dilution technique. In the case that Rf was greater than 10%, QB was
reduced by the volume flow of Rf. Following a safety protocol,reductions of QB were stopped when pulse oximetry saturation
(SpO2) fell below 90%. Likewise, QB was increased when SpO2 fell
below 88%.
RESULTS. Eighteen patients were examined (52 ± 16 years old, 2 ± 1
days on ECMO; mean ± SD). Mean QB was 4 ± 0.7 l/min with a Rf of
15 ± 9 % (0.7 ± 0.48 L/min). Rf exceeded 10% of QB in 11 patients
(21 ± 7%, 0,9 ± 0.46 L/min). QB was reduced in 7 of these 11 patients
by 0.6 ± 0.17 L/min (to 3.3 ± 0.77 L/min; p < 0,05) resulting in a new
Rf of 10 ± 5 %. QB reduction resulted in a decrease in arterial oxy-
genation (before reduction: SpO2 98 ± 2 %, arterial partial pressure
of oxygen, PaO2 101 ± 24 mmHg; post reduction: SpO2 96 ± 3 %,
PaO2 85 ± 23 mmHg; p < 0.05). Despite a Rf > 10%, QB was not re-
duced in 3 patients with SpO2 < 90% and increased in one patient
with SpO2 < 88%.
CONCLUSION. Ultrasound-based estimation of blood recirculation in
a V-V ECMO setting provides an objective measure supporting the re-
duction of recirculation to optimize ECMO blood flow within safe
limits of arterial oxygenation.
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INTRODUCTION. Lung and diaphragmatic injury can be related to an
unsuitable respiratory drive (1).
It’s usually handled by the airway occlusion pressure or by the
esophageal pressure (2).
OBJECTIVES. To assess the usefulness of tracheal pressure (Ptrach) to
monitoring the respiratory drive.
METHODS. We studied 18 patients under pressure support ventila-
tion with different levels of assistance and a maximum sensitivity of
the inspiratory trigger. Esophageal (Pes), airways pressure (Paw),
Ptrach and flow were registered at 560 Hz. A total of 151 cycles were
analyzed. Ptrach was measured using a specific dedicated Intratra-
cheal catheter. P100 was measured in Paw between 0 and 300 milli-
seconds (ms) after occlusion, selecting the segment with greater
slope, at 100 ms. The cycles prior to occlusion were analyzed to
measure the Ptrach 100, from nadir to backwards selecting the
greater slope segment.
The results are expressed as mean±SD, median (IRQ), or percentage.
The comparisons by t-student. Bland-Altman and linear regression
analyses were performed.
RESULTS.
CONCLUSION. Tracheal pressure may be useful for continuous moni-
toring of respiratory drive. The good fit agrees as the respiratory
drive increases.
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INTRODUCTION. While mechanical ventilation is a mainstay of ther-
apy for the acute respiratory distress syndrome (ARDS), it can simul-
taneously trigger adverse complications, most prominently
ventilator-induced lung injury (VILI). This fatal association necessitates
the need for optimized ventilation strategies, and for a better under-
standing of alveolar dynamics and the mechanisms underlying alveo-
lar epithelial injury in the mechanically ventilated, injured and
edematous lung.
OBJECTIVES. In previous studies, we observed a variety of abnormal
dynamics (alveolar dyskinesias) including pendelluft, alveolar stun-
ning and inversed ventilation, but never anatomical collapse and re-
opening of alveoli [1, 2]. Therefore, we propose that during ventila-
tion of injured lungs, edema fluid will – according to LaPlace´s law -
cyclically shift in and out of the alveolus as a function of ventilation
pressure. We suspect that the cyclic flooding of alveoli with edema li-
quid, termed by us “alveolar tidal flooding” (ATF), rather than ana-
tomical opening-and-collapse of alveoli contributes critically to the
development of alveolar damage during VILI by exerting excessive
shear stresses upon the alveolar epithelium.
METHODS. We tested this concept by direct visualization of alveolar
dynamics with lung intravital microscopy (IVM) in a murine model of
alveolar edema [3]. Onset, extent, and time course of ATF in injured
lungs as well as the cyclic fluid shifts in and out of the alveolar space
will be analyzed under a range of ventilation settings with variation
of IPP, PEEP, and driving pressure (ΔP). Further the cellular damage
exerted by ATF will be assessed with characteristic markers.
RESULTS. ATF was detectable in fluid-filled, yet not in control lungs.
ATF frequency increased as a function of inspiratory plateau pressure
(IPP) at PEEP = 0 cmH20, and decreased in turn with higher PEEP.
We compared the effects of three ventilation settings with different
IPP and PEEP values (IPP /PEEP: 18/1; 24/7; 30/13 cm H2O) but same
driving pressure in a mouse model of edema. In line with the driving
pressure hypothesis, no significant differences in wet-to-dry weight
ratio, oxygen saturation, serum pH and lung compliance weredetected between groups. Further studies comparing different driv-
ing pressure, as well as flooded and unflooded lungs are presently
ongoing.
CONCLUSION. We think understanding of this physiological principle
will have direct impact on clinical care in terms of optimized ventila-
tion strategies to prevent ATF.
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INTRODUCTION. Two distinct hypo- and hyper-inflammatory sub-
phenotypes have been identified in patients with ARDS. The hyper-
inflammatory sub-phenotype is associated with fewer non-
pulmonary organ failure free days and increased mortality 1. Necrop-
tosis is a form of programmed cell necrosis mediated through activa-
tion of receptor interacting serine/threonine kinase-3 (RIPK3)
signalling. Furthermore, necroptosis is associated with greater degree
of inflammation through extensive cell lysis and release of damage
associated molecular patterns, leading to more severe systemic
inflammation.
OBJECTIVES. To establish if plasma markers of necrosis and necrop-
tosis are different between the sub-phenotypes in ARDS in the pla-
cebo arm of the HARP-2 cohort 2. HARP-2 was a randomised,
controlled clinical trial evaluating simvastatin in patients with ARDS.
METHODS. We measured RIPK3 (necroptosis marker) and
Cytokeratin-18 (CCK18, epithelial necrosis marker) by Sandwich ELISA
(Cusabio & Cytokeratin-18, M65 PEVIVA respectively) in blinded sam-
ples from 30 patients (N=15 per endotype as defined at ARDS diag-
nosis) from the HARP-2 clinical trial over a 14-day time course.
RESULTS. Levels of RIPK3 and CCK18 were significantly higher in the
plasma of the hyper-inflammatory ARDS endotype as compared with
the hypo-inflammatory endotype. This elevation was maintained
across 14 days.
CONCLUSION. We found that markers of necroptosis and epithelial
necrosis were raised in patients with ARDS with a hyper-
inflammatory endotype. These data implicate necroptosis in the
development of the hyper-inflammatory endotype of ARDS. This
pathobiological mechanism may provide an opportunity for pharma-
cological blockade and improved outcomes in this hyper-
inflammatory cohort.
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Table 1 (abstract 000805). Data shown as median with interquartile
range for epithelial necrosis and necroptosis markers. Comparisons were
made between hyper-inflammatory vs hypo-inflammatory groups using
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INTRODUCTION. Long-term mechanical ventilation is the most com-
mon situation where tracheostomy is indicated for patients in Inten-
sive Care Units (ICU). Percuteneous dilatational tracheotomy (PDT)
was first described in 1985 and now is a well-established procedure
that can be performed at the bedside by an intensivist with less sur-
gical equipment required.
OBJECTIVES. The use of a laryngeal mask airway was compared with
the existing endotracheal tube in terms of the safety, effective-
ness and duration of the procedure. Our aim was to compare the
safety and effectiveness of bronchoscope guided percutaneous
tracheostomy performance via endotracheal tube (ETT) vesrus Laryn-
geal Mask Airway (LMA) in critically ill adults patients
METHODS. 287 patients 18-83 yrs of age, 132 females and 155 males
with body mass index 31±6 kg/m² underwent PDT with bronchos-
copy assistance due to prolonged endotracheal intubation between
December 2009 and March 2019. The procedures of percuteneous
dilatation tracheotomy with guide wire dilator forceps (GWDF) were
done bedside with bronchoscopic guidance under general anaesthe-
sia in the (ICU). Operative and post operative complications were ob-
served. In 57 patients (23 females and 29 males) the ETT tube was
changed to LMA 20 min before the procedure. The rest of the pa-
tients underwent PDT via the pre-existing ETT. Bronchoscope was
used in both groups during procedure.
RESULTS. Overall complication rate was low and occurred in 56 pa-
tients, there was no procedure-related mortality. 18 accidental extu-
bations were noted in PDT via ETT group. Subcutaneous emphysema
without pneumothorax occurred in twelve patients ( 2 in LMA group
and 10 in ETT group), nine patients had transient hypotension re-
lated to sedation (1 in LMA group and 8 in ETT group) and seventeen
patients had peristomal oozing (3 in LMA group and 14 in ETT
group). The mean time for procedure completion was 15 minutes for
the EET group and 12 minutes for the LMA group, and no patient re-
quired conversion to surgical tracheotomy
CONCLUSION. Use of LMA seems to shorten the duration of the pro-
cedure with better visibility field through bronchoscope and thisshortens the period during which the airway is insecure. On the basis
of the limited number of patients investigated it is not possible to
draw any conclusions as to which procedure is superior in terms of
the likelihood of occurrence of mortality and adverse events
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INTRODUCTION. Measurement of esophageal pressure (Pes) allows
quantification of respiratory muscle activity, and transdiaphragmatic
pressure (Pdi) represents a specific measure of diaphragm contractil-
ity. However, acquisition and interpretation of the relevant wave-
forms remains a complex procedure, limiting wide implementation
of the technique in everyday ICU clinical practice. Ultrasonography,
on the other hand, is an increasingly popular tool in the diaphrag-
matic assessment of ICU patients. However, no association has so far
been described between Pes or Pdi and sonographically acquired in-
dexes of diaphragmatic function, such as diaphragmatic displace-
ment (DD).
OBJECTIVES. The purpose of this study was to investigate a possible
correlation between Pes and Pdi values with diaphragmatic displace-
ment, in patients during a T-piece weaning trial.
METHODS. In fifteen patients undergoing a T-piece weaning trial, we
recorded diaphragmatic displacement along with simultaneous Pdi
and/or Pes recording. When assessing displacement along with Pdi
recording, we studied two consecutive stages: i) breathing normally,
and ii) breathing normally with performance of sniff-like maneuvers.
When assessing displacement along with Pes recording, we again
studied two different breathing conditions: i) breathing normally,
and ii) breathing with resistances of 40cmH2O/L.
RESULTS. A total of 1360 breaths were studied at all different breath-
ing conditions (approximately 350 breaths/study condition). Statis-
tical significant correlations were observed in all stages. Pearson
correlation coefficient for the Pdi – DD relationship was r=0.57 (p<
0.001) and r=0.67 (p<0.001) for normal breathing and breathing with
sniff-like maneuvers respectively. Pearson correlation coefficient for
the Pes – DD relationship was r=0.65 (p<0.001) and r=0.8 (p<0.001)
for normal breathing and breathing with resistances respectively.
CONCLUSION. Our results suggest a statistically significant correl-
ation between the amplitude of diaphragmatic motion and the de-
rived changes in esophageal and transdiaphragmatic pressures. More
research is needed to confirm the potential of this non-invasive
index of diaphragmatic function to provide information once consid-
ered strictly provided by esophageal pressure catheters.
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INTRODUCTION. The evaluation of muscular effort, measured by PTP
and Wob, during mechanical ventilation, requires the use of esopha-
geal pressure, scarcely used in clinical practice. We evaluated a new
method based on the tracheal pressure, easier to use and, more con-
venient than esophageal.
OBJECTIVES. Assess the usefulness of tracheal pressure (Ptrach) to
monitoring Wob and PTP.
T1
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from tracheal pressure, based on respiratory mechanic related to re-
sistances of the endotracheal tube (Rett) and Elastance of the respira-
tory system (Ers) obtained from the time constant (τ). A new signal is
generated as Alveolar pressure (P Alv), by subtraction from the tra-
cheal pressure the product of the instantaneous volume and Ers.
METHODS. We have studied 12 patients mechanically ventilated dur-
ing pressure support ventilation (PSV) at three different levels of as-
sistance. We recorded the signals of Flow (V’), Airway pressure (P
Aw), Esophageal pressure (P Eso), Tracheal pressure (P Trach, sam-
pling at 561 Htz. A total of 310 cycles were selected. Pressure drop
across the ETT (DPETT) was obtained by subtraction of P trach to
Paw. The ratio DPETT change to the corresponding change in flow
was calculated to obtain the ETT resistance (Rett) using linear regres-
sion. Time constant (τ) was determined by exponential regression
from exhaled volume. Ers was calculated as the ratio of the Rett to τ.
The work of breathing (WOB, J/L) and effort as product pressure-time
product (PTP, cmH2O*s/min) were calculated, according to the P Eso
and P Alv. The results are expressed as mean±SD, the comparisons
by t-student; the relationship and agreement by linear regression
and Bland-Altman analysis.
RESULTS.
CONCLUSION. This method using tracheal pressure is a good ap-
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INTRODUCTION. Prone position reduces mortality among patients
with moderate to severe acute respiratory distress syndrome. We
aimed to evaluate whether the radiographic extent in high resolution
computed tomographic (CT) has predictive value for prone position-
ing response and its role in outcomes prediction.
METHODS. This study was conducted in a medical center from October
2014 to June 2016. Patients with moderate to severe acute respiratory dis-
tress syndrome underwent prone-position were included. Each lung was di-
vided into three representative levels (apex, hilum and base lung) and each
levels was divided into three sections (sternal, central and vertebral part).
Each area was rated on a six-point scale of 0–5 for the extent of consolida-
tion or ground glass opacity (GGO). Prone-responders are patients whose
PaO2/FiO2 ratio (PF ratio) increases by at least 20% or by ≧ 20mmHg.
RESULTS. Among 52 patients, 34 (65.4%) patients was prone re-
sponders and 18 (34.6%) patients were non-responsive. The consoli-
dation difference between dorsal and ventral section at basal lung
level was higher in prone responder than non-responder (5.3±2.6 vs
2.0±2.5, p<0.001). If the dorsal section had ≧ 4 points ofconsolidation score than ventral section at basal lung, the sensitivity/
specificity/positive-predictive-value/positive-predictive-value of prone
response prediction were 73.5%/77.8%/86.2%/60.9%, respectively.
Neither prone oxygenation response nor dorsal-ventral consolidation
difference at base lung was independently associated with 60-day
mortality, but a CT GGO score more than 14 was an independent fac-
tor associated with 60-day mortality (Odds ratio =4.46, p=0.030).
CONCLUSION. The results indicated that high vertical consolidation
difference (≧ 4 points) at base lung level was a helpful predictor in
predicting prone response. High extent of GGO change (≧ 14 points)
significantly correlated to 60-day mortality in patients with moderate
to severe acute respiratory distress syndrome.
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INTRODUCTION. ARDS has recently been proposed to consist of
‘hypo-‘ and ‘hyper-inflammatory’ subphenotypes. Patients with ARDS
with a hyper-inflammatory phenotype have a higher mortality.
Microvesicles (MVs) are plasma membrane-derived extracellular parti-
cles of 0.1-1μm size, produced in response to cell activation, and
retaining the antigenic characteristics of their parent cells. Circulating
MVs in ARDS represent the status of intravascular cell activation, ei-
ther within the systemic (e.g. from underlying sepsis, trauma or
burns) or pulmonary (e.g. from ventilator-induced lung injury) circula-
tion. We hypothesised that ARDS subphenotypes may be differenti-
ated by these circulating MVs.
OBJECTIVES. To test our hypothesis, we analysed the profiles of MVs
in platelet-poor plasma samples from patients with ARDS from the
HARP-2 clinical trial(1), according to their allocation to a hypo- or
hyper-inflammatory subphenotype(2).
METHODS. Plasma samples from 30 ARDS patients (15 hypo-, 15
hyper-inflammatory as defined at ARDS diagnosis) were analysed at
baseline (<48h ARDS onset) and day 7. Samples were analysed in a
blinded manner by flow cytometry for endothelial-(CD146+), neutro-
phil-(CD66b+), monocyte-(CD14+), and total leukocyte-derived
(CD45+) MV counts.
RESULTS. Endothelial- and neutrophil-derived MVs were significantly
increased at baseline in the hyper-inflammatory group. MV counts
decreased in both MV subpopulations at day 7 (Table 1).
CONCLUSION. These results demonstrate that a significant early re-
lease of endothelial- and neutrophil-derived MVs into the circulation
occurs with ‘hyper-inflammatory’ but not 'hypo-inflammatory' ARDS,
suggesting that intravascular inflammation, either within the sys-
temic or pulmonary circulation, plays a crucial role in defining ARDS
subphenotypes and early ARDS pathophysiology. Further research
into the cargoes and biological effects of these MV subpopulations,
and the contribution of ventilator-induced pulmonary microvascular
inflammation to MV production in ARDS, is warranted.
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48.2 ± 38.9 92.6 ± 50.7* 1.6 ± 6.1$$ 4.5 ± 9.7$$
Neutrophil-derived
MVs/μl
59.5 ± 59.6 115.2 ± 49.4** 4.0 ± 8.4$$ 22.8 ± 30.0$$
Monocyte-derived
MVs/μl
5.6 ± 7.6 12.6 ± 14.5 3.7 ± 6.2 7.3 ± 8.2
Leukocyte-derived
MVs/μl
210.9 ± 107.5 204.8 ± 129.1 111.9 ±
84.9$$
109.9 ± 78.2$
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INTRODUCTION. In hemodynamically stable patients with acute re-
spiratory distress syndrome (ARDS), a conservative fluid management
strategy has been shown to improve lung function and shorten the
duration of mechanical ventilation (1). However premature initiation
of diuresis can increase non-pulmonary organ failure such as acute
kidney injury. Previous study demonstrated high E/E’ and weight
gain predict poor tolerance of negative fluid balance (NFB) defined
as development of hypotension or AKI, or need for fluid expansion
(2), but no study has investigated whether urine output in response
to a small dose of diuresis predicts the poor tolerance of NFB. We hy-
pothesized that urine output after the administration of small dose
of diuresis are predictive to the poor tolerance of NFB in patients
with acute respiratory failure.
OBJECTIVES. We aimed to investigate whether the amount of urine
output after a small dose of furosemide administration predicts the
poor tolerance of NFB in acute respiratory failure patients.
METHODS. This study was a prospective observational study. All
mechanically ventilated and hemodynamically stable patients with
evaluations of hypervolemia for whom diuresis were planned were
included. A small amount of furosemide was administered (10mg for
eGFR>50, 20mg for eGFR 30-50), and the urine output was examined
for 4 hours, which is a part of the traditional practice in our hospital
to predict tolerability to NFB although no study has validated the
practice. Before administrating the furosemide, we performed trans-
thoracic echography to investigate several parameters, such as E/E’,
inferior vena cava diameters. After 4 hours of the meseaurement, the
patients were diuresed to achieve an NFB of more than 1000ml in 24
hours with additional doses of furosemide as needed. The primary
outcome of this study was the tolerance to NFB. Tolerance to NFB
was defined as absence of hypotension, acute kidney injury, or need
for fluid expansion.
RESULTS. A total of 60 mechanically ventilated patients were in-
cluded in the intensive care unit at Tokyo Bay Urayasu/Ichikawa med-
ical center. 48 patients (80%) had a tolerance of NFB and 12 patients
(20%) did not. The urine output following the furosemideadministration in patients who did not have tolerance of NFB
showed significantly lower urine output than that of patients with
tolerance to NFB in each of the first 4 hours (p<0.01). The area under
the receiver operator (AUC) characteristic curves for the urine output
in the first 4 hours following FST to predict tolerance to NFB was
0.826. The cutoff point of 500ml has the sensitivity of 0.85, and the
specificity of 0.75. The AUC of the urine output was higher than
those of E/E’ (AUC=0.626) and an amount of positive fluid balance
(AUC=0.633).
CONCLUSION. The urine output in response to a small dose of fur-
osemide could predict poor tolerance of NFB in patients with acute
repiratory failure. Further studies to validate this finding are needed.
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INTRODUCTION. Researchers have assumed that compressing the
point (P_max.LV), beneath which the left ventricle (LV) diameter is
maximum, would improve cardiopulmonary resuscitation (CPR) out-
comes. Defining the mid-sternum, the currently recommended chest
compression, as the reference (x=0), the lateral deviation (x_max.LV)
of personalized P_max.LV has become estimable using posteroanter-
ior chest radiography (chest_PA) (Fig 1).[Ref. 1]
OBJECTIVES. We aimed to investigate whether out-of-hospital car-
diac arrest (OHCA) victims, whose x_max.LV was closer to the mid-
sternum (where x=0) and thus had their P_max.LV compressed closer
during CPR, showed better chances of return-of-spontaneous-circula-
tion and survival-to-discharge (Fig 2).
METHODS. A retrospective, cross-sectional study was performed on
adult OHCA victims with available chest_PA checked before the car-
diac arrest. For each clinical outcome, multivariable logistic regres-
sion was performed grouping x_max.LV into tertiles and adjusting
the variables selected among the core elements of the Utstein tem-
plate showing possible differences (p>0.10) in univariate analysis.
RESULTS. Among 309 cases (age: 65.6±15.8 y, female 106 (34.3%)),
141 (45.6%) achieved ROSC and 48 (15.5%) survived to discharge.
Compared with the third tertile of x_max.LV (58~87 mm), its first
(-15~47 mm) and second (47~58 mm) tertiles whose P_max.LV were
closer to the mid-sternum, were negatively associated with return-of-
spontaneous-circulation (OR: 0.461 (0.250, 0.849), p=0.013; and OR:
0.429 (0.236, 0.782), p=0.006, respectively) and survival-to-discharge
(OR: 0.272 (0.086, 0.861), p=0.027; and OR: 0.131 (0.035, 0.492), p=
0.003, respectively).
CONCLUSION. OHCA victims with P_max.LV located closer to the
mid-sternum showed worse chances of return-of-spontaneous-circu-
lation and survival-to-discharge. This challenges the traditional as-
sumption identifying P_max.LV as the optimum compression point.
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Fig. 1 (abstract 000021). See text for description
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INTRODUCTION. Cardiovascular accidents are the leading cause of
death. A cardiopulmonary resuscitation (CPR) of quality has well
shown that can reduce the mortality; despite this, survival rate has
not changed significantly during last years.
OBJECTIVES. Aim of this study is to test a new wearable glove to
provide lay people with instructions during out-of-hospital CPR.
METHODS. After ethical committee approval, we performed a
blinded, controlled trial on an electronic mannequin AmbuMan (Bal-
lerup, Denmark) to test the performance of adult volunteers, non-
healthcare professionals performing a simulated CPR both, without
and with glove, following the glove instructions. The group without
glove, also called “no-glove” is intended as control group. Each com-
pression performed on theelectronic mannequin AmbuMan was re-
corded by a connected laptop computer, drawing a depth frequency
curve over the time. Primary outcome was to compare the accuracy
of the two simulated CPR sessions in terms of depth and frequency
of chest compression performed by the same lay volunteers. Second-
ary outcome was to compare the decay of performance and percent-
age of time in which the candidate performed accurate CPR. Finally,
the participants were asked if the glove was useful for CPR maneu-
vers. The difference between the two groups in regard to change in
chest compression depth over time due to fatigue, defined as decay
were also analyzed.
RESULTS. 571 chest compressions were included: 293 in control
group, 278 in glove group (Table 1). Mean depth of compression in
the control group was 55.17 mm versus 52.11 mm in the glove-
group (p=0.000016). Compressions with an appropriate depth were
not statistically different (81.9% vs 73.6%, p=0.017). Mean frequency
of compressions in the group with glove was 117.67 rpm vs 103.02
rpm in the control group (p<0.00001). The percentage of compres-
sion cycles with an appropriate rate (>100 rpm) was 92.4% in the
group with the glove versus 71% in the control group, with an ob-
served difference of 21.4% between the two groups, which was sta-
tistically significant (p<0.0001, CI=95%). A mean reduction over time
of compressions depth of 5.3 mm (SD 10.28) was observed in the
control group versus a mean reduction of 0.83 mm in the group
wearing the glove (SD 9.91), but this mean difference in the decay of
compressions delivery was not statistically significant (f-ratio=5.680,
SS=579.61, df=1, MS=579.61, p=0.018).
CONCLUSION. The use of the glove was effective in reducing by
more than 20% the inappropriateness of the frequency of chest com-
pressions during CPR. The visual and acoustic feedbacks provided by
the device were useful in dictating the correct rhythm for non-
healthcare professionals, translating in a significantly more accurate
CPR.
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INTRODUCTION. In addition to poor neurological outcome, circula-
tory failure has been described as an important determinant of prog-
nosis after out of hospital cardiac arrest (OHCA). The role of left
ventricle dysfunction after cardiac arrest has been established in mul-
tiple studies [1]. However, data on right ventricle (RV) dysfunction in
this setting remains scarce.
OBJECTIVES. To investigate a potential association between RV fail-
ure and mortality after OHCA.
METHODS. A retrospective single-centred study was conducted. All
patients ≥18 years, admitted to the ICU with return of spontaneous
circulation (ROSC) after OHCA between 2011 and 2018 were in-
cluded. By protocol, all OHCA patients were equipped with a pul-
monary artery catheter that enables near-continuous assessment of
RV ejection fraction (RVEF). (Vigilance® CCO/SvO2/CEDV Monitor, Bax-
ter Healthcare Corporation, Irvine, CA). Resuscitation characteristics,
hemodynamic variables and 1-year all-cause mortality were recorded.
Primary endpoint of the study was 1-year all-cause mortality in differ-
ent RVEF-subsets (group A: <20%, group B: 20-30%, group C: >30%).
RVEF was calculated as an average over the first 24h of ICU admis-
sion. Data are presented as median [IQR].
RESULTS. N=238, divided over group A: 47 (20%), group B: 123
(52%), group C: 68 (29%); 77% male, median age 66 [55-73]. Patients
with the lowest RVEF had a significantly longer time to ROSC and the
incidence of a non-shockable rhythm and adrenaline administration
was significantly higher. However, presumed aetiology and the per-
centage of patients with an intervention of the right coronary artery
were not different across groups. 1-year all-cause mortality was sig-
nificantly different across groups (group A: 64%, group B: 43%, group
C: 32%; p<0.01). In a Kaplan-Meier survival analysis there was a sig-
nificant separation between groups (X2=18.90; p=<0.001; fig.). How-
ever, in multivariate analysis, with statistical correction for potential
baseline confounders, this association between RVEF (as a continu-
ous variable) and 1-year all-cause mortality was not independent (OR
0.99, CI 0.93-1.06, p=0.81).
CONCLUSION. The incidence of patients with an RVEF of <20% after
OHCA was 20%. 1-year all-cause mortality was significantly higher in
patients with the lowest RVEF in the first 24h after OHCA. However,
after correction for potential baseline confounders this association
did not remain statistically significant.
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INTRODUCTION. Development of acute kidney injury (AKI) after out-
of-hospital cardiac arrest (OHCA) is a well-known predictor for mor-
tality and poor neurological outcomes in both adult and paediatric
populations [1,2]. However, the natural course of AKI in terms of its
recovery rate after OHCA is uncertain. If we know the natural course
of AKI after OHCA, it will be helpful in making appropriate clinical de-
cisions such as determining the initiation time for renal replacement
therapy and making a prognosis in OHCA patients with AKI develop-
ment. We hypothesized that recovery from AKI may affect the sur-
vival discharge and neurological status at discharge in OHCA
patients treated with targeted temperature management (TTM).
OBJECTIVES. This study investigated the clinical course of AKI after
OHCA and determined whether recovery from AKI impacted the out-
come of OHCA.
METHODS. This retrospective multicentre cohort study included
adult OHCA patients treated with TTM between January 2016 and
December 2017. AKI was diagnosed using the Kidney Disease: Im-
proving Global Outcomes criteria [3]. The primary outcome was the
recovery rate after AKI and its association with survival discharge.
RESULTS. A total of 3,697 OHCA patients from 6 hospitals were
screened and 275 were finally included. AKI developed in 175/275
(64%) patients and 69/175 (39%) patients recovered from AKI. In
most cases, AKI developed within 3 days of return of spontaneous
circulation [155/175 (89%), median time to AKI development: 1 (1–2)
day] and patients recovered within 7 days of return of spontaneous
circulation [59/69 (86%), median time to AKI recovery: 3 (2–7) day].
The median duration of AKI was 4 (2–7) days. Duration of AKI was
significantly longer in the AKI non-recovery group than in the AKI re-
covery group [5 (2–9) vs. 1 (1–5) days, P < 0.001]. Most patients were
diagnosed with AKI Stage 1 initially [120/175 (69%)]. However, the
number of Stage 3 AKI patients increased from 30/175 (17%) to 77/
175 (44%) after the initial diagnosis of AKI. The rate of survival
Page 412 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55discharge was significantly higher in the AKI recovery group than in
the AKI non-recovery group [45/69 (65%) vs. 17/106 (16%), P <
0.001]. Recovery from AKI was a potent predictor of survival dis-
charge in multivariate analysis (adjusted odds ratio, 12.622; 95% con-
fidence interval: 3.390–46.993; P < 0.001).
CONCLUSION. The recovery rate from AKI after OHCA was 39% and
recovery from AKI was a potent predictor of survival discharge in
adult OHCA patients treated with TTM.
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INTRODUCTION. The prognosis of non-shockable out-of-hospital car-
diac arrest (OHCA) patients is poorer than that of shockable OHCA
patients[1]. The advantage of extracorporeal cardiopulmonary resus-
citation (E-CPR) for OHCA has been suggested[2], but as most studies
involved shockable OHCA patients with a relatively favorable out-
come[3], the usefulness of E-CPR in patients with non-shockable
OHCA remains to be clarified.
OBJECTIVES. The purpose of this study was to examine the applica-
tion of percutaneous cardiopulmonary support (PCPS: V-A ECMO) as
E-CPR and its outcome-improving effects in patients with non-
shockable OHCA developed after EMS arrival.
METHODS. Of 16,452 patients accumulated in the SOS-KANTO 2012
study (OHCA patients admitted to 67 emergency hospitals in Kanto
region (central Japan) from January 2012 until March 2013 were reg-
istered), the subjects (n=531) were selected. We retrospectively ana-
lyzed the background and clinical outcomes by dividing the subjects
into two groups: the PCPS group and the non-PCPS group.
RESULTS. Thirty-eight patients (7.2%) was undertaken PCPS and not
for 493 patients (92.8%). On univariate analysis of background fac-
tors, the age was significantly younger (p<0.001), ADL before the on-
set were significantly more favorable (p=0.002), the body weight was
significantly heavier (p=0.02), and the interval from onset until hos-
pital arrival was significantly shorter in the PCPS group than in the
non-PCPS group (p=0.001). The incidences of ACS, non-ACS cardiac
disease, and pulmonary embolism were significantly higher in the
PCPS group than in the non-PCPS group (p<0.001, p=0.004, P<0.001).
The 3-month survival/favorable cerebral function outcome rates were
significantly higher in the PCPS group than in the non-PCPS group
(p=0.003, p=0.001). On multivariate analysis corrected for back-
ground factors, the execution of PCPS and interval from onset until
hospital arrival were independent prognostic factors for favorable
cerebral function outcome at 3 months (OR 7.62, 95%CI 1.641 - 35.38
/ OR 1.08, 95%CI 1.004 - 1.194).
CONCLUSION. In this study, the outcomes at 3 months were signifi-
cantly more favorable in the PCPS group than in the non-PCPS
group, although there were differences in the background factors.
Even in patients with non-shockable OHCA, E-CPR may improve the
outcome if patients are carefully selected.REFERENCE(S)
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INTRODUCTION. In patients resuscitated from out-of-hospital cardiac
arrest (OHCA), severe metabolic acidosis occurs due to whole-body
ischemia and anaerobic metabolism. Lactate level at hospital admis-
sion is often used as a marker og ischemia and prognosis. However,
hyperlactatemia does not alone explain the metabolic acidosis after
OHCA, since other metabolic products is formed during ischemia.
Base excess, which is an easily obtainable measure of the total meta-
bolic acid-base status, could potentially have additional prognostic
information compared with lactate.
OBJECTIVES. We aimed to investigate and compare the prognostic
value of base excess and lactate at hospital-admission and during in-
tensive care after OHCA.
METHODS. We included 939 consecutive, comatose OHCA-patients
in the targeted temperature management (TTM)-trial, which ran-
domly allocated patients to TTM at 33°C and 36°C for 24 hours. Base
excess and lactate were prospectively measured at hospital admis-
sion and at several time points during TTM and mortality was re-
ported in all patients after 180 days. Receiver operation characteristic
(ROC) curves for admission base excess and admission lactate were
computed in respect to 180-day mortality with calculation of optimal
cut-off values to predict ICU mortality. Repeated measurements
models were used to assess differences in base excess during TTM
between survivors and non-survivors.
RESULTS. We excluded 5 (1%) patients with no base excess data
which left 934 patients (99%) eligible for analysis. The admission-
base excess measurement was missing in 62 (6%) patients. Patients
were 64 (±12) years old, 81% were men and 89% had a witnessed
OHCA. At hospital admission, mean base excess was -9.09 (±6.15)
mmol/L and median lactate was 6.0 (3.0-9.5) mmol/L. Comparing
survivors and non-survivors, admission-base excess was less nega-
tive in survivors (-7.63±5.59 versus -10.57±6.53, p=0.01). Further-
more, during TTM, not including the admission values, base excess
remained significantly less negative in survivors (β = 1.31 [95% con-
fidence limit, 1.85 – 0.78 mmol/L]; pgroup <0.0001). Pairwise com-
parison of ROC-curves showed no difference in predictive value
between base excess (area under the (AU) ROC = 0.66 (95%-CI 0.62-
0.69)) and lactate (AUROC = 0.64 (95%-CI 0.61-0.68)) (p = 0.88). The
optimal base excess cut-off value to predict mortality was <-9.35
mmol/l (sensitivity 61%, specificity 69%, Youdens Index: 0.28). For
lactate the optimal cut-off value to predict mortality was >5.65
mmol/L (sensitivity 63%, specificity 59%, Youdens Index: 0.21). In a
multivariate Cox regression model adjusted for confounders includ-
ing admission-lactate, admission-base excess <-9.35 mmol/L was in-
dependently associated with mortality (hazard ratio: 1.83 [95%-CI
0.44-2.32], p<0.0001).
CONCLUSION. Admission base excess below a cut off -9.35 mmol/l
was independently associated with mortality. Lactate and base ex-
cess had identical predictive value and can be used interchangeably
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INTRODUCTION. Choosing the appropriate candidate who can get
benefit from early coronary angiography(CAG) and targeted
temperature management(TTM) is still challenging. Simplified CAHP
(sCAHP) score is a validated tool to predict neurological outcomes
following out-of-hospital cardiac arrest (OHCA).
OBJECTIVES. To evaluate whether the effect of CAG and TTM is mod-
ulated by the sCAHP score in OHCA patients.
METHODS. Consecutive OHCA patients were evaluated from 2011 to
2017 in a tertiary medical center. The optimal cutoff value of sCHAP
score for neurological prognosis was estimated by generalized addi-
tive model (GAMs).
RESULTS. There were 412 patients included in the study and 94 pa-
tients (22.8%) had favorable neurological outcome with cerebral per-
formance category (CPC) 1-2. The optimal cutoff value of sCAHP for
differentiating high risk from low risk was 185 by GAM plot. There
was interaction between the sCAHP score and TTM in regression ana-
lysis for predicting the favorable neurological outcome. TTM was as-
sociated with favorable neurological outcome only in the patients
with sCAHP score < 185 (odds ratio (OR) 2.13, 95% confidence inter-
val (CI) 1.10–4.13, p=0.02). Improvement of survival outcome was as-
sociated with TTM independent of sCAHP scores (OR 2.66, 95% CI
1.54–4.59, p<0.001). Early CAG was associated with favorable neuro-
logical (OR 4.43, 95% (CI) 2.28–8.60, p<0.001) and survival outcome
(OR 3.47, 95% CI 1.93–6.25, p<0.001) irrespective of low or high
sCAHP scores.
CONCLUSION. Early CAG should be considered for all OHCA pa-
tients, irrespective of the immediately predicted neuroprognosis
after ROSC. The appropriate selection of candidate for TTM needs
further studies, especially for those with worse predicted immedi-
ate neuroprognosis.
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INTRODUCTION. High-quality chest compressions (CC) with mini-
mized interruptions are one of the most essential prerequisites for an
optimal outcome of resuscitation. Therapy of reversible causes of car-
diac arrest, such as coronary angiography, often requires intra-
hospital transport (IHT) during ongoing resuscitation. There is con-
cern for a relevant decline of compression quality while moving pa-
tients. Therefore, automatic CC devices have been developed by the
industry. As guidelines only recommend these devices under certain
circumstances, such as transport during resuscitation, manual CC re-
mains the gold standard [1].
OBJECTIVES. The present study investigated manual CC quality dur-
ing IHT in two different provider positions in comparison with the
automatic CC device Corpuls-CPR.
METHODS. 20 paramedics were enrolled into a manikin study (Laer-
dal Resusci Anne QCPR) with four groups: a reference group (RG)
with the provider kneeling beside the manikin on the floor and 2
groups performing CC during a simulated IHT: kneeling in bed beside
the patient (group 1, figure 1) or squatting above the patient in bed
(group 2,figure 2). Each participant completed each scenario. In com-
parison, 20 simulated IHT were performed using the Corpuls-CPR (GS
Elektromedizinische Geräte G. Stemple GmbH) (group 3, figure 3). In-
dicators of CC quality (pressure point and depth, compression fre-
quency, complete relief and sufficient pressure depth) were
measured as defined in the European Resuscitation Council Guide-
lines 2015 [1].
RESULTS. The RG was able to perform high quality CC. Compared to
the RG, there were no statistical differences in CC quality in groups 1-3.
Notably, CC quality was similar in the manual groups 1 and 2 as com-
pared to Corpuls-CPR in group 3. Detailed results are shown in table 1.
CONCLUSION. Carrying out guideline-compliant CC [1] during IHT is
feasible with multiple provider positions. A manual CC in this context
is not inferior to a mechanical CC with the Corpuls-CPR. These results
suggest that even in the absence of automatic devices high quality
CC are possible during intra-hospital transportation.
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n Cause of cardiac arrest n
Induction 5 Difficult airway during induction 4
Septic shock 1
Intraoperative 9 Acute haemorrhage 5
Obstructed endotracheal tube 2
Septic shock 1
Dislocated endotracheal tube 1
Tension pneumothorax 1
Vagal 1
Postoperative 2 Malignant Hyperthermia 1
Hypoxemic attack in pneumothorax and Fallot's
pentalogy
1
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INTRODUCTION. Cardiac arrest (CA) in the peri-operative care of
paediatric patients is a dreaded event [1,2]. The incidence ranges be-
tween 3-21 per 10,000 paediatric anaesthetic procedures, depending
on the investigated patient population. [1,2]
OBJECTIVES. The aim of our study was to characterize the causes of
perioperative paediatric CA at a German tertiary care hospital be-
tween 2008-2018.
METHODS. The anaesthetic database was screened for perioperative
paediatric CA during all anaesthesiologic procedures in patients <16
years of age. We defined the peri-operative period from anaesthesia
induction until the end of care of the team of anaesthesists care. CA
was defined as the necessity of performing chest compressions. In
each case the cause of CA was documented and it was assigned to
one of the 3 peri-operative phases: induction of anesthesia, intraop-
eratively and postoperatively until the end of anaesthesiologists´
care.
RESULTS. During the 10 year observation period,18 perioperative
paediatric CA were observed in a total of 22650 general anaesthesia
procedures according to an incidence of 7,9 ± 4,2 per 10,000 paedi-
atric anaesthetics (CI 95 4,2-11,6). In 17 cases a surgical procedure
was performed, while in one case a bronchoscopy was the reason for
anaesthesia. Five CA occurred during induction of anaesthesia,
eleven intra-operatively and two in the post-operative phase. The
causes of CA are displayed in Table 1. Two children died intraopera-
tively as a result of liver haemorrhage and one child at the post-
anaesthesia care unit as a result of malignant hyperthermia. After 30
days seven children with perioperative CA had died during the hos-
pital stay as a result of their underlying condition, nine of the resusci-
tated children survived.
CONCLUSION. Paediatric peri-operative CA is a rare event. During an-
aesthesia induction, CA mainly occurs in association with a difficult
airway. Intraoperatively, acute shock events (haemorrhage, sepsis)
and complications with the endotracheal tube are the most common
causes of paediatric perioperative CA.
REFERENCE(S)
[1] Habre W. et al. Incidence of severe critical events in paediatric
anaesthesia (APRICOT): a prospective multicentre observational study in
261 hospitals in Europe. Lancet Respir Med 2017; 5: 412-25
[2] Davis PJ. Et al. Anesthesia-Related Cardiac Arrest in Children with Heart
Disease: Data from the Pediatric Perioperative Cardiac Arrest (POCA)
Registry Anesthesia & Analgesia: May 2010 - Volume 110 - Issue 5 - p
1376–1382 doi: 10.1213/ANE.0b013e3181c9f927000264
Multi-vessel versus culprit-only revascularization in cardiac arrest
survivors with multi-vessel coronary artery disease: A multi-center
cohort study
CK. Wu1, CW. Sung2, CH. Huang1, WJ. Chen1, SN. Wu1, WT. Chang1,
T. Ming-Sham1
1Department of emergency medicine, National Taiwan University
Hospital and College of Medicine, Taipei, Taiwan; 2Department of
emergency medicine, National Taiwan University Hospital Hsin-Chu
Branch, Hsinchu, Taiwan
Correspondence: C.K. Wu
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000264
INTRODUCTION. Conflicting results existed as to the recommenda-
tion of complete revascularization for multi-vessel coronary artery
disease (CAD) in patients with ST-elevation myocardial infarction
(STEMI). In survivors successfully resuscitated from cardiogenic arrest
with multi-vessel CAD, whether multi-vessel revascularization or
culprit-only revascularization benefit outcomes more remains un-
determined and worth further investigation.
OBJECTIVES. To evaluate whether multi-vessel revascularization fol-
lowing return of spontaneous circulation (ROSC) is associated less in-
hospital mortality and poor neurological recovery than culprit-only
revascularization.
METHODS. Two hundred and seventy-three non-traumatic, adult
(ages ≥ 18) cardiac arrest patients with sustained ROSC and under-
went emergent coronary angiography (CAG) within 24 hours follow-
ing cardiac arrest were retrospectively recruited from three hospitals
from 2012 to 2017. Patients with definite coronary artery stenosis (<
70%) (n=72) or 1-vessel stenosis (n=74) or failed percutaneous coron-
ary intervention (PCI) (n=37) were excluded. Multi-vessel PCI was de-
fined as revascularization of more than one major vessel during the
index CAG, and culprit-only PCI as revascularization of the infarct-
related artery only. In-hospital mortality and neurological function at
hospital discharge were compared between groups.
RESULTS. A total of 90 patients were enrolled in the final analysis
and classified into multi-vessel (n=45) and culprit-only (n=45) groups.
No significant differences of baseline characteristics, CPR events, and
post-arrest care was noted between these two groups. Twenty-five
patients (55.6%) in the culprit-only groups failed to survive to dis-
charge while 17 patients (37.8%) in the multi-vessel group did (ad-
justed HR = 0.54, 95% CI = 0.28 – 0.98, p = 0.04). There were 27
patients (60.0%) in the culprit-only groups discharged with poor
neurological recovery (cerebral performance category: 3-5) while 25
patients (55.6%) in the multi-vessel group (adjusted OR = 0.89, 95%
CI = 0.29 – 1.98, p = 0.78). Consistent decrease of in-hospital mortal-
ity in patients receiving multi-vessel revascularization was noted with
CPR duration ≥ 10 mins.
T1
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multi-vessel revascularization is associated with less in-hospital mor-
tality as compared with culprit-only revascularization.
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INTRODUCTION. The incidence of cardiac arrest after cardiac surgery
is around 1,4-2,7%, while reported survival rate is 30-56%.
OBJECTIVES. Aim of our study is to investigate whether cardiac surgi-
cal patients who survived after cardiac arrest during the first 48
hours, are more likely to experience major postoperative
complications
METHODS. We retrospectively studied patients who suffered cardiac
arrest during the first 48 h after cardiac surgery , from June 2012 to
March 2019.The following complications were investigated: Post op
atrial fibrillation(AF), Acute Kidney Injury based on KDIGO criter-
ia(AKI), need for renal replacement therapy(RRT), postop stroke, ster-
nal wound infection and low cardiac output syndrome(LCOS).We
compared cardiac arrest survivors with the rest of the cohort exclud-
ing patients who died during hospital stay. Cardiopulmonary resusci-
tation was conducted according to the Cardiac Advanced Life
Support(CALS) protocol. Chi square test was used for the statistical
analysis.
RESULTS. From a total of 86 pts who suffered cardiac arrest, 42 sur-
vived (group A, mean age 67,2± 10,8 and mean Euro Score II 3,5±
3,1). Group B consisted of 3217 patients (mean age 65,3± 10,6 and
mean Euro Score II 2,2±3,1) who underwent cardiac surgery and dis-
charged from hospital. Results are shown in table 1.
CONCLUSION. Cardiac arrest survivors after cardiac surgery have
higher incidence of postoperative stroke, atrial fibrillation, AKI, AKI re-
quiring RRT, and Low Cardiac Output Syndrome compared with the
rest of patients who discharged from hospital. No statistical signifi-
cant difference was found regarding sternal wound infections.
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Stroke(n,%) 4 (9,5%) 46 (1,4%) <0,01
AF(n,%) 25 (59,5%) 985 (30,6%) <0,01
AKI(n,%) 16 (38,1%) 414 (12,9%) <0,01
AKI-RRT(n,%) 7 (16,7%) 44 (1,4%) <0,01
LCOS(n,%) 10 (23,8%) 157 (4,9%) <0,01
Sternal infections(n,%) 2 (4,8%) 115 (3,6%) 0,68000350
Ischemic injury of the upper digestive tract after cardiac arrest:
results of the prospective, multicentric ENTRACT study
D. grimaldi1, S. Legriel2, N. Pichon3, P. Colardelle4, S. Leblanc5, F. Canoui-
Poitrine6, O. Ben Hadj Salem7, G. Muller8, N. De Prost9, S. Herrmann10,
S. Marque11, A. Baron12, B. Sauneuf13, J. Messika14, J. Creteur15,
JP. Bedos16, FS. Taccone15, E. Boutin6, A. Cariou17
1Soins intensifs, ULB Erasme, Anderlecht, Belgium; 2Medical surgical
intensive care, General Hospital Center, Versailles, France; 3Medical
surgical intensive care unit, General Hospital Center, Brive-la-Gaillarde,
France; 4Gastroenterology, C.H. de Versailles, Le Chesnay, France;
5Gastroenterology, Hospital Cochin, Paris, France; 6Statistic and
epidemiology, Hôpital Henri-Mondor Ap-Hp, Créteil, France;
7Icu, Hospital Center Intercommunal Poissy/Saint-Germain-En-
Laye, Poissy, France; 8Icu, The Regional Hospital of Orleans, Orléans,
France; 9Icu, Hôpital Henri-Mondor Ap-Hp, Créteil, France;
10Gastroenterology, The Regional Hospital of Orleans, Orléans, France;
11Icu, Hospital Center Sud Francilien, Corbeil-Essonnes, France;
12Gastroenterology, Hospital Center Sud Francilien, Corbeil-Essonnes,
France; 13Icu, Chpc - Hospital Center Public Du Cotentin : Hospital Louis
Pasteur, Cherbourg-en-Cotentin, France; 14Icu, Louis-Mourier Hospital
(AP-HP), Colombes, France; 15Soins intensif, ULB Erasme, Anderlecht,
Belgium; 16Icu, C.H. de Versailles, Le Chesnay, France; 17Medecine
intensive reanimation, Hospital Cochin, Paris, France
Correspondence: D. grimaldi
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000350
INTRODUCTION. Post-CA ischemia/reperfusionn of the gastro-
intestinal tract is suspected to provoke endotoxin translocation, con-
tributing to shock and organ failure (1, 2). However, incidence, char-
acteristics and consequences of these GI ischemic injuries are
unknown
OBJECTIVES. Main objective: to assess the incidence of upper digest-
ive tract ischemia in a prospective cohort of patients resuscitated
from an out-of-hospital cardiac arrest (OHCA).
Secondary objectives: to determine the incidence of severe digestive
ischemia; to determine if upper digestive digestive tract ischemia (se-
vere or not) is associated with occurrence and duration of post-CA
resuscitation shock, and with favorable neurological outcome.
METHODS. The ENTRACT study was a prospective, interventional,
non-controlled, multicentric study. Included patients underwent a
gastroscopy 2 to 4 d after OHCA if still intubated. Digestive ischemia
was determined by the gastroenterologist who performed the gas-
troscopy. Severe lesion were defined as ulceration or necrosis. Post-
CA shock was defined by the needs for vasopressors despite appro-
priate fluid management and vasopressors-free days over the first 10
days. CPC 1/2 at hospital discharge defined a favorable outcome
(FO). Patients with and without digestive ischemia were compared.
Multivariate regression analysis were performed to identify variables
associated with digestive ischemia.
RESULTS. 221 patients were included, 214 were suitable for complete
analysis. Mean age was 62, 74% were male. CA was witnessed in
90%, initial rhythm was VT/VF in 53%, median no-flow was 5 (0-9)
min and low flow 21 (15-30) min. 121 (57%, CI95% 50-63%) patients
had at least one ischemic lesion lesion of upper digestive tract (103
(85%) didn't present any digestive symptoms before endoscopy).
Fundus was the most frequent localization of ischemia followed by
antrum, duodenum and esophagus. Ischemic lesions were severe in
55/121 (45%) patients and mild in 66 (mucosal oedema/erythema).
Patients with digestive ischemia, compared to patients without, had
similar demographic characteristics but were less frequently treated
with proton pump inhibitor (PPI) before CA (16% vs 31%). CA charac-
teristics were similar except that patients with digestive ischemia re-
ceived more epinephrine (2(1-4) vs 1(0-3) mg) despite similar low-
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0.3 (0.09-0.94)) previous PPI (OR 0.49 (0.23-1.03)) and hypochloremia
(OR 0.9 (0.84-0.97)) as protective factors whereas hematocrit (OR 1.04
(1.00-1.09)) and epinephrine dose during CPR (OR 1.17 (1.03-1.32)
were associated with upper digestive ischemia. 138 (64%) patients
presented post-resuscitation shock and 82 (38%) had a FO. These
proportions were similar between the 2 groups as well as vasopres-
sors free days. In pre-specified sub-group analysis, patients with se-
vere digestive ischemia had a lower rate of FO (26% vs 41% and
36% for patients with moderate or no digestive ischemia, p=0.04).
Analyses on post-CA shock and on organ failure are ongoing.
CONCLUSION. In this multicentric study, upper digestive tract ische-
mia was frequent after CA (57% of the patients) and associated with
epinephrine dose during CPR. Digestive ischemia involved mainly the
stomach, necrosis was rare. Severe ischemia seems to be associated
with outcome. Main limitation is that patients extubated or dead be-
fore d2 were not included.
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INTRODUCTION. The aim of this study was to identify predictive fac-
tors for successful weaning in patients who received extracorporeal
cardiopulmonary resuscitation (ECPR) after cardiac arrest.
METHODS. Between December 2015 and November 2018, we retro-
spectively analyzed all patients who had in-hospital cardiac arrest
(IHCA) and out-of-hospital cardiac arrest (OHCA) and were treated
with venoarterial extracorporeal membrane oxygenation (VA-ECMO)
at our institution. We divided the patients into two groups (weaned
and unweaned) and compared the patients’ baseline characteristics,
low-flow time, and laboratory findings between the two groups.
RESULTS. Of the 151 patients included in the study, 30 (19.9%) had
OHCA and 121 (80.1%) had IHCA. Seventy-three patients (48.3%)
were successfully weaned from VA-ECMO, while 78 (51.7%) were not.
The mean low-flow time was 24.9 ± 16.9 minutes in all the patients,
20.9 ± 15.9 minutes in the weaned group, and 28.6 ± 17.1 minutes in
the unweaned group (p = 0.005). Multivariate analysis revealed
shorter low-flow time as an independent predictor of successful
weaning from VA-ECMO, whereas IHCA and age did not predict suc-
cessful weaning from VA-ECMO.
CONCLUSION. Low-flow time was a significant predictor of successful
weaning from VA-ECMO in the patients who received ECPR in this
study.
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INTRODUCTION. Current treatments for out-of-hospital comatose
cardiac arrest patients have improved the survival rate and neuro-
logic prognosis. However, early neurologic prognostication still re-
mains a challenge. We assumed that initial serum ammonia and
lactate levels may be associated with the patients neurologic
outcome.
OBJECTIVES. This is a single-centered prospective study comprising
213 patients with 14 exclusions. Blood samples were taken after the
return of spontaneous circulation (ROSC). Neurologic prognosis was
evaluated using cerebral performance scale (CPC). Patients were di-
vided into two groups: Good neurologic outcome (CPC 1, 2 = 80)
and Poor neurologic outcome (CPC 3, 4, 5 = 133).
METHODS. Variables were compared using Chi-square or T-Test. All
variables found to be significant by univariate analysis then under-
went multivariate logistic regression analysis for determine whether
each variable has an independent relationship with poor neurological
prognosis. The primary model was constructed by extracting statisti-
cally significant variables and performing multiple logistic regression
analysis. The secondary model consisted of the discriminative power
of the primary model for the prediction of neurological prognosis,
and the concentration of serum ammonia and blood lactate,
respectively.
RESULTS. Serum ammonia and lactate levels in the poor outcome
group were significantly higher than those of the good outcome
group. On multivariate logistic regression analysis, age (OR, 1.029;
95% CI, 1.003-1.055; p =0.027), non-shockable rhythm (OR, 12.682;
95% CI, 5.855-27.471; p < 0.001), and time from collapse to ROSC
(OR, 1.062; 95%CI, 1.037-1.088; p < 0.001) were the most significant
predictive variables for poor neurologic outcomes, and comprised
our primary prediction model for poor neurologic outcomes. Second-
ary model consisted of either or both of ammonia and lactic acid in
the primary model. These two models were compared and no signifi-
cant differences were found.
CONCLUSION. In conclusion, serum ammonia and lactate levels were
associated with prognosis of the out-of-hospital comatose cardiac ar-
rest patients but did not provide incremental prognostic value.
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INTRODUCTION. Current basic life support guidelines recommend
two minute shifts for compression between two rescuers (1). How-
ever, rescuer fatigue coupled with a decay in the quality of chest
compressions occurs within one minute.
OBJECTIVES. To compare alternating rescuers in one-minute and
two-minute chest compressions, in terms of: chest compression qual-
ity metrics and rescuer fatigue.
METHODS. This prospective randomized cross-over study was con-
ducted at Songklanagarind hospital, Hat Yai, Songkhla, Thailand. The
study enrolled sixth year medical students and residents. All partici-
pants were randomly grouped into pairs to perform 8 minutes of
chest compression, utilizing both the one-minute and two-minute
scenarios on a mannequin model. The primary end-points were:
chest compression depth and rate. The secondary end-points in-
cluded rescuer’s fatigue, respiratory rate and heart rate.
RESULTS. One-hundred and four medical students and residents par-
ticipated in this study. In the one-minute group, compared with the
two-minute group, there was significant, higher mean (SD) compres-
sion depth [mm] (45.8 (7.2) vs 44.5 (7.1), P=0.01), but no difference in
the mean (SD) compression rate [per min] (116.1 (12.5) vs 117.8
(12.4), p = 0.08). The rescuers in the one-minute group were lower in
the fatigue visual analog scale (P<0.001), change in respiratory rate
(P<0.001), however, there was no difference in the change of heart
rate (P=0.59), compared with the two-minute group.
CONCLUSION. There was statistically significant, higher compression
depth and lower rescuer fatigue in 1-minute chest compression
groups, compared with 2-minutes. (Thai Clinical Trials Registry
TCTR20170823001)
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INTRODUCTION. Out of hospital cardiac arrest (OHCA) affects 60,000
people in the UK annually and good outcomes rely on a ‘chain of
survival’, which has pre-hospital and in-hospital components. Our
700-bedded UK DGH has a 24-7 Cardiac Cath Lab service, receives
100 OHCA patients each year, and is served by two ambulance ser-
vices – South East Coast (SECAMB) and South Central (SCAS).
OBJECTIVES. To quantify our hospital survival after OHCA and con-
trast this with local ambulance service data.
METHODS. We analysed prospectively collected data from all adult
post-OHCA patients admitted via ED over a 5-year period (01/01/12-
31/12/16) using Trust electronic databases, and compared this with
nationally published ambulance service data.
RESULTS. [Presented as median (range) or percentages] Of 499 pa-
tients identified: age 71 (20-96); primary rhythm VF 40%, VT 3%, PEA
29%, asystole 19%, none recorded 9%; died in ED 45%, admitted to
ICU 43%; admitted to a ward 12%; survived 25%. Of VF patients: age
68 (20-93), admitted to ICU 59%, survived 44%. Of VT patients: age
76 (57-91), to ICU 38%, survived 38%. Of PEA patients: age 72 (23-
96), to ICU 28%, survived 7%. Of asystole patients: age 74 (25-96), to
ICU 26%, survived 3%. Monthly OHCA ambulance service survival
data during study period: SCAS 15.4% (5.5-26.9), SECAMB 7.6% (0.7-
12.3), national 8.5% (6.3-10.6). Of the 31192 ambulance arrivals in
2016: conveyed by SECAMB 77%, conveyed by SCAS 23%.
CONCLUSION. 1) Our data show that patients presenting with VF are
younger, more likely to be selected for ICU support and survive to
hospital discharge: a relationship that is well known. 2) The national
incidence of cardiac arrests presenting with shockable rhythms is
20%; in our population this was 43%. 3) Our overall survival rate is
well above average (observed 25%; expected 8.5%), which could be
be explained, in part, by selection bias by pre-hospital teams, who
consciously select in patients with favourable outcomes (those in VF
and most likely to benefit from a heart attack centre) and uncon-
sciously select out those with unfavourable outcomes via unsuccess-
ful resuscitation. 4) Both SECAMB and SCAS follow national
guidelines and are able to pronounce life extinct (PLE) at the scene.
However, they have dramatically different survival data; reasons for
which we will continue to investigate. We hypothesise that, among
others, differences in data collection and/or PLE thresholds may be
at play here. 5) SCAS conveys <¼ of our patients, so excess survival
directly attributable to SCAS should have minimal impact on our out-
comes. 6) Increased VF prevalence does not completely explain the
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erly patients in ICU as older age has been associated with poor clin-
ical outcome.
OBJECTIVES. We analyzed patients above the age of 80 admitted to
our ICU during the past four years and evaluated clinical outcomes.
METHODS. Retrospective cohort study of patients aged 80 and
above admitted to the ICU of Hospital de Mostoles in Madrid, Spain,
from January 2014 to December 2018. We collected data from elec-
tronic medical records on demographics, functional status prior to
admission, Simplified Acute Physiology Score III (SAPS III), admission
cause, need of mechanical ventilation, vasopressor support, continu-
ous renal replacement therapy (CRRT), mortality in ICU, hospital mor-
tality and mortality up to one year after ICU discharge.
RESULTS. 347 patients aged 80 and over were admitted to our Unit
during the study period. Mean age was 83 years, 47% women and
68,7% totally independent for activities of daily living according to
the Barthel index. The most common cause of admission was cardio-
vascular, 48.1%, including cardiac arrest, acute coronary syndrome,
pulmonary embolism and arrhythmias. Mean SAPS III score was
57,70. Vasopressor support was administered in 37% of patients, in-
vasive mechanical ventilation 25% and non-invasive mechanical ven-
tilation or high flow oxygen cannula in 19%. Only 2% of patients
required CRRT. Median ICU stay 3 days. ICU mortality was 19.6% and
overall hospital mortality 28,53%; 10% died within the first year after
ICU discharge.
In the univariate analysis, a statistical association with mortality was
found with vasopressor support, OR 4.86, 95% CI (2.75-8.61) and both
invasive and non-invasive mechanical ventilation with OR 78, 95% CI
(26,5-230) and OR 7.29, 95% CI ( 2.1-24.5) respectively. For each unit
increase in SAPS III, there was an increased odds of death of 1.1
(95% CI 1.07–1.13). Similarly, the odds of dying in patients partially
dependant for activities of daily living was 3,09 (95% CI :1-17-8.15)
whereas totally independent subjects showed OR 1.07 (95% CI: 1.01-
1.13). Finally, age revealed no association with increased risk of mor-
tality (OR 0.96 with a 95% CI 0.88-1.05) and male sex had a lower risk
of dead (OR 0.45 with a 95% CI 0.26-0.77). The multivariate logistic
regression analysis determined that only functional status (partially
dependent OR 3.09, 95% CI 1.17-8.15) and length of hospital stay (for
each day increase OR 1.07, 95% CI 1.01-1.13) were associated with
mortality at one year.
CONCLUSION. Admission of elderly patients to ICU should be consid-
ered after a careful evaluation of their functional status and comor-
bidities. As expected, patients requiring more ICU support (invasive
mechanical ventilation, vasopresssors) have higher mortality. Age by
itself does not seem to predict poor clinical outcome.
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INTRODUCTION. The use of peripherally inserted central venous
catheters (PICC) is increasing in the ICU due to the easy peripheral
access and the lower number of complications related to insertion.
Some studies indicate a higher frequency of venous thrombosis re-
lated to PICC than to central venous catheters (CVC). However, there
are no conclusive data on the incidence of catheter-related venous
thrombosis (CRVT) in critically ill patients. Despite there are different
diagnosis possibilities, the gold standard technique is the ecography.OBJECTIVES. The aim of the study is to investigate the incidence of
catheter related venous thrombosis (CRVT) in ICU and compare this
incidence between patients with PICC and CVC (jugular or sub-
clavian). A secondary objective is to locate the role of ultrasound
screening for the early diagnosis of the CRVT. Additionally, the study
describes the characteristics of the patient, the canalized vein, the
clinical expression, and the relationship of these variables with the
appearance of CRVT.
METHODS. The study was carried out as a prospective, open, non-
randomized cohort study of consecutive patients between March
and November 2018. PICC and CVC used were polyurethane 7F cath-
eters. All PICC were placed by trained nurses. Resident or senior doc-
tors placed CVC. Clinical (daily) and ultrasound (3 established exams)
follow-up was applied to each patient during the first 20 catheter
days (or until the catheter was removed). All data concerning the pa-
tient, the anticoagulation treatment and the diagnosis of other non-
thrombotic complications related to the catheters was collected.
RESULTS. A total of 150 patients have been analyzed; 83 patients
underwent PICC placement, and CVC was used in 67 patients. Both
groups were comparable in terms of baseline characteristics. We
found a significantly higher incidence of CRVT in the PICC group:
25% (n=21) vs 8,9% (n=6) in the CVC group (p = 0,001). PICC patients
had an increased risk of thrombosis OR=3,20 (IC95% 1,18-8,69). More-
over, thrombosis appeared at day 4,81 in average in PICC patients,
while appeared at day 7,83 in CVC patients (p=0,0029).
Just 8 of the 27 patients with thrombosis had clinical signs of phle-
bitis, while 19 (70,3%) of patients had subclinical thrombosis, only di-
agnosed by ecography. Then, the PPV of phlebitis is just 29,6%.
CONCLUSION. In our cohort, PICC catheters have an increased risk of
thrombosis and this thrombosis appeared before than thrombosis re-
lated with CVC. Phlebitis was not a reliable sign of thrombosis, most
patients with thrombosis had no clinical features. Ultrasound screen-
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INTRODUCTION. Frailty is characterized by age-associated declines in
physiologic reserve and function across multiorgan systems, leading
to increased vulnerability for adverse health outcomes.
OBJECTIVES. To asses the impact of frailty in the outcomes of pa-
tients suffering from a cardiac arrest during their hospital stay.
METHODS. A descriptive, observational and retrospective study was
conducted from January 2015 to June 2018. We analyzed all calls to
the ICU resuscitation team in Guadalajara Hospital in this period. Demo-
graphic variables (age and sex), frailty, causes of CPA, limitation of CPR
and outcomes were determined. Frailty assessment was performed
using the Clinical Frailty Scale (CFS). Frailty divide patients in 2 categor-
ies: prefrail and frail (PF-F) (CFS > 3) and non-frail (NF) (CFS ≤ 3).
For statistical analysis of the data, quantitative variables are
expressed as means ± standard deviation and qualitative variables as
percentages. Categorical variables were assessed using the chi-
square test and continuous variables were assessed using t-Student
or U-Mann-Withney tests. Multivariate analysis was performed using
a logistic regression model. A p-value <0.05 was considered statistical
significance
RESULTS. 105 calls for CPA were recruited. 17 patients were excluded
because CFS could not be determined. We studied 88 patients with a
main age of 74.9 ± 10,9 years, with a higher proportion of men
(68.2%). In our sample, 69.3 percent of patients were considered PF-F
(61/88) (Image 1). In-hospital mortality was 94,3% (83/88), with no
statistically significant difference in age, sex, limitation of CPR and
causes of CPA. People with frailty are significantly more likely to die.
Multivariant analysis, adjusted by age, sex and CPR cause showed
that only CFS>3 (PF-F patients) was a significant independent prog-
nosis factor of mortality (OR 10,43; IC 95% 1,11 - 98,35; p=0,04).
CONCLUSION. Frailty is a significant independent prognosis factor of
mortality in patients suffering from a CPA. Assessing frailty may help
clinicians in CPR or non CPR decision-making.
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n 213 25 49
Male gender, % 57.7% 64.0% 67.3%
Age, years, %
<40 41.8% 24.0% 38.8%
41-60 37.6% 32.0% 28.6%
>60 20.6% 44.0% 32.6%
ICU admission cause, %
Trauma 31.9% 64.0% 40.8%
Non-trauma 68.1% 36.0% 59.2%
ICU length of time, mean
(days)
9.5 ± 7.8 14.8 ± 13.0 13.4 ± 8.18
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INTRODUCTION. The use and availability of point-of-care care ultra-
sound is increasingly being recognised as a valuable diagnostic and
monitoring tool in the Intensive Care Unit (ICU). When used at the
bedside, ultrasound-guided vascular access, drain insertion and
ultrasound-guided regional anaesthesia have been shown to en-
hance the safety and are now considered standard practice. Equally,
the use of focused transthoracic echocardiography (TTE) has become
readily available for real-time haemodynamic assessment and moni-
toring of patients with sepsis, congestive heart failure, shock and
traumatic injuries. Separate from the scope of a comprehensive TTE
study, a focused TTE study is intended to answer specific questions
related to the ICU patient. Limited to acquisition of four basic cardiac
views and one view of each lung base, a focused scan can serve as a
rapid assessment of the cardiac structure and function in acutely un-
well patients. However, there are currently no robust quality assur-
ance systems in place for ensuring responsible practice in the use of
focused echocardiography by intensive care clinicians after the initial
training period. To assess the quality of focused TTE studies com-
pleted on our ICU we conducted a retrospective analysis of our
current practice to establish the level of consistency and reproduci-
bility of focused TTE studies.
METHODS. A retrospective analysis of focused TTE studies conducted
on Royal Papworth Hospital ICU. Data collection included repeated
audit cycles of 3-months duration between April 2016 – Feb. 2018.
All focused TTE studies conducted on Royal Papworth ICU during the
audit periods were included. Focused TTE studies were analysed
using a 22-point audit tool to assess technical quality, reporting,
documentation and upload to the local PAC system. Data were ana-
lysed using Chi-squared tests, with a p-value <0.05 regarded as
significant.
RESULTS. Data were collected from 409 focused TTE studies during
four audit cycles. Inclusion of patient details and attachment of ECG
was similar between audit cycles (64.4%). Studies with four recorded
cardiac views improved from the first audit cycle (31%), with the
highest percentage of complete images obtained during April-June
2017 (53%). The subcostal view was the least obtained view across
all cohorts, with more than 50% of all studies missing a subcostal
image. Chamber function, pericardial collections and hypovolaemia
were assessed on average the same across all cohorts (>90%). As-
sessment of pleural collections declined from 2016 (69%) to 2018
(48%). A decrease in the number of studies uploaded to the PAC sys-
tem was also observed, with only 4% of studies uploaded in June-
Aug 2017.
CONCLUSION. Basic echocardiography training for intensive care cli-
nicians is regarded as valuable screening tool, which can be used
quickly and effectively in the management of patients in acute set-
tings. However, variation in practice related to incomplete studies, re-
duced number of standard images obtained and poor compliance
with clinical documentation were highlighted in this retrospective
analysis. In response to these findings, we have implemented a struc-
tured system of senior review and on-going audit during monthly
quality assurance meetings. BSE accredited Cardiologists and Cardiac
Physiologist contribute to a quality assurance scoring system and
provide direct feedback on quality of echocardiography images and
on the accuracy of reporting, enabling qualitative review of focused
TTE studies that was not possible in the previous quantitative audit
parameters.
REFERENCE(S)
1. Yanick Beaulieu, Paul E Marik Bedside Ultrasonography in the ICU Elsevier
Chest Journal August 2005; 128: 881-895 DOI:10.1378/chest.128.3.17662. S. Price, E. Nicol, D.G . Gibson, T.W Evans Echocardiography in the
critically ill: current and potential roles Intensive Care Medicine January
2006; 32:48-59.
3. International Expert Statement on training standards for critical care
ultrasonography- Expert Round Table on Ultrasound in ICU. Intensive
Care Med 2011;37:1077-83.
4. Fox K: On behalf of a Collaborative Working Group of the British Society
of Echocardiography (BSE). A position statement: echocardiography in
the critically ill. JICS 2008;9:197-98.
5. none
000824
Evaluation of the dependence degree for basic activities of daily
living in ICU survivors
PA. Duarte1, TC. Lievore2, L. Rossi2, W. Batista2, TV. Lordani2, CR. Lordani3,
JB. Costa4, AC. Jorge1, KC. Luzzi1
1General icu, Hospital Universitario do Oeste do Parana, Cascavel, Brazil;
2Nursing department, Hospital Universitario do Oeste do
Parana, Cascavel, Brazil; 3Department of clinical nutrition, Hospital
Universitario do Oeste do Parana, Cascavel, Brazil; 4Deparment of
psychology, Hospital Universitario do Oeste do Parana, Cascavel, Brazil
Correspondence: P.A. Duarte
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000824
INTRODUCTION. Among the several physical, cognitive and psycho-
logical consequences of ICU stay, the activities ot daily living (ADL)
are indicative tasks of the ability to lead an independent life, such as
housework, shopping, self-medication.
OBJECTIVES. To assess the capacity of the dependence degree for
basic daily activities in adult ICU survivors.
METHODS. Cross-sectional descriptive study by evaluating adult ICU
survivors in a University Hospital, for 2 years. The sample was com-
posed by patients who returned for the multiprofessional follow-up
clinic 3 months after ICU discharge. The data were collected through
consultation and application of the Katz index.
RESULTS. A total of 287 patients were evaluated (mean age 46.3 y;
56.8% male; 36% trauma as ICU admission cause). The pre-ICU de-
pendence status was: 95.8% independent; 0.8% partial dependence;
3.5% total dependence. Table 1 shows the post-ICU dependence de-
gree and some variables.
CONCLUSION. Although most post-ICU patients were independent,
the incidence of dependence was relatively high, particularly in older
and non-trauma patients. The evaluation of ADL may be an import-
ant marker of outcome in this group, as well as the quality of care
performed during hospitalization.
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Table 1 (abstract 000839). Patients discharged alive from a general







n 3943 735 4678 n/a
Overall % of sample 84.29 15.70 100 n/a
Male sex (%) 57.32 59.32 57.63 0.313








3.00,4.37 3.25,4.20 3.04,4.35 0.009
Medical admission (%) 47.05 51.02 47.67 0.048
Post-ICU mortality (%) 3.73 4.63 3.87 0.247
ICU readmission rate
(%)
4.24 4.08 4.21 0.849
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INTRODUCTION. Lactate is considered to be a useful prognostic bio-
marker in critically ill patients. However, few studies address the as-
sociation of lactate with mortality specifically in octogenarian
patients, a population that deserves to be individualized given
changes in clinical presentations of diseases, functional reserve, social
demands and, among others that occur over the years.
OBJECTIVES. To assess the accuracy of lactate in predicting mortality
in very old patients.
METHODS. A retrospective cohort study with very old patients (≥ 80
years) with a length of stay > 24 hours in a general ICU during the
period August 2015 to August 2018. Lactate serum level was ob-
tained within the first 6 hours of admission. The D'agostino test was
used to determine normality in lactate values. In order to evaluate
the median levels of lactate between the populations that were dis-
charged and those who died and its accuracy, the Mann-Whitney U
Test and the Area Under Receiver Operating Characteristic Curve
(AUROC) were respectively used.
RESULTS. A total of 691 patients were analyzed, 65% (451) of whom
were women, the mean ± SD and the maximum age was 87 ± 4.9
and 103 years. The mean Simplified Acute Physiology Score 3
(SAPS3) was 55.7 ± 9.4 and mean Charlson Comorbidity Index was
1.78 ± 1.73, without the assignment of points for age. Overall mortal-
ity was 28% (194), 7-day mortality was 13% (92), and there was 20%
(144) of patients with an elevated lactate (≥ 2 mmol/dL). In compari-
son to those who survived (1.1; IQR: 0.8 – 1.8), the median lactate
was higher in patients who died in all period (1.5; IQR: 1.1 – 3.05) [p
< 0.0001] and in those who died in 7-day (2.0; IQR: 1.3-4.4) [p <
0.0001]. However, lactate did not demonstrate a good accuracy in
determining the outcome of the patients, either to determine death
during ICU stay (AUROC: 0.63) or even early death (AUROC: 0.73).
CONCLUSION. In the very old critically ill patients of our cohort, lac-
tate had a poor correlation with mortality.
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INTRODUCTION. We have previously reported higher in-hospital
mortality in patients discharged from the ICU out-of-hours compared
to in-hours.1 When patients discharged for end-of-life care or organ
donation were excluded, the discrepancy in mortality rates was much
smaller. This could be explained because organ donation procedures
are frequently undertaken at night and the mortality rate is 100%.
We hypothesised that later discharge of patients undergoing organ
donation or other end of life care might be a major influence on the
frequently reported finding of apparent excess mortality in out-of-
hours discharges.2 This new study seeks to establish in-hospital mor-
tality rates for those discharged in-hours and out-of-hours over a 3
year period, with those discharged for organ donation or end-of-life
care excluded.
METHODS. This is a single centre retrospective cohort study. Dis-
charge data were collected for all patients admitted to our unit from
01/07/2015 to 31/07/2018. Patients were excluded if they did notsurvive to ICU discharge or if they had an APACHE II score of 0. Read-
missions were defined as patients readmitted to ICU within the same
hospital stay; the first admission for these patients was included. Pa-
tients discharged for end of life care or organ donation were identi-
fied and excluded. Data collected included age, sex, APACHE II score,
nature of admission, length of stay, hospital outcome and readmis-
sions to ICU.
RESULTS. 3943 patients were included. The patients discharged out-
of-hours were significantly older and had higher APACHE II scores,
but there was no significant difference in mortality rate or readmis-
sion rate (table 1). Out-of-hours was defined as 22:00 to 07:00.
CONCLUSION. There was no excess mortality in patients discharged
out-of-hours once the effect of end-of-life or organ donation patients
had been excluded. These groups should be considered separately
to other patients surviving to ICU discharge, as their prognosis is
equivalent to those who have not survived. This cohort of patients
may be disproportionately discharged out of hours. The inclusion of
patients discharged from ICU but for end-of-life on the ward may ex-
plain the previously reported, but unexplained, finding of higher
mortality rates in patients discharged from ICU out of hours.
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Table 1 (abstract 000866). Differences in quality of communication in
the ICU perceived by patients and relatives
Variables Mean (T.D.) t (p)
Patients Relatives
Frequency of communication 6.88 (0.56) 6.60 (0.73) 3.262 (0.001)
Sincerity in communication 6.88 (0.63) 6.69 (0.63) 2.328 (0.021)
Communication time 6.89 (0.46) 6.65 (0.64) 3.192 (0.002)
Satisfactory communication 6.94 (0.30) 6.64 (0.67) 4.313 (0.000)
Communication form 6.92 (0.44) 6.66 (0.64) 3.465 (0.001)
Understandable communication 6.93 (0.25) 6.88 (0.36) 1.424 (0.156)
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steroids are important in regulating the glucocorticoid (GC) activity.
GC actions are mediated by the glucocorticoid receptor (GCR) and its
dysfunction leads to tissue resistance to GCs.
OBJECTIVES. To evaluate the expression of GCR-α and GCR-β in per-
ipheral polymorphonuclear cells in relation to cortisol and adrenocor-
ticotropin (ACTH) in critical illness for a 13-day period.
METHODS. Forty-two mechanically ventilated, steroid-free patients
were studied. Blood samples were collected on admission in the ICU
and on days 4, 8, and 13, to measure GCR expression, cortisol and
ACTH. Twenty-five age- and sex-matched subjects were used as
controls.
RESULTS. Acutely, in critically ill patients GCR-α mRNA expression
was 10-fold that of controls (p< 0.0001), while GCR-β mRNA levels
were 3-fold the expression of controls (p< 0.0001). Cortisol was ele-
vated and ACTH was within normal limits. During the sub-acute
phase, the expression of the isoforms was lower compared to con-
trols, cortisol remained high and ACTH increased.
CONCLUSION.GCR expression and hypothalamic-pituitary-adrenal
axis function undergo a biphasic response during critical illness;
acutely, the expression of both GCRs is increased, however, GCR-α ex-
pression dominates and there is probably no GC resistance. During
the sub-acute phase, the expression of both isoforms decreases and
there is dissociation between low GCR expression and high cortisol,
implying an abnormal stress response. Elevated cortisol is preserved
through both ACTH and non-ACTH pathways.
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INTRODUCTION. To improve the quality of care provided to patients and
their relatives in the ICU, assessing their satisfaction with the care they re-
ceive is important, being communication a crucial item to take into
account.
OBJECTIVES. To evaluate whether the quality of communitation by
the healthcare personnel in the Intensive Care Unit perceived by pa-
tients and relatives influences their level of satisfaction.
METHODS. Information was collected from June to September 2018
through a survey adapted to patients and family members. The ques-
tionnaire included a 7-score Likert scale conformed by different items
aimed at assessing the quality of communication between patients
and relatives and the healthcare personnel in the ICU. The dimen-
sions are based on the work of Mora Lourido (2015). We conducted a
difference analysis of means using the student’s T, to check the dif-
ferences in patients and relatives’ satisfaction.
Subsequently, a multivariate linear regression analysis was performed
to analyze the influence of perception of the quality of communica-
tion on satisfaction with the quality of care in the ICU.
RESULTS. In the scale of quality of the communication there are six
variables shown in the previous table. In the regression analysis of
the quality of the communication on the patients and relatives’ satis-
faction, we find that "Sincerity" is the variable that has the greatest
influence on satisfaction (β=0.316, t=4.220, p=0.000), followed by the
"Satisfactory communication" (β=0.247, t=2.787, p=0.006), being the
rest of the variables not relevant to explain the satisfaction of pa-
tients and relatives.
The value of the F statistic indicates that, globally, the model is acceptable
(F=52.905, p=0.000) and that it explains 59.1% of the total variance.
CONCLUSION. A high perception of the quality of the communica-
tion positively influences the satisfaction with the quality of theservice on the part of patients and relatives. The most important fac-
tor in satisfaction is the sincerity in communication, followed by satis-
factory communication. The communication by the healthcare
personnel in the ICU is so important that it is able to explain 59.1%
of the variability of satisfaction with the quality of the service, which
is why it is a fundamental aspect to which health professionals
should give importance.
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INTRODUCTION. An unplanned Intensive Care Unit (ICU) admission is a
serious complication in postoperative patients. Identification of patients at
risk of postoperative deterioration is crucial to support the anesthesiolo-
gist’s decision on patient direct admission to a higher-acuity facility, such
as the ICU or the surgical ward. Currently, no evidence-based criteria exist.
OBJECTIVES. To identify predictors for postoperative deterioration,
which could aid allocation of postoperative patients to the appropri-
ate level of care.
METHODS. Retrospective data collection of surgeries was performed
between January 2013 and December 2017. Only first surgery per pa-
tient per hospital admission was included for analysis. All possibly
relevant preoperative, intraoperative and early postoperative factors
were collected. An unplanned ICU admission was used as criterion
for postoperative deterioration.
RESULTS. A total of 27369 postoperative patients were selected. An
unplanned ICU admission complicated recovery of 187 (0.7%) pa-
tients. These patients were significantly older (65 versus 54 years),
more often male (52.4 % versus 37.5%), known to have higher ASA
scores (38.4% ASA III versus 16.6%) and underwent longer surgeries
(273 versus 159 minutes). Multivariate analysis resulted in 9 variables
as best predictors of unplanned ICU admissions, consisting of age
(OR 1.02; 95% CI 1.00-1.03), general in combination with epidural
anesthesia (OR 3.31; 95% CI 2.26-4.84), surgical specialism (OR 2.76;
95% CI 1.89-4.03), ASA score 3 (OR 2.02; 95% CI 1.43-2.87), adminis-
tration of phenylephrine (OR 1.71; 95% CI 1.21-2.42), or erythrocytes
Fig. 1 (abstract 000878). See text for description
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tachycardia (OR 2.15; 95% CI 1.53-3.03) and duration of surgery in mi-
nutes (OR 1.005; 95% CI 1.004-1.006). The ROC curve of this model
resulted in AUC of 0,865.
CONCLUSION. Combining preoperative, intraoperative and early
postoperative factors results in good prediction of unplanned ICU ad-
missions. The model could improve decision support for the patients’
allocation after surgery.
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INTRODUCTION. Renal ultrasound is increasingly used in critically ill
patients, although studies show different levels of performance for
predicting various conditions, such as acute kidney injury (1, 2). Per-
forming renal ultrasound may be difficult in critically ill patients due
to suboptimal positioning, pain or wounds. Previous studies however
did not report data on feasibility, which could provide an overly opti-
mistic impression.
OBJECTIVES. To explore the feasibility and image quality of renal
ultrasound in a population of critically ill patients.
METHODS. This is a predefined substudy of SICS-II (3), a large pro-
spective observational cohort in patients acutely admitted to the In-
tensive Care Unit (ICU). Patients underwent a protocolized
ultrasonography exam within 24 hours of ICU admission by re-
searchers who were not involved in patient care. All researchers were
trained by experts before the start of the study and the first 20 study
exams were supervised. We primarily assessed the right kidney and
attempted to visualize the left kidney if image quality of the right
kidney was considered insufficient. If necessary, the radiologist, who
was not involved in patient care, was asked to perform the ultra-
sound. We recorded renal length, and arterial and venous doppler
measurements. Images were validated by an expert radiologist who
was blinded for patient characteristics.
RESULTS. So far, 403 patients were included in the SICS-II. In 81
out of 403 patients, no images were available, as ultrasound was
not attempted due to severe abdominal pain, bandages or large
wounds in 47 patients, and image quality was insufficient in 34
patients. In the remaining 322 patients, the right kidney was im-
aged in 90% of exams and the left kidney in the remaining 10%.
Renal length could be obtained in 315, arterial doppler in 270 and
venous doppler in 244 of the 322 patients, respectively. In 201 of
the 322 patients (62%), all indices were obtained. So far, valid-
ation was completed for the first 125 exams (39%, validation is
ongoing). The radiologist approved 84% of renal length measure-
ments, 94% of arterial doppler measurements and 90% of venous
doppler measurements (figure 1).
CONCLUSION. Renal ultrasound could be performed in 322 out of
403 patients. Kidney length could be measured in almost all patients,
while doppler seems successful in around 80% of patients. When ob-
tained, at least 84% of measurements were of sufficient quality as
judged by an independent expert.REFERENCE(S)
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INTRODUCTION. Auscultation has historically been an essential com-
ponent of physical examination in critically ill patients but may be
challenging. A more advanced modality like lung ultrasound (LUS)
seems easy to use and has shown to be superior to chest x-ray and
comparable to CT scan in detecting interstitial syndrome (1).
OBJECTIVES. In this sub-study of a large observational study, we
aimed to explore the level of agreement between auscultation and
LUS for interstitial syndrome.
METHODS. This post-hoc analysis included all patients with LUS out
of the SICS-I study (2). In SICS-I, patients acutely admitted to Inten-
sive Care Unit (ICU) within 24 hours after admission were eligible for
inclusion, consisting of physical examination and LUS by trained
Page 424 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55researchers not involved in patient care. Physical examination was
performed first and included auscultation of six regions bilaterally for
crepitation and rhonchi, if either was present, auscultation was con-
sidered abnormal. LUS consisted of the BLUE protocol (3) using a
phased array probe targeting six scan-sites on the patient´s chest.
Interstitial syndrome was defined as three or more B-lines in at least
two scan-sites bilaterally. We evaluated sensitivity, specificity, nega-
tive predictive value and positive predictive value of the results of
auscultation. We performed a sensitivity analysis to assess whether
the diagnostic accuracy differs in patients with or without mechan-
ical ventilation.
RESULTS. From the 1075 SICS-I patients, 926 (86%) had LUS per-
formed in at least 2 scan sites and 535 of these patients (57%) were
mechanically ventilated during the examination. A total of 302 pa-
tients (32%) had abnormal auscultation, and 307 patients (33%) had
interstitial syndrome on LUS. Specificity of auscultation to diagnose
interstitial syndrome on LUS was 76% (95%CI 72-79), sensitivity was
49% (95%CI 44-55), positive predictive value 50% (95%CI 45-54) and
the negative predictive value was 75% (95%CI 72-77). Overall diag-
nostic accuracy was 67% (95%CI 64-70). Amongst those mechanically
ventilated, the specificity was 73% (95%CI 68-78), sensitivity was 47%
(95%CI 39-55) and accuracy was 65% (95%CI 61-69). Among those
not mechanically ventilated, the specificity was 79% (95%CI 73-84),
sensitivity was 52% (95%CI 43-61) and accuracy improved to 70%
(95%CI 65-74).
CONCLUSION. The diagnostic accuracy of auscultation for interstitial
syndrome on LUS was poor. Even though diagnostic accuracy and
specificity of auscultation was better in patients who were not mech-
anically ventilated, a wide variation existed between auscultation and
LUS. This leads on to whether routine use of LUS, as opposed to aus-
cultation, should become a necessity rather than an optional skill set
in the assessment of critically ill patients.
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INTRODUCTION. It is widely known that COPD exacerbations lead to
lung function Decline. Short-term Health-related quality of life (HRQL)
after intensive care is poorly reported and a relevant concern for
COPD patients, their relatives and providers of health care.
OBJECTIVES. To describe HRQL change in acute exacerbation of
COPD ICU-admitted patients 3 months after discharge from a med-
ical Tunisian ICU.
METHODS. We analyzed a prospective collected database including
consecutive patients admitted for AE/COPD in a 9-bed medical ICUbetween February 1, 2017 and March 30, 2018. Patients’ quality of
life was assessed using Web-based version of the St George’s Re-
spiratory Questionnaire score (SGRQ) recorded at admission and
within three months of ICU discharge via phone calls. The SGRQ vari-
ables (symptoms, activity, impacts) were compared before and after
3 months of ICU discharge using Wilcoxon test.
RESULTS. Among 102 patients admitted for AE/COPD during the
study period, 75(73.5%) were included in the second evaluation. Gen-
eral characteristics were: age, 66.4±9.5 years old; sex ratio, 7/1; Charl-
son index>3, 40(53.3%); COPD GOLD D, 65(86.7%); median SAPSII
score, 27 [22-34]; initial invasive mechanical ventilation, 20 (26.7%);
median length of stay, 10 [6-16] days. Median SGRQ total score re-
corded at admission for the included patients was 33.8 [25.4-44]. The
phone evaluation contact was performed in 71 (94.6%) patients.
There was statistically significant increase in the total SGRQ score at
admission compared to the total SGRQ score recorded after 3
months of ICU discharge 33.8 [25.4–44.] vs 55.8 [41.4-78], p<0.0001.
Autonomy impairment increase was significant for all items of the
SGRQ score (Symptoms 43 [41.4-78] vs 56.05 [45-74], p<0.001; Activ-
ity 47.6 [46-61.5] vs 66.1 [59.4-86], p<0.001 and impacts 21.4 [13.2-
35] vs 47.7 [33.6-75], p<0.001).
CONCLUSION. In this study, ICU stay was associated with a signifi-
cant decline in the short-term HRQL in this cohort of Tunisian COPD
ICU survivors.
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INTRODUCTION. Mechanical ventilation (MV) is used during respira-
tory failure to reduce work of breathing and improve gas exchange.
However, its efficacy depends on the visco-elastic properties of the
respiratory system(1).
OBJECTIVES. To identify discriminative properties of respective air-
way pressures to predict difficult weaning process.
METHODS. A retrospective charts' review of MV patients admitted to
a medical ICU of Farhat Hached hospital from November 2015 to
February 2018. Difficult weaning process was indirectly expresse d by
prolonged MV (≥ 7 days), Ventilator freedays (VFD), and a composite
outcome defined as death and/or length of stay ≥14 days. Were col-
lected patients' characteristics at admission and respective airway
pressures (Peak, plateau, driving and intrinsic PEEP) at admission and
at day 4. High airway pressure (NDHP) is defined as the number of
days spent with high pressures : Peak ≥40 and/or plateau ≥30; and/
or driving pressure ≥15 and/or; intrinsic PEEP ≥6) were extracted
from medical records. Univariate and multivariate regression analyses
were performed to identify factors independently associated with
mortality.
RESULTS. 304 mechanically ventilated patients were collected within
the study period. 199(65%) were non-COPD patients. They were 50±
18 years aged; ARDS, 25(12.6%); pneumonia, 14(7%) Pulmonary
edema, 11(5.52%); SAPS II, 35.1±15.7; pH, 7.31±0.14; PCO2, 42.4±19.9;
PaO2/FiO2, 210.6±109.2mmHg; MV duration, 8.9±9.4days; tracheos-
tomy, 18(9%); length of stay, 10±10 days. Mortality, 114(57%). Mean
airway pressures were respectively for peak, plateau, driving and in-
trinsic PEEP at admission : 30.2±8.9, 20.2±6.22, 13.5±4.9, 2.7±4.2
cmH2O and at day 4 : 30.9±8.9, 20.8±7, 13.7±5.8, 2.4±3.8 cmH2O.
Univariate analysis and multivariate logistic regression showed the
following factors associated to : 1) 28VFDs, peak at day 4 (OR, 1.06;
95%CI, [1.01- 1.13]; p=0.03), 2) prolonged MV, NDHP (OR, 1.35; 95%CI,
Page 425 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55[1.13- 1.60]; p=0.001) 3) composite outcome, plateau at day 4 (OR,
1.52; 95%CI, [1.21- 1.91]; p=0.000).
CONCLUSION. Peak pressure, Plateau pressure and number of days
spent with high airway pressures may alter significantly the weaning
process in MV non-COPD patients.
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INTRODUCTION. Objective: To evaluate the relationship between psycho-
logical symptoms (particularly Posttraumattic stress disorder [PTSD]) and
the memories (real or illusory) reported by ICU survivors.
METHODS. Prospective cohort study for 7-year period in the Post-ICU
multiprofessional outpatient office of a University Hospital, attending
adult patients 3 months after ICU discharge. In order to evaluate the
ICU memories, a cheklist was used, consisting of 9 items grouped in
4 domains of memories: treatment-related; environmental; related to
emotional experiences, and illusory memories (dreams, nightmares
and hallucinations). PTSD symptoms were evaluated using the IES-R.
Levels of anxiety and depression were measured using HADS.
RESULTS. During the study period, 834 patients were evaluated by
outpatient clinic/ psychology team: 61.8% male, mean age 45.4 y,
mean APACHE II 19.8, 81% used MV, 39% used continuous sedation,
mean ICU length of time 10.5 days. Most patients (54.6%) described
some type of ICU memory (40.0% memories of real events; 2.6%
illusion memories, such as dreams, nightmares and hallucinations;
13.0% a combination of memories of real events and illusions). The
most frequent memories of real events were: discharge to the ward,
family visit, see other patients and feel thirsty. Remarks related to the
endotracheal tube, such as aspiration and extubation were reported
by only 24.7% of the patients. Among patients with post-ICU memor-
ies, the incidence of psychological disorders was high, particularly
those with PTSD symptoms (Table 1).
CONCLUSION. The presence of ICU memories may be an additional factor
for the onset of PTSD symptoms, three months after discharge from the
ICU. Early identification of patients at risk for PTSD after an ICU stay may im-











n 843 383 460
Any kind of
psychological disorder
30.6% 36.0% 63.9% p<0.001
Anxiety symptoms 24.4% 40.3% 59.7% 0.8819
Depression symptoms 19.0% 49.1% 50.9% 0.3030
PTSD symptoms 18.1% 11.1% 88.9% p<0.001000915
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INTRODUCTION. Early mortality and severity prognostication in the
critically ill is a challenge in intensive care medicine. The conception
of large, trial validated Scores, as the SAPS II or the SOFA Score, of-
fered a tool to more efficiently tackle this task. Nevertheless, these
Scores were not intended for individual patient assessment. It has
been shown that MR-proADM on admission is a marker of poor out-
come prediction in septic ICU patients [1]. However, there is no data
regarding the use of MR-proADM in a general medical ICU
population.
OBJECTIVES. To propose MR-proADM as an admission prognostic
biomarker for ICU and 28-day mortality, as well as for therapy refrac-
tory multi-organ dysfunction during the course of the ICU stay.
METHODS. Between January 2018 and February 2019 all patients, aged
≥18 and with given consent, admitted to the Medical ICU of the Univer-
sity Hospital Zurich were prospectively included. Blood samples for MR-
proADM testing were obtained and the standard monitoring and la-
boratory analytics recorded on the moment of admission, the next 7
consecutive days and on the day of ICU-discharge.
RESULTS. The studied population, comprising 475 patients, presented
with an age of 63 [52-72] years, a SOFA Score of 7 [4–10], a SAPS II of
43 [30–58] and a Charlson Comorbidity Score of 3 [1–5] at admission. In
ICU mortality was 17% and 28-day mortality 24%. Admission MR-
proADM was 2.38 [1.34–5.17] nmol/l. MR-proADM was highest on ICU
admission and decreased on average by 31% until discharge. Kinetics
of MR-proADM were independent of age and sex. Patients with KDIGO
stage ≥ 2 presented overall higher MR-proADM levels.
MR-proADM values at admission correlated with a higher ICU and
28-day mortality (p < 0.0001). The AUROC of admission MR-proADM
(0.73) in its prediction of ICU mortality was comparable to those of
the SAPS II (0.71) and SOFA Score (0.78) (both calculated for the ini-
tial 24h in ICU). Admission MR-proADM was more specific (Cut-Off: 5
nmol/l, LR+: 4.1) than SAPS II and SOFA regarding the prediction of
persistence of multi-organ impairment (organ specific SOFA sub-
scores > 2) after 7 days. The AUROCs for admission MR-proADM
showed a good predictive capacity for death or continued ICU-stay
(AUC: 0.72, Cut-off: 6 nmol/l, LR+: 3.2) and for status at home (AUC:
0.7, Cut-off: 1.3 nmol/l, LR+: 3.0) after 28 days. Daily measurement of
MR-proADM during the subsequent ICU days did not improve the
predictive power of admission MR-proADM, except MR-proADM
levels at discharge, which presented an AUROC of 0.85 (Cut-Off: 4.9
nmol/l, LR+: 10.7) for the prediction of 28-day mortality.
CONCLUSION. We, for the first time, show that in a general medical
ICU population, admission MR-proADM is a sensitive and specific
prognostic marker for sustained ICU dependency by day 7 and 28-
day mortality and hence a triage tool to identify those patients with
prolonged ICU dependency and poor outcome.
REFERENCE(S)
1. Charles, P. E., Péju, E., Dantec, A., Bruyère, R., Meunier-Beillard, N., Dargent,
A., ... & Quenot, J. P. (2017). MR-ProADM elevation upon ICU admission
predicts the outcome of septic patients and is correlated with upcoming
fluid overload. Shock: Injury, Inflammation, and Sepsis: Laboratory and
Clinical Approaches, 48(4), 418-426.
T1
Page 426 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55000916
Mortality review process in the intensive care unit (ICU): Are we
learning from the past?
J. Macallan, A. Cavalier, M. Alice, T. Samuels, F. Lamb
1Critical care, East Surrey Hospital, Redhill, UK
Correspondence: J. Macallan
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000916
INTRODUCTION. Mortality review meetings are used in healthcare to
review patient deaths and to allow learning from these cases. Na-
tional guidance recommends that these meetings are multi-
disciplinary, held at least quarterly and provide non-judgemental dis-
cussion of events to allow improvements in care to be identified (1).
Local guidance suggests that unexpected deaths should all be dis-
cussed in detail (2). Our ICU uses a dedicated, bespoke mortality
database for review and presentation of these cases.
OBJECTIVES. To examine our current mortality review process using
our database and to assess the recommendations produced by these
cases.
METHODS. A retrospective search of cases entered into the mortality
database of our ICU in a district general hospital in the UK. Cases
were entered between January 2017 and March 2019. Recommenda-
tions from cases that have been presented were reviewed.
RESULTS. A total of 326 deaths were entered on to our mortality
database. Cases were classified into five different categories based
on whether the death was expected or not. This ranged from cat-
egory 1 (anticipated due to terminal illness/ death pre-hospital ar-
rival) to category 5 (unexpected resulting from medical intervention).
244 cases (74.8%) have been categorised, 25.2% cases are currently
unclassified. Of the 326 cases entered, 202 (61.9%) have been pre-
sented at a mortality review meeting. The median number of days
between death and presentation was 117 (IQR 77- 203). 77 out of
202 cases (38.1%) had recommendations for further action or sugges-
tions for future management. 14 cases had more than one recom-
mendation with a total of 94 recommendations made. These have
been reviewed and grouped into themes (Table 1).
CONCLUSION. The largest category of recommendations is “feedback
to another team”. Our tailored database facilitates this through re-
cording documentation and providing a presentation that can be de-
livered independently. The database approach also enables us to
easily identify which deaths are classified as unexpected so that
these can be selectively reviewed in-depth and presented as per rec-
ommendations. Reviewing every death would represent a large add-
itional workload. Currently a quarter of deaths have not been
categorised and there is a considerable time lag in presenting several
of the cases. Even with our database approach, we may still be miss-
ing important leaning points. Future work should focus on reducing
the interval from death to presentation through regular meetings
and finding out how other ICUs manage the workload of preparing
cases for mortality review.
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INTRODUCTION. Obesity and overweight are associated with an
increased risk of mortality in the general population, however, in
some pathological processes such as respiratory distress syndrome
(ARDS) have an unexpected behavior known as "obesity paradox".
OBJECTIVES. The objective of this study is to assess the relation
between obesity and mortality in patients admitted to the ICU with
diagnosis of sepsis.
METHODS. Prospective observational multicenter study. The
incidence of obesity in septic patients admitted to the ICU during a
period of five years and it relation to mortality was studied. Obesity
was defined as an IBM ≥ 30 kg / m2. Multivariable logistic regression
was used to evaluate the adjusted relationship between obesity and
mortality. The levels are expressed in median and interquartile range
(IQR)
RESULTS. Among 621 patients admitted in five different hospitals in
Spain with the diagnosis of sepsis, 221 (35,6%) were considered
obese. Mean age was 63,7±14,4 (61,78-65,6); 41,6% were men. The
global mortality was 33% and 34,1% in the obesity group (ns).
Mortality subgroup analysis by origin did not show significance
differences between non-obese and obese patients respectively: sur-
gical patients: 24% vs 26,3%; abdominal focus septic patients 24,2%
vs 24,6% ; bacterial pneumonia 41,3% vs 45,3% severe pneumonia
caused by H1N1 virus 32,3% vs 37,5%. Kaplan-Meier survival analysis
showed no significant survival variations in septic patients with and
without obesity . Also the ICU and hospital stay did not differ signifi-
cantly. Severity scores (APACHE II, SAPS II, SOFA), biomarkers (MR-
proADM, PCR, PCT and lactate), iron metabolism and immunity (lym-
phocytes subsets CD14+ and HLA-DR) did not differ significantly nei-
ther among septic group vs obesity group. In the survival subgroups
in obese patients, the SOFA score was higher in the non survivor
than in the survivors: 12 (5-11) vs 8 (5-11) (p <0.001) and the Apache
II score 27 (21- 35) vs 19 (12-25) (p = 0.0001). In the multivariate ana-
lysis (Cox proportional-hazards regression) the Apache II score at ad-
mission was statistically significant predictors for mortality in obese
patients. Multivariate analysis showed that obesity was not signifi-
cantly associated with an increase in mortality in septic patients.
CONCLUSION. Despite obesity is a common find in septic patients
admitted to the ICU it does not related to an increase in mortality.
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INTRODUCTION. Due to its pleiotropic activities vitamin C combined
to steroids has been recently proposed as a potential beneficial
strategy in patients with septic shock. In 2017 we decided to
introduce in our institutional protocol for management of septic
shock the use of vitamin C in patients receiving low-dose steroids be-
cause poorly responsive to vasopressors. In this pre-post analysis, we
Page 427 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55compared clinical outcome of septic shock patients treated and non-
treated with vitamin C.
METHODS. Forty-one patients admitted to our ICU in 2017 and 2018
with septic shock and treated by low dose steroids (i.e. hydrocorti-
sone, 240 mg/day) and vitamin C (1,5 g every 6 hours) were matched
by a propensity score including age, SAPS II score and comorbidities
with 41 control patients admitted to our ICU in 2015-2016 with sep-
tic shock and treated by low-dose steroids without vitamin C. 30-day
and in-hospital mortality, length of vasoactive drug therapy and
mechanical ventilation, and occurrence of renal failure requiring re-
placement therapy were used as clinical outcome for the compari-
son. P< 0,05 was used for clinical significance.
RESULTS. SAPS II score, age, comorbidities, source of infection and
incidence of infection by multidrug resistant bacteria were similar in
vitamin C treated (T) and in controls (NT). 30-day (46% T vs 49% NT)
and in-Hospital (54% T and 61% NT) mortalities, duration of vaso-
pressors (5±5 days T vs 5±4 days NT) and mechanical ventilation (6±
10 days T vs 8±9 days NT) were similar (p> 0,05) in the treated and
in controls. A trend for reduction of renal replacement therapy were
observed in treated patients (34%) compared to controls (46%).
CONCLUSION. In patients with septic shock treated with low-dose
steroids, the addition of vitamin C seems to reduce the occurrence
of renal failure without any significant improvement in survival rate
and vasopressor time.
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bacterial growth and host response to infection. Important
alterations have been described in severe viral infections.
OBJECTIVES. We studied the metabolism of iron in patients with
severe sepsis from pulmonary origin due to influenza virus
pneumonia admitted to the ICU.
METHODS. Prospective observational multicentre study. We recruited
patients admitted consecutively to the ICU from five different
hospitals in Spain with a diagnosis of severe sepsis due to influenza
A and B virus pneumonia. Epidemiological data, immunological
parameters, biomarkers levels (RCP, PCT, MR-proAdrenomedullin) and
iron metabolism parameters were collected at admission. Data were
compared with a control group (CG) of patients with pneumonia due
to the different influenza viruses with less severity and who were not
admitted to the ICU.
RESULTS. 156 patients were included: 95 patients suffered severe
pneumonia caused by influenza virus (N1H1, N2H3 and B) and 61
patients were included in the control group (CG). The mortality of
the group admitted to the ICU was 30.52% (29/95). Iron levels at ICU
admission were 68 mcg / dl; similar values in both groups. Ferritin
levels at admission were 194.8 ng / ml versus 95.4 ng / ml in the CG
(p = 0.0047).
Regarding the different types of influenza, Ferritin levels were
significantly higher in patients with pneumonia due to influenza A
N1H1, both in the severe and those not admitted to the ICU: N1H1
648 ng / ml; N2H3 74.9 ng / ml; influenza B 64.25 ng / ml. In the
survival subgroups Ferritin levels were higher in the non survivors
than in the survivors in the total group and in the subtypes of
influenza N1 H1 (2225 ng / ml vs 421 ng / ml) and influenza B (274
ng / ml vs 60 ng / ml).
The Area Under the ROC Curve (AUC) for severity prognostic (ICU
admission) was 0.732 (p <0.0001) for Ferritin levels in patients with
influenza A N1H1, 0.561 for type A N2H3 and 0.509 for type B. The
Area Under the ROC Curve (AUC) for mortality prognostic at
admission was 0.786 (p = 0.0001) for Ferritin levels in patients with
influenza A N1H1.
For ferritin levels of 830 ng / ml and above, there was an increase in
mortality (p <0.0001) in Kaplan-Meier survival curve. In multivariate
analysis (Cox proportional-hazards regression), ferritin levels at admis-
sion were statistically significant predictors for mortalityin patients
with influenza A N1H1v .
CONCLUSION. Ferritin levels at ICU admission help us to determine
the unfavorable evolution in the Emergency Department and the risk
of mortality in patients with pneumonia due to influenza A N1H1
virus but not for pneumonia due to other types of influenza viruses
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INTRODUCTION. The analysis of lymphocyte subpopulations in BAL by
flow cytometry has represented an important advance in the
understanding of the physiopathology and in the diagnosis of certain
pulmonary diseases. However, its usefulness for diagnosis and prognosis in
mechanical ventilation (MV)critical septic patients has not been described.
OBJECTIVES. To study the lymphocyte populations in BAL in
different types of critical septic patients admitted to the ICU with
pulmonary infiltrate and to evaluate their diagnostic and prognostic
usefulness.
Page 428 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55METHODS. Observational and prospective study. We recruited
mechanically ventilated patients admitted to the ICU with the
diagnosis of sepsis with pulmonary infiltrate. Epidemiological data,
APACHE II, SAPS II, SOFA, immunological parameters, biomarker
levels in blood were collected at ICU admission. BAL bronchoscopy
was performed for microbiologic and cellular study. Lymphocyte
subpopulations in blood and BAL were studied by flow cytometry.
The results were compared with a control group of patients with
normal BAL. Multivariate logistic regression was used to evaluate the
relationship between the immunophenotype and mortality.
RESULTS. 57 patients were analyzed: 43 mechanically ventilated
patients and a control group of 14 without infectious disease (control
group (CG)) . ICU mortality was 41,8%; mean age of 59.9 ± 13.24, with
55.8% of male patients, Apache II 18 ±7. Mechanically ventilated
patients were classified according etiology: 21 bacterial pneumonia, 9
Influenza A N1H1, 3 fungal pneumonia and 9 Acute respiratory distress
syndrome (ARDS) without pulmonary infection. The BAL
immunophenotype of MV patients, showed a significant increase in B
and NK lymphocytes and a decrease in double negative T lymphocytes
(CD3+/CD4-/ CD8-) compared to the CG. In the analysis of mortality in
the total group of patients in VM showed no significant differences in
the CD4+T cells percentage and the CD4 / CD8 ratio. Nevertheless, In
the bacterial pneumonia group, CD4+T cells percentage was
significantly higher in the non-survivors (46% vs 18% p = 0.0284) and
also the CD4 / CD8 ratio (1.2 vs 0.2 p = 0.0218). The Area Under the
ROC Curve (AUC-ROC) for mortality prognostic was 0.778 (p = 0.0114)
for CD4+ T cells percentage and 0.790 for the quotient CD4 / CD8. For
CD4+ T cells levels equal to or greater than 36% and CD4 / CD8 ratios
greater than 7 in BAL of patients with bacterial pneumonia, an increase
in mortality (p <0.0001) was found in the Kaplan-Meier survival curve.
The multivariate analysis (Cox proportional hazards regression), the per-
centage of CD4+ T cells in BAL was a statistically significant predictor
for mortality similar to the Apache II score at admission in bacterial
pneumonias in MV admitted to the ICU.
CONCLUSION. The appearance of NK, B lymphocytes and the
disappearance of CD3+/CD4/CD8- (double negative) T cells in BAL of
patients intubated with pulmonary infiltrate is suggestive of
pulmonary infectious disease. The increase of CD4+ T cells and
consequent increase of the CD4 / CD8 ratio in BAL in patients with
bacterial pneumonia has a predictive value of poor prognosis.
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INTRODUCTION. The early administration of sepsis bundles including
appropriate antibiotics has been demonstrated to improve patient
outcomes. However, there is a growing concern of the indiscriminate
use of antibiotics and omission of microbiology investigations in
patient management (1). Additionally, there is no recent description
of the microbiology of sepsis on the wards or the real-life antibiotic
choices used in sepsis in Wales.
OBJECTIVES. The primary objective of the study was to investigate
antibiotic prescribing practices on general wards and emergency
departments (ED) in at-risk population of patients in acute hospitals
in Wales. Secondary objective was the evaluation of microbiology in-
vestigations of sepsis patients.
METHODS. Secondary analysis of patient episodes was performed on
patient population recruited into three annual 24-hour point-prevalence studies on the general wards and ED across all Welsh
acute hospitals in years 2016-2018. We recruited patients after writ-
ten informed consent with a NEWS ³ 3 and proven or suspected in-
fection documented in the clinical notes; methodology described in
detail in our previous studies (2, 3). Data were collected on patient
demographics; as well as radiological, laboratory and microbiology
data within 48 hours of the study. For statistical analysis Mann-
Whitney U and Chi-square tests were used as appropriate.
RESULTS. We screened 19,453 patients over the three 24 hours study
periods and recruited 1252 patients who fulfilled the entry criteria.
We had information about the antibiotics use for 1195 patients. 775
(64.9%) patients were treated with intravenous antibiotics. The
antibiotics used were broad spectrum, with Piperacillin/Tazobactam
being the most commonly used (40.5% of patients treated with Abx,
314/775). The vast majority of patients did not undergo microbiology
investigations. Only in 33.65% (421/1252) of all recruited patients
healthcare providers obtained blood cultures, in 25.64% (321/1252)
urine cultures, in 8.63% (108/1252) sputum cultures, in 6.79% (85/
1252) wound cultures and in 15.25% (191/1252) other cultures.
Analysing only patients who received Abx we found that only
49.75% (300/603) had blood cultures, 13.81% (70/507) sputum
cultures, 35.47% (210/592) urine cultures, 9.01% (53/588) wound
cultures and 13.42% (104/775) other microbiology investigations. Out
of the recruited patients 59.1% (740/1252) fulfilled SEPSIS-3 criteria.
Patients with SEPSIS-3 criteria were significantly more likely to re-
ceive Abx than the non-septic cohort (p<0.0001). Nevertheless,
33.78% (250/740) of patients fulfilling SEPSIS-3 criteria did not receive
any Abx. Patients who were screened for sepsis using an official tool
were also significantly more likely to receive Abx in comparison to
non-screened patients (p<0.0001) and to obtain blood cultures (p=
0.001) but no other microbiology investigations.
CONCLUSION. Our study shows that antibiotics prescription practice
is not guided by microbiology investigations. Significant proportion
of sepsis patients are still at risk of not receiving appropriate Abx
treatment and microbiology investigations, which may be improved
by more thorough implementation of sepsis screening tools.
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Page 429 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. The early detection of sepsis (SE) and septic shock
(SS) with automated electronic models (AEM) is a problem due to
the high percentage of false positives (FP), which generates
fatigability to clinicians (1).
OBJECTIVES. To compare an AEM published and commonly used in
our Electronic Health Record (EHR) (2) with those generated from AI
and ML techniques for the detection of SE/SS.
METHODS. Retrospective observational study comparing predictive
models for the detection of SE/SS in patients of 14 years of age or
more in all hospital areas (ED, wards and ICU). We value according to
SEPSIS.2, because it was the definition used during the study period.
The AEM is based on 15 clinical-analytical variables with different
weights and a discrimination score that we usually use (2). In con-
trast to others based on ML techniques that used different structured
and unstructured databases (free text) of the EHR. All cases were
evaluated and validated prospectively by the Multidisciplinary Sepsis
Unit. The Mann-Whitney-Wilcoxon test was used to identify statisti-
cally significant clinical and analytical variables, as well as wrapper
techniques, with a significance level of 0.01. And to obtain relevant
unstructured data Natural Language Processing (NLP) techniques
such as the Dunning test were applied. The total sample was divided
into 2 groups: the 5/7 proportion of the total of randomly selected
records constituted the training set and the rest of the records (2/7)
formed the test set.
RESULTS. From January 2014 to October 2018, we included 218,562
patients, mean age of 67.5 years and 57% males, where 9301 (4.6%)
patients had SE/SS. The ML models included 244 structured and
unstructured variables associated with SE/SS. We have identified 75
clinical and analytical variables in our ML models compared to 15 in
the EAM (p<0.0,01). Interestingly, three variables normally associated
with sepsis such as Glascow Coma Score (GCS), mean arterial blood
pressure (MAP) and platelet count were not significantly related to
SE / SS in ML predictive models. And neither the MAP nor the
platelet numbers were significantly associated in the predictive
model of the AEM, which does not include the GCS in its score.
There were 28,294 patients with AEM alerts, where there were 62%
of false positive (FP) cases and 12% of false negatives (FN). We have
obtained 3 models with ML, being that the best (named BISEPRO)
identified 11,2% FP and 0,9% FN cases compared to AEM (p=0,001 in
both analyzes). The AUC-ROC, sensitivity and specificity to detect SE/
SS of the best ML model was 0.95 (95% CI 0,94-0,96), 0,94, 083 com-
pared to the AEM with 0.86 (95% CI 0,83-0,88), 0,78 and 0,68, re-
spectively. But the three models of ML were significantly superior to
that of the AEM both to detect SE / SS and with lower cases of FP
and FN.
CONCLUSION. ML predictive models were significantly higher for SE/
SS detection than traditional automated ones, lowering FP by more
than 50%.
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INTRODUCTION. The Surviving Sepsis Campaign recommends
targeting a mean arterial pressure (MAP) of at least 65 mm Hgduring initial resuscitation of patients with septic shock. However,
the impact of such MAP target on cerebral perfusion remains
unknown.
OBJECTIVES. To assess the effects of changes in MAP on cerebral
autoregulation (CAR) in critically ill septic patients.
METHODS. Prospective study of 32 patients with septic shock
without intracranial disease; severe arrhythmias; treatment with
extracorporeal membrane oxygenation; or supra-aortic arteriopathy.
MAP was progressively increased at three levels: 70±5 mmHg (low-
target group), 80 ±5 mmHg (middle-target group) and 90 ±5 mmHg
(high-target group). Transcranial Doppler (DWL, Germany) was per-
formed at each target group, insonating the left middle cerebral ar-
tery (LMCA) with a 2MHz probe. LMCA blood flow velocity (FV) and
arterial blood pressure (BP) signals were simultaneously recorded for
at least 6 minutes; Pearson´s correlation coefficient between BP and
FV (MXa) was calculated using MATLAB (MathWorks, USA). Impaired
CAR was defined as MXa > 0.3.
RESULTS. In the 32 patients (median age: 69 [60-78] years), actual
MAP were 70 (range: 55-80), 78 (63-88) and 90 (80-103) mmHg in the
low-, middle- and high-target group, respectively. At different time-
points, mean MXa was 0.29 (±0.36), 0.27 (±0.34) and 0.20 (±0.32), re-
spectively (p=0.55). In patients with intact CAR (n=17), increasing
MAP resulted in a significant increase of MXa over time (ANOVA; p=
0.03), in particular from low- to middle-target levels (p=0.02). In pa-
tients with altered CAR (n=15), increasing MAP resulted in a signifi-
cant decrease of MXa over time (p=0.003), in particular from low- to
high-target levels (p=0.006).
CONCLUSION. Targeting higher MAP in septic shock patients can
improve cerebral autoregulation when it is altered at baseline.001211
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INTRODUCTION. Healthcare-acquired sepsis is known to be associ-
ated with higher mortality than community-acquired sepsis. More
specifically, mortality associated with intensive care unit (ICU)-ac-
quired sepsis is extremely high. However, little is known about pa-
tient characteristics, pathogens, treatments, and outcomes according
to admission sources among patients with severe sepsis and septic
shock in Japan.
Page 430 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55OBJECTIVES. To describe characteristics and outcomes according to
admission sources in patients with severe sepsis and septic shock in
Japan.
METHODS. We included adult patients (≥16 years old) with severe
sepsis and septic shock, based on the sepsis-2 criteria published in
2003,[1] who were admitted to the ICU in the Focused Outcomes Re-
search in Emergency Care in Acute Respiratory Distress Syndrome, Sep-
sis, and Trauma (FORECAST) study [2]. It conducted at 59 ICUs in Japan
from January 1, 2016 to March 31, 2017. Patients whose admission
sources data was missing were excluded. We compared baseline and
infection characteristics, treatments such as initial antibiotics, and out-
comes among patients from different admission sources which were
emergency departments (ED), inside ICUs, and wards.
RESULTS. Overall, 1182 patients were included in this study. There
were 676 (57.2%), 49 (4.1%), and 457 (38.7%) patients admitted to
the ICU from EDs, inside ICUs, and wards, respectively. The median
[interquartile range (IQR)] age of patients in the EDs, inside ICUs, and
wards was 75 [66–83], 69 [61–81], and 71 [61–79] years old,
respectively (p < 0.01). There was no significant difference in gender,
Charlson comorbidity index, having shock, APACHE II and SOFA
scores according to admission sources. The most common infected
sites were as follows: the lungs (33.4%), abdomen (23.4%), and
urinary tract (21.7%) in patients from the ED; the abdomen (34.7%),
lungs (20.4%), and skin and soft tissue (10.2%) in patients inside the
ICUs; the abdomen (29.3%), lungs (28.7%), and urinary tract (14.9%)
in patients from wards. Common pathogens obtained from the
blood culture were: E. coli (30.8%), Staphylococcus species (MSSA or
CNS) (17.2%), and Klebsiella (9.7%) in patients from EDs; Klebsiella
(20.0%), E.coli (16.0%), and Pseudomonas (12.0%) in patients inside
ICUs; and E.coli (18.4%), Staphylococcus species (12.4%), and Klebsiella
(9.8%) in patients from wards. In opportunistic pathogen positivity of
blood cultures, MRSA was 1.4%, 4.0% and 3.8% and Pseudomonas
was 1.4%, 12.0% and 2.6% in patients from the ED, inside ICUs, and
wards, respectively. In regard to initial antibiotic’s selection, more
than 70% patients were administered carbapenem or PIPC/TAZ and
approximately 20% of patients were administered vancomycin as
initial antibiotic regardless of admission sources.There was no
significant difference in in-hospital mortality rates according to ad-
mission sources (22.1% from EDs, 35.6% inside ICUs, and 24.2% from
wards, p = 0.108).
CONCLUSION. In this multicenter study in Japan, in-hospital mortality
was not different according to admission sources. The initial anti-
biotic selection was similar irrespective of admission location al-
though infection characteristics such as common pathogens were
different according to admission locations.
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INTRODUCTION. Sepsis and septic shock are related to high
mortality. The Hospital Clínico Universidad de Chile applies the
recommendations of the Chilean Society of Intensive Care Medicine
which include the sepsis bundle proposed by the Survival Sepsis
Campaign (SSC) in order to reduce morbidity and mortality in septic
patients. However, the adherence to these recommendations
including the SSC-bundle fulfillment and it's possible impact t is
unknown.OBJECTIVES. To assess the adherence to fulfill the SSC bundle and its
impact on in-hospital mortality and length of stay (LOS) in Intensive Care
Unit (ICU) in a cohort of ICU patients with severe sepsis or septic shock.
METHODS. Retrospective cohort study based on patients’ records. All
patients diagnosed with severe sepsis or septic shock, according to
the 2001 International Sepsis Definitions Conference, and who
entered the ICU at Hospital Clínico Universidad de Chile between
January and December 2017 were included (n = 91). We assessed
the fulfillment of the SSC bundle, compared expected versus (vs)
actual mortality, according to the Acute Physiology And Chronic
Health Evaluation II (APACHE II) and Sequential Organ Failure
Assessment (SOFA) (at day 1) scores, and ICU LOS in patients who
fulfilled it vs those who did not. Comparisons were performed using
Fisher’s exact test and Mann Whitney’s U test. In addition, logistic
and linear regression models were performed to evaluate the effect
of bundle compliance on mortality and LOS adjusting by age, sex,
SOFA score, and lactate levels.
RESULTS. Patients were 61.4 ± 16.4 years old (yo) (49.5% older than
65 yo), 57.1% were men; 40.7% sepsis were diagnosed at the
emergency room, and abdominal and respiratory foci were the most
frequent sepsis sources (41% and 32 %, respectively). APACHE II and
SOFA scores were 19 [IQR 12-23], and 7 [IQR 5-10], respectively. Pa-
tients had at least 3 dysfunctions at admission, the most frequent be-
ing the cardiovascular one with vasopressors requirement in 82% of
cases. The resuscitation bundle was fulfilled in 76% of cases. The
least fulfilled step during the first 3 hours was the administration of
30ml/kg of crystalloids (63%). Assessment of potential further re-
sponse to volume using pulse pressure variation or echocardiog-
raphy was registered in 71% of cases during the 6 hours. In-hospital
mortality was 23% and was higher in cases which did not fulfill the
bundle (32% vs 15%, p-value= 0.047). Fulfillment of the sepsis bundle
was significantly and independently associated with less mortality
(OR= 0.25, p-value= 0.026). On the other hand, ICU LOS in survivors
who fulfilled the bundle was 11 [IQR 5-16] days, while it was 19 [IQR
10-37] days in those who did not (p-value= 0.004), and it was inde-
pendent of age, sex, SOFA and lactate levels (Beta= -16.8, p-value=
0.017).
CONCLUSION. Fulfillment of the sepsis bundle is high but still needs
improvement. SSC-bundle fulfillment is associated with lower mortal-
ity and less ICU LOS independent of age, sex and severity scores.
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Page 431 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. Levels of MR-proAdrenomedullin (MR-proADM)
have been related to the diagnosis and mortality of septic patients
associated with organ failure even at low SOFA scores, being more
effective than other biomarkers
OBJECTIVES. To evaluate the usefulness of MR-proADM levels in the
diagnosis and prognosis of sepsis in patients admitted to the ICU ac-
cording to its focus of origin, etiology and severity.
METHODS. Prospective observational multicenter study. Patients
with suspected sepsis were recruited to the ICU of six spanish
hospitals. Epidemiological, clinical, laboratory data and MR-proADM,
procalcitonin , and C reactive protein levels were collected at the
time of admission, at 48 hours, at the 5th day and on the day of dis-
charge from the ICU. Also the MR pro ADM clerance at 48 hours and
at the 5th day were calculated. The results were compared by differ-
ent foci of infection and germs. The results were compared with
groups of patients with non-septic SIRS, critical cardiac patients and
healthy volunteers. The levels are expressed in median and interquar-
tile range (IQR)
RESULTS. A total of 606 patients were enrolled: 484 septic patients,
36 patients with SIRS without sepsis, 61 patients with infectious
diseases not admitted to the ICU, 9 critical cardiac patients and 10
healthy volunteers. MR-proADM levels were in patients with sepsis
2,567 nmol/l, compared to patients with SIRS (1,373 nmol/l, p=
0.0061), to infectious patients not admitted to the ICU (0,034 p<
0,001), to critical cardiac patients (0.034 nmol/l p<0.001) and healthy
volunteers (0.020 nmol/l;p <0.001). Regarding the distribution by
source of focus: urological origin had higher levels of MR-proADM
(5,147 nmol / l) compared to abdominal sepsis (3,307 nmol / l, p =
0.0195), and pulmonary sepsis ( 1.266 nmol / l, p <0.0001), even to
bacterial pneumonias (2.3475 nmol / l; p <0.0001). According to the
degree of SOFA the differences were significant: SOFA> 13 points
were of 6.44 nmol / l for SOFA 7-12 points: 3.01 nmol / l and for
SOFA < 6 points 1.84 nmol/l (p<0.0001). Depending on the type of
germs, we found no significant differences except for viral sepsis
(1.05 nmol / l), which were lower than gram + bacteria (2,568;p<0.05)
gram- (3.13 nmol/l;p<0.05) fungi (2.95 nmol/l;p<0.05) and polymicro-
bial (3.01 nmol / l; p <0.05). The ROC-AUC to predict the mortality in-
crease with the time of evolution 0.608 to the income, 0.724 to the
48 hours of income and 0.767 to the 5th day; similar improves for
the biomarker clearance.The ROC-AUC comparison for germs are
similar to both at admission and at 24 hours and in the 5th day ex-
cept for influenza A N1H1 viruses (0.756 at admission and 0.782 at
48 hours). The AUC-ROC of the SOFA group <6 point was 0.654 vs
0.579 of the SOFA group>13 point. In multivariable model, MR-
proADM levels at 48 hours and on day 5 and clearance on day 5 fol-
lowing admission were statistically significant predictive factors of
mortality. The subgroup of severe pneumonias due to influenza A
N1H1v since admission was statistically significant predictive mortal-
ity factor.
CONCLUSION. In clinical practice, high levels of MR-proADM help to
diagnose organic failure secondary to sepsis and, after 48 hours of
evolution, the prognosis of the risk of death with some differences
depending on the foci of origin, germ and organic dysfunction
severity.
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INTRODUCTION. There has been adequate evidence based literature
to suggest and conclude that high sugars portend a worse prognosis
in subsets of sepsis and there have been a gamut of trials effectively
backing up on the above statement. This communication deals indiabetic patients with sepsis with variable Glycosylated hemoglobin
(Hba1c) levels and a focus on correlating their outcomes with the
same.
OBJECTIVES. Objective:
To analyze outcomes of diabetic patients with elevated HBa1C levels
with sepsis and to look for an association between the same.
Setting: Multidiscliplinary tertiary care medical surgical ICUs of two
hospitals.
METHODS. Study Module:
Consecutive patients with diabetes and sepsis were admitted and
analyzed with reference to demographics, Hba1C levels at baseline(<
7 versus>7), SOFA scores (<10 versus>10), Length of stay in days
(LOS) and type of infections. Discharges from ICU/mortality were
considered as end points. SPSS version 24 was used for statistical
analysis.
RESULTS. Results:
Sixty eight patients were included (n=68, M:F- 44:24/Range-32 -80/
Mean-59.1±10.6).HBA1C levels were 8.5±1.24(Range-6.9-12).LOS was
6.78±4 days(Range-2-27).SOFA scores were 13.04±2.64(Range-8-18).In
hospital mortality was n=26 (38.24%).Infections demonstrated were
urinary tract infections-36.8% (n=25), Cutaneous infections- 26.5%(n=
18) ,Pneumonias 20.6%(n=14), Intrabdominal infections-7.4% (n=5)
and Mucormycosis 8.8%(n=6).Chi square test was applied. The subset
with a higher HBA1C value (>7) had a higher percentage mortality
vis-à-vis the subset with lower HBA1C value (<7) [38% v/s30% re-
spectively] the test did not achieve a statistical significance when
subjected to analysis (p -0.85NS).A skewing of data with reference to
higher clustering of HBA1C patients in higher cut off group was
noted. SOFA scores were tested [>10 versus <10] for association with
mortality across the subsets and there was no demonstrable statis-
tical significance for the same (p-0.65NS).ROC curves were drawn and
AUC for HBA1C levels and SOFA scores was 0.30 and 0.47 respect-
ively for association with mortality.
CONCLUSION. Conclusion:
Our study demonstrates no significant statistical differences in
patient outcomes for sepsis in diabetic cohorts based on poor
remote glycemic control. This would probably translate into mortality
in diabetic sepsis cohorts independent of remote glycemic control.
However, we will require bigger numbers with HBA1C levels <7 for
data to be more equitably comparable.
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INTRODUCTION. The red blood cell (RBC), an essential actor of the
microcirculation, is exposed to various levels of shear stress (SS) in
the blood flow and has the capacity to modify its shape to pass
through capillaries. Two recent studies (1,2) performed on RBCs from
healthy volunteers, showed that after prolonged physiological SS
exposure (< 30 Pa during 300s) like in blood flow, RBC deformability
was improved.
OBJECTIVES. We investigated the effect of preconditioning on the
RBC deformability from septic patients.
METHODS. Blood samples from 20 healthy volunteers and 20
critically ill patients with sepsis were compared. RBC deformability
was assessed by the elongation index (EI) via an ektacytometry
(Laser-assisted Optical Rotational Red Cell Analyzer – LORRCA) for SS
from 0.3 to 50 Pa. EI was defined as (A-B)/(A+B), where A is the
length and B is the width of the RBC. A higher EI indicates greater
RBC deformation.
To evaluate the effect of preconditioning on RBC deformability, we
studied EI just after a constant physiologic SS of 5 Pa during 300 s.
Data were reported in mean ± SD or median values with 25-
Page 432 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 5575thpercentiles and compared by Kruskall-Wallis test. The effect of
preconditioning on EI was assessed by Wilcoxon test. Correlations
were tested by Spearman test.
RESULTS. Compared to volunteers, septic patients were significantly
older and had a high APACHE II score: 22 (15-24). As expected, they
were also significantly more anemic and had a higher inflammatory
syndrome than volunteers.
RBCs deformability was significantly altered in septic patients
compared to healthy volunteers for all SS > 4.89 Pa. After
preconditioning, only RBCs from healthy volunteers improved EI for
low SS (0.3 to 3.07 Pa) as demonstrated in previous studies (1,2).
Despite a large variability in the response, no significant effect of
preconditioning was observed on EI for RBCs from septic patients for
all SS. Only RBCs from septic patients showed an inverse significant
correlation between EI before preconditioning and delta EI (EI after –
EI before preconditioning); r = -0.65; p = 0.001 for SS 0.3, 0.48, 1.21
and 1.93 Pa.
CONCLUSION. The RBC deformability is significantly altered during
sepsis. In contrast of RBCs from healthy volunteers, preconditioning
with low SS, as observed in blood flow, did not improve the
deformability. Nevertheless, the response was variable and was
inversely correlated with the EI at baseline. Mechanisms of these
alterations should be investigated.
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INTRODUCTION. Sepsis is the main cause of death due to infection
OBJECTIVES. Aim of the study was to evaluate the impact of sepsis
in critically ill patients’ outcome in relation to site of sepsis
acquisition ( ICU vs non-ICU acquired)
METHODS. We retrospectively reviewed ICU admissions during 2018.
We analyzed data from patients with sepsis either on admission or
during ICU stay. Demographic data, site of infection, pathogen and
ICU mortality were recorded. Data of 183 patients (64% men, of
mean age 60± 18 years, with APACHE II score 20± 8) were available
and were analyzed.
RESULTS. Fifty six patients (31%) had sepsis on admission. Twenty
four of them had subsequent septic episode during ICU
hospitalization and were excluded from analysis, and 32 patients
comprised group A. Seventeen patients (9%) had ICU acquired
infection (group B). Mortality of septic-patients was more than 2fold
compared to patients never presenting sepsis. Nevertheless, ICU ac-
quired sepsis presented a significant lower mortality compared to
non-ICU acquired sepsis (18% vs 63%, p<0.001).
The respiratory system was the most frequent site of infection in
group A (30%) while bacteremia was in group B. Sepsis was most
frequently attributed to Gam negative microbes in both groups
although at different rates (22% and 59%). Klebsiella sp. and
Acinetobacter sp. were the main causative pathogen (29% and 24%)
in group B.
Among the mortality-correlated risk factors examined (sex, comorbid-
ity, medical history, APACHE II score) only age was statistically differ-
ent between the groups (66±13 vs 56±21, P=0.04). Group’s Amortality risk, compared to group-B remained much higher after
age-adjustment (OR: 6.7 CI 95% 1.5-30, p:0.014)
Delayed admission of septic patients was recorded to be very
frequent (more than 70% of non-ICU acquired sepsis patients were
admitted more than 12 hours post sepsis onset). Since immediate
treatment of these patients has a significant impact on outcome, the
delayed admission could explain the different mortality. Nevertheless,
further studies are needed to make concrete conclusions.
CONCLUSION. Forty percent of ICU patients presented at least one
septic episode. Non-ICU acquired sepsis had a worse outcome com-
pared to ICU acquired sepsis, possibly due to delayed ICU admission
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INTRODUCTION. Sepsis, a syndrome of physiologic, pathologic, and
biochemical abnormalities induced by infection, remains to be a
significant health care issue associated with high mortality. Our
understanding of the pathogenesis of sepsis is broader, however the
function of some cellular elements that are an essential part of the
innate immune line is still unknown. Unlike the alterations documented
in neutrophils and lymphocytes during sepsis, the role played by
monocytes is still unclear, especially if the absolute count is directly or
inversely associated with the prognosis of these patients.
OBJECTIVES. To evaluate the association of monocytic counts with
the severity and mortality in patients with septic shock at the
intensive care unit (ICU) of a tertiary hospital Mexico City.
METHODS. Retrospective analysis during 6 months in 2018, collected
patients with septic shock (Sepsis-3). Monocyte counts were
categorized into <300 and >1000 cell/UL; 28-day mortality and organ
dysfunction were defined as the primary endpoint and compared be-
tween the groups. Pearson´s correlation coefficient was used for sta-
tiscal test to evaluate the association of initial monocytes counts
with severety. To determiny 28-day mortality risk, the odds ratio (OR)
was calculated with 95% confidence intervals, and p < 0.05 was con-
sidered significant. The data are presented as absolute values and
percentages. Treatment standardized protocols were followed for
each patient.
RESULTS. We collected 48 patients (54.2% female), mean age was 48
±17.3 years. The causes of septic shock were: medical 54.2%, surgical
43.8% and trauma 2%. Mean APACHE II and SOFA score were 17.8 ±
7.9 and 9.7 ± 4.9 respectively. The length of stay in ICU was 6.4 ± 5.8
days. Eleven patients (22.9%) died during the follow-up. Pearson´s
correlation coefficient between initial monocytes counts and organ
dysfunction was -0.094 (p=0.52), with determination coefficient of
0.9. Initial monocyte counts < 300 cells/uL showed highest risk of
mortality at 28 days with OR 2.375 (95% IC 0.553 – 10.196, p=0.244),
whereas patients group > 1000 cells/uL showed lower risk of mortal-
ity with OR 0.950 (95% IC 0.086 –10.499, p=0.966).
CONCLUSION. In our study monocyte count <300 cells/uL was
associated with highest mortality and severity in patients with septic
shock but without statistically significance contrary to international
Page 433 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55literature. Additional studies are be needed to elucidate the
potentially role of monocytes on prognosis septic shock.
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INTRODUCTION. Since 2018, Surviving sepsis campaign recommended
1 hour bundle therapy in septic shock patients. However the evidence
of bundle therapy has not been established. The object of this study
was to determine a prognostic value of 1 hour bundle completion in
septic shock patients.
METHODS. This prospective, registry based, observational study was
performed between January 2016 and December 2018. 1 hour
bundle in septic shock was defined as a serum lactate measurement;
obtain blood cultures; administration antibiotics and adequate fluid
within 1 hour from emergency department admission. Eligible septic
shock patients were included for analysis and we analyzed
prognostic ability of all completion of 1 hour bundle and each of
them. The primary outcome was 28-day mortality.
RESULTS. The study included 381 patients and overall 28-day mortality
was 24.7%. Overall 1 hour bundle completion rate was 12.2% and each
completion rate of serum lactate measurement; obtain blood cultures;
administration antibiotics and adequate fluid were 85.0%, 72.5%,
18.8%, and 52.3% respectively. However, overall bundle completion as
well as each bundle were not associated with 28-day mortality except
adequate fluid administration (Odd ratio (OR) 0.67 [95% Confidential
interval (CI) 0.30-1.50], OR 1.33 [95% CI 0.66-2.70], OR 1.50 [95% CI 0.85-
2.64], OR 1.17 [95% CI 0.66-2.07], and OR 0.54 [95% CI 0.34-0.87], re-
spectively). Multivariate logistic regression analysis shows that adequate
fluid administration was an independent predictable factor in 28-day
mortality (OR 0.50 [95% CI 0.29–0.84], p=0.009).
CONCLUSION. In this study, we found since septic shock is very
complicated, most of 1 hour bundle completion were not associated
with mortality. Although adequate fluid administration was associated
with 28-day mortality, to generalize this result, we need multicenter
interventional study with improving physician’s compliance.
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INTRODUCTION. Pneumonia due to gram negative multiresistant bacteria
(GNMB) is an important problem in the intensive care unit. There are few
studies evaluating the efficacy of aerosolized antibiotics.
OBJECTIVES. To compare whether combined intravenous and inhaled
colistin administration is better than intravenous colistin alone in the
treatment of respiratory infection by multiresistant microorganisms in
critically ill patients.
METHODS. This study was observational and retrospective. Patients
admitted to the ICU who received intravenous colistin, inhaled colistin or
both, as a treatment for a respiratory infection due to multiresistant
pathogens were analyzed in the period between January 2014 and January
2019. The primary outcome was the clinical response. Secondary outcomes
included microbiological response, ICU and hospital mortality and side
effects such as neurologic or renal failure. Chi-square, t-Student, Mann-
Whitney and Kaplan-Meyer tests were used for the statistic analysis.
RESULTS. Total 107 patients were studied but only 90 with lung infection
were included: 43 pneumonia, 47 tracheobronchitis). 53 patients received
endovenous colistin, 24 received both endovenous and aerosolized colistin
and 13 received aerosolized colistin and other endovenous antibiotic.
Pseudomonas aeruginosa caused lung infection in 93% of patients. No
differences between groups in age, sex, gravity, previous colonization, shock
development or type of infection were found. Treatment related adverse
events were reported in 21 patients. Main results are shown in the table.
CONCLUSION. In conclusion, additional aerosolized colistin did not
show better outcomes in critically ill patients with lung infection
caused by multiresistant microrganisms.
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Table 1 (abstract 001320). See text for descriptionEV colistin
N:53INH colistin
N: 37p
valueAge, years 56 ± 16 54 ± 17 0.50Female sex, n (%) 10 (18.9) 9 (24.3) 0.60Charlson comorbidity index 1 (0 – 1.5) 1 (0 – 2) 0.56SAPS II 48 ± 16 48 ± 16 0.95APACHE II 26 ± 11 26 ± 8 0.89Lower respiratory tract infection, n (%)Pneumonia 24 (45.3) 19 (51.4)Tracheobronchitis 29 (54.7) 18 (48.6)Median length of stay (interquartile range: IQR), daysIn the ICU 29 (20 –
44)41 (26 –
57)0.02In the hospital 46 (30 –
76)85 (50 –
120)0.004Median duration of mechanical ventilation
(IQR), days22 (13 –
31)30 (16 –
39)0.06Mortality at 30 days, n (%) 18 (34.0) 6 (16.2) 0.09001758
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INTRODUCTION. Dysregulated endothelial activation is the key
mechanism in development of septic shock, resulting in an increased
permeability and dysfunction of the endothelial barrier. Endoglin as a
part of the transmembrane TGF-β receptor complex is located on the
surface of endothelial cells. Its extracellular domain can be cleaved,
leading to the production of soluble endoglin (sEng). sEng produc-
tion seems to be forced by hypoxia/oxidative stress, and can be con-
sidered to be a marker of endothelial activation/dysfunction (1,2).
Endoglin is also expressed on monocytes, where it has regulatory
functions during the immune response (3).
OBJECTIVES. The aim of the study was to evaluate a kinetics of sEng
plasma concentration in septic shock patients and determine
whether sEng could be used as biomarker in prediction of mortality
of sepsis and whether it correlates with other biomarkers and
severity of septic shock.
METHODS. Patients admitted to the ICU with early septic shock were
prospectively enrolled into the study. Plasma samples and clinical
data were collected at admission (T1) and in subsequent six days
(T2-T7). Soluble endoglin concentration was measured using Human
Endoglin/CD105 Quantikine ELISA Kit (R&D systems). Obtained data
were compared to 3-months mortality and Pearson coefficient was
used for estimation statistical correlation of sEng with patient’s age,
sex, CRP and procalcitonin.
RESULTS. Recruited patients (n=24) were predominantly male (71.4
%) with median age 68.5 (53.5-73.0) years. All patients were
mechanically ventilated and the average SOFA and APACHEII scores
at admission were 11.5 (9.5-13.5) and 28.0 (26.5-35.5) respectively. 3-
months mortality rate was 43.8 %. There were no statisticaldifferences in the patients’ past medical history, chronic medication
or sepsis severity at the time of admission between survivors and
non-survivors. Median sEng concentration at admission was signifi-
cantly higher (p=0.004) in deceased patients 5.18 (3.78-10.21) μg/l
compared to survivors 3.24 (2.92-3.66) μg/l. There was no statistical
correlation between sEng and age, APACHEII, CRP or PCT. Regarding
7-day trend, there were no changes in sEng levels in the group of
surviving patients, but sEng levels were consistently elevated in the
group of deceased patients with a slight drop observed on the 6-7th
day. Data are provided as median (IQR).
CONCLUSION. Our pilot data suggests that soluble endoglin has a
good predictive power in prediction of mortality in septic shock
patients. Markedly higher levels of sEng in the group of deceased
patients over the entire seven-day follow-up period might reflect a
high degree of sEng production and therefore a high degree of
endothelial dysfunction. Results needs to be verified in the bigger co-
hort of septic patients. Whether sEng could also differentiate be-
tween infectious (sepsis) and non-infectious etiology (SIRS) of shock
or what is its specific function in endothelial dysfunction or host-
response reaction in sepsis remains to be elucidated.
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INTRODUCTION. Spirituality substantially influences coping strategies
of family members of patients hospitalized in an Intensive Care Unit
(ICU). Spirituality might also influence the communication between
family members and ICU physicians and nurses.
OBJECTIVES. To explore the effect of spirituality of critically ill
patient’s family members on their satisfaction during communication
with ICU health professionals.
METHODS. The research was conducted from March 2018 to March
2019. Family members (first degree relatives, close relatives and
intimate friends) of patients hospitalized in a University ICU
constituted our research material. A questionnaire for
sociodemographic data and the Spiritual and Religious Attitudes in
Dealing with Illness (SpREUK) Scale was completed by family
members during the first week after their beloved one’s ICU
admission. One way ANOVA and MANCOVA was used for statistical
analysis.
RESULTS. One hundred and three family members mean-aged
45.92±11.43 years corresponded to 86 ICU patients responded to the
Study. Forty-four of them were men (42.7%) and 59 women (57.3%),
Most of them were children (48.5%) and the remaining family mem-
bers were patients’ companions (23.3%), siblings (7.8%), parents
(7.7%) or other relatives (12.7%). Spirituality was found to positively
increase the satisfaction of family members (F=3.632, p=.009). Gen-
eral linear model analysis found strong association between “Trust in
Page 435 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Higher Guidance/Source” (SpREUK) and feelings of information com-
pleteness (p=.034), openness and honesty of information (p=.020),
understanding of the information (p=.010) and ease of accessing in-
formation (p=.010) among family members during their communica-
tion with ICU physicians and nurses. Data analysis did not show any
significant difference in spirituality of family members based on sex,
marital status and place of residence except for the educational level
of relatives with the SpREUK subscale “reflection” (p=.001); the higher
the educational level the higher was the score in “reflection” subscale
while the most prominent differences were found between ‘high
school’ and ‘postgraduate’ family members (p=.041).
CONCLUSION. Critically ill patients’ relatives are more satisfied with
their communication with ICU health professionals when they have
higher levels of spirituality and they believe in something “higher” to
overcome the difficulties.
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INTRODUCTION. Simultaneous pancreas and kidney transplantation
(SPK) has been established as the treatment of choice for type 1
diabetic patients with end-stage nephropathy, leading to marked im-
provement in cardiovascular function and long-term survival. Ad-
equate fluid therapy is essential to maintain intravascular volume
and to obtain appropriate graft perfusion. Hypovolemia can result in
further organ injury or thrombosis. Furthermore, excessive volume in-
fusion with hemodilution and tissue edema, increases oxygen diffu-
sion distance and impairs graft perfusion.
METHODS. Retrospective study of patients admitted for SPK during
2018 in an Intensive Care Unit (ICU) in a Transplant Reference Center.
Fluid management was implemented according to protocol (urine-
output per hour plus 200mL for two days). Doppler ultrasound was
done on the first post-operative day and when clinically relevant. All
patients received 100mg aspirin pre and post-transplant associated
with low-molecular weight heparin. Immunosuppression induction
and maintenance included thymoglobulin, methylprednisolone, ta-
crolimus and mycophelonate mofetil. Daily fluid balance, serum urea,
creatinine and C peptide were recorded every day during the first 4
days post-SPK. Fluid balance was defined as primary exposition and
pancreatic thrombosis as primary outcome.
RESULTS. Nineteen caucasian patients (63% male) were admitted.
Fourteen were under pre-transplant dialysis for more than 1 year.
One needed plasmapheresis before SPK. Pancreatic graft thrombosis
happened in 5 patients (26%) between the 2-6 days of ICU. No posi-
tive differences were found in both groups according to donor’s age
or past history of thrombosis. No relevant differences were found influid balance on the first three days pos-SPK transplant in both
groups. Fourth day fluid balance was significantly lower in the group
of pancreatic thrombosis (-1,20L vs +0,03L, p < 0,05). The percentage
of patients who needed vasopressor support during surgery was
higher in the thrombotic group (80% vs 35,7%,p = 0,14). Time-to-
event analysis (Cox regression) with Kaplan-Meyer curves adapted for
vasopressor support revealed a 30 day pancreatic graft survival worse
for those who needed perioperative vasopressor (56% vs 90%, p =
0,11). Hospital mortality rate of 10,5%.
CONCLUSION. SPK survival can be influenced by multifactorial
variables where fluid balance is one of them. Nevertheless, optimal
fluid management remains a challenge for both peri and post-
operative periods. The use of minimal invasive hemodynamic devices
with patient-centered targets may play an important role in best un-
derstanding flow parameters in this specific group of patients with
impaired cardiovascular physiology and reduced hemodynamic auto-
regulation. Avoiding excessive fluid resuscitation and its conse-
quences as well as hypovolemia may be helpful in increasing graft
survival and patient outcomes.
REFERENCE(S)
1. Wiseman A, Gralla J. Simultaneous pancreas kidney transplant versus
other kidney transplant options in patients with type 2 diabetes. Clin J
Am Soc Nephrol. 2012;7:656-664.
2. Stadler M, Theuert E, et al. Persistent arterial stiffness and endothelial
dysfuncion following successful pancreas-kidney transplantation in Type
1 diabetes. Diabetic Medicine.2009;26:1010-1018.
3. Schnuelle P, van der Woude FJ. Perioperative fluid management in renal
transplantation: a narrative review of the literature. Transplant
International.2006;19:947-959.
4. Calixto Fernandes MH, Schricker T, et al. Perioperative fluid management
in kidney transplantation: a black box. Critical Care.2018;22:14.
000187
Critically ill elderly patients in the emergency department: Critical
information for clinical decisions
J. Wagner1, A. Krohn1, T. Schilling1, D. Räpple2, J. Heymer1
1Interdisciplinary emergency department, Klinikum Stuttgart -
Katharinenhospital, Stuttgart, Germany; 2Interdisciplinary intensive care
unit, Klinikum Stuttgart - Katharinenhospital, Stuttgart, Germany
Correspondence: J. Heymer
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000187
INTRODUCTION. Elderly patients have a high in hospital mortality1.
Physicians may support patients and families in the decision making
process by providing information2.
OBJECTIVES. We aimed to characterize the patients admitted via the
emergency department to medical and neurologic intensive care
units and analyze in hospital mortality and transition to palliative
care
METHODS. We conducted a retrospective study of patients ≥80 years
who were admitted in 2016 and 2017 via the emergency department
to a medical or neurointensive care unit. The electronic medical
record of each patient was studied to extract data regarding the
therapies, outcomes and the decision making process.
RESULTS. During the two- year period 248 (114 male, 134 female)
patients ≥80 years were admitted from the emergency department
to our ICUs. Mean age was 85,27 (±3,61; range 80,1-96,78) years,
mean length of stay was 11,9 (±18,5; range 0-202) days.
In 66 (26,6%) patients, therapy was transitioned to palliative care, 68
(27,4%) patients died in hospital and 83 (33,5%) patients either died
or therapy was changed to palliative care.
Frequent primary diagnosis include stroke/ICB, infection, cardiac
disease, trauma, renal disease/electrolyte disorders and GI-Bleed.
113 patients required mechanical ventilation (92 patients invasive
ventilation, 21 patients non invasive ventilation), 73 patients received
catecholamines.
Patients requiring mechanical ventilation had a higher rate of the
combined result of in hospital death or transition to palliative care
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4,27, 95%CI 2,43-7,51; p < 0,0001).
In the subgroup of patients treated with invasive ventilation the rate
of in hospital death was 53,3%.
In 51 of the 68 patients (75%) that eventually died therapy was
changed to palliative care.
The differences in age between survivors (mean 85,3 ±3,4 years,
median 84,5 years) and non survivors (mean 85,2 ±3,2 years, median
84,8 years) were not significant (p=0,7642).
CONCLUSION. Patients ≥ 80 years admitted to the ICU had a high
rate of death or transition to palliative care. The high rate of
transition to palliative care in the non- survivors underlines the
importance of support in the decision making process in order to
prevent futile treatments. In this group of patients ≥80 years we did
not find a significant age difference between survivors and non
survivors.
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INTRODUCTION. A 2009 review conducted by the UK Centre for
Policy on Ageing found evidence of ageist attitudes among hospital
staff and suggested that doctors may be more ageist than other
healthcare professionals. The authors emphasised the need to study
this in more detail.
The incidence of frailty and chronic illness increase with increasing
age yet are not always present so should not be assumed to co-exist.
In 2017, 18.2% of the population were aged 65 or older, compared
to 10.6 % in 1948, when the NHS was created.
OBJECTIVES. To explore attitudes regarding age within our own
multi-disciplinary team.
METHODS. A survey was distributed to healthcare professionals:
acute internal medicine (AIM) physicians (n=14); intensive care
doctors (n=8), and ICU nurses (n=9). Responses were anonymous and
without conferring or using additional information. Of the 8 multiple-
choice questions, three tested knowledge and two specifically asked
whether the respondent felt doctors (physicians and intensivists) had
an ageist attitude when making decisions about critical care referral/
admission. Options were “Never”, “Occasionally”, “Sometimes”,
“Often” and “Always”.
RESULTS. Regarding escalation and/or setting ceilings of treatment
in elderly patients, only half of doctors (43% of AIM, 50% of
intensivists), compared with a majority of ICU nurses (89%) were
happy with decision-making in their workplace. A minority of AIM
(36%) and intensivists (38%) but a majority of nurses (78%) felt it
was sometimes acceptable to use age as the main factor in
deciding whether or not a patient’s treatment should be escalated.
Regarding knowledge-based questions, intensivists gave reasonably
accurate answers regarding ICU mortality in the elderly and the
average age of patients admitted to ICU. The majority of AIM over-
estimated both mortality and average age. All groups significantly
underestimated average life expectancy in the elderly population.
Both physician groups viewed both AIM and intensivists as having
an ageist attitude at least some of the time, but using bootstrapping
methods (10,000 replications), the difference between the opinions
of the ICU and AIM doctors was not statistically significant (p =
0.1969).CONCLUSION. There is significant dissatisfaction amongst both acute
physicians and intensivists regarding escalation of treatment
decision-making in elderly patients. ICU nurses are more satisfied,
and are much more likely to accept the use of age as the main factor
when decisions are made. Both doctor groups viewed both AIM and
intensivists as having an ageist attitude at least some of the time,
but this difference in opinion was not statistically significant. Intensi-
vists had better awareness about ICU mortality and average patient
age, but all groups significantly underestimated life expectancy in
the elderly. A larger multicentre study would be useful to further ex-
plore these findings, and more training and education is needed to
address the issues raised.
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INTRODUCTION. For many years there has been a reluctance to
admit cancer patients to the ICU. However, whether ICU clinicians
tend to discriminate cancer patients is unknown.
OBJECTIVES. The aim of this study was to compare the time until
treatment limitation decisions (TLDs) and death, and the one year
outcomes in patients with and without concordant perceptions of
excessive care (PECs) by two or more ICU clinicians in the following
subgroups : uncontrolled and controlled cancer vs. patients without
cancer.
METHODS. Subanalysis of the DISPROPRICUS study performed in 68
ICUs in 12 European countries and the USA between 2014 and 2015
[1]. Clinicians (nurses and physicians) completed daily a
questionnaire about the appropriateness of care for each of their
patients during a 28 day period. We compared the cumulative
incidence of patients with concordant PECs, TLDs and death, and the
proportion of patients attaining the combined endpoint (death, poor
quality of life or not being at home) at one year across subgroups
via Cox-regression (accounting for competing risk) and Fisher-exact
tests, respectively. To adjust for country, ICU and patients characteris-
tics we used inverse probability weighting based on propensity
scores. Results are presented as weighed % and hazard ratios (HR)
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without cancer was used as reference category.
RESULTS. Of the 1641 patients not admitted for monitoring only
during the study period, 117 (7.1%) had uncontrolled cancer and 270
(16.4%) had controlled cancer. Of the 2690 participating clinicians,
2293 (85.2%) provided 25025 perceptions of appropriateness of care,
of which 2279 (9.1%) PECs by 728 (27.0%) clinicians in 334 (20.3%)
patients. The cumulative incidence of concordant PECs in patients
with uncontrolled and controlled cancer vs. patients without cancer
was 20.4%, 9.2% and 8.9% (p=0.005 and 0.85, respectively). In
patients with concordant PECs, we found no evidence for a
difference in time from concordant PECs until death (HR 0.99, 95%CI
0.59-1.65 and 0.90, 95%CI 0.50-1.62) and TLDs (HR 0.93, 95%CI 0.36-
2.40 and 0.68, 95%CI 0.24-1.89) across subgroups. In this group, the
risk of reaching the combined endpoint at one year was 93.7% and
82.5% vs. 93.4% (p=0.99 and p<0.001). In patients without
concordant PECs, we found evidence for a difference in time from
admission until death (HR 2.23, 95%CI 1.58-3.15 and 1.66, 95%CI
1.28-2.15) whereas the time from admission until TLDs was
statistically non-significant (NA, p=0.3 and 0.7) across subgroups. In
this group, the risk of reaching the combined endpoint at one year
in patients with uncontrolled and controlled cancer vs. patients with-
out cancer was 70.8% and 63.0% vs. 54.5%,respectively (p=0.003 and
p=0.02).
CONCLUSION. The absence of evidence of a higher risk of TLDs and
death in patients with concordant PECs makes discrimination of
cancer patients by ICU clinicians unlikely. However, relative to
patients without cancer, our results suggest prognostic pessimism in
ICU clinicians who provided PECs in patients with controlled cancer
and prognostic optimism or ignorance in ICU clinicians who did not
provide PECs in patients with uncontrolled cancer, respectively. This
study highlights the need to improve intra-and interdisciplinary eth-
ical reflection and subsequent decision-making in the ICU [1].
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INTRODUCTION. The increasing number of older patients admitted
to the ICU with multiple comorbidities and frailty is often at thecenter of debate in daily practice. However, whether ICU clinicians
tend to discriminate elderly patients is unknown.
OBJECTIVES. The aim of this study was to compare the time until
treatment limitation decisions (TLDs) and death, and one year outcomes in
patients < and ≥75 year with and without concordant perceptions of
excessive care (PECs) by two or more ICU clinicians.
METHODS. Subanalysis of the DISPROPRICUS study performed in 68 ICUs
in 12 European countries and the USA between 2014 and 2015 [1].
Clinicians (nurses and physicians) completed daily a questionnaire about
the appropriateness of care for each of their patients during a 28 day
period. We compared the cumulative incidence of patients with
concordant PECs, TLDs and death, and the proportion of patients attaining
the combined endpoint (death, poor quality of life or not being at home)
at one year across subgroups via Cox-regression (accounting for competing
risk) and Fisher-exact tests, respectively. To adjust for differences in country,
ICU and patient characteristics, we used inverse probability weighting
based on propensity scores. Results are presented as weighed % and haz-
ard ratios (HR) with their 95% confidence intervals (CI).
RESULTS. Of 1641 patients not admitted for monitoring only during
the study period, 405 (25%) were ≥75 years. Of the 2690
participating clinicians, 2293 (85.2%) provided 25025 perceptions of
appropriateness of care, of which 2279 (9.1%) PECs by 728 (27.0%)
clinicians in 334 (20.3%) patients. The cumulative incidence of
patients with concordant PECs was significantly higher in patients
≥75 years than in patients < 75 years (13.6 % vs. 8.5 %, p-value =
0.01). In patients with concordant PECs, we found no evidence for a
difference in time from concordant PECs until death (HR 1.08, 95%CI
0.73-1.61) and TLDs (HR 0.98, 95%CI 0.51-1.91) between older and
younger patients. We neither found evidence for a difference in risk
of reaching the combined endpoint at one year in this group be-
tween older and younger patients (90.4% vs. 93%, p= 0.54). In pa-
tients without concordant PECs, we found evidence for a difference
in risk of death (HR 1.38, 95%CI 1.11-1.73) and TLDs (HR 2.11, 95%CI
1.37-3.27), though half of the TLDs were installed already before ICU
admission. The risk of reaching the combined endpoint was also sig-
nificantly higher in older compared to younger patients (62.1% vs.
52.8%, p<0.001).
CONCLUSION. The absence of a higher risk of TLDs, death and one
year outcomes in patients with concordant PECs makes
discrimination of older patients by ICU clinicians unlikely. The poorer
one year outcomes in older patients without concordant PECs after
weighing for confounders confirms that age need to be taken into
account during ethical decision-making.
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INTRODUCTION. Objectives: To evaluate among ICU patients that
evolved to death those with an indication of performing and
applying end-of-life decisions and palliative care (EL-PC); and to
F2
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items of ‘futile/unnecessary treatment’.
METHODS. Observational prospective cohort in five ICUs. Patients
who evolved to death were evaluated searching for indication of EL-
PC. The correct application of nine preselected items was studied.
RESULTS. Among 253 admissions, 52 patients died; and among
these, 38.5% met criteria for EL-PC. Among PC candidates (n = 20),
the PC was started later (after day 3) in 60%, and only 3 patients re-
ceived adequate palliative care. ‘Analgesia’ and ‘Daily family inter-
views’ were the most correctly applied PC items. ‘Terminal
extubation/weaning’ was not performed in any of the patients. A re-
duction in the interval from the onset of PC to death was observed
in patients who underwent ‘correct’ interventions—66.6% died onFig. 1 (abstract 000558). See text for descriptionthe first day of PC.
CONCLUSION. In a low/medium-income country, one-third of pa-
tients who died in the ICU had indications for EL-PC; however, the
PC was adequately performed for only 15% of the candidates, with
great heterogeneity and delays in regards to its initiation.
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INTRODUCTION. The decision-making process regarding end of life
treatment is complex and challenging. Several authors report a sub-
stantial variability in this process among intensivists 1-3.
OBJECTIVES. The primary aim of this qualitative study was to
investigate Swedish intensivists’ perceptions and attitudes towards
withdrawing or withholding life sustaining treatments. The secondary
aim was to identify underlying factors that may contribute to
inherent biases in the decision-making process.
METHODS. This is a descriptive study with qualitative approach.
Semi-structured interviews was chosen as method for the study. The
interviews were recorded and transcribed verbatim. All the data was
categorized into thematic patterns as the primary basis for organiz-
ing findings and data coding was used. A two-step process, begin-
ning with basic coding in order to distinguish overall themes, which
was followed by a more in depth, interpretive code in which more
specific trends and patterns were interpreted.RESULTS. Nineteen semi-structured interviews with intensivists with
different experience, education, age and gender, from five different
hospitals were performed. The main finding of this study is that there
is an unchallenged, accepted variability in end of life decision mak-
ing among Swedish intensivists. The contributory factors to this vari-
ability are personality of the intensivist, lack of continuity among
senior intensivists, disagreements with physicians from other special-
ties, lack of competence during on call hours, and concerns of criti-
cisms for making questionable decisions. Few of the respondents
had any formal education on how to approach end of life decisions
and it was generally not demanded. All of the respondents knew
about existing on-line guidelines, but few used them in daily clinical
practice.
CONCLUSION. There are significant variabilities in the decision-
making on withdrawing or withholding life sustaining treatments on
the intensive care units. We propose a more structured approach,
formal education and routine adherence to clinical guidelines in
order to improve the management of this group of complex
patients.
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INTRODUCTION. Alternatives to prospective consent by patients are
necessary for conducting clinical research with critically ill patients. It is
important that such consent practices align with the perspectives of
key stakeholder groups - patients, relatives and clinical practitioners.
OBJECTIVES. To determine the perspectives of different stakeholder
groups towards current consent practices for research with critically
ill patients, with the overall objective of informing good practice
guidance on consent to intensive care unit (ICU) studies.
METHODS. Mixed methods study comprising surveys and in-depth
interviews in 14 English ICUs.
RESULTS. 1409 surveys were included (ICU patients n=333,
relatives n=488, practitioners n=588) and 58 stakeholders were
interviewed. Survey responses indicated that most stakeholders
agreed it was acceptable for relatives to decide about research
participation on behalf of incapacitated patients, although the
proportion of patients who agreed (68%) was lower than relatives
(83%) or practitioners (76%). The practice of doctors consenting
to research on behalf of incapacitated patients was supported by
most stakeholders in situations where there were no known
relatives (patients 60%, relatives, 63% practitioners 63%) or if
time was too short to contact relatives (patients 57%, relatives,
51%, practitioners 53%). Most patients (55%) and relatives (52%)
also supported consent by doctors when relatives were
unavailable, but only 45% of practitioners supported this.
Practitioner experience of research influenced their views on
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accepting of this practice than practitioners with no research
role. In all three stakeholder groups approximately 25% of
members disagreed with doctor consent for ICU studies whatever
the situation. However, interviews indicated that stakeholders
were more flexible towards doctors consenting on behalf of
incapacitated patients than their survey responses suggested,
with the views of most patients and relatives, and some
practitioners shifting markedly depending on particularities of the
study and situation.
CONCLUSION. Stakeholder support for current ICU research consent
practices that involve relatives in decisions was generally high. In
situations where involving relatives was not possible, most
stakeholders also supported consent by doctors, although a sizable
minority disagreed with this consent practice. When interviewed,
stakeholders were rarely fixed in their views, with many willing to
countenance a range of consent practices depending on their
perceptions of what the research involved and provided safeguards
were in place. Findings point to the importance of explaining clearly
why alternative consent practices are used in ICU studies and what
safeguards are in place.
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INTRODUCTION. Stagnation in the number of donors after brain
death (BD) requires strategies to increase the pool of donors to
meet expanding waiting lists. Intensive care to facilitate organ
donation (ICOD) has been defined as the initiation/continuation
of intensive care measures in patients with a devastating brain
injury (DBI) in whom treatment for curative purposes is deemed
futile, and who are considered possible organ donors, with the
aim of offering donation after brain death (DBD) inside their end-
of-life care plans [1].
OBJECTIVES. We describe the impact on the donation activity in Vall
d’Hebron University Hospital, Barcelona, following introduction of a
new strategy promoting the referral of possible donors from outside
the ICU to consider ICOD over a 4-year period.
METHODS. Retrospective analysis (2015-2018) of all patients located
outside the ICU with a DBI referred to the donor coordination (DC) to
be considered for ICOD. Once the DC evaluated the medical
suitability and likelihood of progression to brain death (BD), families
were approached to discuss the option of donation. If favourable,
further evaluation and maintanance was performed in the ICU until
BD ensued, leading to donation in elegible cases. In those cases
where BD did not occur, life-sustaining therapies were withdrawn
and the option of controlled donation after circulatory death (cDCD)
was offered to the family.
RESULTS. Of the 983 possible donors evaluated during the study
period, ICOD was considered in 206 (21%), of whom 115 (55.8%)
were medically unsuitable for donation.Family consent was obtained for 69 (76%) of the remaining patients.
Refusal rate was twice as high when non-therapeutic ventilation was
required for organ donation (34%) compared to those patients previ-
ously ventilated (13.6%) (p =0.02). Patients subject to ICOD died in a
median of 2 days [1 – 3] and 88.4% became actual donors (AD) (39
after BD/22 after circulatory death). Nine (17.6%) donors were finally
not utilized. ICOD contributed to 27% of the 195 utilized donors and
26% of the 603 organs transplanted. Over the 4 years analyzed, ICOD
was responsible for a progressively greater percecentage of AD ran-
ging from 27.7% in 2015 to 31.6% in 2018.
CONCLUSION. ICOD has proved to be a procedure well-accepted
by families, which facilitated the offer of donation in end-of-life
care to an increasing number of patients at our hospital. It also
provided, with a short ICU stay, an important and sustained in-
crement of the organ pool for transplantation.
REFERENCE
1. The Spanish recommendations on Intensive Care to facilitate Organ





End-of-life decisions may influence ICU mortality and hospital
lengths of stay
S. von Düring1, PD. Wendel Garcia2, JC. Schefold3, K. Tisljar4, S. Doll5, H.
Pargger6, B. Ricou1
1Medical surgical intensive care unit, University Hospitals of Geneva and
University of Geneva, Geneva, Switzerland; 2Medical intensive care unit,
University Hospital of Zurich, Zürich, Switzerland; 3Department of
intensive care, Inselspital, Bern University Hospital and University of Bern,
Bern, Switzerland; 4Medical intensive care unit, University Hospital of
Basel, Basel, Switzerland; 5Medical surgical intensive care unit, Cantonal
Hospital of Fribourg, Fribourg, Switzerland; 6Surgical intensive care unit,
University Hospital of Basel, Basel, Switzerland
Correspondence: S. von Düring
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000734
INTRODUCTION. More than 70 % of ICU deaths occur after an End-
Of-Life (EOL) decision consisting in withholding or withdrawing of
life-sustaining therapy (LST). EOL decision-making varies greatly
within Europe. Switzerland is separated into distinct cultural regions
defined by languages related to the neighboring countries. The three
linguistic regions are the French (FR), the German (GR) and the Italian
speaking region.
OBJECTIVES. To determine the differences in EOL decisions between
the FR and GR, and their influence on ICU and hospital length-of-stay
(LOS) and mortality. As secondary objectives, we evaluated whether
the type and timing of EOL decision had an influence on outcome
issues.
METHODS. Patients admitted to ICU and who had treatment
limitations over a 6 month period were included as part of the
ETHICUS 2 study. Seven Swiss ICUs (3 in FR, 4 in GR) allowed us to
compare two cultural regions. Patients were followed from admission
until discharge from the ICU, death, or 2 months after the decision to
limit the therapy.
RESULTS. Results of 1’115 patients are summarized in Table 1. ICU
and hospital mortality differed significantly between FR and GR (33
vs 63 %, p < 0.0001, 48 vs 75 %, p < 0.0001 respectively), whereas
mortality after ICU was similar in both groups. ICU LOS was similar in
both groups. Post-ICU LOS was longer in FR and EOL decisions were
made earlier in FR. Time from decision to death was considerably
longer in FR than in GR. FR took decisions in multiple steps
T1
Page 440 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55compared to GR (40 vs 24 %, p < 0.013), and GR withdrew LST as a
single decision that impacted shortly on survival.
CONCLUSION. Mortality was significantly higher in GR. EOL decisions
were made later in GR ICUs but with more withdrawals that were
associated with more deaths. ICU LOS was similar in both regions
but hospital LOS after ICU and total hospital LOS was significantly
shorter in GR. Depending on the way EOL decision is made, the
hospital LOS and the outcome may be impacted.
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Table 1 (abstract 000734). Comparison between FR and GRFR n=550
(49.3)GR n=565
(50.7)p
Total Hospital Length of stay (LOS) [days] 22.27 ±
1.0811.59 ± 0.77 <
0.0001- ICU LOS [days] 4.99 ± 0.32 4.15 ± 0.26 0.04- Hospital LOS after ICU [days] 12.16 ±
0.763.2 ± 0.34 <
0.0001Time to 1st EOL limitation after ICU
admission [days]0.79 ± 0.24 1.92 ± 0.28 < 0.01Time to ICU discharge after first EOL
limitation [days]3.97 ± 0.31 4.18 ± 0.39 0.67Time to death after first EOL limitation [days] 10.6 ± 1.01 2.27 ± 0.23 <
0.0001000814
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INTRODUCTION. Many ICU patients receive end-of-life care. There is
a lack of knowledge about current end-of-life practices in Germany.
OBJECTIVES. This study presents data from the subset of German
ICUs which participated in the worldwide Ethicus-2 study on ICU
end-of-life care practices (EOLP) in ICUs.METHODS. Observational study of consecutive ICU patients with
end-of-life care, defined as patients who died and/or had end-of-life
decisions (EOLD) during a 6-months period.
RESULTS. Eleven German ICUs participated, 9 were mixed medical/
surgical, 1 medical and 1 neurosurgical, 9 centers were in academic
hospitals. A total of 1092 patients were included, representing 13,7
% of all admitted ICU patients. Median age was 72 (IQR 60-80) years,
647 (59.2%) patients were male. Patients had a median ICU and hos-
pital length of stay of 4 (IQR 1-11) days and 10 (IQR 4-22) days, re-
spectively. Patients with EOLD had longer median ICU and hospital
stays (4 days (IQR 1-12) and 11 days (IQR 4-23), respectively) than pa-
tients without EOLD 2 (IQR 0-6) days and 5 (IQR 1-11) days respect-
ively, both p≤ .0001). Most frequent admission diagnoses were
respiratory disease (37%), surgery (35.6%) and neurological disease
(23.6%). Among all patients, 270 (26.9% of all) had an advance direct-
ive, 440 (43,7%) had legal patient representatives and 126 (11.7%) of
patients were mentally competent at the time of EOLD decision-
making.
Among all patients, 967 (89%) had limitations of life-sustaining ther-
apy: 555 (57%) decisions to withdraw (WD), 411 (43%) decisions to
withhold (WH) and one patient with active shortening of the dying
process (SDP) (0.1%). Among 125 patients without therapy limita-
tions, 33 (26%) experienced brain death (BD) and 92 (73%) received
full cardiopulmonary resuscitation (CPR). Overall, 941 (86%) of pa-
tients died in the hospital, among these 125 (13%) without and 816
(87%) with therapy limitations. In median, the time interval between
ICU admission and first EOLD was 2 (IQR 0-8) days and between the
first EOLD and death 1 (IQR 0-3) days.
EOLD were commonly initiated by physicians (80.4%) but rarely by
nurses (0.1%). The primary reason for EOLD were unresponsiveness
to maximal therapy (35%), neurologic reasons (18%) or patient
preference (15%). Old age (0.4%) or poor quality of life (4%) were
rarely primary reasons.
CONCLUSION. End-of-life decisions occurred for nine out of ten pa-
tients with end-of-life care. The final EOLD was more often to with-
draw than to withhold life sustaining therapy. The fact that nurses
almost never initiate EOL decisions suggests that nurses lack oppor-
tunity or motivation to make meaningful and specific contributions
in the EOLD process. In a third of patients with EOLD, the primary
reason was unresponsiveness to maximal therapy. Age was almost
never the main reason for EOLD.
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INTRODUCTION. Integration of bereavement care into the
management of relatives of intensive care (ICU) patients is endorsed
by international ICU societies. When a patient dies at the ICU, the
relatives need to make a transition from aiming at recovery of their
beloved one, to preparation for an unavoidable death. Relativesmay
develop complicated griefas a consequence of this unpredictable
situation. Complicated grief is defined as serious and persistent grief
with adjustment problems in the long run [1]. To support the
relatives during ICU admission, a multidisciplinaryICU team has
developed strategies to guide the bereavement process [2], e.g., an
evidence-based checklist. However, little is known about needs for
follow-up bereavement care.
OBJECTIVES. To explore relatives’ needs for follow-up bereavement
support.
METHODS. A qualitative study design in a 48-bed ICU in a university
hospital with semi-structured conversations by telephone. All re-
ported first and second contact persons of patients who died in the
ICU in 2018 (n=305) have been approached by medical students.
They invited the bereaved relatives to participate in a large study
Page 441 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55exploring complicated grief and gathered contact details to send
additional written information and an Informed Consent Form.
RESULTS. In total 180 persons have been called of which 123 agreed
to participate, 12 refused further contact, and 45 were unavailable.
The pre- scheduled time was 5 minutes per call, although; 55 “call-
hours” with an average of 20 minutes were measured.
The respondents spontaneously started to explain the patient’s life
and their experiences during and after the death of their loved one
in the ICU. They felt acknowledged and subsequently shared their
grief with the medical students. The widespread and profound need
evoking from the conversations, was an unknown and unexpected
result showing the need for supportive follow-up bereavement care
by ICU professionals.
CONCLUSION. Relatives of a patient who died in the ICU showed
needs to support them in their bereavement. ICU professionals
should meet those needs by listening, recognizing and providing
information in structured follow-up bereavement care.
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INTRODUCTION. Over the last 10-15 years Paediatric Critical Care has
evolved from a service that provides specialist care to mostly
previously-well, acutely ill children to being one part of a multidiscip-
linary system delivering care to children with complex chronic condi-
tions, many of whom regularly rely on life-sustaining interventions.
With this evolution there has been an inevitable increase in the fre-
quency with which judgements are made by clinical staff of the ap-
propriateness of therapeutic interventions being delivered. There is
however little data available evaluating the consistency of such as-
sessments made by individual team members.
OBJECTIVES. We undertook a prospective, interview-based project in
a tertiary, general Paediatric Intensive Care Unit (PICU), to determine
the consistency between assessments of appropriateness of treat-
ment made by multidisciplinary team members for individual pa-
tients. The data was analysed according to professional group
(medical staff Vs nursing staff) and according to seniority (Consultant
medical staff Vs doctors in training/Advanced Practitioners (junior
medics), and senior nurses Vs bedside nurses).
METHODS. A convenience sample of individual PICU staff were
approached and asked to make an assessment, for any patient
whose circumstances they felt they had sufficient understanding of,
on whether the overall treatment being delivered, in their opinion,
was appropriate, inappropriate or futile according to standard
definitions.
RESULTS. In total, 534 assessments were made regarding 25 patients,
by 66 PICU staff members (7 Consultants, 12 junior medics, 9 senior
nurses and 33 bedside nurses). There was a significant lack of
consistency in assessments of appropriateness of treatment. In only 9
patients (36%) was there complete consensus, and these patients were
all considered to be receiving appropriate treatment. In 11 cases (44%)
treatment for the same patient was assessed as appropriate,
inappropriate and futile by different PICU staff members.
Overall, 22.1% of assessments were deemed inappropriate or futile
with more senior staff, both medical and nursing staff, much morelikely to draw these conclusions. Consultants considered 34.4% of
assessments inappropriate or futile, compared to only 9% of junior
medic assessments (p=0.00004). Senior nurses considered 26.8% of
assessments inappropriate or futile, compared to 20.5% of bedside
nurse assessments (p=0.11).
Even amongst the 7 Consultants involved in the project there was a
considerable lack of consistency in assessments with the treatment
of 4 patients being deemed appropriate, inappropriate and futile by
different Consultants.
CONCLUSION. We have demonstrated a significant lack of
consistency in assessments of appropriateness of treatment amongst
PICU staff members. Junior members of medical and nursing staff are
far more likely to consider treatment to be appropriate, and even
within distinct professional groups there is a striking lack of
consistency. These factors must be taken into account when
discussing the appropriateness of treatment with critically ill children
and their care-givers.
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INTRODUCTION. Despite technological advances death in the
intensive care unit (ICU) remains common. When life support is likely
to result in an unacceptable outcomes, ICU clinicians must ensure
that patients die with dignity. The concept of dignity in death
implies that patients remain in the center of care until the very end.
Enrollment the family in the process is part of “Dying with Dignity”.
OBJECTIVES. To determine the practice of end-of-life care in a gen-
eral ICU located in South of Portugal, and understand the role of the
family in the process of dying.
METHODS. Retrospective analysis of patients who died in the ICU
from July 1, 2016, to May 30, 2018.
End-of-life care was defined as the clinical care for patients in whom
a decision to withhold or withdraw therapy was made. Data were
analyzed using the SPSS statistical program v. 25.0. The significance
level used was 0,05.
RESULTS. During the period of study 602 patients were admitted to
the ICU, the mean APACHE II and SAPS II for these patients was 19
and 44, respectively. Of these 164 (27%) died, 114 (70%) were males,
the median (IQR) age was 72 (61-80) years and ICU length of stay
(LOS) was 3 (1-8) days. The mean± SD APACHE II was 29 ± 8, SAPS II
63± 18 and SOFA score on admission 10±4. Type of admission was
medical in 130 (79%), urgent surgery in 25 (15%), elective surgery in
7 (4%) and trauma in 2 (1%) patients. Cause of death was refractory
septic shock in 99 (60%) patients, cardiogenic shock in 18 (11%),
associated with anoxic encephalopathy in 16 (10%), massive stroke
in 9 (5%), ARDS in 8(5%), hypovolemic shock in 7 (4%) and 9 (5%)
from other causes.
In 150 patients (91%) death was associated with an end-of-life decision ei-
ther withholding or withdrawing; always after team discussion and the de-
cisions based on predicted outcome of the critical illness. All this patients
had comfort therapy. End-of-life decision regarding ventilator support were:
weaning from mechanical ventilation in 80 (53%) patients, extubation in 29
(19%) and a Do Not Intubated decision in 41 (27%).
Only in 14 patients (8.5%) dead occurred unexpectedly. These
patients were older [74 (61-78) vs. 72 (61-81) years, p=0.994], with
similar APACHE II 31±7 vs. 29±8 (p=0.671), SAPS II 70±19 vs. 64±18
(p=0.964) and SOFA score 10±3 vs. 10±4 (p=0.308) but with a shorter
LOS [1 (0-7) vs. 3 (1-10), p=0.019] than those in whom an end-of-life
decision was taken.
Table 1 (abstract 001036). WLST, withdrawal of life‐sustaining therapy;
ICU, intensive care unit; M, Male; F, Female; TBI, traumatic brain injury; L,
liver; RL, Right Lung; LL, Left Lung; RK, Right Kidney; LK, Left Kidney
Age Sex Cause of WLST ICU stay Donation/Transplantation
Patient 1 71 M Hemorrhagic stroke 8 L, RK, LK
Patient 2 74 M Hypoxic–ischemic encephalopathy 9 L, RK
Patient 3 57 F Hemorrhagic stroke 9 L, RL, LL, RK, LK
Patient 4 59 M Hypoxic–ischemic encephalopathy 5 RK, LK
Patient 5 65 F Ischemic stroke 6 LK
Patient 6 62 M Hypoxic–ischemic encephalopathy 10 RK, LK
Patient 7 66 M Hemorrhagic stroke 15 L
Patient 8 64 M TBI 10 L, RK, LK
Patient 9 57 F Poisoning 10 L, RK, LK
Patient 10 70 F Hemorrhagic stroke 8 L, RK
Patient 11 52 M Hypoxic–ischemic encephalopathy 17 RK, LK
Patient 12 76 F Hemorrhagic stroke 4 RK, LK
Patient 13 68 M Hemorrhagic stroke 8 L, RK, LK
Patient 14 69 M Respiratory failure 8 L, RK, LK
Patient 15 52 F Hemorrhagic stroke 14 L, RL, LL, RK, LK
Patient 16 19 F Hemorrhagic stroke 16 RK, LK
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first 24 hours and the medical decisions were reported daily. Excepted in
12 patients (7.3%) who had no any close family, in remain cases the
families accompanied the patient along their end of life.
CONCLUSION. End-of-life care is frequent in an ICU in South of
Portugal. The different end-of-life categories were withholding and/
or withdrawing life support. In 14 patients (8.5%) dead occurred un-
expectedly. These patients had similar severity scores them those
with decision of end-of-life, but the LOS was shorter (p=0.019). The
family were involved in the dying process in 93% of death.
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INTRODUCTION. Scarcity of potential dead brain donors and the
persistent mismatch between supply and demand of organs for
transplantation has led the transplant community to reconsider
donation after circulatory death (DCD) as a strategy to increase the
donor pool. Normothermic regional perfusion (nRP) by extracorporeal
membrane oxygenation (ECMO) may be the most effective method for
preserving abdominal organs in DCD, especially in liver transplantation.
A pitfall of this method is its complexity and the unavailability of this
resource in some hospitals, especially in regional hospitals, where
potential DCD donors may exist.
OBJECTIVES. Aim of this study is to report the use of Mobile ECMO
team in controlled DCD.
METHODS. From June 2018 to Abril 2019 our group has worked as a
mobile ECMO team for cDCD outside our center. The portable
equipment included cannulation material and the ECMO device. The
transplant team consisted of 1 transplant coordinator (anesthesiologist-
intensivist, ECMO operator and organ extraction supervisor), 1 cardiac
surgeon (cannulation), 1 interventional radiologist (cannulation) and
one cardiovascular perfusionist (ECMO operator).
RESULTS. Sixteen cDCD donations were performed. Characteristics of
donors and organs retrieved are summarized in Table 1. From 16
cDCD, 10 livers, 4 lungs, 27 kidneys were obtained. The evolution of
grafts and receptors was favorable at day 30 post-transplant.CONCLUSION. Mobile ECMO teams may enable cDCD in hospitals
without these resources, thereby increasing the pool of donors and
optimizing graft outcomes.
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INTRODUCTION. Decision-making about end-of-Life (EoL) care is fre-
quent in Intensive Care Units (ICUs). EoL situations can be traumatic
for physicians, nurses and families. Conflicts - often triggered by lack
of communication - can arise from EoL situations. Since 2005, the
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legial procedure" that involves the whole ICU care team and a phys-
ician not involved in patient care. However, guidelines regarding the
practical organization of the "collegial procedure" are vague. Nurses
often feel that they aren't involved enough in these decisions. This
may have a detrimental impact on the clinician well-being and qual-
ity of care.
OBJECTIVES. We hypothesized that there is significant variation in
the conduct of EoL decisions in French ICUs. We conducted this
study to i) describe EoL decision-making processes, ii) explore differ-
ences between ICUs in terms of organization of collegial procedures,
iii) and define the place and roles granted to nurses in those EoL
decision-making processes.
METHODS. We selected a sample of 5 university affiliated ICUs (4
adult / 1 pediatric units) representative in terms of medical case
mix and geography. In each ICU, we conducted structured
interviews of physicians (residents, junior and senior consultants)
and nurses (young and experienced) for a total of 57 interviews
in the goal of reaching theoretical saturation. Interviews wer
transcribed verbatim and analyzed using the grounded theory
methodology (Glaser & Strauss 1967). We also attended ICU team
meetings regarding EoL decisions in those ICUs whenever
possible.
RESULTS. We interviewed a total of 27 physicians (20 M/7F, age 33
y.o. [IQR 28.7-52]; median ICU experience 6 years [2-22]) and 27
nurses (5M/22F, age 29 y.o. [26.2-32.7]; median ICU experience 5
years [2.3-8]). Data analysis revealed a common 5-steps chronology
in EoL decision-making processes. First: informal discussions begin-
ning either inside the medical or the nursing team, or both at the
same time. Second, disclosure: open questions related to appropri-
ateness of care raised by a clinician (physician or nurse) during a mo-
ment of interprofessional communication (staff meetings, rounds,
etc). Third, formalization of the EoL decision in interprofessional
meeting. Fourth, information of the patient and his/her relatives
when applicable. Fifth, implementation of the EoL decision, if con-
sensus achieved. Step 3 can occur in 2 distinct models. In the vertical
model, the goal of the meeting is to advise nurses and allied health-
care professionals (NAHP) of the medical decision. Those meetings
aim to improve the NAHP’s understanding of the overall project and
promote homogeneous communication with patient and family. In
the horizontal model, NAHP & physicians share information & opin-
ions & discuss the best possible care for the patient; the meeting
ends with a written summary of the decision signed by every care-
giver present at the meeting.
CONCLUSION. The "collegial procedure" for EoL decision-making as
described in the French law gives way to very different interpreta-
tions. Although the decision-making chronology includes 5 steps in
all ICUs studied, processes can be very different between ICUs. The
role of the ICU nurses varies a lot depending on the model of inter-
professional collaboration. Further investigation is needed to under-
stand the reasons of this variability, the factors that drive the
approach in each unit, and the outcomes associated with each
model of interprofessional decision-making.
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INTRODUCTION. Ventilator-associated tracheobronchitis (VAT) has
not been tracked for surveillance purpose despite its increasingly rec-
ognized impact on antibiotic use and outcomes in critically ill pa-
tients. Moreover, there are no data comparing long-term effect of
the ventilator care bundle on ventilator-associated pneumonia (VAP)
and VAT.
OBJECTIVES. To compare the annual rates of VAP versus VAT among
critically ill children before and after the application of a ventilator
care bundle over a 9 years period.
METHODS. A cohort study of a prospectively collected quality
improvement database from 2010 to 2018 in a 16-bed-medical-surgi-
cal Pediatric Intensive Care Unit. Basal data were recorded in 2010. A
ventilator-bundle was implemented in 2011. Cases of VAP and VAT
were recorded according to the United States Centers for Disease
Control and Prevention criteria (1).
RESULTS. 5,414 patients (20,357 ventilatory-days) were analyzed over
9 years. We documented a total of 37 VAP and 115 VAT during the
study period. VAP incidence decreased from 4.13 per 1,000
ventilator-days to 1.2 per 1,000 ventilator-days (p= 0.230). The de-
crease was greatest until 2014, three years after the implementation
of the ventilator-care bundle (0.44 per 1,000 ventilator-days; p=0.010)
followed by a steady rise over the subsequent years and a new de-
crease in 2018 after optimizing adhesion to the ventilator-bundle.
VAT rates always were higher than VAP rates. As in case of VAP, VAT
incidence experienced the lowest rate in 2014, decreasing from 6.88
to 3.96 per 1,000 but this was not statistically significant (p=0.357). In
the following years, VAT rates remained stables between 5.81-5.98
per 1,000 ventilator-days without parallelism with the ventilator-
bundle effect on VAP. Even more, in the last year there was a spike
on VAT incidence (from 5.98 to 10.2 per 1,000 ventilator-days)
whereas VAP incidence experienced a fall (from 2.39 to 1.2 per 1,000
ventilator-days).
CONCLUSION. VAT incidence were three times higher than VAP
incidence. VAT rates showed a different behavior than VAP rates to
the ventilator-bundle. Clinical impact of VAT must be considered
Page 444 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55when assessing emerging surveillance definitions, quality indicators
and bundles.
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INTRODUCTION. Subject recruitment in the critically ill and injured
pediatric population is challenging due to the complexities of the
consent process, limited population, and vulnerabilities of the child
research subject. Recruitment can be further complicated by
differing perceptions of risk with respect to patient age. A critically ill
or injured child may meet enrollment criteria for a clinical trial, yet
parental opinions toward research may hinder research participation.
Further, few studies have focused on co-enrollment (participation in
multiple research studies) in this population.
OBJECTIVES. To examine the opinions of parents of critically ill or
injured pediatric patients toward research based on age.
METHODS. Study participants who required a pediatric intensive care
unit (PICU) stay >24 hours were identified at an urban hospital.
Parents were approached to complete an anonymous electronic
survey between 3-7 days following PICU admission. Surveys con-
sisted of 20 closed-ended questions aimed at assessing parental
opinion toward research participation for their ill or injured child.
Subject responses were stratified based on their respective child’s
age and divided into three age groups: infancy (<12 months), child-
hood (1-9 years), adolescence (10-17 years). Data was analyzed using
Chi-squared test for categorical variables and Student’s t-test for con-
tinuous variables.
RESULTS. A total of 201 parents of critically ill or injured children
were surveyed from April 2018 to April 2019. Among them, 41.8%
(84) were parents of infants (I), 32.3% (65) were parents of children
(C), and 25.9% (52) were parents of adolescents (A). There were no
differences in mean age, race, gender or length of hospital stay
among the age groups. Most parents would consider research
participation for their child. Significantly fewer parents would
consider enrollment in multiple studies (62.7% vs. 43.3%, p<.001).
Parents of adolescents were significantly more likely to consider
research participation than parents of children or infants (A=80.8%
vs. C=58.5% vs. I=54.8% respectively, p=0.007). There was no
significant difference in attitudes toward participation in multiple
research studies across the age groups (A=50.0% vs. C=40.0% vs. I=
41.7%, p=0.514). Parents were significantly more likely to consider
participation in research if there was perceived direct benefit to their
child as opposed to benefitting other children (81.6% vs 45.3%,
p<.001).
CONCLUSION. Parental attitudes toward research participation in the
critically ill or injured pediatric population are generally favorable.
However, parents of adolescents are more inclined to participate inresearch compared to those with younger children. Parental
enthusiasm toward research participation appears to be greatest
when there is a perception of direct benefit toward their child. Many
parents appear receptive to co-enrollment and this may be an ac-
ceptable recruitment practice.
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INTRODUCTION. There is an increasing incidence of type 1 diabetes
mellitus (T1D) among children in Croatia. A study published in 2014
showed annual increase of 5.87% and that is higher than the
European average, which is 3.9%. Diabetic ketoacidosis (DKA) is the
leading cause of morbidity and mortality in children with T1D, with
cerebral edema as most severe complication. Development of brain
edema is likely a consequence of abnormalities in cerebral perfusion
and inflammation that occur during DKA. Since early recognition of
cerebral edema leads to better outcome, it is important that patients
with moderate or severe DKA are closely monitored and treated in
Pediatric Intensive Care Units (PICU).
OBJECTIVES. The aim of this study is to investigate clinical and
laboratory parameters of children treated in PICU because of DKA.
METHODS. Patients treated due to DKA in PICU of the University
Hospitals of Split and Osijek from 2013 to 2017 were included in this
study. Retrospectively collected data included age, gender, clinical
signs and symptoms, and various laboratory parameters. After
dividing subjects into two groups: newly diagnosed with T1D (NT1D)
and previously diagnosed with T1D (PT1D), collected data was
compared between the two groups.
RESULTS. Total of 82 patients were enrolled. Those with NT1D were
more often treated in PICU. Decreased consciousness level was
found in 41.5% of patients, with majority of them being somnolent.
No difference was found between the groups. Of the total number of
DKA patients, the rate of cerebral edema was 2.4% and both patients
with cerebral edema belonged to the NT1D group. Dehydration was
the most frequent clinical sign, found in 95% patients at admission.
There was no significant difference regarding laboratory data at
admission.
CONCLUSION. More children with NT1D required treatment in PICU
due to DKA with two of them developing cerebral edema. Since
cerebral edema is a life threatening condition, treatment of patients
with moderate or severe DKA in PICU will provide necessary
monitoring enabling early recognition and treatment of cerebral
edema and better treatment outcome. As the dehydration is the
leading sign at admission, a good estimation of dehydration severity
is important during the initial management as well. To minimize the
incidence of DKA among NT1D it is important to continuously carry
out public health education programs aimed to early identification of
signs and symptoms of T1D. For patients with PT1D it is essential to
well educate and support both children and their families aiming for
good control of diabetes and prevention of complications.
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INTRODUCTION. Acute Kidney Injury (AKI), Fluid Overload (FO) and
MODS increase mortality in Pediatric Acute Respiratory Distress
Syndrome (PARDS). AKI in PARDS may be multi-factorial due to hypo-
volemia, SIRS and cytokine storm and exposure to nephrotoxic drugs.
It has been shown in critically ill children that FO is associated with
AKI and increased mortality. At our center, retrospective analysis has
shown a high PARDS mortality and that FO>10% and AKI are not un-
common. Hence the need for this prospective study.
OBJECTIVES. To study the effects of AKI and FO on severity of
PARDS and its mortality
METHODS. Prospective observational study from August 2017 to
August 2018, in a tertiary care PICU in North India, including 48
children aged 31 days to 12 years, mechanically ventilated for PARDS
(PALICC definition)
RESULTS. Thirty-five children (72.9%) had severe, while 9(18.8%) had
moderate and 4(8.3%) had mild PARDS. The median (IQR) P/F ratio
and oxygenation index(OI) were 164 (122,213) and 7.21(4.7,13.9) re-
spectively. Thirty two (66.6%) children had FO%>10; more so in se-
vere as compared to mild-moderate ARDS (80% vs. 30.8%;P<0.001).
Odds of severe ARDS were 9 times higher in children with FO (OR
9;95%CI:6.125-13.224;P<0.0001). Linear mixed modeling regression
analysis of peak FO%(PFO) on serial OI showed that PFO was a sig-
nificant predictor of worst OI (F-value 23.47; P<0.001); for every 1%
increase in PFO, worst OI increased by 0.67 (95% CI: 0.40-0.94;P<
0.001). Also, for every 1% increase in daily FO%(DFO), mean OI in-
creased by 0.9 [95% CI:0.82-0.96; P<0.001].
Children with AKI had higher baseline vasoactive-inotrope score (VIS)
(mean+SD=38.5±38.0;P-0.038), severe ARDS(n=26/30;P-0.005) and
higher mortality (n=24/30;P-0.001), than those without AKI. Logistic
regression failed to show a relationship between AKI and PFO (OR
1.02;95%CI: 0.97-1.07, P-0.40). However, on linear mixed modeling,
for every 1 mg/dL rise in creatinine, there was a rise in FO by 3%(P<
0.001).
The odds of undergoing RRT increased by 6% for every 1% increase
in FO (OR-1.06;95%CI:1.01-1.11,P-0.03). The area under curve (AUC)
for PFO, as a predictor of RRT was 0.69 (95%CI:0.54-0.85;P-0.024).
Higher proportion of non-survivors (25/30;83.3%) as compared to sur-
vivors (7/18;38.8%) had FO(P-0.002). Although higher proportion of
children with progressive MODS (23/31;74.2%) had FO, this was not
statistically significant.
CONCLUSION. AKI and FO together contribute to worsening lung
injury and increased mortality in PARDS. Children with shock are at
high risk for developing AKI. Early detection of AKI using non
creatinine based markers and initiation of RRT based on FO% could
prevent worsening ARDS.
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INTRODUCTION. Admission to an intensive care unit (ICU) is an
extraordinary experience for the patient’s relatives. Critical illness
paired with an uncertain future triggers substantial psychological
symptoms.
OBJECTIVES. This study analyses the baseline data of the ongoing
randomised controlled trial (RCT, ClinicalTrials.gov Identifier:
NCT02931851) and examines the degree to which relatives of ICU
patients are affected by symptoms of anxiety, depression and stress
at the time of a relative’s admission to an ICU.
METHODS. This RCT study was performed in Austria and Switzerland.
The Hospital Anxiety and Depression Scale (HADS) and the Impact of
Event Scale (IES) were assessed for relatives upon admission of the
patient to the ICU (0-2 days after admission, T0) using face-to-face in-
terviews. Clinically relevant values on the HADS score are those ≥11,
while values over 15 indicate severe symptoms. For the IES, scores
≥27 points are deemed to be clinically relevant, while values ≥35 can
support a diagnosis of PTSD in the right context. Data collection took
place between 2017 and 2019.
RESULTS. 60 relatives (12 male, 48 female) were included in the
study, with an average age of 46.9 13.6 years. Relatives were
recruited in Graz (n=11), Vienna (n=8) and Bern (n=41).
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observed. On average, women scored higher than men at T0 (18.1
6.3 vs. 11.1 4.9).
At T0, a mean IES score of 28.3 12.3 (min. 1.0 max. 60.0) points was
observed. On average, women scored higher than men at T0 (30.5
11.3 vs. 19.4 12.5).
There is a positive correlation between HADS and IES (p <.0001,
Pearson correlation coefficient 0.64). The need for nursing care of a
relative before admission to ICU did not correlate with HADS score
or IES score (Spearman correlation coefficients: -0.13, -0.05).
CONCLUSION. The relatives reported clinically relevant symptoms of
anxiety, depression and stress at admission. Women reported higher
scores than men, and psychological symptoms occurred regardless
of whether or not the patient was urgently in need of care before
admission.
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INTRODUCTION. Monitoring of the sublingual microcirculation (SMC)
offers insight into oxygen transport. In contrast to findings in adults,
it remains unclear whether children with congenital heart disease
(CHD) undergoing cardiac surgery on cardiopulmonary bypass (CPB)
also show microcirculatory alterations and thus altered tissue
oxygenation.
OBJECTIVES. 1. To assess whether the SMC differs between CHD
patients and healthy controls before surgery;
2. To assess whether the SMC is altered during the first 6h after
cardiac surgery on CPB.
METHODS. A prospective observational study was performed in a
tertiary children’s hospital, comparing CHD patients aged 0 – 17
years undergoing cardiac surgery on CPB and healthy controls aged
0 – 17 years undergoing minor non-cardiac surgery. The SMC was
monitored with handheld vital microscopy, after induction of
anesthesia (baseline) in both groups and intermittently until 6h after
cardiac surgery. Parameters of vessel density and perfusion were
assessed for all vessels (diameter <100μm) and small vessels (diam-
eter <20μm). Linear mixed models were built to assess differences
between groups and change over time.
RESULTS. Thirty-eight CDH patients (median age 0.62 years (IQR: 3.06),
16 females, 20 cyanotic heart defects, frequency RACHS-1 categories 1-
6: 6, 21, 9, 1, 0 and 1 respectively) were included. In addition, 35 healthy
controls (median age 1.29 years (IQR: 2.99), 15 females) were included.
Survival was 100%. CHD patients showed lower median microcircula-
tory flow index (MFI) (MFIall 2.86 vs. 3.00, p<0.001; MFIsmall 2.83 vs.
3.00, p<0.001) and lower median proportion of perfused vessels (PPV)
(PPVall 98.8% vs. 100%, p<0.001; PPVsmall 98.7% vs. 100%, p<0.001)
than controls at baseline. After cardiac surgery, MFIall and MFIsmall de-
creased compared to baseline and did not improve during the first 6hafter surgery. Other SMC parameters were unaltered after cardiac sur-
gery and did not change over time. Also, cyanotic heart disease did not
affect SMC parameters.
CONCLUSION. Children with CHD presented with altered
microcirculatory perfusion, with lower blood flow quality and less
perfused vessels than healthy controls. Blood flow quality decreased
even further during the first hours after cardiac surgery.
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INTRODUCTION. Mechanical ventilation(MV) is the most widely used
of life support in Intensive care unit(ICU).But accurately and timely
identify the "time window" to weaning successfully from mechanical
ventilation is challenging.Both premature and delayed weaning can
increase mortality,ICU duration and costs,So an objective and
convenient predicting parameter is very important to mechanical
ventilated patients.
OBJECTIVES. To assess the diagnostic accuracy of Tidal volume(VT),Rapid
shallow breathing index(RSBI),Max inspiratory pressure(MIP) and P0.1 for
weaning success by diagnostic meta-analysis
METHODS. PubMed, Web of Science, Embase, Cochrane Library and
gray literature were searched from inception to December,2018 to
collect retrospective and prospective studies about weaning index of
mechanical ventilated patients in Intensive care unit.Two authors
independently extracted data and evaluated study quality using the
Quality Assessment of Diagnostic Accuracy Studies-2 tool and Stan-
dards for Reporting of Diagnostic Accuracy Studies Checklist. Stata
13.0 and Review Manager 5 software were used for data analysis.
RESULTS. A total of fourteen studies,1 720 patients were included.the
pooled sensitivity and 95%CI of VT,RSBI,MIP and P0.1 respectively was
0.87(0.74,0.94), 0.82(0.68,0.91), 0.84(0.71,0.92) and 0.86(0.78,0.91), the
pooled specificity and 95%CI was 0.54(0.46,0.63), 0.66(0.56,0.74),
0.41(0.21,0.65) and 0.62(0.43,0.78).the DOR respectively was 8.08, 8.94,
3.68 and 9.76,SROC and sensitivity analysis showed that all no
threshold phenomenon and were stability
CONCLUSION. The sensitivity and specificity of the four weaning
index were similar,but P0.1 showed a better diagnostic value on the
weaning success from mechanical ventilation.then was the RSBI,the
VT and MIP
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INTRODUCTION. Sleep is one of the most basic physiological
needs of human beings. One third of life is spent in sleep.
Sufficient sleep can make people relieve fatigue, better restore
their mental and physical strength, maintain a good awakening
state after sleep, improve work efficiency, and is also a necessary
condition for the rehabilitation of patients in intensive care unit.
However, a large number of studies have shown that ICU
patients suffer from sleep disturbances due to various factors,
and more than 80% of ICU patients have sleep disorders. Sleep
disorders or sleep cycle disturbances cause great damage to the
body, especially for ICU critically ill patients. Therefore, it is very
important to find interventions to improve sleep disorders in ICU
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practice are divided into drug therapy and non-drug intervention.
Drug therapy includes sedative drugs, analgesic drugs and hyp-
notic drugs. Although the use of sedative analgesic hypnotics is
quickly and effective, it is easy to cause different degrees adverse
reactions and drug dependence, so non-pharmacological inter-
ventions are receiving more and more attention. At present, the
study on the effect of non-drug intervention on improving sleep
quality in ICU patients has been started in clinical practice, but
the results are not the same, and there is no reliable clinical re-
search literature support. Network meta-analysis is a method de-
veloped from traditional meta-analysis. Its greatest advantage is
that it can summarize the different interventions for treating simi-
lar diseases and perform quantitative statistical analysis according
to a certain result.
OBJECTIVES. To study the effect of non-drug intervention on im-
proving sleep quality in ICU patients by network meta-analysis.
METHODS. Computer search database The Cochrane Library,
PubMed, Embase, Web of Science, China Journal Full-text Data-
base (CNKI), Wanfang Database (WanFang Data), VIP Database
(VIP) and China Biomedical Literature Database (CBM), search and
construction The library reviewed the RCT literature on non-
pharmaceutical interventions to improve the sleep quality of ICU
patients in December 2018, using the Stata13.0 software for net-
work meta-analysis.
RESULTS. This study included 18 RCTs with a total of 1720 patients
and 11 non-pharmacological interventions. The Pittsburgh Sleep
Quality Index (PSQI) network meta-analysis showed that non-drug in-
terventions improved sleep quality in ICU patients, and comprehen-
sive nursing interventions, lavender essential oil aromatherapy, eye
masks, eye masks and earplugs were statistically different from con-
ventional care. There was no significant difference between the
Richards-Campbell Sleep Scale and the VSH sleep scale. The Pitts-
burgh Sleep Quality Index (PSQI) ranked as follows: eye mask and
earplugs > eye mask > comprehensive nursing intervention > laven-
der essential oil aromatherapy > routine care.
CONCLUSION. Based on the results of the Pittsburgh Sleep Quality
Index (PSQI) network meta-analysis and ranking results, non-drug
intervention eye mask and earplugs were the best in improving sleep
quality in ICU patients compared with other interventions.
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INTRODUCTION. Urinary catheter securement is recommended as
part of care bundles for general Urinary Catheter (UC) care and for
Catheter Associated Urinary Tract Infection (CAUTI) prevention (1–4).
However, prevalence studies show a low prevalence of catheter
securement(5). Moreover, the relationship between this care and
CAUTI, discomfort and urinary meatus injuries have not been studied
individually.
OBJECTIVES. The purpose of this study was to determinate the
impact of securing urinary catheters on the rate of CAUTI, urinary
meatus injuries and discomfort in critically ill patients
METHODS. Randomized, non-blinded multicentre clinical trial con-
ducted in two general Intensive Care Units of two tertiary hospitals.
Inclusion criteria: Age> 18, UC inserted in Intensive Care Unit or in
the Operating room, informed consent. Exclusion criteria: Securement
not possible, urinary tract infection at the admission, UC plan to be
used and anticipated ICU stay for 48 hours or more. Participants were
randomized into the control group (CG), to which the UC received
traditional care, and the experimental group (EG), to which the UC
was secured to the upper half thigh. Before securing, a barrier film
was applied to protect the thigh skin from adhesive lesions. Proto-
cols from both sites were equivalent. Data were obtained twice a day
until study ends, including: properly done securement, sings of
CAUTI, UC related injuries and discomfort. Study ends was defined
as: If CAUTI was diagnosed, 48 hours after catheter removal, 48 hours
after ICU discharge or after 30 days of catheter use. If CAUTI was sus-
pected an urine sample was collected. A descriptive and bivariate
analysis performed with SPSS 21 program. IRB approval from both
sites was obtained.
RESULTS. Sixty-seven patients have been analysed at the moment
(47,8% male, 52,2% female. Mean age 59 ± 14 years). Allocation:
55,2% IG (n=37), 44,8% CG (n=30).[U1] Six CAUTI have been diag-
nosed, all of them from CG (p<0,05). Twenty five percent of commu-
nicative patients from CG experimented UC related discomfort, in
front of 5% from EG (p<0,05). The Incidence of urinary meatus injur-
ies was found to be 10,4%, without statistically differences between
two groups
CONCLUSION. UC securement seems to decrease CAUTI and UC-
related discomfort, according to the preliminary analysis
REFERENCE(S)
1. European Association of Urology Nurses. Evidence-based Guidelines for
Best Practice in Urological Health Care. Catheterisation. Indwelling cathe-
ters in adults. Urethral and suprapubic. 2012. 2. Wound Ostomy and Con-
tinece Nurses Society. Indwelling Urinary Catheter Securement: Best
Practice for Clinicians. 2012. 3. Ansell T, Network HI. Indwelling urinary
catheters: should we secure them? Br J Nurs. 2016;25(18):22–5. 4. Sam-
pathkumar P, Barth JW, Johnson M, Marosek N, Johnson M, Worden W,
et al. Mayo Clinic reduces catheter-associated urinary tract infections
through a bundled 6-C approach. Jt Comm J Qual Patient Saf.
2016;42(6):254–61. 5. Appah Y, Hunter KF, Moore KN. Securement of the
Page 448 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Indwelling Urinary Catheter: A Prevalence Study. J Wound Ostomy Con-
tinence Nurs. 2015;43(2):173–7.
2. This project has been granted by the Societat Catalana de Medicina
Intensiva i Crítica as the best research project in nursing. 2017.
000817
End-expiratory volume and lung stress and strain longitudinal
changes evoked by PEEP escalation in ARDS and non-ARDS
children
S. Ilia, E. Geromarkaki, P. Briassoulis, P. Bourbaki, T. Tavladaki, M. Miliaraki,
G. Briassoulis
1Picu, university hospital, medical school, University of Crete, Heraklion,
Greece
Correspondence: S. Ilia
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000817
INTRODUCTION. End-expiratory lung volume (EELV) is functional re-
sidual capacity (FRC) plus lung volume increased by the applied posi-
tive end expiratory pressure (PEEP). Monitoring EELV has been
proposed as a valuable tool to optimize ventilator settings and im-
prove lung protective ventilation in clinical practice
OBJECTIVES. To detect longitudinal changes of EELV, compliance
(Crs), driving pressure (ΔPrs), stress and strain when applying
incremental PEEP levels in mechanically ventilated (MV) children with
or without acute respiratory disease syndrome (ARDS).
METHODS. Twenty-five critically-ill children were enrolled in this co-
hort study. Patients with ARDS (oxygenation index ≥4) or non-ARDS
(at risk of ARDS or without lung injury) were subjected to PEEP trials
of 4-6-8-10cmH2O. At each PEEP level, EELV (nitrogen washin/wash-
out technique), Crs, ΔPrs, strain and stress were calculated at 6-12-
24-48-72 hours.
RESULTS. Seven-hundred measurements were carried out. Age,
height, ideal-weight, and body mass index (BMI) influenced EELV and
Crs in all groups, better in ARDS (p<0.001). EELV was related with Crs
(p<0.001); ΔPrs with EELV/kg and Crs/kg (p<0.001). Following PEEP
increases, EELV increased at all time-points. EELV remained lower in
the ARDS compared to at-risk group only the first 12 hours (p<0.05).
Stepwise incremental PEEP from 4 to10 cmH2O raised static and glo-
bal stress and strain earlier in non-ARDS groups compared to ARDS
group (p<0.05). Changes in strain, stress, EELV, and Crs were evident
by 72 hours of MV (p<0.001). Longitudinally, at all studied PEEP
levels, stress and strain remained within safe limits and did not inter-
fere with hemodynamics.
CONCLUSION. EELV and Crs are weight-height and ΔPrs dependent,
differently in ARDS compared to non-ARDS patients. Repeated, non-
invasive calculations of EELV and lung strain/stress in children with
and without ARDS using the nitrogen washin/washout technique
might represent a promising tool for optimizing PEEP in mechanically
ventilated children.Table 1 (abstract 000855). See text for description
High Risk Low Risk Re-referral
Screening Outcome 26 patients (53%) 21 patients (42%) 2 patients (4%)
Developed PPC 8 patients (31%) 0 patient 0 patient
Time to Mob > 30 m 5.58d 4.65d 5d
Physio complete 6.65d 0d 10.5d
Length of stay 9.31d 6.60d 11d
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INTRODUCTION. The benefit and necessity for prophylactic
physiotherapy post-operatively remains unclear [1]. Combined with an in-
creased demand on resources, scores to identify those patients who
would most benefit are being increasingly used [2]. At present no vali-
dated tool exists for those following cardiac surgery. The Birmingham car-
diac surgery screening tool (BCSST) was developed to identify patients at
high risk of developing post-operative pulmonary complications (PPC’s).
OBJECTIVES. To evaluate the effectiveness of introducing a post-operative
screening tool to identify patients at risk of PPC’s following cardiac surgery
METHODS. All patients undergoing cardiac surgery between 25th
November and 24th December 2018 were included in the analysis.
BCSST scores were calculated on day 1 post-operatively. For patients
identified as low risk, post-operative care was led by nursing staff
with no physiotherapy involvement. High risk patients received
standard physiotherapy input, including respiratory interventions and
mobilisation. Primary outcome was development of PPC’s, assessed
using the Melbourne risk prediction tool.
RESULTS. During the trial period 21/47 (42%) of patients were classified
as low risk. None of the patients in the low risk group developed a PPC,
although two patients were re-referred to physiotherapy (1 for mobility
assessment and 1 for respiratory deterioration). Patients in
the low risk group mobilised 30m earlier and spent less time in
hospital than the high risk group.
CONCLUSION. The BCSST was effective at identifying low risk
patients, with no patients in this group developing a PPC. For these
low risk patients care was safely led by nursing staff with no adverse
events or falls reported.References
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INTRODUCTION. Previous studies have shown that patients'
perceptions of their illness can influence their health behaviours.
While Acute Coronary Syndrome (ACS) is an acute event, it is
indicative of a chronic illness. Few studies have described the
perceptions of those with ACS in the acute phase of their illness.
OBJECTIVES. To describe illness perceptions of patients with ACS
while still hospitalized for the event.
METHODS. Every Israeli patient admitted to a hospital over a 2
month period with ACS (n=1958) was included in a bi-annual, na-
tional, two month prevalence study, Acute Coronary Syndrome Israel
Study (ACSIS). Clinical medical data were collected for the entire sam-
ple. A convenience sub-sample of these patients (n=990) completed
the Brief Illness Perception Questionnaire. Patient demographic and
clinical data were collected from the patient's medical record.
RESULTS. ACS patients reported mean levels of 4.8/10- 7.7/10 of
their perceptions of their illness, with highest scores for medical
treatment control and coherence and lower scores for identity and
emotional representations. Some respondents reported that their
illness would have little or no impact on their life (n=230, 30%) and
its effects were for a short time period (n=314, 31%)
CONCLUSION. While most ACS patients perceived that they
understood their illness and its impact on their lives, many did not.
Increased efforts should therefore be made by nurses in the acute
phase to educate patients about the full implications of coronary
disease.
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INTRODUCTION. Over the last years has been stablished sedation
guides recommending that the mechanical ventilation (MV) should
be applied with low doses of sedation, to avoid complications and
prolonged admissions (6,3,2). Therefore, more often we can find ICU
patients awake with MV. Not being able to communicate leads to
negative emotions and frustrating levels for the health team, the
patient and the family (3,5). Some needs within the context of ICU
are easy to unsdesrtandand,but there are some other needs, social
and emotional, where the use of a communication tool can be useful
(5,10,4).OBJECTIVES.
 Identify which methods and/or communication tools are used
in Catalonia ICUs with intubated or tracheostomized patients.
 To know the degree of acceptance perceived by nursing
professionals in the use of pictograms/ electronic devices.
METHODS. Multicentre, observacional , descriptive and transversal
study carried out from November 2018 to March 2019. Charge
nursers and nurses of all adult ICUs of Catalonia with more than 2
years of experience in ICU were included. Those nurses that are not
regular staff of ICU were excluded. The nurse manager was informed
by phone about the purpose of the study and her collaboration and
the collaboration of two nurses per shift was requested. We collected
demographic variables, professional category, work shift, years of
experience at ICU, hospital name and type of ICU. An ad-hoc ques-
tionnaire was developed to know the communication tools used and
the degree of acceptance perceived by nursing (Likert scale from 0
to 10) in the use of pictograms and electronic devices by their own
group, the patients and the relatives. A pilot test with nursing at the
ICU Universitiy Hospital Mutua Terrassa was carried out to assess the
suitability of the questionnaire. Intentional non-probabilistic sam-
pling. Descriptive statistics with averages (standard deviation) and
percentages.
RESULTS. An 89.2% of UCIs responded (33 out of 37) and a total of
140 questionnaires were received. Low-tech tools (pen/paper, alpha-
bet, blackboard) are used by 91% of ICUs, and 30% of them use pic-
tograms. High-tech tools (tablets) are used by 9% of ICUs. The 73%
of respondents value the use of pictograms as a tool that improves
communication and 82% have the same opinion about electronic de-
vices. The 61% of respondents did not have pictograms neither elec-
tronic devices, but 99% indicate the need to have them.
The degree of acceptance perceived by nursing in their own group,
patients and relatives scored an average of 6.2 (DE=1.7) points in the
use of pictograms and 6.7 (DE=1.9) in the use of electronic devices.
CONCLUSION. Most ICUs use basic methods and low-tech tools. The
use of more technological devices is recent at ICUs and they are well
accepted. The degree of acceptance perceived by nursing in the use
of these devices is good. It will be necessary to revalue it when its
use is more extensive. We propose a new study to know at first hand
the acceptance of these tools by relatives and patients. The findings
of this study are a motivation to continue working on communica-
tion and thus improve an element that will give high quality to our
care.
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INTRODUCTION. Early mobilisation has been demonstrated to be
safe and feasible for patients admitted to intensive care units (ICU),1
however there is significant heterogeneity in its definition.
Mobilisation has often been defined as early when it occurs within
the first 2 to 5 days of admission to ICU or alternatively, within 72
hours of admission2. However the course of patients’ critical illness
varies greatly with decisions to initiate mobilisation based on a
patients’ clinical condition as opposed to time. Recent interventions
to facilitate earlier rehabilitation have resulted in mobilisation during
a more acute phase of illness as measured by the SOFA score,
despite not meeting the traditional definitions of early mobilisation3.
OBJECTIVES. To compare time to first mobilisation and SOFA score
on first mobilisation for critically ill adults.
METHODS. A retrospective review was undertaken in a general adult
ICU of a UK university teaching hospital. Patients admitted to the ICU
receiving invasive ventilation for more than 48 hours between
August 2017 and March 2019 were included. Patients who active
mobilisation was deemed inappropriate were not included e.g.
palliative treatment pathway. Mobilisation was defined as sitting on
the edge of the bed/dangling or any out of bed activity, and termed
early when occurring within 72 hours of admission.
RESULTS. The analysis included 303 patients with a median duration
of ventilation of 5 days (IQR 3-9) and time to first mobilisation of 4
days (IQR 3-8). For those receiving early mobilisation (n= 114), me-
dian SOFA score was 4 (IQR 2-6) and day of mobilisation was 2 (IQR
2-3). In the group receiving late mobilisation (n= 187) the median
SOFA score was also 4 (IQR 2-5), however the day of mobilisation
was 6 (IQR 4-9).
CONCLUSION. In this study of patients receiving invasive ventilation
for more than 48 hours, time to first mobilisation was comparable to
previous published ICU rehabilitation studies. Patients who did not
meet traditional definitions of early mobilisation were mobilised with
the same level of acute illness as those receiving early rehabilitation.
Early mobilisation is better defined through acuity of illness as
opposed to time based metrics, which would allow better evaluation
of future mobilisation interventions in ICU.
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INTRODUCTION. Respiratory failure (RF) in children is one of the
most common causes of admission in pediatric intensive care
units (PICU). Chest x-ray has an important role in diagnosis and
assessment upon presentation and during clinical course.
OBJECTIVES. We aim to propose a radiography-based severity scor-
ing system for the assessment of children with RF in PICU and inves-
tigate possible correlations with clinical and laboratory indicators of
clinical severity and with predictors of outcome.
METHODS. 104 children under 18 years old hospitalized with
acute RF in PICU between 2014-2018 were enrolled. Disease se-
verity (PRISM and PELOD scores), PaO2/FiO2 (PF) ratios, duration
of ventilator support, length of PICU stay (LOS), and outcome
were recorded. A five-point radiographic severity score was intro-
duced by enhancing Taylor et al1 score, considering all possible
radiographic abnormalities. Chest x-rays upon admission and on
worst PICU day (defined by maximum respiratory support and
worst oxygenation/ventilation parameters) were blindly reviewed
and independently scored by four doctors, 2 radiologists and 2
intensivists, following training.
RESULTS. 104 children (68 males) aged 5.44±0.6 years were
evaluated. 62 (59.6%) patients were mechanically ventilated for
10.8±2.1 days; PICU LOS was 15.1±2.1 days. 162/283 radiographs
(85 upon admission, 77 on worst PICU day) were assessed. PRISM
and PELOD scores, duration of mechanical ventilation and PICU
LOS were positively related with radiographic scores, and
negatively related with PF ratio (all, p<0.001). Higher imaging
score from previous radiography, indicating deterioration, was
associated with lower PF ratio, prolonged mechanical ventilation
and PICU LOS (all, p<0.001). Mortality (5.8%) was related to
increased number of radiographs (p<0.001) and higher
radiography severity score (p<0.001). There was a strong
statistical correlation of radiographic scores between radiologists
and intensivists (Spearman’s p<0.001).
CONCLUSION. We introduce a reliable radiography-based severity
score for assessing respiratory failure in critical ill children. This
valuable bed side tool, associated with outcome, can be reprodu-
cibly utilized by both radiologists and clinicians following
training.REFERENCE(S)
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Table 1 (abstract 000531). See text for description
Group A Group B P value
Chronic Kidney disease 77% 11,8% P<0,01
Hypertension 82,2% 65,5% P<0,01
Diabetes mellitus 56,8% 21,9% P<0,01
Chronic heart failure 14,4% 3% P<0,01
Bleeding complicacions during hospitalization 12,3% 4,8% P=0,01
CPE 73% 32,4% P<0,01
Mortality 67,8% 24,8% P<0,01
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INTRODUCTION. Coma is considered an emergency and life-
threatening condition in children. According to the 2019 edition
guidelines for management of pediatric brain Injury, monitoring of
intracranial pressure (ICP) and cerebral perfusion pressure (CPP) is
recommended. Marshall Computed tomography (CT) scores of the
brain correlate with outcome in adult patients with traumatic brain
injury. Similar evidence for children with traumatic and non-
traumatic coma is lacking.
OBJECTIVES. We sought to determine whether a newly introduced
imaging severity scoring system correlates with intracranial
monitoring, therapeutic strategies, and outcome in children
undergone head CT for coma, regardless of its aetiology.
METHODS. Data of all children under 18 years old with traumatic
and non-traumatic coma admitted to pediatric intensive care unit
(PICU) between 2014 and 2018 were retrospectively reviewed. Demo-
graphics, ICP, CPP, PICU course, and outcome were recorded. A modi-
fied Marshall CT score was evaluated for all CT scans upon
admission, and on worst clinical PICU-day, when available.
RESULTS. 85 children (47 males) aged 7.5±5.3 years were classified in
three groups, traumatic coma (n=21), non-traumatic non-surgical
coma (n=62), and non-traumatic coma requiring neurosurgery (n=2).
Mortality was 2.3%. 14 children (16.5%) had at least 2 CT scans. CT
score was positively associated with increased PRISM (p<0.001), pro-
longed mechanical ventilation (p<0.01), and length of PICU stay (p<
0.01). CT score was higher in patients with ICP monitoring (p<0.01)
and, particularly, when ICP>15mmHg (p<0.04) in all groups. CPP<
50mmHg was related to increased number of CT scans, higher CT
score, need for intracranial hypertension treatment, and mortality in
all groups (all, p<0.001). Repeated CT scan due to clinical deterior-
ation or increased intracranial pressure exhibited higher imaging
scores (p<0.02) and contributed to new information, change of diag-
nosis and/or treatment in 63% of re-scanned children (p<0.001).
CONCLUSION. The introduced modified Marshall CT score is
associated with ICP/CPP measurements and outcome, contributing to
therapeutic adjustments in children with coma.
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INTRODUCTION. Improvements in antithrombotic therapy have led
to a significant reduction in ischemic events in patients with acute
coronary syndrome (ACS), although at the expense of an increase in
hemorrhagic complications.
OBJECTIVES. The objective of this study was to evaluate the impact
of the high risk of high bleeding risk in the therapeutic treatment of
patients diagnosed with ACS and its influence on the very long-term
prognosis.
METHODS. An observational, analytical, retrospective study of
patients admitted in Cardiology department with the diagnosis of
ACS between May 2012 to September 2013. We included 578
patients (p).They were divided in 2 groups:
- Group A: patients with high bleeding risk (n: 126; 21,8%; 43,2%
female)
- Group B:patients without high bleeding risk (n: 452; 78,2%; 27,8%
female)
High bleeding risk was defined as a CRUSADES Score > 40. They
were compared according to clincial and invasive management,
mortality and composite primary endpoint (CPE) : reinfarction, stroke
and cardiovascular death; at 5 yeras follow-up.
RESULTS. Patients in group A were older (A= 72,3 ± 9,3 vs B= 63,3±
13,9; p = 0,08), had more chronic kidney disease, arterial
hypertension, diabetes mellitus, and chronic heart failure. (Table 1)At
admission, 63,7% of group A presented with non-ST elevation ACS
and Killip> 1 was presented in 54,1% of patients. Patients in group A
had less invasive risk stratification (A= 54,8% vs B= 67,0%; p< 0,01).
There were no differences regarding dual antiplatelet therapy (DAPT)
or anticoagulantion during hospitazation or at discharge.
During hospitalization, group A presented with more bleeding
complications. At 5 years follow-up, group A had higher rates of CPE.
(Table 1)
CONCLUSION. Patients with a high risk of bleeding were associated
with a worse cardiovascular profile. Although there were no
statistical differences between the groups with respect to invasive
stratification or antithrombotic therapies, in the very long term
follow-up, these patients presented a worse prognosis.
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INTRODUCTION. Ischemic heart disease (IHD) represents the main cause
of mortality worldwide. Among the ischemic heart diseases, ST-segment
elevation myocardial infarction (STEMI) is noteworthy, as not only it occurs
more frequently with severe complications, such as cardiogenic shock and
heart failure, but also the simple presence of the ST-segment elevation is
an independent risk factor for mortality prediction. Emergency medical sys-
tem (EMS) -based STEMI networks allows not only STEMI diagnosis in the
pre-hospital phase but also reduces treatment delays; treat your fatal com-
plications and the immediate activation of the catheterization laboratory.
OBJECTIVES. The aim of study was investigate the effect of Pre-
hospital versus Hospital treatment in the length stay and survival of
patients with STEMI diagnosis.
METHODS. We performed an observational retrospective through
single centre registry of consecutive patients (n = 360) admitted with
STEMI to the intensive care unit of the Guadalajara Hospital, Spain,
between 2015 and 2018. Two groups were established; on the one
hand the intervention group or prehospital care by MICU (Group I)
and the control group of patients who came to the Hospital by their
own means (group II). We compared demographic variables,
cardiovascular risk factors, treatment in prehospital phase or in ED,
time to firs medical contact to percutaneous coronary intervention
(PCI), location of coronary lesions, GRACE score, length in ICU and
hospital stay as well as survival to discharge and about 30 days.
RESULTS. 360 were evaluated by STEMI, 219 (60.8%) by MICU and
141 (39,2%) arrived themselves to hospital. 280 (77,8%) male and
mean age was 61.0 (RIC: 53.0-71.0) years old.
Patients treated for MICU had a GRACE score greater than the
control group 119.85 (112.5 – 127.1) Vs 97.4 (87.2-107.5) (p= 0.002).
There were differences in P2Y12 inhibitor administered. Ticagrelor
was more frequent in patients admitted directly in hospital 94
(66.7%) Vs 82 (37.4%) (p=0.00) and Prasugrel was more frequent by
MICU physicians 13 (9.2%) Vs 112 (51.2%) (p=0.00). Morphyne was
more administered in MICU 49 (34.8%) VS 121 (55.3%) patients (p=
0.00).
The initial attention of patients with STEMI by MICU reduced time to
PCI, stay length in ICU: 76.8 (37.4-191.0) Vs 44.8 (36.6-53.1) hours (p=
0.02), and was associated with lower mortality at hospital discharge
13 (9.2%)Vs 8 (3.7%) (p=0.02) and at 30 days compared to those who
went to the hospital by themselves 15 (10.6%) VS 10 (4.6%) patients
(p=0.02).
CONCLUSION. Around of 40% of patients with STEMI still come to
hospital by themselves. An EMS based STEMI networks and MICU
with presence of physicians on board allow to reduce the time to PCI
and decrease the mortality of patients with STEMI in Guadalajara.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):001708INTRODUCTION. Ventriculo-arterial coupling (Ees) optimisation allows
to increase stroke work efficiency and is a parameter of growing
interest in intensive care unit. Chen method is the most validated
non-invasive method to estimate ventriculo-arterial coupling, yet,
several simplified methods are often used at bedside. Those method
assume that the end systolic volume pressure relationship (ESPVR)
passes through the origin and calculate Ees as a derivate from ESP/
ESV. However, neither of those simplification have been tested
against Chen method in the intensive care unit.
OBJECTIVES. The objective of the present study was to determine
whether the simplifications proposed by Tanoue and Robotham
might substitute to Chen formula for the measurement of ventriculo-
arterial coupling at baseline and to track ventriculo-arterial coupling
change with therapeutic intervention.
METHODS. We perfomed a monocentric retrospective study in
Dijon teaching hospital. Ventriculo-arterial coupling was calculated
as Ea/Ees. The 3 non-invasive Ea/Ees calculation methods were
applied on 87 patients, cardiac surgical ICU patients. The refer-
ence method for measuring Ees was this of Chen (1). Ees was
also calculated according to Tanoue et al. (2): 0.9 * SAP/ ESV and
Robotham et al. (3): Ea/(1/LVEF)-1. All patients received either
fluid expansion (n=35), norepinephrine (n=32) or dobutamine (n=
20) (prescribed by the physician in charge). Measurement were
performed before and after intervention.
RESULTS. Eighty seven patients were analysed. Median age was 67
[60-75] years, 76% were male. To measure baseline Ea/Ees, the
concordance correlation coefficient (CCC) was of 0.13[-0.05;0.30], the
bias was of -0.19, limit of agreement ranged from -4.1 to 3.8 and
mean absolute percentage error (MAPE) was of 57% for Tanoue.
Regarding Robotham, the CCC was of 0.32 [0.14;0.49] bias was of
0.26, limit of agreement ranged from -2.4 to 2.9 and MAPE was of
42%. When used to follow Ea/Ees evolution with interventions, only
65 and 70% of measures evolved in the same direction (four-
quadarant plot analysis with a 15% exclusion zone) respectively for
Tanoue and Robotham methods when compared to Chen.
CONCLUSION. Our results do not support interchangeability
between Tanoue or Robotham and Chen method. These methods
neither allowed a precise estimation of ventriculo-arterial coupling
nor to follow its change with hemodynamic treatment.
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INTRODUCTION. Management after major cardiac surgery is typically
done by the integration of data from monitoring, echocardiography,
lab values, imaging techniques and patient observation. Monitoring
of pressures and flow is often used to titrate vasoactive and
inotropic agents postoperatively. Optimal targets for therapy are
often driven by institutional habits but are not universally accepted.
OBJECTIVES. We aimed to determine whether an optimal level of
common hemodynamic parameters can be identified that are
associated with an improved outcome.
T1
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artery catheter after cardiac surgery to one ICU from 2012-2015. All
data were extracted from the patient data management system Crit-
ical Care Manager (PICIS) that stored values every 10 minutes. We
calculated first median values for a 1 hour period and excluded
thereafter extreme values that are most likely artefacts (e.g. pressures
below zero, heart rate below 40 and above 200). For each patient a
minimum, maximum and median value for the whole stay was deter-
mined. These values were coded as categorical variables based on
quintiles, the middle category serving as reference for all logistic re-
gression analysis (STATA 15.1). Results are given as odds ratios with
95% confidence intervals from models including all 3 selected values.
We analysed heart rate, systolic blood pressure, diastolic blood
pressure, central venous pressure, continuous cardiac output and
mixed venous saturation in 645 patients that stayed in the ICU for
219 242 hours. 59 patients died during the hospital stay.
RESULTS. We found a U-shaped association in the combination of
minimum and maximum values with the exeption of cvp where high
minimum and maximum appear detrimental.
CONCLUSION. We found that simple hemodynamic variables can be
analysed to identify an optimal zone where both low minima and
high maxima are associated with poor outcome whereas for cvp the
lowest values for minimum and maximum are associted with better
outcome.
A multivariable model including duration of states may allow safe
margins of treatment in the future.
Table 1 (abstract 001756). Odds ratio for hospital death after cardiac
surgeryVariable Q1 Q2 Q3 Q4 Q5heart rate minimum 6.5(2.4-17.3) 2.9 (1.0-7.8) 1 0.4(0.1-
1.6)0.07(0.01-
0.72)heart rate maximum 0.04(0.005-
0.36)0.11(0.03-
0.43)1 0.9(0.4-
2.2)1.4(0.6-2.2)systolic minimum 35.5(7.9-158) 4.8(1.0-23.2) 1 0.5(0.05-
5.7)-
systolic maximum 0.3(0.1-0.99) 0.6(0.2-1.8) 1 1.4(0.5-




5.1)2.2(0.8-5.8)cvp minimum 0.9(0.3-2.4) 0.5(0.2-1.4) 1 1.7(0.7-
4.5)1.4(0.5-3.8)cvp maximum 0.5(0.1-2.0) 0.6(0.2-2.2) 1 1.4(0.5-
3.8)7.2(2.8-18.0)cardiac output
minimum8.4(2.8-25.4) 1.7(0.6-6.0) 1 0.5(0.2-
1.7)0.2(0.04-0.7)cardiac output
maximum0.4(0.1-1.2) 0.4(0.1-1.3) 1 1.1(0.4-
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INTRODUCTION. Continuous reliable evaluating of left ventricular
(LV) contractile function in patients with advanced heart failurerequiring intensive care remains challenging. Recently, continual
monitoring of dP/dtmax from arterial line became available for
hemodynamic monitoring. However, factors influencing the accuracy
of arterial dP/dtmax for the assessment of LV dP/dtmax remain not
fully understood.
OBJECTIVES. The aim of our study was to determine hemodynamic
factors that affect the relationship between arterial dP/dtmax and LV
dP/dtmax in patients with acute heart failure.
METHODS. Fifty patients with acute heart failure requiring intensive
care, inotropes/vasopressors and hemodynamic monitoring were
recruited into the study (mean age 70.2 years, 64% were males).
Hemodynamic variables including arterial dP/dtmax were continually
monitored using arterial line pressure waveform analysis. LV dP/
dtmax was assessed using continuous-wave Doppler analysis of mi-
tral regurgitation flow.
RESULTS. The values from continual arterial dP/dtmax monitoring
significantly correlated with the LV dP/dtmax assessed by
echocardiography (r=0.70, 95% confidence interval [CI] 0.51-0.82,
P˂0.0001). Linear regression revealed that (LV dP/dtmax) =
1.25×(arterial dP/dtmax), P˂0.0001. We analyzed the relation between
arterial dP/dtmax and LV dP/dtmax in the subgroups above or
bellow the mean value of individual hemodynamic variables. We
have found markedly stronger correlation in subjects with higher
systemic vascular resistance (>900 dyn.s/cm5, N=20, Spearman r=
0.91, 95%CI 0.78 to 0.97, P<0.0001), in the subgroup with cardiac
output <6 L/min, (N=26, Spearman r=0.81, 95%CI 0.60 to 0.91, P<
0.0001) and in patients with heart rate ˂92 beats/min (N=26,
Spearman r=0.90, 95%CI 0.79 to 0.96, P˂0.0001).
CONCLUSION. Our results indicate that arterial dP/dtmax values
correlate with LV dP/dtmax, particularly in patients with higher
systemic vascular resistance, lower heart rate and lower cardiac
output. Arterial dP/dtmax could be, therefore, used for continual
monitoring of LV contractility especially in hemodynamic conditions
corresponding to cardiogenic shock.
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INTRODUCTION. Treatment with VV-ECMO or VA-ECMO interferes
with thermodilution methods for measuring cardiac output (CO) [1].
The thermal pulse generated in a central vein or the right atrium can
be considerably disturbed by or even largely diverted into the ECMO
system.
OBJECTIVES. Explore the feasibility of using the water heater unit
(HU) circuit of the ECMO system itself as a transducer of defined
thermal pulses.
METHODS. A pig with a body weight of 49 kg was anesthetized,
ventilated and connected to a Cardiohelp (Maquet Cardiopulmonary
AG, Rastatt, Germany) VV-ECMO system. Thermistor-tipped catheters
were used to measure the temperature as a function of time T(t) at 3
places: at the venous inlet of the ECMO: T-VE(t), at the arterial outlet
of the ECMO: T-AE(t), and in the femoral artery: T-FA(t). The mem-
brane oxygenator was connected with a heater unit (HU) (HU-35,
Maquet Cardiopulmonary AG, Rastatt, Germany) that provided a con-
tinuous water flow temporarily set at a temperature 1 to 1.5 oC
above body temperature. The ability of the ECMO-HU to generate
thermal pulses was assessed by interrupting the water flow from the
T1
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and T-FA(t). The interaction of the ECMO-HU with incoming thermal
pulses was assessed by comparing T-AE(t) and T-VE (t) after central
venous injection of 20 ml cold boluses. High time-resolution experi-
ments were performed in triplicate.
RESULTS. Interruption of HU water flow generated a rapid decrease
of ≥0.5 oC in T-AE, followed after a median time of 7 seconds by a
drop T-VE of 0.1 oC and after 14 seconds by a drop of T-FA by 0.3
oC. Systemic cold bolus injections generated distinct thermal spikes
in T-VE (t) and T-AE(t). The nadir value for T-VE was followed 11 sec-
onds later by a nadir value for T-AE. This interval is largely explained
by the transit time resulting from the blood flow and dead volume.
When the area under the curve of the thermal pulse entering the
ECMO system was compared with the pulse leaving the ECMO sys-
tem, we saw a 66% reduction, indicating considerable thermal trans-
fer to the HU- water circuit.
CONCLUSION. Modifying heater unit water flow or temperature can
be used to generate thermal signals in the arterial output of the
ECMO system, which are propagated to the venous input of the
ECMO system and the femoral artery. Thermal signals originating in
the patient are also propagated to the ECMO system and may even
be transduced to the water circuit.
REFERENCE(S)
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INTRODUCTION. The setting of peep during operative period is
recommended to avoid derecruitement and atelectasis. High peep
decrease venous return and cardiac output and can be deleterious in
hypovolemic patients. it is widely accepted that the dynamic indices,
pulse pressure variation (PPV) , stroke volume variation (SVV) ,
systolic pressure variation(SPV) accurately predict fluid
responsiveness in mechanically ventilated patients passively adapted
to the ventilator.
OBJECTIVES. The objective of this study was to evaluate the fluid
responsiveness using peep challenge in patients undergoing
digestive surgery
METHODS. 30 patients, Asa 1, 55 +-10 years old, without cardiac
failure or pulmonary pathology were enrolled for programmed
digestive surgery. Anesthesia was performed using propofol,
sufentanil and cisatracurium and all the patients were intubated. We
evaluated the increase of peep on hemodynamics in patients Asa 1
selected for digestive surgery. This group of 30 patients was
submitted to a peep challenge 60 minutes after induction, increasing
peep progressively from 4cmh2o to 10 cmh2o with a time of 5
minutes to reach 10cmh2o. We monitored arterial pressure with a
catheter inserted in radial left artery and central venous pressure
with a three lumen catheter inserted in right jugular vein. We
recorded continuously, systolic pressure variation, mean arterial
pressure and pulse pressure variation from the arterial wave line.
Central venous pressure(CVP) , pulse pressure variation(PPV), systolic
pressure variation(SPV) and mean arterial pressure (PAM) were
observed and recorded before and after the peep challenge whichconsisted in increasing peep from 4to 10cmh2o. So, recordings of
these hemodynamic parameters were performed at peep 4cmh20
(control value) and at peep 10(peep challenge). Fluid responsiveness
was defined as a more than 10% decrease of arterial pressure and
pulse pressure variation more than 13% after peep challenge
RESULTS. Statistical analysis was performed using student’s t test.
We observed finally that peep challenge from control values at peep
4, increase PPV, SPV, CVP and decreases PAM. Results were
expressed as mean +- std deviation. PAM(mmHg) decreases from
77,258 +- 4,016 to 69,581+-5,714.(p<0.001). PPV(%) increases from
10,097 +-1,904 to 16,677 +-1,641 (p<0.001). SPV(%)increases from
7,839+-1,393 to 14,968 +-1,835 (p<0.001). CVP(cmh20) increases from
8,516+- 2,143 to 10,129 +-2,061 (p<0,007).After fluid challenge , we
came back to the control values.
CONCLUSION. During operative period, the setting of peep 10 (from
peep 4) can detect fluid responsiveness in patients undergoing
digestive surgery.
REFERENCE(S)
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Table 1 (abstract 001367). See text for description
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INTRODUCTION. Global end-diastolic volume is a static marker of
preload. Indexation to body surface area BSA results in GEDVI. Sev-
eral studies demonstrated better prediction of fluid responsiveness
by GEDVI compared to CVP. However, the results are inconsistent
and at least two studies suggest inappropriate indexation by BSA
(1;2). Furthermore, the two commercially available devices measuring
GEDVI use different indexations: The PiCCO uses predicted body-
weight (BW_pred) to calculate BSA_pred, while the EV-1000 uses ac-
tual BW to calcualte BSA_act.
Recently, the concept of context-sensitive indexation (CSI) has been
introduced to optimize indexation. Based on analyses of a large
haemodynamic database including about 20,000 haemodynamic
measurements, CSI individually adjusts each haemodynamic param-
eter according to its specific association to biometric data including
age and gender in addition to weight, height and BSA. Furthermore,
CSI also adjusts for „contexts“ such as atrial fibrillation (AF) , mechan-
ical ventilation and catheter position, which might have a stronger
impact on the haemodynamic raw value than biometric data.
OBJECTIVES. This study tried to validate CSI of GEDV (GEDVI_CSI) in
a group of 33 ICU-patients with shock undergoing a volume chal-
lenge (VC) with 7mL/kg saline 0.9% over 30 minutes.
METHODS. Methods: All patients were equipped with PiCCO-
monitoring (Pulsion; Germany) and under assisted mechanical venti-
lation. Transpulmonary thermodilution was performed immediately
before and after the VC. GEDVI_CSI was calculated as described pre-
viously using a formula adjusting GEDV for age, gender, weight,
height, CVC-position (femoral or jugular) and heart rhythm (sinus
Page 455 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55rhythm or AF). Statistics: Primary endpoint: increase in Cardiac Index
CI ≥10%. Second endpoint: Change in cardiac power index CPI
≥10%. ROC-analysis. SPSS 25.
RESULTS. 12 (36%) female, 21 (64%) male patients. SOFA 13±4. AF in
7 of 33 patients (21%). 31 of 33 patients were under vasopressor
therapy (noradrenaline dosage 1476±3277μg/h).
The VC resulted in significant increases in CI (4.8±2.1 vs. 4.6±2.2L/
min/m², p=0.002), CVP (16.5±4.8 vs. 13.9±6.3mmHg, p=0.002), GEDVI
(831±203 vs. 790±175mL/m², p=0.020), MAP (82±10 vs. 76±8mmHg,
p=0.001), cardiac power index (0.86±0.36 vs. 0.78±0.42W/m², p<
0.001) and stroke volume index (±, p<0.001), while heart rate
decreased (100±17 vs. 102±18/min, p=0.006). Stroke volume
variation SVV (p=0.287) and pulse pressure variation PPV (p=0.596)
did not change significantly.
As expected due to the lack of controlled mechanical ventilation,
baseline PPV (AUC=0.566; p=0.566) and SVV (AUC=0.664; p=0.145) did
not predict an increase in CI ≥10%. While baseline CVP (AUC=0.423; p=
489), unindexed GEDV (AUC=0.510; p=0.933), GEDVI indexed to
BSA_pred (AUC=0.433p=0.554) and GEDVI indexed to BSA_act (AUC=
0.400; p=0.375) did not predict the primary endpoint, GEDVI_CSI was
the only significant predictor of an increase in CI ≥10% (AUC=0.745; p=
0.028). Similarly, GEDVI_CSI was the only baseline parameter to predict
an increase in CPI ≥10% (AUC=0.733; p=0.025).
CONCLUSION. GEDVI_CSI adjusted according to CSI was the only
significant predictor of fluid responsiveness, whereas CVP, SVV, PPV
and GEDVI according to all other indexations were not predictive.
These data support the concept of context-sensitive indexation.
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INTRODUCTION. Changes in cardiac output (CO) caused by central
venous pressure (CVP) are the most important concerns in the
treatment of shock. It is a pathophysiological axiom that the lower
the CVP, the better.
OBJECTIVES. This study was performed to explore how to use CVP
and what its relevant mechanisms with respect to CO in the critically
ill patients.
METHODS. A total of 134 patients with circulatory shock were
retrospectively included and analyzed. Hemodynamic data were
recorded and analyzed at PICCO initiation and 24 hr after PICCO.
Data regarding 28-day mortality and renal function were also
collected.
RESULTS. The patients were divided into a CVP↑+ CO↑ group (n=23),
a CVP↑+ CO↓ group (n=29), a CVP↓+ CO↑ group (n=44), and a CVP↓+
CO↓ group (n=38) based on PICCO initiation and 24 hr after PICCO.
Post hoc tests showed the CVP↓+ CO↑ group had higher 28-day sur-
vival than the other groups [log rank (Mantel-Cox)=8.758, P=0.033]. In
terms of hemodynamic characteristics, the CVP↓+ CO↑ group had a
lower cardiac function index (CFI) (4.1±1.4 /min) and higher extravas-
cular lung water index (EVLWI) (11.0±4.7 ml/kg) at PICCO initiation.
This group used more cardiotonic drugs (77.3%, P<0.001) and had a
negative fluid balance (-780.4±1720.6 ml/24 hr, P=0.018) 24 hr after
PICCO than the other three groups. Cardiotonic drug use and dehy-
dration treatment was associated with increased CFI (from 4.1±1.4
/min to 4.5±1.3/min, P=0.07) and reduced ELVWI (from 11.0±4.7 ml/
kg to 9.0±3.5 ml/kg, P=0.029). Renal function tests showed that SCr
and BUN levels in the CVP↓+ CO↑ group were significantly improved
(SCr from 197.1±128.9 mmol/L to 154.4±90.8 mmol/L; BUN from 14.3
umol/L±7.3 to 11.6±7.0 umol/L, P<0.05).CONCLUSION. Lower CVP associated with CO increased, which may
improve 28-day prognosis in patients with circulatory shock. Higher CO de-
rived from lower CVP may also contribute to renal function improvement.
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INTRODUCTION. Acute Coronary Syndrome (ACS) is one of the
leading causes of cardiovascular morbidity and mortality. Therefore,
stratification of risk is a very important issue for the prevention and
management of ACS.The platelet/lymphocyte ratio, a marker of the
systemic inflammatory response, was significantly correlated with
mortality during ACS according to several studies.
OBJECTIVES. To study the prognostic value of platelet/lymphocyte
ratio in patients admitted to emergency departments for acute
coronary syndrome .
METHODS. This was a prospective study, conducted over a period of
3 months from January to March 2019 at the emergency department
of CHU La Rabta. We included all patients over the age of 18,
admitted for ACS and analyzed the correlation of platelet/lymphoctic
ratio (DPR) to intrahospital mortality using SPSS 22 software. The
significance threshold was set at 0.05.
RESULTS. We included 100 patients. The average age was 65.74 ±
11.91 and the sex ratio was 1.34. The platelet/lymphoctic ratio (RPL)
ranged from 10.35 to 3093.3 with an average of 199.7 ±333.99. We
found STEMI in 46% of patients. The percentage of complications
was 34% and the mortality rate was 15%. RPL was 150 in 48.2% of
patients. We found a significant correlation between an RPL 150 and
the mortality rate (p=0.000015, OR=2.6, IC=[0.8318674 -9.099468]).
The area under the ROC curve was 0.61.
CONCLUSION. High platelet/lymphocyte ratio could be a predictor of
mortality in patients with ACS.
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INTRODUCTION. Theupstreampressureforvenous return (VR) is
considered to be acombinedconceptualblood pressurewithin the
systemic vessels - the mean systemic filling pressure (MSFP). The
relevance of the bedside estimation of the MSFP during dynamic
changes of the circulation is controversial.
OBJECTIVES. To studie the effect of blood volume on the relationship
between VR and central venous pressure (CVP) near zero blood flow.
METHODS. In 9 healthy mechanically ventilatedpigs under
anaesthesia, MSFP was estimated from the extrapolated CVP versus
VR relationships during inspiratory hold maneuvers (IHMs) with
different levels of ventilatory pressure (Pvent), see Maas et al. for a
detailed description of the used method (1). VR was recorded
continuously using an ultrasonic flow probe, placed around the
pulmonary artery. MSFP was measured 3 times during different
F2
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induced by bleeding with 10 ml/kg or until CO was halved compared
to baseline. The estimated MSFP values were compared to the
arterial blood pressure recording after induced ventricle fibrillation.
RESULTS. Our results revealed a strong linear correlation between
cardiac output and CVP (R^2 of 0.92 [range: 0.67-0.99]), during IHMs
with different levels of Pvent. Volume status significantly alters the
resulting MSFP, 20 ± 1 mmHg and 16 ± 2 mmHg for euvolemia and
hypovolemia respectively (Figure 1). This estimation of the MSFP was
strongly correlated - but not interchangeable- to the venous blood
pressure recording after induced ventricle fibrillation (R^2=0.8 and
p=0.045).
CONCLUSION. Absolute values of the VR curve - acquired using IHMs
at the bedside – are statistically significant but clinically irrelevant
and should therefore not be used to guide clinical volume therapy in
its current form.
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curves during different volumetric states in order to estimate the
mean systemic filling pressure. Right; Hemodynamic parameters
(normalized to baseline) during the different volumetric states:
Euvolemia (Eu) and Hypovolemia (Hypo). Estimation of the mean
systemic filling pressure using inspiratory holds (MSFP_IH), Cardiac
output (CO), Mean arterial pressure (MAP), and central venous
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INTRODUCTION. A radial to central pressure gradient (RCG) is a
common finding during a cardiopulmonary bypass or during sepsis.
This gradient leads the clinician to under evaluate the arterial
pressure that can lead to fluid or vasopressor therapy overuse.
OBJECTIVES. We assessed in the present study the prevalence of RCG in
patients in intensive care unit and the accuracy of non-invasive assess-
ment of the radial to humeral pressure gradient (RHG) to detect the RCG.
METHODS. Adults patient in an intensive care unit treated with a
vasopressor and equipped with a femoral and a radial artery were
selected. We recorded arterial pressure at the radial and the femoral
artery invasively, and non-invasively at the four limbs: on the arm at
the humeral level and on the thigh and calf at the femoral and at
the tibial level. This was repeated each hour for 2 hours. A significant
RCG was assessed with the invasive radial and femoral arterial line,
defined by either a mean arterial pressure difference of more than10 mmHg or a systolic pressure difference of more than 25 mmHg.
We assessed the prevalence of a RCG, and evaluate the correlation
between RCG and RHG. We assessed the diagnostic accuracy of the
RHG to detect a significant RCG.
RESULTS. Eighty-one patients were included. A significant gradient
occurred in 15 patients with a prevalence of 18.5 % [95% CI: 10.8 -
28.7 %]. Considering the 229 measurements, 41 have shown a signifi-
cant RCG 17.9% [95% CI: 13.2 - 23.5]. No demographic data were sig-
nificantly associated with a significant gradient. Systolic RCG
correlated with systolic RHG (r²=0.36; p<0.001) and mean RCG also
correlated with mean RHG (r²=0.34; p<0.001).
The area under the curve of the receiving operative curve (ROC AUC)
of the mean RHG to predict the RCG was 0.84 [95% CI: 0.68- 0.97].
The best threshold was 14 mmHg with a specificity of 89% [95% CI:
81- 95] and a sensitivity of 80% [95% CI: 60- 100].
CONCLUSION. A significant RCG occurs in almost one in every five
patients Non-invasive RHG assessment can be used to detect a sig-
nificant HRG.
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INTRODUCTION. Daily fluid assessment, prescription and
administration are essential daily tasks on intensive care, medical
and surgical units. Published data suggests that intravenous (IV) fluid
management is poor and patient outcomes are adversely impacted
by both under and over hydration. Surgical audit data suggests that
fluid related complications occurs in 17-54% of post-operative pa-
tients contributing to mortality and increased length of hospital stay.
OBJECTIVES. As clinician knowledge has been identified as a major
factor in previous reviews of poor fluid management we examined
current knowledge in 348 junior and middle-grade medical doctors
in Greater London and compared this to that in consultant intensi-
vists to determine if progress had been made to address this issue in
recent years.
METHODS. Pre-registration (PRD; n=146) and junior medical doctors
(JMD; n=70), specialty medical trainees (SpR; n=133) from 'acute' (e.g.
ICU) and non-acute (e.g. rheumatology) medical specialties and consult-
ant intensivists (CIs; n=18) were asked to complete a structured ques-
tionnaire which included: 1. Assessment of their previous training in
fluid management; 2. How often they had managed fluid related com-
plications (and whether these were reported as significant incidents); 3.
Twenty 'best of 5' multiple choice knowledge questions (10 of these
questions were similar to those used in previous fluid knowledge as-
sessments (2001-2018) to enable change over time to be assessed) 4.
Self-reported confidence in relation to fluid prescription. For compari-
son 18 CIs completed the questionnaire. Aspects of knowledge ad-
dressed included electrolyte composition of commonly administered IV
fluids, normal daily fluid and electrolyte requirements and excretory
mechanisms, fluid distribution, fluid and electrolyte physiology in
health and disease and 4 clinical scenarios relating to the UK NICE
guideline (CG 174) 'IV fluid therapy in adults in hospital'.
RESULTS. As in previous reports, PRD and JMD responsible for most
IV fluid prescriptions, reported limited training (<10hrs) during
medical school and early clinical training. Fluid related complication
Page 457 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55were common and had been managed by 25% PRD (mainly <5
episodes) and 90% of JMD and SpR (<5 to >20 episodes). The
majority of these were 'never' or 'rarely' reported. On the multichoice
questions CIs correctly answered 15.1±2.1 (mean±SD) questions. PRD
achieved 6.66±2.4; JMD 8.37±2.6 and SpR 8.14±2.84 correct answers
(with 'acute' specialty SpRs performing significantly better than non-
acute specialities). Compared to previous knowledge assessments
there were improvements in knowledge related to several areas in-
cluding sodium content of commonly prescribed fluids, daily water
and electrolyte requirements and NICE guidelines. Self reported con-
fidence in fluid management was higher than might be expected
based on multiple choice question results in all groups except CIs.
CONCLUSION. This study suggests that although fluid management
remains a cause for concern in junior clinicians, with evidence of
relatively poor training, failure to report complications, poor overall
knowledge scores and over-confidence, there is evidence of improve-
ment in a number of key areas previously highlighted in the UK NICE
guideline CG174.
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INTRODUCTION. Ventriculoarterial coupling (VAC) is often impaired
in septic shock patients. Fluid administration is one of the most used
treatments in these patients, but its effects on VAC have been
scarcely described until now. We made the hypothesis that VAC
improves with a preload increase only in case of preload
responsiveness because, in this condition, the fluid-induced increase
in stroke volume may decrease the arterial elastance (Ea) with lesser
effects on the ventricular end-systolic elastance (Ees).
METHODS. We included septic shock patients in whom fluid
administration was mimicked by a passive leg raising (PLR) test.
Hemodynamic variables and transthoracic echocardiography data
before and during the PLR test were compared. Preload
responsiveness was defined by a PLR-induced increase in cardiac
output ≥10%. VAC was calculated as the ratio of Ea over Ees. Ea was
calculated as 0.9 x systolic arterial pressure/stroke volume. Ees was
calculated according to the method validated by Chen et al [1].
RESULTS. We performed 31 measurements among 20 patients
(SAPSII on admission = 50±13, SOFA = 10±3, 28-day mortality = 30%,
pneumonia in 55% of cases, norepinephrine administered in all
cases). The PLR test revealed 8 preload responder cases (R) and 23
non-responder cases (NR). The left ventricular end-diastolic volume
increased to a similar extent in R and NR (from 67 [57-85] to 75 [67-
92] mL in R, from 75 [58-92] to 83 [68-101] mL in NR). Stroke volumeincreased by 19 [14-23]% in R and by 4 [0-4]% in NR. In R, Ea signifi-
cantly decreased from 2.46 [1.59-2.65] to 2.01 [1.49-2.61] mmHg/mL
and Ees did not change significatively (from 2.05 [1.6-2.78] to 2.09
[1.56-2.64] mmHg/mL). As a result, VAC significantly decreased from
1.14 [0.83-1.44] to 1.02 [0.74-1.3] in R cases. Among NR cases, neither
Ea nor Ees showed a significant change during PLR (p=0.80 and p=
0.20, respectively). Similarly, VAC did not change in these cases (p=
0.18).
CONCLUSION. These results suggest that, in septic shock patients,
increasing cardiac preload improves VAC only in cases of preload
responsiveness. This suggests an improvement in cardiac efficiency
with fluid under this condition. The inclusions are ongoing.
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INTRODUCTION. Predicting preload responsiveness by using
dynamic indicators before administering fluids to critically ill patients
is nowadays routinely performed at the bedside (1). Unlike other
dynamic indicators of preload responsiveness that require cardiac
output monitoring, pulse pressure variation (PPV) can be simply
obtained via an arterial catheter (2). However, PPV is not reliable in
mechanically ventilated patients with spontaneous breathing activity
(2). We hypothesized that an increase in PPV after a tidal volume (TV)
challenge (TVC) or a decrease in PPV during passive leg raising (PLR)
will predict preload responsiveness in such cases.
OBJECTIVES. to examine if the change in PPV during PLR and after a
TVC can predict preload responsiveness in patients with mechanical
ventilation and persistent spontaneous breathing
METHODS. Prospective non interventional study conducted in two
intensive care units. Patients under mechanical ventilation with
spontaneous cycles, for whom the physician in charge decided to
test preload responsiveness were included. Firstly, transthoracic
echocardiography was performed to measure the velocity time
integral (VTI) of the left ventricular outflow tract and to calculate
delta VTI before and during PLR. Patients were considered as preload
responsive when delta VTI was ≥10% (3). Secondly, a TVC was
performed by increasing the TV by 2mL/kg predicted body weight
from its baseline value. PPV was recorded before and after the TVC.
RESULTS. Thirty patients were included, their mean age was 61 ± 16
and their SAPSII was 57 ± 17. At baseline the TV was of 6.2±0.7 mL/
kg predicted body weight, their PEEP was of 11±4 cmH2O and their
plateau pressure was of 20±5 cmH2O. Norepinephrine was
administered in 29 patients, its mean dose was of 0.37±0.44 μg/kg/
min. The blood lactate was of 1.3 [1.1-1.9] and the MAP was 83 ± 12
mmHg. According to the PLR test, 14 were preload-responders and
16 non responders. PPV at baseline predicted preload responsiveness
with an area under the receiver operating characteristic curve
(AUROC) (with 95% CI) of 0.53 (0.33-0.71). During PLR, the absolute
decrease in PPV predicted preload responsiveness with a sensitivity
of 86%, a specificity of 63%, an AUROC (95% CI) of 0.72 (0.53–0.87)
and a cutoff value of -1%. The increase in PPV during the TVC pre-
dicted preload responsiveness with a sensitivity of 71%, a specificity
of 88%, an AUROC of 0.74 (0.55–0.89) with a cutoff value of 2. The
T1
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PPV during TVC were similar but were significantly different from 0.5
and from that for baseline PPV.
CONCLUSION. In mechanically ventilated patient with spontaneous
breathing activity, PPV does not predict fluid responsiveness,
however either the decrease in PPV during PLR or the increase in
PPV during a TVC may help physicians to distinguish preload
responders from non-responders with an acceptable accuracy.
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INTRODUCTION. Surgical procedures cause pain – neuroendocrine
(1), inflammatory and immune response that can be modified by
anaesthesia (2, 3).
There are several opioids that are used for perioperative and
postoperative analgesia: sufentanil (S), alfentanil (AL), remifentanil (R)
and fentanyl (F).
OBJECTIVES. Objectiveof this study wasto compare the effects of
these opioid analgesic regimens on cardiovascular and hormonal
reaction of patientsundergoing elective aortal aneurism surgery
under general endotracheal anaesthesia.
METHODS. A total of 60 elderly patients, ASA 3, scheduled for
elective surgery of aneurysms of abdominal aorta were randomized
in four equal groups to receive either F(0.1 μg/kg ivbolus +0.1 mg
maintenance dose) or a equivalent doses of AL, Rand S.
Haemodynamic parameters and concentrations of prolactine (PRO),
cortisol (COR) and growth hormone (GH) were determined at critical
points: baseline (BL), intubation (INT), first incision (FI), surgical
manipulation (SM), extubation EXT and 24 h postop (24hPO).
Analgesics were repeated hourly or if cardiovascular parameters
changed by more than 20% of their BL values.
A blood sample of 10 ml was taken 10 min after insertion of
ivcatheter (BL) and sampling and was repeated at critical points of
operations and 24 h postoperatively.
RESULTS. In the F group there was a significant increase in systolic
and diastolic BP after INT and SM as well as pulse pressure after SM.
Diastolic BP was significantly increased after EXT.
A decrease in systolic pressure was found after INT in the R, S
andALgroup (by 32±5%, 25±4% and 18±2%, respectively). Pulse pressure
was significantly increased at SM and 24 h postop in the Rgroup.
Emergence from anaesthesia was best after use of R (4.9±5 vs. 9.5±2,
12 .9±8 ;12.6±2min in F, Al and S group, respectively). Postoperative
analgesia was significantly shorter after use of R (27±6 min) than of
F, Sand AL (50±6, 55±8and 42±7 min, respectively).
Only COR positively correlated with mean arterial pressure (MAP) in
all opioid groups, while there were no correlations between PRO or
GH and cardiovascular parameters.
During the maintenance of anaesthesia, prolactin values were
significantly increased in all groups in Iphases of NT, M and EXT.
CONCLUSION. Cortisol plasma concentration correlates positivelywith
cardiovascular parameters in patients undergoing elective surgery of
abdominal aorta aneurysm during the operation and thereafter
under all used opioid regimens. Its suppression is better marker of
analgesia than the changes of prolactin and GH levels.REFERENCE(S)
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INTRODUCTION. Patients with cardiogenic shock refractory to
treatment still have a very poor prognosis with a hospital mortality
above 50%(Thiele, EurHeartJ 2015).
Therefore in patients with refractory cardiogenic shock extracorporal
support (ECLS) is increasingly used to treat such patients in order to
decrease mortality. However only limited data about the results are
availaible. Accordingly we evaluated all patients with refractory
cardiogenic shock treated with an ECLS between 2015 and 2018 in
our department.
OBJECTIVES. Comparing the predicted mortality (SAVE score) with
the actual hospital mortality in patients with refractory cardiogenic
shock and treatment with an extracorporal support (ECLS).
METHODS. We compared the predicted hospital mortality with the
actual hospital mortality of all patients with refractory cardiogenic
shock treated with extracorporal support in the Asklepios Klinik in
Langen, Germany (Department of Anestesia and perioperative
medicine) between January 2015 and December 2018. To predict
mortality we used the SAVE-score, which has been developed by
Schmidt. et al. (2).
We devided all patients treated in a palliative care group (patients with
unfavorable prognosis and short survival times due to poor
neurological outcome/ strict living will) and a non palliative care group.
RESULTS.
CONCLUSION. The actual in hospital mortality of our non palliative
care patients was less than half oft that predicted by the SAVE-score.
In addition in the non palliative care patients with refractory cardio-
genic shock treated with ECLS the hospital mortality was about one
third lower than the mortality published in current literature.
Thus, the use of an extracorporal support system like ECLS might
improve mortality in patients with refractory cardiogenic shock.
A randomized prospective evaluation of ECLS/ECMO application in
patients with refractory cardiogenic shock (ECLS-SHOCK) is under
way to answer this question.
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INTRODUCTION. Intestinal fatty acid binding protein (I-FABP) is a cytosolic
protein in the (mainly) small intestine that is released into circulation upon
enterocyte necrosis and rapidly cleared renally (Treskes 2017). As such it
parallels the onset and cessation of enterocyte damage, e.g. due to
ischaemia. Little is known about I-FABP dynamics in a general ICU population.
OBJECTIVES. To describe I-FABP in ICU patients during their first week of stay.
METHODS. Consecutive adult patients in 5 ICUs were studied. Plasma was
collected immediately after ICU admission and thereafter daily. Following
storage at -80 °C, samples were analyzed for I-FABP using ELISA (R&D Sys-
tems Inc., US). I-FABP values between groups were compared using the
SPSS Median Test for each day separately.
RESULTS. I-FABP was measured in 224 patients (median age 66.5, range
29-94 years; median APACHE II 18, IQR 11-23; 28 day mortality 10.3%). Me-
dian I-FABP level of all measurements was 903 (425-1862), being higher in
28 d survivors [963 (IQR 461-1882)] vs nonsurvivors [502 (IQR 284-1197)
pg/mL]. Median of individual highest I-FABP values was 2596 (IQR 1286-
4691) pg/mL and occurred on admission day in 69% of patients. I-FABP
levels were lower in patients after GI surgery (days 3-4) and in patients
with sepsis (days 1-3) compared to patients without these conditions re-
spectively. Figures present I-FABP dynamics in all patients, 28 d survivors
vs nonsurvivors, sepsis vs no sepsis and GI surgery vs no GI surgery.
CONCLUSION. I-FABP levels were elevated at admission, but rapidly de-
creased to the reference range by day 2. Interestingly, and different from
previous observations, rather lower I-FABP levels were observed in non-
survivors vs survivors and in sepsis vs no sepsis.
REFERENCE(S)
1. Treskes N, Persoon AM, van Zanten ARH. Diagnostic accuracy of novel
serological biomarkers to detect acute mesenteric ischemia: a systematic
review and meta-analysis. Intern Emerg Med. 2017; 12(6): 821–836.
2. This study is a part of the iSOFA study (NCT02613000) endorsed by
ESICM and funded by Fresenius Kabi and institutional grant from the
Ministry of Education and Research of Estonia (IUT34-24).Fig. 1 (abstract 000698). I-FABP dynamics in all patients000728
Factors associated with blood transfusions and early extubation in liver
transplantation recipients. Prospective observational preliminary data
C. Spina1, G. Burgio2, G. Martucci2, M. Barbara3, D. Pagano3, M. Farbo2, F.
Lullo2, G. Chiaramonte2, R. Fumagalli4, S. Gruttadauria3, A. Arcadipane2
1School of anesthesia and intensive care, University of Milano-Bicocca, Milano,
Italy; 2Anesthesia and intensive care unit, IRCCS-ISMETT, Palermo, Italy;
3Department for the treatment and study of abdominal diseases and abdominal
transplantation, IRCCS-ISMETT, Palermo, Italy; 4Department of anesthesia and
critical care, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
Correspondence: C. Spina
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000728
INTRODUCTION. Fluid restriction and early extubation in operating room




Page 460 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55liver transplantation (LT) recipients in order to avoid hemodilution, blood
transfusion and to minimize ICU stay and complications.
METHODS. This prospective cohort study included 18 consecutive
patients who underwent a deceased-donor LT at ISMETT from Sep-
tember 2018 to March 2019. Packed red blood cells (PRBC) trans-
fused and early extubation were analyzed in relation to pre and
intraoperative variables. LT were performed with the standard tech-
nique with or without veno-venous bypass.
RESULTS. Patient characteristics, intra and postoperative variables
are described in table 1.
Major indications for liver transplantation were cirrhosis caused by
viral diseases n= 7 (38.9%) followed by NASH syndrome n=6 (33.3%).
The overall intraoperative PRBC transfusion was 1.7 ± 2.5 units on
average. Patients who received blood transfusions (n=8, 44%)
needed in median 3.5 PRBC (2.5-5.5).
Patients were divided between those no required blood transfusion
versus those received more than one unit. The factors associated
with PRBC transfusions are listed in table 2.
Patients extubated in operating room (n=13, 72%) had a significant
lower dose of norepinephrine used during transplantation [0.1 vs 0.3,
p 0.019] and were all treated with neuromuscular blockade reversion
by Sugammadex (p<0.001).
CONCLUSION. These preliminary results show that low preoperative
Hb, high INR value, MELD score, CP, high dose of norepinephrine and
long time of surgery and anaesthesia were associated to the need of
intraoperative blood transfusions during LT. These data provide also an
external validation of the Mc Cluskey index as predictor of
intraoperative blood loos. Hemodynamic stability and Sugammadex
use were associated with extubation in OR during LT. Further increase
of the sample size should confirm these preliminary results.
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INTRODUCTION. Gastrointestinal system(GIS) complications are
frequent within first 7 days in patients started to feed by enteric route
in Intensive Care Unit(ICU).Researches have been published reporting
that these complications are due to the product, the patient or the
feding method.(1)In this study, we aimed to investigate and compare
the rates of complicaitions related to feeding method. Which today
frequently used methods are continuous feeding(CF) and intermitent
feeding(IF) via nasogastric tube.
METHODS. After obtaining approval of Institutional Ethics Committee, the
patients, who admitted to ICU for different reasons within 4 months, aged
18-95, who had no GIS pathology, no contraindication for enteral nutrition,
were included the study and randomly assigned to CF and IF group.In-
formed consets of subjects were obtained.After reaching the aimed calories
within 72 h, diarrhea, constipation, aspiraiton, distantion, residue, nausea
and reflux recorded for 7 days.Significance was defined as p<0.005.
RESULTS. The study was performed with a total of 62 cases (31(50%)
male and 31(50%) female).The mean age was 74.45 ± 13.43 years.
37(59.7%) patients were followed-up with CF and 25 patients(40.3%) with
IF. Results showed that there was no statistically significant difference be-
tween these two groups. Complications rates are summerized at Table 1.
CONCLUSION. In the studies comparing CF and IF, stool frequency is
higher and access to aimed calories is delayed in the IF compared to
CF.(2) Howerver, some other studies declared that there was no
significant difference in the effects of both methods related to GIS
functions. (3) In our study, although there was no statistically significant
difference between the two groups, the rates of two complicitons
showed clinically significance. The rate of distension was higher in
patients IF (CF-3(%8,1),IF-6(%24)),while the rate of diarrhea was higher
in patients CF(CF-10(%27),IF-5(%20)).As a result,CF did not show any
superiorty to IF in terms of GIS complications. We suggest that IF can
be considered as an option in selected critically ill patients.
REFERENCE(S)
1. Hiebert JM et al., Comparison of continuous vs intermittent tube
feedings in adult burn patients., JPEN J Parenter Enteral Nutr. 1981 Jan-
Feb;5(1):73-5
2. Patel JJ et al., Intermittent versus continuous feeding in critically ill
adults., Curr Opin Clin Nutr Metab Care. 2018 Mar;21(2):116-120
3. Blumenstein I, Gastroenteric tube feeding: techniques, problems and
solutions.,World J Gastroenterol. 2014 Jul 14;20(26):8505-24
Table 1 (abstract 000788). Evaluation of complicationsCF n (%) IF n (%) Total n (%) PDiarrhea Absent 27 (%73) 20 (%80) 47 (%75,8) 0,740Present 10 (%27) 5 (%20) 15 (%24,2)Constipation Absent 34 (%91,9) 24 (%96) 58 (%93,5) 0,642Present 3 (%8,1) 1 (%4) 4 (%6,5)Aspiration Absent 37 (%100) 25 (%100) 62 (%100) -Distension Absent 34 (%91,9) 19 (%76) 53 (%85,5) 0,139Present 3 (%8,1) 6 (%24) 9 (%14,5)Residue Absent 22 (%59,5) 14 (%56) 36 (%58,1) 0,993Present 15 (%40,5) 11 (%44) 26 (%41,9)Nausea Absent 35 (%94,6) 22 (%88) 57 (%91,9) 0,385Present 2 (%5,4) 3 (%12) 5 (%8,1)Reflux Absent 37 (%100) 25 (%100) 62 (%100) -
T1
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INTRODUCTION. Cytokines play a role in the pathogenesis of sepsis
by mediating the dysregulation of immune response. Omega-3 fatty
acids may exert anti-inflammatory effects, affecting various elements
of inflammation together with proinflammatory cytokines.
OBJECTIVES. The aim of the present study was to investigate the
effects of omega-3 fatty acids on the level of proinflammatory cyto-
kines and survival in a sepsis rat model.
METHODS. In the study, 40 adult Wistar albino rats weighing 300-
350 g were divided randomly into three groups: the Sham Group (n=
10): Tactile stimulation of the intestine and cecum after laparotomy,
the Control Group (n=15): Saline solution (1 mL/kg/day) administered
intraperitoneally for one week before the induction of an abdominal
sepsis model through cecal perforation, and the Omega-3 Group (n=
15): Omega-3 fatty acid lipid emulsion (1 mL/kg/day) administered
intraperitoneally for one week prior to the induction of an abdominal
sepsis model through cecal perforation. After one week period,
serum interleukin (IL)-1, IL-6 and tumor necrosis factor-alpha (TNF-α)
levels were measured prior to surgery (basal value) and 3 hours after
surgery in all groups.
RESULTS. The 24-hour survival rates were 60% in the omega-3 group
and 13.3% in the control group (p=0.008). Serum IL-1, IL-6, and TNF-
α levels were significantly lower in the omega-3 group than in the
control group at hour 3 (p<0.001).
CONCLUSION. We determined the positive effects of omega-3 fatty
acids on proinflammatory cytokine levels, immune response develop-
ment, and survival in experimental sepsis rat model that is consid-
ered to be related to the anti-inflammatory and immunomodulator
properties of omega-3 fatty acids.
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INTRODUCTION. Multiorgan failure is the leading cause of death in
the ICU. The severity of multiorgan failure, as defined by the
Sequential Organ Failure Score (SOFA), as well as increases in SOFA
score are known predictors of death during and after intensive care.
OBJECTIVES. To identify the metabolomic profile at ICU admission
that is related to worsening of multiorgan failure versus improving of
multiorgan failure during early ICU stay.
METHODS. Consecutive patients over 18 years old admitted to the ICU
at the Karolinska University Hospital between September and December
2017 were included if they gave written consent and had no prior
decision of withholding treatment. Plasma was sampled on ICU
admission and analyzed for metabolomics. Liquid-Chromatography Mass
Spectrometry (LCMS) and Gas-Chromatography Mass Spectrometry(GCMS) were used for targeted metabolomics analysis. SOFA scores were
calculated automatically using data from the electronic medical record.
DeltaSOFA was calculated as the difference between the highest SOFA
score on ICU day 2 or 3, and the initial SOFA score. Fisher’s exact test was
used for non-parametric data. T-tests with False Discovery Rate adjusted
P-values and Fold Change Analysis were used to identify compounds that
varied significantly between the two groups. R version 3.5.3 and Meta-
boAnalyst 4.0 were used for all statistical analyses.
RESULTS. From 100 patients, data to calculate DeltaSOFA were
available in 89 patients. Metabolomics data were available for 87
patients, out of which 19 patients had DeltaSOFA≥2. Mortality at 30
days was 5/19 in patients with DeltaSOFA≥2, compared to 2/68 in
patients with DeltaSOFA<2 (p = 0.0049).
A total of 369 metabolites were identified. 17 metabolites were
significantly different at admission between patients with
DeltaSOFA<2 and patients with DeltaSOFA≥2, using a P-value cutoff
of 0.1 and a fold change threshold of 2.
The 17 significant metabolites were classified according to the
Human Metabolome Database (HMDB) (Table 1).
CONCLUSION. Early increase in SOFA score is associated with 30-day
mortality. In this pilot study changes in levels of metabolites of differ-
ent classes at admission are seen in patients with increase of SOFA
score during their early ICU stay, suggesting alterations in multiple
metabolic pathways in parallel. These findings need to be validated
in cohorts with different case-mix and ethnicity.
Table 1 (abstract 000801). See text for descriptionHMBD Class Number of significant metabolitesCarboxylic acids and derivatives 4Steroids and Steroid Derivatives 6Fatty Acyls 3Organooxygen compounds 1Purine Nucleotides 1Other 2000961
Usefulness of modified Nutrition Risk in Criticallly ill score to
determine the risk of malnutrition in ICU patients
S. Canelles1, MC. Gilavert1, M. Cartanyà1, J. Gómez1, F. Esteban1, M. Bodí1
1Intensive care unit, Hospital Universitari de Tarragona Joan XXIII,
Tarragona, Spain
Correspondence: S. Canelles
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000961
INTRODUCTION. The identification of reliable parameters which can
help ICU professionals to identify patients at high risk of malnutrition
could be important in terms of reducing length of stay, mechanical
ventilator days or mortality in ICU. According to the different societies
(European Society for Clinical Nutrition and Metabolism, American
Society for Enteral and Parenteral Nutrition, Society of Crtical Care
Medicine, Canadian Critical Care Nutrition), there is no consensus in
which might be the best values to be included in this evaluation.
OBJECTIVES. Determine whether there are differences between ICU
patients at low against high risk of malnutrition according to
modified Nutrition Risk in Critically ill (NUTRIC) score values.
METHODS. Retrospective study of cohorts carried out in a 30-bed
polyvalent ICU. Inclusion criteria: patients admitted to ICU (May 2018
- March 2019) with nutritional risk calculated. Nutritional risk was cat-
egorized by the modified NUTRIC score (0-4 Low risk; 5-9 High risk).
All data were acquired from our Clinical Information System (Centri-
city Critical Care from General Electric) database through Extract,
Transform and Load processes using Qlik Sense scripts. Statistical
analysis was performed using R (https://cran.r-project.org/), applying
chi² test for categorical variables and the Mann-Whitney U test for
continuous variables. P values < 0,05 were considered significant.
RESULTS. 506 patients out of 865 incomes were included. Median
age 63 (50-73), 64% male, median APACHE II 20 (15-26), median
SOFA 4 (2-6), median length of stay 4,8 (2,6-10,75) days, median days
Page 462 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55of mechanical ventilation 5 (2-13), median days with vasopressors 4
(2-7) and 13.24% of mortality.
High risk of malnutrition was determined in 124 patients. Comparing
the variables obtained between both groups, there were significant
differences in terms of gender, age, days of mechanical ventilation
and days with vasopressors, administered KcaL, length of stay in ICU
and mortality. No differences in days of renal replacement therapy or
administered proteins were found.
CONCLUSION. Modified NUTRIC score could be a good parameter to
identify patients at high risk of malnutrition in the ICU. The detection
of these patients has changed the professionals’ attitude towards the
administered KcaL according to the required needs.
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INTRODUCTION. Vitamin C deficiency is common in critically ill
patients. Vitamin C, the most important antioxidant, is likely
consumed during oxidative stress and deficiency is associated with
organ dysfunction and mortality [1-4]. Assessment of vitamin C
status may be important to identify patients who might benefit
from vitamin C administration. Up to now, vitamin C concentrations
are not available in daily clinical practice. Recently, a point-of-care
device has been developed that measures the static oxidation-
reduction potential (sORP), reflecting oxidative stress, and antioxi-
dant capacity (AOC).
OBJECTIVES. Aim of this study was to determine whether plasma
vitamin C concentrations were associated with plasma sORP and
AOC.
METHODS. Plasma vitamin C concentration, sORP and AOC were
measured in three groups: healthy volunteers, critically ill patients, and
critically ill patients receiving 2- or 10-grams vitamin C infusion. Its associ-
ation was analysed using regression models and by assessment of
concordance.
RESULTS. We measured 211 samples obtained from 103 subjects.
Vitamin C concentrations were negatively associated with sORP (R2=
0.816) and positively associated with AOC (R2=0.842). A high
concordance of 94-100% was found between vitamin C concentra-
tion and sORP/AOC.
CONCLUSION. Thus, plasma vitamin C concentrations are strongly
associated with plasma sORP and AOC, as measured with a novel
point-of-care device. Therefore, measuring sORP and AOC at the
bedside has the potential to identify and monitor patients with
oxidative stress and vitamin C deficiency.REFERENCE(S)
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INTRODUCTION. Lactate is a strong prognostic marker for outcome
of critically ill patients.[1] Metformin-associated lactic acidosis is a
rare but severe complication of metformin therapy. It is unknown
whether the prognostic value of lactate is different among critically
ill metformin users, because metformin may cause elevated lactate
levels in itself.[2]
OBJECTIVES. To determine whether the association between early
lactate level and mortality during critical illness is different in
metformin users compared to metformin nonusers, we conducted
a registry-based cohort study of patients admitted to an intensive
care unit (ICU) with available arterial or venous lactate levels and
extensive data on preadmission drug prescriptions.
METHODS. The cohort study included patients admitted to ICUs in
northern Denmark between 2010 and 2017 with any lactate
measured during the period from 12 hours before until 6 hours after
ICU admission. The association between mean lactate in this period
and 30-day mortality was determined for metformin users and nonu-
sers by estimating hazard ratios (HR) with 95% confidence interval
(95%CI) using Cox regression analysis. The magnitude of effect meas-
ure modification was assessed by calculating the relative excess risk
due to interaction (RERI).[3]
RESULTS. Of 37,293 included patients, 3831 (9%) used metformin at
the time of ICU admission. Median (interquartile range) lactate level
was 1.6 (1.0-2.7) mmol/L in metformin nonusers and 1.8 (1.2-3.2)
mmol/L in metformin users, respectively. Compared to metformin
nonusers with a lactate level of <1.3 mmol/L, metformin users within
the same lactate category had no increased risk to die (HR 0.94,
95%CI 0.78-1.14). Compared to nonusers with a lactate level of <1.3
mmol/L, metformin nonusers with lactate level between 1.3 and 2.0
mmol/L had increased mortality (HR 1.46, 95%CI 1.36-1.57), while this
association was less pronounced in metformin users (HR 1.16, 95%CI
0.97-1.39, RERI -0.24, 95%CI -0.52 to 0.03). Higher lactate categories
were strongly associated with mortality, and the magnitude of effect
measure modification by metformin use increased accordingly.
CONCLUSION. In this large observational cohort of critically ill patients,
increasing lactate levels were strongly associated with mortality.
However, this association was only present at higher lactate levels for
Page 463 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55metformin users compared to nonusers, indicating that the prognostic
value of lactate was modified by metformin use. Therefore, elevated
lactate levels should be interpreted differently in these patients.
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INTRODUCTION. Acid-base status is related to the changes in hydrogen
ion concentration ([H+]), and it is affected by three independent vari-
ables: carbon dioxide, strong ion difference and weak acids (1,2). Re-
cently, unmeasured anions (UAs), which are determined by calculating
strong ion gap (SIG), have also been added as the 4th independent
variable (3). Additionally, they have been mathematically linked to the
total pH (pHtot) (4). However, the effects of independent variables on
pHtot changes have not been made a current issue until now.
OBJECTIVES. We hypothesize that there are nine independent
variables which directly effect pHtot and the sum of the effects of
each of them on [H+] is equal to the pHtot’s deviation from 7.40.
METHODS. The pHtot formula was revised by using 8 independent
variables instead of HCO3;
pHtot ¼ 6:1þ Na‐Clð Þ þ KCaþMg‐Lactate‐ Alb½ ‐ Pi½ ‐UA
0:03 CO2
Delta-pHtot (ΔpHtot) was defined as the pHtot’s deviation from 7.40.
The normal values for Na-Cl difference and albumin were accepted
as 32mmol/L and 42g/L (5). The midpoints of current normal limits
were accepted as normal for K, Ca, Mg, lactate and inorganic phos-
phorus (Pi) (4, 1.22, 0.86, 1.1, 1.2 mmol/L respectively) whereas UAs’
normal value was accepted as zero. According to the pHtot formula,
the deviations from 7.40 caused by every unit change in an inde-
pendent variable were named as its ΔpH while other independent
variables were normal. Every ΔpH formula was obtained from correl-
ation graphs between independent variables’ deviations and ΔpHs
by using Pearson correlation test. This newly created mathematical
model was named as ‘The Partitioned pH Model’ and used in this
prospective observational study.
ΔpHtot ¼ ΔpHCO2þ ΔpH Na‐Clð Þ þ ΔpHKþ ΔpHCa
þ ΔpHMgþ ΔpHLactateþ ΔpH Alb½  þ ΔpH Pi½ 
þ ΔpHUA
All patients over 18 years old who were admitted to ICU were
included. Demographic data, blood gas parameters, and calculated
ΔpHs were recorded. The multivariate linear regression model was
used to detect pHtotal’s independent variables. UAs values of
patients were calculated with two different ways: SIG and ΔpHUA. To
calculate ΔpHUA, the sum of all independent variables’ ΔpHs wassubtracted from ΔpHtot. Pearson correlation test was used for the
correlation between ΔpHUA and SIG.
RESULTS. One hundred and twenty blood gas samples of thirty-one
patients were evaluated. In the multivariate linear regression model,
1mmol/L increase in Na-Cl difference, K, Ca and Mg caused 0.015,
0.018, 0.023, 0.025 increase in pHtot, whereas 1mmHg increase in
carbon dioxide and 1g/L increase in albumin and 1mmol/L increase
in lactate, Pi and SIG caused 0.01, 0.004, 0.017, 0.032, 0.015 decrease
in pHtot respectively (p<0.05 for all). ΔpHUA was significantly corre-
lated with SIG (p<0.001 R2=0.95).
CONCLUSION. The partitioned pH model allows us to discuss the
acid-base status through [H+] changes by separately determining ef-
fects of nine independent variables on ΔpHtot. Hence, the usage of
this model leads us to clearly identify all metabolic components to-
gether with carbon dioxide in critically ill patients.
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INTRODUCTION. Severe liver failure is often accompanied by low
plasma albumin (P-alb). This might in part be caused by poor synthesis
capacity of the liver, but the relation to other indices of compromised
liver function is sparsely investigated in literature.1,2
OBJECTIVES. To study the absolute synthesis rates of albumin and
fibrinogen in patients with advanced liver cirrhosis, Child-Pugh scores B
and C. To correlate these synthesis rates to Child-Pugh and MELD scores,
and to describe albumin pharmacokinetic parameters of distribution.
METHODS. Patients (n=28) were studied while under evaluation for
liver transplantation. Synthesis rates of albumin and fibrinogen, were
estimated by the flooding technique using deuterium labeled
phenylalanine. Plasma volume and transcapillary escape rate of
albumin was assessed by radio iodinated (125I) human serum
albumin.
RESULTS. Albumin absolute synthesis rate was 65 (30-203) mg/kg/day
and was negatively correlated to Child-Pugh (rs = -0.60, p = 0.0008)
and MELD scores (rs = -0.62, p = 0.0005). Fibrinogen absolute synthesis
rate was 12.8 (2.4-52.9) mg/kg/day and correlated negatively to both
Child-Pugh score (rs = -0.47, p = 0.013) and MELD (rs = -0.48, p =
0.010). Spearman rank correlation (rs) between these rates was 0.717
(p<0.0001). Transcapillary escape rate was 6.2 ± 2.1 % per hour, and
plasma volume was 4.3 ± 0.7 L. With a P-alb of 26.5 ± 4.5 g/L, the corre-
sponding intravascular albumin mass amounted to 113 ± 29 g.
CONCLUSION. Worsened liver function was related to lower
synthesis of both albumin and fibrinogen. P-alb was low, but, be-
cause plasma volumes were increased compared to anthropomet-
ric values i.e. an increased volume of distribution, the total
intravascular albumin mass was only slightly lower than normal
values.
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INTRODUCTION. Enteral nutrition (EN) is reported to have several
advantages over parenteral nutrition (PN) in critically ill patients[1,2].
Benefits of EN compared to PN include shorter length of stay (LOS),
improved bowel function and lower incidence of infectious
complications[1,2]. However, the results of previous studies suggest
that there is a gap between prescribed and administered EN [3-5].
OBJECTIVES. The aim of this study was to find out the success rate
and factors associated with inadequacy of EN delivery in mixed
general intensive care unit (ICU).
METHODS. A retrospective single center study of 892 patients with
ICU LOS ≥4 days. The factors associated with adequacy of enteral
nutrition on day 4 were analyzed. These included disease specific
factors, patient related factors, severity of illness and procedural
factors.
RESULTS. Of the 892 patients, 349 (39.1%) had EN success rate of
≥70%, which was associated with lower amount of prescribed enteral
energy (500 kcal [500-800] vs 800 kcal [500-1200], P<0.001), bolus
administration of enteral nutrition (41 of 349 vs 27 of 543, P<0.001),
GI (gastro intestinal) diagnosis OR (1.83 (1.15-2.91), P=0.01), severe
inflammation (CRP≥100) OR (1.42 (1.08-1.88), P=0.01) and surgery on
d4 OR (2.31 (1.12-4.78), P=0.02).
CONCLUSION. In this study we found that in fourth day during ICU
stay discrepancy between prescribed and administered enteral
nutrition was associated to severe inflammation, GI-related diagnosis,
surgical procedures on day 4 and prescription policy. In our study
the patients receiving bolus EN had higher caloric intake and it was
closer to prescribed amount of administered enteral calories com-
pared to those receiving continuous EN infusion.
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INTRODUCTION. Malnutrition is frequent in intensive care unit (ICU)
patients and it is related with higher morbidity and mortality rates,
more risk of infectious diseases and higher costs of illness. In this study,
we aimed to evaluate the effect of frequently used malnutrition scoring
systems on ICU outcome in patients who were consulted to nutritional
support unit (NSU) in tertiary ICU’s of a university hospital.
METHODS. In this study, ICU patients who were consulted to NSU
between 2014-2018 in Gazi University Hospital were enrolled. Rela-
tionship between rates of reaching nutrition targets and clinical out-
comes were evaluated. Nutritional Risk Screening-2002 (NRS-2002)
score, Subjective Global Assesment (SGA) score and Mini Nutritional
Assessment (MNA) score were used to evaluate the nutritional status.
Patients with NRS-2002 score ≥ 3, SGA score < 6, MNA score <11
were accepted as risky for malnutrition. Data about reaching nutri-
tion targets and ICU outcome were evaluated by using univariate
and multivariate analysis.
RESULTS. 757 ICU patients were evaluated for the study. Median age
was 68 [56-80] and 53% of the study patients were male. Detailed
baseline characteristics of the patients were shown in Table-1. The most
common causes of hospitalization were central nervous system diseases
(25%), respiratory system diseases (20%) and malignancies (17%). Fre-
quency of malnutrition risk in study patients was 90% according to NRS-
2002 score, 89% according to SGA and 87% according to MNA score. Tar-
geted calorie levels were reached only in 54% of the patients and tar-
geted protein levels were reached only in 27% of the patients. Target
calorie level was 1700 kcal/day [1500-1851], maximum delivered calorie
was 1470 kcal/day [1240-1729], median delivered calorie was 1002 kcal/
day [800-1100] in study patients. Target protein level was 98 gram/day
[90-109], maximum delivered protein was 70 gram/day [59-90] median
delivered protein was 55 gram/day [32-66]. ICU mortality was 38% in the
study group. There was no significant difference in mortality between pa-
tients who reached to targeted calorie or protein levels and who did not
(p<0.05). When we evaluated the independent risk factors for mortality
with the aspect of nutritional parameters, the strongest independent risk
factor was being under malnutrition risk according to SGA (OR (95% CI):
3.12 (1.34-7.29), p<0.01) score and others were being enterally fed with a
feeding tube (OR (95% CI): 2.57 (1.87-3.51), p<0.01), being under malnutri-
tion risk according to NRS-2002 (OR (95% CI): 1.97 (1.02-3.79), p=0,042),
lover admission albumin level (OR (95% CI): 1.88 (1.42-2.48),p<0.05), being
followed in medical ICU (OR (95% CI): 1.40 (1.01-1.94), p=0.042), higher
admission creatinine level (OR (95% CI): 1.31 (1.16-1.48), p<0.01) and
advanced age (OR (95% CI): 1.01 (1.00-1.02), p<0.01).
CONCLUSION. Malnutrition risk according to SGA score was the
strongest independent risk factor for mortality. However, depending
on complexity of ICU patients, there are many factors effecting their
outcome. Thus, there may be different results about the effect of
reaching nutritional targets alone on outcome and it should be
evaluated along with additional parameters like ICU prognostic
scoring systems.
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INTRODUCTION. Euglycemic diabetic ketoacidosis (euglycemic DKA) is
among side effects of sodium-glucose co-uptake receptor 2 inhibitors
(SGLT2 inhibitor). While the incidence of euglycemic DKA associated
with SGLT2 inhibitors is reported as approximately 0.1%,[1] the exact in-
cidence of euglycemic DKA is unknown during perioperative periods.
OBJECTIVES. The objective of this study is to describe the incidence
of diabetic ketoacidosis caused by SGLT2 inhibitors during
perioperative periods.
METHODS. Patients who received SGLT2 inhibitors within two days prior
to elective surgeries between April, 2014 and March, 2019 were included.
Patients who underwent cardiovascular surgeries using cardiopulmonary
bypass, emergency operations, and those who were on hemodialysis
were excluded. All arterial blood gas samples during the postoperative
ICU stay were analyzed. Blood ketone bodies were not measured for any
of the patients. The primary outcome was the incidence of euglycemic
DKA, which was defined with high anion gap metabolic acidosis (arterial
blood pH< 7.3, anion gap> 12 mmol/L, and PaCO2< 45 mmHg), without
significant hyperglycemia or hyperlactemia (lactate levels < 2.0mmol/L
and glucose <14mmol/L).[2]
RESULTS. Two hundred and forty arterial blood gas samples from
thirty-two patients who received preoperative SGLT2 inhibitors were
analyzed. Six patients (18.5%) had at least one blood gas sample sug-
gesting euglycemic DKA. Off-pump coronary artery bypass grafting
(n=3), lung resection (n=2), and nephrectomy (n=1) were performed
for those six patients, respectively. The minimum arterial blood pH
was 7.252 and the maximum anion gap was 24.0 mmol/L.
CONCLUSION. Postoperative euglycemic ketoacidosis may be common
in patients who take SGLT2 inhibitors preoperatively. Larger studies are
needed to investigate the exact incidence of perioperative euglycemic
ketoacidosis associated with SGLT2 inhibitors.
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INTRODUCTION. Nutritional risk and malnutrition are highly
prevalent among critically ill patients. Screening and assessment
tools used to evaluate nutrition status, composed of subjective data.
Low phase angle (PhA) derived by BIVA associated with higher
severity of malnutrition defined by SGA and NRS2002 in difference
populations, but there was no data in the critical ills.
OBJECTIVES. To assess the relationship between nutritional risk tools
and PhA derived by BIVA in ICU patients, and the association of clinical
outcomes and PhA compared to conventional nutritional risk tools.METHODS. Nutritional risk screenings and PhA (determined by BIVA )
were performed in 64 medical ICU patients (44 male, and 22 female)
within the first 24-hrs of admission. Sensitivity and specificity were
calculated for PhA compared to degrees of malnutrition stratified by
SGA, NRS2002, and NAF. The cut-off values for severe malnutrition
risk were assessed by receiver operator characteristics area under the
curve (AUC).
RESULTS. PhA was lower in more severe malnutrition risk classified
by SGA, NAF, and NRS 2002 (p<0.001). PhA of less than 5.8
correlated with severe malnutrition risk defined by SGA [AUC 0.90,
sensitivity 92% (95%CI:77-98) and specificity 78% (95%CI: 58-92)];
NAF [AUC 0.90, sensitivity 78% (95%CI:87-100) and specificity 92%
(95%CI: 79-97)]; NRS2002 [AUC 0.93, sensitivity 100% (95%CI:16-100)
and specificity 66% (95%CI: 53-78)]. The patients with PhA of less
than 5.8 have higher mortality, prolonged ICU and hospital length of
stay but not statistical significance.
CONCLUSION. PhA has excellent correlation with SGA, NAF, and
NRS2002. It is a useful measure for assessment the patients at risk for
impaired nutritional status in critically ill patients. PhA below 5.8 is
cut - off point for severe malnutrition in our ICU patients.
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INTRODUCTION. Post-operative liver failure (PLF) remains a feared
complication after liver resection. Related to its central role in glu-
cose metabolism, changes in glucose metabolism can be an early
sign of liver failure. The effect of the size of the functional liver
remnant on the early time courses of glucose and insulin require-
ments are unknown.
OBJECTIVES. To determine the early changes in glucose levels
(Glu(t)), and insulin requirements (Ins(t)) after minor, intermediate
and major liver resection. A secondary objective was to compare
those early changes between patients with and without PLF.
METHODS. This is a single centre retrospective cohort (2008-2014) of
all consecutive patients admitted to the intensive care unit (ICU) after
liver resections. In total 382 patients were included. Patients were
classified as “minor” (n=72), “intermediate” (n=183) or “major” (n=127)
liver resection based on a functional liver remnant (FLR) of >60%, 35 -
60% and <35% respectively. Patients with initial portal vein
embolization were excluded. Glucose was targeted at 4 to 8 mmol/L by
a computerized nurse-centered algorithm. Insulin was delivered by con-
tinuous infusion. Insulin resistance, IR(t) was estimated by Glu(-
t)∙(Ins(t)+1) mmol∙IU∙L-1∙h-1. PLF was defined by the ‘50/50 criteria’ [1].
RESULTS. Glucose levels were significantly higher in the patient
group with minor liver resections (P<0.05) from ICU admission up to
5h later. After 15h the opposite occurred when the patients with the
largest resection had the highest glucose levels (P<0.05). Insuline
resistance (IR) was initially lowest in patients with the largest
resection (P<0.05) but 18h after ICU admission IR became lowest in
patients with the smallest resection (P<0.05). Post-operative liver fail-
ure was present in N=27 (7%). For the first 12h the glucose values
(P<0.0001) and IR (P<0.0001) both correlated with PLF.
CONCLUSION. Glycometabolic changes as measured by glucose
levels and insulin requirements are significantly different depending
on the size of liver resection and the post-operative time. Persistent
normal-low glucose levels and low insulin requirements during the
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PLF. With regard to these findings there might be a role for protect-
ive strategies to support the liver in its early postoperative state of
energy crisis and thereby improving its capacity to regenerate and
restore its functions.
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INTRODUCTION. Hyperglycaemia in the critically unwell is oftentimes
due to a stress response and can be compounded by their existing
insulin resistance. Hyperglycaemia is associated with poorer clinical
outcomes but not necessarily causes it. Furthermore strict control
may be more detrimental and put patients at risk of hypoglycaemia
causing seizures, arrhythmias or death. For example, the COITTSS
trial showed no difference between intensive and liberal insulin
therapy. In addition, the NICE SUGAR trial showed a higher mortality
rate and evidence of hypoglycaemia with intensive insulin therapy. A
specific variable rate insulin infusion (VRII) guideline for our ITU is
needed as the patients differ from the other ward patients.
OBJECTIVES. The primary objective was to compare our current
clinical practice against the local unit guidance. Secondly we will use
the results as a baseline for comparison after implementing a new
critical care specific VRII guideline to determine if a quality
improvement has been made.
METHODS. This was an observational study with a retrospective
review of ITU charts.We studied adult patients >16 years old who
had VRII started whilst being an ITU inpatient from Nov 2018-Jan
2019. We excluded patients on the DKA/HHS protocol, peri-op pa-
tients on ‘sliding scales’ or those with overly complicated glucose
control eg necrotising pancreatitis.
RESULTS. 20 patients were included with a median age of 68 (38-78yo)
and average of 4 days of VRII (1-10days). These patients had VRII when
their CBG was >10mmol/L although there was a wide inconsistency of
number of insulin units started; with only 7 patients (35%) having the
correct units/hr as per guidelines. Only 15% of patients had their hourly
CBG check for 4 hours after VRII was commenced. 60% of patients did
not have the recommended CBG check an hour after a rate change.
There was a 15% incidence rate (3 patients) of hypoglycaemia. Overall,
we made a rough estimate of to check patients CBGs were in range of
6-10mmol/L by dividing the number of times their CBGs were 6-10 over
total number of CBG taken whilst on VRII. The result was a mean of
68.6% and median of 72.1%. In addition, there was a T1DM who did
not receive their regular long acting insulin and another T2DM who re-
ceived it after 3 days of VRII.
CONCLUSION. The lack of CBG checks and absence of a clear
guideline could be a strong contributing factor to poor control. We
also expressed strong interest in wanting to know the events leading
to their hypoglycaemia. How low were their CBGs? Were they eating,
on NG feed or TPN? If so were they stopped at any point? Were they
having intravenous fluids or glucose? How was the hypoglycaemia
managed and how quickly did it resolve? These points will be more
closely looked at during the subsequent audit after a few months.
We also recommended HbA1C and ketone testing as well as diabetic
team referral when appropriate. New hyperglycaemia guidelines willbe disseminated to medical and nursing staff via various methods
and reaudited soon. Similar VRII audits of other ITUs can also shed
more light on how we treat hyperglycaemia around the country.
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INTRODUCTION. Hyperbilirubinemia, defined as bilirubin levels ≥ 33
mmol/L, is present in 11–33% of all critically-ill patients and associ-
ated with increased mortality and a greater length of stay in the In-
tensive Care Unit (ICU). (1-3) However, studies investigating
hyperbilirubinemia as an independent predictor of outcome have
yielded conflicting results. (2-4)
OBJECTIVES. This study aims to investigate the association between
early hyperbilirubinemia and 30-day-mortality in a large prospectively
collected cohort in two tertiary ICU's in the Netherlands.
METHODS. This is an unplanned secondary analysis of the ‘Molecular
Diagnosis and Risk Stratification for Sepsis’ (MARS) biorepository.
Patients with measured bilirubin levels within two days after
admission were included, except for patients with liver cirrhosis.
Multivariable logistic regression modeling was used to determine
important characteristics associated with 30-day-mortality and to es-
timate the impact of early hyperbilirubinemia.
RESULTS. Early hyperbilirubinemia was present in 559 (11.9%) of 4836
patients. These patients demonstrated higher rates of organ failure and
mortality compared to patients without hyperbilirubinemia (p < 0.001).
Multivariable logistic regression modelling revealed thrombocytopenia to
be an effect modifier for the association between early hyperbilirubinemia
and 30-day-mortality (p = 0.005). An independent association between
early hyperbilirubinemia and 30-day-mortality was found in patients with
a low platelet count (p < 0.001; Table 1), but not in patients with a normal
platelet count (p = 0.655; Table 2).
CONCLUSION. In this large prospective cohort study, 11.9% of all ICU
patients presented with early hyperbilirubinemia. We found an
independent association between early hyperbilirubinemia and 30-
day-mortality in patients with thrombocytopenia suggesting that this
may possibly be feature of intravascular hemolysis, dyserythropoiesis
or thrombosis in critically ill patients.
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hyperbilirubinemia and 30-day-mortality in patients with a low
platelet count (< 150 x 109/l) (N = 1780)Effect Estimate OR
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CI)p-
valueCrude analysis 0.708 2.03
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INTRODUCTION. Gastro-intestinal bleeding is a common event which
may be so severe to require hospitalization within an intensive care
unit (ICU). Management of patients with an active bleeding depends
on clinical examination and laboratory tests to predict the likelihood
of self resolution, persisting or new episodes of bleeding. Identifica-
tion of high risk patients is often challenging because changes in
clinical signs and tests are delayed. Often the attending physician's
own experience and practice within the institute contribute more to
the final decision than evidence based data.
OBJECTIVES. We sought to develop an artificial intelligence algorithm
aimed at predicting high risk patients for active GI bleeding or
successive re-bleeding. Because the outcome we try to predict (GI
bleeding) was not recorded, blood transfusion was used as a surrogate.
We propose a clinically translatable model trained on a fixed time win-
dow containing the data gathered during the first hours of a patient’s
ICU stay able to predict the likelihood of persisting or progressing GI
bleeding within the subsequent 24 hours.
METHODS. We exploited the publicly available MIMICIII database to
extract parameters and laboratory values of interest for the first ICU
stay per hospital admission of adult non-pregnant patients with diag-
nosed GI bleeding. Extracted parameters were filtered first by clinic-
ally driven hypothesis of relevance and subsequently by data
availability. We attempted to include in our analysis the maximumnumber of observations (patients) available with the lowest missing
features, resulting in 48 clinical, anamnestic and laboratory parame-
ters across 2925 patient ICU stays. Patient observations gathered
within the first 3 to 6 hours of ICU admission were fed into two ma-
chine learning models (Bagged logistic regression and Random For-
est) in order to predict if the patient would subsequently receive a
blood transfusion. The insights of the two models are then combined
together through a weighted average of the predicted probabilities.
All the hyperpameters of our pipeline are fixed through a model
based bayesian optimization procedure and cross-validation.
RESULTS. Results obtained were evaluated based on model accuracy
(number of correct assessments over number of all assessments),
AUC ROC, recall (sensitivity) and precision (true positive rate) across
different time windows of data gathering and prediction time
interval as detailed in table 2. Our best performing model could
successfully forecast 76.09% of patients who would then receive or
not a blood transfusion within 24 hours from data gathered within
the first 3 hours of ICU stay.
CONCLUSION. While our model could be refined and optimized to
incorporate also temporal patterns within the dataset, we
demonstrate a comprehensive application of machine learning
models to address clinically relevant open questions from a publicly
available database.
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INTRODUCTION. Hypertension has long been considered an important
risk factor for aneurysm rupture. Some studies had assessed the impact
T1
Page 468 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55of premorbid hypertension treatment on clinical course, but the data in
the literature assessing the effect of blood pressure on admission is
scarce.
OBJECTIVES. Investigate the impact of the blood pressure on the
first medical contact on clinical course and outcome of patients with
aneurysmal subarachnoid haemorrhage (aSAH).
METHODS. We retrospectively reviewed clinical data of patients
with aSAH admitted to our institution from January 2014 to July
2018. Based on the blood pressure, all patients were divided into
hypertensive group (BP ≥ 140/90mmHg) and non-hypertensive
group (BP <140/90mmHg). Patient characteristics, imaging fea-
tures, clinical complication, and outcome were analysed between
the two groups using STATA 14.0.
RESULTS. A total of 79 patients were included in this study. 67%
were women with a mean age 56.84 (SD 1.58), 53.6% were
premorbid hypertension. 64.6% of aSAH patients were on the
hypertensive group. There was no difference between age, sex or
premorbid hypertension between both groups. Fisher grade 4
was 64.29% vs 46.43%, p 0.25 and Hunt Hess 4 or 5 was 46.43%
vs 37.25%, p 0.43, for non-hypertensive vs hypertensive group.
Neurological complications were vasospasm (21.34% vs 23.53%, p
0.83), hydrocephalus (21.34% vs 23.53%, p 0.83) and rebleeding
(7.14% vs 9.8%, p 0.69). Medical complications as cardiac abnor-
malities (14.29% vs 15.69%, p 0.87) or electrolyte abnormalities
(10.73% vs 11.76%, p 0.88). In-hospital mortality was 32.14 vs
31.37% (p 0.94).
Outcome evaluated at 3 month using the Glasgow Outcome
Scale (GOS) is described in table 1. Difference was not significant,
p 0.30.
Ordinal regression analyses for GOS at 3 months, adjusted by age
and Hunt Hess grade 4 or 5, found no association with the
exception of Hunt Hess grade 4 or 5 itself (OR 0.06, 0.01- 0.28, p
0.00).
CONCLUSION. Non-hypertensive patients had worse grade in the
prognostic scales and higher mortality, but no diferences in out-
come at 3 months. There was no difference on neurological and
medical complications.
Table 1 (abstract 000204). See text for descriptionGOS at 3 monthsNon hypertensive group Hypertensive group1 32.14% 31.37%2 - 7.84%3 7.14% 7.84%4 32.14% 15.69%5 28.57% 37.25%T1000267
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INTRODUCTION. In patients that need of Mechanical Ventilation
(MV) have shown in multiple studies until 80% of neurocognitive
disorders as part of the Post Intensive Care Syndrome (PICS).
OBJECTIVES. Evaluate the association between the changes of PEEP
during MV, cerebral hemodynamic variables and PICS.
METHODS. This is a descriptive observational study, conducted in
patients with MV, evaluated by TCD and TTE, who are assessed
for PICS one month after the discharged from ICU betweenAugust 2018 to January 2019. The inclusion criteria involve all
patients who underwent MV support and complete PICS battery
evaluation. Exclusion criteria were met by any patient who had
been previously diagnosed by neurocognitive disorders or was in
treatment with psychoactive drugs. Head trauma, evidence of
neuroinfectious disease, cardiac arrest, drug dependence or abuse
and history of chronic alcoholism were excluded.
RESULTS. During the study period, 4 patients met the inclusion
criteria of 89 patients admitted to the ICU. They received
mechanical ventilation for 7 days on average. All the patients
had an increase in the CaO2. However, the DO2 Index remained
below normal parameters. In the cerebral hemodynamic variables,
it was observed that the ICP calculated was higher than 14.3 mm
Hg, while CPP was between 52.5 ml and 60.49 mm Hg
respectively. The average SV at the beginning of MV support was
52.5 ml, that later with PEEP change improved. It was also
observed that, with the change of PEEP, the patients presented
an increase above the normal ranges in the average speeds both
MCA (101.3 mm/sec) and the OA (45.23 mm/sec) which could be
due to the increase in MAP and CPP. The mean PI of the MCA at
the start of ventilator support was high (1.40 mm Hg), which
correlates with the transient elevated PIC. All the 4 patients
presented at least one neuropsychological disorder. Only one
patient presented CAM-ICU. The MoCa test was positive in 3 out
of 4 patients. In respect to sleep disorders, 3 of the 4 patients
presented alterations in the subscales of insomnia and hyper
insomnia.
CONCLUSION. These patients had prolonged mechanical
ventilation with an average of 7 days, in which they maintained
a PEEP under 10. They had low levels of DO2 Index and CaO2. In
the 30 days after the ICU discharge, all had at least one
neuropsychological disorder. Even though there are few cases
studied on this research, the context of low O2 contribution to
tissues regardless of the MV support with an increased ACM and
AO velocities, it is possible to infer as a possible cause of brain
damage, causing PICS because of the increase in the PEEP.
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Table 1 (abstract 000267). See text for descriptionParameter Initial PEEP (3 Cm H2O) Final PEEP AV (6Cm H2O)MAP (mm Hg) 74.5 97.8ICP calculated (mm Hg) 14.09 9.41CPP (mm Hg) 60.41 88.39CI (lt/min/m2) 2.63 2.83CaO2 (ml/dl) 14.75 15DO2 Index (ml/min/m2) 387.25 412.5MCA Mean (cm/s) 79.98 101.3OA Mean (cm/s) 30.85 45.23
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INTRODUCTION. It has been established that hypoxanthine, xanthine
and uric acid (UA) are present in the brain, their content changes
after ischemia, UA is the final product of degradation of purines in
the brain, xanthine oxidase (XO) is also present in the brain, catalyzes
the oxidation of hypoxanthine to xanthine, and then to UA, and can
be a source of free radicals, inhibition of XO and exogenous
administration of UA are accompanied by explicit anti-ischemicand
neuroprotective effects in the experiment, whereas endogenous in-
creased production, with "by-product" synthesis of XO free radicals
oxygen reflects the severity of ischemic and reperfusion injury.
OBJECTIVES. Our attention was drawn to the comparative evaluation
of the prognostic value ofimpairments of purine metabolism.
METHODS. We examined 402 patients in the acutest period (1st 7-10
days) of cerebral ischemic stroke at the age of 30-87 years. Patients,
in addition to conventional laboratory parameters, determined the
blood levels of guanine, hypoxanthine, adenine, xanthine and urica-
cid by direct spectrophotometry. Evaluated the effects of the conser-
vation of coma and death following the onset of which drugs are
widely used in intensive neurology.
RESULTS. The most adverse prognostic factors associated with
prolongation sopor or coma are: laboratory - hyperuricemia and
hyperHYPOXANTHINemia. The most favorable prognostic factor,
"countering" the preservation of a coma and the coming of death in
cerebral ischemic stroke is the use of antiplatelet agents.
Hyperuricemia most researchers viewed as an unfavorable
prognostic factor, although intravenous injection of uric acid in acute
cerebral ischemia can improve the results of thrombolytic therapy.
Prognostic value of supranormal blood hypoxanthine level in
contrast to the hyperuricemia has been insufficiently studied.
CONCLUSION. Launched from the development of acute cerebral
ischemia, dynamic control of the blood levels of uric acid and
hypoxanthine to predict its course and outcome.
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INTRODUCTION. Along with the classic triad: edema, proteinuria,
hypertension, many clinicians as an indicator of preeclampsia using
the high content of uric acid in blood serum hyperuricemia. It was
also found that the hypoxanthine, xanthine and uric acid (UA) are
present in the brain, and their content is changed after ischemia,
UA is the endproduct of purine degradation in the brain,xanthine
oxidase is also present in the brain, it catalyzes the oxidation of
hypoxanthine to xanthine, and then in UA and can be a source of
free radicals, inhibition of xanthine oxidase and exogenous
administration of UA accompanied by explicit antiischemic and
neuroprotective effects in the experiment and clinic, while the
endogenous increased its production, with the"side" synthesis of
xanthine oxidase oxygen free radicals, reflects the severity of
ischemic andreperfusion injury. We also know that most fatal path
of pathogenesis (and tanatogenesis) in preeclampsia is the
development of brain stroke.OBJECTIVES. Our attention was attracted by a comparative
assessment of the features of purine metabolism in women with
preeclampsia and acute brain stroke
METHODS. The study involved 33 women with preeclampsia and
350 women in acute period of cerebral stroke, in which, in addition
to conventional laboratory parameters were determined in the blood
and cerebrospinal fluid - guanine, hypoxanthine, adenine, xanthine
and uric acid by direct spectrophotometry.
RESULTS. It was established that between preeclampsia and cerebral
stroke there are clinical and pathobiochemical parallels, including
according to the characteristics of purine metabolism. Hyperuricemia
the most famous and at the same time the most pronounced
adverse metabolic factor (marker or predictor) for preeclampsia, and
for cerebral stroke. High value level of oxypurines (hypoxanthine,
xanthine and uric acid) in the cerebrospinal fluid is good sign for a
stroke, and low value level of oxypurines is good sign for
preeclampsia.
CONCLUSION. Cerebrospinal liquor can be seen not only as a
medium of administration of drugs for spinal anesthesia, but also
and a source of valuable diagnostic (and predictive) information.
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INTRODUCTION. Refractory hyponatremia is intimately related to
condition changes of patients in NICU.
OBJECTIVES. This study was conducted to explore the causes of
refractory hyponatremia in patients with neurologic critical disease.
In order to further improve the level of diagnosis and treatment of
hyponatremia.
METHODS. A retrospective analysis was including 22 patients with
refractory hyponatremia in the Chinese Peoples’ Liberation Army
General Hospital from June 2010 to June 2018. Hyponatremia was
divided into mild, moderate and severe types according to serum
sodium level (mild hyponatremia: 130mmol/L≤ Na+<135mmol/L;
moderate hyponatremia: 125mmol/L≤ Na+<130mmol/L; and severe
hyponatremia: Na+<125mmol/L).
RESULTS. From June 2010 to June 2018, 22 patients in the Chinese
Peoples’ Liberation Army General Hospital were eligible for inclusion
in accordance with the diagnostic criteria of refractory hyponatremia,
including 15 males (68.2%) and 7 females (31.8%). The age ranged
from 20 to 88 years old, with an average age of 55.0±22.0 years old.
The prevalence of young, middle-aged and elderly patients was
40.9%, 18.2% and 40.9%, respectively. Among the enrolled 22 pa-
tients with refractory hyponatremia, 5 were cerebrovascular diseases
(22.7%), 8 were infectious and immunological diseases (36.4%), 3
were peripheral neuropathy (13.6%), 2 were metabolic encephalop-
athy (9.1%), 1 was meningeal cancer (4.5%), 1 was leukoencephalo-
pathy (4.5%) and 1 was neurodegenerative disease (4.5%).
Furthermore, mild hyponatremia occurred in 1 case (4.5%) with cere-
bral infarction, moderate hyponatremia in 11 cases (50%) with most
of which are cerebrovascular disease, and severe hyponatremia in 10
cases (45.5%) with most of which were tuberculous meningitis, men-
ingeal carcinomatosis or central pontine myelinolysis. The primary
causes of refractory hyponatremia were infection and neuroimmune
diseases (53.8%) in young and middle-aged patients, while cerebro-
vascular diseases (44.4%) were the main causes of refractory hypona-
tremia in elderly patients. Meanwhile, 0 (0%), 6 cases (46.2%) and 7
cases (53.8%) were found to have mild, moderate and severe hypo-
natremia in young and middle-aged patients, and 1 case (11.1%), 5
cases (55.6%) and 3 cases (33.3%) in elderly patients, respectively.
The average hospitalization time of patients with moderate
Page 470 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55hyponatremia in the NICU was 40.33±46.38 days, and that was
67.75±111.57 days in patients with severe hyponatremia.
CONCLUSION. The prevalence rate of refractory hyponatremia is
higher in patients of NICU. Cerebrovascular disease is the first cause
of hyponatremia in elderly patients, while intracranial infection,
especially tuberculous meningitis, is the most common pathogenic
factors in young and middle-aged patients. Furthermore, in patients
with high intracranial pressure, high doses of dehydrating drugs for
sodium excretion may aggravate the degree of refractory hyponatre-
mia and prolong the treatment duration of hyponatremia. In clinical
practice, early detection of hyponatremia and active formulation of
reasonable sodium supplementation therapy can reduce the length
of stay in hospital for patients.
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INTRODUCTION. Neurocritical care is a subspecialty of critical care
medicine that focusses on the evaluation, diagnosis, and management
of patients with acute life-threatening central nervous system dis-
eases.(1,2) Because of their complexity, neurocritical patients needs spe-
cific continuous monitorization, to allow their recovery.
OBJECTIVES. To evaluate the influence of neuromonitoring in the
outcome of neurocritical patients
METHODS. An observational retrospective study included 90
neurocritical patients in our intensive care unit (ICU) during the year of
2018. Collected variables included age, gender, diagnoses, severity scores
(APACHE, SAPS, initial SOFA), in local Glasgow coma score (GCS), hospital
admission GCS, Marshall, Hunt & Hess scale, Fisher scale, National
institute of Health stroke scale (NIHSS), intracranial pressure (ICP) at ICU
admission, time with ICP>24 in the first 72h after ICU admission, mean
ICP during ICU stay, doppler variables in the first 24h of ICU stay (middle
cerebral artery (MCA) blood velocity and pulsatility index) and Glasgow
Outcome Scale (GOS) at ICU discharge and after 1 year from discharge.
RESULTS. Ninety neurocritical patients were included: traumatic
brain injury (TBI) (49), aneurism (28) of which 27 had subarachnoid
haemorrhage, stroke (10) and arteriovenous malformation (3).45,5%
of the TBI population present Marshall scores of 4 and above. We
found no statistical significant association between in local and
hospital GCS, Marshal scale, mean ICP at ICU admission, time with
ICP>24 in the first 72h after ICU admission, mean ICP during ICU stay
and GOS at the moment of ICU discharge and GOS 1 year after
discharge. In patients with aneurism, in local and hospital GCS, Hunt
Hess scale, Fisher scale, time with ICP>24 in the first 72h after ICU
admission, mean ICP during ICU stay and doppler variables in the
first 24h of ICU stay were not statistically significantly associated with
GOS at ICU discharge and GOS 1 year after discharged.
CONCLUSION. Neuromonitoring was not statistical significantly
associated with outcome in the group of patients included in the
present study. Several limitations must be acknowledged: the
retrospective character of the study which implies that important
data may have not be included, namely doppler records. Our sample
needs to improve in order to make more robust conclusions.REFERENCE(S)
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INTRODUCTION. To evaluate patients admitted to ICU diagnosed
with spontaneus supratentorial intracerebral hemorraghe and
intraventricular hemorraghe,in terms of functional situation and it’s
relation to surgical intervention.
METHODS. Patients with spontaneus supratentorial intracerebral
hemorraghe who were admitted to ICU during 2009-2012 in
three different spanish hospitals with Neurosurgery Services, had
been studied. Effect of surgical intervention in patients with intra-
ventricular hemorraghe had been studied. Using a propensity
index, 26 patients who had undergone surgery were paired with
26 who had not.
RESULTS. 163 patients were admitted with spontaneus supratentorial
intracerebral hemorraghe and intraventricular hemorraghe. This
patients presented at admisssion a 8+4 in Glasgow, 21.42+7.55
points in APACHE-II, and 2.75+0.9 score in ICH with a 65% predicting
mortality(30 days) and a 59.5% mortality( 30 days). 13.5% presented
non-reactive bilateral midriasis. 23.3% of patients (N=38) were surgi-
cally intervened. Mortality of patients intervened was 34.2% and
67.2% (p<0.001) for patients who were not intervened. In the multi-
factorial analysis OR for surgical intervention was 0.14(0.05-
0.41).Afterwards a pairment of 26 surgically intervened patients with
other 26 non-intervened in relation to a propensisty index had been
done. This index was calculated in relation to age, presence of pu-
pilar abnormalities, hemorraghe size and location, and Glasgow at
admission. Patients intervened and not intervened presented similar
carachteristics (age, Glasgow, ICH score, APACHE II, hemorraghe volu-
men and location) and non of them presented non reactive bilateral
midriasis at admission. Hospital mortality of patients surgically inter-
vened was 30.8% and 65.4% for patients not intervened (p=0.001)
and OR 0.23; CI:95%: 0.07–0.75.After 5 years of admission from the
52 paired patients, 20 of them were still alive, 29 no survived and 3
were missing (1 was surgically intervened and 2 of them were not).
From the 25 who were intervened, 14 were still alive (56%) and from
the 24 not intervened 6 were still alive (25%) (p=0.027) OR =0.26
(0.08-0.89).For the 14 patients intervened who were still alive, the
functional situation evaluated with Barthel index was 38+38 points;
and for the 6 patients who were not intervened presented a 54+39
puntos, (p=0.403) in the Barthel index. For he 25 patients surgically
intervened, 5 (20%) were still alive and presented a slight depend-
ence (Barthel >60) and for the 24 non intervned, only 2 (8.3%) were
still alive and presented a slight disfunction (p=0.245)
CONCLUSION. Patients admitted into ICU with spontaneus
intracerebral hemorraghe with ventricular involucration who were
surgically intervened presented less mortality after five years in
comparision to the ones who were not intervned. In the other
hand, survivors presented a poor functional situación with a high
dependence degree.
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INTRODUCTION. Whereas diabetes mellitus is a clearly risk factor for
the occurrence of stroke and for its poor prognosis, hyperglycemia
without pre-existing diabetes mellitus is also linked to increased mor-
tality and morbidity in stroke patients.
OBJECTIVES. To assess the role of glyemic control in influencing
stroke outcome regarding duration of hospital stay, motor deficit,
hemorrhagic transformation and mortality.
METHODS. This retrospective study was conducted in Elzaiton
Specialized Hospital from June 2016 to June 2017. A sample size of
80 subjects achieves nearly 90% power to detect this difference.
Inclusion criteria
 Age: 40-70years
 Sex: Any sex
 Patients with acute ischemic stroke without other major
comorbidities within 24 hours of onset of symptoms.++
On ICU admission the random blood sugar was recorded and
categorized to less than 150mg/dl (accepted) and more than
150mg/dl (not controlled). Also serial Random blood sugar daily
was recorded and categorized to good control if less than
150mg/dl and poor control if more than 150mg/dl.
Patients were divided into 2 groups ( 40 patients each group)
(A) Patients with accepted random blood sugar on admission and
controlled blood sugar during hospital stay
(B) Patients with increased random blood sugar on admission and
poor blood sugar control during hospital stay
RESULTS. A total of 80 patients were enrolled in the study. There
were no significant differences regarding gender, HbA1C%, body
mass index (p=0.654), (p=0.114),( p=0.381) respectively between
both groups, but poor control group showed significantly higher
age, random blood sugar on ICU admission and during hospital
stay and longer duration of hospital stay (p <0.001), (p<0.001), (p<
0.001), (p=0.022) respectively. Comorbidities (p =0.007),
hemorrhagic transformation (p = 0.048) and 30 days mortality (p <
0.001) were significantly higher in poor control group. Glascow
coma score on ICU admission and on discharge, motor power on
ICU admission and on discharge (p < 0.001), (p= 0.044), (p <
0.001), (p=0.015) respectively showed significantly higher values in
good control group.
CONCLUSION. Hyperglycemia is common among acute stroke
patients and is associated with less favorable outcomes regarding
mortality, hospital stay and functional outcome, euglycemic control
is recommended for those patients.Fig. 1 (abstract 001029). Respiratory parameters before and after
esophageal catheter replacement and titrating PEEP according to
transpulmonary pressure measurement. Circles represent mean
values and lines represent 95% confidence intervalsREFERENCE(S)
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INTRODUCTION. Determining and setting the optimal and safest PEEP
levels in overweight and obese patients (body mass index>25) can be
challenging for the ICU physicians. Real time transpulmonary pressure (Ptp)
measurement by an esophageal balloon catheter and titrating PEEP levels
according to the end expiratory Ptp shows promising results in these
patients (1,2,3).
OBJECTIVES. To assess the feasibility and effect of Ptp guided PEEP
titration in overweight and obese patients.
METHODS. An esophageal balloon catheter (Cooper Surgical Inc,
Trumbull, CT, USA) was inserted to monitor the esophageal pressure in
overweight and obese patients under invasive mechanical ventilation.
Patients were connected to a ventilator capable of monitoring airway,
esophageal and transpulmonary pressure waveforms real time breath-by-
breath (Hamilton G5, Hamilton Medical AG, Bonaduz, Switzerland). PEEP
levels were adjusted to achieve a Ptp 0 to 10 cmH2O at end expiration.
RESULTS. Eleven patients were enrolled. Data are expressed as mean±SD
and comparisons were done using paired sample t-test. Mean age was 49±
21 years and body mass index was 29±4 . PEEP was increased to 20 ± 5 from
10±4 cmH2O after titrating PEEP according to the Ptp at end expiration (p=
0.001). This also led to a significant improvement in PaO2/FiO2 ratio (from
86±25 to 220±86 , p= 0.001) and allowed a significant decrease in FiO2 levels
(from 0.9±18 to 0.67±25, p=0.008). Arterial pH increased from 7.33±0.16 to
7.40±0.10 (p =0.042) and PaCO2 decreased from 54±18 to 44±9 mmHg (p=
0.08).
CONCLUSION. Ptp guided PEEP titration can be effective and safe
especially in overweight and obese patients who are in need of high
PEEP levels.
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Fig. 2 (abstract 001029). Representative waveforms of a patient
before and after PEEP titration according to transpulmonary pressure
measurement.
Fig. 3 (abstract 001051). See text for description
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INTRODUCTION. Frailty is an independent predictor of short and
long term mortality in patients admitted in intensive care unit (ICU).
OBJECTIVES. Describe the impact of frailty at 30 days (30-d) mortality
from ICU admission in patients who underwent tracheostomy.
METHODS. Observational retrospective study from May 2014 to
October 2018; patients who underwent tracheostomy in ICU were
included. Exclusion criteria: patients with tracheostomy before ICU
admission and re-admission patients. Demographic (age, gender) clin-
ical (co-morbidity), IMV, tracheostomy, ICU and hospital length data,
were collected. To assess de frailty we used Clinical Frailty Scale (CFS)
(fragile: CFS ≥ 5). We describe qualitative variables as frequency and
percentage; and continuous variables as mean ± SD or median, and
interquartile range. We compared percentages using chi-square or
Fisher test, and continuous variables with t-Student or U Mann-Whitney
tests. Survival was described with the Kaplan-Meier technique (long-
rank) and with multivariate Cox proportional-hazard models, adjusted
by age, gender, co-morbidities, APACHE II (without age), re-intubation,
% of time in IMV, day of tracheostomy, disconnection from the IMV
and discharge from ICU without tracheostomy.
RESULTS. Of the 2630 patients admitted to ICU, 105 were analyzed;
16.2% were fragile (Figure 1). Median age 69.9 years (IR: 62.0-77.3) and
71.4% males; median APACHE II 23.0 (17.0-28.0). There were no
significant differences in age, gender, co-morbidities, severity scores,
variables related to IMV or tracheostomy. Frailty patients had signifi-
cantly shorter time in IMV (p=0.038). Survival analysis showed a higher
probability of 30-d mortality in frailty patients (long-rank=0.018) (Figure2). Multivariate analysis showed fragility as independent predictor fac-
tor of 30-d mortality (OR 3.80; IC 95% 1.59 – 9.12; p= 0.003)
CONCLUSION. There were no differences in characteristics and
management between frailty and non-frailty patients whom tracheot-
omy were made during ICU stay. Time of IMV in frailty patients, was
probably shorter because they died earlier. Frailty is an independent
predictive factor of 30-d mortality in patients who need tracheos-
tomy during ICU admission.
Table 1 (abstract 001051). See text for description
Table 2 (abstract 001051). See text for description001054
Effect of Anti-IL-33 treatment in a murine model of Acute
Respiratory Distress Syndrome
R. Muñoz-Bermúdez1, J. Marin-Corral1, I. Dot Jordana1, A. Salazar-
Degracia1, O. Roca2, L. Pijuan3, G. Tagmouti3, JR. Masclans1
1Critical care department, Hospital del Mar, IMIM-GREPAC, Barcelona,
Spain; 2Critical care department, Vall d´Hebron University Hospital, Vall d´
Hebron Research Institute, Barcelona, Spain; 3Anatomic pathology
department, Hospital del Mar, Barcelona, Spain
Correspondence: R. Muñoz-Bermúdez
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001054
INTRODUCTION. Acute respiratory distress syndrome (ARDS) is
characterized by pulmonary edema due to alveolar epithelial-interstitial-
F2
F2
Fig. 1 (abstract 001055). Note: In SP interaction between PEEP and
delta Ppl in both INSP and EXP (p < 0001), in PP no statistical
interaction. Gradient Ppl =Ppl ventral -Ppl dorsal (in absolute value).
Fig. 2 (abstract 001055). Note: Regional Vt calculated from
EIT(quadrant). Both SP and PP have interaction with PEEP (p < 0001).
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dysfunction. The IL-33/ST2 axis has a key role in the development of
immune-inflammatory responses in the lung.
OBJECTIVES. To assess the anti-inflammatory and restorative capabil-
ities of using Anti-IL33 antibody to alleviate the pathological events oc-
curring in a murine lipopolysaccharide (LPS)-induced lung injury model.
METHODS. Eight to tenweeks-old male BALB/c mice (Harlan, Horst, The
Netherlands) were used for the experiments (IRB: JME-16-0025). All mice
were anesthetized with 2% isoflurane and challenged with a single intrana-
sal instillation of 8 mg/kg of LPS (E. coli 055:B5:Sigma-Aldrich) dissolved in
50 μl of PBS (ARDS group), or administered 50 μl of PBS alone (control
group) on day 0. Day 1, 2 and 3, mice received 3,6μg/day intraperitoneally
Anti-IL-33 (treatment group), orintraperitoneally saline (placebo group). The
following groups of mice were studied: 1) Control group (n=12) with non-
ARDS controls+placebo (n=6) and non-ARDS controls + Anti-IL33 (n=6), 2)
ARDS + placebo (n=12) and 3) ARDS + Anti-IL33 (n=12).Body weight gain
was registered and bronchoalveolar lavage and blood samples were recol-
lected. Cell count, total protein levels, IL-33 (Abnova, Walnut, CA, USA) and
IL-6 (Cloud-Clone Corp, Katy, TX, USA)levels were measured in BAL fluid.IL-33
levels were also measured in blood samples. Histological evidence of lung
injury was assessedthrough previous methodology (histological parameter
scoring)1 and wet-to-dry lung weight ratio was also evaluated in some ani-
mals.The data was expressed as mean (standard deviation) or as median
(interquartile range). Significance was set to p <0.05. Statistical analyses were
performed using Portable SPSS, PASW Statistics v18.0; SPSS Inc, Chicago, IL.
RESULTS. There were no differences in any studied variables between
non-ARDS controls + placebo and non-ARDS controls + Anti-IL33 and
therefore they were analysed together as a control group. Both ARDS
groups presented a decrease in the body weight gain and an increase in
the wet-to-dry lung weight, neutrophil percentage in BALF, protein levels
in BALFand alveolar space polymorphonuclear cells (PMN) in the histologic
evaluation compared with control group. ARDS + placebo group pre-
sented higher levels of IL-33 and IL-6 in BALF, and histologic interstitial
space PMN and proteinaceous debris compared with control group. ARDS
+ Anti-IL-33 mice presented a decrease in the wet-to-dry lung weight
[0.13(0.02) vs 0.16(0.02);p=0.024], in the BALF neutrophil percentage
[63.1(52.6-68.1) vs 69.4(67.4-71.1);p=0.038], interstitial space PMN [0.4(0.5)
vs 1.1(0.4);p=0.015] and proteinaceous debris [0.3(0.4) vs 1.1(0.7);p=0.022]
in the histologic evaluation compared to ARDS + placebo group.
CONCLUSION. Anti-IL-33 treatment could partially restore the acute
histopathological and biochemical changes occurring after endotoxin
challenge. Anti-IL-33 antibody could have a therapeutic potential for
ARDS but further studies will be necessaries in the advance toward
clinical applications
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INTRODUCTION. Prone position (PP) is a cornerstone in the treatment of
acute respiratory distress syndrome (ARDS) increasing oxygenation and
protecting the lung against ventilator induced lung injury (VILI). Its
precise mechanism of lung protection, interaction with PEEP and the
regional mechanical response of the respiratory system care still lacking.
OBJECTIVES. To assess the changes in pleural pressure gradient,
ventilation homogeneity and regional respiratory mechanics at
different PEEP levels, during supine and prone positioning.METHODS. Twelve pigs (weight 36.1 ± 1.9 Kg) were anesthetized and
mechanical ventilated. Catheters were inserted into dorsal and ventral
pleural space to obtain a direct measurement of regional pleural pressure
(Ppl), PA catheter, an esophageal balloon and an EIT belt were added.
Lung injury was established with saline lavages to obtain a PaO2 <
100mmHg followed by high-stress ventilation until a decrease in respira-
tory system compliance (Crs) by 20%. After a recruitment manoeuvre
(RM) each animal underwent a decremental PEEP protocol (PEEP from 20
to 3 cmH2O, steps of 1cmH2O every 5-6 breaths, volume control, 6 ml/
kg) in both SP and PP. At every level of PEEP, Plateau pressure, Pes,
regional Ppl (dorsal & ventral), and EIT were measured. Vertical gradient
of Ppl, distribution of ventilation, compliance (respiratory system, lung
and chest wall; total & regional) were calculated.
RESULTS. PP induces a uniform vertical Ppl gradient (Ppl ventral – Ppl
dorsal) during expiration and inspiration (i.e. maintains lung
homogeneity) and is PEEP independent. Whereas, in SP vertical gradient
of Ppl is PEEP dependent (Fig.1). Lower PEEP distributes VT toward non-
dependent regions; in SP more than PP. At lower PEEP levels, vertical gra-
dient of ventilation (VT dependent – VT non-dependent) is lower in PP.
Levels of PEEP required to achieve the best regional lung compliance
(CL) in dependent and non-dependent lung was congruent in PP (13 and
12cmH2O respectively) compared to SP (15 and 10 cmH2O respectively).
CONCLUSION. The vertical Ppl gradient across the lung is stable
during PP i.e. not affected by both high (overdistension) or low
(collapse) PEEP. Thus, lung homogeneity is maintained as reflected
by homogenous regional ventilation, stable gradient of ventilation
and more uniform best PEEP for regionals CL.
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Fig. 2 (abstract 001058). See text for description
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INTRODUCTION. Reverse triggering (RT) is a type of patient-
ventilator interaction where respiratory muscle contractions are trig-
gered by the ventilator under different patterns of entrainment. Be-
cause it occurs during expiration, RT may potentially cause eccentric
myotrauma while on the other hand it could protect the diaphragm
from atrophy. The impact of RT on diaphragm function remains
uncertain.
OBJECTIVES. To establish the effect of RT in comparison to passive
ventilation on diaphragm function in an experimental model of
acute lung injury.
METHODS. Sixteen pigs (35±5kg) were anesthetized, mechanically
ventilated, and monitored. Lung injury was induced by surfactant
depletion and high-stress ventilation to reach PaO2 <150 mmHg
and 10% decrease in respiratory system compliance. After lung
injury, recruiting maneuver and baseline measurements, pigs
were randomized to receive either passive ventilation (n=8; VCV;
RR: 35 bpm; VT: 10ml/kg), or ventilation adjusted to induce RT
(n=8; VCV; variable RR and VT), for 3 hours. Based on preliminary
experiments, we induced RT by stepwise changes in the following
settings: (1) decreasing VT and increasing RR; (2) decreasing dose
of sedatives; (3) increasing PEEP. Diaphragm function was
assessed by measuring transdiaphragmatic pressure (Pdi) during
phrenic nerve stimulation by single electrical twitches (PdiTw)
and at different stimulation frequencies (10, 20, 30, 40 and 60
Hz) to construct force/frequency curves. PdiTw and Pdi,max after
1, 2, and 3 hours of ventilation was compared to baseline PdiTw
and Pdi,max, respectively. Finally, we conducted a post-hoc ana-
lysis in the RT group based on the level of respiratory effort
[average Pes swing > 10 cmH2O and 1:1 entrainment (n=4) vs.
Pes swing <10 cmH2O and 1:2 entrainment (n=4)].
RESULTS. The RT group had lower VT, higher RR, and higher PEEP
level as compared with the passive group. There was no
difference in PaCO2 but a higher PaO2 with RT. PdiTw ratio and
Pdi ratio were not different between groups but a post- hoc
analysis showed that in the RT animals with high respiratory
effort (n=4), PdiTw and Pdi,max was reduced by 25%. Decrease
in diaphragm force was significantly different than both passive
and RT with low respiratory effort (Figure 1)
CONCLUSION. Reverse triggering might acutely impair diaphragm
strength, and this effect seems to be modulated by the level of
respiratory effort.
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INTRODUCTION. Esophageal pressure (Pes) measurements are
increasingly used as state-of-the-art monitoring technique in venti-
lated ICU patients. To validate the position and filling volume of the
esophageal balloon, the Baydur maneuver is performed. An expira-
tory hold is applied for at least one breath, during which the ratio of
airway pressure (Paw) and Pes is measured. Pes measurements are
considered reliable when the Paw/Pes ratio has a value between 0.8-
1.2.[1] However, it is unknown if a shorter expiratory hold could be
sufficient for validation of the Pes measurements. This would be
beneficial as it is less uncomfortable for patients and might allow
near continuous calculation of this ratio by the ventilator in the
future.
OBJECTIVES. To determine the minimal duration of an expiratory
hold in patients on partially-supported modes of ventilation in order
to obtain a reliable Paw/Pes ratio.
METHODS. Expiratory hold maneuvers were performed in ICU patients
with an esophageal balloon catheter (Nutrivent®, Sidam Italy), ventilated in
a partially supported mode. A continuous ratio between Paw and Pes was
calculated offline. Subsequently, it was determined how many
milliseconds (ms) after the start of patient effort the Paw/Pes ratio reached
the reliable range of 0.8-1.2 and stayed stable for 40ms thereafter (Fig. 1).
RESULTS. We analyzed 86 Baydur maneuvers obtained from 10
different patients. The Paw/Pes ratio reached the reliable range
of 0.8-1.2 after a median time of 200ms [IQR 94-384ms] after the
onset of patient effort.
CONCLUSION. In 75% of the maneuvers, a reliable and stable
Paw/Pes ratio can be obtained 384ms after onset of patient
effort. Therefore, we advise that an expiratory hold should have a
minimal duration of 430ms after onset of patient effort.
Implementation of automatic expiratory occlusions within the
ventilator software enables a continuous verification of
esophageal balloon measurements, increasing its clinical value.
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Fig. 1 (abstract 001060). Airway pressure (Paw), esophageal
pressure (Pes) and the Paw/Pes ratio during one expiratory hold. The
blue asterisks show the onset of patient effort. The green lines show
the period of time that the Paw/Pes ratio is in the reliable range of
0.8-1.2. The red cross indicates the first moment when the ratio was
stable in the reliable range for at least 40ms. Per expiratory hold
maneuver the time between the blue asterisk and red cross is
calculated.
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INTRODUCTION. Intraoperative support by extracorporeal membrane
oxygenation (ECMO) is widely used during lung trasplantation (LT)
for cardiac, respiratory or both type of failure. Compared to
cardiopulmonary bypass (CPB) ECMO is simplest, lower priming
volumen, lesser anticoagulation requirement, lower coagulopathy
and systemic inflammatory response. At our institution, CPB has
been replaced by ECMO in this setting. Nevertheless, bleeding is an
important complication in these patients.
OBJECTIVES. To describe demographic characteristics, ECMO
indications, technical aspects, type of membrane oxygenation, ECMO
weaning and mortality in LT patients with intraoperative support by
ECMO and perioperative bleeding.
METHODS. Descriptive study between Juin 2009 to March 2019 in 12
beds ICU. Inclusion criteria for ECMO entry were cardiac failure (left,
righ or both), severe pulmonay hypertension and/or respiratory
failure before or during LT proceeding. ECMO systems have
centrifugal pumps and polimethilpentene or polypropylene
membrane oxygenation. Demographic data, APACHE II, type of
ECMO support, thoracic bleeding, anticoagulation practice, ECMO
weaning and ICU survival were collected.
RESULTS. ECMO support was used in 49 patients (p). In 35p
(71.4%) ECMO was used for intraoperative support. In this group,
APACHE II was 21.3 (12-29); 51.4% (18p) were woman with a
median age of 49.7 years (rank 16-63). Pulmonary fibrosis was
the most common disease for LT in this entity in 13 p (37.1%),
COPD/emphysema in 5 p (14.2%), primary pulmonary hyperten-
sion in 4 p (11.4%), QF in 3 p (8.5%). Type of ECMO support was
VA in 28 p (central 9p, peripheral 19p) and VV in 7p. Cardiac
support was needed in 22p, respiratory in 7p and both in 7p.
ECMO was weaned at the operating room (OR) in 51.4% (18p).
Massive bleeding was present in 17p (48.5%), needing toracot-
omy in 10p (58.8%). Polypropylene membrane was used in 12 of
them (70.5%). Only 6p (35.29%) in this group was weaned at the
OR. Anticoagulation during lung transplanation was used in all
patients during LT, but 5p (29.41%) didn´t receive anticoagulation
at the ICU. Thrombotic complications were not seen. ICU mortal-
ity in patients with massive bleeding was 35.2% (6 p).
CONCLUSION. In patients with ECMO as intraoperative support,
massive bleeding was present in 48.5% of patients with a ICUmortality of 35.2%. Anticoagulation regimen and type of oxygenator
must be reconsidered.
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INTRODUCTION. Spontaneous breathing has been suggested in ARDS
patients on ECMO to prevent diaphragm dysfunction. However, the use
of spontaneous breathing is controversial in severe ARDS as it may
promote further lung injury.
OBJECTIVES. To compare the effects of spontaneous breathing
versus controlled near-apneic ventilation, on lung injury and dia-
phragm structure, in a porcine severe ARDS model assisted by ECMO.
METHODS. Twelve pigs (30±5kg) were anesthetized, mechanically
ventilated and monitored. Lung Injury was induced by repeated lavages
(30 ml/kg of warm saline) until PaO2/FiO2 dropped below 200, followed
by 2-h injurious ventilation (PEEP 0 cmH2O, PInsp 40 cmH2O, RR 10/min).
After completing lung injury (T0) animals were connected to ECMO. Dur-
ing the first 3 hours, animals were ventilated with near-apneic ventilation
(PEEP 10, driving pressure 10, RR 5/min) and NMB. After T3, animals were
randomized into 2 groups: i) Near- apneic ventilation, which continued
with the same settings, and ii) SB: in this group, NMB was stopped and
sweep gas flow decreased until regaining respiratory efforts. Thereafter,
ventilation was switched to PS mode (PS 10 cmH2O, PEEP 10 cmH2O)
and sweep gas flow adjusted preserving SB at a respiratory rate of 30 to
70 bpm. ECMO weaning started in both groups at T18, sweep gas flow
was stopped and animals ventilated in PS mode (adjusted to Vt=6 ml/kg)
until T24. Respiratory and hemodynamic variables, as well as regional
lung impedance, were collected. After 24 hours, animals were euthanized
and tissues extracted (lung and diaphragm). Lung edema was estimated
by the wet-dry weight ratio. Lung injury and muscle morphometrics were
assessed by histological analysis.
RESULTS. Although the SB group developed higher respiratory rates
and minute ventilation, at T18 both groups exhibited similar
oxygenation and systemic hemodynamics. At T18, all animals
regained spontaneous efforts and could be weaned from ECMO
without hemodynamic or respiratory deterioration, and with no
differences in the breathing pattern (Table 1). No differences were
observed in lung wet/dry weight ratio, cytokines concentration in
lung tissues or in the histological lung injury score (Fig 1).
Quantification of cross-sectional area showed that slow- and fast-
Page 476 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55twitch diaphragm muscle fibers in SB group were smaller (near-ap-
neic ventilation vs SB, fast: 662.9 ± 9.2 vs 460.7 ± 7.4 μm2; slow:
583.1 ± 10.7 vs 356.7 ± 5.6 μm2) (Fig 2). The fraction of each type of
fibers did not differ between groups.
CONCLUSION. We found no differences between SB and Near-apneic
ventilation in lung injury and lung function, but the SB group exhib-
ited smaller slow- and fast- twitch diaphragmatic fibers.
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Fig. 1 (abstract 001085). Histological assesment of lung injury.(A)
Representative images of lung histology for each group (original
magnification: 10x hematoxilin and eosin). Images of both, near-
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similar diffuse alveolar; (B) Quantative score for lung injury (from 0 =
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Fig. 2 (abstract 001085). (A) Immunohistochemically stained cross-
sections of diaphragm muscle fiber biopsies in experimental groups
by fiber type. Original magnificatio: 20x. Red: wheat germ agglutinin
indication membranes. Green: Myosin heavy chain antibody specific
for fast - and slow-twitch fibers.(B) Diaphragm fiber cross-sectional
area (μm2) in slow- and fast-twitch fibers by group, CSA: cross-
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INTRODUCTION. The intravenous agents used for induction of
general anesthesia prior to intubation in ICU are either propofol,
ketamine or etomidate. Their choice depends on indications,
risks, benefits and preferences without clear superiority among
them.
OBJECTIVES. To evaluate the association between agents used for
endotracheal intubation and ICU and hospital outcomes in critically
ill patients.
METHODS. Retrospective single-center cohort study of consecu-
tive adult critically ill patients who were given a single anesthetic
agent (propofol, ketamine or etomidate) for endotracheal intub-
ation in all ICUs of a tertiary center between January 01, 2012
and December 31, 2017. Cardiac arrests and lack of research
authorization were excluded. Primary outcomes were ICU and
hospital mortality. Second outcomes were ICU- and hospital-free
days through 28 days. An inverse probability of treatment
weighed approach was used to compare treatments; multiple im-
putations were used for missing data. The propensity score was
estimated using a generalized logit model as a function of pa-
tient characteristics: age, sex, BMI, admission source, ICU location,
readmission status, length of ICU stay prior to intubation, and
acute physiology score. Mortality outcomes were assessed with
weighted logistic regression and –free days assessed by weighted
linear regression.
RESULTS. The analysis included 2,673 patients, 962 (36%)
received propofol, 792 (30%) received ketamine and 919 (34%)
received etomidate. Overall ICU and hospital mortality were 19%
and 29% respectively and lower with propofol than with
ketamine or etomidate, 13, 22, 23% and 23, 32, 32% for each
drug respectively. Compared with propofol, patients inducted
with ketamine had higher odds of ICU mortality (Odds Ratio; 95%
CI; p-value) (1.45; 1.07, 1.94; p=0.015) and higher odds of hospital
mortality (1.34; 0.98, 1.84; p=0.07), and those with etomidate had
higher odds of both ICU mortality (1.87; 1.40, 2.49; p<0.001) and
hospital mortality (1.43; 1.09, 1.86; p=0.009). Ketamine had fewer
ICU-free days (-1.24; -2.41, -0.06; p=0.039) and fewer hospital-free
days (-1.21; -2.37, -0.05; p=0.041) compared to propofol. Etomi-
date was also associated with fewer ICU-free days (-2.10; -3.21,
-1.00; p<0.001) but not hospital-free days (-0.92; -1.97, 0.13; p=
0.087). When compared between them, etomidate and ketamine
groups had similar outcomes except for ICU mortality which was
slightly higher in the etomidate than in the ketamine group (OR,
1.29; 0.99, 1.68; p=0.057).
CONCLUSION. Compared to ketamine and etomidate, propofol is
associated with better outcome in critically ill patients undergoing
anesthesia for intubation. The hemodynamic effects of propofol
might be more predictable than those with ketamine and the
metabolic effects of etomidate might exert their own influence on
outcome.REFERENCE(S)
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INTRODUCTION. Even though it’s widespread implementation, the
benefits of bronchoscopy-guided percutaneous dilatational tracheos-
tomy (BG-PDT) have not been consistently demonstrated. One pos-
sible cause is the heterogeneity of techniques described(1).
OBJECTIVES. To develop a model for BG-PDT that includes a step by
step design for successful execution, based on the literature review
of published descriptions and posterior experts’ consensus.
METHODS. Major medical databases were searched with the terms:
tracheostomy, percutaneous, cricothyroidotomy, cognitive task
analysis, toolkit, and evaluation. Relevant descriptions and checklists
of BG-PDT and similar procedures were retrieved. Activities were ex-
tracted from each report and the adherence to McKinley’s dimen-
sions of procedural competence were analyzed: preparation,
infection control, communication and work with the patient, team-
work, safety, procedural competence, and post-procedure care(2).-
With this information, we developed a model represented in
Business Process Model Notation (BPMN). To further validate the
model, we used the Delphi method by conducting an online survey
in which experts from Latin America were asked to score with a five-
point Likert scale the suitability of the proposed activities. Also, ex-
perts were allowed to propose changes to the order of activities or
propose new ones. Predefined criteria were used to define the “ex-
pert” group, to finalize the Delphi panel: more than 80% correlation
with Pearson’s R test or 3 rounds, and more than 80% of median
consensus for inclusion activity in the model. Non-parametric de-
scriptive statistics were used, dates present as median and range.
RESULTS. Twelve descriptions found in the literature and the local
protocol were included for analysis. The descriptions presented 19
[6-33] steps and had 3 [1-5] of McKinley’s dimensions. No description
had all the dimensions. The most frequently represented (85%) were
“preparation” and “procedural competence”, while no descriptionincluded “patient communication”. The first model used for the
Delphi panel includes all McKinley’s dimensions, with two operators
(bronchoscopy and tracheostomy), with a total of 51 steps divided
into 6 stages. The Delphi panel was answered by 25 experts from 9
countries and was ended in the second round with a correlation of
0.83. The final model (Figure 1)included 45 activities proposed in the
initial model and 6 new activities proposed by the experts; 6
activities from the initial model were excluded.
CONCLUSION. We have presented a BG-PDT model that includes ne-
cessary competence dimensions to be considered complete. The
model has been validated by an experts’ consensus, allowing to cap-
ture the inter-center variability. This model can be used to define
local standards or for the training of physicians.
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INTRODUCTION. Patients who are undergoing emergency laparotomy
are at risk of both intraoperative hypoxemia and postoperative
pulmonary complications (POPC). POPCs are frequent complications
following open abdominal surgery and may be associated with hospital
mortality. The most important postoperative pulmonary complications
are atelectasis, pneumonia, respiratory failure, and exacerbation of
underlying chronic lung disease requiring postoperative mechanical
ventilation.Driving pressure, a simple surrogate marker of lung strain
has been found to be strongly correlated with mortality in acute
respiratory distress syndrome patients and also correlated with POPC in
patients undergoing surgery under general anaesthesia.
OBJECTIVES. We hypothesize that Driving pressure is a prognostic
marker in patients undergoing emergency laparotomy and may be
useful in detecting patients who might require postoperative
ventilatory support.
METHODS. The parent study is a prospective observational single
centric study, where adult patients of American Society of
Anesthesiologists physical status I or II either sex aged between 18-
and 65-years undergoing emergency laparotomy for clinically proven
Fig. 1 (abstract 001099). Total histologic score between groups
comparison
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identify correlation between oxygen index (OI= mean airway pres-
sure x FiO2/PaO2) and oxygen saturation index (OSI)and whether OSI
is a predictor of postoperative mechanical ventilation. All patients
were followed till hospital discharge.
RESULTS. Data of n=38 patients were analyzed in this interim
analysis. Median [IQR] age of the patients was 32.5 [23- 45]y and 12
of them were female. Fifteen patients (41.7%) required postoperative
mechanical ventilation and 16.7% patients died during hospital stay.
Patients who required postoperative mechanical ventilation, had
lower PaO2 (p=0.01), lower oxygenation index (p=0.0004) and higher
driving pressure (p=0.0001) after induction of general anaesthesia.
However, pCO2, pH and arterial lactate were statistically similar. In a
multivariable logistic regression model which included age, baseline
INR, baseline arterial lactate, OI and DP, only DP was found to be a
significant predictor of postoperative mechanical ventilation [adjusted
odds ratio (95% CI) 1.75 (1.14, 2.68), p=0.01; goodness-of-fit p=0.95].
CONCLUSION. We conclude that in patients who are undergoing
surgery and having risk of POPC, intraoperative DP is a predictor
postoperative mechanical ventilation irrespective of oxygenation status.
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INTRODUCTION. Pulmonary perfusion block might be associated
with a combination of deleterious mechanisms, including alveolar
hypocapnia and heterogeneous distribution of ventilation, which, in
turn, could induce lung injury.
OBJECTIVES. To describe the effects of unilateral complete
pulmonary perfusion block in healthy pigs undergoing protective
controlled mechanical ventilation for 48 hours.METHODS. Ten anesthetized pigs were randomly allocated to surgical
left pulmonary artery ligation (Ligation group, n = 7) or no intervention
(Control group, n = 3). All animals were ventilated on volume
controlled mode with 10 ml/kg tidal volume, respiratory rate 25 bpm,
FiO2 0.5 and PEEP 5 cmH2O for 48 hours or until PaO2/FiO2 fell below
100 mmHg (Tend). Gas exchange, hemodynamic parameters, and
respiratory mechanics data were collected at Tend before sacrifice.
Quantitative CT scan was performed to assess lung weight variation at
Tend compared to initial. At autopsy, portions of left and right lung
were fixed in formalin for histologic examination. Plasma samples were
stored every 12 hours to measure cytokine levels (IL-6).
RESULTS. Two animals from the Ligation group were sacrificed at 24
and 36 hours, while all animals from the Control group safely arrived
at 48 hours. Total histologic score was significantly higher in the
Ligation group compared to the Control group, both for the left and
the right lung (p<0,001, Figure 1). Most represented histologic
alterations were alveolar neutrophils infiltration, alveolar
macrophages proliferation and interstitial lymphocytes proliferation
and affected both lungs of the Ligation group. In parallel, IL-6 level
in the Ligation group reached a higher peak value than Controls dur-
ing the study period (35.75±25.61 pg/mL vs 8.90±5.63 pg/mL, p=
0.03). At Tend, Ligation group showed lower respiratory system com-
pliance, higher driving pressure, lower oxygenation and higher in-
crease of the lung weight (Table 1).
CONCLUSION. Unilateral ligation of pulmonary artery induces bilateral lung
injury in animals undergoing otherwise protective mechanical ventilation.
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INTRODUCTION. Cellular profiles in bronchial secretions of
mechanically ventilated patients are largely unknown. Different
sampling procedures might result in different cellular profiles in
material aspirated from the airways.[1]
OBJECTIVES. We aimed to evaluate bronchial secretions in terms of
differential cell count and percentages obtained by mechanical
ventilated critical care patients using different methods of sampling.
METHODS. This prospective study took place in the Intensive Care
Unit of a tertiary Greek hospital during a six-month period. Patients
were included if they were under MV for less than 24 hours and re-
quired bronchoscopy. Furthermore, non-mechanically ventilated sub-
jects who underwent a single bronchoscopy, were assessed as
controls. In all patients, aspiration of bronchial lining fluid (BLF) was
performed, Bonchoalveolar lavage (BAL)and two types of Bronchial
Washings (BW40 and BW5) were performed with the instillation of
normal saline (ml) 150, 40, 5, while visible bronchial secretions were
obtained via bronchoscopy (VBS) and blinded, via a common cath-
eter for tracheobronchial aspiration (AC). Samples were homogenized
in a Heidolph Silent Crusher S and total cell counting was performed
after Trypan Blue staining, while cell types were assessed after May
Gruenwald-Giemsa staining.
RESULTS. Twenty-five patients and six controls were evaluated. Mean (SE)
age was 65.9(3.0) and APACHE II 18.5(1.5). Ten patients were admitted
due to surgical problems. The mean total cell number (TCn) in BLF, BAL,
BW40, BW5, VBS and AC were 54.2x104 (82.1x103), 11.6x105(28.8x104),
11.3x105(3.0x105), 80.7x104(13.3x104), 15.2x105(29.9x104), 10.2x105
(12.7x104) in patients and 11.2x104(17.01x104), 10.9x104(15.5x103),
12.2x104(16.8x103), 6.6x104(9.9x103), 10.9x104 (21.5x103) in controls re-
spectively. The percentage of neutrophils (%Net) were 37.31(2.1), 22.4(2.1),
19.5(2.0), 25.8(2.1), 21.9(2.6), 24.5(1.9) vs 21.2(4.5), 23.7(5.0), 20.1(3.9),
16.2(3.9), 22.8(5.3), 11.7(5.0), in patients and controls, respectively. There
were significant associations between BAL and BW40 in terms of TCn and
%Net (p=0.006, p=0.03) and between VBS and AC in terms of TCn and
%Net (p=0.001 and p=0.05).
CONCLUSION. BAL and BW40 may present similar TCn and %Net in
mechanical ventilated critical care patients. Samples obtained by
blind catheter tracheobronchial aspiration, as in common clinical
practice, may present similar TCn and %Net with visible secretions
obtained by bronchoscopy.
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INTRODUCTION. Intubation in Intensive Care Unit (ICU) is high risk ( 1,2
) with serious airway complications 55 more likely to occur in ICU than in
operating theatres (3). Airway training for ICU nurses is challenging: ICU
nurses often lack anaesthetic airway experience (1,2); there are limited
low risk cases for training (2);nurses receive infrequent exposure to
airway management especially advanced and rescue techniques; and
skill decay is an issue which affects senior and junior staff alike (4).
OBJECTIVES. Our aim was to design and deliver an airway training
programme using the "Bath Tea Trolley" method , (5) teaching ICU
staff to use a bougie and apply cricoid pressure during a rapid
sequence induction.METHODS. We ran a month of concentrated airway training
named "Janu-Airway" using a trolley with airway training
equipment on the top and pot of tea on the bottom. A trainer
and the trolley travelled around the ICU providing 10-15 minutes
teaching sessions for ICU staff at the bedisede during their nor-
mal working shifts. Cricoid pressure application was practiced and
its effec on the view at laryngoscopy was demonstrated using a
manikin and C-MAC videolaryngoscope (Karl Storz GmbH) and
assisting intubation using a bougie was practised. Posters were
distributed via email/closed social media groups, and handouts
were given to participants to facilitate reflective learning. Feed-
back was collected with staff self-rating confidence before/after
training using a five point Likert scale, followed by a cup of tea.
RESULTS. 81 members of staff received training; 18 senior nurses, 43
staff nurses, 11 junior doctors, 3 physiotherapists, 3 medical students,
1 outreach sister, 2 advanced critical care practitioners (ACCP). This
included 100% of ICU nurses and junior doctors. Feedback forms
were completed after 57/81 (72%) of training sessions. Resulsts as
follows: increase in confidence by one point or more on the Likert
scale reported for both cricoid pressure (45/58, 83%) and the use of
a bougie (49/58, 84%); improvement in the abilityto assist with
intubation reported by all participants - 56/58 (97%) strongly agreed,
2/58 (3%) agreed; similar training in the future was requested by all
participants - 47/58 (81% strongly agreed, 11/58 (19%) agreed.
CONCLUSION. Our "Bath tea trolley" training programme provided
effective, practical and non-threatening multidisciplinary airway train-
ing in the workplace. Training was provided to 100% of our ICU staff
-during their usual shifts and for minimal cost. It was quick and easy
to set up, flexible and fun. This training method could be transferable
and reproducible in other ICUs
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INTRODUCTION. Lung ultrasound (LUS) is gaining recognition as a
useful tool for assessing lung pathophysiology.Lung Ultrasound
Scores (LUSS) have been proposed for the assessment of pulmonary
edema without having been validated with a reference gold
standard, i.e. invasively determined EVLW
OBJECTIVES. This study has two main goals. First, to test the
feasibility of a modified automatic and quantitative scoring system
based on the percentage of pleura involved by B-lines in an attempt
to provide an objective, operator-independent and quantitative clas-
sification of the severity of pulmonary edema in comparison with the
previously described semi-quantitative scores. Second, to compare
the ability of this new scoring system and those previously proposed
T1
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by standard thermo-dilution method.
METHODS. Prospective observational study. Single-center, mixed
medical-surgical ICU in Europe. Patients over 18 years old admitted to
the Intensive Care Unit with acute respiratory distress syndrome (ARDS).
Images were collected by a system (Esaote MyLab alpha or Myndray
DC-N3) with high-frequency (10 MHz), linear-array probe, with the pa-
tients in a supine position. Transverse scanning was used to visualize
the pleural line avoiding acoustic interference from the ribs. Six stand-
ard areas of each hemi-thorax were identified relative to sternum and
axillary lines: anterior, lateral, and posterior, each ones divided into
upper and lower halves. On each scan the following data were re-
corded: presence of A lines, maximum number of B-lines, visual per-
centage of lung area occupied by confluent B-lines, visual pleural
involvement >50% or ≤50% and tissue-like patterns (consolidations).
Five scores were defined as follows 1) maximum number of B-lines de-
tected (nLUSS), 2) visual percentage of lung area occupied by B-lines
(%LUSS)[5], 3) B-line coalescence (cLUSS)[6], 4) modified B-line coales-
cence score (qLUSS)[7], 5) computer-aided score (QLUSS).
RESULTS. 144 thoracic areas in 12 ICU patients were examined. Five
scores were defined as follows 1) maximum number of B-lines detected
(nLUSS), 2) visual percentage of lung area occupied by B-lines (%LUSS),
3) B-line coalescence (cLUSS), 4) modified B-line coalescence score
(qLUSS), 5) computer-aided score (QLUSS). EVLW index was significantly
correlated with QLUSS mean value (r=0.898; p<0.0001), qLUSS (r=0.822;
p=0.001), %LUSS (r=0.743; p=0.006) and cLUSS (r=0.619; p=0.032), but
not nLUSS (r=0.055; p=0.865). Absolute agreement between raters was
strong for cLUSS [ICC: 0.703 (95 % CI 0.303 to 0.858)], %LUSS [ICC: 0.745
(95 % CI 0.631 to 0.822)], qLUSS [ICC: 0.825 (95 % CI 0.705 to 0.896)]
and nLUSS [ICC: 0.895 (95 % CI 0.835 to 0.931)], with the best correl-
ation for QLUSS [ICC: 0.998 (95 % CI 0.996 to 0.999)].
CONCLUSION. This pilot study shows that only computer-aided
methods measuring the percentage of pleural line affected by B-lines
can give a reliable assessment of extra vascular lung water and per-
forms better than scores. This approach to B-lines quantification can
turn images into numbers, thus providing an operator-independent
analysis of large amounts of data and improving inter-observer
agreement.
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INTRODUCTION. Nasal High Flow (NHF) is a non-invasive respiratory
support for patients with hypoxic respiratory failure. Currently, inter-
mediate physiologic outcomes that accurately predict mortality lack,
but could be useful to test new treatments and to stratify severity.OBJECTIVES. We aimed to identify physiological parameters that
independently predict mortality at 48 hours in hypoxic patients
initially supported by NHF.
METHODS. We enrolled eighty-three hypoxic patients with pneumo-
nia and initially supported by NHF. We recorded baseline demo-
graphics, disease severity (SOFA, APACHE II, PSI scores) and
quadrants involved at chest radiograph. Then, intubation rate and
physiological parameters were collected at 48 hours and, finally, in-
hospital mortality was recorded. By use of relevant parameters at 48
hours, we calculated a new Saturation Index as (FiO2 × Mean Airway
Pressure (MAP))/SpO2; where MAP was 0 for non-intubated and not
on NHF patients, flow/10 cmH2O for patients on NHF and the one
measured by the ventilator in intubated patients. Finally, we con-
ducted univariate and multivariate analysis for parameters at 48
hours to disclose independent predictors of mortality.
RESULTS. 66% patients were female and mean age was 59 ± 14.7
years old. APACHE II and PSI scores were 17 ± 7 and 104 ± 40. NHF
was initially started with flow 42 ± 7 L/min and FiO2 0.68 ± 0.23. At
48 hours, sixteen patients were intubated (19.3%), while thirteen
(15.7%) were weaned from NHF support. In-hospital mortality was
30.2% (25 patients). Univariate analysis showed that, at 48 hours,
FiO2, SpO2/FiO2, Saturation Index and number of intubations were
significantly different between survivors and non-survivors (Table
1). At logistic multivariate analysis performed with these four pa-
rameters, only SpO2/FiO2 ratio emerged as independent predictor
of hospital mortality (OR 0.97, 95% CI 0.95 to 0.99, p=0.011). ROC
curve analysis confirmed this result with AUC-ROC of 0.807 (95%
CI 0.69 to 0.92, p<0.001) and cut-off of 138 (sensitivity 65% and
specificity 87%).
CONCLUSION. In hypoxic patients initially supported by NHF, lower
SpO2/FiO2 ratio measured at 48 hours independently predicts
hospital mortality.
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Table 1 (abstract 001141). Univariate statisticsSurvivors
(n=58)Non-survivors
(n=25)Parameters at 48 hoursRespiratory rate 20 (17.25; 24) 22 (20; 26) p=0.127FiO2 60 (45; 60) 72.5 (60; 85) p<0.001SpO2 96 (95; 98) 96 (95; 97) p=0.843SpO2/FiO2 163 (156; 216.3) 123 (112.5; 159.5) p<0.001Saturation Index 2.46 (1.25; 3.16) 3.51 (2.52; 7.94) p=0.002Intubation rate at 48 hours 8 (13.8%) 8 (32%) p=0.054Patients still on NHF 40 (69%) 14 (56%) p=0.254Data are expressed as median (interquantile range)
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Page 481 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. Overweight and obesity are increasingly prevalent
worldwide and account for about 30-40% of patients with acute re-
spiratory distress syndrome (ARDS). How body mass index (BMI) influ-
ences respiratory mechanics in ARDS is unclear.
OBJECTIVES. To compare the respiratory mechanics of obese and
non-obese ARDS and assess the influence of BMI on respiratory me-
chanics and lung volumes.
METHODS. This study is a secondary analysis of 2 cohorts of ARDS
according to the Berlin definition: a bicenter Canadian study of 45
ARDS of any BMI enrolled in a prospective study (NCT02457741), and
a French monocenter cohort of selected ARDS with a BMI > 40 kg/
m2. Airway pressure, flow and esophageal pressure were collected in
all patients and we report data at a set positive end-expiratory pres-
sure (PEEP) of 5 cmH2O. Presence of complete airway closure (1) and
airway opening pressure were assessed using a low-flow inflation
pressure-volume curve. End expiratory lung volume (EELV) was mea-
sured using the nitrogen washout/washin technique. The ratio EELV
to predicted functional residual capacity (2) was calculated.Patients
were sorted in 3 groups according to the World Health Organization
overweight classification (BMI < 30, from 30 to < 40, and ≥40 kg/m2).
RESULTS. Among the 54 patients included, 18 patients (34%) had
BMI < 30 kg/m2, 16 (30%) between 30 and 40 kg/m2, and 19 (36%)
≥40 kg/m2. The median PaO2/FiO2 was 138 mmHg with a PEEP of
15 cmH2O, and mortality was 32% without difference across groups.
Airway closure occurrence increased with BMI (22%, 38% and 58%,
p= 0.04). When present, airway opening pressure was 9.6 cmH2O
(8.5-13.2) and similar between the 3 groups. With increasing BMI,
total PEEP increased from 6.0 to 9.0 cmH2O between groups (p=
0.02). All values of esophageal pressure increased with BMI. End-
expiratory esophageal pressure was strongly correlated with BMI
(rho= 0.71, p<0.001), as illustrated in Figure 1. Consequently end-
expiratory transpulmonary pressure decreased from -2.7 to -9.3 cm
H2O with increasing BMI (p= 0.008). The ratio of EELV to predicted
functional residual capacity was negatively correlated with end-
expiratory pressure (Rho= -0.39, p= 0.01), but not with BMI. Driving
pressure and elastance of the respiratory system, chest wall and lung
were similar across all ranges of BMI. Likewise, EELV was similar be-
tween groups.
CONCLUSION. In ARDS, increasing BMI is associated with increased
occurrence of airway closure and increased values of esophageal
pressure. Conversely, chest wall elastance is not influenced by BMI,
as well as lung elastance. Including BMI in interpreting respiratory
mechanics in ARDS patients can provide additional information for
the clinical management.
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INTRODUCTION. Mottling is a patchy discolouration of the skin,
thought to be secondary to a reduction of blood flow within the
superficial skin vasculature [1]. Although it may occur in the absence
of acute illness, in intensive care patients it is associated with
haemodynamic collapse and failing circulation. Mottling was first
described as a sign of poor perfusion as early as 1894 [2], but in the
last decade there has been a renewed interest in assessing mottling
in critical care [3-7]. Previous studies, where attempts have been
made to quantify the extent of mottling, have shown that increased
mottling of the lower limb is associated with higher mortality rates
[3]. The reported incidence of mottling varies considerably. Estimates
range from 2.5% [8] to 70% [3], which may be due to relatively small
cohorts in these studies (ranging from 14 [4] to 791 [5] patients). It
has been suggested that persistent mottling of the skin is an
independent risk factor for ICU mortality, after adjusting for the use
of vasopressors, mechanical ventilation and hyperlactaemia [5].
However, these factors might not adequately adjust for illness
severity, leading to a lack of clarity on whether mottling is truly an
independent risk factor of poor prognosis.
OBJECTIVES. The aim of this retrospective cohort study was to assess
the incidence of mottling in the intensive care unit (ICU) and its
relationship with mortality and length of stay.
METHODS. We used data collected as part of the Post-Intensive-Care
Risk-adjusted Alerting and Monitoring (PICRAM) study of patients ad-
mitted to ICU at a large UK hospital between June 2008 and Decem-
ber 2015. The presence of mottling was extracted from nursing lower
limb skin assessment which were documented from a pre-defined list
of terms including 'mottled'. Admissions were classified as either
'mottled for any duration during ICU stay' or 'never mottled'. For
each admission, we also calculated the Oxford Acute Severity of Ill-
ness Score (OASIS), and outcome data comprising ICU mortality, ICU
length of stay and hospital mortality were extracted. Logistic regres-
sion analysis was used to assess the effect of mottling status on
outcomes.
RESULTS. 8,556 unique admissions to ICU were identified, of which
1,136 (13.3%) had documented mottling of the lower limb at some
point during their ICU admission. Unadjusted mortality rate in the
mottled group was 33.9% compared to 7.1% in the never-mottled
group. Unadjusted within-ICU mortality was significantly higher in
the mottled group (OR 6.71 (95% CI 5.76-7.80)). When adjusted for
severity of illness using OASIS, ICU mortality risk in mottled patients
remained significantly elevated at OR 3.07 (95% CI 2.59-3.64). ICU
length of stay was increased by a factor of 1.54 or 4.2 days.
CONCLUSION. This is the largest study of mottling in critical care. We
calculated the incidence of mottling to be 13.3% of ICU admissions,
which is at the lower end of previous estimates. The lower estimates
of our cohort may be due to under-reporting of mottling when a
minor degree of mottling over the knee was present (equating to
mottling score of 1 out of 5). Mottling is a clinical sign of poor skin
perfusion and is associated with significantly increased mortality risk
with OR 6.71. It is an independent predictor of ICU mortality.
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INTRODUCTION. Exposure to excessive oxygen concentrations may
be harmful to acutely unwell patients (Girardis 2016; Helmerhorst
2016) and new guidelines recommend avoiding an oxygen
saturation (SpO2) >96% (Siemieniuk 2018). Little emerging literature
and guidance is specific to patients on the intensive care unit (ICU)
and robust data, describing normal practice, in this cohort is absent.
We aimed to determine the standard of care for oxygenation in
patients admitted to ICUs in England.
METHODS. Data was interrogated from the Critical Care Health
Informatics Collaborative (CC-HIC) data infrastructure (Harris 2018; Shi
2017) - a collaboration between five National Health Service Trusts in
England, aggregating high fidelity time series data on patients from
12 ICUs. SpO2 values were queried for patient episodes from January
2014 to December 2018. Raw data were presented as time-weighted
mean values for SpO2 (SpO2-tw) for a number of predetermined sub-
groups. Statistical analysis was not performed as the sample size
would be powered to detect clinically meaningless signal.
RESULTS. After applying centrally determined validation procedures,
we identified 6,524,918 SpO2 values from 44,150 individual patient
episodes. The median [IQR] SpO2-tw for the whole cohort was 96.7%
[95.5-97.8]. When patients receiving a fractional inspired oxygen con-
centration (FIO2) of 0.21 were excluded, the median SpO2-tw was
96.9% [95.5-98.1]. For apriori defined subgroups the median [IQR]
SpO2-tw were: invasively ventilated (97.1% [95.5-98.3]) versus patients
not invasively ventilated (96.5% [95.3-97.6]) (Fig. 1); primary medical
(96.4% [95.0-97.6]) versus surgical diagnosis (97.0% [96.0-98.0]); prior or
current diagnosis of chronic obstructive pulmonary disease (COPD)
(94.5% [92.9-96.1]) versus no such diagnosis (96.8% [95.6-97.8]) (Fig 2).
CONCLUSION. In an unselected ICU cohort, the median SpO2-tw was
higher than recommended for acutely unwell patients outside of theICU. Statistical analysis was not performed, but visual inspection of
the distributions shows clear differences between subgroups. The
median SpO2-tw, for patients with COPD, is higher than current
guideline recommendations (88-92%)(O’Driscoll 2017). Future study
design should be mindful of this standard of care.
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INTRODUCTION. One of the main goals of a rapid response team
(RRT) is to prevent a “failure to rescue” which is the lack of a reaction
for a patient which has abnormal vital signs and could increase the
probability of a serious adverse event.. The ideal trigger method
should increase the accuracy for detection preventing false positives,
which could result in fatigue of the team, and decreasing false
negatives resulting in a “failure to rescue” and its consequences. (1–
3) One of the main problems using a method developed in other
hospital, country or population is the implicit heterogeneity and
variance, highlighting the importance of personalized tools internally
developed using a self-learning machine. We developed a personal-
ized cell phone app based on the data collected from our RRT, show-
ing that every hospital could develop their own tool increasing its
applicability and accuracy.
METHODS. Prospective observational study including adult
hospitalized non-critically ill patients, excluding obstetric patients
and “do not resuscitate” order patients. Every vital sign reported
by the nursing staff, age, gender and admission diagnosis was
collected in a data base with the final outcome of transfer to the
Intensive Care Unit (ICU) during a 3 months period. R version
3.4.0 (20017-04-21) was used for the data analysis and shinyapp-
s.io for the cell phone app.
RESULTS. 6040 cases (set of variables) were included in the final
analysis. In order to program the self-learning machine the “caret”
package was used in R, using the neural network method or
“nnet” with the following parameters: decay of 0.0001, 100 itera-
tions, scaling and centering pre-processing. The final formula
used for the self-learning machine was “TRANSFER (to the ICU)~
Age+ SBP (systolic blood pressure)+ DBP (diastolic blood pres-
sure)+ HR (Heart rate)+ RR (Respiratory rate)+ SAT_O2 (Oxygen
saturation)”. The data frame for training contained 75% of the
data and the 25% left for the testing stage.
CONCLUSION. The use of learning machine methods to develop a
personalized tool for RRT activation is a promising field. Every
hospital has the potential to develop their own tools based on their
unique characteristics and keep enhancing it when considered
necessary.
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INTRODUCTION. ICU populations have increasing levels of
multimorbidity. The APACHE-II model is currently used in
Scotland to publicly report risk-adjusted mortality in ICUs and
benchmark care quality(1,2). However, the model only accounts
for severe comorbidity. In Scotland, two national population-wide
datasets exist from which milder comorbidities can be derived.
These are the Scottish Morbidity Record (SMR01) comprising hos-
pital discharge records for all Scottish hospitals(3), and the Pre-
scribing Information System (PIS), a dataset comprising all
community dispensed medical prescriptions(4).
OBJECTIVES.
 To derive comorbidity measures from SMR01 and PIS, report
prevalence of comorbidities and their association with
mortality in a Scottish ICU population
 To ascertain whether adding comorbidities derived from the
two data sources to the APACHE-II-derived risk prediction
model improves mortality prediction
METHODS. Cohort study of all patients admitted to Scottish ICUs
from 2010-2017 (excluding readmissions) derived from the Scottish
Intensive Care Society Audit Group (SICSAG) database, comprising all
admissions to Scottish ICUs(5). Comorbidities were derived from two
datasets: SMR01-derived comorbidities defined by Charlson(6); PIS-
derived comorbidities using British National Formulary codes,
adapted from a study using Anatomical Therapeutic Chemical
codes(7). Prevalence of derived comorbidities was reported. Logistic
regression was used to report the univariable association of each co-
morbidity with ultimate hospital mortality. After excluding patients
ineligible for APACHE-II risk scoring, three risk prediction models for
ultimate hospital mortality were developed using multivariable logis-
tic regression: current APACHE-II model, APACHE-II plus PIS comor-
bidities, and APACHE-II plus SMR01 comorbidities. ROC graphs, area
under the receiver operating characteristic curve (AUROC), AIC, BIC
and Brier’s score were compared.
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Fig. 1 (abstract 000416). MDS of inter-rater agreements measured
with Cohen's kappa. Distance between points represent the extent
of disagreement between ratings by different individuals. Arrows
show changes of Junior MD and RN assesment adjusted with the Al
model trained on data from senior clinicians.
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19108 (19.2%) died before ultimate hospital discharge. 17 comorbidity
categories were derived from SMR01, and 20 from PIS. The most
prevalent SMR01 comorbidity was cancer (15521 (15.6%)), the least was
HIV (162 (0.2%)). The most prevalent PIS comorbidity was pain (42354
(42.5%)), the least was dementia (266 (0.3%)). The median number of
comorbidities by SMR01 was 1 (IQR 0,1); PIS was 2 (IQR 0,4). On
univariable analysis of SMR01, “moderate-severe liver disease” held the
highest OR for mortality (OR 3.76 (CI 3.46,4.08), p<0.001); from PIS, the
highest was dementia (OR 1.68 (CI 1.44,2.49), p<0.001). Adding
comorbidity increased the predictive ability of both models compared
to the APACHE-II model, as measured by AUROC, AIC, BIC and Brier’s
score. The best model measured by AUROC was “APACHE plus SMR01
comorbidities” (AUROC=0.871 vs 0.865, p<0.001).
CONCLUSION. Prescribing data yielded greater prevalence of
comorbidities than hospital discharge records. Adding comorbidities
to risk prediction models for patients admitted to ICU leads to a
small improvement in prediction of mortality compared with the
current APACHE II model. Current ICU risk prediction models may
need to be revised to include wider comorbidity measures as
increasingly multimorbid patients are admitted to ICUs.
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INTRODUCTION. To decide whether or not to escalate care, clinicians
must accurately assess risk of patients’ cardio-respiratory instability
(CRI) based on continuously monitored multi-parameter Vital Signs
(VS). Assessment accuracy depends on experience, and is a challenge
for clinicians.
OBJECTIVES. We propose that an Artificial Intelligence (AI) model
built on expert clinicians’ adjudication could assist junior nurses (RN)
and doctors (MD) to improve their assessments.
METHODS. VS data (heart rate, respiratory rate, blood pressure, oxygen
saturation by pulse oximetry) were collected from 1087 continuouslymonitored step-down unit patients. We fit a multi-class random forest
AI model using four-level annotation labels provided by expert senior
clinicians (1 RN, 1 MD) suggestive of patients’ CRI severity levels and
need for care escalation. We also asked two junior clinicians (1 RN and
1 MD) to provide independent assessment of patients’ severity levels,
blinded to experts’ annotations. To emulate scenarios where AI models
may be used in practice to assist clinicians’ subjective assessment, we
applied a conservative adjustment rule on junior clinicians’ assessment
by overriding their decisions only if the severity level determined by
the model was higher than theirs.
RESULTS. We computed pairwise disagreement (1-Cohen's kappa)
between expert clinicians, junior clinicians, and the AI model,
visualized as distances in the multidimensional scaling (MDS) plot in
Fig. 1. Before adjustment, the Junior RN and Junior MD widely
disagreed with expert assessment, but converged toward experts
when supplemented by the model’s suggestions (arrows). Changes
of Cohen’s kappa with respect to experts’ consensus are from .28 to
.56 for Junior RN, and .36 to .49 for Junior MD. Also, disagreement
between the Junior RN and Junior MD decreased, with Cohen’s
kappa increased from .27 to .62. After incorporating the AI model’s
suggestions, the true positive rate (proportion of high CRI risk
patients correctly identified, computed using experts’ consensus as
ground truth) increased (.376 to .836 for Junior RN; .633 to .907 for
Junior MD), both converging towards the model’s and experts’
rating, at a low false positive rate (.03 for junior RN, .22 for junior
MD).
CONCLUSION. Incorporating AI encoding expert opinion into the
decisional process of junior clinicians’ assessment of patient’s
propensity for severe CRI could improve their clinical decisions.
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INTRODUCTION. Hypernatremia is a known independent risk factor
for mortality and increases length of stay in the ICU, and slow rates
Page 485 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55of correction have also been shown to increase mortality. Most
patients are undercorrected based on previous studies. Machine
learning methods have the potential to improve the management of
this condition.
OBJECTIVES. The study is aimed to use machine learning methods to
develop a model which can predict appropriate serum sodium
correction in patients with hypernatremia in 24 hours from ICU
admission. The secondary aim is to identify which factors are most
influential in recovery from hypernatremia.
METHODS. Using the Medical Information Mart for Intensive Care
Database (MIMIC-III), we performed a retrospective analysis of
patients with hypernatremia (defined as sodium >145 mmol/L) on
admission to the ICU. Appropriate correction was defined as either a
decrease in serum sodium by 6 to 10 mmol/L or to less than 145
mmol/L without correcting >10 mmol/L in the first 24 hours. The
primary exposure was fluid volume controlled for sodium content
received in the first 24 hours of admission. We calculated the total
sodium content of fluids received and created categories of total free
water intake and total crystalloid intake. We queried the database for
clinically relevant covariates, including lab data and admission
diagnoses. We trained our model in 75% of the patients and tested
the model in 25% of the patients. We used both a regularized
logistic regression and a random forest classifier to build predictive
models. We examined the importance of the covariates in the
random forest model.
RESULTS. 1902 patients met criteria for inclusion. 54.6% of patients
achieved appropriate correction. Factors associated with lack of
correction included older age, sepsis, higher initial sodium value, and
elevated BUN. Those who did not correct had a higher mortality rate
(24.6% vs. 20.2%). The volume of free water and total fluid volume
were not significantly different between the groups. The logistic
regression model produced an AUC of 0.74, and the random forest
model produced an AUC of 0.76. By examining the variable
importance of the random forest model, we identified baseline
sodium and BUN as influential predictors for hypernatremia
correction.
CONCLUSION. The management of hypernatremia is challenging,
and inappropriate correction rates lead to worse outcomes in both
the ICU and general hospital population. We were able to create a
predictive model for hypernatremia correction using a random forest
classifier with a 76% success rate, suggesting that machine learning
can be a valuable tool in managing this condition. We also found
that baseline sodium and BUN level were influential in predicting
correction. Our next step will be to utilize the larger eICU
Collaborative Research Database and apply similar methods to create
a more reliable model. We hope to eventually develop more
effective and efficient methods of hypernatremia correction.
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INTRODUCTION. Population pharmacokinetic (PK) model-based
Bayesian analysis is playing an important role in optimizing
vancomycin treatment for intensive care (ICU) patients. A strength
of Bayesian analysis is the ability to include historical PK data to
improve the estimation of PK parameters for the betterment of
concentration forecasting. However, this strength may turn into a
potential weakness due to the high PK variabilities in ICU pa-
tients which may affect Bayesian forecasting. In this study, we in-
vestigated the impact of using historical data of ICU patients on
the performance of Bayesian forecasting of vancomycin plasma
concentration.
METHODS. A published one-compartmental population PK model of
vancomycin in ICU patients was used in this study [1]. The model has
been validated in a large cohort of 839 ICU patients of our own [2].
To assess the impact of historical data in Bayesian forecasting of the
vancomycin concentrations in ICU patients, we performed Bayesian
analysis in a real dataset of 490 ICU patients including multiple days
where PK data was available. By reorganizing the data set, the future
1-day concentrations were forecasted by using the Bayesian esti-
mates of the last 1, 3, 5, 7, 10, and 14 days. Thereafter, we calculated
the bias of forecasted versus actual plasma concentrations. Nonlinear
mixed-effects modeling software (NONMEM, version 7.4.3; ICON De-
velopment Solutions, MD, USA) was used to perform the analysis.
Data organization and visualization were carried out with R (version
3.5.2; R-project.org).
RESULTS. The forecasted plasma vancomycin concentration was not
significantly biased (-3.8%) when using only the last 1-day samples
for Bayesian analysis. However, when including further historical data
(last 3 to 14 days), the concentration was increasingly under-
forecasted (-6.1% to -18.6%). The Bayesian estimates of every day for
clearance decreased over time indicating the potential deterioration
in the renal function of patients staying in ICU for long, which was in
line with our clinical experience.
CONCLUSION. Through Bayesian analysis, vancomycin plasma
concentration can be reasonably forecasted for ICU patients when
the PK data from last 1-day was used. Inclusion of further historical
data could be detrimental to Bayesian forecasting, which may mis-
lead clinicians into treating patients inadequately.REFERENCE(S)
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Fig. 1 (abstract 000290). Elapsed time for our example Inform-DB
query to run. The query, which runs to return a single week's
admissions, quickly falls below 450ms with Postgres caching.
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INTRODUCTION. A recent UK study of elective surgery found that
one in ten patients had experienced a prior cancellation with lack of
Intensive Care Unit (ICU) beds being a major contributory factor [1].
Forecasting ICU bed occupancy to prevent on-the-day cancellation
could potentially curb the physical, emotional and economic costs of
postponement [2]. Occupancy forecasting requires an optimal database
schema to house clinical data – “Clinical Data Warehouse (CDW) de-
sign”. If forecasts are to be based on real-time Electronic Health Record
(EHR) data, the database powering them must integrate directly into
the hospital’s outward data flows. Then, once the data is stored in the
CDW, the needs of data scientists creating new models differ from
those of software developers looking to deploy transferable forecasting
systems. Good CDW design should support both use cases.
OBJECTIVES. The core objective was to design and build a CDW to
enable research into EHR-driven occupancy forecasting. As a first
milestone, we focused on ingesting ADT (Admission Discharge Trans-
fer) data as important indicators of short term occupancy. A key out-
come was to demonstrate the CDW’s robustness to the high data
volumes leaving the hospital. To be viable, any design also has to
support two major output layers for our data science users. The first
was the Observational Medical Outcomes Partnership (OMOP) Com-
mon Data Model, a well-documented patient-centric data model with
uptake in the ICU community for retrospective research [3,4]. The
second was the Fast Health Interoperability Resource (FHIR), an emer-
ging interoperability standard, with a clear API specification for app
development [6].
METHODS. The design process began with a literature review. This
informed a prototype transformation of our ICU EHR to the OMOP
Common Data Model. We then formalised the CDW design, named
‘Inform-DB’. This schema was load-tested in PostgreSQL 11.2 with a
million fabricated patients, twice the number of yearly admission
messages to our hospital.
RESULTS. The design process for Inform-DB resulted in a schema
specification for ADT messages [6]. A preliminary translation to the
OMOP data model has been built. This design withstood load testing
across two years’ worth of admission data in less than 36 hours. A
standard query of patients admitted across one week was returned
in less than 3 seconds, and from the third repetition onwards in less
than 450 milliseconds (Fig. 1).
CONCLUSION. This early work shows that Inform-DB has the neces-
sary speed to handle real-time data flows from a large tertiary hos-
pital. Work is underway to integrate the schema with our hospital’s
live outbound messages. This will enable incorporation of real-time
data into EHR-driven forecasting systems.
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INTRODUCTION. The MIMIC-III dataset is a large, freely-available
database containing anonymised healthcare data associated with
over forty thousand patients who stayed in critical care units of the
Beth Israel Deaconess Medical Centre between 2001 and 2012 (1). It
can be a challenging process to manipulate the data in such a way
as to make it useful. Artificial neural networks (ANNs) are constructed
by a set of computing units that simulate neurons linked together.
An architecture for the network is established and then an algorithm
is used to find the weights of the connections between the neurons.
We sought to determine whether hospital outcome (e.g. alive or
dead) could be predicted more accurately using an ANN or by more
familiar methods (e.g. generalised linear modelling) using the MIMIC-
III dataset.
METHODS. Following data cleansing (e.g. removal of all multiple
admissions, selection of data recorded within first 24 hours of
admission) our dataset comprised of 11,759 patients (18 to 89 years
old). We chose similar physiological variables as used by the
Intensive Care National Audit & Research Centre (ICNARC) Case Mix
Programme ICNARCH-2018 regression model (2): age, lowest pH,
highest lactate, highest urea, highest creatinine, highest sodium, low-
est white blood cell count and lowest platelet count. We chose to
use one hidden layer with 5 neurons for our ANN. Prior to training
the neural network the dataset was normalised using a min-max
scale method. The dataset was randomly divided into a training and
F2
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of our predictions we used the mean squared error (MSE), confusion
matrices and ROC curves for both the ANN and multivariate regres-
sion model. All data mining and statistical analyses was performed
using R version 3.5.3 (packages dplyr, lubridate, ggplot2, neuralnet,
plotROC); computation was performed using an Intel Core i7-8750H
hexacore processor.
RESULTS. The median age of our dataset was 64 [IQR 52 – 76] years,
with the training and testing dataset comprising of 8231 and 3528
patients respectively. The ANN training time was approximately 4
minutes and produced an MSE of 0.118 (figure 1) and ROC AUC of
0.81 (figure 2). The multivariate regression model required
approximately 0.04 seconds of computational time and produced an
MSE of 0.127 and ROC AUC of 0.77 (figure 2); all variables were
considered statistically significant at an alpha level of 0.05. The
confusion matrices for the ANN and regression model demonstrated
an accuracy of 84% and 83% respectively.
CONCLUSION. The ANN performed only marginally better when
compared to the multivariate regression model, suggesting little
difference between the two methods for predicting hospital
mortality. However, neural networks remain flexible and once trained
can compute predictions as quickly as other well-known methods. In
addition, given that datasets such as MIMIC-III continue to grow and
encompass more and more data, being able to feed this new data
into an ANN as it accumulates over time will inevitably be less re-
source intensive due to its nature of ‘online’ learning as opposed to
‘batch’ learning.
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INTRODUCTION. Acute physiology scores (APS) are used to risk
stratify patients on admission to Intensive Care (ICU), and intuition
would suggest determining illness trajectories could improve
prognostication. Underlying pathology is likely to be a significant
factor in the trajectory of critical illness, but there is little data
supporting this. The trajectory of sepsis is of particular interest as the
SEPSIS-3 definition requires a change in SOFA score (1).
METHODS. This was a planned analysis of data from a prospective
cohort study of consecutive deteriorating ward patients assessed for
ICU admission in 49 NHS hospitals (1 November 2010 to 31December 2011). Trajectory was defined as the change per hour in
severity score between the ward assessment and first 24 hours
within ICU, calculated based on the ICNARC APS score (2). A negative
trajectory represents improvement. Multiple imputation via chained
equations was used to manage missing data. The primary admission
diagnosis was extracted from the clinical coding on admission.
RESULTS. Imputed data for 5,429 patients were analysed. 1,791
patients had a confirmed ICNARC sepsis diagnosis occurring with a
frequency of greater than 1 per cent (pneumonia, septicaemia, septic
shock, acute kidney injury (AKI) related to infection, or urosepsis).
Patients with a confirmed ICNARC sepsis diagnosis are on an
improving median trajectory of -0.5 (IQR -3.00 – 0.08) at time of
admission to ICU, but show less improvement than patients without
a sepsis diagnosis, with a median trajectory of -0.75 (IQR -4.00 –
0.08). The difference is significant (Kruskal-Wallis test, H = 9.49, 1 d.f.,
p = 0.002)
Using a binomial generalised linear model including age, lactate,
presence of ICNARC sepsis diagnosis, and ward severity score,
trajectory was an independent predictor of death at 28 days (odds
ratio 1.084, 95% confidence interval 1.079 – 1.092, p = <2 x 10-16).
The interaction between severity score trajectory and ICNARC diag-
nosis of sepsis, modeled in a separate binomial generalised linear
model, was not significantly predictive of outcome.
CONCLUSION. This dataset reveals that patients with a sepsis
diagnosis are improving on admission to ICU, which is of interest
given the new SEPSIS-3 definition, and there is significant variation in
trajectory between patients with sepsis and non-sepsis diagnoses.
Further work is needed on the potential for trajectory before and
during ICU admission as a predictor of outcome.
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mortality, which is a major catastrophic event and hard to predict.
Various early warning scores have been developed, but they mostly
rely on in-hospital data such as vital signs from the current events,
and suffer from low accuracy and high false positive rate. Here we
tested if claims data can be used to predict in-hospital mortality, be-
cause we hypothesized that historical events play a role in predicting
patient outcomes. We employed a deep learning approach, which
has been shown to be useful in learning hidden patterns.
OBJECTIVES. To develop models capable of predicting in-hospital
mortality based on historical claim data from Taiwan National Health
Insurance Research Database (NHIRD).
METHODS. Taiwan NHIRD is derived from its single payer health
insurance program that covers 99% of the population. It provides
nationwide longitudinal claim records from all healthcare providers.
We selected 8 years of de-identified claims (2003–2010) correspond-
ing to persons with cardiac arrest and resuscitation with at least one
emergency department (ED) visit or one hospitalization event. Pri-
mary outcome was all-cause in-hospital mortality. We constructed a
deep learning system involving two steps. First, we used a taxonomy
mapping system Text2Node, to generate a distributed representation
for each concept. Second, we applied a multilevel hierarchical deep
learning model based on the long short-term memory (LSTM) archi-
tecture. The resulting model was trained using the multi-task learn-
ing approach,
RESULTS. We included a total of 1,227,739 hospitalizations and
1,346,782 ED visits involving 326,180 patients. In in-patient events,
in-hospital mortality is 7% (109,131 cases).The dataset is split ran-
domly into training (70% of the patients), test (15%) and validation
(15%) sets (figure 1). Hyper-parameters for each model was opti-
mized by maximizing the area under the receiver operating charac-
teristic curve (AUROC) for the validation set. The optimized set of
hyper-parameters was then used to train the model on all events ex-
cluding the test set. For model evaluation, the AUROC, test accuracy,
and F1 score were calculated on the held-out test set. Our model
achieved high accuracy, with an AUROC value of 0.96, 95% of accur-
acy, and an F1-score of 0.63.
CONCLUSION. Longitudinal claim databases such as NHIRD provide
valuable information in predicting rare catastrophic events when
employing a deep learning approach. To implement this system in a
real-world ED setting, a study on interpretability is underway.
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INTRODUCTION. Sepsis mortality is still unacceptably high and an
appropriate prognostic tool may increase the accuracy for clinical
decisions. Several techniques of artificial intelligence (AI) are
currently providing efficient ways for data mining and analysis. Thus,
sepsis is a very attractive area for implementation and evaluation of
several models of AI
OBJECTIVES. To develop and to evaluate several supervised
techniques of data mining and AI for classification and prediction of
mortality in adult patients hospitalized by emergency services with
sepsis diagnosis
METHODS. Secondary data analysis of a prospective cohort
conducted between June 2014 and February 2016 in three
emergency services of university hospitals in Medellin, Colombia.
Patients 18 years older were included, provided they were
hospitalized because of suspected or confirmed infection and any
organ dysfunction according to SOFA score. The outcome variable
was hospital mortality and the prediction variables were grouped in
either those related with treatment and initial clinical attention or
those that measure directly physiological derangements. Five
supervised classification techniques were analyzed: C4.5 Decision
Tree (C4.5), Random Forest (RF), Artificial Neural Network (ANN) and
Support Vector Machine (SVM) by either dot or ANOVA. Their
performance was evaluated by the concordance between observed
and predicted mortality (accuracy) and by the discrimination
according to AUC-ROC
RESULTS. The study cohort was composed of 2510 patients with a
median age of 62 years (IQR=46-74) and an overall hospital mortality
rate of 11.5 % (n=289). The best discrimination was provided by the
ANN using physiological variables (Table).
CONCLUSION. Deep learning and artificial intelligence are
increasingly used as supporting tools in clinical medicine. Their
performance in such a complex and heterogeneous syndrome as
sepsis may be a new a horizon in clinical research. Artificial Neural
Networks seem promising for improving sepsis classification and
prognosis
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INTRODUCTION. The target for optimal glycemic control in the
intensive care setting remains uncertain, despite more than a decade
of debate. Randomized clinical trials suggest that different patient
populations may benefit from different targetss. Van den Berghe
et al. showed that glucose targets of 80 – 110 mg/dL resulted in a
decrease in morbidity and mortality for surgical ICU patients, without
the same effect observed in medical ICU patients. Meanwhile Finfer
et al. showed that an intensive blood glucose target of 81 – 108 mg/
dL compared to the conventional target of ≤ 180 mg/dL resulted in
significantly higher 90 day mortality in both medical and surgical
patients. Current research is limited with regards to evidence
supporting specific glucose targets for heterogeneous patient
populations.
OBJECTIVES. We hypothesize that dynamic glucose targets (based
on variables such as patient physiologic parameters, duration of ICU
stay and disease trajectory) may improve outcomes in the ICU
patients. Since randomized controlled trials for different glucose
targets and sub-populations of patients are impractical, we have uti-
lized observational data in large publicly available datasets. To begin
to analyze outcomes, we have first curated the database and per-
formed descriptive analysis of current practices.
METHODS. This study utilized the publicly available MIMIC-III data-
base which contains over 58,000 ICU admissions between 2008-2012
for a cohort of approximately 38,600 adults. Retrospective data were
extracted in the following categories: blood glucose measurements
(finger-stick glucometer and serum values), dextrose inputs, and insu-
lin inputs (short, intermediate and long acting). Glucose and insulin
values were paired to match them according to timestamp criteria.
Data extraction and alignment was performed with SQL queries exe-
cuted in Python.
RESULTS. A combined 373,239 glucose values were extracted
between 155,168 laboratory chemistry readings and 218,071 finger-
stick readings. 151,184 total insulin values were extracted;
138,561(91%) short-acting, 3,982(3%) intermediate-acting and
8,641(6%) long-acting. When frequency of insulin dosing was plotted
it was shown that the majority of short acting insulin administered
was in the range of 2 to less than 4 units (nearly 35,000 occurrences).
After applying the algorithm for alignment, 41,387(95.9%) of short-
acting intravenous infusions and 84,070(94.6%) of short-acting sub-
cutaneous boluses were matched to corresponding glucose values.
Dashboards were created for each ICU admission (plotting glucose
and insulin values over time) to clinically validate the alignments. To
evaluate the quality of glucose control, glucose values after short-
acting subcutaneous insulin administration were plotted for the fol-
lowing intervals, <60 min, 60-120 min and 2-6 hours.
CONCLUSION. Blood glucose control in the ICU does not meet the
current recommended guidelines. Despite suggested targets, glucose
often falls outside of this range, and patients often experience
hyperglycemia. For research on targets to be effective, we need to
be able to control glucose well. Strategies for management need to
be developed in tandem with accurate personalised targets if we are
to improve outcomes. Future analysis with this dataset will seek to
find trends between glucose control and clinically meaningful
intermediary outcomes, such as indices of illness severity such as
SOFA scores.REFERENCE(S)
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INTRODUCTION. Sepsis is a life-threatening condition, arising from a
dysregulated and harmful host response to infection [1]. Due to its
syndromic nature, no solitary biomarker with sufficient clinical per-
formance is available and reliable diagnosis of sepsis remains chal-
lenging. Apart from rapid identification of the causative pathogen,
the bloods’ immune system is proposed to contain important infor-
mation, especially on gene expression level. In recent years, machine
learning approaches revolutionized the way of using high-
dimensional data and also proved its diagnostic value when integrat-
ing electronic health record data of ICU patients [2].
OBJECTIVES. We performed a pilot study utilizing deep-learning arti-
ficial neural networks based on a large set of public microarray data
and aiming to evaluate its performance for the accurate diagnosis of
sepsis.
METHODS. Public repositories (NCBI GEO, EMBL-EBI Array Express)
were searched for microarray data series containing septic patients
(n=1,354), trauma patients (n=478), and healthy controls (n=383).
Those were integrated into a comprehensive meta-dataset, contain-
ing gene expression values of a consensus of 5,932 genes for further
analysis. After data preprocessing, samples were randomly divided
into subsets for training (65%), validation (20%), and testing (15%).
Training and validation samples were used as input for the step-wise
training process of neural networks within the Google TensorFlow
framework to learn binary discrimination of the entity of patients
with sepsis and “controls” (trauma patients and healthy controls).
Classification performance of trained neural networks was subse-
quently tested with the unknown samples. The full process of ran-
dom data splitting, network training and prediction was repeated
250 times to test the robustness. Furthermore, stratified ShuffleSplit
cross-validation of the whole approach was used to verify the
reproducibility.
RESULTS. A total of 250 iterations resulted in an area under the
curve (AUC) of 0.999 (Min=0.998, Max=1.000), with a corresponding
sensitivity of 0.98 (Min=0.94, Max=1.00), specificity of 0.99 (Min=0.95,
Max=1.00), and diagnostic accuracy of 0.96 (Min=0.96, Max=1.00).
Random limitation of the provided genes to a fraction of 25% still
enables reliable classification with nearly unaltered performance (n=
250; AUC=0.99 (Min=0.99, Max=1.00), sensitivity=0.98 (Min=0.91,
Max=1.00), specificity=0.97 (Min=0.90, Max=1.00), accuracy=0.97
(Min=0.94, Max=0.99)).
CONCLUSION. The presented approach surpasses the most
advanced solutions for sepsis classification and closes the gap to
comparable studies on cancer diagnosis. By limiting the number of
available genes for prediction, we can prove that, instead of learning
idiosyncratic features tailored to specific data series, generalized
Page 490 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55strategies for sample discrimination have developed in the trained
artificial neural networks. The combination of artificial neural
networks and microarray gene expression data is therefore capable
of achieving sepsis diagnosis with superior accuracy and thus
augments the current diagnostic scope.
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INTRODUCTION. With the rise of the electronic health record (EHR),
new data resources have become available to explore the dynamics
of sepsis through longitudinal physiology. The Critical Care Health
Informatics Collaboration (CC-HIC) is a multicentre research project,
aggregating high-fidelity, time-varying data on critical care patients
from 12 intensive care units across five Biomedical Research Centres
in the UK (1). 263 fields are available including demographics, bed-
side monitoring, drug infusions, microbiology and organ support. We
set out to explore the impact of organ dysfunction trajectories, mea-
sured as the Sequential Organ Failure Assessment (SOFA) score, on
outcomes in sepsis.
OBJECTIVES. To determine how the rate of change of organ
dysfunction (organ dysfunction trajectory) impacts upon prediction
of death in sepsis from a respiratory source. Particular focus is given
to addressing the methodological aspects of informative censoring
and measurement error that characteristically bias analysis of this
type.
METHODS. Joint models allow simultaneous modelling of time-to-
event and mixed effects models through shared latent parameters
(2). Joint models are a class of model that account for informative
censoring, and error-prone repeated measures biomarkers. We ap-
plied joint models to a sample of patients with a diagnostic label of
pneumonic sepsis between 1st January 2014 and 31st December
2018.
RESULTS. A pilot cohort of 611 patients met the entry criteria. There
was a 1.17 fold increase (p = 1.32 x 10-6) in the hazard for death for
every 1 unit increase in organ dysfunction severity (absolute value of
SOFA). The same model describes a 4.93 fold (p = 5.67 x 10-4) in-
crease in the hazard for death for every 1 unit increase in the trajec-
tory of SOFA. The likelihood ratio comparing this model to a model
omitting the trajectory term was 13.57 (p = 0.0002, chi-square, 1 d.f),
suggesting a significant improvement in model fit from the addition
of the trajectory parameter.
CONCLUSION. In pneumonic sepsis, the trajectory of organ
dysfunction (measured as the rate of change of SOFA) not only adds
important information for predicting outcomes, but exerts a
substantially greater effect size over death than organ dysfunction
severity alone.
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INTRODUCTION. Patients are commonly admitted to the intensive
care unit (ICU) in the absence of historical baseline laboratory blood
results, with derangements in hemoglobin and creatinine levels
being particularly common. However, the chronicity and therefore
clinical significance of the derangement is often unknown (Pivovarov
et al., 2014). The richness of data collected in the electronic health
record presents an opportunity to deploy machine learning
techniques to impute baseline hemoglobin and creatinine values.
This lends context to abnormal laboratory results to distinguish
between acute and chronic conditions and can aid optimal medical
decision making.
METHODS. *Design & Participants: Data from the Medical Information
Mart for Intensive Care (MIMIC-III) was used. The MIMIC-III database is
compiled from adult and neonatal ICU stays at an urban tertiary care
center between 2001 and 2012. Adult patients with pre-admission
(“baseline”) hemoglobin and creatinine values available were selected
(6,435 and 5,470 patients respectively). Demographics, vital signs, and
admission laboratory results obtained within two hours of ICU admis-
sion were extracted as model inputs. Patient cohorts were split into
training (75%) and testing datasets (25%). Prediction was done as both
a classification task, using a threshold of 10 g/dL for hemoglobin and
1.2 mg/dL for creatinine, and as a regression task, for which the actual
baseline value was predicted. We trained and compared several differ-
ent types of model: linear regression, logistic regression, gradient
boosting, random forest, and optimal classification trees.
*Outcome measures: Model performance on the classification task
was evaluated with the accuracy and AUC. Performance on the
regression tasks was evaluated using different metrics: R2, MAE, and
MSE. Models were also qualitatively assessed for interpretability.
Strong predictors of baseline hemoglobin and creatinine were
identified via the machine learning techniques.
RESULTS. For the classification task, the AUC across the models
developed was 0.87-0.88 for hemoglobin and 0.88-0.92 for creatinine. For
the regression task, the best-performing model yielded a mean absolute
error (mean difference between predicted and observed value) of 1.0 g/
dL for hemoglobin and 0.30 mg/dL for creatinine, and with a mean
squared error of 1.68 g/dL for hemoglobin and 0.54 mg/dL for creatinine.
R2 values ranged from 0.55-0.58 for hemoglobin and 0.78-0.81 for cre-
atinine. Given that inter-analyzer laboratory variability for hemoglobin
measurement has been reported at 0.3-1.5 g/dL,36 and for creatinine at
0.1-0.2 mg/dL,37 these results are quite significant. We provided an opti-
mal trees diagram (Decision Tree) and ready-to-use application that
shows how the predictions are made (with an AUC of 88-89%).
Page 491 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55CONCLUSION. This study is proof-of-concept that machine learning
methods can predict pre-admission laboratory values when historical
data are lacking. It also proposes a workflow that could be applied to
predict other types of laboratory results. Expansion of these tools
promises to add a new dimension of clinical parameters, help to dif-
ferentiate acute from chronic conditions using limited data, and aid
in real-time clinical decision making.
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Page 492 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. Healthcare-associated infections (HAIs) remain a
major issue among critical ill patients in the intensive care unit (ICU), as-
sociated with substantial morbidity and mortality. Even if the use of
contact precautions (CPs) is highly recommended for patients who
have Multi-Drug Resistant Organisms (MDROs) (1), and considered a
Quality Indicator in Intensive Care Medicine (2), Health Care Workers
(HCWs) effective compliance with its practice seems to be low. Out-
breaks of MDROs strengthened the role of improving adherence to CPs
as part of a multifaceted infection prevention strategy, which may be a
controversial recommendation for some (3). Auditing and giving feed-
back may be a strategy to improve professional practice (4).
OBJECTIVES. Auditing the HCWs (senior physicians, residents, nurses
and healthcare assistants) compliance with indications for isolation
(either preventive or documented) and with supplemental measures;
to evaluate the effects on HCWs practice of giving them feedback
and performing an educational intervention.
METHODS. This is a single ICU study. The ICU includes: 10 level 3
beds and 12 level 2 beds; protocols for preventive isolation and
active screening for carbapenem-resistant Enterobacteriaceae (CRE)
on ICU admission, hand hygiene (HH) and documented isolation. The
audit tool was developed and approved institutionally. The observa-
tion methodology was explained to the auditing team and had 2 pe-
riods of 2 weeks to collect data (November/December 2018 and
March/April 2019), once on each nurse shift, 1 to 3 shifts a day, for
30 minutes, either in level 2 and level 3 ICU beds. In between the
two periods, results of the first audit were disclosed to ICU HCWs,
followed by an intervention (educational sessions with targets and
action plan included).
RESULTS. On the pre-intervention audit, data were collected in 57
shifts (228 observations of patients assigned to contact isolation pre-
cautions); after the educational intervention, data were collected in
37 shifts (162 observations). Main results are presented (pre-interven-
tion %; post-intervention %). Documented isolation was mostly re-
lated to CRE (64%; 72%) and Methicillin-resistant Staphylococcus
aureus (18%; 12%). Personal protective equipment (gown, gloves,
mask) was available at the isolation unit (48%; 57%); was adequately
wore (77%; 87%) and removed (73%; 90%). Glove use was appropri-
ate (84%; 91%) more often than mask (46%; 92%).
Supplemental measures included barriers (69%; 61%) and isolated
rooms (32%; 39%), waste sorting bags next to the bed (98%, 90%).
Concerning HCWs groups, nurses were the most audited (46%; 43%)
and the most compliant with CPs and senior doctors the least
audited (6%; 6%).
CONCLUSION. The adherence of HCWs to CPs was low. Audit and
feedback resulted in practice improvement, however we still seem to
be far from the desirable target of 100%.
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INTRODUCTION. Immobilization during hospitalization stimulates a
complex adaptative response that results in muscle atrophy and loss
of functional performance. Immobility is a frequently understimated
phenomenon during ICU stay and it could be associated with worse
outcomes. Its prevalence and association with mortality is unknown.
OBJECTIVES. To estimate the prevalence of severe ICU-immobility
and its association with 28-day mortality
METHODS. Retrospective study. Over a 6-month period we included
all adults who were admitted to ICU and stayed for more than 48
hours. Patient mobilization was carried out according to local protocol.
Mobility status was assesed daily using the Intensive Care Unit Mobility
Scale (IMS). We considered severe ICU immobility as the inability to sit
with active trunk control (over edge of bed) or IMS <3 during all over
ICU stay (may be assisted by staff). Observed outcomes were 28-day
mortality and ICU lenght of stay (LOS). We performed a multivariate
analysis and Kaplan Meier plots with log-rank test.
RESULTS. 178 patients were included, mean age 60 years old (±18),
APACHE II 16 (±9). The main diagnosis was sepsis (n=60 % 33,7). 96
patients (53,9%) required mechanical ventilation. ICU LOS was 7,2
days (±6), 28-days mortality was 24% (n=42). Severe ICU-immobility
prevalence was 68,5% (n= 122) and was independently associated
with both 28-days mortality OR 6,0 CI 95% 1,8 -19,8 (Figure 1) and
longer stay in ICU (6,2±5,4 vs 9,1±6,8). Requirements of mechanical
ventilation and emergency surgery were independently associated
with severe ICU-immobility (Table 1).
CONCLUSION. Severe ICU- immobility defined as the inability to sit
actively during hospitalization has a high prevalence and is
independently associated with a higher 28-days mortality.
REFERENCE(S)
1. Doiron KA, Hoffmann TC, Beller EM. Early intervention (mobilization or
active exercise) for critically ill adults in the intensive care unit. Cochrane
Database of Systematic Reviews 2018, Issue 3. Art. No.: CD010754.
2. Morris, Peter E.. “Moving our critically ill patients: mobility barriers and
benefits.” Critical care clinics 23 1 (2007): 1-20 .
3. Brown, C. J. et al. “Prevalence and outcomes of low mobility in
hospitalized older patients.” Journal of the American Geriatrics Society 52
8 (2004): 1263-70 .
4. Winkelman, Chris. “Inactivity and inflammation in the critically ill patient.”
Critical care clinics 23 1 (2007): 21-34 .
5. Tipping, Claire J. et al. “The ICU Mobility Scale Has Construct and
Predictive Validity and Is Responsive. A Multicenter Observational Study.”
Annals of the American Thoracic Society 13 6 (2016): 887-93 .
6. Hodgson, C. et al. Feasibility and inter-rater reliability of the ICU Mobility
Scale. Heart and Lung: Journal of Critical Care, 43(1), 19-24.Fig. 1 (abstract 000926). Kaplan Meier plot for ICU mobility status
and 28-days survival
T1
Fig. 2 (abstract 000926). See text for description
Fig. 3 (abstract 000926). See text for description
Fig. 4 (abstract 000926). See text for description
Page 493 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Table 1 (abstract 000926). See text for descriptionVariable Non Severe immobility
(n =56)Severe immobility
(n=122)p
Age - yr (SD) 60,5 (±18,7) 59,7 (±16,7) NSAPACHE II - (SD) 14,1 (±8,5) 16,3 (±8,8) NSICU stay- days (SD) 6,2 (±5,4) 9,1 (±6,8) 0,003Mechanical Ventilation-
n (%)21 (37,5) 75 (61,4) 0,0428 days Mortality- n (%) 4 (7,1) 38 (31,1) <
0,001Sepsis- n (%) 16 (28,5) 44 (36) NSEmergency Surgery- n
(%)2 (3,5) 18 (14,7) 0,038Immunocompromised-
n (%)12 (21,4) 29 (23,7) NSAcute Kidney Injury- n
(%)14 (25) 27 (22,1) NS000936
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INTRODUCTION. The evolvement of airway pressures (Paw) within
the mechanical ventilation may reflect the modifications of the
viscoelastic properties of the respiratory system and may predict
difficult weaning.
OBJECTIVES. To investigate the impact of airway pressures trends on
weaning in mechanically ventilated (MV) patients.
METHODS. Medical records were abstracted for all consecutive MV
patients who were admitted from November, 2015 to February, 2018
in the MICU of Farhat Hached teaching hospital, Sousse,Tunisia. Data
regarding demographics, clinical variables, trends of Paw (Paw at day
4 of hospitalization - Paw upon admission) and outcomes were
recorded from chosen eligible charts. Poor outcomes were defined
as : a ventilator-free days at day 28 (VFDs) = 0 and a composite out-
come : death or length of stay ≥ 14 days. Univariate and multivariate
regression analyses were used to identify factors independently asso-
ciated to difficult weaning.
RESULTS. A total of 304 MV patients were included. Their main
characteristics were : mean age, 56±18 years; male sex ratio,
64.8%(n=197); mean SAPS II, 34.9±14.3; pH, 7,3±0,1; pCO2, 50±
23mmHg; P/F ratio, 204±101; AE/COPD, 105(34.5%); ARDS, 25(8.2%);
restrictive lung disease, 20(6.6%); pneumonia, 14(4.6%); pulmonary
edema, 11(3.6%); median mechanical ventilation duration, 3[6-14]
days; tracheostomy, 44(14.5%); median length of stay, 13[6-21] days;
median VFDs, 0[0-2] days; mortality, 173(56.9%). Median differential
airway pressures for delta peak, delta plateau, delta driving and delta
auto-PEEP were respectively : 0[-5;5], 1[-2;3], 0[-2;3] and 0[-2;0]
cmH2O. Univariate analysis than multivariate logistic regression
showed that an elevated delta plateau is associated with a zero VFDs
F2
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associated with poor composite outcome : (OR, 1.05; 95%CI, [1.009-
1.09]; p=0.017). In COPD patients : an elevated delta plateau was as-
sociated with zero VFDs (OR, 1.1; 95%CI,[1.01-1.21]; p=0.028) and
poor composite endpoint (OR, 1.13; 95%CI, [1.01-1.27]; p=0.026).
While in non-COPD patients it was the elevated delta peak that was
associated with poor outcomes : zero VFDs (OR, 1.06; 95%CI, [1.01-
1.12]; p=0.016) and composite outcome (OR,1.1; 95%CI, [1.03-1.18];
p=0.002).
CONCLUSION. The trends of airway pressures (delta peak and delta
plateau) in mechanically ventilated patients could predict difficult
weaning and so poor outcomes.Fig. 1 (abstract 000945). See text for description
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INTRODUCTION. Internal jugular vein (IJV) and subclavian vein (SV)
approaches are commonly used for central venous catheterization
(CVC) under ultrasound (US) guidance. However, the lateral short axis
approach of distal IJV has been poorly described and never
compared to SV approach.
OBJECTIVES. The aim was to describe the lateral short axis in plane
technique of distal internal jugular vein catheterization and to
compare this approach to the SV approach.
METHODS. Single centre randomized controlled open-label pilot
study. All patients requiring CVC in intensive care unit (ICU)
were randomly assigned to US-guided IJV or to SV approach
(Figure 1). After two unsuccessful punctures, an alternative CVC
site was considered. The primary outcome was the success rate
at the second puncture. The secondary outcomes were proced-
ure characteristics and complications.
RESULTS. A total of 210 patients were included over 18
months. Nine patients were excluded leading to 201 patients
analyzed: 100 in the IJV group, 101 in the SV group. 33% were
female, mean (SD) age was 63 ± 15 years, median (IQR) BMI
was 26 (23-30) and median SAPS II was 44 (35-56). The success
rate at the second puncture was 96% (IC 95% 90-99) for IJV
and 89% (IC 95% 81-94) for SV, p=0.06. In the IJV group, 7
complications occurred: 2 hematoma, 1 arrhythmia and 4 arter-
ial punctures whereas 14 complications were observed in the
SV group: 1 pneumothorax, 2 hematoma, 3 arterial punctures
and 8 catheter misplacements. The first puncture success rate
was 90% for IJV and 81% for SV, p=0.05. The duration until
guidewire insertion was 60 sec in IJV group and 96 sec in SV
group.
CONCLUSION. US-guided IJV and SV approaches are safe and
efficient techniques for CVC insertion. The lateral short axis in-
plane IJV approach deserves first consideration when CVC is
performed in ICU patients given its high success rate, low com-
plication rate and its facility to perform. US-guided SV ap-
proach is a good alternative when no IJV vascular access is
possible.000957
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INTRODUCTION. Following cardiac arrest and return of spontaneous
circulation patients are frequently admitted to the intensive care unit (ICU)
for cardiovascular support and neuroprotection followed by neuroprognos
itication1. This process involves neuroradiological imaging demonstrating
hypoxic brain injury along with other indicators of poor neurological
outcome. Anecdotally, lack of concordance of local reporting of neurorad
iological imaging with clinical and other neurophysiological findings causes
delay in clinical decision making, pending specialist radiological reporting.
Any improvement in this process is likely to improve timely decision
making and lighten the burden of delay and uncertainty for relatives.
OBJECTIVES. A clinical audit to assess for the incidence of
discrepancy between neuroradiological reporting, clinical assessment
and specialist neurological opinion and its impact on definitive
management of post cardiac arrest ICU patients.
METHODS. A retrospective clinical audit was performed on post cardiac
arrest patients admitted to a 15 bed district general ICU over a 3 year
period. Data was collected to evaluate for neuroradiology reporting by
general radiologist, neurologist opinion, neuroradiologist reporting;
whether there was any discrepancy between the opinions and with
clinical findings or other prognostic tests; whether such discrepancies
incurred a delay in definitive management.
RESULTS. 68 applicable patients were identified of which 7 (10.3%) were
found to have a discrepancy between neuroradiology reporting by general
radiologist, neurologist opinion or neuroradiologist reporting. 3 patients
experienced a delay in definitive management as a direct result of this
(mean delay 3.3 days).
Discrepancies between neuroradiology reports by general radiologists and
other modalities of assessment were not fed back to the radiology
department and the quality of clinical information supplied in scan
requests was variable. There was a lack of consistency in the approach to
investigating patients post cardiac arrest which may also have contributed
to delays in definitive care.
CONCLUSION. Although only a small population stands to benefit from
improved management of post cardiac arrest hypoxic brain injury on ICU,
the individual burden is high and potential benefits are to the patient, their
relatives and the efficient use of ICU resources.
T1
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designed to streamline the investigation and treatment of post
cardiac arrest hypoxic brain injury and a referral pathway for
neuroradiology MDT for general radiologists with an interest in
neuroradiology has been created.
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Table 1 (abstract 000957). Results of patients with image reporting
discrepancies% of patients affected by discrepancies in reporting/specialist
opinion10.3% (7)Mean length of time between MRI head and withdrawal of care 1.7 days (0-
7)Percentage of patients affected by delay in definitive management 28.6% (3)Mean length of delay 3.3 days (1-
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INTRODUCTION. Previously, stress ulcer prophylaxis was prescribed
routinely for all patients admitted to the William Harvey Hospital
(WHH) intensive care unit (ICU). Recent RCT and meta-analyses ques-
tion the rationale behind the recommendation of stress ulcer
prophylaxis in ICU as the incidence of gastrointestinal (GI) bleeding
in these patients is low(1). Furthermore, evidence suggests this ap-
proach may not reduce incidence of upper GI bleeds, and may con-
tribute to increased risk of hospital acquired pneumonia and
mortality (2). Many factors put patients at higher risk of GI bleeding;
including mechanical ventilation, coagulopathy, and recent GI bleed.
For those patients, evidence suggests stress ulcer prophylaxis out-
weighs the negatives.
OBJECTIVES. An audit in 2017 aimed to compare the practice at
WHH ICU against published best practice. The findings showed that
many patients admitted to the ICU were prescribed ulcer prophylaxis
unnecessarily. As a result, local guidelines were updated and rolled
out. After 3 months, a re-audit was conducted to assess whether
these guidelines were being followed.
METHODS. Data was collected from patient notes and prescription
charts over two cycles, 1 year apart. Each assessed whether patients
met the accepted criteria for ulcer prophylaxis. Also, if prophylaxis
was prescribed, the drug chosen and route were audited. Finally, we
assessed whether the prescription overall adhered to the guidelines.
In total 97 adult ICU patients were included, 47 in the first cycle, and
50 in the second. Standards are based on Guidelines for the
Provision of Intensive Care Services, edition 1, 2015. The guidelines
state that stress ulcer prophylaxis should be used judiciously, and
only in patients considered to be at high risk of upper GI bleeding.
Risk Factors are: Coagulopathy, (platelet count <50,000, INR >1.5, or
PTT >2 times control value); Mechanical ventilation for >48 hours;
History of GI ulceration or bleeding within the past year; Traumatic
brain injury, traumatic spinal cord injury, or burn injury; Two or more
of the following minor criteria: sepsis, ICU stay >1 week, occult GI
bleeding, or glucocorticoid therapy (>250 mg hydrocortisone).
RESULTS. In the first cycle ulcer prophylaxis was appropriately
prescribed in 15 patients (35%), and prescribed inappropriately in 28
(65%).This improved in the second cycle as ulcer prophylaxis was
appropriately prescribed in 40 patients (80%), and inappropriately in
10 (20%)
CONCLUSION. These findings show a 45% increase in patients that
have ulcer prophylaxis prescribed appropriately between the initial
audit and this repeat.
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INTRODUCTION. To describe the results of the early attention of
critical patients outside the ICU, through a team of intensivists
intended for the "ICU without walls (ICUWW)" from 8 a.m. to 8 p.m.
in a hospital of 400 beds in Lleida, Spain.
METHODS. A descriptive study from January to December of 2018.
Developed in 4 phases: 1: elaboration of the project of ICUWW. 2:
establish activation criteria. 3: dissemination to the services involved
4: implementation and evaluation of the results. The IWW is formed
by a team that is activated with calls from the ER and other services
of the hospital; for the assessment, assistance and follow-up of pa-
tients with clinical impairment and/or risk patients previously
assessed by the ICU night shift or after the discharge of the ICU. The
variables are described as mean± standard deviation or percentage.
For the comparison of the variables the statistical test of Chi-squared
(χ2) was used for categorical variables, and the Mann- Whitney test
for the continuous variables.
RESULTS. The ICUWW attended 932 patients, with a total of 1496
interventions. 63% were men and 37% women, with an average
age of 61±17 years. The average time of attention was 81±60
minutes/patient with one average follow-up of 1.36 days. 52%
had medical pathologies, 38.2% surgical and 9.8% traumatic. The
29.7% were assessed at the ER, 13.2% at the general surgery unit
and the rest in other areas. 49.3% of the attention was made by
a direct call; 5.6% was a follow-up of patients assessed in the
previous ICU night shift, 11,4% required central venous catheter
placement, 14.2% any other procedure, 5.7% were the follow-up
of fragile patients after the ICU discharge and the rest 19,5% by
other causes. The 17.2% required admission to ICU, 13.5% did
not require admission because of the absence of criteria or for
having completed adequate management outside of the ICU. A
limitation of therapeutic effort was decided in 8.5%. Of the pa-
tients that required follow-up (N=193), 20.7% needed more than
2 days; 14% admission to ICU and the rest avoided the admis-
sion. Only (N=53) 24.5% of the patients with a follow-up after
the discharge from ICU required re-entry out the global of our
unit (N=1053) that is 6,12%.
CONCLUSION. The number of patients treated outside of the ICU
justifies the creation of the ICUWW. We also describe different
groups of patients attended by the ICUWW. During the study period,
the ICUWW avoided admission to ICU in 26.3% of cases thanks to
the early care of patients with clinical deterioration and the
management of these by an intensivist regardless of the location
and pathology.
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INTRODUCTION. Practitioners have limited evidence to guide
them in the use of extracorporeal membrane oxygenation
(ECMO) for adult patients with septic shock. Studies suggest the
mortality of septic shock not on ECMO can be greater than 40%
while the mortality of septic shock on ECMO may be as high as
70%. Given the high incidence of sepsis in intensive care units
(ICUs), it’s important to understand the impact of ECMO on
resource utilization and survival.
OBJECTIVES. Our primary objective was to determine the mortality
difference in septic shock patients in those requiring ECMO and
those who did not. Secondary outcomes included the rates of blood
product transfusions, subsequent organ failure, and ICU. We then
sought to determine the risk factors for death in the ECMO group
using multivariate analysis.
METHODS. A single center retrospective study was performed on
adult patients (≥ 18 years) at Mayo Clinic Rochester with septic
shock between 01/01/2009 and 06/30/2018. Post-cardiotomy pa-
tients were excluded. Data extraction was accomplished using
digital queries from the institutional data repository and included
demographic, laboratory, blood product transfusion, and outcome
data. Patients were categorized into those with septic shock and
those with septic shock subsequently requiring ECMO and
assessed for differences in the primary and secondary outcomes.
Multivariate analysis was performed on the ECMO patients explor-
ing risk factors for death.
RESULTS. Of the 3335 patients with septic shock, 52 of them
underwent ECMO. Significant differences existed between the two
groups with those requiring ECMO being younger and having an
elevated SOFA score as well as increased lab derangements at
baseline. In-hospital mortality in the ECMO group was 50% as
compared to those not on ECMO with 32% (P=<0.0074). Second-
ary outcomes in the ECMO and non-ECMO groups respectively in-
cluded: i) packed red blood cell use of 10,567.25 ± 9572.46 ml vs
1136.60 ± 4094.56 ml (P=<0.0001) ii) acute kidney injury inci-
dence during the hospital stay was 69% vs 29% (P=<0.0001) with
77% patients requiring hemodialysis vs 26% iii) the median ICU
length of stay of 20.56 ± 33.8 vs 6.01 ± 8.34 days (P=<0.0001)
and hospital length of stay of 37.74 ± 38.35 vs 16.32 ± 23.99
days (P=<0.0001). Multivariate analysis of risk factors for death on
ECMO included association of diabetes (P=0.0575), maximum total
serum bilirubin concentrations > 10.9 mg/dl (P=0.0146), maximum
lactate elevation > 11.9 mmol/L (P=0.0319) and charlson score
>2.8 (P=0.0250). Area under the curve with these four variables
was 0.89.
CONCLUSION. Mortality is significantly increased in patients with septic
shock requiring ECMO compared to those not requiring ECMO with
mortality of 50% while also suffering from increased rates of blood
product transfusion, multiorgan failure and overall length of stay. Risk
factors for mortality in septic shock patients supported on ECMO included
lactic acidosis, hyperbilirubinemia, diabetes and high charlson score.
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INTRODUCTION. Advances in intensive care medicine is increasing
patient survival in Intensive Care Units (ICU) and outcome
assessment should shift from short-term mortality to long-term out-
comes of ICU survivors (1). Long-term mortality after acute critical ill-
ness can be considered a patient-centered outcome (2).
OBJECTIVES. This study aimed to evaluate factors influencing
survival of ICU patients 5 years after hospital discharge.
METHODS. A retrospective study was conducted in adult patients
admitted to a 20-bed multipurpose ICU of a tertiary center during 6
months.
RESULTS. Of a total of 209 patients, 21.5% died during ICU stay.
Factors statistically associated with death in ICU were age (p=
0.005), Charlson Score (p<0.001), SAPS II (p<0.001), APACHE II (p<
0.001), SOFA at admission (p<0.001), need for vasoactive drugs
(p=0.015), invasive mechanical ventilation (<0.001) and need for
renal replacement therapy (p=0.024). All these factors were also
associated with in-hospital mortality in ICU survivors (cumulative
mortality of 36.3%). In addition, late readmission (>72h) in ICU
(p=0.008), but not early readmission, was associated with in-
hospital death. Overall mortality of ICU patients was 46.9%, 53.6%
and 56.9%, 1, 3 and 5 years after hospital discharge, respectively.
Mortality in patients surviving hospital admission (N=133) at 3
and 5 years after discharge was associated with age (p<0.001)
and Charlson Score (p<0.001).
CONCLUSION. Long-term mortality of critically ill patients was associ-
ated with age and comorbidities, but not with factors of acute illness
that were associated with ICU and in-hospital mortality.
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INTRODUCTION. Since its first description in humans, increased
blood lactate levels have been related to morbidity and mortality (1).
Although lactate is mistakenly considered a biomarker for sepsis,
there are many other causes for hyperlactatemia in Intensive Care
Unit (ICU) general population (2).
OBJECTIVES. To evaluate the influence of patient and clinical
characteristics on blood lactate values in a non-infected versus an in-
fected population at ICU admission and define differences in
outcomes.
METHODS. Post-hoc analysis on hyperlactatemia in the INFAUCI
study, a prospective, observational, cohort, multicenter study,
conducted in 14 Portuguese ICUs with data collected between 1
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chotomized around the median values for all the patients.
RESULTS. A total of 3766 patients were admitted to INFAUCI
study, with 1619 patients being included in the non-infected
group and 1640 patients in the group infected at admission for
the purpose of this post-hoc analysis, having a median lactate of
2.0 and 2.15 mmol/L (p<0.001), respectively. In both non-infected
and infected groups, lactate significantly increased with SAPS II
score, SOFA score and Charlson score. Only in infected group lac-
tate was also higher with age. Longer ICU length of stay was not
associated with differing lactate at admission in the non-infected
group, but a significant decrease in lactate was observed in the
infected group. ICU survivors had a median lactate at admission
of 1.9 mmol/L [1.1-3.0] in the non-infected group and 2.0 mmol/L
[1.2-3-1] in the infected group, while non-survivors had signifi-
cantly higher values of 3.3 mmol/L [1.8-7.0] and 3.4 mmol/L [1.9-
7.0], respectively. This difference between survivors and non-
survivors was higher in both groups when ICU length of stay was
less than 6 days. The ROC curve for ICU mortality in the non-
infected group had an AUC of 0.679 [0.637-0.722] compared with
0.865 [0.838-0.892] for SAPS II. In the infected group, the AUC for
lactate was 0.667 [0.63-0.70] compared with 0.734 [0.710-0.767]
for SAPS II.
CONCLUSION. Lactate is a predictor of mortality for both non-
infected and infected patients, showing similar variations in both
groups. Lactate levels were similar in both groups meaning that is
not a good biomarker to differentiate between infection and other
causes of admission.
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INTRODUCTION. The shared decision making(SDM)has became the
major care model enbodying patient centered care and physician-
patient equality interaction. Tracheostomy creation was not well ac-
cepted in critical patients due to mis-understanding of patients or
their family, espcially in Taiwan. The aim of this study is to investi-
gate the impact of novel interactiveSDM on early tracheostomyin
prolonged intubated critical patients.
METHODS. Medical record ofconsecutive patients with respiratory
failure in adult intensive care unitof tertiary medical centerfrom
2016 to 2017 was retrospectively reviewed. These patients were
further divided into pre-SDM (2016) and post-SDM(2017) interven-
tion period for analysis. Prolonged intubation was defined as dur-
ation of mechanical ventilation more than 14 days and sub-acute
respiratory care center transferal needed. Early tracheostomywas
defined as tracheostomy created within 14 days since being intu-
bated and ventilated. Conversely, late tracheostomy was defined
as tracheostomy created beyond the 14th day after intubation
and mechanical ventilation. Patient who was successful weaning,
chronic ventilator dependent before admission, post tracheos-
tomy creation surgery, or expired were excluded. Data includingtotal tracheostomy rate, early and late tracheostomy rate, ventila-
tor weaning rate and ventilator days, in-hospital mortality, and
length of hospital stay of prolonged intubated patient were col-
lected. SPSS was applied for statistically analysis, and a p value
less than 0.05 was considered significant difference.
RESULTS. Total 1253 patients with 7137 patient ventilator days
were enrolled. Total tracheostomy rate improved from 8.8% in
pre-SDM(2016) phase to 9.6% in post-SDM(2017) phase. Among
1253 patients, there were 128 patients with prolonged intubation
in2016 and 112 patients in 2018for further analysis.After introdu-
cing SDM, late tracheostomy rate reduced from 43.8% to 40%
and ventilator weaning rate improved from 69.5% to 74.1%in
prolonged intubated patients. However there was no significant
difference in in-hospital mortality(4% v.s 5%), and length of hos-
pital stay(65.2 v.s 64.5) in prolonged intubated patients. In com-
parison late tracheostomy, the early tracheostomy patients had
lower ventilator days(34.6+/-17.6 v.s 47.5+/-28.4, p: 0.004) and the
length of hospital stay(57.2+/-21.8 v.s 68.4+/-26.8, p: 0.028). How-
ever, there was no difference in the ventilator weaning
rate(69.2% v.s 76.7%, p: 0.389) and in-hospital mortality(10.3% v.s
8.2%, p: 0.737) between early tracheostomy and late tracheos-
tomy of prolonged intubated patient.The tracheostomy decision
making time delay in post-SDM phage was shown 5 days less
than pre-SDM phase.
CONCLUSION. This studydemonstrated that introducing novel
interactive shared decision making can shorten the tracheostomy
decision time delay, further improve total tracheostomy rate,late
tracheostomy rate and ventilator weaning rate.The latetracheostomy
patients had higher ventilator daysand length of hospital stay than
early tracehostomypatients.
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INTRODUCTION. Critical illness is strongly linked to malnutrition and
diaphragm dysfunction (DD) in intensive care unit (ICU) patients.
Bedside ultrasonography is a useful tool to detect DD with high
specifity. In this study, we aimed to adress the relationship between
malnutrition risk and diaphragmatic measurements in medical ICU
patients.
METHODS. We measured the diaphragmatic excursion, thickness
and thickening fraction (TF) in all patients with B-Mode ultrason-
ography. Nutritional risk screening-2002 (NRS-2002), Subjective
global assesment (SGA), Modified Nutrition Risk in Critically ill
(MNUTRIC) scores and measurement of Mid-upper arm circumfer-
ence (MUAC) were used to differentiate the nutritional status. Pa-
tients with NRS-2002≥3, SGA<6, mNUTRIC score>4, MUAC<22 cm
for female and<23 cm for male were accepted under malnutrition
risk. Definition of DD was accepted TF≤20% and/or tidal DE<10
mm, diaphragm atropy (DA) was accepted diaphragm thickness
of <0.2 cm measured at the end of expiration. Comparisons be-
tween DD, DA and nutritional status were analyzed by using Fish-
er's exact and Chi square test.
RESULTS. Median age was 71 [60-72], 52% were female, 62%
were mechanically ventilated and ICU mortality was 32% in 50
study patients. APACHE-II score was 20±6, SOFA score was 6±2.
The most common cause of ICU admission was pulmonary dis-
eases (68%) and the most common comorbidity was heart failure
(40%). Malnutrition risk rate was varied between 54% and 78%.
28% of the patients had DA and 24% had DD. Malnutrition risk
T1
T1
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with DD (p<0.05) but was not correlated with DA (p>0.05). In-
versely, malnutrition risk diagnosed by MUAC was not correlated
with DD but it was correlated with DA. Malnutrition risk accord-
ing to mNUTRIC score was an independent risk factor for DD
(OR:6.6, 95%CI, 1.3-34; p=0.026). DD, DA and malnutrition risk as
mNUTRIC score were more frequent in non-survivors (p<0.05) but
none of them were independent risk factors for mortality
(p>0.05)
CONCLUSION. Diaphragmatic measurements can be a good
indicator for malnutrition risk or nutritional status in medical ICU
patients.
Table 1 (abstract 001022). Relationship between diaphragmatic
measurements and malnutrition risk in medical ICU patients
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INTRODUCTION. Chronic critical illness (CCI) is defined as prolonged
length of stay (LOS) in the intensive care unit (ICU) (longer than 21
days) due to mechanical ventilation dependence or other intensive
care treatments[1].
OBJECTIVES. We aimed to determine CCI rates and its cost for our
hospital.
METHODS. A retrospective cohort study was designed in patients
admitted between 1 January 2017 and 31 December 2018 in Dr. Suat
Seren Chest Disease and Surgery Teaching and Research Hospital
ICU, İzmir, Turkey. Patients with a LOS less than 24 hours in ICU were
excluded. We collected patient data from the hospital electronic
system.
RESULTS. Data are expressed as median (25th-75th percentiles).
1015 patients were included to the study and 152 of them (15%)
were chronic critically ill. Age, APACHE-2 score, LOS and daily
cost were higher in patients with CCI (Table 1). LOS of patients
with CCI was 31 (25-48) days. Daily cost for patients with CCI
was 1020 (212$) Turkish Liras (TL) and 956TL (199$) patients
without CCI (p<0.001). The need for vasopressor drugs and renal
replacement therapy (RRT) in patients with CCI was 73% and
22%, respectively (p<0.001).
CONCLUSION. The rate of CCI was 15% in our ICU. More use of
vasopressor drugs and RRT in patients with CCI may result in a
slightly higher daily cost.
REFERENCE
1. Carson SS, Bach PB (2002) The epidemiology and costs of chronic critical
illness. Crit Care Clin 18:461–476
.




Age (yr), median (IQR) 68 (59-76) 71 (62-79) 0,019APACHE-2, median (IQR) 18 (14-23) 20 (16-25) 0,001LOS (Days) median, (IQR) 6 (4-9) 31 (25-48) <
0,001Tracheostomized patients n, (%) 32 (4%) 77 (51%) <
0,001Day of Tracheostomy, median
(IQR)7 (6-11) 16 (9-22) 0,001Daily Cost (TL)*, median (IQR) 956 (888-1126) 1020 (956-1099) <
0,001CCI Chronical critical illness, LOS Length of stay, TL Turkish Lira
*1TL≅0.20$
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INTRODUCTION. Sepsis survivors are at increased risk of death up to
10 years after their ICU treatment.(1)The reasons are not fully known,
but post-sepsis abnormal immune function may play a role. Acute in-
flammation may be followed by a chronic anti-inflammatory state with
a severely impaired immune function which could associate with in-
creased morbidity.(2) The immune suppressed state may last long and
could lead to an increased risk for malignant disease as has been re-
ported in other immune suppressed states, such as organ transplant-
ation.(3, 4) Sepsis and cancer may also share common risk factors.
OBJECTIVES. To study the incidence of cancer in patients admitted
to intensive care units for the treatment of sepsis and compare it
with that of the general population.
METHODS. The study cohort was formed of adult patients admitted to
an intensive care unit (Swedish Intensive Care Registry) in 2005-2015
and who had a diagnosis of sepsis (ICD-10 codes A41.9, R57.2, R65.1).
Patients with no record in the population register or aged <20 years at
the index admission were excluded. The data on cancer diagnoses
were obtained by linking the cohort to the Swedish Cancer database of
The National Board of Health and Welfare. The individuals were
followed from the index admission until death, emigration or end of
2015, whichever occurred first. We calculated the standardized inci-
dence ratio (SIR) of any cancer and ten most frequent cancer types as
the ratio between the observed and the expected number of cancers.
The Swedish population served as the reference and cancer statistics
on this population was retrieved from the NORDCAN database.(5, 6) To
account for the potential detection bias and reverse causation, we
assessed the SIRs by follow-up time divided into smaller intervals and
focused the SIR calculated among 6-month survivors.
RESULTS. After applying the exclusion criteria, the study population
comprised 30051 individuals, of whom 841 patients died on
admission day. The median follow-up time was 2.2 years (IQR 0.25-
4.86). A total of 6928 patients died within six months and 10091 dur-
ing the whole follow-up period. Six-month survivors contributed to
the follow-up with 85321.3 person years. The median age at the be-
ginning of the follow-up was 69 (IQR 60-77). New cancer diagnoses
F2
F2
Page 499 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55were found on 1801 patients. Focusing on new diagnoses six months
after sepsis and later, we found an increased SIR in non-melanoma
cancer of skin and cancer of liver and gallbladder. Decreased SIRs
were observed in colorectal, prostate, lung, bladder, breast and ovar-
ian cancers. Forest plots demonstrating the standardized incidence
ratios for each gender are shown in Figure 1.
CONCLUSION. Long-term incidence of malignant disease in patients
treated in intensive care units for sepsis is altered, as compared with
age and gender-matched general population.
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INTRODUCTION. The most frequent management strategy in
critically ill patients is intravenous fluids. There is still debate about
the amount administered, becoming a problematic intervention. For
this reason, it is recommended to perform a liquid therapy guided
by goals, given that the fluid overload, defined as an increase of 15%
of the body weight of the income (equivalent to approximately 2.5
liters of absolute balance), is associated with increased morbidity,
mortality, over-cost and prolonged hospital stay.
OBJECTIVES. To determine if a positive balance of fluids is an
independent factor of mortality in the postoperative critically ill
patient in the Intensive Care Unit at the University HospitalFundacion Santa Fe de Bogotá in Colombia, between January and
December 2017.
METHODS. We conducted a retrospective, cross-sectional, observa-
tional study in an Intensive Care Unit in Colombia for one year. We
collect data on patient characteristics. The primary outcome was hos-
pital mortality. Bivariate and logistic models were done to explore
the association between Fluid overload and mortality in this cohort
RESULTS. Three hundred sixty-four patients were meeting the inclu-
sion criteria. Three hundred thirty-five patients with complete data
on fluid balance. Mean age was 60 years; 51,9% were women. The
acute physiologic and chronic health evaluation (APACHE) II score
was nine at ICU admission, and median ICU stay duration was 6,4
days. The fluid balance median in 24 hours is 1200 ml, and 60 % of
patients had a fluid overload at ICU discharge. Overall mortality was
6%, and statistically association was found between the positive bal-
ance of fluids and mortality at ICU admission, at 24 hours, at seven
days after admission, and a total balance of 3.5 liters or more with
inhospital mortality.
CONCLUSION. Positive fluid balances more than 3.5 liters lead to
negative outcomes for patients, in this case in the critically ill and
post-operative should be goal directed therapy, maintaining a neu-
tral fluid balance. In case that not check this therapy in your bundles
it could be negatively impacted in mortality, especially at the 7th day
ICU stay.
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INTRODUCTION. End of life practice (EOLP) – i.e. care of ICU patients
with an end-of-life decision (EOLD) to limit life-sustaining therapies –
is common practice nowadays. Critical Care Physicians face these de-
cisions nearly every day However, data on the organizational burden
accompanying this procedure is sparse.
OBJECTIVES. We evaluated ICU days spent on patients with an EOL
decision order (EOLD).
Page 500 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55METHODS. This study presents data from our ICU which participated
in the worldwide Ethicus-2 study on ICU end-of-life care practices
(EOLP) in ICUs.
RESULTS. During a 6 month period 1958 adult patients were
admitted to a 42 bed surgical ICU of a tertiary hospital. In 183
(9,34%) - 115 male; mean age 71,7 ± 11,7 SD; 68 female; mean age
74,3 ± 11,2 SD - EOLP was applied. 26 left the ICU alive and 16
survived the hospital stay which corresponds to an ICU mortality of
85,8% and a hospital mortality of 91,3% respectively. The ICU stay
(LOS) until the EOLD was 104,36 hours [mean, 95% CI 128,57-80,15]
and 47,86 hours [mean, 95% CI 61,65-34,07] elapsed between the
decision and death or discharge. The mean LOS in the EOLD patients
was 6,7 ± 9,3 days (mean, SD). The LOS from EOLD until ICU
demission corresponded to 364,17 patients days.
CONCLUSION. In times of shortage of ICU beds in level 3 hospitals
this may be an important finding. Since the mean LOS in this
particular ICU is 3,3 days this means that during the 6 month
observation period about 110 additional patients did not get access
to the ICU and thus possibly received suboptimal care. This capacity
strain (1) may further impede the process of triage recently
recommended by a Task Force of the World Federation of Societies
of Intensive and Critical Care Medicine (2). The considerable
organizational burden of palliative care in the ICU calls for alternative
resource allocation and end-of-life care pathways.
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INTRODUCTION. Medical Emergency Teams (METs) provide
assessment and early intervention for patients outside critical care
areas. The implementation of METs led to the decrease of
resuscitations, critical care transfers, overall mortality and cost.
In 2015 the authors implemented a MET in their hospital. Activation
criteria were adapted to the local reality and were grouped under:
airway, ventilation, circulation, neurological status and clinical criteria.
After 3 years of implementation, the results obtained from the
present and previous studies (1,2) are worrying. The future
interventions are now set to improve education and early
recognition of signs and symptoms of patient clinical deterioration.
OBJECTIVES. To evaluate the MET implementation adequacy.
METHODS. Observational prospective study of the MET activity, from
October 2015 to December 2018. Data was obtained from the MET
registry and from the patient clinical charts. Categorical variables
were described as absolute frequencies (n) and relative frequencies
(%). Median and interquartile range were used for continuous
variables. Statistical analysis was performed using the software
Statistical Package for the Social Sciences v. 25.0.
RESULTS. During this period, 1672 primary activations were
registered, 56.1% of which for male patients. The median age was 76
years (IQR 65, 84); the youngest patient was 1 year old and the
oldest was 99 years old.
The surgical department was responsible for the majority of
activations, representing 47.2% (n= 789) of the total events.
Going through the evolution of the number of activations there was
a progressive decrease since the first quarter of activity (2015: n=185;
2016: n=628; 2017: n=410: 2018: n=449).
Mortality was evaluated at 30 days, with 773 deaths (46.2% of total
activations), of which 43.9% were under the event Circulation and
38.6% under Airway/Ventilation. Of the total deaths, 66.8% occurred
within 72 hours of the MET intervention. The MET was activated 197times for the event Cardiac Arrest, with an increase in the relative
frequency from 2015 until 2017 and a slight drop in 2018 (2015:
8.4%, 2016: 11.3%, 2017: 13.6%, 2018: 12.0%). This subgroup of
events presents a 30-day mortality of 94%. Available hospital mortal-
ity rate data are 7.46 in 2015; 8.35 in 2016 and 8.64 in the first quar-
ter of 2017.
CONCLUSION. Hospital mortality is high and consistent with MET
data. However, it should be emphasized that it was not possible to
exclude end-of-life decisions from both the hospital and the MET
mortality.
The activation decline over time reinforces the importance of
continuous education.
The mortality results, even after the MET intervention, point towards
a delay in activation, with a small benefit to the intervened
population.
A multidisciplinary intervention is necessary. A certified training
center has already been set in 2019 and the official training program
has started. Besides basic and advanced life support formation, the
team activation criteria will be recalled, and emphasis will be given
on the need for early recognition of signs of clinical instability.
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INTRODUCTION. Sepsis still represent a major health issue. Many
sepsis biomarkers have been tested in the past years. Pentraxin-3
(PTX-3) has been proposed as a valuable diagnostic tool.
OBJECTIVES. To compare PTX3 and Procalcitonin (PCT) in the
diagnosis and prognostication of sepsis in medical critically ill
patients in a medico-surgical intensive care unit.
METHODS. PTX3 and PCT plasma concentrations were measured in
prospectively adult medical intensive care unit (ICU) patients within
24 hours from admission and thereafter daily. Their levels were
compared in infectious and non-infectious conditions. The ability of
PTX3 and PCT to discriminate sepsis was evaluated using receiver op-
erating characteristic (ROC) curves and the respective areas under
curves (AUCs). The best cut-off values of both sepsis markers were
calculated using diagnostic odds ratio (DOR). To assess the prognos-
tic value of the day-by-day changes of PCT and PTX3 plasma levels
wecomparedthe incidence of ICU- and in-hospital mortality in pa-
tients with and without two consecutively increases of these markers
above the value exceeding the cut-off level.
RESULTS. We included 37 consecutive patients who were admitted
to our ICU for an expected time longer than 48 hrs (186 patient-
days-pd). The mortality rate was 21.6%. Patients with sepsis (66 pd)
and septic shock (29 pd) had higher PTX3 (3.69± 2.83 μg/L and 5.35
± 3.13 μg/L) and PCT plasma concentrations (7.82 ± 13.6 μg/L and
8.45 ± 11.5 μg/L), compared to those without infection (91 pd, 3.18 ±
2.9 and 0.88 ± 0.93 μg/L, respectively, p < 0.01). The area under the
ROC curve for PCT was greater than the one for PTX3: 0.89 (CI 95%:
0.83-0.93) vs 0.65 (CI 95%: 0.57-0.72) (p=0.037). The cut-off values of
2.4 μg/Lfor PTX-3, and of 1.4 μg/Lfor PTX3 yielded the highest DOR
for sepsis diagnosis. Patients who survived had lower values of PCT
and PTX3 compared to the group of patients that died, both at ad-
mission time (7.14 ± 15.08 μg/L vs 12.3 ± 14.3 μg/L p=0.4 for PCT
Page 501 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55and 5.08 ± 3.42 μg/L vs 9.03 ± 1.0 μg/L p<0.009 for PTX3), anddaily
(PCT: 4 ± 9.6 μg/L vs 7.1 ± 10.7 μg/L p=0.09 and PTX3: 3.1 ± 2.7 μg/L
vs 6.2 ± 3.2 μg/L p<0.001). Patients with two consecutive daily in-
creases of PCT and PTX3 had in-hospital mortality rate of 66.7% and
61.5% respectively, compared to patients without two consecutive
daily increases of PCT and PTX3 that had an in-hospital mortality rate
of 8.0% and 8.3% (p < 0.01) respectively.
CONCLUSION. In our small cohort of medical ICU patients, both PCT
and PTX3 could discriminate sepsis, PCT being a highly better
diagnostic tool. Both marker time course revealed to have some
prognostic power to be further investigated.
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INTRODUCTION. Patients with septic shock have a catabolic state
that leads to a depletion of the skeletal muscle compartment early.
The loss of muscle mass is associated with an increased risk of
nosocomial infections, prolonged mechanical ventilation, longer ICU
and hospital stays, and increased mortality.
OBJECTIVES. To determine the loss of muscle mass in patients with
septic shock by ultrasound evaluation of the right rectus femoris
muscle, and its correlation with morbidity and mortality.
METHODS. Prospective study that includes 11 patients with septic
shock of different focus. Ultrasound measurement of the area of the
rectus femoris muscle (CSA RF) was performed on admission and
after 7 days, as well as a qualitative assessment using Heckmatt
Score. Demographic variables were collected, time MV, ventilator-
associated pneumonia, weaning failure, tracheostomy, ICU and hos-
pital stay, mortality.
RESULTS. The average age was 60.6 years +/- 11.9. 72.7% were male.
Reason for admission: Respiratory (72.7%), abdominal (18.2%) and
urological (9.1%) sepsis. Apache II mean at admission was 23.73 +/-
9.27; the mean SOFA upon admission was 10.64 +/- 2.76. The median
time on mechanical ventilation was 18 days. 45.5% had VAP and
72.7% required a tracheostomy. The median stay in the ICU was 24
days. The mortality in the ICU was 27.3%, the survival at 6 months
was 54.55%.
We observed significant differences between the loss of muscle mass
during the first 7 days and mortality (Test Chi2 p 0.027), however,
when performing the ANOVA analysis we found no significant
relationship between the variables (F 3.4, p 0.102). We did not find
significant differences with the duration of mechanical ventilation,
VAP or stay. It is a small sample, so it is not yet possible to draw
conclusions.
CONCLUSION. - Muscle ultrasound is a useful tool at bedside and
easy to perform, specifying a small learning curve
- Wasting muscle plays a fundamental role in the evolution of the
critical patient, so its monitoring and minimization is key to modify
the prognosis of our patients.
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INTRODUCTION. Neutrophil extracellular traps (NETs) formation is a
novel mechanism by which neutrophils immobilise and kill
pathogens and are increase in critical illnesses such as sepsis (1, 2).
Recent studies highlight the harmful effects of NETs by providing a
scaffold for thrombosis, resulting in microvascular occlusion and
multiple organ failure (MOF) (3). Interleukin-8 (IL-8) is a potent factor
for neutrophil recruitment and activation during sepsis, and has re-
cently been demonstrated to induce NETs in vitro(4, 5).
OBJECTIVES. To establish the pathophysiological role of IL-8 induced
NETs formation in a murine model of sepsis.
METHODS. Sepsis was induced in mice by caecal ligation and
puncture (CLP) or intraperitoneal (i.p) injection of Escherichia
coliwithout and with anti-IL-8 therapy. Histopathological analysis was
used to measure NETs formation and Acute Lung Injury (ALI). Blood
Urea Nitrogen (BUN) and Alanine aminotransferase (ALT) were mea-
sured to investigate the levels of organ injury. Survival analysis was
observed in CLP septic mice.
RESULTS. We specifically observed NETs positive staining (cit-H3)
in the lung tissue of mice following sepsis, which was associated
with increases in lung injury scores compared to control mice.
Ten hours following induction of both sepsis models, lung injury
was significantly attenuated by anti-IL-8 therapy (CLP: P<0.001,
E.coli: P<0.001), along with circulating markers of both liver
(BUN [CLP: P=0.005, E.coli: P<0.001]) and kidney (ALT [CLP: P=
0.01, E.coli: P=0.002]) injury. Finally, we observed significantly im-
proved survival times in septic mice treated with anti-IL-8 ther-
apy compared to septic mice without therapeutic intervention
(P=0.004).
CONCLUSION. Targeting IL-8 reduced NETs-induced organ injury and
increases survival rates in mice with sepsis. This could provide a
novel therapy in improving clinical outcome in critically ill patients.
REFERENCE(S)
1. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS,
et al. Neutrophil extracellular traps kill bacteria. science.
2004;303(5663):1532-5.
2. Czaikoski PG, Mota JMSC, Nascimento DC, Sônego F, Melo PH,
Scortegagna GT, et al. Neutrophil extracellular traps induce organ
damage during experimental and clinical sepsis. PloS one.
2016;11(2):e0148142.
3. McDonald B, Davis RP, Kim S-J, Tse M, Esmon CT, Kolaczkowska E, et al.
Platelets and neutrophil extracellular traps collaborate to promote intra-
vascular coagulation during sepsis in mice. Blood. 2017;129(10):1357-67.
4. Ness TL, Hogaboam CM, Strieter RM, Kunkel SL. Immunomodulatory role
of CXCR2 during experimental septic peritonitis. The Journal of
Immunology. 2003;171(7):3775-84.
5. Hazeldine J, Harris P, Chapple IL, Grant M, Greenwood H, Livesey A, et al.
Impaired neutrophil extracellular trap formation: a novel defect in the
innate immune system of aged individuals. Aging cell. 2014;13(4):690-8.
001366
Alfatorquetenovirus: a new sepsis biomarker?
N. Segura-Marín1, E. Albert2, S. Martinez1, P. Pardo1, D. Navarro2, G.
Aguilar1
1Anaesthesia and critical care, University Hospital, València, Spain;
2Microbiology, University Hospital, València, Spain
Correspondence: N. Segura
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001366
Page 502 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. The use of biomarkers in sepsis is very useful for the
early diagnosis of and to establishing a prognosis. The desired marker
should be sensitive, specific, fast and accurate. Procalcitonin (PCT) is one
of the measurements approved by the FDA, although its efficacy is still
questioned1. The determination of alfatorquetenovirus (TTV) could be a
useful marker2.
OBJECTIVES. 1. Establish a relationship between the viral TTV load
and the prognosis of sepsis
2. Relate the viral TTV load with inflammatory parameters
METHODS. We analyzed 55 samples from 23 patients admitted to
intensive care with clinical suspicion of sepsis. Analytical data of C-
reactive protein (CRP), neutrophils and procalcitonin were collected.
The SOFA and APACHE II scores were calculated, and the patients
were stratified according to these five values in good and poor
prognosis.
A quantitative determination of TTV was carried out from each
sample using a quantitative PCR3. We calculate the area under the
curve of the TTV plasma values as a function of time.
The differences between medians were compared using the U-Mann-
Whitney test. The correlation between variables was measured using
the Spearman correlation. The relationship between qualitative vari-
ables was studied through Chi2 analysis. The value of P <0.05 was
considered statistically significant.
RESULTS. We have found an inverse relationship, not significant,
between the TTV AUC and the patient´s proinflammatory level and
therefore with the disease´s prognosis.
A tendency (not significant) was found between poor prognosis and
the procalcitonin´s median values and CRP being higher in the group
with poor prognosis.
A trend was observed indicating that at a lower TTV DNAnemia is
related to worse prognosis.
An inverse relationship was found between procalcitonin and CRP
values and the TTV copies / ml in plasma, (rho = -0.132 and -0.349
respectively) nonsignificant correlation in the case of procalcitonin.
There was a clear trend between the neutrophils´ expansion and the
regression line slope, obtained between the TTV loads in the first two
study times.
The results obtained indicate a possible relationship between
immune exacerbation degree and TTV DNAemia.
CONCLUSION. The TTV quantitative determination could be useful as
a proinflammatory marker in sepsis, both for its low cost and its ease
in the determination as for its relationship with the functionality of
the patient's immune system. It is necessary to carry out a study with
a larger sample size to corroborate the validity of our hypothesis and
in turn to establish a TTV threshold that allows us to anticipate the
disease clinical outcome.
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INTRODUCTION. Sepsis-induced myocardial dysfunction (SIMD) leads
to increased mortality in septic patients. Mitochondrial dysfunction is
confirmed to be involved in the development of SIMD. Sirt3 is identi-
fied as one of the major mitochondrial deacetylases, whose activity is
necessary to prevent mitochondrial dysfunction. However, the role of
Sirt3 in the development of mitochondrial dysfunction associated
with SIMD have not been determined.
OBJECTIVES. To investigate the potential role of Sirt3 in SIMD and
identify the key protein post-translational modifications related to
mitochondrial dysfunction.
METHODS. In a lipopolysaccharide (LPS)-induced sepsis mouse
model, animals were divided into 4 groups: WT-PBS, WT-LPS, Sirt3(-/-
)-PBS, and Sirt3(-/-)-LPS. Cardiac function of animals was evaluated by
echocardiography, and the indicators of cardiac hypertrophy and in-
flammatory factors were detected in heart tissues. The level of mito-
phagy in the hearts by examining the expression of autophagy-
related proteins and autophagosome, as regulated by LPS and/or
SIRT3 was also detected. Furthermore, label-free quantitative prote-
omic analysis by using mass spectrometry was performed to
characterize the acetyl-proteome of hearts and the role of SIRT3-
dependent regulation of the acetylation under LPS stimulation.
RESULTS. LPS-induced cardiac dysfunction was more severe in
Sirt3(-/-) mice compared with WT mice. The indicators of cardiac
hypertrophy as well as the inflammatory mediators including IL-1β,
IL-6, and TNF-α in LPS groups increased significantly compared with
those in PBS groups. The expression of autophagy-related protein
LC3 and the number of autophagosomes increased in Sirt3(-/-) mice
and aggravated under LPS stimulation. A total of 1600 unique sites
were identified as acetylated, most belonged to mitochondrial pro-
teins. Several metabolic pathways including fatty acid catabolic
process were significantly hyperacetylated in Sirt3(-/-) mice (WT-LPS
vs WT-PBS, Sirt3(-/-)-LPS vs Sirt3(-/-)-PBS). Finally, we identified that
key enzymes in the tricarboxylic acid (TCA) cycle could be commonly
regulated by acylation and exacerbated by Sirt3 deficiency in sepsis,
among which malate dehydrogenase (MDH2) and isocitrate dehydro-
genase (IDH2) might be the key targets for further intervention.
CONCLUSION. These findings established Sirt3 as a global regulator
of lysine acetylation in mitochondria. Sirt3 deficiency exacerbates
SIMD via changing the level of mitochondrial proteins acetylation,
which enriched in the metabolic pathways including fatty acid
degradation and TCA cycle.
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INTRODUCTION. Post-sepsis mortality has been related to a syn-
drome with persistent inflammation, immunosuppression and catab-
olism (PICS) [1], Among varying alterations, septic associated
cognitive dysfunction is a common condition [2] and a change in
sympathetic nerve activity (SNA) during the acute sepsis, such as an
increase in cardiac SNA and the display of a biphasic pattern of renal
SNA (rSNA). However, little is known about the role of the sympa-
thetic nervous system over abdominal organs commonly compro-
mised in sepsis and after sepsis recovery.
OBJECTIVES. Evaluate the renal (rSNA) and splanchnic (sSNC)
baseline sympathetic nerve activity kinetics in the acute sepsis phase
and in post-sepsis survivals
METHODS. Female Wistar rats (250-300g) underwent DL50 sepsis
model induction (2mL E. coli 108 CFU/mL, iv.) After 6 hours of sepsis
induction (S8-6h group), 1 month (S8-1mo group) and 3 months (S8-
3mo group) surviving rats had their femoral vein and artery
cannulated. After 24h of cannulation, BP and HR were recorded in
conscious rats and then they were anesthetized with urethane (1,2
g/Kg, iv) and underwent rSNA and sSNA monitoring.
RESULTS. All animals showed no clinical signs of illness in 1- and 3-
months post-sepsis, and their BP and HR were within the normal
range. However, there was a clear trend to the increase in SNA in
post-sepsis periods, the sSNA was augmented in the S8-1mo and
both rSNA and sSNA were significantly increased in the S8-3mo.
CONCLUSION. These preliminary findings suggest that there is a
sympathetic overactivation state after sepsis which may contribute
to a handicapped cardiovascular physiological response to overcome
the new pathological challenge events in post-sepsis recovery pe-
riods. Ongoing studies are in course to check other neurological
mechanisms related to PICS.
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INTRODUCTION. sepsis is defined as life-threatening organ dysfunc-
tion caused by dysregulated host response to infection. The systemic
inflammatory response syndrome (SIRS) criteria are replaced now by
SOFA score inside intensive care unit (ICU) and quick SOFA (qSOFA)
for patients outside ICU to identify patients who are potentially at
risk of dying from sepsis. Soluble CD14 subtype (sCD14-ST), known
as presepsin, is an immunological biomarker which can be consid-
ered as an indicator of activated innate immune effector cells in re-
sponse to invasive pathogens.
OBJECTIVES. The aim of this study is to evaluate significance of
presepsin for early identification of sepsis and prediction of mortality
in ICU patient in comparison to SIRS criteria and qSOFA scores.
METHODS. 40 patients were selected randomly after admission to
adult ICU department from ER in Security Forces Hospital Dammam
in the period from June to December 2018 without respect of
admission diagnosis. Data from ER triaging and initial laboratory
results were gathered to calculate qSOFA score, SIRS criteria and
SOFA score. Presepsin measurement in full blood sample was
performed within 6 hours from ER triaging.
After complete course in ICU patients were divided retrospectively
into 2 groups; group A (patients with sepsis) and group B (patients
with no sepsis) depending on clinical and microbiological criteria
and SOFA score changes
RESULTS. 26 patients were diagnosed as sepsis 16 males and 10
females with average age of 68.04 ± 18.60 years while 14 patients
were remarked as non-septic 8 males and 6 females and average age
was 51.71 ± 24.88 years with significant difference regarding Age
and APACHE 2 score being higher in septic group while no signifi-
cant difference was found regarding sex.
With significant AUC of 0.848 (p<0.001), prespsin with cutoff value
>640 pg/ml identified septic cases with sensitivity of 73.08% and
specificity of 92.86% compared to non-significant SIRS criteria (AUC
0.670, sensitivity 69.23% and specificity of 57.14%) or qSOFA (AUC
0.652, sensitivity 38.46% and specificity of 78.57%).
Also, with significant AUC of 0.920 (p<0.001) prespsin with cutoff
value >775 pg/ml predicted mortality with sensitivity of 100.0% and
specificity of 76.67 % compared to non-significant SIRS criteria (AUC
0.540, sensitivity 70.0% and specificity 43.33%) or qSOFA (AUC 0.670,
sensitivity of 60% and specificity of 76.67%)
CONCLUSION. Early presepsin measurement in ICU patients has
significant role in diagnosis of sepsis and prediction of mortality
compared to SIRS criteria or qSOFA score
REFERENCE(S)
1. Singer M, Deutschman CS, Seymour CW, et al. The Third International
Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;
315:801.
Page 504 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 552. M. Sandquist, H.R. Wong, Biomarkers of sepsis and their potential value in
diagnosis,prognosis and treatment, Expert Rev. Clin. Immunol. 10 (10)
(2014) 1349–1356.
3. no grant was given , unfunded research
001448
Prognostic value of Reactive C Protein (RCP) and Procalcitonin
(PCT) in critically ill patients with community-acquired respiratory
sepsis
R. Carbonell1, G. Moreno1, J. Gómez2, M. Bodí3, A. Rodríguez3
1Intensive care, Hospital Universitari de Tarragona Joan XXIII, Tarragona,
Spain; 2Intensive care unit, Hospital Universitari de Tarragona Joan XXIII,
URV, Tarragona, Spain; 3Intensive care unit, Hospital Universitari de
Tarragona Joan XXIII, URV, IISPV/CIBERES, Tarragona, Spain
Correspondence: R. Carbonell
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001448
INTRODUCTION. Severe sepsis and septic shock are frequent and
serious complications in critically ill patients. Timely diagnosis and
treatment are highly important in reducing the morbidity and
mortality associated with sepsis. Serum biomarkers are very helpful
tools in the early diagnosis and management of sepsis. PCT has been
reported as a useful biochemical marker to differentiate early sepsis
from other non-infectious causes of systemic inflammatory response
syndrome, and its clearance is useful to check the response to ther-
apy (1). However, the use of PCT as a prognostic marker is still
uncertain.
OBJECTIVES. To evaluate the association between serum PCT and
RCP levels on ICU admission and ICU-mortality in patients with
community-acquired respiratory sepsis.
METHODS. Prospective cohort study of critically ill patients with
confirmed Influenza pneumonia admitted to 184 ICUs in Spain,
between June 2009 and April 2018. Only patients with determination
of PCT and CRP levels on ICU admission were included. We analyzed
global population, and differentiating those with primary viral
pneumonia (PVP) and those with bacterial co-infection (BC). We re-
corded demographic characteristics, comorbidities, outcomes, as well
as clinical variables and complications during admission. The statis-
tical analysis was performed using chi-squared test (categorical vari-
ables) and Student t test (continuous variables). The multivariate
analysis (binary logistic regression) was performed to determine vari-
ables independently associated with ICU-mortality.
RESULTS. We included 1610 patients, 1186 (73.6%) with PVP and 424
(26.3%) with BC. The median age was 56 years old (IQR 46-67), with
median APACHE II and SOFA scores of 17 (IQR 12-22) and 6 (IQR 4-9)
respectively. The most frequent comorbidity was chronic obstructive
pulmonary disease (20.4%); 32.9% (530 patients) developed acute
renal failure, 57.1% had shock on admission and 81.9% required
mechanical ventilation. Overall mortality was 23.7% (n = 382). Pa-
tients with BC had higher PCT levels (4.25 [0.6-19.5]) and CRP (36.7
[20.23-118]) compared with PVP group (PCT 0.6 [0.2-2.3, p=0.001],
and CRP (28.05 [13.3-109, p=0.001]). PCT levels were lower in survi-
vors compared with non survivors, in both groups: PVP (0.53 vs 0.82,
p <0.001), BC (3.88 vs 6.94, p=0.03). However, no differences were
found in RCP levels between both groups. The multivariable analysis
showed that PCT and RCP were not variables independently associ-
ated with mortality in global population neither at differentiating
PVP from BC.
CONCLUSION. Serum PCT and RCP levels on ICU-admission in pa-
tients with viral pneumonia and/or bacterial co-infection are not fac-
tors independently associated with the prognosis.
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INTRODUCTION. We analyse whether there is an association
between high levels of initial IL-6 and the development of multior-
gan dysfunction (MODS) and higher mortality in septic shock pa-
tients admitted to ICU.
METHODS. Retrospective analysis of prospectively collected data of
patients with abdominal, respiratory and urinary septic shock that
were activated by Sepsis Code (SC) in the hospital and admitted to
ICU, whose samples were stored in the Sepsis Bank during the
period 2015-2017.
The cohort was divided into two groups depending on IL-6 levels >
1000 pg/mL (1, 2). We analyse demographic variables, severity (APA-
CHE II), the development of MODS defined through the Sequential
Organ Failure Assessment score (SOFA) >9, at ICU admission (ICU-
SOFA), and its evolution through the highest levels (H-SOFA) during
the first 96 hours, the mortality, the levels of Procalcitonin (PCT) and
Lactate.
The data has been expressed in the form of "n" (%) if they are
categorical, median and interquartile range if they are quantitative.
The comparison of qualitative data was done with the Chi-square
test. The comparison of quantitative data has been made with the
Mann Whitney U test. The study was authorized by CEIC (PR (AG) 11/
2016, PR (AG) 336/2016) and the patients or their representatives
have signed the informed consent
RESULTS. During the study period, 72 activated patients by SC
presented the inclusion criteria. Characteristics of the study
population: 66.7% men, age= 61.9 (54.2-73) years, APACHE II= 23.1
(18.2-28), ICU- SOFA= 8.9 (7-10), H-SOFA=10.5 (7-13).
63.9% of patients had IL-6 > 1000 pg/ml, their most frequent focus
was the respiratory (38.9%), the mortality rate was 27.8% and in the
ICU (16.7%). High IL-6 levels was associated with the development of
MODS at admission (58.7% vs. 41.3% p = 0.09), ICU-SOFA= 9.7 (7-10)
vs. 7.5 (6-7) p=0.01, and tend to be associated with a worsening evo-
lution H-SOFA= 11 (8-10) vs 9.5 (6.7-10) p = 0.06.
We found no association between high IL-6 levels and hospital Mor-
tality (32.6 % vs 19.2 % p = 0.24), and ICU Mortality (21.7 % vs.7.6 %
p = 0.11).
The highest levels of IL6 were observed in patients with abdominal
focus (91.3% vs 53.6 and 47.6 % p = 0.02). There was association
between IL 6 and PCT =43.5 mg/dl (7.1-18) vs 28.9 mmol/L (0.3-3) p
= 0.00 and Lactate= 5.1 mmol/L (2.6-4.2) vs 2.2 mmol/L (1.3-1.9) p=
0.00.
In multivariate analysis, high levels of IL 6 are associated
independently with high levels of lactate OR=2.4 (1.4 – 4,1) p= 0,01.
CONCLUSION. Elevated initial levels of IL 6 in septic patients are not
associated with the development of MODS and is not associated
with an increased in the mortality. Only the high levels of lactate are
associated independently with high levels of IL 6.
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INTRODUCTION. Serum lactate is an interesting biomarker that
allows the clinician a diagnostic, prognostic and therapeutic
approach. Therefore, at present, it is included in the most commonly
used prognostic scales in the Intensive Care Units.¹ ²
We have created an alert system in which the LAB contacts us when
they detect a serum lactate >4 mmol/L in a blood test. After that, we
review individualy each case in order to know if there is a change in
the approach of the patient that could be done.
OBJECTIVES. To determine the adequacy of the therapeutic rescue
measures performed in the first hour of patients whose serum
lactate is greater than 4 mmol/L in a blood test.
METHODS. Emergency patients and inpatients with AL levels> 4
mmol / L were included. The period of analysis was from August
10th, 2018 to February 4 th, 2019. Post anesthesia Unit Care,
obstetric, pediatric and palliative areas were excluded. The measures
evaluated in case of septic patients are those promoted by the
guidelines of the Surviving Sepsis Campaign. We determine
descriptive parameters by means, medians and frequencies. The
computer program used was IBM SPSS v.20
RESULTS. 114 patients were included with a mean age of 68.25 years
(18-95), 37.7% were women and 62.3% were men. 93% of the cases
obtained the sample by venipuncture with mean values of 6.58
mmol / L (4-17).
After all cases were evaluated by two physicians, 69 of them would
met criteria for admission to Intensive Care in case of requiring it.
Thirty-three of them were admitted to ICU.
The diagnoses were sepsis (33%), cardiological pathology (15.2%),
neurological (15.2%), renal (15.2%), digestive (12.1%) and bleeding
(9.1%). 81.8% of cases of sepsis received all the required measures of
fluid therapy with crystalloids, antibiotherapy and taking cultures
prior to admission; 90.9% of patients with other pathologies also
received appropriate treatment. A total of 3 patients who were
candidates for invasive therapy were admitted to intensive care days
after admission to the hospital ward.
CONCLUSION. We have been able to observe a possible room of
improvement in 18.2% of the cases of sepsis and 9.1% for other
pathologies, about the measures that could be adopted in the first
hour.
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INTRODUCTION. Sepsis still represent a major health issue, mostly in
intensive care medicine. Among the available diagnostic tools,Presepsin (P-SEP) has been proposed as a valuable point-of-care
biomarker.
OBJECTIVES. We investigated the potential role of P-SEP during the
diagnosis of sepsis and as an early prognostic tool in an acute care
setting within our medico-surgical intensive care unit (ICU).
METHODS. From May 2016 to February 2018 we evaluated all
consecutive patients admitted to our ICU with an expected length of
stay of more than 48 hours. We reported demographic
characteristics, daily clinical and laboratory data. For each patients
we recorded procalcitonin (PCT) and P-SEP levels. P-SEP assay was
obtained with luminescent monoclonal antibodies (the so called
“pathfast method). At admission and every day during the ICU stay
we assigned every patient according to the last published sepsis cri-
teria (Sepsis 3). Daily SOFA score was used to categorize patient-days
in three different quartiles (SOFA <6, SOFA 7-12, SOFA >=13). At the
fifth day we used SOFA score variation (delta SOFA score) to divide
patients in good or unfavourable clinical performance.
Primary and secondary aims were to evaluate diagnostic and
prognostic ability of P-SEP, compared to PCT.
RESULTS. 284 patients (1912 patient-days) were included. Mean P-
SEP levels in septic shock patients (343 patient-days) were signifi-
cantly higher than those classified as septic (955 patient-days) or
not-septic (614 patient-days)(mean and 95% CI): 3763 (3290,778 -
4235,810) vs 2081 (1911,970 - 2251,574) vs 767 (673,40 - 860,61) pg/
ml, respectively. PCT showed the same trend and indeed PCT and
PSEP had similar accuracy (AUC ROC curves for sepsis diagnosis were
0.784 for P-SEP and 0.787 for PCT). The best diagnostic cut-off for P-
SEP was 1039 pg/ml.
We did not find a correlation (r=0,29) with APACHE score at
admission. Both markers presented significantly different values
when patient-days were divided in the three SOFA quartiles. During
the first five days P-SEP trend was significantly different (two way
ANOVA) between survivors and non-survivors: 1187 (1058-1315) vs
2726 (1816-3636) pg/ml respectively. PCT trend was conversely not
statistically different between the two groups. Patients with un-
favourable outcome presented a continuous and progressive P-SEP
increase, meanwhile this was not found for PCT.
CONCLUSION. This study confirms that P-SEP has similar diagnostic
potential as PCT, but is far more rapid in its execution and point of
care. P-SEP trend may represent a promising early prognostic marker
of recovery and mortality.
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INTRODUCTION. The gut as a motor of sepsis hypothesis was first
investigated in trauma patients 30 years ago. Although the
hypothesis is well accepted among physicians, there has been a lack
of evidence so far that bacterial translocation directly causes the
development and perpetuation of systemic inflammation.
OBJECTIVES. Quantification of bacterial translocation and correlation
with markers of gut barrier failure, systemic inflammation and
severity of illness in an ICU patient cohort with major trauma.
METHODS. Prospective monocentric observational cohort study
(ethical approval Göttingen University 22/1/14) in 14 subsequent ICU
patients with major trauma. Inclusion into the study was within eight
hours after hospital admission. Quantification of Bacteroides and
Enterococcus species DNA und surrogate parameters for altered
epithelial permeability (iFABP, Claudin 3, sCD14) in patient blood and
urine was performed on admission (d0), d1, d2, d3, d5, d7, d10, and
Page 506 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55d14 of ICU stay. Severity of illness scores were calculated on
admission, organ failure scoring was used in the further course of
ICU stay.
RESULTS. Enterococcus or Bacteroides DNA was detected in 54% of
patients with major trauma and in 45% of those patients, who
developed sepsis. Patients with bacterial translocation developed
sepsis in 63 % of cases, whereas all patients without bacterial
translocation developed sepsis. Neither disease severity scores nor
organ failure scores differed between patients with or without
bacterial translocation. iFABP concentration in urine was comparable
in patients with and without bacterial translocation (466 [121; 3435]
vs. 674 [208; 3758] pg/mL) as well as in patients with and without
sepsis (505 [128; 3520] vs. 514 [263; 6513] pg/mL). This also applied
for Claudin 3 and sCD14.
CONCLUSION. Bacterial translocation of two gut-specific bacteria into
the blood was present in approximately half of patients with major
trauma. There was no association between bacterial translocation
and the development of sepsis in this cohort of patients. Neither
iFABP nor other surrogate markers for gut barrier failure were associ-
ated with bacterial translocation or sepsis.
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INTRODUCTION. Statins have anti-inflammatory effects that are inde-
pendent of their lipid-lowering abilities, but their role in critically ill
patients is still a matter of debate. On the other hand lower levels of
cholesterol and a higher level of triglycerides are usual findings in
that population oh patients especially in patients with sepsis.
OBJECTIVES. Aim of this study is to examine the survival of critically
ill patients with or without previous taking statins in regular therapy
and also compare levels of cholesterol and triglycerides in these
patients.
METHODS. We provided a retrospective analysis of 311 patients who
were hospitalized in the medical intensive care unit.
RESULTS. We analysed data of 311 patients. Forty-two (13.5%) of
them were taking statins (statin group- SG) as regular therapy before
their hospitalization in MICU. Two hundred and eight patients
(73.31%) have infection and/or sepsis. Survival rate of SG was
80.95%, whilst survival rate of the rest of the patients (non-statins
group- NSG) was 68.4%. Mean APACHE II score in SG was 19.79 (SD
9.814) and in NSG group 18.66 (SD 9.945). Mean GCS was 13.45 (SD
3.964) in SG, and 12.97 (SD 3.464) in NSG. The average level of the
lowest values of cholesterol was 3.878 mmol/l in SG, and 3.853 in
NSG. Mean level of the lowest values of triglycerides was 1.510
mmol/l in SG, and 1.709 mmol/l in NSG. We didn't find statistically
significant difference in levels of cholesterol and triglycerides, mean
APACHE II score or GCS. When we compare APACHE II score in the
group of patients with infection and/or sepsis according to their tak-
ing or not taking statins we also didn't find statistical significance.
But in the rest of patients (critically ill without infection and/or sepsis
(83 patient, 26.68%) – patients with statins had mean APACHE II core
17.85, and without statins 12.51 which was statistically significant (p=
0.009). The mean age of patients in SG was 70.74 years (SD 12.445)
and in NSG 66.17 years (SD 16.323) which wasn't statistically signifi-
cant but there was a trend to higher age in SG (p= 0.084).
CONCLUSION. Although SG in the population of analysed patients
was small, our findings could show some trends towards the benefits
of statins. Survival of SG was better despite they were older and
despite the fact that some of them had statistical higher APACHE II
score than NSG. Also, it is very interesting that the levels ofcholesterol and triglycerides weren't statistical significant between
SG and NSG. That fact could speak towards the protective effect of
statin. During inflammation we usually can see the trend to lower
cholesterol and higher triglycerides. We couldn't prove reverse effect
in our SG but can maybe see some nonsignificant trends towards
that. It would be necessary to provide further research with more
patients.
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INTRODUCTION. Heparin-binding protein (HBP) is a bactericidal pro-
tein stored in granule of neutrophils and released upon neutrophil
activation. It alters endothelial barrier function and induces plasma
leakage. HBP has been recognized as a possible marker for sepsis
and high circulating levels of HBP have been demonstrated early in
septic patients.
Cardiopulmonary bypass (CPB) during heart surgery is associated
with a pronounced inflammatory reaction with activation of
leukocytes. This reaction is thought to be induced by contact
activation of the CPB circuit, and is elicited without any exposure to
bacterial agents.
OBJECTIVES. To study how non-infectious activation of leukocytes
during CPB affects plasma levels of HBP and to correlate this to
changes in plasma myeloperoxidase (MPO), a neutrophil granule
product known to be released during CPB.
METHODS. Forty adult patients undergoing coronary artery bypass
surgery with CPB were studied. Plasma samples were obtained at
baseline, before induction of anesthesia, at the end of CPB before
protaminisation and at 4 hours after surgery. HBP was measured by
an ELISA assay and MPO by a multiplex bead assay. Friedmans
ANOVA on ranks followed by Wilcoxon paired test with Bonferroni
correction and Spearmans rank correlation was used for statistical
analysis, results are presented as median and interquartile range.
RESULTS. HBP increased from normal low levels at baseline 5.9 (5.9-
5.9) μg/L to very high levels at end of CPB 513 (436-688) μg/L and
decreased to 44.9 (31-62) μg/L at 4 h after surgery (all p<0.001). MPO
increased in parallel from 30 (0.2-44) μg/L at baseline to 3034 (2292-
3763) at end of bypass and 457 (290-602) μg/L at 4 h after surgery
(all p<0.001). Plasma HBP correlated with MPO levels at end of CPB
R=0.64 and at 4 h after surgery R=0.84 (both p<0.001).
CONCLUSION. CPB is accompanied by a marked, up to 100-fold, in-
crease in plasma levels of HBP. These concentrations are approxi-
mately 10 times higher than those seen in sepsis and septic shock.
The increase in plasma HBP is parallel to increased plasma MPO and
presumably reflects activation of neutrophils by the extracorporeal
circle. Increased plasma HBP seems therefore not to be a marker of
neutrophil activation exclusively by bacteria or infection, but rather a
non-specific marker of neutrophil activation. Whether heparin
present in the blood during CPB influences the high HBP levels seen
requires further studies.
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INTRODUCTION. Recently was proposed for the Surviving Sepsis
Campaign a 1-hour bundle for the treatment initial of patients with
sepsis and sepsis shock. The Impact in-hospital mortality in compari-
son with the 3-hour bundle stills unclear.
OBJECTIVES. To evaluate the accomplished of the 3- hour bundle vs. 1-
hour bundle in patients admitted in the emergency department (ED).
To assess the impact on the mortality between 1-hour vs. 3 -hour
bundle.
METHODS. We collected prospective data from patients admitted in
the emergency department from January 2016 to December 2018
with the diagnosis of sepsis and septic shock activated with the
informatics system. General characteristics of patients and the time
in minutes from admission until the completion of the 1-hour and 3-
hour bundle was analyzed.
RESULTS. 497 patients were collected from the informatic activation
system, were men 58,4%, mean age was 68 years +/- 15,5 (SD). From
advanced medical ED were 62%, basic medical ED 26,6% and from
advanced surgical ED 8%. Mainly patients were medical in 64%,
surgical 11,9%, hematological 7,5% and neoplastic 16,5%. Respiratory
sepsis was the principal diagnosis in 39% of patients, urinary sepsis
27,5%, abdominal sepsis 16,2% and medical sepsis (soft-tissue,
endocarditis, etc.) 12%, blood cultures were positive in 34%. The
mean SOFA was 7,87 +/- 2,27SD. Patients with hypotension and
lactate > 4mmol/l were 65% and had septic shock in 19%. Received
hydrocortisone in 33% and fluid bolus 30ml/kg in 51% of patients
with hypotension. Mechanical ventilation was required in 4,5% of
patients, non-invasive ventilation in 10,9%, renal replacement ther-
apy 5,1% and was admitted to the ICU in 21%. In-hospital mortality
was 13,3%. Time from admission to complete the bundle was
350min +/- 822 SD. For each item of the bundle, from admission to
antibiotic administration 211min +/- 353 SD, to lactate obtention
192min +/- 567 SD and blood cultures obtained in 276min +/-1474
SD. The initial bundle was completed in 82,9% of patients, in less of
3-hour in 76,9% and less of 1- hour in 38,1%. In-hospital mortality
was 13,8% in less 1- hour bundle vs. 14,4 % in less than 3-hour group
without statistical significative differences between groups.
CONCLUSION. In this series of septic patients seems there is no impact
in mortality between 1-hour bundle vs. 3-hour bundle, but the use of
1- hour bundle is still low, and patients probably were sicker.
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septic shock has not been widely studied since it is assumed that
fluids must be administered in advance
OBJECTIVES. To evaluate whether a very early start of VP (preceding
or simultaneously to the first resuscitation fluid load) could impact
clinical outcomes in patients with septic shock
METHODS. Retrospective analysis of 337 patients with sepsis
requiring vasopressor support. The attending physician decided in
each case when start VP support according his clinical judgment.
Very early start of VP (VE-VPs) was defined as VP support
initiatedbefore or within the next hour of the first fluid load with
resuscitative intention (FRLoad). A VP start >1hour after the FRLoad
was considered as delayed (D-VPs). A propensity score was fitted
using the age, previous chronic hypertension; lactate, heart rate,
systolic and diastolic pressure at VPs; source of admission
(emergency room, general wards, intensive care unit); andthe heart
rate/diastolic blood pressure ratio at the first fluid load. Then, a
nearest neighbor-matching algorithm extracted 1:1 matched pairs of
VE-VPs (n=93) and D-VPs (n=93) individuals. A risk-adjusted Cox pro-
portional hazard model was fitted to assess the association between
VE-VPs and day-28 mortality. A p<0.05 was considered as significant
RESULTS. Patients subjected to VE-VPs received significantly less fluid
at the VP start (0[0-510] vs. 1,500 [650-2,300] mL, p<0.001) and at 6-
hours (1,000[500-1,680 vs. 1,965[1,200-3,050] mL, p<0.001). VE-VPs
strategy was related with significant lower net fluid balances at VP
start, 6-hours and 24-hours after. The Cox-proportional hazard model
revealed a significant lower risk of death for VE-VPs at day-28
(HR:0.44, CI95% 0.24–0.79, p=0.006). There were no significant differ-
ences for renal replacement therapy requirements between VE-VPs
and D-VPs groups
CONCLUSION. Very early start of VP, even preceding initial
resuscitation fluid load, seems to be safe and it could be related with
better clinical outcomes in sepsis-related cardiovascular dysfunction001542
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INTRODUCTION. Sepsis is a severe condition in which a patient’s
hemodynamics are compromised in response to a generalized
infectious insult(1). Its prognosis is often ill-fated, and various indices
Page 508 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55have been investigated to predict response to therapy, including the
shock index (SI), a ratio of systolic pressure (SP) and heart rate
(HR)(2). We hypothesize that modified shock indices based on the
diastolic (DP), mean (MP), or pulse pressure (PP) could be as good in
predicting survival in sepsis.
OBJECTIVES. The purpose of the analysis was to compare the
discriminative ability of modified shock indices with regard to
response to therapy of septic patients.
METHODS. The Medical Information Mart for Intensive Care version
III (MIMIC-III)(3) database was used for the analysis. Patients in the 18-
89 age range, admitted for at least 48 hours and fulfilling the inter-
national consensus sepsis-3 criteria(4) were included. In-ICU mortality
was chosen as a surrogate outcome for response to therapy, and pa-
tients dying within 48 hours from admission were excluded. Clinical
data relative to the first 6 hours of ICU stay were used to formulate pre-
dictions. Patients were stratified in 5 subcohorts of increasing severity
using mean dosage of vasopressor equivalents (VPE), and divided in
survivors (S) and non-survivors (D). The discriminative ability of SI, dia-
stolic shock index (DSI = DP/HR), mean shock index (MSI = MP/HR) and
pulse pressure shock index (PPSI = PP/HR) was compared. In addition,
machine learning models including routinely measured values were
built and validated for outcome prediction.
RESULTS. A common pattern was observed when plotting the mean
of the selected indices across the 5 subcohorts of patients (figures 1-
4): none was able to distinguish between survivors and nonsurvivors
in the ‘no vasopressor’ subcohort, while a significant difference ap-
peared in the ‘low VPE’ subcohorts (with survivors showing higher
values than nonsurvivors), becoming again non significant for higher
VPEs. For MP and DP, a significant difference was found in the ‘very
high VPE’ sub-cohort, although reversed for survival classes (i.e. with
survivors showing lower index values than nonsurvivors). Machine
learning models considering these indices and other routinely mea-
sured values showed poor discrimination.
CONCLUSION. All modified shock indices significantly stratify
survivors and nonsurvivors of sepsis on low vasopressor dose,
suggesting that they could be used to predict the response to or
guide the treatment with vasopressors in the early phases of septic
shock. Indices based on MP and DP also significantly stratify septic
patients receiving very high VPE.
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INTRODUCTION. Sedation guidelines are widely available, but
international surveys have shown low compliance with them. In our
ICU, we implemented a quality improvement strategy to achieve
appropriate sedation levels.
OBJECTIVES. To evaluate the effect of an educational program to
improve consumption profile and dosing of analgosedative (AS)
drugs, and sedation level in patients on mechanical ventilation (MV)
METHODS. Before-after study in a 14-bed medical-surgical ICU in
Argentina. We included consecutive patients on MV>2 days, and re-
corded characteristics and outcomes, prescribed doses of midazolam
and fentanyl, level of sedation (RASS), midazolam and fentanyl con-
sumption -as equivalents of benzodiazepines (BZD) and opioids-, pro-
pofol and dexmedetomidine. A special team (pharmacists/
intensivists) designed nomogram templates for each drug, as a tool
for proper prescription (maximum doses, adequate ranges/dilution,
encouragement for not using BZD). After an educational session,
nomogram templates were implemented. We compared prescribed
doses of AS drugs, level of sedation, and consumption (mg of AS
drug/100 occupied bed days) among Pre-I/Post-I. P value<0.05 sig-
nificant for comparisons.
RESULTS. We included 231 and 186 patients in Pre-I/Post-I periods
respectively; age was 44±20, 44±18; APACHEII 16±7,16±8; MV-days
10[3-24], 7[2-27] respectively; ICU mortality was 74(32%) and 58
(31%). RASS scale - 4[- 2 to -5], - 2[-0.5 to -4](p<0.01); midazolam pre-
scribed dose (mg/kg/h): 0.23 [0.1-0.4], 0.12[0.04-0.2] and fentanyl pre-
scribed dose(mg/kg/h): 1.04[0.7-2.4], 3[2-5.6] (p<0.01)
respectively.The evolution of consumption drugs for AS is shown in
Table 1. In Post-I, consumption profile was significantly higher, for
propofol, dexmedetomidine, and opioid equivalents, and lower, for
BZD equivalents.
CONCLUSION. After an educational intervention with nomogram
templates as main tools, it was possible to decrease the level of
sedation, to better adjust the prescription doses of AS drugs, and to
modify their consumption profile.
Table 1 (abstract 000959). Consumption profile of AS drugs
(expressed as mg/100 occupied bed day)AS drug Year 2014 Year 2015 Year 2016 Year 2017 p




2.6]<0.01BZD eq. (mg x 10³) 26 [16-30] 25 [22-29] 20 [16-27] 12 [8-13] <0.01Propofol (mg x 10³) 0.5 [0-15] 33 [31-41] 71 [39-89] 89 [70-99] <0.01T1Dexmedetomidin(mg) 0 [0-0] 0 [0-0.02] 2 [0.5-8.5] 28 [18-43] <0.01001007
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Page 509 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. Patient tolerance is critical for non-invasive ventila-
tion (NIV) success. However, sedation is not routinely used in agi-
tated patients during NIV, due to lack of specific protocols and safety
concerns (1,2). Literature on the topic is scarce and no studies are
available on sedation in patients treated with NIV outside intensive
care units.
OBJECTIVES. To assess characteristics of patients treated with NIV in
our high dependency units (HDU) and outcome of agitated patients
requiring sedation.
METHODS. A single centre observational prospective study was
performed in adult patients receiving NIV, in a medical HDU in Città
della Salute e della Scienza Hospital (Turin, Italy) from April 2018 to
March 2019. Patient and ventilation characteristics were collected.
Richmond Agitation Sedation Scale was used to classify agitation
during observation time (48 hours since start of NIV) and
pharmacological/behavioural interventions were recorded. The
escalation plan to intubation was collected from clinicians on
admission (not routinely or formally done in Italy): patients were
classified accordingly as “for full escalation” or “do not intubate”
(DNI). NIV and sedation were started/continued in some patients as
part of palliative care (“palliation” group). Primary outcomes were
rate of intubation, discontinuation of NIV and mortality.
RESULTS. 104 patients were screened and 99 included. Mean age
was 75 and mean Apache II 20. Indications for NIV were chronic
obstructive pulmonary disease exacerbation (21%), acute pulmonary
oedema (26%), pneumonia (25%), mixed diagnosis or neuromuscular
diseases (28%). 45% of patients were considered “for full escalation”,
42% were classified as DNI (remaining 13% unknown). 40% of
patients had at least one episode of agitation during the first 48
hours, 71.6% of which received pharmacological sedation. Only 17%
of agitated patients required discontinuation of NIV (3 patients were
not sedated, 7 after sedation). 11% of patient received NIV and
sedation for palliation and were excluded from mortality analyses.
Overall 4 patients required intubation, two of which were agitated.
Agitation was not correlated with higher intubation rate, mortality
during HDU admission and at 30 days, both in DNI and full
escalation group. Mortality was higher in patient with pneumonia.
CONCLUSION. In our study, agitated patients receiving sedation
during NIV did not present a greater rate of intubation or mortality
during HDU-stay and at 30 days.
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INTRODUCTION. In the environment of intensive care unit, the
incidence rate of delirium is 16-85%, 63~75% of patients have pain
experience and 71% have had agitation, which might be related todi-
sease, treatment, noise, lighting or other multiple factors. Therefore,
the assessment and management of pain, agitation, and delirium are
critical for the quality of care in critical patients.The aim of this study
is to investigate the impact of Innovativeartificial intelligence system
on quality care of pain, agitation and delirium (PAD) in critical patientsMETHODS. A multidisciplinary team among intensivists, cardiologists,
surgeon and nursing staffs in a tertiary medical center was organized
since May 2017. The key interventions include analgesic and sedative
drug dosage artificial intelligenceinformation system, smart healthcare
digital communication platform among patients, family, nursing and
intensivists, wisdom situation lighting system, PAD information
system, and PADIS integrated information monitoring dashboard.All
patients admitted between January 2017 and December 2018 were
enrolled. The patientswere divided into three groups: pre-
interventional group from Jan to July 2017, Interventional group
from August to September 2017 and post-interventional group from
October 2013 to December 2018.
RESULTS. The pain assessment rate improved from 75.7%in pre-
interventional group, to 98‰ in interventional group and to 102% in
post-interventional group (p<0.05). The agitation assessment rate in-
creased from 0%, 96% to 102% in post-interventional group (p<
0.05).The delirium assessment rate increased from 0%, 77% to 103%
in post-interventional group (p<0.05). The pain control rate improved
from 55.8%, 66.6% to 84.3% in post-interventional group (p<0.05).
The agitation control rate improved from 91.5% to 95.1% in post-
interventional group (p<0.05). The delirium control rate also im-
proved from 70.8% to 85.3% in post-interventional group (p<0.05).
CONCLUSION. The study demonstrated that implementation of
artificial intelligence system could increase pain, agitation and
delirium assessment rate. Furthermore, pain, agitation anddelirium
control rate also significant improved.
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INTRODUCTION. Neuraxial anesthesia represents the clinical
standard for hip fracture surgery. However, lumbar puncture is
contraindicated in coagulation disorders. The most common
alteration of coagulation in the elderly patient is the prophylactic or
therapeutic use of anticoagulant drugs. Indications for New Oral
Anticoagulants (NOACs) have increased: NOACs has become the first
choice in many diseases such as non-valvular atrial fibrillation and
deep vein thrombosis.
Common laboratory test cannot detect the anticoagulation activity of
these medications. However, monitoring of NOAC plasma
concentration has become widely available, and was recently
implemented in our clinical practice together with standard
laboratory tests and tromboelastography (TEG) for urgent orthopedic
surgery. Concentration cutoff depends on laboratory technique and
at our institution it was fixed at 30 ng/mL as a safe threshold for
surgery[1]. Contrarily, anesthesiology societies only suggest a
temporal criterion to define the security of neuraxial blocks after
NOAC discontinuation[2,3]. NOACs, like all drugs, have an inter-
individual variable metabolism time, and a great variability in drug
clearance has been reported. The aim of the study is to verify if the
monitoring of NOAC plasma concentration could guide the clinical
decision more precisely than the timing criteria alone.
METHODS. We included in our retrospective single center study
patients on NOACs admitted to Emergency Department (ED) of ASST
Monza for hip fracture. NOAC concentration, Kaolin TEG, aPTT, PT,
platelets and serum creatinine were collected at the admission.
NOAC levels and TEG tracings were recorded up to 96 hours after
the last anticoagulant administration.
Page 510 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55RESULTS. 38 patients on NOACs (4 on Dabigatran, 23 on Apixaban
and 11 on Rivaroxaban) were enrolled. Average age was 80 ± 10
years, serum creatinine at ED admission was 1.0 ± 0.3 and calculated
creatinine clearance 57 ± 26. Decrease of NOAC levels over time is
shown in Figure 1. Interestingly, DOACs concentration was already
less than 30 ng/mL at 24 h in 4 patients, whereas in 7 patients the
concentration was higher than the threshold at 72 hours. Kaolin TEG
R time did not correlate significantly with DOAC levels, except for
dabigatran (p=0.19, R2 0.9).
CONCLUSION. Interindividual difference in metabolism of the drugs
affects the NOACs half-life. Measuring NOAC concentration may sup-
port the clinical decision of the anesthesia strategy, regardless the
time from the last administration.
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INTRODUCTION. Acute Pancreatitis (AP) is a low incidence disease
with high mortality rates. It is characterized by a systemic
proinflammatory state many times associated with distributive andhypovolemic shock. Several studies report a better outcome when
high volume of fluids is given in the first hours of disease.1
OBJECTIVES. We conducted this study to assess if the amount of
fluids given in the first 24h of admission in the Intensive Care Unit
(ICU) had impact in AP’s outcome.
METHODS. We included all patients admitted between 2017 and
2018, with AP as main diagnosis and made a retrospective analysis
using IBM SPSS V20 (2011). Comparison between groups was made
using the non-parametric test Mann-Whitney.
RESULTS. There were 19 patients with diagnosis of AP (11 male), 5 of
whom died. The average age was 56.4±21.2. The majority of cases
occurred in Portuguese people (16). There were 3 cases in foreigners
from Argentina, Finland and Honduras. The most common cause of
AP was lithiasis (10 cases) followed by alcohol (4 cases); 2 cases
occurred in context of hypertriglyceridemia and 1 after endoscopic
retrograde cholangiopancreatography; in 2 cases no etiology was
found. The APACHE score at admission ranged from 7 to 34 (15.7±
6.3). We found that the APACHE score of patients who died was
higher and had statistic significance (U=13, p<0.05). Nine of the 19
patients were directly admitted from the Emergency Room (ER) to
the ICU. The mean APACHE score in those was 18.2 ± 7.14 (vs 13±
4.37 in those who were admitted later in the course of disease) but
this difference had only borderline statistic value (U=23, p=0.07).
Those who died had a greater fluid balance (FB) in the first day after
admission than those who survived (4302±5020 vs 783±1666mL),
but that difference was not statistically significant (U=15.5 p=0.71).
Patients with local AP complications had a FB in the first 24h
superior to those who did not (1791±3848 vs 1531±960mL), whereas
in patients with systemic complications, FB was smaller than in those
without such complications (1495±2960 vs 2076±3757mL). In both
comparisons, no statistical difference was found (U=38, p=0.93; U=
38.5, p=0.767).
CONCLUSION. In sates of shock, FB is an important tool in aiding
monitoring and adjustment of tissue O2 delivery. However, it is
known that excess intake of fluids can negatively affect the outcome
of such patients. We report a higher FB in patients who died, fact
that can be justified by a greater complexity and severity of disease
in those patients. In such cases, hemodynamic monitoring can be
challenging. Invasive tools can be helpful and may be useful in
guiding clinical decision. International guidelines recommend
aggressive fluid resuscitation in the first hours of disease. Given the
timming of admission, we weren’t able to access this point, and
cannot draw conclusions related to the outcome.
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INTRODUCTION. Inadequate microcirculatory perfusion during
cardiac surgery with cardiopulmonary bypass (CPB) contributes to
postoperative organ failure. Several techniques have been proposed
to estimate microcirculatory perfusion during CPB, of which
intraoperative lactate measurement is widely used. Lately, oxygen
derived parameters are suggested as even better predictors of
anaerobic metabolism. As a first step, we compared the course of
oxygen delivery (DO2) with lactate levels during cardiac surgery with
CPB.
T1
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adult patients undergoing elective cardiac surgery with CPB. Intraop-
erative DO2 was calculated via the heart-lung machine (System M -
M4) at the start, during and the end of aortic cross-clamping. Lactate
measurement was performed at the same time-points by arterial
blood gas analysis.
RESULTS. The study population consisted of 83 male and 26 female
patients, aging 69 [63-74] years and had a mean body mass index of
26±4 kg/m2. Hypertension (n=65) and hypercholesterolemia (n=59)
were the most common comorbidities. Mean duration of CPB and
aortic cross-clamping was 117 [91-144] and 84 [62-102] minutes, re-
spectively. When compared to the start of aortic cross-clamping, DO2
increased during (315±44 mL/min/m2 vs. 310±49 mL/min/m2; P=
0.001) and up to the end of aortic cross-clamping (325±52 mL/min/
m2 vs. 310±49 mL/min/m2; P=0.026). Lactate levels showed an initial
decrease mid cross-clamping compared to starting levels (1.06±0.49
mmol/L vs. 1.25±0.49 mmol/L; P<0.001). At the end of cross-
clamping, the lactate level returned to baseline level (1.24±0.56
mmol/L vs. 1.25±0.49 mmol/L). Only at the start of aortic cross-
clamping a weak correlation between DO2 and lactate level was
present (r=-0.25; P=0.017). No correlation was found between DO2
and lactate levels at any other time-point.
CONCLUSION. DO2 and lactate levels have a divergent course and a
merely weak correlation during cardiac surgery with CPB. This
difference suggests that one parameter could be a superior predictor
of postoperative complications when compared to the other.
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INTRODUCTION. Red blood cell transfusion (RBCT) increases tissue
oxygen delivery (DO2) and may improve microcirculation. However,
the effects on blood flow are inconsistent.
OBJECTIVES. To assess the effects of RBCT on tissue perfusion and
identify the hemodynamic variables predicting such response.
METHODS. We studied 36 ICU patients with stable hemodynamic
status (mean arterial pressure (MAP) ≥ 65 mmHg for at least 6 hours)
and without active bleeding, who required RBCT. Skin blood flow
(SBF) was determined (Periflux System 5000, Perimed, index finger;
perfusion unit, PU) together with MAP, heart rate (HR), hemoglobin
(Hb), lactate levels and ScvO2 before and after RBCT. In each case,
SBF was measured at basal temperature (BT) for 3 min. According to
previous data indicating an SBF of 151 PU in non-infected patients,
all patients were analyzed according to the baseline SBF (i.e. <151
PU - low SBF vs. ≥151 PU – high SBF). A positive RBCT responder was
defined as a > 10% increase in SBF. Data were expressed by median
(25th-75th percentile).
RESULTS. In all patients, RBCT was associated with increases in Hb,
MAP, and ScvO2 but no change in SBF (Table 1). At baseline, there
were no difference in Hb (p=0.6), MAP (p=0.5), lactate (p=0.2), and
ScvO2 (p=0.3), between the patients with low and high SBF (Table 1).
During the transfusion, MAP and Hb increased in both groups (Table
1) but SBF rose only in patients with an initially low SBF (Table 1).
Baseline ScvO2 was somewhat lower in the responders (n=19) than
in the non-responders to RBCT (p=0.07).
CONCLUSION. RBCT increases skin blood flow when it is low at
baseline.Table 1 (abstract 001107). Hemodynamic and oxygenation variables
before and after RBCT in patients with lower and higher baseline skin
blood flow
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INTRODUCTION. Critically ill patients are subject to a multitude of
environmental changes in the Intensive Care Unit (ICU) which
contribute to the development of delirium, ultimately affecting their
long-term morbidity and mortality in the ICU. ICU patients may regis-
ter these environmental changes through their five senses including
their auditory sensation. One way of enhancing auditory sensation is
through music either with or without self-controlled patient-directed
music (PDM).
OBJECTIVES. To investigate whether a novel music delivery system
produced by Yamaha with capabilities of self-controlled PDM can
prevent ICU delirium.
METHODS. We performed a randomized controlled open-label trial
with intubated and non-intubated patients in the ICU at a tertiary
university hospital between December 2017 and June 2018. Patients
in the intervention group were allowed to choose their preferred
genre of music at any time and listen to it as much as they like
through Yamaha's sound system under development for medical use
until ICU discharge. The control group was not able to listen to music
through the Yamaha sound system. For patients who had altered
level of consciousness or who were unable to operate the system by
themselves, ICU nurses instead chose the music genre and the dur-
ation of music delivery for their patients. Delirium was assessed every
3 hours by ICU nurses using the Confusion Assessment Method for
the ICU. A competing risk survival analysis was used to examine the
relative risk of delirium in the intervention group vs the control
group. We performed additional analyses with data stratified by the
length of ICU stay and the age of the patients.
RESULTS. A competing risk survival analysis indicated that the
protective effect of the intervention on delirium incidence was not
statistically significant (subdistribution hazard ratio: 0.79, 95% CI 0.42-
1.51) in the whole sample with intubation. Stratified analysis by the
Page 512 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55length of ICU stay and the age of the patients suggested that the
intervention may reduce the risk of delirium among intubated
elderly (> 70 years old) patients who stayed in the ICU ≤ 7 days
(Figure; subdistribution hazard ratio: 0.11, 95% CI 0.02-0.63). Among
patients without intubation no effect of the intervention was
detected.
CONCLUSION. PDM did not reduce delirium progression in the ICU,
however subgroup analysis showed that PDM may reduce the onset
of ICU delirium in intubated elderly patients.
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INTRODUCTION. Fluid resuscitation is one the most influential
aspects in perioperative management for critically ill patients with
complicated intra-abdominal infection (cIAI). However, fluid overload
may increase risk of developing pulmonary complications and result
in adverse outcomes. Therefore, we evaluated the impact of exces-
sive fluid administration on mortality and morbidity of the post-
operative patients with cIAI in surgical ICU (SICU).
METHODS. We reviewed medical records of 320 patients
administered to SICU after emergency abdominal surgery for cIAI
between January 2013 and December 2018. Firstly, fluid balance of the
patients was reviewed for maximum of seven days including the day of
operation. Next, average fluid balance over body weight per day was
calculated. Then, the patients were divided into two groups with a cut-
off value of 20mL/kg/day. Baseline differences of patients in each group
are matched using propensity score matching method.
RESULTS. Fluid-overloaded patients (≥20mL/kg/day) were associated
with higher rates of 30-day mortality (11.8% vs 2.4%; p = 0.036) than
those who received less fluid (<20mL/kg/day). Kaplan-Meier survival
curves for 30-day mortality in these groups also showed a statisticalsignificance (p = 0.020). Pneumonia occurrence (47.1% vs 24.7%; p =
0.004) were also higher in fluid-overloaded group. Rate of pleural ef-
fusion development (61.2% vs 57.7%; p = 0.755), reintubation (18.8%
vs 10.6%; p = 0.194), and infectious complication (55.3% vs 49.4%; p
= 0.539) showed no significant differences between two groups.
CONCLUSION. Fluid overload in patients after emergency surgery for
cIAI was associated with higher rates of 30-day mortality, and pneu-
monia. Postoperative fluid balance in these patients should be care-
fully adjusted to avoid adverse clinical outcomes.
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INTRODUCTION. Recent evidence suggests that a lower than
recommended range for anticoagulation during ECMO may be safely
used without major side effects [1]. There are also a few case reports of
heparin-free ECMO runs in polytrauma patients indicating that ECMO
could be performed without systemic anticoagulation even for prolonged
periods of time in the presence of an high bleeding risk [2]. The safety of
prolonged (> 24hours) periods of anticoagulation-free veno-venous (vv)
ECMO in non-trauma patients has not been studied yet. The aim of this
study was to evaluate the complications occurred during anticoagulation-
free vvECMO in our cohort of patients with respiratory failure.
METHODS. We retrospectively reviewed our digital database on
patients supported with vvECMO for severe respiratory failure from
January 2012 to February 2019 at Fondazione IRCCS Ca’ Granda
Ospedale Maggiore Policlinico di Milano and selected vvECMO
patients not receiving heparin or any other anticoagulant drug for at
least 24 hours (and a concomitant aPTT ratio in the normal ranges).
Thrombotic adverse events defined as cannula related thrombosis,
deep vein thrombosis (DVT) checked at ultrasonography within 24
hours after ECMO removal and exchange of the ECMO circuit due to
induced coagulopathy (defined as hypofibrinogenemia, elevation of
DDimers and decrease of platelet count, once ruled out other
causes) during the anticoagulation-free period are reported.
RESULTS. Ten out of 148 (6.8%) patients supported with vvECMO from
2012 to 2019 were identified and reviewed. Heparin coated circuits were
used in all patients. Median time of vvECMO without anticoagulation was
42.25 (range 28.5-617.5) hours and median total ECMO time was 17 days.
Main reasons for withholding anticoagulation are reported in table 1. Six
(60%) patients died on ECMO or after removal. No cannula related
thrombosis nor DVT were observed. The ECMO circuit was exchanged in
3/10 (30%) of patients during the anticoagulation-free period.
CONCLUSION. Prolonged periods of vvECMO without
anticoagulation occurred rarely in our cohort and mostly because of
uncontrolled bleeding. Although it was not possible to assess
thrombosis in all patients, its incidence was low.
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Table 1 (abstract 001130). LTX (lung transplant), ARDS (Acute
Respiratory Distress Syndrome). *Two patients had more one
anticoagulation-free vvECMO period (total anticoagulation-free time
is considered). §ECMO circuit exchange during the anticoagulation-
free period. °Evaluated through Compression Ultrasound (CUS) 24-48
hours after ECMO removal. ^Not evaluated because patient died
during vvECMO support or soon after removal
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INTRODUCTION. Vasoplegia is a frequent complication after cardiac
surgery with cardiopulmonary bypass (CPB) and is associated with
increased complications. As most healthcare structures do not allow
for intravenous vasopressors outside of the intensive care unit (ICU),
midodrine, an orally administered alpha agonist, could potentially
reduce intravenous vasopressor use and accelerate ICU discharge of
otherwise stable patients.
OBJECTIVES. We aimed to explore the clinical contexts in which
midodrine is used in a high-volume cardiac surgery center as well as
the prescription patterns and safety of this strategy.
METHODS. This is a retrospective cohort study that included all
consecutive patients having received midodrine while being on
vasopressor support in the ICU within 72 hours after cardiac surgery
with CPB, between January 2013 and January 2017 at the Montreal
Heart Institute. Outcomes included time on intravenous vasopressors,
ICU length of stay, ICU readmission rate, occurrence of kidney injury
and in-hospital mortality.
RESULTS. A total of 72 patients fulfilled inclusion criteria during the
study period. Surgical interventions consisted of revascularization
(N=39, 54.4%), valve surgery (N=13, 18.1%), combined surgery (N=15,
20.8%) and other (N=5, 6.9%). Median Euroscore II [IQR] was 1.94
[0.98-2.78], and median CPB duration was 77 [61-111] min. The
median norepinephrine dose at midodrine initiation was 0.04 [0.03-
0.08] mcg/kg/min with a cumulative vasopressor index1 at that time
of 2.5 [2-4]. The first dose of midodrine was administered at a post-
operative median time of 24 [20-44] hours at an initial dose of 10
[8.75-10] mg and treatment duration was 37 [22-73] hours. Median
increase in creatinine after midodrine initiation was 5 [0-26.5] μmol/Land acute kidney injury (AKIN stage 1 or more) occurred in 18 pa-
tients (25%). Intravenous vasopressors were stopped 17 [4-40] hours
after midodrine initiation, for a total of 52 [36-72] hours post-op. In
16 patients (22.2%), intravenous vasopressors had to be reinstituted
after more than 2 hours of cessation. ICU length of stay was 93 [53-
120] hours and 17 patients (23.6%) were still receiving midodrine on
the surgical ward after ICU discharge. A total of 7 patients (9.7%) had
to be readmitted to the ICU, of which one (1) was initially discharged
while still receiving midodrine. Overall in-hospital mortality was 8.3%
(N=6).
CONCLUSION. We report the practice of midodrine administration as
an adjunct to intravenous vasopressors for vasoplegia syndrome
after cardiac surgery. In a selected cohort of patients, this therapeutic
approach appears to be associated with higher than expected ICU
readmission rate and mortality. Even though these results may
represent confounding by indication, routine prescription of
midodrine to hasten ICU discharge after cardiac surgery should be
done very cautiously until further prospective study is conducted.
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INTRODUCTION. Delirium is a neuropsychiatric disorder that affects
patients in the ICU, is associated with increased mortality, prolonged
hospitalization and long-term cognitive impairment. There are few
tools that evaluate the risk of presenting it. The prediction model
PRE-DELIRIC contains 10 risk factors, age, APACHE-II score, type of ad-
mission, coma, infection, metabolic acidosis, use of sedatives and
morphine, urea, and urgent admission. The model had an area under
the receiver operating characteristics curve of 0.87 (95% confidence
interval 0.85 to 0.89) and 0.86 after bootstrapping. It is divided into 4
groups of low, moderate, high and very high risk.
OBJECTIVES. To determine whether the PRE-DELIRIC model is a good
predictor of delirium in patients admitted to the ICU.
METHODS. Observational, analytical, prospective longitudinal study
in 400 patients admitted to the ICU to whom PRE-DELIRIC was ap-
plied at 24 hours of admission, during the period from June 2018 to
January 2019, sociodemographic and clinical data were obtained, in
addition to risk factors of the predictive scale. To identify the pres-
ence of delirium, patients were evaluated with the CAM-ICU scale.
The information was analyzed by descriptive statistics. The variables
were evaluated on a numerical scale and reported in terms of per-
centages and standard deviation.
RESULTS. Low risk 136 (34%), moderate 96 (24%), high 48 (12%),
very high 120 (30%), of the latter group 73% male, age: 63.8 ±
16.82 years, with diabetes 7%, hypertension 33%, 70% developed
delirium, 50% with sepsis, APACHE-II 18 ±7.5 points, SOFA 8.3 ±
3.8, use of sedatives 83%, use opioids 77%, 75% with metabolic
acidosis, 50% with neoplasia, emergency admission 77%, medical
43%, surgical 20%, neurological or neurosurgical 30%, mortality
37% in this group.
CONCLUSION. PRE-DELIRIC is a static model that shows calculated
probability for delirium 24 hours after admission, it is a useful tool to
detect risk of delirium in ICU. However, it was found that it is not a
good predictor of delirium for cancer patients. A predictive scale is
needed for this group of patients. By using this predictive scale
Page 514 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55routinely we could establish non-pharmacological preventive mea-
sures to reduce mortality and days of hospital stay due to delirium.
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INTRODUCTION. Patients undergoing emergency laparotomy for
intra-abdominal infection experience high peri-operative risk. Mortal-
ity rate remains high despite of advancement of surgical technique,
antibiotic therapy and intensive care support. In the UK, 30-day mor-
tality is one in seven overall, and for the elderly (age ≥ 80 years), al-
most one in four (1). Perforative peritonitis is linked with Multiple
Organ Dysfunction Syndrome (MODS) in up to 73% patients and
mortality reaches 30% in such cases (2, 3). Early identification of pa-
tients of severe peritonitis with higher risk of mortality will helpful
earlier institution of intensive care management (4)
OBJECTIVES. In this study we have evaluated the risk factors for in-
hospital mortality in peritonitis patients who are undergoing emer-
gency laparotomy.
METHODS. This study is a secondary analysis of a previously
conducted randomized controlled trial (5). Briefly, in that trial n=100
adult patients of either sex undergoing emergency laparotomy for
clinically proven or suspected peritonitis were included. Patients
were randomized in two arms; in group A mechanical ventilation
was achieved with 6-8 ml/kg of tidal volume, 6- 8 cm H2O of PEEP
with additional recruitment maneuver at thirty minutes. In group B,
mechanical ventilation was delivered with 10 ml/kg of tidal volume,
PEEP of 5 cm H2O and maximum allowable plateau pressure of 30
cm H2O. All patients were followed till hospital discharge and base-
line preoperative demographic and laboratory parameters were
noted.
RESULTS. During hospital stay, 25 patients died, and 69 patients
were discharged from the hospital. Rate of in- hospital mortality
(95% CI) was 26.6 (18, 36.7) %. Median [IQR] duration of ICU/ HDU
stay was 6 [3- 11] days and duration of total hospital stay was 13 [9-
21] days. Non survivors had similar length of ICU/ HDU stay (p=0.16)
but shorter length of hospital stay (p=0.001). Non- survivors had
longer duration of symptoms before surgery (p=0.003), lower platelet
count (p=0.02), higher international normalized ratio (p=0.009) and
higher arterial lactate (p=0.001). We have found that only duration of
symptoms before surgery [adjusted odds ratio (95% CI) 1.61 (1.14,
2.27); p=0.007] and arterial lactate [adjusted odds ratio (95% CI) 2.25
(1.08, 4.70); p=0.031] were significant predictor of mortality (p=0.22,
goodness-of-fit for the model) in a binary logistic regression model.CONCLUSION. Perforation peritonitis still carries a high hospital
mortality and duration of symptoms before surgery and baseline
arterial lactate was found to be a significant predictor of mortality in
these patients.
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INTRODUCTION. Patients with severe trauma often experience
delirium due to head injury, pain, and surgery. Hospital-induced delir-
ium is a risk factor for increased long-term mortality. Additionally ,
post-intensive care syndrome (PICS) in a critically ill patient is a long-
term health problem, but the hospitalization-related factors are
unknown.
OBJECTIVES. We aimed to clarify the association between hospital-
induced delirium and PICS, one year after discharge, in severe trauma
patients.
METHODS. This single-institutional prospective study included 213
injured patients who were admitted to the trauma surgical intensive
care unit (TSICU) and survived until discharge to home between
2016 and 2017.We evaluated the activities of daily living one year
after the discharge using physical and mental component scores of
SF-36®and defined physical dysfunction and mental disorder as a
score of less than the 25thpercentile of the national standard value
for the same age. Further, cognitive impairment was determined by
self-administered screening. PICS was diagnosed when one of the
following three components was recognized: physical dysfunction,
mental disorder, and cognitive impairment. We divided the patients
in the PICS and control (without PICS) groups and compared the
groups.
RESULTS. The patients had experienced blunt injuries, including
pedestrian injuries (19.7%) and falls (34.3%). The mean age was 61.6
years (men: 70%); the median injury severity score (ISS) was 21
(interquartile range: 16–29); and the mean length of TSICU stay was
4.3 days. The average period from the injury until the investigation
was 17.9 months. The PICS group included 121 patients (56.8%), of
which 99 (46.5%), 46 (21.6%), and 28 (13.1%) had physical
dysfunction, mental disorder, and cognitive impairment, respectively.
More patients in the PICS group were transferred to a rehabilitation
facility and were receiving outpatient treatment at the time of the
study compared to the control group. Furthermore, they had more
health-related and financial problems (P< 0.01). The frequency of
emergency surgery (50.4% vs. 33.7%) and mechanical ventilation
(37.2% vs. 23.9%) in the PICS group were significantly higher com-
pared to the control group. The incidence of delirium in the PICS
group was significantly higher compared to the control group (33.1
Page 515 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55% vs. 12.0%). A multivariate analysis, which was adjusted for age, se-
verity, and gender, revealed the factors affecting PICS: delirium (odds
ratio [OR]: 3.54; 95% confidence interval [CI]: 1.54–8.16; P=0.003),
emergency surgery (OR: 2.36; 95% CI: 1.24–4.46; P=0.08), and spinal
cord injury (OR: 4.42; 95% CI: 1.48–13.12; P=0.07).
CONCLUSION. In severe trauma patients, hospital-induced delirium
was independently associated with PICS, lasting up to one year after
discharge.001197
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INTRODUCTION. Heat stroke is a high fever associated with systemic
inflammatory response, which can lead to multiple organ
dysfunction syndrome, mainly encephalopathy[1]. High heat
stimulation causes intestinal ischemia, mucosal barrier dysfunction
and release of inflammatory factors[2], eventually leading to systemic
inflammatory response. Mesenchymal stem cells have many
mechanisms, such as immune regulation and repair of tissue
damage. Many studies have found that MSCs can regulate the level
of inflammatory factors through paracrine effect, and also affect
regulatory T cells[3] and macrophages[4], thus playing an anti-
inflammatory role. MSCs can also repair tight junctions[5] and allevi-
ate ischemia-reperfusion injury, thereby improving intestinal mucosal
barrier function.
OBJECTIVES. To explore whether MSCs can reduce intestinal damage
and systemic inflammation caused by heat stroke, and ultimately
improve survival rate.
METHODS. Sprague-Dawley (SD) male rats were used to establish
heat stroke injury model, and MSCs were infused into HS rats treated
with MSC. Rats in model group and treatment group were divided
into early, middle and late stages. The levels of biochemical markers
(ALT, AST, etc.), inflammatory factors (IL-1beta, IL-6, TNF-alpha) and
chemokines (Eotaxin, Rantes, MIP-2) in intestine and blood were de-
tected respectively. The intestinal injury was compared by intestinal
histopathology. The intestinal injury was compared by intestinal
histopathology. Survival rate was estimated by 28-day observation.
RESULTS. The 28-day survival rate of rats in the treatment group was
significantly higher than that in the model group, and the level of
biochemical markers was significantly better than that in the model
group. According to Chiu's score of intestinal mucosa, the treatment
group was significantly lower than the model group. In intestinal tis-
sue and blood, the level of anti-inflammatory factors in the treatment
group was higher than that in the model group, and the level of pro-
inflammatory factors was lower than that in the model group, with
statistical difference. The change trend of chemokine levels in the
two groups was the same, but the overall level in the treatment
group was lower than that in the model group.
CONCLUSION. In animal models of heat stroke, MSCs can play an
anti-inflammatory role, reduce organ damage and improve survival
rate. MSCs can also reduce stress injury of intestinal mucosa and pro-
mote tissue repair.
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INTRODUCTION. In major abdominal surgery plasma albumin
concentration decreases more than explained by bleeding,
presumably due to increased transcapillary leakage into the
interstitial space and alterations in plasma volume. The contribution
of compromised lymphatic return to net albumin leakage has not
been investigated. Here we study this contribution by using
pancreatic Whipple surgery with aortocaval lymphadenectomy as a
model for compromised lymphatic return in the postoperative
period.
METHODS. Patients scheduled for pancreatic resection were studied
in two groups, A (n=12, Whipple procedure) and B (n=13, Whipple +
aortocaval lymphadenectomy), Albumin mass balance was assessed
from start of anesthesia until postoperative day 3 (POD 3). Endpoints
were albumin net leakage at end of surgery (EOS) and on POD 3.
RESULTS. Plasma albumin decreased from 35.0 ± 3.6 g/L and 32.7 ±
3.6 g/L at start of anesthesia to 28.6 ± 4.4 g/L (p<0.0001) and 27.9 ±
4.8 g/L (p=0.0002) at EOS for groups A and B respectively,
corresponding to decreases of 18 ± 8 and 15 ± 10 %, respectively. At
EOS this corresponds to an albumin shift from plasma of 22 ± 10 g
and 23 ± 12 g in group A and B, respectively. At POD 3 the shifted
amount in group A was 9 ± 29 g (p = 0.34 compared to EOS) and 23
± 29 g (p = 0.99) in group B.
CONCLUSION. Plasma albumin decreased by 16 % until EOS. The
decrease in albumin leakage in group A postoperatively failed to
reach statistical significance, indicating that lymphatic return might
not be the main contributor. The large variability suggests a
multifactorial explanation behind the postoperative shift of albumin.
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INTRODUCTION. Accurate measurement of hemoglobin (Hb)
concentration is a major target of monitoring in critically ill.
Furthermore, it guides decision making regarding blood transfusion.
Standard laboratory hemoglobin measurement requires time and
T1
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as Radical 7 Pulse Co-Oximeter (MASIMO, USA) are of high interest.
Despite a number of attempts to validate this device, its accuracy es-
pecially at low Hb values remains unclear.
OBJECTIVES. Therefore, we investigated, if noninvasive pulse-
oximetry Hb (SpHb) appropriately indicates the need for blood trans-
fusion according to invasive hemoglobin measurements (primary
endpoint) in critical ill patients.
METHODS. This prospective observational study was performed on a
general ICU of a University Hospital in Munich. Only patients with a
need to blood transfusion (Laboratory Hb <7mg/dl; in case of pre-
existing cardiovascular disease: Hb <8 mg/dl) were included in this
study. All patients (n=44) were equipped with Radical 7. Reference la-
boratory Hb (Hb_BGA) values were determined by RAPIDPoint 500
Blood Gas analyzer (Siemens, Germany). 35 out of 44 patients were
equipped with transpulmonary thermodilution monitoring (PiCCO,
Germany). All measurements were performed prior and after the
transfusion of two units of red blood cells. Statistics: Fisher´s exact
test. Wilcoxon-test for paired samples. IBM SPSS 25.
RESULTS. All 44 patients fulfilled the pre-defined criteria for blood
transfusion according to Hb_BGA. Pre-transfusion Hb_BGA was 6.7±
0.6 mg/dl. In 8 out of these 44 patients (18%) Radical 7 was not able
to generate a hemoglobin value. In none of the remaining 36 pa-
tients SpHb would detected the need for blood transfusion. Conse-
quently, the need for transfusion was detected in 0/44 (0%) by SpHb
compared to Hb_BGA (44/44 (100%); p<0.001).
SpHb prior to transfusion significantly overestimated Hb according to
the gold standard laboratory measurement (9.3±1.3 vs. 6.7±0.6 mg/
dl, p<0.001) with a bias of 2.6±1.2 mg/dl, lower and upper limits of
agreement f of 0.02 and 4.97 mg/dl, and a percentage error of 30%.
Similarly SpHb overestimated Hb_BGA after transfusion of 2 units of
red cells (10.2±1.5 vs. 8.8±0.8mg/dl, p<0.001), with a bias of 1.4±1.5
mg/dl and limits of agreement of -1.4 and 4.2 mg/dl, and a
percentage error of 29%.
Also trending capacities of SpHb were poor: Changes in SpHb after
transfusion did not correlate with changes in Hb_BGA (r=0.206; p=
0.220).
While Hb_BGA increased in 44 of 44 patients (100%), SpHb increased
in only 32 of 37 displayed mesaurements (p=0.017).
Increases in Hb_BGA after transfusion compared to baseline were
significantly higher than changes in SpHb (2.1±0.6 vs. 1.0±0.9g/dl; p<
0.001).
CONCLUSION. 1.) Radical 7 Pulse CO-Oximeter does not accurately
measure decreased Hb-values in critically ill patients.
2.) SpHb is not appropriate to trigger transfusion and and to track
changes in Hb critically ill patients with a low hemoglobin values.
TEM - New aspects in cardiac arrest
management
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INTRODUCTION. Triage plays a critical role in mass casualty incidents
by optimizing the use of medical resources. The Formosa Fun Coast
(Baxian Water Park) dust explosion incident in 2015 revealed the lack
of resources for mass burn and scald casualties in the Taiwanese
medical system, however mortalities in this incident were only 3%
(15/499) by the end of 2015.
OBJECTIVES. This study examined the key feature of the prehospital
settings of the 15 mortalities.
METHODS. This was a retrospective cohort study, and all the patients
from the Formosa Fun Coast incident (N = 499) were enrolled. The
follow-up period was from June 27, 2015 to December 31, 2015. We
first examined the correlation between patient survival and various
variables and then tested the correlation between the survival-correlated variables and the level of the hospitals that provided
treatment.
RESULTS. The survivor and nonsurvivor groups shared similar
distributions of all the study variables.The patients were divided into
two groups: survivors (N = 484) and nonsurvivors (N = 15). The two
groups shared a similar average age and sex division. Most of the
patients were sorted to more severe levels; this is evident from both
the emergency severity index and EMT-performed triage assessment.
Regarding the emergency severity index, the majority of the patients
were Level 1 or Level 2 (100% of nonsurvivors; 74.7% of survivors).
For EMT-performed triage assessment, most of the patients’ condi-
tions were of high or medium severity (100% of nonsurvivors; 79.6%
of survivors). The burn and scald classification and Baux score were
higher in the nonsurvivor group; the majority of nonsurvivors had a
third-degree burn (86.7%) and a Baux score of more than 50 (100%).
CONCLUSION. The lack of effect of hospital level on patient mortality
indicated that in addition to a satisfactory EMT-performed triage sys-
tem, all hospitals, regardless of their level, are equipped with ad-
equate medical capacity for handling patients with burns and scalds.
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INTRODUCTION. Major burn injury can cause massive tissue
destruction and initiates cytokine-mediated inflammatory response,
impaired coagulation and fibrinolysis. This condition features an ini-
tial transient thrombocytopenia followed by normalization of platelet
count and eventual reactive thrombocytosis.
OBJECTIVES. Our aim was to investigate the kinetics of platelet
antisedimentation rate (PAR), C reactive protein (CRP) and
procalcitonin (PCT) levels in the early period after burn and to assess
whether these parameters can predict development of septic
complications and ICU outcome.
METHODS. In a prospective, observational study 23 consecutive
patients with more than 20% body surface burn injury were followed
Page 517 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55for five days (T1-T5) after admission to ICU. PAR was measured by
one-hour gravity sedimentation indicating the percentage of plate-
lets had crossed the half line of blood sample column. Serum CRP
and PCT values were measured by standard laboratory methods and
sepsis diagnosis was based on American Burn Association guideline.
RESULTS. Ten patients developed septic complications. In the whole
group platelet concentration decreased by time and became
significant at T3 (p<0.001) in survivors (n=16) and at T2 (p<0.05) in
non survivors comparing to T1. In survivors mean PAR continuously
increased between T1 and T5. Mean PAR of survivors were
significantly higher than that of non survivors at T1, T4 and T5 (all p<
0.05). In non survivors PAR increased significantly (p<0.05) from T3
and reached its peak at T5. PAR had showed a decreasing tendency
in septic patients during three days before clinical diagnosis of sepsis
was made. Drop of mean CRP was significant (p<0.05) just a day
before sepsis was clinically evident. Serum PCT increased right on
the day of sepsis commencement (p<0.05).
CONCLUSION. In patients with a significantly higher PAR value on T2
(p<0.05) were more likely to survive ICU treatment. A sudden drop in
the PAR levels may predict the onset of sepsis earlier than
conventional clinical signs. Earlier detection of septic complications
can result in earlier therapeutic interventions. Ten patients who
developed sepsis as a consequence of burn injury do not provide
enough data required for the complete description of sepsis kinetics.
A greater number of patients will be needed in the future.
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INTRODUCTION. MDRO are an increasing problem in hospitals and
especially in intensive care units(1). Furthermore, infections with
MDRO have significant economic effects(2). Taking into account the
increasing health and socioeconomic issues, recent findings show
that up to 37% of healthcare facilities in a rich industrialized country
do not perform any screening at admission(2). An effect of MDRO in
injured patients is not yet described.
OBJECTIVES. This study describes for the first time the rate and
impact of MDRO in severely injured patients.
METHODS. Retrospective, multicenter study from three trauma level-
1 centers in Germany. The study was approved by local ethics
committees.
All patients treated in the trauma room and admitted to an intensive
care unit between 2013 and 2017 were included. Data were
extracted from the german trauma registry( Traumaregister DGU ®)
and completed with data of microbiological screening. Data are
presented as mean +/- standard deviation.
RESULTS. We included 3887 trauma patients, mean ISS was 16.25
(+/- 13.18). Incidence of positive screening for MDRO was 1.4 %.
Comparing MDRO positive vs MDRO negative patients , MDRO
positive patients showed an extended length of stay in icu (26.80
days +/- 24.29 vs. 6.42 days +/- 12.21; p=<0.001), duration of
mechanical ventilation (395.3 hours, +/- 455.9 vs 64.94 hours,
+/-194.7 ; p=<0.001), sepsis (n=25=45,5% vs n=214=5,5%, p=<0.001),
multi organ failure (n=9=16,4% vs n=271=7%, p=<0.007), Glasgow
Outcome Scale (median 2 vs median 1, p=<0.001).CONCLUSION. MDRO are rare in severely injuried patients but they
are associated with a devasting worser outcome . We strongly
recommend extented screening for MDRO in critically ill trauma
patients.
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INTRODUCTION. Oxidative stress induced by ischemia, mechanical
stress or toxins is a condition that results from the imbalance
between the production of oxygen species and free radicals as well
as inappropriate antioxidant function. The dexmedetomidine (DEX) is
a highly selective alpha-2 adrenergic receptor agonist that is com-
monly used in the clinic as a sedative and anesthetic. In addition,
DEX protective effects against oxidative damage in both in-vitro and
in vivo conditions have been demonstrated. The Alkali Comet
Method is an in-vitro method that allows the determination of single
strand fractures of DNA.
OBJECTIVES. It was aimed to evaluate the protective effects of DEX
and Ascorbic Acid (AA) on DNA against alkali-induced DNA damage
caused by Hydrogen Peroxide (H2O2) induced oxidative stress in hu-
man lymphocyte cell cultures in vitro by alkaline comet method.
METHODS. Lymphocyte cell cultures were divided into five groups as
negative control; solvent control; positive control; H2O2 (150 μM) +
DEX (1μM; 2.5μM; 5μM); H2O2 (150μM) + AA (1μM; 2.5μM; 5μM) and
incubated at 37°C for 1 hour. Cell viability was measured by Trypan
Blue test. DNA damage was measured by Alkali Comet Technique
and % tail intensity was evaluated. Statistical analysis was performed
by one-way analysis of variance and Tukey’s multiple comparison
test.
RESULTS. It was observed that H2O2 significantly induced DNA
damage in lymphocytes and this damage decreased significantly
with AA and DEX. It was observed that AA at 1μM and 2.5μM doses
had a significantly stronger antioxidant effect, but there was no
significant difference between the antioxidant effects of AA and DEX
in 5μM doses. The concentration of 5μM DEX was found to be most
effective in reducing oxidative DNA damage.
CONCLUSION. The anti-oxidative effects of dexmedetomidine have
been reported to be associated with extracellularly signal-regulated
kinase signaling pathways. It has been reported that produces pro-
tective effects by suppressing in toll-like receptor, nuclear factor-
kappa B like and phosphoinositide-3 kinase signaling pathways
against oxidative injury. Our results showed that dexmedetomidine is
Fig. 2 (abstract 000169). Forest plot of the gain of weight in the
rehabilitation phase.
Page 518 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55a protective against H2O2 induced in vitro oxidative DNA damage in
lymphocyte cell cultures in a dose-dependent manner.
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INTRODUCTION. Burn patients experience a hypermetabolic
response that induces several pathophysiological changes leading to
catabolism. This response can be potentially countered with optimal
fluid resuscitation, excision and grafting, early enteral nutrition and
physical rehabilitation. Pharmacological modulation of the
hypermetabolic response due to severe burns can help improve the
prognosis. The anabolic steroid, Oxandrolone, possibly finds its place
here.
OBJECTIVES. The objective of this systematic review on the use of
Oxandrolone in adult burn injury patients is to provide an overview
of the effectiveness on weight, nitrogen balance, metabolism, length
of stay, side effects and mortality.
METHODS. PubMed, Google Scholar, Web of Science, Embase and
Cochrane Library databases were searched up to November 2018.
Forest plots were created in Review Manager.
RESULTS. Six randomized controlled trials (RCTs) and two
retrospective studies with a total of 541 patients were included in
this study. The RCTs had a total of 257 patients; 5 single centre
studies from one author (total of 176 patients), and 1 multicentric
study from a second author (total of 81 patients). The systematic
review on the six RCTs showed that Oxandrolone had a potentially
beneficial effect on the healing process of the adult burn patient in a
dosing of 2 times 10mg Oxandrolone per day. No additional side
effects could be observed by the use of oxandrolone on liver
function (P=0.41), glycemic control or hirsutism. There was less
weight loss in the acute phase (P<0.001) as well as a better increase
in weight in the rehabilitation phase (P<0.001). This beneficial effect
on weight remained noticeable up to six months after
discontinuation of Oxandrolone. Furthermore, there was a better
nitrogen balance (P<0.001). No effects on metabolism could be
observed (P=0.47). There was a significant faster wound healing (P<
0.001). No impact on length of stay or mortality could be
demonstrated.
CONCLUSION. Although this systematic review clearly shows a
significant benefit towards adequate weight control and wound
healing, currently no clear recommendation can be made. The lowquality nature of the evidence does not allow for therapeutic advices
to be drawn. Further methodologically robust research including
more patients as well as centres needs to be conducted.
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INTRODUCTION. Phenytoin (PHT)is frequently used in the treatment
of acute seizures. Inadequate dose or wrong interpretation of the
total phenytoin plasma level (TPPL) could lead to significant
consequences. Five different formulas can be used to estimate the
concentration of free PHT, but no clinical guidelines are available to
determine which formula to use(1).
OBJECTIVES. The main objective was to determine the proportion of
therapeutic TPPL within the first 48 hours of treatment. The
secondary objectives were to describe the doses of PHT used and
the TPPL interpretation, evaluate the proportion of patients to whom
a TPPL is prescribed, the impact of different loading doses (LD) and
interventions of a clinical pharmacist.
METHODS. A descriptive, longitudinal and retrospective study design
was used. The health records from a single university hospital of all
adult patients receiving intravenous PHT were included. The
exclusion criterias were therapeutic hypothermia and pregnancy. The
TPPL was analysed if the patient file contained one albumin and
creatinine plasma concentration measured within 72 hours of the
TPPL. The adequacy of the formula used was determined by an
algorithm developed by the authors after a literature review.
RESULTS. 401 patients from January 3rd 2014 to April 19th 2018
were included. After excluding files with missing data, 156 patients
and 383 PHT dosages were included in the analysis. 60.7% of the
TPPL were within the therapeutic range at 48 hours. The mean initial
LD was 12.4 ± 3.7 mg/kg. A TPPL was ordered for 44.1% of patients
in the first 7 days of treatment. The TPPL were corrected with the
appropriate formula in 53.4% of cases by pharmacists and in 10.9%
by physicians. The initial LD of 1g resulted in 65.5% therapeutic
dosages at 48 hours and those between 15-20 mg/kg in 80.6% (p=
0.04).
CONCLUSION. The PHT levels of four out of ten patients were
subtherapeutic due to insufficient initial LD. Drug monitoring of PHT
was inadequate in a large proportion of patients because the wrong
formula was used. Less than half of the patients had a TPPL
prescribed and even less had an analysable result without missing
Page 519 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55data. This is worrisome, seeing as it could lead to therapeutic failure
or adverse events with this narrow therapeutic index drug. This
study demonstrates that education is still needed to insure an
optimal treatment of seizures with PHT.
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INTRODUCTION. Shock index (a ratio between heart rate and systolic
blood pressure, SI) has been shown to predict transfusion
requirements and the need for hemostatic resuscitation in severe
trauma patients. Trauma-induced coagulopathy frequently occurs in
patients with traumatic shock and increases mortality by up to four
times. Fibrinogen is the first clotting factor that reaches critical levels.
Resuscitation strategy based on early fibrinogen supplementation
has recently been shown to be superior in coagulopathy reversal
compared to fixed plasma to packed red blood cells ratio approach.
In the present study, we aimed to determine whether prehospital
and on-admission shock index values can be used to predict low
plasma fibrinogen in trauma patients.
METHODS. Between January 2016 and February 2017, all trauma
patients whose prehospital vital signs record was available were
assessed for demographics, injury characteristics, shock index and
admission plasma fibrinogen level. An area under the receiver
operating characteristics curve (AUROC), sensitivity, specificity,
positive and negative predictive values and accuracy were
calculated. Clinicaltrial.gov ID: NCT0269539 (registered 27 November
2015).
RESULTS. AUROC for prespecified cut-offs of plasma fibrinogen con-
centrations and the worst prehospital shock index was 0.7 (95% CI
0.63 - 0.76) for fibrinogen 2.3 g.l-1, 0.78 (95% CI 0.71 - 0.84) for 2.0
g.l-1 and 0.76 (95% CI 0.64 - 0.86) for 1.5 g.l-1. For the admission SI,
AUROC was 0.65 (95% CI 0.59 - 0.71), 0.8 (95% CI 45 0.68 - 0.91) and
0.8 (95% CI 0.68 - 0.91) for the same levels of fibrinogen as above.
For the worst prehospital shock index ≥ 1 and plasma fibrinogen ≤
1.5 g.l-1 sensitivity was 0.54 (0.25 - 0.81), specificity 0.87 (0.83 - 0.91),
positive predictive value 0.16 (0.10 - 0.25), negative predictive value
0.98 (0.96 - 48 0.99) and accuracy 0.86 (0.81 - 0.90).
CONCLUSION. Shock index is an easy-to-perform clinical tool, which
may help identify adult trauma patients at risk of hypofibrinogen-
emia from the very early contact with the patient. Levels < 1 ex-
cluded severe hypofibrinogenemia with 98% predictive value. Taken
to the patient’s bedside, this means that whenever the systolic blood
pressure remained higher than the heart rate, the risk of critical
hypofibrinogenemia was low. These findings should prompt emer-
gency physicians to consider early fibrinogen administration when fi-
brinogen levels are not available, and shock index is high.
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INTRODUCTION. Burn injury is a complex process with high mortality
with a high economic burden and social implications. Specific risk
factors for mortality has been outlined in recent reports, including
the total body surface area (TBSA) of burns, the TBSA of full-
thickness burns, age, and presence of inhalation injury. However in-
formation on our environment is scarce.
OBJECTIVES. To assess mortality risk factors and to update the
epidemiological distribution of patients with major burns treated in
Catalonia.
METHODS. Retrospective monocentric cohort study of patients
admitted to Burns ICU (BICU) at Vall d'Hebron university Hospital in
Barcelona between February 2009 and January 2017 were included.
Demographic data, presence of inhalation injury defined by the
presence of facial burns, singed nasal vibrissae, soot in the mouth or
sputum, history of closed space injury and patient`s history of
breathed smoke. Infection related variables and resuscitation related
variables as hemodilution were recorded, Multivariate stepwise
logistic regression was performed to identify factors associated with
mortality.
RESULTS. 276 patients were admitted in the BICU during the study
period. All population mortality was around 18% (51) patients. Septic
shock was identified as number one predictive factor of mortality in
this cohort (OR 46.7; IC95% 6-363.8; p=0.001), followed by age (OR
1.12; IC95% 1.07-1.17; p=0.001) and TBSA (OR 1.07; IC95% 1.04-1.12;
p=0.001). A total liquid balance near to 0 measure by hemodilution
on deltaHb at first 48h and an initial management in the ICU with a
shorter length of stay in this unit were identified as protective factors
for mortality.
CONCLUSION. Septic shock was identified as major risk factor for
mortality, other non modifiable factors such as age and higher TBSA
Page 520 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55were identified. Further studies are necessary to early detect sepsis
in this group of patients. Neutral liquid balance in the first 48h was
associated with a better survival.
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INTRODUCTION. S-100 B Protein has been identified as a biomarker
for traumatic brain injury, but studies suggest that extracranial injur-
ies lead to elevated S-100 B levels as well. Hence, the impact of dif-
ferent concomitant injuries on S-100 B levels in trauma and its role in
multiple trauma patients remain unclear.
OBJECTIVES. . In this study, we therefore aimed to quantify the
impact of concomitant injuries on S-100 B levels in trauma patients
and further investigate the role of S100-B levels to predict mortality
and injury severity.
METHODS. All patients with suspected multiple trauma treated at a
Level 1 Trauma centre in Switzerland over a three-year period were
included in this retrospective cohort analysis. The extent of injuries
and their severity, reflected by the abbreviated injury scale (AIS) and
injury severity score (ISS), was assessed and S-100 B levels on admis-
sion were obtained. Potential predictors of pathological S-100 B
levels (>2.0 μg/L) were identified through uni- and multivariable
analysis.
RESULTS. In total, 1,338 patients with suspected multiple trauma,
76.5% of them with pathological S-100 B levels, were included in the
analysis. In multivariable logistic regression adjusting for sociodemo-
graphic characteristics, concomitant injuries and trauma severity, the
following predictors showed a significant association (p<0.001) with
pathological S-100 B levels: Longbone fracture (OR 3.0, 95% CI: 2.2-
4.3, p<0.001), non-longbone fracture (OR 2.3, 95% CI: 1.3-4.1, p=
0.004), thoracic injury (OR 2.6, 95% CI 1.6-4.2, p<0.001), flesh wounds
(OR 1.9, 1.4-2.6, p<0.001). Head trauma with intracerebral bleeding
was only weakly associated (OR 2.0 (1.19 - 3.45) p< 0.010) and head
trauma without intracranial bleeding was not associated with in-
creased S-100 B protein levels at all (p< 0.706). Trauma severity was
also related to S-100 B protein increase (OR per ISS: 1.1, 95% CI 1.0-
1.1, p<0.001). In-hospital death was strongly associated with patho-
logical S-100 B levels (OR 24.8, 95% CI: 3.4-179.4, p<0.001).S-100 B
levels below 0.575 μg/L had a high diagnostical value to rule out in-
hospital mortality (negative predictive value: 0.99, 95% CI: 0.98-1.00).CONCLUSION. Fractures and thoracic injuries are the main predictors
for elevated S-100 B levels. Despite common perception, head injur-
ies play a minor role in S100-protein elevation in multiple trauma pa-
tients S-100 B has a good negative predictive value for in-hospital
mortality and is associated with trauma severity and hence might be
of use as a prognostic marker in trauma patients.
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INTRODUCTION. ICU delirium is a neuropsychiatric disorder,
characterised by an acute fluctuation in consciousness, which affects
between 30-50% of the critically ill [1]. Haloperidol is the most com-
monly used pharmacological agent in the management [2]. However,
the European Medicines Agency recently suggested that Haloperidol
is now contraindicated for utilisation in combination with other QT
prolonging drugs due to the risk of ventricular tachyarrhythmia [3].
OBJECTIVES. However, before practice changes to another
potentially harmful alternative, it is essential to understand the
influence of Haloperidol in combination with other QT prolonging
drugs on VT in comparison to Haloperidol alone. It is also necessary
to correct for the influence of other risk factors including age,
gender, electrolyte disturbances such as mild hypokalaemia, severe
hypokalaemia, hypomagnesaemia or hypocalcaemia and a past
medical history of Ischaemic Heart Disease or previous arrhythmia on
VT. To ascertain if episodes of VT are clinically significant, it is
important to determine the odds of VT requiring intervention in
relation to each factor.
METHODS. A case control study involving 4,189 admissions was
performed. Electronic records for each were interrogated to provide
information pertaining to the aforementioned factors and receipt use
of Haloperidol or other QT prolonging drugs. It was also documented
as to whether the patient experienced VT during their stay.
Multivariate logistic regression analysis calculated odds ratios to
ascertain factors associated with VT and to determine if these
episodes were clinically significant, odds ratios were calculated for VT
requiring treatment.
RESULTS. Our results identified that 2.1% of patients in ICU
developed VT and that hypocalcaemia, IHD, previous arrhythmia and
the administration of QT prolonging drugs were all associated with
VT. The effect was strongest for Haloperidol administration without
another QT prolonging drug (OR 12.309, 95% CI 3.396 – 44.618). The
administration of a QT prolonging agent in combination with
Haloperidol did not further increase this (OR 8.599, 95% CI 3.175 –
23.291). Intervention was required for 48.3% of patients that
developed VT and included electrolyte replacement, antiarrhythmic
drugs and DCCV. The administration of any QT prolonging drug
resulted in the greatest odds of VT requiring treatment (OR 4.373,
95% CI: 1.337 – 14.299).
CONCLUSION. Despite concerns regarding its safety, Haloperidol
should remain the first line treatment option in delirium since
the chance of developing VT remains low, even though the odds
are significantly increased. Additional QT prolonging drugs do not
increase this further and this combination in patients whom it is
clinically appropriate appears to be safe. However, alternatives
including atypical antipsychotics should be considered in patients
with concomitant risk factors such as IHD and previous
arrhythmias.
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INTRODUCTION. The presence of hypothermia is an independent
predictor of outcome in traumatic shock. Nevertheless, hypothermia
may be an effective therapeutic approach for otherwise lethal
traumatic hemorrhage.
OBJECTIVES. To characterize the effects of hypothermia on
microcirculation in normal conditions and in hemorrhagic shock.
METHODS. We studied 24 anesthetized and mechanically ventilated
sheep. We measured cardiac output (CO, mL/min/kg) by
thermodilution, renal (RBF, mL/min/100g) and intestinal (IBF, mL/
min/100g) blood flow by ultrasonic probes, and systemic O2
consumption (VO2, mL/min/kg) by a metabolic cart. Renal (rVO2, mL/
min/100g) and intestinal (rVO2, mL/min/100g) O2 consumption were
calculated from RBF and IBF and the respective arteriovenous O2
content difference. Cortical renal, intestinal villi and sublingual
microcirculation were assessed by IDF-videomicroscopy. After basal
measurement, sheep were assigned to normothermia (N, n=12) and
hypothermia (H, n=12) groups. In the former, central temperature
(Temp, °C) was maintained at basal values and in the latter, it was re-
duced to ~34°C. Measurements were repeated after 1 h of
hemodynamic stable conditions and 1 h of hemorrhagic shock.
RESULTS. During hemodynamic stability, hypothermia decreased CO,
RBF, and systemic and regional VO2. Renal, villi and sublingual red
blood cell velocity (RBCV, μm/s) decreased while perfused vascular
density (PVD, mm/mm²) remained unchanged. In normothermia
group, all these variables were unchanged.
During hemorrhagic shock, systemic and regional flow and VO2,
and RBCV and PVD were similarly reduced in normo- and
hypothermia groups. The microcirculatory derangements were
higher in the renal cortex than in the villi and the sublingual
mucosa: PVD was reduced to 25±28, 67±29, 82±21% from basal
values, in renal, villi and sublingual microcirculation; and RBCV to
37±28, 56±15, and 54±9% (P<0.001 for both, renal vs. villi and
sublingual microcirculation).
CONCLUSION. 1) In stable hemodynamic conditions, hypothermia
decreased peritubular, villi and sublingual RBCV but PVD was
unaffected. 2) In hemorrhagic shock, hypothermia showed neither
beneficial nor detrimental effects on microcirculation. 3) Renal
microcirculation was more sensitive than villi and sublingual
microcirculation to hemorrhagic shock.REFERENCE
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INTRODUCTION. Patients suffering from acute intoxication, whether
voluntarily for autolytic or accidental purposes, often require life
support in intensive care units.
METHODS. Retrospective observational study of all patients admitted
for acute intoxication who required admission to the ICU of the
Regional Hospital of Malaga between January 2012 and August 2016,
older than 14 years with admission to the ICU for intoxication of any
kind. We study patient characteristics in terms of age, sex and
medical history, type of toxicity, severity and evolution in our unit.
RESULTS. We found 70 cases of patients who required admission to
the ICU due to acute intoxication, of which 55.6% were women. The
average age was 47.36 (standard deviation 18.22). The average stay
in ICU was 5.04 (standard deviation 8.09). 54.2% of patients had a
psychiatric history. As other background highlights, 19.4% were
addicted to illegal drugs and 25% were hipertensive. Most patients
took more than one toxic 83.3% and intoxication was voluntary in
84.7% versus accidental in 12.5% of cases. The toxic was known in
68%. The most used benzodiazepines in 26.4% of the total. The main
cause of admission to the ICU was due to neurological deterioration
in 49 of the cases registered and mechanical ventilation was
necessary in 44 patients. The maximum time in mechanical
ventilation was 34 days. The infection occurred in 24.3%, with the
majority being respiratory infection. The 4.7% died in ICU. The
hospital stay presented an average of 9.3 days.
CONCLUSION. The profile of patient admitted to the ICU due to
acute intoxication is a woman of middle age and psychiatric history,
with voluntary intoxication of several toxic substances and requiring
Page 522 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55mechanical ventilation for a low level of consciousness for an
average of 3 days. The survival is very high it would be necesary to
analyze the possible relapses of these patients
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INTRODUCTION. Only some of the cases of exposure to toxic
substances entails a serious poisoning that requires admission to the
ICU. The initial instability in need of supportive treatment, alteration
of the internal environment, or the appearance of sequelae differs
widely depending on the degree, etiology and characteristics of the
intoxication.
OBJECTIVES. To analyze the possible complications of the poisoning
admitted in the ICU, as well as make a prognostic assessment of
cases through the use of some analytical markers such as pH, lactate
levels and the clearance of this one (obtained by the difference
between the level of the first and the second day)
METHODS. We performed a retrospective observational study of all
patients admitted for acute intoxication that required admission to
the intensive care unit of the Regional Hospital of Malaga between
January 2012 and August 2016. The inclusion criteria were age
above14 years admitted to the ICU due to poisoning of any kind. We
used the t-test or chi 2 for the univariate analysis according to need
with an alpha error of 5%.
RESULTS. We recorded 70 patients, in which a 68% the poison was
known, being 83.3% of the total caused by multiple toxics. The
21.7% of the patients underwent early gastric lavage or activated
charcoal was administered, not finding significant differences with
the group that did not receive treatment when compared to
alterations in the internal environment (pH, lactate in the blood). The
mortality of patients admitted for poisoning was 4.7%. There was a
tendency, although not statistically significant between patients with
worse pH and less of lactate clearance in the first 6 hours with
mortality (p=0.09). No significant relationship between the patients
who have neurological sequelae at discharge with those blood levels
studied.
A 7.1% of the patients required dialysis during the stay in the ICU.
There is a association of this fact with the finding of an average
value of lactate in the early hours (p=0.038).
CONCLUSION. The mortality of the intoxicated patient is not
negligible in our environment. The profile is of a middle-aged male
patient, with
voluntary intoxication with several medications that requires VMI or
dialysis in a variable percentage. The highest levels of lactate to
income or in the early hours were associated with greater need of
CRRT. Perhaps the concordance of these values with other
complications can be demonstrated continuing the study and
increasing the sample.
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INTRODUCTION. Meropenem is an ultrabroad-spectrum antibiotic of
carbapenem family. In brain-dead organ donors, administration of
standard meropenem dosages does not reach therapeutic levels.OBJECTIVES. Our objectives were to determine the plasma
concentration of meropenem after administration of standard
meropenem dose and to estimate an improved dosage regimen for
these patients.
METHODS. One gram of meropenem was administered as 1-h infu-
sion every 8 h for 1–3 days, and blood samples were collected. The
plasma concentration of meropenem was measured and subjected
to pharmacokinetic analysis. Simcyp simulation was performed to
predict the optimum plasma levels and dosage based on the pa-
tients’ individual pharmacokinetic parameters.
RESULTS. The maximum plasma concentration of meropenem was
3.29 μg/ml, which was lower than four times the minimum inhibitory
concentration of 8 μg/ml. Although mean creatinine clearance of
patients was moderately low (67.5 ml/min), apparent volume of
distribution at steady state (Vss) and time-averaged total body clear-
ance (CL) of meropenem were markedly elevated (4.97 l/kg and 2.06
l/h/kg, respectively) owing to massive fluid loading to decrease the
high sodium levels and to treat shock or dehydration. The simulation
revealed that dose and infusion time of meropenem should be in-
creased based on patients’ Vss and CL and loading dose is recom-
mended to reach rapidly the target concentration.
CONCLUSION. In conclusion, standard meropenem regimen is
insufficient to achieve optimal drug levels in brain-dead patients and
increase in dose and extended or continuous infusion with intraven-
ous bolus administration of loading dose are recommended for these
patients.
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INTRODUCTION. Trauma patients are at risk for severe infections
after trauma. The risk of developing these infections is associated
with the severity of tissue damage and the amplitude of the
following immune response. Neutrophils act as important effector
cells in the immune response to trauma. Previous studies showed
that shifts in neutrophil phenotypes directly after trauma are a
promising predictor for inflammatory complications. Unfortunately,
technical and logistical difficulties preclude application of such a test
in the clinical setting. However, recently a fully automated point-of-
care 24/7 “load & go” flow cytometry system became available, that
can possibly overcome these challenges.
OBJECTIVES. The aim of this study was to assess the feasibility of
implementing a point-of-care 24/7 “load & go” flow cytometry test in
the shock room.
METHODS. A prospective mono-center cohort study was performed
in our level one trauma center from November 2018 until February
2019. All trauma patients >18y initially presented at the shock room
were included by the trauma team. An extra tube of blood was ob-
tained during standard diagnostic workup and was placed in the 24/
7 available “load & go” flowcytometer, AQUIOS CL©, co-located in
the shock room by the trauma team. The markers CD35, CD16,
CD62L, CD11b, active CD11b, CD10, CD66b and CD11c were immedi-
ately measured with and without the bacterial stimulus fMLF. All pa-
tient characteristics and follow-up data were collected from the
electronic medical record.
RESULTS. A total of 235 patients were presented in the shock room
during the inclusion period, of whom 166 patients were eligible for
inclusion. Only in 3 patients the trauma team failed to start the
analysis. This resulted in a total of 163 successfully placed tubes in
the machine. Technical difficulties resulted in the exclusion of 4
samples, resulting in a total of 159 successfully analyzed patients. A
total of 38 patients were marked as multi trauma (ISS ≥16) patients.
Patients without any significant tissue damage had one clear
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trauma patients with significant tissue damage always developed
two new neutrophil subsets, CD16dim/CD62Lhigh and CD16high/
CD62Ldim neutrophils. The amount of CD16dim neutrophils (5-50%)
was related to the extent of tissue damage after trauma. All trauma
patients that are admitted to the ICU showed CD16dim cells,
however the amount of CD16dim cell differed between patients.
Moreover some patients showed about 50% progenitor cells and all
of them died <48h after admission.
CONCLUSION. Implementation of routine neutrophil analysis by
point-of-care 24/7 “load & go” flow cytometry in the shock room is
applicable. The percentage of CD16dim neutrophils is associated
with the amount of tissue damage that can result in immune dysreg-
ulation and immune related complications after trauma. This quick
analysis of CD16dim neutrophils as read out for tissue damage might
proof a valuable tool to predict immune related complications in the
ICU. A large prognostic study should be deployed.
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INTRODUCTION. More and more severely injured patients survive
the critical first phase after trauma. A substantial portion of these
patients require long-term critical care support and suffer from recur-
rent infections. This clinical condition fits in a syndrome also referred
to as “Persistent inflammation, immunosuppression and catabolism
syndrome” (PICS).
OBJECTIVES. The aim of this study was to investigate the incidence
of PICS and clinical outcomes of these trauma patients with PICS in a
level one trauma center.
METHODS. All trauma patients ≥ 16 years who were admitted to the
intensive care unit (ICU) for ≥ 14 days between 2007 and 2017, were
included. Patients with isolated neurological injuries were excluded.
PICS patients were identified by ICU stay ≥ 14 days, ≥ 3 infectious
complications and increased catabolism. Infectious complications
included infections during hospitalization and readmissions due to
an infection. Increased catabolism was defined as weight loss >10%,
a body mass index <18 or persistent albumin levels <30g/L. Long
term clinical outcomes of PICS patients were analyzed.
RESULTS. Of the 3859 polytrauma patients, only 194 patients had an
ICU stay ≥ 14 days. After exclusion of patients with isolated
neurological injuries, 78 patients were included. Of these patients, 18
developed PICS. PICS patients sustained 5 infectious complications
on average (compared to 1 in the non-PICS group, p<0.001) and
72.2% of the PICS patients developed sepsis. There were no signifi-
cant differences in Injury Severity Score and in-hospital mortality be-
tween PICS patients and the other patients with an ICU stay ≥ 14
days. However, these PICS patients had a longer hospital stay (mean
of 90 days versus 50 days, p<0.001) and sustained more surgical pro-
cedures (mean of 13 versus 4 per patient, p<0.001). Infectious read-
missions occurred until 5 years after the initial trauma.CONCLUSION. Patients who develop PICS experience long-term in-
flammatory complications that lead to frequent readmissions and
surgical procedures. Therefore, this clinical condition forms a burden
on patients and a substantial financial burden on society, despite its
low incidence.
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INTRODUCTION. Patients often develop life-threatening infections
after severe trauma. Neutrophils are the main immune cells to com-
bat these infections by phagocytosis and killing of pathogens. How-
ever, severe injuries can induce malfunction of neutrophil killing.
Analysis of this dysfunction is laborious and can therefore not be ap-
plied in routine diagnostics. Neutrophil phagosomal acidification,
however, one of the last steps in the killing process, can nowadays
be measured within an hour. Hence, we developed a quick and auto-
mated method to assess phagosomal acidification.
OBJECTIVES. The aim of this study was to investigate the relation
between neutrophil phagosomal acidification and infectious
complications in critically ill trauma patients.
METHODS. Multitrauma patients aged 18-80 years with an ex-
pected stay in the intensive care unit of ≥ 2 days, were prospect-
ively included. Blood samples were obtained <12 hours after
trauma, after 3 days, 6 days, 10 days and 15 days. Phagosomal
acidification was analyzed using the fully automated “Load & Go”
AQUIOS CL© flow cytometer after incubation of whole blood with
double labeled (promofluor[PF]/pH insensitive and pHrodo/pH
sensitive) Staphylococcus Aureus bioparticles for 60 minutes. Data
are presented as mean ratio pHrodo/PF after 60 minutes ± stand-
ard error (SE).
RESULTS. Ten patients were included. Of these patients, 5 developed
an infection between day 6 and 10 after trauma. Neutrophil
phagosomal acidification remained stable and within reference
values (0.83 – 1.05) in patients who did not develop an infection. In
patients with infectious complications however, phagosomal
acidificiation was slightly elevated on day 0 and day 3 (1.10±0.11
and 1.16±0.12 respectively), after which phagosomal acification
decreased to below reference values (day 10: 0.78±0.11 and day 14:
0.74±0.07).
CONCLUSION. Flow cytometry analysis of neutrophil phagosomal
acidification is a fast and clinical applicable method to assess
neutrophil function. This method can be used to detect changes in
neutrophil function in critically ill trauma patients and could
therefore potentially be a useful method to identify patients at risk
for infectious complications.
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INTRODUCTION. Implementing the biological knowledge on the
pathophysiology of ARDS and on different coagulative and
inflammatory pathways activated by ECMO may improve patient’s
survival.
OBJECTIVES. Explore miRNAs expression changes in ARDS patients
during ECMO treatment, as predictive markers of survival and
monitoring of the disease.
METHODS. 754 human miRNAs were screened in whole blood
before cannulation and on day 7 and 14 of ECMO support in ARDS
patients weaned from ECMO. The miRNAs were analyzed by PCR
using TaqMan™ Array Human MicroRNA A+B Cards Set v3.0 (Applied
Biosystems).
RESULTS. From September 2018 to March 2019, 9 patients were
supported with VV-ECMO for ARDS and n=7 survived (77.8%): age 53
(44-57) years, male gender n=6 (86%), BMI 26.5 (24.7-27.8), SAPS II at
admission 37 (34.5-43.5), PaO2/FiO2 preECMO 60.5 (56.3-64.8), Pre-
serve score 3.5 (2.3-5), Respscore 3 (-2.5-4.7), duration of ECMO sup-
port 19 days (9-31).
After quality control screening (amplification score > 1.1, Cq
confidence > 0.8, high expression (Ct < 33), and detectable
expression in more than half of the samples), 318 miRNAs were
selected. Volcano plot analysis (p < 0,05 and fold change > 2)
identified 12 miRNAs deregulated on day 7 and 27 miRNAs on day
14. In particular, we identified 6 upregulated miRNAs (figure 1A) and
6 downregulated miRNAs (figure 1B) on day 7, whereas 27
upregulated miRNAs on day 14
(figure 1C). Hierarchical clustering analysis showed systematic
variations in the miRNAs expression among the different groups.
To correlate deregulated miRNAs and ARDS, we considered, through
DIANA-miRPath v3.0, representative pathways for ARDS in which
deregulated miRNAs are involved, reducing to 7 the miRNA deregu-
lated on day 7, and to 20 the miRNA on day 14. The clustering of this
new list of miRNAs leads to a complete cluster separation after 7
days of treatment, and an almost complete separation after 14 days
of treatment.
These miRNAs are correlated to the pathways tissue remodeling
cellular stress and apoptosis, regulation of immune system and
regulation of coagulation process.
CONCLUSION. Up- and down-regulated miRNAs, tend to cluster in
ARDS and ECMO support. MiRNAs from the whole blood are promis-
ing biomolecular markers to monitor ARDS evolution and the impact
of ECMO on inflammation/coagulation system.Fig. 1 (abstract 000385). See text for description000388
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INTRODUCTION. Prone positioning in severe ARDS patients improves
oxygenation, reduces ventilator-induced lung injury and is associated
with mortality reduction[1]. A strong physiologic rationale supports
prone positioning (PP) in ARDS patients receiving ECMO therapy.
However, the fear of complications historically limited its use during
ECMO. To date, despite an increase in utilization of this procedure in
ECMO patients[1], only few monocentric retrospective studies have
been published on this topic.
OBJECTIVES. We conducted a multicentric retrospective study to
evaluate safety, efficacy of PP during ECMO support. Secondly,
we aim to compare outcomes between patients who underwent
PP during ECMO (PP-ECMO group) with a matched population of
patients treated with extracorporeal support (supine-ECMO
group).
METHODS. A multicenter, retrospective trial including patients
admitted to 6 ECMO referral centers between 2014 and 2018 and
treated with veno-venous ECMO for respiratory failure: patients in
the PP-ECMO group are enrolled in 4 ECMO centers where PP is
a standard procedure during extracorporeal support, whereas pa-
tients in the supine-ECMO group are enrolled in 2 ECMO centers
where PP is not performed during ECMO. In the PP-ECMO group,
respiratory and hemodynamic parameters were recorded at four
different steps: 1 - Supine; 2 - Start PP; 3 - End PP; 4 - Return to
supine position We plan to include about 130 patients in the PP-
ECMO group and 100 patients in the supine-ECMO group. Out-
comes (survival, icu LOS, duration of ECMO support) will be com-
pared between groups after individual and propensity-score
matching.
RESULTS. We report preliminary data from 2 of 6 centers. During the
study period 37 patient were included in the PP-ECMO group and 69
patients in the supine-ECMO group. In the PP-ECMO group the num-
ber of PP cycles was 3 [2-4] per patient and the duration was 12 [8-
17] hours per cycle.
No major complication related to the procedure (extubation, cannula
displacement, uncontrolled bleeding) was recorded.
Prone positioning was associated with an improvement of
oxygenation and respiratory mechanics (see Figure 1 below). Lung
Injury Score, SOFA and SAPS II did not differ between PP-ECMO and
supine-ECMO group. ICU mortality did not differ (35% and 41% re-
spectively, p=0.58).
CONCLUSION. Prone positioning during ECMO was safe and
effective. The impact of this procedure on outcome during ECMO
has still to be assessed.F2REFERENCE
[1] C. Guérin et al., “Prone positioning in severe acute respiratory distress
syndrome,” N. Engl. J. Med., vol. 368, no. 23, pp. 2159–2168, Jun. 2013.
F2
Fig. 1 (abstract 000388). See text for description
Fig. 1 (abstract 000391). See text for description
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INTRODUCTION. Diaphragmatic atrophy starts within 12-18 hours
after initiation of mechanical ventilation[1] and reaches a peak by 69-
72 hours[2]. Both the duration and mode of ventilation are significant
factors in determining the magnitude of atrophy[3, 4] Assist Control
Mechanical Ventilation (ACMV) and Synchronized Intermittent
Mandatory Ventilation with Pressure Support (SIMV+PS) are com-
monly used in ICUs. In ACMV the ventilator delivers the set tidal vol-
ume in both mandatory and spontaneous breaths. In SIMV+PS the
inspiratory pressure support is tailored to the patient’s effort and the
mechanical properties of the lungs.
OBJECTIVES. We compared the decrease in diaphragmatic thickness
(DT) measured ultrasonically between patients on ACMV and SIMV+PS.
METHODS. Ethical clearance and informed consent from the next of
kin were obtained. 42 patients were randomly allocated to two equal
groups (Group A: ACMV, Group B: SIMV+PS) within 6 hours of ICU
admission. Tidal volume was set to 6-7 ml/kg. PS level was adjusted
to deliver ~80% of the set tidal volume. DT was measured using a
straight probe at the zone of transition on the mid-axillary line at the
liver and spleen windows on the right and left sides (Sonosite Fuzi-
film M-Turbo) within 6 hrs of initiation of mechanical ventilation and
after 72 hours. Three repeat measurements were done separately for
each hemidiaphragm and averaged. The quadriceps muscle thickness
was also measured at each time point. Enteral feeding (1500-1600
Kcal/day) was started within 24 hours of ICU admission and serum
procalcitonin was measured at 72 hours in all patients.
RESULTS. The decrease in DT was significantly greater in ACMV
compared to SIMV+PS (7.2 vs 5.1 mm; Difference between groups:
mean 1.9 mm, 95% CI: 0.9-3.8 mm, p=0.002, Welch's T-test). Quadri-
ceps thickness and serum procalcitonin did not significantly change
after 72 hours in either group. (Figure 1)
CONCLUSION. Using SIMV+PS reduces the magnitude of
diaphragmatic atrophy compared to ACMV in critically ill patients on
mchanical ventilation.REFERENCE(S)
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diaphragmatic structure and function. Crit Care Med. 2009; 37(10): S347-
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et al. The course of diaphragm atrophy in ventilated patients assessed
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humans. N Engl J 3. Med. 2008; 358(13): 1327–35.
4. Futier E, Constantin JM, Combaret L, Mosoni L, Roszyk L, Sapin V, et al.
Pressure support ventilation attenuates ventilator-induced protein modifi-
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INTRODUCTION. Microaspiration of gastric and oropharyngeal
contaminated secretions occurs frequently in intubated critically-ill
patients, and plays a major role in the pathogenesis of ventilator-
associated pneumonia (VAP). At steady state, patients with chronic
obstructive pulmonary disease (COPD) have an increased risk of
microaspiration (due to gastro-esophageal reflux disease, pharyngo-
laryngeal dysfunction…), this risk may even be more important
under mechanical ventilation.
OBJECTIVES. The purpose of this study is to determine if COPD is a
risk factor for global abundant microaspiration (GAM) and its
complications (ventilator-associated tracheobronchitis (VAT), VAP,
death) in intubated critically-ill patients.
METHODS. We gathered data from three prospective randomized
trials (1–3) focused on enteral nutrition or microaspiration in
intubated patients. In all included patients, pepsin and salivary
amylase were prospectively measured in all tracheal aspirates for
48h. Data on COPD were retrospectively collected. GAM was defined
as the presence at significant level of pepsin (>200 ng/ml) and/or
salivary amylase (>1685UI/L) in at least 30 % of the tracheal aspirates
during the first 48 hours after intubation.
RESULTS. 540 patients were included among which 121 had COPD
(70 with spirometric-proven COPD). GAM was present in 102 COPD
patients and in 349 non-COPD patients (84.3% vs 83.3%, p=0,79).
Abundant gastric microaspiration was found in 59 COPD patients
and in 194 non-COPD patients (48.7% vs 46.3%, p=0.63). Abundant
oropharyngeal microaspiration was found in 86 COPD patients and
Page 526 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55in 304 non-COPD patients (71% vs 75.5%, p=0.83). Neither
spirometric-proven COPD nor COPD severity were found as risk fac-
tors for GAM. There was no statistical difference between COPD and
no-COPD groups for the rates of VAT (2.4% vs 2.1%, p=0.82), VAP
(18% vs 22%, p=0.34), or ICU mortality (27% vs 27%, p=0.97). Similar
outcomes were found in no-COPD and spirometric-proven COPD
groups.
CONCLUSION. COPD is not associated with increased risk for GAM or
VAP.
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INTRODUCTION. Post-extubation respiratory failure (PERF) is a com-
mon complication in electively extubated patients, it is unclear
whether high-flow nasal cannula (HFNC) and non-invasive ventilation
(NIV) decrease rates of re-intubation in patients with established
post-extubation respiratory failure. As high-flow oxygen therapy de-
livered through nasal cannula could improve oxygenation, secretions
management and reduce work of breathing, we assessed whether
HFNC could reduce the rate of re-intubation in patients with estab-
lished PERF compared with NIV by helmet or oronasal mask.
METHODS. Between March 1, 2017 and December 31, 2018, eighty-
nine patients had established respiratory failure after elective extuba-
tion and were applied HFNC or NIV. The data of these 89 patients
were collected prospectively in a medical intensive care unit (ICU),
academic, tertiary care hospital and retrospectively analyzed.
RESULTS. The data of 89 patients were collected. HFNC was
administered to 46 and NIV by helmet or oronasal mask was
administered to 43. There were no differences between baseline
characteristics in the two groups. A comparison of the HFNC and NIV
groups showed no differences between rates of re-intubation, ICU or
hospital mortalities in patients with established post-extubation re-
spiratory failure. pH, PaO2/FiO2 in the NIV group were significantly
lower and PaCO2 was higher than in the HFNC group before HFNC
or NIV application.
CONCLUSION. In previous study, among high-risk patients who have
undergone extubation, there was no difference in preventing re-
intubation between HFNC and NIV. Similar to previous study, in pa-
tients with established pos-extubation respiratory failure, the effect-
iveness of HFNC was not significantly inferior to NIV in our study. A
prospective study that takes into account patient selection and HFNC
or ventilator settings is required to determine the clinical efficacy of
HFNC or NIV.REFERENCE(S)
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INTRODUCTION. Acute severe asthma (ASA) is a common cause of
admission in intensive care units (ICU). In some rare cases, it can lead
to invasive mechanical ventilation. There is currently few recent data
in the literature about this specific subtype of patient.
OBJECTIVES. The aim of this retrospective and bicentric study was to
investigate the factors associated with mortality of ASA requiring
invasive mechanical ventilation.
METHODS. All ASA requiring invasive mechanical ventilation
between 2008 and 2017 were analyzed.
Patients’ characteristics and laboratory tests were tested in bivariate
analysis for association with 28-day mortality. Factors achieving p <
0.20 were introduced into a multivariable model.
RESULTS. The main strength of this study is its completeness: it
concerns the Reunion Island, a French overseas territory with only 2
ICU, both having participated in this study. Therefore, all ASA
requiring invasive mechanical ventilation during the study period
were analyzed without exception.
Eighty-one patients were evaluated in this study, among whom 52
(64%) were women. All patients were known to have asthma. The
median age was 49 years old [interquartile range, 42-60] with a me-
dian Simplified Acute Physiology Score II (SAPS II) of 40 [30–54].
About a quarter of the patients (n=20) had experienced a previous
ASA that required invasive mechanical ventilation. No decompensa-
tion risk factor was found in almost half of the cases (49% - n=40).
The other decompensation risk factors found were cessation of
asthma treatment (12% - n=10), allergenic exposure (10% - n=8),
extra-respiratory sepsis (11% - n=9), bacterial or viral pneumonia
(15% - n=12) and acute bronchitis (14% - n=11). Seven patients
underwent salvage therapy, sometime in combinaison: ECMO for 6
patients, hallogenated gaz for 1 patient and anti-IL5 antibody (mepo-
lizumab) for 2 patients.
The mortality rate was 14% (n = 11). In bivariate analysis, the
occurrence of a cardiac arrest prior to admission, a cardiac arrest as
the reason for intubation, the absence of a decompensating risk
factor found and an intubation in prehospital setting were
significantly associated with a poorer outcome. In non-survivor, SAPS
II, creatinine level and lactatemia at admission were significantly
higher whereas pH and HCO3 at admission were significantly lower.
Multivariable analyses retained a positive fluid balance at day 1 (OR
6 [1-11] for 1L, p = 0.02) and the occurrence of a cardiac arrest prior
to admission (OR 36.6 [3.6-374.9], p < 0.01) as being independently
associated with 28-day mortality.
CONCLUSION. Nowadays, ASA requiring invasive mechanical
ventilation is still responsible of high 28-day mortality. The prognostis
is mainly related to multiorgan failure with the occurrence of a
Page 527 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55cardiac arrest prior to admission as the worst risk factor. A positive
fluid balance at day 1 is also associated with poor outcome, challen-
ging the usual dogma that recommends a liberal hydratation in such
patients.
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INTRODUCTION. Predisposing conditions and risk modifiers have
been recently used to identify patients at risk for acute respiratory
distress syndrome (ARDS) instead of causes and risk factors. Risk
modifiers of ARDS caused by sepsis due to pneumonia which is one
of the most common predisposing conditions are well known.
However, little is known about risk modifiers of ARDS especially
among patients with non-pulmonary sepsis.
OBJECTIVES. Our aim was to evaluate risk modifiers associated with
ARDS among patients with non-pulmonary sepsis.
METHODS. This is a secondary analysis of the sepsis cohort in the
Focused Outcomes Research in Emergency Care in Acute Respiratory
Distress Syndrome, Sepsis and Trauma (FORECAST) study. [1] This
was a multicenter, prospective cohort study conducted in 59
intensive care units (ICUs) in Japan from January 2016 to March
2017.We included adult patients with severe sepsis and septic shock
caused by non-pulmonary infection, who admitted to ICUs. The pri-
mary outcome was having ARDS defined as meeting the Berlin defin-
ition [2] at the first or the fourth day of ARDS screening. The
secondary outcome was developing ARDS defined as both of (1) ab-
sence of ARDS at the first day of ARDS screening and (2) presence of
ARDS at the fourth day of ARDS screening. The explanatory variables
were prespecified a priori based on clinical experience and prior
studies, such as age, gender, admission source, body mass index,
smoking status, congestive heart failure, chronic obstructive pulmon-
ary disease, diabetes mellitus, steroids, statin, site of infection, septic
shock, and APACHE II score. After carefully checking collinearity, to
identify risk modifiers associated with having ARDS and developing
ARDS, we developed multivariate logistic regression models.RESULTS. 594 patients with non-pulmonary sepsis met the inclusion
and exclusion criteria of the study. 85 patients had ARDS at the first
or the fourth day of ARDS screening, and 16 patients developed
ARDS at the fourth day of ARDS screening.
There was no significant difference between patients with and
without ARDS regarding baseline characteristics such as age, body
mass index, coexisting conditions, smoking, and sites of infection.
80% of patients with ARDS and 66% of patients without ARDS had
septic shock (P = 0.01). APACHE II scores were higher in patients with
ARDS than those without ARDS (26.0 vs 21.0, P < 0.01). In the
multivariate logistic regression model, ICU admission from other
wards compared with emergency departments (odds ratio (OR) [95%
confidence interval (CI)], 0.53 [0.294–0.947]), smoking status (current
smoking compared with never having smoked: OR [95%CI], 0.18
[0.056–0.587]), soft tissue infection compared with abdominal
infection (OR [95% CI], 2.39 [1.040–5.400]), and higher APACHE II
score (OR [95% CI], 1.08 [1.050–1.120]) were independently
associated with having ARDS. No risk modifiers were independently
associated with developing ARDS in our cohort.
CONCLUSION. Soft tissue infection, ICU admission from hospital
wards, and higher APACHE II score may be risk modifiers of ARDS in
patients with non-pulmonary sepsis.
REFERENCE(S)
1. JAMA. 2012;307(23):2526-33.
2. Crit Care. 2018;22(1):322.
000443
Retrospective Evaluation of Factors Affecting Development of
Tracheomalacia in Critically ill Patients with Prolonged Intubation
ZO. Simsek1, K. Gundogan2, M. Sungur1
1Department of internal medicine, division of intensive care, Erciyes
University, School of Medicine, Kayseri, Turkey; 2Department of internal
medicine, division of intensive care, Erciyes University, School of
medicine,, Kayseri, Turkey
Correspondence: K. Gundogan
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000443
INTRODUCTION. Tracheomalacia (TM) is defined as diffuse or
segmental weakness of the trachea. Acquired TM, is more common
than the congenital form and more frequent in male gender. The
most important diagnostic method is observation of airway collapse
via bronchoscopy.
OBJECTIVES. Aim of this study is to identify development frequency
of and factors affecting TM in critically ill patients with prolonged
intubation.
METHODS. This study was performed in Intensive Care Unit.
Intubation time longer than 7 day patients were included into the
study. A chest disease specialist examined the bronchoscopy video
records and the study included patients who had a bronchoscopy
video record on the first day of intubation and at least one
bronchoscopy video record in the period between seventh day of
intubation and extubation.
RESULTS. The study included 40 patients. Mean age of the patients
was 59.9±13.2 years. Mean body mass index (BMI) of the patients
was 26.4±4.9 kg/m2. Patients' median APACHE II and SOFA scores
were 18 (range: 9-35) and 6 (range: 3-13), respectively. TM was
identified in 4 patients (%10) among all the patients included in
the study. When we checked risk factors for TM development,
two patients had history of COPD. One patient had history of in-
tubation. No risk factor was identified in the other patient. During
follow-up weaning failure, requirement of re-intubation and fatal
progress were identified in patients with TM. Gender distribution
was equal in patients with TM.
CONCLUSION. We identified weaning failures, re-intubation require-
ments and fatal progress in all patients with tracheomalacia. TM is an
important condition that increases morbidity and mortality in the
Page 528 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55settings of intensive care units and suspected patients in terms of
TM should undergo bronchoscopy.
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INTRODUCTION. Acute pulmonary embolism (PE) is the most serious
clinical presentation of venous thromboembolism and causes
obstructive shock and hemodynamic instability [1-3]. It is stratified
on the basis of the early PE-related mortality risk, and the high-risk
group is defined as patients who have shock or systemic
hypotension [2,3]. Unfortunately, despite the expedited lifesaving
treatments such as systemic thrombolysis and surgical embolectomy,
acute high-risk PE is associated with significant morbidity and mortal-
ity [2-5].
OBJECTIVES. Although extracorporeal membrane oxygenation
(ECMO) has been used for the treatment of acute high-risk pulmon-
ary embolism (PE), reports focusing on this approach are limited. We
describe our experience with ECMO for acute high-risk PE.
METHODS. We retrospectively reviewed the medical records of
patients treated for acute high-risk PE with ECMO between January
2014 and December 2018.
RESULTS. Among the 16 patients included, 6 (37.5%) were men.
The median age was 51 years (interquartile range [IQR], 38–71
years). Cardiac arrest occurred in 12 patients (75.0%), including 2
with out-of-hospital arrest. All the patients underwent venoarterial
ECMO for a median duration of 1.5 days (IQR, 0.0–4.5 days).
Seven (43.8%) and 9 patients (56.3%) underwent systemic
thrombolysis and surgical embolectomy, respectively, including 3
(18.8%) who received both treatments. The overall 30-day mortal-
ity rate was 43.8% (95% confidence interval, 23.1%–66.8%) and
showed no significant difference among the treatment groups
(thrombolysis vs. non-thrombolysis: 42.9% [n=3/7] vs. 44.4% [n=4/
9], p=0.870 and embolectomy vs. non-embolectomy: 44.4% [n=4/
9] vs. 42.9% [n=3/7], p=0.870).
CONCLUSION. Despite treatment efforts, the patients with acute
high-risk PE had substantial morbidity and mortality. ECMO may be
considered in these patients in conjunction with either systemic
thrombolysis or surgical embolectomy.
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INTRODUCTION. 25% of critical care admissions in our hospital are
for respiratory failure. High flow nasal oxygenation (HFNO) in
respiratory failure has been shown to be safe and effective (1) and
has been used at the Freeman Hospital since 2009. By introducing a
formalized outreach nursing service led, ward based HFNO service
for patients with single organ respiratory failure we aimed to reduce
unnecessary critical care admissions without compromising patient
safety.
OBJECTIVES. 2 prospective audits were conducted assessing the
outcome of patients requiring critical care ventilatory support for
single organ respiratory failure but managed with HFNO in a ward
setting under outreach nursing team care.
METHODS. In a pilot audit 53 patients referred by the ward team to
critical care for single organ respiratory failure via an early warning
scoring system (NEWS) were reviewed by the critical care outreach
team over a 12 month period.
If assessed as suitable for ward management, the patients were
commenced on HFNO (Airvo 2 Fisher & Paykel) on the ward. The
prescription was determined clinically to maintain patient comfort
with targeted SpO2 and arterial blood gas monitoring as necessary.
A medical decision was taken daily to either: escalate to critical care,
continue HFNO or move to palliative care.
Triggering of the NEWS score or an admitting team request led to an
urgent medical critical care review in accordance with hospital
policy. Patient demographics and ultimate outcomes were recorded
on every patient.
The second audit was of 200 patients using the same referral and
assessment system over another 12 month period in 2016-17.
RESULTS. In the pilot audit of 53 patients, 43% remained on the
ward and survived to discontinuation of HFNO. 42% were admitted
to critical care and 15% received palliative care. In the follow up
audit of 200 patients, 57.5% remained on the ward, 23.5% were
admitted to critical care with 19% receiving palliative care.
No difference was seen in mortality rates between those managed
on the ward and those admitted directly to critical care.
CONCLUSION. In our 2 prospective audits, ward based HFNO for
respiratory failure significantly reduced critical care admissions
without affecting patient outcomes, saving 582 bed days and
potentially a net cost saving of £459,174(2).
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INTRODUCTION. Percutaneous dilatational tracheostomy (PDT) is
commonly performed in intensive care unit (ICU). Although it is safe
and easily performed at bedside, it always needs endotracheal
guidance such as bronchoscopy or light wand.
OBJECTIVES. We sought to the feasibility of PDT without
endotracheal guidance.
METHODS. In the presenting ICU, PDT has been routinely performed
without endotracheal guidance by single medical intensivist using
Griggs technique PDT kit (Portex percutaneous tracheostomy kit,
Smith Medical, England). We retrospectively reviewed the outcome
of PDT without endotracheal guidance.
RESULTS. From January 2018 to December 2018, 78 cases of PDT
were performed in medical ICU and coronary care unit. Mean age
was 71.9 ± 11.5 years and 29 patients (37.2%) were female. Most
patients were admitted to pulmonology (46 patients, 59.0%) and
followed by cardiology (7 patients, 9.0%). PDT was successful in 76
patients (97.4%). Two patients were converted to surgical
tracheostomy because of failure of guidewire passage. One patient
were re-intubated for the surgical tracheostomy and in the other pa-
tient, supraglottic airway device (i-gel, Intersurgical, Wokingham, UK)
were inserted during tracheostomy. No significant procedure related
complication was observed in both patients. Another patient was re-
intubated due to guidewire passage failure, however PDT was suc-
cessfully performed.
Procedure related complication was observed in 5 patients (6.4%)
and all of them were observed with 24 hours after PDT and
controlled with simple local compression. In-hospital mortality was
33.3% (26 of 78 patients) and mean time from PDT to death was
41.7 ± 43.2 days.
CONCLUSION. PDT without endotracheal guidance is safe and
feasible.
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INTRODUCTION. The invasive mechanical ventilation weaning
protocol aims at the progressive removal of ventilatory support, after
presenting acute respiratory insufficiency or not, and having
overcome it totally or partially, this process is relayed after a
standardized evaluation with international guidelines. Several authors
have explored risk factors and prediction rates that are associated
with failure in the release of ventilation.OBJECTIVES. Evaluate if there is an association between the use of
release failure rates in our population and the initial evaluation with
Tobin's mandatory criteria.
METHODS. A retrospective study was conducted, which included 65
patients, in the intensive therapy unit of the "Hospital San Ángel Inn
Universidad", in the period from May 2015 to July 2018, the included
patients, were in mechanical ventilation for any cause with more
than 24 hours of intubation, the included patients were over 18
years old; patients with incomplete records of the ventilation
withdrawal protocol, diagnosis of failed extubation in the current
hospitalization, pregnant or puerperal patients were excluded;
criteria for elimination were voluntary discharge and signature of
advance will. The patients were analyzed in two groups: success, 58
patients, or failure to withdraw, 7 patients. The data were analyzed
by Student's t and sum ranges of Wilcoxón or Man-Whitney U as the
case may be. A ROC curve was performed to describe the effect on
the release of the different ventilation withdrawal rates.
RESULTS. There was no significant difference in the variables
collected between the groups. Later in the analysis of ROC curves
the variables Tobin 1, Tobin 2, p.01 and IWI did not show significant
performance in the detection of failure in the extubation of this
sample (p> 0.05 against Area under the Curve of 0.5), so that is not
continued with subsequent corresponding analyzes.
CONCLUSION. In patients who undergo removal of invasive
mechanical ventilation, using a protocol that evaluates the
mandatory criteria cited by Tobin, it is not relevant to measure
predictors of success as index of superficial respiration, at 1and 30
minutes, as well as the index of IWI.
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represents the standard of care in acute respiratory distress syndrome
(ARDS), assisted MV has gained interest in recent years because of its
recognized beneficial effects (e.g. more homogeneous ventilation,
prevention of diaphragmatic atrophy, reduction in sedative requirements).
Nevertheless, maintaining some degree of spontaneous ventilation also
has a potential for harm (e.g. occult increase in transpulmonary pressure,
Pendelluft phenomenon, loss of control of tidal volume). No clinical
studies have compared spontaneous breathing to controlled MV during
acute respiratory failure, and none has been conducted in the context of
moderate to severe ARDS. Moreover, guidelines recommend limiting tidal
volume (TV) to 4-8 ml/kg of predicted body weight (PBW), but the useful-
ness of TV limitation during assistedMV remains unproven.
OBJECTIVES. We aimed to evaluate the impact of spontaneous
breathing on TV during the initial phase of moderate and severe
ARDS, and to assess the association between high tidal volume (HTV)
and outcome in spontaneously breathing patients.
METHODS. We conducted a retrospective analysis including all
moderate to severe ARDS patients mechanically ventilated in pressure
support mode for at least 72 hours between 2012 and 2018, within a
22-bed mixed ICU of a tertiary medical center. All data were retrieved
from electronic medical recordings. Patients were divided into a HTV
group and a low tidal volume (LTV) group based on the mean TV rela-
tive to PBW, patients with a mean TV > 8 ml/kg PBW being classified in
the HTV group. LTV and HTV groups were compared in terms of demo-
graphics, comorbidities, MV and respiratory parameters,
hemodynamics, adjuvant therapies and outcomes. In a subgroup ana-
lysis, we compared patients’ characteristics and outcomes of the HTV
group with the LTV group, stratified by ARDS severity.
RESULTS. Among 100 patients who fulfilled inclusion criteria, forty-
six (46%) had a mean TV > 8 ml/kg PBW and were classified in the
HTV group. The 90-day mortality rate was not significantly different
between the LTV and the HTV group (44.4 vs 56.5%; p=0.25), despite
higher severity in the HTV group. Median number of Ventilator-Free
days at day 28 (9.5 days vs 11 days, p=0.89) and length of stay in the
ICU (15.5 days vs 14 days, p=0.48) did not differ between LTV and
HTV group. In the most severe patients (PaO2/FiO2 < 100, n=31),
HTV was associated with a trend towards higher 90-day mortality (43
vs 73%, p=0.09), whereas in moderate ARDS patients (n=69), no dif-
ference between groups was shown, despite patients in the HTV
group being significantly older.
CONCLUSION. In this retrospective analysis of patients
spontaneously breathing during the first 72 hours of moderate-to-
severe ARDS, TV > 8 ml/kg PBW was frequent and was not associated
with adverse outcomes.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):000479INTRODUCTION. The WHO defines drowning as “ the process of
experiencing respiratory impairment from submersion/immersion in
liquid”. It is a mayor public health problem that causes 7% of deaths
from unintentional injury worldwide
OBJECTIVES. To know the epidemiologic and clinical characteristics
(by organs), as well as therapeutic measures and evolution of
drowning patients admitted to a medical ICU in a second-level hos-
pital in a six-year period ( from January 2013 to December 2018).
METHODS. Retrospective and descriptive study of drowning patients
admitted to a medical ICU. The following parameters were analyzed:
gender, mean age by group, location of drowning, causes of
drowning, period of the year, source of admission, Simcock
classification on hospital admission, alterations: respiratory,
neurological, cardiac, renal and temperature, as well as therapeutic
measures in terms of ventilatory support, inotropic support and
rewarming. Time spent under mechanical ventilation and mortality
were also analyzed. Statistical analysis: quantitative variables are
expressed as mean and standard deviation (SD) and qualitative
variables as percentages (%). The difference between qualitative
variables are expressed using Chi-square test and quantitative using
an ANOVA analysis.
RESULTS. 19 drowning patients admitted to our ICU were analyzed:
11 female (8 male), mean age by group: <30 years old: 1, 30-50 years
old: 3, 51-70 years old: 8 (42%) and >70 years old: 7 ( 37%). Location
of drowning: ocean 14 (73,5%), river 3 and swimming pool 2. Period
of the year: between May - September: 12 ( 63%), between October -
April: 7. Causes of drowning: unintentional l 8 (42%) , trauma 4
(21%), syncope 4 (21%), suicide attempt 2, seizures 1. Source of ad-
mission: paramedics 12 (63%), hospital A&E 4 , other hospital 3. Sim-
cock classification: group II 1, group III 11 (58%), group IV (cardiac
arrest) 7 (37%), shockable rhythm 5 (71%) non-shockable rhythm 2.
Respiratory alterations: noncardiogenic pulmonary edema 12 (63%),
single alveolar pulmonary infiltrate 4, barotrauma 1 and no alter-
ations 2. Neurological alterations: category A (awake) 9 (47%), cat-
egory B ( blunted) 4 and category C ( comatose) 6 (31,5%): C1 (
decorticate) 1, C2 ( decerebrate) 3 and C3 (flaccid) 2. Renal alter-
ations: acute kidney injury ( AKI) 2, rhabdomyolysis 1. Hypothernia:
>32ºC 12 (67%) and between 32-28ºC 7 (33%), Ventilatory support:
NIV 6 ( 31,5%): BiPAP 4 and CPAP 2, High Flow nasal cannula (HFNC)
1, low flow oxygen therapy ( Venturi face mask) 2, intubation +
mechanical ventilation 10 (52,6%), lung protective mechanical venti-
laton (ARDS) 3; inotropic support 6 (31,5%) and rewarming 7 (37%)
(4 active external and 3 active internal). In patients who required in-
tubation (10), 8 (80%) were extubated, 5 within 72 hours (50%) and
>72 hours 3 (20%). 2 patients (10,5%) died.
CONCLUSION. In our series, the drowning patient is a female
between 51-70 years old, who suffered an unintentional drowning in
the ocean, Simcock type III who required intubation and mechanical
ventilation ( 52,6%), was extubated within 72 hours (50%) and re-
quired inotropic support (31,5%) and rewarming (37%) with a mortal-
ity rate of 10,5%.
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INTRODUCTION. In Asian countries, critical care delivery systems are
underdeveloped compared to Western countries: there would be
distinct characteristics regarding tracheostomy in patients with
translaryngeal intubation
OBJECTIVES. Our study aimed to compare effect of early versus late
or no tracheostomy on clinical outcomes in patients with prolonged
acute mechanical ventilation (ventilator care ≥ 96 hrs).
T1
Page 531 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55METHODS. Data were obtained from 592 patients [median age 68
yrs (range, 17-93 yrs), 69.4% were male] at a medical intensive care
unit (ICU) of a university-affiliated tertiary care hospital during 9
years. Early tracheostomy was defined as ≤ 10 days after translaryn-
geal intubation.
RESULTS. Of total patients, 271 (45.8%) patients underwent early
tracheostomy. Early tracheostomy group showed significantly lower
Acute Physiology and Chronic Health Evaluation II [median 18, (range
3-41) vs 22 (6-35), p<0.001] and Sequential Organ Failure Assessment
[5 (1-18) vs 8 (2-17), p<0.001] scores, and Charlson’s Comorbidity
Index [2 (0-14) vs 4 (0-15), p<0.001)] as well as shorter ICU and hos-
pital length of stay [15 (1-776) vs 22 (4-219) and 24 (6-745) vs 36 (6-
374) days, (all p<0.001, respectively)] than late or no tracheostomy
group. Also, they had lower healthcare-associated costs [19155.8
(2482.4–240960.5) vs 26677.9 (5711.4-206636.3) USD, p<0.001] and
higher successful decannulation (41.0 vs 24.5%, p=0.004) during hos-
pital stay. However, there were no significant differences between
the both groups for in-hospital, 6-months, and 1-year mortality (38.4
vs 42.1%, 55.0 vs 55.5%, and 62 vs 62%, respectively).
CONCLUSION. The patients who underwent early tracheostomy were
associated with lower severity-of-illness, comorbidities on ICU admis-
sion, lower total medical cost, and more success of decannulation.
However, there was no significant difference in mortality.
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INTRODUCTION. The pleth variability index (PVi) has been shown to
be a predictor of fluid responsiveness (FR) in mechanically ventilated
(MV) patients(1). Patients treated with nasal high-flow (NHF) show
similar haemodynamic changes to those observed in MV patients(2).
However, the usefulness of PVi for predicting FR in NHF patients has
not been evaluated.
OBJECTIVES. To analyze whether PVi can predict FR in acute
respiratory failure (ARF) patients supported by NHF.
METHODS. Proof of concept study that included ARF patients ≥18 y
treated with NHF (≥40lpm) showing signs of inadequate tissue
perfusion. At baseline, they were all in Fowler position (head of the
bed at 45º angle). Stroke volume (SV) was measured by transthoracic
echocardiography and PVi was monitored using a pulse oximeter
(Masimo Radical-7® Pulse CO-Oximeter®, Irvine, CA). Fluid-response
was defined as an increase ≥10% in SV after passive leg raising (PLR).
Responders then received a 250ml fluid challenge for 10 minutes.
After PLR and fluid challenge, SV and PVi were reassessed. Results
are expressed as mean (95% CI) or frequency (%).
RESULTS. Twenty patients were included, with a mean age of 63
years (56-59). They were treated with a mean flow of 48 (40-57) lpm
and FIO2 of 0.6 (0.5-0.7). Mean SOFA at the moment of inclusion was
9 (7-10) and SAPS-II 48 (40-51), with a PaO2/FIO2 of 141 (112-171).
Eleven (55%) patients required noradrenaline, with a mean lactate
level of 3.7 (2.7-4.7) mmol/L. Twelve patients (60%) responded to
fluid administration. Responders showed higher baseline values ofPVi (24 [20-28]% vs 13 [8-18]%;p=0.001) and higher PVi variation
(ΔPVi) after PLR (6.8 [5.0-8.5]% vs -1.7 [-4.8-1.4]%;p<0.001). Moreover,
ΔPVi after PLR was similar to ΔPVi after fluid challenge (6.8 [5.0 – 8.5]
vs 7.4 [5.3 – 9.4];p=0.237); both values were strongly correlated (r=
0.84;p<0.001). PVi and ΔPVi after PLR showed excellent diagnostic ac-
curacy (AUROC 0.92 [0.77-1.00];p< 0.001 and AUROC 1.00 [1.00-
1.00];p<0.001 respectively). The best cut-off points using the Youden
index were baseline PVi ≥16 and ΔPVi after PLR ≥2 (Sensitivity, Speci-
ficity, PPV and NPV are presented in Table 1).
CONCLUSION. PVi may predict fluid responsiveness in ARF patients
treated with NHF.
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Table 1 (abstract 000496). See text for descriptionSensitivity Specificity PPV NPV LR+ LR-Baseline PVi ≥16 91.7% 87.5% 91.7% 87.5% 7.33 0.10ΔPVi after PLR ≥2 100% 100% 100% 100% NA NAPPV Positive predictive value, NPV Negative predictive value, LR Likelihood
ratio
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INTRODUCTION. Acute respiratory distress syndrome (ARDS) is an
inflammatory syndrome of the lungs and associated with significant
morbidity and mortality. Mechanical power is an estimation of the
energy delivered to a patient during mechanical ventilation and is
associated with both ventilator-induced lung injury and survival out-
comes. Respiratory rate is one of the determinants of mechanical
power; however, its influence on outcomes remains unclear.
OBJECTIVES.
1. Determine the association between respiratory rate and 28-day
ventilator free days (VFDs), 28-day hospital survival and 3-year
survival in patients with ARDS
2. Determine patient factors associated with an increased
respiratory rate
3. Determine the optimal respiratory rate threshold for mortality
METHODS. A prospective standardized screening program for ARDS
(4 intensive care units (ICUs) within Calgary Alberta from 2010 to
2012) was conducted. Demographics and outcomes of this cohort
have previously been reported. An ancillary analysis of this database
was performed. Outcomes included 28-day hospital survival, 3-year
survival as well as 28-day VFDs. Adjusted logistic and linear regres-
sion were used to model the association between respiratory rate
and these outcomes; models were adjusted for sex, age, height,
weight, admission APACHE, pH, PF ratio, and PaCO2. Multivariable
linear regression was also used to determine patient factors associ-
ated with increased respiratory rate. Youden’s J statistic and area
T1
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the optimal respiratory rate threshold for 28-day and 3-year
mortality.
RESULTS. During the study period 7944 patients were screened and
633 patients (7.9%) met criteria for sustained ARDS. The median
respiratory rate was higher in hospital non-survivors vs survivors (24,
interquartile range [IQR] 20-28 vs 21, IQR 18-24 respectively, p<
0.001). Adjusted models showed that respiratory rate was associated
with an increase in 28-day hospital mortality (odds ratio [OR]1.11,
95% confidence interval 1.06-1.17, p<0.001), 3-year mortality (OR
1.11, 95% CI 1.06-1.16, p<0.001), and reduced VFDs (mean difference
-0.75, 95% CI -0.91 to -0.58, p<0.001). Patient factors associated with
increased respiratory rate in a multivariable model included age,
pneumonia or sepsis as ARDS etiology, admission pH, and initial
mechanical ventilation on spontaneous mode. The respiratory rate
threshold associated with an increase in 28-day hospital mortality
and 3-year mortality was 22 for both.
CONCLUSION. Increased respiratory rate is associated with increase
mortality and reduced 28-day VFDs. Further study will be required to
determine if interventions targeted at reducing the respiratory rate
can modify outcomes.
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INTRODUCTION. Personalized positive end-expiratory pressure (PEEP)
might attenuate lung injury and improve patient's outcome in acute
respiratory distress syndrome (ARDS). However, how to set the opti-
mal PEEP level remains controversial. Electrical impedance tomog-
raphy (EIT), which monitors ventilation distribution, and esophageal
pressure, which allows measure of transpulmonary pressure (PL),
have been proposed as guide for personalized PEEP setting.
OBJECTIVES. To test if PEEP-EIT and PEEP-PL differs in terms of
values,gas exchange and lung mechanics.
METHODS. After obtaining consent, an esophageal catheter
(Nutrivent, SIDAM, Mirandola, Italy) and a 32-electrodes EIT monitor
(Swisstom BB2, Swisstom, Landquart, Switzerland) were positioned in
20 ARDS patients . Each patient underwent, in random order, two
PEEP titration trials to find the levels of PEEP associated with 1) posi-
tive end-expiratory PL based on a PL/FiO2 table (PEEP-PL) [1] and 2)
the lowest PEEP providing silent spaces ≤15% (PEEP-EIT). FiO2 was
set to obtain SpO2=88-95%, Vt was 6 ml/kg/PBW and RR to maintain
normocapnia. After identifying the 2 PEEP levels, each was main-
tained for 20 minutes in a random order. Lung mechanics, gas ex-
change, hemodynamics and EIT data were recorded at the end of
each step. Regional respiratory system compliance was calculated in
4 cranio-caudal regions of interest (ROI1=ventral;ROI4=dorsal). Wil-
coxon signed-rank test was used to evaluate if the difference be-
tween variables during the two steps was significant.
RESULTS. Baseline P/F was 149 [108-210], RR 19 [16-24] bpm and Vt
380[358-440] ml. Median values of PEEP-EIT and PEEP-PL were 14 [8-
17] cmH2O and 13 [11-14] cmH2O, with a median difference within
patient of 1.5 [(-)7-5.8] cmH2O (p=0.95). No patient was assigned thesame PEEP and correlation between the levels of PEEP was not sig-
nificant (Rs=0.25; p=0.29). PEEP-EIT and PEEP-PL resulted in no statis-
tically significant differences in gas exchange, but airway driving
pressure (DP) was significantly higher and regional ventral lung com-
pliance was lower at PEEP-EIT. On the other hand, PEEP-PL was asso-
ciated with higher total and dependent hypoventilated regions
(table 1).
CONCLUSION. Personalized PEEP levels assigned by EIT and PL were
not correlated at the individual patient-level. PEEP-PL might be asso-
ciated with lower risk of dynamic lung stress and overdistension
while PEEP-EIT might be more protective from excessive lung
inhomogeneity.
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Table 1 (abstract 001167). See text for description
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INTRODUCTION. Airway pressure release ventilation(APRV) is a type
of inverse-ratio, pressure-controlled,
mode.In addition to being used in patients with acute respiratory
distress syndrome(ARDS), lung protective effects have recently
become prominent (1).The aim of this study is to investigate whether
the use of early airway pressure release ventilation(APRV) mode as a
lung protective strategy is superior to conventional methods in ARDS
development.
METHODS. The study was planned as, randomized controlled study
between 2016-2018 in an 18-bed general intensive care unit(ICU).Pa-
tients with invasive mechanical ventilation but who were not diag-
nosed with ARDS at baseline, had LIPS(Lung Injury Prediction Score)
>7 and intensive care hospitalization for more than 24 hours were
Page 533 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55included in the study.The patients were evaluated as APRV and P-
SIMV groups.
RESULTS. 65 patients who met the eligibility criteria were included in
the study.Thirty-three patients (50.8%) underwent P-SIMV mode and
32(49.2%) patients underwent APRV mode.P/F ratio values were
higher in APRV group.This difference was statistically significant on
day 3(p=0.032).The FiO2 value was lower in the APRV group.There
was a statistically significant difference between the groups at day
7(p=0.011).Patients who needed sedation in the groups were statisti-
cally lower in the APRV group(p=0.048).The duration of mechanical
ventilation was 9(3-65) days in the P-SIMV group and 7.5(2-29) days
in the APRV group.No difference was found between the groups(p =
0.171).Duration of ICU stay was 8(2-11) days in the APRV group and
13(8-81) days in the P-SIMV group(p=0.019). (Table 1)
CONCLUSION. The goal of ventilation with APRV is to remain on the
steep portion of the compliance curve between the lower and upper
inflection points to prevent atelectrauma/barotraumas.Our study
contributed to the results of a few preemptive studies in the
literature.The same positive effects were also demonstrated in
healthy lungs.Follow-up period, duration of ICU stay, sedation
requirement and oxygenation parameters improved significantly.
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Table 1 (abstract 001175). Comparison of end points without mortal
patientsTotal P-SIMV+PS APRV pAPACHE II 17 (7 - 35) 16 (7 - 24) 17 (7 - 35) 0.164MV / Extubation duration (total
day)9 (2 - 65) 10 (3 - 65) 8 (2 - 26) 0.211ICU stay (day) 16.5 (2 -
81)23.5 (10 -
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INTRODUCTION. Conventional catheter RSS causes pain and injuries
to the tracheobronchial mucosa, and other complications. MIE
generates high expiratory air flow, simulating spontaneous cough,
and is used extensively in debilitated non-intubated patients for air-
way clearance. HS-HA is nebulized to fluidify secretions and facilitate
RSS.
OBJECTIVES. Safety and tolerability of both interventions in
intubated critically ill patients.
METHODS. Randomised controlled trial of the effect of a single RSS
manoeuvre on respiratory and cardiovascular (CV) parameters and
pain, sedation-agitation scores in 120 consecutive patients, assigned
to 1) catheter RSS, 2) catheter RSS after HS-HA, 3) MIE, and 4) MIEwith HS-HA. Patients with an artificial airway (AAW) with cuff, on
mechanical ventilation (MV) or spontaneous breathing (SB), without
bronchospasm or haemoptysis were included after obtaining in-
formed consent. Catheter RSS was done according to local protocol
(-120 to -150 mBar), MIE was programmed at +50/-50 cmH2O and a
jet nebulizer administered 5 ml of HS-HA placed at the AAW (group
2) or MIE tubing (group 4). Data were collected before, during and 5
and 60 minutes after the intervention, and occurrence of adverse
events (predefined respiratory and CV and other) was monitored
from inclusion to ICU discharge. We used chi2, one-way Anova and
Bonferroni post hoc test.
RESULTS. 19 eligible subjects met exclusion criteria and 30 per
group were enrolled and completed the study protocol. There were
no differences in baseline characteristics and total, respiratory and
CV adverse events (Table). Pain Scale (Behavior Indicators of Pain,
“ESCID”) rose significantly during RSS in groups 1 and 2 and were
significantly higher during RSS in groups 1 and 2 for all comparisons.
No difference in ESCID was observed at 5 and 60 minutes after RSS.
Richmond Agitation-Sedation Scale did not differ between time-
points or study groups. Chest x-rays within 24 hours after RSS did
not disclose AEs.
CONCLUSION. MIE and HS-HA are save and better tolerated than
conventional catheter RSS in critically ill patients with AAW. Future
studies should address the efficacy of both measures.
Table 1 (abstract 001178). See text for descriptionCatheter
RSSCatheter RSS +
HS-HAMIE MIE +
HS-HAAge 64.7±16.2 69.7±11.1 64.5±15.9 62.5±14.2Sex, Male/Female 24/6 23/7 21/9 22/8Diagnostic group (M/S/T) 15/14/1 12/16/2 13/12/5 12/14/4Apache II score, mean±SD 22.8±8.1 22.1±7.0 22.3±8.1 21.2±6.7Endotrachel Tube/Tracheal
cannula
Size, mean±SD (mm)25/5; 7.9±
0.524/6; 7.9±0.4 25/5;
7.8±0.626/4;
7.9±0.4PaO2/FiO2 281±101 254±98 239±85 299±86Noradrenaline, n (%) 17 (56.7) 18 (60) 15 (50) 14 (46.7)Adverse events, total, n (%) 9 (30) 8 (26.7) 4 (13.3) 9 (30)Respiratory, n (%) 3 (10) 4 (13.3) 1 (3.3) 2 (6.7)CV, n (%) 8 (26.7) 4 (13.3) 6 (20) 8 (26.7)001179
Esophageal balloon calibration versus conventional technique to
assess esophageal pressure during volume control, pressure
support, and pressure support – Sigh ventilation
G. Cammarota1, E. Santangelo2, G. Lauro2, N. Devita2, E. Boniolo2, R.
Tarquini2, F. Verdina2, R. Perucca1, I. Sguazzotti1, E. Spinelli3, A. Bruni4, E.
Garofalo4, F. Longhini4, A. Messina5, F. Della Corte2, E. Bignami6, P.
Navalesi7, T. Mauri8, R. Vaschetto2
1Anesthesia and intensive care, Azienda Ospedaliero Universitaria
Maggiore della Carità di Novara, Novara, Italy; 2Department of
translational medicine, Università Degli Studi Del Piemonte Orientale,
Novara, Italy; 3Department of anesthesiology, Fondazione IRCCS
Ca’Granda Ospedale Maggiore Policlinico, Milano, Italy; 4Anesthesia and
intensive care unit, Magna Græcia University, Catanzaro, Italy;
5Anesthesia and intensive care, Humanitas Research Hospital, Rozzano,
Italy; 6Anesthesia and intensive care, University of Parma, Parma, Italy;
7Department of medical and surgical sciences, University Hospital Mater
Domini, Magna Grecia University, Catanzaro, Italy; 8Department of
anesthesiology, Fondazione IRCCS Ca’Granda Ospedale Maggiore
Policlinico - Servizio Beni Culturali, Milano, Italy
Correspondence: G. Cammarota
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001179
INTRODUCTION. Esophageal balloon pressure calibration (Ebc) is a 2-
steps procedure that was proven to increase accuracy of esophageal
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controlled mechanical ventilation (VCV) in the intensive care unit 1
(ICU) and the operating room 2.
OBJECTIVES. Aim of present study was to compare Pes measures
after Ebc during VCV, pressure support (PSV), and PSV+Sigh with
those obtained with conventional inflating at volume of 4 ml as
manufacturer-recommended (V4).
METHODS. In 11 adult patients admitted in ICU, after esophageal
balloon catheter was inserted, Ebc was performed to obtain optimal
filling volume (Vbest) and to correct for pressure generated by
esophageal wall and balloon during VCV, PSV and PSV+Sigh, applied
in random order. The expiratory and inspiratory calibrated Pes values
(Pescal), those obtained at Vbest (PesVbest) and at V4 (PesV4) were
recorded.
RESULTS. PesV4 and PesVbest were higher than Pescal at end-
expiration (13.1 ± 3.2 cmH2O vs 8.4 ± 3.1 cmH2O, P<0.0001; 11.1 ±
4.6 cmH2O vs 8.4 ± 3.1 cmH2O, P=0.0427) and end-inspiration (15.6
± 3.1 cmH2O vs 11.7 ± 3.3 cmH2O, P<0.0001; 14.3 ± 5.1 cmH2O vs
11.7 ± 3.3 cmH2O, P=0.0427), respectively, during VCV. During PSV,
expiratory and inspiratory PesV4 was greater than Pescal (14.1 ± 4
cmH2O vs 9.6 ± 3.9 cmH2O, P=0.0020; 17.2 ± 4 cmH2O vs 13.8 ± 4.4
cmH2O, P=0.0020). During Sigh, expiratory and inspiratory Pescal was
lower compared to PesVbest (9.3 ± 3.9 cmH2O vs 14.9 ± 5 cmH2O,
P=0.0002; 16.9 ± 4 cmH2O vs 22.4 ± 5.2 cmH2O, P=0.0002) and
PesV4 (9.3 ± 3.9 cmH2O vs 13.4 ± 3.7 cmH2O, P=0.0060; 16.9 ± 4
cmH2O vs 20.1 ± 3.5 cmH2O, P=0.0232), respectively.
Vbest for Sigh was greater compared to that computed at VCV (5 ±
1.6 cmH2O vs 2.4 ± 1.9 cmH2O, P=0.0086) and PSV (5 ± 1.6 cmH2O
vs 2.5 ± 1.8 cmH2O, P=0.0168), respectively. Esophageal wall
pressure at Vbest increased moving from VCV and PSV to Sigh (2.6 ±
2.9 cmH2O vs 5.6 ± 2.7 cmH2O, P= 0.0086; 2.6 ± 2.6 cmH2O vs vs 5.6
± 2.7 cmH2O, P= 0.0168), whereas no modifications were noted at
V4 over the trials. Esophageal wall pressure was higher at V4 in VCV
(5 ± 1.2 cmH2O vs 2.6 ± 2.9 cmH2O, P=0.0371) and PSV (5.1 ± 1
cmH2O vs 2.6 ± 2.6 cmH2O, P=0.0195) compared to Vbest.
CONCLUSION. Ebc improved Pes assessment during VCV, PSV and
sigh. Average Vbest at VCV and PSV never achieved V4 and Vbest at
Sigh. Balloon filling volume and esophageal wall artifacts were the
only factors that negatively affected conventional Pes assessment in
our series.
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INTRODUCTION. Ventilator-Induced Diaphragm Dysfunction (VIDD) is
considered a major determinant of the ability to successfully wean
patients from mechanical ventilation (1). Maintaining diaphragm
work using electrical stimulation during mechanical ventilation (MV)
has been proposed to attenuate VIDD (2).
OBJECTIVES. This first-in-human study assessed the safety and feasi-
bility of temporary Percutaneous Electrical Phrenic Nerve Stimulation
(PEPNS) on user-specified inspiratory breaths while on MV. Primary
endpoints included the ability to synchronize electrical stimulation
with inspiration to mobilize the diaphragm and to maintain work of
breathing (WOB) within defined limits. Secondary endpoints includedthe percentage of patients with successful pdSTIM multipolar lead
placement via ultrasound guidance and serious device/procedure-re-
lated adverse events.
METHODS. This prospective, multi-center, single-arm trial enrolled
ICU patients on MV. PEPNS was used for 6 two-hour sessions at
eight-hour intervals over 48 hours. Electrical stimulation was used to
activate the diaphragm in synchrony with inspiration while on MV.
Data collected included lead deployment success, nerve integrity,
ventilation parameters, blood gasses, vital signs, WOB, electrical
stimulation parameters, stimulation-breath synchrony and diaphragm
thickness measured by ultrasound at 0, 24 and 48 hours.
RESULTS. Twelve patients were enrolled with 2 initial pilot patients
having leads inserted on the left side only. Lead insertion was
successful in 21 of 22 attempts (95.5%). An analysis of 36,059
stimulated breaths from the 10 non-pilot patients in whom the
pdSTIM leads were placed bilaterally demonstrated phrenic nerve
stimulation had a mean inspiratory lag of 23.66 msec (p<0.001 vs.
null hypothesis of <88msec). WOB was maintained between 0.2 and
2.0 joules/L for 96.77% of the time, exceeding the 80% target. No ser-
ious device/procedure-related adverse events were reported. Dia-
phragm thickness increased for both stimulated and unstimulated
diaphragm hemispheres.
CONCLUSION. Our results demonstrate the ability to safely and
successfully place PEPNS leads in MV patients and the feasibility of
using this approach to synchronize electrical stimulation with
inspiration while also maintaining WOB between defined limits.
REFERENCE(S)
1. Jaber S, Petrof BJ, Jung B, et al. Rapidly Progressive Diaphragmatic
Weakness and Injury during Mechanical Ventilation in Humans. Am J
Respir Crit Care Med 2011; 183:364-371.
2. Pavlovic D, Wendt M. Diaphragm pacing during prolonged mechanical
ventilation of the lungs could prevent from respiratory muscle fatigue.
Med Hypotheses 2003; 60:398-403.
3. This study was funded by a research grant from Stimdia Medical, Inc.
Edina, Minnesota, USA.001196
Predictors of successful weaning from high-flow nasal oxygen
therapy in patients with acute respiratory failure: a retrospective
monocenter study
M. Rodriguez, AW. Thille, F. Boissier, A. Veinstein, D. Chatellier, R. Robert,
S. Le Pape, JP. Frat, R. Coudroy
Médecine intensive et réanimation, CHU de Poitiers, Poitiers, France
Correspondence: R. Coudroy
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001196
INTRODUCTION. Several trials have reported promising clinical
effects of high flow nasal oxygen therapy (HFOT) as compared to
standard oxygen therapy or noninvasive ventilation in various
settings. However, factors associated with successful HFOT weaning
have never been assessed. As HFOT continuation might lead to
unnecessarily prolonged ICU stay, we aimed at identifying predictors
of successful HFOT weaning.
METHODS. This is a retrospective monocenter study over a 2-year
period including all patients treated with HFOT for acute respiratory
failure. Patients who died or were intubated without prior HFOT
weaning attempt, those who were treated with noninvasive ventila-
tion at the time of HFOT weaning, and those who received HFOT as
a preventive treatment during the post-extubation period were ex-
cluded. HFOT weaning was driven by the attending physician. HFOT
weaning failure was defined as a respiratory failure requiring HFOT
resumption, noninvasive ventilation initiation, intubation, or death
within the first 48 hours after HFOT weaning. Demographic data,
ventilatory settings, and vital parameters under HFOT were collected
before each weaning attempt. The pulse oximetry to fraction of in-
spired oxygen ratio (SpO2/FiO2) and the ROX index (SpO2/FiO2 to re-
spiratory rate) were calculated under HFOT before each weaning
attempt (1).
F2
Fig. 1 (abstract 001208). See text for description
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gas flow and FiO2 set under HFOT were 50 ± 3 L/min and 75 ± 21 %,
respectively. The main reason for HFOT initiation was pneumonia in
46% of cases. The first HFOT weaning attempt was successful in 168
patients (88%). Their baseline characteristics were not different from
those who failed. They required lower FiO2 under HFOT than those
who failed (39 ± 7% vs. 48 ± 16%, respectively, p= 0.02). A FiO2 ≤
40% was a predictor of successful HFOT weaning with a sensitivity of
85%, a specificity of 41%, a positive predictive value of 92%, a
negative predictive value of 26% and an accuracy of 80%. Likewise,
the ROX index was higher in patients who were successfully weaned
from HFOT than in those who failed (12.7 ± 1.2 vs. 10.2 ± 3.0, p =
0.002). A ROX index > 9.2 was a predictor of successful HFOT
weaning with a sensitivity of 84%, a specificity of 50%, a positive
predictive value of 93%, a negative predictive value of 30% and an
accuracy of 80%.
ICU length of stay was longer in patients who failed the first HFOT
weaning attempt than in those who succeeded: 10 (7-12) vs. 5 days
(4-8) respectively (p < 0.0001). The main reason for failure was
hypoxemia in 95% of cases (21 out of 22) and required HFOT
resumption after 13 (5-26) hours under standard oxygen. After the
first HFOT weaning failure, 86% of patients (19 out of 22) were
eventually weaned successfully from HFOT. Their ROX index before
the weaning success was higher than before their prior weaning
failure (12.4 ± 3.8 vs. 10.1 ± 3.1, respectively, p = 0.04).
CONCLUSION. In this retrospective monocenter study, a FiO2 ≤ 40%
and a ROX index > 9.2 were the best predictors of successful HFOT
weaning at the bedside. A multicenter prospective study is
mandatory to confirm the usefulness of these two easy-to-assess pa-
rameters to predict the successful HFOT weaning.
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INTRODUCTION. Acute respiratory failure with respiratory acidosis is
characterized by hyperinflation and insufficient, inappropriate muscle
function with usually high muscle energy expenditure. Non-invasive
assisted ventilation (NIV) via face mask can be used to facilitate gas
exchange in the lungs but also to assist the distressed respiratory
muscle function and diminish dyspnea levels. Indirect calorimetry
uses gas exchange at the level of the lungs to calculate energy ex-
penditure (EE) by incorporating O2consumption and CO2production
in the Weir equation.
OBJECTIVES. The aim was to investigate the influence of NIV on
indirect calorimetry and its correlation with respiratory effort.
METHODS. In 5 healthy subjects NIV (V60, Philips, Eindhoven, The
Netherlands) was administered at a level of positive end expiratory
pressure (PEEP) around 4 cmH2O and without additional inspiratory
support. Inspiratory support was then increased by 2 cmH2O every 2
minutes until 8 cmH2O was achieved for 2 minutes. The EE was
measured using indirect calorimetry (Q-NRG, Cosmed, Italy). To
measure respiratory effort, the combined reversed RPE-scale was cre-
ated for the purpose of the study. It uses the validated “rate of per-
ceived exertion” scale (RPE-scale) which was altered by adding a
reversed part. This could result in a score of -10 (no respiratory effort)until +10 ( maximal respiratory effort) where 0 represents the basal
respiratory condition.
RESULTS. The application of NIV without inspiratory support resulted
in a mean EE of 1080 ±267 Kcal/day and a combined reversed RPE-
score of 1.8 ±1.1. After incremental increase of inspiratory support to
8 cmH2O, mean EE changed to 1138 ±397 Kcal/day (p=0.46)and the
combined reversed RPE-score to -4.6 ±2.1 (p=0.004). From the in-
spiratory support, EE could be predicted as 16.91* X + 1037 (R2=
0.74) and combined reversed RPE-score as -0.845*X + 1.12 (R2= 0.91)
using linear regression. Pearson r test showed a correlation coeffi-
cient of -0,828 (p=0.083).
CONCLUSION. NIV seems to induce a minimal metabolic burden in
healthy subjects. Surprisingly a reversed relationship was observed
between respiratory relieve by NIV and energy expenditure in
healthy subjects. This suggests that in healthy subjects, respiratory
relieve is not due to altered muscle energy expenditure.001215
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INTRODUCTION. Tracheotomy (TT) is a frequent procedure in
critically ill patients. Its risks and benefits are matter of an ongoing
debate. At least in theory there are some advantages including lower
airway resistance due to the shorter tube length and less dead
space. However, data on improved outcome are conflicting, and
there is consensus about early and late complications as well as a
substantial procedural mortality of up to 0.6%.
Little is known about short term haemodynamic effects.
OBJECTIVES. Therefore, we compared pre- and post TT
hamodynamics and respiratory effects in 30 ICU-patients with trans-
pulmonary thermodilution (TPTD) and pulse contour analysis (PCA)
monitoring with the PiCCO-device (Pulsion; Germany).
METHODS. Analysis of a prospectively maintained database on
haemodynamic monitoring with the PiCCO device. Comparison of
the last values before and the first values after TT (primary endpoint).
RESULTS. 30 patients undergoing surgical tracheotomy for
prolonged mechanical ventilation, 17 male; 13 female. APACHE-II 26±
8; age 72±10 years; height 170±10cm; weight 75±15kg.
Haemodynamics: SVRI was higher before compared to after TT:
1552±524 vs. 1361±437dyn*s/cm5/m²; p=0.020.
All other haemodynamic parameters were comparable before and
after TT: Heart rate 89±15 vs. 93±18/min; p=0.156. MAP 87±18 vs.
83±13mmHg; p=0.304; CVP 13±5 vs. 13±6mmHg; p=0.775. dPmax
1447±522 vs. 1469±553 mmHg/s; p=0.516; global enddiastolic
volume index GEDVI 799±244 vs. 830±231mL/m²; p=0.897;
extravascular lung water index EVLWI 9.6±3.0 vs. 9.8±3.1mL/kg; p=
0.894; stroke volume index SVI 46±14 vs. 46±14mL/min; p=0.869;
Page 536 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Cardiac index CI 4.11±1.44 vs. 4.13±1.11L/min/m²; p=0.674; global
ejection fraction GEF 24±7% vs. 24±8%; p=0.418.
Respiratory parameters: Tracheotomy resulted in an increase in the
number of patients with controlled compared to assisted or
spontaneous ventilation (8/30 vs. 2/30; p=0.038). All other respiratory
parameters were comparable before and after TT: Respiratory rate
22±8 vs. 22±8/min; p=0.920; tidal volume 488±167 vs. 493±158mL;
p=0.728; PEEP 7.6±1.9 vs. 7.9±1.9cmH2O; p=0.382; P_peak 24±6 vs.
23±6cmH2O; p=0.305; P_mean 12±4 vs. 12±3cmH2O; p=0.972; FiO2
0.42±0.11 vs. 0.42±0.10; p=0.859. P/F-ratio 240±77 vs. 234±84mmHg;
p=0.349; Oxygenation index 6.2±3.9 vs. 6.6±4.0cmH2O/mmHg; p=
0.313; compliance 35±15 vs. 42±29mL/cmH2O; p=0.241.
CONCLUSION. 1.) TT did not result in haemodynamic impairment.
2.) TT induced a slight short-term increase in the rate of patients
under controlled mechanical ventilation, but did not improve any re-
spiratory parameter.
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INTRODUCTION. Esophageal balloon calibration (Ebc) has been
proposed in intensive care unit 1 (ICU) and the operating room 2 to
improve accuracy of esophageal pressure (Pes) measure in patients
undergoing invasive mechanical ventilation. Ebc is a 2-step proced-
ure and consists in 1) identifying optimal balloon filling volume
(Vbest) and 2) subtracting esophageal wall recoil pressure to Pes
measured at Vbest (PesVbest) to obtain calibrated Pes (Pescal).
OBJECTIVES. The present study aimed to evaluate Ebc and Pescal in
intubated patients undergoing pressure support ventilation (PSV)
compared to the technique recommended by the manufacturer (i.e.,
standard filling volume of 4 ml (V4)).
METHODS. In intubated and mechanically ventilated adult patients,
admitted to the ICU for acute hypoxemic respiratory failure, a naso-
gastric tube equipped with esophageal balloon was inserted (Nutri-
vent, Sidam, Mirandola, Italy). After correct insertion depth was as-
sured, Ebc was carried out while patients were ventilated on PSV.
Briefly, the balloon was progressively inflated with volume ranging
between 0 and 8 ml. Aiming to construct the end-expiratory and in-
spiratory balloon pressure-volume curve, a series of short end-
inspiratory and end-expiratory holds were applied at each filling vol-
ume, assuring patient’s relaxation during occlusions and interval of
15-30 breaths between each occlusion 3 - 5. Vbest, was identified as
the filling volume associated with the maximal tidal Pes swing (Pes-
swing) on tidal volume (Vt) ratio (Pesswing/Vt). Then, on the end-
expiratory pressure-volume curve, esophageal wall elastance was
quantified to quantify esophageal recoil pressure at Vbest and, fi-
nally, Pes measured at Vbest (PesVbest) was corrected for esophageal
wall pressure to obtain Pescal. Raw Pes at V4 values (PesV4) were re-
corded, too. Finally, the Baydur occlusion calibration test was per-
formed to compare accuracy of the two methods. Finally, pressure
generated by esophageal balloon pressure was computed.RESULTS. Ebc was performed in 11 patients. Occlusion test was
accurate (0.8-1.2 ratio) in 11/11 (100%) at Vbest and 5/11 (45.5%)
patients at V4 (P = 0.0124), being 0.87 ± 0.07 with Vbest and 0.79 ±
0.1 with V4 (P = 0.0098), respectively. Vbest and Vmin was lower
than Vmax (2.5 ± 1.8 vs 6.3 ± 1.3 ml, P = 0.0316; 0.6 ± 0.2 vs 6.3 ±
1.3 ml, P < 0.0001). Pesswing/Vt at Vbest was higher than that
computed at V4 (8.5 ± 3.1 vs 5.9 ± 3.5 cmH2O/l, P = 0.0010).
Esophageal wall pressure computed at Vbest was lower than at V4
(2.6 ± 2.6 vs 5.1 ± 1 cmH2O, P = 0.0195). Esophageal balloon
pressure was negligible at Vbest and V4. Expiratory and inspiratory
Pescal was lower than PesV4 (9.6 ± 3.9 vs 14.1 ± 4 cmH2O, P =
0.0020; 13.8 ± 4.4 cmH2O, P 0.0020).
CONCLUSION. Ebc is feasible in patients undergoing PSV and it
might be associate with more accurate assessment of the
esophageal pressure swings, which are a critical component of the
risk of lung and diaphragm injury during assisted ventilation.
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INTRODUCTION. Application of Sigh in patients with the acute
respiratory distress syndrome undergoing invasive assisted
mechanical ventilation has been shown to improve oxygenation and
lung recruitment 1.
OBJECTIVES. Aim of present study was to compare, in patients
undergoing pressure support ventilation (PSV) + Sigh, the pressure
applied to the lung (Pl) during Sigh breaths, measured at optimal
esophageal balloon filling volume (Vbest) versus at recommended
filling volume of 4 ml (V4).
METHODS. In intubated ICU adult patients with hypoxic acute
respiratory failure of various etiologies, mechanically ventilated in
PSV, a naso-gastric catheter equipped with esophageal balloon
(Nutrivent, Sidam, Mirandola, Italy) was inserted. During PSV, inspira-
tory 4 sec-long PCV mode Sigh at a pressure of 35 cmH2O was set at
a rate of 1 per minute. After the correct position of esophageal bal-
loon was reached, esophageal balloon calibration was performed to
obtain calibrated esophageal pressure at Vbest during Sigh. Hence,
expiratory and inspiratory Pl for dependent (Pld) and non-dependent
(Plnd) lung regions was calculated at Vbest and V4 2.
RESULTS. In 11 patients we performed esophageal balloon
calibration during Sigh. Vbest was similar to V4 (5 ± 1.6 vs 4 ± 0 ml,
P = 0.0859). Expiratory Pld at Vbest was 0.1 ± 4.2 cmH2O vs -4 ± 4.2
cmH2O at V4 (P = 0.0010). Expiratory Plnd was slightly lower at Vbest
compared to V4 (6.4 ± 2.5 vs 6.8 ± 2.5 cmH2O, P = 0.0020).
Page 537 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Inspiratory Pld was 18.2 ± 4 cmH2O at Vbest vs 14.9 ± 3.5 at V4 (P =
0.0049) whereas Inspiratory Plnd at Vbest was 24.5 ± 4.5 cmH2O vs
25.9 ± 4.5 cmH2O at V4 (P = 0.0020). Lung, chest wall, and
respiratory system elastances at sigh pressure were 23.8 ± 25.2
cmH2O/l, 7.5 ± 6.6 cmH2O/l, and 31.35 ± 28.5 cmH2O/l, respectively.
Tidal volume during sigh was 1,371 ± 0.841 l (tidal volume -
predicted body weight ratio 21.3 ± 11. 04 ml/Kg). Lung and
respiratory system driving pressure was 18.1 ± 4.9 cmH2O and 25.6 ±
3.8 cmH2O, respectively. Inspiratory Plnd was directly correlated with
lung driving pressure (Spearman r = 0.8091, confidence interval
0.3891 – 0.9506, P = 0.0039).
CONCLUSION. In patients undergoing mechanical ventilation under
PSV + Sigh, Pl assessment was more accurate applying Vbest
compared to V4. Noteworthy, when Sigh is delivered at 35 cmH2O,
inspiratory Plnd exceeded the safety threshold of 20-22 cmH2O, sug-
gesting that setting sigh at lower pressure might be safer.
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INTRODUCTION. Major suegery and taruma patients are important
subset of patients who are liable to acute respiratory distress
syndrome (ARDS).
OBJECTIVES. We intended to validate a previously derived lung
injury prediction scores (LIPS) in predicting ARDS and in-hospital
mortality in high risk major trauma and surgical ICU patients.
METHODS. 79 patients with APACHE-II score≥15 admitted to the ICU
by major trauma and/or major surgery were included in our pro-
spective observational study. LIPS was calculated within six hours of
admission using two previously derived formulas by Cartin-Ceba et
al, 2009 and Trillo-Alvarez et al, 2011. We measured C-reactive pro-
tein on admission (CRP-0) and 48-hours later (CRP-48). Our endpoints
included ARDS development and in-hospital mortality.
RESULTS. 33 patients (41.8%) developed ARDS after median(Q1-Q3)
of 4(2-7) days. The LIPS of Cartin-Ceba et al and Trillo-Alvarez et al
were 5(4-6) and 4.5(3-6.3) in ARDS patients compared to 3(1.8-4.3)
and 3(1.5-4.6) in non-ARDS patients (P=0.000 & 0.001 for them re-
spectively). CRP-48 was 96(57-192)mg/L and 48(24-96)mg/L in both
groups respectively (P=0.000). The AUC was 0.741 and 0.712 for
Cartin-Ceba et al and Trillo-Alvarez et al respectively. LIPS of Cartin-
Ceba et al of 3.5 was 79% sensitive and 59% specific while LIPS of
Trillo-Alvarez et al of 2.25 was 91% sensitive and 41% specific for
ARDS prediction. CRP-48 was the only variable which was signifi-
cantly higher in non-survivors (P=0.000). CRP-48 of 94 mg/L was 73%
sensitive and 69% specific in predicting in-hospital mortality.
CONCLUSION. We concluded that despite both LIPS scores are
equally effective in predicting ARDS in ICU trauma and major surgery
patients, they were less accurate than in general ICU population.001689
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INTRODUCTION. ARDS (Acute Respiratory Distress Syndrome) is a
common (up to 25%) and serious complication of malaria. Factors
associated with its development and prognosis are poorly
understood.
OBJECTIVES. This study aims to identify risk factors for ARDS and
related prognosis.
METHODS. We retrospectively evaluated the clinical records of 99
patients with severe malaria due to P. falciparum who were admitted
to an Intensive Care Unit (ICU) of a Tertiary Care Hospital from
January 2009 to December 2018. We defined severe malaria
according to World Health Organization (WHO) 2015 guidelines and
used the Berlin criteria for ARDS. Continuous variables were
compared among groups using the t test or Mann-Whitney test and
categorical variables using the chi-square test.
RESULTS. We identified 33 ARDS cases (33%). The mean age was
44.7 ± 11.3 years and 87.9% were males. Patients developed
ARDS 7.4 ± 3.5 days after the onset of symptoms. At the time of
the admission to the ICU, 36.4% of patients already had ARDS.
Three patients were managed with non-invasive ventilation (NIV)
only, 30 patients required invasive ventilation (IMV), 10 of which
had failed NIV trial. The ventilator parameters were available for
30 patients: none had mild ARDS, 43.3% had moderate ARDS and
56.7% had severe ARDS. The mean time between ICU admission
and intubation was 1.9 days (minimum 0, maximum 5 days) and
the mean duration of IMV was 8.95 days (min 1, max 52 days).
Thirteen patients required curarization, 3 prone positioning and 3
Extra Corporeal Membrane Oxygenation (ECMO), for 7, 15 and 45
days, respectively. Cough was the only factor significantly associ-
ated with ARDS (OR 2.7; 95% CI 1.1 - 6.7). Time to endotracheal
intubation was not associated with duration of IMV, need for cu-
rarization, prone positioning or ECMO. The overall fatality rate
was 4% and the fatality rate in those with ARDS was 6.4%, with
no deaths directly attributed to ARDS. Patients with ARDS had
longer ICU stay (16.6 ± 11.3 vs 4.4 ± 4.4), longer hospital stay
(24.7 ± 14.9 vs 9.5 ± 7.7) and a higher risk of nosocomial infec-
tion (OR 2.1; 95% CI 1.4-3.2), namely ventilator-associated pneu-
monia (OR 1.4; 95% CI 1.1 – 1.8).
CONCLUSION. Cough, a clinical parameter, was the best predictor of
development of ARDS in our study which highlights the need to
evaluate these patients thoroughly and monitor for the development
of respiratory failure. NIV trial, although with a high failure rate, did
not worsen the prognosis of these patients and might be an
adequate therapy for some patients. The treatment of malaria ARDS
by specialized teams with access to advanced techniques
dramatically improves the chance of survival.
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INTRODUCTION. Mechanical ventilation (MV) induces changes in
lung volumes and intrathoracic pressures which are transmitted to the
heart, great arteries and veins and therefore independently affect the
key determinants of cardiovascular performance and consequently
Heart rate (HR) and myocardial contractility. New ventilatory modes as
Proportional assist Ventilation (PAV+) with more patient synchrony may
have better hemodynamic effects.
OBJECTIVES. To evaluate the changes in hemodynamics , left & right
ventricular functions during weaning from MV & to document the
hemodynamic impact of MV in patients with normal & impaired left
ventricular systolic function.
METHODS. 100 patients who received MV using pressure control
mode were recruited in the study after fulfilling all the criteria for a
spontaneous breathing trial. Every patient underwent 4 phases of
ventilation with 2 hours apart and each phase lasted for 3 hours which
were Pressure control – Assisted control ventilation (PC-ACV) with a
preset pressure sufficient to maintain tidal volume of 4-6ml/kg & preset
respiratory rate (RR) which is sufficient to eliminate CO2 in arterial
blood gases, spontaneous breathing trial (SBT) with Pressure Support
(PS) 10 , Positive end Expiratory pressure (PEEP) 5 , PAV+ mode with
20-30% assist and finally after discontinuation of MV. During each
phase, the changes in change in HR, RR, systolic and diastolic blood
pressures (SBP & DBP) were followed. Thoracic electrical bioempedance
was used to measure stroke index (SI), cardiac index (CI) and systemic
vascular resistance (SVR) in each phase of ventilation. Echocardiography
and tissue Doppler imaging (TDI) were used to assess the changes in
Left and right ventricular systolic and diastolic functions during each
phase of ventilation. Patients with atrial fibrillation (AF), receiving vaso-
pressors and inotropes and patients who failed weaning trial within less
than 24 hours post extubation were excluded.
RESULTS. SBP, DBP, SI, CI & SVR did not show any significant
changes between all phases of ventilation in all groups (P: Non
significant). HR & E/A were higher during spontanous breathing in
all patient groups (P<0.001 & P<0.012 respectively). EF was highest
during PAV+ in all patient groups (P<0.018). Left ventricular “S”
wave was higher during PAV+ & PC-ACV in Normal & Impaired sys-
tolic function groups (P 0.024). E/E’ was lower during PC-ACV in Nor-
mal systolic function group (P 0.037).
TAPSE was higher during PAV+ & PC-ACV in Normal systolic function
group (P<0.008). Right ventricular “S” wave was higher in PAV+ in
impaired systolic function group (P 0.024). Tricuspid E/E’ was higher
during Spontanous breathing in all patient groups (P 0.002). Pul-
monary artery systolic pressure (PASP) was lower during PC-ACV in
impaired systolic function group (P 0.04).
CONCLUSION. PAV+ may have favourable effects on hemodynamics,
left & right ventricular functions in patients ready for weaning.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):001704INTRODUCTION. Extravascular lung water (EVLW) and pulmonary
vascular permeability index (PVPI) measured by transpulmonary
thermodilution (TPTD) add objectivity to ARDS diagnosis.
Paradoxically, up to a third of patients who meet ARDS criteria have
near-normal EVLW. In addition, ARDS can be classified as focal or
non-focal according to computed tomography (CT) lung attenuation
pattern.
OBJECTIVES. To assess the association between EVLW or PVPI and CT
lung attenuation pattern in patients with acute respiratory failure
(ARF).
METHODS. Retrospective observational study. Inclusion criteria were
invasive mechanical ventilation, PaO2:FiO2 ratio <300, hemodynamic
monitoring with TPTD (PiCCO®, Pulsion Medical System) and CT of
the chest performed <8 hours apart form a TPTD measurement.
Patients with cardiogenic pulmonary edema or chronic lung diseases
were excluded. Measurement of EVLW indexed by predicted body
weight (EVLWi), PVPI (EVLW/pulmonary blood volume), PaO2:FiO2
and oxygenation index (mean airway pressure/PaO2:FiO2*100) closest
to the CT acquisition were recorded. Patients were classified
according to CT attenuation distribution as non-focal ARDS (bilateral
diffuse), focal ARDS (bilateral dependent) and non-ARDS (unilateral).
Data are expressed as median [IQR]; variables were compared ac-
cording to morphologic categories using the Kruskal-Wallis test and
p<0.05 was considered significant.
RESULTS. 36 patients were included, 29 fulfilled the Berlin definition
for ARDS. Age 65 [51-71] years, APACHE II 18 [13-26], PaO2:FiO2 176
[107-252], oxygenation index 7.6 [3.7-13.2]. Oxygenation and TDTP
variables according to morphologic categories are presented in table
1. There were no differences in oxygenation between groups. EVLWi
was significantly higher in patients with non-focal ARDS (n=20) than
in those with focal ARDS (n=9) or non-ARDS (n=7). PVPI was also
higher in non-focal than in focal ARDS. EVLWi and PVPI were not dif-
ferent between focal ARDS and non-ARDS patients. Among the 29
patients with ARDS, 10 (34%) had EVLWi <10 ml/Kg; 7 of these (70%)
were focal.
CONCLUSION. Patients who meet conventional ARDS criteria with
EVLWi <10 ml/Kg are likely to have focal morphology. Conversely,
ARDS with EVLWi >10 ml/Kg is likely non-focal. Focal ARDS has an
oxygenation and TPTD profile similar to ARF with unilateral lung
opacities. Non focal or difuse ARDS may represent true permeability
pulmonary edema.
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Page 539 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. High flow nasal cannula (HFNC) oxygenation is an
emerging therapy for hypoxic respiratory failure(1,2,3). Frequently
patients receiving HFNC therapy also require nebulised drug delivery;
in particular, bronchodilators such as salbutamol. Some of these
patients are unable to tolerate even brief periods of time without
HFNC oxygen and desaturate if the HFNC is swapped to a face mask
with a nebuliser attached. Therefore, nebulised drugs should ideally
be delivered simultaneously to HFNC therapy. The optimal method
to achieve this simultaneous delivery is not yet established. Studies
exist on HFNC therapy combined with nebuliser therapy - showing
optimal aerosol particle sizes in vitro in nebuliser delivered through
HFNC compared to via face mask with jet nebulisation(4); and
looking at identification of optimal settings for the implementation
of nebulisation within HFNC circuits(5) - but comparison of nebuliser
delivery method with ongoing HFNC has not been widely studied.
OBJECTIVES. To compare effects of nebulisation therapy in
conjunction with HFNC therapy between delivery with face mask
plus nebuliser attachment, and delivery with nebuliser attachment
in-line with HFNC tubing.
METHODS. A retrospective observational study on critical care
patients with respiratory failure requiring HFNC therapy and
bronchodilators (n=20). Group 1 (n=9) received nebuliser therapy via
a face mask fitted with a jet nebulisation chamber which was placed
over the nose and mouth, with the HFNC still in place.Group 2 (n=
11) received nebuliser therapy via a nebulisation chamber which was
attached upstream of the HFNC in-line with the HFNC tubing. Clinical
and biochemical parameters were compared in each patient within 1
hour before and within 1 hour after nebuliser therapy with 2.5 mg
salbutamol. Heart rate (HR), respiratory rate (RR) and peripheral capil-
lary oxygen saturation (SpO2) were measured as the clinical parame-
ters. Arterial blood gas sampling was used to assess biochemical
parameters: pH, PaCO2, PaO2 and HCO3-.
Data collection and analysis was carried out using Excel.
RESULTS. Twenty patients were included in the study with an
average age of 59 +/- 15 years.
An initial direct comparison of means showed a generally favourable
outcome in parameters post nebuliser therapy delivered via tubing
compared with delivery via face mask. Using t-test analysis (signifi-
cance set a p value of <0.05), we observed a statistically significant
reduction (p=0.037) in heart rate with nebuliser therapy delivered
through tubing compared to delivery via face mask. Changes in
other parameters were statistically comparable between the two
groups (RR: p = 0.107; SpO2: p = 0.316; pH p = 0.238; PaCO2 p =
0.313; PaO2: p = 0.298, HCO3-: p = 0.298).
CONCLUSION. Current statistical analysis suggests that nebuliser
therapy delivered in conjunction with HFNC via tubing is at least as
effective as nebuliser therapy delivered in conjunction with HFNC via
face mask, with a statistically significant improvement in heart rate in
the tubing group. The improvement in mean parameters for
nebuliser delivered via tubing compared to face mask is promising,
although not statistically significant. However, it is possible that the
small population size could lead to a Type II error (failure to reject a
false null hypothesis), and it would certainly be of value to extend
this initial study to a prospective study over a larger timescale with a
greater sample population.
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INTRODUCTION. Enzymatic debridement has supposed a great
advance in the treatment of critically burned patients, reducing time
until debridement and therefore ICU stay. There is a great amount of
systemic implications that hasn’t been fully studied about these topic
treatments, including those in patients with Inhalation injury.
OBJECTIVES. To describe our experience using enzymatic
debridement in critically burn patients with inhalation injury and
determine possible complications of its use in this set of patients.
METHODS. We performed a Retrospective observational study in the
Critical Burn Unit of the La Paz Hospital in Madrid Spain from
January 2017 until February 2019. All critically burned patients over
18 years old with a high suspicion or confirmed Inhalation Injury
were included. Mean and standard deviation were used for normal
quantitative variables and median and interquartile range in the
opposite case. Qualitative variables were presented by absolute and
relative frequencies.
RESULTS. We studied 152 patients admitted in our Critical Burn
Unit. 16 patients (10.5%) had high suspicion or compatible
criteria with Inhalation Injury, with initial carboxyhemoglobin over
4% at admission. Mean age was 59 (+- 24.5), Median TBSA was
17% (RI 6-42%), APACHE II was 15 (RI 10-19), ABSI score was 7
(RI 5-9). The median initial levels of Carboxyhemoglobin at admis-
sion in the ICU was 13 (RI 5-22), mean Lactate at admission was
4.2. Out of the 16 patients studied, 5 patients (31%) underwent
enzymatic debridement in the first 12 hours of admission. 3 out
of 5 patients (60%) in whom enzymatic debridement was per-
formed presented a prolongation of corrected QT interval, two of
them developed Ventricular Tachycardia followed by cardiac ar-
rest in the first 24 hours.
CONCLUSION. Inhalation of toxic gas in critically burn patients might
worsen the systemic response typical of these patients. 60% of the
patients that received enzymatic debridement presented
abnormalities in the electrocardiogram, 2 of them resulting in fatal
Ventricular Tachycardia. Although more studies are needed, we
suggest close monitoring and follow-up of patients with inhalation
injury who undergo early enzymatic debridement because it can in-
crease the inflammatory response or potentiate the effects of inhaled
toxins.
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INTRODUCTION. Since the definition of “subjective experience of
breathing discomfort” provided in 1999 by the ATS consensus
statement, the concept of dyspnea has been widened covering not
only a sensory-perceptual domain (i.e., dyspnea due to increased
work of breathing) but also a behavioral-emotional area. Hence, the
relief of dyspnea may not be strictly linked to the improvement of
gas exchange, but also to the reduction of psychological suffering.
Do-not-intubate (DNI) patients with acute hypoxemic respiratory fail-
ure (AHRF) are usually treated with noninvasive respiratory supports,
mainly aimed at improving patients’ comfort. High flow oxygen ther-
apy (HFOT) seems to have a significant impact on dyspnea Limited
literature data are available about the treatment of AHRF in DNI pa-
tients, included the relief of dyspnea
OBJECTIVES. To assess the effects of HFOT in DNI patients affected
by AHRF, hospitalized in general wards
METHODS. We selected a subset of patients included in a larger trial
evaluating the use of HFOT outside the ICU under the constant
supervision of an Intensivist. 9 wards of Ospedale Policlinico (Milan,
Italy) were equipped with HFOT devices; in each ward, educational
meetings were given by an ICU physician and an ICU nurse. HFOT
was started in patients with AHRF (PaO2/FiO2 ≥150 and <300). The
ICU Outreach team followed the patients daily. Arterial blood gases,
respiratory rate (RR), dyspnea (assessed by Borg scale) and comfort
(assessed through a visual analogic scale) were collected just before
the beginning of HFOT, after 2 hours and then every 24. Data are
presented as median and interquartile range.
RESULTS. From November 2017 to April 2019, the ICU Outreach
Team followed 118 patients. 50 patients (42%) were classified as DNI;
18 (36%) were terminally ill (End-Of-Life). Median age was 76 [66.75-
85] years. Hospital mortality was 68%. Twenty-four patients (48%)
had oncologic comorbidities and 16 (32%) had COPD. Median PaO2/
FiO2 was 156 [116-191]. The duration of HFOT was 10 [4-15] days.
After 2 hours from the beginning of HFOT, we observed a significant
reduction of RR from 28 [24-31] to 23 [20-28] breaths/min (p <0.05),
a reduction of Borg scale value from 3 [2-5] to 2 [1-3] points (p <
0.05) and an increase in comfort scale from 3 [2-3] to 3.5 [3-4] points
(p <0.05). Gas exchange did not improve
CONCLUSION. HFOT is effective inalleviating dyspnea and improving
comfort in DNI patients with AHRF hospitalized in general wards. The
effect on dyspnea is not explained by an improvement of PaO2/FiO2
ratio
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INTRODUCTION. Exosomes have been studied extensively in several
diseases including cancers and cardiovascular diseases as an
inflammatory marker, however, little is known about their role and
behavior in sepsis. Sepsis is a dysregulated inflammatory response
syndrome that leads to multiple organ failure. Current sepsis
biomarkers may be helpful in determining organ failure and
evaluating the patients’ clinical course, but there are no direct
molecular biomarkers to predict subsequent organ failure. Exosome
play an important role in the inflammatory response, coagulation
process, and cardiac dysfunction in sepsis.
OBJECTIVES. The objective of this study was to evaluate the
association of plasma exosome with severity of sepsis and mortality
in critically ill patients with sepsis.
METHODS. Plasma exosome levels were measured in 80 patients
prospectively enrolled in ongoing ICU cohort in Korea between April
2014 and January 2019, in comparison to healthy controls (n = 4).
The levels of plasma exosomes expressing CD9 among groups of
healthy donor, sepsis and septic shock were compared. To detect
and quantify exosomes in plasma, we used a CD9 expression based
enzyme-linked immunosorbent assay (ELISA) kit according to the
manufacturer’s protocol (Novusbio, Littleton, CO, USA).
RESULTS. A total of 80 patients admitted to the medical ICU and
diagnosed sepsis or septic shock at our institution were recruited,
among which 36.5% presented with septic shock. The median age of
patients was 68 (IQR; 61–75) years and 73% were male. Patient with
septic shock had higher exosome levels in the plasma compared
with healthy controls and patients without shock (median(IQR);
Page 541 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55200(158–242) μg vs. 490(468–473) μg vs. 928(899–946) μg, p <
0.001). Serum levels of lactic acid and procalcitonin were also higher
among patients with septic shock (p < 0.001) compared to sepsis
patients. We also performed ROC analysis and Delong’s test to
demonstrate and compare the predictive value of exosomes as a
prognostic predictor of 28-day all-cause mortality. The area under
the ROC curve (AUC) was 0.68 (95% CI; 0.44–0.92) for plasma exo-
somes, while the AUC of serum lactic acid and procalcitonin were
0.50 (95% CI; 0.30–0.69) and 0.65 (95% CI; 0.38–0.92), respectively.
Pairwise comparisons of ROC curves showed that there was no differ-
ence to predict 28-day mortality between exosome and either lactic
acid (p = 0.11) or procalcitonin (p = 0.86) in this study.
CONCLUSION. Our findings suggest that the elevated levels of
plasma exosomes in patients admitted to the ICU are associated with
septic shock and organ failure. Further studies involving molecular
characterization of exosomes are required to fully understand their
role in the pathophysiology of sepsis.
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INTRODUCTION. Recent observational studies demonstrated that
septic patients who received the combination of vitamin C,
hydrocortisone, and thiamine had a substantial mortality benefit [1,
2]. Several randomized controlled trials are ongoing to assess the
effect of this combination therapy on clinically important outcomes
in sepsis. Better prediction of mortality in these patients may help
clinicians to target patients most likely to benefit from vitamin C
protocol.
OBJECTIVES. To develop a model for predicting ICU mortality at
initiation of vitamin C protocol for septic shock.
METHODS. Data were obtained from severe septic shock patients
(requiring high-dose vasopressors such as norepinephrine ≥0.2 ug/
kg/min ± vasopressin) treated with the vitamin C protocol between
September 2018 and February 2019 at a university-affiliated tertiary
care hospital in Korea. Binary logistic regression was used to identify
pre-treatment variables predicting ICU mortality. The Vitamin for Sep-
sis (VITASEP) score was calculated as the sum of simplified regression
weights (SRW).
RESULTS. Data from 55 patients were reviewed. A total of 22
patients (40%) died during ICU admission. On the basis of
multivariate analysis, the following factors were included in the
VITASEP score: non-urosepsis (SRW 1), body temperature <37.1°C
(SRW 1), white blood cell <14,000/mm3 (SRW 1), and C-reactive pro-
tein <200 mg/L (SRW 2). The area under the receiver operating char-
acteristic curve of the VITASEP score predicting ICU mortality was
0.77 (95% confidence interval, 0.64–0.89). For VITASEP scores 0–1, 2,
3, and 4–5, the 28-day mortality rates were 17%, 27%, 35%, and 71%,
respectively (log-rank test, P = 0.02). For VITASEP scores 0–1, 2, 3,
and 4–5, the mean number of vasopressor-free days at day 28 were
24.7, 17.1, 13.6, and 9.0, respectively (Kruskal-Wallis test, P = 0.02).
CONCLUSION. Our results suggest that VITASEP score may predict
ICU mortality among septic patients treated with combined vitamin
C, hydrocortisone, and thiamine therapy. Vitamin C protocol maybenefit septic patients with a “hyperinflammatory” subphenotype.
Further validation in a larger sample is required.
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INTRODUCTION. Sepsis may result in life-threatening organ dysfunc-
tion, which is caused by various infections and dysregulated immune
responses of host. Phosphorus is an important substance that plays
various roles in the body such as intracellular energy exchange and
mineral metabolism. Several studies reported that the phosphate
concentration is associated with prognosis in diseases which cause
ischemic injury of tissues such as intestinal ischemia, coronary heart
disease, critical limb ischemia, and cardiac arrest. In sepsis, tissue hy-
poperfusion induces cytopathic hypoxia at the cellular level and it re-
sults in ischemic tissue injury and organ dysfunction. Therefore, we
hypothesized that the phosphate concentration, which was a marker
of ischemic tissue injury, could be used to predict prognosis in pa-
tients with sepsis.
OBJECTIVES. Ischemic injury caused by tissue hypoperfusion is one
of the major mechanisms of sepsis, and phosphate concentration is
elevated in ischemic tissue injury. This study was performed to
investigate the association of the phosphate concentration with the
mortality of patients with sepsis.
METHODS. This was a retrospective cohort study of patients with
sepsis. The patients were divided into three groups according to the
phosphate concentration: hypophosphatemia (P < 2.5 mg/dl),
normophosphatemia (2.5 ≤ P ≤ 4.5 mg/dl), and hyperphosphatemia
(P > 4.5 mg/dl). Multivariable Cox proportional hazard regression
analysis was performed to evaluate the independent association of
phosphate concentration with 28-day mortality.
RESULTS. A total of 3,034 patients were included in the study and
the overall mortality rate was 21.9%. The 28-day mortality rates of
the hypophosphatemia, normophosphatemia, and hyperphosphate-
mia group were 14.8%, 19.8%, and 38.1%, respectively (p <0.001). In
the multivariable Cox proportional hazards regression analysis, hyper-
phosphatemia was independently associated with 28-day mortality
compared with normophosphatemia (hazard ratio, 1.27; 95% confi-
dential interval, 1.05-1.54).
CONCLUSION. Hyperphosphatemia was associated with 28-day mor-
tality in patients with sepsis and could be used as a prognostic factor
in sepsis.
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INTRODUCTION. The surviving sepsis campaign guidelines
recommend empirical broad-spectrum therapy within earlier time
from triage such as one hour for both sepsis and septic shock.
OBJECTIVES. To describethe association timing of antibiotic
administration and outcomes among patients with severe sepsis and
septic shock in real-world clinical setting in Japan.
METHODS. We included adult patients (≥16 years) with severe sepsis
based on the sepsis-2 criteria published in 2003 [1], who were admit-
ted to the ICU in the Focused Outcomes Research in Emergency Care
in Acute Respiratory Distress Syndrome, Sepsis and Trauma (FORE-
CAST) study [2]. It used a sample of 59 ICUs in Japan from January 1,
2016 to March 31, 2017. The primary outcome was in-hospital mor-
tality. We compared characteristics and outcomes among patients
initiating antibiotics at different timing (0-60, 61-120, 121-180, 181-
240, 241-360, and 361-1440 minutes after the time of sepsis recogni-
tion), with analysis of variance, Kruskal-Wallis test, or chi-square tests.
We estimated the impact of antibiotic timing on risk-adjusted hos-
pital mortality using the generalized estimating equation (GEE)
model with an exchangeable within-group correlation matrix where
hospital was the panel or grouping variable. The covariates were pre-
specified a priori based on clinical experience and prior studies, such
as patient age; gender; admission source (emergency department
(ED), ward, or in intensive care unit (ICU)); CCI; antibiotic use before
arrival; site of infection (e.g., lung, abdomen, urinary tract, soft tissue,
central nerve system, blood stream-related, or others); and SOFA
score.
RESULTS. 1124 patients met criteria in 54 hospitals. Of these
patients,30.5% of patients received antibiotics within one hour and
73.9% of patients received antibiotics within three hours. The median
time to antibiotic administration was 102 min (IQR, 55–189 min).
Patients in ED or those diagnosed sepsis in ICU received antibiotics
earlier than those in ward. The earlier antibiotic use group was likelyto achieve the 3-hour bundle. Overall crude mortality was 23.4% in
the study population. Patients who received antibiotic within 60 mi-
nutes had highest mortality (28.0%). Patients received antibiotics
within the first 60 min had also highest adjusted mortality rate
(28.5% [23.1–33.9]), whereas that of patients administered antibiotics
between 61 and 120 min was the lowest (21.6% [16.5–26.6]). Differ-
ences in mortality were noted only between the 0–60 min and the
61–120 min groups. There was not significant difference among pa-
tients initiating antibiotics at different timing in ICU-free days, venti-
lator free days, and length of hospital stay. Similar results were
observed even if patients from ED were stratified.
CONCLUSION. This prospective observational study failed to show
the association between earlier antibiotic administration and
reduction of in-hospital mortality among patients with severe sepsis.
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INTRODUCTION. Extracorporeal blood purification techniques aim to
ameliorate the excessive host response to sepsis and/or remove
circulating endotoxin. Various devices have been evaluated in
randomised clinical trials (RCTs) (1-3) although not in routine use.
OBJECTIVES. We conducted a meta-analysis and trial sequential ana-
lysis (4) of RCTs to determine the potential mortality benefit of extra-
corporeal blood purification techniques in sepsis.
METHODS. A systematic search of MEDLINE, Embase,
clinicaltrials.gov, and the Cochrane Central Register of Controlled
Trials for RCTs was conducted. Mortality was assessed using Mantel-
Haenszel models and I2 used for heterogeneity. Data are presented
ad odds ratios (confidence intervals); p-values; I2).
RESULTS. We identified 28 RCTs including 2,194 patients, with 1,115
(51%) in the treatment arm. Eight studies used haemofiltration, 15
endotoxin absorption devices, four non-specific cytokine removal de-
vices, and one used plasma exchange. An improvement in mortality
was associated with the use of endotoxin removal devices (0.47 (0.28-
0.79); p=0.004; I2=68%), but not haemofiltration (0.74 (0.49-1.13); p=
0.17; I2=0%) nor non-specific cytokine removal (0.81 (0.33-2.00); p=0.65;
I2=72%). Subgroup analyses revealed that mortality benefit was limited
to the use of endotoxin removal devices in Asian (0.23 (0.12-0.47); p<
0.001; I2=47%) but not Western countries (1.10 (0.82-1.48); p=0.54; I2=
5%). The use of endotoxin removal devices (0.21 (0.12-0.34); p<0.001;
I2=0%) and cytokine removal devices (0.43(0.20-0.94); p=0.02; I2=51%)
was associated with an improvement in mortality only among patients
with a high risk of death (control arm mortality >50%). Patients with
documented Gram-negative sepsis were most likely to benefit from
endotoxin removal devices (0.22 (0.12-0.42); p<0.001; I2=0%).
CONCLUSION. The use of endotoxin removal devices in sepsis is
associated with mortality benefit, particularly in patients with high
mortality risk and with documented Gram-negative sepsis.
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INTRODUCTION. Although small animal sepsis model is well
established, longitudinal assessment of hemodynamic variables,
laboratory values, and blood culture in a single living sepsis model is
limited.
OBJECTIVES. Therefore, we aimed to comprehensively characterize
the fecal peritonitis-induced sepsis in the porcine model.
METHODS. Autologous feces (1g/kg) were administered into the
peritoneum of eleven male pigs (49 ± 8 kg). The pigs were
monitored up to 12 hours with the full support of fluid and
vasopressors to maintain over 65mmHg of the MAP. Longitudinal
blood culture and laboratory values were obtained every one or two
hours. The cytokine levels in plasma were analyzed. Moreover,
clinical registry of sepsis patients in single emergency department
was utilized to compare the SOFA score with those of the porcine
model.
RESULTS. The hyperdynamic phase of increasing cardiac output with
decreasing systemic vascular resistance was maintained until 2 hours,
followed by the reverse hypodynamic phase. With the escalating
requirement of fluid and vasopressor, the lactate level was
progressively increased while platelet counts, urine output, and
serum albumin level were consistently decreased. Bacteremia was
developed at 7 hours after administration of feces and the
Escherichia coli was the most common pathogen. The pattern of
SOFA score with prominent cardiovascular failure was comparable to
clinical data.
CONCLUSION. We implemented the porcine fecal peritonitis-induced
sepsis model which demonstrates culture-proven bacteremia and
multiple organ failure, particularly the cardiovascular system. This
model could be utilized in the development of early diagnostic tech-
nology of bacterial pathogens in the blood.
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INTRODUCTION. Thrombomodulin (TM) on vascular endothelium
binds to thrombin and acts as anticoagulant. In addition, the
thrombin-TM complex activates protein C to produce activated pro-
tein C, which inactivates factors Va and VIIIa, thereby inhibiting
thrombin formation. Furthermore, TM has anti-inflammatory and
cytoprotective activities [1]. In Japan, recombinant human soluble TM(rhTM) has been used for treatment of disseminated intravascular co-
agulation (DIC) since 2008.
OBJECTIVES. The objectives of this study are to evaluate the
effectiveness of rhTM on platelet count, fibrin/fibrinogen degradation
products (FDP), prothrombin time (PT) ratio, and C-reactive protein
(CRP) levels in patients with sepsis-induced DIC.
METHODS. We retrospectively searched patients with sepsis who
were admitted to ICU between April 2015 and January 2019, and
investigated patients who are diagnosed as sepsis-induced DIC and
received rhTM. Sepsis was defined according to Sepsis-3. DIC was di-
agnosed based on DIC score ≥ 4 on the Japanese Association for
Acute Medicine (JAAM) DIC scoring system [2]. Platelet count, FDP,
PT ratio, DIC score, and CRP levels were collected. Dose and duration
of rhTM was also collected. DIC resolution was defined as DIC score
≤ 3 by the day after the last rhTM.
RESULTS. Total 137 patients with sepsis were admitted to ICU and
34 patients (25%, 66 ± 15 years) out of them were diagnosed as
sepsis-induced DIC and received rhTM. Sources of sepsis are abdo-
men (n =19), urine (n = 5), lungs (n = 3), skin (n = 2), blood (n = 2),
and unknown (n = 3). The mean ± SD values of dose and the dur-
ation of rhTM were 292 ± 121 U/kg/day and 5 ± 2 days, respectively.
The platelet count (median, IQR) increased significantly (p < 0.001)
from 99 [41-99] to 147 [87-379] (×1000/μL) after rhTM administration.
The PT ratio and FDP level (median, IQR) significantly (p < 0.001) de-
creased from 1.49 [1.27-1.66] to 1.13 [1.06-1.27] and from 30.75
[21.15-51.25] to 14.05 [6.7-17.8] (μg/mL), respectively. The DIC score
(median, IQR) significantly (p < 0.001) decreased from 5[4.25-7] to
2[1-4] and 23 patients (68 %) were recovered from DIC after rhTM ad-
ministration. The CRP levels (median, IQR) significantly (p < 0.001) de-
creased from 21.1 [14.4-28.0] to 8.2 [5.3-11.5] (mg/dL). Twenty eight-
day mortality was 20.6%.
CONCLUSION. This study showed that rhTM significantly increased
platelets counts and significantly reduced PT ratio, FDP level, DIC
score and CRP levels, resulting in improvement of DIC in patients
with sepsis-induced DIC. Further studies are needed to verify the ef-
fectiveness of TM-α on these patients.
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INTRODUCTION. Severe sepsis and septic shock are important issues
of public health worldwide and persist as the leading causes of
death in children under 5 years-old (with mortality rates around
25%).
We classified shock under two different patterns during clinical
evaluation: hypodynamic shock, most frequent in patients who
present with low cardiac output, and hyperdynamic shock, most
frequent in patients who present with high cardiac output.
Hypodynamic shock has been reported as the predominant type of
shock in children. However, diagnosis made by clinical findings alone
Page 544 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55has its limitations and we propose that, with adequate hemodynamic
monitoring, we can find a change in the initial patterns of shock,
often changing from the most prevalent hypodynamic shock to a
hyperdynamic shock pattern 48 hours after admission.
It is of utmost importance identifying the hemodynamic type of
shock to improve our clinical approach and treatment plans, both
relevant to the outcome of patients
METHODS. This was a retrospective observational study aimed to
classify and identify the hemodynamic profiles of patients admitted
in the Pediatric Intensive Care Unit of Martagão Gesteira Pediatric
Childcare Institute – Rio de Janeiro Federal University (IPPMG-UFRJ),
between November 2016 and December 2018, as well as assess if
there was any change, 48 hours after PICU admission, in the pattern
initially identified.
RESULTS. 44 patients were included in the study, with median age
13.5 months, 75% presenting comorbidities, 40.9% with primary
respiratory disease, and death occurring in 20.5% of patients. The
shock pattern was observed at admission and 48 hours later for us to
classify patients with hypodynamic or hyperdynamic shock. At
admission, 9 patients (20.5%) had hyperdynamic shock and 35
patients (79.5%) presented with hypodynamic shock, with those
numbers changing after 48 hours post admission, with 19 patients
(43.2%) presenting with hyperdynamic and 25 patients (56.8%)
presenting with hypodynamic shock. Within the patients who
modified the shock pattern, 85.7% were from the hypodynamic
group at admission, with statistical significance in the associations
observed (p < 0.05 – Fisher's test). Clinical/Non-invasive criteria (97%)
were predominant for the definition and initial approach of shock in
the first evaluation at admission, followed by lactate (75%), central
venous saturation and oxygen extraction rate (40.9%). Monitoring
with invasive blood pressure (45%) and central venous pressure
(34%) were less utilized as a primary tool.
CONCLUSION. Our results were compatible with recent researches,
meaning that we observed a considerable percentual change in the
hemodynamic profiles, mostly from a hypodynamic to a
hyperdynamic type of shock, between ICU admission and the
following 48 hours. Patients' evaluation was mostly through clinical
evaluation, with only 40-45% of patients receiving invasive monitor-
ing, which may have contributed to our findings. However, even
within our limitations, it was indeed observed a clear pattern that
seems to occur somewhat frequently, as described in similar studies
on the subject.
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INTRODUCTION. Bacteremia is common in severely ill patients.
However, little research has been done on clinical characteristics and
outcomes of bacteremia among patients with sepsis.
OBJECTIVES. We aimed 1) to compare the clinical characteristics and
outcomes of severe sepsis patients with and without bacteremia, and
2) to assess the relationship between procalcitonin (PCT) and
bacteremia, including different pathogen species.
METHODS. This is a secondary analysis of the sepsis cohort of the
Focused Outcomes Research in Emergency Care in Acute Respiratory
Distress Syndrome, Sepsis and Trauma (FORECAST) study, a
multicenter, prospective cohort study of patients with severe sepsis
which was conducted in 59 ICUs in Japan over 15 months [1]. Adult
patients (≥16 years) with severe sepsis or septic shock admitted to a
participating ICU were included. We compared characteristics and
outcomes of patients with and without bacteremia. To know a
characteristic of bacteremia of each pathogen in details, we also
assessed the prognostic utility of PCT for bacteremia of each
pathogen by drawing a receiver operating characteristics (ROC)
curve.
RESULTS. One thousand one hundred sixty-seven patients from the
FORECAST database met the study criteria. Among those, 636 pa-
tients (54.5%) with bacteremia were identified. Patients with
bacteremia had significantly higher rates of septic shock than those
without (422 [66.4%] vs. 313 [58.9%], p<0.01). There was no signifi-
cant difference in the comorbidities of the groups. Sepsis severity
scores such as APACHE II and SOFA were higher for patients with
bacteremia than patients without bacteremia (median [interquartile
(IQR)] 23 [18–30] vs. 22 [16–29], p=0.02 and 9 [6–12] vs. 8 [5–11], p<
0.01, respectively). Regarding the laboratory data, white blood cell
count and platelet count were lower in patients with bacteremia
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17,300]/μL vs. 12,440 [6,620–18,430]/μL, p=0.02 and 12.4 [7.5–18.6]
×104/μL vs. 17.5 [11.1–24.5] ×104/μL, p<0.01, respectively). PCT con-
centration was significantly higher in patients with bacteremia than
in patients without bacteremia (median [IQR] 21.3 [3.5–75.6] ng/mL
vs. 5.2 [1.1–34.4] ng/mL, p<0.01). In-hospital mortality was 158/614
(25.6%) for patients with bacteremia and 108/515 (21.0%) for those
without (p=0.08). Length of hospital stay was 23 (IQR 12–44) days for
patients with bacteremia and 24 (IQR 13–50) days for those without
(p=0.10). The area under the ROC of PCT for predicting bacteremia
was 0.631. The optimal cutoff value of PCT for predicting bacteremia
was 3.84 ng/mL. The highest PCT level was found in Klebsiella (me-
dian [IQR] 60.8 [20.8–130.1] ng/mL), followed by E. coli (30.0 [5.5–100]
ng/mL) and Pseudomonas (24.7 [5.6–49.1] ng/mL). The lowest PCT
level was found in Staphylococcus (7.7 [2.0–25.4] ng/mL).
CONCLUSION. Severe sepsis patients with bacteremia had more
shock and higher severity scores than those without. However, there
was not much difference between the two groups in outcomes such
as in-hospital mortality. PCT levels were different among patients
with bacteremia of different pathogen species.
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INTRODUCTION. Despite a decrease in the mortality rate of septic
shock, morbidity remains high due to the sequelae of sepsis and
prolonged stay in intensive care unit. Among the different sequelae
included in the post-Intensive Care syndrome, Intensive Care Unit -
associated weakness (ICU-AW) plays a particular role. This generalized
muscle weakness affects 30 to 50% of septic shock patients and is as-
sociated with an increased duration of both mechanical ventilation
and hospitalization. In addition, one-third of patients will suffer se-
vere sequelae such as the inability to walk or breathe on their own.
The pathophysiology of this syndrome appears to be multifactorial
but is largely based on pre-clinical data: sodium channel inactivation,
oxidative stress, proteolysis, mitochondrial dysfunction and muscle
stem cell dysfunction.
OBJECTIVES. The objective of this study was to characterize in a
multimodal way the early muscle dysfunction in patients with septic
shock or severe sepsis compared to control patients.
METHODS. Three patient populations were included in the DISCUSS
study: a septic patient population requiring surgery; an inflammatory
non-septic patient population in brain death or cardiogenic shock;
and a non-inflammatory non-septic patient population operated on
scheduled visceral surgery. After obtaining the consent or non-
opposition of the relatives (brain-dead state), patients were sampled
when they went to the operating room or when they were placed
on the ECMO with 2 cm3 of muscle and 5 ml of blood. This research
has been approved by the Comité de Protection des Personnes Ile
de France V (06/10/2015, N°15051). The samples were processed atthe Institut Pasteur for mitochondrial morphological analysis by
Transmission Electron Microscopy (TEM), proteomic analysis and ana-
lysis of mitochondrial parameters of muscle stem cells and serum.
RESULTS. Sixty-seven patients were included between June 2016
and April 2018. Eighteen septic patients, eighteen brain-dead pa-
tients, twelve cardiogenic shock patients and nine controls. The TEM
analysis showed a difference in mitochondrial ultrastructure and a
significantly different morphotype distribution: more type 2 morpho-
types were found in the control group while there were more type 3
morphotypes (mitochondrial suffering with swelling and loss of
peaks) in septic patients. Compared to the other conditions, prote-
omic analysis of septic patients showed significant differences in pro-
tein expression related to acetyl-CoA metabolism pathways, Krebs
cycle, propanoate metabolism, amino acid biosynthesis and pyruvate
metabolism. Serum analysis showed a significant difference between
groups regarding the amounts of reactive oxygen species, of acetyl-
CoA and of ATP but no differences were found regarding reactive ni-
trogen species and SOD activity.
CONCLUSION. In the acute phase of sepsis in humans, we therefore
show an early muscle dysfunction secondary to mitochondrial
damage and to a structural impairment of the proteins involved in
muscle synthesis and proteolysis. Yet, we did not find any evidence
for specific damage to satellite cells.
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INTRODUCTION. Sepsis is a life-threatening multi-organ dysfunction
caused by dysregulated host response to infection with unmet clin-
ical needs. In the context of adults, patients who survive sepsis can
develop long-term immune dysfunction, with an expansion of the IL-
33/M2 macrophages/regulatory T (Treg) cell axis (1). However, these
findings were reported in humans and adult mice; however, there is
no evidence of these alterations in the pediatric sepsis.
OBJECTIVES. To investigate the role of age in the genesis of
immunosuppression following sepsis
METHODS. C57BL/6 mice (infant and adults) were submitted to
sepsis and treated with antibiotic for three days. On day 15 after
infection, Treg cells frequency and the activation of IL-33/Th2 profile
cytokines/ILC2 cells/M2 macrophages axis were evaluated. To assess
the immunosuppression, surviving sepsis mice were inoculated intra-
nasally with Pseudomonas aeruginosa or by subcutaneous inoculation
of B16LucF10 Melanoma cell line. Finally, blood samples from
pediatric and adult surviving sepsis patients were collected and the
Treg cells and Th2 profile cytokines were evaluated
RESULTS. Here we showed that sepsis surviving-infant mice, in con-
trast with the adult mice, were resistant to secondary infection and
controlled the tumoral growth suggesting the non-development of
immunosuppression. Mechanistically, the "resistance" was related to
the decrease in Foxp3 expression, lower phosphorylation of SMAD2/3
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bility. Furthermore, infant mice presented lower production of IL-33
as well as a lower expansion of ILC2 cells and production of Th2 pro-
file cytokines (IL-4 and IL10), leading to a progressive decrease in the
M2 macrophages population and Tregs cell expansion. Importantly,
in a translational manner, we demonstrated that sepsis-surviving
pediatric patients, in contrast to adult patients, did not exhibit an in-
crease in Treg cell, IL-33 and IL-10 in their peripheral blood, indicat-
ing that "resistance" to the development of immunosuppression
observed in infants could be associated with the impairment of the
IL-33/cytokines of the Th2 profile/ILC2 cells/M2 macrophages/Tregs
cells axis
CONCLUSION. These findings demonstrate for the first time that the
immunosuppression post-sepsis is related to the age of host. Thus, a
better understanding of the process could lead to differential thera-
peutic treatments of adult and pediatric sepsis.
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INTRODUCTION. Cardiac function is known to be negatively
impacted by sepsis. Stroke volume (SV) change in response to
Passive Leg Raise (PLR) is an effective method to predict fluid
responsiveness (FR) or cardiac response to preload expansion.
Preload functional status and trends in cardiac output may identify
patient phenotypes with varying cardiac reserve, dysfunction and
outcome.
OBJECTIVES. The goal of this study is to identify resuscitation
phenotypes based on fluid responsiveness and evidence of cardiac
dysfunction, and assess outcome differences between them
METHODS. FRESH is randomized controlled study, evaluating the
incidence of FR in critically ill patients with sepsis or septic shock
(NCT02837731). Patients randomized to PLR guided resuscitation
were classified as FR if SV increased ≥ 10% when measured with
non-invasive bioreactance (Starling SV, Cheetah Medical). Patients
were characterized asNon FR if SV increased <10%. Patients were
grouped into 6 different sextets based on the percentage of FR PLRs.
Patients in Group 1 (N=11) exhibited 100% FR PLRs, where Group 2
(N=5) exhibited between 80-90% FR PLRs. Groups 3-5 (N= 19, N=26,
and N=20) exhibited FR rates between 5-75%, with Group 6 (N=15)
exhibiting 0% incidence of FR PLRs.
RESULTS. A total of 670 PLR assessments were performed in 96
patients over a 72 hour monitoring period. 60 % were female, and
the average age was 61 years. Overall, 40% of assessments
demonstrated a FR positive response after receiving initial
resuscitation fluid of 2.3 (+/- 0.6) L. There were no differences among
the 6 groups with respect to age, gender, or QSOFA score. Fluidresponsiveness was dynamic changing over the 72 hours of the
study. When Groups 1-3 (54%-100% incidence FR PLRs) were com-
pared to Groups 4-6 (50%-0% incidence FR PLRS) there were differ-
ences in patient outcome. Patients in Groups 1-3 exhibited a
significant reduction in need for new onset dialysis (0%) compared
to groups 4-6 (18%), p=0.012, and a decreased incidence of MACE
(0% compared to 11.7%, p=0.04). Patients in Groups 1-3 also exhib-
ited a notable trend toward decreased mortality (8.6%) compared to
Groups 3-6 (25%) p=0.059. Patients in Group 6 exhibited the highest
incidence of mortality during the 30 day follow up period (40%).
CONCLUSION. Short-term sepsis resuscitation phenotypes based on
SV and responses to PLR identify discrete and significantly different
patient sub-groups. Patients who were FR, and who augmented CO
in response to the resuscitation experience decreased need for dialy-
sis and a decreased incidence of MACE, as well as a trend towards
decreased mortality. Periodic dynamic monitoring may predict pa-
tient outcome and guide treatment for sepsis-associated cardiac
dysfunction.
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INTRODUCTION. In sepsis, blood hypo-flow into the splanchnic terri-
tory has been related to cytopathic hypoxia, microcirculatory dys-
function, gut bacterial overgrowth, gut barrier dysfunction, bacterial
translocation, activation of lymphoid tissue associated with the intes-
tine and exacerbation of systemic inflammation in the host, culminat-
ing with organic dysfunction and clinical worsening [1-3]. The main
hypothesis for these events has been attributed to the selective re-
duction of physiological blood flow to the gut in order to preserve
the nobler organs for the preservation of life. However, the dynamics
of splanchnic blood flow distribution during sepsis and survivors re-
mains relatively unknown.
OBJECTIVES. Evaluate the kinetics of blood flow distribution to
splanchnic territory in the acute phase of sepsis and after recovery
from sepsis.
METHODS. Following DL50 sepsis model induction (2mL E.coli 108
CFU/mL, iv) in adult Wistar female rats, the animals were monitored
to macro (MAP, HR and abdominal aorta blood flow by Transonic,
TS420 transit-time flowmeter), regional (mesenteric artery, celiac
trunk artery and portal vein by Transonic, TS420 transit-time flow-
meter), and micro hemodynamics (kidney cortical microcirculation by
SDF videomicroscopy). Animals were monitored at before sepsis (T-0)
and at 3 hours (T-3h), 6 hours (T-6h) and 1month (T-1m) post-sepsis
periods. Naïve animals (N) were used as control. (n=4-5/period). All
rats were euthanized at the end of experiments.
RESULTS. The results showed a significant fast fall of the aorta's
blood flow until 6h after sepsis induction and partial recovery at 1
month, but not reaching T-0 value. The celiac trunk artery, mesen-
teric artery and portal vein showed a significant blood flow decrease
up to 6h after sepsis induction and remained significantly low up to
1 month after sepsis (fig1). These observations were even more evi-
dent when verifying the delta-percent of their blood flow decay in
relation to the naive group without sepsis (T-0h). (Fig.2). Following,
when examined the proportion of blood flow of the same vessels in
relation to of the aorta flux to evaluate the blood fraction distribu-
tion, we observed a similar pattern in all splanchnic vessels (fig.3).
The percentage of flow from the aortic artery to the celiac trunk ar-
tery increased in the acute phase of sepsis (T-3h and T-6h)
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and after 1-month survival presented a significant reduction of their
distributive percentage compared to the other periods. The blood
flow to the mesenteric artery and portal vein showed a similar pat-
tern between T-0 and T-3h periods but was significantly decreasing
in other periods. These data suggest that the blood flow of splanch-
nic vessels and of the abdominal aorta do not return to normal levels
until 1 month after sepsis, and this hypovolemic feature may be as-
sociated with the chronic oxygen deficiency stress in splanchnic
organs.
CONCLUSION. Splanchnic hemodynamics decays substantially since
the early acute phase of sepsis and remains in a state of
hypovolemic stress up to one month after recovery. Studies are
evaluating if this hemodynamic dysfunction in post-sepsis is transi-
tory or permanent.
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INTRODUCTION. Bacterial CNS infections lead to high morbidity and
mortality requiring early diagnosis and treatment. The aim of the
study is to assess the utility of PCT and lactate levels in the
cerebralspinal fluid (CSF) as biomarkers of bacterial infection in
neurocritical patients.
METHODS. An observational study of a group of 65 patients
admitted to an ICU of 18 beds between the period of July 2017 and
December 2018. Patients who, due to admission to ICU, were
included in the analysis of the CSF. Demographic variables, lactate
and PCT in blood and lactate, PCT, Gram staining and CSF culture
were collected. The CSF PCT/serum PCT and CSF lactate/serum
lactate quotients were also analyzed. The patients were put into 2
groups and were classified according to the final diagnosis: bacterial
infections of the CNS and other CNS affections.RESULTS. In the sample analyzed (n = 65), 61.5% were men. The
mean age was 54 ± 16. Mortality was 21.5%. The average APACHE II
was 25.3 ± 6.4 and the average SOFA of 6.1 ± 3.2. With an average
PCT in CSF of 0,5 ± 1,6 ng/mL and an average lactate in CSF of 36,4
± 30,4 mg/dL. In the group of bacterial infections of the CNS, Gram
staining was positive in 54.55% of the cases. The culture was positive
in all of them. The isolated germs were: S. Pneumoniae (45.4%), E.
Coli (18.2%), L. Monocytogenes (18.2%) and M. Tuberculosis (18.2%).
CONCLUSION. PCT in CSF is not a useful biomarker for the diagnosis
of bacterial infections of the CNS. Lactate in CSF is elevated in
different pathologies of the CNS, being significantly higher in
bacterial infectious pathology. In addition, lactate index CFS/serum
could be a good early marker of bacterial infection of the CNS.
Table 1 (abstract 000472). See text for descriptionBacterial infections
CNS
(n = 11)Other affectations
CNS
(n = 54)p
Serum PCT (ng/mL) 9.3 ± 13.6 7.1 ± 28.9 NSSerum lactate (mg/dL) 15 ± 6.1 22.1 ± 25.1 NSCSF PCT (ng/mL) 0.7 ± 1.5 0.4 ± 1.6 NSCSF Lactate (mg/dL) 90.4 ± 38.2 25.4 ± 10.6 <
0,01CSF PCT/serum PCT 9.2 ± 13.6 11.2 ± 29.1 NSCSF lactate/Serum
lactate6.4 ± 2.5 1.9 ± 1.6 <
0,01000498
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INTRODUCTION. Hyperchloremia is known to be associated with
poor clinical outcomes in sepsis patients. However, the clinical
significance of hypochloremia is not well studied.
OBJECTIVES. We investigated the association between
hypochloremia and mortality in patients with septic shock.
METHODS. This is a retrospective analysis of prospectively collected
multicenter registry including 11 emergency departments. The
Outcome was defined as 28-day mortality. Patients were divided into
three groups according to initial serum chloride level; hypochloremia
(<98 mEq/L, 760/2037 [37.3%]), normochloremia (between 98 mEq/L
and 110 mEq/L, 1182/2037 [58.0%]), and hyperchloremia (>110 mEq/
L, 95/2037 [4.6%]). Multivariate logistic regression analysis was used
to test the independent association between chloride categories and
the 28-day mortality.
RESULTS. The 28-day mortality rates were 34.7% (33/95), 23.8% (181/
760), and 19.2% (227/1182) (Chi square test, p <0.001) in
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spectively. Multivariate logistic regression analysis showed that both
hyperchloremia (adjusted odds ratio [OR], 1.65, 95% confidence inter-
vals [CI], 1.00–2.70; p value, 0.048) and hypochloremia (adjusted OR,
1.30, 95% CI, 1.02–1.67; p value, 0.035) were independently associ-
ated with 28-day mortality.
CONCLUSION. Hypochloremia (37.3%) was more frequently observed
than hyperchloremia (4.6%) and it was independently associated
with 28-day mortality in patients with septic shock in the emergency
departments.
REFERENCE(S)
[1] Neyra JA, Canepa-Escaro F, Li X, Manllo J, Adams-Huet B, Yee J, et al.
Acute kidney injury in critical illness study group: association of hyper-
chloremia with hospital mortality in critically ill septic patients. Crit Care
Med 2015;43:1938-44.
[2] McCluskey SA, Karkouti K, Wijeysundera D, Minkovich L, Tait G, Beattie
WS. Hyperchloremia after noncardiac surgery is independently associated
with increased morbidity and mortality: a propensity-matched cohort
study. Anesth Analg 2013;117:412-21.
[3] Boniatti MM, Cardoso PR, Castilho RK, Vieira SR. Is hyperchloremia
associated with mortality in critically ill patients? A prospective cohort
study. J Crit Care 2011;26:175-9.
[4] Rochwerg B, Alhazzani W, Sindi A, Heels-Ansdell D, Thabane L, Fox-
Robichaud A, et al. Fluid resuscitation in sepsis: a systematic review and
network meta-analysis. Ann Intern Med 2014;161:347-55.
[5] Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M: Association
between a chloride-liberal vs chloride-restrictive intravenous fluid admin-
istration strategy and kidney injury in critically ill adults. JAMA
2012;308:1566-72.
[6] Raghunathan K, Shaw A, Nathanson B, Sturmer T, Brookhart A, Stefan MS,
et al. Association between the choice of IV crystalloid and in-hospital
mortality among critically ill adults with sepsis. Crit Care Med
2014;42:1585-91.
[7] Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW,
et al. Balanced crystalloids versus saline in critically ill adults. N Engl J
Med 2018;378:829-839.
[8] Funk GC, Zauner C, Bauer E, Oschatz E, Schneeweiss B. Compensatory
hypochloraemic alkalosis in diabetic ketoacidosis. Diabetologia
2003;46:871-3.
[9] Yasuda K, Hayashi M, Murayama M, Yamakita N. Acidosis-induced hypo-
chloremic alkalosis in diabetic ketoacidosis confirmed by the modified
base excess method. J Clin Endocrinol Metab 2016;101:2390-5.
[10]Shin TG, Hwang SY, Kang GH, Kim WY, Ryoo SM, Kim K, et al. Korean
Shock Society septic shock registry: a preliminary report. Clin Exp Emerg
Med 2017;4:146-53.
[11]Angus DC, Barnato AE, Bell D, Bellomo R, Chong CR, Coats TJ, et al. A
systematic review and meta-analysis of early goal-directed therapy for
septic shock: the ARISE, ProCESS and ProMISe Investigators. Intensive
Care Med 2015;41:1549-60.
[12]ProCESS Investigators. A randomized trial of protocol-based care for early
septic shock. N Engl J Med 2014;370(18):1683-93.
[13]Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD,
et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J
Med 372(14):1301-11, 2015.
[14]Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al.
Surviving Sepsis Campaign: international guidelines for management of
severe sepsis and septic shock, 2012. Intensive Care Med 2013;39:165-
228.
[15]Kaukonen KM, Bailey M, Pilcher D, Cooper DJ, Bellomo R. Systemic
inflammatory response syndrome criteria in defining severe sepsis. N
Engl J Med 2015;372:1629-38.
[16]Shao M, Li G, Sarvottam K, Wang S, Thongprayoon C, Dong Y, et al.
Dyschloremia is a risk factor for the development of acute kidney injury
in critically ill patients. PLoS One 2016;11:e0160322.
[17]Thongprayoon C, Cheungpasitporn W, Cheng Z, Qian Q. Chloride
alterations in hospitalized patients: Prevalence and outcome significance.
PLoS One 2017;12:e0174430.
[18]Ryoo SM, Kang GH, Shin TG, Hwang SY, Kim K, Jo YH, et al. Clinical
outcome comparison of patients with septic shock defined by the new
sepsis-3 criteria and by previous criteria. J Thorac Dis 2018;10:845-53.[19]Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al.
Definitions for sepsis and organ failure and guidelines for the use of
innovative therapies in sepsis. The ACCP/SCCM Consensus Conference
Committee. American College of Chest Physicians/Society of Critical Care
Medicine. Chest 1992;101:1644-55.
[20]Yessayan L, Neyra JA, Canepa-Escaro F, Vasquez-Rios G, Heung M, Yee J,
et al. Effect of hyperchloremia on acute kidney injury in critically ill septic
patients: a retrospective cohort study. BMC Nephrol 2017;18:346.
[21]Suetrong B, Pisitsak C, Boyd JH, Russell JA, Walley KR. Hyperchloremia
and moderate increase in serum chloride are associated with acute
kidney injury in severe sepsis and septic shock patients. Crit Care
2016;20:315.
[22]Oh HJ, Kim SJ, Kim YC, Kim EJ, Jung IY, Oh DH, et al. An increased
chloride level in hypochloremia is associated with decreased mortality in
patients with severe sepsis or septic shock. Sci Rep 2017;7:15883.
[23]Stewart PA. Modern quantitative acid-base chemistry. Can J Physiol Phar-
macol 1983;61:1444-61.
[24]Palmer BF, Alpern RJ. Metabolic alkalosis. J Am Soc Nephrol 1997;8:1462-
9.
[25]Edwards SL. Pathophysiology of acid base balance: the theory practice
relationship. Intensive Crit Care Nurs 2008;24:28-38.
[26]Kreu S, Jazrawi A, Miller J, Baigi A, Chew M. Alkalosis in critically ill
patients with severe sepsis and septic shock. PLoS One
2017;12:e0168563.
[27]Tani M, Morimatsu H, Takatsu F, Morita K. The incidence and prognostic
value of hypochloremia in critically ill patients. ScientificWorldJournal.
2012;2012:474185.
000520
Candidemia in intensive care unit patients, study from a tertiary
care hospital in Dubai
A. Alsabbah1, M. Salam1, H. Celiloglu2, S. Tausif2, S. Al-Sabbah3
1Intensive care unit, Mediclinic City Hospital, Dubai, UAE; 2Microbiology
department, Mediclinic City Hospital, Dubai, UAE; 3Department of
statistics, Administration and Economics college, Kerbala University,
Karbala, Iraq
Correspondence: A. Alsabbah
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000520
INTRODUCTION. · Candidemia remains a major cause of morbidity
and mortality in the health care setting, and the epidemiology of
Candida infection is changing.
· . Non-albicans Candida species have emerged as major causes of
candidemia in many countries. Added to it is the problem of antifun-
gal resistance in Candida isolates.
OBJECTIVES. · To find out the prevalence of candidemia in our
intensive care unit (ICU), the ratio of candida albicans to non albicans
and what are the difference in the outcome of each type along with
the antifungal susceptibility pattern of Candida isolates and various
risk factors associated with candidemia.
METHODS. · A single-center, retrospective analysis over 5 years cov-
ering the period from January 1, 2012 to December 31, 2017 was
performed.
· The epidemiology, risk factors, demographic features, species
distribution, and clinical outcome associated with candidemia in
patients admitted to a single tertiary-care hospital in Dubai, were
analyzed.
RESULTS. A total of 30 Candida isolates were isolated during the
study period (overall incidence of 13.5 cases/1,000 ICU admission).
Candida Non albicans were isolated more than Albicans in 63% (n=
19) vs 37% (n=11). Among Non albicans Candida parapsilosis was
the most common isolate 58.8% (n=10) followed by Candida
tropicalis 26.3% (n=5), Candida glabrata 11.8% (n=2) while only one
case isolated of Candida kefyr and Candida auris. 26 Candida isolates
(86.7%) were pansensitive while 4 isolates (13.3%) were resistant to
fluconazole & amphotericine B.
· The most common medical problem associated with candidemia
was cancer patient followed by Diabetes Mellitus, CVA and renal
failure. The risk factors commonly associated with candidemia
patients were use of central venous catheters, mechanical
T2
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parenteral nutrition and post abdominal surgery.
· There was no significant difference in mortality between male and
female 60% vs 55% while the mortality was significantly higher in
old age group above 60 year old comparing to younger patient than
60 ( 58% vs 33%). The species distribution and outcome of
candidemia showed significant difference in the crude mortality
between patients infected with C. albicans and non-albicans 45% vs
63% while among non albicans candidemia both candida Tropicalis
& candida Parapsilosis had the highest mortality rate around 60%.
CONCLUSION. Candidemia is emerging as a significant problem in
hospitalized patients. Non-albicans Candida species are the major
cause of candidemia as found in our study. The epidemiology and
choice of therapy for candidemia are rapidly changing. Additional
multicentric studies involving many hospitals are required to know
the true prevalence of candidemia, differences in virulence among
Candida species and to determine the best therapeutic regimen.
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INTRODUCTION. Early use of antibiotics is a critical point in the
treatment of patients with sepsis. The exact time of initiation is
controversial and may be a difficult intervention in crowded
emergency services
OBJECTIVES. To estimate, using a matched propensity score, the
effectiveness on hospital mortality of using antibiotics within one or
three hours of diagnosis of sepsis, on patients hospitalized by
emergency services (ES)
METHODS. Secondary data analysis of a prospective cohort
conducted between 2014 and 2016 in three emergency services of
university hospitals in Medellín, Colombia. A propensity score
analysis for use of antibiotic, both within one and three hours of
admission by the ES, was fitted with 28 variables related with clinical
attention and physiological changes. As a sensitivity analysis, a
logistic regression model was fitted for antibiotic use adjusted both
by propensity score and confounding variables.
RESULTS. The study cohort was composed of 2,454 patients with a
median age of 62 years (IQR=46-74). Among them, 32% (n=781)
received antibiotics within three hours and 14% (n=340) within the
first hour. The main diagnosis were urinary tract infection (28%, n=
682) and pneumonia (27%, n=671). Blood cultures were requested in
87% (n=2140) and yielded positive in 29% (n=629), mainly with
Escherichia coli (37%, n=230), Staphylococcus aureus (21%, n=132)
and Klebsiella pneumoniae (102%, n=64). Hospital mortality rate was
11.5% (n=283). There were no significant differences in mortality
using antibiotics either in the first hour (OR 1.09; 95% CI = 0.69; 1.72)
or three hours (OR 0.98; 95% CI = 0.74; 1.32). There were no changes
with different models for sensitivity analysis (Table).
CONCLUSION. Despite the obvious constraints given for sample size
and residual confounding, our results suggest that we need a more
comprehensive approach to sepsis treatment, considering multiple
interventions and goals beyond the simple time-to-antibiotics
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INTRODUCTION. Patients undergoing elective and major
maxillofacial surgery are one of the groups of greater risk of
psychomotor agitation. It is associated with a greater frequency of
complications, longer stay in ICU and hospital stay.
OBJECTIVES. Evaluate the factor asociated to the presence of
agitation in maxillofacial surgery postoperative.
METHODS. Retrospective revission in the clinical histories of the
patients entered into ICU in the prospector of maxillofacial surgery
higher in the last 6 years.
It was recorded basal variables, records, clinics and evolutive. To
determinate the agitation it was used Riker scale and
AgitatedBehaviorScales (ABS) scale. And we define psychomotor
agitation as a ABC value bigger than or equal to 21. The cuantitative
data are expressed like medium (interquartile range) and cathegorics
like counting (percentage).
RESULTS. We get 60 patients, of wich 28 (46,7%) were agitated
patients. We compare patients without agitation regarding patients
with agitation. There are differences in males (78,1% vs 96,4%; p=
0,037); the most important history antecedent was to be an active
drinker (43,8% vs 64,3%; p=0,112); SOFA (1(1-1) vs 1(1-2);p=0,022).
Tracheostomy was present (78,1% vs 96,4%;p=0,037).
There are evolutionary differences in re-surgery (21,9% vs 50%;p=
0,023), infectious complications in ICU (12,5% vs 42,9%;p=0,008),
rebleeding (9,4% vs 28,6%; p=0,055) and graft thrombosis (6,3% vs
21,4%;p=0,084); longer sedation time, (1 (1-1,5) vs 4 (2-7) days; p=
0,001); start weaning (1 (1-1) vs 2 (1-3) days; p<0,001); mechanical
ventilation duration (1 (1-2) vs 4 (2,5-9,5) days; p<0,001); days in ICU
(3 (2-5,5) vs 4 (1,5-6,5) days; p<0,001).
CONCLUSION. Know the factors asociated to psychomotor agitation
in the maxillofacial surgery postoperative will help us to get better in
knowledge and use prophylaxis of it in certain treatment groups
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associated to longer stays and postoperative complications.
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INTRODUCTION. Many procedures and tests have been performed
for the diagnosis and treatment of children. Young patients feel
anxious and fear for repeated tests and procedures irrespective of
the occurrence of pain. Many hours and manpower are consumed
throughout all these process.
OBJECTIVES. These were two cases about the deep sedation which
was undergone daily radiation therapy (RT) due to malignant solid
tumor. They were failed in previous sedation with other agents
(chlroral hydrate and midazolam), so referred to our department to
solve the problem.
METHODS. One is the case for a 5 year-old-child (weight 20.8~22.9
kg) who was diagnosed into anaplastic ependymoma. After subocci-
pital craniotomy with tumor removal, they were scheduled to 28
fractions tomotherapy 1.8 Gy/d (total of 50.4 Gy/28d) at two target
sites; posterior cranial fossa and spine. The other is for a 34-month-
old infant (weight: 12.7~12.9 kg) was diagnosed to neuroblastma in
adrenal gland with metastasis. After liver wedge resection and Lt.
adrealectomy, they were scheduled to 12 fractions tomotherapy 1.73
Gy/d (total of 20.76Cy/12d) at two target sites; Lt. adrenal area and
Rt. Fibular. Before RT, the former, midazolam 0.05mg/kg was injectedand the latter, dexmedetomidine (Dex) 1mcg/kg for 10minutes as
premedication. In both cases, after premedications were applied,
three times of 1mg/kg of 1% propofol at a time were administered
and then 150mcg/kg/min were continuously infused during RT.
Blood tests were performed the next days after radiotherapy.
RESULTS. In both of these cases, there were no abnormal findings
other than mild decreased hemoglobin, platelet and ANC (absolute
neutrophil count) by bone marrow suppression. They were done all
RT cycles well and discharged without complications. there were no
gradual increases in dose of sedatives and drug dependence which
were resulted from repeated sedation. In addition, hemodynamic
adverse reactions; severe hypo or hypertension and bradycardia
except for slight hypotension (systolic blood pressure 85~95mmHg)
during sedation were not observed and other vital signs; pulse rate,
SpO2 (saturation of percutaneous oxygen), respiration rate were kept
constant within normal range. In sedation status, the RSS (Ramsay
sedation scale) was maintained satisfactorily at level 4~5 and the
Bispectral Index for measuring anesthetic depth was also showed at
40~50.
CONCLUSION. Generally, midazolam and propofol are widely used in
procedural sedation. Recently, various trials through Dex are applied.
The use of Dex is increasing as the way to maintain a safe sedation
in cases of respiratory problems or in ICU. However, Dex alone is not
enough to maintain an effective anesthetic depth during procedures
or clinical tests, and does not show the same effect as propofol with
shorter duration and recovery. However, due to the side effects of
benzodiazepine as a sedative, it has gradually been replaced by
other stable sedative agents, one of which is Dex. Therefore, Dex
instead of midazolam was used as an adjuvant agent based on
propofol sedation. Through this case, we suggest that Dex was able
to maintain the sedation reliably when it is used as only
pretreatment loading and also strengthen the sedation state even
though not a the continuous infusion of Dex.
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INTRODUCTION. In recent years, hemodilutional autologous blood
transfusion (HAT) has attracted attention for its effects in reducing
hospital stay days and postoperative complications in cardiovascular
surgery. HAT is a blood conservation technique using polyvinyl
chloride bag with CPDA fluid including citrate sodium, glucose,
adenine and sodium dihydrogenphosphate at room temperature
without shaking. But this is not suitable for maintaining platelet
functions because of low pH of CPDA fluid, and low gas permeability
of polyvinyl chloride bag. At present, HAT has not been
implemented mainly for the purpose of hemostasis. Therefore, there
is a need to develop new HAT that can preserve platelet functions
and be used as an optimal hemostatic products in cardiovascular
surgery.
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can best maintain platelet functions. We used polyolefin bag with
shaking to maintain platelet functions. Since polyolefin have high
gas permeability, shaking storage can release carbon dioxide
generated by the equilibrium reaction of lactic acid and bicarbonate,
and maintain an appropriate pH.
METHODS. Informed consent was given and the protocol was
approved by the ethical committee. Venous blood was taken from 3
healthy volunteers who had not taken any medication at least for
two weeks before blood collection. 50 ml of whole blood were
preserved in polyolefin bag with shaking at 50/min or polyvinyl
chloride bag without shaking for 8 hours at 22 degrees Celsius.
CPDA fluid was used as preservative solution. We performed blood
gas analysis (PaO2, PaCO2, pH, BE, lactate, HCO3-), complete blood
count (hematocrit, platelet count, mean platelet volume (MPV)) and
platelet function tests including ADP-induced aggregability using
light transmission method and P-selectin expression with or without
ADP stimulation using flow cytometry at 0 and 8 hours after blood
collection. Wilcoxon signed rank test was used to compare the two
groups. P values less than 0.05 were considered to indicate statistical
significance.
RESULTS. No statistically significant difference was found between
the two groups in any of the items, but in the polyvinyl chloride
group and the polyolefin group, the aggregability was reduced by
61.0% and 25.3%, non-ADP stimulated P-selectin expression was in-
creased by 193.7% and 104.5%, after 8 hours, respectively. MPV and
ADP-stimulated P-selectin expression were almost similar. The poly-
olefin group had tendency to keep PaO2 high, PaCO2 low, and pH
high. P-selectin expressions with or without ADP stimulation repre-
sent potential platelet adhesivity and platelet activation level by HAT
procedure itself, respectively. MPV indicates platelet activation. Fur-
ther cases are needed to determine whether platelet functions are
maintained in the polyolefin group due to the high oxygen perme-
ability with shaking. 8 hours might be too short to detect the super-
iority of polyolefin storage in platelet aggregability and adhesivity.
Other platelet function evaluations, including release ability, hypo-
tonic shock recovery rate, intracellular Ca concentration, clot dynam-
ics, and morphology are needed to clarify the effectiveness of
polyolefin preservation with shaking.
CONCLUSION. Further evaluations are needed to confirm the
usefulness of polyolefin preservation with shaking on maintaining
platelet functions.
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INTRODUCTION. Blood loss in hip fracture patients is common,
resulting both from initial trauma and subsequent operative
intervention. As UK national standards mandate operative fixation
within 36h of presentation to hospital, rapid correction of anaemia is
paramount to optimise postoperative mobility (Lawrence 2003).
However, multi-centre trials have found no benefit from using a lib-
eral (transfusion if Hb <100 g/L) over a restrictive strategy (Hb <80 g/
L or patient symptomatic) (Carson 2011), indicating that adverse ef-
fects of red cell transfusion could offset the potential benefits of
higher Hb levels. Parenteral iron replacement promises to increase
Hb without transfusion-related morbidity (Bernabeu-Wittel 2016).
OBJECTIVES. To assess and optimise our use of parenteral iron to
treat iron deficiency in anaemic hip fracture patients.
METHODS. Initial cohort of 43 consecutive hip fracture patients,
median age 81, 63% female, admitted to our UK district general
hospital over six weeks from November 2018 to January 2019. Fortypatients survived to operative fixation and were included in the
primary analysis. We deployed a care bundle to improve testing for
and correction of perioperative iron deficiency in April 2019, will
assess its impact in June and present our findings at the congress.
RESULTS. All but one (97%) patient were anaemic (Hb <130 g/L,
from Muñoz 2017) during their inpatient episode. Thirty-seven (93%)
patients had their serum iron levels measured, which was low in 29
(78%) cases. Only four patients (10%) had transferrin saturation
(TSAT) measured, which were low in all cases (100%). Ferritin was
measured in 21 (53%) patients, but only in three (13%) cases was less
than 100 mcg/L (threshold in presence of inflammation, from Muñoz
2017). Twelve patients (30%) received ferric carboxymaltose (FCM), all
with low serum iron levels. However, only two (50%) of the patients
with low TSAT, and only one (33%) of the patients with low ferritin
received FCM. Seventeen patients (59%) with low serum iron did not
receive FCM, although four of those patients additionally had either
low TSAT or low ferritin, see above.
CONCLUSION. Both anaemia and iron deficiency were extremely
common. Serum iron was the most commonly used biomarker of
iron deficiency and showed overwhelmingly low iron stores in our
cohort. TSAT was underused, despite being the most sensitive
marker for insufficient iron supply in the presence of trauma. Ferritin,
despite still being the diagnostic mainstay (Muñoz 2017) was poorly
sensitive in our cohort, likely due to false elevation as part of the
acute phase response. Although most patients would likely have
benefited from parenteral iron replacement, only a minority received
it. We will intensify staff education, deploy a care bundle containing
prompts for blood sampling as well as indications for parenteral iron
replacement and will report the result of this intervention at the
congress.
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INTRODUCTION. The coagulation system in human is extraordinarily
fragile. Various stimuli may deteriorate the system, cause life-
threatening events such as Disseminated intravascular coagulation
(DIC). Replacement of decreased antithrombin may improve the co-
agulopathy caused by noxious stimuli such as sepsis or severe
trauma.
Recently, recombinant antithrombin gamma (Kyouwa Hakkou Kirin
Co.Ltd. Tokyo) has been introduced into Japan. This novel
recombinant protein will reduce adverse effects related to the blood
extracts, but also may diminish the problem of blood supply.
We investigated the efficacy of the newly introduced recombinant
antithrombin. This study is a brief report of the administration of the
antithrombin gamma for 54 patients who were diagnosed as DIC or
decreased antithrombin activity.
METHODS. From December 2017 to November 2018, 54 patients
who were diagnosed DIC and were administered the antithrombin
Page 552 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55gamma were surveyed by retrospectively using medical records. The
collected data were as follows, patients age, sex, body weight, the
illness of patients, acute DIC scores (defined by the Japanese Society
of Emergency and Critical Medicine), dose of study drug, other
combination therapies and prognosis of the patient.
RESULTS. In 54 studied patients, 34 cases were diagnosed DIC;
however, all patients showed antithrombin activities below 70% of
normal. Twenty-eight in 54 patients had sepsis. The average dose of
the antithrombin gamma was 1877±450U. The administration days
were 1 day (1 to 14 days) in 65% of cases. Administration of the anti-
thrombin gamma had increased antithrombin activities linearly. Aver-
age activity before administration and after were 47±12% and 72±
12%, respectively. Eleven in 34 patients recovered from DIC after ad-
ministration. Also, 36 in 54 patients were survived at the time of
discharge.
CONCLUSION. Various stimuli may cause abnormality of coagulation
systems. Despite a long history of investigations, there have been no
well-established therapies. However, antithrombin administration for
the patients who were suffered by coagulopathy is a controversial
issue; some guidelines mention about this therapy. Recently, recom-
binant antithrombin has been developed and introduced into clinical
practice. Our result showed the recombinant antithrombin gamma
restored the activity of antithrombin, and recover from DIC in one-
third of the study group. This finding is compatible with the former
studies of antithrombin administration which was extracted from the
human blood. In the study group, we have not experienced any ad-
verse events related to the antithrombin gamma. A phase I trial of
the antithrombin gamma has been conducted in Europe from April
2018. Still, little literature revealed its feasibility and equivalency of
AT gamma over conventional antithrombin. We will need to further
investigations, especially a RCT, to assess the efficacy and safety of
the recombinant antithrombin gamma.
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INTRODUCTION. Objective: Presenting clinical and epidemiological
data of patients with a radical cystectomy with urinary diversion who
required ICU admission.
METHODS. Retrospective, descriptive study of patients admitted in
ICU from May 2018 to December 2018. Clinical, epidemiological and
result-related variables were analyzed. Quantitative variables are
expressed as mean and standard deviation, while qualitative vari-
ables are expressed as ratios and absolute value.
RESULTS. A total number of 15 patients took part in this study; mean
age was 60.73 ± 9.49 years (73.3% were males). APACHE II at
admission was 10.6 ± 1.35. SAPS3 52.6 ± 10.03. Between the
comorbidities 40% of the patients presented high blood pressure,
26.7% had dyslipidemia, 20% were diabetics, 46.7% were smokers,
13.3% took alcohol, and 26.7% had others as obesity or COPD. 6.7%
had no comorbidities. All of the patients had history of urologicaldisease; the most frequent were prostatic hyperplasia (13.3%) and
urinary tract infections (UTI) (13.3%). Previous abdominal surgery was
performed in 26.7% of the patients. In 12 of the cases the radical
cystectomy was necessary because of muscle-infiltrating urothelial
bladder carcinoma. Two patients required the surgery because of ob-
structive problems, and one of them because of neurogenic bladder
(multiple sclerosis). 66.7% patients received at first transurethral re-
section (TUR). 6.7% required chemotherapy before the procedure;
braquitherapy was administered also in 6.7%. None of them had neo-
adjuvant radiotherapy. The most common urinary diversion was
Bricker (only one was Nesbitt). At the ICU admission 53.5% of the pa-
tients presented creatinine values between 1 and 1.5mg/dl. 33.3%
had light metabolic acidosis and none of them hydroelectrolyte
imbalance.Peri and postoperative antimicrobial prophylaxis with
Amoxicillin-Clavulanic was done in 80% of the patients; 13.3% were
treated with Quinolones and only in 6.7% Piperacillin-Tazobactan
was used. 26.7% (4) of our patients had complications, the most fre-
quent was paralytic ileus (50%); 25% had acute renal failure, and only
one (25%) had minor bleeding which didn’t need surgery. A patient
need re-entry en UCI due to Sepsis of unknown origin, dying after 7
days of intensive therapy. Average ICU stay was 1.26 ± 0.59 days. ICU
mortality rate was 6.7% and one-year mortality after the cystectomy
was 20%.
CONCLUSION. The profile of the patient admitted to the ICU after
cystectomy is a 60 year old patient with comorbidities, muscle-
infiltrating urothelial carcinoma and normal renal function, to those
who underwent prophylactic treatment with Amoxicillyn-Calvulanic.
A good postoperative progress and no re-entry en ICU was observed.
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INTRODUCTION. We consider severe preeclampsia when the
increase in blood pressure is associated with certain symptoms,
analytical alterations, oligohydramnios or Intrauterine growth
restriction (IUGR). Treatment sometimes requires admission to the
ICU, depending on the severity of the episode, aimed at controlling
blood pressure levels with maternal and fetal monitoring, maturing
the fetus, if necessary, and avoiding possible complications.
METHODS. We conducted a descriptive retrospective study in which
the patients who required admission to the gynecological ICU in our
hospital were collected during 2018 with a diagnosis of gestosis to
evaluate the type of preeclampsia, the treatment performed and the
results obtained.
RESULTS. A total of 14 patients diagnosed with preeclampsia, who
required admission to the ICU during 2018, were collected. The
gestational age was between 22 and 39 weeks. Fetal maturation with
betamethasone was performed in 64.3% of the cases, only 14.7% if
the pregnancies were multiple. All patients who required admission
to the ICU were diagnosed with severe preeclampsia. The most
frequent symptoms that they presented were visual anomalies
(85.7%), followed by edema and abdominal pain (71.4% each),
headache (57.1%) and proteinuria (42.9%). No cases of acute
pulmonary edema (APE) or oliguria were observed. Upon admission
to the ICU, 71.4% had SBP ≥ 160 mmHg with a medium of 120.7 and
a typical deviation of 14.16. 100% required more than one
antihypertensive to control blood pressure and in all cases labetalol
was used, followed by hydralazine (71.4%), alpha methyl dopa
(42.9%), and nifedipine (21.4%) . Magnesium sulfate was used in
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deviation of 4.87. End of the pregnancy for maternal or fetal benefit
was needed in most of the cases, been early caesarean section
performed in 85.7% of patients; only 1 case was delayed 9 days due
to low gestational age. Maternal complications after ICU admission
only appeared in 3 of the 14 cases and were: 1 post-cesarean bleed-
ing, 1 urinary tract infection and 1 case of paralytic ileus. As far as
the fetus IUGR was observed in 14.3% of the cases and only one pre-
sented oligohydramnios. Maternal survival was 100% meanwhile
87.5% was observe in newborns.
CONCLUSION. All patients admitted to the ICU due to gestosis
present criteria of severe preeclampsia. The most frequent symptoms
were visual alterations, abdominal pain and edema. A 71.4% on
admission showed arterial hypertension. 100% of the cases required
more than 1 antihypertensive for the control of blood pressure in the
ICU, being labetalol the antihypertensive that was administered in all
cases. It is a small sample but with full survival despite the severity
of the case we continue with the collection of data to confirm that
patients diagnosed with severe preeclampsia benefit from admission
in ICU.
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INTRODUCTION. The incidence of hypertensive disorders associated
with pregnancy is increasing due to maternal age, obesity, assisted
reproductive techniques, etc. Preeclampsia refers to a blood pressure
≥140/90 mmHg, with proteinuria in pregnant women over 20 weeks
or up to 2 weeks after delivery. Risk factors are: maternal age, (<20
or > 35), personal or family history of preeclampsia, hypertension,
diabetes, obesity, renal failure, primiparous or multiparity, multiple
pregnancy, and coagulation disorders.
OBJECTIVES. We wanted to know the epidemiology of the patients
who needs ICU admission due to gestosis, risk factors, mortality
scores and survival of pregnant women and newborns.
METHODS. Retrospective, descriptive study of patients admitted in
ICU from January 2018 to December 2018 . Clinical, epidemiological
and result-related variables were analyzed. Quantitative variables are
expressed as mean and standard deviation, while qualitative vari-
ables are expressed as ratios and absolute value.
RESULTS. During 2018, 14 patients with a diagnosis of gestosis
required ICU admission. The patients had between 23 and 50 years,
medium age of 35.14 years and standard deviation of 7.8.
Gestational age at admission was between 22 and 39 weeks with a
medium of 31.5. 100% of pregnant women had at least a risk factor
(nuliparity was the most frequent (57.14%), 42.9% were older than 35
years, diabetes and coagulation disorders were observe in 28.6% of
the patients, and hypertension, preeclampsia history and multiple
pregnancy in 21.4%. Only 2 patients were in vitro fertilisation, in
both cases were their first pregnancy. ICU stay was between 1 and 6
days with a medium of 2.6 days and standard deviation of 1.5.
APACHE II at admission was 6.3 with a standard deviation of 3.6. All
of our patients were alive when the results were taken. Two of the
sixteen babies died: one of them was a twin who died in uterus a
month before the admission; the second one had a gestational age
of 22 weeks.
CONCLUSION. Our low incidence of preeclamsia, which need ICU
admission, could be explained by primary prevention and treatment
in healthcare centres. Patient admitted in our ICU with preeclamsia,
is a 35 years old woman who at least has one risk factor, been
nuliparity the most frequent, as well as age over 35 year, diabetes
and coagulation disorders; and with a low mortality predicted by
APACHE II at admission.HSRO / TEM - Predicting outcome:
Influenceable variables
001079
Scientific evidences as a policy for the optimization of beds in
public ICUs in Brazil
G. Rossone Reis1, W. Rodrigues2, GJ. Von Glehn Dos Santos3, E. Barbosa4,
SE. Bazzo Júnior5
1Physiotherapy, UnirG - Universidade de Gurupi, Gurupi, Brazil;
2Economics, UFT - Universidade Federal do Tocantins, Palmas, Brazil;
3Medicine, UnirG - Universidade de Gurupi, Gurupi, Brazil; 4Critical care,
HGP - Hospital Geral de Palmas, Palmas, Brazil; 5Physiotherapy, HDT -
Hospital de Doenças Tropicais da Universidade Federal do Tocantins,
Araguaína, Brazil
Correspondence: G. Rossone Reis
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001079
INTRODUCTION. The availability of beds in intensive care units in
Brazil has become a serious public health problem. Through the
identification of studies and data collection that resulted from the
analysis of variables that generated better indicators of quality in
intensive care, such as the reduction of length of stay, costs of care
and mortality rate.
OBJECTIVES. To analyze whether the implementation of public
policies based on scientific evidence focused on ICU patient
admission criteria and infection control can contribute to increase
the availability of beds and reduce hospital costs in public ICUs in
Brazil.
METHODS. The retrospective, quantitative and statistical
documentary research through collection, correlation and
comparison of data, aiming to analyze if the admission criteria and
the incidence of nosocomial infection is related to length of stay,
costs and mortality rate in patients hospitalized in Brazilian public
ICUs. Data were analyzed of all hospitalizations of patients admitted
to the three largest public ICUs in the State of Tocantins, in the north
of Brazil, from January to December, 2018. The clinical data of the
1013 patients admitted to the ICUs in the year of 2018 were
collected, based on the ICU vacancy request form sent to the
Regulation Center, where they were allocated to the priority
admission groups (Groups with priority 1, 2 and 3, and Group with
priority 4). After the analysis of the patients' records at the respective
hospitals, the length of stay, the infection index, the mortality rate
and the cost estimate were collected. Regarding the statistical
analysis, the correlation data between the quality indicators (length
of stay, costs and mortality rate) on the presence or absence of
hospital infection and the admission criteria, were analyzed by the
coefficient of Pearson and Staverman in order to evaluate the degree
of linear association.
RESULTS. A total of 1013 patients were collected, however, some
patients did not present the necessary information to perform the
study, and only 634 patients were considered to compose the
sample. Through analysis of the pearson correlation, it can be
observed that high infection rates (n=260 or 41%) and lack of
admission criterion (criteria 4 with n=134 or 21%) corroborate for
higher mortality (p<0.001), longer stay time (p=0.0019) and higher
costs (p<0.001), reducing the quality indicators of public ICUs in
Brazil.
CONCLUSION. Evidence shows that the adoption of continuous
assessment measures based on technical knowledge and the
application of evidence-based medicine in the management of pub-
lic health policies, especially in the intensive care unit, can corrobor-
ate better quality indicators, with a greater supply of beds and,
consequently lower waiting time for vacancy in ICU, lower mortality
rate and lower costs, without investments in new units and/or open-
ing of new beds.
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INTRODUCTION. Medical Emergency Team (MET) is implemented in
many hospitals all over the world and it seems associated with the
prevention of cardiac arrests and unexpected deaths in wards,
reduced rates of admissions to intensive care units and hospital
mortality (1). Therefore, international bodies of quality certification,
such as the Joint Commission and the Institute for Healthcare
Improvement, support creation and implementation of MET in every
hospital (2). Although its implementation is recommended, little is
known about the presence of MET and its organization in Italian
National Health Service hospitals (3).
OBJECTIVES. To investigate the presence of MET and its organization
in Italian National Health Service hospitals.
METHODS. A national survey was conducted for two months in
2018. All public and private National Health Service associated
hospitals with a service of intensive care were invited to participate.
An online questionnaire was sent via e-mail to nursing coordinators
or MET referents.
RESULTS. Among the 544 Italian hospitals identified, 197 (36.2%)
answered the questionnaire. In every hospital there was a physician
who answered the emergency calls, but a real MET (intensivist
physician and critical care nurse) was present only in 59.9% of the
hospitals, particularly in the north of Italy and in the community
hospitals (61.5%). MET activity started about 10 years ago (51.7%)
and in most hospitals the service is available 24/24 hours, 7/7 days
(84.8%). The team members’ minimal education was a specialization
on intensive care medicine (100%) for physicians, while the most
usual criteria for nurses were working experience in critical care
(70.3%), besides specific internal courses were also performed
(21.2%). The MET nurses belonged to the intensive care unit (83.1%)or to the emergency room (21.2%). Unfortunately, the intensivist
physician and the critical care nurse weren’t dedicated to MET
(67.8% and 69.5% respectively), in particular in the community
hospitals. The Modified Early Warning Score was used in 22.9%, while
in 34.8% of hospitals no warning score was used.
CONCLUSION. This survey has shown that in Italian National Health
Service hospitals MET appears structured and consolidated in some
realities, while in others it is totally absent or lacking in some
fundamental peculiarities of an intra-hospital emergency system.
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INTRODUCTION. Burnout (BO) is reaching epidemic levels in the
medical population with prevalence reported around or over 50%.¹
Its presence is associated with poor patient safety outcomes.² Those
working in ICM are disproportionately affected, rating higher on
stress, BO and compassion fatigue indices.³ In Ukraine, specifically,
the concept of BO in ICM remains poorly understood and is largely
under recognized, or dismissed. With paucity of literature addressing
the issue, we decided to investigate the reality of BO experience in
our country.
OBJECTIVES. To assess the BO experience and identify associated
risk factors in the ICU of a university teaching hospital.
METHODS. The focus of the study was the frontline ICU staff nurses
(n=40) and doctors (n=49). Data collection was performed with the
help of the Maslach Burnout Inventory (MBI) survey. The BO rate was
assessed across various ICU types, seniority, gender and age groups.
RESULTS. The overall prevalence of BO in ICU staff was 60.7 %
(nurses 62.5% doctors 59.2%). There was no difference on BO
subscales between doctors and nurses (95%CI,P>0,05).We also found
no statistically significant difference in the incidence of BO between
doctors and nurses (P>0,05). Our study showed no difference (P>
0,05) in the incidence of BO in doctors across ICU type, seniority
level, gender or age group. In contrast, there was a difference in the
incidence of BO in nurses across the ICU type (P < 0,05).
CONCLUSION. The response rate was 92%. BO prevalence was
notably high in both ICU nurses and doctors. Our findings indicate
that doctors and nurses are equally at risk of a BOexperience. The
study showed no clear association between any of the risks and the
incidence of BO in doctors. With regard to nurses,the ICU type
proved to be a factor in the incidence of burnout. The nurses of
general and neurosurgery ICUs were most affected by BO possibly
due to demanding workload and severity of the patients in these
units. Limitations of our study include a relatively small number of
respondents that prevents from drawing conclusions in the context
of a country/healthcare system. Further research across more
hospitals in Ukraine is warranted to determine the BO rates and risk
factors. In conclusion, we expect to raise awareness of the ICU staff
BO in Ukraine and advocate for more research in this field. In a wider
perspective, we hope that our study contributes to a better
understanding of BO experience and promotes a broader discussion
on the welfare and sustainability of the ICM workforce.
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INTRODUCTION. It has recently been shown that mitochondrial DNA
(mtDNA) is associated with outcome in critically ill patients, however
measurement of mtDNA is time consuming and cumbersome. Uric
acid is a product of the metabolic breakdown of purine nucleotides
and can be measured routinely.
OBJECTIVES. To analyze whether uric acid is associated with levels of
mtDNA and predicts 30-day survival in ICU.
METHODS. In this prospective, observational cohort study, 222
consecutive patients admitted to a cardiac ICU at a tertiary care
center were enrolled. Blood was taken at admission to the ICU and
levels of circulating mtDNA were quantified by real-time.
RESULTS. Mean Apache II score was 19.6±8.3 and 30-day mortality
was 26.1%. Uric acid correlated with circulating mtDNA plasma levels
(R=0.21; p<0.002). Non-survivors showed significantly higher uric acid
levels as compared to survivors (7.8±3.9 vs 6.2±2.5mg/dL). Patients
with uric acid levels in the highest quartile (≥8.5mg/dL) showed a 2.8
(1.7 - 4.8)-fold risk of death as compared to patients in the lower
quartiles (p<0.001). This increased risk of death was independent of
age, gender, serum creatinine and APACHE II score.
CONCLUSION. Uric acid levels correlate with circulating mtDNA and
predict mortality in critically ill patients.001090
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INTRODUCTION. Critically ill patients have a decline in their muscle
strength and in their functional capacity, which may occur after their
hospital discharge.
OBJECTIVES. To evaluate the functionality and peripheral muscular
strength of patients who were hospitalized in the ICU after three
months of their discharge
METHODS. Retrospective study with data collected from January to
December 2018, performed through the analysis of medical records
of patients who were admitted to the ICU in the Hospital
Universitário do Oeste do Paraná - Brazil, who returned for
evaluation in the outpatient clinic three months after their discharge
from the ICU. This study was approved by the Ethics Research
Committee from the Western Parana State University, protocol
number 436.770/2013. During ICU the patients were allocated into
three groups: passive group (PG), Active-Assisted Group (AAG) Active
Group (AG), according to their condition and clinical evolution. Per-
ipheral muscle strength was assessed by the Medical Research Coun-
cil (MRC), and functionality by the Functional Independence Measurescale (FIM) on discharge from the ICU and outpatient clinic. Variables
with normal distribution were compared using the Student's T-Test,
and the non-normally distributed variables were compared using the
Man Whitnney tests. All analyzes were performed at 5% significance.
RESULTS. The sample had 54 patients, 18 in the passive group, 17 in
the active-assisted, and 19 in the active, predominating the mascu-
line gender, with age of 46.83 ± 21.37 vs 45.05 ± 19.24 vs 48.73 ±
15.56; p=0.91, with neurological (44%), non-neurological (35%) and
neurological (31%) admission causes in PG vs AAG vs AG, respect-
ively. The variables APACHE II (27.05 ± 5.47 vs 24.35 ± 8.50 vs 23.57
± 8.19, p = 0.40), SOFA (11.16 ± 2.92 vs 7.23 ± 3.71 vs 8.11 ± 2.28, p
= 0.002), sedation time in hours (93.17±76.80 vs 80.71±84.52 vs
20.17±31.27; p=0.008), mechanical ventilation in hours (224.16±
130.56 vs 162.31±154.86 vs 50.47±56.95; p=0.0009), ICU length of
stay in days (14.72 ± 8.52 vs. 13.11 ± 11.27 vs 5.63 ± 4.33, p =
0.0004), Glasgow coma scale at discharge from the ICU (9.5 ± 3.11 vs
13.23 ± 2.01 vs. 14.38 ± 1.41; p <0.0001) in PG vs AAG vs AG respect-
ively. Table 1 presents a comparison of the variables of the periph-
eral muscle strength and functionality in the ICU and in the
outpatient clinic. In all three groups there were an increase in MIF
and MRC, showing a recovery of the patient.
CONCLUSION. Functional and peripheral muscle strength improved
in all groups three months after their discharge from the ICU.
Table 1 (abstract 001090). See text for descriptionICU Clinics p-valuePassive Group (PG) FIM 33.44 ± 21.05 109 ± 26.76 <0.001MRC 12 ± 14.49 44.33 ± 16.92 0.0004Active-Assisted Group (AAG) FIM 72.35 ± 35.53 118.11 ± 17.57 <0.001MRC 38.35 ± 8,81 52.70 ± 5 0.0005Active Group (AG) FIM 69.15 ± 32,12 115.15 ± 24.05 <0.001MRC 52.31 ± 5,55 54.05 ± 6.60 0.46001131
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INTRODUCTION. Depending on the definition and the method used
for detecting, up to 34% of intensive care unit (ICU) patients have a
history of an alcohol use disorder. (1-3) One study has reported high
prevalence of risky alcohol use and its association with increased
incidence of bacterial infection, and a recent systematic review
found an increased risk for ARDS among patients with harmful
alcohol use. (3,4) However, reports on its association with mortality
are contradictory, partly because of the diagnostic methods used are
variable (1-3).
OBJECTIVES. To study the prevalence of alcohol use disorders and
their association with the length of stay (LOS), treatment intensity
and outcome in ICU treated patients.
METHODS. Since the beginning of 2017, ICUs in Finland have
collected AUDIT-C (Alcohol use disorder identification test-
Page 556 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55consumption) data from ICU patients into the Finnish Intensive Care
Consortium Database. AUDIT-C is based on the interview of the pa-
tient or a close relative. Risky drinking is defined as ≥5 points (of 12)
for females and ≥6 for males. We used the registry data from January
1 to March 31 2018 to study the prevalence of risky alcohol use. Data
from centres with an AUDIT-C recording rate less than 70% of admis-
sions were excluded. We compared the disease severity scores, ICU
LOS, Therapeutic Intervention Scoring Systems (TISS) and ICU-, hos-
pital-, and one-year mortality in patients with and without risky
drinking. Here, we report the results of the preliminary analyses.
RESULTS. Ten centres had a 70% or higher availability of AUDIT-C
score. Of the 2186 admissions in these centres, AUDIT-C was avail-
able in 1660. AUDIT-C scores suggesting risky drinking were recorded
in 22% of the patients. Patients with risky drinking were younger
[median age 55 (IQR 42-65) vs 67 (IQR 57-74), (p>0.001)] and more
often male, 78.1% vs 60.9% (p<0.001) than other patients. In un-
adjusted analyses we found no difference in disease severity scores,
LOS, TISS, ICU or hospital mortality. According to preliminary analyses
(data of 299 patients pending), the 1-year mortality curve according
to AUDIT-C divided in subclasses is U-shaped with the highest mor-
tality in the group of AUDIT-C 11 to 12 points (Figure). Final analyses
will be performed after completing the mortality data.
CONCLUSION. Based on results obtained by using a validated self-
report tool AUDIT-C, the prevalence of AUDs in Finnish ICU:s was 22%.
We did not find an association of AUDs with patient outcomes in pre-
liminary unadjusted analyses. However, one-year mortality appears
highest in patients with very high AUDIT-C score as well as abstainers.
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INTRODUCTION. Predictions of survival or functional outcome may
influence clinical decision making in critically ill patients. One study
investigating the discriminative accuracy of mortality estimations by
physicians and nurses found that nurse’s estimations of in-hospital
mortality were most accurate. (1)
OBJECTIVES. To validate previous observations on forecasting in-
hospital mortality. To study the accuracy of students’ estimations and
the association of combined estimations by physicians, nurses and
students with in-hospital mortality.
METHODS. This is a substudy of the Simple Observational Critical
Care Study (SOCCS, NCT0355306), by the SICS study group. (2) All
patients acutely admitted to a tertiary centre Intensive Care Unit
(ICU) were included. Within three hours of ICU admission a medical
student, an ICU nurse and a physician independently predicted in-
hospital mortality. Medical students had at least completed their first
year of medical school and were trained to perform a structured
one-time physical examination. Physicians and nurses received no
additional training.
RESULTS. So far, 702 patients were included between May 12, 2018
and March 28, 2019. In 151 patients no estimations were made, due
to absence of the researcher or interference with clinical care,
leaving 551 patients for analysis. Estimations concerning in-hospital
mortality were obtained from medical students in all cases, from the
nurses in 486 cases (88%) and from the physicians in 331 cases
(60%). Medical students predicted an in hospital-mortality of 11.4%,
nurses 15.2%, and physicians 18.1%. Observed in-hospital mortality
was 19.2%. Estimations by medical students, nurses and physicians
all were correct in 81% with no differences between groups (p=0.6).
The estimations of students, nurses and physicians were all associ-
ated with mortality (OR 5.8, CI 3.3-10.1, OR 6.8, CI 4.1-11.5 and OR
8.3, CI 4.5-15.2 respectively), and when more estimators forecasted
non-survival, odds of non-survival increased (OR 2.7, CI 2.1-3.5 per
additional estimate).
CONCLUSION. Physicians, nurses and students accurately estimate
in-hospital mortality in 81% of cases. When more caregivers esti-
mated non-survival, the risk of death increased. Future research
should focus on investigating the conditional dependencies between
the estimates and the variables obtained from clinical examination,
ie using Bayesian networks, to assess how caregivers come to their
predictions.REFERENCE(S)
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INTRODUCTION. Early and proper management of multimorbid
hospital patients have an important role in improving the quality of
care. The aim of this study is to determine which pre-operative vari-
ables were significantly associated with mortality of patients before
admission to the surgical intensive care units(SICU).
METHODS. 307 patients who admitted to SICU after emergency
operation from 2013 to 2018 were recruited at the Department of
General Surgery at Ajou university hospital. A total of 35 variables
from database were extracted. Cox regression model and restricted
cubic spline (RCS) were used to evaluated the association between
preoperative variables and mortality.
RESULTS. In the final model, serum albumin level was the most
important predictor of mortality (χ2-df=23.7, p<0.001). The
respiratory rate(RR) was the 2nd most important predictor. (χ2-df=
17.7, p<0.001). The likelihood ratio χ2 test showed significant added
value of RR (p=0.008). The bias corrected C-statistic was 0.788 with
RR and 0.768 without RR.
CONCLUSION. Compared with a set of available clinical risk factors,
increase of RR was a stronger predictor of preoperative mortality. In
critically-ill patients who need emergency operation, increased RR
could be a good surrogate marker for predicting a need for prompt
management including surgery and careful intensive care.
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INTRODUCTION. The Christie Hospital is a tertiary cancer centre in
northwest England. The Critical Care Unit (CCU) provides level 2 and
3 support to patients with cancer. Patients are referred by a patient’s
oncologist, haematologist or surgeon.
OBJECTIVES. To compare mortality of non-elective patients admitted
to CCU at The Christie based on the opinion of the patient’s oncolo-
gist and the admitting critical care consultant (CCC).METHODS. Non-elective patients referred to CCU at The Christie are
always reviewed by a CCC. Following initial review, the on-call CCC
was asked what their opinion of the ceiling of care should be. This
was either level 1, 2 or 3 care. The patient’s parent consultant was
also asked the same question. Where possible, the opinion of a sec-
ond CCC was obtained and recorded. All consultants involved were
blinded to the study.
The responses were recorded and compared against the maximum
level of treatment the patient went onto receive during that episode
and the subsequent outcome. Primary outcome was mortality on
CCU.
RESULTS. 91 referrals to critical care led to 74 (81%) non-elective ad-
missions. Medical oncology made up over half of referrals (56%), and
others were from haematology (20.8%), clinical oncology (12.1%) and
surgery (11%).
There was agreement between the CCC and the parent oncologist/
surgeon about the ceiling of care in 49.5% of cases. In 47.2% of
cases the CCC recommended a lower level of care and in 3 patients
(3.2%) the CCC recommended a higher level of care than the
admitting oncologist.
When a second CCC reviewed the patient, there was agreement
between CCC about the ceiling of care in 46/91 cases, disagreement
in 28/91 cases and no data in 17 cases.
13 patients (14.3%) went on to receive a higher level of treatment
than that recommended by a CCC. These patients had the highest
mortality on the unit (table 1).
CONCLUSION. This study shows that while the parent team may
know a patient well, the opinion of the CCC is more accurate in
predicting mortality on a critical care environment. Mortality was
100% if a patient received level 3 support against the advice of the
CCC.
Table 1 (abstract 001199). Mortality on CCU based on the opinion of






patientsNumber of patients who
died on CCU (mortality
rate %)Received care at a or below the level
recommended by a CCC61 16 (26.2%)Level 1 Level 2 3 1 (33.3%)Level 1 Level 3 3 3 (100%)Level 2 Level 3 7 5 (71.4%)001203
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INTRODUCTION. Prompt reperfusion treatment is important for the
patients with ST elevation myocardial infarction (STEMI). However,
patients often need interhospital transfer for percutaneous coronary
intervention (PCI) because not all facilities are available for this
procedure. The purpose of this study is to reduce the PCI delay
through the regionalization protocol, in the patients with STEMI
when they are transferred from the hospital where PCI not available.
METHODS. We established revascularization protocol named
PREPARE (Preparing Revascularization Equipment before Patients
Arrival as Regionalization Engagement) for the STEMI patients
transferred from an outside regional hospital. The protocol included
immediate referral acceptance by emergency physician, real-time
electrocardiogram sharing via messenger service and early activation
Page 558 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55of the PCI team. We analyzed the differences between PREPARE
group with non-PREPARE group about time consumption for PCI,
length of hospital stay and major adverse cardiac events within 4
weeks.
RESULTS. In PREPARE group, the median time from the visit of first
hospital to the PCI in receiving facility (D1toB time) was 111 minutes,
and it was significantly shorter than non-PREPARE group (147 mi-
nutes). Rate of D1toB time achieved within 120 minutes was 26.0%
(13/50%) in Non-PREPARE and 60.0% (30/50) in PREPARE and showed
meaningful differences between the two groups(p=0.000). There
were no statistically significant differences in hospital length of stay
and major adverse cardiac events within 4 weeks.
CONCLUSION. PREPARE protocol as a regionalization strategy was
effective to reduce revascularization time in transferred STEMI
patients.
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INTRODUCTION. Patients on the Intensive Care Unit (ICU) require
high levels of nurse staffing. Critically ill patients have complex
multiple diseases and are exposed to many diagnostic and
therapeutic interventions. Therefore, they are at risk for Adverse
Events (AEs). Many studies have looked at the association between
nurse staffing and AEs with contradictory results. The omission of
variables such as units, days of the week, shifts and nurse education
are potential sources of bias.
OBJECTIVES. The aims of this study were, 1) to describe the shift
variation of the patient-to-nurse ratio (PNR) of an ICU in the Swiss
setting; 2) to describe, whether AEs vary by shifts and days of the
week and 3) to investigate nurse staffing per shift and their associ-
ation with AEs.
METHODS. Retrospective analysis of nurse staffing, routine patients
and AE data was performed on one interdisciplinary ICU with eight
units. Data were from January 1st, 2014 to January 31st, 2016. After
merging the three data sources, PNR were calculated for each nurse
educations (critical care nurse, critical care nurse in training, and
registered nurse (RN)) and for every unit, day of the week and shift
separately. To assess the association between nurse staffing per shift
and AEs, two regression models were fitted: 1) model to predict
nurse staffing with patient, units, days of the week, shifts and nurse
educations variables; and 2) model to predict AEs with shifts and
observed over expected (OE) estimator. The OE was obtained by
dividing the observed (actual data) PNR through the expected
(predicted data from staffing model) PNR. Three values were
possible: 1) OE = 1 meant predicted staffing equals the actual
staffing; 2) OE < 1 meant actual staffing higher than expected
(unusually high staffing); and 3) OE > 1 meant actual staffing lower
than expected (unusually low staffing).
RESULTS. A total of 6’938 shifts with 11’979 patients and 235 nurses
(115 critical care nurses, 45 critical care nurses and 75 RN) were
analysed. The PNR ranged from 0.93 to 1.01 for morning, from 0.98
to 1.10 for afternoon, and from 1.25 to 1.37 for the night shift. There
was little to no PNR variation between units, days of the week, shiftsand nurse education. No pattern could be seen between the
occurrence of AEs and days of the week, but an increase of AEs from
morning to afternoon to night shifts was observed. For the OE, the
percentage of shifts with unusually low and high staffing were from
10.4% to 14.4% and from 13.0% to 17.1%, respectively. No
association between the occurrence of AEs and shifts with unusually
low or high nurse staffing could be established.
CONCLUSION. Although no association between PNR and AEs was
identified with the current statistical approach and variables, the OE
estimator allowed to describe the low and high staffing variability in
the given ICU units on a shift basis. The OE estimator provided a
new perspective to describe nurse staffing, which opens new
possibilities for the future.
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INTRODUCTION. The prolonged mechanical ventilation (MV) causes
deleterious effects to the patients, such as the decrease of muscle
strength, interfering negatively in the weaning of the MV.
OBJECTIVES. To compare Maximal Inspiratory Pressure (MIP) and
Glasgow Coma Scale (GCS) in extubated and tracheostomy patients
for weaning from MV, evaluated in the ICU and in the outpatient
clinic.
METHODS. Retrospective study with data collected from January to
December 2018 of patients who were admitted to the ICU in the
Hospital Universitário do Oeste do Paraná- in south of Brazil, and
who returned for evaluation in the outpatient clinic three months
after their discharge from the ICU. Variables with normal distribution
were compared using the Student's T-Test, and the non-normally dis-
tributed variables were compared using the Man Whitnney and
Kruskal-Wallis test. All analyzes were performed at 5% significance.
RESULTS. The sample consisted of 57 patients, 36 extubated and 21
requiring tracheostomy. The main causes of admission were,
extubated group (EG): 33% clinical neurological condition, 19%
clinical non-neurological condition, and 19% postoperative elective;
tracheostomy group (TG): 66% clinical neurological and trauma with
TBI and 29% clinical non-neurological. The variables comparing EG vs
TG: age in years (47.33±16.81 vs 46.90±19.06; p=0.88), male gender
(61% vs 52%); APACHE II (24.8±6.80 vs 26.5±6.38, p=0.39), SOFA
(8.25± 3.07 vs 10.95±2.87, p=0.002), sedation time in hours (26.64±
44.73 vs 104.08±83.56, p=0.0007), time of MV (64.97±75.82 vs 256±
136, p=<0.0001), ICU length of stay in days (6.34±4.68 vs 17.14±10.15,
p=<0.0001). GCS of EG on the day of extubating, on the day of dis-
charge, and in the clinics (10.58±0.64 vs 14.05±1.09 vs 14.06±1.04,
p=<0.001). GCS of TG on the day of tracheostomy, on day of dis-
charge, and in the clinics (5.23±1.26 vs 9±1.92 vs 14.71±0.88, p=<
0.001). Both groups had gain MIP in the discharge vs clinics, EG
(-38.05 vs -68.47, p=<0.0001) and TG (-28.23 vs -54.76; p=0.0003).
Table 1 shows the EG and TG variables. TG had a lower level of con-
sciousness on the day of the procedure and on discharge. In the out-
patient clinic, there was no difference in GCS between the groups.
The MIP of the TG on discharge from the ICU was low when com-
pared to the EG.
CONCLUSION. Patients submitted to the TG, presented worse SOFA,
and even with tracheostomy, had a longer time of sedation and MV.
This may be related to the cause of admission, with a prevalence of
T2
Page 559 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55neurological patients. The TG also demonstrated lower MIP, and
lower level of consciousness compared to extubated patients.
Table 1 (abstract 001232). See text for descriptionVariables Tracheostomy
GroupExtubation
Groupp-valueGCS on the day of the
procedure5.23 ± 1.26 10.58 ± 0.64 p<
0.0001GCS discharge ICU 9 ± 1.92 14.5 ±1.09 p<
0.0001GCS clinics 14.71 ± 0.88 14.6 ± 1.04 0.86MIP discharge ICU -28.23 ± 12.37 -38.05 ± 19.23 0.06MIP clinics -54.76 ± 23.01 -68.47 ± 25.97 0.04001234
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INTRODUCTION. The Doppler-based renal resistive index (RRI) [(peak
systolic velocity – end-diastolic velocity)/peak systolic velocity] is a
newly recognized non-invasive technique to detect earlier patients
with renal tissue hypoxia and imminent acute kidney injury [1]. More-
over, the ratio of veno-arterial PCO2 difference to arterio-venous O2
content difference (ΔPCO2/ C(a-v)O2), has been recognized as a reli-
able marker of global anaerobic metabolism [2].
OBJECTIVES. The objective of our study was to evaluate whether the
combination of both RRI and ΔPCO2/ C(a-v) O2 ratio is better
associated with the presence of shock and clinical outcome in
intensive care unit (ICU) patients than either of them.
METHODS. A prospective observational study was conducted in our
multidisciplinary university intensive care unit (ICU). Patients
requiring mechanical ventilation, without pre-existing chronic kidney
disease were enrolled. Illness severity scoring systems (APACHE II and
SOFA) were calculated on ICU admission. RRI measurements were ob-
tained within the first 24 hours post-ICU admission, after the initial
hemodynamic resuscitation. At the same time the ΔPCO2/ C(a-v) O2
ratio was calculated. A cutoff value ≥ 1.4 was used to characterize a
high ΔPCO2/C(a-v) O2 ratio, whereas a cutoff ≥ 0.7 was used to
characterize a high RRI value.
RESULTS. A total of one hundred and twenty-six critically ill patients
(median age 61 years, 58.7% males) were included. Median values
(IQR) for APACHE and SOFA scores, RRI and ΔPCO2/ C(a-v)O2 ratio
were 18 (15-25), 9 (7-10), 0.7 (0.7-0.8) and 1.7 (0.6-3.4) respectively.
Shock was present in 60 patients (47.6%) and sepsis in 57 patients
(45.2%). The ICU mortality rate was 27.8% (35/126 patients). Patients
with high values of both RRI and ΔPCO2/ C(a-v)O2 had an increased
likelihood of shock presence (77.2% ), compared to those who had
only one of these markers high (30.4%) or those with both values
low (12.5%), p=0.001. Similarly, patients with high values of both RRI
and ΔPCO2/ C(a-v)O2 were more likely to have a fatal ICU outcome
(49.1%), than those having one of them high (13%) or those with
both values low (2.5%), p=0.001.
CONCLUSION. The combination of RRI and ΔPCO2/ C(a-v) O2
measurements was better associated with the presence of shock and
the prediction of clinical outcome, than either of them.
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INTRODUCTION. Infections due to extensively drug-resistant (XDR)
Acinetobacter baumannii is a therapeutic challenge in critical care
patients.
OBJECTIVES. We aimed to study prospectively clinical characteristics
and outcomes of patients with ventilator associated pneumonia
(VAP) due to XDR Acinetobacter baumannii (VAPxdrAB) and to
compare them with similar characteristics and outcomes of patients
with non-XDR VAP or no-VAP
METHODS. The present is an one-centre prospective study. Consecu-
tive patients were recruited from the ICU of a tertiary hospital of cen-
tral Greece in a three month period in 2018. Inclusion criteria
included mechanical ventilation and ICU stay > 48 hours while pa-
tients with pneumonia at admission or COPD, Asthma were excluded.
Diagnosis of VAP required microbiologic confirmation of the bacterial
agent.
RESULTS. Sixty-one patients were assessed. Mean(SE) age was
62.6(1.9), APACHE II score 18.5(1.9), SOFA score 7(0.4). There were
16(26.2%) patients with VAP, 8(13.1%) of them had VAPxdrAB. No pa-
tient presented a second VAP episode. Mean(SE) age and APACHE II
scores in VAPxdrAB , VAP-non-XDR and no-VAP patients were 60.2(6),
57.0(4), 61.9(2) and 16.5(1.4), 17(2.5), 18.2(1.2) respectively, (p=ns).
Mean ICU day of VAP diagnosis in VAPxdrAB and VAP non XDR were
6.4(0.9) and 7.8(1.1)(p=ns). VAP treatment duration and overall anti-
biotic treatment duration were not significantly different; ICU dur-
ation (days) were 31.4(3), 24.1(3), 11.3(1) (p=0.001 between
VAPxdrAB and non VAP and p=0.15 between VAPxdrAB and VAP
non-XDR). ICU mortality in VAPxdrAB , VAP-non-XDR and non VAP
patients was 0(0%), 2(25%) and 10(22.2%).
CONCLUSION. VAP due to XDR Acinetobacter baumannii was
associated with significant prolongation of ICU stay in our
population, underlying that the necessity of the implementation of
strict infection control measures.
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INTRODUCTION. Trauma is characterized by endothelial dysfunction and
is especially apparent in patients in hemorrhagic shock. A disruption of
intercellular connections may be an underlying mechanism(1).
Vasopressin analog ddAVP (desmopressin) acts through a cAMP-
dependent pathway, resulting in reorganization and redistribution of ad-
hesive and tight junction molecules, enhancing endothelial barrier func-
tion. Furthermore, ddAVP increases von Willebrand Factor plasma levels
and thereby potentially enhances platelet-based coagulation
OBJECTIVES. We aimed to assess whether the use of ddAVP will
result in a restoration of the endothelial barrier function and an
improvement in platelet-based coagulation without aggravating
organ failure in a rat model of trauma and transfusion.
METHODS. Blood products were prepared from syngeneic rat blood
according to blood bank standards. Polytrauma was induced in
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by fracture of the femur. The rats were hemorrhaged by phlebotomy
until a mean arterial pressure (MAP) of 40mmHg was reached. Rats
were randomized (n=8 per group) to receive transfusion of RBCs,
FFPs and platelets in a 1:1:1 ratio to achieve a MAP of 60 mmHg,
with or without a single dose of ddAVP. Blood samples were taken
up to 6h after trauma to assess biochemistry and coagulation status
by rotational thromboelastometry (ROTEM). Organ damage was
assessed by histopathology and biochemical parameters. Animals
were continuously monitored with an arterial and urinary catheter.
RESULTS. Rats receiving ddAVP had significantly higher MAP values
after the bolus was given. As reflected by their pH levels, a trend
towards a more effective correction of shock was found in rats
treated with ddAVP (7.36 vs 7.25, p=0.10). EXTEM CT and MCF
remained stable in the ddAVP group, while rats in the control group
showed a prolongation of their CT and a decrease in their MCF. This
difference between the groups increased for both parameters over
time. Platelet function relative to baseline values (reflected by EXTEM
minus FIBTEM) also remained stable in the ddAVP group (around
100%), while it dropped markedly in the control rats (90%, 88% and
83% after 45, 75 and 120 minutes respectively). A trend towards
lower soluble VE-cadherin levels was found in rats having received
ddAVP compared to controls (133 vs 311%, p=0.17). No difference in
organ injury was found between groups.
CONCLUSION. The use of ddAVP in a rat trauma-transfusion model
increased blood pressure and improved ROTEM parameters of clot
formation, with a trend towards an increased endothelial barrier
function. However, this did not abrogate the amount of organ injury.
The use of ddAVP should be further studied as an adjunctive therapy
in trauma hemorrhage.
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INTRODUCTION. Current treatment of trauma-induced coagulopathy
consists of large volumes of plasma and early administration of anti-
fibrinolytic and pro-coagulant medication. While half of trauma-
related deaths occur in the first hours post-injury due to bleeding,
the other half occurs during or after hospital admission(1). The devel-
opment of thromboembolic events is an important contributor to
morbidity and late mortality(2). Currently it is unknown whether the
changes in resuscitation strategies increases the risk of developing
thromboembolic complications.
OBJECTIVES. The aim of this systematic review is to identify risk
factors of current resuscitation strategies for the development of
thromboembolic complications.
METHODS. An electronic search was conducted in MEDLINE, PubMed
and Embase. Relevant studies were screened by two independent
reviewers and were included if they reported on thromboembolic
complications in patients with severe trauma (ISS≥16) who received
transfusion. Thromboembolic events was the primary outcome
measure, either diagnosed when patients showed clinical symptoms
or by routine screening using ultrasound or CT scan.
RESULTS. A total of 11.074 bleeding trauma patients were included,
in which a total of 1.145 thromboembolic events were reported
(incidence 10%). In studies performing routine screening for
thromboembolic complications, the incidence was 12 to 23%. The
risk of thromboembolic events in trauma patients was increased
after administration of tranexamic acid (OR 2.6, 95%CI 1.7-4.1, p<0.001) and after fibrinogen concentrate (OR 2.1, 95%CI 1.0-4.2, p=
0.04). Blood product ratio, the use of prothrombin complex
concentrate or the use of recombinant factor VIIa showed no
association with thromboembolic complications.
CONCLUSION. This systematic review of the literature identified an
incidence of thromboembolic events of 10% in severely injured
hemorrhaging trauma patients. The use of tranexamic acid and
fibrinogen concentrate showed an association with the development
of a thromboembolic complication. These results may beg the
question whether routine screening in these patient populations
should be implemented, in particular in patients treated with
tranexamic acid and/or fibrinogen concentrate.
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INTRODUCTION. Hypoxic hepatitis or “shock liver” is an acute liver
injury characterised by a massive and transient rise in serum
aminotransferases secondary to the anoxic necrosis of centrilobular
liver cells. It is frequently observed in the intensive care units varying
from 10-15%, however currently there is no study evaluating the
prognostic relevance of this entity in critically ill cirrhotics. We evalu-
ated the prevalence, predictors and outcome of hypoxic hepatitis in
a prospective cohort of cirrhotics admitted to a dedicated liver inten-
sive care.
METHODS. Consecutive patients with cirrhosis admitted to the liver
intensive care were screened for presence of hypoxic hepatitis.
Hypoxic hepatitis was defined as an increase in AST more than 5 fold
from the baseline in the absence of viral or drug induced liver injury
in an appropriate clinical setting of cardiac, respiratory or circulatory
failure.
RESULTS. Five hundred and fifty-three patients with mean age 44(±
12) years, 89% males with mean MELD 32 (±9) and SOFA score of 11
(±3.5) were evaluated. Alcohol was the predominant etiology in 310
(56%). Hypoxic hepatitis was seen in 119 (21%) patients. On multi-
variate logistic regression analysis it was significantly associated to
the MELD score (P,OR,95%CI) (<0.001,1.06,1.03-1.09), presence of hyp-
oxia (<0.001,3.77, 1.78-7.98), variceal bleed (<0.001,3.19,1.72-5.93)
and female gender (p<0.001,4.77,2.23-10.2). Patients with hypoxic
hepatitis had significantly higher worsening of serum bilirubin (p=
0.002), Lactate (p=0.04), MELD (p=0.014) and SOFA (p<0.001) scores
from baseline till day 15 as compared to patients without hypoxic
hepatitis. On multivariate analysis, using Cox-Proportional hazard
model, presence of hypoxic hepatitis (p<0.001, HR 2.06, 95%CI1.58-
2.6), hepatic encephalopathy (p=0.018,HR 1.36,95%CI1.05-1.74), high
MELD (≥32) (P<0.001, HR1.96, 95%CI1.52-2.52), Leucocyte
counts(≥16,000) (p=0.005, HR1.38,95%CI1.10-1.74), serum so-
dium(≥130) (p=0.03,HR1.27,95%CI 1.01-1.60) and serum lactate(≥2)
(p=0.003, HR1.42, 95%CI1.13-1.8) were independent predictors of
mortality.
CONCLUSION. Hypoxic hepatitis is frequently seen in critically ill
cirrhotics which correlates with the severity of liver disease.
Development of hypoxic hepatitis is associated with worsening liver
T2
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cirrhotics.
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INTRODUCTION. Bacterial infections and systemic inflammation(SIRS)
are the major precipitants of organ failure including acute kidney
injury (AKI) in critically ill(CIC) and predispose to increased
progression requiring dialysis. Timely identification of AKI is therefore
an unmet need. Biomarkers can help in differential diagnosis and
prediction of the trajectory of AKI course. We evaluated Cystatin
C(CysC) and urinary neutrophil-gelatinase-associated lipocalin (NGAL)
as biomarkers of glomerular and tubular injury respectively in pre-
dicting a progressive AKI requiring dialysis in CIC.
METHODS. CIC admitted to the Liver ICU were prospectively
followed up. Dialysis was done for standard indications.
RESULTS. A total of 688 CIC, mean age 48.4±11.5 years, 87% males
were followed until death or recovery. The median serum NGAL and
CysC was 1004(803-1386) ng/ml and 2.1(1.7-2.6) mg/l respectively.
SIRS was seen in 52% and sepsis in 60%. AKI at admission was
present in 82% (Stage 1:2:3 18%vs 38%vs 44%) of which 65(11%)
had progressive AKI requiring dialysis by day 7. On univariate
analysis, lower MAP, higher arterial lactate, presence of leucocytosis
and higher urine NGAL and serum CysC predicted requirement of
dialysis at day 7. However, on multivariate analysis (OR,95% CI), u-
NGAL (OR 6.3, 2.6-14.9), Cyst C (OR 6.4, 1.9-21.3) significantly pre-
dicted need of renal replacement therapy at day 7. The levels of
NGAL (HR 2.3, 1.7-3.1) and Cyst C( HR 5.1,3.5-7.5) could also predict
30-day mortality in CIC.
CONCLUSION. Almost 80% of CIC have AKI at presentation, which in
majority is a result of sepsis, is progressive and is associated with
worse outcome. u-NGAL and CysC can accurately predict progression
of AKI to dialysis and adverse outcomes which can help in stratifying
patients for early therapeutic intervention.
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INTRODUCTION. CT fat area at the level of the third lumbar vertebra
is a gold standard of fat mass measurement, because it correlates
very well with whole body fat mass. So far only abdominal but not
appendicular ultrasound fat thickness has been validated to CT fat
area (1). Moreover a large-scale study comparing US fat thickness to
CT fat area in patients does not exist so far.
OBJECTIVES. The objective of the study was to validate appendicular
ultrasound fat thickness in comparison to subcutaneous and visceral
CT area in non-ICU patients.
METHODS. 119 non critically ill patients were recruited after routine
abdominal CT scanning. Ultrasound fat thickness was measured at 2
measuring points on each upper arm and 3 measuring points on
each thigh. Mean of upper arm fat thickness and mean of thigh fat
thickness was calculated. Limb length was measured. Minimal
compression was applied during ultrasound measurement. Theultrasound fat thickness was compared to CT L3 subcutaneous and
visceral fat area by regression model. The covariables thigh fat
thickness, upper arm fat thickness, thigh length, upper arm length,
height, weight, age and sex were taken into account in multivariable
regression models. Only statistically significant covariables were
retained in the final model.
RESULTS. 79 men and 40 women were recruited. Median (IQR) age
was 61 (47-69) years. Mean upper arm fat thickness better predicted
CT L3 subcutaneous fat area (r2=0,69) than mean thigh fat thickness
did (r2=0,54). In a multivariable regression model for prediction of CT
L3 subcutaneous fat area only upper arm fat thickness and weight
remained statistically significant (r2=0,73) (see Table 1). For
prediction of CT L3 visceral fat area only age and weight were
statistically significant covariables (r2=0,57).
CONCLUSION. Upper arm fat thickness but not thigh fat thickness
correlated with subcutaneous L3 fat area in a multivariable model.
Neither upper arm fat thickness nor thigh fat thickness correlated
with visceral L3 fat area. Therefore upper arm fat thickness may be
used as a surrogate for subcutaneous L3 fat mass but not for visceral
L3 fat mass.
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INTRODUCTION. Intravenous administration of fructose leads to
increased lactate levels [1]. Oral co-ingestion of fructose together
with glucose during sustained exercise has been associated with
both a better performance and higher lactate levels as part of the so
called “reverse Cori cycle” [2,3].
OBJECTIVES. We examined whether a pre-operative drink containing
fructose might affect intra-operative lactate levels.
METHODS. As part of the VAPOR-1 trial, renal transplant donors re-
ceived 800ml of Preop® (Nutricia) orally the night before and 400ml
at least 2h before surgery. This latter volume contained 0.8 g glucose,
5.2 g fructose, 2.4 g maltose and 40 g of polysaccharides. The trans-
plant recipients did not receive Preop®. Mean ±SD lactate levels (ref-
erence value <1.5 mmol/L; <14 mg/dL) from preoperative arterial
blood gas measurements were compared between renal transplant
donors and recipients at four subsequent intra-operative time points
(T1 through T4). Patients were carefully monitored for complications
that might lead to increased lactate levels.
RESULTS. Significantly elevated lactate levels were found in the
donor (Preop®) group compared to both the reference range (T1: 1.8
±0.8 mmol/L, P<0.005), (T2: 2.2 ±0.7 mmol/L,P<0.0001) and also to
Page 562 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55the recipients values at T1: 1.1 ±0.5 mmol/L (P<0.0001) and T2: 1.6 ±
0.8 mmol/L, (P<0.0001). Lactate levels normalized and were similar
for the two groups at T3 (1.6 ±0.5 mmol/L) and T4 (1.5 ±0.5 mmol/L).
CONCLUSION. The early mild intra-operative lactate increase ob-
served in the donor group may be related to the preoperative carbo-
hydrate drink. This lactate may originate from hepatic conversion of
fructose to lactate as part of the reverse Cori cycle [3]. If analogous
to exercise physiology, this hepatogenic lactate may actually be a
useful fuel for stressed tissues and should thus not be considered an
adverse but a benign effect. Planned trials where oral preoperative
feeding is randomized, can verify this phenomenon.
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INTRODUCTION. Secondary acute liver failure, also known as hypoxic
liver injury (HLI) or shock liver, is the most frequent cause of liver
failure in hospital. Up to ten percent of critically ill patients develop
HLI during their stay at the intensive care unit and have dramatically
increased mortality rates. The only established procedures in these
patients are symptomatic therapy and treatment of the underlying
disease. Liver transplantation is no therapeutic option. Albumin
dialysis by molecular adsorbent recirculating system (MARS®) can be
used in patients with acute liver failure as symptomatic therapy for
bridging to regeneration or liver transplantation.
OBJECTIVES. The aim of this study is to investigate the clinical
impact of MARS® therapy in critically ill patients with HLI.
METHODS. We performed a binational randomized controlled study
in two tertiary care centers (Medical University Vienna, Austria and
University Medical Center Hamburg-Eppendorf, Germany). Forty pa-
tients with severy hypoxic liver injury (defined as aminotransferase
levels 40 times upper the limit of normal) were included in this study
and randomized to early initiation of MARS therapy (MARS, 4 ses-
sions) (n=20) or standard therapy (SMT) (n=20). One individual in the
SMT group was not included in the subsequent analyses due to
transfer to another hospital immediately after randomisation without
receiving any study related treatment.
Primary end point was the difference of the indocyanine plasma
disappearance rate (ICG-PDR) at day 7. ICD-PDR is an independent
predictor of mortality and represents liver function idependently of
established liver function parameters in patients with HLI. (1) Second-
ary end points included among others mortality, days free of vaso-
pressors and mechanical ventilation within the first 28 days after
randomisation.
RESULTS. There were no significant differences in the MARS and SMT
group at baseline.Patients in the MARS group had significantly higher median ICG-PDR
at day 7 compared to SMT (17.75%/min, IQR 5.8-9.8 versus 6.3%/min,
IQR 4-11.9, p < 0.05).
We observed a non-significant higher 90-day mortality rate in the
SMT group (63%) compared to the MARS-group (40%). Median days
free of vasopressors within the first 28 days after randomisation were
significantly higher in the MARS group (24 days) compared to SMT,
median days free of mechanical ventilation within the first 28 days
after randomisation did not differ significantly in the MARS group
(20.5 days) compared to SMT.
CONCLUSION. Early initiation of albumin dialysis using the MARS-
system lead to significant improvement of the liver function repre-
sented by ICD-PDR in critically ill patients with severe HLI.
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INTRODUCTION. Indirect calorimetry is a reliable method for
assessing resting energy expenditure (REE) in mechanically ventilated
patients. The Deltatrac Metabolic Monitor (Datex-Ohmeda, Helsinki,
Finland) has been considered the gold standard in the ICU setting,
using a mixing chamber technology. The Beacon Caresystem
(Mermaid Care, Nørresundby, Denmark) is a modern device allowing
calorimetry with breath-by-breath analysis; however, it needs to be
validated against the reference device.
OBJECTIVES. To determine the level of agreement between Beacon
Caresystem and Deltatrac II for gas exchange and REE in
mechanically ventilated ICU patients.
METHODS. Mechanically ventilated adult patients admitted to the
ICU of a university hospital during June to October 2018 were screened
for recruitment. Patients with respiratory rates >35, an air leak in the
ventilator circuit of >10% of minute volume or requiring FiO2 ≥ 0.6
were excluded. Repeated measurements were allowed in the same
patient on different days. Measurements of oxygen consumption (VO2)
and carbon dioxide production (VCO2) with both devices were
performed concurrently for at least 20 minutes. REE was calculated
with the modified Weir equation using average values of VO2 and
VCO2 for each measurement. Bland-Altman plots were used to depict
bias and limits of agreement (bias ± 2 standard deviations).
RESULTS. 60 measurements were performed. 11 measurements were
excluded (n=9 RQ <0.6 from Deltatrac, n=1 lack of informed consent,
n=1 missing VO2 values from Beacon), with 49 valid measurements
in 18 patients analyzed. Patients had a mean age of 54±17 and body
mass index of 28±6 kg/m2. Mean VO2 between Beacon and
Deltatrac was not different (289±90 vs 280±87 ml/min, p=0.068),
while there were differences in terms of mean VCO2, RQ and REE
(265±83 vs 201±62 ml/min; 0.92±0.06 vs 0.72±0.08;2063±643 vs
1909±586 kcal/day, respectively, p <0.001 for all). Compared to
Deltatrac, Beacon had a bias for VO2 of +9 ml/min with limits of
agreement (LoA) of ±68 ml/min and a percentage error (PE) of ±24%,
whereas bias and LoA for VCO2 were +64 ml/min and ±58 ml/min
(PE±25%). For REE there was a bias of +154 kcal/day (about 7% of
REE measured by Beacon) with LoA of ±433 kcal/day (PE±22%).
Linear regression did not show a proportional bias for VO2 and REE
(R2=0.01 and 0.07; p=0.45 and 0.06, respectively).
Page 563 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55CONCLUSION. In this validation study of Beacon Caresystem
compared to Deltatrac, we found a good agreement between mean
VO2 of both instruments. Despite a significant bias for VCO2, REE
measured by Beacon was overestimated by only 7%, with similar
limits of agreement compared to published data from other breath-
by-breath devices in relation to Deltatrac [1].
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INTRODUCTION. Stress-induced hyperglycemia is a common feature
of intensive care unit (ICU) patients. Hyperglycemia and
hypoglycemia have been highlighted as independent predictors of
ICU and hospital mortality. Recent ICU recommendations suggest
using insulin infusion protocols that can minimize glucose variability
and reduce hypoglycemic risk.
OBJECTIVES. Our aim was to assess the efficacy, safety, and
acceptance by nurses of a paper-based dynamic insulin protocol.
METHODS. This was a prospective study 7-month period, which in-
cluded all adult patients admitted in the intensive/intermediate care
unit of a private Hospital of Lisbon. Patients with diabetic ketoacido-
sis and hyperglycemic hyperosmolar state were excluded. Patients
were divided in 2 groups: A, non-critical ill patients and B, critical ill
patients. Critical ill patients were classified if they had one or more
organ dysfunction, if they were submitted to cardiac surgery or to a
major postoperative surgery. In A group, subcutaneous insulin proto-
col was applied. In B group protocol insulin was administrated ac-
cording to modified Yale protocol. The target glucose level was
between 140-180 mg/dl.
RESULTS. We included 999 patients, 75 (7,5 %) in B group and 924
(92,5%) in A group. In B group: 35 patients needed insulin perfusion;
the mean time to achieve the target was 3,81 h; 9 patients needed
more than 4 hours to achieve the target glucose level and only 1
episode of hypoglycemia was registered. In A protocol no
hypoglycemia were observed; 3 patients transited to B protocol due
to failure to glycemic control or presence of a critical event.
CONCLUSION. Our insulin protocols demonstrated to be very safe.
Individualized protocols in Intensive/intermediate care units should
be individualized according to patients severity. The great majority of
our patients achieved the target glucose level in less than four hours,
minimizing the potential risks of hyperglycemia.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):001616INTRODUCTION. Disturbances of the endocrine function are a
frequent finding in critically ill patients. Among thyroid hormone
system, the downregulated of the thyroid function may be an
adaptative response to conserve energy. However, this condition can
limit response to additional stress factors such as a onset of
circulatory shock. In later stage, this adaptive response may result in
the condition known as euthyroid sick syndrome. In the early stages,
there is commonly observed a drop of the peripheral conversion of
thyroxine (T4) to triiodothyronine (T3) with a consequent increase in
reverse triiodothyronine level (rT3).
OBJECTIVES. To evaluate the association of increased level of rT3
and mortality in clinical critical ill patients.
METHODS. This was a retrospective analysis of observational data
prospectively collected during a 7-month period (2018) in a mixed
medical/surgical adult ICU in a tertiary hospital in Brasilia, Federal
District, Brazil. All consecutive clinical patients, older than 18 years,
admitted to the ICU were included. Free T4 (fT4), total T4 (tT4),
thyroid-stimulating homone (TSH), free T3 (fT3) and rT3 was collected
in the first 48 hours after admission. Patients with a prior diagnosis
of hyperthyroidism or hypothyroidism and surgical patients were ex-
cluded. According to rT3 levels, patients were divided into 2 groups:
increased rT3 group and non-increased rT3 group.
RESULTS. During the study period, 304 patients were included. Age
was 68.3±18.2 years, APACHE II score 16.9±8.1, SOFA 3.2±2.9, and
ICU mortality was 17.1% (n=52). Increased rT3 level was observed in
216 patients (71.1%). Patients with incresead rT3 level had higher
mortality (19.9% vs 10.2%, p=0.042). Non-survivors patients also had
higher age (75.2±16.3 years versus 66.5±19.4 years, p=0.001), APA-
CHE II (23.5±7.5 versus 15.3±7.4, p<0.001), and SOFA (5.7±3.0 versus
2.6±2.5, p<0.001). In the multivariate analysis, increased rT3 (p=
0.039), APACHE II (p=0.024), and SOFA (p=0.041) were independently
associated with ICU mortality.
CONCLUSION. Increased rT3 was independently associated with ICU
mortality. Determination of reverse T3 levels may be a valuable aid
to improve identification of clinical critical ill patients with higher risk
of mortality.
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INTRODUCTION. Sepsis, owing to its wide spectrum of
pathophysiological mechanisms but limited treatment options, is a
condition too difficult to manage and is the most important causes
of increased mortality among critical patients admitted to intensive
care units (ICUs). It is still hypothetical that vitamin D, with its
immunomodulator function along with many other functions, has a
therapeutic effect in sepsis when supplemented in critical patients.
Fig. 1 (abstract 000471). See text for description
Page 564 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55OBJECTIVES. We aimed to determine if cholecalciferol treatment,
when enterally administered in two different doses, had any
relationship with infectious agent, sepsis, and mortality among
critical patients diagnosed with vitamin D deficiency at the time of
ICU admission.
METHODS. This study included all patients older than 18 years of
age not meeting the exclusion criteria, who were admitted to and
expected to stay for more than 24 hours at a tertiary, mixed type, 20-
bed ICU for a period of 1 year between 2016 and 2017. Based on
vitamin D level checked in the first 24 hours of admission, the pa-
tients were grouped into four groups as those with a normal vitamin
D level; those with a low vitamin D level but not receiving therapy;
those with a low vitamin D level receiving a single 300.000 IU bolus
dose enteral cholecalciferol; and those with a low vitamin D level
and receiving a bolus dose of 300.000 IU flowed by 2000 IU daily
maintenance dose of cholecalciferol. Demographic data; APACHE-II,
SOFA, and GCS scores as predictors of clinical prognosis; diagnoses
of sepsis, septic shock, and MODs at the time of admission and dur-
ing follow-up; the highest among SOFA scores daily calculated dur-
ing follow-up; duration of ICU and hospital stay; clinical outcomes;
infectious markers; liver and kidney function tests and parathormone
(PTH) levels were analyzed and compared across the groups.
RESULTS. The study included a total of 210 patients of whom 185
had vitamin D deficiency (61.08% with severe deficiency, 24.32%
with deficiency, and 14.59 with insufficiency). Patients with vitamin D
deficiency had a significantly higher rate of sepsis (p < 0.05). The
group with severe vitamin D deficiency had significantly higher rates
of sepsis, septic shock, MODs compared to those with a normal
vitamin D level (p < 0.05). The patients with higher PTH levels had
significantly greater age, BMI, rate of immobility, and rate of tight
dressing compared to those with a normal level (p < 0.05). Moreover,
as compared to those with a normal PTH level, patients with a
higher PTH level had a significantly higher admission APACHE-II and
SOFA scores; higher rates of sepsis, septic shock, and MODs at admis-
sion; higher rates of sepsis, septic shock, and MODs during follow-up;
higher rates of acute renal failure (ARF) and mortality (p <0.05). How-
ever, vitamin D levels of both groups were similar (p=0,691). The
group that did not receive vitamin D supplementation had a higher
rate of MODs at admission (p <0.05). Nevertheless, the groups with-
out vitamin D supplementation had a significantly higher rates of
sepsis, septic shock, MODs, ARF, and mortality than the group that
received vitamin D supplementation. The rates of sepsis, septic
shock, or MODs were higher, albeit statistically non-significant, in the
group that received a single dose of cholecalciferol compared to
those receiving a maintenance dose.
CONCLUSION. This study showed that critical patients with vitamin D
deficiency and PTH elevation with and without vitamin D deficiency
were prone to sepsis, septic shock, and MODs development. PTH
elevation was also shown to increase mortality by exacerbating the
severity and course of critical illness. Even though serum vitamin D
levels similarly rose, patients put on maintenance therapy with
cholecalciferol, as compared to those that were administered a single
dose of the same drug, developed less sepsis, septic shock, and
MODs and hence maintenance therapy was deemed superior to
single dose treatment.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):001732INTRODUCTION. Vitamin D, beside its involvement in bone and
electrolyte metabolism homeostasis, has pleiotropic effects, including
immunomodulatory, cardiovascular, and muscular effects. Low
vitamin D blood levels are associated with high morbidity and
mortality in critically ill patients. However, there is controversy about
vitamin D supplementation in this population.
OBJECTIVES. The objective of this systematic review and meta-
analysis was to evaluate if vitamin D administration reduces mortality
in critically ill patients.
METHODS. PubMed, Embase, and the Cochrane Library were
searched up to April 1st, 2019 for randomized placebo-
controlled trials on the use of vitamin D in adult patients with
critical illness in comparison to placebo. The primary endpoint
was mortality at longest follow-up available. We performed a
random-effects meta-analysis with results expressed as risk ratio
(RR) and 95% confidence interval (CI). Cochrane methodology
was employed [1].
RESULTS. Ten studies published between 2011 and 2019, for a total
of 926 patients, were included in the present meta-analysis. Nine tri-
als administered enteral or intramuscular vitamin D3, also known as
cholecalciferol, while 1 trial administered intravenous calcitriol. Vita-
min D administration was associated with a significantly lower mor-
tality compared to placebo (119/474 [25%] in the Vitamin D group
versus 143/452 [32%] in the placebo group, RR = 0.80 [95% CI, 0.66
to 0.97], p = 0.03, I2 = 0%) (Figure 1).
At subgroup analysis according to clinical setting, the positive effects
were mostly evident in a subgroup of trials including a
heterogeneous mixed intensive care unit population (Figure 1). The
risk of mortality was similar in vitamin D-deficient patients random-
ized to receive vitamin D supplementation (3 trials and 551 patients,
RR = 0.64 [95% CI, 0.37 to 1.11]) or in trials enrolling patients with
low or normal vitamin D levels (RR = 0.78 [95% CI, 0.39 to 1.57]). Trial
sequential analysis was inconclusive for a relative risk reduction in
mortality of 15% (RR = 0.80 [adjusted 95% CI, 0.54 to 1.17]), since
only 32.61% of the information size was accrued and no firm conclu-
sions on benefit, harm, or futility of vitamin D could be supported at
the current stage.
CONCLUSION. In critically ill patients, vitamin D administration may
be associated with a reduction in mortality. However, the quantity of
evidence is still insufficient to draw a firm conclusion. Large
multicenter randomized trials are warranted before systematic
implementation of this therapy in clinical practice.
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INTRODUCTION. Parenteral Nutrition (PN) is an alternative route to
feed the critical patient, completely or partially, when the digestive
tract can not be used for any reason.
PN monitoring has been established by the Spanish Society of
Intensive Medicine and Coronary Care Unit (SEMICYUC) as a clinical
quality indicator for intensive care units (ICU).
OBJECTIVES.
To evaluate the fulfillment of the Clinical Indicator: “adequate use of
parenteral nutrition in an Intensive Medicine Service”.
METHODS. Our investigation is a retrospective descriptive study.
Data were collected from every patient admitted to our intensive
care unit who received artificial nutrition (Enteral or Parenteral
Nutrition) in the last four months. The variables collected were age,
sex, PN indication and number of days from admission until PN was
prescribed. The quality indicator was evaluated using SEMICYUC
criteria: number of patients with indication of PN \ total number of
patients needing artificial nutrition x 100 (standard = 16% with PN,
and 25% with complementary PN). To assess whether the indication
of PN is correct or not, we followed the criteria included in the guide
of quality indicators in critical patient of SEMICYUC 2017.
RESULTS. During the study period 75 patients were analyzed. 66.6%
were men, the mean age was 64.77 years and the average number
of days from admission to the prescription of NP was 5.3 days. Only
24 were indicated to receive PN, 8 with complementary parenteral
nutrition (CPN) and only 2 patients received PN without indication. 6
patients received PN as they were not expected to be fed in 5-7 days
by oral or enteral route, 4 had intestinal insufficiency, 1 mesenteric is-
chemia and 5 intestinal obstruction. Using the formula described, the
proportion of patients with NP indication was 32% and 10.6% with
CPN.
CONCLUSION. The quality standard of this indicator is not reached.
The exclusive administration of EN is impossible in certain scenarios
like gastrointestinal dysfunction associated with the critical process.
Depending on the clinical diagnosis at admission, the value of this
standard will fluctuate, but monitoring this indicator is important to
assess both, under and overprescription.
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INTRODUCTION. Parenteral nutrition (PN) is indicated when it is
impossible or insufficient to cover the estimated energy
requirements and substrates by enteral route but PN can be
accompanied by a number of complications.
OBJECTIVES. The Aim of work is to determine the safety of PN in
patients with severe combined traumatic brain injury (SCMT).
METHODS. 20 pts enrolled in the study in all patients started the EN
from the 2nd day after the injury. From 8.8 ± 1.3 days after
admission, PN is added. The average duration of a PN is 3-7 days. For
PN - three-component blend Nutriflex Lipid 70/180 (B. Braun,
Germany), volume 625 ml (amino acids 35.9 g, carbohydrates 90 g,fats 25 g, total nitrogen 5 g, total energy value 740 kcal). Mixture was
infused during 12 hours (52 ml / hour). The concentration of triglyc-
erides (TG) and glucose level in venous blood was determined and
(PaO2 / FiO2) in arterial blood, were investigated according to the
following scheme:
• Prior to the start of infusion of PN (11: 30-12: 00)
• 2 hours after the start of PN infusion (14:00)
• Immediately after the end of the infusion of PN (24:00)
• 6 hours after the end of the infusion of PN (06:00)
RESULTS. The introduction of PN was accompanied by the
development of hyperglycemia and a slight increase in the
concentration of TG. Glucose level increase was noted after 2 hours
and 12 hours after the start of PN, 6 hours after the end of infusion
the glucose concentration tended to decrease. An increase in TG 2
hours after the start of the infusion did not affect the pulmonary gas
exchange.
The glucose concentration before the introduction of PN was 7.8 ±
1.9 mmol / l (n = 90), two hours after the start of the PN 9.6 ± 2.8
mmol / l (n = 90) (p <0.05 ), immediately after the end of the
administration of PN 10.2 ± 3.9 mmol / l (n = 90) (p <0.05), six hours
after the end of the administration of PN 8.9 ± 3 mmol / l (n = 90) (p
<0.05). The concentration of TG before the introduction of PN was
1.48 ± 0.64 mmol / l (reference values <1.71 mmol / l) PaO2 / FiO2
333 ± 81 (n = 90), two hours after the start of PN TG 1.67 ± 0.9
mmol / l, PaO2 / FiO2 363 ± 72 (n = 90), immediately after the
introduction of PN TG 1.53 ± 0.82 mmol / l, PaO2 / FiO2 357 ± 63 (n
= 90), after the end of the introduction of PN TG 1.51 ± 0.8 mmol / l,
PaO2 / FiO2 352 ± 64 (n = 90).
CONCLUSION. Introduction of parenteral nutrition as part of mixed
artificial nutrition in patients with severe combined traumatic brain
injury is not accompanied by hypertriglyceridemia and pulmonary
dysfunction, but lead to slight glucose plasma level increase.
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INTRODUCTION. Instability of daily body temperature rhythm is
known to correlate with worse prognosis. Yet, the management of
body temperature rhythm in critically ill patients remains elusive and
is still left up to facilities. We aimed to assess whether body
temperature variation beyond expected with circadian rhythm affect
intensive care unit (ICU) mortality by machine learning. We also
hypothesized if other physiological variables affect ICU mortality.
METHODS. We extracted 15,365 from 61,132 patients in the single
center ICU database, MIMIC-III®, whose average Oxford Acute Severity
of Illness Score (OASIS) was 37 points. They had at least two mea-
surements of body temperature in a day and were compared the dif-
ference of body temperature between morning and afternoon for 28
days survival (OASIS=36) vs. non-survival (OASIS=40) patients in ICU.
Page 566 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55Using a machine learning approach, we created a predictive linear
regression model to investigate the effect of physiological variables
of all extracted patients in the same database against ICU mortality.
RESULTS. Variations of nycterohemeral body temperature change in
ICU were distinct between survival and non-survival groups (adjusted
P=0.03). Hyperthermia (standardized weight (SW)=0.138),
hypothermia (SW=0.514), and the chronological phase shift of body
temperature circadian rhythm (SW=0.499) worsened ICU mortality.
CONCLUSION. Our study shows that permissive body temperature
management for ICU patients is harmful by itself. Not only
magnitudal but chronological deviation of body temperature directly
increases ICU mortality. Further studies utilizing multicenter data are
needed to evaluate this effect.
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INTRODUCTION. Decision-making in the ICU is largely based on doc-
tors’ experience and intuition, due to a lack of patient-reported out-
come information regarding long-term physical and mental
functioning. Moreover, patients and relatives are often not involved
in the decision-making process, which can lead to a decline in pa-
tient satisfaction and lower patient quality of life (QoL).
OBJECTIVES. To develop a prediction model for QoL one year after
ICU admission.
METHODS. Adult patients admitted ≥12 hours to a university
hospital ICU between July 2016 and December 2017 were included
(MONITOR-IC study, clinicaltrials.gov NCT03246334). Moribund
patients were excluded. Patients (or relatives) rated their QoL before
and one year after ICU admission by completing the Short-Form (SF)
36, that consists of the following outcome domains: physical func-
tioning, role limitations due to either physical or emotional problems,
social functioning, pain, vitality, mental health, general health and
change in health (ranging 0-100; higher scores indicate better func-
tioning or health). Demographic and medical data were extracted
from the patients’ electronic health record (EHR). Multivariate linear
regression analysis was utilized using a subset of selected variables
based on expert opinion as predictors.
RESULTS. Modelling with candidate predictors in 2603 ICU patients
showed that if there was an association, higher age, female gender,
medical admission, emergency surgery, lowest haemoglobin level,
APACHE-IV, COPD and immunodeficiency were generally negatively
associated with the QoL domains, whereas QoL at baseline was posi-
tively associated with the domains. The explained variance of the
prediction model was 0.17. Women scored worse for nearly all SF-36
domains, most notably physical functioning and role limitations due
to physical problems (β= -10.24, p<.01 and β= -9.65, p<.01, respect-
ively). Especially medical admission (compared to planned admission)
was strongly negatively associated with these two domains as well
(β= -10.38, p<.01 and β= -12.21, p<.01, respectively). None of the
predictors except QoL at baseline (β= 0.13, p<.01) were associated
with mental health.
CONCLUSION. From a subset of predictors, gender and admission
type emerged as strong predictors for various SF-36 domains one
year after ICU admission. The explained variance of this preliminary
model needs to be improved. The final prediction model can be usedbefore or during admission to facilitate healthcare professionals, pa-
tients and their relatives in the shared decision-making process, by
providing them information regarding prognosis and by manage-
ment of health expectations, thereby possibly enhancing long-term
patient care satisfaction and QoL.
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INTRODUCTION. Prediction analytics using machine learning and big
data generated by the electronic health records and patients'
monitoring have recently gained a lot of traction, especially in critical
care. However, most algorithms are trained and evaluated at the
population level, meaning that good overall performance may not
translate into accurate individual predictions. We argue that online
machine learning algorithms that can leverage time-series obtained
from individual patients may generate better personalized
predictions.
OBJECTIVES. The goal was to use innovative machine approaches to
predict acute hypotensive episodes, defined as a mean arterial
pressure (MAP) < 65 mmHg for more than 5 minutes.
METHODS. We used the data from the MIMIC II, a publicly and freely
available database associating medico-administrative data, physio-
logic measurements and treatment administration prospectively and
consecutively collected at the bedside over a seven-year period
(2001-2008) from any of the five ICUs of Boston’s Beth Israel Deacon-
ess Medical Center (BIDMC).1 Our methodology extends the super-
vised ensemble machine learning algorithm called the SuperLearner,
allowing for online, fast prediction tailored for each subject.2 In par-
ticular, we develop an online Super-Learner for a collection of unit-
specific time-series that leverages information learned from the
population of time-series, stratified population of time-series taking
into account their baseline covariates as well as treatment, and indi-
vidually trained single-unit fits. As such, we are able to utilize the
wealth of subject trajectories in order to learn global patterns in data,
while tailoring the prediction for the single-unit of interest. We dem-
onstrate the benefits of using the Online Super-Learner for a collec-
tion of unit-specific time-series, and clear advantages over
population-based on one-sample prediction settings in a clinical set-
ting using MIMIC II data.
RESULTS. 200 patients were included in this pilot study, with 50
samples having at least one hypotensive episode. The performance
of the Combined Online SuperLearner to predict acute hypotension
are illustrated in figure 1. The area under the receiver operating
curve for the Combined Online SuperLearner was 98%.
CONCLUSION. Most algorithms are trained and evaluated at the
population level, while the clinicians are interested in taking accurate
clinical decisions at the individual levels. We show for the first time
that online machine learning algorithms that have the ability to
leverage the information encompassed in individual time-series may
be extremely useful in predicting short-term outcomes such as acute
hypotension episodes in critically ill patients.
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Right Data, Right Now - Robust external validation of a deep
reinforcement learning model to optimize hemodynamic
treatment of critically ill patients with sepsis
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INTRODUCTION. Sepsis is defined as life-threatening organ dysfunc-
tion caused by a dysregulated host response to infection [1]. Sepsis
leads to haemodynamic changes, low blood pressure and insufficient
tissue oxygenation. To determine whether a patient has received 'ad-
equate fluid resuscitation' or needs vasopressor therapy, no criteria
can be explicitly specified. Furthermore, it is recommended to
individualize the target blood pressure during shock resuscitation [2].
Truly, there is a need for a more personalised treatment protocol.
In 2017, Raghu et al. developed a deep reinforcement learning
algorithm to determine optimal treatment policies for septic patients
by using a continuous state space reinforcement learning model [3].
Their model was developed on data 24hours prior to 48hours after
the onset of sepsis. They found that their model could reduce
patient mortality in the hospital. To the best of our knowledge, no
external validation of this model design has been performed.
OBJECTIVES. To perform a clinical external validation of
reinforcement learning models for the haemodynamic treatment of
sepsis. The goal is to evaluate whether a reinforcement learning
model could improve sepsis treatment if incorporated in an intensive
care clinical workflow.
METHODS. We perform a quantitative and qualitative analysis of
reinforcement learning for sepsis treatment. Due to data limitations,
we redeveloped a double deep duelling Q-learning model on the US
based on Raghu’s design on the MIMIC dataset. We applied the
model to a new Dutch dataset of over 4000 critically ill patients
treated in the ICU between 2003 and 2016. We perform robust exter-
nal validation by assessing model performance and transferability
under clinically applicable inclusion criteria on two time periods with
different data granularity. Furthermore, we develop a sparse model
based on physiological parameters only to investigate the import-
ance of severity scores in relation to transferability. We quantify the
performance using the weighted doubly robust (WDR) estimator and
the weighted importance sampling (WIS) methods.RESULTS. Physician performance on the MIMIC dataset was 9.2
(WDR) and 7.8 (WDR) on the Dutch dataset consistent with the
higher observed mortality in the Dutch dataset. Further results of the
model performance are pending.
CONCLUSION. Reinforcement learning based model performance
varies across different patient populations. It is possible to develop a
model based on sparse physiological parameters only. It is vital to
evaluate model performance under clinical settings that simulate
how a model would be incorporated into a clinical workflow. Model
performance should be robust against conceptual drift; differences in
data granularity, treatment plans and patient populations. More
research is needed to evaluate model performance before such
models can be applied in a clinical setting and potentially help
reduce ICU mortality.
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INTRODUCTION. Delayed Cerebral Ischemia (DCI), manifests in
approximately 30% of patients with Aneurismal subarachnoid
hemorrhage (aSAH), and is one of the most important causes of
morbidity (1). Several clinical and radiological scales have been
proposed to predict DCI. We hypothesized that easy-to use clinical
scales, such as Hunt and Hess (HH), World Federation of Neurosurgi-
cal Societies (WFNS), Glasgow Coma Scale (GCS), Fisher Scale and the
recently proposed VASOGRADE scale may be associated with DCI de-
velopment (2,3).
OBJECTIVES. To analyze if higher values in the above mentioned
clinical scales may be associated with DCI development in patients
with aSAH.
METHODS. Single-centre observational prospective cohort study in-
cluding adult (+18 years) patients with aSAH diagnosis who were ad-
mitted to a tertiary ICU between June 1st 2017 and April 1st 2019.
Patients with do-not-intubate order were excluded. DCI was defined
as the occurrence of focal neurological impairment or a decrease of
≥ 2 points on the GCS for at least 1 hour (4). Cerebral ischemia was
defined as hypodensities on CT or MR imaging. Vasospasm is defined
as a radiological finding, either CT angiography, MR angiography, or
digital subtraction angiography. GCS, HH, WFNS, Fisher and VASO-
GRADE were assessed at ICU admission. Quantitative variables are
presented as mean (95%CI) and categorical as frequency (percent-
age). Differences between DCI and non-DCI patients were assessed
using Chi square or Fisher's exact test, as appropriate.
RESULTS. Sixty-six patients were included, with a mean age of
58.77(55.56-31.98) years, 49(74.2%) were female. Mean SOFA at ICU
Page 568 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55admission was 3.36(2.52-4.21) and APACHE-II score was 18.26(16.30-
20.21). Twenty-one(31.8%) aneurisms were located at anterior com-
municating artery, 17(25.8%) at posterior communicating artery and
12(18.2%) at middle cerebral artery. Twenty-three (34.8%) patients de-
veloped DCI. Nine(39.1%) of them showed radiological signs of cere-
bral ischemia, and 10(43.5%) had radiologic signs of vasospasm.
Mean GCS and GOS at ICU discharge of all patients were 13.60(13.06-
14.11) and 3.39(2.99-3.78) respectively. The scales: GCS≤8 [5(22.7%)
vs. 18(41.9%);p=0.173], WFNS≥4 [6(24.0%) vs 17(42.5%); p=0.18)],
HH≥4 [5(21.7%) vs 18(42.9%);p=0.11], Fisher=4 [18(36.7%)vs
5(31.3%);p=0.77] and Vasograde=3 [4(20%)vs19(42.2%);p=0.10] were
not associated with a higher incidence of DCI.
CONCLUSION. worse values of clinical-radiological scales were not
statistically associated with DCI development in patients with aSAH,
probably by the small sample size. However, more studies are re-
quired to identify predictors of DCI in patients with aSAH.
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INTRODUCTION. Patients with acute stroke may develop venous
thromboembolism (VTE) during their hospitalization. The incidence
of clinically evident deep vein thrombosis (DVT) and pulmonary
embolism (PE) is 1-5% and 1% respectively. When stroke patients are
routinely assessed using imaging techniques VTE incidence rises to
40%. Patients admitted in Intensive Care Unit (ICU) have high VTE
risk and the incidence of DVT and PE in the general ICU population
is 5.4%-23.6% and 7-27% respectively. Although ICU stroke patients
have prolonged immobilization, undergo interventions that increase
their VTE risk (i.e. central venous catherization (CVC), surgical opera-
tions etc.) and have high mortality, their incidence of clinically evi-
dent thromboembolism is not well known.
OBJECTIVES. Our objective was to identify the incidence of clinically
evident VTE in our ICU stroke population and to assess whether the
outcome of these patients differed from non VTE stroke patients.
METHODS. We retrospectively identified all stroke patients admitted
in our academic ICU over a three-year period (2016-2018) and inves-
tigated which of them developed clinically suspected VTE confirmed
by imaging techniques during their ICU stay. It must be emphasized
that not all patients underwent a diagnostic test for VTE but only
those with a clinical suspicion of a possible VTE. A descriptive statis-
tical analysis followed comparing survival, disability and length of
ICU hospitalization between VTE- and non VTE- ICU stroke patients.
RESULTS. Seventy-five patients, 47 (62.7%) men and 28 (37.3%)
women, mean-aged 66.5±12 years with stroke were admitted in our
ICU over a three-year period. Thirty-six (48%) patients had an ische-
mic stroke and 39 (52%) a hemorrhagic stroke. Eleven out of 75
(14.6%) patients (4 ischemic/7 hemorrhagic stroke) developed clinic-
ally evident VTE (5 DVT and 6 PE cases). All DVT cases were related
to a central venous catheter placement. There was no difference in
age or gender among VTE and non-VTE group. Stroke patients with a
VTE episode had higher mortality (45% vs 36%), longer ICU
hospitalization (30.7 days vs 16.9 days), required more often a trache-
ostomy (72% vs 50%) and had more severe disability on discharge
(modified Rankin scale 4.2 vs 3.7). Adverse events related to anticoa-
gulation were noted in 3/11 stroke VTE patients (2 patients devel-
oped subcutaneous hematoma requiring blood transfusion and a
patient suffered hemorrhagic transformation of his ischemic stroke.CONCLUSION. Clinically evident thromboembolism is more common
in ICU stroke patients than in the general stroke population. Patients
suffering a thromboembolic event have a longer ICU hospitalization,
higher mortality and more disability than non-VTE stroke patients
and maybe these patients should be routinely assessed for VTE using
imaging techniques. Larger multicenter studies are required to con-
firm the above findings.
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INTRODUCTION. The main causes of an ischemic stroke are
embolism or vascular atherosclerosis. Stroke can also occur because
of inflammatory, infectious, congenital, vasospastic and other non-
atherosclerotic vascular causes. This heterogeneous group of disor-
ders is called non-atherosclerotic vasculopathies and its true inci-
dence and outcome in an Intensive Care Unit (ICU) setting is
unknown.
OBJECTIVES. The purpose of this study was to identify the patients
with a non-atherosclerotic vasculopathy admitted in our academic
ICU with an ischemic stroke over the last three years and compare
their outcome with that of patients with an atherosclerotic/embolic
ischemic stroke.
METHODS. All cases of ischemic stroke admitted in our ICU over the
last three years were retrospectively identified. They were divided in
two groups according to their cause: either atherosclerotic vascular/
embolic or non-atherosclerotic vascular. Clinical outcome (ICU sur-
vival, ICU length of stay and the modified Rankin scale for measuring
the degree of disability or dependence in the daily activities) was
assessed and compared using descriptive statistical analysis.
RESULTS. Overall, the last three years 36 patients, 22 (61%) males, 14
(38.8%) females, mean-aged 66.5±12.6 years, with ischemic stroke
were admitted to our ICU. Thirty-one patients suffered an athero-
sclerotic/embolic ischemic stroke while the remaining 5/36 patients
suffered a stroke of non-atherosclerotic vascular origin: one case of
thrombotic thrombocytopenic purpura, one case of HELLP syndrome,
one case of Listeria-associated stroke, one tuberculous meningitis-
associated stroke case and one case of reversible vasoconstriction
syndrome. The two groups were of similar average age and sex dis-
tribution. The non-atherosclerotic vasculopathy group had worse ICU
survival (60% vs 67.7%), longer ICU length of stay (41.6±28.6 vs
11.42±11.6 days) and more disability (modified Rankin scale 5±0.89
vs 3.77±1.9). All survivals of the non-atherosclerotic vasculopathy
group had a prolonged rehabilitation period for several months after
F2
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activities.
CONCLUSION. Although non-atherosclerotic vasculopathies represent
only a minor proportion of patients suffering an ischemic stroke, they
are an existent entity in ICU, with a high impact on mortality, ICU
length of stay and disability.
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INTRODUCTION. Neurologic injury is one of the most frequent
causes of death in patients undergoing extracorporeal membrane
oxygenation (ECMO). As neurological examination is often unreliable
in sedated patients, additional neuromonitoring is needed. However,
the value of electroencephalogram (EEG) in adult ECMO patients has
not been well assessed.
OBJECTIVES. To assess the occurrence of EEG abnormalities and their
relationship to outcome in patients treated by ECMO.
METHODS. Single-center analysis of all patients undergoing veno-
venous (VV) or veno-arterial (VA) ECMO with a contemporary (either
intermittently or continuous) EEG monitoring (April 2009 - December
2018). EEG findings of interest were: a) “mild-moderate encephalop-
athy” (i.e. diffuse slowing with reactivity/variability) vs. “severe en-
cephalopathy” (i.e. diffuse slowing without reactivity/variability); b)
“burst suppression” or flat; c) epileptiform activity (i.e. ictal EEG pat-
tern, sporadic epileptiform discharges or periodic discharges); d) EEG
reactivity. EEG findings were analyzed according to the primary diag-
nosis (presence of cardiac arrest (CA) or not) and the use of VA vs.
VV ECMO.
RESULTS. We studied 139 sedated patients (54 [41-62] years; 60
[43%] male gender) out of 596 treated with ECMO. ICU mortality was
65% (n=90). There were more unreactive EEGs among VA-ECMO (n=
98) patients than in VV-ECMO (n=41; 58% vs. 37%; p=0.03). As ex-
pected, patients after cardiac arrest (n=86) more frequently had burst
suppression or flat EEG than the others (n=53; 28% vs. 13%; p=0.05)
but less epileptiform activity (6% vs. 21%, p=0.01). Severe encephal-
opathy (28/42, 67%) or burst suppression/flat EEG (30/31, 97%; p<
0.001) had a higher mortality than mild/moderate encephalopathy
(32/66, 48%); the frequency of epileptiform activity was similar in sur-
vivors and non-survivors. Burst suppression/flat EEG was strongly as-
sociated with ICU mortality (OR 24.02 [4.16-251.25]; p<0.001), even
after adjustment for confounders.
CONCLUSION. EEG monitoring can identify sedated patients with
severe neurological injury during ECMO.000951
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INTRODUCTION. Nearly 50% of the brain-injured patients require
acute invasive mechanical ventilation. Very few studies have investi-
gated predictors for successful ventilator liberation in these patients.
OBJECTIVES. To identify physiological parameters obtained during a
successful spontaneous breathing trial (SBT) to predict successful
ventilator liberation in brain-injured patients.
METHODS. A prospective study was conducted in a general ICU.
Patients meeting criteria for a SBT [1] and who successfully passed
this 30-min. SBT (CPAP 5 cmH2O) were enrolled. Respiratory rate
(RR), tidal volume (Vt), esophageal pressure (Pes) and diaphragm
electrical activity (EAdi) were continuously measured during the SBT.
From these data, RR/Vt, neuromechanical efficiency (Pes/EAdi) and
neuroventilatory efficiency (Vt/EAdi) were calculated breath-by-
breath. Successful liberation from the ventilator was defined as
breathing without ventilator support for more than 48 hours after
the SBT.
RESULTS. Forty-five patients (51.6±14.6 years; 60.0% male) were en-
rolled. The proportion of patients without requirement for ventilator
support is shown in Fig.1. 68.9% patients were successfully liberated.
There were no differences in baseline characteristics or physiological
parameters (see Table) between patients in successful and failed ven-
tilator liberation groups.
CONCLUSION. These data provide new and clinically relevant
insights in ventilator liberation in brain-injured patients. First, 30% of
patients successfully completed a SBT failed liberation < 48h. Second,
in depth respiratory physiological parameters obtained during a SBT
do not predict liberation success.
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SBT in both groupsSuccess (n=31) Failure (n=14) P-valueRR/Vt(breaths·min-1·L-1) 50.0±37.4 61.2±37.3 0.41941.7±29.8 52.3±31.2* 0.172Pes (cmH2O) 6.5±4.2 8.8±4.3 0.1137.9±3.3* 10.3±5.2* 0.072Table 1 (abstract 001016). See text for descriptionEAdi (mV) 7.6±5.8 7.4±4.4 0.8428.6±4.7 9.5±4.8 0.548NME (cmH2O/mV) 1.2±0.8 1.5±1.1 0.2751.2±0.7 1.3±0.9 0.635NVE (ml/mV) 118±127 94.8±72.3 0.53995.8±97.1 62.4±31.3 0.219Table 2 (abstract 001016). See text for description* compared within groups, p < 0.05
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INTRODUCTION. Second level therapeutic maneuvres for controlling
intracranial hypertension (ICH) proposed by the European Brain
Injury include barbiturates, moderate hypothermia and
decompressive craniectomy (DC) but outcome is controversial. Our
aim was to evaluate the factors associated with disability and
mortality after ICU discharge in patients undergoing DC.
OBJECTIVES.
METHODS. Prospective study of patients admitted from January 1,
2013 to March 2019 who required DC. DC was performed due ICH
refractory to medical treatment. We analyzed: main admission
diagnosis; demographic data; neurological data (clinical examination
and Glasgow Coma Score: GCS); hypotension type of craniectomy
and DC complications; Rankin scale, and Glasgow outcome scale
(GOS) at 30, 60 days after ICU admission, at ICU discharge and 6
months after ICU discharge; preoperative serum lactate levels ; hypo
and hyperglycemia; application of mannitol or hypertonic saline
solution before and after DC; leukocytes and platelets previous and
after DC and other factors related to prognosis. Univariate analysis of
disability (Rankin > 3) and mortality in ICU, 60 days after DC and 6
months after ICU discharge were performed. Statistical significance
was set at p ≤ 0.05.
RESULTS. Twenty eight DC patients were collected. Demographic
data and types of admission are shown in Table 1.Most DC were
subarachnoid haemorrhages (SAH) 13 (46%) and 75% of then were
hemicranial. The most frequent complications were reoperation due
to complications (50%) and hydrocephalus (46%). Six patients died at
ICU discharge (39.3%), 4 (66,6%) of them were SAH. Rankin score at
ICU discharge was 4,5 and GOS was 3..Rankin score 6 months after
ICU discharge was 2 and GOS was 4. Reoperation due to
complications and the highest ICU GCS was associated with
disability, 60 days after DC (Table 2).Mortality 6 months after
discharge was significantly associated with bilateral pupillary
reactivity prior DC (less mortality), female sex, the presence of focal
contusion with edema and expansivity, Rankin 30 days after
admission and at ICU discharged (Table 3). We found no significant
risk factors associated with disability in the ICU and six months after
discharge.
CONCLUSION. DC patients showed low ICU mortality (21,4%) Rankin
and GOS reflected moderate / severe disability of these patients, at
ICU discharge. Rankin and GOS also showed disability deterioration,sixty days and 6 months after ICU discharge. Reoperation due to
complications and the highest ICU GCS was associated with disability
and 60 days after DC. Mortality at 6 months after discharge was
significantly associated with bilateral pupillary reactivity prior DC,
female sex, presence of focal contusion with edema and expansivity,
Rankin 30 days after admission and at ICU discharge.
Table 3 (abstract 001016). See text for description
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INTRODUCTION. In the acute phase of subarachnoid haemorrhage
(SAH), patients may develop neurogenic stress cardiomyopathy
(NSC), expressed as cardiac necrosis markers elevation, ECG
alterations and left ventricular wall motion abnormalities (WMA). A
catecholamine storm induced by SAH is central in its pathogenesis.
NSC may worsen the patient outcome. Several predictors have been
proposed in literature for the development of NSC, without definitive
evidences.
OBJECTIVES. Primary aim of this study was to evaluate the
occurrence of cardiac dysfunction measured as cardiac necrosis
markers, ECG and echocardiographic abnormalities in SAH patients,
during the first 5 days after admission. Secondary aim was to
evaluate whether polymorphisms of adrenergic receptors and related
proteins may be associated with an increased risk of cardiac injury
after SAH.
METHODS. Adult SAH patients (World Federation of Neurosurgical
Societies score IV-V) admitted at the university ICU in Torino were en-
rolled. Exclusion criteria: admission >48hrs, previous myocardial in-
farction, prior left ventricle ejection fraction <40%, pregnancy.
Myocardial necrosis markers, ECG and WMA were evaluated daily
during the first 5 days. Severity indices and physiological variables
were collected at the same time points. For the genetic analysis, we
evaluated polymorphisms of Catecol-OssiMethyl Transferase (COMT)
rs4680, endothelial Nitric Oxide Synthase (eNOS) rs20707144, β2 ad-
renergic receptor (ADRB2) rs1042713 and ADRB2 rs1042714 and their
association with cardiac dysfunction.RESULTS. 49 patients were enrolled in this pilot study: 82% female,
63±12 yrs. Median (IQR) for APACHE II (Acute Physiology and Chronic
Health Disease Classification System II) and SAPS II (Simplified Acute
Physiology Score II) were 19 (16-23) and 48 (39-53) respectively.
Aneurysm was secured by coiling in 67% of patients, clipping in
25%. The prevalent location of aneurysms was the mean cerebral
artery (24.5%), followed by anterior communicating (2.4%) and
intracranial carotid arteries (8.2%). In-hospital mortality was 24.5%.
Troponin T was elevated in 53% of patients, with median (IQR) de-
creasing from 56 (16-261) ng/L at day0 to 23 (10-75) at day4. NT pro-
BNP increased in 59% of patients and its value remained stable dur-
ing the first 5 days. Copeptin was elevated in all patients and
remained elevated during the study period. ECG abnormalities were
recorded in 76% of patients and WMA in 25%. Genetic analysis was
performed in the first 25 patients and the AA genotype of COMT
rs4680 polymorphism was more common in patients with WMA (p=
0.042). This genetic variant is associated with a reduction in catechol-
amines degradation, suggesting a possible catecholamine toxic injury
on myocardium.
CONCLUSION. We demonstrated a high incidence of cardiac
abnormalities in the early period of ICU admission after SAH. A
possible association between NSC and specific genetic
polymorphisms has been observed. Larger studies are needed to
confirm these results and to evaluate the role of other possible
predictors.
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INTRODUCTION. Neurocritical care patients are at risk of developing
secondary brain injury (SBI) following primary lesion. Prevention,
detection and treatment of SBI are of paramount importance for the
clinical outcomes of patients with acute brain injury (ABI). Taking into
account the complex pathophysiology of ABI, the use of multimodal
neuromonitoring, including brain tissue pO2 (PbtO2), may have a
major role in this purpose.
OBJECTIVES. To investigate the association between PbtO2
monitoring and prevention of SBI in neurocritical care patients.
METHODS. An observational (preliminary) study was performed in a
Greek ICU from July 2018 to March 2019, including 23 patients with
ABI (11 Traumatic brain injury, 9 Subarachnoid haemorrhage, 2
Intracerebral haemorrhage, 1 Ischemic stroke) and intracranial
pressure (ICP) / PbtO2 monitoring. We selected 19 of them who
survived and we divided them in two groups. The first group
included all survivors who developed SBI and the second group all
survivors without SBI. Monitoring of ICP and PbtO2 was performed,
considering as critical thresholds of ICP > 22 mmHg and PbtO2 < 15
mmHg. We collected data from ICP and PbtO2 measurements in the
first 24 h and > 24 h.
RESULTS. Included 23 patients had a mean age of 48.7 (± 16.8)
years, ICU admission GCS 7.8 (± 3.9) and APACHE II score 17 (± 6.3).
An external ventricular drain was inserted in 11 patients. 19 patients
(82.6%) survived and 4 (17.4%) died. Among survivors, 7 patients
(36.8%) developed SBI. In this group during the first 24 h PbtO2 < 15
mmHg was detected in all patients (100%) and remained low for
time interval > 24 h in 5 patients (71.4%). It was remarkable that ICP
> 22 mmHg was detected in only 2 patients (28.6%). We observed
that 4 patients with SBI (57.1%) had a low PbtO2 and a normal ICP.
From the group of 12 patients who did not develop SBI 7 of them
(58.3%) had brain hypoxia in the first 24 h, but after 24 h of
treatment none had.
Page 572 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55CONCLUSION. Brain hypoxia may occur despite normal ICP.
Therefore, monitoring of PbtO2 can provide additional information
on early detection and prevention of SBI. Measurement of brain
tissue oxygenation may be part of multimodality monitoring in order
to achieve appropriate guidance of treatment and consequently
improve outcomes. However, there remains a need for more, high
quality trials in patients with ABI.
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INTRODUCTION. Acute respiratory distress syndrome (ARDS) is
associated with a high mortality rate (1). In patients with ARDS
without intracranial pathology, prone positioning (PP) sessions
significantly decrease mortality and improve oxygenation (2). We can
presume similar benefits on ARDS in patients with acute brain injury;
however the effect of PP on cerebral hemodynamics remains
controversial.
OBJECTIVES. Our objective was to evaluate the tolerance of PP on
intracranial pressure (ICP), in patients with acute brain injury and
ARDS.
METHODS. This study was conducted in three intensive care units
(ICU) in France between January 2013 and January 2018. We
retrospectively analyzed data from patients with moderate and
severe ARDS (PaO2/FiO2 ratio < 150, according to Berlin
definition(3)) and a continuous monitoring of intracranial pressure.
Cerebral, respiratory and hemodynamic parameters were collected
hourly before, during and after PP. The primary endpoints were PP
efficacy on PaO2/FiO2, and tolerance through the number of
patients who had at least one ICP measurement over 25 mmHg
during PP. Secondary endpoints were the effect of prone positioning
on cerebral oxygenation via the measuring of brain oxygen partial
pressure (PbtO2). This study was conducted in accordance with
French and European ethical guidelines.
RESULTS. Twenty-seven patients (46 years old [36.5-55], 5 female) were
included: 10 traumatic brain injury, 11 subarachnoid hemorrhage and 6
stroke. During PP, PaO2/FiO2 rose from 100 [89.5-126] to 216 [171-257]
and was at 146 [122-186] after PP. During PP, ICP increase of +10.5 mm
Hg [5.25-17.75] and rose above 25 mmHg in 14 (52%) patients. The ICP
increase was greater in patient who had intracranial hypertension (ICH)
than those without ICH during PP (+19mmHg [13.5-20] vs +6mmHg
[3.5-8.5] respectively, p=0.025). Before PP, patients who developed ICH
had a significantly higher ICP compared to those without ICH (20mmHg
[13-26] vs 11mmHg [7-12], p = 0.005) and the cerebral perfusion pres-
sure was also significantly lower (67 [64.25-74.75] vs 79 [77-87]respectively, p = 0.04). Other variable before prone position onset were
not significant different. In this population, all patients with an ICP >
17.5 mmHg before PP had ICH during PP.
There were no significant differences in the duration of mechanical
ventilation, mortality and Rankin Scale at ICU discharge between
patients with or without ICH during PP. PbtO2 was monitored in 4
patients and rose from 20.5 mmHg [18.75-23.5] before PP to
28mmHg [22-31] during PP. Two patients with initial PIC at 19mm
Hg and 9mm Hg died of brain death following complicated
refractory ICH after PP. In total, the mechanical ventilation time was
23 days[11.5-36], mortality rate was 25.93% and Rankin's score at ICU
discharge was 4[4-5.5].
CONCLUSION. These data suggest that PP could be beneficial safe in
brain injured patient with ARDS. However, patients with ICH before
are at risk of worsening ICH during PP, and require precautions.
Special handling would have to be defined for PP in patients with
ICH for securing such maneuver.
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INTRODUCTION. Although high meropenem concentrations have
been associated with clinical neurological deterioration in septic
patients, no data have been reported
OBJECTIVES. To assess the association between meropenem
concentrations and EEG abnormalities in ICU patients with sepsis.
METHODS. We reviewed all ICU patients over a 5-year period (2012-
2017), who were treated with meropenem and in whom at least two
β-lactam concentrations (trough, Cmin; concentration 2 hours after
the bolus injection, C2H) and a concomitant EEG monitoring were
available. Drug levels were measured using high-performance liquid
chromatography. An “altered” EEG was defined when at least one be-
tween ictal EEG pattern, generalized periodic discharges (GPDs) or
burst suppression was identified.
RESULTS. We collected 526 meropenem concentrations (263 at Cmin
and 263 at C2H) from 193 patients over the study period. Altered EEG
was found in 52 (20%) of cases, with ictal EEG pattern in 32 of them.
Meropenem Cmin and C2H were higher in patients with an altered EEG
than others (7.2 [5.1-11.8] vs. 4.8 [2.2-8.1] mg/L; p<0.001 – 25.1 [17.5-
33.9] vs. 19.6 [12.9-29.1] mg/L, p=0.01). A multivariate analysis (adjusted
for patients) identified the following as independent predictive factors
for altered EEG: mechanical ventilation (OR 1.225 [1.072-1.978], p=0.04),
high Cmin (OR 1.128 [1.072-1.188], p<0.001) and high pH (OR 1.072
[1.019-1.128], p=0.007).
CONCLUSION. There was a significant association between both trough
and maximal meropenem concentrations and an increased occurrence of
EEG abnormalities in ICU patients with sepsis. However, only high Cmin
were the main determinant of potential drug toxicity.
Table 1a (abstract 001113). Characteristics of the patients
Table 1b (abstract 001113). Characteristics of the Patients
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INTRODUCTION. Delayed cerebral ischemia (DCI) is a major
contributor to the high case fatality rate and morbidity of
aneurysmal subarachnoid hemorrhage. About 30% of the
subarachnoid hemorrhage (SAH) patients develop DCI but it is
difficult to predict which patients will develop it
OBJECTIVES. To assess the development of DCI risk factors in
patients with SAH, admitted in a neurotraumatic ICU.
METHODS. Prospectively collected data of patients admitted
from October, 2013 to December 2017 to a 10-bed Neurotrau-
matic ICU. We analyzed: main diagnosis at admission; demo-
graphic data including sex and race; neurological data (clinical
examination, pupils reactivity and size, and Glasgow Coma
Score: GCS; localization and aneurysm size; presence of intracra-
nial hematoma (ICH); presence and volume of intraventricular
bleeding; days to develop vasoespam; development of DCI;
Fisher scale, Modified Fisher scale, Hunt and Hess scale, Word
Federation of Neurosurgeons (WFNS) scale; presence of vasoe-
spasm in doppler or arteriography; delayed of admission in ICU;
treatment of the aneurysm; complications, including infections;
Glasgow Outcome Scale (GOS) at ICU discharge and 6 months
after ICU discharge and several other risk factors. A univariate
and a multivariate logistic regression analysis of DCI were per-
formed. It was considered significant if p ≤.05.
RESULTS. Eighty three SAH patients were collected, 24 (28,9%) of
them developed DCI. Demographic data and types of admission
are shown in Table 1a and 1b. Anterior /Aco) and posterior (Pco)
communicating artery aneurysms were the most frequently found
and most of them were localized in the left side. The most
frequent complications were hydrocephalus 36 (43.9%) and
ventriculitis 9 (11.4%).The Fisher scale was 3 in SAH and in DCI
patients, modified Fisher scale was 4 for the SAH and DCI
patients. Hunt and Hess scales was 2 for SAH patients and DCI
patients. WFNS was 2 in SAH and DCI patients. GOS at ICU
discharge was 4 and, six months after ICU discharged, was 5 in
patients with SAH. Patients who developed DCI had GOS at ICU
discharged of 4 and it was also 4 six months after ICU discharge.
Eleven SHA patients died (13.4%) Three DCI patients died.To be
orientated OR, IC 95% (IQR): 0.184 (0.058 ; 0.579) and PCo
aneurysms OR, IC 95% (IQR): 4.559 (1.314 ; 15.817) were
independently associated with DCI.
CONCLUSION. Our data showed 28,9 % of DCI patients. GOS
reflect low disability of DCI patients both at ICU discharge and
six months after it. To be orientated and PCo aneurysm were
independently associated with the development of DCI.
Table 2 (abstract 001113). Multivariate logistic regression for the DCI.
Variables were selected using the best subset regression and BIC criteria
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INTRODUCTION. Stroke in women of child-bearing age could be more
common during pregnancy. Subarachnoid haemorrhage (SAH) is the
third leading cause of non-obstetrical death in pregnant women
OBJECTIVES. We aimed to study the clinical and epidemiological
characteristics of pregnant patients with spontaneous brain haemorrhage
or SAH secondary to aneurysms or arteriovenous malformations (AVM).
METHODS. This descriptive retrospective study was undertaken in
2008-2013 in a third-level ICU attending pregnant patients. All preg-
nant women with brain haemorrhage were included. Analyses were
made of the scores of severity, Glasgow on admission and discharge
from the ICU, clinical and epidemiological variables, CT, cause of the
haemorrhage, treatment if given, term, pregnancy outcome and de-
livery, and prognosis according to the GOSE scale and Barthell index,
among others.
RESULTS. During the 6-year study period 6 patients experienced a
brain haemorrhage. The mean age was 37.16±55 years. The haemor-
rhages presented in the third term, except for one in the second
term. The mean Glasgow score on admission was 12.33±2.8 and on
discharge 14.33±0.63. All had SAH, and 4 patients also had associ-
ated parenchymal haemorrhages. The mean Hunt and Hess on ad-
mission was 2.5±0.84 and the Fisher 3.67±0.82. The cause detected
was: 3 with anterior communicating artery aneurysms, 1 with AVM, 1
with vasculitis and haemorrhage at the time of delivery, and another
with gestosis and haemorrhage at the time of delivery. The aneu-
rysms (3 patients) were treated with embolization at a mean of 2.66
days. Only one of the hematomas required neurosurgical evacuation.
Caesarean section was required in all 6 pregnancies, 4 between 3
months and 4 days posthaemorrhage, and in 2 (gestosis and vascu-
litis) the haemorrhage occurred at the time of delivery. The GOS at 6
months and one year was 4 (moderate disability) in three patients
and 5 (good recovery) in the other three. Sequelae included head-
ache, epilepsy without aura and depression. No mother and no new-
born died.
CONCLUSION. SAH in pregnant women is a severe condition,
requiring diagnosis and interdisciplinary treatment. In our series, as
in others, the attitude was to treat the aneurysm and/or its cause as
soon as possible, and to use a caesarean delivery.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):001148INTRODUCTION. Subarachnoid hemorrhage (SAH) is an acute
cerebrovascular event associated with high morbidity and mortality.
Several studies showed the independent impact of a lymphopenia
with poor outcome during critically illness but no data are available
for SAH.
OBJECTIVES. To evaluate the prevalence of lymphopenia among SAH
patients and its association with infections occurrence
METHODS. Retrospective analysis of an institutional database of
adult (>18y) patients admitted to the Department of Intensive Care
after non-traumatic SAH between January 2011 and May 2016.
Lymphocyte count was obtained daily for a maximum of 5 days; lym-
phopenia was defined as lymphocyte count < 1000/mm3. We col-
lected the occurrence of infection during the hospital stay as well as
ICU mortality and unfavorable neurological outcome (UO; i.e. Glas-
gow Outcome Scale of 1-3 at 3 months).
RESULTS. Data from 270 patients were analyzed (median age 54
years; male 45%); 62 (23%) patients developed infections during
hospital stay. Mortality was 29% and UO 40%. The median
lymphocyte count on admission was 1280 (890-1977)/mm3 and 45%
(n= 121) had lymphopenia. Lymphopenic patients had more
frequently infections (38/121, 31% vs. 24/139, 17% - p= 0.003), while
mortality and UO were similar when compared to non-lymphopenic
patients. In a multivariate analysis, seizures on admission and the use
of mechanical ventilation were independent predictors of infection,
while lymphopenia was not. Independent predictors of lymphopenia
was the Fisher score on admission and the development of fever
CONCLUSION. Early lymphopenia is common after SAH; however, it
is not significantly associated with the development of infections.
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INTRODUCTION. Fever is a modifiable complication contributing to
poor functional outcome and increased mortality in traumatic brain
injury (TBI) patients.
OBJECTIVES. We sought to identify risk factors for the development
of fever in TBI patients admitted to the intensive care unit (ICU).
METHODS. This is a retrospective analysis of data acquired in a
European prospective, multicenter, observational cohort study
(CENTER-TBI). Patients were included if they were admitted to an ICU
as a direct consequence of TBI and data on highest body
temperature were available on at least 2 different days. Fever was
defined as body temperature above 38.3°C. Statistical analysis was
performed using binary logistic regression models.
RESULTS. Two-thousand and seventy-four patients were included.
Median age was 49 (29-65) years. Pre-injury variables associated with
the development of fever were younger age (p=0.035), male sex (p<
0.001) and a medical history of a neurologic disease (p=0.036). Fever
was most common in patients with diffuse brain injury as primary
intracranial pathology (59%), followed by subdural hematoma
(49.6%), contusions (49.1%), traumatic subarachnoid hemorrhage
(43.3%) and epidural hematoma (34.7%). Regarding injury details and
pre-ICU management, a Glagow Coma Scale score below 14 (p<
0.001), injury severity score above 30 (p<0.001), episodes of hypoxia
(p<0.001), hypotension (p=0.004), or hypothermia (p=0.009), neuro-
worsening (p<0.001), clinical symptoms of skull base fracture (p<
0.001), a focal neurological deficit (p<0.001), any airway treatment
(p<0.001), and any circulatory support (p<0.001) were associated
with a more common occurrence of fever. During the ICU stay, any
surgery (p<0.001), any infectious complication (p<0.001), seizures (p<
Page 575 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 550.001), and intracranial lesion progression (p<0.001) were risk factors
for the development of fever.
CONCLUSION. In this study we identified risk factors for the
development of fever in a European cohort of TBI patients admitted
to the ICU. Demographic variables, markers of injury severity, pre-ICU
course and complications during the ICU stay were associated with
the development of fever. Multivariable models and a differentiation
between infectious and non-infectious fever will be presented at the
meeting.
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INTRODUCTION. The pulsatility index (PI), measured by transcranial
Doppler (TCD), is useful to assess cerebrovascular resistances.
Although it has been associated with septic encephalopathy, the
relationship between PI and cerebral autoregulation (CAR) in septic
patients has not been well defined.
OBJECTIVES.
 To evaluate if pulsatility index (PI) is a surrogate of CAR in
critically ill septic patients.
METHODS. Observational study of 50 adult septic patients (with or
without shock). Exclusion criteria were: any intracranial disease; major
arrhythmias; treatment with extracorporeal membrane oxygenation;
any supra-aortic arteriopathy. Transcranial Doppler (DWL, Germany)
was performed by insonating the left middle cerebral artery (LMCA)
with a 2MHz probe. LMCA blood flow velocity (FV) and arterial blood
pressure (BP) signals were simultaneously recorded for at least 6 mi-
nutes; Pearson´s correlation coefficient between BP and FV (MXa)
was calculated using MATLAB (MathWorks, USA). Impaired CAR was
defined as MXa > 0.3. High PI was defined as > 1.2. The first PI avail-
able was registered from the same TCD recording.
RESULTS. The 50 patients had a median age of 64 [54-74] years.
Median MXa was 0.25 (-0.07 - 0.43) and median PI was 0.97 (0.76 -
1.18). There was no correlation between MXa and PI (p=0.83). Both in
the 24 patients with altered and in the 26 patients with intact CAR,
there was no significant correlation between MXa and PI (p=0.58 and
0.93, respectively). Mean PI were similar in patients with altered and
intact CAR (1.04 and 1.06, respectively). Also, the number of patients
with high PI was similar in patients with altered (7/24) or preserved
CAR (6/26).
CONCLUSION. Pulsatility index cannot reliably assess cerebral
autoregulation in septic patients.
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INTRODUCTION. An integral part of neuroregulatory systems of the
brain stem are opioid and adrenergic antinociceptive systems. The
use of anesthesia, including a combined effect on opioid and
adrenergic antinociceptive systems, creates favorable conditions for
performing operations on brain tumors.OBJECTIVES. To assess changes in SVI and SVRI during anesthesia,
including alpha2-adrenoagonist.
METHODS. The study included 118 patients (mean age 50.5±13.6
(Mean ± Std)) who underwent planned surgical treatment about
brain tumors.
In all patients induction of anesthesia included: muscle relaxants,
hypnotics (propofol), opioid analgetic (fentanyl 4.8±0.6mcg/kg) +
alpha2-adrenoagonist (clonidine or dexmedetomidine). Maintenance of
anesthesia: hypnotic (propofol), opioid analgetic (fentanyl 1.3±0.4mcg/
kg/h) + alpha2-adrenoagonist (clonidine or dexmedetomidine).
All patients were divided into three groups, depending on the
alpha2-adrenoagonist used and its dosage.
In group I (26 patients) induction of anesthesia: clonidine 1.5±
0.4mcg/kg; maintenance of anesthesia: clonidine 0.4±0.15mcg/kg/h.
In group II (58 patients) induction of anesthesia: dexmedetomidine
1.5±0.4mcg/kg; maintenance of anesthesia: dexmedetomidine 0.4±
0.2mcg/kg/h. In group III (34 patients) induction of anesthesia:
dexmedetomidine 0.7±0.1mcg/kg; maintenance of anesthesia:
dexmedetomidine 0.2±0.1 mcg/kg/h. All three groups are statistically
comparable by sex, age, initial blood pressure, initial heart rate,
position on the operating table and localization of the brain tumor.
RESULTS. In group I, after induction anesthesia, SVI 37,4 ± 6 ml/m2,
SVRI 2487 ± 620 dyn·sec/cm5/m2. After positioning the patient on
the operating table, SVI 34,4 ± 11 ml/m2, SVRI 3078 ± 1490 dyn·sec/
cm5/m2. At the stage of tumor removal, SVI 34,2 ±9 ml/m2, SVRI
3176 ± 921 dyn·sec/cm5/m2. At the stage of wound closure, SVI
34,1±8 ml/m2, SVRI 3265 ± 1201 dyn·sec/cm5/m2.
In group II, after induction anesthesia, SVI 36,2± 8 ml/m2, SVRI 4006±
1692 dyn·sec/cm5/m2. After positioning the patient on the operating
table, SVI 34,2±7 ml/m2, SVRI 3971±1179 dyn·sec/cm5/m2. At the
stage of tumor removal, SVI 33,6±6 ml/m2, SVRI 3894±1042 dyn·sec/
cm5/m2. At the stage of wound closure, SVI 34,5±7 ml/m2, SVRI
3842±1123 dyn·sec/cm5/m2.
In group III, after induction anesthesia, SVI 38,9±8 ml/m2, SVRI 3294±
1198 dyn·sec/cm5/m2. After positioning the patient on the operating
table, SVI 35,4±9 ml/m2, SVRI 3170±808 dyn·sec/cm5/m2. At the
stage of tumor removal, SVI 36,1±7 ml/m2, SVRI 3400±795 dyn·sec/
cm5/m2. At the stage of wound closure, SVI 36,9±6 ml/m2, SVRI
3747±1001 dyn·sec/cm5/m2.
CONCLUSION. SVI lower and SVRI higher, than the reference value in
the during anesthesia, including alpha2-adrenoagonist. These values
are stored at all stages of the operation.
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INTRODUCTION. The functionality of platelets during coagulation is
essential for stopping bleeding. Our study aims to assess the
disturbance of platelet aggregation capacity in spontaneous cerebral
hemorrhages (SCH), both intraparenchymal hemorrhage (IPH) and
subarachnoid hemorrhage (SAH), and its correlation with severity
and mortality.
METHODS. Patients with SCH admitted in ICU were included. A
blood sample is analyzed with the Multiplateâ platelet function test
at admission (day 0) and at 24h (day 1). This system measures
platelet aggregability to arachidonic acid (AA), adenosine
diphosphate (ADP), collagen (Col), Ristocetin (Ris) and thrombin
(Trom). Hematoma volume was determined as a marker of severity in
HIP and Hunt and Hess scale for HSA. Patients with oral antiplatelet
Page 576 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55therapy were excluded. The prevalence of the platelet alteration was
estimated, and it was related to severity and mortality using the chi-
square test or Fisher's exact test.
RESULTS. 69 patients included. IPH 37 (53.62%), SHA 32 (46.38%);
Mean age 50-60 years. Mean hematoma volume 48.28 cc. In SHA
Hunt & Hess scale were IV-V in 35.48% of patients. Mortality rate at 6
months 33.33%.
A disturbance in platelet aggregability (at least one of the tests) was
observed in 100% of patients, both on day 0 and day 1. Platelet
dysfunction is associated with higher mortality in all tests, although
it was only significant with Collagen test (p 0.048). It´s also
associated with a greater hematoma volume in IPH, only significant
with Ristocetin test (p 0.015) (Figure 1).
CONCLUSION. There is a disturbance in platelet aggregability at the
global of SCH, also correlated with a higher mortality and greater
hematoma volume in the group of IPH.
NAHP / DS - From basics to advances in
care delivery
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INTRODUCTION. Recent studies have shown that in-bed exercises
are the most prevalent activity performed in mechanically ventilated
patients receiving early mobilization. However, the barriers to achiev-
ing a higher activity level may vary in different cultures, and the rea-
sons for this may be both clinical and structural. The objective of this
study was to evaluate the clinical and structural barriers to achieving
a higher activity level in mechanically ventilated patients. Recent
studies have shown that in-bed exercises are the most prevalent ac-
tivity performed in mechanically ventilated patients receiving early
mobilization. However, the barriers to achieving a higher activity
level may vary in different cultures, and the reasons for this may be
both clinical and structural.
OBJECTIVES. The objective of this study was to evaluate the clinical
and structural barriers to achieving a higher activity level in
mechanically ventilated patients.
METHODS. A multicenter observational study performed in 3 ICUs in
Sao Paulo, Brazil during a 3-month period (from January to March
2019). Demographic data, prevalence of early mobilization, types of
mobility activities, clinical and structural barriers to achieving a
higher activity level were collected daily from all adult patients in
mechanical ventilation longer than 24 hours.
RESULTS. In total, 85 patients were included in this study, with a
total of 327 observations. The mean (SD) age was 72(4.5) years and
58% of patients were male. Early mobilization during MV was
performed in 92% [301/327] of the observations. Early mobilization
activities encompassed in-bed exercises (n=301; 92%), a sit over the
edge of bed (n=21; 6.4%), and actively transferring from bed to chair
(n=5; 1.5%); no patients were engaged in standing or walking activ-
ities. Sedation represented the most common clinical barrier to
achieving a higher activity level (n=125; 38.2%), followed by use of
vasoactive drug (n=107; 32.7%), consciousness impairment (n=107;
32.7%), hemodynamic instability (n=91; 27.8%), respiratory instability
(n=54; 16.5%), continuous hemodialysis (n= 46; 14%), and delirium
(n=16; 4.9%). Limited resources were identified as the most common
structural barrier (n= 17; 5.2%), followed by time for therapy (n= 3;
0.9%) and limited staff (n=2; 0.6%).
CONCLUSION. In order to achieve a higher activity level during
mobilization of mechanically ventilated patients, clinical barriers weremore prevalent than structural barriers. The most prevalent clinical
barriers were sedation, use of vasoactive drug, and consciousness
impairment. Structural barriers were more related to limited
resources.
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INTRODUCTION. There is growing interest in involving family
members at the ICU. Family Centered Care (FCC) and Shared
Decision Making (SDM) are becoming more common in hospitals
(Burns, Gerritsen). However, introducing FCC and SDM at the ICU is
difficult due to limited evidence and despite a widely supported 23
recommendations guideline as provided by Davidson. At our 20 bed
referral teaching ICU we developed a small size questionnaire to
assess families needs, based on the five components of family
involvement as described by Olding.
OBJECTIVES. To perform a small volume qualitative study to assess
new or growing needs of family members of ICU patients to improve
our medical and/or nursing services as provided on a daily basis. The
questionnaire was aimed at five areas: ICU presence; having needs
met/families being supported; communication and information;
shared decision making (related to family expectancy) and families
contributing to ICU care.
METHODS. The study was performed using a semi structured
questionnaire (20 questions) and questions to determine patient and
respondent characteristics (3 questions). During a six month period
34 families, usually one or two representative(s), were interviewed.
Only families from patients with a ICU length of stay over 48 hour
were included.
RESULTS. Family members of ICU patients endure a lot of stress and
hardship during ICU admittance of their loved one. They experience
disturbed sleep (76%), mental exhaustion (86%) and struggle
balancing work (36%) and family (13%) as key issues. Despite their
problems, 85% of families are coping sufficiently to still be able to
support the ICU patient during the recovery period. 25% of families
stated needing an (undefined) form of support from the hospital.
Also a surprising need is found in a high number of families wanting
to attend medical and nursing meetings and/or handovers and
access to specific information as quality of life, incidents and risks of
treatment and procedures. These needs are supported by almost
80% of the interviewed respondents, however the current offering of
information and accessibility at our ICU is valued very positively.
With concerns to SDM expectations, 18% of families stated needing
no influence at all and 76% wanting only a consulting role. Only 3%
stated that all (medical) decisions must be made by the family or
only with full family consent. Despite insecure positive effects,
families are willing to participate in daily ICU care. This is applicable
on non-physical and physical (nursing) tasks. In general no statistical
significant differences were found between patient or respondent
characteristics.
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patient’s’ family members are developing as well. This provides a
growing challenge for hospitals and ICU nurses and doctors to meet
these needs of those family members and balance it with the daily
care for the ICU patient. It is time to define new frontiers related to
the role and participation of family members at the ICU. Maybe it is
also time to shape the ICU workflow more to patient and families
needs instead of being based on the doctors and/or nurses
workflow. This will not be an easy transition. One simple question
can be asked to family members today and immediately: what are
your current needs and how can we support this?
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INTRODUCTION. The significance of multidisciplinary rounds and
patient care where family members and parents of critically ill
children are actively involved in their child’s care is receiving
increased recognition as a vital complement to medical treatment.
There are several studies in adults showing that the use of ICU
diaries has decreased anxiety and depression in both patients and
families. Despite the potential benefits, there is a paucity of
information regarding the use of family care journals (FCJ) in the
Pediatric Intensive Care Unit (PICU).
OBJECTIVES. The objectives of this quality improvement study are: 1) to
develop a reliable process to learn about the experiences of families in
the PICU, 2) to give families a resource tool to enhance their critical care
stay, and 3) to develop improvement strategies for communication with
families and enrich their PICU experience.
METHODS. An electronic point of care (POC) 10-item questionnaire
was designed to obtain a baseline assessment during the first phase of
the project. The survey was administered upon transfer from the PICU.
Gaps were identified and the FCJ, developed by the Family-Centered
Care Program, was distributed in the second phase. Throughout the
second phase of the project, the survey administration continued to
evaluate the impact of the FCJ on the identified gaps.
RESULTS. A total of 500 FCJ were distributed and 188 completed
surveys were collected. A significant improvement in all of the
questions between the two phases of the project was seen:
Encouraging families to write down questions (+35%), inviting
families to join rounds (+16%), and understanding the patient’s plan
of care (+9.7%). Of all the respondents, 90% found the FCJ to be a
useful tool during their PICU stay. Open-ended questions revealed
more improvement opportunities including: communication withnon-ICU consultants, comfort level at the time of transfer to a lower
level of care environment. Additionally, the majority of respondents
gave positive feedback about the excellent nursing care provided
while in PICU.
CONCLUSION. Using a readily-accessible electronic POC survey in
combination with the FCJ can provide teams with real-time meaning-
ful and actionable information to improve the partnership between
clinical providers and families. The clinical team can use this informa-
tion to drive improvement strategies focused on the partnership be-
tween families and ICU teams.
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INTRODUCTION. Health care disparity in critically ill children
according to health insurance status is not well known.
OBJECTIVES. We aim to study whether there are differences in
management and outcome between health insurance and Medical
aid patients.
METHODS. We conducted a retrospective cohort analysis of the
Health Insurance Review and Assessment (HIRA) database. All
pediatric admission (<18 years of age) to intensive care units in
Korea from August 1, 2009, through September 30, 2014, were
enrolled, and we excluded i) admissions to neonatal intensive care
units, ii) patients under 28 days of age, iii) primary diagnosis Z of
International Classification of Disease, and iv) other than the first
admission during study periods. We compared the management
procedure and hospital death, Intensive care unit (ICU) length of stay
between health insurance group and Medical aid group.
RESULTS. A total of 18,291 patients were enrolled, and 17,147
(93.7%) were health insurance status and 1,144 (6.3%) were Medical
aid status. Age was higher in Medical aid patients (11 vs. 7 years, P<
0.001), the proportion of tertiary hospital admission was lower in
Medical aid patients (67.5 vs. 39.5%, P<0.01). The proportion of
mechanical ventilation (43.2 vs. 35.1%, < 0.01) and vasopressor drugs
(15.8 vs. 12.0%, P<0.01) were lower in Medical aid patients. Crude
mortality rate was not different between 2 groups (5.0 vs. 5.9%, P=
0.223). In adjusted analyses, medical aid state was not significant risk
factor of mortality (Odds ratio 1.09, Confidence interval 0.79-1.51).
However medical aid state was a risk factor of re-admission (Odds ra-
tio 1.25, confidence interval 1.11-1.43) and visit to emergency room
(Odds ratio 1.32, confidence interval 1.07-1.62).
CONCLUSION. The mortality rate of critically ill children who
admitted to intensive care unit was not different between health
insurance and medical aid patients, but the incidence of hospital re-
admission and emergency room visits within 3 months after dis-
charge was significantly higher in medical aid patients. Further stud-
ies about health care disparities outside ICU are neede according to
health insurance status.
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INTRODUCTION. High-frequency oscillatory ventilation (HFOV) is
often considered as the final rescue therapy for patients with refrac-
tory respiratory failure. However, there is limited data regarding the
treatment outcomes and the risk factors of mortality after neonates
on HFOV.
OBJECTIVES. To describe current clinical practice and predict the
mortality risk for neonates receiving HFOV.
METHODS. A single retrospective, observational study was
conducted and all neonates treated with HFOV during the study
period from January 2010 to December 2017 were enrolled. Patients
were classified into five cohorts based on underlying diagnosis. We
used univariate analysis to identify factors associated with 30-day
mortality following HFOV use and multivariate logistic regression to
identify independent predictors of mortality risk.
RESULTS. A total of 1036 neonates ever supported on HFOV were
enrolled, of which 64.1% had HFOV as the rescue therapy, 27.2% as
elective use, and 8.7% for air leak. 755 (67.1%) had good response to
HFOV and can be weaned within 3 days, whereas 87 (7.7%) patients
died within 3 days after initiation of HFOV. The overall in-hospital
mortality rate was 31.7%. An average oxygenation index (OI) greater
than 25 within the first 24 hours after initiation of HFOV and patients
with secondary pulmonary hypertension exhibited the greatest pre-
dictive power (p < 0.001) for increased mortality risk. After decision
tree regression analysis, a pre-HFOV OI of more than 20.5 was identi-
fied as the cut-off point to be highly associated with final in-hospital
mortality.
CONCLUSION. We identified the predictive factor and cut-off point
that is independently associated with treatment failure in neonates
on HFOV. Further efforts to optimize the outcomes are still needed.
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INTRODUCTION. Although the physiotherapists are routinely
involved in the critical patients care, the albanian intensive care units
(ICU) have no exclusive ICU Physiotherapists.
OBJECTIVES. To give a view of physiotherapy practice in the ICU, to
determine the role of intensive care nurses and their involvement in
physiotherapeutic techniques.
METHODS. ICU nurses of 6 Intensive Care Units in the university
hospitals of Tirana were requested to fill a questionnaire. The
questionnare consisted of 25 short-form questions, which examined
the nurses’ involvement in respiratory care, early mobilisation and
other physiotherapeutic techniques.
RESULTS. Physiotherapists do not work exclusively in the ICU-s, they
perform therapeutic procedures only in some patients, they work inthe ICU for 2-3 hours during the morning shifts. They are absent dur-
ing the afternoon and night shifts, and also on public holidays and
at the weekends.
100 completed questionnaries were analyzed. Nurses are routinely
involved in ICU patients care. Treatment techniques performed “very
often” included out-of-bed mobilisation (60%), passive and active
limb mobilization (23%), in-bed mobilisation and positioning (81%)
and airway suctioning (100%).
The nurses were no involved in the adjustment of mechanical
ventilation, in weanings from mechanical ventilation, in extubation
and in the implementation of invasive mechanical ventilation,
considering these procedures the doctors’ responsibility.
ICU nurses had graduated as general nurses, and had not post-
graduate specialisation in ICU therapy or respiratory therapy. They
also state that their knowledge in ICU physiotherapy is insuficient
(73%), and absolutely absent (27%).
CONCLUSION. There is a lack of regular physiotherapy service in
Albanian ICU-s. The low availability shows that the need and import-
ance of regular physiotherapists in ICU is still not clearly recognized
in Albania. Physiotherapists should be part of multidisiplinary inten-
sive care team, in order to offer high-quality physiotherapy servises
and improving the outcome of patients. Besides, systematic educa-
tional programs are necessary for improving nurses knowledge on
physiotherapeutic procedures, especially in early mobilisation and re-
spiratory physiotherapy.
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INTRODUCTION. Patients surviving an admission to an Intensive Care
Unit (ICU) frequently experience long-term physical impairment, de-
creased health related quality of life (QoL) and low rates of return to
employment.1 Despite this there has been limited investigation of
the reasons for poor physical function. Musculoskeletal (MSK) condi-
tions are wide raging, affecting approximately 25% of the UK popula-
tion and are one of the main causes of sickness absence at work.2
Patients in ICU experience rates of muscle mass loss of 20% in the
first week of admission,3 which may put them at risk of developing
further MSK complications. However, the MSK complications experi-
enced by ICU survivors are unknown.
OBJECTIVES. To undertake a scoping review to gain an
understanding of the evidence base surrounding the long term MSK
complications experienced by ICU survivors.
METHODS. A systematic search was conducted of the following
databases: Cochrane, CINAHL, AMED and EMBASE. Studies were
included if they evaluated at least on aspect of MSK health in ICU
survivors following hospital discharge. Abstracts and case reports
were excluded.
RESULTS. Of the 22 included papers: 8 reported decreased muscle
mass or muscle weakness; 7 reported MSK related chronic pain; 3
reported abnormal neuromuscular function; 3 reported joint related
complications; and 1 paper reported increased fracture risk. Most
papers (n=21) reported on a single aspect of MSK health.
CONCLUSION. The nature of critical illness and its long term
consequences, along with the prevalence and detrimental effect of
MSK conditions in the general population, means that it is highly
likely that MSK conditions are having a negative impact on patient’s
physical function and QoL. The small number of studies investigating
long-term MSK complications to date has identified a variety of prob-
lems extending beyond weakness. Further investigation of MSK com-
plications following critical illness may guide future post-ICU
rehabilitation interventions.
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INTRODUCTION. The application of prone positioning (PP) during
veno-venous extracorporeal membrane oxygenation (VV-ECMO) has
shown to be a safe and reliable technique when performed in a rec-
ognized ECMO center with the appropriately trained staff and stand-
ard procedures. [1] Several clinical studies evaluated the safety and
efficacy of PP in mechanically ventilated patients, however a higher
frequency of pressure ulcers has been reported. [2]
OBJECTIVES. To detect the incidence and the characteristics of
pressure ulcers in PP patients with severe acute respiratory distress
syndrome undergoing ECMO treatment.
METHODS. Observational retrospective analysis of all the patients
admitted to our intensive care unit (ICU) of a tertiary level hospital
from January 2013 to December 2017. Only the patients undergoing
PP for at least 12 hours were included. The Braden scale was used to
assess the patients’ risk of developing a pressure ulcer at ICU
admission while the pressure ulcers were staged according to the
NPUAP staging system (National Pressure Ulcer Advisory Panel). Age,
sex, BMI, ICU length of stay, SAPS and SOFA score and mortality
were recorded.
RESULTS. A total of 50 PP patients undergoing ECMO were identified
in the medical records. The pressure ulcers incidence was 46% and
the main part of the body with skin lesions were: face (51.3%), rib
cage (15.4%), hip bones (7.7%) knees (5.1%) and others (20.5%).
Fourteen patients (28%) report 3 pressure ulcers present
simultaneously in different anatomical sites. During all PP maneuvers,
no adverse events, like ECMO cannula dislocation, were recorded.
The other results are summarized in table 1.
CONCLUSION. In this sample, PP is a safe procedure but it is
associated with a high risk of pressure ulcers on the face. For this
reason, further preventive measures to protect the skin should be
implemented.
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Characteristics Clinical score
Age (mean, SD) 55 ± 16 BMI (median, IQR) 25 (21 - 29)
Sex (male) 31 (62%) Braden score (median, IQR) 10 (9 - 12)
ICU length of stay (days) 28 (19 - 39) SAPS II (median, IQR) 42 (29 - 54)
Mortality (%) 14 (28%) SOFA (median, IQR) 9 (7 - 12)001403
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INTRODUCTION. Autophagy executes an intracellular recycling process
through the lysosomal-mediated pathway. Previous studies have re-
vealed a possible association between insufficient autophagy and a
detrimental outcome in critically ill patients. However, the autophagy
flux and its dysregulation by critical illness is not well described and
cannot be measured in critically ill pediatric patients in vivo.
OBJECTIVES. To examine how serum from critically ill children
influence the autophagy flux in human skeletal muscle cells in vitro,
compared with serum from healthy children.
METHODS. Three independent experiments were conducted. Serum
from 82 pediatric ICU (PICU) patients (age < 18 years) and 50 age-
matched healthy subjects were incubated with cultured primary hu-
man skeletal muscle cells in 96-well plates for 24 hours. The expres-
sion of p62 protein in the muscle cells was analysed with and
without an autophagy blocker (chloroquine or bafilomycin A1) using
In-Cell Western assay. The autophagy flux was determined by the dif-
ference in p62 levels between the conditions with and without the
autophagy blocker. Serum-free media was used as a control condi-
tion and the autophagy flux was reported as the percentage of this
control. Clinical parameters of the PICU patients were also recorded.
Mann-Whitney U test and Kruskal-Wallis H test were used for statis-
tical analysis because of non-parametric distribution of the data. Data
is presented as median and interquartile range[IQR].
RESULTS. The levels of basal p62 expression were comparable
between PICU and control group (98.7 [88.0-111.1] vs 91.9 [86.4-
104.5] A.U., p=0.13). No difference in autophagy flux was observed
between the PICU and control group (44.4 [19.3-76.6] vs 54.7 [25.9-
78.0] %control, p=0.21). However, the PICU group had more outliers
of autophagy flux, with 13% (n=11) of values lower than the mean
minus SD (blockers) and 15% (n=12) of values higher than the mean
plus SD (inducers). The blockers group had significantly higher p62
levels than the non-responder group (autophagy flux within mean ±
SD, n=59) and the inducers group (121.5 [100.7-164.2] vs 98.3 [90.6-
110.3] vs 87.8 [82.2-99.6] A.U. respectively, p=0.015). There was no
difference in terms of number of organ failure among these groups
(p=0.675); however, days of mechanical ventilation tended to be
higher in the blockers group (7 [4-18.5] vs 3 [0.3-7] vs 2.5 [0-4] days
respectively, p=0.07).
CONCLUSION. We observed a variation of autophagy in muscle cells
modulated by serum from critically ill children with 13% of serum
initiating a block in autophagy.
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lead to preventable errors and adverse events. In particular,
unexpected ICU readmission is associated with longer length of
stay and an increase in mortality.[1] Many prediction models
have been developed but none are currently widely
implemented to prevent ICU readmission. Our recently
developed model employed extensive feature engineering and
start-of-the-art machine learning algorithms and achieved an
ROC AUC of 0.82. (P.J. Thoral, et al, ESICM LIVES 2018 Meeting
Abstract. Manuscript in preparation). An important part of imple-
mentation is applying the model to external datasets, different
from and independent of the one it was originally trained on, in
order to both validate the model and increase its versatility and
value.
OBJECTIVES. To increase the performance and implementability of
our prediction model for ICU readmission and mortality by
extending the training dataset with clinical data collected during
the last two years in the electronic health records (EHR) at the
ICU of Amsterdam UMC, as well as datasets from other Dutch
ICUs.
METHODS. Our model was developed using patient data from
2004 to 2016 extracted from our Patient Data Management
System (MetaVision, iMDsoft). We tested performance of our
model on data extracted from our current EHR (EpicCare, Epic
Systems) from 2016-2018 and are currently testing performance
on data from other Dutch ICU’s. Since a change in clinical prac-
tice associated with transition to another EHR (e.g. different
standardization of orders using order sets) and different patient
populations between ICUs will lead to datasets with features
characterized by different distributions, we explore multiple
methods suggested in the literature to ensure external validity.[2,
3] To address possible covariate shift caused by different patient
populations, we implement importance weighting to better align
feature distributions between ICUs. To address potential concept
shift, due to, for example, differences in practice, we add data
from multiple sources to the training set and restrict the feature
set to features that are expected to generalize well. Code for
model development and analysis was written in Python using the
scikit-learn package.
RESULTS.
Applying our model without adjustments to our current EHR
results in a lower ROC AUC of 0.77 with an average precision
(AP) on the precision-recall curve (PRC) of 0.21. (Fig. 1 and 2).
Through careful feature selection, combination of training data
and domain shift mitigation techniques we improve the model
performance and increase the ROC AUC to 0.83 and the AP to
0.26. Results for validation on and combination with datasets
from other Dutch ICUs are pending.
CONCLUSION. Our validation approach overcomes the problem of
concept shift due to datasets originating from different sources and
leads to a model with increased performance and versatility that is
ready for implementation.
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INTRODUCTION. Immunotherapy with CAR-T cells is a new approach
to treat B-cell lymphoblastic leukemia in children and young adults.
The most important acute adverse event is the cytokine release syn-
drome (CRS).
OBJECTIVES. To evaluate the CRS after infusion of CAR-T cells in chil-
dren that required admission to the pediatric intensive care unit
(PICU).
METHODS. Retrospective review of the patients that had received
CAR-T therapy between April 2016 to February 2018 and needed
PICU due to the CRS. During these period two different CAR-T cells
therapies were used (Group 1 and group 2), both with 4-1BB as costi-
mulatory signal. The CRS was graded using the Penn definitions.
Fig. 1 (abstract 001497). See text for description
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quired a reinfusion. Seven patients required intensive care due to
CRS (7/27, 25.9%). Four were girls (57.1%), and the median age was 8
years (IQR 6-19). Five patients were in the group 1 and 2 in the group
2. Six patients presented a high percentage of blasts before infusion.
In group 1 there were 3 girls (60%) and the median age was 8 years
(IQR 7-21.5). The CRS began in the 3th day (IQR 2.5-4.5) and the me-
dian day since the infusion until the admission to the PICU was 6
day (IQR 3.5-6). Four presented CRS grade 3 (80%) and one pre-
sented CRS grade 4 (20%). All required inotropic support with a me-
dian inotropic score of 15 (IQR 9-92.5). None required mechanical
ventilation. Three patients received one dose of tocilizumab (60%) in
the day 1 of admission to the PICU. Two patients (40%) received ste-
roids (prednisone) in the day 2.5. Three patients (60%) presented
mild neurological impartment. The median days in the PICU was 5
(IQR 2-6.5) and in hospital was 31 days (IQR 15-47.5).
In group 2 there were 1 girl and 1 boy with an age of 4 and 11 years
old, respectively. Both patients began the CRS symptoms in the day
of infusion and were admitted to the PICU at the day 2 and day 1
after infusion. The maxim CRS were grade 4 and 5, respectively, and
the second patient presented mild neurological toxicity. Both
required inotropic support and mechanical ventilation. They were
intubated at the second and third day after be admitted to the PICU.
Both received 2 dose of tocilizumab and prednisone. The first patient
was extubated at the day 5 and was transferred to the ward at the
day 10th. The second patient behaved like a hemophagocytic
lymphohistiocytosis and died due to the CRS at the 4th day of
admission. This patient presented higher values of procalcitonin,
lactate and ferritin.
The global survival of the CRS was 85.7%, considering all the infusion
of CART-T cells 96.3% (26/27).
CONCLUSION. CRS was a frequent adverse event after infusion CAR-
T therapy. In a third cases needed admission to the PICU. Toci-
lizumab was administered in CRS 3 and 4, always before steroids.
The most severe CRS began with symptoms in the first day of infu-
sion and needed two dose of tocilizumab. The survival of CRS was
high.
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INTRODUCTION. Clinical data science, and machine learning in
particular, is on the rise with new ICU related prediction models
being published continuously. However, few models make it to the
bedside and are able to influence clinical decision making. Recently,
we developed a machine learning based ICU readmission model (P.J.
Thoral, et al, ESICM LIVES 2018 Meeting Abstract. Manuscript in
preparation). We hypothesize that a tool based on our model should
be adapted to be explainable to the intensivist and offer an intuitive
user interface (UI).OBJECTIVES.
To test both model output explainability from a software prototype
based on our ICU readmission model and usability of the UI.
METHODS. A two-phase multicentre usability study was performed
at the Amsterdam University Medical Center, location VUmc,
Amsterdam, the Elisabeth-TweeSteden Ziekenhuis, Tilburg and the
University Medical Center Utrecht, Utrecht. The study was performed
using a software prototype of our ICU readmission model showing
twelve representative patients, predicting the combined 7-day risk of
ICU readmission or mortality on the moment of ICU discharge (see
Figures 1 and 2 ).
As part of the technical file for CE application of the software, the
study was set up according to the applicable guideline[1]. In phase 1
the software was tested by scripted end-user interaction. Results of
these tests were used to improve the software. In phase 2 the im-
proved software was tested. Both phases focused on the users’ un-
derstanding of the model predictions and the user
-friendliness of the interface design. All responses were scored
against the requirements of the software in order to evaluate safe
use of the tool.
RESULTS. Phase 1 was completed by 15 individual intensivists; the
second phase by six new and three recurrent intensivists. In phase 1
the explainability of the predictive features shown per patient was
insufficient with the average number of difficult to interpret features
being 4.9 out of 10 displayed features.
Table 1 shows the identified problems.
Furthermore, the graphical indicators and their meaning for specific
ICU supportive care were potentially confusing. Based on these
results explainability was improved by removing some less predictive
features and by simplifying feature aggregates. The UI was enhanced
by changing the display of feature importance and the supportive
care indicators. In phase 2, after these modifications, the participants
showed better understanding of the model output. The average
number of clinically difficult to interpret features dropped to 2.2/10.
In both phases all safety related equirements were met, meaning
that >90% of participants correctly understood and applied the
intended purpose of the tool.
CONCLUSION. We evaluated the use of an ICU readmission model in
a software prototype and improved both the explainability of the
model and usability of the software towards a valuable tool
intensivists can understand and safely use in their decision on
discharging a patient from the ICU.
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INTRODUCTION. Intensive Care Unit –acquired weakness (ICUAW) is
a clinical syndrome that develops while a patient is critically ill. In a
recent multi-centre cohort study, ICUAW was present in more than
50% of patients at ICU discharge. In an official American Thoracic So-
ciety Clinical Practice Guideline, ICUAW was reported to be more
common in patients with severe sepsis, prolonged mechanical venti-
lation, or difficulty with liberation from mechanical ventilation. There
is no consensus on the approach to diagnosis of ICUAW. Physical
examination of three muscle groups in each of the upper and lower
limbs has been developped by the medical research council (MRC) in
the UK and it results in a composite score of 60. This method has
been proven reliable in a cooperative patient. In a prospective, multi-
centre cohort study, hand-held dynamometry was used in non co-
operative patients to identify ICUAW and this method was
independently associated with increased hospital mortality in pa-
tients with ICUAW. The leuven protocol is the most frequently used
in ICU and it also correlates with mortanily.
OBJECTIVES. To identify the incidence of ICU-AW in patients admit-
ted to a tertiary neursugical ICU in a large teaching hospital. To im-
plement measures to prevent ICU-AWMETHODS. The study was conducted in a 24 beds neuro ICU in a
teaching hospital. This is an adult ICU admitting over 2000 neur-
neurosulgical patients per year and with over 200 cases per year
remaining in the ICU for over 7 days. One doctor and one physio-
therapist performed daily rounds to assess the incidence of ICU AW,
shoulder subluxation and ankle limitations in all neurosurgical pa-
tients. General characteristics were collected including age, gender,
reason for admission, length of ICU stay, others. The Leuven protocol
and planning was used to assess ICU-AW. Investigators collected data
related to the position of the patient, presence or supporting devices
for the shoulders, for the ankles, and the time and duration of
physiotherapy provided every day. Data collected were daily com-
pared and the diagnosis was agreed among doctors and the rehabili-
tation team. The nurses educators were involved in implementing
new meaasures to prevent ICU-AW and to support the rehabilitation
team .
RESULTS. Data were collected between the 13th decemebr and the
11 of November 2018. Interventions to reduce the incidence of ICU
AW were implemented in January 2019. Data were anonymous and
patients consented for the study. 101 measurements were
performed in 25 patients. 100% of the patients had low cooperation
(0-2) and low MRC score. 28% of the patients had shoulder
subluxation at ICU discharge. 36% of the patients had ankle
limitations (of whom 5% bilateral). Doctor was more likely to detect
the shoulder subluxation (80% of relevations) and physiotherrapists
the ankle limitations (65%). Nurses were not aware of this problem
and they did not felt this could affect outcome.
CONCLUSION. ICU-AW and limitations are frequent in long standing
neuro-surgical patients. Nursing staff is not aware and physiotherapy
cannot prevent alone this complication. Combined complex interven-
tions are needed to prevent ICU-AW. The nursing staff should be
trained in positioning adequately the patient and support shoulders
and ankles. Pillow and simple support devices are sufficient. Physio-
therapy cannot provide enough resources to prevent these complica-
tions and these are frequently not diagnosed. Doctors should be
trained in examining and recognise ICU AW because mortality is as-
sociated with the presence of sub-luxations or ankle limitations at
ICU discharge. The Leuven protocol is ideal because it has a progres-
sion and an intervention scale which is easy to use. However, aware-
ness and training of the staff in the ICU is needed.
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INTRODUCTION. ICU nurses are sometimes criticized as “high tech. &
low touch” in the medical literature, which may create patient and
nurse dissatisfaction patient but also to nurses. Stayt (2007) studied
ICU nurse’s emotional experiences and reflected ICU nurses face a
fundamental conflict both between the role expectations of patient
care, professional ideals and being a human which may contribute to
occupational stress.
OBJECTIVES. To test a “Therapeutic Nurse Relationship Program”
designed to improve nursing communication skill with patients and
relatives in ICU
METHODS. From Nov.2018, a pre-survey was conducted to ex-
plore nurse communication within established therapeutic rela-
tionships with patients/families. Inclusion criteria: patient ICU stay
> 72 hours, either patient or relatives were recruited by conveni-
ence sampling.
T2
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item questionnaire with a 5-point Likert response scale (1=poor to
5=excellent).
It focused on nursing communication with patient / relatives
regarding: 1. Explanation before performing a procedure (such as
suction/turning), 2. Care about patient’s comfort, 3. Proactively
updating the condition, 4. Providing psychological / mental support,
5. Offering religion support / referral, and 6. Overall satisfaction to
nursing care
3 qualitative questions were also used to explore the subject’s views
of nursing communication. A teaching program was conducted at
Dec., 2018 & focused on: 1. Different skills on communication -
including verbal & non-verbal, and 2. Promotion of various referral
service from hospital
79 (70%) of nurses attended the program and a post survey was
conducted from Jan.- Feb.,2019 for comparison.
RESULTS
Data in table one shows that there was a substantial increase in
positive response in three areas: 1. Providing explanation to patient /
relatives before perform procedure (from 65% to 90%), 2. Providing
psychological / mental support (from 55% to 70%), and 3. Offer
religion support / referral (from 15% to 25%).
There was no substantial increase in the other domains, although
overall baseline responses in the remaining domains were already
good (>70%). Overall satisfaction baseline responses (excellent &
very good) was already 80%, and increased to 90%.
CONCLUSION. The post-survey demonstrated a more positive feed-
back from patient’s relatives than the pre-survey. This positive trend
was confirmed in the in qualitative descriptions. It suggests the pro-
gram may enhance nursing communication to improve the thera-
peutic relationship between nurses to patient & patient’s relatives.
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Table 1 (abstract 001731). Results of pre-intervention and post-
intervention surveyQuestions: Pre-test (% rated
excellent OR very
good)Post-test (% rated on
excellent OR very good)1.Explain before perform
procedure (such as suction /
turning)65% 90%2.Care about patient’s comfort 70% 75%3.Proactively update the
condition75% 80%4.Provide psychological / mental
support55% 75%5.Offer religion support / referral 15% 25%6.Overall satisfaction to nursing
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INTRODUCTION. Cardiac arrest (CA) is a leading cause of mortality in
Europe and United States. The average survival to discharge rate in
out-of-hospital cardiac arrest patients (OHCA) is approximately 10%,in contrast to in-hospital cardiac arrest (IHCA) where it is 17-20%. The
risk of neurological disability remains high among survivors in both
groups.
Machine Learning (ML) is a type of artificial intelligence that provides
systems the ability to automatically learn and improve from
experience without being explicitly programmed.
OBJECTIVES. The aim of this study was to develop a type of ML
algorithm using data from the Wardwatcher Intensive Care Unit (ICU)
Swansea database to predict 30-day survival of patients admitted to
ICU post cardiac arrest.
METHODS. All cardiac arrest patients admitted to our regional
intensive care unit in South West Wales, United Kingdom between
January 2007 and June 2018 were included in this analysis. Data
included were age, gender, comorbidities, biochemical and
haematological results as well as temperature within 24h of
admission, length of stay, follow-up time and survival status.
RESULTS. Of the 1034 patients (532 OHCA and 502 IHCA) included in
the study, 600 (58%) patients died within 30 days. Random forest
(RF) was used as the type of ML algorithm. The area under the
receiver operating characteristic curve (AUROC) and area under the
precision-recall curve (AUPRC) predicting survival within 30 days of
admission was AUROC: 0.89 and AUPRC: 0.91 (.80-.90= good and .90-
1= excellent). For patients admitted with OHCA alone, the same RF
algorithm showed AUROC: 0.86 and AUPRC: 0.91. The ML modelling
took 0.99-2.32 seconds to be built.
CONCLUSION. ML modelling of the data of post cardiac arrest
patients admitted to ICU can predict 30-day survival with a reason-
able level of accuracy. Therefore, the data obtained from ML model-
ling may be used as an adjunct in making treatment decisions in
these group of patients, however larger studies comparing different
ML modelling are required to establish this.
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INTRODUCTION. Coding of diagnoses based on the International
Classification of Diseases (ICD) is a world-wide standard used for the
identification of health trends and statistics. Coded data is used for
multiple purposes including billing, health care allocation, and re-
search, presenting thus an urgent need for valid routine data. How-
ever, data validation of ICD-10 routine data in relation to the
completeness and correctness of comorbidity documentation is rare.
OBJECTIVES. Purpose of this study is to examine whether co-
morbidities of the Charlson-Comorbidity Index (CCI) that are derived
from routinely documented ICD-10 codes in patient records corres-
pond to manually assessed co-morbidities by a health professional
on the basis of anamnesis data.
METHODS. This is a secondary analysis of the FRAIL-AMB project, a
prospective observational study of elderly patients undergoing sur-
gery in a German university hospital between 2017 and 2018. Ethical
approval from the local authorities was obtained (EA1/227/16). The
CCI was calculated according to Quan et al. from the ICD-10 coded
routine data and compared to prospectively collected data from the
FRAIL-AMB project that was defined as gold standard. We drew on
result pair analyses.
RESULTS. A total of 1,186 patients were included into analyses. CCI
completeness of 52% (95% CI: 51.4-52.7) and a correctness of 60.5%
(95% CI: 59.9-61.2) was calculated for all comorbidity classes in the
ICD-coded routine data (Figure 1, SAP_CCI1=ICD-coded routine data).
Overall, a general undercoding was found.
Page 584 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55CONCLUSION. The study suggests that ICD-10 routine data cannot
provide consistently reliable information on all CCI comorbidity clas-
ses and should be used with caution. In a next step, improvement
potentials of critical CCI comorbidity classes should be investigated.
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INTRODUCTION. Acute Kidney Injury (AKI) is a frequent and severe
complication after major surgery, and is a common critical care
outreach call and a frequent reason for ICU admission. With millions
of surgeries performed worldwide every year, AKI have a high impact
in terms of morbidity, mortality and costs. According to KDIGO
guidelines, AKI is amenable to prevention, treatment and resolution
(1). However, early AKI detection and patients stratification in
standard surgical wards remains a significant challenge.
OBJECTIVES. To assess if mean arterial pressure (MAP) is associated
with AKI after high-risk surgeryMETHODS. Deidentified data from Electronic Health Records (EHR) of
a large teaching hospital were included in the analysis. We selected a
mixed surgical population of 1700 adult patients undergoing high risk
vascular and thoracic surgery from Jan 2015 to Dec 2018. AKI was
defined according to KDIGO guidelines (1), applying urinary and
creatinine criteria to vitals and laboratory data derived from EHR. A
subset including the first 7 postoperative days (POD) was selected for
the analysis. MAP was estimated from systolic and diastolic pressure.
Standard statistical regressions and machine learning techniques were
applied using R (R Core Team 2019) for data analysis.
RESULTS. 1441 patients were finally included in the analysis, with
245 patients (17%) developing AKI. Mean MAP was lower in patients with
AKI compared to controls on POD 1, 2 and 3, while there was no
difference on the day of surgery or after POD 4. (Fig 1). A similar pattern
was detected when plotting mean MAP up to AKI development against
control MAP (Fig2). The association between mean MAP and AKI was
confirmed when controlling for baseline variables and type of surgery in
a logistic regression model, (OR 0.96 [0.94-.98]), while statistical
significance was lost when adjusting for panel data. Machine learning
models resulted in lower accuracy than standard models.
CONCLUSION. MAP in the first days after high-risk surgery is associated
with AKI development. While both AKI and lower MAP can reflect an insult
occurred during surgery, models based on EHR data may permit early
stratification and detection of AKI, allowing to start timely treatment.
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INTRODUCTION. In cardiac surgery, heparin and protamine are
fundamental for management of anticoagulation, and its management is
known to affect bleeding. The effect of protamine on platelet function,
however, is not fully understood. In previous in vivo-studies(1) using
impedance aggregometry, a decrease in platelet function after exposure to
protamine has been seen.
OBJECTIVES. The aim of this study was to further examine the effect
of protamine on platelet function in vitro, using both aggregometry
and flow cytometry.
METHODS. Seven elective CABG patients were studied using impedance
aggregometry (Multiplate). Blood was mixed with protamine to a
concentration of 0, 20, 40 and 80 μg/ml. Adenosine diphosphate (ADP) was
used as activator and aggregation was expressed as the area under the
curve (AUC).
Blood from 7 healthy volunteers was studied using flow cytometry with
protamine added in the same concentrations as above, either alone or
together with ADP. Median fluorescence intensity (MFI) from the
monoconal antibody PAC-1-FITC, which binds to the activated fibrinogen
receptor on activated platelets, was studied. We also studied expression of
P-selectin using the antibody anti-P-selectin-PE (CD62P, clone: AK-4).
Statistics used were ANOVA and paired T-test. Data are expressed as
mean ± standard deviation.
RESULTS. With aggregometry, mean AUC for platelets activated by ADP
decreased with protamine from 73.8 ± 29.4 U (no protamine) to 61.8 ± 29.4
U (20 μg/ml), 51.7 ± 26.8 U (40 μg/ml), and 46.9 ± 26.1 U (80 μg/ml); p=
0.003. With flow cytometry, when activated with ADP, protamine reduced
platelet activation seen by MFI from 5.1± 2.0 (no protamine) to 4.1 ± 0.7
(20 μg/ml), and 3.1 ± 0.4 (40 μg/ml); p=0.02. When only activated with
protamine, mean MFI increased from 0.4 ± 0.04 (no protamine) to 0.7± 0.2
(20 μg/ml), 1.9± 1.0 (40 μg/ml), and 3.1± 0.8 (80 μg/ml); p<0,001. At 80 μg/
ml protamine, mean MFI was similar both with and without activation with
ADP (3.4 ± 0.2 and 3.1 ± 0.8, respectively).
Protamine with and without any activator, produced a significant
concentration-dependent increase in the proportion of platelets ex-
posing P-selectin, which indicates release of alfa-granule. The mean
proportion of P-selectin-positive platelets when no other activator
was used, increased from 4.0 ± 2.7 % (no protamine) to 95.3 ± 3.0
%(80 μg/ml); p<0.001. When activated with ADP, the proportion in-
creased from 22.8 ± 17.6 % (no protamine) to 95.8 ± 2.5 % (80 μg/
ml); p<0.001.
CONCLUSION. Protamine in vitro interacts with platelets with both a
direct activating effect and impairment of activation by other
activators. This impairment is consistent with previous in vivo-data
showing reduced platelet function after protamine exposure. The
direct activating effect may have significance for the risk of
thrombosis in cardiac surgery.
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INTRODUCTION. Alterations in microcirculation have been shown to
influence patient outcome and survival in different types of shock.
[1] Spinal cord is extremely sensitive to changes in microcirculation
and spinal cord hypoperfusion or ischemia with consecutive
paraplegia are major complications in thoraco-abdominal aortic re-
pair [2] The positive effects of albumin administration on macro and
microcirculatory state in shock have recently been described [3].
However none of this studies primarily focused on the effects on
spinal cord microcirculation.
OBJECTIVES. To date the direct effect of albumin administration on
spinal cord microcirculation has not been systematically assessed.
Therefore the aim of this study was to test whether a albumin based
volume resuscitation can improve spinal cord microcirculation in a
experimental model of shock
METHODS. The study was designed as prospective trial in 10
domestic pigs. Animals were anaesthetized and mechanically
ventilated. A laser – Doppler fluxmetry (LDF) Needle probe was
directly placed in the lumbar spinal cord for measurement of
microcirculatory blood flow (mFLUX). After baseline measurements
(M0) . Shock was in induced by hypovolemia (M1) (withdrawal of
blood 20ml/kg bodyweight). Thereafter volume loading was
performed using 5 % human albumin until no positive macro-
hemodynamic response to volume administration occurred (M2). An
increase in stroke volume >10% was considered as a positive volume
response.
RESULTS. Spinal cord mFLUX significantly decreased (47,8 at M0 to
22,7 at M1 p<0.05) during shock and was significantly increased after
albumin administration ( 22,7 at M1 to 51,2 at M2 p<0.05).
Furhtermore there was no significant difference between the mFLUX
values at M2 and baseline.
CONCLUSION. In our experimental animal model albumin based
volume resuscitation was able to improve spinal cord
microcirculation.
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INTRODUCTION. Remote ischemic preconditioning is a perspective
method of cardioprotection.
OBJECTIVES. To evaluate cardioprotective effects of remote ischemic
preconditioning (RIPC) and myocardial protein kinase C epsilon (PKC-
Table 1 (abstract 001344). Table showing the method of Assessment
used and the opinion of their accuracy in assessing fluid responsiveness
in each round
Fig. 1 (abstract 001344). See text for description
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different types of anesthesia.
METHODS. In prospective randomized study we enrolled 48 patients,
aged 64(56;69) years, which were scheduled for elective aortic valve
replacement using cardiopulmonary bypass (CPB). We divided them
into 4 groups: 1) RIPC performed during propofol anesthesia (RIPC
prop, n=12), 2) RIPC performed during sevoflurane anesthesia (RIPC
sevo, n=12), 3) propofol anesthesia without RIPC (CONTROL prop, n=
12), 4) sevoflurane anesthesia without RIPC (CONTROL sev, n=12).
Initial data of participants was similar in all groups. RIPC protocol
consisted of 3 simultaneous 5-min ischemic episodes of both lower
limbs with 5-min reperfusion intervals. Right atrium myocardium inci-
sion biopsy was performed for PKC-ε expression assessment using
Western immunoblot. Troponin I levels (cTnI) were measured before
anesthesia induction, after 30 min, 6, 12, 24, 48 hours after CPB com-
pletion. Data were assessed using Mann-Whitney U-test and
Newman-Keuls method for multigroup comparison. p<0.05 was con-
sidered significant. The data are presented as median (25th;75th
percentile).
RESULTS. RIPC showed cardioprotective effects only after sevoflurane
anesthesia: significant differences in cTnI were found between RIPC
sevo and CONTROL sevo groups at 6, 12 and 24 hours: 1.68(1.28;2.09)
ng/ml vs 3.66(2.07;4.49) ng/ml, respectively at 6 hours (p=0.04);
1.89(1.59;2.36) ng/ml vs 3.66(2.91;5.64) ng/ml, respectively at 12 hours
(p=0.001); 1.68(1.55;2.23) ng/ml vs 3.32(2.10;5.46) ng/ml, respectively at
24 hours (p=0.01). There were no differences found in cTnI between
RIPC prop and CONTROL prop groups in all timepoints. RIPC applied
during sevoflurane anesthesia also significantly increased PKC-ε expres-
sion: 1221(921;1438)Units in CONTROL sev group vs 1882(1564;
2131)Units in RIPC sevo group (p<0.05). Performing RIPC during propo-
fol anesthesia was not associated with any significant difference in
PKC-ε expression compared with control group: 620(436;782)Units in
CONTROL prop versus 788(574;1063)Units in RIPC prop group. PKC-ε
expression between control groups was significantly higher in sevoflur-
ane anesthesia than propofol anesthesia.
CONCLUSION. RIPC showed cardioprotective effects only during
sevoflurane anesthesia. This was confirmed by PKC-ε expression in-
crease and lower value of cTnI.
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INTRODUCTION. The ability to assess and appropriately interpret a
patient’s fluid responsive status is a critical skill for all ICU staff when
managing complex patients with hemodynamic compromise. There
are several techniques of varying complexity available to assess
preload responsiveness. Intravenous fluid administration is not risk-
free and should only be used under the right circumstances.
OBJECTIVES. The primary outcome was to assess the overall change
in knowledge about fluid responsiveness assessment amongst the
ICU staff in response to interventional educational processes.
Secondary outcomes looked at the changes amongst the varying
groups and the change in opinion/practice following education.
METHODS. A 25-question survey was composed based on a land-
mark paper by Monnet et al and it was given out to all ICU staff, in-
cluding consultants, trainees, nurses and medical students. Results
from this were determined at baseline and after education by meansof a fact sheet, a tutorial and it being a ‘’hot topic of the week”. Each
stage of the project was administered over 2 weeks: that is, the first
round of surveys was given out and collected over the first 2 weeks,
then the educational processes were delivered over the following 2
weeks, and finally, the second round of surveys was given out and
collected over the subsequent 2 weeks. There were 25 participants in
the first round and 14 participants in the second round.
RESULTS.
CONCLUSION. There was an overall improvement in the knowledge
of fluid responsiveness assessment in the critical care unit healthcare
workers in response to the educational processes. There was a
decrease in the number of people who used CVP, CXR and lactate in
their assessment, for which there is no role in gauging fluid
responsiveness. There was also a decrease in the number of people
who used fluid challenges as their technique of choice with
increased usage of other techniques, such as pulse pressure variation
and passive leg raising. This highlighted an increase in awareness of
the fact that a fluid challenge is a treatment in and of itself with
associated risks and less invasive means should be used, where
feasible. Review of cases of iatrogenic fluid overload is needed in the
future to assess the impact of this increase in knowledge, change in
opinion and change in practice of fluid responsiveness assessment
on patient outcome.
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Page 587 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. Right ventricular (RV) dysfunction has been largely
investigated in ARDS in terms of acute cor pulmonale (ACP).
However, ACP represents the last stage of RV failure. We aim to
investigate early RV dysfunction signs with echocardiography in
patients undertaking whole lung lavage (WLL) for pulmonary alveolar
proteinosis (PAP).
OBJECTIVES. To evaluate the correlation between echocardiographic
parameters of RV function and respiratory mechanics at different
steps of transpulmonary pressure during WLL.
METHODS. Prospective observational study of patients undertaking
WLL for PAP from January 2014 to March 2019. All patients were
intubated with selective orotracheal tube. WLL entails the
performance of alternatively single-lung ventilation while large-
volume (20 L) lavages are instilled and drained on the non-ventilated
lung along with chest physiotherapy and postural positioning. Cali-
brated values of oesophageal pressure were used as surrogate for
pleural pressure (Ppl); transpulmonary pressure (PL) was calculated
during end-inspiratory (insp) and end-expiratory (exp) occlusion ma-
noeuvres (1). Paw is the airway pressure. Right ventricular longitu-
dinal function (TAPSE) and the ratio between trans-tricuspid early
diastolic flow (E wave) and tricuspid annular tissue velocity displace-
ment (E’) were collected to evaluate respectively systolic and diastolic
function of RV (2). Ratio of RV to LV end-diastolic area – RVEDA/
LVEDA- is a marker of ventricular interdependence sensitive to RV
afterload variations (3). Respiratory mechanics and echocardiographic
parameters were collected at ZEEP (t0), at clinical PEEP right before
the procedure (t1), after the first lung lavage (t2), and at end of pro-
cedure after the lavage of the second lung (t3).
RESULTS. Preliminary results on 13 patients (69% males). RVEDA/
LVEDA ratio correlates with Paw insp (p < 0.0001, r 0.61), Paw exp (p
< 0.0001, r 0.6), PL insp (p 0.0001, r 0.5) and PL exp (p 0.0006, r 0.46),
but not with Ppl. RV E/E’ was related to Paw insp (p < 0.001, r 0.47),
Paw exp (p< 0.001, r 0.49) and PL insp (p<0.001, r 0.5269). TAPSE was
not related to respiratory mechanics parameters. Table Values of
respiratory and echocardiographic variables tested: mean (± standard
deviation)
CONCLUSION. In the setting of WLL, the increment in RVEDA/LVEDA
and in E/E’ could be considered sensitive markers of early RV
dysfunction. Absolute values of transpulmonary and alveolar
pressures, and not their respiratory variations (the driving pressures),
are correlated with RV function.
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Variables t0 t1 t2 t3
Paw end-insp 15,4 (±4) 19,5 (±4,4) 25,4 (±5,6) 26,4 (±4,2)
Paw end-exp 1,03 (±0,9) 5,7 (±0,6) 11,7 (±1) 12,9 (±1,7)
PL insp 8,5 (±3,9) 11,3 (±5) 16,3 (±3,9) 16,8 (±3,6)
PL exp -3 (±3,9) -0,3 (±4,3) 5,2 (±3) 5,8 (±3,5)
RVEDA/LVEDA 0,36 (±0,04) 0,4 (±0,07) 0,51 (±0,09) 0,45 (±0,05)
E/E’ 5,1 (±1,25) 5,7 (±1,4) 10,5 (±1,26) 6,75 (±1,6)
TAPSE 20,3 (±2,64) 18,7 (±3,3) 16,2 (±1,9) 18,1 (±1,5)001475
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INTRODUCTION. Circulatory shock is common, accounting for one
third of all ICU admissions. Despite current resuscitative practices
aimed at restoring macro-hemodynamics, mortality remains high at
over 50%. (1) This residual mortality has been attributed to micro-
circulatory failure, yet clinical monitoring of microcirculatory function
remains elusive. Venous-to-arterial carbon dioxide difference (Pcv-
aCO2 gap) has emerged as potential clinical marker of microcircula-
tory function, with some studies suggesting that values greater than
6 mmHg are predictive of poor outcomes. (2,3)
OBJECTIVES. We carried out a systematic review and quantitative
meta-analysis to determine if high Pcv-aCO2 gap is associated with
increased mortality in adult critically ill patients presenting with circu-
latory shock admitted to medical, cardiovascular and surgical ICUs.
METHODS. We conducted a systematic search using MEDLINE® and
EMBASE® electronic databases, using OvidSP search interface, from
inception through October 2017. Searches were restricted to studies
published in English language. The MOOSE checklist was followed
and methodological quality was assessed using Newcastle-Ottawa
Scale (NOS).
RESULTS. We included 50 studies (n=3948 patients) from medical
(n=26), cardiovascular (n=15), surgical (n=5) and mixed (n=4) ICUs.
The majority of studies were observational with prospective (n=40)
or retrospective (n=8) designs, and two were randomised controlled
trials (RCT). Eighteen studies reported the primary outcome (either
hospital or 28-day mortality). In these studies, high Pcv-aCO2 gap (>
6mmHg) was associated with higher hospital mortality with an odds
ratio of death of 2.6 (95% CI [1.6, 4.4], P<0.001). Subgroup analysis,
showed that Pcv-aCO2 gap may be a stronger predictor of mortality
in the medical ICU patients in comparison to cardiac and surgical
population. This occurred on the background of similar cardiac index
(0 hr: P=0.07; 6 hrs: P=0.2; 24 hrs: P= 0.96), lactate (0 hr: P=0.15; 6 hr:
P=0.06; 24 hrs: P=0.49), and central venous oxygen saturation (0 hr:
P=0.5; 6 hr: P=0.41; 24 hrs: P=0.93) between high and low Pcv-aCO2
gap groups. Meta-regression showed that the high gap has a predict-
ive power even if the differences in the established predictors of
mortality (APACHE II and SOFA) are accounted for (P= 0.0296, R² =
0.60 and P= 0.0151, R² = 0.83, respectively). There was no statistical
difference in terms of secondary outcomes such as ICU and hospital
length of stay, mechanical ventilation days and requirements for va-
sopressors and inotropes between the two groups. However, a high
Pcv-aCO2 gap was associated with an increased odds of requiring
renal replacement therapy (odds ratio: 1.95, 95% CI [1.32, 2.9], P=
0.001).
CONCLUSION. In patients with circulatory shock, high Pcv-aCO2 adds
predictive power over established predictors of hospital mortality
despite similar indices of macro-circulation and tissue perfusion. Fu-
ture studies should evaluate whether resuscitation aimed at closing
the Pcv-aCO2 gap Improves mortality in shock.
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INTRODUCTION. Fluidoverload in critical ill patients leads to worse
prognosis.Therefore the assessment of VR is crucial and we should
refrain from blind administering of volume in order to evaluate the
VR.Tests looking at change of cardiac output (CO) using reversible
increase of preload (e.g. passive leg raise PLR) are preferred
instead.Continual monitoring of CO for assesment of fast changes is
necessary e.g. echography or pulse contour analysis (PCA)
monitors.Recent data showed promising results of assessing the VR
by easy ultrasound (US) examination of carotic blood flow changes
in patients on ICU.Unlike echography this method has short learning
curve and does not need expensive PCA monitor.But there are no
data for patients with HF or CS yet.
OBJECTIVES. The first aim was evaluating the relationship between
changes of CO measured by echography and PCA monitor and
changes of carotic flow measured by US in patiens with HF or CS on
mechanical ventilation.The second aim was to find out cut-off values
of these parameters for determination of VR.
METHODS. We examined 21 patients with HF or CS on mechanical
ventilation from Jan 2018 to Mar 2019.17 patients required inotropes
at the time of examination being in state of CS either alone or
combined with distributive shock.All patiens underwent complex
analysis of VR (increase of CO by 15% after volume challenge or after
PLR were considered as VR).All patients had PLR test and stroke
volume variation examined,measured by echography (velocity-time
integral in outflow tract) and PCA monitor.Additional parameters
were taken into account-echographic signs of left ventricle(LV) filling
pressure (transmitral diastolic flow /E,A,E´/,gradients on pulmonary
and mitral regurgitation jets) and colabsibility of inferior vena cava,-
pulmonary capillary wedge pressure (4patients had Swan-Ganz/SG/
catheter).Patients considered as volumresponsive underwent volum
challenge.Those considered nonresponsive underwent volum chal-
lenge only if it was regarded as safe.We examined following carotic
parameters: respiratory variation of peak velocity(Vmax),effect of PLR
test on corrected carotic flow time (CFT) and carotic blood flow
(CBF).
RESULTS. Average LV ejection fraction was 35.6%.10 patients were
deemed as volumresponsive.All of them had positive response on
volume administration.11patients were deemed as nonresponsive.5
of them had volum challenge done without positive response,
remained 6 patients were considered not safe for volume challenge
but 4 of them had SG catheter and PCWP above 20torr.Linear
regression analysis revealed relationship between relative change of
CO (ΔCO) and CBF calculated by equation ΔCBF=1,21*ΔCO+8,53. We
found linear relationship also between ΔCO and changes of both
Vmax and CFT (ΔVmax=0,62*ΔCO+3,64 and ΔCFT=0,61*Δ+1,82)The
cut-off value for volumresponsivness was found by ROC analysis 15%
for ΔCBF,10.7% for ΔVmax and 6.2% for ΔCFT.
CONCLUSION. Although it is a small cohort of patients, our data
imply possible applicability of easy carotic US examination in fluid
management in patients with HF or CS.Change of ΔCBF seems to be
the most promising parameter.REFERENCE
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INTRODUCTION. Although inflammation is recognized as a major
contributor for heart failure (HF) progression, clinical trials targeting
proinflammatory cytokines in HF have been disappointing. A better
understanding of the inflammatory pathways triggered in acute HF
(AHF) is urgently needed to identify putative therapeutic targets to
alter the course of this disease. A new paradigm of the
inflammatory process has emerged recently, introducing
endogenous specialized pro-resolving mediators (SPMs) that stimu-
late the resolution of inflammation and tissue regeneration. These
include resolvins (Rvs) and lipoxins (LXs) that were never studied in
human AHF.
OBJECTIVES. To evaluate SPMs and their correlation with markers of
inflammation, oxidative stress, cardiovascular dysfunction and also
with prognostic scores/biomarkers in human AHF.
METHODS. AHF (n=10) and cardiogenic shock (CS) (n=9) patients
were included and blood samples were collected at days 1-2, 3-4
and 5-7. Blood donors were used as controls (n=10). LXA4, 15-epi-
LXA4, RvD1, RvE1, endocan (endothelial dysfunction/proinflammatory
marker), IL-10, myeloperoxidase (MPO) and nitrotyrosine were mea-
sured with ELISA kits. C-reactive protein (CRP), B-type natriuretic pep-
tide (BNP), high-sensitivity troponin I (hsTi), lactic acid, APACHE II and
SAPS II scores were also evaluated.
RESULTS. At admission, CS was associated with significantly lower
RvD1 (CS vs AHF, p=0.024) and higher values of RvE1 (CS vs
controls, p=0.004) and IL-10 (CS vs controls, p=0.044). Both AHF
and CS groups exhibited higher endocan and MPO serum con-
centrations (p<0.05 or p<0.001 vs controls) and unaltered LXs
values. During hospitalization, we only observed significant
marked reductions for LXs values. Within patients, we observed
that RvD1 presented inverse correlations with endocan (r=-0.38,
p=0.009), lactic acid (r=-0.51, p=0.041), 15-epi-LXA4 (r=-0.32, p=
0.029), IL-10 (r=-0.35, p=0.004) and SAPS II (r=-0.50, p=0.029),
while positive correlations were observed for RvE1 with CRP (r=
0.30, p=0.047) and MPO (r=0.29, p=0.048), LXA4 with 15-epi-LXA4
(r=0.70, p<0.001), and IL-10 with endocan (r=0.43, p=0.004), nitro-
tyrosine (r=0.35, p=0.018), hsTi (r=0.37, p=0.017), CRP (r=0.41, p=
0.007) and APACHE II (r=0.62, p=0.006).
CONCLUSION. RvE1 increases with clinical severity, being positively
associated with proinflammatory status. RvD1 appears to be
exhausted/inactivated in worse clinical scenarios in AHF spectra,
being probably a protective mediator and a potential therapeutic
target as suggested by its inverse correlations with biomarkers of
endothelial dysfunction, inflammatory status and prognostic scores/
biomarkers. The drastic reductions in LXs values during
Page 589 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55hospitalization may be related to poor prognosis in AHF after
discharge, as higher severity of chronic HF was previously shown to
be associated with lower values of these SPMs.
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INTRODUCTION. Nowadays, the prevalence of aortic stenosis is
increasing and some of these patients present comorbidities where
the surgical replacement is contraindicated. As an alternative
solution, there is TAVI intervention, available in our hospital since
2010 with an important rise in survival for this population.
OBJECTIVES. Mortality rates review during hospital stay and one year
mortality, for patients who underwent TAVI in a tertiary level hospital
without Cardiac Surgery Department.
METHODS. Between January 2011 and November 2018, all patients
undergoing TAVI with transfemoral self-expandable and balloon-
expandable bioprotesis at Burgos University Hospital, were included
in a retrospective registry (CEIC: 2062). Demographic characteristics,
periprocedural complications and comorbidities were recorded in
Excel database with posterior analyses in SPSS. Survival was esti-
mated using the Kaplan-Meier method.
RESULTS. During study period, 103 TAVI were implanted in our
hospital. 30-day mortality was 7%, one year mortality was 18% in-
stead. Mortality during Intensive Care Unit stay was 4%. Survival
probability was calculated with mortality rates: 50% at 45 months
since TAVI implantation.
Once all mortality causes were bundled, a 6,8% of patients died
due to severe complications during the implantation,
predominantlyvascular issue. During post-implant period, 7% of
the patients died because of acute heart failure, 1,9% cardiac
block, 1,9% had severe hemorrhage to death and 3,9% had sys-
temic infection to death with organ failure.
Presenting previous malignant illness or an active one, was
associated with global mortality independently (OR 1,42, 95% [IC]
0,258 – 7,896; p= 0,027).
CONCLUSION. TAVI implantation is being introduced as a treatment
with high survival in our center with similar outcomes comparing
with the available data. The careful selection of best candidates for
TAVI implantation based on patient risk factors and comorbidities is
the clue for success.Fig. 1 (abstract 001547). See text for descriptionREFERENCE(S)
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INTRODUCTION. Acute heart failure (AHF) is a high mortality disease with
a complex pathophysiology, including renin angiotensin aldosterone
system disorders. Therapeutics of AHF are lacking (1). Dipeptidyl peptidase
3 (DPP3) is a protein whose main substrate are angiotensin II and
enkephalins (2). Recently, high DPP3 levels were associated to a high
mortality and organs failure in septic patients (3).
OBJECTIVES. The aim of our work is to describe consequences of
high DPP3 levels and effects of its inhibition in an experimental mice
model of AHF.
METHODS. Our study obtained approval of local ethic committee and
used 3 month old C57Bl6 mice. (A) DPP3 was IV injected in mice followed
during 2h after injection. (B) In an isoproterenol (ISO) induced stress
protocol mice followed during 24h were blinded injected by a antibody
against DPP3, the Procizumab (PCZ), or PBS. Myocardial oxidative stress
staining was realized by dihydroethidium (DHE) immunofluorescence.
Datas were expressed as mean ± SEM (intergroup comparison by 2 ways
of ANOVA and Mann Whitney test, p<0.05 was significant).
RESULTS. (A) 7 mice were included in DPP3 injection protocol (n=3 sham,
n=4 DPP3). Shortening fraction (SF) decreased and reached low value at 15
min after DPP3 injection (53 ± 1 vs 62 ± 1, p<0.05), renal resistive index
(RRI) increased at 60 min (0.77 ± 0.05 vs 0.56 ± 0.01, p<0.05) and increased
myocardial oxidative stress at 120 min (4.8±0.7 AU vs 1.4±0.3 AU, p<0.05).
(B) 15 mice were included in ISO + Procizumab protocol (n=5/group). In
ISO + PCZ group, SF increased from the first hour (48 ± 1% vs 60 ± 1, p<
0.0001), RRI decreased at 6h (0.62 ± 0.02 vs 0.81 ± 0.06, p<0.05), and
decreased myocardial oxidative stress at 1h (2.6 AU ± 0.5 vs 9.3 AU ± 0.9
p<0.05) after Procizumab injection, compared to ISO + PBS group.
CONCLUSION. Excess of circulating DPP3 induced myocardial
depression. DPP3 inhibition by Procizumab restore cardiac function
and kidney hemodynamics and decrease oxidative stress. Studies are
necessary to understand the role of DPP3 in AHF pathophysiology.
Procizumab could be an interesting therapeutic in AHF.
REFERENCE(S)
1. Eur. Heart J. 2016
2. Biol. Chem. 2016
3. J. Appl. Lab. Med.,2018.F2
Page 590 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55001559
Effects of transfusion of two units of red blood cells on
haemodynamics in severely anaemic critically ill patients: an
observational study in patients with MASIMO (Radical 7) and
PiCCO monitoring
A. Herner, W. Huber, R. Schmid, I. Hartter
1Medizinische klinik und poliklinik ii, Klinikum rechts der Isar; Technische
Universität München, Munich, Germany
Correspondence: W. Huber
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001559
INTRODUCTION. Anaemia due to acute or chronic loss of blood or
due to dilution is frequent in critically ill patients. Thresholds to
initiate transfusion with red blood cells (RMC) are matter of an
ongoing debate. Nevertheless, there are only few studies
investigating the impact of transfusion on extended haemodynamic
monitoring (1).
Therefore, we investigated changes in haemodynamic parameters
induced by transfusion of two units of red blood in 45 critically ill
patients under haemodynamic monitoring with Radical 7 (MASIMO,
USA; 45 patients) and PiCCO (35 patients; 10 patients required
transfusion before initiation of PiCCO-monitoring).
METHODS. This prospective observational study was performed on a
general ICU of a University Hospital in Munich. Only patients at pre-
defined need of blood transfusion (laboratory haemoglobin Hb <
7mg/dL; in case of pre-existing severe cardiovascular disease: Hb <8
mg/dL; measured with RAPIDPoint 500 Blood Gas analyzer (Siemens,
Germany)) were included. All measurements were performed prior
and after the transfusion of two units of red blood cells. Statistics:
Wilcoxon-test for paired samples. IBM SPSS 25.
RESULTS. 12 (27%) female and 33 (73%) male patients, height
175±8cm, weight 79±17kg. Hb measured by the blood gas
analyzer increased from 6.7±0.6 to 8.8±0.8g/dL (p<0.001). Among
MASIMO-parameters, perfusion index PI decreased from 2.7±2.3
to 2.3±1.7 (p=0.024) and pleth variability index (PVI; only ana-
lyzed in patients with sinus rhythm SR and controlled mechanical
ventilation CMV) increased from 10.4±5.5 to 14.5±10.4; p<0.001.
By contrast, PiCCO-derived stroke volume variation SVV (9.4±7.9
to 8.5±7.2%; p=0.442) and pulse pressure variation PPV (6.8±5.9
to 7.6±7.3%; p=0.719) did not change. Among the other PiCCO-
derived parameters, the most pronounced change was an in-
crease in mean arterial pressure MAP (87.6±11.6 vs. 97.2±
14.1mmHg; p<0.001). Furthermore, cardiac power index CPI in-
creased from 0.82±0.25 to 0.91±0.26W/m² (p=0.009), and SVRI in-
creased from 1093±483 to 1353±653dyne/cm2/m5; p<0.001.
Global ejection fraction decreased from 25.3±6.6 to 23.7±6.8%
(p<0.001). All other parameters did not change significantly from
before to after transfusion: Heart rate 93±15 vs. 92±17/min (p=
0.154); cardiac index CI 4.9±1.4 vs. 4.7±1.3L/min/m²; p=0.064;
stroke volume index SVI 53.6±13.2 vs. 52.2±14.1mL/m²; p=0.098;
extravascular lung water index EVLWI 10.9±3.8 vs. 11.4±3.2mL/kg;
p=0.099; CVP 19.9±17.8 vs. 17.7±8.1mmHg; p=0.203; global end-
diastolic volume index GEDVI 878±187 vs. 894±172mL/m²; p=
0453; dPmax 1328±414 vs. 1354±393mmHg/s; p=0.184. Further-
more, the noradrenaline dosage was comparable before and after
transfusion (413±317 vs. 398±345μg/h; p=0.465).
CONCLUSION. 1.) Transfusion of two units of red blood cells in
severely anaemic patients resulted in marked increases in MAP
(11%) and CPI (11%). 2.) In patients with SR and CMV, changes in
dynamic indices of fluid responsiveness derived from MASIMO
and PiCCO were not congruent: While PVI increased despite the
volume load, SVV and PPV did not change. 3.) MASIMO-measured
perfusion index PI decreased despite the volume load by two
units of red blood cells.
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INTRODUCTION. Fluid administration is the first therapeutic response
in perioperative patients where there are signs of decreased tissue
oxygenation and impaired organ perfusion [1]. Inadequate fluid
therapy can cause hypovolemia. Conversely, excessive fluid
administration leads to a positive cumulative fluid balance which can
lead to complications for the cardiac surgery (CS) patient [2]. No real
endpoint for optimal administration of fluids is currently available
and global macrohemodynamic parameters may not always reflect
microcirculatory dysfunction [3]. Here we introduce a non-invasive in-
tegrative hemodynamic monitoring (IHM) approach to monitor the
hemodynamic impact of fluid therapy by monitoring the systemic
circulation microcirculation and tissue water composition. We
propose this integrative hemodynamic platform as a comprehensive
physiologically based approach for fluid management of the CS
patient.
OBJECTIVES. We aimed to determine how microcirculation,
macrocirculation, and body fluid compartments are affected in post-
ICU CS patients.
METHODS. Twenty-five patients whom underwent open CS were in-
cluded in the study. Non-invasive IHM was accomplished by meas-
urement of sublingual microcirculation (Cytocam-IDF, Braedius
Medical, Huizen, the Netherland), systemic hemodynamic parameters
(Nexfin, BMEYE, Amsterdam, The Netherlands) and of the body fluid
status (Body Composition Monitor, Fresenius Medical Care, Bad Hom-
burg, Germany). Measurements were performed before CS (T0), first
(T1) and on day 3 (T3) after admission to the ward from the ICU.
RESULTS. Seventeen patients with three-time points and eight pa-
tients with two-time points were analyzed using dedicated software.
The baseline body weight was 84.5 kg (79.4; 93.8) which T0, in-
creased to 89.4 kg (82;101) at T1 and 86.5 kg (80.9; 97.3) at T3 (p<
0.001). Total vessel density showed an inverse relationship to body
weight (T0: 24 mm/mm2(22.9;25.3), T1: 20.2 mm/mm2(18.5;21;6), T3:
21.6 mm/mm2(19.4;23.5), p<0.001). Total body water and extracellu-
lar water changed in parallel with the change in body weight (p=
0.002 and p<0.001, respectively). Interestingly, intracellular water
(ICW) at T3 was found to decrease significantly lower than baseline
although ICW at T1 was not significantly different from T0 (T0: 20.3 lt
(17.5; 22.8), T1: 20.7 lt (18.8; 23.1), T3: 18.9 lt (16.4; 21.1), p=0.012).
Systolic, diastolic and mean arterial pressure at T1 and T3 were found
to be lower than baseline (p=0.004, p=0.024, p=0.005, respectively).
Cardiac output/index and dP/dt did not differ within time points (p=
0.08 and p=0.42, respectively). Stroke volume was 96 ml (85;104) at
T0, and decreased to 82 ml (74; 94) at T1, and 85 ml (67; 93) at T3
(p=0.004).
CONCLUSION. Our study shows that non-invasive IHM allows com-
prehensive identification of behaviour of fluid therapy in CS patients.
Results show that CS related microcirculatory perfusion disturbances
and loss of hemodynamic coherence occur as a result of fluid ther-
apy which persists even after discharge from the ICU.
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INTRODUCTION. Acute Myocardial Infarction (AMI) is a potentially
life-threatening condition, frequently diagnosed in critical care envir-
onment. The presence of concomitant medical conditions such as in-
fection or hematological disorders may reduce therapeutic options. It
is therefore important to characterize this subset of patients, since
the medical approach is often challenging.
OBJECTIVES. To analyze the population of patients admitted in
Polyvalent ICUs with the diagnosis of AMI in a two-year period.
METHODS. We performed a retrospective characterization of patients
admitted in two Polyvalent Intensive Care Units between January of
2017 and December of 2018, with the primary or secondary
diagnosis of AMI.
RESULTS. The final diagnosis of AMI was made in 72 patients, 31,9%
of which (n=23) classified as STEMI. The median age of the
population was 71 years.
72,2% (n=52) of the patients had a previous diagnosis of Arterial
Hypertension, and 48,6% (n=35) of Diabetes mellitus. 26,3% of the
patients (n=19) had previously known coronary heart disease.
51,4% (n=37) were admitted in circulatory shock (cardiogenic or
other).
43% of the patients (n=31) did not perform coronary angiography,
either due to clinical instability from concomitant medical conditions
or to the likely diagnosis of type 2 myocardial infarction.
Among the STEMIs, 7 cases were admitted in Polyvalent ICUs after
successful cardiopulmonary resuscitation and immediately after
cardiac revascularization in order to initiate hypothermia protocol.
56,9% (n=41) of the total number of patients were submitted to
coronary angiography, and in 33,3% (n=24) Primary Coronary
Angioplasty of one or more coronary arteries was performed. Seven
patients were proposed for Coronary Artery Bypass Graft surgery.
The remaining patients were considered to have no benefit from
revascularization.
The intra-hospital mortality was of 37,5% (n=27).
CONCLUSION. The patients diagnosed with AMI in Polyvalent ICUs
require different medical and interventional approaches, since there
are often distinct pathophysiology processes involved and conditions
preventing early revascularization. An experienced team and
availability of resources are fundamental to ensure the best
outcomes among these patients.
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INTRODUCTION. Atrial fibrillation (AF) is the most common
arrhythmia in critical ill patients (1). New onset AF (NOAF) is linked
with severity of disease and is associated with poorer outcomes,
including prolonged ICU stays and higher mortality rates (1-3).
National guidelines exist in the UK for management of AF, but they
are not specific to critical care (4). The most effective treatment for
AF in critical care remains unclear.OBJECTIVES. To retrospectively assess the incidence and
management of new-onset atrial fibrillation in a single centre critical
care setting.
METHODS. Notes of 909 patients admitted to critical care at the
Royal University Liverpool Hospital between 2008 and 2014 were
reviewed. Patients were identified as having pre-existing AF (PEAF, ei-
ther chronic or paroxysmal), NOAF, or no AF during a period of up to
7 days. Pharmacological treatment regimes for rate or rhythm control
of AF, heart rate before and after onset of AF, inotrope usage at on-
set of AF, presence of sepsis, age, APACHE II score and 28 day mor-
tality rates were also recorded.
RESULTS. 199 patients (21.9%) were identified as having new onset
AF; 53 patients had pre-existing AF (5.8%), and the remaining 657 pa-
tients (72.3%) did not have AF. The mean age of patients with new
or pre-existing AF was higher than those without AF (72, 70 and 56
respectively) and APACHE II scores followed a similar pattern (21, 22
and 18). Mortality rates were higher amongst patients with NOAF
than PEAF or no AF (30.7%, 24.5% and 16.2%). 481 patients had sep-
sis (52.9%); 142 of these patients had NOAF and 14 had PEAF. 55 pa-
tients only had electrolyte replacement (Mg2+ and K+) after the
onset of AF, and 53% of these patients reverted to sinus rhythm; but
the majority of patients were given amiodarone, in combination with
electrolytes, alone, or with other anti-arrhythmics.
CONCLUSION. New-onset atrial fibrillation is more common in older
patients with higher APACHE II scores, and these patients have a
higher 28 day mortality rate than patients with pre-existing AF. Fur-
ther research is needed to clarify the best treatment strategy for new
onset AF in critically ill patients.
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INTRODUCTION. There is an increased concern on the specifics of
the geriatric population, still the role of continuous renal
replacement therapies in survival is not very clear and most certainly
not for a subgroup of very old patients (> 80y.o.)
OBJECTIVES. The primary objective of this study was to access the
impact of CCRT (continous renal replacement therapy) on survival of a
specific geriatric subgroup, the so called, very old patients (> or = 80
years old), comparing it with the younger population who was also
submitted to CCRT on the same time period.
METHODS. 141 ICU patients were included, from March/2010 to
March/2019 (84 patients were excluded due to lack of data needed
for the analysis). Age group: the younger patient was 18y.o., the
oldest was 92 y.o. (mean 69.4 ±14.1), from those, 80 patients were >
80 y.o. (it means 70.9% of the patients). Concerning the gender, 37.6
% (n=53) were females, 62.4% (n=88) were males and 95% (n=134)
Caucasians vs. 5% (n=7) Blacks. The data was collected through a
Page 592 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55retrospective analysis of these patient´s medical reports and
analyzed using SPSS version 23.
RESULTS. The survival curve (Kaplan-Meier) showed that patients in
an age range = or > 80y.o. submitted to CCRT had lower survival
rates after starting the therapy, this data is of statistical significance
(Log Rank test, p<0.05). Their survival was influenced by: age > 80
(H.R 4.3, confidence interval 95%, p value <0.05) and by duration of
CRRT (measured in days), the shortest the therapy the highest the
mortality (HR 15.7, confidence interval 95%, p- value < 0.01). Using
Cox regression, it was found that the cause of patient´s admission on
ICU had no impact on survival (p-value >0.05), likewise if it was a
newly diagnosed acute renal failure or an acute renal failure on a
patient with stablished chronic kidney disease. Serum levels of
creatinine, urea, potassium, pH and HCO3 on arterial blood gas
analysis, immediately before starting the CRRT also did not have
impact on survival. Oliguria, defined as urine output < or = 0.3 mL/
kg/min previous to the therapy, as well as type of therapy applied
(hemodialysis, hemofiltration, both), type of anticoagulant (citrate or
heparin), prescribed dose of therapy, did not have impact on survival
of this geriatric subgroup (very old patients).
CONCLUSION. The geriatric patients, specially the very old patients
(> or = 80 y.o.) should be thought as a particular population and that
should guide the clinician to make a different clinical approach
comparing to younger patients. The highlight of this study was to
find out that regardless of the etiology of renal insufficiency,
regardless of lab values or presence/absence of oliguria, age prevails
and that variable itself should help on making decisions on weather
to start/not to start CRRT since it showed no improvement on
survival of this age group
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INTRODUCTION. The prevalence of acute renal failure in intensive
care units (ICU) is about 66%. From those, 13,5% meet the criteria for
CRRT. The short term mortality of these patients is around 70%. The
ideal CRRT technique is not yet stablished and some studies showed
no difference on mortality.
OBJECTIVES. Retrospective survival analysis of patients submitted to
CVVHF (continuous venovenous hemofiltration) vs CVVHD (continuous
venovenous hemodyalisis).
METHODS. One hundred forty four ICU patients submitted to CRRT were
selected, from March 2010 to March 2019. Seventy two patients were
excluded, because they were submitted to continuous venovenous
hemodiafiltration.
Those on regular program of hemodialysis were also excluded.
The demographic data were collected from patient’s medical reports
and it was analyzed through SPSS 23 statistics software.
RESULTS. Seventy two patients were included. From those 63,9% (n=
46) were male. The mean age was 69,0 ± 5,6 years old (18 to 87
years old).
Most of the patients were submitted to CVVHD (n=47; 65,3%). The
mean survival was 4 days (0-33 days) and 70,8% (n=51) died during
ICU admission.
The survival curve (using Kaplan-Meier method) showed lower sur-
vival for patients submitted to CVVHD, although it was not statisti-
cally significant.Excluding the patients who died within 48 hours after hospital
admission, in whom the mortality is strongly influenced by admission
cause, the results weren´t any different.
The other variables analyzed (age, gender, cause of admission,
previous diagnosis of chronic renal insufficiency, duration of CRRT,
degree of metabolic acidosis or creatinine and urea serum levels)
had no impact on survival.
CONCLUSION. This study showed that there is no statistically
significant difference between the CVVHD vs CVVHF groups survival.
Like other studies available, this analysis has a small sample and it’s a
retrospective and monocentric study.
A bigger scale study is needed so that we have more reliable
information to approach these patients.
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INTRODUCTION. Acute kidney injury in trauma patients is a problem
that has been little studied in the ICU. Its occurrence has been
shown to be associated with high morbidity and mortality.
OBJECTIVES. To determine the outcome in ICU trauma patients with
AKI, including the incidence of death in the ICU, of non-reversible
renal impairment and ICU complications. As well as to identify pre-
dictive factors of ICU mortality and poor outcome.
METHODS. This is a ten-month long prospective cohort-study, con-
ducted in the department of emergencies and intensive care unit
(ICU) of a university hospital, including trauma patients with a mini-
mum ICU stay of 7 days. Renal failure was defined based on the new
KDIGO classification. Predictors of mortality and poor outcome were
identified using univariate and then multivariate analysis.
RESULTS. One hundred thirty patients were admitted during the
study period for the management of post-traumatic injuries, among
which 86 patients were included. The incidence of AKI in the studied
population was 53% (46 cases) with 26 (56%) diagnosed with stage
one, ten (22%) with stage two and ten (22%) with stage three. The
overall mortality of patients with post-traumatic AKI was 34.8% (16
patients) with a mean lengh of ICU stay (LOS) at 22 ± 18 days (ex-
tremes ranging from 5 to 68 days), and of days on ventilator at 17 ±
15 days (extremes ranging from 2 to 68 days). Eight patients (17.4%)
needed renal replacement therapy and thirty-four had non-reversible
renal impairement (74%). During ICU stay, thirty-two (69%) patients
developed nosocomial infections and eight (17%) were diagnosed
with pulmonary embolism.
On univariate analysis, the following variables were associated to
mortality in patients with post-tramatic AKI including; age,
hemodynamic instability on the day of diagnosis, the use of vaso-
active support, transfusions and bilirubin levels on the day of AKI
diagnosis.
Besides, according to our analysis, the use of renal replacement
therapy and the non-reversibility of renal impairment during ICU stay
were also associated to ICU mortality.
Among these factors, the non-reversibility of renal impairment in the
ICU was a predictor of mortality on multivariate analysis (p = 0.009,
OR = 29, CI: 4-142).
Moreover, in this cohort, the following variables were predictive of
non-reversible renal impairment during ICU stay; including age (with
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tension, high injury severity score and diuretics’ administration.
The early delay to AKI from trauma was also predictive of the non-
reversibility with a best cut-off at 2.5 days (AUC ROC= 0.87, Se=
83.3%, Sp=82.4%). On multivariate analysis, the age(p = 0.004, OR =
0.9, CI: 0.80-0.97) and use of diuretics (p = 0.003, OR = 33, CI: 3.1-359)
were associated to non-reversible AKI in the ICU.
CONCLUSION. Our study confirms that post-traumatic AKI in the ICU
is associated to high morbidity and mortality. The identification of
outcome predictors could be valuable to guide the management AKI.
INF / ETH - Onco-hematologic issues
and approaches to improve ICU
outcomes
000556
ICU mortality among oncological patients at a public cancer
hospital in São Luís-Northeast Brazil: three-year evaluation
AP. Pierre de Moraes1, G. Alves1, JR. Lima1, AA. Silva2, Y. Assis1
Intensive Care Unit, Cancer Hospital of Maranhao Tarquinio Lopes Filho,
São Luís, Brazil; 2Public health, Federal University of Maranhão, São Luís -
Vila Maranhão, São Luís - State of Maranhão, Brazil, Brazil
Correspondence: A.P. Pierre de Moraes
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000556
INTRODUCTION. Recent studies point out that the severity of acute
complications, the number of organ disfunction, the management
complexity and performance status have more impact on ICU
mortality among cancer patients than the underlying neoplasm
disease [1-3].
OBJECTIVES. To evaluate risk factors for ICU mortality among cancer
patients
METHODS. A retrospective study conducted at a 11-bed ICU of a
public cancer hospital in São Luis, one of the capitals of northeastern
Brazil. We evaluated all cancer patients > 18 years old requiring ICU
admission from January 2016 to December 2018, excluding those in
palliative care support, readmission, and those that had ICU stay <24
hours. We evaluated demographic and clinical variables, ICU support
at admission and during ICU stay by univariate and multivariate ana-
lysis. The risk factors for ICU mortality were investigated through
multiple logistic regression analysis.
RESULTS. Out of 1021 patients, 699 (68%) had solid locoregional
tumors, 182 (18%) had solid metastatical tumors and 140 (14%) were
onco-hematology patients. The main solid tumor sites were gastro-
intestinal 254 (25%), gynecological 152 (15%), and urological 107
(11%). There were 438 (43%) admissions due to medical reasons, 553
(52%) and 50 (5%) for postoperative care after elective and emer-
gency surgery, respectively. The overall ICU mortality was 34%. At
multivariate analysis, the independent risk factors for ICU mortality
were: admission due to medical reasons (OR = 7,57; 95%CI: 4,39-
13,08) or due to emergency surgery (OR=2,78; 95%CI 1,27-6,08), high
SAPS 3 (OR = 1,03; 95%CI: 1,01-1,04) and high SOFA scores at admis-
sion (OR = 1,17; 95%CI: 1,08-1,26), need of mechanical ventilation
(OR = 2,94; 95%CI: 1,94-4,46), use of vasoactive drugs during ICU stay
(OR = 2,19; 95%CI: 1,36-3,55) and nosocomial ICU infection (OR =
3,96; 95%CI: 2,26-6,93).
CONCLUSION. An unplanned ICU admission, higher severity scores
upon ICU admission, complex support and infection during ICU stay
were identified as risk factors for ICU mortality. The severity of acute
illness at ICU admission may suggest that prompt recognition of
organ dysfunction and the possibility of early ICU referral could offer
opportunities to better management of acute critical complications.
The expansion of prevention strategies to reduce hospital-acquired
infection would be important for improving ICU mortality rates.REFERENCE(S)
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INTRODUCTION. Cervical cancer presents large geographic variations
in incidence and mortality rates. Control and prevention measures
also differ markedly worldwide. It is estimated that almost 90% of
deaths occur in low- and middle-income countries. [1-2]
OBJECTIVES. To evaluate the characteristics and outcomes of cervical
cancer patients requiring ICU admission and compare them to those
with other solid cancer patients also requiring ICU admission
METHODS. This retrospective study was conducted at a 11-bed ICU
of a public cancer hospital in São Luis, one lower income capital of
northeastern Brazil. All patients > 18 years old with a solid tumor re-
quiring ICU admission from January 2016 to December 2018 were in-
cluded and were classified based on their primary solid tumor site in
cervical and other solid tumor patients. We evaluated demographic
and clinical variables at ICU admission, ICU support. The primary out-
come were ICU and in-hospital mortality. Statistical differences were
tested using Pearson´s chi-square or Mann-Whitney tests as appropri-
ate. The significance level adopted was 0,05.
RESULTS. Out of 1369 patients, 148 (11%) had cervical uterine cancer
and 1221 (89%) had other solid tumors. The main admission reasons
were elective surgery 80 (54%), medical admission due to infection/
sepsis 20 (14%) and renal disfunction 17 (12%). Compared to other
solid cancer patients, cervical cancer patients were younger (p<
0,001), but did not differ in the presence of metastatical disease(p=
0,59), comorbidities (p=0,73), functional status (p=0,40), SAPS 3 score
(p=0,58) and SOFA score on the first ICU day (p=0,38). Regarding ICI
support, cervical cancer patients had higher need for renal
replacement therapy (p<0,001), but lower need for mechanical
ventilation (p=0.01). Compared to other solid cancer patients, ICU
mortality was lower in cervical cancer patients (29% versus 19%, p=
0,02), but there is no difference between groups in in-hospital mor-
tality (40% versus 39%, p=0,69).
CONCLUSION. There was a considerable occurrence of ICU admission
of young or middle-aged women with a preventable disease that
had high morbidity and mortality. The results of this study reinforce
the importance of providing adequate prevention programs, early
diagnosis, access to medical attendance and prompt reference in
order to improve cervical cancer outcomes.
Fig. 1 (abstract 001225). See text for description
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INTRODUCTION. Hidden mortality is a relevant problem in many
critical conditions, including hematopoietic stem cell transplantation
recipients (HSCT-R). Despite a significant number of HSCT-R die in
the Hematology ward after been discharged from the Intensive Care
Unit (ICU), this aspect has not been extensively studied. So, we be-
lieve that a better understanding of this population would help to
improve their prognosis.
OBJECTIVES. Our aim was to analyze the differences between HSCT-
R discharged from the ICU who died before being discharged from
hospital and those who survived.
METHODS. Retrospective study, including adult (+18 years) patients
who received an HSCT and required ICU admission between 2010
and 2018, and were discharged alive to the Hematology ward. X-
Square, Fisher´s test, T test, U Mann-Whitney and logistic regression
were employed as required. Quantitative variables are reported as
median (IQR) and categorical as frequency (%).
RESULTS. During this eight year period, 79 HSCT-R were admitted to
the ICU. Thirty-three (42%) of them were discharged to the
Hematology ward and 20 (25%) finally survived the hospital admis-
sion. Nineteen (58%) were men, with an age of 57 (37-62) years.
Twenty-five (76%) were allogeneic HSCT and 18 (55%) were neutro-
penic. APACHE was 20 (14-24) and SOFA score 8 (6-9). Twenty-one
(64%) were treated with vasoactive drugs (VAD), 15 (47%) with high
flow nasal cannula (HFNC), 9 (27%) received mechanical ventilation
(MV) and 2 (6%) renal replacement therapy (RRT). Seven (6%) were
readmitted to the ICU. Allogeneic HSCT (OR: 1.9, IC95%: 0.3-11.7, p=
0.476) and neutropenia (OR: 4, IC95%: 0.8-19.8, p=0.09) were not re-
lated to hidden mortality, nor were the use of HFNC (OR: 1.8, IC95%:
0.4-8.6, p=0.441), MV (OR: 1.1, IC95%: 0.2-6, p=0.890), VAD (OR: 0.75,
IC95%: 0.2-3.6, p=0.75) or RRT (OR: 1.9, IC95%: 0.1-33.7, p=0.662).
APACHE score (OR: 1.1, IC95%: 1-1.2, p=0.233) and SOFA score (OR:
1.2, IC95%: 0.9-1.7, p=0.268) were not different in both groups, but
those who did not decrease their SOFA score at fifth day had a
greater hidden mortality (OR: 18.3, IC95%: 1.5-222.9, p=0.022).
CONCLUSION. A significant amount of HSCT-R discharged from the
ICU die before being discharged home. We did not find any relation-
ship with the type of HSCT or the requirements of organ support,
but we found a strong relationship between the persistence of organ
dysfunction at day five. Those with no improvement in SOFA score in
the first five days, despite being discharged to the ward are at
greater risk of mortality before being discharged home.001225
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INTRODUCTION. Treatment of acute leukemia pts can be associated
with the life-threating complications requiring ICU admission.
OBJECTIVES. To compare frequency of ICU admission and short and
long-term outcomes of de novo ALL and AML pts who required and
not required ICU admission during induction chemotherapy.
METHODS. All de novo ALL (median age 28 yo, 17-60 yo) and AML
(median age 28 yo, 17-60 yo), treated from 2013 to 2017, were en-
rolled in the study. ALL and AML pts were divided into 4 groups: pts
required ICU admission (ALL and AML ICU-groups), and pts not re-
quired ICU admission (ALL and AML non-ICU groups).
RESULTS. ICU admission was required in 18 (20.6%) of 87 ALL pts
and in 44 (27.5%) of 160, (p = 0.2394) AML pts. The reasons for ICU
admissions were similar for ALL and AML pts: acute respiratory
failure (44% and 47.7%, p = 0.637), acute neurological events (28%
and 13.6%%, p = 0.759), tumor lysis syndrome (17% and 4.6%%, p =
0.112), septic shock (SS) (11% and 20.4%%, p = 0.383) respectively.
Needs of mechanical ventilation and infusions of vasopressors were
independent predictors of ICU mortality (p<0.05) in ALL and AML pts.
28-day mortality was 47.5% for AML ICU-group and 50% for ALL-CU-
group (p=0.196). Any pts did not die in both non-ICU groups during
28 days. In ALL pts 5-year overall survival (OS) was worse in ICU-
group (44%) than in non-ICU group (44% vs. 76% p <0.05) (fig. 1).
There were no significant differences in 5-year OS of AML pts from
ICU and non-ICU groups (42.6% and 48.6%, p=0.946) (fig 2).
CONCLUSION. The frequency of ICU admission, reasons for ICU
admission and 28-day mortality rate were similar for ALL and AML
pts. The long-term OS was lower in discharged from ICU ALL pts
than in non-ICU ALL pts. In AML pts long term OS was similar in pts
discharged from ICU and non-ICU pts.
Fig. 1 (abstract 001755). See text for description
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INTRODUCTION. Acute leukemia (AL) is the most common cancer of
childhood. AlthoughEven great advances have been made, admission to
Pediatric Intensive Care Unit (PICU) is related with an increase inof mortality
rate. Data in pediatric population is scarce, which leads to a lack in
information regarding outcome of patients with AL admitted to the PICU.
OBJECTIVES. The objective was to describe the clinic and
epidemiologic characteristics of the pediatric patients with AL admitted
to PICU, and the differences between emergent or planned admission.
Second goal was to evaluate mortality during their PICU stay.
METHODS. Retrospective study conducted in a tertiary referral
hospital in Barcelona, Spain (July 2010-July 2016).
All patients with acute lymphoblastic leukemia (ALL) or acute
myeloid leukemia (ALM) (28 days-18 years) who required PICU admis-
sions were included. Patients with hematopoietic stem cell transplant
and CAR-T cell therapy were excluded. Mortality was differentiated
between PICU and out PICU mortality. The study was approved by
the ethic review board of our hospital.
RESULTS. Out of 156 consecutive patients diagnosed with acute
leukemia, 48 patients (69 episodes), required PICU admission, 58%
were female, and the median age was 10.5 years (range 0-18). There
were 38 (80%) diagnosed with ALL and 10 (20%) with AML. The ad-
mission was urgent in 45 episodes (65%), the planned admission was
for bronchoalveolar lavage procedure (BAL) in 12 (50%) cases. Main
reasons for admission were respiratory failure (11, 16%), sepsis (11,
16%) and BAAL (12, 17%). The Pediatric Risk Score Mortality resulted
in 3 points. 23 (33.3%) patients required mechanical ventilation (MV)
(mean days 1;1-7) due to pneumonia in 64,3%. Inotropic support was
administered in 11 (15.9%) and 2 (2.9%) required hemofiltration. 28
(40.6%) patients had multiorgan failure, and 6 (12,5%) died (2 in PICU
due to sepsis and 1 due to a BAL pulmonary haemorrhage). Mean
days of PICU stay were 3,8 (0-58). All these variables were statistically
significantly worse in emergency admission cases compared with a
planned one, p< 0.001.
Two children died during the following 60 days after PICU discharge
and one during the following 6 months; all of them were patientswith relapsed ALL , 2 patients were in palliative care treatment and
died from progressive disease and one due to treatment toxicity
(hepatic sinosuoidal obstructive syndrome). Median length of stay for
patients who died in PICU was 14 days (13-15.5).
PRISM ≥5 (OR 3,12; IC95%0,9-10,86), requiring MV (OR 9,47;
IC95%0,99-90) or inotropes(OR 4,97; IC95%0,6-27,87) and severe
neutropenia (OR 1,26; IC95%0,36-4,44) were independent factors for
death
CONCLUSION. Pediatric patients with AL frequently required PICU
admission (almost one third) and respiratory failure and sepsis were
the main cause of admission. Patient who died were the higher risk
ALL cases (relapsed patients) or AML. Accurate efforts need to be
conducted when these patients require MV, or inotropes and if data
of multiorgan failure are present.
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INTRODUCTION. Subclavian central venous access (SCVA) has a
lower rate of infective and thrombotic complications compared to
femoral and internal jugular venous access(1). This data also
demonstrates higher rates of mechanical complications such as
pneumothorax, but in the context of high rates of insertion guided
by landmark technique(1). The subclavian vein’s anatomical position
is variable(2) and the rate of mechanical complications is reduced by
the use of real time ultrasound scanning (USS)(3). We hypothesised
that few anaesthetic or intensive care medicine (ICM) trainees in our
region had received formal training in landmark or ultrasound-
guided SCVA and are not confident in it. We sought to establish if a
short teaching session with live human USS and subclavian gel phan-
tom needling practice would improve confidence.
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interest in developing these skills from consultants in anaesthesia
and ICM. We therefore refined and extended it to further promulgate
these skills in our region. We aimed to increase regional use of
ultrasound-guided SVCA in order to minimise central line-associated
bloodstream infection (CLABSI) and mechanical complications associ-
ated with SCVA.
METHODS. We conducted a survey of all Anaesthetic and ICM
trainees in the Thames Valley deanery in the UK to ascertain
previous experience of SCVA. Having identified this need for training,
we conducted teaching sessions for anaesthetic and ICM physicians.
These comprised a lecture, in vivo scanning of the subclavian vein
and needling a subclavian gel phantom with USS.
We also gathered data on participant grade, formal teaching
experience in SCVA and number of times they had performed SCVA.
We compared their confidence in performing ultrasound-guided
SCVA before and after the training session using a visual analogue
scale (VAS) running from 0 to 100. Continuous data were checked for
normality using the Shapiro-Wilk test. When this failed to detect nor-
mality, data were compared using the Mann-Whitney test.
RESULTS. 49 specialty registrars in anaesthetics or ICM responded to
the SCVA training survey (response rate of 49% of deanery trainees).
This revealed that 33% of respondents had sited no subclavian lines
and 71% had sited 5 or fewer. Only 29% had any formal training in
SCVA and mean confidence score was 35 out of 100 on the VAS.
42 physicians in total were then taught over four teaching sessions.
86% had received no previous instruction in ultrasound-guided SCVA.
64% had inserted no subclavian lines under ultrasound guidance and
93% had inserted five or fewer. The median baseline confidence in
SCVA was 12 and after teaching this rose to 52 on the VAS (p <
0.001 by Mann-Whitney U test). The sessions were highly valued by
trainees and consultants alike.
CONCLUSION. This study demonstrates that anaesthetic/ICM
physicians in our region have little experience in inserting SCVA and
receive little formal training in it. Furthermore, we have shown that a
short training session can improve their confidence. We have used
the teaching sessions to encourage use of this technique in order to
help minimise overall complications of central venous access
including CLABSI and mechanical complications. Further teaching
sessions are planned given the ongoing demand for these skills in
our region.
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INTRODUCTION. In modern concepts of pathogenesis of inflammatory
diseases, much attention is paid to nonspecific humoral factors of
immune system, including lysozyme.
OBJECTIVES. The aim of the study was to evaluate level of lysozyme
activity in serum in patients with ventilation-associated pneumonia.METHODS. A complex examination of 43 patients with ventilation-
associated pneumonia and 43 practically healthy people was per-
formed. Blood was taken from the ulnar vein before meals into sterile
test tubes.
RESULTS. We have created a simpler and a cheaper way of
evaluating lysozyme activity in biological fluids, which demands little
time and has clear evaluation criteria. The invention relates to
medicine, namely to laboratory diagnosis. From cell walls of
Micrococcus lysodeikticus culture ATCC 4698 peptidoglycan substrate
was prepared, and the activity of lysozyme was calculated by the
formula obtained after constructing calibration curve for lysozyme,
which showed the dependence of the concentration of lysozyme
and the optical density of the solution of Congo red. The positive
effect of the proposed method was that the substrate for the
production of reaction was prepared once and could be used for a
long time. The way was easy and simple in play. The sensitivity of
this method to lysozyme was 0.06 mg / ml. This is enough to
determine immunodeficiency states, because the content of
lysozyme in biological fluids varies according to various data in a
wide range from 0.2 to 28 mg / ml in normal.
It was found that the lysozyme activity in the serum was lower in
patients with ventilation-associated pneumonia (246.7; 141.2-298.7
mcg/ml) than that in donors (445.5; 350.1-816.1 mcg/ml). After inacti-
vation of the complement both in patients with ventilation-
associated pneumonia (116.0; 56.5-160.1 mcg/ml) and in donors
(246,0; 183,6-305,7 mcg/ml) a statistically significant decrease in lyso-
zyme activity occured.
CONCLUSION. There was a statistically significant decrease of
nonspecific humoral resistance in patients with bacterial infection,
namely, lysozyme, which was a risk factor for the development of
ventilation-associated pneumonia.
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INTRODUCTION. Surfactant protein B (SP-B), a member of Saposin-
like family of proteins (SAPLIP), plays roles in both lowering surface
tension and antimicrobial activity in the lung. Recent studies demon-
strated the patients with the C allele of SP-B gene are susceptible to
bacterial pneumonia. In the study we examined the effects and mo-
lecular mechanisms of the T and C alleles of human SP-B gene with
humanized transgenic mice in bacterial pneumonia model.
METHODS. SP-B 1580 locus polymorphisms and SP-B protein level in
BALF of thirty S. aureus-infected pneumonia patients and thirty-five
age-matched, unrelated healthy subjects were analyzed. Then, hu-
manized transgenic (hTG) mice, which expressed the C or T allele of
human SP-B genetic variants in a mouse SP-B (-/-) background, was
generated and used in this study. Pneumonia model was induced
using S. aureus(CFU: 5x108/mouse) intratracheal injection in hTG SP-B
mice. Lung tissue and bronchoalveolar lavage fluid (BALF) were har-
vested 24h after exposure to S. aureusor saline (control). Histological
changes were consistent with pneumonia. Cellular and molecular
analysis were performed by Western blot, ELISA, CFU counts.The p38
mitogen-activated protein kinase (MAPK) and the nuclear factor-
kappa B(NF-κB) signaling pathways were measured by Western blot.
In vivo imaging system was also used to analyze the dynamic bacter-
ial clearance in the lung.
RESULTS. Human subjects with the SP-B1580 CC genotype were
more susceptible to S. aureus-infected pneumonia.S. aureus-infected
pneumonia patients with SP-B-1580CC genotype exhibited signifi-
cantly lower SP-B level in BALF. S. aureus-treated hTG SP-B-C mice ex-
hibited higher mortality than hTG SP-B-T mice (p<0.05). In vivo
T2
Table 1 (abstract 001373). See text for description
System Pre-AAS (call activation criteria) Post-AAS (automatic alert
system)
Respiratory - RR ≤ 8/min, or ≥ 28/min
- SpO2 ≤ 90%
- Sudden respiratory distressed
symptom
- RR ≤ 8/min, or ≥ 28/
min
- SpO2 ≤ 90%
Cardiovascular - HR ≤ 40/min, or ≥ 130/min
- SBP ≤ 80mmHg, or ≥ 200mmHg
- SBP 80~90 mmHg with symptoms
- Chest pain sustained with
nitroglycerin medication
- HR ≤ 40/min, or ≥ 130/
min
- SBP ≤ 80mmHg, or ≥
200mmHg
Neurologic - Sudden deterioration of
consciousness
- Sudden onset facial or extremities
paralysis
- New onset epilepsy
- Non-specific unexplained agitation
Others - Concerns by physician
- Hypoperfusion signs
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creased bacterial clearance 24h post-infection compared to infected
hTG hSP-B-T mice. Infected hTG SP-B-C mice showed more severe
lung injury (p<0.05), inflammation (p<0.01) and bacterial load in the
lung compared to infected hTG SP-B-T mice 24 hrs after infection.The
levels of surfactant phospholipid and surfactant proteins B, A and D
in BALF, decreased significantly (p<0.01) in infected hTG SP-B-C mice,
when compared with infected hTG SP-B-T mice. Moreover, infected
hTG SP-B-C mice showed increased apoptotic cells and caspase-3 as
well as decreased levels of Bcl-2 in the lung compared to infected
hTG SP-B-T mice. Furthermore, levels of NF-κB P65, phosphorylated
IkB-α and P38MAPK increased significantly in the lung of infected
hTG SP-B-C mice which were related with significant increased levels
of IL-6 and TNF-a in BALF than infected hTG SP-B-T mice.
CONCLUSION. Mice with C allele or T allele of human SP-B genetic
variants exhibited different susceptibility to bacterial Staphylococcal
pneumonia probably through regulating p38 MAPK-mediated NF-κB
pathway related inflammation and apoptosis.
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INTRODUCTION. Rapid response system (RRS) has been developed
for early detection of deteriorated patients. To improve the results of
RRS, early detection and early intervention is warranted. However,
there is no definite criteria of activation in RRS or no universal
consensus for method of activations.
OBJECTIVES. The aim of study is to estimate the effect of a real-time
automatic alerting system (AAS) based on electronic medical record
(EMR) on RRS.
METHODS. We retrospectively reviewed the clinical data of patients
who were activated by RRS in a tertiary university hospital. From
August, 2015, RRS have been developed with activation by clinicians’
calls and by active screening of high-risk patients in surgical wards.
Activation criteria was suggested as Table. From November, 2016, we
added a new real-time AAS to conventional activation systems. We
compared the periods before and after the application of AAS in RRS
as unplanned ICU transfer and other clinical outcomes; from January
to October, 2016 (pre-AAS) vs from January to October, 2017 (post-
AAS1) vs from January to October, 2018 (post-AAS2).
RESULTS. After application of AAS, the number of RRS activation
significantly increased from 15.5 per 1,000 admissions in pre-AAS to
30.7 in post-AAS1 (p < 0.001), but decreased after adaptation (9.3 per
1,000 admission in post-AAS2). AAS activation (42.7%) was the most
common cause of RRS activation in post-AAS1, followed by active
screening (41.4%). Modified early warning score of activated patients
in post-AAS2 was significantly higher than that of pre-AAS or post-
AAS1 (p < 0.001). During study period, 264 unplanned ICU transfer
occurred (2.88 per 1,000 admission in pre-AAS, 2.77 in post-AAS1,
and 2.40 in post-AAS2, p = 0.475). In post-AAS1, 91.1% were acti-
vated by AAS before unplanned ICU transfer (62.5% in pre-AAS,
64.1% in post-AAS2, p < 0.01). There were no differences in ICU days
and cardiopulmonary resuscitation rate among three groups (p =
0.341 and p = 0.49).CONCLUSION. Use of a real-time AAS based on EMR might be help-
ful to detect unplanned ICU transfer. However, a learning period
would be required for adaptation with increased RRS alarms.
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INTRODUCTION. Few studies have evaluated risk factors for
ventilator-associated events (VAE) and there is no data comparing
them between the adult and children population.
OBJECTIVES. To identify differences in factors associated with VAE in
patients who underwent mechanical ventilation (MV) ≥48 h, between
adults and children.
METHODS. Secondary analysis of a prospective combined
multicentre cohort (adult and children). Six Intensive Care Units (ICU)
in 4 European countries (France, Greece, Spain, and Turkey) and one
children’s ICU (Spain). Subjects who had undergone MV ≥48 hours
were included. Age ≤ 16 yr was categorized as children. In subjects
with multiple episodes of MV, only the first one was eligible. The
adult definitions for VAEs were adjusted to the 2015 update of the
2013 United States Center for Disease Control and Prevention
definition (1). The pediatric definition of VAE (PedVAE) was reported
by Peña-López et al. (2). Association of risk factors with VAE and
PedVAE was estimated through multivariate logistic regression
analysis.
RESULTS. A hundred and sixty-three MV episodes in adults and 88 in
children (2,178 and 731 ventilator-days respectively) were included.
Median age was 60 yr in adults and 1.0 yr in children. Eighty-three
adults (50.9%) and 43 children (48.9%) had high severity ICU index
T2
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and 7 (4 - 9) days in children (p<0.005). We documented 76 VAE in
adults (46.6%) and 23 PedVAE in children (26.1%) (p=0.002). The me-
dian (IQR) onset time of VAE and PedVAE was 6 (4-9) and 4 (3 - 6)
days (p=0.065), with 52 (68.4%) and 19 (82.6%) presenting within the
first 7 days of MV, respectively (p=0.186). MV> 7 days was associated
with VAE (OR 5.03, 95%CI 1.95-13; p=0.001) and PedVAE (OR 4.55;
95%CI 1.3-15.86; p=0.017). Other independent predictors of VAE were
selective digestive decontamination (SDD) absence (OR 4.45; 95%CI
1.78-11.12), tracheostomy (OR 3.55; 95%CI 1.35-9.32), midazolam
use>3 days (OR 3.48; 95%CI 1.19-10.21), and surgical/trauma patients
(OR 2.62; 95%CI 1.1-6.26) (p<0.05). High severity score, delirium, early
mobility, and pharmacological paralysis did not show a statistically
significant association with VAE or PedVAE on multivariate logistic re-
gression analysis. In children, SDD and tracheostomy were not per-
formed on the analysis due to the low number of cases. In contrast
to adults, surgical/trauma patients and midazolam use>3 days in chil-
dren did not show a statistically significant association with PedVAE
and there was a trend toward increased risk of PedVAE in the
pediatric population when the reason for intubation was respiratory
failure (OR 3.35; 95%CI 0.89-12.57; p=0.071).
CONCLUSION. Future bundles should include SDD implementation
and midazolam restriction as potential strategies to prevent VAEs in
adults. Respiratory failure as cause of intubation may be more
determinant for PedVAE than prolonged midazolam use in children.
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INTRODUCTION. The ventilator protects airway in patients who are
critically ill, and there are many reasons for a patient with failure to
wean from ventilator. How to successfully wean patients from
ventilator requires consideration of various factors.
OBJECTIVES. We want to detect the effect of implantation of
informatics system and care bundle in ICU on unplaned extubation
and re-intubation rate in the ICU.
METHODS. Taipei Medical University Hospital is a community based
teaching hospital with 736 beds capacity (includes 58 ICU beds). We
set up electronic ICU (e-ICU) to automatically upload ventilator
parameters and clinical data within critical care unit for providing
real time information to the care team in Feb 2017. We use e-ICU
software with automatic upload clinical information of ventilator:
FiO2,, PaO2/FiO2, PEEP, RSBI(rapid shallow breathing index)、Tidal
volume、Respiratory rate、Minute ventilation, minute Ventilation. We
use ventilator associated bundle (VAP) and continuously monitor all
the parameters including laboratory results, image findings and vital
signs. This is a before and after study aims to detect the effect of im-
plantation of informatics system and care bundle in ICU.
RESULTS. There are 1857 patients who admitted to our ICU during
this period (915patients before e-ICU and 942 after). There are 458
(50.1%) patients received intubation with ventilator support and 472
patients (50.1%) after. There is no significant difference in back-
ground (APACHE II, gender and age) and mortality rate (33.5% vs
32.9%; p=0.39) between the two groups. The duration of ventilator
usage was not significantly different (10.3 days before and 10.1 days
after; p=0.46), and 48 hours re-intubation rate reduced from 6.98%(n=32) to 3.39% (n=16) and un-expected extubation reduced from
2.0% (n=9) to 0.2 % (n=1).
CONCLUSION. Implantation of information system (e-ICU) and care
bundle in ICU can help reduce unplaned extubation and 48 hours re-
intubation rate.
Table 1 (abstract 000495). See text for descriptionBefore (n=915) After (n=942) P valueMale 546 (69.7%) 549(58.2%) 0.40Age 68.0 ± 0.6 67.5 ± 0.7 0.12APACHE II 11.9 ± 0.3 11.8 ± 0.3 0.20Mortality 317 (33.5%) 310(32.9%) 0.39Patient with ventilator support 458 (50.1%) 472(50.1%) 0.59Ventilator days 10.3±12.5 10.1±13.6 0.46Re-intubation with 48 hours 32(6.98%) 16(3.39%) 0.001Un-expected extubation 9(2.0%) 1(0.2%) 0.007000923
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INTRODUCTION. Mechanical ventilation (MV) may produce
ventilation induced lung injury (VILI). To solve it, protective
mechanical ventilation (PMV) appears as TV<8ml/Kg of predicted
body weight (PBW) and Plateau pressure <30 cmH2O. Spanish
society of intensive critical care and coronary units (SEMYCIUC) have
created an indicator to evaluate the adherence to clinical practice
guidelines. MV is dynamic, so few manual data collection entails a
huge loss of information. Thanks to CIS we can collect MV data every
two minutes, and create fully automated and more accurate quality
indicators.
OBJECTIVES. Evaluate clinical practice adherence to TV
recommendations. Create fully automated and more accurate quality
indicators through the data stored into the CIS.
METHODS. Retrospective study of cohorts carried out in a 30-bed
polyvalent ICU. Inclusion criteria: patients admitted to ICU (2015-
2018) connected to MV. Exclusion criteria: Patient whose height and/
or APACHE was not registered and height <140cm. PBW and the %
of time in which each patient had a TV> 8ml/Kg PBW (%_OV) was
calculated automatically in the ETL (Extract, Transform and Load)
process. Cohort was divided into quartiles according to % T_OV (Q1:
lower % T_OV and Q4: higher % T_OV) and extreme quartiles were
compared based on 24 variables: demographic, clinical, respiratory
modality (volume control (VC) or pressure support (SP)) and evolu-
tion. A subanalysis of extreme quartiles according to %_OV within
the Q4 of % T_OV was carried out using the same methodology. We
proposed two indicators: 1) Patients with adequate TV (nº of patient-
s>80%time with TV<8ml/Kg PBW/ total nº of patients with MV x100;
proposed standard> 90%), 2) Time of inadequate TV (Total time_OV/
Total time in MV x100, proposed standard <20%). Statistical analysis
was performed using R (https://cran.r-project.org/), applying the
'chi2' test for categorical variables and the ‘Mann-Whitney U' for con-
tinuous ones.
RESULTS. 1071 patients were included. Median age 64 (51-73), 67,3%
male, median APACHE 25 (20-31) and median SOFA 7 (4-9). Median
TV was 0,53L (0,49-0,58). % of patients with adequate TV was 15,8%
and total time of inadequate TV was 63,2% (Q1: 14,9%, Q2: 47,4%,
Q3: 76% and Q4: 95,5%). Higher height (and as consequence higher
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associated with lower %T_OV. There were also significant differences
between respiratory modality, being higher those referred to VC.
Overall mortality was 27,7%, without significant differences between
Q1 and Q4, neither in MV days nor stay in ICU. In our subanalysis,
patients in Q4 of % T_OV with <%OV had shorter ICU stays.
CONCLUSION. CIS are an opportunity to create fully automated and
more accurate quality indications to evaluate PMV adherence.
Patients with lower TV are taller, with higher PBW. It will be
necessary future investigation to adjust the proposed standards.
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INTRODUCTION. Early mobilization in intensive care unit (ICU) is a
candidate intervention to reduce the incidence and severity of ICU
acquired weakness and improve outcomes. Implementing early goal
directed mobility (EGDM) was shown to improve duration ofmechanical ventilation, ICU stay, long-term functional independence,
and possibly mortality. However, it remained challenging issue in
daily practice.
OBJECTIVES. The aim of this study is to investigate the impact of
early goal directed mobility using novel information system on
patients’ outcome in intensive care unit
METHODS. All consecutive patients form 2017-2018 in adult ICU
were enrolled. The key interventions include novel early rehabilitatio-
ninformation system and virtual reality rehabilitation system for crit-
ical patients.The patientswere divided into three periods: pre-EDGM
system period from Jan to July 2017, EDGM system setting period
from August to September 2017 and post-EDGM system period from
October 2017 to December 2018.
RESULTS. The early rehabilitationrate improved from 17.1%in pre-
EDGM system period, to 20‰ in EDGM system setting period and to
95.1% in post-EDGM system period (p<0.05).Average ICU stay de-
crease from 7.9 days to 6 days after intervention (p<0.05).Average
ventilator days improved from 5.5 days to 4.9 days in post-EDGM sys-
tem period (p<0.05). The incidence of ventilator-associated pneumo-
nia decreased from 1.3‰to 0.83‰(p<0.05).
CONCLUSION. The study showed that implementation ofearly goal
directed mobility using novel information system could increase
early rehabilitation rate, and reduceaverage ICU stay and ventilator
days. Furthermore, the incidence of ventilator-associated pneumonia
also improved.
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INTRODUCTION. Immunoglobulins act as one of host defense
systems against microorganisms such as bacteria, virus, and fungi.
Severe infection causes sepsis and the related multiple organ failure,
resulting in the cause of death in intensive care unit. Recent study
shows that serum IgG concentration in sepsis patients is often low
and the patients with hypo-IgG have high mortality (1). It is assumed
that increased capillary permeability, increased catabolism, and the
consuming effect of antigen-antibody reactions can reduce immuno-
globulin concentrations. However, the precise mechanisms under-
lying low IgG in sepsis remains unclear. There have been many
studies showing that low IgG level is associated with poor prognosis
in sepsis patients. However, the effectiveness of supplementation of
intravenous immunoglobulin (IVIG) for improving mortality has not
been elucidated.
OBJECTIVES. We conducted this study to determine whether
administration of IVIG for patients with a low IgG level can improve
the prognosis.
METHODS. This study was conducted retrospectively. Inclusion
criteria were the patients with severe infection in whom serum IgG
level was determined on admission to the ICU. First, we investigated
the prognosis of the patients and drew the Receiver-operating char-
acteristic (ROC) curve. From the ROC curve, we determined the cut
off of serum IgG level. Second, we identified the patients with low
IgG below the cut off level. Information on patients’ characteristics,
severity score (APACHE II, SOFA score), IgG level, and the dose of IVIG
given was obtained from medical records in the period from January
2013 to August 2018. The primary outcome was set to 28-day
mortality.
RESULTS. There were 247 patients with infection in whom serum IgG
level was determined on admission to the ICU during the study
period. The mortality rate of the patients was 23.9%, and we
determined the low IgG level below 663mg/dL from the ROC curve.
Sixty-one of those patients had a low IgG level. We divided the
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non-IVIG group (n=21) and IVIG group (n=40). The 28-day mortality
rate in the IVIG group were significantly lower than that in the non-
IVIG group (p = 0.024).
CONCLUSION. Our results demonstrated that administration of IVIG
for patients with a low IgG level is associated with improvement in
mortality. These findings indicate the rationale for performing a
prospective study with a large number of patients to investigate the
efficacy of IVIG therapy for patients with severe infection with low
IgG levels.
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INTRODUCTION. The last decade has seen a remarkable change in the
landscape of organ donation after brain death (DBD) and circulatory
death (DCD) in the UK1. The Organ Donation Taskforce highlighted the
urgent need to address the lack of a clear ethical, legal and
professional practice framework2, and it has been established that
higher referral rates and the presence of a specialist nurse for organ
donation (SNOD) lead to higher successful donors3,4.We publish the
trends in organ donation of Cardiothoracic (CT) and non-CT Intensive
Care Units (ICUs) in the UK, from 1st April 2014 to 31stDecember 2018.
OBJECTIVES. We conducted a retrospective analysis to demonstrate
the reasons behind these sustained improvements in number of
referrals and organ donations. We identified the differences between
CT-transplant and non CT-transplant ICUs.
METHODS. Data analysed were extracted from the NHSBlood&Transplant
(NHSBT) potential donor audit, the organ donor register and renal registry.
Data collection included all patients deceased at Royal Papworth CT-ICU
from April 2014 to December 2018 and we compared these with other CT-
ICUs. Variables analysed (Key metrics):
 Referral– If suitable patients are not referred, the patient's
decision to be an organ donor is not honored.
 SNOD- The consent rate in the UK is higher when a SNOD is
present.
 Waiting lists - The number of patients receiving a life-saving or
life-changing organ transplant in the UK is increasing, but pa-
tients are still dying while waiting.
RESULTS. In 2007/08 there were 13.4 deceased donors pmp, in total
809 donors. By 2017/18 this has risen to 24.9 pmp (1574 donors).
However during 2017/18 there were still 426 deaths waiting for
transplant. Transplant CT-ICUs had lower referral rates that non-
transplant CT-ICUs.
CONCLUSION.
The reasons why transplant CT-ICUs have lower referral rates have
raised questions, as it would seem these units should have a vested
interest in the benefits of transplant. Some have postulated that
transplant CT-ICUs are more likely to make local decisions that cer-
tain patients may not be candidates. Furthermore, transplant centres
offers invasive organ support, including extracorporeal life support
(ECMO) and mechanical circulatory assist device; therefore with-
drawal of patients happens in a later stage. In addition, the issue of
confirming death on such devices is contentious5,6,7. Clear definition
of key metrics (referral, SNOD and waiting list), that demonstrablychange outcome, contributes to improvement in outcome towards
the target donor numbers, advocated in the latest NHS Blood &
Transplants document “Taking Organ Transplantation to 2020”4. Royal
Papworth Hospital has tackled this by empowering the “embedded
SNODs” in promoting teaching within the staff, and supporting a
multidisciplinary team-based approach. This has contributed to in-
crease our referral rates and SNOD involvement from 79.5% and 76%
respectively, in 2017, to a 100% in both metrics in 2018. Donation is
now considered to be a component of good end of life care. Further-
more, the UK is moving towards deemed consent for organ dona-
tion8. An implementing strategy has been used at Royal Papworth in
the last year: referrals of all deteriorating patients, at the very early
stage of the withdrawal process, identification of potential donors,
embedded SNODs, incorporation of organ donation audit into the
monthly Morbidity&Mortality Meetings. The results of this strategy
have been: increased number of referral to the success of 100% re-
ferrals, earlier referrals, and a more efficient multidisciplinary work
with Transplant Surgeons.
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INTRODUCTION. There is increasing evidence that continuous EEG
monitoring (cEEG) can reliably predict poor, and possibly also good
outcome of patients in postanoxic coma within 24 hours after
cardiac arrest (1, 2). As a result, cEEG may soon be included in
clinical guidelines for prognostication of these patients. The
acceptability of a novel medical technology, however, also hinges on
its broader impacts on practices of care and society at large.
Responsible innovation implies that possible impacts of a new
technology are anticipated and discussed with stakeholders and
responded to during its development (3).
OBJECTIVES. To explore the broader impacts of cEEG on practices of
care and identify under which conditions cEEG may be a responsible
innovation.
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and 1 American IC, all engaged in clinical research with cEEG.
Explorative, semi-structured interviews were held with 11 care pro-
fessionals, 2 surviving patients and 7 relatives of patients who were
or had been in postanoxic coma (all Dutch), focusing on what they
valued in and were concerned about in relation to prognostic prac-
tice and the impacts of cEEG. Additionally, semi-structured interviews
were held with 22 Dutch professionals who may become involved in
the implementation of cEEG, focusing on enablers and constraints of
implementation. Field notes and the first set of interview transcripts
were qualitatively analysed, first inductively and then deductively
with insights from the ethical literature. The second set of transcripts
was analysed deductively, based on well-known determinants of im-
plementation. Findings were discussed with and validated by a panel
of representatives of stakeholders.
RESULTS. It was clear to most of our interviewees that cEEG may
have added value for prognostication of patients in postanoxic
coma, but they also pointed to potential impacts that may be less
desirable. The concerns identified centred around: 1. the meaning of
cEEG measurements (for example of ‘grey’ results); 2. the
interpretation of measurements (like the tension between ease of
use and careful interpretation); and 3. communication about
measurements (for example with regard to timing).
CONCLUSION. The concerns identified point to several conditions for
the responsible development, design as well as organizational
embedding of cEEG, including: more research on long term
outcomes, in particular of those with ‘grey’ cEEG results; an interface
that reduces the risk of lay interpretations of measurements; and
different communication policies for poor, good and ‘grey’ results.
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INTRODUCTION. Within a six-years-period (2013-2018) 3554 patients
were treated ad Neuro-ICU of CDK Salzburg. Average ICU-mortality
was 6.7%, average length of stay in ICU (LOS) was 5.4 days.
Average LOS of ICU-survivers was 5.2 days, of ICU-fatalities was 7.9
days.
From 2016 to 2017 we started standardized mandatory
documentation of formerly only sporadic decision for limitation of
therapeutic interventions (TLD) in order to prevent futile ICU-
interventions.
OBJECTIVES. This paper aims to compare ICU-mortality and LOS dur-
ing first of four years before (2013) to last of two years after (2018)
implementation of TLD.
METHODS. ICU-patients-statistics and patients records were reviewed
retrospectively for fatalities, LOS and TLD.
RESULTS. Within six years overall ICU-mortality sunk from 7.1% four
years before to 4.8% two years after implementation of standardizeddocumentation of TLD. Overall LOS was 6.1 days in 2013 and 5.2
days in 2018, average LOS of deceased patients was 7.9 days, 11.9
days four years before and 5.5 days two years after implementation
of TLD.
CONCLUSION. Against opposite apprehensions implementation of
TLD decreased average Neuro-ICU-mortality and LOS of deceased pa-
tients. As intended but exceeding anticipations, length of futile ICU-
treatment could be cut into half.
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INTRODUCTION. Major head and neck surgery with flap
reconstruction is a frequent treatment option for cancer patients. It
may be indicated for primary tumor care (head and neck cancer) or
to manage treatment’ complications (e.g. osteonecrosis).
This intervention presents a high risk of airway compromise(1) and
most patients require post-operative vigilance in an intensive care
setting due to their comorbidities, aggressiveness of the surgical pro-
cedure and to ensure adequate free flap monitoring perfusion(2).
OBJECTIVES. Understand critical care outcomes of cancer patients
submitted to major head and neck surgery with flap reconstruction.
METHODS. Retrospective cohort study of cancer patients admitted to
a polyvalent intensive care unit (ICU), between 2015–2018, after
major head and neck surgery with flap reconstruction. Exclusion
criteria were ICU stay <24h and trauma patients.
RESULTS. During this period, 209 patients were admitted to the ICU
after this procedure and 55 fulfilled the enrollment criteria.
The majority of these patients were proposed for surgery as part of
their anti-cancer treatment, but 12 were due to osteonecrosis (2
medical and 10 after radiotherapy). Median age was 60 years, most
patients were male (72.7%) with an ECOG-PS of 0-1 (94.5%) and a lo-
cally advanced disease (52.7%). The median weight at admission was
68Kg (min. 57Kg - max. 76.25Kg).
Median surgery length was 10h30 (min. 7h20 – max. 14h30), 36.4%
of patients required intra-operative blood transfusion and intra-
operative net fluid balance was positive in the majority of patients
(69.1%). Median APACHE and SAPS II scores were 13 and 24, respect-
ively. In the post-operative setting, 67.3% of patients required mech-
anical ventilation (median duration of 4 days) and 29.1% vasopressor
support (median 3.5 days). Flap necrosis was the most common sur-
gical complication (10.9%) and 13 patients (23.6%) required re-
intervention. One patient developed bacteremia associated with cen-
tral venous line. Median ICU length of stay was 4 days (min. 24h -
max. 28 days). There were no deaths in the ICU, with a 9% mortality
rate at 6 months after discharge.
Weight correlated with the duration of ventilation (r: 0.370; p=0.026)
and with the ICU stay (r: 0.305; p=0.025). Longer surgery duration
was associated with prolonged ICU stay (>5 days) (p=0.049) on
univariate analysis. On multivariate analysis, positive fluid balance
was associated with prolonged ICU stay (p=0.049).
CONCLUSION. Patients submitted to major head and neck surgery
had good outcomes during ICU stay. Positive net fluid balance
Page 602 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55during surgery was significantly associated with prolonged ICU stay
in this subset of patients and should be closely monitored.
REFERENCE(S)
1. Arshad H, Ozer HG, Thatcher A, Old M, Ozer E, Agarwal A, et al. Intensive
care unit versus non-intensive care unit postoperative management of
head and neck free flaps: comparative effectiveness and cost compari-
sons. Head & neck. 2014;36(4):536-9.
2. Marsh M, Elliott S, Anand R, Brennan PA. Early postoperative care for free
flap head & neck reconstructive surgery–a national survey of practice.
The British journal of oral & maxillofacial surgery. 2009;47(3):182-5.
3. None
001669
Outcome of Diabetic patients with Cardiomyopathy in Critical Care
Unit: Hospital and Short Term Outcome in a period of 6 Months to
One Year
N. awadh1, S. El-Hadidy-Samir2, K. Hassan2
1Cairo University, Faculty Of Medicine, Kasr Al Ainy, Cairo, Egypt; 2Critical
care medicine, Cairo University, Faculty Of Medicine, Kasr Al Ainy, Cairo,
Egypt
Correspondence: N. awadh
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001669
INTRODUCTION. : Diabetes mellitus (DM) is major risk factor for heart
failure (HF) and coronary artery disease (CAD).DM causes structural
changes involving the left ventricle (LV) systolic and diastolic
function.
OBJECTIVES. To compare diabetic patients who have ischemic
cardiomyopathy (ICM) to those with non ischemic cardiomyopathy
(NICM) in terms of clinical course, left ventricular (LV) systolic
function, diastolic function, in hospital, short term and long term
mortality.
METHODS. Sixty diabetic patients with heart failure and left
ventricular ejection fraction ( LVEF ≤ 35% ) admitted to Critical Care
Medicine department Cairo University in a period of 16 months
divided into two groups based on coronary angiography results
group I ( ICM) n=32 patients and group II (NICM)n=28 patients.
RESULTS. Results Group I patients had higher mean age (63±7)
years, (p=0.004). Hypertension ( p ˂0.001) and dyslipidemia ( p ˂0.008)
was significant in group I compared to group II. No significant
differences were found regarding LVEF, global longitudinal strain
(GLS), E/A and E/É ratio in both groups. A significant wall motion
score index (WMSI) in group I; (1.4±0.4) vs group II;(1.1±0.2),( p=
0.005).
In the study, 4 patients in group I had cardiogenic shock with no
documented in hospital mortality. At 6 months a significant mortality
difference was found between the two groups, (p= 0.006), while at
one year there was no significant mortality difference between the
two groups,(p=0.077).In comparison of survived and non survived
patients at 6 months the LVEF,GLS were significantly higher in those
who survived (41±5.3%) vs (23±6.3%),(p˂0.001) and GLS (-8±2.4%) vs
(-4.67±2.7%),(p= 0.027).The E/A and E/É ratio was significantly lower
at 6 months in survived patients (1.33±0.91 vs 1.8±0.61),(p 0.037)
and E/É (12.12±7.8 vs 21±3.7),(p= 0.016) respectively. At one year,
there was a significant difference between survived and non
survived; LVEF (39±6.8%) vs (25%), (p= 0.001) and GLS ( -8±2.9%C) vs
(-5 %),(p= 0.011).The E/A ratio in survived patients was(1.5±0.94 vs
3.3), p= (0.033) while E/É was not significantly different between
survived and non survived patients (15±5.2 vs 15 ),(p= 0.868).
CONCLUSION. The combination of cardiomyopathy and diabetes
affects LV systolic and diastolic function. ICM is associated with the
worst prognosis.
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INTRODUCTION. Chinese Critical Care Medicine has developed
rapidly in recent years. The uneven level of economic and medical
development in different regions lead to differences in treatment
efficiency and clinical outcomes.
OBJECTIVES. In order to understand the quality of medical care in
Chinese critical Care Medicine, a quality survey on the medical
quality of ICUs in China in 2015 was used to explore the risk factors
of critically ill patients in the intensive care unit in China.
METHODS. 15 indicators of medical quality of critical care medicine
were recommended by the experts’ panels of Chines Society of
Critical Care Medicine. The database of the National Clinical
Improvement System was desinged to collect this information.
(https://ncisdc.medidata.cn/login.jsp). The multivariate logistic
analysis was performed to identify factors related to mortality in ICU.
RESULTS. Data on 15 indicators of medical quality were collected
from ICUs in 1,174 hospitals in China. The indicators were as follows:
the proportion of the total inpatients in the ICU (1.83%), proportion
of total inpatient bed occupancy accounted for by the ICU (1.44%),
proportion of ICU patients with APACHEII scores ≥15 (51.08%), 3-
hour Surviving Sepsis Campaign (SSC) bundle compliance (74.37%),
6-hour SSC bundle compliance (76.6%), rate of microbiology detec-
tion before the administration of antibiotics (62.93%), proportion of
ICU patients administered deep vein thrombosis (DVT) prophylaxis
(58.24%), proportion of endotracheal extubations that was un-
planned (1.49%), proportion of extubated patients reintubated within
48 h (1.99%), proportion of patients whose transfers to the ICU were
unplanned (6.38%), 48-hour ICU readmission rate (1.20%), incidence
of ventilator-associated pneumonia (VAP) (1.28 per 1000 ventilator
days), incidence of catheter-related bloodstream infections (CRBSI)
(3.06 per 1000 catheter days), incidence of catheter-associated urin-
ary tract infections (CAUTI) (3.65 per 1000 catheter days), and in-
hospital mortality rate (10.19%). Unplanned transfer to the ICU and
higher APACHE II scores are mortality risk factors in Chinese ICUs
Fig. 2 (abstract 001755). See text for description
Page 603 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55(OR=3.798 & OR=4.588, respectively). Treatment in certain regions
(Central and North China) and 3-hour SSC bundle compliance may
benefit critically ill patients (OR=0.560, OR=0.581 & OR=0.667,
respectively).
CONCLUSION. Unplanned transfer to the ICU and higher APACHE II
scores are risk factors for higher mortality rates in Chinese ICU. 3-
hour SSC bundle compliance and the economic level of the area
where the hospital is located maybe benefits. Improving the identifi-
cation of critically ill patients and the implementation of appropriate
and timely treatment interventions are of very important for improv-
ing the level of critical care in China.
REFERENCE(S)
1. Ray B, Samaddar DP, Todi SK, Ramakrishnan N, John G, Ramasubban S.
Quality indicators for ICU: ISCCM guidelines for ICUs in India. Indian J Crit
Care Med. 2009 Oct;13(4):173-206.
2. Chrusch CA, Martin CM, Project TQ. Quality Improvement in Critical Care:
Selection and Development of Quality Indicators. Can Respir J.
2016;2016:2516765.
3. Rhodes A, Moreno RP, Azoulay E, Capuzzo M, Chiche JD, Eddleston J,
Endacott R, Ferdinande P, Flaatten H, Guidet B, Kuhlen R, León-Gil C,
Martin Delgado MC, Metnitz PG, Soares M, Sprung CL, Timsit JF, Valentin
A; Task Force on Safety and Quality of European Society of Intensive Care
Medicine (ESICM). Prospectively defined indicators to improve the safety
and quality of care for critically ill patients: a report from the Task Force
on Safety and Quality of the European Society of Intensive Care
Medicine (ESICM). Intensive Care Med. 2012 Apr;38(4):598-605.
4. NA
001681
Hypercapnic exacerbations of COPD carry a high risk of
readmission or death independently of the severity
G. Cavalot1, T. Piraino2, R. Coudroy1, F. Damiani1, N. Philips1, V.
Dounaevskaia3, O. Smith1, K. White2, L. Brochard1
1Interdepartmental division of critical care medicine - university of
toronto, Hospital St. Michael and Keenan research center, Toronto,
Canada; 2Department of respiratory therapy, St Michael's Hospital,
Toronto, Canada; 3Department of medicine, St Michael's Hospital,
Toronto, Canada
Correspondence: G. Cavalot
Intensive Care Medicine Experimental 2019, 7(Suppl 3):001681
INTRODUCTION. Patients with chronic obstructive pulmonary
disease(COPD) admitted to the hospital for acute hypercapnic
respiratory failure(AHRF) have shown poor outcomes including high
readmission rates and mortality at one year.(1) Studies suggested
that the use of non-invasive ventilation(NIV) reduces in-hospital mor-
tality but is followed by poorer outcomes after discharge.(2) Recent
data also showed that most of these patients have multiple comor-
bidities often untreated. (3)This study examined 1-year outcomes in
COPD patients surviving hospital admission for exacerbation and the
impact of the initial severity (respiratory support, intensive care uni-
t(ICU) admission) on readmission and death.
OBJECTIVES. To describe characteristics and evaluate 1-y readmission
and mortality rates of COPD patients admitted for exacerbation to
one academic hospital in Toronto.
METHODS. We conducted a retrospective study including patients
admitted to the emergency department (ED) of St Michael’s Hospital
in 2017 with AHRF defined on arterial or venous blood gas and
presence of respiratory symptoms at admission. We selected COPD
patients using appropriate ICD10 codes (J44.0,J44.1). Demographic,
clinical and laboratory data, admission to ICU, use of NIV and 1-y re-
admission rates and mortality were collected. Patients readmitted
and not readmitted were compared. We conducted a survival ana-
lysis comparing patients who didn’t receive any respiratory suppor-
t,received NIV in the ED or received NIV and were admitted to ICU.
RESULTS. 350 patients met our inclusion criteria for AHRF; among
those, 80 patients were labelled as COPD as per ICD10 codes. Most
patients were male (59%) with mean age of 67±10years; at
admission mean pH was 7.28±0.06, mean pCO2 was 67±12 mmHg.50% of patients had more than 2 comorbidities. 24 patients (30%)
received respiratory support (NIV and/or invasive ventilation), 12
(15%) were admitted to ICU and 3(4%) died. 48 out of 77 patients
(62%) were readmitted at least once or died in the follow-up year.
No differences were seen between patients readmitted and patients
not readmitted in terms of demographics, clinical data and labora-
tory values. We performed the survival analysis in the three groups:
patient that didn’t receive any NIV, patients that received NIV only
and patients that received NIV and were admitted to ICU. The
Kaplan-Meier curves for these three groups (figure) did not differ.
The readmission and mortality rate in the following year was 64%(7/
11) in patients that received NIV only and 73%(8/11) in patients that
received NIV and were admitted to the ICU.
CONCLUSION. All patients that survive an hypercapnic episode of
COPD exacerbation are at high risk of hospital readmission or death
no matter if they received NIV or were admitted to the ICU during
index admission. This whole group should be targeted for prevention
of readmissions.
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INTRODUCTION. Weaning from mechanical ventilation (MV) is
prolonged (>7 days) in 8.7% of all ICU patients (1). Previously, there
was no dedicated weaning unit in the Netherlands. In January 2016,
a specialized ICU for patients with complex weaning from MV was
opened at Radboud University (Radboudumc Centre of Expertise for
Weaning from MV, @NExCOB) aiming to improve outcome with a
better cost efficiency for this group of patients.
METHODS. We use a multidisciplinary approach including a
dedicated team of ICU nurses, physiotherapists, speech therapists,
T2
F2
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(2). If possible (hygiene) and indicated, patients receive
hydrotherapy (3). Patients with difficult or prolonged weaning are
eligible for admission (team decision). Descriptive analysis of the
first cohort, 3-month outcome data, derived from MONITOR-IC
study (4), and survival data (population register data) are reported.
RESULTS. From January 2016 to November 2017, 109 patients were
admitted. 28% came from other hospitals, 36% had a history of
COPD and 15% of cardiac failure. Median duration of MV before
admission was 19 days [IQR 12-25]. 61% suffered from delirium, 41%
from anxiety, 39% from sleep disturbances. Most patients (75%) were
highly motivated for treatment. Median length of stay in our unit
was 11 days [IQR 6-20]. Dysphagia was observed frequently resulting
in prolonged admission. Survival was 22±1 months (mean±SE, fig. 1).
CONCLUSION. Patients treated at a new dedicated ICU for complex
weaning from MV in the Netherlands have a high rate of successful
weaning. Patients were vulnerable before admission with increase
of frailty at discharge improving modestly after 3 months, while
mental health was comparable to before admission. Long-term sur-
vival in this population was reasonable.
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Table 1 (abstract 001752). Outcomes of treatmentSuccessful weaningFig. 1 (abstract 001752). See text for description86 (79%)Death during admission 7 (6%)Readmission to ICU due to deterioration 8 (7%)Back to referring ICU after diagnosis with detailed treatment plan 9 (8%)Table 2 (abstract 001752). Long-term outcomesParameter
median [IQR]Before
admissionAt hospital
discharge3 months after ICU
admissionFrailty (CFS) (0-
9)3.5 [3-5.25] 6.0 [5.5-7] 5.0 [4-6]Quality of life (SF36) (0-100)PCS 30 [21-44] n.a. 27 [22-37]MCS 49 [32-54] n.a. 48 [37-58]001760
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):001760INTRODUCTION. The surgical resection of the liver is the only
curative treatment for primary liver cancers.
To reduce blood loss, surgeons will apply the Pringle Manoeuvre
which occlude inflow of blood to the liver. However, the application
of the Pringle will cause ischemia reperfusion injury (IRI) to the liver,
characterized by the infiltration of leukocytes. Leukocytes can be
visualized using Incident Darkfield (IDF) imaging. Monitoring the
inflammation in the sublingual microcirculation during and 24 hours
after liver resection, provides a potential clinical parameter
(microcirculatory leukocytes) to monitor critically ill patients whom
would benefit from early intervention.
METHODS. 19 patients undergoing major or minor hepatectomy
were enrolled. Using Cytocam-IDF imaging, their sublingual microcir-
culation was measured before skin incision but after the induction of
anaesthesia (T0), before skin closure (T1) and 24 hours after surgery
(T2). The microcirculatory parameters measured were TVD, PVD, PPV,
MFI and PVS. Systemic leukocytes and microcirculatory leukocytes
were counted in all time points.
RESULTS. 8 patients of the 19 included patients were analysed. An
increase in the number of rolling(r), non-rolling(nr) and total(tl) sub-
lingual leukocytes can be seen from T0 to T1 to T2 (r= 2±1, nr= 5±3,
tl= 8±7 to r= 5±6, nr=7±3, tl=4±3 to r=6±5, nr=13±3, tl=12±6, p=
0.62 p=0.309 and p=0.055 respectively). There was also an increase
in systemic leukocyte count seen (8±4 to 12±6 to 20±13, p=0.097).
There was a significant decrease seen in the MFI from To to T1 to T2
(2.7±0.3 to 2.8±0.0 to 2.3±0.4, p= 0.029).
CONCLUSION. The number of microcirculatory leukocytes increased
from T0 to T2 in concordance with the increase in systemic
leukocyte count. This study shows that the monitoring of the
sublingual microcirculation using IDF imaging identifies non-
invasively the level of inflammation and perfusion.
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INTRODUCTION. Subarachnoid hemorrhage (SAH) is associated with
high morbidity and mortality. Studies have shown that both anemia
and red blood cell transfusions (RBCT) are independent risk factors
for poor outcome.
OBJECTIVES. To evaluate the role of anemia and RBCT on long-term
neurological outcome after SAH.
METHODS. We reviewed our institutional database of adult (>18y)
patients admitted to the Department of Intensive Care after non-
traumatic SAH over a 5-year period. We recorded hemoglobin (Hb)
levels daily for a maximum of 15 days, as well as RBCT (with the pre-
RBCT Hb values). We collected unfavorable neurological outcome
(UO; i.e. Glasgow Outcome Scale of 1-3) at 3 months.
RESULTS. We collected data from 270 patients (median age 54 years;
male 45%); UO was 40%. Hb on admission was 13.4 (12.2-14.3) g/dL;
highest and lowest Hb values were 14.3 (12.9-15.2) and 10.3 (8.4-
11.9) g/dL, respectively. The patients with UO were more likely to
have Hb <11, <10, <9, <8 or <7 g/dL than the others (79 vs. 51% -
63 vs. 32% – 51 vs. 18% - 37 vs. 11% – 20 vs. 5% - respectively; p<
0.05 for all). Patients with UO had consistently lower Hb over the
study period, in particular since the second day (p<0.001). More
patients with UO received RBCT (15/109, 14% vs. 6/161, 4% - p<0.01);
pre-RBCT Hb values were similar in UO and in the other patients (6.9
[6.6-7.1] vs. 7.3 [6.3-8.1] g/dL – p=0.21). In a multivariable analysis,
older age, chronic renal failure, neurological status on admission, the
use of mechanical ventilation and the development of delayed
Page 605 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55cerebral ischemia, but neither Hb nor RBCT were independent pre-
dictors of UO.
CONCLUSION. Although anemia is associated with unfavorable
neurological outcome after SAH, it does not seem to be an
independent prognostic factor.
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INTRODUCTION. Autonomic nervous system (ANS) dysfunction is
frequently observed in critically ill patients. Heart rate variability
(HRV) can provide an estimation of the ANS integrity but requires
specific software and expertise. Assessment of pupillary light reflex
using automated pupillometry (AP) could also assess ANS
dysfunction at the bedside.
OBJECTIVES. To explore whether changes in AP-derived variables
correlate with changes in HRV in critically ill patients.
METHODS. We prospectively studied (Nov 2018 - March 2019) 53
adult patients (median age 62 [52-69] years – APACHE II on
admission 18 [14-25]), with normal sinus rhythm and an estimated
ICU stay > 3 days. Patients with pupillary abnormalities were
excluded. Assessment of HRV and AP was performed within the first
24 hours in the ICU (T1) and at least 48 hours thereafter (T2). HRV
was assessed for at least a 6-minute period using a specific software
(Kubios HRV Premium version 3.2.0) analysing both time-domain and
frequency-domain methods of RR intervals. Automated pupillometry
(NPi-200 – Neuroptics) was performed with light stimulation three
times during the HRV recording on each eye; and mean values were
averaged. Changes in HRV and AP-variables were calculated as: (T2-
T1)/T2*100.
RESULTS. The 53 patients had an ICU length of stay of 8 [5-13] days
and a 28% ICU mortality. There was no significant correlation
between changes in AP derived Neurologic Pupil Index and the
dilation velocity and changes in HRV. However, changes in pupil size,
constriction rate and constriction velocity were significantly
correlated with changes in HRV variables, such as root mean square
of differences between successive NN intervals (RMSSD), low- and
high-frequency power (which captures the magnitude of underlying
oscillations in the different HR patterns) and the Poincaré plot stand-
ard deviation perpendicular (SD1) or along the line of identity (SD2)
parameters. Changes in pupillary latency correlated with changes in
other HRV variables, such as the mean R - R interval (mRR), the nor-
malized low-frequency power (FFT-LFnu) and the detrended fluctu-
ation analysis (DFAa1).
CONCLUSION. Automated pupillometry could be used to assess
changes in autonomic nervous system dysfunction in critically ill
patients.
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INTRODUCTION. Stroke is the major cause of disability and the
second most common cause of death. The majority of acute strokes
are managed on the ward; however, a significant proportion require
more specialized care. Neurological impairment with airway orrespiratory compromise, seizures, and need for close management of
blood pressure and monitoring of post stroke complications are the
common indications for Intensive Care Unit (ICU) admission.
OBJECTIVES. This study aims to determine the rate of ICU admission
for acute stroke, to analyze and characterize this population, and to
determining the functional status at ICU and hospital discharge and
at 3 months follow up.
METHODS. Retrospective and observational study conducted at
Centro Hospitalar e Universitário do Porto, a tertiary hospital and
reference center for thrombolysis and neurosurgery, from January
2013 to December 2016. All patients with acute stroke admitted in
the ICU were included. Patients under 18 years of age, stoke due to
subarachnoid hemorrhage and due to traumatic etiology and
admitted for organ donation were excluded. The functional score
was evaluated by Modified Rankin Scale (mRS).
RESULTS. A total of 156 patients, 4.3% of all ICU admission, were
included, 78 (50%) for ischemic stroke. The mRS at admission was
similar in ischemic and hemorrhagic stroke. The Glasgow Coma Scale
(GCS) was lower in hemorrhagic stroke and cardiovascular risk factors
were more prevalent for ischemic. SAPS II and SOFA were similar in
both groups. The most common locals of occlusion for ischemic
stroke were basilar artery and segment M1 of middle cerebral artery.
51% of patients had no infarction in brain computed tomography.
Thrombolysis was performed in 35 patients (49%) and 56 (74%) were
submitted to thrombectomy. Complete recanalization (TICI 3) was
obtained in 12 (21%) of patients and 9 (16%) had no recanalization
(TICI 0). Deep hemorrhage was the most common type, being
responsible for 41 (53%) of hemorrhagic strokes. Neurosurgical
procedure was performed in 62 (80%) of patients with hemorrhagic
stroke, being external ventricular shunt the most common
procedure. Time to neurosurgical procedure was higher in ischemic
stroke (1977 min vs 1089 min). The ICU length of stay was higher in
hemorrhagic stroke (12 days vs 6 days). Most of the patients had an
mRS score of 5 at ICU and hospital discharge in both types of stroke.
Three months after discharge the mortality rate was 44% for
ischemic stroke and 40% for hemorrhagic stroke.
CONCLUSION. Despite the incidence of ischemic stroke being higher
than hemorrhagic stroke, in our population the rate of admission for
both types of stroke was similar. As expected, the cardiovascular risk
factors were more frequent in ischemic stroke. Time to neurosurgical
procedure was higher in ischemic stroke since it is performed most
often due to hemorrhagic complications. Despite the ICU
management, the mortality rate and the functional status is poor in
the population of patients admitted to ICU.
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INTRODUCTION. Severe traumatic brain injury (TBI) is often accompanied
by coagulopathy and its presence has been shown to be a poor prognostic
factor. Rapid assessment of coagulation status and successful treatment of
bleeding disorders are crucial. Standard coagulation tests are usually time
consuming and provide information only on the initiation of clot formation.
In contrast, thromboelastometry (ROTEM) assess coagulation status within
minutes and offer information on clot firmness and clot stability, as well as
the initiation of coagulation.
T2
Page 606 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55OBJECTIVES. This retrospective study was designed to assess the
potential role of ROTEM in patients (pts) with TBI, to identify
associated coagulopathy and to correlate these hemostatic disorders
with outcome.
METHODS. This retrospective evaluation comprised ICU pts with TBI.
Blood samples were obtained on admission, after 12 and after 24-48
hours. ROTEM analysis (EXTEM, INTEM, FIBTEM tests) and standard la-
boratory coagulation tests ( PT, INR, aPTT, platelets count, fibrinogen
concentration) were compared. The hemostatic parameters were
compared between survivors and non survivors. We evaluated the
time course of hemostatic disorders and their relationship with the
expansion of hemorrhage, as confirmed by CT-scan. Using standard
laboratory tests coagulopathy was defined as one or more of follow-
ing: INR>1.5, aPTT>35s, fibrinogen<150mg/dL, PLT<100000/μL. Using
ROTEM coagulopathy was defined as one or more of the following
results: CTextem>80s, CFTextem>159s, MCFextem<50mm, CTin-
tem>240s, CFTintem>110s, MCFintem<50mm, A10fibtem<7mm.
RESULTS. 29 pts with TBI aged 48.31 years were evaluated. 23 pts
survived (79.3%) and 6 (20.6%) died. Coagulopathy as defined by
both tests were observed in 10 pts (34.48%). In this group 7 pts
survived (70%) and 3 (30%) died, while 8 developed expansion of
hemorrhage on CT-scan (80%). Out of 29 pts in 19 (65.5%) were ob-
served abnormalities in ROTEM variables, while 9(47.36%) pts of
them revealed normal standard coagulation tests. In this group 15
(78.9%) pts survived and 3 died. Remarkably, 16 pts with abnormal
ROTEM analysis developed expansion of hemorrhage and 3 did not,
which difference is statistically significant (p<0.05). Also we observed
abnormal CTextem in 18 (62%), CTintem in 8 (27.5%) and A10fibtem
in 7 (24.1%). Abnormalities in ROTEM were observed in 15pts (51.7%)
on admission, in 13pts (44.8%) after 12h and in 15pts (51.7%) after
24-48h.
CONCLUSION. Coagulopathy is a frequently encountered and highly
morbid complication of TBI that has been consistently linked to poor
outcomes. ROTEM provides rapid and useful information on the
coagulation status of pts with TBI. ROTEM appeared to offer an early
signal of life-threatening TBI. Further studies are warranted to con-
firm these results and to investigate the role of ROTEM in optimizing
coagulation therapy.
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INTRODUCTION. Aneurysmal subarachnoid hemorrhage (SAH) is an
acute and severe cerebrovascular event, with high mortality and
morbidity. The moment of aneurysm repair could have an impact on
outcomes, but the optimal timing remains controversial.
OBJECTIVES. Our goal is to describe the association of the moment
of aneurysm repair procedure with the mortality.
METHODS. This study was conducted in two reference centers – one
in Rio de Janeiro and one in Porto Alegre. From July 2015 to March
2019, every adult patient admitted to the ICU with aneurysmal SAH
was enrolled in the study. Data were collected prospectively during
the hospital stay. Patients were divided into four groups according to
the moment of aneurysm repair after bleeding – up to the 3rd day, 4to 8 days, above eight days and those not repaired. The primary
endpoint was mortality at hospital discharge. A multivariate model
was made using the group with higher mortality as the reference
group (4 to 8 days).
RESULTS. A total of 437 patients were enrolled in the study. Median
age was 55 years, mostly female (73%). 31% of patietes had poor-grade
SAH (WFNS 4-5), with 22% mortality and 50% poor functional outcome
(modified Rankin of 4 to 6). In the multivariate model for mortality
(table 1), hydrocephalus, post-procedure neurological worsening, DCI
were associated with higher mortality, but late repair (after eight days)
was associated with lower mortality (OR 0.4) against aneurysm occlu-
sion between 4 to 8 days, and surgical treatment was associated with
lower mortality than endovascular treatment (OR 0.3).
CONCLUSION. Our study shows higher mortality in patients
submitted to aneurysm occlusion procedure from day 4 to 8 when
compared to a late repair, with higher mortality on patients who
underwent endovascular treatment. Still a controversial topic, the
timing of aneurysm repair needs more studies to define what would
yield the best outcome.
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Table 1 (abstract 001537). Association of studied variables and
mortality – Multivariate modelVariable Odds
Ratio95% CI P
valueAge 1.05 1.02-
1.090.002Time to occlusion <96h 0.6 0.2-1.6 0.24 – 8 days
(Ref)-
>8 days 0.4 0.2-0.9 0.03Surgical treatment vs endovascular
treatment0.3 0.14-
0.640.002Poor Grade (WFNS 4 or 5) 2.2 1-4.7 0.05Neurological deterioration post-
procedure3.15 1.5-6.8 0.003Hydrocephalus 2.9 1.34-
6.410.007DCI 4.1 1.9-8.9 <
0.0001001552
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INTRODUCTION. Maintaining blood flow and oxygen transport are of
primary importance in neurosurgical patients, avoiding overload and
cerebral edema.
OBJECTIVES. We compared 2 fluid therapies in patients undergoing
neurosurgery: a restrictive one based on literature data and a goal-
directed (GD) one through the evaluation of the stroke volume vari-
ation. The primary outcome variable was the hospital length of stay
(LOS).
Page 607 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55METHODS. For 2 months we included all patients undergoing elective
craniotomy for a supratentorial non-vascular lesion, in the IRCCS Neuro-
logical Science Institute of Bologna. We excluded all the patients with an
age<18 years old, pregnancy, BMI>35, ASA≥4, Revised Cardiac Risk Index≥2,
a respiratory disease requiring home oxygen therapy, renal replacement
therapy or an increase of more than 50% of the normal values of creatinine.
We randomly assigned these patients to the restrictive group (Z Group) or
the GD one. In figure 1 we showed the 2 strategies; SVV was measured
through the FloTrack/Vigileo (Edwards Lifescience©, Irvine, CA, USA). We re-
corded demographics, neurosurgery type and indication, intraoperative
hemodynamic parameters, postoperative complications, ICU and hospital
LOS. We collected neurological status and biochemical data before and
after surgery.
RESULTS. We enrolled 20 patients; the mean age was 51.8±7.8 years with
a prevalence of female (65%); 45% of the lesions were meningiomas, 20%
glial lesions, 20% epileptogenic dysplasia and the remaining 15% brain
metastasis or colloidal cysts. The groups didn’t show any differences
regarding patients basal characteristics (age, ASA, preoperative GCS, Apfel
score, biochemical data), mean surgical duration (283±88.6vs273±
94.7,p>0.05) and types of crystalloids. In the GD group we infused a less
amount of crystalloids (1862±757mlvs2254±851.6ml,p>0.05); this data
reaches the statistical significance when we translate it in terms of
perioperative fluid balance (-319.2±634.7ml for the GD group vs 107±
229.4ml for the Z group,p=0.04). Arterial pH was more close to the
physiological value in the GD group (7.4±0.04 vs 7.36±0.05, p=0.005); other
markers of perfusion and homeostasis such as arterial lactate and base
excess tended to approach more physiological values in this group
(lactate:1.75±1.3 vs 2.02±0.6,BE: 2.97±3.4vs -1.99±2.5,p>0.05). We didn’t find
any other differences in terms of neurological evaluation (GCS/RASS),
postoperative complications (NRS, nausea/vomit), hydroelectrolytic status
and inflammations. While the ICU-LOS is similar, the hospital one tends to
be shorter in the GD group (6.4±1.3days vs 7.4±2.5days, p=0.07).
CONCLUSION. We observed a better preservation of the physiological
status of the patient with a GD fluid therapy.
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1. Navarro et al. Perioperative Medicine (2015)4:3
2. Luo et al. Ann.Intensive Care(2017)7:16Fig. 1 (abstract 001552). See text for description
Table 1 (abstract 001615). Univariable analysis of BIB associated with
mortality. +Mean±SDE
BIB DEATH+ ALIVE+ p
BNP 0 199,1±37 84,3±10 0,005
Day 1 153,2±27,7 86,8±8,2 0,027
Day 2 154,1±28.6 86,4±8,3 0,029
Day 3 176,5±29,9 92,5±10,8 0,012
DD Day 1 1599,5±378 763,7±116 0,041
Day 2 1786,9±318 776,2±112 0,005
Day 3 2196,1±386 962,5±118 0,004001615
Brain injury biomarkers as prognostic factors in patients with
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):001615INTRODUCTION. Spontaneous intracerebral hemorrhage (sICH) are
responsible for 9-27% of cerebrovascular diseases worldwide, with
37-52 % of mortality at 30 days and 54% a year. Brain injury bio-
markers (BIB) have been studied to predict prognosis in this
pathologies.
OBJECTIVES. To related BIB with mortality and functional outcome in
patients with sICH.
METHODS. We performed a prospective study with patients
admitted in ICU with sICH. BIB were determined (Enolase, S-100B,
Dimer D/DD, Brain natriuretic peptide/BNP) at admission,1,2, and 3rd
day. APACHE II, SOFA, GCS and GRAEB were determined at admission
and the modified Rankin Scale (mRS: poor outcome >2) and Glasgow
Outcome Scale (GOS: poor outcome <4) at ICU discharge and 6
months after the event. Variables were summarized using %, mean
(SD) and median. We used T-Student and χ2(p <0.05) for univariable
analysis.
RESULTS. We enrolled 120 patients, 63,3% were men, mean age
63,3 ± 12.6 ys. Global mortality was 30,8%. In the univariable
analysis of mortality we obtain an stadistically significance with
APACHE II 18,4 ± 5,3 vs 12,4 ± 5,4 (p<0,001), SOFA 6,7 ± 2 vs 3,5
± 2 (p< 0,001); GCS 8 ± 3 vs 11,8 ±3 (p < 0,001), GRAEB 3,84±
0,56 vs 2,46±0,39 (p 0,05); it was also significantly associated with
BNP at admission, 1, 2 and 3rd day (p: 0,005, 0,027, 0,029 and
0,012, respectively) and DD at 1, 2 and 3rd day (p 0,041, 0,005,
0,004 respectively). Otherwise, the univariable analysis of poor
outcome with mRS and GOS at ICU discharge were associated
with DD at admission, 1, 2 and 3rd day (GOS: p 0,005, 0,05,
0,001, 0,001; mRankin p 0,001, 0,001, <0,001, <0,001; respectively)
and S100B at admission, 1, 2 and 3rd day (GOS p: 0,015, 0,003,
0,003, 0,008; mRankin p: 0,016, 0,003, 003 and 0,004;
respectively). We obtained a significance association between
poor mRS and GOS at 6 months with S100B 2nd day(p 0,003).
CONCLUSION. BIB as BNP (at admission, 1, 2 and 3rd day) and DD (1,
2 and 3rd day) were related to mortality. S-100B and DD (both at ad-
mission, 1, 2 and 3rd day) in an early stage were related to worse
outcome at ICU discharge. But only S100B 2 day was related to poor
outcome at 6 months.
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Table 2 (abstract 001615). Univariable analysis of BIB associated with
mRS and GOS at ICU discharge. +Mean±SDE
BIB POOR GOOD p
GOS+ mRankin+ GOS+ mRankin+ GOS mRankin
DD 0 693±106 693±99,7 358±42 320±42,4 0,005 0,001
Day 1 966±156,8 1017±157 554±113 419±54 0,05 0,001
Day 2 1105±171,9 1118±163 475±60 390±39,7 0,001 <0,001
Day 3 1415±201 1446±191 612±97,4 448±53,2 0,001 <0,001
S100B 0 0,4±0,09 0,39±0,08 0,16±0,02 0,16±0,02 0,015 0,016
Day 1 0,34±0,06 0,33±0,06 0,12±0,02 0,13±0,02 0,003 0,003
Day 2 0,19±0,02 0,19±0,02 0,10±0,01 0,09±0,01 0,003 0,003
Day 3 0,12±0,02 0,12±0,02 0,06±0,01 0,06±0,01 0,008 0,004
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INTRODUCTION. Diabetes insipidus (DI) is a known complication of
patients with catastrophic brain injury resulting in brain death. The
pathophysiology of the DI is not fully understood. The presumed
mechanism is the injury of the pituitary gland and stalk from brain
tissue shift. In the present study, we reviewed the relationship of
brain shift and edema and the appearance of DI.
METHODS. We reviewed a series of patients with near complete loss
of brainstem reflexes leading to brain death. Baseline Mean Arterial
Pressure (MAP) and baseline demographic information were
collected. Effacement of basal cisterns and midline shift were
assessed using baseline CT scan and correlated to DI using standard
diagnostic criteria of specific gravity, and serum and urine osmolarity.
RESULTS. In our series, 26% of patients developed DI before the
diagnosis of brain death. The mean midline shift on baseline CT scan
in patients who developed DI was 7.2 mm, comparing to 3.6 mm in
patients with no DI. (p=0.005). Effacement of basal cisterns was
noted in 84% of patients with DI as opposed to 44% of patients
without DI (p<0.05). The MAP was not significantly different between
the two groups (p=0.33). 40% of patients with subarachnoid
hemorrhage, 32% of patients with intracerebral hemorrhage, 22% of
patients with anoxic brain injury and 10% patient with traumatic
brain injury developed DI.
CONCLUSION. DI is associated with much more profound brain
tissue shift and effacement of the basal cisterns in patients who
progress to brain death.
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INTRODUCTION. Monitoring and management of intracranial
pressure (ICP) and cerebral perfusion pressure (CPP) based on brain
trauma foundation guidelines(1)is the standard of care in the
management of patients with traumatic brain injury (TBI). However,
there is a wide variation in the way CPP is measured.Councils of
Neuroanaesthesia and Critical Care Society of Great Britain and
Ireland (NACCS) and the Society of British Neurological Surgeons
(SBNS) recommend that in the management of TBI, when
calculating CPP, the arterial transducer used to estimate mean
arterial pressure (MAP) for the calculation CPP =MAP–ICP should
be positioned at the level of the tragus (which is an approximation
for middle cranial fossa level)(2).In a person with 30 degrees head
elevation and 30 cm distance between heart(Phlebostatic Axis)and
the head,the difference in measured MAP/CPP levels will be 11
mmHg depending on the calibration level.
METHODS. We conducted a retrospective audit of the position of
arterial transducer in patients with TBI who had continuous ICP
and CPP monitoring with an aim to ensure correct positioning
of transducer at tragus level,as per national recommendations
(2).We implemented continuous teaching sessions for nursing
staff and introduced a mandatory drop-down list for arterial
transducer position(Figure 1)on our electronic patient observation
chart. We re-audited the position of transducer after implementa-
tion of above changes. Audits were conducted for a period of 1
month where patients with TBI were observed over a period of 3
days with twice daily recording of the position of the transducer.
We excluded patients with non-traumatic brain injury and pa-
tients with significant extracranial polytrauma even if they had
continuous ICP monitoring.Figure 1 showing the ‘’drop-down
list” of arterial transducer position in our electronic patient ob-
servation chart.
RESULTS. A total of 24 observations were recorded from 4
patients with TBI and continuous ICP and CPP monitoring over
their first 3 days of admission, checking the position of
transducer twice daily, corresponding to nursing shift
changes.Only on 1(4%)occasion was the transducer positioned
correctly (tragus) in the 1st audit. After the implementation of
nursing education and change in electronic patient observation
chart,on 18(75%) occasions, positioning of transducer was at
correct level.
CONCLUSION. We demonstrated significant improvements in
adherence to national recommendations on arterial transducer
position in patients with isolated TBI requiring continuous ICP and
CPP monitoring, after implementation of changes to our patient
observation chart as well as improved nursing education on this
topic.We recognise that there is scarcity of evidence of benefit for
this practice,in terms of outcomes for this cohort of patients.It is
perhaps time to design high quality studies to see if there are
benefits,in terms of neurological outcomes,of measuring cerebral
perfusion pressure at midbrain level.
F2
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INTRODUCTION. Intracranial hypertension (ICH) - the most frequent
and terrible complication that occurs in patients with intracranial
hemorrhage.One of the main tasks of the intensive care of patients
with intracranial hemorrhage is the diagnosticsand correction of ICH.
OBJECTIVES. We evaluated the possibilities of the optic nerve
ultrasound in the diagnosticsof ICH.
METHODS. This prospective observational study enrolled 51 adult
patients with SAH (n=14) and TBI (n=37) with mean age of 48±14
years.All patients underwent neurological examination, performed CT
scan of the brain, invasive monitoring using intracranial pressure
sensors and dynamic measurement of the optic nerve sheath
diameter (ONSD) and optic nerve diameter (OND) within the first 14
days following the onset of the disease. All patients were operated
on. We examined 26 healthy volunteers to determine the normal
values of ONSD and OND (n=26).
RESULTS. The normal values of the ONSD according to ultrasound in
healthy volunteers were 4,7±0,2mm, OND - 2,3±0,1mm.In patients
with SAH the mean ICP initially was 12,4±2,0mmHg, OND - 2,5±
0,1mm, ONSD - 5,1±0,2mm. Further was found a tendency to ICH
(average ICP values - 32±9mmHg, OND - 2,5±0,2mm, ONSD - 6,3±
0,2mm), then ICP returned to normal values - 14±1,9mmHg, OND -
2,6±0,2mm, ONSD - 5,5±0,2mm. In patients with TBI ICP initially and
during first 5 days was high - 37,6±3,1mmHg, OND - 2,6±0,2mm,
ONSD - 6,4±0,1mm, then the level of ICP returned to normal values
(mean ICP values 14,1±3,2mmHg, OND - 2,4±0,2mm, ONSD - 4,9±
0,2mm). A strong correlation was found in patients with ICP >=
20mmHg and ONSD compared to healthy volunteers (Spearman N=
803, R=0,3, p<0,001; Kruskal-Wallis p<0,001), the OND in the exam-
ined patients and in healthy volunteers did not differ (Spearman N=
829, R=0,0055, p=0,9). The ROC analysis showed the ONSD of 5,9mm was the best cutoff value with a sensitivity of 91% and a specifi-
city of 86% for identifying ICP ³20mmHg.
CONCLUSION. The use of ultrasound of the optic nerve can serve as
an additional screening non-invasive method for diagnostics ICH.001371
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INTRODUCTION. Non-traumatic subarachnoid hemorrhage (SAH) rep-
resents a dramatic disease.
OBJECTIVES. To analyze prognostic factors and long-term outcomes
of patients with SHA.
METHODS. Descriptive study (2009-2017). We collected: age, sex,
Hunt & Hess (HH), Modified Fisher (MF), arteriography results and
treatment: endovascular coiling (EVC) or surgical clipping (SC). We
recorded the complications during ICU stay and the necessity of
invasive procedures as external ventricular drain (EVD),
mechanical ventilation (VM) and tracheostomy (TR). The time
between diagnosis and treatment was analyzed too. Mortality
and Glasgow Outcome Score (GOS) was evaluated at hospital
discharge and at 6 months.
RESULTS. For 9 years, 184 patients with SAH were recruited,
58.7% were women, median age was 53 (46-64). HH was I-II in
120 patients (65.5%), III in 24 and IV-V in 39 (21.3%). MF was III-
IV in 149 patients (81.4%). Arteriography (180) was positive for
aneurysm in 134 cases (72.8%), arteriovenous malformation in 6
patients and negative in 40. The median size of aneurysm was 5
mm (4-7). EVC was performed in 117 patients (64.6%), surgical
clipping in 17. The time between diagnosis and treatment was
less than 24 hours in 58.8% cases. No spontaneous rebleeding
was observed. Complications rates were: hydrocephalus 40.4%,
vasospasm 26.9%, hyponatremia 17.1%, seizures 5.7%, myocardial
injury 9%, lung injury 3% and infection 23.7% (urinary tract infec-
tion 51.1%, pneumonia 25.6% and ventriculitis 11.6%). Sixty-eight
patients needed an EVD, 59 MV and 26 TR. The average hospital
stay was 21.5 (13-33) days and 9 in the ICU (4-19). At hospital
discharge 63.5% of the patients had GOS IV-V (moderate disabil-
ity - good recovery), 22.6% GOS III (severe disability) and 13.8%
GOS I-II (dead - vegetative state). At 6 moths 73.3% patients pre-
sented GOS IV-V. The overall mortality at six months was 11.4%.
In the univariate analysis HH, MF, aneurysm, treatment, timing for
EVC, EVD, hydrocephalus, infection, MV and age were related with
worse outcome at hospital discharge (GOS I-III) (p< 0.05) (table
1). After the logistic regression analysis, the factors independently
associated with worse functional status (GOS I-III) were: HH IV-V,
hydrocephalus, necessity of MV and age (p<0.05) (table 2).
T2
Page 610 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55CONCLUSION. SAH had a high incidence of complications during
ICU stay. HH IV-V, hydrocephalus, MV and age were independent
risk factors for a worse outcome at hospital discharge. However,
we observed a high rate of good-moderate recovery. In our
series, no rebleeding was found, probably due to the early
treatment.Table 1 (abstract 001371). See text for description
Table 2 (abstract 001371). See text for description
Fig. 2 (abstract 000502). See text for description
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INTRODUCTION. Mechanical power has been increasingly recognized
as the unifying variable that gathers the ventilator associated
parameters which are responsible for VILI. Since the assessement of
mechanical power is somehow difficult at the bedside, finding an
easily available surrogate to estimate the energy delivered to the
lung over time could be clinically interesting. Our aim is to evaluate
the agreement between the measured mechanical power and two of
its possible surrogates that we built up starting from the most
available ventilation parameters.
METHODS. We collected experimental data from 78 mechanically
ventilated pigs and clinical measurements obtained from 36 ICU
patients for a total of 1002 observations. The so called "Peak power"
was calculated as the product between peak pressure, tidal volume
and respiratory rate. For the "Driving power" we used driving
pressure instead of peak pressure.
RESULTS. Peak power overstimate actual mechanical power both in
animals and human patients, with a significant positive bias of 7.68
J/min and 3.48 J/min respectively. The proportional error was similarin the two groups, with an increasing difference of 0.27 J/min
(animals) and 0.25 J/min (patients) for each J/min increase of
mechanical power delivered. The R2 of the linear regression was 0,97
for animals and 0,98 in patients, indicating an almost perfect linear
relationship. When driving pressure was used instead of the peak
pressure the goodness of fit of the model was reduced with an R2 of
0,65 in animals and 0,66 in patients. Driving power leads to an
underestimation of the actual mechanical power of 7.35 J/min
(animals) and 5.79 J/min (human patients) Both animals and patients
showed a proportional error, with an increasingly negative difference
of 0.33 J/min (animals) and 0.45 J/min (patients) for each J/min
increase of mechanical power delivered.
CONCLUSION. Between the two surrogates we analyzed, peak power
compared to driving power. Peak power overestimate the value of
power, but this bias is moderate in the range of ventilation parameters
commonly used in clinical practice. Moreover, an overestimation is
probably safer than the underestimation provided by driving power
which also does not take into account the energy needed to overcome
PEEP. This might be relevant not only in the context of VILI prevention,
but also in the hemodynamic management of the patients.
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INTRODUCTION. Ventilator associated pneumonia (VAP) is usually
suspected when a patient develops a new or progressive infiltrate on
chest radiograph, leukocytosis, purulent tracheobronchial secretions,
and worsening gas exchange evidenced either by increasing oxygen
requirements or ventilator demand.
Taken from respiratory samples, endotracheal aspirate (EA) and
bronchoalveolar lavage (BAL) play an important role by allowing to
know bacteriology, antibiotic sensitivity and epidemiology of
different centers. Nevertheless respiratory samples are only one of
various components in diagnosing VAP.
OBJECTIVES. Measurement of the impact of respiratory samples (EA
and BAL) in diagnosing VAP.
METHODS. A retrospective, single-center observational study over a
period of 1 year (2017- 2018) was carried out in 233 respiratory sam-
ples of 145 patients with suspected VAP.
RESULTS. Out of the 233 samples in 145 patients with suspected
VAP, 52% (122) were EA and 48% (111) BAL. 64% of the patients
were men and the average age was 53 years.
Page 611 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55The most frequent pathologies were respiratory (38%) neurological
(18%) and polytrauma (14%).
Clinical criteria, radiological evidence, alterations in gas exchange
and respiratory samples were used to define VAP (as Criteria of
centers for the control and prevention of diseases). Only in 18% (27)
of the patients did the respiratory samples define an accurate
diagnosis of VAP in the context of the suspected criteria.
CONCLUSION. The sole use of the respiratory samples (EA and BAL)
for the diagnosis of VAP without taking into account clinical criteria,
does not increase the accuracy of the diagnosis and it can lead to
error, with an important impact on health costs and inadequate
management of antibiotic therapy which generates greater bacterial
resistance. Among the population studied with the implementation
of international guidelines, in 18% of the patients the respiratory
samples concluded a definitive diagnosis of VAP.
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INTRODUCTION. ARDS is a heterogeneous disease and its mortality
rate is still high in intensive care unit (ICU). Causes of death
generally are not only pulmonary pathologies, but concomitant
extrapulmonary dysfunction.
OBJECTIVES. To characterize patients who developed ARDS.
METHODS. Retrospective study with data collected from January to
December in 2017, performed through the analysis of the medical
records of patients admitted to the ICU in the Hospital Universitário
do Oeste do Paraná - Brazil. The variables were described by mean,
standard deviation and percentage. Variables with normal
distribution were compared using the Student's T-Test, and the non-
normally distributed variables were compared using the Man Whitn-
ney tests. All analyzes were performed at 5% significance.
RESULTS. The sample consisted of 36 patients who developed ARDS,
22 survivors (SG) and 14 deaths (DG). The variables comparing were
SG vs DG: age in years (45.6 ± 21.8 vs 52.7 ± 26.8; p=0.55), male (63%
vs 50%), non-neuro clinical causes of admission (29.16 vs 50%), se-
vere traumatic brain injury (29.16% vs 21.42%), APACHE II (29.90 ±
7.13 vs 34.92 ± 7.42; p=0.05), SOFA (10.90 ± 3.03 vs 15.28 ± 3.02; p=
0.0002), higher FiO2 (57.5 ± 17.30 vs 53.21 ± 12.95; p=0,48), worst
plateau pressure (19.13 ± 6.95 vs 21.5 ± 4.20; p=0.55), worst static
complacency (31.40 ± 8.16 vs 32.78 ± 9.93; p=0.66), worst PaO2/FiO2
(155.54 ± 59.85 vs 142.92 ± 62.07; p=0.55), tidal volume ml/kg (6.90
± 0.52 vs 6.57 ± 0.64; p=0.08), higher PEEP (12.40 ± 4.15 vs 12.85 ±2.87; p=0.70), drive pressure (12.07 ± 3.02 vs 11.86 ± 4.45; p=0.85).
The SG had an ICU length of stay of (24.04 ± 24.04) days, time of
sedation in hours (253.10 ± 164.21), and time of the mechanical ven-
tilation in hours (398 ± 338.29). The death group had an ICU length
of stay of 14 ± 16 days. The alveolar recruitment maneuver was used
in all patients and the prone position was used in 27% SG and 79%
DG.
CONCLUSION. Patients with ARDS who died had the higher APACHE
II and SOFA scores.
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INTRODUCTION. Mechanically ventilated (MV) patients may present
airway inflammation and elevated secretion production. However, it
is not known whether total protein counts in bronchial samples may
be useful to evaluate the clinical condition of patients and bronchial
sampling for such purposes is not yet standardized.
OBJECTIVES. We aimed to evaluate bronchial secretions, with or
without cells, in terms of differential total protein count obtained by
mechanical ventilated critical care patients using different methods
of sampling
METHODS. This study took place in the Intensive Care Unit of a
tertiary Greek hospital during a six-month period. Patients were in-
cluded if they were under MV for less than 24 hours and required
bronchoscopy. Furthermore, non-mechanically ventilated subjects
who underwent a single bronchoscopy, were assessed as controls. In
all patients, aspiration of bronchial lining fluid (BLF) was performed,
Bonchoalveolar lavage (BAL)and two types of Bronchial Washings
(BW40 and BW5) were performed with the instillation of normal sa-
line (ml) 150, 40, 5, while visible bronchial secretions were obtained
via bronchoscopy (VBS) and blinded, via a common catheter for tra-
cheobronchial aspiration (AC). Samples were divided in two and one
of them was homogenized in a Heidolph Silent Crusher S and total
protein was measured using the Bradford method after treatment
with Lysis buffer (20 mM Tris-Cl pH 8.0, 150 mM NaCl, 1% Triton X-
100, 1 mM dithiothreitol, 100 mg/mL-1 PMSF). Cell extracts were
cleared by centrifugation (1000g, 20min, 4°C) and optical density was
measured photometrically in samples with or without cells.
RESULTS. Twenty-five patients and six controls were evaluated. Mean
(SE) age was 65.9 (3.0) and APACHE II 18.5(1.5). Ten patients were ad-
mitted due to surgical problems. Protein concentration was elevated
in homogenized samples [14.98(1.45) μg/ml] compared to non-
homogenized ones [13.69(2.25) μg/ml, *p<0.05]. Regarding the sam-
pling technique, AC and VBS appear to be no different, while protein
concentrations were elevated in VBS compared to BAL and BW sam-
ples (*p,0.05). There appeared to be no differences in samples with
or without cells.
CONCLUSION. Both the sampling technique chosen and the
homogenization of the sample, but not the presence of cells in the
sample, can affect protein concentration in both MV patients and
controls. These results show that total protein concentration in
bronchial secretions could represent a potential inflammation
biomarker.
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INTRODUCTION. The single cell gel electrophoresis (comet assay) is a
sensitive technique for the detection of DNA damage which could serve as
an index of cellular stress in the lung during mechanical ventilation (MV).
OBJECTIVES. DNA damage caused in lung parenchyma and bronchi
in mini-bronchoalveolar lavage (mini-BAL) and bronchial washing
(BW) samples obtained from patients under mechanical ventilation,
was presently assessed.
METHODS. This prospective study took place in the Intensive Care
Unit of a tertiary Greek hospital during a six-month period. Patients
were included if they were under MV and required two bronchos-
copy sessions; a. within the first 48 hours and b. at the 7th MV-day.
Non-mechanically ventilated subjects who underwent a single bron-
choscopy, were assessed as controls, as well. In all patients mini-BAL
and BW were performed with the instillation of 40 ml and 5 ml of
normal saline, respectively. Cellular stress response was assessed by
the comet assay in which the fragmented DNA migrates out of the
nucleus forming a tail, known as a "comet". Damage was quantified
using the parameter %DNA in the comet’s tail, which represents the
percentage of total DNA migrated in the tail and is calculated as ratio
of total intensity of the tail and total intensity of the comet.
RESULTS. Nine patients were assessed. Mean±SE age was 66.4±3.4 and
APACHE II 18±1.8. Five patients were admitted due to medical problems
(three of them with respiratory failure). Mean % DNA in the comet’s tail
were 9.84±3.1 and 6.3±2.7 in BW and mini-BAL, respectively; 7.6±2.0,
5.2±1.5 and 12.9±7.0, 7.6±3.3 in the first and second week, respectively,
whereas % DNA damage in control samples was lower (1.10±0.3).
CONCLUSION. The comet assay may be useful in the evaluation of
the cellular stress response in the lung due to mechanical stress of
MV. A larger study will help to assess separately the role of various
insults that can affect the lung during MV.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):001263INTRODUCTION. The optimal hemoglobin threshold to trigger
transfusion of packed red blood cells (PRBCs) in critically ill adults
with acute respiratory distress syndrome (ARDS) is unknown. While
several guidelines recommend to maintain the hemoglobin
concentration within normal ranges, a restrictive transfusion strategy
has been proven safe in many other clinical settings. However, the
outcome of different hemoglobin thresholds that trigger blood
transfusions in patients with ARDS has not been evaluated.
OBJECTIVES. To assess the effect of different transfusion thresholds
on short-term outcome in patients with ARDS. We hypothesized that
short-term outcome in patients transfused at lower hemoglobin
thresholds is not inferior compared to patients transfused at higher
hemoglobin thresholds.
METHODS. This retrospective observational study was conducted in
a tertiary ARDS referral center. Patients admitted with an ARDS
between January 2007 and December 2018 that received at least
one PRBC transfusion were included into the study. For each patient,
the hemoglobin concentration prior to each PRBC transfusion was
identified and then the average over the number of PRBC
transfusions was calculated. According to this individual hemoglobin
threshold, patients were assigned to 5 different groups (<7 g/dl, 7-8
g/dl, 8-9 g/dl, 9-10 g/dl, 10-13 g/dl). In each group, a transfusion was
not given until the hemoglobin concentration dropped into the
group specific range. The primary endpoint was ICU mortality. Cox
proportional hazards regression was used to estimate the risk of mor-
tality in each group and to control for between-group differences of
prognostic determinants in ARDS. (Ethical approval: Charité - Univer-
sitätsmedizin Berlin, No. EA2/018/19).
RESULTS. A total of 1042 ARDS patients were screened and 904
(86.8%) patients receiving overall 17.197 PRBC units were
included in the analysis. The main cause for ARDS was
pneumonia (64.6%). Most patients were graded with severe ARDS
(84.8%) and 569 (62.9%) patients were treated with an
extracorporeal lung assist device (ELAD). A total of 42 (18; 101)
[median (25%; 75% quartiles)] hemoglobin values per patient
were screened to calculate the individual hemoglobin threshold
for each patient, resulting in 67 patients transfused at <7 g/dl,
275 patients at 7-8 g/dl, 309 patients at 8-9 g/dl, 147 patients at
9-10 g/dl, and 106 patients at 10-13 g/dl, respectively. After
adjusting for confounders of mortality in ARDS, the risk for ICU
mortality was not higher in patients transfused at lower
hemoglobin thresholds (<7 g/dl and 7-8 g/dl) compared to pa-
tients transfused at higher hemoglobin thresholds (8-9 g/dl, 9-10
g/dl, and 10-13 g/dl). This finding was concordant with the re-
sults found in the subgroup of patients with ARDS and therapy
with an ELAD.
CONCLUSION. In critically ill ARDS patients, the risk of death in the
ICU is not higher when a restrictive transfusion strategy is applied
compared to a liberal approach.
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INTRODUCTION. Phrenic nerve damage from cardiac surgery
occurs in 1 to 60% of cases depending on the procedure and
methods of diaphragm evaluation. During atrial fibrillation
ablation procedures it occurs in up to 20% of patients. Phrenic
injures can results in symptoms of mild dyspnea, dependency on
non-invasive ventilation (NIV) and failure to wean off mechanical
ventilation (MV) with associated morbidity and mortality. Data on
spontaneous recovery post injury is sparse and historically nerve
recover can take up to 18 months.
T2
T2
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modality to improve diaphragm function post phrenic nerve injury.
METHODS. This is a retrospective review of a compassionate off label
use of an FDA approved humanitarian use device under IRB approval
(#02-10-18). Patients with diaphragm dysfunction (DD) from phrenic
nerve injury underwent laparoscopic direct evaluation of the
diaphragm. If the diaphragm was stimulateable, two intramuscular
electrodes were placed in each diaphragm and electrical stimulation
was begun to facilitate diaphragm strengthening and phrenic nerve
recovery. Electrical stimulation therapy to strengthen the diaphragm
ensued. Serial diaphragmatic electromyography (dEMG) through the
implanted electrodes, chest radiographs (CXR), ventilation use and
patient reported symptoms were obtained.
RESULTS. Twenty-three of 115 patients in the database had DD post
cardiac procedure. Three developed DD post ablation and 1 after
pericardial effusion procedure. Nineteen had median sternotomies: 3
left ventricular assist devices, 3 heart transplants, 2 atrial myxoma re-
sections and 9 valve or coronary bypass isolated or combined cases.
Nine were dependent on invasive MV with 8 tracheostomis. Nine
used NIV with 5 continuous full-time NIV. Average age was 66.7 years
(47-85). Time from insult to implant was 2 weeks to 15.5 years( me-
dian 2 months). Eight of the nine MV were weaned with five trache-
ostomy decannulations. Complete weaning averaged between 1 to
35 days (13.45 average). Initial dEMG data, available for 19, showed
minimal to no activity on the affected side. Seventeen had significant
improvement in dEMG. Overall survival is 23.6 months(2 weeks-7.5
years) with 6 deaths. Twenty patients had demonstrated diaphragm
and phrenic nerve improvement (86.9%).
CONCLUSION. Patients requiring prolonged MV post cardiac
procedure have significant morbidity with only a 30% one year
survival. Reported spontaneous improvement of diaphragm paralysis
is less than 45%. In this report DP showed improvement in 86.9% of
patients utilizing diaphragm electrical stimulation as physical therapy
to overcome the atrophied diaphragm and help nerve recovery. Early
use of DP can help prevent the elevated diaphragm from paradoxical
movement that can lead to lung collapse which would increase
pneumonia risk. Early use may decrease the morbidity of
tracheostomies. Future randomized trials will elucidate the role of
early diaphragm pacing in preventing prolonged MV.
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INTRODUCTION. Neurally adjusted ventilatory assist (NAVA) is a
mode that delivers proportional ventilation using esophageal probe
to detect the electrical activity of the diaphragm (EAdi).
Difficulty in weaning is partly associated with the presence of
asynchronies between the patient and the ventilator ,which occurs
when either the initiation and/or termination of mechanical breath is
not in time agreement with the neural inspiration, or if the
magnitude of mechanical assist does not respond to the patient’s
respiratory demands.OBJECTIVES. To evaluate role of NAVA mode in reducing asynchrony
versus PSV mode
METHODS. A prospective, randomized, interventional, single-center
study, which was approved by the lEthics and Research Committee
in both Cairo University and Suez Canal Authority. Before inclusion,
patients and/or families (next of kin) gave their consent about partici-
pation after information on the aim of this study.The study was con-
ducted in the service of the ICU of Suez Canal Authority Hospital
over a period of 14 months (from June 2017 till August 2018)
Inclusion criteria:
Invasively ventilated patients with predictive criteria of difficult
weaning
Exclusion criteria:
 Contraindication to EAdi catheter placement
Patients who met the inclusion criteria and give their or their families
consent about participation were successively ventilated for 24 h
using PSV and then they were ventilated for another 24 h in the
NAVA. dysynchronies were recorded and calculated .
RESULTS. Fifteen critically ill invasively ventilated patients were
included in this study after fulfilling the inclusion criteria and giving
their or their families consents.
CONCLUSION.
 Using NAVA mode was helpful in reducing patient ventilator
desynchronies significantly when compared to PSV (which
allow more patient comfort).
 There were significant increase in oxygenation index during
NAVA than during PSV
REFERENCE
1. The author(s) received no financial support for the research, authorship,
and/or publication of this article.
Table 1 (abstract 001630). prevalance of dyssynchrony in both groupsPSV NAVA PAsynchrony index 2.8 1.1 0.001Ineffective efforts (median value) 0.9% 0.1% 0.004Auto triggering (median value) 0.66 % <0.001 0.005Double triggering (median value) 0.3% 0.8% 0.47Delayed cycling (median value) 0.15% 0 0.007Auto peep <0.001 0 0.16Table 2 (abstract 001630). arterial blood gases and hemodynamics
during PSV and NAVAPSV NAVA PPaO2 / FiO2 210±37.2 258±31.4 <0.001Pa CO2 (mmHg) 38.6±4.5 40±2 0.92HCO3- (mmol/L) 21.2±2.6 22.4±1.5 0.35MAP (mmHg) 78±9.8 74±6.6 0.015HR (beats/min) 108±14.5 88±7.7 <0.0001663
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INTRODUCTION. Transpulmonary Pressure(TPP) measurement is a
promising tool used for ventilatory adjustments in ARDS patients. Its
Page 614 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55usefulness and application in the management of severe ARDS
remains unclear.
OBJECTIVES. 1) Does TPP measurement help in ventilatory adjustments
in severe ARDS patients?
2)Do TPP guided ventilator strategies improve gas exchange?
3) Does TPP guided PEEP adjustment increases incidence of barotraumas?
METHODS. Prospective observational study. TPP measured by an
esophageal balloon catheter(Nutrivent, Sidam, Italy) and a suitable
ventilator( Hamilton G5, Switzerland)
Inclusion criteria – Adult patients with Body Mass Index > 25, Severe
ARDS (PO2/FiO2 ratio < 100) having set PEEP ≥ 15 cm, Airway plateau
pressure > 30 cm and under deep sedation with neuromuscular
blockade and at least one 16 hour prone position trial instituted.
Exclusion Criteria – 1)Patients receiving ECMO 2) Patients in whom
position of esophageal balloon and measurement of TPP could not
be confirmed by cardiac oscillation and abdominal pressure
technique. Ventilatory parameters and blood gas parameters were
documented before measuring TPP and after measuring TPP.
Ventilatory setting adjustments done after TPP measurements were –
i)increasing PEEP in hypoxic patients( SpO2 < 88 %) till oxygen
saturation remained > 90% provided plateau TPP remained < 23 cm
and end expiratory TPP remained > 0 cm ii)Increasing tidal volume(
> 6 ml / KG) in hypercapnoeic acidotic patients ( pH< 7.20 and
PCO2> 80mm Hg) provided plateau TPP remained < 25 cm.
RESULTS. Consecutive 18 patients who met inclusion criteria were
screened only 10 patients included in the study. All 10 of our study
patients were eligible for ECMO. However ECMO therapy could not be
offered to these patients due to resource limitations. Average weigh of
these patients was 88.3 ± 20.3 with BMI 30.8 ± 6.8 . Average PEEP set
was 15.1 ±2.1 cm of H2O prior TPP measurement. Post intervention
PEEP was 20.5 ± 3.1 cm of H2O. (p = 0.000043). The mean PO2/FiO2
ratio before intervention was 85.5 ± 24.41 and after intervention it was
103.4 ± 20.9 . The difference in PO2/FiO2 ratio before and after
intervention was significant, 68.7 ± 14.34 versus 81 ± 12.28 (p =
0.0473). None of these 10 patients developed pneumothorax even at
average PEEP of 20.5 ± 3.1 cm and average airway plateau pressure of
41.2 ± 4.2 cm. 6 out of 10 patients survived till hospital discharge and 4
patients died due to sepsis and MODS.
CONCLUSION. TPP measurement is useful in setting appropriate
PEEP and tidal volume in severe ARDS patients without increasing
the risk of barotrauma. TPP guided ventilation strategy in ECMO
eligible severe ARDS patients , can improve outcome in resource
limited settings.
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INTRODUCTION. The current research is mostly focused on nasal high-
flow oxygen therapy (NHFO). Whether the high-flow oxygen therapy
has the same physiological effect through tracheotomy catheter is still
unknown(THFO) , and there are certain doubts in the clinic.OBJECTIVES. Investigate the physiological role of tracheotomy high-
flow oxygen therapy in the patients with severe craniocerebral injury
after tracheotomy.
METHODS. From July 1st to December 31st, 2018, we entered the
emergency department of our hospital with craniocerebral injury
(GCS ≤ 8) and underwent tracheotomy. Patients who successfully
detached from the ventilator for 24 hours were followed up by
themselves. Give venturi mask gas mask (MO) and tracheotomy
high flow oxygenation (THFO), high flow rate from 30L / min,
45L / min to 60L / min in turn, each method lasted for 30
minutes. The main observation was the measurement of end-tidal
lung volume (△EELI) during the different oxygenation modes of
patients by electrical impedance tomography (EIT). Secondary ob-
servations included different oxygenation methods for vital signs,
oxygenation and the impact of gas exchange.
RESULTS. Total of 20 patients with severe craniocerebral injury
were included in the study. The end-expiratory lung volume
(EELI) decreased significantly with the increase of flow rate after
high-flow oxygen therapy (p<0.05), mainly in the non-gravity
lung. The decline in lung volume in the dependent area. The
oxygenation index and carbon dioxide partial pressure were sig-
nificantly improved compared with the oxygen absorption in the
venturi, which were p <0.01 and p <0.05, respectively. However,
the oxygen concentration did not increase significantly with the
increase of THFO flow, p = 0.234, and the change of PaCO2 did
not cause a significant change in blood pH (p = 0.298). The
patient's respiratory rate was lower at high flow oxygen therapy
(p < 0.05), but the increase in the THTO flow did not decrease
further (p = 0.554). Other vital signs such as tidal volume, heart
rate, blood pressure, and mean arterial pressure were not statisti-
cally different between high-flow oxygen therapy and venturi.
CONCLUSION. Tracheotomy high flow oxygen therapy can reduce
the respiratory rate, end-tidal and arterial blood carbon dioxide par-
tial pressure in patients with severe craniocerebral injury, and im-
prove the patient's oxygen and without affecting other vital signs.
THFO does not produce PEEP effect, and the end-expiratory lung
volume even has a tendency to decline. The specific reasons need
further study.
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Page 615 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55INTRODUCTION. Prone ventilation (PV) is a standard of care for
severe ARDS . Factors associated with outcome of PV are not well
studied.
OBJECTIVES. This retrospective analysis aims at finding the factors
associated with survival as an outcome in patients who received PV
in severe ARDS.
METHODS. Single center retrospective observational study. Patients
with severe ARDS who received lung protective ventilation as per the
ARDSnet protocol and received prone ventilation(PV) were considered
for the analysis. Inclusion criteria - 1)PO2/FiO2 ratio < 100 2)Plateau
Pressure > 28 cm 3)PEEP > 12 cm 4) Received at least 1 session of PV
for consecutive 14 hours. Exclusion criteria –i)Patients who received
ECMO or ECCO2R Extended prone session was defined as a prone
ventilation session continued for more than 24 hours consecutively.
Multivariable regression analysis used as a statistical method.
RESULTS.
Data of 44 patients was analysed. Mortality was 54.44%( 24/44).Average
days of mechanical ventilation were 14.84 days.ICU length of stay was
18.72 days. Average days of mechanical ventilation were 14.84 days.ICU
length of stay was 18.72 days .In univariate analysis, we analysed 32
clinical, organ function, gas exchange and lung mechanics parameters
of each patient. Survival as an outcome was significantly associated
with Extended Prone Session ( P<0.005) and number of Extended
Prone Sessions ( P < 0.05) while following factors were significantly
associated with death as an outcome:
1)pH < 7.15 at the end of first prone session ( P = 0.000) 2)Presence
of shock needing vasopressors ( OR 9.86 ; CI 1.07 to 90.7) 3)Need for
Renal Replacement Therapy (OR 5.4;CI 1 to 28.93) 4)PCO2 > 55 mm
Hg at the end of first prone session ( OR 4.46; CI 1.24 to 17.41) In
multiple regression analysis, 2 factors were independently associated
with outcome. pH < 7.15 at the end of first prone session( 1.25 ±
0.57;P=0.03) was associated with Mortality and number of extended
prone position sessions ( 0.10 ± 0.04;P=0.02) was associated with
Survival
CONCLUSION. Extended sessions of prone position are associated
with survival and persistent respiratory acidosis at the end of first
prone session is associated with death in patients of severe ARDS
treated with prone position.
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INTRODUCTION. Neurally adjusted ventilatory assist (NAVA) is a mode
that delivers proportional ventilation using esophageal probe to detect
the electrical activity of the diaphragm (EAdi).Difficulty in weaning is
partly associated with the presence of asynchroniesbetween the
patient and the ventilator ,using Proportional modes vs traditianoal PSV
in weaning appears to reduce dyssynchrony and aid weaning(1)
OBJECTIVES. To evaluate the role of NAVA compared to PSV in
patient with difficult weaning
METHODS. This is a prospective randomized control study
conducted on 30 critically ill, invasively ventilated patients with
predictive criteria of difficult weaning(2) admitted during the period
from June 2017 till August 2018 ,the patients were evaluated for
readiness criteria and presence of weaning indices then they were
randomly divided into two groups: group A include fifteen patients
were ventilated in PSV (as a weaning mode) and evaluated for
successful weaning and group B: including Fifteen patients were
NAVA was used as a weaning mode for 24 hours.Research and Ethics
comittee approval was taken prior to performing the study and a
written consent from each patient and or his next of kin before
participating in the study.RESULTS. There was no difference between both groups regarding
demographics ,baseline charecteristics and initial cause of venilation
or initial ventilatory support.
There was no significant difference between both groups regarding
length of mechanical ventilation ,susessful weaning, length of
hospital stay.see table(1)
The assyncrony index was lower in group B using NAVA while the
oxygenation index was significantly higher in same group compared
to group A using PSV during weaning .
CONCLUSION. Using NAVA during sponteneous breathing trial in
difficult weaning patients reduced Assynchrony index and improved
oxygenation index but this did not affect the sucess of weaning nor
the outcome of patients(mortality LOS nor LOV ).
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INTRODUCTION. Activation and assembly of the NLRP3
inflammasome is dependent on interaction between NLRP3 and the
intermediate filament protein vimentin in ARDS model.
OBJECTIVES. The roles of vimentin in the process of ARDS were
further investigated.
METHODS. The human fetal lung (HFL-1) fibroblasts with vimentin
transfergene or knockout were treated with LPS intervention. The oxidative
stress damage, inflammation and cytokines, apoptosis, autophagy, and
pyroptosis were measured and analyzed the relevant mechanism.
RESULTS. We demonstrated that vimentin expression less in the HFL-1
cells with vimentin knockout in response to LPS. Specifically, an increase
of oxidative stress, a decrease of mitochondrial membrane potential, and
an increase of calcium ion permeability resulted in an increase in the
level of fibroblast apoptosis. As the same time, inflammatory response of
vimentin knocked out were also upregulated, including the higher levels
of TNF-a, IL-1ß, IL-6, and IL-10. Importantly, the mechanism of suppres-
sion of vimentin in lung fibroblasts was caused by a decrease in autoph-
agy, a decrease in mitochondrial membrane protein, and a decrease in
mitochondrial function, which might contribute to the augmented cellu-
lar injury in response to LPS exposure.
CONCLUSION. This study provided insights into that vimentin may
interfere inflammatory cascade by activating the mitochondrial
autophagy pathway of lung fibroblasts in the early stage of acute
lung injury.
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INTRODUCTION. A series of quality control (QC) targets (SpO2≠100%,
PaCO2≮40mmHg, Pmean ≯10cmH2O) was put forwarded and widely
used in a single intensive care unit (ICU) setting.
OBJECTIVES. The aim of this study is to assess whether these QC
targets could improve outcomes of the critically ill patients.
METHODS. The real-time clinical data of patients with mechanical
ventilation at ICU admission between May 2013 to May 2017 in the
Department of Critical Care Medicine of Peking Union Medical Col-
lege Hospital were collected and analysed.
RESULTS. A total of 7,670 patients (mean age, 58 years; 3,943 [51.5%]
male) were divided into QC before (n = 3,936) or QC after (n = 3,734)
group. QC targets (SpO2, PaCO2, Pmean) and respiratory parameters
(FiO2%, PaO2, PEEP, tidal volume, respiratory rate) within 72-hour ICU ad-
mission, primary outcome (ICU mortality, 28-day, 60-day, and 90 day mor-
tality) and secondary outcomes (against advise discharge, ICU admission
days, mechanical ventilation times, and central venous pressure) were
calculated and made the comparisons between QC before and after.72-
hour averaged SpO2, Pmean, FiO2%, PaO2, and VT were significantly
lower and PaCO2 was higher after QC (P<0.05). Lower 90-day mortality,
less against advise discharge, ICU admission days and mechanical ventila-
tion times were found after QC (P<0.05). Interestingly, CVP significantly
decreased accordingly in the QC after group (P<0.05).
CONCLUSION. The QC targets (SpO2≠100%, PaCO2≮40mmHg,
Pmean ≯10cmH2O) contributed to avoid the high oxygen hazards,
protect the lung injury, and improve the circulatory function, which
resulted in better prognosis of critically ill patients.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):001171INTRODUCTION. The imbalance between organ demand and organ
availability has led to the development of new strategies to increase
the donor pool. The ACCORD-Spain project, carried out in 68 Spanish
hospitals between November 2014-April 2015, evaluated the number
of patients deceased after a devastating brain injury (DBI) and not
admitted to intensive care (ICU) due to their bad neurological prog-
nosis, that could have become potential donors. This project laid the
grounds for what it is known as intensive care to facilitate organ do-
nation (ICOD).
OBJECTIVES. To evaluate the impact of a new protocol aimed at
promoting ICOD in patients with a DBI once active treatment
(medical and/or surgical) has been deemed futile.
METHODS. Retrospective descriptive study (January 2016-
December 2018) carried out in a Spanish tertiary hospital with a
transplantation program that performs all transplants except
small bowel and pancreas. The new protocol for ICOD compre-
hended the elaboration of a banner explaining which patients
could be eligible for ICOD together with informative talks in the
Emergency, Neurology, Neurosurgery and Internal Medicine De-
partments. We reviewed all patients notified to the Transplant
Coordination Team and data were recovered from their data-
base. Evaluation and analysis of all notifications were carried
out.
RESULTS. During the period evaluated, 27 cases were notified; 21
(77%) out of the Emergency Department, four (15%) out of the
neurology ward and two (8%) were ICU patients admitted after a
DBI secondary to complications of an endovascular
neurointervention. Mean age: 84.5 years with 21 (77%) females.
The most frequent cause of DBI was intracranial hemorrhage (n=
18; 66%) followed by severe traumatic brain injury (n=6; 22%),
stroke (n=2; 8%) and acute subarachnoid hemorrhage (n=1; 4%).
Eleven (40%) out of the 27 patients were admitted to ICU with
five (18.5%) of them becoming effective organ donors. An
average of 2 organs were retrieved from each donor, with a total
of 10 organs being implanted (1 bilateral and 1 single lung, 4
livers and 4 kidneys). This accounted for 7% of our total annual
donor pool. Reasons for discarding the other six (21.5%) patients
as donors were: absence of progression to brain death (n=2),
new diagnosis of a neoplastic process, hemodynamic instability,
medical contraindication and dismissal by the National Organ &
Tissue Transplantation Organization due to lack of recipient (one
case each).
Sixteen patients (60%) were not eligible for ICOD because of: age
above 90 years plus comorbidities (n=5); clinical and radiological
criteria that oriented to a low probability of evolving towards
brain death (n=3); family refusal for ICOD (n=3) and absence of
free ICU beds (n=2). Hemodynamic instability, the impossibility of
correctly studying a neoplastic process at the time of admission
and reasons not detailed in the clinical history constituted the
three remaining cases.
CONCLUSION. ICOD represents a good and feasible option to
increase the organ donor pool. For this reason, we believe all
patients with a DBI in which treatment has been deemed futile
should be evaluated by the Transplant Coordination Team.
ICOD will only be possible after efforts have been made to raise
awareness towards organ donation across different hospital
departments.REFERENCE(S)
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INTRODUCTION.Do-not-resuscitate (DNR) orders apply to the decision
to withhold cardiopulmonary resuscitation (CPR) and should not
impact on other diagnostic or therapeutic measures. When there is
limitation of life-sustaining therapies (LT), DNR is frequently the only
or the first therapy to be limited and to many physicians a pre-
requisite for other limitations.
OBJECTIVES. To evaluate the use of DNR orders worldwide and how
they are related to LT.
METHODS. ICUs worldwide were invited to participate in Ethicus-2
through their country societies. Consecutively admitted patients who
died or had LT during a 6 month period from 1.9.2015 to 30.9.2016
were prospectively studied. Regions included North, Central and
Southern Europe (NE, CE, SE), North and Latin America (NA, LA), Asia
(As), Australia/New Zealand (Au/NZ) and Africa (Af). Previous end-of-
life practices (EOLP) definitions (1) were used.
RESULTS. 199 ICUs in 36 countries participated, enrolling 12850
patients. Decisions to LT, either withholding (WH) or withdrawing
(WD) or to actively shortening the dying process (SDP) for the different
regions were (WH %,WD %, SDP %): Af (20;13;0); As (41;39;0); NE
(38;53;0.2); CE (47; 37; 1); SE (41;25;1); LA (60;6;0); NA (54;36;1); Au/NZ
(45;46;0). The % of use of DNR orders in patients with LT for region
was: Af (8); As (80); NE (92); CE (85); SE (50); LA (41); NA (95); Au/NZ
(97). DNR orders are common when a decision to WH, WD or SDP is
taken in Asia, NE and CE, NA and Au/NZ, but not in Af, SE and LA.
CONCLUSION. DNR orders are used differently with other limitations
of LT around the world.
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INTRODUCTION. Moral distress, a powerful and detrimental
psychological response experienced when moral action is
constrained (Jameton, 2008) has been reported in end-of-life care
(Hamric and Blackhall, 2007). Increasingly intensive care unit (ICU)
end-of-life decisions were expected to involve approaches for
organ donation and opt in opt out approaches to organ donation
high on international political agendas. However, organ donation
related moral distress and the impact on clinicians and patients’
relatives was under-investigated.
OBJECTIVES. To explore the triggers for moral distress and the
consequences for physicians, nurses and relatives involved in
approaches for organ donation in end-of-life decisions.
METHODS. This qualitative narrative inquiry thematic analysis was
undertaken, in a large 19-bedded ICU in Northern Ireland, from Au-
gust 2012-November 2013. Twenty bereaved relatives and 45 nurses
and physicians involved in 21 end-of-life patient cases were purpos-
ively recruited and interviewed using in-depth digitally recorded
methods.
RESULTS. The timing and sensitivity of the organ donation
approach was important for supporting relatives to make morally
comfortable decisions. Physicians and nurses roles of carer versus
broker for organs created moral conflict. Physicians perceived
pressure to challenge relatives’ decisions not to donate. Such
challenge was morally distressing for relatives and nurses,
jeopardising autonomy, integrity and relationships. Rapid therapy
withdrawal in donation after circulatory death clashed with
notions of ‘a good death’. Lengthy delays in organ retrieval
threatened relatives’ fulfilment of culturally important after-death
rituals and obligations and risked withdrawal of consent to do-
nate. Moral distress impacted negatively on the grieving process,
well-being and attitudes about organ donation and positively on
quests to promote organ donation.
CONCLUSION. Organ donation decisions can generate
considerable moral distress. Findings have important implications
for: (a) the educational preparation and support of ICU clinicians
to recognise and manage the ethical challenges and sensitivities
of organ donation approaches and processes; (b) timely organ
retrieval supportive of important familial and cultural obligations
and beliefs; and (c) for organ donation opt in-opt out policies
and legislation and organ donation consent rates.REFERENCE(S)
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INTRODUCTION. Hypertensive derangements, preeclampia included,
complicate 8-10% of pregnancies worldwide and represent a major
cause of maternal and foetal morbidity and mortality. Preeclamptic
patients are often hypovolemic and oedematous with increased sys-
temic vascular resistances (SVR), low cardiac output (CO) and variable
degree of left ventricular hypertrophy and dysfunction. In these pa-
tients the haemodynamic variations induced by loco-regional
anesthesia (LRA) during caesarean section (CS), despite common,
may be unpredictable and risky.
OBJECTIVES. This observational study aimed to minutely evaluate
the haemodynamic effects of LRA in preeclamptic and hypertensive
patients, compared to healthy controls.
METHODS. Pregnant(18-40 y) and informed women, single fetus,
gestational age> 31weeks, ASA II or ASA III, elective or urgent CS
under LRA. Used monitoring system: Clear-sight finger cuff (Edwards
Lifescience). Recorded hemodynamic parameters were: CO, cardiac
index (CI), systolic, diastolic and mean arterial pressure (SAP,DAP,-
MAP) and heart rate (HR), stroke volume (SV), stroke volume index
(SVI), stroke volume variation (SVV). Precise chosen waypoints were:
baseline,left lateral decubitus, LRA, skin incision, fetal extraction,
afterbirth.
RESULTS. 10 preeclamptic patients (PE, 5 early and 5 late
preeclampsia), 5 hypertensive patients (HT) and 22 controls (CN). No
statistically significant differences for preoperative data (age, weight,
height, comorbidities, chronic therapy) were found, except
hypertension and hypertensive drugs. Hemodynamic parameters
varied during surgery within all groups, being pathological from the
beginning in PE and HT patients; pressure followed physiological and
LRA-induced changes, PE and HT pts maintained higher PAM values
than controls; CI downward variation was higher in preeclamptic pa-
tients than in hypertensive ones, with a 25% increase in CN and HT
patients after LRA nadir; non compensatory HR increase was wit-
nessed in PE patients; SVI variation pattern was group specific after
LRA maximal effect. Fig.1-2.
CONCLUSION. Pathological pregnancy is characterized by a
heterogenous response to LRA. Preeclampsia may not be treated as
hypertension.Fig. 1 (abstract 001558). See text for description001566
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INTRODUCTION. Emergence delirium is defined as a cognitive
disturbance during emergence from general anesthesia resulting in
hallucinations, delusions and confusion manifested by agitation,
restlessness, involuntary physical movement and extreme flailing in
bed. Postoperative emergence delirium develops in 12% to 18% of al
children undergoing general anesthesia for surgery. This postanesthetic
phenomenon changes cognitive and psychomotor behavior, and puts
pediatric patients and health care personnel at risk of injury.
OBJECTIVES. To describe a single-institution pilot study regarding preva-
lence and risk factors for delirium in children after maxillofacial surgery.
METHODS. A ptospective observational pilot study was made, from
Jenuary to March 2019 in the pediatric operating room (maxillofacial
surgery) at an urban academic medical center. Thirty consecutive patients,
aged 28 to 185 months were enrolled. When the patients were awake
(Richmond Agitation and Sedation Score > -3), two trained investigators
conducted the Paediatric Assessment of Emergent Delirium (PAED) and
the pediatric Confusion Assessment Method for the Intensive Care Unit
(pCAM-ICU) three times: basal (at the preliminary anesthetic visit, before
surgery), 30 minutes after the end of general anesthesia and 6 h later.
RESULTS. All children have been accopanied to operating room by their
caregivers. Only 6% recived an oral premedication before surgery. 86%
received opioids during anesthesia. Pediatric delirium was present on 2%
patient at awake time, 12 % after 30 min and 3% 6 h late. Both pediatric
delirium scales was similar in recognizing the presence of delirium. All of
this children with delirium received opioids during induction and/or
general anestehesia. Only 1 of this patients had a IV cannula at the
operating room admission. No one of them received a premedication
before surgery. The children who developed delirium were the youngest.
CONCLUSION. In our institution, pediatric delirium is a prevalent
problem, with identifiable risk factors (opioids during anesthesia, no
premedication before surgery, smal age). Some have a short-lasting
course, which underlines the need for early screening. The pCAM-ICU
scale, usually used in the intensive care unit to recognize pediatric
delirium, could be used in other departments than in intensive care
setting, as demonstrated. Our findings support the view of delirium
as a continuum of acute neurocognitive disorder. Further research is
needed to investigate prophylactic and treatment approaches for
postoperative pediatric delirium.
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INTRODUCTION. Guidelines published suggested appropriate
management of pain, agitation and delirium (PAD) is crucial in
improving patient outcomes. However, the practice of PAD
assessment and management in community hospitals is unclear and
the mechanisms contributing to the potential care gap are unknown.
Because of this, we want to know their perception in our ICUs
OBJECTIVES. To describe the perception of the management of PAD
in ICU by its professionals in 4 ICUs in Northern Spain.
METHODS. Multicenter descriptive study on the management of PAD in 4
ICUs of 4 Medical centers: Complexo Hospitalario Universitario de Ourense
(CHUO), Hospital Álvaro Cunqueiro de Vigo (HAC), Hospital Montecelo de
Pontevedra (CHOP) and Clínica Mompía de Cantabria (CMC).
An anonymous survey was conducted from December 2018 to
March 2019 to the ICUs staff (physicians and nurses). We ask about
demographic variables and different characteristics of PAD
assessment and management in the 4 ICUs.
RESULTS. They answered 152 surveys (CHUO 41.4%, HAC 36.8%, CHOP
15.1% and CMC 6.6%). The 74.3% were nurses with age between 31-45
years (56.6%). 45.4% were permanent staff and 36.8% had more than
10 years of experience. Only 1 center had a PAD protocol.
The pain scales used were: VAS and NRS in communicative patients
(95.8%) and ESCID in non-communicative (61.8%). The most used an-
algesic drugs were acetaminophen (64.5%) and fentanyl (32.9%). Pre-
emptive analgesia before nursing procedures was ocassional. The
46.7% of the staff thought that patients had pain. The 50.7% be-
lieved that the response to treatment was satisfactory.
97.4% used RASS as a sedation scale. Light sedation strategy was the
most used (59.9%). The preferred sedatives were midazolam (83.6%)
and propofol (72.4%). The combination of midazolam and fentanyl
was the most popular (88.2%). The sedation degree was uneven:
33.3% poor, 36.2% correct and 27% over sedated. Physicians
subgroup consider that patients were overstated (71.8%).
Delirium evaluation was uncertain: occasional (52.6%). Among those
who used a diagnostic tool, CAM-ICU was preferred (74.3%). Our re-
sults indicated that delirium was underdiagnosed (66%) and overse-
dation contributed to its appearance (75.7%).
Non-pharmacological measures were used in 69.1%. The preferred
by our surveyed were: light control (32.2%) and family support
(47.3%). Only 1 of the ICUs had an open visits schedule more than 6
hours. Haloperidol is the most commonly drug used in treatment
(78.9%)
CONCLUSION.
 The global use of scales is high.
 Despite of the Guidelines recommendations, benzodiazepines
(midazolam) use is elevated. Exist a different perception in sedation degree between nurses
and physicians.
 It is necessary to implement protocols to optimize and
standardize the handling of PAD.
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INTRODUCTION. Exist a large number of scientific publications that
describe the importance of delirium in terms of outcomes (mortality,
days of hospital stay and sequelae), but the association with the
alterations in the quality of life and executive function is not well
understood1,2.
OBJECTIVES. Evaluating the impact of delirium in the decline of
cognitive and executive functions, quality of life and survival of the
critically ill.
METHODS. A nested case-control study in a cohort of six months.
The prevalence of delirium, mortality, cognitive and executive disor-
ders, and the quality of life in survivors in a period greater than three
months after discharge from the ICU were evaluated. The CAM - ICU
for delirium screening was performed daily for all patients to find the
cases, defined as a positive score, and a homogeneous sample with
a negative score was considered as a control group3. For the follow-
up, the scales of quality of life in health (SF-36), instrumental
activities of daily life (PGC - IADL) and minimental test (MMSE) were
carried out.
RESULTS. 457 patients were hospitalized between April and
September of 2018. 81 patients were evaluated after three months of
discharge from the ICU, with a mean of 61.3 ± 18 years. Of this
group, 43 subjects had delirium and 38 did not. We found
differences with statistical significance in the cognitive functions (p <
0.01), with greater affectation of the domains of the orientation, the
calculation and the language / praxis (p <0.05) and deterioration in
the quality of life (QoL) in the subscales of social function (p <0.006),
emotional role (p <0.04) and mental health (p <0.04) in cases.
Although the executive functions were not affected by the presence
of delirium in the hospitalization, it was diminished in both groups.
CONCLUSION. Cognitive capacity, social function, emotional role,
and mental health were affected with statistical significance in
the group of patients who had delirium during the stay in ICU
for any reason when compared with a control group not
exposed to this factor, but with similar socio-demographic
characteristics.
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INTRODUCTION. In patients undergoing surgical procedures, the
type of surgical procedure and the perioperative sampling time may
influence the correlation between the standard laboratory tests (SLT)
and their equivalent ROTEM parameters.
OBJECTIVES. Prospective study (ABCD study, NCT:026552897) funded by
Carlos III Institute (PI15/00512), aimed at investigating the correlation
between prothrombin time (PT) vs. clotting time of ex-TEM (CT-exTEM),
and between plasmatic Clauss fibrinogen level (pFBN) vs. maximum clot-
ting firmness (MCF-fibTEM), in patients undergoing procedures with high
(glioblastoma multiforme resection: GBR) or moderate (colon cancer re-
section, by laparoscopy: CCR) degree of surgical injury, at different peri-
operative time-points.
METHODS. ExTEM clotting-time (CT-exTEM) and FibTEM maximum clot
firmness (MCF-fibTEM), as measured by ROTEM, were correlated with pro-
thrombin time (PT) and plasma fibrinogen (pFBN, Clauss method), as
measured at SLTs, in GBR (N=60) and CCR (N=40) patients. Blood samples
for SLTs and ROTEM assessments were drawn simultaneously within 24-
hours before surgery (baseline) and 2, 24 and 48-hours after surgery. Cor-
relations between ROTEM parameters and SLTs values assessing similar
coagulation profile were evaluated by Spearman r rank-order. Receiver-
Operator Characteristic (ROC) curves were performed in order to screen-
ing the efficiency of best CT-exTEM and MCF-fibTEM cut-offs for detect-
ing prolonged PT (>15 s) and low pFBN values (<2 g/L), respectively.
RESULTS. The correlations between PT and CT-exTEM and between
pFBN and MCF-fibTEM were weak (r < 0.40) or moderate (r ≈ 0.40 –
0.65), respectively, and remained unchanged over the studied peri-
operative period in both groups. Recommended cut-offs for CT-
exTEM (>75 s) and MCF-fibTEM (<10 mm) had poor sensitivity (%
[95% confidence interval]) for identifying a prolonged prothrombin
time (17 % [8, 31]) or a low pFBN (46 % [32, 62]).
CONCLUSION. As SLTs and their ROTEM equivalents parameters are
poorly related, they should not be used interchangeably in patients
undergoing GBR or CCR. Neither the type of surgery nor the
perioperative timing significantly influenced these correlations.REFERENCE
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INTRODUCTION. Critically ill, mechanically ventilated patients in
intensive care units generally require sedation treatment to relieve
anxiety and agitation. But long-term mono-sedative use is associated
with some adverse effects. Different sedatives sequentially used after
meeting the sequential criteria may reduce these adverse effects, lead-
ing to patient faster recovery, earlier extubation and better outcome.
OBJECTIVES. This study aimed to evaluate the factors influencing
ventilator weaning time in sequential sedation patients.
METHODS. A total of 216 ventilated patients who received sequential
sedation and completed sequential sedation protocol were enrolled to
this analysis. The primary endpoint in this study was patient weaning
time defined as duration of mechanical ventilation after patients met
the sequential criteria. Sequential criteria indicated patients passed
spontaneous breathing trial (SBT) safety screen, but failed the 30-
minute SBT. Univariate and multivariate Cox proportional hazards re-
gressions were used to predict factors influencing weaning time.
RESULTS. In this analysis, older age (RR=0.984, 95%CL 0.974-0.993, p=
0.001), longer time from meeting the sequential criteria to stopping
sedation (RR=0.968, 95%CL 0.959-0.977, p<0.001), more accumulated
dose of fentanyl after patients met the sequential criteria for extubation
(RR=0.891, 95%CL 0.801-0.993, p=0.036), and faster rapid shallow
breathing index (RSBI) when patients undergoing SBT trial (RR=0.992,
95%CL 0.985-0.998, p=0.008) were independent risk factors for
prolonging patient weaning time. Non-smokers (RR=2.456, 95%CL 1.489-
4.053, p<0.001), lighter average sedation depth (RR=1.221, 95%CL 1.053-
1.416, p=0.008), sequential sedation with propofol (RR=2.612, 95%CL
1.796-3.800, p<0.001), and sequential sedation with dexmedetomidine
(RR=2.543, 95CL% 1.727-3.744, p<0.001) after patients met the sequential
criteria were associated with earlier ventilator weaning.
CONCLUSION. In sequential sedation patients, older age, longer time from
meeting the sequential criteria to stopping sedation, more accumulated
dose of fentanyl after patients met the sequential criteria for extubation and
faster RSBI were independent risk factors for delaying ventilator weaning.
However, non-smokers comparing with current smokers, lighter average
sedation depth, sequential sedation with propofol or dexmedetomidine after
patients met the sequential criteria could shorten patient weaning time.
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ARDS1. It’s role in elective major abdominal surgery is controversial2.
Peritonitis patients undergo laparotomy and often develop ARDS.
OBJECTIVES. To identify whether use of lung protective ventilation during
laparotomy in abdominal sepsis patients affect mortality and morbidity.
METHODS. After Institutional ethics committee clearance and informed
written consent, 100 adult patients undergoing emergency laparotomy
for peritonitis were randomized in to two groups. In Group1: Vt 6-8ml/
kg, PEEP 6-8cmH2O and recruitment maneuver every 30min and in
Group 2 Vt 10-12ml/kg, no PEEP and no recruitment were used. All the
patients were followed up till death/discharge.
RESULTS. All the patients received allocated treatment. Follow up
was lost for six patients and data from 94 patients (45 patients in
Group1 & 49 patients in Group2) were analyzed.
Demographic & laboratory parameters were comparable in two groups.
In-hospital mortality was 26.7% in Group1 versus 26.5% in Group2 (risk
difference 0.14%, 95% CI -17.7- 18.0; p=0.98, Chi- square test). Kaplan
Mayer survival analysis confirmed similar in-hospital mortality in two
groups (p=0.79, log-rank test). Duration of hospital stay [median (IQR)
13(9-18) days in Group1 versus 13(8-21) days in Group2; p=0.82] & dur-
ation of ICU stay [median (IQR) 7(4-10) days versus 6(3-12) days; p=
0.88] were also similar. Postoperative pulmonary complications (POPC)
during hospital stay were also similar [median (95% CI) of POPC grade
in Group1 was 2(1-4) versus 3(1-4) in Group2; p=0.45].
CONCLUSION. Intraoperative lung protective ventilation does not
provide mortality benefit in peritonitis patients undergoing emergency
laparotomy.
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INTRODUCTION. Certain groups of critically ill patients are archetypally
at high risk of coagulopathy and severe bleeding. Detection and
correction of coagulopathy frequently relies on standard laboratory
tests (SLTs). The viscoelastic tests (VET) offers an alternative approach
to assess coagulation alterations, offering faster turn-around-time and
performing a more global assessment of coagulation.
OBJECTIVES. This study aimed to ascertain the relationship between
thromboelastography (TEG®) and standard laboratory tests (SLTs)
values with the presence of bleeding in critically ill patients with
known coagulopathy.
METHODS. Consecutive coagulopathic patients with hepatic failure,
postoperative period of prolonged cardiac surgery or complex
abdominal surgery with sepsis, were prospectively included in this
study. On intensive care unit (ICU) admission, patients were stratified
into two groups according to whether yes or not they had major
bleeding (MB) [whether evident overt bleeding, important bleeding
apparent on image studies and/or need of moderate-massive blood
transfusion and hemodynamic instability]. Blood samples were drawn
for SLTs [international normalized ratio (INR), activated partial
thromboplastin time (aPTT), platelets count and fibrinogen level
(Clauss)] and TEG (R, reaction time; MA, maximal amplitude and Ly30,clot lysis at 30 min.). Receiver-Operator Characteristic (ROC) curves
analysis were performed in order to screening the efficiency of TEG
and SLTs in detecting bleeding. Correlation between SLTs and TEG
parameters assessing similar coagulation profile was evaluated by
Spearman rank-order.
RESULTS. Eighty-tree patients were included and bleeding was con-
firmed in 45 (54%). Fibrinogen level demonstrated the best accuracy,
even low, for detecting bleeding with an area under curve and 95%
confidence intervals (AUC (95% CI)): 0.74 (0.63-0.85) for a best cut-off
≤ 2 g/L. Regarding to TEG-MA, values for an optimal cut-off ≤ 51 mm
were AUC: 0.68 (0.56-0.80).
CONCLUSION. Both conventional clotting tests and TEG values were
poorly associated with bleeding in this critically ill cohort patients
with coagulopathy.
Table 1 (abstract 001648). Accuracy of thromboelastography and
laboratory tests in predicting bleeding from variables assessing initiation
of coagulation or final clot firmnessVariables AUC (95%) Optimal
cut-offSensitivity Specificity LR+ LR-INR 0.55 (0.44-0.66);
p=0.4161> 1.2 64 (49-
78)29 (15-
46)0.91 1.23aPTT (s) 0.54 (0.43-0.65);
p=0.4940> 36 35 (22-
51)66 (48-
80)1.04 0.98TEG-R (min) 0.62 (0.50-0.72);












p=0.0126≤ 52 35 (21-
51)86 (71-
95)2.70 0.74TEG-MA (mm) 0.68 (0.57-0.78);
p=0.0028≤ 51 33 (20-
49)87 (72-
95)2.53 0.77001658
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INTRODUCTION. Cardiovascular complications due to ischemic injury
of the myocardium after major non-cardiac surgery are frequent and
cause a considerable amount of morbidity and mortality in patients
undergoing noncardiac surgery. Major Cardiovascular and Cerebro-
vascular Events (MACCE), are the most common causes of serious
postoperative complications. Current risk stratification systems have
limited sensitivity and specificity in identifying patients at risk of
MACCE and postoperative symptoms and clinical signs of myocardial
injury are often diffuse or lacking. Endothelin-1, a potent vasocon-
strictor considered to have an important pathophysiological role in
cardiovascular dysfunction, is proposed as a promising biomarker in
predicting adverse cardiovascular events.
OBJECTIVES. The purpose of this study is to identify if ECG-changes
and levels of C-terminal pro-endothelin-1, CT-proET1 can predict
MACCE in patients undergoing major abdominal surgery.
METHODS. We conducted a multicenter prospective study including
387 surgical patients. This was a preplanned substudy of the MINSS
study (NCT03436238). Perioperative blood samples and ECGs were
obtained at five sample points: pre-surgery, immediately post-
surgery, and on Days 1,2,3 after surgery. We analysed plasma levels
Fig. 1 (abstract 001671). See text for description
Fig. 1 (abstract 001671). See text for description
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for their association with MACCE within one month of surgery.
RESULTS. Perioperative plasma levels of CT-proET-1 were significantly
higher in patients affected by MACCE and the prognostic value
exceeded that of cTnT, the number one cardiac biomarker used today,
in all analyses. The number of ECGs interpreted at the end of this study
was not sufficient to run statistical analyses, however, the distribution
of ECG-changes did not seem to be a predictor of MACCE.
CONCLUSION. Our analysis suggests that increased perioperative CT-
proET-1 levels significantly identify patients at risk of MACCE in the
ensuing month following major abdominal surgery and the prognos-
tic value exceeded that of cTnT.
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INTRODUCTION. NIRS is frequently used in cardiac surgery to assess
adequacy of cerebral oxygenation (rSO2). Current NIRS devices are
categorized as oxygen saturation monitors although there are possibly
additional benefits to NIRS monitoring. This study was performed to
investigate the ability of NIRS monitoring to detect changes in cerebral
blood flow during hypovolemia and resuscitation.
OBJECTIVES. To investigate the ability of the INVOS 5100C system
(Medtronic, Boulder USA) to detect changes in cerebral blood flow
during hypovolemic shock and resuscitation.METHODS. In an animal study approved by the local animal use
committee we anesthetized, intubated and ventilated 19 pigs.
Hypovolemic shock was accomplished by removing 50% of the
animal’s blood volume over a 20-minute period in 3 steps. Resuscita-
tion by blood returned to the animal over a 20-minute period in 3
steps. 30-minutes allowed between end of blood removal and start
of resuscitation. Blood pressure, heart rate, arterial oxygen saturation,
internal carotid blood flow (CBF), rSO2 and end-tidal carbon dioxide
was measured continuously. Normocapnia was maintained in all
animals.
RESULTS. CBF and rSO2 correlated during bleeding (r2 0.88).
Bleeding resulted in a final CBF of 66 ml/min a decrease of 58%
while rSO2 fell by 31% (Fig 1).
During resuscitation CBF and rSO2 correlated during the first infusion
of 10% of the shed volume increasing the CBF from 115 ml/min to
176 ml/min and rSO2 from 46% to 55%. The second and third
infusion increased CBF to 207 ml/min without a major change in
rSO2 (59%) (Fig 2).
CONCLUSION. During blood loss rSO2 may be an indicator of
cerebral blood flow since fall in rSO2 and decrease in CBF correlated.
Allowing 30 minutes for stabilization after final blood removal
resulted in recovery of CBF due to peripheral vasoconstriction.
Increased CBF did not result in increased rSO2 probably because
of increased cerebral oxygen extraction. Infusion of the first 10%
of shed volume led to rSO2 correlation with increase in CBF.
Further infusionsion did not result in increased rSO2 despite
increase in CBF. During resuscitation there may be very limited
correlation between rSO2 and cerebral blood flow due to
compensatory oxygen extraction and vasoactive behavior because
of prior ischemia during shock.
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INTRODUCTION. Therapeutic plasma exchange (TPE) is an
extracorporeal treatment used in the removal of high molecular
weight particles causing acute toxicity, whose applications have
been undergoing constant development.
OBJECTIVES. Retrospective analysis of patients undergoing TPE and
respective outcomes
METHODS. Review of the clinical files of patients who underwent
TPE since 2014
RESULTS. Between January 2014 and April 2019, 15 patients
underwent TPE. The most frequent indication was
hypertriglyceridemic pancreatitis, in 7 cases. All were young male
patients, most commonly with favorable response after a single
session. We highlight the occurrence of 2 deaths due to
necrohemorrhagic pancreatitis and multiorgan dysfunction. There
were 3 cases of thrombotic microangiopathy. In 2 of these
(HELLP syndrome in a 41-year-old puerperal patient and atypical
hemolytic-uremic syndrome in a 31-year-old patient), there was
resolution of hemolysis and complete recovery of renal function.
In a case of thrombotic thrombocytopenic purpura in a 66-year-
old patient, refractory shock and death was observed. There was
only 1 case of dialysis-dependent ANCA+/PR3 vasculitis with dif-
fuse alveolar hemorrhage in a 79-year-old patient, with unfavour-
able outcome. In 2 cases of myasthenic crisis submitted to short
cycles of TPE, along with immunosuppressive therapy, significant
symptomatic improvement and reduction of fatigability were ob-
served. Finally, in 2 patients diagnosed with autoimmune enceph-
alitis, who underwent prolonged cycles of TPE, response varied,
with ad integrum recovery in a 19-year-old patient with anti-
NMDAr encephalitis, and persistence of neurological deficits and
development of hydrocephalus in a 51-year-old patient. Complica-
tions included pneumothorax associated with placement of cen-
tral venous catheter, transient hemodynamic instability and
electrolyte imbalance.
CONCLUSION. TPE has a proven benefit, and is sometimes a life-saving
therapy. This is the case of thrombotic microangiopathy and myas-
thenic crisis, where we also observed the most favorable results. On the
other hand, its role is not established in hypertriglyceridemic pancrea-
titis as well as in autoimmune encephalitis (except for anti-NMDAr),
where it remains a reasonable alternative, to be considered in cases of
immunosuppressive therapy failure. Complications are rare and gener-
ally related to central venous access catheterization, need for anticoa-
gulation or associated with the replacement fluid used.
In sum, TPE is a useful treatment in a wide range of diseases
observed in the critical patient.
Table 1 (abstract 001721). See text for description001728
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INTRODUCTION. Recombinant activated Factor VII (rVIIa) enhances
haemostasis with action limited to areas of injury. It is approved for
use only in haemophilia and presence of clotting factor inhibitors.
We sought to audit its use outside these recommendations and
evaluate its efficacy in improving outcome.
OBJECTIVES. To observe efficacy of Factor VII (rVIIa) outside its
prescribed indications and monitor its outcome.
METHODS. We performed a retrospective observational study of all
patients who received factor rVIIa in two tertiary care hospitals
between January 2008-December 2012 for persistent haemorrhage
refractory to conventional treatment. Efficacy of factor rVIIa was
assessed by mortality and blood product requirements.
RESULTS. Total of 42 patients were given factor rVIIa. Indications
included cardiac surgery (26%), haematological disorders (21%),
intracerebral haemorrhage (14%), obstetric bleeding (9.5%), abdominal
surgeries (7.1%), sepsis (7.1%), trauma (7.1%), liver diseases (4.7%) and
dengue (2.3%). The median of units of packed red blood cell (PRBC),
platelets, fresh frozen plasma (FFP) and cryoprecipitate requirement
before and after factor rVIIa administration in medical patients were
4,3,5,2 and 1.5,0,0.5,0 respectively. In surgical patients requirements of
PRBC, platelets, FFP and cryoprecipitate before and after use of rVIIa were
6,3.5,5,6 and 3,0,2,1 respectively. Mortality was 28% among medical
patients and 46% among surgical patients. There was no documented
thromboembolic phenomenon in the study patients.
CONCLUSION. Recombinant Factor rVIIa is widely used beyond
conventional recommendations. It appears to be effective in
reducing further need for blood product transfusions in medical
patients but not in surgical patients. Higher mortality in surgical
patients receiving factor rVIIa may be contributed by inadequate
source control of the bleeding. Cost effectiveness of rVIIa therapy
needs to be factored in prior to use in all patients.
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INTRODUCTION. The continuous techniques of renal clearance in
patients admitted to the intensive care units (ICU) continue to be
used up to 20%, in which anticoagulation of the extracorporeal
circuit is mandatory. The regional anticoagulation with citrate has
been used in recent years to prevent circuit coagulation, maintain
filter performance and reduce the risk of bleeding.
OBJECTIVES. To determine the prevalence of filter consumption
according to the use of anticoagulation with unfractionated heparin
in relation to the regional anticoagulation with citrate.
Page 624 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55METHODS. Retrospective observational study, performed on patients
admitted to the intensive care unit with renal clearance in the period
from 2016 - 2018 at the University Hospital of Bellvitge.
RESULTS. We analyzed 186 patients admitted to the ICU which
required renal clearance techniques, 41 patients of them received
anticoagulation with unfractionated heparin, 15 ± patients with
citrate anticoagulation and 115 of the patients did not receive
anticoagulation.
The average of the days that required techniques of renal clearance
with unfractionated heparin was 7.6 ± 7.9, that of regional citrate
anticoagulation was 8.4 ± 7.9; the average daily use of filters was 0.8
± 0.6, in patients with anticoagulation of unfractionated heparin, 0.7
± 0.8 in patients with regional citrate anticoagulation and 0.8 ± 0.6 in
patients who did not receive anticoagulation. The mean number of
filters used with unfractionated heparin was 4.8 ± 4.6 and 4.6 ± 4.7
for citrate anticoagulation.
CONCLUSION. No significant differences were found between the
consumption of filters of patients who received anticoagulation with
fractionated heparin in relation to patients who received
anticoagulation with citrate. It was difficult to find significant
difference due to a small population.
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INTRODUCTION. The occurrence of acute kidney injury (AKI) in
trauma patients is a problem that has been little studied to date. Its
presence has been shown to be associated with an increased risk of
morbidity and mortality in affected individuals.
OBJECTIVES. To determine the incidence of post-traumatic AKI and
identify its predictive risk factors that could be eventually prevented.
METHODS. This is a ten-month long prospective cohort-study, con-
ducted in the department of emergencies and intensive care unit
(ICU) of a university hospital, including trauma patients with a mini-
mum ICU stay of 7 days. Renal failure was defined based on the new
KDIGO classification. Predictors of AKI were identified using univari-
ate and then multivariate analysis.
RESULTS. One hundred thirty patients were admitted during the
study period for the management of post-traumatic injuries, among
which 86 patients were included. The incidence of AKI in the studied
population was 53% (46 cases) with 26 (56%) diagnosed with stage
one, ten (22%) with stage two and ten (22%) with stage three.
On univariate analysis, older age and medical history of diabetes or
hypertension were predictors of AKI. Injury assessment found traumatic
brain injury (AIS>3), Glasgow (GCS) on admission, and the diagnosis of
fat embolism to be associated to post-traumatic AKI. Moreover,
hemodynamic instability on admission and during ICU stay, shock-
index on admission, the amount of fluid administered the use of vaso-
active drugs, sepsis, hyperbilirubinemia, P/F ratio and acute respiratory
distress syndrome (ARDS) were also associated to post-traumatic AKI.
Among these factors, ARDS (p = 0.001, OR = 9 , CI: 6-100), fat embol-
ism (p = 0.028, OR = 2, CI: 1.6-2.5), Shock index (p = 0.02, OR = 15.2,
CI: 2.2-105), and bilirubin levels (p = 0.006, OR = 1.035, CI: 1.01-1.06)
were identified as independent predictors of post-traumatic AKI on
multi-variate analysis.
Besides, according to our analysis, the following variables were
predictive of stage3 AKI, including bilirubin levels on the day of AKI
diagnosis (p = 0.026, OR = 1.032, CI: 1.004-1.061), transfusions (p =
0.02, OR = 1.5, CI: 1.1-1.9), fat embolism (p = 0.015, OR = 11.3, CI: 1.6-
75), and diuretics’ administration (p = 0.004, OR = 10.4, CI: 1.8-57).CONCLUSION. Post-traumatic AKI could be associated with signifi-
cant morbi-mortality in the ICU. The identification of predictors from
the initial onset of trauma could be valuable to guide its
management.
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INTRODUCTION. Sepsis-associated acute kidney injury is the most
common syndrome in ICU. CRRT may be useful during sepsis, but de-
finitive recommendations are lacking. Early and appropriate antibiotic
therapy is the mainstay to successfully treat sepsis, but no compre-
hensive guidelines exist that provide antibiotic dosing recommenda-
tions for adult patients receiving CRRT.
The factors that need to be considered when dosing patients on RRT
are related to the drug being used, type of RRT, and patient status.
Particularly, the type of membrane plays a major role in drug removal.
New synthetic and biocompatible membranes have high adsorptive
affinity to proteins, endotoxins, inflammatory mediators, but also drugs.
Two antibiotics, Vancomycin (VAN) and Teicoplanin (TEC), are
frequently used in critically ill adult patients receiving CRRT to treat
Gram-positive infections, especially sustained by methicillin-resistant
Staphylococcus aureus.
OBJECTIVES. The aim of this study was to evaluate, in an in vitro
system simulating the in-vivo permeability drugs, the convective and
adsorptive drug clearance of VAN and TEC during CVVH with poly-
methylmethacrylate filter.
METHODS. VAN (1448 Da) and TEC (1885 Da) clearance was assessed
in vitro in blood from healthy donors, spiked with one antibiotic
under investigation. Closed circuit simulating CVVH was performed
using PMMA filter at 10 ml/min ultrafiltrate and 50 ml/min blood
flow rates. The duration of the experiment was of 360 min. Samples
were collected at 5, 10, 30, 60, 120, 240 and 360 minutes from in-
flow, out-flow and ultrafiltrate line; antibiotic concentrations were
measured with biochemistry analyzer. Convective clearance was eval-
uated in terms of sieving coefficient, and adsorptive clearance was
calculated using mass balance analysis.
RESULTS. The target initial VAN and TEC plasma concentrations set in
this study were respectively 100 and 130 mg/L. Although the initial
VAN concentration was 99.7 mg/L, after 360 minutes of CVVH, VAN
concentration slightly decreased to 90.7 mg/L, with a total estimated
adsorbed mass per surface area of 10.86 mg/m2. The blood SC ranged
from 0.84 to 0.87. The initial TEC concentration was of 129 mg/L. After
two hours, the concentration decreased of 25% and of 44% at the end
of simulation, with a total estimated adsorbed mass per surface area of
65.12 mg/m2. The blood SC ranged from 0 to 0.19.
CONCLUSION. Our findings suggest that VAN prescription should
take into account the elevated SC with PMMA membrane and
dosage should be adjusted proportionally with ultrafiltration flow.
Otherwise, TEC is largely adsorbed by PMMA membrane; a loading
dose should be considered at the beginning of each treatment to
balance the adsorptive phenomenon.
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INTRODUCTION. Acute Kidney Injury (AKI) occurs frequently among
patients with septic shock (SS) and is associated with worse prognosis,
particularly if renal replacement therapy (RRT) is required. International
guidelines recommend rapid recognition and initiation of treatment of SS.
OBJECTIVES. We examined the characteristics and outcomes of
patients with SS who developed AKI requiring RRT.
METHODS. Data on 53 SS patients (requiring vasopressors - VP) were
collected from acute physiologic and chronic health evaluation
(APACHE) Outcome database and medical records. Data included age,
gender, APACHE III score, APS (acute physiologic score), Sequential
Organ Failure Assessment (SOFA) score at time of VP initiation (T0) and
at 72 hours (T72), Delta SOFA (SOFA T0 - SOFA T72), lactic acid at T0,
serum creatinine (Cr) at T0, duration of vasopressors in days, Input/
Output (I/O in cc) at 6 hours and 24 hours, hospital length of stay (LOS
in days), and hospital mortality. AKI was diagnosed based on Kidney
Disease Improving Global Outcomes (KDIGO) criteria.
RESULTS. Of the 53 patients with SS, AKI occurred in 24 patients (65%) of
which 16 patients (67% of AKI cases) required RRT. Overall, the prevalence
of AKI requiring RRT among SS patients was 30%. The SS-RRT group (16)
and the SS without RRT group (37) were comparable on age (65 ± 12 vs
66 ± 15, p = 0.8), gender (male, 63 % vs 65 %, p = 0.9), APACHE III scores
(114 ± 26 vs 99 ± 36, p = 0.2), SOFA T0 (13.4± 3.6 vs 11.6 ± 3.8, p = 0.1),
lactic acid (4.9 ± 1.9 vs 5.9± 4.2, p = 0.3), I/O at 6 hrs (2200 ± 1800 vs 2100
± 2100, p = 0.9), I/O at 24 hrs (6900 ± 4000 vs 5900 ± 3300, p = 0.4), and
hospital mortality (38% vs 48%, p = 0.5). The SS-RRT group had higher
APS (102 ± 24 vs 84 ± 33, p = 0.05), higher SOFA T72 (11.6 ± 3.8 vs 9.2 ±
4.4, p = 0.05), less Delta SOFA (1.8 ± 5.0 vs 4.4 ± 5.9, p = 0.03), higher Cr
(3.7 ± 1.5 vs 2.2 ± 1.3, p < 0.001), longer duration of VP (6.0 ± 3.5 vs 3.3 ±
2.3, p < 0.01), and longer hospital LOS (24 ± 13 vs 14 ± 12, p < 0.01).
CONCLUSION. AKI and AKI requiring RRT are prevalent among patients
with septic shock. Patients who developed AKI requiring RRT during
septic shock have a significantly higher acute physiologic derangements,
worsening organ failures, higher creatinine, longer duration of
vasopressors, and longer hospital LOS than those without.
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Intensive Care Medicine Experimental 2019, 7(Suppl 3):001697INTRODUCTION. Currently, there are no reliable predictors of risk of
development and severity of acute kidney injury (AKI) in septic
patients. In the prospective study, we sought to determine plasma
surfactant protein D (SP-D) levels and SP-Dpolymorphisms
rs721917C/T and rs2243639A/G of septic patients with AKI(defined
with KDIGO criterion) versusthose without AKI. The association
between SP-Dpolymorphisms and plasma SP-D level and subsequent
development and severity of AKI were analyzed.
METHODS. The study enrolled septic and septic shock patients
admitted to the Department of Critical Care Department of two
tertiary care hospitals. SP-Drs721917C/T and rs2243639A/G
polymorphisms were determined using the PCR-SSP method. Fur-
thermore, plasma SP-D and urine NGAL contents were examined
using commercially available ELISA kits.
RESULTS. Totally 330 septic patients including 121 patients with
septic shock were included. Their mean SOFA scores were 12 ± 3
(range 8-21). Septic patients with AKI (n=156) had significantly higher
plasma SP-D levels (median: 150 ng/mL, range: 138-160 ng/mL) than
those without AKI (median: 101 ng/mL, range: 82-111 ng/mL;P=
0.01).Plasma SP-D levelsof septic AKI patients were correlated with
urine NGAL contents(r=0.596) and duration for CRRT(r=0.448). Septic
patients with AKI had a significantly higher rate of rs721917 CC
genotype (AKI: 35% vs. non-AKI:20%; P = 0.012), but a significantly
lower rate of TT genotype (AKI: 19%vs.non-AKI: 26%; P= 0.005). Our
multivariate analysis showed that SP-D rs721917 CC genotype was a
significant independent predictor of AKI (P= 0.044) and mortality (P=
0.014) of septic patients.
CONCLUSION. Our study showed that septic patients with AKI had
significantly higher plasma SP-D levels versusthose without AKISP-D
rs721917CC genotype is an independent and significant predictor of
AKI development and mortality of septic patients. SP-D rs721917C/T
polymorphisms should be further studied as a diagnostic and prog-
nostic biomarker to facilitate early recognition of AKI so that treat-
ment can be instituted promptly.
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INTRODUCTION. Cardiogenic shock occurs in 2-6% of patients under-
going cardiac surgery. One percent will require mechanical support
using VA ECMO. Acute Kidney Injury (AKI) is one of the most frequent
complications in patients undergoing ECMO support and is associ-
ated with mortality.
OBJECTIVES. The aims of our study were to 1/ describe the
epidemiology and 2/ identify the risk factors of AKI in adult patients
assisted by VA ECMO in perioperative of cardiac surgery.
METHODS. We conducted an observational, retrospective and
monocentric study in the Surgical Intensive Care Unit of the
Cardiology Institute of La Pitié-Salpêtrière University Hospital in Paris,
France. All patients hospitalized in the department between January
1, 2013 and December 31, 2016 on a cardiac surgical peri-operative
basis and assisted by VA ECMO for more than 48 hours were in-
cluded in the study. A multivariate statistical analysis identified the
risk factors for severe AKI in this cohort.
RESULTS. Of the 319 patients included, 211 (66%) developed severe
AKI (KDIGO 3 stage), for an overall 30-day mortality of 48%, increased
to 59% in patients undergoing renal replacement therapy (86% of
patients with AKI). Risk factors for AKI werehigh preoperative LVEF
Page 626 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55(OR 1.02 CI 95%[1.01-1.04], p=0.006); maximumperoperative
adrenaline dose (OR 1.04 CI 95%[0.75-1.45], p=0.002); presence of
right ventricular dysfunction (OR 2.20 CI 95%[1.14-4.23], p=0.009);
arterial lactate level (OR 1.07 CI95%[0.97-1.18], p=0.009), bilirubi-
nemia (OR 1.01 CI95%[1.004-1.020], p<0.001) and creatinine level
(OR 1.01 CI 95%[1.01-1.02],p=0.001) on the day of VA ECMO im-
plantation. The implantation of VA ECMO percardiotomy (OR 0.51
CI 95%[0.28-0.94], p=0.02) and high protidemia (OR 0.96
CI95%[0.92-0.99], p=0.04) were protective factors for AKI. Several
risk factors ofday 30 mortality have been identified: chronic arter-
iopathy (OR 3.59 CI 95%[1.42-9.10], p=0.01); biventricular failure
(OR 1.77 CI 95%[1.00-3.11], p=0.048) and high arterial lactate level
(OR 1.17 CI 95%[1.07-1.28], p<0.001) at VA ECMO implantation.
Heart transplantation was a protective factor of mortality
compared to other types of surgery (OR 0.34 CI 95%[0.14-0.80],
p=0.01). In this cohort, AKI was not associated with increased
mortality.
CONCLUSION. AKI in patients assisted with VA ECMO undergoing
cardiac surgery is frequent and associated with significant mortality.
Several risk factors for AKI are identified. The implantation of VA
ECMO in per cardiotomy is a protective factor.T2HSRO / NAHP - Outcomes and quality
assessments in the intensive care
setting
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INTRODUCTION. The ability of Pseudomonas Aeruginosa strains to
cause infection is complex, because not only they provide strong
infection ability, but because invade the tissues with discretion as
well. Spreading of these strains may lead in developing severe
infections in critically ill ICU patients.
OBJECTIVES. The aim of our observation retrospective study was
to test the hypothesis that a statistical significant correlation
exists among nursing, severity and outcome indexes and
percentage of Pseudomonas Aeruginosa positive cultures in
severely ill patients in our both medical and surgical ICU served
in community hospital.
METHODS. From January 2006 to December 2017, 1107 patients
admitted to our ICU. Mean age 66 years, mean length of stay
(LOS) 12.2 days, mean APACHE II score on admission 21.5,
predicted mortality 39.5 %, actual mortality 29.3 %, Standardized
mortality ratio (SMR) 0.74. From our database we looked for
percent of total of Pseudomonas Aeruginosa positive cultures and
nursing (number of patients, number of patients ventilated,
length of stay, hospitalization days, ventilation days per patient
ventilated, percentage of ventilated patients, plentitude,
mechanical ventilation days), severity (age, APACHE II score,
predicted mortality) and outcome (actual mortality, Standardized
mortality ratio) indexes per year from 2006 to 2017 (mean
values). Using linear correlation method, we looked for linear
slope, correlation coefficient (r), and coefficient of determination
(r2), and by linear regression method using ANOVA test we
looked for p value, according Pseudomonas Aeruginosa % and
ICU indexes.
RESULTS.CONCLUSION. According to our data, there was no statistical
significant correlation detected among all severity, all outcome and
all of the nursing indexes and the percentage of Pseudomonas
Aeruginosa positive cultures. Our data suggest that in our study, the
impact of the incidence of Pseudomonas Aeruginosa infection was
not statistical significant or not strong enough to influence the
length of stay or the outcome.
Table 1 (abstract 000136). See text for descriptionSlope r r2 St. error P valueNoof patients 3.3180 0.4544 0.2065 2.0570 0.1378Hosp days 28.2890 0.4230 0.1790 19.1610 0.1706LOS -0.1122 -0.2409 0.0585 0.1423 0.4488Age 0.1823 0.2349 0.0551 0.2386 0.4624% ventilated 0.1009 0.1361 0.0185 0.2323 0.6733Plentitude 0.0539 0.0393 0.0015 0.4336 0.9035Pts ventilated 3.1260 0.4627 0.2141 1.8940 0.1299Days M V 20.5140 0.3569 0.1274 16.9760 0.2547VD per pt -0.0607 -0.1414 0.0199 0.1345 0.6612APACHE 0.0569 0.1066 0.0113 0.1681 0.7415Pred Mort. -0.0054 -0.0034 1.2200 0.4968 0.9914Actual mort 0.4760 0.2792 0.0779 0.5176 0.3794SMR 0.0133 0.4244 0.1801 0.0090 0.1691000843
ICU mortality in relation with age, co morbidities and Apache II
Score, what’s the correlation for the outcome?
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INTRODUCTION. Advanced age is associated with higher mortality
and adverse outcomes in ICUs
OBJECTIVES. The aim of this study was to evaluate the possible
effect of age correlated to apache II score, co morbidities and reason
for admission for the final outcome.
METHODS. Our study included 280 patients aged 18 and older that
were admitted in the ICU from January 2016 till March 2019.
Demographic parameters, apache score II, admission diagnosis, underling
diseases, ICU length of stay and finally outcome were recorded.
RESULTS. We enrolled 280 patients, 156 males and 124 females with
mean age 55±37 years. The main reasons for ICU admission were:
post operative (after elective operation), trauma, acute respiratory
failure and sepsis. Out of 280 patients the 171 had co morbid
medical illness (e.g. ischemic heart disease, arterial hypertension,
diabetes mellitus, COPD, chronic renal failure). The mean length of
stay was 22 days but it ranged from 1 to 72 days. 196 patients were
discharged from the ICU and 84 patients died. Apache II score
ranged from 6 to 39, higher values were correlated with longer
hospitalization and worse outcome. Post operative patients
independently from the age and co morbidities had the best
outcome. There were not differences in the outcome as far as the
gender was concerned.
T2
Page 627 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55CONCLUSION. Reasons for mortality appears to be multifactorial.
High age alone is not a factor to predict morbidity. Previous health
state, co morbidities, high apache II score and the reason of
admission in the ICU play a very important role for the final
outcome.
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INTRODUCTION. In the past, quality and improvement in healthcare
have focused on what proffesionals think should be valued and have
been less interested in what serve userd felt was important. In the
Intensive Care Unit, the patient's perspective, as well as their
relatives’, is central to quality improvement.
OBJECTIVES. To evaluate the level of technical and structural human
quality of an Intensive Care Unit (ICU) from the perspective of
patients and their relatives.
METHODS. Information was collected from June to September 2018
through a survey adapted to patients and family members. The
questionnaire included a 7-score Likert scale conformed by different
items aimed at assessing the quality of the service provided to pa-
tients in the ICU.
Based on the work of Mora Lourido (2015), we took the dimensions
created to measure the technical and structural human quality in the
ICU, and we conducted an analysis of means using the student’s T,
to check the differences in the perceived quality by patients and
relatives.
RESULTS. The measurement scale was consisted of 7 dimensions,
whose average values are shown in the attached table.
CONCLUSION. We may conclude that the relatives’ group is more
critical when evaluating the technical and structural human quality
of the ICU. Statistically significant differences were found in the
valuation of all the dimensions, excepto for “food” and “facilities,
available resources and environmental atmosphere”, being able to
explain why there are dimensions where aspects in which the
human factor does not intervene are valued. On the other hand,
“waiting room” was punctuated only by relatives, since this ítem was
not included in the patient's questionnaire.The human dimension
and professionalism in patient care were the aspects that were best
valued by both patients and relatives. On the other hand, the
dimension referring to visits has been the worst evaluated by both
groups, so an improvement should be considered in the future.REFERENCE
1. Mora Lourido CJ. Análisis del impacto de la dirección de recursos
humanos orientada a la gestión de la calidad y la excelencia
organizativa: una aplicación en los servicios de Medicina Intensiva del
Complejo Hospitalario Universitario Insular-Materno Infantil. Tesis doctoral
Universidad de Las Palmas de Gran Canaria (2015).
Table 1 (abstract 000864). Descriptive analysis of the factors of the ICU
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INTRODUCTION. Potassium is one of the body's major ions, 98% of the
body's potassium is intracellular. It is important for generating action
potentials. Disturbance in potassium homeostasis common in critically ill
patients s it can induces lethal arrhythmias and result in cardiac
dysfunction
OBJECTIVES. We determined the incidence of potassium
abnormalities in critically ill patients.
METHODS. The stduy was conduct at a University Teaching Hospital
between June 2018 and December 2018. changes in potassium
concentration in adult critically ill patients was studied. The serum
potassium was measured on admission and dialy for seven days.
Normal range: for potaasium described as 3.5 -5.0, Mild Hypokalemia
as 3.0-3.4 and severe: as potassium <3.0. Mild Hyperkalemia defined
as potassium > 5.0 -6.0 and severe potassium >6.0
RESULTS. A total of 120 patients were studied. The median age 36 years,
the meadian duration of ICU admission was 5 days. Hypokalemia was
observed n 61.6%, In patients with hypokalemia; mild hypokalemia
observed in 37.3% and severe hypokalemia was observed in 24.3%.
Hyperkalemia in 17.6% of patients. Mild hyperkalemia in 12.7% and
severe hyperkalemia in 4.9% of patients. The median duration of onset of
hypokalemia and hyperkalemia was 2 days. While the median duration
of hypokalemia and hyperkalemia were 2 and 2.5 days respectively.
CONCLUSION. Potassium derangement is not uncommon in critically
ill patients at our institution.
REFERENCE
1. Lara Hessels ,Miriam Hoekstra, Lisa J Mijzen Mathijs Vogelzang , Wim Dieperink
et al :The relationship between serum potassium, potassium variability and in-
hospital mortality in critically ill patients and a before-after analysis on the im-
pact of computer-assisted potassium control Critical Care (2015) 19:4
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INTRODUCTION. Emergency departments receive an increasing
number of elderly patients in often critical condition. The APACHE II
score usually calculated at intensive care unit admission could be
useful to determine the prognosis in elderly patients admitted to
emergency department.
OBJECTIVES. The aim of this study is to evaluate the ability of
APACHE II score to predict prognosis in elderly patients hospitalized
at emergency department (ED).
METHODS. This is a retrospective study conducted in all old patients
(≥65years) admitted to ED between September 2018 and March
2019. Data of all patients were collected and the APACHE II score
was calculated at admission. The main study endpoints were the use
of mechanical ventilation or vasoactive drugs and inpatient mortality.
RESULTS. •A total of 257 elderly patients were included.The mean
age was 75±7 years.
• 134 (52%) were females and 123 (48%) were males. Patients had an
history of hypertension (56%), diabete (56%) and coronary disease
(29,6%).
• Diagnosis of hospitalization were: diabetic ketoacidosis (29%), acute
coronary syndrom (16%), acute heart failure (9%),
meningoencephalitis (9%), sepsis (8%), hypoxemic pneumonia (8%),
acute exacerbation of chronic obstructive pulmonary disease (6%),
hemorrhagic syndrome (6%), stroke (4%).
•ventilation was performed in 24% of patients and vasoactive drugs
were used in 13%.
•35% were discharged, 45% were transferred to other services
including 5% to intensive care unit.
•The mean duration of stay was 35,7±7hours.
• In hospital mortality rate was 20% and mean score of APACHE II
was 18±23.
•The APACHE II score was significantly correlated with using
mechanical ventilation (p=0,000) and vasoactive drugs (p=0,04) but
not with inhospital mortality (p=0,99).
CONCLUSION. The APACHE II score wasn’t useful for predicting
inhospital mortality in elderly patients admitted to ED but it was
significantly correlated to the use of mechanical ventilation or
vasoactive drugs.
Further studies seem necessary to confirm these results.
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INTRODUCTION. Pregnancy involves many physiologic adaptations
and sometimes physiopathological changes also ensue.
Per year, around 200-700/100.000 pregnant women are admitted
into an Intensive Care Unit (ICU). The admission reasons are diverse,
involving obstetric and also non obstetric causes. Thereafter, this
population is frequently a challenge when in the ICU.OBJECTIVES. This study’s aim is to describe the demographic, clinical
data and outcomes of patients admitted in the ICU of Cascais’
Hospital for obstetric reasons.
METHODS. We conducted a retrospective descriptive analysis of
patients admitted to the ICU with the following inclusion criteria:
pregnant or puerpera women admitted for obstetric reasons, either
in the antepartum, postpartum period or late puerperium. The
statistical analysis of epidemiological and clinical data was performed
with the software SPSS®. The study period comprised between June
1st 2017 to 31th December 2018.
RESULTS. During the study period, 31 patients were admitted to the
ICU for obstetric reasons: 14.8% in the antenatal period, 11.1% on
the vaginal pospartum period and 70.4% post-cesarean section. The
medium age of this sample was 33 years (SD=6), the median of the
gestational age at admission was 34 weeks (IQR 10) and 81,5% had a
surveilled pregnancy. The main reason of admission was pre-
eclampsia (18.5%), followed by hemorrhage and HELLP syndrome,
both accounting 14.8% of admissions. In our sample, the mortality
rate was 0%, nevertheless 29.6% required ventilatory support, 14.8%
vasopressor/inotropes and 7.4% renal replacement therapy. The me-
dian duration of stay in the ICU was 3 days (IQR 3).
CONCLUSION. Despite the low incidence of admissions in ICU among
pregnant women, the higher maternal age and increasing cesarean
deliveries, are contributing to the increasing physiopathological
changes and potentially fatal disorders, such as hypertensive disorders
of pregnancy (pre-eclampsia, eclampsia and HELLP syndrome) and
post-partum hemorrhage.
The authors highlight the importance of the prompt diagnosis and
multidisciplinary approach (involving obstetricians, neonatology and
ICU) of this obstetric disorders, aiming for the best maternal and
neonatal outcome.
REFERENCE(S)
1. Guntupalli et al. Critical Illness in Pregnancy Part I: An Approach to a
Pregnant Patient in the ICU and Common Obstetric Disorders. CHEST
2015; 148 (4): 1093 - 1104
2. Crozier, T. General Care of the Pregnant Patient in the Intensive Care
Unit. Semin Respir Crit Care Med 2017;38:208–217
000011
Multiple boluses of intravenous tranexamic acid to reduce hidden
blood loss and the inflammatory response following major surgery
after severe traumatic injury: a randomised clinical trial
D. Dmytriiev
Grushevskogo 21/15, Vinnytsia, Ukraine
Intensive Care Medicine Experimental 2019, 7(Suppl 3):000011
INTRODUCTION. The aim of this study was to examine the efficacy
and safety of multiple boluses of intravenous (IV) tranexamic acid
(TXA) on the hidden blood loss (HBL) and inflammatory response
following major surgery after severe traumatic injury (STI).
METHODS. A total of 102 patients were allocated randomly to
receive a single bolus of 20 mg/kg IV TXA before the incision (group
A), a single bolus followed by a second bolus of 1 g IV-TXA three
hours later (group B) or a single bolus followed by two boluses of 1
g IV-TXA three and six hours later (group C). All patients were treated
using a standard perioperative enhanced recovery protocol. Primary
outcomes were HBL and the level of haemoglobin (Hb) as well as the
levels of C-reactive protein (CRP) and interleukin-6 (IL-6) as markers
of inflammation. Secondary outcomes included the length of stay in
hospital and the incidence of venous thromboembolism (VTE).
RESULTS. The mean HBL was significantly lower in group C (244.14
ml standard deviation (sd) 125.97) than group A (464.23 ml sd
198.23, p < 0.001) or B (334.12 ml sd 193.26, p = 0.012). The
decrease in the level of Hb between the pre-operative baseline and
the level on the third post-operative day was 29.32 g/L (sd 5.84 g/L)
in group A, 30.16 g/L (sd 6.44) in group B and 29.94 g/L (sd 4.32) in
group C. This decrease differed significantly among the three groups
Page 629 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55(p < 0.01). The mean level of CRP was significantly lower in group C
than in the other two groups on the second (p ≤ 0.030) and third
post-operative days (p ≤ 0.010). The levels of IL-6 were significantly
lower in group C than group A on the first three post-operative days
(p = 0.020). The mean length of stay was significantly lower in group
C than group A (p = 0.024). No VTE or other adverse events
occurred.
CONCLUSION. Anterior rectus sheath blocks using local anesthetics
and steroids are safe and long-term successful in more than one-
third of children suffering from abdominal pain due to anterior cuta-
neous nerve entrapment syndrome after laparoscopic oncology
surgery.
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INTRODUCTION. Being hospitalized in the Intensive Care Unit (ICU) can
lead to unpleasant experiences that involve pain and discomfort for most
patients. Sedation and analgesia have become common treatments for
alleviation of these symptoms, especially for those receiving mechanical
ventilation. As a result, patient – caregivers communication is impaired,
leading to caregivers’ decreased ability to distinguish between pain and
other sources for discomfort. Since patient behaviour might look the
same whether the patient is in pain agitated or just uncomfortable.
Caregivers may fail to recognize sources for discomfort as opposed to
pain. This in turn lead to inappropriate treatment when the patient is
uncomfortable but not in pain
OBJECTIVES. The present study is aimed at exploring and understanding
caregivers and patients’ perception of discomfort in the ICU.
METHODS. This is a descriptive qualitative study using content
analysis. Caregivers (n=25, nurses and physicians) and patients (n=
12), treated in the ICU for more than 48h and receiving mechanical
ventilation, were interviewed after ICU discharged using a semi-
structed interview.
RESULTS. Two main categories (physical and emotional discomfort)
and other sub-themes categories emerged from this analysis. Differ-
ences and similarities were found in the perception of discomfort in
the ICU discomfort as described by patients and caregivers. Care-
givers described both objective and subjective ways to differentiate
between discomfort pain and agitation.
CONCLUSION. Patients experienced discomfort in the ICU. In order
to improve quality of care it is important, that caregivers be aware of
other sources of discomfort other than pain, while caring for the ICU
patients. Strategies to identify discomfort where described.
INF - Insights in specific infectious
situations
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INTRODUCTION. Patients in Intensive Care Units (ICU) are at higher
predisposition to acquire nosocomial infection with high mortalityrates. Vast majority of bacteremias in ICU is caused by Gram-negative
rods. The rate and resistance of nosocomial infections is increasing in
hospitals all over the world.
OBJECTIVES. The aim of study was to analyze sensitivity of multi-
drug-resistant (MDR) Acinetobacter spp. strains of nosocomial mono-
bacteremia and associating factors for primary bacteremia and mor-
tality in ICU.
METHODS. Ongoing work: the retrospective data analysis of patients
treated in Kaunas Clinic’s ICU with positive blood culture of
nosocomial MDR Acinetobacter spp. strain during past 10yrs period
was carried out. Bacteremia was defined as nosocomial, if positive
blood culture was taken after 72hrs of hospitalisation. Strain was
defined as MDR, if resistant to ≥ 3 classes of antibiotics.
RESULTS. There were recorded 79 cases of nosocomial MDR
Acinetobacter spp. strain monobacteremia with sensitivity to
antimicrobial drugs: imipenem and colistin (n=79, 100%, P=0.001),
meropenem (n=71, 89.9%, P=0.03), amikacin (n=36, 45.6%),
ciprofloxacin (n=18, 22.8%), piperacillin/tazobactam (n=14, 17.7%),
gentamicin (n=13, 16.5%), piperacillin (n=12, 15.2%), cefuroxim (n=
10, 12.7%), ampicillin and ampicillin/sulbactam (n=2, 2.5%). For
patients with primary origin of nosocomial MDR Acinetobacter spp.
monobacteremia (n=58, 73.4%, P=0.02, OR=2.06, CI95%=2.67-14.98)
invasive procedures (n=62, 78.5%, P=0.01, OR=2.75, CI95%=1.67-
15.87) and abdominal surgery were performed (n=56, 70.9%, P=0.02,
OR=3.66 CI95%=4.76-11.65), previous hospitalization recorded (n=48,
60.8%, P=0.04, OR=1.48 CI95%=3.56-7.86), treatment with wide-
spectrum antibiotics during previous 30 days was used (n=45, 57.0%,
P=0.04, OR=1.77, CI95%=4.67-8.67). Lethal outcome (n=68, 86.1%)
was found in patients with mechanical ventilation (n=68, 100%, P=
0.001, OR=1.73, CI95%=2.56-7.89), septic shock (n=62, 91.2%, P=
0.001, OR=1.15 CI95%=3.78-9.64), primary bacteremia (n=58, 85.3%,
P=0.03, OR=2.08, CI95%=2.56-7.56), inadequate empiric antimicrobial
treatment (n=58, 85.3%, P=0.03, OR=2.08, CI95%=2.56-7.56), SOFA
score ³13 (n=55, 80.9%, P=0.02, OR=2.06 CI95%=4.78-11.67), ³3 co-
morbidities (n=41, 60.3%, P=0.04, OR=1.39 CI95%=3.65-9.65), elderly
(n=35, 51.5%, P=0.04, RR=16.5).
CONCLUSION. Acinetobacter spp. MDR strains of nosocomial
bacteremia were found to be sensitive to imipenem and colistin.
Primary bacteremia was associated with invasive procedures,
abdominal surgery, previous treatment in hospital and use of wide
spectrum antibiotics during 30 days before bacteremia. Nosocomial
MDR Acinetobacter spp. monobacteremia was characterized by high
mortality rate of 86% and associated with mechanical ventilation,
septic shock, primary bacteremia, inadequate antibacterial treatment,
high SOFA score, comorbidities and elderly.REFERENCE(S)
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bloodstream infections versus non-bloodstream infections of Acinetobac-
ter spp. Clinical Infectious Diseases, 2018;67:189-95.
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INTRODUCTION. Carbapenem resistant bacteria (CRB) infection is
currently one of the most common causes of high mortality in ICU
with very few antibiotic options.
No studies have been published about epidemiology, antibiotic
susceptibility patterns and treatment outcome related to these
infections in portuguese ICU’s.
Page 630 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55OBJECTIVES. Analyze epidemiology and treatment outcomes of CRB
infections in a portuguese general ICU
METHODS. Retrospective study on patients who were admitted or
developed CRB infections in a general ICU in a two year period
RESULTS. Forty four infections were identified : thirty nine due to
Klebsiella pneumoniae and five due to Pseudomonas aeruginosa.
Eleven pneumonias, thirty bloodstream infections, one urinary
tract , one abdominal and one soft tissue infection. Main
admission diagnosis was sepsis and thirteen patients had
hematologic malignancies. Mean days of hospitalization for
infection development was 22,2 days.
Half of patients presented with septic shock. All patients were
initially treated with dual antibiotic therapy; Colistin and Tigecycline
being the most used combination. Ceftazidime Avibactam was used
in nine patients, three of them due to persistent bacteremia.
Ceftolozane Tazobactam was prescribed in three patients due to
multidrug resistant Pseudomonas aeruginosa. With these newer
antibiotics all patients survived, except one. Mortality for all causes
was high (52,3%), especially in hematologic patients. In a significant
proportion it was not possible to determine outcome since some
were transferred to other hospitals with contact loss or were under
life-support interventions limitation at the time of antibiotic
treatment.
CONCLUSION. In a portuguese general ICU, CRB infections are
related to high mortality especially in groups such as hematologic
patients. Susceptibility rates are high to Colistin so it still seems to be
an adequate treatment combined to another antibiotic. Ceftazidime
Avibactam and Ceftolozane Tazobactam achieve good results
regarding outcome but more studies are needed to determine which
patients might benefit from their prescription.
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INTRODUCTION. Community-acquired pneumonia is a pathology
with an important impact on public health. The term community-
severe pneumonia identifies the group of patients with pneumonia
who require admission to the intensive care units.
OBJECTIVES. Our goal is to study the pneumonia acquired in our
community. The incidence of each microorganism, bacteria or virus.
The need of mechanical ventilation of the pathology itself and by
etiological group.
METHODS. A retrospective, observational study was performed with all
the patients who required admission to the Intensive Care Service in a
Tertiary and University Hospital with the diagnosis of Community
acquired pneumonia (CAP) from March 2015 to February 2019.RESULTS. A total of 141 patients were collected. The characteristics
of the patients were: Age 59.6 ± 13.9, SOFA 7.36 ± 3.9, APACHE II
18.5 ± 8.7, SAPS II 40.4 ± 17.5, Sex (Male) 60 , 6%, Diabetes Mellitus
26.8%, Arterial hypertension 39.4, Cardiovascular pathology 22.5%,
Chronic lung disease 43.7%, Cirrhosis 4.2%, Need for vasoactive
drugs 69.7%, Need for mechanical ventilation 55.6%, Our sample
shows a mortality rate of 5.6%.
Viral microorganisms were isolated in 46 patients, whereas in 62
cases, the isolation was bacterial. The two microorganisms most
frequently isolated were Streptococcus pneumoniae (41) and
Influenza virus (32), followed by Staphilococcus Aureus (8). In the
comparative analysis of CAP due to influenza virus and streptococcus
pneumoniae and eliminating co-infections, we found that viral pneu-
monia presents a higher need of mechanical ventilation (82% vs
58%;P = 0.05). Bacterial pneumonia presents higher renal failure
(61.2% vs 30%; P = 0.024). No statistically significant differences were
found in terms of mortality (0% vs 6.4%; P = 0.325) or previous per-
sonal history.
CONCLUSION. CAP is a very common pathology in the ICU. Although
the most frequent cause is bacterial, community viral pneumonia
plays an important role, being the Influenza virus the second most
frequently isolated microorganism. In our sample, viral pneumonia
was associated in a statistically significant way with the need of
mechanical ventilation.
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INTRODUCTION. Ventilator associated pneumonia (VAP) is a
significant cause of morbidity and mortality in critically unwell
patients within the intensive care unit (ICU). Implementation of
protective measures for VAP and early diagnosis can reduce
mortality and reduce the development of multidrug resistant
organisms.
OBJECTIVES. The aim of this study was to evaluate the VAP rate,
ventilator use rate and causative microorganisms isolated in VAP
cases in a five year study period.
METHODS. This study was conducted in the 25-bed anesthesiology
and reanimation intensive care unit (AR-ICU) between 2014 and
2018. VAP rate per 1000 mechanical ventilator-days, device utilization
ratio for mechanical ventilator and pathogens isolated in patients
with VAP were evaluated retrospectively (VAP Rate = VAP Number /
Ventilator Day x 1000). Hospital acquired infection definitions are
made according to the US Centers for Disease Control and Preven-
tion (CDC) criteria.
RESULTS. Results: During the study period totally 2944 patients were
followed in the AR-ICU for 37402 bed days. In 2014, the VAP rate was
14.5 per 1000 mechanical ventilator days and the ventilator use rate
was 55%, whereas the VAP rate was 5.7 per 1000 mechanical ventila-
tor days and the ventilator use was 55% in 2018. Between 2015-
2017, the VAP rate and the ventilator use rate were 13.6, 8.8, 9.5 and
58%, 62%, 52%, respectively. The number of VAP was 44, 44, 47, 43
and 27 in years of 2014-2018, respectively. Generally during the five-
year study period, the mostly isolated pathogens of VAP were Acine-
tobacter baumannii (42.6 %) and Pseudomonas aeruginosa (25.5 %).
The rate of Acinetobacter baumannii in VAP patients was decreased
form 55.7% in 2014 to 27.3% in 2018.
Page 631 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55CONCLUSION. In the AR-ICU, the VIP rate decreased gradually in
the last 5 years, while the ventilator usage rate was generally
similar. We think that infection control measures as well as early
diagnosis and appropriate treatment of VAP can be effective in
reducing the VAP rate.
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INTRODUCTION. Infections caused by Klebsiela pneumoniae
carbapenemase-producing (KPC-p)has become a worldwide emer-
gent health problem considering the difficulty involved in the treat-
ment of these multi resistant organisms and the highmortality rates.
Despite the severity from this disease, treatments are divergent in
medical literature.
OBJECTIVES. This study aims to analyze the characteristics of
patients infected by KPC-p in a single center, in a cohort retrospect-
ive analyzing mortality, treatment options and site infections during
a period from January 1st 2014 until December 31th2016.
METHODS. This study was conducted in a surgical intensive care
unit from a tertiaryhospital in Brazil. KPC-p was observed in 41
patients, with a total of 42 positivecultures for KPC-p. The site in-
fections were distributed between bloodstream(40,47%), respira-
tory tract (23,80%), abdominal (19,04%), urinary tract (9,52%)and
soft tissues (7,14%). Average of SAPS 3 score at the day of admis-
sion at ICU was 63,23 (estimated mortality of 41,2%) and average
of SOFA score atthe day of the culture was 9,30 (estimated mor-
tality of 35%).The average of patients age was 59,5 years old,
and sex distribution was 65,85% male, 34,35% female. All the pa-
tients received vasoactive drugs during the stay in the ICU and
56,07% of them required hemodialysis. A total of 12,19% of pa-
tients did notreceive any specific treatment against KPC-p infec-
tion, 12,19% receivedmonotherapy treatment, 36,58% double
therapy and 39,02% three or moredrugs directed to the KPC-p
treatment. The drugs considered as specific treatment to KPC-c
were carbapenems and tigecycline combined with another drug;
polymyxins and aminoglycosides combined or in monotherapy.
RESULTS. General mortality was 80,48% in our sample and the
mortality when compared initial antibiotherapy containing a specific
treatment to KPC-p or not was,respectively, 84,6% and 80,6%.The
mortality when analyzed the stablished treatment after results from
cultures was 100%, 82,3% and 76,4% respectively in mono, double
and triple therapy. Comparing infection sites as mortality predictor,
this outcome was observed in 89,4%, 85%, 81%, 75% and 33%re-
spectively in bloodstream, abdominal, respiratory, urinary and soft
tissues infections.
CONCLUSION. This study has several limitations. The higher
mortality ratio in all groups canoverestimate the importance from
some variables and our sample wasinsufficient to stablish
differences statistically significance. Despite this,differences of
mortality in monotherapy vs. double therapy vs. triple
therapy,can indicate a better option to treat patients infected by
KPC-p. Differences ratios between site of infections and mortality
can be useful as a predictormortality in future models. Studies
with increase in number of patients are necessary to stablish bet-
ter recommendations in treatment.REFERENCE(S)
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et al.Treatment outcome of bacteremia due to KPC-producing Klebsiella
pneumoniae: superiority of combination antimicrobial regimens. Antimi-
crob Agents Chemother 2012;56(4):2108–13.
2. Maltezou HC, Kontopidou F, Dedoukou X, Katerelos P, Gourgoulis G-M,
Tsonou P, et al. Action plan to combat infections due to carbapenem-
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INTRODUCTION. The treatment of infective endocarditis (IE) has
been widely discussed in order to decide which patients are going to
benefit from a surgical approach.
Surgical indication should be established with caution due to its
technical difficulties and potential postoperative complications.
OBJECTIVES. Describe the clinical and evolutionary characteristics of
patients with infective endocarditis both in native or prosthetic
valves undergoing cardiac surgery.
METHODS. Retrospective study in patients operated of IE between 2010
and 2018, at Fundación Jiménez Díaz and Rey Juan Carlos Hospitals.
Demographic variables (sex, age), affected valve (native, prosthetic),
microorganism (blood cultures, valve or explanted prosthesis), type
of intervention, postoperative complications, lenght of ICU and
hospitalization stay were collected.
In January 2019, the status and functional status (NYHA) of the survivors
was assessed by telephone call or review of the medical record.
RESULTS. 91 patients were operated (67% males) with a mean age
of 65.1 years. 58 (63.7%) had native valve endocarditis. The average
EuroSCORE II was 18.3. There was mitral involvement in 38 patients
(41.8%), aortic in 33 (36.2%) and both in 18 (19.8%). In the mitral
group 23 were native and 15 prosthetic; 25 bioprostheses and 12
mechanics were implanted. In the aortic group 24 were native and 9
prosthetic; 30 bioprostheses and 3 mechanics were implanted. In the
mitral-aortic group 66.6% were pure native and the rest had at least
one previous prosthesis.
The microorganisms isolated in blood cultures (BC) were: 39.5%
Staphylococcus, 25.2% Streptococcus, 16.4% Enterococcus and 2%
fungi. In 7.6% BC were negative.
The postoperative complications were: renal failure (16.4%), atrial
fibrillation (9.8%), bleeding (5.4%), pneumonia (5.4%), polyneuropathy
(5.4%) and stroke (4, 3%). The mechanical ventilation time (MV) was lower
than 72 hours in 71.4% of the patients. 12% required tracheostomy. 9.8%
required a definitive pacemaker (55% within the mitral-aortic group). 4%
of patients were re-admitted to the ICU after being discharged to the
ward. There was a hospital mortality of 13 patients (14.3%).
At the time of follow-up, 13 patients had died, 3 were hospitalized
and the rest (62, 68.1%) were functional grade I (45.1%), II (56.4%)
and III (3.2%), of NYHA respectively.
CONCLUSION. The surgery of the IE has a very good vital and
functional prognosis, with a low mortality, although it is not free of
post-operative complications. There are no major differences in rela-
tion to the native valve affected. The bioprostheses are the most
Page 632 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55used. Patients with bivalvular infection have a higher incidence of
permanent pacemaker due to affectation of the auriculo-ventricular
conduction zone.
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INTRODUCTION. Acute acalculus cholecystitis (AAC) is a serious
complication of critical illness.
However, up until now there are no specific criteria to diagnose AAC
in intensive care units (ICU).
OBJECTIVES. The aim of this study was to evaluate the underlying
diseases, clinical and diagnostic features, and outcome of operatively
treated AAC among ICU population.
METHODS. We conducted a retrospective study, over a five-year
period, between September 1st, 2013 and august 31st, 2018, includ-
ing the patients admitted to our ICU, who undergone surgery for sus-
pected AAC during their ICU stay.
AAC group was defined as the group of patients with confirmed AAC
based on operative findings and anatomopathological examination.
RESULTS. Fourty-eight patients underwent open cholecystectomy for
AAC during the study’s period. Traumatic injury was the most com-
mon admission diagnosis (66.7%), followed by acute respiratory fail-
ure (12.5%), hemorrhagic stroke (8.3%) and cardiac surgery (4.2%).
The mean Sequential Organ Failure Assessment (SOFA) score was 5.8.
On admission, 12 (50%) patients presented with shock and 4 (16.7%)
with acute respiratory distress syndrome (ARDS).
According to operative findings and anatomopathological exam,
thirty patients had confirmed AAC (65%). The mean length of ICU
stay before AAC was suspected was 16.7 days, and the mean delay
of surgical treatment was 2.6 days.
Ultrasonographic (US) abnormalities included gallbladder distension
(66.7%), thickened gallbladder wall (66.7%), ultrasonographic
Murphy’s sign (12.5%) and pericholecystic fluid (50%).
On the day of cholecystectomy, average SOFA score was 5, twenty
patients presented with positive blood cultures including klebsiella
pneumonia in ten cases, pseudomonas in four cases, stenotrophomonas
maltophilia in two cases and candidemia in four cases.
According to our analysis risk factors associated to AAC were trauma,
cardiac surgery, diabetes and blood transfusions. On the day of
diagnosis, hyperglycemia, increased gastric residual volume and
jaundice were predictive of AAC. Moreover the delay to AAC was
also predictive of the diagnosis with a best cut-off at 12.5 days (AUC
ROC =0.77, Se=86% ,Sp=73%).
The mean total length of ICU stay was 31.9 days, and overall
mortality was 17%. Subjects with confirmed AAC had higher
mortality rates (21%). Our study showed that compared to the
survivors, nonsurvivors had higher SOFA scoring on the day of
cholecystectomy (p= 0.001, OR= 1.5, CI= 1.2-2). Intraoperativebleeding was also predictive of mortality (p= 0.001, OR= 4, CI= 2.5-
7.8).
CONCLUSION. Acute acalculous cholecystitis is associated with
multiple organ failure, long ICU stay and death. The diagnosis of AAC
remains challenging and should be suspected especially in critically
ill patient with traumatic injuries or cardiac surgery and jaundice.
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INTRODUCTION. Patients admitted to ICU are prone to various
nosocomial infections (NI) due to various reasons. Gram negative
bacteria (GNB) are often the most important causative organisms for
the same. Of these, multi-drug resistant (MDR) GNB lead to difficulty
in treatment, increase length of ICU stay, cost of treatment and in-
crease morbidity and mortality.
OBJECTIVES. a) To investigate the trends of NI in our ICU over the
period from 2011 to 2018. b) To study the trends in NI caused by
MDR-GNB in that period.
METHODS. A retrospective observational study design. Charts
were reviewed of all patients admitted in ICU in the 12 months
of 2011 and 2018. Patients developing NI (defined as new onset
infection developing after 48 hours of ICU admission) were
included in the study. Data was collected regarding socio-
demographic factors, cause of ICU admission, type of infection
(organ system involved, type of bacteria, sensitivity pattern on
culture, etc.), outcomes [ICU length of stay (LOS), mortality].Vari-
ables were characterised by number and percentage and were
compared by applying Pearson’s Chi-square with Fisher’s exact
test. Trends over time were determined by the Cochran–Armitage
trend test and linear regression.
RESULTS. The results are shown in Table no 1.Of the organisms
causing NI, 20% were found to be MDR in 2011 as compared to 40%
in 2018 (p<0.05). The average ICU LOS was 16.5 and 17.4 days (p=
NS) in 2011 and 2018 respectively, and mortality was 25.3 and 28.4%
(p=0.06) in 2011 and 2018 respectively.
CONCLUSION. There was a significant increase in occurrence of NI.
Though there was a reduction in Respiratory tract infections over the
period of the study, there was an increase in Urinary tract infections
as well as Skin & soft tissue infections. The number of MDR
organisms isolated also saw a significant increase. There was an
increase in ICU LOS and mortality though not statistically significant.
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INTRODUCTION. Carbapenem-resistant Enterobacteriaceae (CRE) in-
fections are associated with poor patient outcomes. Data on risk fac-
tors and molecular epidemiology of CRE in complicated intra-
abdominal infections (cIAI) are limited.
METHODS. In this retrospective analysis, we identified cIAI patients
hospitalized during a period from 1 January 2013 to 31 October
2018 in 14 hospitals in China. 30 CRE isolates were genotyped.
RESULTS. Escherichia coli (34.5%)and Klebsiella pneumoniae (21.2%) were
the leading pathogens. Patients with hospital-acquired (HA)-cIAIhad
lower rate of E. coli(26.0% vs. 49.1%; p<0.001) and highercarbapenem-
resistant Gram-negative bacteria (31.7% vs. 18.8%; p=0.002)than patients
with community-acquired (CA)-cIAI. 16.0% of the Enterobacteriaceaeiso-
lates and 23.4% of the K. pneumoniae isolates were resistant to carbape-
nem.The 28-day mortality was 12.2% and 9.0% in patients with CRE-cIAI
versus non-CRE-cIAI( p <0.001). In-hospital mortality was 4.7-fold higher
for carbapenemase-producing(CP)-CRE versus non-CP-CRE infection (p=
0.049), which was regardless of carbapenem-containing combina-
tions.The risk factors for 28-day mortality in patients with CRE-
cIAIincluded sepsis or septic shock,antibiotic exposure during the preced-
ing 30 days,and comorbidities.
CONCLUSION.Klebsiella pneumoniaeis the highest prevalence in CRE-
cIAI. Infection with CRE, and CP-CRE in particular, is associated with
increased mortality in cIAI.Hot Topics Session
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INTRODUCTION. Moderate therapeutic hypothermia (MTH) is
currently recommended to improve neurological outcomes in
adults with persistent coma after resuscitated out-of-hospital car-
diac arrest (OHCA). However, the effectiveness of MTH in patients
with non-shockable rhythms (asystole or pulseless electrical activ-
ity) is debated. We tested the effectiveness of MTH at 33°C in
patients with non-shockable in- or out-of-hospital cardiac arrest
(CA).
METHODS. HYPERION was a randomized controlled trial comparing
MTH (33°C) to targeted normothermia (37°C) in comatose patients
admitted to 25 intensive care units after non-shockable CA. Outcome
assessment was blinded. The primary outcome was neurological re-
covery assessed on post-randomization day 90 using the Cerebral
Performance Categories (CPC) scale, with CPC 1 and 2 defining a
good outcome.
RESULTS. Between February 2014 and November 2017, 584
patients were randomized and 581 were included in a modified
intention-to-treat analysis (3 patients withdrew consent). On day
90, 29 (10.2% [95% confidence interval, 6.7%;13.7%] of the 284
MTH patients were CPC 1 or 2, compared to 17 (5.7%
[3.1;8.4%]) of the 297 normothermia patients (OR, 1.87
[1.01;3.50]; P=0.048). Day-90 mortality did not differ between
groups (MTH: 81.3% [76.8%;85.9%]; normothermia: 83.2%
[78.9;87.4%]; P=0.81). Pre-specified adverse events were not dif-
ferent between the groups.
CONCLUSION. Neurological outcomes after non-shockable CA are
poor. Compared to normothermia, MTH at 33°C improved
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INTRODUCTION. Most patients admitted to intensive care are
discharged to a general ward in the same hospital, but some
patients require transfer to another hospital. Indications for inter-
hospital transfers (IHT) include referral for specialist treatment, lack of
intensive care beds at the referring ICU and repatriation to ICU in
home hospital [1].
OBJECTIVES. To review mortality of ICU-patients undergoing IHT and
analyse whether different indications for transfer render different
mortalities.
METHODS. Retrospective cohort register study using the Swedish
Intensive Care Registry (SIR) during 2016-2018. The SIR collects data
from 98.8% of Swedish ICUs including data on discharge from ICUs to
other hospitals/ICUs. Transfers were divided into three categories: trans-
fer due to medical reasons, lack of ICU beds or repatriation to ICU in
home hospital. We analysed odds ratios (ORs) for dying within 30 days
after discharge from ICU using risk adjusted (SAPS3 score) multi-level
mixed effect logistic regression with ICUs as random effect.
RESULTS. We identified 12,356 patients who were discharged to
another ICU and hospital, i.e. inter-hospital transfers. The unadjusted
mortality 30 days after IHT was 17.2 % compared to 12.4 % if dis-
charged to ward in the same hospital. Mortality after IHT varied with
the cause of discharge (Figure).Main diagnoses for transfer due to
specialist treatment were subarachnoid haemorrhage, head injury
and multi-trauma whilst for lack of ICU beds post cardiac arrest, re-
spiratory failure and pneumonia dominated. Risk adjusted analysis
showed a significantly increased risk of dying after discharge due to
lack of ICU-beds in comparison with other reasons for IHTs
CONCLUSION. The adjusted risk of dying within 30 days after inter-
hospital transfer was greater among critically ill patients when the
transfer was due to lack of beds in the referring ICU. The increased
mortality lingered for at least 6 months underlining the importance
to identify causes and intervene to avoid unnecessary loss of life.
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INTRODUCTION. Influenza virus epidemics can cause complications
resulting in severe illness and are associated with significant
mortality each year worldwide. Up to one third of adults hospitalized
with influenza require admission to an intensive care unit (ICU) and
up to 80% are mechanically ventilated (MV), due to viral pneumonia
Page 635 of 635Intensive Care Medicine Experimental (2019) , 7(Suppl 3) : 55and acute distress respiratory syndrome (ARDS), with a resultant
mortality rate of up to 30%.
OBJECTIVES. To determine if early oseltamivir treatment (within 48
hours of symptom onset) compared to no treatment and late
treatment is associated with decreased ICU-mortality among patients
with severe influenza infection.
METHODS. Prospective, observational study including subjects with
confirmed influenza infection admitted to 184 ICUs in Spain. Patients
with missing data on antiviral therapy or on outcome were excluded.
The primary outcomes were to investigate the impact on ICU-
mortality of antiviral therapy (All treated [AT], early therapy [ET], and
late therapy [LT]) compared to untreated (UT) patients and the effect
of ET vs LT. To evaluate endpoints, Cox proportional hazards regres-
sion models were made. Propensity Score Matching (PSM) Compet-
ing Risks analysis (CRA) were used to control bias.
RESULTS. Between June 2009 and April 2018, 4175 patients were
enrolled. 3537 patients met the inclusion criteria. AT patients (n=
3439) were compared to UT group (n=98). After adjusting forseverity of illness, AT patients had higher survival compared to UT
patients (HR 0·64; p=0·022). Afterwards, 149 patients were excluded
for timing of oseltamivir study, remaining 3388 patients (ET, n=807
and LT, n=2581). Most of patients developed influenza pneumonia
(84·7%). Overall ICU-mortality was higher in LT group (23·1% vs
19·8%; p=0·05). In the multivariable analysis, ET with oseltamivir was
associated with lower ICU-mortality rate (OR 0·7; p=0·004). PSM was
applied performing the new matched cohort (ET, n=790 vs LT, 2522).
ET with oseltamivir was associated with lower ICU-mortality over time
(HR 0·77; p=0·005) compared to LT and this result remained firm after
CRA (sHR 0·80; p<0·05).
CONCLUSION. In patients with confirmed severe influenza infection,
ET with oseltamivir is associated with better survival rates.Publisher’s Note
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